Report ID,Drug Identification Number,Report Type,Brand name,Company Name,Common or Proper name,Ingredients,Strength(s),Packaging size,Route of administration,Shortage status,Dosage form(s),ATC Code,ATC description,Anticipated start date,Actual start date,Estimated end date,Actual end date,Reason,Date Created,Date Updated
75200,437999,Shortage,(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP,BAXTER CORPORATION,Potassium Chloride in 5% Dextrose Injection,DEXTROSE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,5G  150MG  450MG,1000 mL,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2019-02-08,2019-02-08,2019-02-12,2019-02-12,Demand increase for the drug.,2019-02-08,2019-02-13
34506,1924303,Shortage,0.9% SODIUM CHLORIDE INJECTION USP,B. BRAUN MEDICAL INC,Sodium Chloride,SODIUM CHLORIDE,0.9%,"100mL, 150mL, 250mL, 500mL",INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017-12-22,2017-12-22,,2019-01-01,Disruption of the manufacture of the drug.,2018-01-02,2019-11-06
91156,60208,Shortage,"0.9% SODIUM CHLORIDE INJECTION, USP",BAXTER CORPORATION,"0.9% Sodium Chloride Injection, USP",SODIUM CHLORIDE,900MG,50 mL (JB1301),INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2019-08-08,2019-08-08,2019-08-29,2019-08-29,Shortage of an active ingredient.,2019-08-08,2019-08-30
91720,60208,Shortage,"0.9% SODIUM CHLORIDE INJECTION, USP",BAXTER CORPORATION,"0.9% SODIUM CHLORIDE INJECTION, USP",SODIUM CHLORIDE,900MG,100 mL (JB0043),INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2019-08-16,2019-08-16,2019-11-08,2019-11-08,Shortage of an active ingredient.,2019-08-16,2019-11-09
91723,60208,Shortage,"0.9% SODIUM CHLORIDE INJECTION, USP",BAXTER CORPORATION,"0.9% SODIUM CHLORIDE INJECTION, USP",SODIUM CHLORIDE,900MG,50 mL (JB0042),INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2019-08-16,2019-08-16,2019-11-08,2019-11-08,Shortage of an active ingredient.,2019-08-16,2019-11-09
98688,60208,Shortage,"0.9% SODIUM CHLORIDE INJECTION, USP",BAXTER CORPORATION,"0.9% SODIUM CHLORIDE INJECTION, USP",SODIUM CHLORIDE,900MG,500 mL (JB1323),INTRAVENOUS,Actual shortage,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2019-11-14,2019-11-14,2019-12-31,,Demand increase for the drug.,2019-11-14,2019-11-15
94411,60208,Shortage,"0.9% SODIUM CHLORIDE INJECTION, USP",BAXTER CORPORATION,"0.9% SODIUM CHLORIDE INJECTION, USP",SODIUM CHLORIDE,900MG,50 mL (JB1308M),INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2019-09-19,2019-09-19,2019-10-09,2019-10-09,Shortage of an active ingredient.,2019-09-19,2019-10-10
85239,60208,Shortage,"0.9% SODIUM CHLORIDE INJECTION, USP",BAXTER CORPORATION,"0.9% SODIUM CHLORIDE INJECTION, USP",SODIUM CHLORIDE,900MG,100 mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2019-05-29,2019-05-29,2019-08-08,2019-08-08,Shortage of an active ingredient.,2019-05-29,2019-08-09
98048,1963937,Shortage,0.9% SODIUM CHLORIDE IRRIGATION USP,B. BRAUN MEDICAL INC,SODIUM CHLORIDE,,,"500mL, 1000mL, 2000mL, 4000mL",,Actual shortage,,,,,2017-11-03,,,Requirements related to complying with good manufacturing practices.,2019-11-06,2019-11-06
28240,1963937,Shortage,0.9% SODIUM CHLORIDE IRRIGATION USP,B. BRAUN MEDICAL INC,Sodium Chloride,SODIUM CHLORIDE,0.9%,"500mL, 1000mL, 2000mL, 4000mL",IRRIGATION,Actual shortage,SOLUTION,B05CB,IRRIGATING SOLUTIONS,,2017-11-03,,,Requirements related to complying with good manufacturing practices.,2017-11-06,2019-04-04
90888,786160,Shortage,"0.9% SODIUM CHLORIDE IRRIGATION, USP",BAXTER CORPORATION,"0.9% Sodium Chloride Irrigation, USP",SODIUM CHLORIDE,900MG,500 mL,IRRIGATION,Actual shortage,SOLUTION,B05CB,IRRIGATING SOLUTIONS,2019-08-06,2019-08-06,,,Shortage of an active ingredient.,2019-08-06,2019-08-07
43080,436208,Shortage,2% LIDOCAINE HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE LIFESHIELD,LIDOCAINE HYDROCHLORIDE,20MG,10 x 5mL,INTRAVENOUS,Resolved,SOLUTION,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",2018-04-13,,2018-07-13,2018-07-02,Disruption of the manufacture of the drug.,2018-03-16,2018-07-03
51084,436208,Shortage,2% LIDOCAINE HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE ANSYR,LIDOCAINE HYDROCHLORIDE,20MG,10 x 5mL,INTRAVENOUS,Resolved,SOLUTION,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2018-06-29,,2018-07-31,Disruption of the manufacture of the drug.,2018-06-01,2018-08-01
24792,2141450,Shortage,20% PROSOL,BAXTER CORPORATION,20% PROSOL,PHENYLALANINE  HISTIDINE  TRYPTOPHAN  LEUCINE  ARGININE  THREONINE  ALANINE  DL-METHIONINE  GLYCINE  GLUTAMIC ACID  PROLINE  L-ASPARTIC ACID  TYROSINE  LYSINE  SERINE  VALINE  ISOLEUCINE,1G  1.18G  0.32G  1.08G  1.96G  0.98G  2.76G  0.76G  2.06G  1.02G  1.34G  0.6G  0.05G  1.35G  1.02G  1.44G  1.08G,2000 mL,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2017-11-15,2017-11-15,2017-12-15,2017-11-21,Disruption of the manufacture of the drug.,2017-10-10,2017-11-22
49014,2248489,Shortage,"4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",DENTSPLY CANADA LIMITED,articaine HCl with epinephrine,ARTICAINE HYDROCHLORIDE  EPINEPHRINE,40MG  0.005MG,100 1.8 mL cartridges/box,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-05-10,2018-05-10,2018-07-16,2018-06-15,Disruption of the manufacture of the drug.,2018-05-10,2018-06-19
27274,2248489,Shortage,"4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",DENTSPLY CANADA LIMITED,"Articaine Hydrochloride 40 mg/mL and Epinephrine Injection 1:200,000",ARTICAINE HYDROCHLORIDE  EPINEPHRINE,40MG  0.005MG,100 1.8 mL cartridges/box,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-01,2018-03-01,2018-04-30,2018-03-29,Disruption of the manufacture of the drug.,2017-10-27,2018-03-30
26870,2299135,Shortage,40 (MEQ)MMOL/L POTASSIUM CHLORIDE PLUS 5% DEXTROSE & 0.9% CHLORURE DE SODIUM/SODIUM CHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP 079109254,DEXTROSE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,5.0G  0.3G  0.9G,1000ML,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2017-10-17,,2017-11-30,2017-11-30,Other (Please describe in comments),2017-10-24,2018-12-28
34510,1924281,Shortage,5% DEXTROSE INJECTION USP,B. BRAUN MEDICAL INC,Dextrose,DEXTROSE,50MG,150mL,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2017-12-22,2017-12-22,,2019-01-01,Disruption of the manufacture of the drug.,2018-01-02,2019-11-06
94473,60348,Shortage,"5% DEXTROSE INJECTION, USP",BAXTER CORPORATION,"5% DEXTROSE INJECTION, USP",DEXTROSE,5G,100 mL (JB0089),INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2019-09-20,2019-09-20,2019-10-09,2019-10-09,Shortage of an active ingredient.,2019-09-20,2019-10-10
92505,60348,Shortage,"5% DEXTROSE INJECTION, USP",BAXTER CORPORATION,"5% DEXTROSE INJECTION, USP",DEXTROSE,5G,50 mL (JB0040),INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2019-08-27,2019-08-27,2019-10-09,2019-10-09,Shortage of an active ingredient.,2019-08-27,2019-10-10
97992,60348,Shortage,"5% DEXTROSE INJECTION, USP",BAXTER CORPORATION,"5% Dextrose Injection, USP",DEXTROSE,5G,100mL,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2019-11-05,2019-11-05,2019-11-11,2019-11-11,Demand increase for the drug.,2019-11-05,2019-11-12
30198,37974,Shortage,50% DEXTROSE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,50% DEXTROSE,DEXTROSE,500MG,25x50mL GVL,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,,2018-01-19,,2018-03-02,Disruption of the manufacture of the drug.,2017-11-22,2018-03-05
58741,180041,Shortage,A.C. & C 8MG TAB,VITA HEALTH PRODUCTS INC,Acetylsalicylic Acid 375 mg with 15 mg Caffeine and 8 mg Codeine Phosphate,ACETYLSALICYLIC ACID  CODEINE PHOSPHATE  CAFFEINE,375MG  8MG  15MG,"50, 100, 200",ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,,2018-08-22,,,Other (Please describe in comments),2018-08-22,2019-07-02
98240,2243180,Shortage,AA-FENO-MICRO,AA PHARMA INC,AA-FENO-MICRO,FENOFIBRATE,67MG,100BTL,ORAL,Actual shortage,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2019-11-08,2019-11-08,2019-11-13,,Disruption of the manufacture of the drug.,2019-11-08,2019-11-09
31261,2364190,Shortage,ABSTRAL,PALADIN LABS INC,Abstral,FENTANYL,300MCG,10 tablets,SUBLINGUAL,Actual shortage,TABLET,N02AB,OPIOIDS,2015-11-27,2015-11-27,,,Disruption of the manufacture of the drug.,2017-11-30,2017-11-30
10409,2364174,Shortage,ABSTRAL,PALADIN LABS INC,FENTANYL,FENTANYL,100MCG,10 Tabs,SUBLINGUAL,Actual shortage,TABLET,N02AB,OPIOIDS,,2015-11-27,,,Disruption of the manufacture of the drug.,2017-05-16,2017-11-30
10412,2364182,Shortage,ABSTRAL,PALADIN LABS INC,FENTANYL,FENTANYL,200MCG,10 Tabs,SUBLINGUAL,Actual shortage,TABLET,N02AB,OPIOIDS,,2015-11-27,,,Disruption of the manufacture of the drug.,2017-05-16,2017-11-30
10415,2364182,Shortage,ABSTRAL,PALADIN LABS INC,FENTANYL,FENTANYL,200MCG,10 Tabs,SUBLINGUAL,Resolved,TABLET,N02AB,OPIOIDS,,2015-11-27,,2015-11-27,Disruption of the manufacture of the drug.,2017-05-16,2017-11-30
10418,2364204,Shortage,ABSTRAL,PALADIN LABS INC,FENTANYL,FENTANYL,400MCG,10 Tabs,SUBLINGUAL,Actual shortage,TABLET,N02AB,OPIOIDS,,2015-11-27,,,Disruption of the manufacture of the drug.,2017-05-16,2017-11-30
10445,2364212,Shortage,ABSTRAL,PALADIN LABS INC,FENTANYL,FENTANYL,600MCG,10 Tabs,SUBLINGUAL,Actual shortage,TABLET,N02AB,OPIOIDS,,2015-11-27,,,Disruption of the manufacture of the drug.,2017-05-16,2017-11-30
10448,2364220,Shortage,ABSTRAL,PALADIN LABS INC,FENTANYL,FENTANYL,800MCG,10 Tabs,SUBLINGUAL,Actual shortage,TABLET,N02AB,OPIOIDS,,2015-11-27,,,Disruption of the manufacture of the drug.,2017-05-16,2017-11-30
70234,2303442,Shortage,ACCEL PIOGLITAZONE,ACCEL PHARMA INC,ACCEL PIOGLITAZONE,PIOGLITAZONE,15MG,100 tablets,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-12-20,2018-12-20,2019-02-08,2019-02-06,Shortage of an active ingredient.,2018-12-20,2019-02-07
85709,2303442,Shortage,ACCEL PIOGLITAZONE,ACCEL PHARMA INC,ACCEL PIOGLITAZONE,PIOGLITAZONE,15MG,100 tablets,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-06-06,2019-06-06,,,Disruption of the manufacture of the drug.,2019-06-06,2019-06-07
29649,2303450,Shortage,ACCEL PIOGLITAZONE,ACCEL PHARMA INC,ACCEL PIOGLITAZONE,PIOGLITAZONE,30MG,100 tablets,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-11-17,2017-11-17,2018-01-10,2018-03-19,Disruption of the manufacture of the drug.,2017-11-17,2018-03-20
72804,2463768,Shortage,ACCEL-CANDESARTAN,ACCEL PHARMA INC,Accel Candesartan,CANDESARTAN CILEXETIL,8MG,100 tablets,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-17,2019-01-17,2019-01-24,2019-01-30,Shortage of an active ingredient.,2019-01-17,2019-01-31
85701,2463776,Shortage,ACCEL-CANDESARTAN,ACCEL PHARMA INC,Accel Candesartan,CANDESARTAN CILEXETIL,16MG,100 tablets,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-06,,,Other (Please describe in comments),2019-06-06,2019-06-07
85706,2463784,Shortage,ACCEL-CANDESARTAN,ACCEL PHARMA INC,Accel Candesartan,CANDESARTAN CILEXETIL,32MG,100 tablets,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-06,,,Other (Please describe in comments),2019-06-06,2019-06-07
85714,2463768,Shortage,ACCEL-CANDESARTAN,ACCEL PHARMA INC,Accel Candesartan,CANDESARTAN CILEXETIL,8MG,100 tablets,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-06,,,Other (Please describe in comments),2019-06-06,2019-06-07
14434,2236606,Shortage,ACCOLATE TAB 20 MG,ASTRAZENECA CANADA INC,zafirlukast tablets,ZAFIRLUKAST,20MG,60,ORAL,Avoided shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-12-31,,,2017-08-15,Disruption of the manufacture of the drug.,2017-06-30,2017-08-15
68369,1947664,Shortage,ACCUPRIL 5MG TAB,PFIZER CANADA INC,Accupril,QUINAPRIL,5MG,90's,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-01-18,2019-01-18,2019-02-08,2019-02-07,Demand increase for the drug.,2018-12-01,2019-02-08
68360,1947672,Shortage,ACCUPRIL TAB 10MG,PFIZER CANADA INC,Accupril,QUINAPRIL,10MG,90's,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-03-20,2019-04-11,2019-04-10,Demand increase for the drug.,2018-12-01,2019-04-11
68363,1947680,Shortage,ACCUPRIL TAB 20MG,PFIZER CANADA INC,Accupril,QUINAPRIL,20MG,90's,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-01-30,2019-04-11,2019-04-10,Demand increase for the drug.,2018-12-01,2019-04-11
68366,1947699,Shortage,ACCUPRIL TAB 40MG,PFIZER CANADA INC,Accupril,QUINAPRIL,40MG,90's,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-01-09,2019-04-11,2019-04-10,Demand increase for the drug.,2018-12-01,2019-04-11
41071,2286254,Shortage,ACEBUTOLOL,SANIS HEALTH INC,ACEBUTOLOL,ACEBUTOLOL,200MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-04-02,2018-04-02,,2018-07-16,Disruption of the manufacture of the drug.,2018-02-26,2019-01-22
44143,2286262,Shortage,ACEBUTOLOL,SANIS HEALTH INC,ACEBUTOLOL,ACEBUTOLOL,400MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-04-18,2018-04-17,,2018-07-16,Disruption of the manufacture of the drug.,2018-03-28,2019-01-22
41074,2286246,Shortage,ACEBUTOLOL,SANIS HEALTH INC,ACEBUTOLOL,ACEBUTOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-05-07,2018-05-04,,2018-07-16,Disruption of the manufacture of the drug.,2018-02-26,2019-01-22
38020,2164426,Shortage,ACEBUTOLOL - 400 - TAB 400MG,PRO DOC LIMITEE,ACEBUTOLOL - 400,ACEBUTOLOL,400MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-02-01,,2018-11-15,Delay in shipping of the drug.,2018-02-01,2018-11-16
43748,2164396,Shortage,ACEBUTOLOL-100-TAB 100MG,PRO DOC LIMITEE,ACEBUTOLOL 100 MG,ACEBUTOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-03-23,,2018-11-15,Delay in shipping of the drug.,2018-03-23,2018-11-16
22073,2164418,Shortage,ACEBUTOLOL-200 - TAB 200MG,PRO DOC LIMITEE,ACEBUTOLOL-200,ACEBUTOLOL,200MG,100-500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-09-13,,2018-11-15,Delay in shipping of the drug.,2017-09-13,2018-11-16
80923,2362341,Shortage,ACETAMINOPHEN CAPLETS 325 MG,APOTEX INC,ACETAMINOPHEN CAPLETS 325 MG,ACETAMINOPHEN,325MG,100 BTL,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2019-04-09,2019-04-12,2019-04-11,Disruption of the manufacture of the drug.,2019-04-10,2019-04-12
92010,2362368,Shortage,ACETAMINOPHEN CAPLETS 500 MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,500MG,100 BTL,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2019-08-19,2019-10-07,2019-10-03,Disruption of the manufacture of the drug.,2019-08-21,2019-10-07
17195,2362244,Shortage,ACETAMINOPHEN TABLETS USP 500 MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,500MG,30 BTL,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017-08-18,,2017-09-29,2017-10-02,Disruption of the manufacture of the drug.,2017-07-26,2017-10-05
32028,2028174,Shortage,"ACETAMINOPHEN, CAFFEINE & CODEINE",PHARMASCIENCE INC,ACET CODEINE,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  8MG  15MG,200,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,,2017-12-07,,,Disruption of the manufacture of the drug.,2017-12-07,2017-12-08
4161,2025337,Shortage,"ACETAMINOPHEN, CAFFEINE & CODEINE",PHARMASCIENCE INC,ANALGESICS C.L.,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  8MG  15MG,200,ORAL,Actual shortage,TABLET,N02AJ,,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
43848,2028174,Shortage,"ACETAMINOPHEN, CAFFEINE & CODEINE",PHARMASCIENCE INC,ACET CODEINE,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  8MG  15MG,100,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,,2018-03-23,,,Other (Please describe in comments),2018-03-23,2018-03-24
13688,2025337,Shortage,"ACETAMINOPHEN, CAFFEINE & CODEINE",PHARMASCIENCE INC,ACETOMINOPHEN,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  8MG  15MG,100,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,2017-08-21,2017-08-21,,,Disruption of the manufacture of the drug.,2017-06-23,2018-12-20
23251,2017431,Shortage,ACETAMINOPHENE 160MGCO.CROQUABLE POUR ENFANT,LABORATOIRE RIVA INC,Acetaminophene 160mgco. Croquable pour enfant,ACETAMINOPHEN,160MG,20,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017-09-25,2017-09-25,2017-09-29,2017-10-13,Disruption of the manufacture of the drug.,2017-09-25,2017-10-24
47284,382752,Shortage,ACETAMINOPHENE 325TAB,PRO DOC LIMITEE,ACETAMINOPHENE 325TAB,ACETAMINOPHEN,325MG,1000,ORAL,Avoided shortage,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2018-08-31,,,2018-06-20,Delay in shipping of the drug.,2018-04-26,2018-06-20
5652,386626,Shortage,ACETAMINOPHENE 500TAB,PRO DOC LIMITEE,ACETAMINOPHENE,ACETAMINOPHEN,500MG,1000,ORAL,Avoided shortage,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2018-09-12,,,2018-06-20,Delay in shipping of the drug.,2017-04-05,2018-09-11
35352,545015,Shortage,ACETAZOLAMIDE,AA PHARMA INC,Acetazolamide,ACETAZOLAMIDE,250MG,100 BTL,ORAL,Resolved,TABLET,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-01-09,2018-01-19,2018-01-18,Disruption of the manufacture of the drug.,2018-01-09,2018-04-23
14896,545015,Shortage,ACETAZOLAMIDE,AA PHARMA INC,ACETAZOLAMIDE,ACETAZOLAMIDE,250MG,100 Bottle,ORAL,Resolved,TABLET,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-07-06,2017-07-17,2017-07-12,Disruption of the manufacture of the drug.,2017-07-07,2017-07-13
69535,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,30ml,INHALATION  INTRAVENOUS  ORAL,Actual shortage,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",,2018-10-15,,,Requirements related to complying with good manufacturing practices.,2018-12-13,2018-12-13
2482,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,10ML,INHALATION  INTRAVENOUS  ORAL,Resolved,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",2017-03-14,,2017-04-14,2017-04-24,Disruption of the manufacture of the drug.,2017-03-14,2017-06-26
2486,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,30ML,INHALATION  INTRAVENOUS  ORAL,Resolved,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",2017-03-14,,2017-07-28,2017-07-28,Disruption of the manufacture of the drug.,2017-03-14,2017-08-02
55771,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,10ML VIAL,INHALATION  INTRAVENOUS  ORAL,Resolved,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",,2018-06-23,2018-08-20,2018-08-17,Requirements related to complying with good manufacturing practices.,2018-07-13,2018-08-23
55774,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,30ML VIAL,INHALATION  INTRAVENOUS  ORAL,Resolved,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",,2018-06-23,2018-08-20,2018-08-17,Requirements related to complying with good manufacturing practices.,2018-07-13,2018-08-23
73185,2243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,10,INHALATION  INTRAVENOUS  ORAL,Actual shortage,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",2018-10-15,,,,Requirements related to complying with good manufacturing practices.,2019-01-22,2019-01-21
85112,2459906,Shortage,ACETYLCYSTEINE SOLUTION USP,TELIGENT OU,Acetylcysteine,ACETYLCYSTEINE,200MG,10ml,INHALATION  INTRAVENOUS  ORAL,Actual shortage,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",2019-05-28,,2019-10-31,,Disruption of the manufacture of the drug.,2019-05-28,2019-05-29
55518,2459906,Shortage,ACETYLCYSTEINE SOLUTION USP,TELIGENT OU,Acetylcysteine Solution USP,ACETYLCYSTEINE,200MG,10 mL,INHALATION  INTRAVENOUS  ORAL,Resolved,SOLUTION,R05CB,"EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",,2018-02-12,2018-08-29,2018-08-29,Disruption of the manufacture of the drug.,2018-07-12,2018-09-04
5804,2381486,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,10MG,28 tabs in blister pack per box  |  28 comprimés en plaquette thermoformée par boîte,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-04-01,2017-04-01,2017-04-01,2017-04-01,Disruption of the manufacture of the drug.,2017-04-06,2017-05-09
5806,2381486,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,10MG,28 TABS PER BOX     |     BOÎTE DE 28 COMPRIMÉS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-04-01,2017-04-01,2017-10-20,2017-09-25,Disruption of the manufacture of the drug.,2017-04-06,2017-09-29
5817,2381494,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 TABS PER BOX     |     BOÎTE DE 4 COMPRIMÉS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-03-01,2017-03-01,2017-07-28,2017-07-07,Disruption of the manufacture of the drug.,2017-04-06,2017-07-08
33986,2381486,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,10MG,28 tabs (blister) per box  | 28 comprimés en plaquette par boîte,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-12-11,2018-02-09,2018-02-12,Disruption of the manufacture of the drug.,2017-12-20,2018-02-15
87147,2351218,Shortage,ACH-ANASTROZOLE,ACCORD HEALTHCARE INC,ACH-Anastrozole,ANASTROZOLE,1MG,30 blister,ORAL,Actual shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2019-06-21,2019-06-21,,,Demand increase for the drug.,2019-06-20,2019-06-22
5820,2325985,Shortage,ACH-BICALUTAMIDE,ACCORD HEALTHCARE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017-04-01,2017-04-01,2017-07-14,2017-07-05,Disruption of the manufacture of the drug.,2017-04-06,2017-07-13
70965,2379260,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-03,2019-01-03,2019-02-28,2019-03-20,Disruption of the manufacture of the drug.,2019-01-03,2019-03-21
70968,2379279,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-03,2019-01-03,2019-02-28,2019-03-20,Disruption of the manufacture of the drug.,2019-01-03,2019-03-21
70975,2379287,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-03,2019-01-03,2019-02-28,2019-03-20,Disruption of the manufacture of the drug.,2019-01-03,2019-03-21
97967,2379287,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,ACH-Candesartan 16mg,CANDESARTAN CILEXETIL,16MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-11-05,,,Demand increase for the drug.,2019-11-05,2019-11-06
82422,2379260,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,ACH-Candesartan,CANDESARTAN CILEXETIL,4MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-04-25,2019-04-25,,,Shortage of an active ingredient.,2019-04-25,2019-04-26
16461,2426757,Shortage,ACH-CAPECITABINE,ACCORD HEALTHCARE INC,CAPECITABINE,CAPECITABINE,150MG,60 Tabs Blister Pack/Box     |     60 comprimés en plaquette alvéolées /Boîte,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,2017-07-19,2017-07-19,,2017-12-08,Other (Please describe in comments),2017-07-19,2017-12-20
16466,2426765,Shortage,ACH-CAPECITABINE,ACCORD HEALTHCARE INC,CAPECITABINE,CAPECITABINE,500MG,120 Tabs Blister Pack / Box     |     120 comprimés en plaquettes alvéolées / Boîte,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,2017-07-19,2017-07-19,,2017-12-08,Other (Please describe in comments),2017-07-19,2017-12-20
22174,2426757,Shortage,ACH-CAPECITABINE,ACCORD HEALTHCARE INC,CAPECITABINE,CAPECITABINE,150MG,60 TABLETS PER BOTTLE  |  60 COMPRIMÉS PAR BOUTEILLE,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,2017-09-13,2017-09-13,2017-10-20,2017-10-16,Disruption of the manufacture of the drug.,2017-09-15,2017-10-20
26463,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,6 BLISTERS PACKS/BOX (60 TABS/BOX)  |  6 PLAQUETTES ALVÉOLÉES/BOÎTE (60 COMPRIMÉS/BOÎTES),ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-09-25,2017-09-25,2017-12-01,2017-12-15,Disruption of the manufacture of the drug.,2017-10-20,2017-12-20
26466,2434660,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,3 BLISTER PACKS/BOX (30 TABS/BOX)  | 3 PLAQUETTES ALVÉOLÉES/BOÎTE (30 COMPRIMÉS/BOÎTES),ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-09-26,2017-09-26,2017-11-17,2017-12-08,Disruption of the manufacture of the drug.,2017-10-20,2017-12-20
87150,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,Escitalopram,ESCITALOPRAM,10MG,100 bottle,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-06-20,2019-06-20,,,Disruption of the manufacture of the drug.,2019-06-20,2019-06-21
87153,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,Escitalopram,ESCITALOPRAM,10MG,30 blister,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-06-20,2019-06-20,,,Disruption of the manufacture of the drug.,2019-06-20,2019-06-21
87156,2434660,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,Escitalopram,ESCITALOPRAM,20MG,30 blister,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-06-20,2019-06-20,,,Disruption of the manufacture of the drug.,2019-06-20,2019-06-21
9673,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100 TABS PER BOTTLE   |   BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-05-09,2017-05-09,2017-11-03,2017-10-16,Disruption of the manufacture of the drug.,2017-05-09,2017-10-27
34007,2434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,"10 TABS PER BLISTER PACK, 3 BLISTER PACKS PER BOX   | 10 COMPRIMÉS PAR PLAQUETTE, 3 PLAQUETTES PAR BOÎTE",ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-12-15,2017-12-15,2018-02-09,2018-02-12,Disruption of the manufacture of the drug.,2017-12-20,2018-02-15
9695,2355043,Shortage,ACH-FINASTERIDE,ACCORD HEALTHCARE INC,FINASTERIDE,FINASTERIDE,5MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-05-08,2017-05-08,2017-06-16,2017-07-10,Disruption of the manufacture of the drug.,2017-05-09,2017-07-19
97970,2468948,Shortage,ACH-OLMESARTAN HCTZ,ACCORD HEALTHCARE INC,ACH-Olmesartan HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,90,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-11-05,2019-12-09,,Demand increase for the drug.,2019-11-05,2019-11-06
97973,2468964,Shortage,ACH-OLMESARTAN HCTZ,ACCORD HEALTHCARE INC,ACH-Olmesartan HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,90,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-11-05,,2019-12-09,,Demand increase for the drug.,2019-11-05,2019-11-06
41296,2339595,Shortage,ACH-PIOGLITAZONE,ACCORD HEALTHCARE INC,PIOGLITAZONE,PIOGLITAZONE,45MG,90 tabs per bottle   |   90 comprimés par bouteille,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-02-26,2018-02-26,2018-03-30,2018-03-28,Disruption of the manufacture of the drug.,2018-02-28,2018-03-29
34002,2339595,Shortage,ACH-PIOGLITAZONE,ACCORD HEALTHCARE INC,PIOGLITAZONE,PIOGLITAZONE,45MG,90 tabs per bottle   |   90 comprimés par bouteille,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-12-18,2018-02-23,2018-02-12,Disruption of the manufacture of the drug.,2017-12-20,2018-02-15
72334,2419114,Shortage,ACH-TELMISARTAN HCTZ,ACCORD HEALTHCARE INC,ACH-Telmisartan HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-01-16,2019-01-16,2019-03-20,2019-03-20,Demand increase for the drug.,2019-01-15,2019-03-21
72337,2419122,Shortage,ACH-TELMISARTAN HCTZ,ACCORD HEALTHCARE INC,ACH-Telmisartan HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-01-15,2019-01-15,,2019-04-01,Demand increase for the drug.,2019-01-15,2019-04-02
18283,2389819,Shortage,ACH-TEMOZOLOMIDE,ACCORD HEALTHCARE INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,5 CAPSULES / BOTTLE     |     5 CAPSULES / BOUTEILLE,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-07-04,2017-07-04,2017-09-22,2017-09-20,Disruption of the manufacture of the drug.,2017-08-04,2017-09-22
43707,2389819,Shortage,ACH-TEMOZOLOMIDE,ACCORD HEALTHCARE INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,"1 CAPSULE/SACHET, 5 SACHETS/BOX  | 1 CAPSULE/SACHET, 5 SACHETS/BOÎTE",ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2018-03-09,2018-04-27,2018-05-18,Disruption of the manufacture of the drug.,2018-03-22,2018-05-24
19042,2230507,Shortage,ACID REDUCER,APOTEX INC,RANITIDINE,RANITIDINE,75MG,6/10 BLS,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
3348,2297477,Shortage,ACT AMLODIPINE,ACTAVIS PHARMA COMPANY,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-17,2017-07-31,2017-09-01,Disruption of the manufacture of the drug.,2017-03-17,2017-09-19
61330,2439271,Shortage,ACT AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,6.25MG  6.25MG  6.25MG  6.25MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-01,2018-12-07,2018-12-28,Disruption of the manufacture of the drug.,2018-09-12,2018-12-29
61333,2439298,Shortage,ACT AMPHETAMINE XR,TEVA CANADA LIMITED,AMHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,7.5MG  7.5MG  7.5MG  7.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-01,2018-12-07,2018-12-28,Disruption of the manufacture of the drug.,2018-09-12,2018-12-29
61336,2439239,Shortage,ACT AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,1.25MG  1.25MG  1.25MG  1.25MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-01,2018-12-07,2018-12-28,Disruption of the manufacture of the drug.,2018-09-12,2018-12-29
60068,2439255,Shortage,ACT AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,3.75MG  3.75MG  3.75MG  3.75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-01,2019-01-14,2019-01-30,Disruption of the manufacture of the drug.,2018-09-06,2019-01-31
68265,2439247,Shortage,ACT AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,2.5MG  2.5MG  2.5MG  2.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-11-30,2019-01-30,2019-01-30,Disruption of the manufacture of the drug.,2018-11-30,2019-01-31
60075,2439263,Shortage,ACT AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,5MG  5MG  5MG  5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-01,2019-01-18,2019-01-20,Disruption of the manufacture of the drug.,2018-09-06,2019-01-31
95396,2453908,Shortage,ACT BUPRENORPHINE/NALOXONE,ACTAVIS PHARMA COMPANY,ACT-BUPREN/NALOX TAB,BUPRENORPHINE  NALOXONE,2MG  0.5MG,30,SUBLINGUAL,Actual shortage,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2019-10-02,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-03,2019-11-07
94896,2453916,Shortage,ACT BUPRENORPHINE/NALOXONE,ACTAVIS PHARMA COMPANY,BUPRENORPHINE NALOXONE,BUPRENORPHINE  NALOXONE,8MG  2MG,30,SUBLINGUAL,Actual shortage,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2019-09-26,2019-11-30,,Disruption of the manufacture of the drug.,2019-09-26,2019-10-03
68569,2439654,Shortage,ACT BUPROPION XL,ACTAVIS PHARMA COMPANY,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-12-01,2019-10-31,2019-10-16,Delay in shipping of the drug.,2018-12-04,2019-10-17
68572,2439654,Shortage,ACT BUPROPION XL,ACTAVIS PHARMA COMPANY,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-12-01,2019-10-31,2019-10-09,Delay in shipping of the drug.,2018-12-04,2019-10-10
68577,2439662,Shortage,ACT BUPROPION XL,ACTAVIS PHARMA COMPANY,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,500,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-12-01,2019-11-30,,Delay in shipping of the drug.,2018-12-04,2019-10-03
68580,2439662,Shortage,ACT BUPROPION XL,ACTAVIS PHARMA COMPANY,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,90,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-12-01,2019-12-31,,Delay in shipping of the drug.,2018-12-04,2019-11-14
8767,2301407,Shortage,ACT CABERGOLINE,ACTAVIS PHARMA COMPANY,CABERGOLINE,CABERGOLINE,0.5MG,8,ORAL,Actual shortage,TABLET,G02CB,OTHER GYNECOLOGICALS,,2015-01-01,,,Requirements related to complying with good manufacturing practices.,2017-05-03,2017-10-05
3390,2420155,Shortage,ACT CELECOXIB,ACTAVIS PHARMA COMPANY,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-09-30,2018-02-05,2018-02-15,Disruption of the manufacture of the drug.,2017-03-17,2018-10-11
92232,2420155,Shortage,ACT CELECOXIB,ACTAVIS PHARMA COMPANY,CELECOXIB,CELECOXIB,100MG,100,ORAL,Actual shortage,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-08-22,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-10-17
92235,2420155,Shortage,ACT CELECOXIB,ACTAVIS PHARMA COMPANY,CELECOXIB,CELECOXIB,100MG,500,ORAL,Actual shortage,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-08-22,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-10-17
68583,2420163,Shortage,ACT CELECOXIB,ACTAVIS PHARMA COMPANY,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-12-01,2019-03-30,2019-03-30,Disruption of the manufacture of the drug.,2018-12-04,2019-04-11
68586,2420163,Shortage,ACT CELECOXIB,ACTAVIS PHARMA COMPANY,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-12-01,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2018-12-04,2019-08-06
86923,2247340,Shortage,ACT CIPROFLOXACIN,TEVA CANADA LIMITED,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
61365,2247341,Shortage,ACT CIPROFLOXACIN,TEVA CANADA LIMITED,CIPROFLOXACIN,CIPROFLOXACIN,750MG,50,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-07-30,2018-10-01,2018-10-01,Disruption of the manufacture of the drug.,2018-09-12,2018-10-11
93644,2247340,Shortage,ACT CIPROFLOXACIN,TEVA CANADA LIMITED,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-09-11,2019-10-31,2019-10-09,Disruption of the manufacture of the drug.,2019-09-12,2019-10-10
68599,2247340,Shortage,ACT CIPROFLOXACIN,TEVA CANADA LIMITED,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-12-01,2019-02-15,2019-02-15,Disruption of the manufacture of the drug.,2018-12-04,2019-03-12
68589,2448319,Shortage,ACT DEXTROAMPHETAMINE SR,ACTAVIS PHARMA COMPANY,DEXTROAMPHETAMINE,DEXTROAMPHETAMINE SULFATE,10MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-12-03,2019-04-30,2019-04-30,Disruption of the manufacture of the drug.,2018-12-04,2019-06-04
68594,2448327,Shortage,ACT DEXTROAMPHETAMINE SR,ACTAVIS PHARMA COMPANY,DEXTROAMPHETAMINE,DEXTROAMPHETAMINE SULFATE,15MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-12-01,2019-04-30,2019-04-30,Disruption of the manufacture of the drug.,2018-12-04,2019-06-04
82552,2370611,Shortage,ACT DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-04-01,,,Disruption of the manufacture of the drug.,2019-04-26,2019-04-26
82555,2370638,Shortage,ACT DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-04-01,,,Disruption of the manufacture of the drug.,2019-04-26,2019-04-26
61340,2370654,Shortage,ACT DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-09-12,,,Disruption of the manufacture of the drug.,2018-09-12,2018-10-11
9901,2370638,Shortage,ACT DILTIAZEM CD,ACTAVIS PHARMA COMPANY,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-05-04,2017-05-31,2017-08-30,Demand increase for the drug.,2017-05-10,2017-09-19
68602,2370646,Shortage,ACT DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,,,100,,Actual shortage,,,,,2018-12-01,,,Disruption of the manufacture of the drug.,2018-12-04,2018-12-04
3362,2370522,Shortage,ACT DILTIAZEM T,ACTAVIS PHARMA COMPANY,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,360MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-06-30,2018-09-20,2018-09-30,Disruption of the manufacture of the drug.,2017-03-17,2018-10-11
97602,2291878,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ACT-ENALAPRIL 2.5MG TABLETS,ENALAPRIL SODIUM,2MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-10-31,2020-03-31,,Disruption of the manufacture of the drug.,2019-10-31,2019-11-07
20315,2291886,Shortage,ACT ENALAPRIL,ACTAVIS PHARMA COMPANY,ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-18,2017-09-15,2017-10-06,Disruption of the manufacture of the drug.,2017-08-24,2017-10-10
20326,2291908,Shortage,ACT ENALAPRIL,ACTAVIS PHARMA COMPANY,ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-20,2017-09-15,2017-10-06,Disruption of the manufacture of the drug.,2017-08-24,2017-10-10
61343,2291894,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ENALAPRIL,ENALAPRIL SODIUM,8MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-15,2019-02-15,2019-02-15,Disruption of the manufacture of the drug.,2018-09-12,2019-03-12
61346,2291878,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ENALAPRIL,ENALAPRIL SODIUM,2MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-15,2019-01-18,2019-01-30,Disruption of the manufacture of the drug.,2018-09-12,2019-01-31
61349,2291908,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-15,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2018-09-12,2019-08-06
61352,2291886,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-15,2019-01-18,2019-01-30,Disruption of the manufacture of the drug.,2018-09-12,2019-01-31
92238,2423855,Shortage,ACT ESOMEPRAZOLE,TEVA CANADA LIMITED,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-08-22,2020-01-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-11-07
92241,2423855,Shortage,ACT ESOMEPRAZOLE,TEVA CANADA LIMITED,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-08-22,2020-01-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-11-07
9912,2423863,Shortage,ACT ESOMEPRAZOLE,ACTAVIS PHARMA COMPANY,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-08-01,2018-06-30,2018-06-30,Disruption of the manufacture of the drug.,2017-05-10,2018-07-30
57207,2263866,Shortage,ACT ETIDROCAL,ACTAVIS PHARMA COMPANY,ETIDROCAL,ETIDRONATE DISODIUM  CALCIUM,400MG  500MG,90,ORAL,Actual shortage,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-05-01,,,Disruption of the manufacture of the drug.,2018-08-01,2019-02-21
68592,2390183,Shortage,ACT EXEMESTANE,ACTAVIS PHARMA COMPANY,EXEMESTANE,EXEMESTANE,25MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-12-01,2019-02-15,2019-02-20,Disruption of the manufacture of the drug.,2018-12-04,2019-03-14
9917,2414716,Shortage,ACT EZETIMIBE,ACTAVIS PHARMA COMPANY,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-04,2017-05-30,2017-05-17,Disruption of the manufacture of the drug.,2017-05-10,2017-05-24
65497,2305682,Shortage,ACT FAMCICLOVIR,ACTAVIS PHARMA COMPANY,FAMCICLOVIR,FAMCICLOVIR,125MG,10,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2018-10-23
65500,2305704,Shortage,ACT FAMCICLOVIR,ACTAVIS PHARMA COMPANY,FAMCICLOVIR,FAMCICLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2018-10-23
65502,2305690,Shortage,ACT FAMCICLOVIR,ACTAVIS PHARMA COMPANY,FAMCICLOVIR,FAMCICLOVIR,250MG,30,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2018-10-23
65507,2305704,Shortage,ACT FAMCICLOVIR,ACTAVIS PHARMA COMPANY,FAMCICLOVIR,FAMCICLOVIR,500MG,21,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2018-10-23
40417,2255529,Shortage,ACT FLUVOXAMINE,ACTAVIS PHARMA COMPANY,FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-02-21,2019-04-30,2019-04-30,Demand increase for the drug.,2018-02-21,2019-05-28
40420,2255537,Shortage,ACT FLUVOXAMINE,ACTAVIS PHARMA COMPANY,FLUVOXAMINE,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-02-21,2019-04-30,2019-04-30,Demand increase for the drug.,2018-02-21,2019-05-28
20300,2256142,Shortage,ACT GABAPENTIN,ACTAVIS PHARMA COMPANY,GABAPENTIN,GABAPENTIN,100MG,500,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-18,,,Disruption of the manufacture of the drug.,2017-08-24,2018-10-11
92229,2436256,Shortage,ACT LATANOPROST/TIMOLOL,ACTAVIS PHARMA COMPANY,LATANOPROST-TIMOLOL,TIMOLOL  LATANOPROST,5MG  50MCG,2.5ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-08-22,2019-10-31,2019-10-23,Disruption of the manufacture of the drug.,2019-08-22,2019-10-24
9922,2274191,Shortage,ACT LEVETIRACETAM,ACTAVIS PHARMA COMPANY,LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-05-04,2018-09-01,2018-09-15,Disruption of the manufacture of the drug.,2017-05-10,2018-10-11
9939,2274205,Shortage,ACT LEVETIRACETAM,ACTAVIS PHARMA COMPANY,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-05-04,2018-09-30,2018-09-30,Disruption of the manufacture of the drug.,2017-05-10,2018-10-11
93172,2274191,Shortage,ACT LEVETIRACETAM,ACTAVIS PHARMA COMPANY,LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2019-09-05,,,Disruption of the manufacture of the drug.,2019-09-05,2019-09-06
62458,2274183,Shortage,ACT LEVETIRACETAM,ACTAVIS PHARMA COMPANY,LEVETIRACETAM,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2006-07-30,2018-10-30,2018-10-11,Disruption of the manufacture of the drug.,2018-09-27,2018-10-12
52485,2315432,Shortage,ACT LEVOFLOXACIN,TEVA CANADA LIMITED,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-04-15,2019-05-31,2019-05-15,Disruption of the manufacture of the drug.,2018-06-15,2019-05-28
52488,2315424,Shortage,ACT LEVOFLOXACIN,TEVA CANADA LIMITED,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-04-15,2018-10-30,2018-10-30,Disruption of the manufacture of the drug.,2018-06-15,2018-11-08
68605,2315440,Shortage,ACT LEVOFLOXACIN,TEVA CANADA LIMITED,LEVOFLOXACIN,LEVOFLOXACIN,750MG,50,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-11-20,2019-08-30,2019-08-15,Disruption of the manufacture of the drug.,2018-12-04,2019-08-16
65510,2248572,Shortage,ACT LOVASTATIN,ACTAVIS PHARMA COMPANY,LOVASTATIN,LOVASTATIN,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2019-03-14
65513,2248573,Shortage,ACT LOVASTATIN,ACTAVIS PHARMA COMPANY,LOVASTATIN,LOVASTATIN,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2019-03-14
65990,2441934,Shortage,ACT METHYLPHENIDATE ER,ACTAVIS PHARMA COMPANY,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-10-30,2019-11-30,,Disruption of the manufacture of the drug.,2018-11-01,2019-10-10
65993,2441942,Shortage,ACT METHYLPHENIDATE ER,ACTAVIS PHARMA COMPANY,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2019-02-28,,2019-11-30,,Disruption of the manufacture of the drug.,2018-11-01,2019-10-17
65996,2441950,Shortage,ACT METHYLPHENIDATE ER,ACTAVIS PHARMA COMPANY,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-12-01,2018-12-01,2019-11-30,,Disruption of the manufacture of the drug.,2018-11-01,2019-10-10
65999,2441969,Shortage,ACT METHYLPHENIDATE ER,ACTAVIS PHARMA COMPANY,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2019-03-30,,2020-01-31,,Delay in shipping of the drug.,2018-11-01,2019-11-07
96733,2393603,Shortage,ACT NABILONE,ACTAVIS PHARMA COMPANY,NABILONE,NABILONE,1MG,100,ORAL,Actual shortage,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2019-10-16,,,Other (Please describe in comments),2019-10-17,2019-10-17
3357,2327589,Shortage,ACT OLANZAPINE ODT,ACTAVIS PHARMA COMPANY,OLANZAPINE ODT,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-03-17,2018-06-01,2018-06-01,Disruption of the manufacture of the drug.,2017-03-17,2018-06-15
10972,2327570,Shortage,ACT OLANZAPINE ODT,ACTAVIS PHARMA COMPANY,OLANZAPINE,OLANZAPINE,10MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-05-17,2018-06-01,2018-06-01,Disruption of the manufacture of the drug.,2017-05-24,2018-06-15
10975,2327597,Shortage,ACT OLANZAPINE ODT,ACTAVIS PHARMA COMPANY,OLANZAPINE,OLANZAPINE,20MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-05-17,2018-09-30,2018-09-30,Disruption of the manufacture of the drug.,2017-05-24,2018-10-11
93156,2327562,Shortage,ACT OLANZAPINE ODT,TEVA CANADA LIMITED,OLANZAPINE ODT,OLANZAPINE,5MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2019-09-05,,2019-10-25,Disruption of the manufacture of the drug.,2019-09-05,2019-10-26
65340,2442205,Shortage,ACT OLMESARTAN,TEVA CANADA LIMITED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-22,,,Requirements related to complying with good manufacturing practices.,2018-10-22,2019-01-08
65350,2442191,Shortage,ACT OLMESARTAN,TEVA CANADA LIMITED,OLMESARTAN,OLMESARTAN MEDOXOMIL,20MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-30,,,Requirements related to complying with good manufacturing practices.,2018-10-22,2019-01-08
65343,2443112,Shortage,ACT OLMESARTAN HCT,TEVA CANADA LIMITED,OLMESARTAN HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-22,,,Requirements related to complying with good manufacturing practices.,2018-10-22,2019-01-08
65346,2443139,Shortage,ACT OLMESARTAN HCT,TEVA CANADA LIMITED,OLMESARTAN HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-22,,,Requirements related to complying with good manufacturing practices.,2018-10-22,2019-01-08
61359,2443120,Shortage,ACT OLMESARTAN HCT,TEVA CANADA LIMITED,OLMESARTAN HCT,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  40MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-09-12,,,Disruption of the manufacture of the drug.,2018-09-12,2019-01-08
65519,2403986,Shortage,ACT OLOPATADINE 0.1%,ACTAVIS PHARMA COMPANY,OLOPATADINE,OLOPATADINE,0.1%,1,OPHTHALMIC,Actual shortage,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2018-10-23
65516,2404095,Shortage,ACT OLOPATADINE 0.2%,ACTAVIS PHARMA COMPANY,ACT OLOPATADINE,OLOPATADINE,0.2%,1,OPHTHALMIC,Actual shortage,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2018-09-01,,,Disruption of the manufacture of the drug.,2018-10-23,2018-10-23
3366,2394170,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-03-17,2017-06-30,2017-07-30,Requirements related to complying with good manufacturing practices.,2017-03-17,2017-09-19
3377,2394189,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-03-17,2017-06-30,2017-07-30,Requirements related to complying with good manufacturing practices.,2017-03-17,2017-09-19
3381,2394197,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-03-17,,2017-06-30,Requirements related to complying with good manufacturing practices.,2017-03-17,2017-07-01
3384,2394219,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,80MG,500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-03-17,2017-06-30,2017-07-30,Requirements related to complying with good manufacturing practices.,2017-03-17,2017-09-19
10978,2394200,Shortage,ACT OXYCODONE CR,ACTAVIS PHARMA COMPANY,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-05-17,2017-06-30,2017-07-30,Disruption of the manufacture of the drug.,2017-05-24,2017-09-19
60121,2297302,Shortage,ACT PRAMIPEXOLE,ACTAVIS PHARMA COMPANY,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-09-06,2019-03-30,2019-03-30,Disruption of the manufacture of the drug.,2018-09-06,2019-04-11
60124,2297310,Shortage,ACT PRAMIPEXOLE,ACTAVIS PHARMA COMPANY,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-09-06,2019-03-30,2019-03-30,Demand increase for the drug.,2018-09-06,2019-04-11
60129,2297329,Shortage,ACT PRAMIPEXOLE,ACTAVIS PHARMA COMPANY,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-09-06,2019-03-30,2019-03-30,Demand increase for the drug.,2018-09-06,2019-04-11
3310,2248182,Shortage,ACT PRAVASTATIN,ACTAVIS PHARMA COMPANY,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-17,,,Disruption of the manufacture of the drug.,2017-03-17,2018-12-20
3314,2248184,Shortage,ACT PRAVASTATIN,ACTAVIS PHARMA COMPANY,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-17,,,Disruption of the manufacture of the drug.,2017-03-17,2018-12-20
3394,2402955,Shortage,ACT PREGABALIN,ACTAVIS PHARMA COMPANY,PREGABALIN,PREGABALIN,150MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-17,2017-06-01,2017-08-01,Disruption of the manufacture of the drug.,2017-03-17,2017-09-19
20303,2402920,Shortage,ACT PREGABALIN,ACTAVIS PHARMA COMPANY,PREGABALIN,PREGABALIN,50MG,500,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-20,,,Disruption of the manufacture of the drug.,2017-08-24,2018-12-20
10981,2402920,Shortage,ACT PREGABALIN,ACTAVIS PHARMA COMPANY,PREGABALIN,PREGABALIN,50MG,100,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-05-17,,,Disruption of the manufacture of the drug.,2017-05-24,2017-10-10
97147,2446820,Shortage,ACT PROGESTERONE INJECTION,ACTAVIS PHARMA COMPANY,PROGESTERONE 500MG/10ML INJ,PROGESTERONE,50MG,1,INTRAMUSCULAR,Actual shortage,SOLUTION,G03DA,PROGESTOGENS,,2019-10-23,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-24,2019-10-24
96079,2316080,Shortage,ACT QUETIAPINE,ACTAVIS PHARMA COMPANY,QUETIAPINE TABLETS,QUETIAPINE,25MG,500,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-10-09,2019-10-31,,Disruption of the manufacture of the drug.,2019-10-10,2019-10-24
94384,2316080,Shortage,ACT QUETIAPINE,ACTAVIS PHARMA COMPANY,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-09-18,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-19,2019-11-14
93166,2316080,Shortage,ACT QUETIAPINE,ACTAVIS PHARMA COMPANY,QUETIAPINE,QUETIAPINE,25MG,500,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-09-05,2019-11-30,,Disruption of the manufacture of the drug.,2019-09-05,2019-10-10
10991,2295482,Shortage,ACT RAMIPRIL,ACTAVIS PHARMA COMPANY,RAMIPRIL,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-05-17,2017-07-31,2017-08-20,Disruption of the manufacture of the drug.,2017-05-24,2017-09-19
94846,2248570,Shortage,ACT RANITIDINE,TEVA CANADA LIMITED,ACT-RANITIDINE,RANITIDINE,150MG,60,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-26,,,Disruption of the manufacture of the drug.,2019-09-26,2019-11-14
94849,2248570,Shortage,ACT RANITIDINE,TEVA CANADA LIMITED,ACT-RANITIDINE,RANITIDINE,150MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-26,,,Disruption of the manufacture of the drug.,2019-09-26,2019-11-14
94852,2248570,Shortage,ACT RANITIDINE,TEVA CANADA LIMITED,ACT-RANITIDINE,RANITIDINE,150MG,PP60,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-26,,,Disruption of the manufacture of the drug.,2019-09-26,2019-11-14
94855,2248571,Shortage,ACT RANITIDINE,TEVA CANADA LIMITED,ACT-RANITIDINE,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-26,,,Disruption of the manufacture of the drug.,2019-09-26,2019-11-14
86927,2248570,Shortage,ACT RANITIDINE,TEVA CANADA LIMITED,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
3320,2248571,Shortage,ACT RANITIDINE,ACTAVIS PHARMA COMPANY,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-17,2017-06-15,2017-09-01,Disruption of the manufacture of the drug.,2017-03-17,2017-09-19
3330,2282607,Shortage,ACT RISPERIDONE,ACTAVIS PHARMA COMPANY,ACT  RISPERIDONE,RISPERIDONE,1MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-03-17,2017-06-05,2017-08-01,Disruption of the manufacture of the drug.,2017-03-17,2017-09-19
3337,2282623,Shortage,ACT RISPERIDONE,ACTAVIS PHARMA COMPANY,RISPERIDONE,RISPERIDONE,3MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-03-17,2017-06-07,2017-08-01,Disruption of the manufacture of the drug.,2017-03-17,2017-09-19
10984,2282615,Shortage,ACT RISPERIDONE,ACTAVIS PHARMA COMPANY,RISPERIDONE,RISPERIDONE,2MG,60,ORAL,Actual shortage,TABLET,N05AX,ANTIPSYCHOTICS,,2017-05-17,,,Disruption of the manufacture of the drug.,2017-05-24,2018-10-11
10988,2381702,Shortage,ACT RIZATRIPTAN,ACTAVIS PHARMA COMPANY,RIZATRIPTAN,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-05-17,2017-07-18,2017-08-15,Disruption of the manufacture of the drug.,2017-05-24,2017-09-19
93169,2381702,Shortage,ACT RIZATRIPTAN,ACTAVIS PHARMA COMPANY,RIZATRIPTAN,RIZATRIPTAN,10MG,12,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-09-05,2019-10-31,2019-10-16,Disruption of the manufacture of the drug.,2019-09-05,2019-10-17
96714,2316846,Shortage,ACT ROPINIROLE,ACTAVIS PHARMA COMPANY,ROPINIROLE,ROPINIROLE,0.25MG,100,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-10-16,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-17,2019-10-17
3343,2287390,Shortage,ACT SERTRALINE,ACTAVIS PHARMA COMPANY,SERTRALINE,SERTRALINE,25MG,100,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-03-17,,,Disruption of the manufacture of the drug.,2017-03-17,2018-12-20
92684,2257904,Shortage,ACT SUMATRIPTAN,ACTAVIS PHARMA COMPANY,SUMATRIPTAN,SUMATRIPTAN,100MG,6 U/D,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-08-28,,,Disruption of the manufacture of the drug.,2019-08-29,2019-08-29
97584,2441160,Shortage,ACT TEMOZOLOMIDE,ACTAVIS PHARMA COMPANY,TEMOZOLOMIDE CAPS,TEMOZOLOMIDE,5MG,5,ORAL,Actual shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,,2019-10-31,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-31,2019-11-01
4464,1959034,Shortage,ACT-HIB,SANOFI PASTEUR LIMITED,Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate),HAEMOPHILUS INFLUENZAE TYPE B-PRP  TETANUS PROTEIN,10 μG  30 μG,"5 x 0.5 mL vials / 5 fioles de 0,5 mL",INTRAMUSCULAR,Resolved,Powder For Solution,J07AG,BACTERIAL VACCINES,2017-03-28,2017-03-28,2017-11-15,2018-01-18,Delay in shipping of the drug.,2017-03-28,2018-01-22
5831,2242518,Shortage,ACTONEL,ALLERGAN PHARMA CO.,ACTONEL 5MG,RISEDRONATE SODIUM,5MG,28 COUNT,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-08-01,,,,Other (Please describe in comments),2017-04-06,2018-12-20
5854,2239146,Shortage,ACTONEL,ALLERGAN PHARMA CO.,ACTONEL 30mg,RISEDRONATE SODIUM,30MG,30mg tablets,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-01-23,2017-01-23,2017-01-23,2017-01-23,Other (Please describe in comments),2017-04-06,2017-10-04
93950,2246896,Shortage,ACTONEL,ALLERGAN INC,ACTONEL 35MG,RISEDRONATE SODIUM,35MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2019-09-23,2019-09-27,2019-10-21,2019-10-11,Disruption of the manufacture of the drug.,2019-09-16,2019-10-12
95288,2370417,Shortage,ACTONEL DR,ALLERGAN INC,risedronate,RISEDRONATE SODIUM,35MG,4,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2019-10-07,2019-10-04,2019-10-21,2019-10-03,Disruption of the manufacture of the drug.,2019-10-03,2019-10-03
66328,1968300,Shortage,ACULAR LIQ 0.5%,ALLERGAN INC,ketorolac,KETOROLAC TROMETHAMINE,0.5%,5ml,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2018-11-05,2018-11-05,2019-02-19,2019-02-20,Other (Please describe in comments),2018-11-06,2019-02-21
75873,1968300,Shortage,ACULAR LIQ 0.5%,ALLERGAN INC,ketorolac tromethamine ophthalmic solution,KETOROLAC TROMETHAMINE,0.5%,10ml,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-02-15,2019-02-15,2019-03-15,2019-03-14,Demand increase for the drug.,2019-02-15,2019-03-15
93469,2369362,Shortage,ACUVAIL,ALLERGAN INC,Ketorolac,KETOROLAC TROMETHAMINE,0.45%,60 x 0.4 mL,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-09-10,2019-09-10,2019-10-11,2019-09-30,Disruption of the manufacture of the drug.,2019-09-10,2019-09-30
97097,2369362,Shortage,ACUVAIL,ALLERGAN INC,ketoroalac tromethamine,KETOROLAC TROMETHAMINE,0.45%,60 x 0.4ml,OPHTHALMIC,Avoided shortage,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2019-11-18,2019-12-13,2019-11-07,Disruption of the manufacture of the drug.,2019-10-24,2019-11-07
96084,2369362,Shortage,ACUVAIL,ALLERGAN INC,ketoroalac tromethamine,KETOROLAC TROMETHAMINE,0.45%,60 x 0.4ml,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-10-10,2019-10-10,2019-11-08,2019-10-15,Disruption of the manufacture of the drug.,2019-10-10,2019-10-16
78953,2369362,Shortage,ACUVAIL,ALLERGAN INC,ketorolac tromethamine,KETOROLAC TROMETHAMINE,0.45%,60 x 0.4mL,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-03-20,2019-03-20,2019-04-23,2019-04-24,Disruption of the manufacture of the drug.,2019-03-20,2019-04-26
86664,2369362,Shortage,ACUVAIL,ALLERGAN INC,ACUVAIL 0.45% 60 X 0.4 ML,KETOROLAC TROMETHAMINE,0.45%,60 X 0.4 ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-06-20,2019-07-20,2019-08-23,2019-08-22,Disruption of the manufacture of the drug.,2019-06-17,2019-08-23
63456,2369362,Shortage,ACUVAIL,ALLERGAN INC,Ketorolac,KETOROLAC TROMETHAMINE,0.45%,60 x 0.4 mL,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2018-10-05,2018-10-05,2018-10-18,2018-10-18,Other (Please describe in comments),2018-10-09,2018-10-19
61472,2236926,Shortage,ACYCLOVIR SODIUM INJECTION,FRESENIUS KABI CANADA LTD,Acyclovir Sodium Injection,ACYCLOVIR,50MG,20mL,INTRAVENOUS,Resolved,SOLUTION,J05AB,DIRECT ACTING ANTIVIRALS,2018-09-17,,,2018-10-15,Disruption of the manufacture of the drug.,2018-09-14,2018-10-16
98615,2456524,Shortage,ACYCLOVIR SODIUM INJECTION,STERIMAX INC,ACYCLOVIR SODIUM INJECTION,ACYCLOVIR,50MG,10 VIALS,INTRAVENOUS,Actual shortage,SOLUTION,J05AB,DIRECT ACTING ANTIVIRALS,,2019-11-13,2020-01-31,,Delay in shipping of the drug.,2019-11-13,2019-11-14
78727,2456524,Shortage,ACYCLOVIR SODIUM INJECTION,STERIMAX INC,ACYCLOVIR SODIUM INJECTION,ACYCLOVIR,50MG,10 vials 20 ml,INTRAVENOUS,Resolved,SOLUTION,J05AB,DIRECT ACTING ANTIVIRALS,2019-03-18,,2019-04-15,2019-05-21,Delay in shipping of the drug.,2019-03-15,2019-05-22
1181,2352044,Shortage,ADACEL-POLIO,SANOFI PASTEUR LIMITED,"Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine",INACTIVATED POLIOMYELITIS VACCINE  PERTACTIN  FILAMENTOUS HAEMAGGLUTININ  PERTUSSIS TOXOID  FIMBRIAE TYPES 2 AND 3  INACTIVATED POLIOMYELITIS VACCINE  INACTIVATED POLIOMYELITIS VACCINE  TETANUS TOXOID  DIPHTHERIA TOXOID,8UNIT  3MCG  5MCG  2.5MCG  5MCG  32UNIT  40UNIT  5LF  2LF,"10 x 0.5 mL syringes / 10 seringues de 0,5 mL",INTRAMUSCULAR,Resolved,SUSPENSION,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2016-06-22,2016-06-22,,2018-02-01,Disruption of the manufacture of the drug.,2017-03-13,2018-02-11
48932,2237618,Shortage,ADALAT XL - SRT 20MG,BAYER INC,Nifedipine extended-release tablets Bayer Standard,NIFEDIPINE,20MG,28's and 98's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-05-09,2018-09-15,2018-08-14,Disruption of the manufacture of the drug.,2018-05-09,2018-08-15
66163,2237618,Shortage,ADALAT XL - SRT 20MG,BAYER INC,Nifedipine extended-release tablets Bayer Standard,NIFEDIPINE,20MG,28's and 98's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-10-29,2019-04-01,2019-03-27,Disruption of the manufacture of the drug.,2018-11-02,2019-04-02
80356,2237618,Shortage,ADALAT XL - SRT 20MG,BAYER INC,Nifedipine extended-release tablets Bayer Standard,NIFEDIPINE,20MG,28's and 98's,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-03-27,,,Disruption of the manufacture of the drug.,2019-04-03,2019-04-03
88120,2155907,Shortage,ADALAT XL - SRT 30MG,BAYER INC,Nifedipine extended-release tablets Bayer Standard,NIFEDIPINE,30MG,28's and 98's,ORAL,Anticipated shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-12-31,,2020-01-31,,Disruption of the manufacture of the drug.,2019-07-02,2019-09-26
66909,2155907,Shortage,ADALAT XL - SRT 30MG,BAYER INC,Nifedipine extended-release tablets Bayer Standard,NIFEDIPINE,30MG,28's and 98's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-11-08,2019-07-15,2019-06-26,Disruption of the manufacture of the drug.,2018-11-14,2019-07-02
88117,2155990,Shortage,ADALAT XL - SRT 60MG,BAYER INC,Nifedipine extended-release tablets Bayer Standard,NIFEDIPINE,60MG,28's and 98's,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-06-26,,,Disruption of the manufacture of the drug.,2019-07-02,2019-07-02
82835,2155990,Shortage,ADALAT XL - SRT 60MG,BAYER INC,Nifedipine extended-release tablets Bayer Standard,NIFEDIPINE,60MG,28's and 98's,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-07-15,,,2019-06-26,Disruption of the manufacture of the drug.,2019-04-30,2019-07-02
907,326577,Shortage,ADASEPT ACNE GEL,ODAN LABORATORIES LTD,Acne Treatment Gel,TRICLOSAN  SODIUM THIOSULFATE  SALICYLIC ACID,0.5%  8%  2%,15 g,TOPICAL,Actual shortage,LOTION,D02,EMOLLIENTS AND PROTECTIVES,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
74152,2248811,Shortage,ADDERALL XR,SHIRE PHARMA CANADA ULC,Mixed salts amphetamine,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,5.00MG  5.00MG  5.00MG  5.00MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-02-01,2019-02-08,2019-02-07,Delay in shipping of the drug.,2019-02-01,2019-02-08
77992,2248811,Shortage,ADDERALL XR,SHIRE PHARMA CANADA ULC,Mixed salts amphetamine,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,5.00MG  5.00MG  5.00MG  5.00MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2019-03-07,2019-03-05,2019-03-08,2019-03-08,Demand increase for the drug.,2019-03-07,2019-03-09
29048,2267659,Shortage,ADENOSINE INJECTION,FRESENIUS KABI CANADA LTD,Adenosine Injection,ADENOSINE,3MG,3mg/mL 2mL,INTRAVENOUS,Resolved,SOLUTION,C01EB,OTHER CARDIAC PREPARATIONS,,2017-11-10,2018-01-05,2017-12-21,Disruption of the manufacture of the drug.,2017-11-13,2018-02-01
69035,155365,Shortage,ADRENALIN CHLORIDE SOL 1:1000,ERFA CANADA 2012 INC,ADRENALIN TOPICAL SOLUTION 30ML,EPINEPHRINE,1MG,30ML,NASAL,Resolved,SOLUTION,R01AA,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018-11-28,2018-11-23,2019-05-17,2019-05-21,Requirements related to complying with good manufacturing practices.,2018-12-10,2019-05-22
84233,155357,Shortage,ADRENALIN CHLORIDE SOL 1:1000 AMP,ERFA CANADA 2012 INC,ADRENALIN INJ,EPINEPHRINE,1MG,30 ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2019-05-14,2019-05-16,2019-06-25,2019-06-11,Disruption of the manufacture of the drug.,2019-05-16,2019-06-12
56632,155357,Shortage,ADRENALIN CHLORIDE SOL 1:1000 AMP,ERFA CANADA 2012 INC,ADRENALIN,EPINEPHRINE,1MG,10 X 1ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2018-07-20,2018-07-23,,2018-12-10,Requirements related to complying with good manufacturing practices.,2018-07-26,2018-12-11
32385,155357,Shortage,ADRENALIN CHLORIDE SOL 1:1000 AMP,ERFA CANADA 2012 INC,EPINEPHRINE,EPINEPHRINE,1MG,30 ml,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2018-12-12,2018-12-06,2019-02-15,2019-02-11,Other (Please describe in comments),2017-12-11,2019-02-12
74899,155357,Shortage,ADRENALIN CHLORIDE SOL 1:1000 AMP,ERFA CANADA 2012 INC,ADRENALIN INJ 1ML,EPINEPHRINE,1MG,10 X 1ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2019-01-31,2019-02-09,2019-04-10,2019-04-11,Disruption of the manufacture of the drug.,2019-02-06,2019-04-15
89525,155357,Shortage,ADRENALIN CHLORIDE SOL 1:1000 AMP,ERFA CANADA 2012 INC,ADRENALIN INJ 1ML,EPINEPHRINE,1MG,10 X 1ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2019-05-07,2019-05-07,2019-07-19,2019-07-23,Disruption of the manufacture of the drug.,2019-07-17,2019-08-23
77576,2240836,Shortage,ADVAIR 250 DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate and salmeterol inhalation powder,SALMETEROL  FLUTICASONE PROPIONATE,50MCG  250MCG,1x28,INHALATION,Resolved,POWDER,R03AK,"ADRENERGICS, INHALANTS",,2019-02-27,2019-03-08,2019-03-08,Disruption of the manufacture of the drug.,2019-03-04,2019-03-09
17440,2240836,Shortage,ADVAIR 250 DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate and salmeterol inhalation powder,SALMETEROL  FLUTICASONE PROPIONATE,50MCG  250MCG,1x60 doses,INHALATION,Resolved,POWDER,R03AK,"ADRENERGICS, INHALANTS",,2017-08-08,2017-08-28,2017-08-14,Delay in shipping of the drug.,2017-07-28,2017-08-16
11909,2240836,Shortage,ADVAIR 250 DISKUS,GLAXOSMITHKLINE INC,Fluticasone propionate and salmeterol inhalation powder,SALMETEROL  FLUTICASONE PROPIONATE,50MCG  250MCG,1x28 doses,INHALATION,Resolved,POWDER,R03AK,"ADRENERGICS, INHALANTS",,2017-05-31,2017-07-11,2017-07-06,Disruption of the manufacture of the drug.,2017-06-05,2017-07-07
16538,2240837,Shortage,ADVAIR 500 DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate and salmeterol inhalation powder,SALMETEROL  FLUTICASONE PROPIONATE,50MCG  500MCG,1x28 doses,INHALATION,Resolved,POWDER,R03AK,"ADRENERGICS, INHALANTS",,2017-07-17,2017-08-14,2017-08-03,Delay in shipping of the drug.,2017-07-20,2017-08-04
50215,2450267,Shortage,AFINITOR,NOVARTIS PHARMACEUTICALS CANADA INC,AFINITOR 7.5MG TABS (4X7),EVEROLIMUS,7.5MG,4X7,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2018-06-05,,,2018-07-09,Delay in shipping of the drug.,2018-05-24,2018-07-10
43777,2232570,Shortage,AIROMIR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,AIROMIR,SALBUTAMOL,100MCG,n/a,INHALATION,Resolved,METERED-DOSE AEROSOL,R03AC,"ADRENERGICS, INHALANTS",,2018-03-21,,2018-06-11,Other (Please describe in comments),2018-03-23,2018-06-12
78597,35076,Shortage,ALCAINE,ALCON CANADA INC,PROPARACAINE HYDROCHLORIDE,PROXYMETACAINE HYDROCHLORIDE,0.5%,15 mL,OPHTHALMIC,Resolved,DROPS,S01HA,LOCAL ANESTHETICS,2019-03-01,2019-03-01,2019-04-01,2019-04-15,Shortage of an inactive ingredient or component.,2019-03-13,2019-04-16
20982,35076,Shortage,ALCAINE,NOVARTIS PHARMACEUTICALS CANADA INC,ALCAINE 0.5 SOLN 15ML,PROXYMETACAINE HYDROCHLORIDE,0.5%,15ML,OPHTHALMIC,Resolved,DROPS,S01HA,LOCAL ANESTHETICS,,2017-08-25,2017-10-04,2017-10-10,Delay in shipping of the drug.,2017-09-05,2017-11-28
1416,180408,Shortage,ALDACTAZIDE 25,PFIZER CANADA INC,ALDACTAZIDE 25,HYDROCHLOROTHIAZIDE  SPIRONOLACTONE,25MG  25MG,BOTTLE/BOUTEILLE (100),ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017-07-28,,2018-03-13,Other (Please describe in comments),2017-03-13,2018-03-14
45069,594377,Shortage,ALDACTAZIDE 50,PFIZER CANADA INC,Aldactazide 50,HYDROCHLOROTHIAZIDE  SPIRONOLACTONE,50MG  50MG,100's,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2018-04-03,,2018-04-23,Demand increase for the drug.,2018-04-05,2018-04-24
27679,594377,Shortage,ALDACTAZIDE 50,PFIZER CANADA INC,ALDACTAZIDE,HYDROCHLOROTHIAZIDE  SPIRONOLACTONE,50MG  50MG,100 TAB/BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017-11-08,,2018-03-21,Disruption of the manufacture of the drug.,2017-11-01,2018-03-23
21750,285455,Shortage,ALDACTONE 100 MG,PFIZER CANADA INC,ALDACTONE,SPIRONOLACTONE,100MG,100 tabs BTL,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017-10-09,,2018-07-27,Demand increase for the drug.,2017-09-08,2018-07-30
24674,28606,Shortage,ALDACTONE 25 MG,PFIZER CANADA INC,ALDACTONE,SPIRONOLACTONE,25MG,100's,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017-10-16,,2018-09-06,Demand increase for the drug.,2017-10-06,2018-09-07
45577,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,7.5g,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2018-05-24,,,2018-05-24,Other (Please describe in comments),2018-04-12,2018-05-30
58980,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,NA,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2018-10-04,,2019-03-08,Other (Please describe in comments),2018-08-24,2019-03-15
1637,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,IMIQUIMOD Cream,IMIQUIMOD,5%,5.075g,Topical,Avoided shortage,Cream,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017-03-16,2017-02-16,2017-03-16,2017-03-15,Disruption of the manufacture of the drug.,2017-03-13,2017-03-16
7593,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,CREAM,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2017-04-20,2017-05-12,2017-08-24,Delay in shipping of the drug.,2017-04-21,2017-08-25
90558,2239505,Shortage,ALDARA P,"BAUSCH HEALTH, CANADA INC.",ALDARA P,IMIQUIMOD,5%,7.5g,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2019-07-23,,2019-08-27,Demand increase for the drug.,2019-08-01,2019-09-10
79306,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,pump,TOPICAL,Avoided shortage,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2019-06-15,,2019-07-02,2019-05-08,Shortage of an active ingredient.,2019-03-22,2019-05-08
52705,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,7.5g pump,TOPICAL,Avoided shortage,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2018-12-20,,,2018-08-01,Other (Please describe in comments),2018-06-20,2018-08-03
24052,2239505,Shortage,ALDARA P,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALDARA P,IMIQUIMOD,5%,N/A,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017-10-27,,2017-11-03,2018-01-01,Other (Please describe in comments),2017-10-02,2018-01-17
28166,2299712,Shortage,ALENDRONATE,SIVEM PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-07-03,,2018-07-23,Other (Please describe in comments),2017-11-06,2018-07-24
28174,2299712,Shortage,ALENDRONATE,SIVEM PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-07-03,,2018-07-23,Other (Please describe in comments),2017-11-06,2018-07-24
68912,2299712,Shortage,ALENDRONATE,SIVEM PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,50,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2019-01-03,2019-01-04,2019-11-25,2019-11-15,Requirements related to complying with good manufacturing practices.,2018-12-07,2019-11-18
12091,2352966,Shortage,ALENDRONATE,SANIS HEALTH INC,ALENDRONATE TABS,ALENDRONIC ACID,70MG,4's and 100's,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-06-12,2017-06-15,2018-05-31,2018-05-25,Disruption of the manufacture of the drug.,2017-06-06,2018-05-26
85970,2299712,Shortage,ALENDRONATE,SIVEM PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2019-07-29,,2019-12-20,,Requirements related to complying with good manufacturing practices.,2019-06-10,2019-10-07
21985,2352966,Shortage,ALENDRONATE,SANIS HEALTH INC,ALENDRONATE TABS,ALENDRONIC ACID,70MG,"4, 100",ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-06-12,2017-06-15,2018-05-31,2018-05-25,Disruption of the manufacture of the drug.,2017-09-13,2018-05-26
84960,2103052,Shortage,ALERTONIC,ODAN LABORATORIES LTD,Pipradol-vitamin compound,VITAMIN B2  INOSITOL  PYRIDOXINE HYDROCHLORIDE  NICOTINAMIDE  THIAMINE HYDROCHLORIDE  CHOLINE  PIPRADROL HYDROCHLORIDE,0.111MG  2.222MG  0.042MG  1.111MG  0.222MG  2.222MG  0.044MG,500 mL,ORAL,Resolved,ELIXIR,A13A,TONICS,,2019-05-28,,2019-10-22,Shortage of an active ingredient.,2019-05-28,2019-10-23
65688,2414759,Shortage,ALFUZOSIN,PRO DOC LIMITEE,ALFUZOSIN,ALFUZOSIN HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-10-29,,2018-11-30,Other (Please describe in comments),2018-10-29,2018-12-01
8996,2087286,Shortage,ALKERAN,ASPEN PHARMACARE CANADA INC.,Alkeran Injection / Melphalan,MELPHALAN  BUFFER SOLUTION,50MG  10ML,1 vial,INTRAVENOUS  INTRA-ARTERIAL,Resolved,KIT  POWDER FOR SOLUTION  SOLUTION,L01AA,ALKYLATINGAGENTS,2017-06-01,,2017-06-19,2017-06-16,Delay in shipping of the drug.,2017-05-04,2017-06-17
4023,2382067,Shortage,ALLERJECT,KALEO INC,EPINEPHRINE SOLUTION FOR INJECTION USP 1:1000,EPINEPHRINE,0.3MG,2 UNITS/1 CARTON,INTRAMUSCULAR,Actual shortage,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017-03-23,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-23,2018-12-20
4027,2382059,Shortage,ALLERJECT,KALEO INC,"EPINEPHRINE SOLUTION FOR INJECTION, USP 1:1000",EPINEPHRINE,0.15MG,2 UNITS/1CARTON,INTRAMUSCULAR,Actual shortage,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017-03-23,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-23,2018-12-20
89173,2466821,Shortage,ALMOTRIPTAN,SANIS HEALTH INC,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-07-12,2019-09-18,2019-09-06,Disruption of the manufacture of the drug.,2019-07-12,2019-09-07
14180,2424029,Shortage,ALMOTRIPTAN,PRO DOC LIMITEE,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-11-23,,2018-12-21,Delay in shipping of the drug.,2017-06-28,2018-12-22
73682,2466821,Shortage,ALMOTRIPTAN,SANIS HEALTH INC,ALMOTRIPTAN TAB,ALMOTRIPTAN,12.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2019-02-15,2019-02-13,2019-03-29,2019-03-27,Disruption of the manufacture of the drug.,2019-01-28,2019-03-28
52770,893560,Shortage,ALOMIDE,NOVARTIS PHARMACEUTICALS CANADA INC,ALOMIDE SOLUTION 10ML,LODOXAMIDE,0.1%,10 ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,2018-06-22,2018-06-22,2018-07-31,2018-07-26,Demand increase for the drug.,2018-06-22,2018-07-27
58228,893560,Shortage,ALOMIDE,NOVARTIS PHARMACEUTICALS CANADA INC,ALOMIDE SOLN 10ML,LODOXAMIDE,0.1%,10ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,2018-10-17,,2018-10-16,2018-10-17,Delay in shipping of the drug.,2018-08-16,2018-10-18
51063,893560,Shortage,ALOMIDE,NOVARTIS PHARMACEUTICALS CANADA INC,ALOMIDE SOLN 10ML,LODOXAMIDE,0.1%,10ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2018-05-30,2018-06-13,2018-06-13,Demand increase for the drug.,2018-06-01,2018-06-19
22982,2381710,Shortage,ALOXI,PURDUE PHARMA,Aloxi Injection,,,0.25 mg/5 mL,,Resolved,,,,2017-09-21,2017-09-21,2017-10-30,2017-10-23,Disruption of the manufacture of the drug.,2017-09-21,2017-10-24
97091,2236876,Shortage,ALPHAGAN,ALLERGAN INC,brimonidine tartrate,BRIMONIDINE TARTRATE,0.2%,5ml,OPHTHALMIC,Actual shortage,LIQUID,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-10-30,2019-11-05,2019-11-25,,Disruption of the manufacture of the drug.,2019-10-24,2019-11-07
73016,2248151,Shortage,ALPHAGAN P,ALLERGAN INC,brimonidine tartrate,BRIMONIDINE TARTRATE,0.15%,10mL,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-01-21,2019-01-21,2019-01-28,2019-01-22,Other (Please describe in comments),2019-01-21,2019-01-23
97088,2248151,Shortage,ALPHAGAN P,ALLERGAN INC,brimonidine tartrate,BRIMONIDINE TARTRATE,0.15%,10ml,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-10-24,2019-12-18,2019-11-07,Demand increase for the drug.,2019-10-24,2019-11-08
46209,2349205,Shortage,ALPRAZOLAM,SANIS HEALTH INC,ALPRAZOLAM TAB,ALPRAZOLAM,0.50MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-04-25,2018-04-25,2018-05-14,2018-05-08,Other (Please describe in comments),2018-04-18,2018-05-09
82426,2248706,Shortage,ALPRAZOLAM,PRO DOC LIMITEE,ALPRAZOLAM,ALPRAZOLAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-04-25,2019-08-26,2019-08-21,Delay in shipping of the drug.,2019-04-25,2019-08-22
91908,1908189,Shortage,ALPRAZOLAM-0.25,PRO DOC LIMITEE,ALPRAZOLAM,ALPRAZOLAM,.25MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-08-19,2019-09-27,2019-09-27,Delay in shipping of the drug.,2019-08-19,2019-09-28
21851,1908189,Shortage,ALPRAZOLAM-0.25,PRO DOC LIMITEE,ALPRAZOLAM,ALPRAZOLAM,.25MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-09-11,,2017-11-02,Delay in shipping of the drug.,2017-09-11,2017-11-03
62622,1908170,Shortage,ALPRAZOLAM-0.5,PRO DOC LIMITEE,ALPRAZOLAM,ALPRAZOLAM,.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-09-28,,2018-11-08,Delay in shipping of the drug.,2018-09-28,2018-11-09
6454,2320924,Shortage,ALREX,BAUSCH & LOMB INC,ALREX,LOTEPREDNOL ETABONATE,0.2%,-,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,2017-05-31,,2017-06-07,2017-07-14,Other (Please describe in comments),2017-04-11,2017-07-15
52830,2320924,Shortage,ALREX,BAUSCH & LOMB INC,ALREX,LOTEPREDNOL ETABONATE,0.2%,5 ml,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2018-09-05,,2018-10-18,Other (Please describe in comments),2018-06-22,2018-10-19
37001,2221845,Shortage,ALTACE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE,RAMIPRIL,5MG,na,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-01-05,,2018-02-15,Other (Please describe in comments),2018-01-23,2018-02-16
91582,2221837,Shortage,ALTACE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE,RAMIPRIL,2.5MG,30 caps,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-08-02,,2019-10-07,Other (Please describe in comments),2019-08-14,2019-10-09
56810,2221829,Shortage,ALTACE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE,RAMIPRIL,1.25MG,30 caps,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-08,,2018-08-29,Other (Please describe in comments),2018-07-27,2018-08-31
19723,2283158,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  5MG,NA,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-08-17,2017-10-31,2017-11-23,Other (Please describe in comments),2017-08-17,2017-11-24
19730,2283182,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  10.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017-08-16,,2017-10-31,2017-09-06,Other (Please describe in comments),2017-08-17,2017-09-07
19733,2283166,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  10.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-08-16,2017-10-31,2017-11-21,Other (Please describe in comments),2017-08-17,2017-11-22
19736,2283131,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  2.5MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-11-30,,2018-05-15,Other (Please describe in comments),2017-08-17,2018-05-16
62498,2283158,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  5MG,n/a,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-10-16,,2019-03-05,Other (Please describe in comments),2018-09-27,2019-03-06
11351,2283174,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  5.0MG,NA,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-05-26,2017-07-15,2017-09-01,Demand increase for the drug.,2017-05-26,2017-09-02
26483,2283174,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  5.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-10-20,2018-02-15,2018-03-16,Other (Please describe in comments),2017-10-20,2018-03-17
36998,2283166,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  10.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-12-06,,2017-12-06,Other (Please describe in comments),2018-01-23,2018-05-04
49071,2283158,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  5MG,n/a,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-05-08,,2018-07-20,Other (Please describe in comments),2018-05-11,2018-07-23
49074,2283174,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  5.0MG,n/a,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-05-04,,2018-06-08,Other (Please describe in comments),2018-05-11,2018-06-09
32249,2283166,Shortage,ALTACE HCT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ALTACE HCT,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  10.0MG,na,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-12-07,,2018-05-03,Other (Please describe in comments),2017-12-08,2018-05-11
59166,2285614,Shortage,ALVESCO,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,200MCG,30 doses,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-09-01,2018-09-01,2018-11-01,2018-10-22,Shortage of an inactive ingredient or component.,2018-08-26,2018-10-23
54850,2285614,Shortage,ALVESCO,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,200MCG,120 doses,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-07-16,2018-07-13,2018-10-12,2018-10-04,Shortage of an inactive ingredient or component.,2018-07-09,2018-10-12
22634,2285614,Shortage,ALVESCO,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,200MCG,120 doses,INHALATION,Avoided shortage,"AEROSOL, METERED DOSE",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-10-06,,2017-10-20,2017-10-02,Disruption of the manufacture of the drug.,2017-09-19,2017-10-02
80526,2285606,Shortage,ALVESCO,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,100MCG,120 doses,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2019-04-18,2019-04-18,2019-05-09,2019-05-10,Other (Please describe in comments),2019-04-04,2019-05-11
62170,2285606,Shortage,ALVESCO,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,100MCG,120 doses,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2018-09-19,2018-10-31,2018-10-10,Demand increase for the drug.,2018-09-21,2018-10-12
65525,2285606,Shortage,ALVESCO,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,100MCG,120 doses,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2018-10-18,2019-03-15,2019-02-28,Demand increase for the drug.,2018-10-23,2019-03-01
84096,2387875,Shortage,ALYSENA 21,APOTEX INC,ALYSENA,ETHINYL ESTRADIOL  LEVONORGESTREL,20MCG  100MCG,21 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-05-14,2019-08-09,2019-08-05,Disruption of the manufacture of the drug.,2019-05-15,2019-08-08
41160,2387875,Shortage,ALYSENA 21,APOTEX INC,LEVONORGESTREL+ETHINYL ESTRADIOL,ETHINYL ESTRADIOL  LEVONORGESTREL,20MCG  100MCG,21 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-02-23,2018-05-14,2018-05-02,Disruption of the manufacture of the drug.,2018-02-27,2018-05-03
84101,2387883,Shortage,ALYSENA 28,APOTEX INC,ALYSENA,ETHINYL ESTRADIOL  LEVONORGESTREL,20MCG  100MCG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-05-14,2019-09-13,2019-09-13,Disruption of the manufacture of the drug.,2019-05-15,2019-09-16
41130,2387883,Shortage,ALYSENA 28,APOTEX INC,LEVONORGESTREL+ETHINYL ESTRADIOL,ETHINYL ESTRADIOL  LEVONORGESTREL,20MCG  100MCG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-02-23,2018-04-30,2018-04-11,Disruption of the manufacture of the drug.,2018-02-27,2018-04-12
50558,2245274,Shortage,AMARYL,SANOFI-AVENTIS CANADA INC,AMARYL 4mg,GLIMEPIRIDE,4MG,30's,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-05-29,2018-05-29,2018-06-01,2018-06-07,Other (Please describe in comments),2018-05-28,2018-06-12
31479,2245272,Shortage,AMARYL,SANOFI-AVENTIS CANADA INC,Amaryl 1mg,GLIMEPIRIDE,1MG,30.s,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-11-28,2017-12-08,2017-12-15,Other (Please describe in comments),2017-12-01,2017-12-18
12800,2237820,Shortage,AMERGE,GLAXOSMITHKLINE INC,naratriptan hydrochloride tablets,NARATRIPTAN,1MG,2's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-06-26,2017-08-23,2017-08-17,Demand increase for the drug.,2017-06-15,2017-08-18
2581,2237821,Shortage,AMERGE,GLAXOSMITHKLINE INC,Naratriptan hydrochloride tablet,NARATRIPTAN,2.5MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-03-02,2017-05-15,2017-05-11,Disruption of the manufacture of the drug.,2017-03-14,2017-05-12
18730,2237821,Shortage,AMERGE,GLAXOSMITHKLINE INC,naratriptan hydrochloride tablets,NARATRIPTAN,2.5MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-09-15,2017-11-22,2017-11-14,Shortage of an active ingredient.,2017-08-10,2017-11-16
30577,2237820,Shortage,AMERGE,GLAXOSMITHKLINE INC,naratriptan hydrochloride tablets,NARATRIPTAN,1MG,2's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-01-04,2018-05-09,2018-05-09,Demand increase for the drug.,2017-11-24,2018-05-10
81160,2230575,Shortage,AMETOP GEL 4%,SMITH & NEPHEW INC,Tetracaine Hydrochloride Gel,TETRACAINE,40MG,1.5g,TOPICAL,Resolved,GEL,D04AB,"ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.",2019-01-25,2019-02-01,2019-02-21,2019-02-28,Other (Please describe in comments),2019-04-10,2019-04-10
65569,582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LTD,Aminophylline Injection USP,AMINOPHYLLINE,25MG,10 x 10 mL vial,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-11-28,2019-01-09,2019-01-04,Demand increase for the drug.,2018-10-25,2019-01-13
19872,582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LTD,AMINOPHYLLINE INJ 25MG/ML,AMINOPHYLLINE,25MG,10 X 10mL vial,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-06-25,2017-06-25,2018-01-31,2018-02-16,Disruption of the manufacture of the drug.,2017-08-18,2018-06-14
49613,582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LTD,AMINOPHYLLINE INJ 25MG/ML,AMINOPHYLLINE,25MG,10 X 10mL vial,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-05-17,2018-09-24,2018-10-10,Other (Please describe in comments),2018-05-17,2018-10-11
52948,582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LTD,Aminophylline Injection USP,AMINOPHYLLINE,25MG,10 x 10 mL vial,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-05-16,2018-07-30,2018-07-17,Disruption of the manufacture of the drug.,2018-06-26,2018-07-18
19903,582654,Shortage,AMINOPHYLLINE INJ 50MG/ML,OMEGA LABORATORIES LTD,AMINOPHYLLINE INJECTION,AMINOPHYLLINE,50MG,10ML,INTRAVENOUS,Actual shortage,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-10-31,2017-06-28,,,Disruption of the manufacture of the drug.,2017-08-19,2018-06-14
7647,497193,Shortage,AMINOPHYLLINE INJECTION 25MG/ML,HOSPIRA HEALTHCARE CORPORATION,AMINOPHYLLINE,AMINOPHYLLINE,25MG,25x10mL,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-05-29,,2017-07-11,2017-07-11,Disruption of the manufacture of the drug.,2017-04-24,2017-07-14
77967,497193,Shortage,AMINOPHYLLINE INJECTION USP,PFIZER CANADA ULC,Aminophylline,AMINOPHYLLINE,25MG,25 x 10mL AMP,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2019-04-28,,2019-06-25,2019-06-25,Demand increase for the drug.,2019-03-06,2019-06-26
34014,497193,Shortage,AMINOPHYLLINE INJECTION USP,PFIZER CANADA INC,Aminophylline,AMINOPHYLLINE,25MG,25x10mL,INTRAVENOUS,Resolved,SOLUTION,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-04-12,,2018-12-18,Disruption of the manufacture of the drug.,2017-12-20,2018-12-19
41252,2126745,Shortage,AMINOSYN II,ICU MEDICAL CANADA INC,Aminosyn™ II 15% Amino Acid for Injection (Sulfite-free),HISTIDINE  TRYPTOPHAN  N-ACETYL-L-TYROSINE  L-LYSINE  L-ALANINE  METHIONINE  GLYCINE  GLUTAMIC ACID  L-PROLINE  L-ARGININE  L-VALINE  L-ASPARTIC ACID  L-THREONINE  L-PHENYLALANINE  L-LEUCINE  L-ISOLEUCINE  SERINE,450MG  300MG  405MG  1.575G  1.49G  258MG  750MG  1.107G  1.083G  1.527G  750MG  1.05G  600MG  447MG  1.5G  990MG  795MG,2000ML,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2017-06-05,2017-06-05,2019-01-31,2018-10-31,Disruption of the manufacture of the drug.,2018-02-27,2018-11-29
15451,2242325,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,SANDOZ CANADA INCORPORATED,AMIODARONE,AMIODARONE HYDROCHLORIDE,50MG,9ML VIAL,INTRAVENOUS,Resolved,LIQUID,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017-08-01,,2017-08-18,2017-08-18,Delay in shipping of the drug.,2017-07-11,2017-10-18
2515,2242325,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,SANDOZ CANADA INCORPORATED,AMIODARONE,AMIODARONE HYDROCHLORIDE,50MG,18ML,INTRAVENOUS,Resolved,LIQUID,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017-03-14,,2017-09-21,2017-10-16,Disruption of the manufacture of the drug.,2017-03-14,2017-10-18
2315,2326817,Shortage,AMLODIPINE,PRO DOC LIMITEE,AMLODIPINE,AMLODIPINE,10.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-14,,2017-05-24,Delay in shipping of the drug.,2017-03-14,2017-05-29
2336,2326795,Shortage,AMLODIPINE,PRO DOC LIMITEE,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-29,,2017-05-24,Delay in shipping of the drug.,2017-03-14,2017-05-29
2354,2331292,Shortage,AMLODIPINE,SANIS HEALTH INC,AMLODIPINE TABS,AMLODIPINE,10MG,250,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-02-23,2017-08-31,2017-08-11,Shortage of an active ingredient.,2017-03-14,2017-08-18
2367,2331284,Shortage,AMLODIPINE,SANIS HEALTH INC,AMLODIPINE TABS,AMLODIPINE,5MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-02-23,2017-08-31,2017-08-18,Shortage of an active ingredient.,2017-03-14,2017-08-19
4693,2326809,Shortage,AMLODIPINE,PRO DOC LIMITEE,AMLODIPINE,AMLODIPINE,5.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-29,,2017-06-09,Other (Please describe in comments),2017-03-29,2017-06-12
43543,2326523,Shortage,AMOXI-CLAV,PRO DOC LIMITEE,AMOXI-CLAV,AMOXICILLIN  CLAVULANIC ACID,875MG  125MG,100,ORAL,Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-03-27,,2018-05-30,Other (Please describe in comments),2018-03-20,2018-05-31
13144,2401509,Shortage,AMOXICILLIN CAPSULES,SIVEM PHARMACEUTICALS ULC,AMOXICILLIN,AMOXICILLIN,500MG,500,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017-06-16,,2017-07-03,2017-07-16,Delay in shipping of the drug.,2017-06-16,2017-11-03
68116,2462346,Shortage,AMPICILLIN SODIUM FOR INJECTION BP,AURO PHARMA INC,Ampicillin,AMPICILLIN,2G,20 mL/Vial x 10,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-11-29,,2018-12-12,Shortage of an active ingredient.,2018-11-29,2018-12-13
72011,2462338,Shortage,AMPICILLIN SODIUM FOR INJECTION BP,AURO PHARMA INC,Ampicillin,AMPICILLIN,1G,15 mL Vial x10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-01-11,,2019-01-13,Demand increase for the drug.,2019-01-11,2019-01-14
72014,2462346,Shortage,AMPICILLIN SODIUM FOR INJECTION BP,AURO PHARMA INC,Ampicillin,AMPICILLIN,2G,20 mL/Vial x 10,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-01-11,,2019-01-13,Demand increase for the drug.,2019-01-11,2019-01-14
87653,872652,Shortage,"AMPICILLIN SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,AMPICILLIN,AMPICILLIN,500MG,10 PK,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-06-24,2019-11-30,2019-11-06,Disruption of the manufacture of the drug.,2019-06-27,2019-11-07
86939,1933345,Shortage,"AMPICILLIN SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,AMPICILLIN,AMPICILLIN,1000MG,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-06-18,2019-09-30,2019-09-18,Disruption of the manufacture of the drug.,2019-06-18,2019-09-19
86942,1933353,Shortage,"AMPICILLIN SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,AMPICILLIN SODIUM,AMPICILLIN,2000MG,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-06-18,2019-09-30,2019-09-18,Disruption of the manufacture of the drug.,2019-06-18,2019-09-19
93110,872644,Shortage,"AMPICILLIN SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,AMPICILLIN,AMPICILLIN,250MG,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2019-09-05,,2019-09-30,2019-09-18,Disruption of the manufacture of the drug.,2019-09-05,2019-09-19
2473,582212,Shortage,AMSA PD INJ 50MG/ML,ERFA CANADA 2012 INC,Amsa PD INJ,Amsacrine,50 mg,Vial,Injection,Actual shortage,Liquid,L01XX,OTHER ANTINEOPLASTIC AGENTS,2014-07-21,2014-07-21,,,Requirements related to complying with good manufacturing practices.,2017-03-14,2018-03-14
13478,2221861,Shortage,ANANDRON,SANOFI-AVENTIS CANADA INC,Nilutamide,NILUTAMIDE,50MG,90,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017-06-20,2017-06-20,2017-06-26,2017-06-29,Other (Please describe in comments),2017-06-21,2017-07-06
66394,2395649,Shortage,ANASTROZOLE,PRO DOC LIMITEE,ANASTROZOLE,ANASTROZOLE,1MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-11-07,,2019-03-28,Delay in shipping of the drug.,2018-11-07,2019-03-29
42174,2245972,Shortage,ANDRODERM,ALLERGAN PHARMA CO.,Androderm,TESTOSTERONE,24.3MG,Patches,TRANSDERMAL,Resolved,PATCH,G03BA,ANDROGENS,2018-04-06,,2018-05-18,2018-06-15,Other (Please describe in comments),2018-03-07,2018-09-25
22286,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2017-11-03,,2017-11-17,Delay in shipping of the drug.,2017-09-18,2017-11-20
82221,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30,TRANSDERMAL,Avoided shortage,GEL,G03BA,ANDROGENS,2019-06-03,,2019-06-15,2019-05-28,Requirements related to complying with good manufacturing practices.,2019-04-23,2019-05-28
13912,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2017-07-12,,2017-07-14,Disruption of the manufacture of the drug.,2017-06-26,2017-07-17
86893,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,2019-07-03,,2019-07-09,2019-07-09,Delay in shipping of the drug.,2019-06-18,2019-07-10
15737,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,2017-08-01,2017-08-08,,2017-08-18,Disruption of the manufacture of the drug.,2017-07-14,2017-09-18
70013,2249499,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,1.25G,TRANSDERMAL,Avoided shortage,GEL,G03BA,ANDROGENS,2019-02-04,,2019-02-15,2019-02-01,Delay in shipping of the drug.,2018-12-19,2019-02-01
79000,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30 UNIT TRADE CA,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,2019-04-08,,2019-04-22,2019-04-10,Delay in shipping of the drug.,2019-03-20,2019-04-11
32424,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,"5g sachet, 30 units",TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2018-07-09,2018-07-19,2018-07-20,Delay in shipping of the drug.,2017-12-11,2018-07-21
82876,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30s,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,2019-05-23,,2019-06-03,2019-06-03,Delay in shipping of the drug.,2019-04-30,2019-08-15
75969,2249499,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,1 PUMP,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,2019-03-04,,2019-03-08,2019-03-05,Delay in shipping of the drug.,2019-02-15,2019-03-06
75972,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30 UNIT TRADE CA,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,2019-03-06,,2019-03-08,2019-03-08,Delay in shipping of the drug.,2019-02-15,2019-03-09
78794,2249499,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,1.25G,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,2019-04-04,2019-04-05,2019-04-22,2019-04-30,Delay in shipping of the drug.,2019-03-15,2019-05-01
28364,2245345,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,"2.5 g, 30 sachet",TOPICAL,Resolved,GEL,G03BA,ANDROGENS,2018-11-22,2018-11-30,2018-12-17,2018-12-12,Delay in shipping of the drug.,2017-11-06,2018-12-13
78797,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30,TRANSDERMAL,Avoided shortage,GEL,G03BA,ANDROGENS,2019-04-22,,2019-04-30,2019-04-10,Demand increase for the drug.,2019-03-15,2019-04-10
72934,2245346,Shortage,ANDROGEL,BGP PHARMA ULC,ANDROGEL,TESTOSTERONE,1%,30,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,2019-02-12,2019-02-11,2019-03-08,2019-03-08,Delay in shipping of the drug.,2019-01-18,2019-03-09
73486,2268825,Shortage,ANGELIQ,BAYER INC,drospirenone and estradiol,DROSPIRENONE  ESTRADIOL,1.0MG  1.0MG,28's,ORAL,Resolved,TABLET,G03FA,PROGESTOGENS AND ESTROGENS IN COMBINATION,2019-03-11,,2019-04-17,2019-03-18,Disruption of the manufacture of the drug.,2019-01-24,2019-03-19
73358,2418401,Shortage,ANORO ELLIPTA,GLAXOSMITHKLINE INC,umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation,Vilanterol  Umeclidinium,25MCG  62.5MCG,1x7,INHALATION,Resolved,POWDER,R03AL,"ADRENERGICS, INHALANTS",,2019-01-18,2019-02-15,2019-02-07,Demand increase for the drug.,2019-01-23,2019-02-08
38526,2377179,Shortage,ANTI-NAUSEANT,APOTEX INC,DIMENHYDRINATE,DIMENHYDRINATE,50MG,100 BTL,ORAL,Resolved,TABLET,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,2018-05-01,,,2018-09-10,Disruption of the manufacture of the drug.,2018-02-05,2018-09-12
31812,544981,Shortage,APO ACETAMINOPHEN TAB 325MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,325MG,100 BTL,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2017-12-04,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2017-12-05,2018-07-03
93665,544981,Shortage,APO ACETAMINOPHEN TAB 325MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,325MG,100 UD,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2019-09-09,2019-10-18,2019-10-16,Disruption of the manufacture of the drug.,2019-09-12,2019-10-18
701,545007,Shortage,APO ACETAMINOPHEN TAB 500MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,500MG,100 BLS,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017-06-30,2017-06-23,2017-09-29,2017-10-06,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
19582,603279,Shortage,APO AMPI CAPSULES 250MG,APOTEX INC,AMPICILLIN,AMPICILLIN,250MG,100 BTL & 1000 BTL,ORAL,Actual shortage,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-16,2017-10-05
19589,603295,Shortage,APO AMPI CAPSULES 500MG,APOTEX INC,AMPICILLIN,AMPICILLIN,500MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-16,2017-10-05
19578,603260,Shortage,APO AMPI LIQ 125MG/5ML,APOTEX INC,AMPICILLIN,AMPICILLIN,125MG,60/100/150 ML,ORAL,Actual shortage,LIQUID,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-16,2017-10-05
19586,603287,Shortage,APO AMPI LIQ 250MG/5ML,APOTEX INC,AMPICILLIN,AMPICILLIN,250MG,60/100/150 ML,ORAL,Actual shortage,LIQUID,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-16,2017-10-05
18948,472468,Shortage,APO ASA TAB 325MG,APOTEX INC,ASA,ACETYLSALICYLIC ACID,325MG,100 BTL & 500 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18766,402699,Shortage,APO CARBAMAZEPINE TAB 200MG,APOTEX INC,CARBAMAZEPINE,CARBAMAZEPINE,200MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
18757,360287,Shortage,APO CHLORTHALIDONE TAB 100MG,APOTEX INC,CHLORTHALIDONE,CHLORTHALIDONE,100MG,100 BTL,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
14163,487872,Shortage,APO CIMETIDINE TAB 300MG,APOTEX INC,CIMETIDINE,CIMETIDINE,300MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-08-15,2017-07-17,2017-08-31,2017-08-18,Disruption of the manufacture of the drug.,2017-06-28,2017-08-21
93,487872,Shortage,APO CIMETIDINE TAB 300MG,APOTEX INC,CIMETIDINE,CIMETIDINE,300MG,1000 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-01,2017-06-09,2017-06-07,Disruption of the manufacture of the drug.,2017-03-10,2017-06-08
43505,487872,Shortage,APO CIMETIDINE TAB 300MG,APOTEX INC,CIMETIDINE,CIMETIDINE,300MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-03-19,2018-06-22,2018-06-25,Disruption of the manufacture of the drug.,2018-03-20,2018-07-03
99,600059,Shortage,APO CIMETIDINE TAB 400MG,APOTEX INC,CIMETIDINE,CIMETIDINE,400MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2015-01-23,,,Disruption of the manufacture of the drug.,2017-03-10,2017-10-05
104,600067,Shortage,APO CIMETIDINE TAB 600MG,APOTEX INC,CIMETIDINE,CIMETIDINE,600MG,100 BTL,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-08-23,,,Disruption of the manufacture of the drug.,2017-03-10,2018-09-08
18970,618292,Shortage,APO CLOXI CAP 250MG,APOTEX INC,CLOXACILLIN,CLOXACILLIN SODIUM,250MG,100 BTL & 1000 BTL,ORAL,Actual shortage,CAPSULE,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18967,618284,Shortage,APO CLOXI CAP 500MG,APOTEX INC,CLOXACILLIN,CLOXACILLIN SODIUM,500MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18973,644633,Shortage,APO CLOXI FOR ORAL SOLN 125MG/5ML,APOTEX INC,CLOXACILLIN,CLOXACILLIN SODIUM,125MG,100 ML/200 ML/60ML,ORAL,Actual shortage,POWDER FOR SOLUTION,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
20866,362158,Shortage,APO DIAZEPAM TAB 5MG,APOTEX INC,DIAZEPAM,DIAZEPAM,5MG,1000 BTL,ORAL,Avoided shortage,TABLET,N05BA,ANXIOLYTICS,2017-10-31,2017-10-25,2017-11-30,2017-10-25,Disruption of the manufacture of the drug.,2017-09-05,2017-10-31
8587,362158,Shortage,APO DIAZEPAM TAB 5MG,APOTEX INC,DIAZEPAM,DIAZEPAM,5MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-05-01,2017-06-26,2017-06-12,Disruption of the manufacture of the drug.,2017-05-02,2017-06-13
54174,362158,Shortage,APO DIAZEPAM TAB 5MG,APOTEX INC,DIAZEPAM,DIAZEPAM,5MG,1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-07-02,,2018-09-08,Disruption of the manufacture of the drug.,2018-07-04,2018-09-09
15252,771376,Shortage,APO DILTIAZ TAB 30MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,30MG,100 BTL,ORAL,Resolved,TABLET,C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-07-10,2018-10-19,2018-09-24,Disruption of the manufacture of the drug.,2017-07-11,2018-09-28
11066,771384,Shortage,APO DILTIAZ TAB 60MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,60MG,100 BTL,ORAL,Resolved,TABLET,C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017-07-31,2017-07-31,2018-10-19,2018-10-15,Disruption of the manufacture of the drug.,2017-05-24,2018-10-17
3622,363766,Shortage,APO DIMENHYDRINATE TAB 50MG,APOTEX INC,DIMENHYDRINATE,DIMENHYDRINATE,50MG,1000 BTL,ORAL,Resolved,TABLET,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2017-03-20,2017-04-28,2017-04-28,Disruption of the manufacture of the drug.,2017-03-20,2017-05-02
38518,363766,Shortage,APO DIMENHYDRINATE TAB 50MG,APOTEX INC,DIMENHYDRINATE,DIMENHYDRINATE,50MG,1000 BTL,ORAL,Resolved,TABLET,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2018-02-01,,2018-02-23,Other (Please describe in comments),2018-02-05,2018-02-26
38523,363766,Shortage,APO DIMENHYDRINATE TAB 50MG,APOTEX INC,DIMENHYDRINATE,DIMENHYDRINATE,50MG,100 BTL,ORAL,Resolved,TABLET,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,2018-02-23,,,2018-02-23,Disruption of the manufacture of the drug.,2018-02-05,2018-02-26
39653,426849,Shortage,APO FOLIC ACID TAB 5MG,APOTEX INC,FOLIC ACID,FOLIC ACID,5MG,1000 BTL,ORAL,Resolved,TABLET,B03BB,VITAMIN B12 AND FOLIC ACID,,2018-02-12,2019-01-15,2019-01-15,Disruption of the manufacture of the drug.,2018-02-13,2019-01-16
56983,396788,Shortage,APO FUROSEMIDE TAB 20MG,APOTEX INC,FUROSEMIDE,FUROSEMIDE,20MG,1000 BTL,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2018-07-30,2018-10-31,2018-10-10,Disruption of the manufacture of the drug.,2018-07-31,2018-10-11
55839,362166,Shortage,APO FUROSEMIDE TAB 40MG,APOTEX INC,FUROSEMIDE,FUROSEMIDE,40MG,100 BTL,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2018-07-16,2018-10-31,2018-09-10,Disruption of the manufacture of the drug.,2018-07-16,2018-09-11
327,707570,Shortage,APO FUROSEMIDE TAB 80MG,APOTEX INC,FUROSEMIDE,FUROSEMIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2017-02-27,2017-05-31,2017-05-31,Disruption of the manufacture of the drug.,2017-03-11,2017-06-05
57789,707570,Shortage,APO FUROSEMIDE TAB 80MG,APOTEX INC,FUROSEMIDE,FUROSEMIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2018-08-06,2018-11-16,2018-11-02,Disruption of the manufacture of the drug.,2018-08-09,2018-11-03
17237,1913662,Shortage,APO GLYBURIDE TAB 5MG,APOTEX INC,GLYBURIDE,GLYBURIDE,5MG,100 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-09-15,,2017-10-31,2017-10-02,Disruption of the manufacture of the drug.,2017-07-26,2017-10-05
18957,587702,Shortage,APO HALOPERIDOL LIQ 2MG/ML,APOTEX INC,HALOPERIDOL,HALOPERIDOL,2MG,100 ML & 500 ML & 15 ML,ORAL,Actual shortage,SOLUTION,N05AD,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18760,396796,Shortage,APO HALOPERIDOL TAB 0.5MG,APOTEX INC,HALOPERIDOL,HALOPERIDOL,.5MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,N05AD,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
18763,396818,Shortage,APO HALOPERIDOL TAB 1MG,APOTEX INC,HALOPERIDOL,HALOPERIDOL,1MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,N05AD,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
330,644552,Shortage,APO HYDRO TAB 100MG,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,100MG,100 BTL,ORAL,Actual shortage,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2014-04-17,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
47102,312800,Shortage,APO HYDRO TAB 50MG,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,50MG,100 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2018-04-23,2018-08-03,2018-06-29,Disruption of the manufacture of the drug.,2018-04-24,2018-07-03
11069,646059,Shortage,APO HYDROXYZINE CAP 10MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017-06-09,2017-06-05,2017-08-31,2017-08-09,Disruption of the manufacture of the drug.,2017-05-24,2017-08-10
12289,646024,Shortage,APO HYDROXYZINE CAP 25MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017-07-21,,2017-08-31,2017-09-15,Disruption of the manufacture of the drug.,2017-06-08,2017-09-22
5900,646024,Shortage,APO HYDROXYZINE CAP 25MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017-04-21,,2017-06-07,2017-06-02,Disruption of the manufacture of the drug.,2017-04-07,2017-06-05
11072,646016,Shortage,APO HYDROXYZINE CAP 50MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,2017-06-26,2017-06-12,2017-08-31,2017-09-15,Disruption of the manufacture of the drug.,2017-05-24,2017-09-22
36288,646016,Shortage,APO HYDROXYZINE CAP 50MG,APOTEX INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,,2018-01-15,2018-04-06,2018-04-06,Disruption of the manufacture of the drug.,2018-01-17,2018-04-09
85597,441651,Shortage,APO IBUPROFEN TAB 300MG,APOTEX INC,IBUPROFEN,IBUPROFEN,300MG,100 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-06-03,,,Disruption of the manufacture of the drug.,2019-06-05,2019-06-05
77890,506052,Shortage,APO IBUPROFEN TAB 400MG,APOTEX INC,IBUPROFEN TAB 400MG,IBUPROFEN,400MG,1000 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-03-04,,,Disruption of the manufacture of the drug.,2019-03-06,2019-05-27
79042,506052,Shortage,APO IBUPROFEN TAB 400MG,APOTEX INC,IBUPROFEN TAB 400MG,IBUPROFEN,400MG,100 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-03-18,,,Disruption of the manufacture of the drug.,2019-03-21,2019-05-27
67023,506052,Shortage,APO IBUPROFEN TAB 400MG,APOTEX INC,IBUPROFEN TAB 400MG,IBUPROFEN,400MG,1000 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-11-12,,2018-12-07,Disruption of the manufacture of the drug.,2018-11-16,2018-12-08
42694,585114,Shortage,APO IBUPROFEN TAB 600MG,APOTEX INC,IBUPROFEN,IBUPROFEN,600MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-03-12,2018-06-08,2018-05-08,Disruption of the manufacture of the drug.,2018-03-13,2018-05-09
71665,585114,Shortage,APO IBUPROFEN TAB 600MG,APOTEX INC,IBUPROFEN TAB 600MG,IBUPROFEN,600MG,100 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-01-08,2020-02-07,,Disruption of the manufacture of the drug.,2019-01-09,2019-08-21
18961,611158,Shortage,APO INDOMETHACIN CAP 25MG,APOTEX INC,INDOMETHACIN,INDOMETHACIN,25MG,100 BTL & 1000 BTL,ORAL,Actual shortage,CAPSULE,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18964,611166,Shortage,APO INDOMETHACIN CAP 50MG,APOTEX INC,INDOMETHACIN,INDOMETHACIN,50MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18916,441708,Shortage,APO METHAZIDE 15,APOTEX INC,METHAZIDE,HYDROCHLOROTHIAZIDE  METHYLDOPA,15MG  250MG,100 BTL,ORAL,Actual shortage,TABLET,C02LB,ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
18936,441716,Shortage,APO METHAZIDE 25,APOTEX INC,METHAZIDE,HYDROCHLOROTHIAZIDE  METHYLDOPA,25MG  250MG,100 BTL,ORAL,Actual shortage,TABLET,C02LB,ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
16879,592277,Shortage,APO NAPROXEN TAB 500MG,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-07-24,2017-08-11,2017-08-11,Disruption of the manufacture of the drug.,2017-07-25,2017-09-22
16881,592277,Shortage,APO NAPROXEN TAB 500MG,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL,Avoided shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-12-18,,,2017-11-08,Disruption of the manufacture of the drug.,2017-07-25,2017-11-09
46027,402680,Shortage,APO OXAZEPAM TAB 10MG,APOTEX INC,OXAZEPAM,OXAZEPAM,10MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-04-16,2018-07-27,2018-06-29,Disruption of the manufacture of the drug.,2018-04-16,2018-07-03
43516,402745,Shortage,APO OXAZEPAM TAB 15MG,APOTEX INC,OXAZEPAM,OXAZEPAM,15MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-03-19,2018-08-31,2018-06-29,Disruption of the manufacture of the drug.,2018-03-20,2018-07-03
69455,402737,Shortage,APO OXAZEPAM TAB 30MG,APOTEX INC,OXAZEPAM,OXAZEPAM,30MG,1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-12-10,2018-12-10,2019-01-31,2019-01-24,Disruption of the manufacture of the drug.,2018-12-13,2019-01-28
48846,402737,Shortage,APO OXAZEPAM TAB 30MG,APOTEX INC,OXAZEPAM,OXAZEPAM,30MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-05-07,2018-07-31,2018-06-29,Disruption of the manufacture of the drug.,2018-05-08,2018-07-03
18939,441724,Shortage,APO OXTRIPHYLLINE TAB 100MG,APOTEX INC,OXTRIPHYLLINE,OXTRIPHYLLINE,100MG,100 BTL,ORAL,Actual shortage,TABLET,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18942,441732,Shortage,APO OXTRIPHYLLINE TAB 200MG,APOTEX INC,OXTRIPHYLLINE,OXTRIPHYLLINE,200MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18954,511692,Shortage,APO OXTRIPHYLLINE TAB 300MG,APOTEX INC,OXTRIPHYLLINE,OXTRIPHYLLINE,300MG,100 BTL,ORAL,Actual shortage,TABLET,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
429,642223,Shortage,APO PEN VK,APOTEX INC,PENICILLIN,PENICILLIN V POTASSIUM,200000UNIT,100 ML,ORAL,Resolved,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014-08-05,,2019-03-08,Disruption of the manufacture of the drug.,2017-03-11,2019-03-09
432,642231,Shortage,APO PEN VK,APOTEX INC,PENICILLIN,PENICILLIN V POTASSIUM,480000UNIT,100 ML,ORAL,Resolved,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014-10-09,,2019-03-04,Disruption of the manufacture of the drug.,2017-03-11,2019-03-08
41862,642886,Shortage,APO PIROXICAM CAP 10MG,APOTEX INC,PIROXICAM,PIROXICAM,10MG,100 BTL,ORAL,Resolved,CAPSULE,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-03-05,2018-10-31,2018-10-29,Disruption of the manufacture of the drug.,2018-03-06,2018-10-30
49506,550957,Shortage,APO PREDNISONE TAB 50MG,APOTEX INC,PREDNISONE,PREDNISONE,50MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2018-07-27,2018-07-16,2018-08-27,2018-08-27,Disruption of the manufacture of the drug.,2018-05-15,2018-08-31
12692,550957,Shortage,APO PREDNISONE TAB 50MG,APOTEX INC,PREDNISONE,PREDNISONE,50MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-06-12,2017-07-14,2017-07-28,Disruption of the manufacture of the drug.,2017-06-13,2017-07-31
26629,312770,Shortage,APO PREDNISONE TAB 5MG,APOTEX INC,PREDNISONE,PREDNISONE,5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-10-23,2017-11-30,2017-11-17,Disruption of the manufacture of the drug.,2017-10-23,2017-11-20
7234,312770,Shortage,APO PREDNISONE TAB 5MG,APOTEX INC,PREDNISONE,PREDNISONE,5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-04-19,2017-04-28,2017-04-28,Disruption of the manufacture of the drug.,2017-04-19,2017-05-01
14003,312770,Shortage,APO PREDNISONE TAB 5MG,APOTEX INC,PREDNISONE,PREDNISONE,5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-06-26,2017-08-08,2017-07-27,Disruption of the manufacture of the drug.,2017-06-27,2017-07-28
18913,402788,Shortage,APO PROPRANOLOL TAB 10MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,10MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
18951,504335,Shortage,APO PROPRANOLOL TAB 120MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,120MG,100 BTL,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18769,402753,Shortage,APO PROPRANOLOL TAB 40MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,40MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
18910,402761,Shortage,APO PROPRANOLOL TAB 80MG,APOTEX INC,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,80MG,100 BTL & 1000 BTL,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
45343,445282,Shortage,APO SULFATRIM DS TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,800MG  160MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018-04-09,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2018-04-10,2018-07-03
66546,445282,Shortage,APO SULFATRIM DS TAB,APOTEX INC,SULFATRIM 800-160MG,SULFAMETHOXAZOLE  TRIMETHOPRIM,800MG  160MG,500 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018-11-05,2019-01-04,2018-12-28,Disruption of the manufacture of the drug.,2018-11-09,2019-01-03
30971,445282,Shortage,APO SULFATRIM DS TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,800MG  160MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018-01-01,2018-01-08,2018-01-08,Disruption of the manufacture of the drug.,2017-11-28,2018-01-10
39676,445282,Shortage,APO SULFATRIM DS TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,800MG  160MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018-02-12,2018-04-09,2018-03-15,Disruption of the manufacture of the drug.,2018-02-13,2018-03-16
27741,445274,Shortage,APO SULFATRIM TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,400MG  80MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,2018-01-31,2018-01-15,2018-04-02,2018-03-14,Disruption of the manufacture of the drug.,2017-11-01,2018-03-15
44197,445274,Shortage,APO SULFATRIM TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,400MG  80MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018-03-26,2018-06-29,2018-06-01,Disruption of the manufacture of the drug.,2018-03-29,2018-06-04
69321,445274,Shortage,APO SULFATRIM TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,400MG  80MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,2018-12-10,2018-12-10,2018-12-27,2018-12-19,Disruption of the manufacture of the drug.,2018-12-12,2018-12-21
57823,445274,Shortage,APO SULFATRIM TAB,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,400MG  80MG,100 BTL,ORAL,Resolved,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018-08-06,2018-09-28,2018-08-28,Disruption of the manufacture of the drug.,2018-08-09,2018-08-29
27770,441775,Shortage,APO TRIAZIDE,APOTEX INC,TRIAZIDE,TRIAMTERENE  HYDROCHLOROTHIAZIDE,50MG  25MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017-10-30,2018-03-02,2018-02-16,Disruption of the manufacture of the drug.,2017-11-01,2018-02-17
10439,441775,Shortage,APO TRIAZIDE,APOTEX INC,TRIAZIDE,TRIAMTERENE  HYDROCHLOROTHIAZIDE,50MG  25MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017-05-15,2017-08-04,2017-07-19,Disruption of the manufacture of the drug.,2017-05-16,2017-07-20
8,2396769,Shortage,APO-ABACAVIR,APOTEX INC,Abacavir,ABACAVIR,300MG,60 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2017-01-31,2017-05-15,2017-04-27,Disruption of the manufacture of the drug.,2017-03-10,2017-04-28
34826,2396769,Shortage,APO-ABACAVIR,APOTEX INC,ABACAVIR SULFATE,ABACAVIR,300MG,60 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2018-01-02,2018-03-19,2018-01-15,Disruption of the manufacture of the drug.,2018-01-03,2018-01-18
67019,2396769,Shortage,APO-ABACAVIR,APOTEX INC,ABACAVIR 300MG,ABACAVIR,300MG,60 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2018-11-12,2019-02-08,2019-01-21,Disruption of the manufacture of the drug.,2018-11-16,2019-01-23
34878,2399539,Shortage,APO-ABACAVIR-LAMIVUDINE,APOTEX INC,ABACAVIR-LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30 BLS,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2018-01-02,2018-02-09,2018-01-12,Disruption of the manufacture of the drug.,2018-01-04,2018-01-16
92016,2399539,Shortage,APO-ABACAVIR-LAMIVUDINE,APOTEX INC,ABACAVIR-LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30 BLS,ORAL,Actual shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-08-19,,,Disruption of the manufacture of the drug.,2019-08-21,2019-08-26
82102,2399539,Shortage,APO-ABACAVIR-LAMIVUDINE,APOTEX INC,ABACAVIR-LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30 BLS,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-04-17,2019-08-09,2019-07-26,Disruption of the manufacture of the drug.,2019-04-22,2019-07-29
71098,2399539,Shortage,APO-ABACAVIR-LAMIVUDINE,APOTEX INC,ABACAVIR-LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30 BLS,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-01-02,2019-01-25,2019-01-21,Disruption of the manufacture of the drug.,2019-01-03,2019-01-23
14,2416255,Shortage,APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE,APOTEX INC,Abacavir-Lamivudine-Zidovudine,ZIDOVUDINE  ABACAVIR  LAMIVUDINE,300MG  300MG  150MG,60 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017-02-27,2017-05-31,2017-05-19,Disruption of the manufacture of the drug.,2017-03-10,2017-05-23
68700,2416255,Shortage,APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE,APOTEX INC,ABACAVIR-LAMIVUDINE-ZIDOVUDINE,ZIDOVUDINE  ABACAVIR  LAMIVUDINE,300MG  300MG  150MG,60BTL,ORAL,Actual shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2018-12-03,,,Disruption of the manufacture of the drug.,2018-12-05,2019-03-15
69911,2147629,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL 400MG,ACEBUTOLOL,400MG,100BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-12-18,2019-02-04,2019-01-30,Disruption of the manufacture of the drug.,2018-12-18,2019-02-01
68706,2147602,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,100MG,500BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-12-03,2019-02-08,2019-01-30,Disruption of the manufacture of the drug.,2018-12-05,2019-02-01
20846,2147602,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,100MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-10-06,2017-09-22,2018-11-30,2018-11-07,Disruption of the manufacture of the drug.,2017-09-04,2018-11-09
20849,2147610,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,200MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-09-22,2018-11-30,2018-11-08,Disruption of the manufacture of the drug.,2017-09-04,2018-11-09
20854,2147629,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,400MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-09-29,2017-09-22,2018-11-30,2018-11-07,Disruption of the manufacture of the drug.,2017-09-05,2018-11-09
69293,2147602,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,100MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-12-10,2018-12-10,2019-02-08,2019-01-30,Disruption of the manufacture of the drug.,2018-12-12,2019-02-01
92962,2229977,Shortage,APO-ACETAMINOPHEN CAPLETS 500MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,500MG,1000 BTL,ORAL,Actual shortage,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2019-09-03,2020-01-03,,Disruption of the manufacture of the drug.,2019-09-04,2019-11-18
17198,2207656,Shortage,APO-ACYCLOVIR,APOTEX INC,ACYCLOVIR,ACYCLOVIR,800MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-08-31,2017-08-07,2018-01-05,2017-12-29,Disruption of the manufacture of the drug.,2017-07-26,2017-12-31
89152,2207656,Shortage,APO-ACYCLOVIR,APOTEX INC,ACYCLOVIR,ACYCLOVIR,800MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-08,2019-10-25,2019-08-30,Disruption of the manufacture of the drug.,2019-07-12,2019-08-31
41841,2207656,Shortage,APO-ACYCLOVIR,APOTEX INC,ACYCLOVIR,ACYCLOVIR,800MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-03-05,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2018-03-06,2018-07-03
36257,2207656,Shortage,APO-ACYCLOVIR,APOTEX INC,ACYCLOVIR,ACYCLOVIR,800MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-01-15,2018-02-26,2018-01-30,Disruption of the manufacture of the drug.,2018-01-17,2018-01-31
41834,2207621,Shortage,APO-ACYCLOVIR - TAB 200MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,200MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-03-05,2018-07-16,2018-06-29,Disruption of the manufacture of the drug.,2018-03-06,2018-07-03
630,2207621,Shortage,APO-ACYCLOVIR - TAB 200MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,200MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-04-09,2017-03-20,2017-05-01,2017-04-20,Disruption of the manufacture of the drug.,2017-03-12,2017-04-21
20857,2207621,Shortage,APO-ACYCLOVIR - TAB 200MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,200MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-10-31,2017-10-02,2018-01-05,2017-12-29,Disruption of the manufacture of the drug.,2017-09-05,2017-12-31
18,2207648,Shortage,APO-ACYCLOVIR - TAB 400MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,400MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-09-04,2018-02-19,2018-01-30,Disruption of the manufacture of the drug.,2017-03-10,2018-01-31
41838,2207648,Shortage,APO-ACYCLOVIR - TAB 400MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,400MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-03-05,2018-06-29,2018-05-23,Disruption of the manufacture of the drug.,2018-03-06,2018-05-24
89570,2207648,Shortage,APO-ACYCLOVIR - TAB 400MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,400MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-11,2019-10-25,2019-08-29,Disruption of the manufacture of the drug.,2019-07-17,2019-08-30
21,2207656,Shortage,APO-ACYCLOVIR - TAB 800MG,APOTEX INC,ACYCLOVIR,ACYCLOVIR,800MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-02-27,2017-05-01,2017-04-20,Disruption of the manufacture of the drug.,2017-03-10,2017-04-21
49415,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-05-28,2018-05-28,2018-07-25,2018-06-29,Disruption of the manufacture of the drug.,2018-05-15,2018-07-03
18512,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-08-04,2017-12-29,2017-12-29,Disruption of the manufacture of the drug.,2017-08-08,2017-12-31
25204,2248727,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,5MG,30 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-10-09,2018-03-30,2018-03-26,Disruption of the manufacture of the drug.,2017-10-11,2018-03-27
633,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-04-29,2017-03-28,2017-06-06,2017-06-04,Disruption of the manufacture of the drug.,2017-03-12,2017-06-05
9849,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-05-08,2017-07-20,2017-07-18,Disruption of the manufacture of the drug.,2017-05-10,2017-07-19
54162,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-07-02,2018-11-16,2018-10-05,Disruption of the manufacture of the drug.,2018-07-04,2018-10-09
59284,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-08-27,2018-12-28,2018-11-23,Disruption of the manufacture of the drug.,2018-08-27,2018-11-26
44966,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-04-02,2018-07-05,2018-05-23,Disruption of the manufacture of the drug.,2018-04-04,2018-05-24
13300,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-06-19,2017-09-20,2017-09-01,Disruption of the manufacture of the drug.,2017-06-19,2017-09-03
86271,2248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-06-10,2019-07-11,2019-07-11,Disruption of the manufacture of the drug.,2019-06-12,2019-07-12
30793,2454475,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4 BLS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-11-27,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2017-11-27,2018-07-03
15962,2454467,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE,ALENDRONIC ACID  VITAMIN D3,70MG  2800UNIT,4 BLS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-11-13,2018-05-31,2018-04-05,Disruption of the manufacture of the drug.,2017-07-17,2018-04-06
67708,2454475,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE/VITAMIN D3 70MG/5600UNIT,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4 BLS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-11-26,2019-01-04,2019-01-02,Disruption of the manufacture of the drug.,2018-11-27,2019-01-03
28534,2315866,Shortage,APO-ALFUZOSIN,APOTEX INC,ALFUZOSIN,ALFUZOSIN HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-11-06,2018-01-31,2018-01-17,Disruption of the manufacture of the drug.,2017-11-07,2018-01-18
74014,2402785,Shortage,APO-ALLOPURINOL,APOTEX INC,ALLOPURINOL,ALLOPURINOL,300MG,100 BTL,ORAL,Resolved,TABLET,M04AA,ANTIGOUT PREPARATIONS,,2019-01-28,2019-02-14,2019-02-12,Disruption of the manufacture of the drug.,2019-01-30,2019-02-13
24,2405806,Shortage,APO-ALMOTRIPTAN,APOTEX INC,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014-10-01,,2019-05-13,Disruption of the manufacture of the drug.,2017-03-10,2019-05-14
27,2405792,Shortage,APO-ALMOTRIPTAN,APOTEX INC,ALMOTRIPTAN,ALMOTRIPTAN,6.25MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014-10-01,,2019-05-13,Disruption of the manufacture of the drug.,2017-03-10,2019-05-14
77869,865400,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZ,ALPRAZOLAM,.5MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-03-04,2019-09-06,2019-09-04,Disruption of the manufacture of the drug.,2019-03-06,2019-09-05
93262,865400,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZ,ALPRAZOLAM,.5MG,1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-03-04,2019-10-18,2019-09-13,Disruption of the manufacture of the drug.,2019-09-09,2019-09-16
47950,865400,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZOLAM,ALPRAZOLAM,.5MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-04-30,2018-11-02,2018-11-01,Disruption of the manufacture of the drug.,2018-05-02,2018-11-02
70520,865397,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZOLAM 0.25MG,ALPRAZOLAM,0.25MG,1000BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-12-21,2019-10-18,2019-09-13,Disruption of the manufacture of the drug.,2018-12-27,2019-09-16
54165,865397,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZOLAM,ALPRAZOLAM,0.25MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-07-02,2018-10-31,2018-10-11,Disruption of the manufacture of the drug.,2018-07-04,2018-10-12
77974,865400,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZ,ALPRAZOLAM,.5MG,1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-03-04,2019-10-18,2019-09-06,Disruption of the manufacture of the drug.,2019-03-06,2019-09-09
82331,2243611,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZ,ALPRAZOLAM,1MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-04-22,2019-08-01,2019-08-01,Disruption of the manufacture of the drug.,2019-04-24,2019-08-02
79036,865397,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZ,ALPRAZOLAM,0.25MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-03-18,2019-10-18,2019-09-13,Disruption of the manufacture of the drug.,2019-03-21,2019-09-16
46015,2243611,Shortage,APO-ALPRAZ,APOTEX INC,ALPRAZOLAM,ALPRAZOLAM,1MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-04-16,2018-10-31,2018-10-12,Disruption of the manufacture of the drug.,2018-04-16,2018-10-15
54168,2243612,Shortage,APO-ALPRAZ TS,APOTEX INC,ALPRAZOLAM,ALPRAZOLAM,2MG,100 BTL,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2018-07-02,,,Disruption of the manufacture of the drug.,2018-07-04,2019-11-05
12241,2243612,Shortage,APO-ALPRAZ TS,APOTEX INC,ALPRAZOLAM,ALPRAZOLAM,2MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2017-07-17,2017-06-19,2017-10-25,2017-10-20,Disruption of the manufacture of the drug.,2017-06-07,2017-10-24
69296,784400,Shortage,APO-AMILZIDE TAB,APOTEX INC,AMILZIDE,HYDROCHLOROTHIAZIDE  AMILORIDE HYDROCHLORIDE,50MG  5MG,1000 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,2018-12-10,2018-12-10,2019-01-18,2019-01-14,Disruption of the manufacture of the drug.,2018-12-12,2019-01-17
11956,784400,Shortage,APO-AMILZIDE TAB,APOTEX INC,AMILZIDE,HYDROCHLOROTHIAZIDE  AMILORIDE HYDROCHLORIDE,50MG  5MG,100 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017-06-05,2017-08-31,2017-06-12,Disruption of the manufacture of the drug.,2017-06-06,2017-06-14
26557,784400,Shortage,APO-AMILZIDE TAB,APOTEX INC,AMILZIDE,HYDROCHLOROTHIAZIDE  AMILORIDE HYDROCHLORIDE,50MG  5MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017-10-23,2018-08-10,2018-07-10,Disruption of the manufacture of the drug.,2017-10-23,2018-07-11
49418,2246194,Shortage,APO-AMIODARONE TABLETS,APOTEX INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100 BTL,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2018-06-29,2018-06-25,2018-11-02,2018-10-29,Disruption of the manufacture of the drug.,2018-05-15,2018-11-02
95821,2273373,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,5.0MG,100 BTL,ORAL,Actual shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-10-07,2019-11-25,,Disruption of the manufacture of the drug.,2019-10-09,2019-10-09
47963,2273373,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,5.0MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-04-30,2018-07-23,2018-07-23,Disruption of the manufacture of the drug.,2018-05-02,2018-07-25
41847,2273381,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-03-05,2018-08-31,2018-08-13,Disruption of the manufacture of the drug.,2018-03-06,2018-08-14
59287,2273381,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,10.0MG,100 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-08-27,2018-11-15,2018-10-18,Disruption of the manufacture of the drug.,2018-08-27,2018-10-19
57766,2273373,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,5.0MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-08-06,2018-10-15,2018-09-28,Disruption of the manufacture of the drug.,2018-08-09,2018-09-29
42669,2273373,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,5.0MG,100 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-03-12,2018-05-31,2018-04-18,Disruption of the manufacture of the drug.,2018-03-13,2018-04-19
35536,2273373,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,5.0MG,500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-01-08,2018-05-31,2018-04-18,Disruption of the manufacture of the drug.,2018-01-10,2018-04-19
23533,2273373,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,5.0MG,500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-09-25,2017-10-31,2017-09-29,Disruption of the manufacture of the drug.,2017-09-26,2017-10-03
32511,2273381,Shortage,APO-AMLODIPINE,APOTEX INC,AMLODIPINE,AMLODIPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-12-11,2018-02-14,2018-01-23,Disruption of the manufacture of the drug.,2017-12-12,2018-01-24
19213,2411296,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE  ATORVASTATIN,5MG  80MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2017-08-14,2017-10-23,2017-10-23,Disruption of the manufacture of the drug.,2017-08-14,2017-10-24
33,2411288,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE  ATORVASTATIN,5MG  40MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2017-02-14,2017-03-15,2017-03-16,Disruption of the manufacture of the drug.,2017-03-10,2017-04-04
37945,2411253,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE  ATORVASTATIN,5MG  10MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",2018-04-02,2018-03-26,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2018-02-01,2018-07-03
15420,2411261,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE  ATORVASTATIN,5MG  20MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2017-07-10,2017-08-25,2017-08-04,Disruption of the manufacture of the drug.,2017-07-11,2017-08-08
37717,2411296,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE  ATORVASTATIN,5MG  80MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2018-01-29,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2018-01-31,2018-07-03
75608,2411342,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODOPINE-ATORVASTATIN,AMLODIPINE  ATORVASTATIN,10MG  80MG,100BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2019-02-11,2019-04-19,2019-04-18,Disruption of the manufacture of the drug.,2019-02-13,2019-04-22
75641,2411296,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODOPINE-ATORVASTATIN,AMLODIPINE  ATORVASTATIN,5MG  80MG,100BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2019-02-11,2019-04-19,2019-04-18,Disruption of the manufacture of the drug.,2019-02-13,2019-04-22
12278,2411318,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE - ATORVASTATIN,AMLODIPINE  ATORVASTATIN,10MG  10MG,100 BTL,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",2017-06-23,2017-06-12,2017-08-31,2017-08-07,Disruption of the manufacture of the drug.,2017-06-08,2017-08-08
97034,628123,Shortage,APO-AMOXI,APOTEX INC,AMOXICILLIN,AMOXICILLIN,500MG,500 BTL,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-10-21,2019-11-01,2019-11-01,Disruption of the manufacture of the drug.,2019-10-23,2019-11-05
87057,2245623,Shortage,APO-AMOXI CLAV,APOTEX INC,AMOXICILLIN,AMOXICILLIN  CLAVULANIC ACID,875MG  125MG,100 BTL,ORAL,Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-06-17,2019-09-20,2019-09-20,Disruption of the manufacture of the drug.,2019-06-19,2019-09-23
41,2288559,Shortage,APO-AMOXI CLAV,APOTEX INC,AMOXI CLAV,AMOXICILLIN  CLAVULANIC ACID,400MG  57MG,70 ml,ORAL,Resolved,POWDER FOR SUSPENSION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014-10-09,,2019-05-17,Other (Please describe in comments),2017-03-10,2019-05-18
44,2243986,Shortage,APO-AMOXI CLAV 125MG/31.25MG PER 5ML,APOTEX INC,AMOXI CLAV,AMOXICILLIN  CLAVULANIC ACID,125MG  31.25MG,100 ml,ORAL,Resolved,POWDER FOR SUSPENSION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014-10-09,,2018-09-08,Disruption of the manufacture of the drug.,2017-03-10,2018-09-09
49,2243987,Shortage,APO-AMOXI CLAV 250MG/62.5MG PER 5ML,APOTEX INC,AMOXI CLAV,AMOXICILLIN  CLAVULANIC ACID,250MG  62.5MG,100 ml,ORAL,Resolved,POWDER FOR SUSPENSION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014-10-09,,2019-05-06,Disruption of the manufacture of the drug.,2017-03-10,2019-05-13
38473,2245623,Shortage,APO-AMOXI CLAV 875/125,APOTEX INC,AMPICILLIN,AMOXICILLIN  CLAVULANIC ACID,875MG  125MG,100 BTL,ORAL,Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-02-05,2018-04-20,2018-04-17,Disruption of the manufacture of the drug.,2018-02-05,2018-04-18
636,2245623,Shortage,APO-AMOXI CLAV 875/125,APOTEX INC,AMOXICILLIN,AMOXICILLIN  CLAVULANIC ACID,875MG  125MG,100 BTL,ORAL,Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017-03-20,2017-03-20,2017-04-24,2017-04-24,Disruption of the manufacture of the drug.,2017-03-12,2017-04-25
11959,2245623,Shortage,APO-AMOXI CLAV 875/125,APOTEX INC,AMOXICILLIN,AMOXICILLIN  CLAVULANIC ACID,875MG  125MG,100 BTL,ORAL,Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-07-31,2017-09-08,2017-09-04,Disruption of the manufacture of the drug.,2017-06-06,2017-09-05
13967,628131,Shortage,APO-AMOXI PWR FOR SUSP 125MG/5ML,APOTEX INC,AMOXICILLIN,AMOXICILLIN,125MG,100 ML  &   150 ML,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-06-23,,2018-09-08,Disruption of the manufacture of the drug.,2017-06-26,2018-09-09
44099,628158,Shortage,APO-AMOXI PWR FOR SUSP 250MG/5ML,APOTEX INC,AMOXICILLIN,AMOXICILLIN,250MG,100 ML,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-03-26,2018-04-27,2018-04-20,Disruption of the manufacture of the drug.,2018-03-27,2018-04-24
29028,628158,Shortage,APO-AMOXI PWR FOR SUSP 250MG/5ML,APOTEX INC,AMOXICILLIN,AMOXICILLIN,250MG,100 ML & 500 ML,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-11-13,2018-02-12,2018-01-30,Disruption of the manufacture of the drug.,2017-11-13,2018-01-31
71103,628158,Shortage,APO-AMOXI PWR FOR SUSP 250MG/5ML,APOTEX INC,AMOXI PWR FOR SUSP,AMOXICILLIN,250MG,150ML,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-01-02,2019-01-30,2019-01-31,Disruption of the manufacture of the drug.,2019-01-03,2019-02-01
5888,2374420,Shortage,APO-ANASTROZOLE,APOTEX INC,ANASTROZOLE,ANASTROZOLE,1MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-10-02,2017-12-29,2017-12-10,Disruption of the manufacture of the drug.,2017-04-07,2017-12-11
55,2374420,Shortage,APO-ANASTROZOLE,APOTEX INC,ANASTROZOLE,ANASTROZOLE,1MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-03-10,2017-03-15,2017-03-13,Disruption of the manufacture of the drug.,2017-03-10,2017-04-04
69444,2374420,Shortage,APO-ANASTROZOLE,APOTEX INC,ANASTROZOLE,ANASTROZOLE,1MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2018-12-10,2018-12-10,,2019-10-01,Disruption of the manufacture of the drug.,2018-12-13,2019-10-08
94728,2471124,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,30 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-09-23,2019-11-03,2019-10-21,Disruption of the manufacture of the drug.,2019-09-25,2019-10-22
65588,2471086,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE 2MG,ARIPIPRAZOLE,2MG,30 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2018-10-22,2018-12-12,2018-11-23,Disruption of the manufacture of the drug.,2018-10-25,2018-11-26
69447,2471116,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,30 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-12-10,2018-12-10,2019-01-04,2018-12-28,Disruption of the manufacture of the drug.,2018-12-13,2019-01-03
68709,2471124,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,30BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2018-12-03,2019-02-11,2019-01-17,Disruption of the manufacture of the drug.,2018-12-05,2019-01-18
59809,2471124,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,30 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2018-09-03,2018-11-12,2018-09-18,Disruption of the manufacture of the drug.,2018-09-04,2018-09-21
57769,2471116,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,30 BLS,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2018-08-06,2018-10-05,2018-09-07,Disruption of the manufacture of the drug.,2018-08-09,2018-09-08
45331,2248764,Shortage,APO-ATENIDONE,APOTEX INC,ATENIDONE,CHLORTHALIDONE  ATENOLOL,25MG  100MG,100 BTL,ORAL,Resolved,TABLET,C07CB,BETA BLOCKING AGENTS AND OTHER DIURETICS,,2018-04-09,2018-08-17,2018-07-23,Disruption of the manufacture of the drug.,2018-04-10,2018-07-23
72351,2248763,Shortage,APO-ATENIDONE,APOTEX INC,ATENIDONE,CHLORTHALIDONE  ATENOLOL,25MG  50MG,100 BTL,ORAL,Resolved,TABLET,C07CB,BETA BLOCKING AGENTS AND OTHER DIURETICS,,2019-01-14,2019-02-22,2019-02-19,Disruption of the manufacture of the drug.,2019-01-15,2019-02-21
43498,2248763,Shortage,APO-ATENIDONE,APOTEX INC,ATENIDONE,CHLORTHALIDONE  ATENOLOL,25MG  50MG,100 BTL,ORAL,Resolved,TABLET,C07CB,BETA BLOCKING AGENTS AND OTHER DIURETICS,,2018-03-19,2018-08-13,2018-07-23,Disruption of the manufacture of the drug.,2018-03-20,2018-07-23
49967,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-05-21,2018-11-30,2018-09-07,Disruption of the manufacture of the drug.,2018-05-22,2018-09-08
12668,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-06-12,2017-07-14,2017-07-14,Disruption of the manufacture of the drug.,2017-06-13,2017-07-17
57772,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-08-06,2018-11-19,2018-10-12,Disruption of the manufacture of the drug.,2018-08-09,2018-10-13
23536,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-09-22,2017-11-10,2017-11-06,Disruption of the manufacture of the drug.,2017-09-26,2017-11-07
33783,773697,Shortage,APO-ATENOL TAB 100MG,APOTEX INC,ATENOLOL,ATENOLOL,100MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-12-18,2018-07-06,2018-06-29,Disruption of the manufacture of the drug.,2017-12-19,2018-07-03
94731,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOL,ATENOLOL,50MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2019-09-23,2019-11-13,2019-10-21,Disruption of the manufacture of the drug.,2019-09-25,2019-10-22
17202,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-08-07,2017-08-18,2017-11-15,2017-11-06,Disruption of the manufacture of the drug.,2017-07-26,2017-11-07
49970,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-05-22,2018-11-30,2018-09-08,Disruption of the manufacture of the drug.,2018-05-22,2018-09-09
17205,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-08-31,2017-08-14,2017-10-31,2017-10-20,Disruption of the manufacture of the drug.,2017-07-26,2017-10-24
62864,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,Atenol 50mg,ATENOLOL,50MG,30BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-10-02,2019-01-11,2018-10-11,Disruption of the manufacture of the drug.,2018-10-02,2018-10-12
13970,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-06-26,2017-07-21,2017-07-14,Disruption of the manufacture of the drug.,2017-06-26,2017-07-17
33780,773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,30 BLS,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-12-18,2018-07-06,2018-07-03,Disruption of the manufacture of the drug.,2017-12-19,2018-07-04
61,2318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE HCL,ATOMOXETINE,40MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-02-14,2017-07-24,2017-07-19,Disruption of the manufacture of the drug.,2017-03-10,2017-07-20
64,2318067,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE HCL,ATOMOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2016-11-08,2017-07-24,2017-07-19,Disruption of the manufacture of the drug.,2017-03-10,2017-07-20
49478,2318040,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-05-25,2018-05-28,2019-01-31,2018-11-26,Disruption of the manufacture of the drug.,2018-05-15,2018-11-27
30796,2318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,40MG,100 BTL,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-11-27,2018-06-06,2018-05-23,Disruption of the manufacture of the drug.,2017-11-27,2018-05-24
3160,2318032,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,18MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-05-31,2017-06-05,2017-07-24,2017-07-14,Disruption of the manufacture of the drug.,2017-03-17,2017-07-17
38508,2318067,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,60MG,100 BTL,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-05,2018-07-06,2018-06-29,Disruption of the manufacture of the drug.,2018-02-05,2018-07-03
84108,2318024,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,10MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-05-14,2019-05-24,2019-05-24,Disruption of the manufacture of the drug.,2019-05-15,2019-05-25
62604,2318059,Shortage,APO-ATOMOXETINE,APOTEX INC,APO-Atomoxetine 40mg,ATOMOXETINE,40MG,100BTL,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-09-26,2018-12-28,2018-11-29,Disruption of the manufacture of the drug.,2018-09-28,2018-11-30
84112,2318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,40MG,100 BTL,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-05-14,2019-05-31,2019-05-31,Disruption of the manufacture of the drug.,2019-05-15,2019-06-01
42672,2318067,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-03-05,2018-07-13,2018-07-13,Disruption of the manufacture of the drug.,2018-03-13,2018-07-18
91067,2318024,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,10MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-08-06,2019-10-01,2019-09-20,Disruption of the manufacture of the drug.,2019-08-07,2019-09-23
36806,2318040,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,25MG,100 BTL & 30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-01-22,2018-04-30,2018-04-27,Disruption of the manufacture of the drug.,2018-01-22,2018-05-01
39638,2318024,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,10MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-12,2018-04-27,2018-04-27,Disruption of the manufacture of the drug.,2018-02-13,2018-05-01
39641,2318075,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,80MG,30 BLS,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-12,2018-05-07,2018-04-27,Disruption of the manufacture of the drug.,2018-02-13,2018-05-01
5891,2295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-04-24,2017-04-24,2017-07-10,2017-06-26,Disruption of the manufacture of the drug.,2017-04-07,2017-06-27
88323,2295261,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-07-02,2019-08-09,2019-08-07,Disruption of the manufacture of the drug.,2019-07-03,2019-08-12
34829,2295288,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,20MG,90 BTL & 100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-02,2018-03-15,2018-03-02,Disruption of the manufacture of the drug.,2018-01-03,2018-03-05
34832,2295296,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,40MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-02,2018-03-23,2018-03-02,Disruption of the manufacture of the drug.,2018-01-03,2018-03-05
73308,2295261,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-01-21,2019-03-08,2019-03-04,Disruption of the manufacture of the drug.,2019-01-23,2019-03-07
82013,2295261,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-15,2019-05-06,2019-05-03,Disruption of the manufacture of the drug.,2019-04-18,2019-05-06
84115,2295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-14,2019-05-16,2019-05-17,Disruption of the manufacture of the drug.,2019-05-15,2019-05-18
709,2295261,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,10MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-10,2017-03-24,2017-03-22,Disruption of the manufacture of the drug.,2017-03-13,2017-04-04
712,2295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-10,2017-03-31,2017-04-03,Disruption of the manufacture of the drug.,2017-03-13,2017-04-04
16861,2295261,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,10MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-07-24,2017-08-31,2017-09-11,Disruption of the manufacture of the drug.,2017-07-25,2017-09-22
13305,2295288,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-06-19,2017-08-15,2017-08-04,Disruption of the manufacture of the drug.,2017-06-19,2017-08-08
19126,2247423,Shortage,APO-AZITHROMYCIN,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100 BTL & 6 BLS,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
3083,2415542,Shortage,APO-AZITHROMYCIN Z,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6 BLS,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-07-31,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-03-16,2017-10-03
49481,2415542,Shortage,APO-AZITHROMYCIN Z,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6 BLS & 100 BTL,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2018-06-29,2018-06-25,2019-02-22,2019-02-18,Disruption of the manufacture of the drug.,2018-05-15,2019-02-21
30799,2415542,Shortage,APO-AZITHROMYCIN Z,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6 BLS,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-11-27,2018-04-24,2018-04-16,Disruption of the manufacture of the drug.,2017-11-27,2018-04-17
88328,2139332,Shortage,APO-BACLOFEN,APOTEX INC,BACLOFEN,BACLOFEN,10MG,500 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2019-07-02,2019-08-02,2019-07-26,Disruption of the manufacture of the drug.,2019-07-03,2019-07-29
24328,2139332,Shortage,APO-BACLOFEN TABLETS - 10MG,APOTEX INC,BACLOFEN,BACLOFEN,10MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017-10-02,2017-12-29,2017-12-06,Disruption of the manufacture of the drug.,2017-10-04,2017-12-07
14154,2139332,Shortage,APO-BACLOFEN TABLETS - 10MG,APOTEX INC,BACLOFEN,BACLOFEN,10MG,500 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017-08-04,2017-07-24,2017-08-16,2017-08-16,Disruption of the manufacture of the drug.,2017-06-28,2017-08-17
71107,2139332,Shortage,APO-BACLOFEN TABLETS - 10MG,APOTEX INC,BACLOFEN 10 MG TAB,BACLOFEN,10MG,100 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2019-01-02,2019-02-15,2019-02-07,Disruption of the manufacture of the drug.,2019-01-03,2019-02-08
50038,2139391,Shortage,APO-BACLOFEN TABLETS - 20MG,APOTEX INC,BACLOFEN,BACLOFEN,20MG,100 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2018-05-22,2018-07-09,2018-06-11,Disruption of the manufacture of the drug.,2018-05-22,2018-06-12
71115,2139391,Shortage,APO-BACLOFEN TABLETS - 20MG,APOTEX INC,BACLOFEN 20 MG TAB,BACLOFEN,20MG,100 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2019-01-02,2019-02-15,2019-02-07,Disruption of the manufacture of the drug.,2019-01-03,2019-02-08
43501,2238796,Shortage,APO-BECLOMETHASONE NASAL SPRAY,APOTEX INC,BECLOMETHASONE,BECLOMETHASONE DIPROPIONATE,50MCG,200 doses,NASAL,Resolved,SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2018-03-19,2018-11-23,2018-11-21,Disruption of the manufacture of the drug.,2018-03-20,2018-11-22
19087,2239044,Shortage,APO-BENZYDAMINE ORAL RINSE,APOTEX INC,BENZYDAMINE,BENZYDAMINE HYDROCHLORIDE,0.15%,100/250 ML,BUCCAL,Actual shortage,LIQUID,A01AD,STOMATOLOGICAL PREPARATIONS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
67,2296063,Shortage,APO-BICALUTAMIDE,APOTEX INC,BICALUTAMIDE30,BICALUTAMIDE,50MG,30 BLS,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-01-11,2017-04-05,2017-03-31,Disruption of the manufacture of the drug.,2017-03-10,2017-04-03
20860,2296063,Shortage,APO-BICALUTAMIDE,APOTEX INC,BICLUTAMIDE,BICALUTAMIDE,50MG,30 BLS,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017-10-20,2017-09-22,2018-09-14,2018-08-22,Disruption of the manufacture of the drug.,2017-09-05,2018-08-23
34835,545023,Shortage,APO-BISACODYL,APOTEX INC,BISACODYL,BISACODYL,5MG,1000 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),A06AB,DRUGS FOR CONSTIPATION,,2018-01-02,,2018-09-08,Disruption of the manufacture of the drug.,2018-01-03,2018-09-09
18985,754595,Shortage,APO-BISACODYL SUP 10MG,APOTEX INC,BISACODYL,BISACODYL,10MG,100 BLS/6 BLS,RECTAL,Actual shortage,SUPPOSITORY,A06AB,DRUGS FOR CONSTIPATION,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
26154,2256177,Shortage,APO-BISOPROLOL,APOTEX INC,BISOPROLOL,BISOPROLOL FUMARATE,10MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-10-16,2017-12-14,2017-11-30,Disruption of the manufacture of the drug.,2017-10-17,2017-12-04
17208,2256134,Shortage,APO-BISOPROLOL,APOTEX INC,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-09-18,2017-09-22,2017-12-15,2017-12-13,Disruption of the manufacture of the drug.,2017-07-26,2017-12-14
58580,2256134,Shortage,APO-BISOPROLOL,APOTEX INC,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100 BTL,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-08-20,2018-12-31,2018-12-27,Disruption of the manufacture of the drug.,2018-08-21,2019-01-02
50041,2260077,Shortage,APO-BRIMONIDINE,APOTEX INC,BRIMONIDINE,BRIMONIDINE TARTRATE,0.2%,5 ML & 10 ML,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-05-21,2018-07-16,2018-07-16,Disruption of the manufacture of the drug.,2018-05-22,2018-07-17
36268,2260077,Shortage,APO-BRIMONIDINE,APOTEX INC,BRIMONIDINE,BRIMONIDINE TARTRATE,0.2%,5 ML & 10 ML,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-01-15,2018-04-09,2018-04-05,Disruption of the manufacture of the drug.,2018-01-17,2018-04-09
49484,2177153,Shortage,APO-BROMAZEPAM - TAB 1.5MG,APOTEX INC,BROMAZEPAM,BROMAZEPAM,1.5MG,100 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-06-08,2018-06-04,2018-09-28,2018-08-27,Disruption of the manufacture of the drug.,2018-05-15,2018-08-28
11056,2211076,Shortage,APO-BUSPIRONE - TAB 10MG,APOTEX INC,BUPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,2017-06-12,2017-05-29,2017-06-30,2017-06-26,Disruption of the manufacture of the drug.,2017-05-24,2017-06-27
26564,2211076,Shortage,APO-BUSPIRONE - TAB 10MG,APOTEX INC,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,,2017-10-23,2018-01-05,2017-11-17,Disruption of the manufacture of the drug.,2017-10-23,2017-11-20
41136,2455897,Shortage,APO-CABERGOLINE,APOTEX INC,CABERGOLINE,CABERGOLINE,0.5MG,8 BTL,ORAL,Actual shortage,TABLET,G02CB,OTHER GYNECOLOGICALS,,2018-02-26,2020-04-03,,Disruption of the manufacture of the drug.,2018-02-27,2019-10-07
34838,2365367,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-01-02,,,Disruption of the manufacture of the drug.,2018-01-03,2019-04-08
18517,2365340,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-08-07,,,Disruption of the manufacture of the drug.,2017-08-08,2019-04-08
18520,2365359,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-08-04,,,Disruption of the manufacture of the drug.,2017-08-08,2019-04-08
639,2365367,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,500 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-03-26,2017-03-14,2017-06-19,2017-06-22,Disruption of the manufacture of the drug.,2017-03-12,2017-06-27
3516,2399105,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-03-20,,,Disruption of the manufacture of the drug.,2017-03-20,2018-12-20
706,2365340,Shortage,APO-CANDESARTAN,APOTEX INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-03-10,,2018-09-08,Disruption of the manufacture of the drug.,2017-03-13,2018-09-09
32772,2395134,Shortage,APO-CANDESARTAN/HCTZ,APOTEX INC,CANDESARTAN + HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-12-11,,2018-02-23,Disruption of the manufacture of the drug.,2017-12-14,2018-02-26
28539,2395126,Shortage,APO-CANDESARTAN/HCTZ,APOTEX INC,CANDESARTAN + HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-11-06,,2018-02-23,Disruption of the manufacture of the drug.,2017-11-07,2018-02-26
21199,2367866,Shortage,APO-CANDESARTAN/HCTZ,APOTEX INC,CANDESARTAN + HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16.0MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-04,,2018-02-23,Disruption of the manufacture of the drug.,2017-09-07,2018-02-26
54171,893609,Shortage,APO-CAPTO TAB 25MG,APOTEX INC,CAPTOPRIL,CAPTOPRIL,25MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-07-02,2018-09-28,2018-09-27,Disruption of the manufacture of the drug.,2018-07-04,2018-10-05
89510,893609,Shortage,APO-CAPTO TAB 25MG,APOTEX INC,CAPTOPRIL,CAPTOPRIL,25MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-07-17,2019-09-13,2019-09-13,Disruption of the manufacture of the drug.,2019-07-17,2019-09-16
30992,2247935,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,12.5MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017-12-15,2017-12-12,2018-06-29,2018-05-26,Disruption of the manufacture of the drug.,2017-11-29,2018-05-27
30802,2247936,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,25MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017-11-27,2018-07-31,2018-05-26,Delay in shipping of the drug.,2017-11-27,2018-05-27
85591,2247935,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,12.5MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-06-03,,2019-08-09,Disruption of the manufacture of the drug.,2019-06-05,2019-08-12
85594,2247934,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,6.25MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-06-03,,2019-08-09,Disruption of the manufacture of the drug.,2019-06-05,2019-08-12
95842,2247935,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,12.5MG,100 BTL,ORAL,Actual shortage,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-10-07,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-09,2019-10-21
29031,2247934,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,6.25MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017-11-13,2018-06-29,2018-05-26,Disruption of the manufacture of the drug.,2017-11-13,2018-05-27
95853,2247934,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,6.25MG,100 BTL,ORAL,Actual shortage,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-10-07,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-09,2019-10-21
85153,2247936,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,25MG,100 BTL,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-05-27,,2019-08-09,Disruption of the manufacture of the drug.,2019-05-29,2019-08-12
93668,2247936,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,25MG,100 BTL,ORAL,Actual shortage,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-09-09,2020-01-31,,Disruption of the manufacture of the drug.,2019-09-12,2019-10-21
19036,2230263,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,250MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19039,2230264,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,500MG,100 BTL,ORAL,Actual shortage,CAPSULE,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19066,2237500,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,125MG,100/150 ML,ORAL,Actual shortage,POWDER,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19069,2237501,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,250MG,100/150 ML,ORAL,Actual shortage,POWDER,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19072,2237502,Shortage,APO-CEFACLOR,APOTEX INC,CEFACLOR,CEFACLOR,375MG,100/70 ML,ORAL,Actual shortage,POWDER,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
89155,2240774,Shortage,APO-CEFADROXIL,APOTEX INC,CEFADROXIL,CEFADROXIL,500MG,100 BTL,ORAL,Actual shortage,CAPSULE,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-08,2019-11-29,,Disruption of the manufacture of the drug.,2019-07-12,2019-11-18
7102,2240774,Shortage,APO-CEFADROXIL,APOTEX INC,CEFADROXIL,CEFADROXIL,500MG,100 BTL,ORAL,Resolved,CAPSULE,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-04-14,2017-05-02,2017-04-24,Disruption of the manufacture of the drug.,2017-04-17,2017-04-25
79574,2467496,Shortage,APO-CEFEPIME,APOTEX INC,CEFEPIME,CEFEPIME,1G,20 ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DE,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-03-25,2019-04-01,2019-03-28,Disruption of the manufacture of the drug.,2019-03-27,2019-03-29
90341,2467518,Shortage,APO-CEFEPIME,APOTEX INC,CEFEPIME,CEFEPIME,2G,20 ML,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DE,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-29,2019-07-31,2019-08-01,Disruption of the manufacture of the drug.,2019-07-31,2019-08-02
71,2292998,Shortage,APO-CEFPROZIL,APOTEX INC,CEFPROZIL,CEFPROZIL,250MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2016-03-31,,2017-09-29,Disruption of the manufacture of the drug.,2017-03-10,2017-10-03
74,2293005,Shortage,APO-CEFPROZIL,APOTEX INC,CEFPROZIL,CEFPROZIL,500MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2016-03-31,,2017-09-29,Disruption of the manufacture of the drug.,2017-03-10,2017-10-03
62607,2293005,Shortage,APO-CEFPROZIL,APOTEX INC,APO-Cefprozil 500mg,CEFPROZIL,500MG,100BTL,ORAL,Actual shortage,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-09-25,,,Disruption of the manufacture of the drug.,2018-09-28,2018-09-28
62614,2293951,Shortage,APO-CEFPROZIL,APOTEX INC,APO-Cefprozil 250mg/5mL,,,75mL and 100mL,,Resolved,,,,,2018-09-24,,2019-06-10,Disruption of the manufacture of the drug.,2018-09-28,2019-06-12
62618,2293943,Shortage,APO-CEFPROZIL,APOTEX INC,APO-Cefprozil 125mg/5mL,,,75mL and 100mL,,Resolved,,,,,2018-09-24,2019-05-17,2019-05-17,Disruption of the manufacture of the drug.,2018-09-28,2019-05-24
3163,2244394,Shortage,APO-CEFUROXIME,APOTEX INC,CEFUROXIME,CEFUROXIME,500MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,2017-03-31,2017-03-27,2017-06-15,2017-06-09,Disruption of the manufacture of the drug.,2017-03-17,2017-06-12
38505,2244393,Shortage,APO-CEFUROXIME,APOTEX INC,CEFUROXIME,CEFUROXIME,250MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-02-05,2018-04-16,2018-04-13,Disruption of the manufacture of the drug.,2018-02-05,2018-04-14
39650,2244394,Shortage,APO-CEFUROXIME,APOTEX INC,CEFUROXIME,CEFUROXIME,500MG,100 BTL,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-02-12,2018-04-27,2018-04-13,Disruption of the manufacture of the drug.,2018-02-13,2018-04-14
45334,2418932,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,100MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-04-09,2018-08-20,2018-08-01,Disruption of the manufacture of the drug.,2018-04-10,2018-08-02
36809,2418932,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,100MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-01-22,2018-03-30,2018-03-29,Disruption of the manufacture of the drug.,2018-01-22,2018-04-02
58583,2418932,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,100MG,100 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-08-20,2018-11-15,2018-11-13,Disruption of the manufacture of the drug.,2018-08-21,2018-11-15
58586,2418940,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,200MG,500 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-08-20,2018-10-31,2018-10-30,Disruption of the manufacture of the drug.,2018-08-21,2018-11-02
9951,2418932,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,100MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-10-02,2017-12-04,2017-11-17,Disruption of the manufacture of the drug.,2017-05-10,2017-11-20
23546,2418940,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,200MG,100 BTL,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-09-22,2018-02-28,2018-02-23,Disruption of the manufacture of the drug.,2017-09-26,2018-02-26
19090,2240910,Shortage,APO-CETIRIZINE,APOTEX INC,CETIRIZINE,CETIRIZINE HYDROCHLORIDE,5MG,10/15 BLS,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,,2017-03-10,,2018-05-30,Disruption of the manufacture of the drug.,2017-08-14,2018-05-31
19099,2242329,Shortage,APO-CHLORHEXIDINE ORAL RINSE,APOTEX INC,CHLORHEXIDINE,CHLORHEXIDINE GLUCONATE,0.12%,475 ML,ORAL,Actual shortage,LIQUID,A01AB,STOMATOLOGICAL PREPARATIONS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
6414,2417316,Shortage,APO-CICLESONIDE,APOTEX INC,CICLESONIDE,CICLESONIDE,50MCG,120 doses,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2017-04-30,2017-03-20,,2018-12-17,Disruption of the manufacture of the drug.,2017-04-11,2018-12-20
3520,2417316,Shortage,APO-CICLESONIDE,APOTEX INC,CICLESONIDE,CICLESONIDE,50MCG,120 doses,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017-03-20,,2018-12-17,Disruption of the manufacture of the drug.,2017-03-20,2019-01-03
66919,2298953,Shortage,APO-CICLOPIROX,APOTEX INC,CICLOPIROX,CICLOPIROX,8%,BTL,TOPICAL,Resolved,SOLUTION,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2018-11-01,2019-05-31,2019-05-22,Disruption of the manufacture of the drug.,2018-11-14,2019-05-24
80,2291134,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,1MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-10,2017-03-17,2017-03-17,Disruption of the manufacture of the drug.,2017-03-10,2017-04-04
42675,2291134,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,1MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-03-12,2018-05-31,2018-05-22,Disruption of the manufacture of the drug.,2018-03-13,2018-05-23
44492,2291150,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-04-02,2018-05-31,2018-05-08,Disruption of the manufacture of the drug.,2018-04-02,2018-05-09
16853,2291150,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-07-24,2017-08-18,2017-08-14,Disruption of the manufacture of the drug.,2017-07-25,2017-08-15
14068,2291134,Shortage,APO-CILAZAPRIL,APOTEX INC,CILAZAPRIL,CILAZAPRIL,1MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-06-26,2017-10-31,2017-07-21,Disruption of the manufacture of the drug.,2017-06-27,2017-07-24
34841,2284987,Shortage,APO-CILAZAPRIL/HCTZ,APOTEX INC,CILAZAPRIL HCTZ,HYDROCHLOROTHIAZIDE  CILAZAPRIL,12.5MG  5MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-01-02,2018-09-28,2018-08-17,Disruption of the manufacture of the drug.,2018-01-03,2018-08-18
83,2284987,Shortage,APO-CILAZAPRIL/HCTZ,APOTEX INC,CILAZAPRIL HCTZ,HYDROCHLOROTHIAZIDE  CILAZAPRIL,12.5MG  5MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-02-22,2017-03-20,2017-03-16,Disruption of the manufacture of the drug.,2017-03-10,2017-04-04
19102,2243085,Shortage,APO-CIMETIDINE ORAL SOLUTION,APOTEX INC,CIMETIDINE,CIMETIDINE,300MG,250 ML,ORAL,Actual shortage,LIQUID,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
86,2452693,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,30MG,30 BTL,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2017-01-17,2017-03-31,2017-03-22,Disruption of the manufacture of the drug.,2017-03-10,2017-04-04
37726,2452707,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,60MG,30 BTL,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2018-01-29,2018-11-30,2018-11-22,Disruption of the manufacture of the drug.,2018-01-31,2018-11-23
84118,2452693,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,30MG,30 BTL,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2019-05-14,2019-05-31,2019-05-31,Disruption of the manufacture of the drug.,2019-05-15,2019-06-01
57775,2452693,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,30MG,30 BTL,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2018-08-06,2018-11-30,2018-11-22,Disruption of the manufacture of the drug.,2018-08-09,2018-11-23
48835,2452715,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,90MG,30 BTL,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2018-05-07,2018-11-30,2018-11-22,Disruption of the manufacture of the drug.,2018-05-08,2018-11-23
3619,2229522,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,500MG,500 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-03-20,2017-06-14,2017-06-12,Disruption of the manufacture of the drug.,2017-03-20,2017-06-12
37729,2229521,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,250MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-01-29,,2018-09-08,Disruption of the manufacture of the drug.,2018-01-31,2018-09-09
107,2229522,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-01-03,2017-06-14,2017-06-12,Disruption of the manufacture of the drug.,2017-03-10,2017-06-12
110,2263130,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,0.3%,5 ml,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2014-10-09,,2019-06-03,Disruption of the manufacture of the drug.,2017-03-10,2019-06-12
38806,2229522,Shortage,APO-CIPROFLOX,APOTEX INC,CIPROFLOX,CIPROFLOXACIN,500MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-02-05,,2018-09-08,Disruption of the manufacture of the drug.,2018-02-06,2018-09-09
21061,2246057,Shortage,APO-CITALOPRAM,APOTEX INC,CITALORPAM,CITALOPRAM,40MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-09-04,2018-04-30,2018-03-07,Disruption of the manufacture of the drug.,2017-09-06,2018-03-08
49487,2246056,Shortage,APO-CITALOPRAM,APOTEX INC,CITALORPAM,CITALOPRAM,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-06-29,2018-06-25,2018-11-02,2018-10-18,Disruption of the manufacture of the drug.,2018-05-15,2018-10-19
113,2246057,Shortage,APO-CITALOPRAM,APOTEX INC,CITALOPRAM,CITALOPRAM,40MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-02-01,2017-05-08,2017-04-06,Disruption of the manufacture of the drug.,2017-03-10,2017-04-07
40333,2246056,Shortage,APO-CITALOPRAM,APOTEX INC,CITALORPAM,CITALOPRAM,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-02-19,2018-03-26,2018-03-08,Disruption of the manufacture of the drug.,2018-02-21,2018-03-08
12281,2246056,Shortage,APO-CITALOPRAM,APOTEX INC,CITALOPRAM,CITALOPRAM,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-06-30,,2017-08-31,2017-08-31,Disruption of the manufacture of the drug.,2017-06-08,2017-11-20
12283,2246056,Shortage,APO-CITALOPRAM,APOTEX INC,CITALOPRAM,CITALOPRAM,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-06-30,2017-06-12,2017-10-11,2017-10-11,Disruption of the manufacture of the drug.,2017-06-08,2017-10-12
9925,2274752,Shortage,APO-CLARITHROMYCIN,APOTEX INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-05-08,2017-06-27,2017-06-22,Disruption of the manufacture of the drug.,2017-05-10,2017-06-23
95266,2413345,Shortage,APO-CLARITHROMYCIN XL,APOTEX INC,CLARITHROMYCIN XL,CLARITHROMYCIN,500MG,100 BTL,ORAL,Anticipated shortage,TABLET (EXTENDED-RELEASE),J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2020-01-03,,,,Disruption of the manufacture of the drug.,2019-10-02,2019-10-02
116,2413345,Shortage,APO-CLARITHROMYCIN XL,APOTEX INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016-05-31,2017-05-31,2017-05-04,Disruption of the manufacture of the drug.,2017-03-10,2017-05-05
32520,2245233,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-12-11,2018-02-15,2018-01-25,Disruption of the manufacture of the drug.,2017-12-12,2018-01-26
84532,2245232,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,150MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-05-21,,2019-05-21,Disruption of the manufacture of the drug.,2019-05-22,2019-11-11
74867,2245233,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-02-04,2019-04-26,2019-04-22,Disruption of the manufacture of the drug.,2019-02-06,2019-04-25
119,2245232,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,150MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016-10-03,2017-05-31,2017-05-26,Disruption of the manufacture of the drug.,2017-03-10,2017-05-27
122,2245233,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016-11-14,2017-10-31,2017-10-27,Disruption of the manufacture of the drug.,2017-03-10,2017-10-30
57779,2245233,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-08-06,2018-10-30,2018-10-25,Disruption of the manufacture of the drug.,2018-08-09,2018-10-26
42681,2245233,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-03-12,2018-06-08,2018-05-11,Disruption of the manufacture of the drug.,2018-03-13,2018-05-12
23550,2245232,Shortage,APO-CLINDAMYCIN,APOTEX INC,CLINDAMYCIN,CLINDAMYCIN,150MG,100 BTL,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-09-22,2017-10-13,2017-10-11,Disruption of the manufacture of the drug.,2017-09-26,2017-10-12
36271,2244638,Shortage,APO-CLOBAZAM,APOTEX INC,CLOBAZAM,CLOBAZAM,10MG,30 BLS,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-01-15,2018-03-05,2018-03-02,Disruption of the manufacture of the drug.,2018-01-17,2018-03-03
48838,2244638,Shortage,APO-CLOBAZAM,APOTEX INC,CLOBAZAM,CLOBAZAM,10MG,30 BLS,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-05-07,,2018-06-29,Disruption of the manufacture of the drug.,2018-05-08,2018-06-30
84122,2475162,Shortage,APO-CLOBETASOL SPRAY,APOTEX INC,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,59 ML,TOPICAL,Resolved,SPRAY,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-05-14,2019-06-15,2019-06-14,Disruption of the manufacture of the drug.,2019-05-15,2019-06-21
22870,2177889,Shortage,APO-CLONAZEPAM - TAB 0.5MG,APOTEX INC,Clonazepam - Tab 0.5mg,CLONAZEPAM,.5MG,100 BTL,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-09-22,2017-09-20,2018-10-01,2018-09-08,Disruption of the manufacture of the drug.,2017-09-20,2018-09-09
22970,2177889,Shortage,APO-CLONAZEPAM - TAB 0.5MG,APOTEX INC,CLONAZEPAM,CLONAZEPAM,.5MG,500 BTL,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-10-02,2017-09-29,2018-10-01,2018-10-03,Disruption of the manufacture of the drug.,2017-09-21,2018-10-05
19136,2248732,Shortage,APO-CLONIDINE,APOTEX INC,CLONIDINE,CLONIDINE HYDROCHLORIDE,0.025MG,100 BTL,ORAL,Actual shortage,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
18994,868949,Shortage,APO-CLONIDINE TAB 0.1MG,APOTEX INC,CLONIDINE,CLONIDINE HYDROCHLORIDE,.1MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18997,868957,Shortage,APO-CLONIDINE TAB 0.2MG,APOTEX INC,CLONIDINE,CLONIDINE HYDROCHLORIDE,.2MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
91532,2398591,Shortage,APO-CLOPIDOGREL,APOTEX INC,CLOPIDOGREL,CLOPIDOGREL,300MG,30 BLS,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2019-08-13,2019-10-24,2019-10-11,Disruption of the manufacture of the drug.,2019-08-14,2019-10-15
8859,2252767,Shortage,APO-CLOPIDOGREL,APOTEX INC,CLOPIDOGREL,CLOPIDOGREL,75MG,30 BLS,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017-05-16,2017-05-22,2017-07-21,2017-07-21,Disruption of the manufacture of the drug.,2017-05-04,2017-07-22
19051,2231390,Shortage,APO-CROMOLYN NASAL SPRAY,APOTEX INC,CROMOLYN,CROMOLYN SODIUM,2%,26 ML,NASAL,Actual shortage,SOLUTION  SPRAY,R01AC,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19054,2231431,Shortage,APO-CROMOLYN STERULES,APOTEX INC,CROMOLYN,CROMOLYN SODIUM,1%,2ML,INHALATION,Actual shortage,SOLUTION,R03BC,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
41844,2177145,Shortage,APO-CYCLOBENZAPRINE,APOTEX INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2018-03-05,2018-05-31,2018-04-13,Disruption of the manufacture of the drug.,2018-03-06,2018-04-14
241,2244324,Shortage,APO-CYCLOSPORINE ORAL SOLUTION,APOTEX INC,CYCLOSPORINE,CYCLOSPORIN,100MG,50 ml,ORAL,Resolved,SOLUTION,L04AD,IMMUNOSUPPRESSANTS,,2014-07-01,,2018-09-08,Disruption of the manufacture of the drug.,2017-03-10,2018-09-09
87509,2468905,Shortage,APO-DABIGATRAN,APOTEX INC,DABIGATRAN,DABIGATRAN ETEXILATE,110MG,60 BTL,ORAL,Actual shortage,CAPSULE,B01AE,ANTITHROMBOTIC AGENTS,,2019-06-24,,,Disruption of the manufacture of the drug.,2019-06-26,2019-06-26
20281,2461560,Shortage,APO-DEFERASIROX,APOTEX INC,DEFERASIROX,DEFERASIROX,500MG,30 BLS,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2017-08-18,2017-09-15,2017-09-15,Disruption of the manufacture of the drug.,2017-08-24,2017-09-22
36432,2461560,Shortage,APO-DEFERASIROX,APOTEX INC,DEFERASIROX,DEFERASIROX,500MG,30 BLS,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2018-01-12,2018-02-05,2018-02-05,Disruption of the manufacture of the drug.,2018-01-18,2018-02-12
42717,2461552,Shortage,APO-DEFERASIROX,APOTEX INC,DEFERASIROX,DEFERASIROX,250MG,30 BLS,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2018-03-12,2018-07-05,2018-06-29,Disruption of the manufacture of the drug.,2018-03-13,2018-07-03
275,2284030,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.1MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2016-11-30,2017-05-12,2017-05-12,Disruption of the manufacture of the drug.,2017-03-10,2017-05-13
278,2284049,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.2MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017-02-20,2017-06-27,2017-06-20,Disruption of the manufacture of the drug.,2017-03-10,2017-06-21
16680,2284030,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.1MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017-07-24,2018-01-10,2017-12-19,Disruption of the manufacture of the drug.,2017-07-24,2017-12-20
16683,2284049,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.2MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017-07-24,2018-07-06,2018-08-14,Disruption of the manufacture of the drug.,2017-07-24,2018-08-15
11059,2284030,Shortage,APO-DESMOPRESSIN,APOTEX INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.1MG,100 BTL,ORAL,Resolved,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,2017-05-31,2017-05-29,2017-06-27,2017-06-20,Disruption of the manufacture of the drug.,2017-05-24,2017-06-21
94734,2466996,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,100MG,30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-09-23,2019-12-04,2019-11-01,Disruption of the manufacture of the drug.,2019-09-25,2019-11-04
55836,2466988,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-07-16,2018-11-30,2018-10-01,Disruption of the manufacture of the drug.,2018-07-16,2018-10-02
80926,2466996,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-04-09,2019-05-13,2019-05-13,Disruption of the manufacture of the drug.,2019-04-10,2019-05-14
76582,2466988,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-18,2019-04-05,2019-04-03,Disruption of the manufacture of the drug.,2019-02-21,2019-04-05
44102,2466988,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-03-26,2018-07-31,2018-06-29,Disruption of the manufacture of the drug.,2018-03-27,2018-07-03
92019,2466988,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-08-19,2019-11-15,2019-09-13,Disruption of the manufacture of the drug.,2019-08-21,2019-09-16
40336,2466988,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-02-19,2018-03-30,2018-03-07,Disruption of the manufacture of the drug.,2018-02-21,2018-03-08
82837,2466988,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-04-29,2019-05-10,2019-05-10,Disruption of the manufacture of the drug.,2019-04-30,2019-05-13
38815,2466996,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,100MG,100 BTL & 30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-02-01,2018-07-31,2018-06-29,Disruption of the manufacture of the drug.,2018-02-06,2018-07-03
71118,2466988,Shortage,APO-DESVENLAFAXINE,APOTEX INC,DESVENLAFAXINE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-01-02,2019-01-15,2019-01-14,Disruption of the manufacture of the drug.,2019-01-03,2019-01-17
92513,2250055,Shortage,APO-DEXAMETHASONE,APOTEX INC,DEXAMETHASONE,DEXAMETHASONE,4MG,100 BTL,ORAL,Actual shortage,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-08-28,,,Disruption of the manufacture of the drug.,2019-08-28,2019-08-29
20863,2250055,Shortage,APO-DEXAMETHASONE,APOTEX INC,DEXAMETHASONE,DEXAMETHASONE,4MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017-10-16,2017-10-13,2017-12-29,2017-12-01,Disruption of the manufacture of the drug.,2017-09-05,2017-12-04
24257,2261081,Shortage,APO-DEXAMETHASONE,APOTEX INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100 BTL,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-10-02,2017-12-29,2017-11-27,Disruption of the manufacture of the drug.,2017-10-04,2017-11-28
95861,839183,Shortage,APO-DICLO,APOTEX INC,DICLO,DICLOFENAC SODIUM,50MG,100 BTL,ORAL,Actual shortage,TABLET (ENTERIC-COATED),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-10-07,2019-12-30,,Disruption of the manufacture of the drug.,2019-10-09,2019-10-09
25207,2243433,Shortage,APO-DICLO RAPIDE 50 MG TABLETS,APOTEX INC,DICLOFENAC,DICLOFENAC POTASSIUM,50MG,100 BTL,ORAL,Resolved,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-10-09,2017-12-29,2017-11-21,Disruption of the manufacture of the drug.,2017-10-11,2017-11-22
98557,2243433,Shortage,APO-DICLO RAPIDE 50 MG TABLETS,APOTEX INC,DICLOFENAC,DICLOFENAC POTASSIUM,50MG,100 BTL,ORAL,Actual shortage,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-11-11,,,Disruption of the manufacture of the drug.,2019-11-13,2019-11-13
11062,2162814,Shortage,APO-DICLO SR,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,75MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-06-19,2017-06-12,2017-10-10,2017-09-21,Disruption of the manufacture of the drug.,2017-05-24,2017-09-22
30805,2162814,Shortage,APO-DICLO SR,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,75MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-11-27,2018-05-07,2018-04-16,Disruption of the manufacture of the drug.,2017-11-27,2018-04-17
55264,2091194,Shortage,APO-DICLO SR,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,100MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-07-09,2019-12-13,,Disruption of the manufacture of the drug.,2018-07-11,2019-10-08
55267,2162814,Shortage,APO-DICLO SR,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,75MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-07-09,2019-12-13,,Disruption of the manufacture of the drug.,2018-07-11,2019-10-08
95868,2441020,Shortage,APO-DICLOFENAC OPHTHALMIC,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,0.1%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2019-10-07,2019-10-31,2019-11-01,Disruption of the manufacture of the drug.,2019-10-09,2019-11-04
71121,2441020,Shortage,APO-DICLOFENAC OPHTHALMIC,APOTEX INC,DICLOFENAC OPHTHALMIC,DICLOFENAC SODIUM,0.1%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2019-01-02,2019-01-30,2019-01-16,Disruption of the manufacture of the drug.,2019-01-03,2019-01-17
16856,2441020,Shortage,APO-DICLOFENAC OPHTHALMIC,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,0.1%,10 mL,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2017-07-24,2017-08-28,2017-09-15,Disruption of the manufacture of the drug.,2017-07-25,2017-09-22
19326,2281201,Shortage,APO-DIGOXIN,APOTEX INC,DIGOXIN,DIGOXIN,0.25MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19329,2281228,Shortage,APO-DIGOXIN,APOTEX INC,DIGOXIN,DIGOXIN,0.125MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19332,2281236,Shortage,APO-DIGOXIN,APOTEX INC,DIGOXIN,DIGOXIN,0.0625MG,100 BTL,ORAL,Actual shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
91070,771384,Shortage,APO-DILTIAZ,APOTEX INC,Diltiaz,DILTIAZEM HYDROCHLORIDE,60MG,100 BTL,ORAL,Resolved,TABLET,C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-08-06,2019-08-30,2019-08-28,Disruption of the manufacture of the drug.,2019-08-07,2019-08-30
281,2230997,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016-04-19,,2018-12-17,Disruption of the manufacture of the drug.,2017-03-10,2018-12-18
284,2230998,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016-05-25,,2018-12-17,Disruption of the manufacture of the drug.,2017-03-10,2018-12-18
92965,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-09-03,2019-10-18,2019-10-11,Disruption of the manufacture of the drug.,2019-09-04,2019-10-15
76585,2230997,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ CD,DILTIAZEM HYDROCHLORIDE,120MG,500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-02-18,2019-07-19,2019-07-04,Disruption of the manufacture of the drug.,2019-02-21,2019-07-05
77872,2229526,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ CD,DILTIAZEM HYDROCHLORIDE,300MG,100 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-03-04,2019-11-01,2019-10-30,Disruption of the manufacture of the drug.,2019-03-06,2019-11-05
14168,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017-09-22,2017-09-29,,2018-12-17,Disruption of the manufacture of the drug.,2017-06-28,2018-12-18
75611,2230997,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ CD,DILTIAZEM HYDROCHLORIDE,120MG,100BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-02-11,2019-07-19,2019-07-04,Disruption of the manufacture of the drug.,2019-02-13,2019-07-05
75614,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ CD,DILTIAZEM HYDROCHLORIDE,240MG,500BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-02-11,2019-07-19,2019-07-11,Disruption of the manufacture of the drug.,2019-02-13,2019-07-12
92022,2230998,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ,DILTIAZEM HYDROCHLORIDE,180MG,500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-08-19,2019-10-03,2019-10-11,Disruption of the manufacture of the drug.,2019-08-21,2019-10-15
74872,2230998,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ CD,DILTIAZEM HYDROCHLORIDE,180MG,500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-02-04,2019-07-19,2019-07-11,Disruption of the manufacture of the drug.,2019-02-06,2019-07-12
78484,2230998,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ CD,DILTIAZEM HYDROCHLORIDE,180MG,100 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-03-11,2019-07-19,2019-07-11,Disruption of the manufacture of the drug.,2019-03-13,2019-07-12
76714,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,240MG,100 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-02-20,2019-07-19,2019-07-11,Disruption of the manufacture of the drug.,2019-02-24,2019-07-12
91073,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZ,DILTIAZEM HYDROCHLORIDE,240MG,500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-08-06,2019-10-18,2019-10-11,Disruption of the manufacture of the drug.,2019-08-07,2019-10-15
716,2230999,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016-11-08,,2018-12-17,Disruption of the manufacture of the drug.,2017-03-13,2018-12-18
287,2229526,Shortage,APO-DILTIAZ CD - CAP 300MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,300MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-02-06,,2018-12-17,Disruption of the manufacture of the drug.,2017-03-10,2018-12-18
19030,2222965,Shortage,APO-DILTIAZ SR - 90MG/SRC,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,90MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE (SUSTAINED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19033,2222973,Shortage,APO-DILTIAZ SR - SRC 120MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE (SUSTAINED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19027,2222957,Shortage,APO-DILTIAZ SR - SRC 60MG,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,60MG,100 BTL & 500 BTL,ORAL,Actual shortage,CAPSULE (SUSTAINED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19598,2242232,Shortage,APO-DIPIVEFRIN,APOTEX INC,DIPIVEFRIN,DIPIVEFRIN HYDROCHLORIDE,0.1%,5/10/15 ML,OPHTHALMIC,Actual shortage,LIQUID,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-03-10,,,Other (Please describe in comments),2017-08-16,2017-10-05
58589,895660,Shortage,APO-DIPYRIDAMOLE-FC TAB 75MG,APOTEX INC,DIPYRIDAMOLE,,,100 BTL,,Resolved,,,,,2018-08-20,2018-10-31,2018-09-14,Disruption of the manufacture of the drug.,2018-08-21,2018-09-17
12805,2239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2017-06-23,2017-06-19,2017-07-31,2017-07-25,Disruption of the manufacture of the drug.,2017-06-15,2017-07-26
88331,2239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2019-07-02,2019-08-16,2019-08-16,Disruption of the manufacture of the drug.,2019-07-03,2019-08-19
12059,2239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017-06-06,2017-07-14,2017-07-14,Disruption of the manufacture of the drug.,2017-06-06,2017-07-17
34844,2239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2018-01-02,2018-03-09,2018-02-09,Disruption of the manufacture of the drug.,2018-01-03,2018-02-12
34847,2239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2018-01-02,2018-03-02,2018-03-02,Disruption of the manufacture of the drug.,2018-01-03,2018-03-06
92968,2239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2019-09-03,2019-10-31,2019-10-25,Disruption of the manufacture of the drug.,2019-09-04,2019-10-28
92971,2239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2019-09-03,2019-11-15,2019-11-08,Disruption of the manufacture of the drug.,2019-09-04,2019-11-11
71475,2239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX 500MG,VALPROIC ACID,500MG,100BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2019-01-04,2019-02-15,2019-02-13,Disruption of the manufacture of the drug.,2019-01-08,2019-02-14
75617,2239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2019-02-11,2019-02-22,2019-02-18,Disruption of the manufacture of the drug.,2019-02-13,2019-02-21
46024,2239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2018-04-16,2018-05-31,2018-05-11,Disruption of the manufacture of the drug.,2018-04-16,2018-05-14
87512,2239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2019-06-24,2019-08-23,2019-08-16,Disruption of the manufacture of the drug.,2019-06-26,2019-08-19
19120,2245080,Shortage,APO-DOCUSATE CALCIUM,APOTEX INC,DOCUSATE,DOCUSATE CALCIUM,240MG,100 BTL,ORAL,Actual shortage,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
73311,2103613,Shortage,APO-DOMPERIDONE - TAB 10MG,APOTEX INC,DOMPERIDONE,DOMPERIDONE,10MG,500 BTL,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2019-01-21,2019-09-27,2019-08-23,Disruption of the manufacture of the drug.,2019-01-23,2019-08-26
68719,2103613,Shortage,APO-DOMPERIDONE - TAB 10MG,APOTEX INC,DOMPERIDONE,DOMPERIDONE,10MG,500BTL,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2018-12-03,2018-12-24,2018-12-19,Disruption of the manufacture of the drug.,2018-12-05,2018-12-21
42686,2103613,Shortage,APO-DOMPERIDONE - TAB 10MG,APOTEX INC,DOMPERIDONE,DOMPERIDONE,10MG,500 BTL,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2018-03-12,2018-05-04,2018-04-13,Disruption of the manufacture of the drug.,2018-03-13,2018-04-16
16867,2103613,Shortage,APO-DOMPERIDONE - TAB 10MG,APOTEX INC,DOMPERIDONE,DOMPERIDONE,10MG,500 BTL,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2017-07-24,2017-08-10,2017-08-07,Disruption of the manufacture of the drug.,2017-07-25,2017-08-08
5402,2362260,Shortage,APO-DONEPEZIL,APOTEX INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,"100 BTL, 500 BTL & 30 BLS",ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017-04-03,2017-07-21,2017-07-21,Disruption of the manufacture of the drug.,2017-04-04,2017-07-24
47649,2362279,Shortage,APO-DONEPEZIL,APOTEX INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,30 BLS & 500 BTL,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-04-30,,2018-09-08,Disruption of the manufacture of the drug.,2018-05-01,2018-09-09
9928,2362279,Shortage,APO-DONEPEZIL,APOTEX INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,30 BLS,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017-08-07,2017-09-27,2017-09-29,Disruption of the manufacture of the drug.,2017-05-10,2017-10-04
94737,2299615,Shortage,APO-DORZO-TIMOP,APOTEX INC,DORZO-TIMOP,TIMOLOL  DORZOLAMIDE,5MG  20MG,10 ML,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-09-23,2019-11-22,,Disruption of the manufacture of the drug.,2019-09-25,2019-10-29
290,2299615,Shortage,APO-DORZO-TIMOP,APOTEX INC,DORZOLAMIDE-TIMOLOL,TIMOLOL  DORZOLAMIDE,5MG  20MG,10 mL,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015-10-06,2019-07-12,2019-07-12,Disruption of the manufacture of the drug.,2017-03-10,2019-07-13
36812,2240590,Shortage,APO-DOXAZOSIN,APOTEX INC,DOXAZOSIN,DOXAZOSIN,4MG,100 BTL,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2018-01-22,2018-08-03,2018-06-29,Disruption of the manufacture of the drug.,2018-01-22,2018-07-03
13312,2049996,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,10MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-06-19,2017-06-30,2017-06-30,Disruption of the manufacture of the drug.,2017-06-19,2017-07-04
29957,2050005,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-11-20,2018-01-02,2017-12-07,Disruption of the manufacture of the drug.,2017-11-21,2017-12-08
4389,2050013,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,50MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-03-27,2017-04-10,2017-03-31,Disruption of the manufacture of the drug.,2017-03-27,2017-04-03
294,2049996,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,10MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2016-12-13,2017-04-10,2017-03-31,Disruption of the manufacture of the drug.,2017-03-10,2017-04-03
298,2050048,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,100MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-02-14,2017-04-10,2017-03-31,Disruption of the manufacture of the drug.,2017-03-10,2017-04-03
302,2050005,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-01-24,2017-04-10,2017-04-07,Disruption of the manufacture of the drug.,2017-03-10,2017-04-10
19003,2050056,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,150MG,100 BTL,ORAL,Actual shortage,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
28546,2049996,Shortage,APO-DOXEPIN,APOTEX INC,DOXEPIN,DOXEPIN,10MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-11-06,2017-12-22,2017-12-07,Disruption of the manufacture of the drug.,2017-11-07,2017-12-08
20869,740713,Shortage,APO-DOXY CAP 100MG,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,100MG,250 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017-10-20,2017-10-16,2017-11-30,2017-11-15,Disruption of the manufacture of the drug.,2017-09-05,2017-11-16
41133,740713,Shortage,APO-DOXY CAP 100MG,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,100MG,100 BTL & 250 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2018-02-26,2018-07-06,2018-05-09,Disruption of the manufacture of the drug.,2018-02-27,2018-05-10
26569,874256,Shortage,APO-DOXY TABS 100MG,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,100MG,100 BTL,ORAL,Resolved,TABLET,J01AA,TETRACYCLINES,,2017-12-18,2018-02-19,2018-02-19,Disruption of the manufacture of the drug.,2017-10-23,2018-02-21
33576,2413248,Shortage,APO-DOXYLAMINE/B6,APOTEX INC,DOXYLAMINE,DOXYLAMINE SUCCINATE  PYRIDOXINE HYDROCHLORIDE,10MG  10MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2017-12-11,2018-07-20,2018-06-29,Disruption of the manufacture of the drug.,2017-12-18,2018-07-03
64934,2413248,Shortage,APO-DOXYLAMINE/B6,APOTEX INC,DOXYLAMINE/B6,DOXYLAMINE SUCCINATE  PYRIDOXINE HYDROCHLORIDE,10MG  10MG,500 BLT,ORAL,Resolved,TABLET (DELAYED-RELEASE),R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2018-10-16,2019-05-03,2019-05-02,Disruption of the manufacture of the drug.,2018-10-19,2019-05-03
79577,2413248,Shortage,APO-DOXYLAMINE/B6,APOTEX INC,DOXYLAMINE/B6,DOXYLAMINE SUCCINATE  PYRIDOXINE HYDROCHLORIDE,10MG  10MG,100 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2019-03-25,2019-05-03,2019-05-02,Disruption of the manufacture of the drug.,2019-03-27,2019-05-03
65592,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE 60MG,DULOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-10-23,2018-11-29,2018-11-19,Disruption of the manufacture of the drug.,2018-10-25,2018-11-20
642,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-05-01,2017-05-08,2017-06-09,2017-06-02,Disruption of the manufacture of the drug.,2017-03-12,2017-06-05
645,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-04-20,,2017-06-12,2017-05-30,Disruption of the manufacture of the drug.,2017-03-12,2017-05-31
648,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-04-13,2017-04-03,2017-04-28,2017-04-21,Disruption of the manufacture of the drug.,2017-03-12,2018-04-02
651,2440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,30 BLS,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-04-11,2017-04-03,2017-06-20,2017-04-05,Disruption of the manufacture of the drug.,2017-03-12,2017-10-05
20640,2440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-08-28,2017-11-15,2017-10-19,Disruption of the manufacture of the drug.,2017-08-30,2017-10-20
36282,2440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-01-15,2018-03-16,2018-03-05,Disruption of the manufacture of the drug.,2018-01-17,2018-03-06
55270,2440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,500 BTL & 30 BLS & 100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-07-09,2018-09-17,2018-08-29,Disruption of the manufacture of the drug.,2018-07-11,2018-08-30
55273,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-07-09,2018-08-31,2018-08-21,Disruption of the manufacture of the drug.,2018-07-11,2018-08-22
35565,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,30 BLS,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-01-08,2018-04-27,2018-04-20,Disruption of the manufacture of the drug.,2018-01-10,2018-04-23
43508,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-03-19,2018-06-01,2018-04-20,Disruption of the manufacture of the drug.,2018-03-20,2018-04-23
12286,2440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,100 BTL,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-10-20,2017-10-02,2017-11-15,2017-10-19,Disruption of the manufacture of the drug.,2017-06-08,2017-10-20
77875,2404206,Shortage,APO-DUTASTERIDE,APOTEX INC,DUTASTERIDE,DUTASTERIDE,0.5MG,30 BLS,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-03-04,2019-04-11,2019-04-03,Disruption of the manufacture of the drug.,2019-03-06,2019-04-05
71659,2404206,Shortage,APO-DUTASTERIDE,APOTEX INC,DUTASTERIDE,DUTASTERIDE,0.5MG,30 BLS,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-01-08,2019-02-15,2019-02-12,Disruption of the manufacture of the drug.,2019-01-09,2019-02-13
305,2386054,Shortage,APO-ELETRIPTAN,APOTEX INC,ELETRIPTAN,ELETRIPTAN,20MG,6 BLS,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014-10-01,2019-12-13,,Disruption of the manufacture of the drug.,2017-03-11,2019-10-07
308,2386062,Shortage,APO-ELETRIPTAN,APOTEX INC,ELETRIPTAN,ELETRIPTAN,40MG,6 BLS,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2014-10-01,2019-12-13,,Disruption of the manufacture of the drug.,2017-03-11,2019-10-07
92974,2452006,Shortage,APO-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-09-03,2019-09-17,2019-09-05,Disruption of the manufacture of the drug.,2019-09-04,2019-09-06
89158,2452006,Shortage,APO-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE-TENOFOVIR,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-07-08,2019-08-16,2019-08-16,Disruption of the manufacture of the drug.,2019-07-12,2019-08-17
23663,2452006,Shortage,APO-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE-TENOFOVIR,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017-09-22,2017-10-20,2017-09-29,Disruption of the manufacture of the drug.,2017-09-27,2017-10-02
41868,2452006,Shortage,APO-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE-TENOFOVIR,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2018-03-05,2018-04-30,2018-03-19,Disruption of the manufacture of the drug.,2018-03-06,2018-03-20
80530,2452006,Shortage,APO-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE-TENOFOVIR,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-04-01,2019-05-30,2019-05-17,Disruption of the manufacture of the drug.,2019-04-04,2019-05-21
27703,2019892,Shortage,APO-ENALAPRIL TAB 10MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,10MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-10-30,2018-01-12,2018-01-02,Disruption of the manufacture of the drug.,2017-11-01,2018-01-03
37949,2019892,Shortage,APO-ENALAPRIL TAB 10MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,10MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-03-26,2018-03-26,2018-04-13,2018-04-06,Disruption of the manufacture of the drug.,2018-02-01,2018-04-07
91078,2020025,Shortage,APO-ENALAPRIL TAB 2.5MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,2.5MG,100 BTL,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-08-06,2019-12-20,,Disruption of the manufacture of the drug.,2019-08-07,2019-10-18
27707,2019906,Shortage,APO-ENALAPRIL TAB 20MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,20MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-10-30,2018-04-30,2018-04-06,Disruption of the manufacture of the drug.,2017-11-01,2018-04-07
65595,2019884,Shortage,APO-ENALAPRIL TAB 5MG,APOTEX INC,ENALAPRIL 5MG,ENALAPRIL MALEATE,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-10-23,2018-12-14,2018-12-07,Disruption of the manufacture of the drug.,2018-10-25,2018-12-08
27710,2019884,Shortage,APO-ENALAPRIL TAB 5MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-10-30,2018-01-12,2017-12-19,Disruption of the manufacture of the drug.,2017-11-01,2017-12-20
37953,2019884,Shortage,APO-ENALAPRIL TAB 5MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,5MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-03-28,2018-03-26,2018-04-13,2018-04-06,Disruption of the manufacture of the drug.,2018-02-01,2018-04-07
94168,2019884,Shortage,APO-ENALAPRIL TAB 5MG,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,5MG,100 BTL,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-09-17,2019-11-29,,Disruption of the manufacture of the drug.,2019-09-18,2019-11-18
311,2396955,Shortage,APO-ENTECAVIR,APOTEX INC,ENTECAVIR,ENTECAVIR,0.5MG,30 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2016-10-18,2017-10-31,2017-10-10,Disruption of the manufacture of the drug.,2017-03-11,2017-10-11
59813,2396955,Shortage,APO-ENTECAVIR,APOTEX INC,ENTECAVIR,ENTECAVIR,0.5MG,30 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2018-09-03,2019-05-10,2019-05-10,Disruption of the manufacture of the drug.,2018-09-04,2019-05-13
74875,2461870,Shortage,APO-ERLOTINIB,APOTEX INC,ERLOTINIB,ERLOTINIB,100MG,30 BLS,ORAL,Actual shortage,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-02-04,2019-11-22,,Disruption of the manufacture of the drug.,2019-02-06,2019-10-21
74878,2461889,Shortage,APO-ERLOTINIB,APOTEX INC,ERLOTINIB,ERLOTINIB,150MG,30 BLS,ORAL,Actual shortage,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-02-04,2019-11-22,,Disruption of the manufacture of the drug.,2019-02-06,2019-10-21
74881,2461862,Shortage,APO-ERLOTINIB,APOTEX INC,ERLOTINIB,ERLOTINIB,25MG,30 BLS,ORAL,Actual shortage,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-02-04,2019-11-22,,Disruption of the manufacture of the drug.,2019-02-06,2019-10-21
77878,2295016,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-03-04,2019-03-26,2019-03-08,Disruption of the manufacture of the drug.,2019-03-06,2019-03-09
77881,2295024,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,20MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-03-04,2019-03-26,2019-03-08,Disruption of the manufacture of the drug.,2019-03-06,2019-03-09
92522,2295024,Shortage,APO-ESCITALOPRAM,APOTEX INC,APO-ESCITALOPRAM,ESCITALOPRAM,20MG,100 BTL,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-08-28,,,Disruption of the manufacture of the drug.,2019-08-28,2019-08-29
68218,2295024,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM 20MG,ESCITALOPRAM,20MG,100BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-11-26,2019-02-08,2019-02-07,Disruption of the manufacture of the drug.,2018-11-30,2019-02-08
77971,2295016,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,10MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-03-04,2019-03-26,2019-03-08,Disruption of the manufacture of the drug.,2019-03-06,2019-03-09
69299,2295024,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-12-10,2018-12-10,2019-02-28,2019-02-25,Disruption of the manufacture of the drug.,2018-12-12,2019-02-26
87517,2295016,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100 BTL,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-06-24,,,Disruption of the manufacture of the drug.,2019-06-26,2019-08-28
742,2295016,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,10MG,500 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-02-06,2017-03-28,2017-03-28,Disruption of the manufacture of the drug.,2017-03-13,2017-03-29
745,2295024,Shortage,APO-ESCITALOPRAM,APOTEX INC,ESCITALOPRAM,ESCITALOPRAM,20MG,500 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-02-14,2017-04-30,2017-04-19,Disruption of the manufacture of the drug.,2017-03-13,2017-04-20
97037,2339102,Shortage,APO-ESOMEPRAZOLE,APOTEX INC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100 BTL,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-21,2020-02-28,,Disruption of the manufacture of the drug.,2019-10-23,2019-10-23
97040,2339102,Shortage,APO-ESOMEPRAZOLE,APOTEX INC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,30 BLS,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-21,2020-02-28,,Disruption of the manufacture of the drug.,2019-10-23,2019-10-23
97043,2339102,Shortage,APO-ESOMEPRAZOLE,APOTEX INC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,500 BTL,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-21,2020-02-28,,Disruption of the manufacture of the drug.,2019-10-23,2019-10-23
62868,2339102,Shortage,APO-ESOMEPRAZOLE,APOTEX INC,Esomeprazole ECT 40MG,ESOMEPRAZOLE,40MG,30BLS,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-10-02,2018-10-05,2019-02-08,2019-02-05,Disruption of the manufacture of the drug.,2018-10-02,2019-02-06
314,2419726,Shortage,APO-EXEMESTANE,APOTEX INC,EXEMESTANE,EXEMESTANE,25MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2014-10-02,,2019-06-03,Disruption of the manufacture of the drug.,2017-03-11,2019-06-12
318,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,100 BTL,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-01,2017-03-17,2017-03-14,Disruption of the manufacture of the drug.,2017-03-11,2017-03-15
37956,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,100 BTL,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-02-12,2018-02-05,2018-05-11,2018-04-20,Disruption of the manufacture of the drug.,2018-02-01,2018-04-23
655,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,30 BLS,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017-03-25,,2017-04-28,2017-04-24,Disruption of the manufacture of the drug.,2017-03-12,2017-04-25
91535,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,30 BLS,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-13,2019-10-28,2019-10-03,Disruption of the manufacture of the drug.,2019-08-14,2019-10-07
8862,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,30 BLS,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017-05-23,2017-06-05,2017-07-28,2017-07-17,Disruption of the manufacture of the drug.,2017-05-04,2017-07-18
10400,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,100 BTL,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-15,2017-07-20,2017-07-17,Disruption of the manufacture of the drug.,2017-05-16,2017-07-18
5366,2427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,100 BTL,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-31,2017-04-28,2017-04-24,Disruption of the manufacture of the drug.,2017-04-04,2017-04-25
23553,2292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-09-22,2018-04-10,2018-01-17,Disruption of the manufacture of the drug.,2017-09-26,2018-01-18
84535,2292068,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,500MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-05-21,2019-09-27,2019-09-05,Disruption of the manufacture of the drug.,2019-05-22,2019-09-06
17234,2292068,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,500MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-09-22,2017-08-28,2018-04-10,2018-01-17,Disruption of the manufacture of the drug.,2017-07-26,2018-01-18
20872,2292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-10-13,2017-10-09,2018-04-10,2018-01-17,Disruption of the manufacture of the drug.,2017-09-05,2018-01-18
78497,2292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-03-11,2019-09-27,2019-08-30,Disruption of the manufacture of the drug.,2019-03-13,2019-08-31
72354,2292068,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,500MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-01-14,2019-05-03,2019-04-25,Disruption of the manufacture of the drug.,2019-01-15,2019-04-26
59816,2292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-09-03,2018-12-28,2018-12-14,Disruption of the manufacture of the drug.,2018-09-04,2018-12-18
26572,2292025,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,125MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-10-23,2018-01-22,2018-01-18,Disruption of the manufacture of the drug.,2017-10-23,2018-01-19
719,2292068,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,500MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-03-10,2017-05-24,2017-04-14,Disruption of the manufacture of the drug.,2017-03-13,2017-04-17
55276,2292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-07-09,2018-09-10,2018-08-08,Disruption of the manufacture of the drug.,2018-07-11,2018-08-09
19048,2231119,Shortage,APO-FAMOTIDINE,APOTEX INC,FAMOTIDINE,FAMOTIDINE,10MG,10/12/6 BLS,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
619,1953842,Shortage,APO-FAMOTIDINE TAB 20MG USP,APOTEX INC,FAMOTIDINE,FAMOTIDINE,20 MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2014-10-01,,2018-09-08,Disruption of the manufacture of the drug.,2017-03-11,2018-09-09
616,1953834,Shortage,APO-FAMOTIDINE TAB 40MG USP,APOTEX INC,FAMOTIDINE,FAMOTIDINE,40MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2014-10-01,,2018-09-08,Disruption of the manufacture of the drug.,2017-03-11,2018-09-09
55299,2452375,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,5MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-07-09,2018-09-07,2018-07-31,Disruption of the manufacture of the drug.,2018-07-11,2018-08-01
18543,2452367,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,2.5MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-08-07,2017-09-15,2017-09-15,Disruption of the manufacture of the drug.,2017-08-09,2017-09-22
96647,2452367,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,2.5MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-10-15,2019-11-24,2019-11-15,Disruption of the manufacture of the drug.,2019-10-16,2019-11-18
5894,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,30 BLS,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017-04-14,,2017-06-15,2017-05-25,Disruption of the manufacture of the drug.,2017-04-07,2017-05-26
30995,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,30 BLS,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017-12-05,2017-12-08,2018-07-27,2018-07-13,Disruption of the manufacture of the drug.,2017-11-29,2018-07-17
17228,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,30 BLS,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017-08-21,,2017-10-13,2017-10-02,Disruption of the manufacture of the drug.,2017-07-26,2017-10-05
3749,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,100 BTL,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017-04-02,,2017-05-31,2017-06-01,Disruption of the manufacture of the drug.,2017-03-21,2017-06-05
2295,2239864,Shortage,APO-FENO-MICRO,APOTEX INC,FENOFIBRATE,FENOFIBRATE,200MG,100 BTL,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-13,2017-05-31,2017-05-11,Disruption of the manufacture of the drug.,2017-03-14,2017-05-12
83502,2246860,Shortage,APO-FENO-SUPER,APOTEX INC,FENO-SUPER,FENOFIBRATE,160MG,100 BTL,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-06,2019-08-30,2019-08-16,Disruption of the manufacture of the drug.,2019-05-08,2019-08-19
321,2246859,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100MG,30 BLS,ORAL,Actual shortage,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-01-31,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
8593,2246860,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,160MG,30 BLS,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-08,2017-09-15,2017-08-01,Disruption of the manufacture of the drug.,2017-05-02,2017-08-29
6551,2246859,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100MG,100 BTL,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-07,2017-05-31,2017-04-27,Disruption of the manufacture of the drug.,2017-04-12,2017-04-28
15268,2246859,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100MG,100 BTL,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2018-07-16,2019-05-24,2019-05-24,Disruption of the manufacture of the drug.,2017-07-11,2019-05-25
3524,2246860,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,160MG,30 BLS,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-18,2018-06-22,2018-05-11,Disruption of the manufacture of the drug.,2017-03-20,2018-05-15
49362,2246860,Shortage,APO-FENO-SUPER,APOTEX INC,FENOFIBRATE,FENOFIBRATE,160MG,100 BTL,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2018-05-14,2018-08-24,2018-08-24,Disruption of the manufacture of the drug.,2018-05-15,2018-08-27
622,2225980,Shortage,APO-FENOFIBRATE,APOTEX INC,FENOFIBRATE,FENOFIBRATE,100 MG,100 BTL,ORAL,Actual shortage,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2016-02-02,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
13317,2365383,Shortage,APO-FINASTERIDE,APOTEX INC,FINASTERIDE,FINASTERIDE,5MG,30 BLS,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-06-19,2017-07-24,2017-07-18,Disruption of the manufacture of the drug.,2017-06-19,2017-07-19
80533,2365383,Shortage,APO-FINASTERIDE,APOTEX INC,FINASTERIDE,FINASTERIDE,5MG,30 BLS,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-04-01,2019-08-01,2019-08-01,Disruption of the manufacture of the drug.,2019-04-04,2019-08-02
93671,2365383,Shortage,APO-FINASTERIDE,APOTEX INC,FINASTERIDE,FINASTERIDE,5MG,30 BLS,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-09-09,2019-09-30,2019-09-30,Disruption of the manufacture of the drug.,2019-09-12,2019-10-01
19117,2244842,Shortage,APO-FLAVOXATE,APOTEX INC,FLAVOXATE,FLAVOXATE HYDROCHLORIDE,200MG,100 BTL,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
97048,2275546,Shortage,APO-FLECAINIDE,APOTEX INC,FLECAINIDE,FLECAINIDE ACETATE,100MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2019-10-21,2019-11-11,2019-11-01,Disruption of the manufacture of the drug.,2019-10-23,2019-11-04
97051,2275538,Shortage,APO-FLECAINIDE,APOTEX INC,APO-FLECAINIDE,FLECAINIDE ACETATE,50MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2019-10-21,2019-11-11,2019-11-01,Disruption of the manufacture of the drug.,2019-10-23,2019-11-04
36496,2237371,Shortage,APO-FLUCONAZOLE,APOTEX INC,FLUCONAZOLE,,,50 BTL,,Resolved,,,,,2018-01-12,,2018-05-03,Disruption of the manufacture of the drug.,2018-01-18,2018-05-04
77884,2241895,Shortage,APO-FLUCONAZOLE-150,APOTEX INC,APO-FLUCONAZOLE,FLUCONAZOLE,150MG,1 BLS,ORAL,Resolved,CAPSULE,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2019-03-04,2019-05-03,2019-04-25,Disruption of the manufacture of the drug.,2019-03-06,2019-04-26
32525,2239288,Shortage,APO-FLUNISOLIDE NASAL SPRAY,APOTEX INC,FLUNISOLIDE,FLUNISOLIDE,0.25MG,25 ML,NASAL,Resolved,METERED-DOSE PUMP,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017-12-11,,2018-02-23,Disruption of the manufacture of the drug.,2017-12-12,2018-02-26
42691,2216361,Shortage,APO-FLUOXETINE,APOTEX INC,FLUOXETINE,FLUOXETINE,20MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-03-12,2018-05-16,2018-05-04,Disruption of the manufacture of the drug.,2018-03-13,2018-05-05
30928,1912038,Shortage,APO-FLURBIPROFEN FC TABLETS 100MG,APOTEX INC,FLURBIPROFEN,FLURBIPROFEN,100MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-11-27,,2018-09-06,Disruption of the manufacture of the drug.,2017-11-28,2018-09-07
14171,2231330,Shortage,APO-FLUVOXAMINE TABLETS,APOTEX INC,FLUVOXAMINE,FLUVOXAMINE MALEATE,100MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-08-31,2017-08-09,2018-03-09,2018-03-02,Disruption of the manufacture of the drug.,2017-06-28,2018-03-04
14174,2231329,Shortage,APO-FLUVOXAMINE TABLETS,APOTEX INC,FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-08-14,2017-07-31,2018-03-09,2018-03-02,Disruption of the manufacture of the drug.,2017-06-28,2018-03-04
324,2266016,Shortage,APO-FOSINOPRIL,APOTEX INC,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-02-14,2017-04-17,2017-04-07,Disruption of the manufacture of the drug.,2017-03-11,2017-04-10
658,2266008,Shortage,APO-FOSINOPRIL,APOTEX INC,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-03-17,2017-03-14,2017-04-15,2017-04-07,Disruption of the manufacture of the drug.,2017-03-12,2017-04-10
21082,2426471,Shortage,APO-FROVATRIPTAN,APOTEX INC,FROVATRIPTAN,FROVATRIPTAN,2.5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-09-04,2017-10-06,2017-10-09,Disruption of the manufacture of the drug.,2017-09-06,2017-10-10
80264,2426471,Shortage,APO-FROVATRIPTAN,APOTEX INC,Frovatriptan,FROVATRIPTAN,2.5MG,6 BLS,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-01-07,2020-01-24,,Disruption of the manufacture of the drug.,2019-04-01,2019-10-07
23558,2293366,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,800MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-22,2017-11-17,2017-10-27,Disruption of the manufacture of the drug.,2017-09-26,2017-10-31
31001,2293358,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,600MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-12-28,2017-12-11,2018-04-13,2018-03-21,Disruption of the manufacture of the drug.,2017-11-29,2018-03-22
31004,2293366,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,800MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-12-28,2017-12-11,2018-04-13,2018-03-21,Disruption of the manufacture of the drug.,2017-11-29,2018-03-22
78505,2293358,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,600MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-11,2019-07-05,2019-06-27,Disruption of the manufacture of the drug.,2019-03-13,2019-07-04
79580,2293366,Shortage,APO-GABAPENTIN,APOTEX INC,GABAPENTIN,GABAPENTIN,800MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-25,2019-05-24,2019-05-17,Shortage of an inactive ingredient or component.,2019-03-27,2019-05-21
71662,2293358,Shortage,APO-GABAPENTIN,APOTEX INC,APO-GABAPENTIN,GABAPENTIN,600MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-01-08,2019-01-16,2019-01-11,Disruption of the manufacture of the drug.,2019-01-09,2019-01-12
5897,2244306,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,400MG,100 BTL  &  500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-05-01,2017-04-14,2017-09-11,2017-09-14,Disruption of the manufacture of the drug.,2017-04-07,2017-09-15
30998,2244304,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,100MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-12-29,2017-12-11,2018-02-23,2018-02-20,Disruption of the manufacture of the drug.,2017-11-29,2018-02-21
12064,2244305,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-07-20,2017-08-16,2017-08-15,Disruption of the manufacture of the drug.,2017-06-06,2017-08-16
20000,2244304,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,100MG,100 & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-21,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-08-21,2017-10-04
28726,2244305,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-11-06,2017-12-18,2017-12-18,Disruption of the manufacture of the drug.,2017-11-09,2017-12-19
604,2244306,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,400MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-10,2017-03-28,2017-03-28,Disruption of the manufacture of the drug.,2017-03-11,2017-03-29
661,2244305,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,300MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-01,2017-07-31,2017-07-12,Disruption of the manufacture of the drug.,2017-03-12,2017-07-13
41145,2244304,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,100MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-02-26,2018-04-23,2018-04-20,Disruption of the manufacture of the drug.,2018-02-27,2018-04-24
44497,2244305,Shortage,APO-GABAPENTIN CAPSULES,APOTEX INC,GABAPENTIN,GABAPENTIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-04-02,2018-08-17,2018-08-17,Disruption of the manufacture of the drug.,2018-04-02,2018-08-21
6554,885754,Shortage,APO-GAIN LIQ 20MG/ML,APOTEX INC,MINOXIDIL,MINOXIDIL,20MG,60 ML,TOPICAL,Resolved,LIQUID,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017-04-07,,2018-02-23,Disruption of the manufacture of the drug.,2017-04-12,2018-02-26
610,1979582,Shortage,APO-GEMFIBROZIL,APOTEX INC,GEMFIBROZIL,GEMFIBROZIL,600MG,100 BTL,ORAL,Actual shortage,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2014-10-09,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
607,1979574,Shortage,APO-GEMFIBROZIL CAP 300MG USP,APOTEX INC,GEMFIBROZIL,GEMFIBROZIL,300 MG,100 BTL,ORAL,Resolved,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2014-10-09,,2019-06-03,Disruption of the manufacture of the drug.,2017-03-11,2019-06-12
26159,2245247,Shortage,APO-GLICLAZIDE,APOTEX INC,GLICLAZIDE,GLICLAZIDE,80MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-10-16,2018-06-22,2018-05-21,Disruption of the manufacture of the drug.,2017-10-17,2018-05-22
47680,2245247,Shortage,APO-GLICLAZIDE,APOTEX INC,GLICLAZIDE,GLICLAZIDE,80MG,60 BLS,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-04-23,,2018-09-10,Disruption of the manufacture of the drug.,2018-05-01,2018-09-11
29960,2407124,Shortage,APO-GLICLAZIDE MR,APOTEX INC,GLICLAZIDE,GLICLAZIDE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-11-20,2018-04-30,2018-03-20,Disruption of the manufacture of the drug.,2017-11-21,2018-03-21
36817,2297795,Shortage,APO-GLICLAZIDE MR,APOTEX INC,GLICLAZIDE,GLICLAZIDE,30MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-01-22,2018-06-29,2018-06-11,Disruption of the manufacture of the drug.,2018-01-22,2018-06-12
32536,2295377,Shortage,APO-GLIMEPIRIDE,APOTEX INC,GLIMEPIRIDE,GLIMEPIRIDE,1MG,100 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-12-11,,2019-09-20,Disruption of the manufacture of the drug.,2017-12-12,2019-09-21
31007,2295393,Shortage,APO-GLIMEPIRIDE,APOTEX INC,GLIMEPIRIDE,GLIMEPIRIDE,4MG,100 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-12-15,2017-12-11,,2019-09-20,Shortage of an inactive ingredient or component.,2017-11-29,2019-09-21
55281,2295385,Shortage,APO-GLIMEPIRIDE,APOTEX INC,GLIMEPIRIDE,GLIMEPIRIDE,2MG,100 BTL,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-07-09,,2019-09-20,Disruption of the manufacture of the drug.,2018-07-11,2019-09-21
18945,463698,Shortage,APO-HALOPERIDOL TAB 10MG,APOTEX INC,HALOPERIDOL,HALOPERIDOL,10MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,N05AD,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18184,441627,Shortage,APO-HYDRALAZINE,APOTEX INC,HYDRALAZINE,HYDRALAZINE HYDROCHLORIDE,25MG,100 BTL,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2017-07-31,2017-08-04,2017-10-02,Other (Please describe in comments),2017-08-03,2017-10-10
18187,441635,Shortage,APO-HYDRALAZINE,APOTEX INC,HYDRALAZINE,HYDRALAZINE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2017-07-31,2017-08-04,2017-10-02,Other (Please describe in comments),2017-08-03,2017-10-10
18190,441619,Shortage,APO-HYDRALAZINE,APOTEX INC,HYDRALAZINE,HYDRALAZINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2017-07-31,2017-08-07,2017-10-02,Other (Please describe in comments),2017-08-03,2017-10-10
16931,2327856,Shortage,APO-HYDRO,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017-07-17,2017-09-29,2017-09-11,Disruption of the manufacture of the drug.,2017-07-25,2017-09-15
77887,2327856,Shortage,APO-HYDRO,APOTEX INC,HYDRO,HYDROCHLOROTHIAZIDE,12.5MG,500 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2019-03-04,2019-04-03,2019-03-28,Disruption of the manufacture of the drug.,2019-03-06,2019-03-29
25210,2327856,Shortage,APO-HYDRO,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017-10-09,2018-03-16,2018-03-02,Disruption of the manufacture of the drug.,2017-10-11,2018-03-06
69302,2327856,Shortage,APO-HYDRO,APOTEX INC,HYDRO,HYDROCHLOROTHIAZIDE,12.5MG,500 BTL,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",2018-12-10,2018-12-10,2019-01-18,2019-01-15,Disruption of the manufacture of the drug.,2018-12-12,2019-01-17
26163,2364123,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,2MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-10-16,2018-01-05,2017-12-14,Disruption of the manufacture of the drug.,2017-10-17,2017-12-15
25214,2364115,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,1MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-10-09,2018-01-31,2018-01-19,Disruption of the manufacture of the drug.,2017-10-11,2018-01-22
20105,2364115,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,1MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-08-21,2017-09-05,2017-08-31,Disruption of the manufacture of the drug.,2017-08-23,2017-09-01
27809,2364131,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,4MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-11-01,2017-12-29,2017-12-29,Disruption of the manufacture of the drug.,2017-11-02,2017-12-31
17605,2364158,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,8MG,100 BTL,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-07-31,2017-09-05,2017-09-05,Disruption of the manufacture of the drug.,2017-08-01,2017-09-06
98562,2476622,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,4.5MG,60 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,,2019-11-11,,,Disruption of the manufacture of the drug.,2019-11-13,2019-11-13
77849,2476657,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,12MG,60 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2019-04-19,,,,Disruption of the manufacture of the drug.,2019-03-05,2019-04-20
77852,2476665,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,18MG,60 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2019-05-10,,,,Disruption of the manufacture of the drug.,2019-03-05,2019-05-11
77855,2476673,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,24MG,60 BTl,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2019-03-22,,,,Disruption of the manufacture of the drug.,2019-03-05,2019-03-23
77858,2476681,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,30MG,60 BTl,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2019-07-05,,,,Disruption of the manufacture of the drug.,2019-03-05,2019-07-06
74019,2476614,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE CR,HYDROMORPHONE HYDROCHLORIDE,3MG,60 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,,2019-01-28,,,Disruption of the manufacture of the drug.,2019-01-30,2019-03-07
79039,2476673,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE CR,HYDROMORPHONE HYDROCHLORIDE,24MG,60 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,,2019-03-18,,,Disruption of the manufacture of the drug.,2019-03-21,2019-06-12
71124,2476630,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE CR,HYDROMORPHONE HYDROCHLORIDE,6MG,60 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,,2019-01-02,,,Disruption of the manufacture of the drug.,2019-01-03,2019-03-07
71127,2476649,Shortage,APO-HYDROMORPHONE CR,APOTEX INC,HYDROMORPHONE CR,HYDROMORPHONE HYDROCHLORIDE,9MG,60 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,,2019-01-02,,,Disruption of the manufacture of the drug.,2019-01-03,2019-03-07
20875,2246691,Shortage,APO-HYDROXYQUINE,APOTEX INC,HYDROXYQUINE,HYDROXYCHLOROQUINE SULFATE,200MG,100 BTL,ORAL,Resolved,TABLET,P01BA,ANTIMALARIALS,2017-10-31,2017-11-07,2017-11-30,2017-11-17,Disruption of the manufacture of the drug.,2017-09-05,2017-11-20
91143,2247937,Shortage,APO-HYDROXYUREA,APOTEX INC,HYDROXYUREA,HYDROXYUREA,500MG,100 BTL,ORAL,Actual shortage,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2019-08-07,,,Shortage of an active ingredient.,2019-08-08,2019-08-08
19129,2247937,Shortage,APO-HYDROXYUREA,APOTEX INC,HYDROXYUREA,HYDROXYUREA,500MG,100 BTL,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017-03-10,,2017-12-05,Disruption of the manufacture of the drug.,2017-08-14,2017-12-07
76717,441643,Shortage,APO-IBUPROFEN TAB 200MG,APOTEX INC,IBUPROFEN TAB,IBUPROFEN,200MG,1000 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-02-20,,,Shortage of an active ingredient.,2019-02-24,2019-05-27
31010,2355345,Shortage,APO-IMATINIB,APOTEX INC,IMATINIB,IMATINIB,400MG,30 BLS,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2018-03-26,2018-03-28,2018-04-27,2018-04-17,Disruption of the manufacture of the drug.,2017-11-29,2018-04-18
68221,2355345,Shortage,APO-IMATINIB,APOTEX INC,IMATINIB 400MG,IMATINIB,400MG,30BLS,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2018-11-26,2019-01-11,2019-01-09,Disruption of the manufacture of the drug.,2018-11-30,2019-01-10
56986,2355345,Shortage,APO-IMATINIB,APOTEX INC,IMATINIB,IMATINIB,400MG,30 BLS,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2018-07-30,2018-11-15,2018-11-12,Disruption of the manufacture of the drug.,2018-07-31,2018-11-15
78512,2355345,Shortage,APO-IMATINIB,APOTEX INC,IMATINIB,IMATINIB,400MG,30 BLS,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-03-11,2019-03-29,2019-03-27,Disruption of the manufacture of the drug.,2019-03-13,2019-03-29
17609,2355345,Shortage,APO-IMATINIB,APOTEX INC,IMATINIB,IMATINIB,400MG,30 BLS,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2017-07-31,2017-09-05,2017-09-05,Disruption of the manufacture of the drug.,2017-08-01,2017-09-06
333,2407825,Shortage,APO-IMIQUIMOD,APOTEX INC,IMIQUIMOD,IMIQUIMOD,5%,24 x 250mg packet,TOPICAL,Actual shortage,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2015-09-24,,,Disruption of the manufacture of the drug.,2017-03-11,2018-01-29
94740,2245246,Shortage,APO-INDAPAMIDE 1.25 MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BTL,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2019-09-23,2020-01-31,,Disruption of the manufacture of the drug.,2019-09-25,2019-10-29
15973,2245246,Shortage,APO-INDAPAMIDE 1.25 MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BTL,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2017-07-17,2017-12-20,2017-12-11,Disruption of the manufacture of the drug.,2017-07-17,2017-12-14
8865,2245246,Shortage,APO-INDAPAMIDE 1.25 MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BTL,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2017-06-12,2017-07-17,2017-12-20,2017-12-11,Disruption of the manufacture of the drug.,2017-05-04,2017-12-14
613,2126222,Shortage,APO-IPRAVENT SOLUTION - INH 250MCG/ML,APOTEX INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250µG,20 ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-01-24,2017-04-13,2017-04-10,Disruption of the manufacture of the drug.,2017-03-11,2017-04-11
80536,2126222,Shortage,APO-IPRAVENT SOLUTION - INH 250MCG/ML,APOTEX INC,IPRAVENT SOLUTION - INH 250MCG/ML,IPRATROPIUM BROMIDE,250MCG,20 ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2019-04-01,2019-06-28,2019-06-28,Disruption of the manufacture of the drug.,2019-04-04,2019-07-02
19060,2231494,Shortage,APO-IPRAVENT STERULES,APOTEX INC,IPRATROPIUM,IPRATROPIUM BROMIDE,0.025%,2ML,INHALATION,Actual shortage,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19111,2243827,Shortage,APO-IPRAVENT STERULES,APOTEX INC,IPRATROPIUM,IPRATROPIUM BROMIDE,125MCG,2ML,INHALATION,Actual shortage,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
49408,2386984,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,300MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-05-14,,2018-09-10,Disruption of the manufacture of the drug.,2018-05-15,2018-09-11
55810,2386984,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,300MG,500 BTL,ORAL,Avoided shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-10-31,,,2018-08-17,Disruption of the manufacture of the drug.,2018-07-15,2018-08-21
336,2386976,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,150MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016-06-08,2017-12-18,2017-12-11,Disruption of the manufacture of the drug.,2017-03-11,2017-12-14
339,2386984,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,300MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014-06-17,2017-12-18,2017-12-11,Disruption of the manufacture of the drug.,2017-03-11,2017-12-14
342,2386968,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,75MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016-02-02,2017-12-18,2017-12-11,Disruption of the manufacture of the drug.,2017-03-11,2017-12-14
66534,2386968,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN 75MG,IRBESARTAN,75MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,,,Disruption of the manufacture of the drug.,2018-11-09,2018-11-09
55788,2386976,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,150MG,100 BTL,ORAL,Avoided shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-31,,2018-08-20,2018-08-20,Disruption of the manufacture of the drug.,2018-07-15,2018-08-21
55791,2386968,Shortage,APO-IRBESARTAN,APOTEX INC,IRBESARTAN,IRBESARTAN,75MG,100 BTL,ORAL,Avoided shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-31,,,2018-08-17,Disruption of the manufacture of the drug.,2018-07-15,2018-08-21
345,2387646,Shortage,APO-IRBESARTAN/HCTZ,APOTEX INC,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,500 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014-10-01,2017-04-30,2017-04-21,Disruption of the manufacture of the drug.,2017-03-11,2017-04-24
351,2387654,Shortage,APO-IRBESARTAN/HCTZ,APOTEX INC,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014-10-01,2017-04-30,2017-04-21,Disruption of the manufacture of the drug.,2017-03-11,2017-04-24
25287,2387662,Shortage,APO-IRBESARTAN/HCTZ,APOTEX INC,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-10-09,2017-12-15,2017-11-10,Disruption of the manufacture of the drug.,2017-10-11,2017-11-15
354,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-03-10,2017-04-12,2017-04-07,Disruption of the manufacture of the drug.,2017-03-11,2017-04-10
50044,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2018-05-21,2018-09-07,2018-08-08,Disruption of the manufacture of the drug.,2018-05-22,2018-08-09
8602,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-05-01,2017-07-14,2017-06-26,Disruption of the manufacture of the drug.,2017-05-02,2017-06-27
16871,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2018-01-12,2018-03-19,2018-02-22,Disruption of the manufacture of the drug.,2017-07-25,2018-02-23
16874,2272830,Shortage,APO-ISMN,APOTEX INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-07-24,2017-09-29,2017-09-22,Demand increase for the drug.,2017-07-25,2017-09-25
36295,2237235,Shortage,APO-KETOCONAZOLE,APOTEX INC,KETOCONAZOLE,KETOCONAZOLE,200MG,100 BTL,ORAL,Resolved,TABLET,J02AB,ANTIMYCOTICS FOR SYSTEMIC USE,,2018-01-15,2018-08-20,2018-07-20,Disruption of the manufacture of the drug.,2018-01-17,2018-07-23
19595,2243989,Shortage,APO-KETOROLAC INJECTABLE,APOTEX INC,KETOROLAC,KETOROLAC TROMETHAMINE,30MG,1 ML,INTRAMUSCULAR,Actual shortage,SOLUTION,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-10,,,Other (Please describe in comments),2017-08-16,2017-10-05
19024,2221330,Shortage,APO-KETOTIFEN - SYR 1MG/5ML,APOTEX INC,KETOTIFEN,KETOTIFEN FUMARATE,1MG,250 ML,ORAL,Actual shortage,SYRUP,R06AX,ANTIHISTAMINES FOR SYSTEMIC USE,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19105,2243538,Shortage,APO-LABETALOL TABLETS,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,100MG,100 BTL,ORAL,Actual shortage,TABLET,C07AG,BETA BLOCKING AGENTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19108,2243539,Shortage,APO-LABETALOL TABLETS,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,200MG,100 BTL,ORAL,Actual shortage,TABLET,C07AG,BETA BLOCKING AGENTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
357,2242814,Shortage,APO-LACTULOSE,APOTEX INC,LACTULOSE,LACTULOSE,667MG,1 L,ORAL,Resolved,LIQUID,A06AD,DRUGS FOR CONSTIPATION,,2017-01-13,,2017-10-04,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
360,2242814,Shortage,APO-LACTULOSE,APOTEX INC,LACTULOSE,LACTULOSE,667MG,500 ml,ORAL,Resolved,LIQUID,A06AD,DRUGS FOR CONSTIPATION,,2017-03-10,2017-08-08,2017-07-31,Disruption of the manufacture of the drug.,2017-03-11,2017-07-31
38529,2242814,Shortage,APO-LACTULOSE,APOTEX INC,LACTULOSE,LACTULOSE,667MG,500 ML,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,2018-05-04,,,2018-07-12,Disruption of the manufacture of the drug.,2018-02-05,2018-07-17
38532,2242814,Shortage,APO-LACTULOSE,APOTEX INC,LACTULOSE,LACTULOSE,667MG,1 L,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,2018-07-09,,,2018-09-07,Disruption of the manufacture of the drug.,2018-02-05,2018-09-07
664,2369052,Shortage,APO-LAMIVUDINE,APOTEX INC,LAMIVUDINE,LAMIVUDINE,150MG,100 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,2017-05-08,2017-05-08,2017-05-19,2017-05-15,Disruption of the manufacture of the drug.,2017-03-12,2017-05-16
15271,2369060,Shortage,APO-LAMIVUDINE,APOTEX INC,LAMIVUDINE,LAMIVUDINE,300MG,100 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2017-07-10,2017-09-15,2017-08-30,Disruption of the manufacture of the drug.,2017-07-11,2017-08-31
31907,2375540,Shortage,APO-LAMIVUDINE-ZIDOVUDINE,APOTEX INC,LAMIVUDINE-ZIDOVUDINE,ZIDOVUDINE  LAMIVUDINE,300MG  150MG,100 BTL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017-12-04,2018-07-31,2018-06-29,Disruption of the manufacture of the drug.,2017-12-06,2018-07-03
92978,2245208,Shortage,APO-LAMOTRIGINE,APOTEX INC,LAMOTRIGINE,LAMOTRIGINE,25MG,100 BTL,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2019-09-03,2020-01-31,,Disruption of the manufacture of the drug.,2019-09-04,2019-11-08
91081,2245210,Shortage,APO-LAMOTRIGINE,APOTEX INC,LAMOTRIGINE,LAMOTRIGINE,150MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-08-06,2019-08-22,2019-08-20,Disruption of the manufacture of the drug.,2019-08-07,2019-08-21
71130,2245210,Shortage,APO-LAMOTRIGINE,APOTEX INC,LAMOTRIGINE,LAMOTRIGINE,150MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-01-02,2019-02-28,2019-02-25,Disruption of the manufacture of the drug.,2019-01-03,2019-03-01
95235,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTL,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-30,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-02,2019-10-21
50951,2293811,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-05-28,2018-08-31,2018-08-13,Disruption of the manufacture of the drug.,2018-05-31,2018-08-14
86282,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-10,2019-08-15,2019-08-16,Disruption of the manufacture of the drug.,2019-06-12,2019-08-19
92981,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-03,2019-12-20,,Disruption of the manufacture of the drug.,2019-09-04,2019-10-21
14177,2293811,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-07-21,,2017-10-10,2017-09-29,Disruption of the manufacture of the drug.,2017-06-28,2017-10-03
84125,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-05-14,2019-08-16,2019-08-16,Disruption of the manufacture of the drug.,2019-05-15,2019-08-19
10403,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTl & 500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-05-15,2017-10-10,2017-10-04,Disruption of the manufacture of the drug.,2017-05-16,2017-10-05
44500,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-04-02,2018-05-07,2018-04-30,Disruption of the manufacture of the drug.,2018-04-02,2018-05-01
79583,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-03-25,2019-04-26,2019-04-25,Disruption of the manufacture of the drug.,2019-03-27,2019-04-26
71668,2293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,APO-LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-01-08,2019-03-18,2019-03-15,Disruption of the manufacture of the drug.,2019-01-09,2019-03-16
88374,2470780,Shortage,APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN,APOTEX INC,LANSOPRAZOLE,CLARITHROMYCIN  AMOXICILLIN  LANSOPRAZOLE,500MG  500MG  30MG,56 BLS,ORAL,Resolved,CAPSULE (DELAYED RELEASE)  KIT  CAPSULE  TABLET,A02BD,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-07-02,2019-07-28,2019-07-29,Disruption of the manufacture of the drug.,2019-07-03,2019-07-30
363,2296527,Shortage,APO-LATANOPROST,APOTEX INC,LATANOPROST,LATANOPROST,50MCG,2.5 ml,OPHTHALMIC,Actual shortage,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-04-05,,,Disruption of the manufacture of the drug.,2017-03-11,2018-09-12
739,2414155,Shortage,APO-LATANOPROST-TIMOP,APOTEX INC,LATANOPROST-TIMOLOL MALEATE,TIMOLOL  LATANOPROST,5MG  50MCG,2.5 ml,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015-06-08,2018-09-10,2018-09-10,Disruption of the manufacture of the drug.,2017-03-13,2018-09-11
667,2256495,Shortage,APO-LEFLUNOMIDE,APOTEX INC,LEFLUNOMIDE,LEFLUNOMIDE,10MG,30 BTL,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2017-05-02,2017-04-14,2017-05-31,2017-05-19,Disruption of the manufacture of the drug.,2017-03-12,2017-05-23
83518,2358514,Shortage,APO-LETROZOLE,APOTEX INC,LETROZOLE,LETROZOLE,2.5MG,30 BLS,ORAL,Actual shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-05-06,,,Disruption of the manufacture of the drug.,2019-05-08,2019-05-08
3169,2358514,Shortage,APO-LETROZOLE,APOTEX INC,LETROZOLE,LETROZOLE,2.5MG,30 BLS,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2017-05-23,2017-05-29,2017-07-21,2017-07-19,Disruption of the manufacture of the drug.,2017-03-17,2017-07-20
84538,2285932,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,500MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-05-21,2019-06-10,2019-06-07,Disruption of the manufacture of the drug.,2019-05-22,2019-06-08
17251,2285932,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,500MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-12-22,2017-12-18,2018-04-06,2018-03-14,Disruption of the manufacture of the drug.,2017-07-26,2018-03-15
41852,2285924,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-03-05,2018-06-08,2018-06-07,Disruption of the manufacture of the drug.,2018-03-06,2018-06-08
64938,2285924,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-15,2019-01-11,2019-01-09,Disruption of the manufacture of the drug.,2018-10-19,2019-01-10
76720,2285940,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-02-20,2019-05-03,2019-04-24,Disruption of the manufacture of the drug.,2019-02-24,2019-04-26
69307,2285940,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-12-10,2018-12-10,2018-12-29,2018-12-19,Disruption of the manufacture of the drug.,2018-12-12,2018-12-21
78526,2285932,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,500MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-11,2019-05-03,2019-05-02,Disruption of the manufacture of the drug.,2019-03-13,2019-05-03
79045,2285924,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-18,2019-05-03,2019-04-25,Disruption of the manufacture of the drug.,2019-03-21,2019-04-26
24262,2285940,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-01-12,2018-01-05,2018-03-14,2018-03-14,Disruption of the manufacture of the drug.,2017-10-04,2018-03-15
19096,2241575,Shortage,APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25%,APOTEX INC,LEVOBUNOLOL,LEVOBUNOLOL HYDROCHLORIDE,0.25%,5/10 ML,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-03-10,,,Other (Please describe in comments),2017-08-14,2017-10-05
19093,2241574,Shortage,APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.5%,APOTEX INC,LEVOBUNOLOL,LEVOBUNOLOL HYDROCHLORIDE,0.5%,5/10/15 ML,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
20108,2195968,Shortage,APO-LEVOCARB - TAB 25MG/250MG,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,25MG  250MG,500 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-08-21,2017-11-17,2017-11-08,Disruption of the manufacture of the drug.,2017-08-23,2017-11-09
74911,2195968,Shortage,APO-LEVOCARB - TAB 25MG/250MG,APOTEX INC,LEVOCARB - TAB 25MG/100MG,CARBIDOPA  LEVODOPA,25MG  250MG,100 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2019-02-04,2019-03-01,2019-02-27,Disruption of the manufacture of the drug.,2019-02-06,2019-03-01
24265,2195968,Shortage,APO-LEVOCARB - TAB 25MG/250MG,APOTEX INC,LEVOCArB,CARBIDOPA  LEVODOPA,25MG  250MG,100 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-10-02,2017-11-10,2017-11-08,Disruption of the manufacture of the drug.,2017-10-04,2017-11-09
23561,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,50MG  200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017-09-22,2017-10-20,2017-10-23,Disruption of the manufacture of the drug.,2017-09-26,2017-10-24
45337,2272873,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,25MG  100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2018-04-09,2018-05-25,2018-05-08,Disruption of the manufacture of the drug.,2018-04-10,2018-05-09
85601,2272873,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,25MG  100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2019-06-03,2019-07-05,2019-07-04,Disruption of the manufacture of the drug.,2019-06-05,2019-07-05
36460,2272873,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,25MG  100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2018-01-12,2018-03-30,2018-03-23,Disruption of the manufacture of the drug.,2018-01-18,2018-03-25
20879,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,50MG  200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017-10-13,2017-10-31,2017-10-23,Disruption of the manufacture of the drug.,2017-09-05,2017-10-24
8348,2272873,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,25MG  100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017-04-25,2017-05-31,2017-05-30,Disruption of the manufacture of the drug.,2017-04-28,2017-05-31
54177,2272873,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,25MG  100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2018-07-02,2018-09-10,2018-08-21,Disruption of the manufacture of the drug.,2018-07-04,2018-08-22
10406,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,50MG  200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017-05-15,2017-06-07,2017-06-01,Disruption of the manufacture of the drug.,2017-05-16,2017-06-02
36301,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,50MG  200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2018-01-15,2018-03-20,2018-03-07,Disruption of the manufacture of the drug.,2018-01-17,2018-03-08
50150,2245211,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,50MG  200MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2018-05-22,2018-08-31,2018-08-20,Disruption of the manufacture of the drug.,2018-05-24,2018-08-21
66537,2272873,Shortage,APO-LEVOCARB CR,APOTEX INC,LEVOCARB CR 25MG/100MG,CARBIDOPA  LEVODOPA,25MG  100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2018-11-05,2019-01-16,2019-01-16,Disruption of the manufacture of the drug.,2018-11-09,2019-01-17
74894,2195941,Shortage,APO-LEVOCARB-TAB 25MG/100MG,APOTEX INC,LEVOCARB - TAB 25MG/100MG,CARBIDOPA  LEVODOPA,25MG  100MG,500 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2019-02-04,2019-02-27,2019-02-22,Disruption of the manufacture of the drug.,2019-02-06,2019-02-25
74896,2195941,Shortage,APO-LEVOCARB-TAB 25MG/100MG,APOTEX INC,LEVOCARB-TAB 25MG/100MG,CARBIDOPA  LEVODOPA,25MG  100MG,500 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2019-02-04,2019-02-27,2019-02-22,Disruption of the manufacture of the drug.,2019-02-06,2019-02-25
36298,2195941,Shortage,APO-LEVOCARB-TAB 25MG/100MG,APOTEX INC,LEVOCARB,CARBIDOPA  LEVODOPA,25MG  100MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2018-01-15,2018-03-30,2018-02-26,Disruption of the manufacture of the drug.,2018-01-17,2018-02-27
51201,2325942,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,750MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-06-04,2018-08-07,2018-08-07,Disruption of the manufacture of the drug.,2018-06-04,2018-08-09
36450,2284707,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-01-15,2018-08-17,2018-08-07,Disruption of the manufacture of the drug.,2018-01-18,2018-08-09
75620,2284707,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-02-11,2019-03-08,2019-03-04,Disruption of the manufacture of the drug.,2019-02-13,2019-03-07
366,2284707,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-01-03,2017-04-24,2017-03-15,Disruption of the manufacture of the drug.,2017-03-11,2017-03-16
369,2284715,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-03-10,2017-04-24,2017-03-15,Disruption of the manufacture of the drug.,2017-03-11,2017-03-16
59292,2284707,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-08-27,2018-12-31,2018-12-27,Delay in shipping of the drug.,2018-08-27,2019-01-02
670,2325942,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,750MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2017-03-24,2017-03-13,2017-07-26,2017-07-12,Disruption of the manufacture of the drug.,2017-03-12,2017-07-13
89513,2284715,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 BTL,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-07-15,2019-12-13,,Disruption of the manufacture of the drug.,2019-07-17,2019-10-07
76723,2284715,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-02-20,2019-03-15,2019-03-07,Disruption of the manufacture of the drug.,2019-02-24,2019-03-08
89545,2284707,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100 BTL,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-07-15,2019-12-13,,Disruption of the manufacture of the drug.,2019-07-17,2019-10-07
89548,2325942,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,750MG,100 BTL,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-07-15,2019-12-13,,Disruption of the manufacture of the drug.,2019-07-17,2019-10-07
36304,2284715,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-01-15,2018-08-17,2018-08-17,Disruption of the manufacture of the drug.,2018-01-17,2018-08-21
71133,2284715,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-01-02,2019-02-07,2019-01-25,Disruption of the manufacture of the drug.,2019-01-03,2019-01-28
41855,2426552,Shortage,APO-LINEZOLID,APOTEX INC,LINEZOLID,LINEZOLID,600MG,30 BTL,ORAL,Resolved,TABLET,J01XX,OTHER ANTIBACTERIALS,,2018-03-05,2019-11-01,2019-11-01,Disruption of the manufacture of the drug.,2018-03-06,2019-11-04
11077,2217503,Shortage,APO-LISINOPRIL TABLET 10 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-06-05,2017-05-29,2017-07-07,2017-06-22,Disruption of the manufacture of the drug.,2017-05-24,2017-06-23
8868,2217503,Shortage,APO-LISINOPRIL TABLET 10 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,10MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-05-15,2017-05-08,2017-06-30,2017-06-22,Disruption of the manufacture of the drug.,2017-05-04,2017-06-23
17150,2217503,Shortage,APO-LISINOPRIL TABLET 10 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,10MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-10-31,2017-10-23,2018-06-29,2018-02-05,Disruption of the manufacture of the drug.,2017-07-25,2018-02-09
26166,2217511,Shortage,APO-LISINOPRIL TABLET 20 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,20MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-10-16,2018-02-09,2018-01-25,Disruption of the manufacture of the drug.,2017-10-17,2018-01-26
21085,2217481,Shortage,APO-LISINOPRIL TABLET 5 MG,APOTEX INC,LISINOPRIL,LISINOPRIL,5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-04,2018-01-22,2017-12-29,Disruption of the manufacture of the drug.,2017-09-06,2017-12-31
17254,2242838,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,2017-09-08,2017-08-15,2017-11-06,2017-10-30,Disruption of the manufacture of the drug.,2017-07-26,2017-10-31
36821,2242837,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,100 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2018-01-22,2018-02-26,2018-02-12,Disruption of the manufacture of the drug.,2018-01-22,2018-02-13
30935,2242837,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,100 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-11-27,2018-01-31,2018-01-09,Disruption of the manufacture of the drug.,2017-11-28,2018-01-10
49367,2242838,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,1000 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2018-05-14,,2018-09-10,Disruption of the manufacture of the drug.,2018-05-15,2018-09-11
30938,2242838,Shortage,APO-LITHIUM CARBONATE,APOTEX INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100 BTL,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-11-27,2018-01-31,2018-01-09,Disruption of the manufacture of the drug.,2017-11-28,2018-01-10
372,2212005,Shortage,APO-LOPERAMIDE - TAB 2MG,APOTEX INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,100 BTL,ORAL,Actual shortage,TABLET,A07DA,ANTIPROPULSIVES,,2014-10-09,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
13975,2410753,Shortage,APO-LORAZEPAM SUBLINGUAL,APOTEX INC,LORAZEPAM,LORAZEPAM,1MG,100 BTL,SUBLINGUAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-06-26,2017-08-09,2017-08-15,Disruption of the manufacture of the drug.,2017-06-26,2017-08-18
375,655740,Shortage,APO-LORAZEPAM TAB 0.5MG,APOTEX INC,LORAZEPAM,LORAZEPAM,0.5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2016-09-27,2017-08-31,2017-08-07,Disruption of the manufacture of the drug.,2017-03-11,2017-08-08
26594,655759,Shortage,APO-LORAZEPAM TAB 1MG,APOTEX INC,LORAZEPAM,LORAZEPAM,1MG,100 BTL & 1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-10-23,2018-01-19,2018-01-19,Disruption of the manufacture of the drug.,2017-10-23,2018-01-22
43511,655759,Shortage,APO-LORAZEPAM TAB 1MG,APOTEX INC,LORAZEPAM,LORAZEPAM,1MG,1000 BTL,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-04-13,2018-04-02,2018-07-13,2018-06-11,Disruption of the manufacture of the drug.,2018-03-20,2018-06-12
47652,2353504,Shortage,APO-LOSARTAN,APOTEX INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100 BTL & 30 BLS,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-30,,,Disruption of the manufacture of the drug.,2018-05-01,2019-03-15
49490,2353512,Shortage,APO-LOSARTAN,APOTEX INC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-06-29,2018-05-28,,,Disruption of the manufacture of the drug.,2018-05-15,2019-04-11
70523,2353512,Shortage,APO-LOSARTAN,APOTEX INC,LOSARTAN 100MG,LOSARTAN POTASSIUM,100MG,30BLS,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-12-24,,,Disruption of the manufacture of the drug.,2018-12-27,2019-04-17
722,2353504,Shortage,APO-LOSARTAN,APOTEX INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-02-01,2017-03-12,2017-03-15,Disruption of the manufacture of the drug.,2017-03-13,2017-03-16
55284,2379058,Shortage,APO-LOSARTAN,APOTEX INC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Disruption of the manufacture of the drug.,2018-07-11,2019-03-15
44105,2371251,Shortage,APO-LOSARTAN/HCTZ,APOTEX INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-03-26,2018-11-02,2018-09-10,Disruption of the manufacture of the drug.,2018-03-27,2018-09-11
49493,2371251,Shortage,APO-LOSARTAN/HCTZ,APOTEX INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-07-09,2018-07-10,2018-11-02,2018-09-14,Disruption of the manufacture of the drug.,2018-05-15,2018-09-15
26827,2371243,Shortage,APO-LOSARTAN/HCTZ,APOTEX INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-10-23,2018-11-30,2018-09-10,Disruption of the manufacture of the drug.,2017-10-24,2018-09-11
39656,2371235,Shortage,APO-LOSARTAN/HCTZ,APOTEX INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-02-12,2018-09-14,2018-09-04,Disruption of the manufacture of the drug.,2018-02-13,2018-09-10
55807,2371235,Shortage,APO-LOSARTAN/HCTZ,APOTEX INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-07-23,2018-07-20,2018-09-14,2018-09-14,Disruption of the manufacture of the drug.,2018-07-15,2018-09-15
13322,2220172,Shortage,APO-LOVASTATIN - TAB 20MG,APOTEX INC,LOVASTATIN,LOVASTATIN,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-06-19,2017-07-20,2017-07-18,Disruption of the manufacture of the drug.,2017-06-19,2017-07-19
30941,2220172,Shortage,APO-LOVASTATIN - TAB 20MG,APOTEX INC,LOVASTATIN,LOVASTATIN,20MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-11-27,2018-09-10,2018-09-10,Disruption of the manufacture of the drug.,2017-11-28,2018-09-11
50153,2220180,Shortage,APO-LOVASTATIN - TAB 40MG,APOTEX INC,LOVASTATIN,LOVASTATIN,40MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-05-22,2018-08-31,2018-08-21,Disruption of the manufacture of the drug.,2018-05-24,2018-08-22
19075,2237651,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,5MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19078,2237652,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,10MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19081,2237653,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,25MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19084,2237654,Shortage,APO-LOXAPINE,APOTEX INC,LOXAPINE,LOXAPINE,50MG,100 BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
14186,2277298,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017-08-31,2017-08-15,2017-11-17,2017-10-26,Disruption of the manufacture of the drug.,2017-06-28,2017-10-27
5997,2277298,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017-04-28,,2017-05-25,2017-05-17,Disruption of the manufacture of the drug.,2017-04-07,2017-05-18
24268,2267640,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,100MG,100 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017-10-02,2017-11-15,2017-11-01,Disruption of the manufacture of the drug.,2017-10-04,2017-11-02
14183,2244726,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017-09-08,2017-09-04,2017-11-17,2017-10-25,Disruption of the manufacture of the drug.,2017-06-28,2017-10-26
59299,2244726,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,500 BTL,ORAL,Actual shortage,TABLET,G03DA,PROGESTOGENS,,2018-08-27,,,Disruption of the manufacture of the drug.,2018-08-27,2018-08-28
54184,2244726,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100 BTL,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2018-07-02,2018-09-28,2018-08-21,Disruption of the manufacture of the drug.,2018-07-04,2018-08-22
586,2396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,32 ML & 10 ML,ORAL,Actual shortage,SUSPENSION,,,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-03-11,2018-12-20
589,2396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,100 ML & 180 ML,ORAL,Resolved,SUSPENSION,,,,2017-03-10,,2018-05-01,Disruption of the manufacture of the drug.,2017-03-11,2018-05-02
378,2248974,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,15MG,100 BTL,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-10,2017-07-28,2017-07-12,Disruption of the manufacture of the drug.,2017-03-11,2017-07-13
96650,2396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,100 ML,ORAL,Actual shortage,SUSPENSION,,,,2019-10-15,2019-12-15,,Disruption of the manufacture of the drug.,2019-10-16,2019-10-16
59302,2248973,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,7.5MG,500 BTL,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-08-27,,2018-09-14,Disruption of the manufacture of the drug.,2018-08-27,2019-05-21
8871,2248973,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,7.5MG,500 BTL,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-09-18,,,2017-10-02,Disruption of the manufacture of the drug.,2017-05-04,2017-10-05
10424,2248973,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,7.5MG,500 BTL,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-05-15,2017-07-31,2017-07-12,Disruption of the manufacture of the drug.,2017-05-16,2017-07-13
79589,2396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,180 ML,ORAL,Resolved,SUSPENSION,,,,2019-03-25,2019-06-19,2019-06-14,Disruption of the manufacture of the drug.,2019-03-27,2019-06-21
14191,2366487,Shortage,APO-MEMANTINE,APOTEX INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Actual shortage,TABLET,N06DX,ANTI-DEMENTIA DRUGS,2017-08-31,2017-08-18,,,Disruption of the manufacture of the drug.,2017-06-28,2018-12-20
381,2366487,Shortage,APO-MEMANTINE,APOTEX INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,30 BLS,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,,2017-02-06,2017-03-24,2017-03-20,Disruption of the manufacture of the drug.,2017-03-11,2017-04-04
88336,2460653,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,1000MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-07-02,2019-08-02,2019-08-02,Disruption of the manufacture of the drug.,2019-07-03,2019-08-03
69915,2305062,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN ER 500MG,METFORMIN HYDROCHLORIDE,500MG,500BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-12-17,2019-02-01,2019-01-23,Disruption of the manufacture of the drug.,2018-12-18,2019-01-28
83504,2460653,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,1000MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-05-06,2019-06-24,2019-06-21,Disruption of the manufacture of the drug.,2019-05-08,2019-06-24
92026,2460653,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,1000MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-08-19,2019-09-08,2019-08-29,Disruption of the manufacture of the drug.,2019-08-21,2019-08-30
76726,2460653,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN ER,METFORMIN HYDROCHLORIDE,1000MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-02-20,2019-04-19,2019-04-12,Disruption of the manufacture of the drug.,2019-02-24,2019-04-15
19320,2258935,Shortage,APO-METHIMAZOLE,APOTEX INC,METHIMAZOLE,THIAMAZOLE,5MG,100 BTL,ORAL,Actual shortage,TABLET,H03BB,ANTITHYROID PREPARATIONS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
54770,2182963,Shortage,APO-METHOTREXATE,PFIZER CANADA INC,METHOTREXATE,METHOTREXATE,2.5MG,100's,ORAL,Actual shortage,TABLET,L01BA,ANTIMETABOLITES,2018-12-30,,,,Disruption of the manufacture of the drug.,2018-07-09,2018-12-31
54288,2249332,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-02,2018-10-26,2018-10-10,Disruption of the manufacture of the drug.,2018-07-04,2018-10-11
592,2249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-10,2017-04-04,2017-04-03,Disruption of the manufacture of the drug.,2017-03-11,2017-04-04
49496,2249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-05-31,2018-05-22,2018-09-28,2018-09-11,Disruption of the manufacture of the drug.,2018-05-15,2018-09-12
36446,2273950,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,5MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-01-12,2018-03-16,2018-03-12,Disruption of the manufacture of the drug.,2018-01-18,2018-03-13
41858,2249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-03-05,2018-04-30,2018-04-19,Disruption of the manufacture of the drug.,2018-03-06,2018-04-20
30084,2249332,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-11-21,2018-02-02,2018-01-24,Disruption of the manufacture of the drug.,2017-11-22,2018-01-25
85156,2249332,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-05-27,2019-07-14,2019-07-11,Disruption of the manufacture of the drug.,2019-05-29,2019-07-12
79048,2249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-03-18,2019-07-19,2019-07-05,Disruption of the manufacture of the drug.,2019-03-21,2019-07-06
71673,2249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500 BTL,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-01-08,2019-02-11,2019-02-07,Disruption of the manufacture of the drug.,2019-01-09,2019-02-08
70146,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE ER 36MG,METHYLPHENIDATE HYDROCHLORIDE,36MG,100BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-12-17,2019-07-26,2019-07-16,Disruption of the manufacture of the drug.,2018-12-19,2019-07-17
54285,2452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-02,2018-08-27,2018-07-31,Disruption of the manufacture of the drug.,2018-07-04,2018-08-01
69918,2452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE ER 27MG,METHYLPHENIDATE HYDROCHLORIDE,27MG,100BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-12-17,2019-07-26,2019-07-16,Disruption of the manufacture of the drug.,2018-12-18,2019-07-17
16938,2452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-07-24,2017-11-16,2017-11-02,Disruption of the manufacture of the drug.,2017-07-25,2017-11-03
16942,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-07-24,2017-09-08,2017-08-30,Disruption of the manufacture of the drug.,2017-07-25,2017-08-31
65599,2452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE 18MG,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-10-24,2018-11-30,2018-11-20,Disruption of the manufacture of the drug.,2018-10-25,2018-11-22
37963,2452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-02-19,2018-02-12,2018-05-31,2018-05-23,Disruption of the manufacture of the drug.,2018-02-01,2018-05-24
37966,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-03-12,2018-03-05,2018-06-07,2018-06-01,Disruption of the manufacture of the drug.,2018-02-01,2018-06-04
37732,2452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-01-29,2018-05-31,2018-05-04,Disruption of the manufacture of the drug.,2018-01-31,2018-05-05
384,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-01-31,2017-04-16,2017-03-31,Disruption of the manufacture of the drug.,2017-03-11,2017-04-01
68225,2330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE ER 54MG,METHYLPHENIDATE HYDROCHLORIDE,54MG,100BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-11-26,2019-06-14,2019-06-12,Disruption of the manufacture of the drug.,2018-11-30,2019-06-13
387,2330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2016-12-20,2017-04-16,2017-03-31,Disruption of the manufacture of the drug.,2017-03-11,2017-04-01
28553,2452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-11-06,2018-01-12,2018-01-08,Disruption of the manufacture of the drug.,2017-11-07,2018-01-10
25292,2330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-10-09,2018-01-31,2018-01-22,Disruption of the manufacture of the drug.,2017-10-11,2018-01-23
56541,2330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-23,2018-10-25,2018-10-23,Disruption of the manufacture of the drug.,2018-07-26,2018-10-25
71136,2452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-01-02,2019-05-17,2019-05-16,Disruption of the manufacture of the drug.,2019-01-03,2019-05-17
39659,2330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-12,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2018-02-13,2018-07-03
98569,2285169,Shortage,APO-METOPROLOL SR,APOTEX INC,METOPROLOL,METOPROLOL TARTRATE,100MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-11-11,2020-01-28,,Disruption of the manufacture of the drug.,2019-11-13,2019-11-13
92029,2285169,Shortage,APO-METOPROLOL SR,APOTEX INC,METOPROLOL,METOPROLOL TARTRATE,100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-08-19,2019-11-29,2019-10-07,Disruption of the manufacture of the drug.,2019-08-21,2019-10-08
390,2285177,Shortage,APO-METOPROLOL SR,APOTEX INC,METOPROLOL,METOPROLOL TARTRATE,200MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2015-08-07,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
29969,2084104,Shortage,APO-MINOCYCLINE CAP 100MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017-11-20,2018-02-02,2018-02-02,Disruption of the manufacture of the drug.,2017-11-21,2018-02-06
12680,2084104,Shortage,APO-MINOCYCLINE CAP 100MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017-06-12,2017-07-24,2017-07-18,Disruption of the manufacture of the drug.,2017-06-13,2017-07-19
40343,2084104,Shortage,APO-MINOCYCLINE CAP 100MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2018-02-19,2018-08-13,2018-07-26,Disruption of the manufacture of the drug.,2018-02-21,2018-07-27
8612,2084104,Shortage,APO-MINOCYCLINE CAP 100MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017-05-01,2017-06-02,2017-06-05,Disruption of the manufacture of the drug.,2017-05-02,2017-06-05
31013,2084090,Shortage,APO-MINOCYCLINE CAP 50MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017-12-28,2017-12-11,2018-02-23,2018-01-19,Disruption of the manufacture of the drug.,2017-11-29,2018-01-22
63786,2084090,Shortage,APO-MINOCYCLINE CAP 50MG,APOTEX INC,Minocycline Cap 50mg,MINOCYCLINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2018-10-08,2018-12-21,2018-12-14,Disruption of the manufacture of the drug.,2018-10-11,2018-12-18
12355,2084090,Shortage,APO-MINOCYCLINE CAP 50MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017-06-30,2017-06-19,2017-07-24,2017-07-18,Disruption of the manufacture of the drug.,2017-06-09,2017-07-19
89161,2084090,Shortage,APO-MINOCYCLINE CAP 50MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2019-07-08,2019-08-16,2019-08-09,Disruption of the manufacture of the drug.,2019-07-12,2019-08-12
40346,2084090,Shortage,APO-MINOCYCLINE CAP 50MG,APOTEX INC,MINOCYCLINE,MINOCYCLINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2018-02-19,2018-08-13,2018-07-26,Disruption of the manufacture of the drug.,2018-02-21,2018-07-27
51204,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-06-04,2018-09-28,2018-09-28,Disruption of the manufacture of the drug.,2018-06-04,2018-09-29
15370,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-07-10,2017-10-20,2017-10-16,Disruption of the manufacture of the drug.,2017-07-11,2017-10-17
19226,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-08-14,2017-09-27,2017-09-29,Disruption of the manufacture of the drug.,2017-08-14,2017-10-03
3909,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-04-05,2017-03-27,2017-05-12,2017-04-19,Disruption of the manufacture of the drug.,2017-03-22,2017-05-02
77893,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2019-03-04,2019-04-10,2019-04-04,Disruption of the manufacture of the drug.,2019-03-06,2019-04-05
12358,2286637,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,45MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-06-26,2017-06-12,2017-08-31,2017-08-07,Disruption of the manufacture of the drug.,2017-06-09,2017-08-08
393,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-02-06,2017-04-28,2017-05-04,Disruption of the manufacture of the drug.,2017-03-11,2017-05-10
396,2286637,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,45MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-02-22,2017-03-27,2017-03-22,Disruption of the manufacture of the drug.,2017-03-11,2017-03-23
8874,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-05-26,2017-05-15,2017-06-27,2017-06-14,Disruption of the manufacture of the drug.,2017-05-04,2017-06-15
10429,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-05-15,2017-06-23,2017-06-12,Disruption of the manufacture of the drug.,2017-05-16,2017-06-15
24271,2286637,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,45MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-10-02,2017-10-25,2017-10-16,Disruption of the manufacture of the drug.,2017-10-04,2017-10-17
35545,2286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-01-08,2018-03-30,2018-03-23,Disruption of the manufacture of the drug.,2018-01-10,2018-03-25
36316,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-01-15,2018-04-06,2018-03-23,Disruption of the manufacture of the drug.,2018-01-17,2018-03-25
50156,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-05-22,2018-09-07,2018-08-17,Disruption of the manufacture of the drug.,2018-05-24,2018-08-18
71676,2286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2019-01-08,2019-01-31,2019-01-31,Disruption of the manufacture of the drug.,2019-01-09,2019-02-01
74022,2403587,Shortage,APO-MOMETASONE,APOTEX INC,MOMETASONE,MOMETASONE FUROATE,50MCG,140MS,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-01-28,2019-01-31,2019-01-31,Disruption of the manufacture of the drug.,2019-01-30,2019-02-01
15959,2403587,Shortage,APO-MOMETASONE,APOTEX INC,MOMETASONE,MOMETASONE FUROATE,50MCG,50MCG/SPRY 140MS,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017-07-17,2017-08-18,2017-08-17,Disruption of the manufacture of the drug.,2017-07-17,2017-08-18
50956,2374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,100 BTL,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-05-28,2018-09-30,2018-10-02,Disruption of the manufacture of the drug.,2018-05-31,2018-10-05
32813,2374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,100 BTL,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-12-11,2018-03-09,2018-02-14,Disruption of the manufacture of the drug.,2017-12-14,2018-02-15
63793,2377616,Shortage,APO-MONTELUKAST,APOTEX INC,Montelukast 5mg,MONTELUKAST,5MG,30 BLS,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-10-08,,2018-10-15,Disruption of the manufacture of the drug.,2018-10-11,2018-10-16
72357,2377616,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,5MG,30 BLS,ORAL,Actual shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-01-14,2020-01-31,,Disruption of the manufacture of the drug.,2019-01-15,2019-10-29
57792,2377616,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,5MG,30 BLS,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-08-06,,2018-10-15,Disruption of the manufacture of the drug.,2018-08-09,2018-10-16
78529,2374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,100 BTL,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-03-11,2019-05-13,2019-05-03,Disruption of the manufacture of the drug.,2019-03-13,2019-05-06
94171,2374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,100 BTL,ORAL,Actual shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-09-17,2019-12-30,,Disruption of the manufacture of the drug.,2019-09-18,2019-09-18
45365,2404923,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-04-02,2019-09-06,2019-07-16,Disruption of the manufacture of the drug.,2018-04-10,2019-07-17
36435,2406373,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,0.5%,3 ML,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2018-01-12,,2018-03-12,Disruption of the manufacture of the drug.,2018-01-18,2018-03-13
47966,2406373,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN HCL,MOXIFLOXACIN,0.5%,3 ML,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2018-04-30,2018-08-03,2018-07-10,Disruption of the manufacture of the drug.,2018-05-02,2018-07-12
28556,2404923,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-11-06,2018-03-30,2018-03-26,Disruption of the manufacture of the drug.,2017-11-07,2018-03-27
399,2404923,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30 BTL,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-02-16,2017-05-08,2017-04-26,Disruption of the manufacture of the drug.,2017-03-11,2017-04-27
97474,2406373,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,0.5%,3 ML,OPHTHALMIC,Actual shortage,SOLUTION,S01AE,ANTIINFECTIVES,,2019-10-28,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-30,2019-10-30
63796,2352559,Shortage,APO-MYCOPHENOLATE,APOTEX INC,Mycophenolate,MYCOPHENOLATE MOFETIL,250MG,100 BLS,ORAL,Resolved,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2018-10-09,2019-06-28,2019-06-07,Disruption of the manufacture of the drug.,2018-10-11,2019-06-08
80542,2352567,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50 BLS,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2019-04-01,2019-11-01,2019-10-31,Disruption of the manufacture of the drug.,2019-04-04,2019-11-05
8877,2352567,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50 BLS,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2017-06-08,,2017-06-28,2017-06-28,Disruption of the manufacture of the drug.,2017-05-04,2017-07-04
20927,2352567,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50 BLS,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2017-09-29,2017-10-02,2017-10-20,2017-10-13,Disruption of the manufacture of the drug.,2017-09-05,2017-10-16
48841,2352559,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,250MG,100 BTL,ORAL,Resolved,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2018-05-07,,2018-09-10,Disruption of the manufacture of the drug.,2018-05-08,2018-09-11
95871,2372738,Shortage,APO-MYCOPHENOLIC ACID,APOTEX INC,MYCOPHENOLIC,MYCOPHENOLIC ACID,180MG,120 BLS,ORAL,Resolved,TABLET (ENTERIC-COATED),L04AA,IMMUNOSUPPRESSANTS,,2019-10-07,2019-11-01,2019-11-01,Disruption of the manufacture of the drug.,2019-10-09,2019-11-04
95874,2372746,Shortage,APO-MYCOPHENOLIC ACID,APOTEX INC,MYCOPHENOLIC,MYCOPHENOLIC ACID,360MG,120 BLS,ORAL,Resolved,TABLET (ENTERIC-COATED),L04AA,IMMUNOSUPPRESSANTS,,2019-10-07,2019-11-01,2019-11-01,Disruption of the manufacture of the drug.,2019-10-09,2019-11-04
25296,2238639,Shortage,APO-NABUMETONE,APOTEX INC,NABUMETONE,NABUMETONE,500MG,100 BTL,ORAL,Resolved,TABLET,M01AX,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-10-09,2018-08-15,2018-08-21,Disruption of the manufacture of the drug.,2017-10-11,2018-08-22
31016,2444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE,NALTREXONE HYDROCHLORIDE,50MG,30 BTL,ORAL,Resolved,TABLET,N07BB,DRUGS USED IN ADDICTIVE DISORDERS,2017-12-15,2017-12-12,2018-03-02,2018-01-15,Disruption of the manufacture of the drug.,2017-11-29,2018-01-16
67404,2444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE 50MG,NALTREXONE HYDROCHLORIDE,50MG,30BTL,ORAL,Resolved,TABLET,N07BB,DRUGS USED IN ADDICTIVE DISORDERS,,2018-11-19,2019-01-31,2019-01-28,Disruption of the manufacture of the drug.,2018-11-21,2019-02-01
25299,2444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE,NALTREXONE HYDROCHLORIDE,50MG,30 BTL,ORAL,Resolved,TABLET,N07BB,DRUGS USED IN ADDICTIVE DISORDERS,,2017-10-09,2017-11-30,2017-10-24,Disruption of the manufacture of the drug.,2017-10-11,2017-10-25
91091,2444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE,NALTREXONE HYDROCHLORIDE,50MG,30 BTL,ORAL,Resolved,TABLET,N07BB,DRUGS USED IN ADDICTIVE DISORDERS,,2019-08-06,2019-08-19,2019-08-16,Disruption of the manufacture of the drug.,2019-08-07,2019-08-19
58594,2444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE,NALTREXONE HYDROCHLORIDE,50MG,30 BTL,ORAL,Resolved,TABLET,N07BB,DRUGS USED IN ADDICTIVE DISORDERS,,2018-08-20,2018-10-31,2018-09-24,Disruption of the manufacture of the drug.,2018-08-21,2018-09-28
49499,784354,Shortage,APO-NAPRO-NA,APOTEX INC,NAPROXEN,NAPROXEN SODIUM,275MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-06-08,2018-06-04,2018-10-26,2018-10-04,Disruption of the manufacture of the drug.,2018-05-15,2018-10-05
71139,1940309,Shortage,APO-NAPRO-NA DS,APOTEX INC,NAPRO-NA DS,NAPROXEN SODIUM,550MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-01-02,2019-02-15,2019-02-07,Disruption of the manufacture of the drug.,2019-01-03,2019-02-08
11082,1940309,Shortage,APO-NAPRO-NA DS TAB 550MG,APOTEX INC,NAPROXEN,NAPROXEN SODIUM,550MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-11-30,2017-11-01,2018-10-31,2018-10-04,Disruption of the manufacture of the drug.,2017-05-24,2018-10-05
50961,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-05-28,2018-08-31,2018-08-13,Disruption of the manufacture of the drug.,2018-05-31,2018-08-14
44111,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-03-26,2018-05-04,2018-04-09,Disruption of the manufacture of the drug.,2018-03-27,2018-04-10
37971,522651,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,250MG,500 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-03-01,2018-02-19,2018-04-16,2018-04-04,Disruption of the manufacture of the drug.,2018-02-01,2018-04-05
68228,600806,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN 375MG,NAPROXEN,375MG,500BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-11-26,2018-12-28,2018-12-20,Disruption of the manufacture of the drug.,2018-11-30,2018-12-21
68231,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN 500MG,NAPROXEN,500MG,500BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-11-26,2019-05-24,2019-05-20,Disruption of the manufacture of the drug.,2018-11-30,2019-05-24
41142,600806,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,375MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-02-26,2018-08-13,2018-07-16,Disruption of the manufacture of the drug.,2018-02-27,2018-07-18
69305,522651,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,250MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-12-10,2018-12-10,2018-12-28,2018-12-18,Disruption of the manufacture of the drug.,2018-12-12,2018-12-21
69312,600806,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,375MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-12-10,2018-12-10,2018-12-28,2018-12-20,Disruption of the manufacture of the drug.,2018-12-12,2018-12-21
69315,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-12-10,2018-12-11,2018-12-28,2018-12-24,Disruption of the manufacture of the drug.,2018-12-12,2018-12-27
57799,522651,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,250MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-08-06,2018-10-31,2018-10-25,Disruption of the manufacture of the drug.,2018-08-09,2018-10-26
78536,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-03-11,2019-05-24,2019-05-10,Disruption of the manufacture of the drug.,2019-03-13,2019-05-13
78541,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-03-11,2019-05-17,2019-05-10,Disruption of the manufacture of the drug.,2019-03-13,2019-05-13
24274,592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-12-13,2018-02-28,2018-02-28,Disruption of the manufacture of the drug.,2017-10-04,2018-03-01
40354,2246700,Shortage,APO-NAPROXEN EC,APOTEX INC,NAPROXEN,NAPROXEN,375MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-02-19,2018-08-31,2018-08-07,Disruption of the manufacture of the drug.,2018-02-21,2018-08-09
54297,2246699,Shortage,APO-NAPROXEN EC TABLETS,APOTEX INC,NAPROXEN,NAPROXEN,250MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-07-02,,2018-12-27,Disruption of the manufacture of the drug.,2018-07-04,2018-12-28
20882,2246701,Shortage,APO-NAPROXEN EC TABLETS,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-10-02,2017-09-22,2018-08-08,2018-07-30,Disruption of the manufacture of the drug.,2017-09-05,2018-07-31
40351,2246699,Shortage,APO-NAPROXEN EC TABLETS,APOTEX INC,NAPROXEN,NAPROXEN,250MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-02-19,2018-04-23,2018-04-23,Disruption of the manufacture of the drug.,2018-02-21,2018-05-01
19015,2177072,Shortage,APO-NAPROXEN SR TABLETS 750MG,APOTEX INC,NAPROXEN,NAPROXEN,750MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
12069,2427931,Shortage,APO-NEVIRAPINE XR,APOTEX INC,NEVIRAPINE,NEVIRAPINE,400MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J05AG,DIRECT ACTING ANTIVIRALS,,2017-06-05,,2017-08-29,Disruption of the manufacture of the drug.,2017-06-06,2017-08-30
19018,2181525,Shortage,APO-NIFED PA - SRT 20MG,APOTEX INC,NIFEDIPINE,NIFEDIPINE,20MG,100 BTL & 500 BTL/60 BLS,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19021,2197448,Shortage,APO-NIFED PA - TAB 10MG,APOTEX INC,NIFEDIPINE,NIFEDIPINE,10MG,100 BTL & 500 BTL/60 BLS,ORAL,Actual shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
402,2393433,Shortage,APO-NITROGLYCERIN,APOTEX INC,NITROGLYCERIN,NITROGLYCERIN,0.4MG,200 METERED DOSES,SUBLINGUAL,Resolved,METERED-DOSE PUMP,C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-06-12,,2018-02-23,Other (Please describe in comments),2017-03-11,2018-02-26
405,2248398,Shortage,APO-OFLOXACIN,APOTEX INC,OFLOXACIN,OFLOXACIN,0.3%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2014-05-08,,2019-01-07,Disruption of the manufacture of the drug.,2017-03-11,2019-01-08
26625,2281791,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,2.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-10-23,2018-01-15,2017-12-19,Disruption of the manufacture of the drug.,2017-10-23,2017-12-20
28689,2281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-11-06,2018-01-31,2018-01-09,Disruption of the manufacture of the drug.,2017-11-09,2018-01-10
55842,2281848,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,15.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-07-16,2018-10-12,2018-10-11,Disruption of the manufacture of the drug.,2018-07-16,2018-10-12
32818,2281848,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,15.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-12-11,2018-04-27,2018-04-04,Disruption of the manufacture of the drug.,2017-12-14,2018-04-05
36940,2281791,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,2.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-01-22,2018-06-08,2018-05-23,Disruption of the manufacture of the drug.,2018-01-23,2018-05-23
75623,2281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-02-11,2019-04-12,2019-03-29,Disruption of the manufacture of the drug.,2019-02-13,2019-03-30
17257,2281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-08-18,2017-07-31,2017-10-06,2017-10-02,Disruption of the manufacture of the drug.,2017-07-26,2017-10-05
37997,2333015,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,20.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-03-26,2018-03-19,2018-06-08,2018-05-24,Disruption of the manufacture of the drug.,2018-02-01,2018-05-25
20113,2281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-08-22,2017-10-04,2017-09-29,Disruption of the manufacture of the drug.,2017-08-23,2017-10-03
28564,2281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-11-06,2018-01-15,2018-01-10,Disruption of the manufacture of the drug.,2017-11-07,2018-01-11
84128,2333015,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,20.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-05-14,2019-06-26,2019-06-21,Disruption of the manufacture of the drug.,2019-05-15,2019-06-24
74914,2281791,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,2.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-02-04,2019-04-08,2019-03-28,Disruption of the manufacture of the drug.,2019-02-06,2019-03-29
677,2281848,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,15.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-04-24,2017-04-25,2017-06-03,2017-06-03,Disruption of the manufacture of the drug.,2017-03-12,2017-06-05
74917,2333015,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,20.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-02-04,2019-04-08,2019-03-28,Disruption of the manufacture of the drug.,2019-02-06,2019-03-29
74922,2281805,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,5.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-02-04,2019-04-08,2019-03-28,Disruption of the manufacture of the drug.,2019-02-06,2019-03-29
40362,2281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10.0MG,500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-02-19,2018-05-04,2018-04-24,Disruption of the manufacture of the drug.,2018-02-21,2018-05-01
40367,2281805,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,5.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-02-19,2018-06-08,2018-05-23,Disruption of the manufacture of the drug.,2018-02-21,2018-05-23
76729,2281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-02-20,2019-04-12,2019-03-27,Disruption of the manufacture of the drug.,2019-02-24,2019-03-29
9933,2281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-05-08,2017-06-12,2017-06-09,Disruption of the manufacture of the drug.,2017-05-10,2017-06-13
9954,2333015,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,20.0MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-05-05,2017-06-03,2017-06-03,Disruption of the manufacture of the drug.,2017-05-10,2017-06-05
92984,2360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2019-09-03,2019-10-06,2019-09-30,Disruption of the manufacture of the drug.,2019-09-04,2019-10-01
29036,2360624,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,10MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-11-13,2018-08-20,2018-08-14,Disruption of the manufacture of the drug.,2017-11-13,2018-08-15
18546,2360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-08-07,2017-08-31,2017-08-21,Disruption of the manufacture of the drug.,2017-08-09,2017-08-23
12689,2360640,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-06-12,2017-07-21,2017-07-31,Disruption of the manufacture of the drug.,2017-06-13,2017-07-31
29348,2360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,100 BTL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-11-10,2018-02-28,2018-01-30,Disruption of the manufacture of the drug.,2017-11-16,2018-01-31
69318,2360624,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,10MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-12-10,2018-12-12,2019-03-29,2019-03-27,Disruption of the manufacture of the drug.,2018-12-12,2019-03-29
24277,2360640,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-10-02,2018-02-28,2018-01-26,Disruption of the manufacture of the drug.,2017-10-04,2018-01-29
44507,2360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-04-02,2018-09-07,2018-09-03,Disruption of the manufacture of the drug.,2018-04-02,2018-09-04
44510,2360616,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,5MG,30 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-04-02,2018-08-31,2018-08-14,Disruption of the manufacture of the drug.,2018-04-02,2018-08-15
19231,2453452,Shortage,APO-OLMESARTAN,APOTEX INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,20MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-08-10,2018-01-29,2018-01-18,Disruption of the manufacture of the drug.,2017-08-14,2018-01-19
70529,2453452,Shortage,APO-OLMESARTAN,APOTEX INC,OLMESARTAN 20MG,OLMESARTAN MEDOXOMIL,20MG,30BLS,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-12-24,,,Disruption of the manufacture of the drug.,2018-12-27,2019-04-08
17614,2453460,Shortage,APO-OLMESARTAN,APOTEX INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,40MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-07-31,2018-01-22,2018-01-19,Disruption of the manufacture of the drug.,2017-08-01,2018-01-20
55287,2453460,Shortage,APO-OLMESARTAN,APOTEX INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,40MG,100 BTL,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Disruption of the manufacture of the drug.,2018-07-11,2019-08-16
55801,2453452,Shortage,APO-OLMESARTAN,APOTEX INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,20MG,100 BTL,ORAL,Avoided shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-09-03,,,2018-08-17,Disruption of the manufacture of the drug.,2018-07-15,2018-08-21
16900,2453606,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-12-11,2018-04-30,2018-04-20,Disruption of the manufacture of the drug.,2017-07-25,2018-04-23
16905,2453614,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  40MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-12-18,2018-04-30,2018-04-20,Disruption of the manufacture of the drug.,2017-07-25,2018-04-23
54300,2453622,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,100 BTL & 30 BLS,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-07-02,,,Disruption of the manufacture of the drug.,2018-07-04,2019-04-08
54303,2453606,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,100 BTL and 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-07-02,2018-11-23,2018-11-21,Disruption of the manufacture of the drug.,2018-07-04,2018-11-22
69452,2453614,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN/HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  40MG,30 BLS,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-12-10,2018-12-11,,,Disruption of the manufacture of the drug.,2018-12-13,2019-04-08
70532,2453606,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN/HCTZ 20MG/12.5MG,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,30BLS and 100BTL,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-12-24,,,Disruption of the manufacture of the drug.,2018-12-27,2019-04-08
36321,2453622,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-01-15,2018-04-30,2018-04-20,Disruption of the manufacture of the drug.,2018-01-17,2018-04-23
16895,2453622,Shortage,APO-OLMESARTAN/HCTZ,APOTEX INC,OLMESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-07-21,2017-12-29,2017-11-16,Disruption of the manufacture of the drug.,2017-07-25,2017-11-17
50964,2402823,Shortage,APO-OLOPATADINE,APOTEX INC,OLOPATADINE,OLOPATADINE,0.2%,2.5 ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2018-05-28,2018-10-12,2018-10-11,Disruption of the manufacture of the drug.,2018-05-31,2018-10-12
11567,2402823,Shortage,APO-OLOPATADINE,APOTEX INC,OLOPATADINE,OLOPATADINE,0.2%,2.5 ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2017-05-29,2017-06-30,2017-06-29,Disruption of the manufacture of the drug.,2017-05-30,2017-06-30
82016,2305054,Shortage,APO-OLOPATADINE,APOTEX INC,OLOPATADINE,OLOPATADINE,0.1%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2019-04-15,2019-06-28,2019-06-21,Disruption of the manufacture of the drug.,2019-04-18,2019-06-24
90347,2402823,Shortage,APO-OLOPATADINE,APOTEX INC,OLOPATADINE,OLOPATADINE,0.2%,2.5 ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2019-07-29,2019-07-31,2019-08-01,Disruption of the manufacture of the drug.,2019-07-31,2019-08-02
94744,2245058,Shortage,APO-OMEPRAZOLE,APOTEX INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-23,2019-11-01,2019-10-25,Disruption of the manufacture of the drug.,2019-09-25,2019-10-28
408,2245058,Shortage,APO-OMEPRAZOLE,APOTEX INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-10,2017-04-04,2017-04-03,Disruption of the manufacture of the drug.,2017-03-11,2017-04-04
674,2245058,Shortage,APO-OMEPRAZOLE,APOTEX INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500 BTL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-03-26,,2017-04-04,2017-04-03,Disruption of the manufacture of the drug.,2017-03-12,2017-04-04
32822,2288184,Shortage,APO-ONDANSETRON,APOTEX INC,ONDANSETRON,ONDANSETRON,4MG,10 BLS,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-12-08,2018-09-21,2018-09-25,Disruption of the manufacture of the drug.,2017-12-14,2018-09-28
85604,2288192,Shortage,APO-ONDANSETRON,APOTEX INC,ONDANSETRON,ONDANSETRON,8MG,30 BTL,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-06-03,2019-12-06,2019-11-08,Disruption of the manufacture of the drug.,2019-06-05,2019-11-11
35223,2288184,Shortage,APO-ONDANSETRON,APOTEX INC,ONDANSETRON,ONDANSETRON,4MG,30 BTL,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-01-08,2018-09-28,2018-09-28,Disruption of the manufacture of the drug.,2018-01-08,2018-09-29
42697,2288192,Shortage,APO-ONDANSETRON,APOTEX INC,ONDANSETRON,ONDANSETRON,8MG,10 BLS & 30 BTL,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-03-12,2018-10-01,2018-09-28,Disruption of the manufacture of the drug.,2018-03-13,2018-09-29
91094,2288184,Shortage,APO-ONDANSETRON,APOTEX INC,APO-ONDANSETRON,ONDANSETRON,4MG,10 BLS,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-08-06,2019-12-06,2019-11-08,Disruption of the manufacture of the drug.,2019-08-07,2019-11-11
91097,2288192,Shortage,APO-ONDANSETRON,APOTEX INC,ONDANSETRON,ONDANSETRON,8MG,10 BLS,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-08-06,2019-12-06,2019-11-08,Disruption of the manufacture of the drug.,2019-08-07,2019-11-11
411,2243661,Shortage,APO-OXAPROZIN,APOTEX INC,OXAPROZIN,OXAPROZIN,600MG,100 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2012-03-23,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
19045,2231089,Shortage,APO-OXYBUTYNIN,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,1MG,473 ML,ORAL,Actual shortage,SYRUP,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
14201,2163543,Shortage,APO-OXYBUTYNIN - TAB 5MG,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-07-31,2017-07-10,2018-12-21,2018-11-29,Disruption of the manufacture of the drug.,2017-06-28,2018-11-30
414,2163543,Shortage,APO-OXYBUTYNIN - TAB 5MG,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5 MG,500 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-02-22,2017-05-10,2017-03-31,Disruption of the manufacture of the drug.,2017-03-11,2017-04-03
5865,2163543,Shortage,APO-OXYBUTYNIN - TAB 5MG,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,500 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-04-24,2017-04-21,2018-12-21,2018-11-29,Disruption of the manufacture of the drug.,2017-04-07,2018-11-30
16912,2366746,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,5.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-07-21,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-07-25,2017-10-03
69921,2394782,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE CR 60MG,OXYCODONE HYDROCHLORIDE,60MG,100BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2018-12-17,2019-02-15,2019-02-07,Disruption of the manufacture of the drug.,2018-12-18,2019-02-08
33867,2306530,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-12-18,2018-03-30,2018-03-20,Disruption of the manufacture of the drug.,2017-12-20,2018-03-21
17260,2306530,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017-08-01,2017-07-31,2017-11-03,2017-10-23,Disruption of the manufacture of the drug.,2017-07-26,2017-10-24
17263,2366789,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,80.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017-08-08,2017-07-31,2017-09-18,2017-09-20,Disruption of the manufacture of the drug.,2017-07-26,2017-09-22
417,2366754,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,10.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2014-03-27,,2018-05-15,Disruption of the manufacture of the drug.,2017-03-11,2018-05-16
420,2394774,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,30MG,30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2014-03-27,,2018-09-03,Disruption of the manufacture of the drug.,2017-03-11,2018-09-19
423,2366762,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,20.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-03-10,2017-05-26,2017-05-23,Disruption of the manufacture of the drug.,2017-03-11,2017-05-24
8615,2306530,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-05-01,2017-05-31,2017-06-02,Disruption of the manufacture of the drug.,2017-05-02,2017-06-05
25304,2366762,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,20.0MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-10-09,2018-03-30,2018-03-12,Disruption of the manufacture of the drug.,2017-10-11,2018-03-13
17266,2324628,Shortage,APO-OXYCODONE/ACET,APOTEX INC,OXYCODONE+ACETAMINOPHEN,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2017-12-18,2018-03-30,2018-03-16,Disruption of the manufacture of the drug.,2017-07-26,2018-03-17
426,2324628,Shortage,APO-OXYCODONE/ACET,APOTEX INC,OXYCODONE/ACET,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,500 BTL,ORAL,Resolved,TABLET,N02AJ,,,2017-03-10,2017-04-12,2017-04-06,Disruption of the manufacture of the drug.,2017-03-11,2017-04-07
9936,2324628,Shortage,APO-OXYCODONE/ACET,APOTEX INC,OXYCODONE+ACETAMINOPHEN,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N02AJ,,,2017-06-01,2017-06-30,2017-06-30,Disruption of the manufacture of the drug.,2017-05-10,2017-07-04
19133,2248844,Shortage,APO-PACLITAXEL INJECTABLE,APOTEX INC,PACLITAXEL,PACLITAXEL,6MG,5/25/50 ML,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
92989,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BTL,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-03,2019-11-22,,Disruption of the manufacture of the drug.,2019-09-04,2019-11-18
21090,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-04,2017-09-27,2017-09-29,Disruption of the manufacture of the drug.,2017-09-06,2017-10-03
92525,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500 BTL,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-08-28,2019-12-06,,Disruption of the manufacture of the drug.,2019-08-28,2019-11-18
17296,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-07-31,2017-07-31,2017-09-15,2017-08-25,Disruption of the manufacture of the drug.,2017-07-26,2017-08-28
36326,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-01-15,2018-02-09,2018-02-05,Disruption of the manufacture of the drug.,2018-01-17,2018-02-06
90350,2292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-07-29,2019-08-15,2019-08-16,Disruption of the manufacture of the drug.,2019-07-31,2019-08-19
8723,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-05-02,2017-07-14,2017-06-27,Disruption of the manufacture of the drug.,2017-05-02,2017-06-28
50968,2240907,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,10MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-05-28,2018-08-17,2018-07-13,Disruption of the manufacture of the drug.,2018-05-31,2018-07-18
3175,2240907,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,10MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-04-30,2017-05-01,2017-07-10,2017-06-22,Disruption of the manufacture of the drug.,2017-03-17,2017-06-23
29039,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-11-13,2018-05-15,2018-04-05,Disruption of the manufacture of the drug.,2017-11-13,2018-04-06
68236,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE 20MG,PAROXETINE,20MG,500BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-11-26,2018-12-21,2018-12-19,Disruption of the manufacture of the drug.,2018-11-30,2018-12-20
31910,2240909,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-12-04,2018-03-30,2018-03-08,Disruption of the manufacture of the drug.,2017-12-06,2018-03-08
10434,2240909,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-08-21,2017-10-31,2017-10-25,Disruption of the manufacture of the drug.,2017-05-16,2017-10-27
3529,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-03-20,2017-07-21,2017-07-10,Disruption of the manufacture of the drug.,2017-03-20,2017-07-11
48850,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,500 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-05-07,2018-08-10,2018-07-16,Disruption of the manufacture of the drug.,2018-05-08,2018-07-17
48854,2240908,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,20MG,30 BLS,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-05-07,2018-09-28,2018-09-10,Disruption of the manufacture of the drug.,2018-05-08,2018-09-11
30954,2240907,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,10MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-11-27,2018-03-30,2018-03-02,Disruption of the manufacture of the drug.,2017-11-28,2018-03-05
51194,2240909,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,30MG,100 BTL,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-06-04,2018-07-27,2018-07-23,Disruption of the manufacture of the drug.,2018-06-04,2018-07-25
63800,2289296,Shortage,APO-PERINDOPRIL,APOTEX INC,Perindopril,PERINDOPRIL ERBUMINE,8MG,30 BLS,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-10-09,2018-12-03,2018-11-21,Disruption of the manufacture of the drug.,2018-10-11,2018-11-22
57802,2289261,Shortage,APO-PERINDOPRIL,APOTEX INC,PERINDOPRIL,PERINDOPRIL ERBUMINE,2MG,30 BLS,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-06,2018-12-03,2018-11-16,Disruption of the manufacture of the drug.,2018-08-09,2018-11-19
82907,2289296,Shortage,APO-PERINDOPRIL,APOTEX INC,PERINDOPRIL,PERINDOPRIL ERBUMINE,8MG,500 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-04-30,2019-06-17,2019-06-07,Disruption of the manufacture of the drug.,2019-05-01,2019-06-08
94747,2460912,Shortage,APO-PHENYTOIN SODIUM,APOTEX INC,PHENYTOIN,PHENYTOIN SODIUM,100MG,1000 BTL,ORAL,Actual shortage,CAPSULE,N03AB,ANTIEPILEPTICS,,2019-09-23,2020-01-31,,Disruption of the manufacture of the drug.,2019-09-25,2019-10-21
75638,2460912,Shortage,APO-PHENYTOIN SODIUM,APOTEX INC,PHENYTOIN SODIUM,PHENYTOIN SODIUM,100MG,1000BTL,ORAL,Resolved,CAPSULE,N03AB,ANTIEPILEPTICS,,2019-02-11,2019-03-08,2019-03-07,Disruption of the manufacture of the drug.,2019-02-13,2019-03-08
31913,2460912,Shortage,APO-PHENYTOIN SODIUM,APOTEX INC,PHENYTOIN,PHENYTOIN SODIUM,100MG,100 BTL,ORAL,Resolved,CAPSULE,N03AB,ANTIEPILEPTICS,,2018-01-22,2018-04-30,2018-04-25,Disruption of the manufacture of the drug.,2017-12-06,2018-04-26
49377,2460912,Shortage,APO-PHENYTOIN SODIUM,APOTEX INC,PHENYTOIN,PHENYTOIN SODIUM,100MG,100 BTL,ORAL,Resolved,CAPSULE,N03AB,ANTIEPILEPTICS,,2018-05-14,2018-09-14,2018-08-30,Disruption of the manufacture of the drug.,2018-05-15,2018-08-31
88339,2469677,Shortage,APO-PINAVERIUM,APOTEX INC,PINAVERIUM,PINAVERIUM BROMIDE,50MG,100 BTL,ORAL,Resolved,TABLET,A03AX,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,,2019-07-02,2019-09-23,2019-08-30,Disruption of the manufacture of the drug.,2019-07-03,2019-08-31
91100,2469685,Shortage,APO-PINAVERIUM,APOTEX INC,PINAVERIUM,PINAVERIUM BROMIDE,100MG,100 BTL,ORAL,Resolved,TABLET,A03AX,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,,2019-08-06,2019-08-31,2019-08-30,Disruption of the manufacture of the drug.,2019-08-07,2019-08-31
45340,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-04-09,2018-10-26,2018-10-11,Disruption of the manufacture of the drug.,2018-04-10,2018-10-12
54306,2292394,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-07-02,2018-10-26,2018-10-11,Disruption of the manufacture of the drug.,2018-07-04,2018-10-12
7231,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-04-19,2017-05-26,2017-05-19,Disruption of the manufacture of the drug.,2017-04-19,2017-05-24
27721,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-10-30,2018-01-12,2017-12-18,Disruption of the manufacture of the drug.,2017-11-01,2017-12-19
36943,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-01-22,2018-04-13,2018-03-14,Disruption of the manufacture of the drug.,2018-01-23,2018-03-15
49502,2292386,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-05-25,2018-05-22,2018-10-26,2018-10-11,Disruption of the manufacture of the drug.,2018-05-15,2018-10-12
49517,2292408,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-06-22,2018-05-22,2018-10-31,2018-10-11,Disruption of the manufacture of the drug.,2018-05-16,2018-10-12
96653,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-10-15,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-16,2019-10-21
68239,2292394,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE 1.0MG,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-11-26,2019-01-25,2019-01-02,Disruption of the manufacture of the drug.,2018-11-30,2019-01-03
17309,2292386,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-08-01,2017-07-31,2017-10-31,2017-10-19,Disruption of the manufacture of the drug.,2017-07-26,2017-10-20
17312,2292394,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-08-18,2017-09-04,2017-10-31,2017-10-19,Disruption of the manufacture of the drug.,2017-07-26,2017-10-20
680,2292386,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-03-24,2017-04-10,2017-06-02,2017-05-30,Disruption of the manufacture of the drug.,2017-03-12,2017-05-31
683,2292394,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-03-24,2017-03-24,2017-06-02,2017-06-03,Disruption of the manufacture of the drug.,2017-03-12,2017-06-05
67026,2292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE 0.25MG,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-11-13,2019-01-31,2019-01-11,Disruption of the manufacture of the drug.,2018-11-16,2019-01-12
71142,2292408,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-01-02,2019-03-15,2019-03-15,Disruption of the manufacture of the drug.,2019-01-03,2019-03-16
66540,2292386,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE 0.5MG,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-11-05,2019-02-01,2019-01-11,Disruption of the manufacture of the drug.,2018-11-09,2019-01-12
11038,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-22,2017-12-22,2017-12-18,Disruption of the manufacture of the drug.,2017-05-24,2017-12-20
65602,2243508,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN 40MG,PRAVASTATIN SODIUM,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-10-22,2018-11-23,2018-11-20,Disruption of the manufacture of the drug.,2018-10-25,2018-11-22
23619,2243508,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-25,2017-12-15,2017-11-22,Disruption of the manufacture of the drug.,2017-09-27,2017-11-23
12361,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-07-14,2017-06-26,2017-08-31,2017-08-23,Disruption of the manufacture of the drug.,2017-06-09,2017-09-22
595,2243507,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-07,2017-08-28,2017-08-28,Disruption of the manufacture of the drug.,2017-03-11,2017-08-31
36438,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-12,2018-06-29,2018-04-30,Disruption of the manufacture of the drug.,2018-01-18,2018-05-01
37737,2243508,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-29,2018-06-29,2018-05-08,Disruption of the manufacture of the drug.,2018-01-31,2018-05-09
444,2243508,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-07-31,2017-09-05,2017-08-24,Disruption of the manufacture of the drug.,2017-03-11,2017-08-25
3533,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-20,2017-04-30,2017-04-21,Disruption of the manufacture of the drug.,2017-03-20,2017-04-24
24280,2243506,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-02,2017-12-22,2017-11-06,Disruption of the manufacture of the drug.,2017-10-04,2017-11-07
24283,2243507,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-02,2017-12-22,2017-11-06,Disruption of the manufacture of the drug.,2017-10-04,2017-11-07
35548,2243507,Shortage,APO-PRAVASTATIN,APOTEX INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-08,2018-05-31,2018-05-03,Disruption of the manufacture of the drug.,2018-01-10,2018-05-04
36441,882801,Shortage,APO-PRAZO TAB 1MG,APOTEX INC,PRAZOSIN,PRAZOSIN,1MG,100 BTL,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2018-01-12,2018-07-09,2018-06-11,Disruption of the manufacture of the drug.,2018-01-18,2018-06-12
76732,882801,Shortage,APO-PRAZO TAB 1MG,APOTEX INC,PRAZOSIN,PRAZOSIN,1MG,100 BTL,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2019-02-20,2019-04-05,2019-04-05,Disruption of the manufacture of the drug.,2019-02-24,2019-04-08
31019,882828,Shortage,APO-PRAZO TAB 2MG,APOTEX INC,PRAZOSIN,PRAZOSIN,2MG,100 BTL,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",2017-12-20,2017-12-19,2018-03-02,2018-01-26,Disruption of the manufacture of the drug.,2017-11-29,2018-01-29
67409,882836,Shortage,APO-PRAZO TAB 5MG,APOTEX INC,PRAZO 5MG,PRAZOSIN,5MG,100BTL,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2018-11-16,2019-03-22,2019-03-22,Disruption of the manufacture of the drug.,2018-11-21,2019-03-26
42700,882836,Shortage,APO-PRAZO TAB 5MG,APOTEX INC,PRAZOSIN,PRAZOSIN,5MG,100 BTL,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2018-03-12,2018-07-09,2018-06-11,Disruption of the manufacture of the drug.,2018-03-13,2018-06-12
7704,2394251,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,75MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-04-21,2017-05-08,2017-05-08,Disruption of the manufacture of the drug.,2017-04-24,2017-05-10
11041,2394294,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,300MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-05-22,2017-09-15,2017-09-15,Disruption of the manufacture of the drug.,2017-05-24,2017-09-22
83527,2394278,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,150MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-05-06,2019-07-01,2019-06-14,Disruption of the manufacture of the drug.,2019-05-08,2019-06-17
23623,2394278,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,150MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-25,2017-12-08,2017-10-27,Disruption of the manufacture of the drug.,2017-09-27,2017-10-30
23626,2394235,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,25MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-25,2018-02-15,2018-01-18,Disruption of the manufacture of the drug.,2017-09-27,2018-01-19
89164,2394278,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,150MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-07-08,2019-11-01,2019-10-30,Disruption of the manufacture of the drug.,2019-07-12,2019-11-05
23629,2394243,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,50MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-25,2018-02-05,2018-01-18,Disruption of the manufacture of the drug.,2017-09-27,2018-01-19
18553,2394286,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,225MG,100 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-07,2017-09-15,2017-09-15,Disruption of the manufacture of the drug.,2017-08-09,2017-09-22
12695,2394243,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,50MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-12,2018-02-05,2018-01-18,Disruption of the manufacture of the drug.,2017-06-13,2018-01-19
447,2394278,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,150MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2016-09-07,2017-06-09,2017-05-08,Disruption of the manufacture of the drug.,2017-03-11,2017-05-10
450,2394243,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,50MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-02-14,2017-06-09,2017-05-08,Disruption of the manufacture of the drug.,2017-03-11,2017-05-10
456,2394251,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,75MG,500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2016-09-07,2017-06-09,2017-05-08,Disruption of the manufacture of the drug.,2017-03-11,2017-05-10
728,2394235,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,25MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-02-01,2017-06-09,2017-05-08,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
18976,713325,Shortage,APO-PROCAINAMIDE CAP 250MG,APOTEX INC,PROCAINAMIDE,PROCAINAMIDE HYDROCHLORIDE,250MG,100 BTL,ORAL,Actual shortage,CAPSULE,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18979,713333,Shortage,APO-PROCAINAMIDE CAP 375MG,APOTEX INC,PROCAINAMIDE,PROCAINAMIDE HYDROCHLORIDE,375G,100 BTL,ORAL,Actual shortage,CAPSULE,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18982,713341,Shortage,APO-PROCAINAMIDE CAP 500MG,APOTEX INC,PROCAINAMIDE,PROCAINAMIDE HYDROCHLORIDE,500MG,100 BTL,ORAL,Actual shortage,CAPSULE,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
23632,2243324,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017-09-22,2018-09-28,2018-08-29,Disruption of the manufacture of the drug.,2017-09-27,2018-08-30
20885,2243324,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017-10-10,2017-10-02,2017-11-30,2017-10-26,Disruption of the manufacture of the drug.,2017-09-05,2017-10-27
8880,2243324,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017-06-23,2017-06-05,2017-07-31,2017-07-12,Disruption of the manufacture of the drug.,2017-05-04,2017-07-13
460,2243325,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100 BTL,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017-12-18,2018-09-28,2018-08-29,Disruption of the manufacture of the drug.,2017-03-11,2018-08-30
23635,2313901,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,25MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-09-22,2018-01-22,2018-01-02,Disruption of the manufacture of the drug.,2017-09-27,2018-01-03
26195,2313928,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,100MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-10-16,2018-01-25,2018-01-12,Disruption of the manufacture of the drug.,2017-10-18,2018-01-13
37974,2313928,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,100MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-02-16,2018-02-05,2018-05-31,2018-04-13,Disruption of the manufacture of the drug.,2018-02-01,2018-04-15
27735,2313944,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,300MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-10-30,2018-01-31,2018-01-12,Disruption of the manufacture of the drug.,2017-11-01,2018-01-13
37977,2313901,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,25MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-02-09,2018-02-05,2018-05-31,2018-04-16,Disruption of the manufacture of the drug.,2018-02-01,2018-04-17
37980,2313944,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,300MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-03-09,2018-02-19,2018-04-23,2018-04-20,Shortage of an inactive ingredient or component.,2018-02-01,2018-04-24
70537,2313901,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE 25MG,QUETIAPINE,25MG,100BTL,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-12-24,,,Disruption of the manufacture of the drug.,2018-12-27,2018-12-27
20888,2313936,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,200MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-10-31,2017-10-16,2018-02-02,2018-01-19,Disruption of the manufacture of the drug.,2017-09-05,2018-01-24
56989,2313944,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,300MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-07-30,2018-10-19,2018-09-24,Disruption of the manufacture of the drug.,2018-07-31,2018-09-28
8883,2313936,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,200MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-05-22,2017-05-15,2017-07-07,2017-06-30,Disruption of the manufacture of the drug.,2017-05-04,2017-07-04
39669,2313936,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,200MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-02-12,2018-05-31,2018-04-17,Disruption of the manufacture of the drug.,2018-02-13,2018-04-18
8702,2313928,Shortage,APO-QUETIAPINE,APOTEX INC,QUETIAPINE,QUETIAPINE,100MG,100 BTL,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-05-01,2017-07-10,2017-06-26,Disruption of the manufacture of the drug.,2017-05-02,2017-06-27
74033,2457229,Shortage,APO-QUETIAPINE XR,APOTEX INC,QUETIAPINE XR,QUETIAPINE,50MG,60 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2019-01-28,,,Disruption of the manufacture of the drug.,2019-01-30,2019-05-27
76735,2457237,Shortage,APO-QUETIAPINE XR,APOTEX INC,QUETIAPINE,QUETIAPINE,150MG,60 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2019-02-20,,,Disruption of the manufacture of the drug.,2019-02-24,2019-05-27
76740,2457261,Shortage,APO-QUETIAPINE XR,APOTEX INC,QUETIAPINE,QUETIAPINE,400MG,60 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2019-02-20,,,Disruption of the manufacture of the drug.,2019-02-24,2019-05-27
66543,2457245,Shortage,APO-QUETIAPINE XR,APOTEX INC,QUETIAPINE XR 200MG,QUETIAPINE,200MG,60 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2018-11-05,,,Disruption of the manufacture of the drug.,2018-11-09,2019-05-27
66623,2248499,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL 5MG,QUINAPRIL,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-11-05,,2019-05-17,Disruption of the manufacture of the drug.,2018-11-09,2019-05-21
66626,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL 10MG,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-11-05,,2019-05-17,Disruption of the manufacture of the drug.,2018-11-09,2019-05-21
37740,2248499,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-01-29,2018-06-08,2018-05-24,Disruption of the manufacture of the drug.,2018-01-31,2018-05-25
41865,2248501,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,20MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-03-05,2018-06-08,2018-05-24,Disruption of the manufacture of the drug.,2018-03-06,2018-05-25
17315,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-08-31,2017-08-07,2017-10-20,2017-10-16,Disruption of the manufacture of the drug.,2017-07-26,2017-10-18
41139,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-02-26,2018-06-08,2018-05-24,Disruption of the manufacture of the drug.,2018-02-27,2018-05-25
453,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-10,2017-05-01,2017-05-01,Disruption of the manufacture of the drug.,2017-03-11,2017-05-02
57805,2248501,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,20MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-06,,2019-05-10,Disruption of the manufacture of the drug.,2018-08-09,2019-05-13
463,2248500,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,10MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016-11-01,2017-05-01,2017-05-31,Disruption of the manufacture of the drug.,2017-03-11,2017-06-05
57808,2248502,Shortage,APO-QUINAPRIL,APOTEX INC,QUINAPRIL,QUINAPRIL,40MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-06,,2019-05-17,Disruption of the manufacture of the drug.,2018-08-09,2019-05-21
87060,2408775,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL,HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  20MG,30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-06-17,2019-11-15,2019-11-08,Disruption of the manufacture of the drug.,2019-06-19,2019-11-11
31022,2408767,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL - HCTZ,HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  10MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017-12-15,2017-12-11,2018-05-31,2018-04-17,Disruption of the manufacture of the drug.,2017-11-29,2018-04-18
31025,2408783,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL/HCTZ,HYDROCHLOROTHIAZIDE  QUINAPRIL,25MG  20MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017-12-27,2017-12-11,2018-11-02,2018-11-01,Disruption of the manufacture of the drug.,2017-11-29,2018-11-02
89167,2408783,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL - HCTZ,HYDROCHLOROTHIAZIDE  QUINAPRIL,25MG  20MG,100 BTL,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-07-08,2019-12-20,,Disruption of the manufacture of the drug.,2019-07-12,2019-09-16
23638,2408775,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL - HCTZ,HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  20MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-09-22,2018-05-04,2018-03-28,Disruption of the manufacture of the drug.,2017-09-27,2018-03-29
85607,2408775,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL,HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  20MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-06-03,2019-11-15,2019-11-08,Disruption of the manufacture of the drug.,2019-06-05,2019-11-11
92032,2408783,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL,HYDROCHLOROTHIAZIDE  QUINAPRIL,25MG  20MG,30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-08-19,2019-09-13,2019-09-13,Disruption of the manufacture of the drug.,2019-08-21,2019-09-16
68245,2408783,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL/HCTZ 25mg/20MG,HYDROCHLOROTHIAZIDE  QUINAPRIL,25MG  20MG,30BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-11-26,2019-03-22,2019-03-15,Disruption of the manufacture of the drug.,2018-11-30,2019-03-16
20891,2408775,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL - HCTZ,HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  20MG,30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-12-18,2018-06-08,2018-04-13,Disruption of the manufacture of the drug.,2017-09-05,2018-04-15
91103,2408767,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL,HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  10MG,30 BLS,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-08-06,2019-10-04,2019-09-20,Disruption of the manufacture of the drug.,2019-08-07,2019-09-23
71145,2408775,Shortage,APO-QUINAPRIL/HCTZ,APOTEX INC,QUINAPRIL/HCTZ,HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  20MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-01-02,2019-03-15,2019-03-13,Disruption of the manufacture of the drug.,2019-01-03,2019-03-15
32809,2254514,Shortage,APO-QUININE CAPSULES,APOTEX INC,QUININE,QUININE SULFATE,200MG,100 BTL,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017-12-11,2018-05-04,2018-04-16,Disruption of the manufacture of the drug.,2017-12-14,2018-04-17
20894,2254522,Shortage,APO-QUININE CAPSULES,APOTEX INC,QUININE,QUININE SULFATE,300MG,100 BTL,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,2017-10-31,2017-10-02,2018-05-04,2018-04-16,Disruption of the manufacture of the drug.,2017-09-05,2018-04-17
15375,2345587,Shortage,APO-RABEPRAZOLE,APOTEX INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-10,2017-07-31,2017-07-26,Disruption of the manufacture of the drug.,2017-07-11,2017-07-27
54309,2345587,Shortage,APO-RABEPRAZOLE,APOTEX INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-07-02,2018-09-17,2018-07-12,Disruption of the manufacture of the drug.,2018-07-04,2018-07-17
6516,2345579,Shortage,APO-RABEPRAZOLE,APOTEX INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-04-10,2017-05-29,2017-05-24,Disruption of the manufacture of the drug.,2017-04-11,2017-05-25
466,2345587,Shortage,APO-RABEPRAZOLE,APOTEX INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100 BTL,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-12-20,2017-05-19,2017-05-19,Disruption of the manufacture of the drug.,2017-03-11,2017-05-23
8705,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-05-01,2017-05-31,2017-06-08,Disruption of the manufacture of the drug.,2017-05-02,2017-06-09
8707,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-05-01,2017-06-15,2017-06-08,Disruption of the manufacture of the drug.,2017-05-02,2017-06-08
12074,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-07-07,2017-07-10,2017-09-05,2017-08-28,Disruption of the manufacture of the drug.,2017-06-06,2017-08-28
31028,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-12-18,2017-12-11,2018-03-05,2018-02-19,Disruption of the manufacture of the drug.,2017-11-29,2018-02-21
11087,2251531,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,2.5MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-31,2017-06-05,2017-06-22,2017-06-20,Disruption of the manufacture of the drug.,2017-05-24,2017-06-21
23641,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-12-11,2018-02-28,2017-10-23,Disruption of the manufacture of the drug.,2017-09-27,2017-12-14
23644,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL & 30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-22,2017-11-20,2017-11-06,Disruption of the manufacture of the drug.,2017-09-27,2017-11-09
6000,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-10,2017-05-03,2017-06-12,2017-06-08,Disruption of the manufacture of the drug.,2017-04-07,2017-06-09
14204,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-07-24,2017-07-10,2017-11-21,2017-11-17,Disruption of the manufacture of the drug.,2017-06-28,2017-11-20
14207,2251574,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,5MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-07-21,2017-10-02,2017-12-15,2017-11-06,Disruption of the manufacture of the drug.,2017-06-28,2017-11-09
14210,2251574,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,5MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-01-02,2018-04-09,2018-03-28,Disruption of the manufacture of the drug.,2017-06-28,2018-03-29
14213,2251574,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,5MG,100BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-07-31,2017-07-14,2017-11-10,2017-11-06,Disruption of the manufacture of the drug.,2017-06-28,2017-11-09
20897,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-10-20,2017-10-16,2017-11-20,2017-11-06,Disruption of the manufacture of the drug.,2017-09-05,2017-11-09
13475,2251531,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,2.5MG,30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-06-21,2017-11-17,2017-11-17,Disruption of the manufacture of the drug.,2017-06-21,2017-11-21
59305,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-20,2018-11-30,2018-11-28,Disruption of the manufacture of the drug.,2018-08-27,2018-11-30
74932,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-02-04,2019-03-08,2019-03-04,Disruption of the manufacture of the drug.,2019-02-06,2019-03-07
64956,2251531,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,2.5MG,100 BTL and 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-10-16,2019-02-08,2019-02-04,Disruption of the manufacture of the drug.,2018-10-19,2019-02-06
731,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-10,2017-03-20,2017-03-15,Disruption of the manufacture of the drug.,2017-03-13,2017-03-16
734,2251582,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,10MG,500 BTL & 30 BLS,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-10,2017-03-20,2017-03-15,Disruption of the manufacture of the drug.,2017-03-13,2017-03-16
71148,2251515,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,1.25MG,100 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-01-02,2019-01-17,2019-01-14,Disruption of the manufacture of the drug.,2019-01-03,2019-01-17
30957,2251531,Shortage,APO-RAMIPRIL,APOTEX INC,RAMIPRIL,RAMIPRIL,2.5MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-11-27,2018-03-26,2018-03-07,Disruption of the manufacture of the drug.,2017-11-28,2018-03-08
84541,2280833,Shortage,APO-RANITIDINE,APOTEX INC,RANITIDINE,RANITIDINE,15MG,300 ML,ORAL,Resolved,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-05-21,2019-05-28,2019-05-28,Disruption of the manufacture of the drug.,2019-05-22,2019-05-31
75626,2280833,Shortage,APO-RANITIDINE,APOTEX INC,RANITITDINE,RANITIDINE,15MG,300ML,ORAL,Resolved,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-02-11,2019-04-05,2019-04-04,Disruption of the manufacture of the drug.,2019-02-13,2019-04-05
94180,2280833,Shortage,APO-RANITIDINE,APOTEX INC,RANITIDINE,RANITIDINE,15MG,300 ML,ORAL,Actual shortage,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-17,,,Disruption of the manufacture of the drug.,2019-09-18,2019-09-18
29983,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-11-20,2018-10-01,2018-09-28,Disruption of the manufacture of the drug.,2017-11-21,2018-09-29
11044,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,60 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-05-22,2017-08-08,2017-07-25,Disruption of the manufacture of the drug.,2017-05-24,2017-07-26
3180,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,60 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-04-10,,2017-08-08,2017-07-24,Disruption of the manufacture of the drug.,2017-03-17,2017-07-26
686,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-04-20,2017-03-17,2017-05-01,2017-04-20,Disruption of the manufacture of the drug.,2017-03-12,2017-04-21
8886,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-06-19,2017-05-29,2017-08-08,2017-07-25,Disruption of the manufacture of the drug.,2017-05-04,2017-07-26
94174,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,500 BTL,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-17,,,Disruption of the manufacture of the drug.,2019-09-18,2019-09-18
8938,733059,Shortage,APO-RANITIDINE TABLET 150MG,APOTEX INC,RANITIDINE,RANITIDINE,150MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-06-30,2017-06-15,2017-08-08,2017-07-28,Disruption of the manufacture of the drug.,2017-05-04,2017-07-31
12364,733067,Shortage,APO-RANITIDINE TABLET 300MG,APOTEX INC,RANITIDINE,RANITIDINE,300MG,30 BLS,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-06-30,2017-06-12,2017-07-31,2017-07-24,Disruption of the manufacture of the drug.,2017-06-09,2017-07-26
20645,733067,Shortage,APO-RANITIDINE TABLET 300MG,APOTEX INC,RANITIDINE,RANITIDINE,300MG,500 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-08-28,2017-10-31,2017-10-27,Disruption of the manufacture of the drug.,2017-08-30,2017-10-31
8889,733067,Shortage,APO-RANITIDINE TABLET 300MG,APOTEX INC,RANITIDINE,RANITIDINE,300MG,100 BTL,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-06-12,2017-05-15,2017-08-08,2017-07-21,Disruption of the manufacture of the drug.,2017-05-04,2017-07-22
94177,733067,Shortage,APO-RANITIDINE TABLET 300MG,APOTEX INC,APO-RANITIDINE,RANITIDINE,300MG,100 BTL,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-17,,,Disruption of the manufacture of the drug.,2019-09-18,2019-09-18
86327,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2019-06-10,2019-10-04,2019-08-28,Disruption of the manufacture of the drug.,2019-06-12,2019-08-30
438,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017-02-06,2017-04-30,2017-03-27,Disruption of the manufacture of the drug.,2017-03-11,2017-03-28
441,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2016-09-14,2017-04-30,2017-03-27,Disruption of the manufacture of the drug.,2017-03-11,2017-03-28
14011,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017-06-26,2017-11-15,2017-11-10,Disruption of the manufacture of the drug.,2017-06-27,2017-11-13
8892,2404699,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,1MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,2017-05-26,2017-06-15,2018-04-27,2018-04-04,Disruption of the manufacture of the drug.,2017-05-04,2018-04-05
76743,2404699,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,1MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2019-02-20,2019-10-04,2019-08-28,Disruption of the manufacture of the drug.,2019-02-24,2019-08-30
469,2404680,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,0.5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017-02-06,2017-04-30,2017-03-27,Disruption of the manufacture of the drug.,2017-03-11,2017-03-28
472,2404699,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,1MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2016-09-14,2017-04-30,2017-03-27,Disruption of the manufacture of the drug.,2017-03-11,2017-03-28
475,2355663,Shortage,APO-REPAGLINIDE,APOTEX INC,REPAGLINIDE,REPAGLINIDE,0.5MG,100 BTL,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2014-10-09,,2018-09-10,Disruption of the manufacture of the drug.,2017-03-11,2018-09-11
478,2355671,Shortage,APO-REPAGLINIDE,APOTEX INC,REPAGLINIDE,REPAGLINIDE,1.0MG,100 BTL,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2014-10-09,,2018-09-10,Disruption of the manufacture of the drug.,2017-03-11,2018-09-11
481,2355698,Shortage,APO-REPAGLINIDE,APOTEX INC,REPAGLINIDE,REPAGLINIDE,2.0MG,100 BTL,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2014-09-09,,2018-09-10,Disruption of the manufacture of the drug.,2017-03-11,2018-09-11
89170,2352583,Shortage,APO-RILUZOLE,APOTEX INC,RILUZOLE,RILUZOLE,50MG,60 BTL,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2019-07-08,2019-09-13,2019-09-13,Disruption of the manufacture of the drug.,2019-07-12,2019-09-16
20648,2352583,Shortage,APO-RILUZOLE,APOTEX INC,RILUZOLE,RILUZOLE,50MG,60 BTL,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2017-08-28,2018-03-30,2018-02-27,Disruption of the manufacture of the drug.,2017-08-30,2018-02-28
58626,2353687,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,30 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-08-20,,2018-10-18,Disruption of the manufacture of the drug.,2018-08-21,2018-10-19
26643,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-10-23,2017-11-27,2017-11-10,Disruption of the manufacture of the drug.,2017-10-23,2017-11-15
598,2353687,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,100 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-02-14,2017-04-30,2017-04-28,Disruption of the manufacture of the drug.,2017-03-11,2017-05-02
47969,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,30 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-04-30,2018-08-31,2018-06-29,Disruption of the manufacture of the drug.,2018-05-02,2018-07-03
72360,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,30 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-01-14,,2019-03-07,Disruption of the manufacture of the drug.,2019-01-15,2019-03-11
64981,2353687,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,4 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-10-16,2019-02-15,2018-12-20,Disruption of the manufacture of the drug.,2018-10-19,2018-12-21
20704,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,30 BTL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-08-28,2017-11-10,2017-10-19,Disruption of the manufacture of the drug.,2017-08-31,2017-10-20
484,2377721,Shortage,APO-RISEDRONATE,APOTEX INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1 BLS,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-02-14,2017-03-15,2017-03-14,Disruption of the manufacture of the drug.,2017-03-11,2017-03-15
32827,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-12-11,2018-06-15,2018-05-11,Disruption of the manufacture of the drug.,2017-12-14,2018-05-14
32834,2280396,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,1MG,30 ML,ORAL,Resolved,SOLUTION,N05AX,ANTIPSYCHOTICS,,2017-12-11,2018-02-23,2018-02-13,Disruption of the manufacture of the drug.,2017-12-14,2018-02-14
44114,2280396,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,1MG,30 ML,ORAL,Resolved,SOLUTION,N05AX,ANTIPSYCHOTICS,,2018-03-26,2018-05-28,2018-05-14,Disruption of the manufacture of the drug.,2018-03-27,2018-05-15
601,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-03-10,2017-06-02,2017-05-31,Disruption of the manufacture of the drug.,2017-03-11,2017-06-01
3183,2282119,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.25MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-04-20,2017-04-14,2017-06-02,2017-05-31,Disruption of the manufacture of the drug.,2017-03-17,2017-06-01
14216,2282135,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,1.0MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-07-31,2017-07-17,2017-12-15,2017-11-30,Disruption of the manufacture of the drug.,2017-06-28,2017-12-01
95882,2282178,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,4.0MG,100 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-10-07,2019-10-30,2019-10-23,Disruption of the manufacture of the drug.,2019-10-09,2019-10-29
14219,2282143,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,2.0MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-09-08,2017-08-15,2017-12-15,2017-11-29,Disruption of the manufacture of the drug.,2017-06-28,2017-11-30
20122,2282119,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.25MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-08-21,2017-12-15,2017-11-28,Disruption of the manufacture of the drug.,2017-08-23,2017-11-29
17319,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-09-22,2017-08-15,2017-12-15,2017-11-28,Disruption of the manufacture of the drug.,2017-07-26,2017-11-29
9906,2282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,100 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-05-08,2017-06-07,2017-05-31,Demand increase for the drug.,2017-05-10,2017-06-01
20707,2282119,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.25MG,100 BTL,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-08-28,2017-12-15,2017-11-29,Disruption of the manufacture of the drug.,2017-08-31,2017-11-30
88360,2336758,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,6MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2019-07-02,2019-10-18,2019-10-04,Disruption of the manufacture of the drug.,2019-07-03,2019-10-07
86336,2336723,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,3MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2019-06-10,2019-10-18,2019-10-04,Disruption of the manufacture of the drug.,2019-06-12,2019-10-07
36947,2336731,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,4.5MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2018-01-22,,2018-01-22,Disruption of the manufacture of the drug.,2018-01-23,2018-01-22
36949,2336731,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,4.5MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2018-01-22,2018-03-30,2018-03-26,Disruption of the manufacture of the drug.,2018-01-23,2018-03-27
85610,2336731,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,4.5MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2019-06-03,2019-10-18,2019-10-04,Disruption of the manufacture of the drug.,2019-06-05,2019-10-07
20900,2336715,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,1.5MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,2017-10-20,2017-10-16,2019-10-18,2019-10-11,Disruption of the manufacture of the drug.,2017-09-05,2019-10-15
17322,2336758,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,6MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,2017-09-18,2017-08-28,2018-03-30,2018-03-26,Disruption of the manufacture of the drug.,2017-07-26,2018-03-27
487,2336731,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,4.5MG,100 BTL,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2017-03-10,2017-05-23,2017-05-17,Disruption of the manufacture of the drug.,2017-03-11,2017-05-18
38491,2393476,Shortage,APO-RIZATRIPTAN,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,10MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-02-05,,2019-05-03,Disruption of the manufacture of the drug.,2018-02-05,2019-05-06
67031,2393468,Shortage,APO-RIZATRIPTAN,APOTEX INC,RIZATRIPTAN 5MG,RIZATRIPTAN,5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-11-13,,2019-05-03,Disruption of the manufacture of the drug.,2018-11-16,2019-05-06
14560,2393468,Shortage,APO-RIZATRIPTAN,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-06-29,,2018-01-05,Disruption of the manufacture of the drug.,2017-07-04,2018-01-10
504,2393476,Shortage,APO-RIZATRIPTAN,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,10MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-01-31,2017-08-31,2017-08-17,Disruption of the manufacture of the drug.,2017-03-11,2017-08-18
490,2393492,Shortage,APO-RIZATRIPTAN RPD,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,10MG,6 BLS,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2014-10-01,,,Disruption of the manufacture of the drug.,2017-03-11,2018-01-10
493,2393484,Shortage,APO-RIZATRIPTAN RPD,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,5MG,6 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2014-10-01,,2018-09-10,Disruption of the manufacture of the drug.,2017-03-11,2018-09-11
17325,2403366,Shortage,APO-ROSIGLITAZONE,APOTEX INC,ROSIGLITAZONE,ROSIGLITAZONE,2MG,100 BTL,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-07-31,2017-07-31,2017-10-16,2017-10-13,Disruption of the manufacture of the drug.,2017-07-26,2017-10-16
20214,2403374,Shortage,APO-ROSIGLITAZONE,APOTEX INC,ROSIGLITAZONE,ROSIGLITAZONE,4MG,100 BTL,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-08-21,2017-10-16,2017-10-13,Disruption of the manufacture of the drug.,2017-08-24,2017-10-16
8710,2337983,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-01,2017-08-31,2017-08-15,Disruption of the manufacture of the drug.,2017-05-02,2017-08-16
8713,2338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-01,2017-08-31,2017-08-16,Disruption of the manufacture of the drug.,2017-05-02,2017-08-17
28440,2338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-12-22,2017-12-11,2018-03-26,2018-03-19,Disruption of the manufacture of the drug.,2017-11-07,2018-03-20
7716,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-21,2017-06-07,2017-06-09,Disruption of the manufacture of the drug.,2017-04-24,2017-06-13
31031,2337983,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,10MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-12-15,2017-12-11,2018-04-04,2018-03-12,Disruption of the manufacture of the drug.,2017-11-29,2018-03-13
31034,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-12-15,2017-12-11,2018-03-26,2018-03-19,Disruption of the manufacture of the drug.,2017-11-29,2018-03-20
82019,2338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-15,2019-05-13,2019-05-10,Disruption of the manufacture of the drug.,2019-04-18,2019-05-13
75629,2337975,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,5MG,30BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-02-11,2019-03-08,2019-03-04,Disruption of the manufacture of the drug.,2019-02-13,2019-03-07
18560,2338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-07,2017-11-30,2017-11-06,Disruption of the manufacture of the drug.,2017-08-09,2017-11-07
14223,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-07-24,2017-07-24,2017-10-10,2017-09-29,Disruption of the manufacture of the drug.,2017-06-28,2017-10-03
20623,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-28,2017-11-10,2017-10-27,Disruption of the manufacture of the drug.,2017-08-29,2017-10-30
20626,2337983,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,10MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-28,2017-11-10,2017-11-02,Disruption of the manufacture of the drug.,2017-08-29,2017-11-03
14227,2337975,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,5MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-21,2017-10-31,2017-11-02,Disruption of the manufacture of the drug.,2017-06-28,2017-11-03
725,2337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-10,2017-03-30,2017-03-30,Disruption of the manufacture of the drug.,2017-03-13,2017-03-31
30960,2337975,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,5MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-11-27,2018-03-05,2018-02-26,Disruption of the manufacture of the drug.,2017-11-28,2018-02-27
97054,2245669,Shortage,APO-SALBUTAMOL HFA,APOTEX INC,SALVENT,SALBUTAMOL,100MCG,200 INH,INHALATION,Actual shortage,METERED-DOSE AEROSOL,R03AC,"ADRENERGICS, INHALANTS",,2019-10-21,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-23,2019-10-23
19000,2046741,Shortage,APO-SALVENT 5MG/ML,APOTEX INC,SALBUTAMOL,SALBUTAMOL,5MG,10ML,INHALATION  ORAL,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
18988,790419,Shortage,APO-SALVENT AEM 100MCG,APOTEX INC,SALBUTAMOL,SALBUTAMOL,100MCG,INHALER 15,INHALATION,Actual shortage,METERED-DOSE AEROSOL,R03AC,"ADRENERGICS, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
19057,2231488,Shortage,APO-SALVENT STERULES,APOTEX INC,SALBUTAMOL,SALBUTAMOL,1MG,2.5 ml,INHALATION,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19063,2231678,Shortage,APO-SALVENT STERULES,APOTEX INC,SALBUTAMOL,SALBUTAMOL,2MG,2.5 ml,INHALATION,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
19114,2243828,Shortage,APO-SALVENT STERULES,APOTEX INC,SALBUTAMOL,SALBUTAMOL,0.5MG,5 ML,INHALATION,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
689,2146851,Shortage,APO-SALVENT TABLETS - 4MG,APOTEX INC,SALBUTAMOL,SALBUTAMOL,4MG,100 BTL,ORAL,Resolved,TABLET,R03CC,ADRENERGICS FOR SYSTEMIC USE,2017-04-19,2017-04-14,2017-05-20,2017-05-08,Disruption of the manufacture of the drug.,2017-03-12,2017-05-10
19323,2266393,Shortage,APO-SALVENT-IPRAVENT STERULES,APOTEX INC,SALBUTAMOL,IPRATROPIUM BROMIDE  SALBUTAMOL,0.5MG  2.5MG,5 ML,INHALATION,Actual shortage,SOLUTION,R03AL,"ADRENERGICS, INHALANTS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
87064,2230641,Shortage,APO-SELEGILINE,APOTEX INC,SELEGILINE,SELEGILINE HYDROCHLORIDE,5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2019-06-17,2019-07-24,2019-07-18,Disruption of the manufacture of the drug.,2019-06-19,2019-07-19
17328,2230641,Shortage,APO-SELEGILINE,APOTEX INC,SELEGILINE,SELEGILINE HYDROCHLORIDE,5MG,100 BTL,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,2017-08-31,2017-08-07,2018-03-30,2018-03-23,Disruption of the manufacture of the drug.,2017-07-26,2018-03-27
13334,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-06-19,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-06-19,2017-10-04
28709,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL & 250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-11-06,2018-02-28,2018-01-30,Disruption of the manufacture of the drug.,2017-11-09,2018-01-31
55847,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-07-16,2018-09-10,2018-08-30,Disruption of the manufacture of the drug.,2018-07-16,2018-08-31
88365,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-07-02,2019-10-31,2019-09-05,Disruption of the manufacture of the drug.,2019-07-03,2019-09-06
11090,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-06-26,2017-06-05,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-05-24,2017-10-04
85613,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,250 BTL,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-06-03,2019-12-20,,Disruption of the manufacture of the drug.,2019-06-05,2019-10-18
3186,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-03-31,2017-03-27,2017-05-02,2017-04-28,Disruption of the manufacture of the drug.,2017-03-17,2017-05-01
14233,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-07-31,2017-07-10,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-06-28,2017-10-04
12698,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-06-12,2017-10-11,2017-10-11,Disruption of the manufacture of the drug.,2017-06-13,2017-10-12
80539,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,100 BTL,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-04-01,2019-12-20,,Disruption of the manufacture of the drug.,2019-04-04,2019-10-18
82334,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-04-22,2019-05-30,2019-05-29,Disruption of the manufacture of the drug.,2019-04-24,2019-05-31
20903,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-09-22,,2017-10-31,2017-10-02,Disruption of the manufacture of the drug.,2017-09-05,2017-10-05
85161,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-05-27,2019-12-20,,Disruption of the manufacture of the drug.,2019-05-29,2019-10-18
40377,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-02-19,2018-06-29,2018-06-11,Disruption of the manufacture of the drug.,2018-02-21,2018-06-12
48860,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-05-07,2018-06-25,2018-05-28,Disruption of the manufacture of the drug.,2018-05-08,2018-05-29
57820,2238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-08-06,2018-12-28,2018-11-26,Disruption of the manufacture of the drug.,2018-08-09,2018-11-27
49374,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-05-14,2018-07-06,2018-06-11,Disruption of the manufacture of the drug.,2018-05-15,2018-06-12
30963,2238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-11-27,2018-03-14,2018-02-22,Disruption of the manufacture of the drug.,2017-11-28,2018-02-23
30967,2238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,100 BTL & 250 BTL,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-11-27,2018-02-09,2018-01-17,Disruption of the manufacture of the drug.,2017-11-28,2018-01-18
28700,2248203,Shortage,APO-SILDENAFIL,APOTEX INC,SILDENAFIL,SILDENAFIL,100MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-06,2017-12-29,2017-12-29,Disruption of the manufacture of the drug.,2017-11-09,2018-01-03
42705,2248203,Shortage,APO-SILDENAFIL,APOTEX INC,SILDENAFIL,SILDENAFIL,100MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-03-12,2018-07-31,2018-06-29,Disruption of the manufacture of the drug.,2018-03-13,2018-07-03
48863,2248202,Shortage,APO-SILDENAFIL,APOTEX INC,SILDENAFIL,SILDENAFIL,50MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-05-07,2018-07-20,2018-06-29,Disruption of the manufacture of the drug.,2018-05-08,2018-07-03
64996,2248202,Shortage,APO-SILDENAFIL,APOTEX INC,SILDENAFIL,SILDENAFIL,50MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-10-18,2019-01-04,2019-01-02,Disruption of the manufacture of the drug.,2018-10-19,2019-01-03
507,2418118,Shortage,APO-SILDENAFIL R,APOTEX INC,SILDENAFIL,SILDENAFIL,20MG,100 BTL,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2014-11-06,,2017-08-22,Disruption of the manufacture of the drug.,2017-03-11,2017-08-24
63803,2247011,Shortage,APO-SIMVASTATIN,APOTEX INC,Simvastatin 5mg,SIMVASTATIN,5MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-10-08,2018-11-12,2018-11-01,Disruption of the manufacture of the drug.,2018-10-11,2018-11-02
80545,2247013,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,20MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-01,2019-04-12,2019-04-12,Disruption of the manufacture of the drug.,2019-04-04,2019-04-15
14244,2247014,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,40MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-07-31,2017-07-24,2017-11-17,2017-10-27,Disruption of the manufacture of the drug.,2017-06-28,2017-10-30
14065,2247015,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,80MG,30 BLS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-06-26,2017-11-17,2017-10-26,Disruption of the manufacture of the drug.,2017-06-27,2017-10-27
39673,2247015,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,80MG,100 BTL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-02-12,2018-04-30,2018-03-19,Disruption of the manufacture of the drug.,2018-02-13,2018-03-20
25636,2167794,Shortage,APO-SOTALOL - TAB 160MG,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100 BTL,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-10-09,2018-01-31,2018-01-18,Disruption of the manufacture of the drug.,2017-10-12,2018-01-19
20906,2210428,Shortage,APO-SOTALOL 80MG TABLETS,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017-09-29,2017-09-25,2018-01-31,2018-01-18,Disruption of the manufacture of the drug.,2017-09-05,2018-01-19
54187,2210428,Shortage,APO-SOTALOL 80MG TABLETS,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2018-07-02,2018-10-01,2018-07-12,Disruption of the manufacture of the drug.,2018-07-04,2018-07-13
21096,2125250,Shortage,APO-SUCRALFATE - TAB 1G,APOTEX INC,SUCRALFATE,SUCRALFATE,1G,500 BTL,ORAL,Resolved,TABLET,A02BX,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-04,,2018-09-10,Disruption of the manufacture of the drug.,2017-09-06,2018-09-11
18991,846465,Shortage,APO-SULFATRIM ORAL SUSPENSION,APOTEX INC,SULFATRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,40MG  8MG,100/400/800 ML,ORAL,Actual shortage,SUSPENSION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
45350,2268396,Shortage,APO-SUMATRIPTAN,APOTEX INC,SUMATRIPTAN,SUMATRIPTAN,100MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-04-09,2018-11-30,2018-11-02,Disruption of the manufacture of the drug.,2018-04-10,2018-11-03
14247,2268388,Shortage,APO-SUMATRIPTAN,APOTEX INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2017-08-01,2017-08-07,2017-09-20,2017-08-29,Disruption of the manufacture of the drug.,2017-06-28,2017-08-30
44517,2268388,Shortage,APO-SUMATRIPTAN,APOTEX INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-04-02,2018-11-30,2018-11-01,Disruption of the manufacture of the drug.,2018-04-02,2018-11-02
20245,2422115,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,20MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-08-18,2017-10-20,2017-10-10,Disruption of the manufacture of the drug.,2017-08-24,2017-10-11
26646,2422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-10-23,2017-12-18,2017-11-27,Disruption of the manufacture of the drug.,2017-10-23,2017-11-29
88368,2422107,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,10MG,4 BLS,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-07-02,2020-01-03,,Disruption of the manufacture of the drug.,2019-07-03,2019-11-18
15409,2422085,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,2.5MG,30 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-07-10,2017-12-28,2017-12-06,Disruption of the manufacture of the drug.,2017-07-11,2017-12-07
77896,2422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-03-04,2019-04-26,2019-04-25,Disruption of the manufacture of the drug.,2019-03-06,2019-04-26
37983,2422115,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,20MG,30 BTL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-02-19,2018-02-05,2018-06-29,2018-05-14,Disruption of the manufacture of the drug.,2018-02-01,2018-05-15
79051,2422107,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,10MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-03-18,2019-04-26,2019-04-25,Disruption of the manufacture of the drug.,2019-03-21,2019-04-26
89551,2422115,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,20MG,4 BLS,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-07-15,2020-01-03,,Disruption of the manufacture of the drug.,2019-07-17,2019-11-18
92387,2422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-08-19,2020-01-24,,Disruption of the manufacture of the drug.,2019-08-23,2019-10-21
44520,2422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-04-02,2018-05-14,2018-05-14,Disruption of the manufacture of the drug.,2018-04-02,2018-05-15
36347,2422107,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,10MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-01-15,2018-05-14,2018-05-14,Disruption of the manufacture of the drug.,2018-01-17,2018-05-15
29949,2422115,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,20MG,4 BLS,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-20,2018-01-19,2018-01-08,Disruption of the manufacture of the drug.,2017-11-21,2018-01-08
91106,2421933,Shortage,APO-TADALAFIL PAH,APOTEX INC,TADALAFIL,TADALAFIL,20MG,60 BTL,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-08-06,2019-11-07,2020-01-03,Disruption of the manufacture of the drug.,2019-08-07,2019-11-05
92035,812404,Shortage,APO-TAMOX TAB 10MG,APOTEX INC,TAMOX,TAMOXIFEN,10MG,100 BTL,ORAL,Actual shortage,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-08-19,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-21,2019-11-12
20909,812390,Shortage,APO-TAMOX TAB 20MG,APOTEX INC,TAMOXIFEN,TAMOXIFEN,20MG,100 BTL & 250 BTL,ORAL,Resolved,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,2017-09-25,2017-09-25,2017-12-22,2017-11-24,Disruption of the manufacture of the drug.,2017-09-05,2017-11-27
84154,812390,Shortage,APO-TAMOX TAB 20MG,APOTEX INC,TAMOX,TAMOXIFEN,20MG,100 BTL,ORAL,Actual shortage,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-05-14,2019-12-31,,Disruption of the manufacture of the drug.,2019-05-15,2019-11-12
31039,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-12-29,2018-01-02,2018-02-28,2018-01-19,Disruption of the manufacture of the drug.,2017-11-29,2018-01-22
85619,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-06-03,2019-06-17,2019-06-18,Disruption of the manufacture of the drug.,2019-06-05,2019-06-21
15995,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-07-17,2017-11-10,2017-10-23,Disruption of the manufacture of the drug.,2017-07-17,2017-10-24
82337,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-04-22,2019-06-14,2019-06-18,Disruption of the manufacture of the drug.,2019-04-24,2019-06-21
72363,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-01-14,2019-02-22,2019-02-20,Disruption of the manufacture of the drug.,2019-01-15,2019-02-21
17331,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-08-04,2017-08-01,2017-11-14,2017-11-10,Disruption of the manufacture of the drug.,2017-07-26,2017-11-13
84159,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,500 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-05-14,2019-06-20,2019-06-21,Disruption of the manufacture of the drug.,2019-05-15,2019-06-24
9946,2362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-05-08,2017-05-29,2017-05-12,Disruption of the manufacture of the drug.,2017-05-10,2017-05-13
11047,2420090,Shortage,APO-TELMISARTAN,APOTEX INC,TELMISARTAN,TELMISARTAN,80MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-05-22,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-05-24,2017-10-03
12080,2420082,Shortage,APO-TELMISARTAN,APOTEX INC,TELMISARTAN,TELMISARTAN,40MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-06-05,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-06-06,2017-10-03
55794,2420082,Shortage,APO-TELMISARTAN,APOTEX INC,TELMISARTAN,TELMISARTAN,40MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-08-03,2018-07-30,,2018-09-11,Disruption of the manufacture of the drug.,2018-07-15,2018-09-12
55798,2420090,Shortage,APO-TELMISARTAN,APOTEX INC,TELMISARTAN,TELMISARTAN,80MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-11-01,2018-08-13,,2018-09-11,Disruption of the manufacture of the drug.,2018-07-15,2018-09-12
55290,2420082,Shortage,APO-TELMISARTAN,APOTEX INC,TELMISARTAN,TELMISARTAN,40MG,100 BTL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,2018-07-09,Disruption of the manufacture of the drug.,2018-07-11,2018-07-11
11050,2420031,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,100 BTL,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-05-22,,,Disruption of the manufacture of the drug.,2017-05-24,2018-12-20
6524,2420023,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-04-10,,2018-09-11,Disruption of the manufacture of the drug.,2017-04-11,2018-09-12
8922,2420023,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-07-17,2017-06-26,,2018-09-11,Disruption of the manufacture of the drug.,2017-05-04,2018-09-12
748,2420023,Shortage,APO-TELMISARTAN/HCTZ,APOTEX INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-03-10,2017-03-31,2017-03-30,Disruption of the manufacture of the drug.,2017-03-13,2017-03-31
56538,2451980,Shortage,APO-TENOFOVIR,APOTEX INC,TENOFOVIR,TENOFOVIR DISOPROXIL FUMARATE,300MG,30 BTL,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2018-07-23,2018-10-15,2018-08-31,Disruption of the manufacture of the drug.,2018-07-26,2018-09-04
36353,2234504,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,5MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-01-15,2018-08-31,2018-07-30,Disruption of the manufacture of the drug.,2018-01-17,2018-07-31
37986,2234503,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,2MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-02-14,2018-02-09,2018-08-31,2018-08-17,Disruption of the manufacture of the drug.,2018-02-01,2018-08-20
23655,2234504,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,5MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-09-25,2017-10-16,2017-10-16,Disruption of the manufacture of the drug.,2017-09-27,2017-10-24
37743,2234502,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,1MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-01-29,2018-07-25,2018-07-30,Disruption of the manufacture of the drug.,2018-01-31,2018-07-31
62871,2234505,Shortage,APO-TERAZOSIN,APOTEX INC,Terazosin 10mg,TERAZOSIN,10MG,100BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-10-02,2019-01-11,2018-12-24,Disruption of the manufacture of the drug.,2018-10-02,2018-12-27
14250,2234502,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,1MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-08-18,2017-07-31,2017-11-15,2017-10-16,Disruption of the manufacture of the drug.,2017-06-28,2017-10-17
65008,2234503,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,2MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-10-17,2019-01-28,2018-12-24,Disruption of the manufacture of the drug.,2018-10-19,2018-12-27
36350,2234505,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,10MG,100 BTL,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-01-15,2018-07-30,2018-07-30,Disruption of the manufacture of the drug.,2018-01-17,2018-07-31
11053,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,100 BTL,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017-05-22,2017-07-25,2017-07-18,Disruption of the manufacture of the drug.,2017-05-24,2017-07-19
37989,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,100 BTL,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,2018-04-06,2018-03-26,2018-06-29,2018-04-13,Disruption of the manufacture of the drug.,2018-02-01,2018-04-15
75632,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,30BLS and 100 BTL,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2019-02-11,,,Disruption of the manufacture of the drug.,2019-02-13,2019-05-31
37746,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,30 BLS,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2018-01-29,2018-12-31,2018-09-18,Disruption of the manufacture of the drug.,2018-01-31,2018-09-21
27773,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,100 BTL,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017-10-30,2017-11-30,2017-11-22,Disruption of the manufacture of the drug.,2017-11-01,2017-11-23
18567,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,500 BTL,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017-08-07,2017-09-15,2017-09-15,Disruption of the manufacture of the drug.,2017-08-09,2017-09-22
67034,2239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE 250MG,TERBINAFINE,250MG,30 BLS,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2018-11-12,2019-01-18,2019-01-14,Disruption of the manufacture of the drug.,2018-11-16,2019-01-17
37749,2407590,Shortage,APO-TETRABENAZINE,APOTEX INC,TETRABENZAPINE,TETRABENAZINE,25MG,100 BTL,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2018-01-29,2018-05-31,2018-05-15,Disruption of the manufacture of the drug.,2018-01-31,2018-05-16
21209,2407590,Shortage,APO-TETRABENAZINE,APOTEX INC,TETRABENZAPINE,TETRABENAZINE,25MG,100 BTL,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2017-09-04,2017-12-15,2017-11-21,Disruption of the manufacture of the drug.,2017-09-07,2017-11-22
82343,692700,Shortage,APO-THEO LA,APOTEX INC,THEO LA,THEOPHYLLINE,300MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-04-22,,,Disruption of the manufacture of the drug.,2019-04-24,2019-04-24
19010,2136120,Shortage,APO-TIAPROFENIC TABLETS -300MG,APOTEX INC,TIAPROFENIC,TIAPROFENIC ACID,300MG,100 BTL & 500 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
19007,2136112,Shortage,APO-TIAPROFENIC TABLETS-200MG,APOTEX INC,TIAPROFENIC,TIAPROFENIC ACID,200MG,100 BTL,ORAL,Actual shortage,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-13,2017-10-05
92992,755834,Shortage,APO-TIMOP,APOTEX INC,TIMOLOL MALEATE,TIMOLOL,0.5%,10 ML,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-09-03,,,Disruption of the manufacture of the drug.,2019-09-04,2019-10-29
49509,755834,Shortage,APO-TIMOP,APOTEX INC,TIMOLOL MALEATE,TIMOLOL,0.5%,10 ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2018-06-29,2018-06-04,,2018-11-01,Disruption of the manufacture of the drug.,2018-05-16,2018-11-02
48866,755834,Shortage,APO-TIMOP,APOTEX INC,TIMOLOL MALEATE,TIMOLOL,0.5%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-05-07,,2019-02-04,Other (Please describe in comments),2018-05-08,2019-02-05
510,2290812,Shortage,APO-TIMOP GEL,APOTEX INC,TIMOLOL MALEATE,TIMOLOL,0.5%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2014-10-09,,2019-02-04,Other (Please describe in comments),2017-03-11,2019-02-05
513,755826,Shortage,APO-TIMOP OPH SOLN 0.25%,APOTEX INC,TIMOLOL MALEATE,TIMOLOL,0.25%,5 ML & 10 ML,OPHTHALMIC,Resolved,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015-03-18,,2017-08-24,Disruption of the manufacture of the drug.,2017-03-11,2019-01-03
19123,2245698,Shortage,APO-TOBRAMYCIN,APOTEX INC,TOBRAMYCIN,TOBRAMYCIN,0.3%,5 ML,OPHTHALMIC,Actual shortage,SOLUTION,S01AA,ANTIINFECTIVES,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
516,2369680,Shortage,APO-TOLTERODINE,APOTEX INC,TOLTERODINE,TOLTERODINE TARTRATE,1MG,100 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-02-08,2017-11-24,2017-11-07,Disruption of the manufacture of the drug.,2017-03-11,2017-11-08
519,2369699,Shortage,APO-TOLTERODINE,APOTEX INC,TOLTERODINE,TOLTERODINE TARTRATE,2MG,100 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-02-08,2017-11-24,2017-11-06,Disruption of the manufacture of the drug.,2017-03-11,2017-11-07
523,2369699,Shortage,APO-TOLTERODINE,APOTEX INC,TOLTERODINE,TOLTERODINE TARTRATE,2MG,500 BTL,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-02-08,2018-02-28,2018-02-27,Disruption of the manufacture of the drug.,2017-03-11,2018-02-28
7728,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,25MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-04-21,2017-07-07,2017-07-04,Disruption of the manufacture of the drug.,2017-04-24,2017-07-05
32839,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,25MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-12-11,2018-03-12,2018-03-02,Disruption of the manufacture of the drug.,2017-12-14,2018-03-06
27767,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-10-30,2018-01-19,2018-01-02,Disruption of the manufacture of the drug.,2017-11-01,2018-01-03
95894,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,25MG,100 BTL,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2019-10-07,2019-11-29,,Disruption of the manufacture of the drug.,2019-10-09,2019-11-18
12701,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-06-12,2017-07-10,2017-07-07,Disruption of the manufacture of the drug.,2017-06-13,2017-07-11
3746,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-04-30,2017-05-25,2017-03-20,Disruption of the manufacture of the drug.,2017-03-21,2017-03-21
82340,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,25MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-04-22,2019-07-26,2019-07-17,Disruption of the manufacture of the drug.,2019-04-24,2019-07-19
44200,2279649,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,200MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-03-26,2018-07-31,2018-06-29,Disruption of the manufacture of the drug.,2018-03-29,2018-07-03
84163,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-05-14,2019-07-12,2019-07-04,Disruption of the manufacture of the drug.,2019-05-15,2019-07-05
69324,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-12-10,2018-12-10,2019-01-16,2019-01-14,Disruption of the manufacture of the drug.,2018-12-12,2019-01-17
21216,2279649,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,200MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-04,2017-10-16,2017-10-13,Disruption of the manufacture of the drug.,2017-09-07,2017-10-16
9957,2279630,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-05-05,2017-05-26,2017-05-24,Disruption of the manufacture of the drug.,2017-05-10,2017-05-25
48869,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,25MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-05-07,2018-07-09,2018-06-29,Disruption of the manufacture of the drug.,2018-05-08,2018-07-03
66552,2279614,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE 25MG,TOPIRAMATE,25MG,100 BTL,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-11-06,2019-01-16,2019-01-16,Disruption of the manufacture of the drug.,2018-11-09,2019-01-17
692,2426153,Shortage,APO-TRAMADOL,APOTEX INC,TRAMADOL,TRAMADOL HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,TABLET,N02AX,OPIOIDS,2017-03-29,2017-03-13,2017-04-20,2017-04-14,Disruption of the manufacture of the drug.,2017-03-12,2017-04-17
88371,2336790,Shortage,APO-TRAMADOL/ACET,APOTEX INC,TRAMADOL,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100 BTL,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,,2019-07-02,2019-11-29,,Disruption of the manufacture of the drug.,2019-07-03,2019-07-30
68725,2336790,Shortage,APO-TRAMADOL/ACET,APOTEX INC,TRAMADOL/ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100BTL,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2018-12-03,2018-12-20,2018-12-18,Disruption of the manufacture of the drug.,2018-12-05,2018-12-19
528,2415739,Shortage,APO-TRAVOPROST Z,APOTEX INC,TRAVOPROST,TRAVOPROST,0.004%,5ml,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2015-12-17,2019-01-30,2019-01-02,Disruption of the manufacture of the drug.,2017-03-11,2019-01-03
42708,2147653,Shortage,APO-TRAZODONE D TABLETS 150MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,150MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-03-12,2018-12-21,2018-12-14,Disruption of the manufacture of the drug.,2018-03-13,2018-12-18
6521,2147645,Shortage,APO-TRAZODONE TABLETS 100MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,500 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-04-10,2017-07-10,2017-07-04,Disruption of the manufacture of the drug.,2017-04-11,2017-07-05
21219,2147645,Shortage,APO-TRAZODONE TABLETS 100MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-09-04,2018-10-15,2018-09-28,Disruption of the manufacture of the drug.,2017-09-07,2018-09-29
531,2147637,Shortage,APO-TRAZODONE TABLETS 50MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,250 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-03-10,2017-07-24,2017-07-04,Disruption of the manufacture of the drug.,2017-03-11,2017-07-05
26652,2147637,Shortage,APO-TRAZODONE TABLETS 50MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-10-23,2018-10-29,2018-09-27,Disruption of the manufacture of the drug.,2017-10-23,2018-09-28
74025,2437635,Shortage,APO-TRIAMCINOLONE AQ,APOTEX INC,TRIAMCINOLONE AQ,TRIAMCINOLONE ACETONIDE,55MCG,120MS,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-01-28,2019-04-12,2019-04-10,Disruption of the manufacture of the drug.,2019-01-30,2019-04-11
12085,2437635,Shortage,APO-TRIAMCINOLONE AQ,APOTEX INC,TRIAMCINOLONE,TRIAMCINOLONE ACETONIDE,55MCG,30 BTL,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017-06-05,2017-11-17,2017-11-17,Disruption of the manufacture of the drug.,2017-06-06,2017-11-20
42711,2437635,Shortage,APO-TRIAMCINOLONE AQ,APOTEX INC,TRIAMCINOLONE,TRIAMCINOLONE ACETONIDE,55MCG,120 MS,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2018-03-12,,2018-11-07,Disruption of the manufacture of the drug.,2018-03-13,2018-11-09
8716,2248540,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,CAPSULE,N06AX,ANTIDEPRESSANTS,,2017-05-01,2017-07-24,2017-07-25,Disruption of the manufacture of the drug.,2017-05-02,2017-07-31
534,2248540,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,CAPSULE,N06AX,ANTIDEPRESSANTS,,2016-02-02,2017-05-31,2017-04-11,Disruption of the manufacture of the drug.,2017-03-11,2017-04-12
63807,2248538,Shortage,APO-TRYPTOPHAN,APOTEX INC,Tryptophan 500mg,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-10-08,2018-12-03,2018-11-20,Disruption of the manufacture of the drug.,2018-10-11,2018-11-22
77899,2248538,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2019-03-04,2019-04-26,2019-04-22,Disruption of the manufacture of the drug.,2019-03-06,2019-04-26
17335,2248538,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-09-28,2017-08-14,2018-03-23,2018-03-23,Disruption of the manufacture of the drug.,2017-07-26,2018-03-25
46046,2248540,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL,Resolved,CAPSULE,N06AX,ANTIDEPRESSANTS,,2018-04-16,2018-09-28,2018-08-17,Disruption of the manufacture of the drug.,2018-04-16,2018-08-18
26662,2354705,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-10-23,2018-02-14,2018-01-30,Disruption of the manufacture of the drug.,2017-10-23,2018-01-31
26224,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,30 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-10-16,2018-02-12,2018-01-30,Disruption of the manufacture of the drug.,2017-10-18,2018-01-31
38001,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,30 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2018-03-09,2018-02-19,2018-11-30,2018-09-11,Disruption of the manufacture of the drug.,2018-02-01,2018-09-12
46006,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-04-16,2018-06-15,2018-05-21,Disruption of the manufacture of the drug.,2018-04-16,2018-05-22
3539,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,30 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-03-20,2017-03-23,2017-03-23,Disruption of the manufacture of the drug.,2017-03-20,2017-03-24
82903,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-04-30,2019-06-28,2019-06-14,Disruption of the manufacture of the drug.,2019-05-01,2019-06-17
65005,2295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100 BTL,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-10-15,2018-12-07,2018-11-21,Disruption of the manufacture of the drug.,2018-10-19,2018-11-22
43519,2354705,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21 BLS,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-03-19,2019-01-25,2019-01-17,Disruption of the manufacture of the drug.,2018-03-20,2019-01-18
537,2393824,Shortage,APO-VALGANCICLOVIR,APOTEX INC,VALGANCICLOVIR,VALGANCICLOVIR,450MG,60 BTL,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2016-11-14,,,Disruption of the manufacture of the drug.,2017-03-11,2018-02-21
15412,2238370,Shortage,APO-VALPROIC SYRUP,APOTEX INC,VALPROIC ACID,VALPROIC ACID,50MG,450 ml,ORAL,Resolved,SYRUP,N03AG,ANTIEPILEPTICS,,2017-07-10,2017-08-25,2017-08-17,Disruption of the manufacture of the drug.,2017-07-11,2017-08-18
272,2371529,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,80MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014-10-01,,2018-12-27,Disruption of the manufacture of the drug.,2017-03-10,2019-03-08
549,2371537,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,160MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014-10-01,,2018-12-27,Disruption of the manufacture of the drug.,2017-03-11,2019-03-08
570,2371545,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,320MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014-10-01,,2018-12-27,Disruption of the manufacture of the drug.,2017-03-11,2019-03-11
573,2371510,Shortage,APO-VALSARTAN,APOTEX INC,VALSARTAN,VALSARTAN,40MG,30 BLS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2014-10-01,,2018-12-28,Disruption of the manufacture of the drug.,2017-03-11,2019-03-11
263,2382555,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  160MG,100 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-01-04,,2018-12-28,Disruption of the manufacture of the drug.,2017-03-10,2019-03-21
266,2382547,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  80MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-01-04,,2018-12-28,Disruption of the manufacture of the drug.,2017-03-10,2019-03-21
269,2382555,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  160MG,500 BTL,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-01-04,,2018-12-28,Disruption of the manufacture of the drug.,2017-03-10,2019-03-21
546,2382563,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,25MG  160MG,100 BTL & 500 BTL & 30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-01-04,,2018-12-28,Disruption of the manufacture of the drug.,2017-03-11,2019-03-21
564,2382571,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  320MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014-10-01,,2018-12-28,Disruption of the manufacture of the drug.,2017-03-11,2019-03-21
567,2382598,Shortage,APO-VALSARTAN/HCTZ,APOTEX INC,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,25MG  320MG,30 BLS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2014-10-01,,2018-12-28,Disruption of the manufacture of the drug.,2017-03-11,2019-03-21
74839,2435675,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE  VARENICLINE,0.5MG  1MG,53 BLS,ORAL,Resolved,KIT  TABLET,N07BA,DRUGS USED IN ADDICTIVE DISORDERS,,2019-01-31,2019-11-15,2019-11-15,Disruption of the manufacture of the drug.,2019-02-05,2019-11-18
74935,2419890,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE,1MG,56 BLS,ORAL,Resolved,TABLET,N07BA,DRUGS USED IN ADDICTIVE DISORDERS,,2019-02-04,2019-06-21,2019-06-21,Disruption of the manufacture of the drug.,2019-02-06,2019-06-24
97477,2419882,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE,0.5MG,56 BTL,ORAL,Resolved,TABLET,N07BA,DRUGS USED IN ADDICTIVE DISORDERS,,2019-10-28,2019-11-15,2019-11-15,Disruption of the manufacture of the drug.,2019-10-30,2019-11-18
71151,2419882,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE,0.5MG,56 BTL,ORAL,Resolved,TABLET,N07BA,DRUGS USED IN ADDICTIVE DISORDERS,,2019-01-02,2019-06-21,2019-06-21,Disruption of the manufacture of the drug.,2019-01-03,2019-06-24
50971,2331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100 BTL and 500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-05-28,2019-06-07,2019-05-30,Disruption of the manufacture of the drug.,2018-05-31,2019-05-31
45353,2331705,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,150.0MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-04-09,2018-10-31,2018-11-02,Disruption of the manufacture of the drug.,2018-04-10,2018-11-03
86347,2331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-06-10,2019-07-06,2019-06-28,Disruption of the manufacture of the drug.,2019-06-12,2019-07-02
69458,2331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE XR,VENLAFAXINE,75.0MG,500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-12-10,2018-12-11,2019-04-24,2019-03-07,Disruption of the manufacture of the drug.,2018-12-13,2019-03-08
69460,2331705,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE XR,VENLAFAXINE,150.0MG,100 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-12-10,2018-12-11,,,Disruption of the manufacture of the drug.,2018-12-13,2019-09-16
86364,2331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,75.0MG,500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-06-10,2019-07-06,2019-06-21,Disruption of the manufacture of the drug.,2019-06-12,2019-06-24
82022,2331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE XR,VENLAFAXINE,75.0MG,500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-04-15,2019-06-07,2019-05-17,Disruption of the manufacture of the drug.,2019-04-18,2019-05-21
23658,2331705,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,150.0MG,500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-09-25,2018-03-07,2018-03-07,Disruption of the manufacture of the drug.,2017-09-27,2018-03-08
10442,2331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,75.0MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-05-15,2018-03-23,2018-03-07,Disruption of the manufacture of the drug.,2017-05-16,2018-03-08
89554,2331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-07-15,,,Disruption of the manufacture of the drug.,2019-07-17,2019-09-16
89557,2331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE XR,VENLAFAXINE,75.0MG,500 BTL,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-07-15,,,Disruption of the manufacture of the drug.,2019-07-17,2019-09-16
16886,2331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100 BTL & 500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-07-24,2018-03-23,2018-03-07,Disruption of the manufacture of the drug.,2017-07-25,2018-03-08
94203,2331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,APO-VENLAFAXINE,VENLAFAXINE,37.5MG,500 BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-09-17,,2019-11-15,Disruption of the manufacture of the drug.,2019-09-18,2019-11-16
260,2246894,Shortage,APO-VERAP SR,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,180MG,100 BTL and 500 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2015-04-17,,,Disruption of the manufacture of the drug.,2017-03-10,2017-10-05
552,2246893,Shortage,APO-VERAP SR,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2015-04-17,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
255,2246895,Shortage,APO-VERAP SR,APOTEX INC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,240MG,100 BTL and 500 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2014-03-19,,,Disruption of the manufacture of the drug.,2017-03-10,2017-10-05
47972,782483,Shortage,APO-VERAP TAB 80MG,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-04-30,2018-07-23,2018-07-11,Disruption of the manufacture of the drug.,2018-05-02,2018-07-12
78555,782483,Shortage,APO-VERAP TAB 80MG,APOTEX INC,VERAP TAB 80MG,VERAPAMIL HYDROCHLORIDE,80MG,100 BTL,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-03-11,2019-04-09,2019-04-04,Disruption of the manufacture of the drug.,2019-03-13,2019-04-05
98572,782491,Shortage,APO-VERAP TABLET 120MG,APOTEX INC,VERAP,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL,Actual shortage,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-11-11,2020-02-27,,Disruption of the manufacture of the drug.,2019-11-13,2019-11-13
85164,782491,Shortage,APO-VERAP TABLET 120MG,APOTEX INC,VERAP,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-05-27,2019-07-19,2019-07-04,Disruption of the manufacture of the drug.,2019-05-29,2019-07-05
76746,782491,Shortage,APO-VERAP TABLET 120MG,APOTEX INC,VERAPAMIL TAB,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-02-20,2019-04-12,2019-04-04,Disruption of the manufacture of the drug.,2019-02-24,2019-04-05
42714,782491,Shortage,APO-VERAP TABLET 120MG,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-03-12,,2018-07-11,Disruption of the manufacture of the drug.,2018-03-13,2018-07-12
55296,2409674,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,50MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2018-07-09,,2018-09-11,Disruption of the manufacture of the drug.,2018-07-11,2018-09-12
12088,2409674,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,50MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017-06-05,2017-08-31,2017-08-14,Disruption of the manufacture of the drug.,2017-06-06,2017-08-15
14073,2409682,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,200MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017-06-26,2017-08-31,2017-08-14,Disruption of the manufacture of the drug.,2017-06-27,2017-08-15
252,2409682,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,200MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2014-10-01,2017-03-16,2017-03-14,Disruption of the manufacture of the drug.,2017-03-10,2017-03-15
55293,2409682,Shortage,APO-VORICONAZOLE,APOTEX INC,VORICONAZOLE,VORICONAZOLE,200MG,30 BTL,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2018-07-09,,2018-09-11,Disruption of the manufacture of the drug.,2018-07-11,2018-09-12
695,2242927,Shortage,APO-WARFARIN,APOTEX INC,WARFARIN,WARFARIN SODIUM,4MG,100 BTL,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2017-03-22,2017-03-27,2017-06-12,2017-06-08,Disruption of the manufacture of the drug.,2017-03-12,2017-06-08
50162,2242927,Shortage,APO-WARFARIN,APOTEX INC,WARFARIN,WARFARIN SODIUM,4MG,100 BTL & 500 BTL,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2018-05-18,2018-06-26,2018-06-26,Disruption of the manufacture of the drug.,2018-05-24,2018-07-03
25646,2380951,Shortage,APO-ZOLMITRIPTAN,APOTEX INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6 BLS,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-10-09,,2018-02-23,Disruption of the manufacture of the drug.,2017-10-12,2018-02-26
25649,2381575,Shortage,APO-ZOLMITRIPTAN RAPID,APOTEX INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6 BLS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017-10-09,,2018-09-11,Disruption of the manufacture of the drug.,2017-10-12,2018-09-12
245,2436159,Shortage,APO-ZOLPIDEM ODT,APOTEX INC,Zolpidem,ZOLPIDEM TARTRATE,5MG,30 BLS,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2017-01-27,2017-04-10,2017-04-07,Disruption of the manufacture of the drug.,2017-03-10,2017-04-10
249,2434946,Shortage,APO-ZOLPIDEM ODT,APOTEX INC,ZOLPIDEM ODT,ZOLPIDEM TARTRATE,10MG,30 BLS,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2017-01-31,2017-04-14,2017-04-14,Disruption of the manufacture of the drug.,2017-03-10,2017-04-17
20915,2245077,Shortage,APO-ZOPICLONE,APOTEX INC,ZOPICLONE,ZOPICLONE,5MG,100 BTL,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017-10-27,2017-10-02,2018-02-12,2018-01-18,Disruption of the manufacture of the drug.,2017-09-05,2018-01-19
19558,2218313,Shortage,APO-ZOPICLONE - TAB 7.5MG,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017-08-16,2017-11-30,2017-10-18,Disruption of the manufacture of the drug.,2017-08-16,2017-10-19
59308,2218313,Shortage,APO-ZOPICLONE - TAB 7.5MG,APOTEX INC,ZOPLICONE,ZOPICLONE,7.5MG,100 BTL,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2018-08-27,2018-10-31,2018-10-03,Disruption of the manufacture of the drug.,2018-08-27,2018-10-05
20912,2218313,Shortage,APO-ZOPICLONE - TAB 7.5MG,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,500 BTL,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017-10-13,2017-09-25,2017-11-30,2017-10-17,Disruption of the manufacture of the drug.,2017-09-05,2017-10-18
74224,2375885,Shortage,APPRILON,GALDERMA CANADA INC,Doxycycline Monohydrate,DOXYCYCLINE,40MG,14 capsule blister cards in a carton of 2 cards (28 capsules),ORAL,Resolved,CAPSULE (IMMEDIATE AND DELAYED RELEASE),J01AA,TETRACYCLINES,,2019-01-14,2019-03-04,2019-03-04,Delay in shipping of the drug.,2019-02-01,2019-03-05
91935,723754,Shortage,APRESOLINE,STERIMAX INC,HYDRALAZINE HYDROCHLORIDE FOR INJECTION,HYDRALAZINE HYDROCHLORIDE,20MG,10 VIALS,INTRAVENOUS,Actual shortage,SOLUTION,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2019-08-21,,,Demand increase for the drug.,2019-08-19,2019-08-22
58938,723754,Shortage,APRESOLINE,STERIMAX INC,Hydralazine Hydrochloride for injection,HYDRALAZINE HYDROCHLORIDE,20MG,10 vials,INTRAVENOUS,Resolved,SOLUTION,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",2018-09-28,,,2019-02-27,Disruption of the manufacture of the drug.,2018-08-24,2019-02-28
10868,2317192,Shortage,APRI 21,TEVA CANADA LIMITED,DESOGESTREL ETHINYL ESTRADIOL,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,6,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017-05-15,2017-08-18,2017-09-15,Shortage of an inactive ingredient or component.,2017-05-23,2017-09-19
10871,2317206,Shortage,APRI 28,TEVA CANADA LIMITED,DESOGESTREL ETHINYL ESTRADIOL,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,6,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017-05-15,2017-08-04,2017-09-15,Shortage of an inactive ingredient or component.,2017-05-23,2017-09-19
92660,2317206,Shortage,APRI 28,TEVA CANADA LIMITED,APRI TABS,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,28,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-08-28,2019-10-31,2019-10-23,Disruption of the manufacture of the drug.,2019-08-29,2019-10-24
69680,2194066,Shortage,ARISTOCORT C,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT C,TRIAMCINOLONE ACETONIDE,0.5%,50g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2018-11-13,,2019-02-11,Other (Please describe in comments),2018-12-14,2019-02-12
93526,2194066,Shortage,ARISTOCORT C,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT C,TRIAMCINOLONE ACETONIDE,0.5%,15G,TOPICAL,Actual shortage,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2019-11-15,,2020-03-31,,Other (Please describe in comments),2019-09-10,2019-11-16
98658,2194066,Shortage,ARISTOCORT C,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT C,TRIAMCINOLONE ACETONIDE,0.5%,50g,TOPICAL,Anticipated shortage,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2019-12-31,,2020-03-31,,Other (Please describe in comments),2019-11-13,2019-11-13
67779,2194066,Shortage,ARISTOCORT C,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT C,TRIAMCINOLONE ACETONIDE,0.5%,15g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2018-12-17,,2019-02-11,Other (Please describe in comments),2018-11-28,2019-02-12
77831,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,500g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-03-14,,2019-06-18,Other (Please describe in comments),2019-03-05,2019-06-21
53257,2194031,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,30g tube,TOPICAL,Resolved,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",,2018-07-24,,2018-07-24,Other (Please describe in comments),2018-06-29,2018-08-10
96022,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,500g,TOPICAL,Actual shortage,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-10-22,2020-03-31,,Other (Please describe in comments),2019-10-10,2019-11-13
57902,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,tube 30g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2018-07-24,,2018-10-04,Other (Please describe in comments),2018-08-10,2018-10-05
93516,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,30g,TOPICAL,Actual shortage,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-08-19,2020-03-31,,Other (Please describe in comments),2019-09-10,2019-11-13
29518,2194031,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,na,TOPICAL,Resolved,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",,2017-11-17,2017-11-24,2017-11-30,Other (Please describe in comments),2017-11-17,2017-12-01
45142,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,30g tube,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2018-04-25,,2018-07-06,Other (Please describe in comments),2018-04-06,2018-07-09
93529,2194031,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,30g,TOPICAL,Actual shortage,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-11-06,2020-03-31,,Other (Please describe in comments),2019-09-10,2019-11-13
36995,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,na,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017-12-07,,,2018-02-02,Other (Please describe in comments),2018-01-23,2018-02-03
40851,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,500g jar,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017-12-07,,,2018-12-07,Other (Please describe in comments),2018-02-23,2018-12-14
56785,2194031,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,30g tube,TOPICAL,Resolved,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",,2018-07-20,,2018-10-04,Other (Please describe in comments),2018-07-27,2018-10-05
65746,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,30g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2018-10-29,,,2018-11-07,Other (Please describe in comments),2018-10-29,2018-11-09
73950,2194058,Shortage,ARISTOCORT R,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.1%,30g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-01-22,,2019-03-21,Other (Please describe in comments),2019-01-30,2019-03-22
5,2194155,Shortage,ARISTOSPAN,VALEO PHARMA INC,Triamcinolone Hexacetonide Suspension,TRIAMCINOLONE HEXACETONIDE,20 mg / mL,1 mL / vial,Intra-Articular,Resolved,Suspension,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2014-04-25,,2018-05-31,Disruption of the manufacture of the drug.,2017-03-10,2018-06-05
56322,2451700,Shortage,ARIXTRA,ASPEN PHARMACARE CANADA INC.,Arixtra 0.4 mL single use pre-filled syringe,FONDAPARINUX SODIUM,12.5MG,10,SUBCUTANEOUS,Actual shortage,SOLUTION,B01AX,ANTITHROMBOTIC AGENTS,,2014-01-01,,,Other (Please describe in comments),2018-07-24,2018-07-24
56325,2451719,Shortage,ARIXTRA,ASPEN PHARMACARE CANADA INC.,Arixtra 0.8 mL single use pre-filled syringe,FONDAPARINUX SODIUM,12.5MG,10,SUBCUTANEOUS,Actual shortage,SOLUTION,B01AX,ANTITHROMBOTIC AGENTS,,2014-01-01,,,Other (Please describe in comments),2018-07-24,2018-07-24
29404,2245531,Shortage,ARIXTRA,ASPEN PHARMACARE CANADA INC.,Arixtra® 2.5mg,FONDAPARINUX SODIUM,2.5MG,10 PF syringes,INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B01AX,ANTITHROMBOTIC AGENTS,2018-03-31,2018-03-31,2018-07-23,2018-07-13,Delay in shipping of the drug.,2017-11-16,2018-07-14
29407,2258056,Shortage,ARIXTRA,ASPEN PHARMACARE CANADA INC.,Arixtra® 7.5mg,FONDAPARINUX SODIUM,12.5MG,10 PF syringes,SUBCUTANEOUS,Resolved,SOLUTION,B01AX,ANTITHROMBOTIC AGENTS,2017-12-31,2017-12-31,2018-07-23,2018-07-20,Delay in shipping of the drug.,2017-11-16,2018-07-21
2443,1926713,Shortage,ARLIDIN TABLETS 6MG,ERFA CANADA 2012 INC,Nylidrin,Nylidrin Hydrochloride,6 mg,bottle,oral,Resolved,tablet,C04AA,PERIPHERALVASODILATORS,2015-01-19,2015-01-19,,2018-03-14,Disruption of the manufacture of the drug.,2017-03-14,2018-12-11
73493,2242705,Shortage,AROMASIN,PFIZER CANADA ULC,AROMASIN,EXEMESTANE,25MG,2x15 BLST,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-01-24,2019-03-13,2019-03-13,Demand increase for the drug.,2019-01-24,2019-03-14
4096,2381559,Shortage,ARZERRA,NOVARTIS PHARMACEUTICALS CANADA INC,ARZERRA 100MG VIALS,Ofatumumab,100MG,5ML X 3,INTRAVENOUS,Resolved,SOLUTION,L01XC,OTHER ANTINEOPLASTIC AGENTS,2017-08-01,2017-09-21,,2018-09-26,Other (Please describe in comments),2017-03-23,2018-10-17
4093,2381567,Shortage,ARZERRA,NOVARTIS PHARMACEUTICALS CANADA INC,Arzerra 1000MG VIALS,Ofatumumab,1000MG,50ML X 1,INTRAVENOUS,Resolved,SOLUTION,L01XC,OTHER ANTINEOPLASTIC AGENTS,,2017-02-28,,2018-09-26,Other (Please describe in comments),2017-03-23,2018-09-27
11291,2009013,Shortage,ASAPHEN,PHARMASCIENCE INC,ASAPHEN,ACETYLSALICYLIC ACID,80MG,500,ORAL,Resolved,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017-09-02,,2017-09-29,2017-09-15,Disruption of the manufacture of the drug.,2017-05-25,2017-09-19
7328,2009013,Shortage,ASAPHEN,PHARMASCIENCE INC,ASAPHEN 80 MG,ACETYLSALICYLIC ACID,80MG,100,ORAL,Resolved,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017-08-24,2017-08-24,2017-11-30,2017-10-25,Disruption of the manufacture of the drug.,2017-04-20,2017-10-26
98787,2009013,Shortage,ASAPHEN,PHARMASCIENCE INC,ASAPHEN,ACETYLSALICYLIC ACID,80MG,100,ORAL,Actual shortage,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2019-11-01,2019-12-10,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
13093,2238545,Shortage,ASAPHEN E.C.,PHARMASCIENCE INC,ASAPHEN 80MG,ACETYLSALICYLIC ACID,80MG,1000,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017-09-04,2017-09-04,,2017-06-21,Disruption of the manufacture of the drug.,2017-06-16,2017-10-12
8528,2238545,Shortage,ASAPHEN E.C.,PHARMASCIENCE INC,ASAPHEN,ACETYLSALICYLIC ACID,80MG,500,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017-07-07,2017-07-07,2017-08-21,2017-05-17,Demand increase for the drug.,2017-05-02,2017-10-12
13691,2238545,Shortage,ASAPHEN E.C.,PHARMASCIENCE INC,ASAPHEN EC,ACETYLSALICYLIC ACID,80MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2017-07-11,2017-07-11,,2018-05-04,Disruption of the manufacture of the drug.,2017-06-23,2018-05-05
42092,2238545,Shortage,ASAPHEN E.C. 80 MG,PHARMASCIENCE INC,ASAPHEN,ACETYLSALICYLIC ACID,80MG,1000,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,2018-04-25,2018-04-20,,2018-04-20,Disruption of the manufacture of the drug.,2018-03-07,2018-05-04
79783,2238545,Shortage,ASAPHEN E.C. 80 MG,PHARMASCIENCE INC,ASAPHEN,ACETYLSALICYLIC ACID,80MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2019-03-27,2019-05-01,2019-05-07,Disruption of the manufacture of the drug.,2019-03-28,2019-05-09
50479,2280167,Shortage,ASATAB 80 MG CHEWABLE TABLETS,ODAN LABORATORIES LTD,Acetylsalicylic acid tablets,ACETYLSALICYLIC ACID,80MG,100,ORAL,Resolved,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2018-06-29,2018-07-27,2018-07-25,Delay in shipping of the drug.,2018-05-28,2018-07-26
21898,2280167,Shortage,ASATAB 80 MG CHEWABLE TABLETS,ODAN LABORATORIES LTD,Acetylsalicylic Acid Chewable Tablets,ACETYLSALICYLIC ACID,80MG,100,ORAL,Resolved,TABLET (CHEWABLE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017-09-12,2017-10-20,2017-10-20,Demand increase for the drug.,2017-09-12,2017-10-21
1390,2352427,Shortage,ASATAB EC 325MG,ODAN LABORATORIES LTD,"Acetylsalicylic Acid Delayed Release Tablets, USP",ACETYLSALICYLIC ACID,325MG,100; 1000,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1407,2352435,Shortage,ASATAB EC 650MG,ODAN LABORATORIES LTD,"Acetylsalicylic Acid Delayed Release Tablets, USP",ACETYLSALICYLIC ACID,650MG,100; 1000,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
71291,2355981,Shortage,ASCOR L 500,MCGUFF PHARMACEUTICALS INC,"Ascorbic Acid Injection, USP",VITAMIN C,500MG,50 mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A11GA,"ASCORBIC ACID (VIT C), INCL COMBINATIONS",,2018-01-03,2019-05-31,2019-08-23,Other (Please describe in comments),2019-01-04,2019-09-13
61699,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60 dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-09-27,2018-09-24,2018-11-02,2018-10-25,Delay in shipping of the drug.,2018-09-17,2018-10-26
64262,2243595,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,200MCG,60 dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-10-22,2018-10-19,2018-11-16,2018-11-12,Delay in shipping of the drug.,2018-10-15,2018-11-13
53001,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60 dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-07-12,2018-07-11,2018-07-27,2018-07-17,Delay in shipping of the drug.,2018-06-26,2018-07-18
24866,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,30DOSE,INHALATION,Avoided shortage,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-10-30,,2017-11-17,2017-10-20,Delay in shipping of the drug.,2017-10-10,2017-10-20
31778,2438690,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,ASMANEX TWISTHALER,MOMETASONE FUROATE,100MCG,30DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-01-15,2018-01-02,2018-06-01,2018-05-31,Disruption of the manufacture of the drug.,2017-12-05,2018-06-01
56618,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-08-24,2018-08-24,2018-09-10,2018-08-30,Delay in shipping of the drug.,2018-07-26,2018-08-31
18787,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60 dose,INHALATION,Avoided shortage,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-09-06,,2017-09-21,2017-09-05,Disruption of the manufacture of the drug.,2017-08-11,2017-10-11
14711,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-07-05,2017-07-14,2017-07-07,Delay in shipping of the drug.,2017-07-05,2017-07-08
55419,2243595,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,200MCG,60 dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-07-11,2018-07-11,2018-11-09,2018-10-12,Disruption of the manufacture of the drug.,2018-07-11,2018-10-13
29052,2438690,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,100MCG,30DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-11-24,2017-12-04,2017-12-01,Delay in shipping of the drug.,2017-11-13,2017-12-02
65975,2438690,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,100MCG,30dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-11-09,2018-11-02,2019-03-01,2019-02-19,Demand increase for the drug.,2018-11-01,2019-02-20
48076,2243595,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,200MCG,60 dose,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-06-04,2018-06-04,2018-07-13,2018-07-09,Delay in shipping of the drug.,2018-05-02,2018-07-10
80590,2438690,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,100MCG,30dose,INHALATION,Actual shortage,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2019-11-06,2019-11-05,2020-02-14,,Demand increase for the drug.,2019-04-05,2019-11-06
24803,2243595,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,200MCG,60 DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-11-02,2017-11-01,2017-11-17,2017-11-13,Delay in shipping of the drug.,2017-10-10,2017-11-14
65522,2243596,Shortage,ASMANEX TWISTHALER,MERCK CANADA INC,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,30DOSE,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-11-02,2018-10-30,2018-11-23,2018-11-19,Requirements related to complying with good manufacturing practices.,2018-10-23,2018-11-20
74863,2311658,Shortage,ATACAND,ASTRAZENECA CANADA INC,candesartan cilexetil tablets,CANDESARTAN CILEXETIL,32MG,2 X 15 tablet blisters,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-02-12,,2019-03-15,2019-03-13,Other (Please describe in comments),2019-02-06,2019-03-14
78575,2239090,Shortage,ATACAND,ASTRAZENECA CANADA INC,candesartan cilexetil tablets,CANDESARTAN CILEXETIL,4MG,2 x 15 tablet blisters,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-03-21,,2019-04-15,2019-04-10,Other (Please describe in comments),2019-03-13,2019-04-11
71989,2244021,Shortage,ATACAND PLUS,ASTRAZENECA CANADA INC,candesartan cilexetil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,2 x 15 tablet blisters,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-18,2019-03-15,2019-03-13,Other (Please describe in comments),2019-01-11,2019-03-14
71992,2332957,Shortage,ATACAND PLUS,ASTRAZENECA CANADA INC,candesartan cilexetil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,2 X 15 tablet blisters,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-01-21,,2019-03-15,2019-03-13,Other (Please describe in comments),2019-01-11,2019-03-14
73737,2239092,Shortage,ATACAND TAB 16 MG,ASTRAZENECA CANADA INC,candesartan cilexetil tablets,CANDESARTAN CILEXETIL,16MG,2 x 15 tablet blisters,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-02-09,,2019-04-15,2019-04-10,Other (Please describe in comments),2019-01-28,2019-04-11
71981,2239091,Shortage,ATACAND TAB 8MG,ASTRAZENECA CANADA INC,candesartan cilexetil tablets,CANDESARTAN CILEXETIL,8MG,2 x 15 tablet blister,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-21,,2019-03-15,2019-03-13,Other (Please describe in comments),2019-01-11,2019-03-14
84229,24694,Shortage,ATARAX SYRUP 2MG/ML,ERFA CANADA 2012 INC,ATARAX,HYDROXYZINE HYDROCHLORIDE,2MG,473ML,ORAL,Resolved,SYRUP,N05BB,ANXIOLYTICS,2019-05-16,2019-05-15,2019-07-20,2019-08-09,Disruption of the manufacture of the drug.,2019-05-16,2019-08-23
28205,2238316,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-09-25,,2018-07-23,Other (Please describe in comments),2017-11-06,2018-07-24
28209,2238316,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-11-15,2017-11-27,,2018-07-23,Other (Please describe in comments),2017-11-06,2018-07-24
28212,2238316,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-07-24,,2018-07-23,Other (Please describe in comments),2017-11-06,2018-07-24
28215,2238318,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,100MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-11-01,,2018-07-23,Other (Please describe in comments),2017-11-06,2018-07-24
28218,2238318,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-09-15,,2018-07-23,Other (Please describe in comments),2017-11-06,2018-07-24
14152,828807,Shortage,ATENOLOL,PRO DOC LIMITEE,ATENOLOL,ATENOLOL,50MG,30-500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-10-17,,2018-03-09,Delay in shipping of the drug.,2017-06-28,2018-03-10
14161,828793,Shortage,ATENOLOL,PRO DOC LIMITEE,ATENOLOL,ATENOLOL,100MG,30-100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-10-19,,2018-03-09,Delay in shipping of the drug.,2017-06-28,2018-03-10
31935,2041464,Shortage,ATIVAN,PFIZER CANADA INC,ATIVAN,LORAZEPAM,1MG,1X100 TAB/BTL,SUBLINGUAL,Avoided shortage,TABLET,N05BA,ANXIOLYTICS,2017-12-14,,2017-12-18,2017-12-12,Disruption of the manufacture of the drug.,2017-12-06,2017-12-13
28375,2041448,Shortage,ATIVAN,PFIZER CANADA INC,ATIVAN,LORAZEPAM,2MG,100 TAB/BTL,ORAL,Avoided shortage,TABLET,N05BA,ANXIOLYTICS,2017-12-14,,2017-12-06,2017-12-06,Delay in shipping of the drug.,2017-11-06,2017-12-06
36910,2445948,Shortage,ATOMOXETINE,SIVEM PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-01-15,2018-03-16,2018-03-16,Demand increase for the drug.,2018-01-22,2018-03-17
6457,2396912,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,18MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-04-11,,2017-05-04,Delay in shipping of the drug.,2017-04-11,2017-05-05
6207,2396939,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-04-20,,2018-05-10,Delay in shipping of the drug.,2017-04-07,2018-05-11
76872,2467747,Shortage,ATOMOXETINE,SANIS HEALTH INC,ATOMOXETINE HCL 10MG,ATOMOXETINE,10MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2019-03-04,2019-03-04,2019-07-12,2019-07-19,Disruption of the manufacture of the drug.,2019-02-26,2019-07-20
77941,2467828,Shortage,ATOMOXETINE,SANIS HEALTH INC,ATOMOXETINE HCL 100MG,ATOMOXETINE,100MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2019-03-11,2019-03-11,2019-05-14,2019-05-03,Disruption of the manufacture of the drug.,2019-03-06,2019-05-04
4507,2396920,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-28,,2017-04-24,Delay in shipping of the drug.,2017-03-28,2017-04-25
80579,2396912,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,18MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-04-05,,2019-04-10,Delay in shipping of the drug.,2019-04-05,2019-04-11
85973,2445883,Shortage,ATOMOXETINE,SIVEM PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,10MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2019-06-17,2019-06-13,2019-06-28,2019-06-28,Delay in shipping of the drug.,2019-06-10,2019-06-29
52959,2445913,Shortage,ATOMOXETINE,SIVEM PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-07-09,2018-07-11,2018-07-27,2018-07-23,Delay in shipping of the drug.,2018-06-26,2018-07-31
9702,2396947,Shortage,ATOMOXETINE,PRO DOC LIMITEE,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-05-30,,2017-07-18,Delay in shipping of the drug.,2017-05-09,2017-07-19
98790,2399385,Shortage,ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,20MG,500,ORAL,Anticipated shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-12-16,,2020-03-02,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
65444,2466783,Shortage,ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS,GLENMARK PHARMACEUTICALS CANADA INC.,Atovaquone Proguanil Tablets,PROGUANIL HYDROCHLORIDE  ATOVAQUONE,100MG  250MG,12',ORAL,Resolved,TABLET,P01BB,ANTIMALARIALS,2018-10-23,2018-10-23,2018-11-09,2019-01-11,Delay in shipping of the drug.,2018-10-23,2019-01-12
56126,2299925,Shortage,ATRIANCE,NOVARTIS PHARMACEUTICALS CANADA INC,ATRIANCE INJ 5MG/ML 50ML X 6,NELARABINE,5MG,50ML X 6,INTRAVENOUS,Avoided shortage,SOLUTION,L01BB,ANTIMETABOLITES,2018-08-31,,2018-09-04,2018-08-28,Demand increase for the drug.,2018-07-20,2018-08-28
57885,2432188,Shortage,ATROPINE INJECTION BP,TELIGENT OU,ATROPINE INJECTION BP,ATROPINE SULFATE,0.4MG,1 mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A03BA,"BELLADONNAAND DERIVATIVES, PLAIN",,2018-07-16,2018-08-29,2018-08-23,Delay in shipping of the drug.,2018-08-10,2018-09-04
43076,328154,Shortage,ATROPINE SULFATE INJECTION USP,PFIZER CANADA INC,ATROPINE SULFATE LIFESHIELD,ATROPINE SULFATE,0.1MG,10 x 10mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A03BA,"BELLADONNAAND DERIVATIVES, PLAIN",,2018-05-25,,2018-07-13,Demand increase for the drug.,2018-03-16,2018-07-16
49017,328154,Shortage,ATROPINE SULFATE INJECTION USP,PFIZER CANADA INC,ATROPINE SULFATE LIFESHIELD,ATROPINE SULFATE,0.1MG,10 x 5mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A03BA,"BELLADONNAAND DERIVATIVES, PLAIN",,2018-06-06,,2018-07-13,Demand increase for the drug.,2018-05-10,2018-07-25
63646,328154,Shortage,ATROPINE SULFATE INJECTION USP,PFIZER CANADA INC,Atropine Sulfate Injection USP,ATROPINE SULFATE,0.1MG,10 x 5mL LifeShield,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,A03BA,"BELLADONNAAND DERIVATIVES, PLAIN",,2018-12-21,2019-12-16,,Disruption of the manufacture of the drug.,2018-10-10,2019-09-04
62377,328154,Shortage,ATROPINE SULFATE INJECTION USP,PFIZER CANADA INC,ATROPINE SULFATE INJECTION USP,ATROPINE SULFATE,0.1MG,10 x 10mL LifeShield,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A03BA,"BELLADONNAAND DERIVATIVES, PLAIN",,2018-11-16,,2019-02-15,Disruption of the manufacture of the drug.,2018-09-26,2019-02-16
86516,328154,Shortage,ATROPINE SULFATE INJECTION USP,PFIZER CANADA ULC,Atropine Sulfate Injection USP,ATROPINE SULFATE,0.1MG,10 x 10mL LifeShield,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,A03BA,"BELLADONNAAND DERIVATIVES, PLAIN",,2019-06-11,2019-12-16,,Disruption of the manufacture of the drug.,2019-06-12,2019-09-04
85734,2332477,Shortage,AURALGAN,PALADIN LABS INC,Auralgan (Antipyrine/Benzocaine),ANTIPYRINE  BENZOCAINE,54MG  14MG,14mL,OTIC,Actual shortage,SOLUTION,S02DA,OTHER OTOLOGICALS,,2019-08-19,2019-12-04,,Disruption of the manufacture of the drug.,2019-06-06,2019-11-13
93077,2454513,Shortage,AURO-ABACAVIR/LAMIVUDINE,AURO PHARMA INC,abacavir; Lamivudine,ABACAVIR  LAMIVUDINE,600MG  300MG,30,ORAL,Actual shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-09-04,,,Demand increase for the drug.,2019-09-05,2019-11-11
70316,2454513,Shortage,AURO-ABACAVIR/LAMIVUDINE,AURO PHARMA INC,abacavir; Lamivudine,ABACAVIR  LAMIVUDINE,600MG  300MG,30,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2018-12-20,,2019-03-12,Delay in shipping of the drug.,2018-12-21,2019-03-13
96271,2388553,Shortage,AURO-ALENDRONATE,AURO PHARMA INC,Alendronic Acid,ALENDRONIC ACID,70MG,1x4,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-10-09,,,Delay in shipping of the drug.,2019-10-11,2019-11-11
47443,2388545,Shortage,AURO-ALENDRONATE,AURO PHARMA INC,Alendronic Acid,ALENDRONIC ACID,10MG,100,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-09-04,2019-12-30,,Delay in shipping of the drug.,2018-04-30,2019-10-24
47445,2388545,Shortage,AURO-ALENDRONATE,AURO PHARMA INC,Alendronate,ALENDRONIC ACID,10MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-03-30,,2018-05-18,2018-05-31,Shortage of an active ingredient.,2018-04-30,2018-07-12
47452,2388553,Shortage,AURO-ALENDRONATE,AURO PHARMA INC,Alendronate,ALENDRONIC ACID,70MG,1x4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-03-30,2018-05-18,2018-05-31,Shortage of an active ingredient.,2018-04-30,2018-07-12
61708,2388073,Shortage,AURO-AMOXICILLIN,AURO PHARMA INC,Amoxicillin,AMOXICILLIN,250MG,100 & 500,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-09-17,,2018-10-01,Delay in shipping of the drug.,2018-09-17,2018-10-02
75693,2460025,Shortage,AURO-ARIPIPRAZOLE,AURO PHARMA INC,Aripiprazole,ARIPIPRAZOLE,2MG,30 & 100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-02-12,,2019-02-27,Demand increase for the drug.,2019-02-13,2019-02-28
97180,2471493,Shortage,AURO-ATOMOXETINE,AURO PHARMA INC,Atomoxetine,ATOMOXETINE,18MG,30 & 100,ORAL,Actual shortage,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-10-23,,,Demand increase for the drug.,2019-10-24,2019-10-24
95248,2407280,Shortage,AURO-ATORVASTATIN,AURO PHARMA INC,Atorvastatin,ATORVASTATIN,80MG,90 & 500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-30,,2019-10-09,Demand increase for the drug.,2019-10-02,2019-10-11
67350,2407264,Shortage,AURO-ATORVASTATIN,AURO PHARMA INC,Atorvastatin,ATORVASTATIN,20MG,90 & 500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-11-21,,2018-12-04,Demand increase for the drug.,2018-11-21,2018-12-05
66856,2407272,Shortage,AURO-ATORVASTATIN,AURO PHARMA INC,Atorvastatin,ATORVASTATIN,40MG,90 & 500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-11-13,,2018-12-04,Demand increase for the drug.,2018-11-13,2018-12-05
77099,2407256,Shortage,AURO-ATORVASTATIN,AURO PHARMA INC,Atorvastatin,ATORVASTATIN,10MG,90 & 500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-02-27,,2019-03-07,Demand increase for the drug.,2019-02-28,2019-03-08
63041,2407256,Shortage,AURO-ATORVASTATIN,AURO PHARMA INC,Atorvastatin,ATORVASTATIN,10MG,90 & 500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-10-03,,2018-11-12,Delay in shipping of the drug.,2018-10-03,2018-11-13
97183,2407280,Shortage,AURO-ATORVASTATIN,AURO PHARMA INC,Atorvastatin,ATORVASTATIN,80MG,90 & 500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-23,2019-12-15,,Demand increase for the drug.,2019-10-24,2019-11-11
91692,2449153,Shortage,AURO-BETAHISTINE,AURO PHARMA INC,Betahistine Hydrochloride,BETAHISTINE HYDROCHLORIDE,16MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2019-08-15,,2019-09-04,Delay in shipping of the drug.,2019-08-16,2019-09-05
21037,2449153,Shortage,AURO-BETAHISTINE,AURO PHARMA INC,Betahistine,BETAHISTINE HYDROCHLORIDE,16MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017-08-28,2017-10-16,2018-04-30,Demand increase for the drug.,2017-09-05,2018-05-01
93084,2449145,Shortage,AURO-BETAHISTINE,AURO PHARMA INC,Betahistine Hydrochloride,BETAHISTINE HYDROCHLORIDE,8MG,100,ORAL,Actual shortage,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2019-09-04,2019-12-15,,Demand increase for the drug.,2019-09-05,2019-11-11
97188,2449153,Shortage,AURO-BETAHISTINE,AURO PHARMA INC,Betahistine Hydrochloride,BETAHISTINE HYDROCHLORIDE,16MG,100,ORAL,Actual shortage,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2019-10-23,2019-12-15,,Demand increase for the drug.,2019-10-24,2019-11-11
67353,2445786,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,CANDESARTAN CILEXETIL,4MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-21,,2019-02-12,Requirements related to complying with good manufacturing practices.,2018-11-21,2019-02-13
67356,2445794,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,CANDESARTAN CILEXETIL,8MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-21,,2019-03-28,Demand increase for the drug.,2018-11-21,2019-03-29
78626,2445808,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,CANDESARTAN CILEXETIL,16MG,90,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-21,,,Demand increase for the drug.,2019-03-13,2019-06-21
78628,2445808,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,,,90,,Resolved,,,,,2019-03-13,,2019-03-28,Demand increase for the drug.,2019-03-13,2019-03-29
78631,2445816,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,,,90,,Resolved,,,,,2019-03-13,,2019-03-28,Demand increase for the drug.,2019-03-13,2019-03-29
77102,2445786,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,CANDESARTAN CILEXETIL,4MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-27,,2019-04-04,Demand increase for the drug.,2019-02-28,2019-04-05
81461,2445794,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,CANDESARTAN CILEXETIL,8MG,90,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-11,,,Demand increase for the drug.,2019-04-11,2019-05-24
84701,2445786,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,CANDESARTAN CILEXETIL,4MG,90,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-24,,,Demand increase for the drug.,2019-05-24,2019-05-25
84720,2445816,Shortage,AURO-CANDESARTAN,AURO PHARMA INC,Candesartan Cilexetil,CANDESARTAN CILEXETIL,32MG,90,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-24,,,Demand increase for the drug.,2019-05-24,2019-05-25
85514,2421054,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,hydrochlorothiazide; candesartan cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-06-03,,,Demand increase for the drug.,2019-06-04,2019-06-04
56339,2421054,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,hydrochlorothiazide; candesartan cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-07-25,,2018-08-29,Demand increase for the drug.,2018-07-24,2018-08-30
21040,2421046,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,Candesartan HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-08-08,2017-12-15,2018-05-02,Other (Please describe in comments),2017-09-05,2018-05-03
63044,2421046,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,hydrochlorothiazide; candesartan cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-03,,2018-10-15,Demand increase for the drug.,2018-10-03,2018-10-16
90199,2421038,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,hydrochlorothiazide; candesartan cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-07-29,,,Demand increase for the drug.,2019-07-30,2019-07-30
47473,2421038,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-03-30,,2018-05-18,2018-07-12,Shortage of an active ingredient.,2018-04-30,2018-07-13
47476,2421054,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-03-30,,2018-05-18,Shortage of an active ingredient.,2018-04-30,2018-05-19
74160,2421046,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,hydrochlorothiazide; candesartan cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-29,,2019-03-28,Demand increase for the drug.,2019-02-01,2019-03-29
74163,2421054,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,hydrochlorothiazide; candesartan cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-29,,2019-03-28,Demand increase for the drug.,2019-02-01,2019-03-29
90585,2421046,Shortage,AURO-CANDESARTAN HCT,AURO PHARMA INC,hydrochlorothiazide; candesartan cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-07-31,,,Demand increase for the drug.,2019-08-01,2019-08-01
95251,2418495,Shortage,AURO-CARVEDILOL,AURO PHARMA INC,Carvedilol,CARVEDILOL,3.125MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-09-30,,2019-10-09,Demand increase for the drug.,2019-10-02,2019-10-11
90202,2418509,Shortage,AURO-CARVEDILOL,AURO PHARMA INC,Carvedilol,CARVEDILOL,6.25MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-07-29,,2019-09-16,Delay in shipping of the drug.,2019-07-30,2019-09-18
98437,2418495,Shortage,AURO-CARVEDILOL,AURO PHARMA INC,Carvedilol,CARVEDILOL,3.125MG,100,ORAL,Actual shortage,TABLET,C07AG,BETA BLOCKING AGENTS,,2019-11-09,2019-11-25,,Demand increase for the drug.,2019-11-11,2019-11-11
84269,2445689,Shortage,AURO-CELECOXIB,AURO PHARMA INC,Celecoxib,CELECOXIB,200MG,100 & 500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-05-17,,2019-05-23,Delay in shipping of the drug.,2019-05-17,2019-05-24
64010,2470586,Shortage,AURO-CEPHALEXIN,AURO PHARMA INC,Cephalexin,CEPHALEXIN,500MG,100 & 500,ORAL,Resolved,TABLET,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-10-11,,2018-11-21,Delay in shipping of the drug.,2018-10-12,2018-11-22
79192,2470578,Shortage,AURO-CEPHALEXIN,AURO PHARMA INC,Cephalexin,CEPHALEXIN,250MG,100,ORAL,Actual shortage,TABLET,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-03-21,,,Other (Please describe in comments),2019-03-22,2019-03-22
79195,2470586,Shortage,AURO-CEPHALEXIN,AURO PHARMA INC,Cephalexin,CEPHALEXIN,500MG,100 & 500,ORAL,Actual shortage,TABLET,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-03-21,,,Other (Please describe in comments),2019-03-22,2019-03-22
64013,2275570,Shortage,AURO-CITALOPRAM,AURO PHARMA INC,Citalopram,CITALOPRAM,40MG,30 & 100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-10-11,,2018-12-20,Demand increase for the drug.,2018-10-12,2018-12-21
90206,2436906,Shortage,AURO-CLINDAMYCIN,AURO PHARMA INC,Clindamycin,CLINDAMYCIN,150MG,100,ORAL,Actual shortage,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-07-29,2019-12-25,,Demand increase for the drug.,2019-07-30,2019-11-11
8822,2436914,Shortage,AURO-CLINDAMYCIN,AURO PHARMA INC,Clindamycin,CLINDAMYCIN HYDROCHLORIDE,300MG,100 bottle,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017-05-04,,2017-08-15,2017-09-01,Other (Please describe in comments),2017-05-03,2017-09-05
98442,2436914,Shortage,AURO-CLINDAMYCIN,AURO PHARMA INC,Clindamycin,CLINDAMYCIN,300MG,100,ORAL,Actual shortage,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-11-09,2019-12-10,,Demand increase for the drug.,2019-11-11,2019-11-11
93087,2436914,Shortage,AURO-CLINDAMYCIN,AURO PHARMA INC,Clindamycin,CLINDAMYCIN,300MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-09-04,,2019-10-22,Demand increase for the drug.,2019-09-05,2019-10-24
63239,2436655,Shortage,AURO-DULOXETINE,AURO PHARMA INC,Duloxetine,DULOXETINE,60MG,30 & 100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-10-03,,2019-01-21,Delay in shipping of the drug.,2018-10-03,2019-01-22
64018,2436647,Shortage,AURO-DULOXETINE,AURO PHARMA INC,Duloxetine,DULOXETINE,30MG,30 & 100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-10-11,,2019-01-21,Delay in shipping of the drug.,2018-10-12,2019-01-22
70297,2469308,Shortage,AURO-DUTASTERIDE,AURO PHARMA INC,Dutasteride,DUTASTERIDE,0.5MG,30 & 100,ORAL,Actual shortage,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-12-20,,,Demand increase for the drug.,2018-12-21,2019-09-18
64698,2469308,Shortage,AURO-DUTASTERIDE,AURO PHARMA INC,Dutasteride,DUTASTERIDE,0.5MG,30 & 100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-10-17,,2018-12-12,Demand increase for the drug.,2018-10-18,2018-12-13
61711,2418428,Shortage,AURO-EFAVIRENZ,AURO PHARMA INC,Efavirenz,EFAVIRENZ,600MG,30,ORAL,Resolved,TABLET,J05AG,DIRECT ACTING ANTIVIRALS,,2018-09-17,,2018-10-09,Delay in shipping of the drug.,2018-09-17,2018-10-10
96275,2425157,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,GALANTAMINE (GALANTAMINE HYDROBROMIDE),GALANTAMINE,8MG,30 & 100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-10-09,,,Demand increase for the drug.,2019-10-11,2019-11-11
64021,2425173,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,galantamine hydrobromide,GALANTAMINE,24MG,30 & 100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2018-10-11,,2018-12-27,Delay in shipping of the drug.,2018-10-12,2018-12-28
96278,2425165,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,GALANTAMINE (GALANTAMINE HYDROBROMIDE),GALANTAMINE,16MG,30 & 100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-10-09,,,Demand increase for the drug.,2019-10-11,2019-11-11
58190,2425165,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,galantamine hydrobromide,GALANTAMINE,16MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2018-08-15,,2018-10-10,Delay in shipping of the drug.,2018-08-15,2018-10-11
64664,2406101,Shortage,AURO-IRBESARTAN,AURO PHARMA INC,Irbesartan,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-17,,,Requirements related to complying with good manufacturing practices.,2018-10-18,2018-10-18
64667,2406128,Shortage,AURO-IRBESARTAN,AURO PHARMA INC,Irbesartan,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-17,,,Requirements related to complying with good manufacturing practices.,2018-10-18,2018-10-18
64672,2406098,Shortage,AURO-IRBESARTAN,AURO PHARMA INC,Irbesartan,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-17,,,Requirements related to complying with good manufacturing practices.,2018-10-18,2018-10-18
61705,2447886,Shortage,AURO-IRBESARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Irbesartan,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,90,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-09-17,,,Requirements related to complying with good manufacturing practices.,2018-09-17,2018-10-18
57239,2447878,Shortage,AURO-IRBESARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Irbesartan,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,90,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-01,2018-08-11,2018-08-07,Delay in shipping of the drug.,2018-08-01,2018-08-08
57246,2447886,Shortage,AURO-IRBESARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Irbesartan,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,90,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-01,,2018-08-27,Delay in shipping of the drug.,2018-08-01,2018-08-28
57249,2447894,Shortage,AURO-IRBESARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Irbesartan,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,90,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-01,2018-08-11,2018-08-07,Delay in shipping of the drug.,2018-08-01,2018-08-08
64675,2447878,Shortage,AURO-IRBESARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Irbesartan,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,90,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-17,,,Requirements related to complying with good manufacturing practices.,2018-10-18,2018-10-18
64682,2447894,Shortage,AURO-IRBESARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Irbesartan,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,90,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-17,,,Requirements related to complying with good manufacturing practices.,2018-10-18,2018-10-18
82995,2475340,Shortage,AURO-LACOSAMIDE,AURO PHARMA INC,Lacosamide,LACOSAMIDE,100MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-05-01,,2019-05-31,Demand increase for the drug.,2019-05-02,2019-06-03
79967,2475332,Shortage,AURO-LACOSAMIDE,AURO PHARMA INC,AURO-LACOSAMIDE,LACOSAMIDE,50MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-28,,2019-05-31,Demand increase for the drug.,2019-03-29,2019-06-03
90209,2475340,Shortage,AURO-LACOSAMIDE,AURO PHARMA INC,Lacosamide,LACOSAMIDE,100MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-08-02,,2019-09-30,Delay in shipping of the drug.,2019-07-30,2019-10-01
75702,2475332,Shortage,AURO-LACOSAMIDE,AURO PHARMA INC,Lacosamide,LACOSAMIDE,50MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-02-11,,2019-02-27,Demand increase for the drug.,2019-02-13,2019-02-28
3624,2394472,Shortage,AURO-LISINOPRIL,AURO PHARMA INC,Lisinopril,LISINOPRIL,5MG,100 and 500 bottle,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-16,,2018-11-12,Disruption of the manufacture of the drug.,2017-03-20,2018-11-13
3644,2394480,Shortage,AURO-LISINOPRIL,AURO PHARMA INC,LISINOPRIL,LISINOPRIL,10MG,100 and 500 bottle,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-16,,2018-05-02,Disruption of the manufacture of the drug.,2017-03-20,2018-05-03
57254,2394480,Shortage,AURO-LISINOPRIL,AURO PHARMA INC,Lisinopril,LISINOPRIL,10MG,100 & 500,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-02,,2018-11-12,Delay in shipping of the drug.,2018-08-01,2018-11-13
57257,2394499,Shortage,AURO-LISINOPRIL,AURO PHARMA INC,Lisinopril,LISINOPRIL,20MG,100 & 500,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-02,,2018-11-12,Delay in shipping of the drug.,2018-08-01,2018-11-13
63242,2403358,Shortage,AURO-LOSARTAN,AURO PHARMA INC,Losartan Potassium,LOSARTAN POTASSIUM,100.0MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-03,,2018-10-10,Demand increase for the drug.,2018-10-03,2018-10-11
67366,2403358,Shortage,AURO-LOSARTAN,AURO PHARMA INC,Losartan Potassium,LOSARTAN POTASSIUM,100.0MG,30 & 100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-21,,,Demand increase for the drug.,2018-11-21,2019-02-28
68135,2403331,Shortage,AURO-LOSARTAN,AURO PHARMA INC,Losartan Potassium,LOSARTAN POTASSIUM,50.0MG,30 & 100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-29,,,Demand increase for the drug.,2018-11-29,2019-02-28
70897,2403323,Shortage,AURO-LOSARTAN,AURO PHARMA INC,Losartan Potassium,LOSARTAN POTASSIUM,25.0MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-08,,,Demand increase for the drug.,2019-01-03,2019-02-28
97294,2423669,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30 & 100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-25,,,Demand increase for the drug.,2019-10-25,2019-10-26
64024,2423669,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-11,,2018-10-17,Demand increase for the drug.,2018-10-12,2018-10-18
56361,2423642,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-07-25,2018-08-07,2018-08-07,Demand increase for the drug.,2018-07-24,2018-08-08
66860,2423669,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-13,,2018-12-04,Demand increase for the drug.,2018-11-13,2018-12-05
56364,2423669,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-07-25,2018-08-08,2018-08-07,Demand increase for the drug.,2018-07-24,2018-08-08
77117,2423642,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30 & 100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-02-27,,,Demand increase for the drug.,2019-02-28,2019-02-28
77120,2423650,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-02-27,,2019-09-04,Demand increase for the drug.,2019-02-28,2019-09-05
77123,2423669,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-02-27,,2019-09-04,Demand increase for the drug.,2019-02-28,2019-09-05
72017,2423650,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-11,,2019-01-31,Demand increase for the drug.,2019-01-11,2019-02-01
97195,2423650,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30 & 100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-23,,,Demand increase for the drug.,2019-10-24,2019-10-24
57260,2423650,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-01,2018-08-08,2018-08-07,Delay in shipping of the drug.,2018-08-01,2018-08-08
64685,2423642,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-17,,2018-11-12,Demand increase for the drug.,2018-10-18,2018-11-13
64688,2423650,Shortage,AURO-LOSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Losartan Potassium,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30 & 100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-17,,2018-11-12,Demand increase for the drug.,2018-10-18,2018-11-13
74174,2299836,Shortage,AURO-MIRTAZAPINE OD,AURO PHARMA INC,Mirtazapine,MIRTAZAPINE,45MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,,2019-01-31,,2019-02-27,Demand increase for the drug.,2019-02-01,2019-02-28
70903,2299801,Shortage,AURO-MIRTAZAPINE OD,AURO PHARMA INC,Mirtazapine,MIRTAZAPINE,15MG,5X6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,,2019-01-14,,2019-02-12,Delay in shipping of the drug.,2019-01-03,2019-02-13
3655,2430487,Shortage,AURO-MODAFINIL,AURO PHARMA INC,MODAFINIL,MODAFINIL,100MG,30,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-16,2017-04-07,2017-09-01,Delay in shipping of the drug.,2017-03-20,2018-04-30
67369,2401274,Shortage,AURO-MONTELUKAST,AURO PHARMA INC,Montelukast,MONTELUKAST,10MG,30 & 90,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-11-21,,2018-12-21,Delay in shipping of the drug.,2018-11-21,2018-12-22
56343,2448726,Shortage,AURO-OLANZAPINE ODT,AURO PHARMA INC,OLANZAPINE,OLANZAPINE,5MG,3X10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-07-25,,,Disruption of the manufacture of the drug.,2018-07-24,2019-01-24
56346,2448734,Shortage,AURO-OLANZAPINE ODT,AURO PHARMA INC,OLANZAPINE,OLANZAPINE,10MG,3X10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-07-25,,,Disruption of the manufacture of the drug.,2018-07-24,2019-01-24
56349,2448742,Shortage,AURO-OLANZAPINE ODT,AURO PHARMA INC,OLANZAPINE,OLANZAPINE,15MG,3X10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-07-25,,,Disruption of the manufacture of the drug.,2018-07-24,2019-01-24
56352,2448750,Shortage,AURO-OLANZAPINE ODT,AURO PHARMA INC,OLANZAPINE,OLANZAPINE,20MG,3X10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-07-25,,,Disruption of the manufacture of the drug.,2018-07-24,2019-01-24
79970,2443872,Shortage,AURO-OLMESARTAN,AURO PHARMA INC,Olmesartan Medoxil,OLMESARTAN MEDOXOMIL,40MG,30 & 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-04,,2019-05-24,Demand increase for the drug.,2019-03-29,2019-05-25
85093,2443864,Shortage,AURO-OLMESARTAN,AURO PHARMA INC,Olmesartan Medoxil,OLMESARTAN MEDOXOMIL,20MG,"30, 100 & 500",ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-28,,,Demand increase for the drug.,2019-05-28,2019-09-18
85098,2443872,Shortage,AURO-OLMESARTAN,AURO PHARMA INC,Olmesartan Medoxil,OLMESARTAN MEDOXOMIL,40MG,"30, 100 & 500",ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-28,,,Demand increase for the drug.,2019-05-28,2019-07-05
73461,2443872,Shortage,AURO-OLMESARTAN,AURO PHARMA INC,Olmesartan Medoxil,OLMESARTAN MEDOXOMIL,40MG,"30, 100 & 500",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-15,,2019-02-27,Demand increase for the drug.,2019-01-24,2019-02-28
47467,2415208,Shortage,AURO-PANTOPRAZOLE,AURO PHARMA INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 & 500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-03-30,2018-03-30,,2018-09-05,Shortage of an active ingredient.,2018-04-30,2018-09-06
61701,2383276,Shortage,AURO-PAROXETINE,AURO PHARMA INC,Paroxetine,PAROXETINE,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-09-17,,2018-11-12,Delay in shipping of the drug.,2018-09-17,2018-11-13
64044,2424096,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,Pramipexole Dihydrochloride monohydrate,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-10-12,,2018-12-11,Demand increase for the drug.,2018-10-12,2018-12-12
63024,2424088,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,Pramipexole Dihydrochloride monohydrate,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-10-03,,2018-12-11,Demand increase for the drug.,2018-10-03,2018-12-12
72020,2424096,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,Pramipexole Dihydrochloride monohydrate,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-01-11,,2019-04-23,Demand increase for the drug.,2019-01-11,2019-04-24
57269,2424061,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,Pramipexole Dihydrochloride monohydrate,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-08-01,,2018-10-12,Demand increase for the drug.,2018-08-01,2018-10-13
70329,2424096,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,Pramipexole Dihydrochloride monohydrate,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-12-20,2019-01-07,2019-01-07,Demand increase for the drug.,2018-12-21,2019-01-08
64709,2424118,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,Pramipexole Dihydrochloride monohydrate,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-10-19,,,2018-11-12,Demand increase for the drug.,2018-10-18,2018-11-13
70909,2424088,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,Pramipexole Dihydrochloride monohydrate,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-01-02,,2019-04-18,Demand increase for the drug.,2019-01-03,2019-04-22
93099,2458977,Shortage,AURO-PRAVASTATIN,AURO PHARMA INC,Pravastatin Sodium,PRAVASTATIN SODIUM,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-04,2019-12-30,,Demand increase for the drug.,2019-09-05,2019-11-11
93102,2458985,Shortage,AURO-PRAVASTATIN,AURO PHARMA INC,Pravastatin Sodium,PRAVASTATIN SODIUM,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-04,2019-12-30,,Demand increase for the drug.,2019-09-05,2019-11-11
93107,2458993,Shortage,AURO-PRAVASTATIN,AURO PHARMA INC,Pravastatin Sodium,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-04,2019-12-30,,Demand increase for the drug.,2019-09-05,2019-11-11
61696,2433877,Shortage,AURO-PREGABALIN,AURO PHARMA INC,Pregabalin,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-09-17,,2019-07-04,Delay in shipping of the drug.,2018-09-17,2019-07-05
56358,2433877,Shortage,AURO-PREGABALIN,AURO PHARMA INC,Pregabalin,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-07-25,,2018-07-31,Demand increase for the drug.,2018-07-24,2018-08-01
21034,2433877,Shortage,AURO-PREGABALIN,AURO PHARMA INC,Pregabalin,PREGABALIN,50MG,100 bottle,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-28,2017-10-31,2018-04-30,Demand increase for the drug.,2017-09-05,2018-05-01
63051,2433907,Shortage,AURO-PREGABALIN,AURO PHARMA INC,Pregabalin,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-10-03,,2019-07-04,Demand increase for the drug.,2018-10-03,2019-07-05
97204,2390256,Shortage,AURO-QUETIAPINE,AURO PHARMA INC,Quetiapine,QUETIAPINE,300MG,100 & 500,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-10-23,2019-12-30,,Disruption of the manufacture of the drug.,2019-10-24,2019-10-24
89540,2390205,Shortage,AURO-QUETIAPINE,AURO PHARMA INC,Quetiapine,QUETIAPINE,25MG,100 & 500,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-07-16,2019-12-15,,Disruption of the manufacture of the drug.,2019-07-17,2019-10-21
96284,2473305,Shortage,AURO-QUINAPRIL HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Quinapril (Quinapril Hydrochloride),HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  20MG,28 & 90,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-10-09,2019-12-30,,Demand increase for the drug.,2019-10-11,2019-10-24
96291,2473321,Shortage,AURO-QUINAPRIL HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Quinapril (Quinapril Hydrochloride),HYDROCHLOROTHIAZIDE  QUINAPRIL,25MG  20MG,28 & 90,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-10-09,2019-12-30,,Demand increase for the drug.,2019-10-11,2019-10-24
91018,2473305,Shortage,AURO-QUINAPRIL HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Quinapril (Quinapril Hydrochloride),HYDROCHLOROTHIAZIDE  QUINAPRIL,12.5MG  20MG,28 & 90,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-08-06,,2019-09-04,Demand increase for the drug.,2019-08-06,2019-09-05
91021,2473321,Shortage,AURO-QUINAPRIL HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Quinapril (Quinapril Hydrochloride),HYDROCHLOROTHIAZIDE  QUINAPRIL,25MG  20MG,28 & 90,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-08-06,,2019-09-04,Demand increase for the drug.,2019-08-06,2019-09-05
96296,2424274,Shortage,AURO-REPAGLINIDE,AURO PHARMA INC,Repaglinide,REPAGLINIDE,2MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-10-09,,2019-10-23,Demand increase for the drug.,2019-10-11,2019-10-24
96299,2424258,Shortage,AURO-REPAGLINIDE,AURO PHARMA INC,Repaglinide,REPAGLINIDE,0.5MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-10-09,,2019-11-09,Demand increase for the drug.,2019-10-11,2019-11-11
63057,2424274,Shortage,AURO-REPAGLINIDE,AURO PHARMA INC,Repaglinide,REPAGLINIDE,2MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-10-03,,2018-10-09,Demand increase for the drug.,2018-10-03,2018-10-10
72027,2424266,Shortage,AURO-REPAGLINIDE,AURO PHARMA INC,Repaglinide,REPAGLINIDE,1MG,100,ORAL,Actual shortage,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-01-11,2019-11-25,,Demand increase for the drug.,2019-01-11,2019-11-11
93090,2424274,Shortage,AURO-REPAGLINIDE,AURO PHARMA INC,Repaglinide,REPAGLINIDE,2MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-09-04,,2019-09-30,Demand increase for the drug.,2019-09-05,2019-10-01
77944,2442760,Shortage,AURO-RISEDRONATE,AURO PHARMA INC,Risedronate sodium,RISEDRONATE SODIUM,150MG,1,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-03-05,,,Disruption of the manufacture of the drug.,2019-03-06,2019-03-06
87274,2406306,Shortage,AURO-RISEDRONATE,AURO PHARMA INC,Risedronate sodium,RISEDRONATE SODIUM,35MG,1x4,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-06-21,2019-12-30,,Demand increase for the drug.,2019-06-21,2019-10-24
57278,2441144,Shortage,AURO-RIZATRIPTAN,AURO PHARMA INC,Rizatriptan,RIZATRIPTAN,10MG,1x6 & 2x6,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-08-01,,,Disruption of the manufacture of the drug.,2018-08-01,2019-03-06
70916,2442582,Shortage,AURO-ROSUVASTATIN,AURO PHARMA INC,Rosuvastatin,ROSUVASTATIN,10MG,90 & 500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-01-02,,2019-01-11,Demand increase for the drug.,2019-01-03,2019-01-12
3665,2442590,Shortage,AURO-ROSUVASTATIN,AURO PHARMA INC,ROSUVASTATIN,ROSUVASTATIN,20MG,90 and 500 bottle,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-16,2017-04-07,2017-09-01,Delay in shipping of the drug.,2017-03-20,2017-09-05
63066,2442582,Shortage,AURO-ROSUVASTATIN,AURO PHARMA INC,Rosuvastatin,ROSUVASTATIN,10MG,90 & 500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-10-03,,2018-11-12,Demand increase for the drug.,2018-10-03,2018-11-13
47455,2390906,Shortage,AURO-SERTRALINE,AURO PHARMA INC,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-03-30,2018-06-25,2018-07-12,Shortage of an active ingredient.,2018-04-30,2018-07-13
47458,2390914,Shortage,AURO-SERTRALINE,AURO PHARMA INC,SERTRALINE,SERTRALINE,50MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-03-30,,2018-06-25,2018-07-12,Shortage of an active ingredient.,2018-04-30,2018-07-13
57309,2390914,Shortage,AURO-SERTRALINE,AURO PHARMA INC,Sertraline,SERTRALINE,50MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-08-01,,2018-10-02,Delay in shipping of the drug.,2018-08-01,2018-10-03
57312,2390922,Shortage,AURO-SERTRALINE,AURO PHARMA INC,Sertraline,SERTRALINE,100MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-08-01,,2018-10-02,Delay in shipping of the drug.,2018-08-01,2018-10-03
56336,2405180,Shortage,AURO-SIMVASTATIN,AURO PHARMA INC,SIMVASTATIN,SIMVASTATIN,80MG,30 & 100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-07-25,2018-07-27,2018-07-27,Demand increase for the drug.,2018-07-24,2018-08-01
64047,2405148,Shortage,AURO-SIMVASTATIN,AURO PHARMA INC,SIMVASTATIN,SIMVASTATIN,5MG,90,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-10-12,,2019-02-27,Delay in shipping of the drug.,2018-10-12,2019-02-28
47461,2446375,Shortage,AURO-SOLIFENACIN,AURO PHARMA INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-03-30,2018-07-27,2018-07-31,Shortage of an active ingredient.,2018-04-30,2018-08-01
47464,2446383,Shortage,AURO-SOLIFENACIN,AURO PHARMA INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-03-30,,2018-05-23,2018-07-12,Shortage of an active ingredient.,2018-04-30,2018-07-13
57282,2446375,Shortage,AURO-SOLIFENACIN,AURO PHARMA INC,Solifenacin Succinate,SOLIFENACIN SUCCINATE,5MG,30 & 100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-08-01,,2018-11-12,Shortage of an active ingredient.,2018-08-01,2018-11-13
63245,2435934,Shortage,AURO-TADALAFIL,AURO PHARMA INC,Tadalafil,TADALAFIL,10MG,2x2,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-10-03,,2018-10-16,Demand increase for the drug.,2018-10-03,2018-10-18
93063,2435934,Shortage,AURO-TADALAFIL,AURO PHARMA INC,Tadalafil,TADALAFIL,10MG,2x2,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-04,2019-12-20,,Delay in shipping of the drug.,2019-09-05,2019-11-11
88786,2435942,Shortage,AURO-TADALAFIL,AURO PHARMA INC,Tadalafil,TADALAFIL,20MG,2x2,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-07-08,,2019-09-04,Delay in shipping of the drug.,2019-07-05,2019-09-05
68144,2453568,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,Telmisartan,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-29,,2018-12-11,Demand increase for the drug.,2018-11-29,2018-12-12
66875,2453576,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,Telmisartan,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-13,,2018-12-11,Demand increase for the drug.,2018-11-13,2018-12-12
99162,2453568,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,Telmisartan,TELMISARTAN,40MG,100,ORAL,Anticipated shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-11-18,,,Demand increase for the drug.,2019-11-18,2019-11-18
70336,2453568,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,Telmisartan,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-12-20,,2019-07-16,Demand increase for the drug.,2018-12-21,2019-07-17
70339,2453576,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,Telmisartan,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-12-20,,2019-03-13,Demand increase for the drug.,2018-12-21,2019-03-14
57315,2453568,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,Telmisartan,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-08-01,,2018-09-04,Demand increase for the drug.,2018-08-01,2018-09-05
57318,2453576,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,Telmisartan,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-08-01,,2018-09-04,Demand increase for the drug.,2018-08-01,2018-09-05
67382,2456397,Shortage,AURO-TELMISARTAN HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Telmisartan,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-21,,2019-05-31,Demand increase for the drug.,2018-11-21,2019-06-03
66878,2456389,Shortage,AURO-TELMISARTAN HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Telmisartan,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-13,,2019-05-31,Demand increase for the drug.,2018-11-13,2019-06-03
93048,2456389,Shortage,AURO-TELMISARTAN HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Telmisartan,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-04,,,Demand increase for the drug.,2019-09-05,2019-09-05
57321,2456389,Shortage,AURO-TELMISARTAN HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Telmisartan,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-01,,2018-08-28,Demand increase for the drug.,2018-08-01,2018-08-29
57324,2456397,Shortage,AURO-TELMISARTAN HCTZ,AURO PHARMA INC,Hydrochlorothiazide; Telmisartan,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-01,,2018-08-08,Demand increase for the drug.,2018-08-01,2018-08-09
68797,2439050,Shortage,AURO-TRAMADOL/ACETAMINOPHEN,AURO PHARMA INC,Tramadol Hydrochloride; Acetaminophen,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2018-12-05,2019-01-07,2019-01-07,Delay in shipping of the drug.,2018-12-05,2019-01-08
64727,2439050,Shortage,AURO-TRAMADOL/ACETAMINOPHEN,AURO PHARMA INC,Tramadol Hydrochloride; Acetaminophen,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2018-10-17,,2018-10-19,Delay in shipping of the drug.,2018-10-18,2018-10-20
87269,2439050,Shortage,AURO-TRAMADOL/ACETAMINOPHEN,AURO PHARMA INC,Tramadol Hydrochloride; Acetaminophen,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2019-06-21,,2019-07-04,Demand increase for the drug.,2019-06-21,2019-07-05
95254,2471868,Shortage,AURO-TRANDOLAPRIL,AURO PHARMA INC,Trandolapril,TRANDOLAPRIL,0.5MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-09-30,,,Demand increase for the drug.,2019-10-02,2019-11-11
98462,2471876,Shortage,AURO-TRANDOLAPRIL,AURO PHARMA INC,Trandolapril,TRANDOLAPRIL,1MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-11-09,,,Demand increase for the drug.,2019-11-11,2019-11-11
98465,2471884,Shortage,AURO-TRANDOLAPRIL,AURO PHARMA INC,Trandolapril,TRANDOLAPRIL,2MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-11-09,,,Demand increase for the drug.,2019-11-11,2019-11-11
81464,2405040,Shortage,AURO-VALACYCLOVIR,AURO PHARMA INC,Valacyclovir,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-04-11,,2019-05-13,Demand increase for the drug.,2019-04-11,2019-05-14
72833,2405040,Shortage,AURO-VALACYCLOVIR,AURO PHARMA INC,Valacyclovir,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-01-16,,2019-02-04,Delay in shipping of the drug.,2019-01-17,2019-02-05
96302,2435179,Shortage,AURO-VALGANCICLOVIR,AURO PHARMA INC,Valgancyclovir,VALGANCICLOVIR,450MG,60,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-10-09,,2019-10-23,Demand increase for the drug.,2019-10-11,2019-10-24
72836,2435179,Shortage,AURO-VALGANCICLOVIR,AURO PHARMA INC,Valgancyclovir,VALGANCICLOVIR,450MG,60,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-01-16,,2019-01-23,Delay in shipping of the drug.,2019-01-17,2019-01-24
70921,2414201,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,40MG,30 & 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-02,,2019-05-01,Demand increase for the drug.,2019-01-03,2019-05-02
70926,2414228,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,80MG,100 & 500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-02,,2019-05-01,Demand increase for the drug.,2019-01-03,2019-05-02
70929,2414236,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,160MG,100 & 500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-02,,2019-05-01,Demand increase for the drug.,2019-01-03,2019-05-02
70932,2414244,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,320MG,30 & 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-02,,2019-07-16,Demand increase for the drug.,2019-01-03,2019-07-17
56369,2414244,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,320MG,30 & 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-25,,2018-12-18,Demand increase for the drug.,2018-07-24,2018-12-19
64653,2414236,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,160MG,100 & 500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-17,,2018-12-18,Demand increase for the drug.,2018-10-18,2018-12-19
90573,2414201,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,40MG,30 & 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-08-09,,,2019-09-04,Demand increase for the drug.,2019-08-01,2019-09-05
90576,2414228,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,80MG,30 & 100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-31,,,Demand increase for the drug.,2019-08-01,2019-08-01
90579,2414236,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,160MG,30 & 100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-31,,,Demand increase for the drug.,2019-08-01,2019-08-01
90582,2414244,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,320MG,30 & 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-31,,2019-09-04,Demand increase for the drug.,2019-08-01,2019-09-05
57327,2414236,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,160MG,100 & 500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-08-01,,2018-10-03,Demand increase for the drug.,2018-08-01,2018-10-04
57330,2414201,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-08-01,,2018-10-03,Demand increase for the drug.,2018-08-01,2018-10-04
57333,2414228,Shortage,AURO-VALSARTAN,AURO PHARMA INC,Valsartan,VALSARTAN,80MG,100 & 500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-08-01,,2018-12-18,Demand increase for the drug.,2018-08-01,2018-12-19
68160,2408147,Shortage,AURO-VALSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Valsartan,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  320MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-29,,2018-12-20,Demand increase for the drug.,2018-11-29,2018-12-21
70344,2408139,Shortage,AURO-VALSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Valsartan,HYDROCHLOROTHIAZIDE  VALSARTAN,25MG  160MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-12-20,,2019-01-02,Demand increase for the drug.,2018-12-21,2019-01-03
61693,2408139,Shortage,AURO-VALSARTAN HCT,AURO PHARMA INC,Hydrochlorothiazide; Valsartan,HYDROCHLOROTHIAZIDE  VALSARTAN,25MG  160MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-09-21,2018-09-21,,2018-11-12,Demand increase for the drug.,2018-09-17,2018-11-13
84288,2452855,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,150MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-05-17,,2019-05-23,Demand increase for the drug.,2019-05-17,2019-05-24
68163,2452855,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,150MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-11-29,,2019-01-15,Demand increase for the drug.,2018-11-29,2019-01-16
79198,2452839,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,37.5MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-03-27,,2019-04-11,Demand increase for the drug.,2019-03-22,2019-04-12
90212,2452847,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,75MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-07-29,,2019-08-15,Demand increase for the drug.,2019-07-30,2019-08-16
82566,2452839,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,37.5MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-04-26,,2019-06-21,Demand increase for the drug.,2019-04-26,2019-06-24
76440,2452839,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,37.5MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-20,,2019-02-27,Demand increase for the drug.,2019-02-20,2019-02-28
95144,2452839,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,37.5MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-10-01,,2019-10-22,Demand increase for the drug.,2019-10-01,2019-10-24
74181,2452855,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,150MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-01-31,,2019-04-10,Demand increase for the drug.,2019-02-01,2019-04-11
70137,2452839,Shortage,AURO-VENLAFAXINE XR,AURO PHARMA INC,Venlafaxine,VENLAFAXINE,37.5MG,100 & 500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-12-19,,2019-01-15,Demand increase for the drug.,2018-12-19,2019-01-16
57344,2449579,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,Ziprasidone Hydrochloride Monohydrate,ZIPRASIDONE,80MG,60 & 100,ORAL,Resolved,CAPSULE,N05AE,ANTIPSYCHOTICS,,2018-08-01,,2018-09-05,Demand increase for the drug.,2018-08-01,2018-09-06
56355,2449552,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,Ziprasidone Hydrochloride Monohydrate,ZIPRASIDONE,40MG,60 & 100,ORAL,Resolved,CAPSULE,N05AE,ANTIPSYCHOTICS,,2018-07-25,,2018-10-02,Demand increase for the drug.,2018-07-24,2018-10-03
68151,2449552,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,Ziprasidone Hydrochloride Monohydrate,ZIPRASIDONE,40MG,60,ORAL,Resolved,CAPSULE,N05AE,ANTIPSYCHOTICS,,2018-11-29,,2018-12-18,Delay in shipping of the drug.,2018-11-29,2018-12-19
93051,2449552,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,Ziprasidone Hydrochloride Monohydrate,ZIPRASIDONE,40MG,60,ORAL,Resolved,CAPSULE,N05AE,ANTIPSYCHOTICS,,2019-09-04,,2019-09-30,Shortage of an active ingredient.,2019-09-05,2019-10-01
57336,2449544,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,Ziprasidone Hydrochloride Monohydrate,ZIPRASIDONE,20MG,60 & 100,ORAL,Resolved,CAPSULE,N05AE,ANTIPSYCHOTICS,,2018-08-01,,2018-09-05,Demand increase for the drug.,2018-08-01,2018-09-06
57341,2449560,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,Ziprasidone Hydrochloride Monohydrate,ZIPRASIDONE,60MG,60 & 100,ORAL,Resolved,CAPSULE,N05AE,ANTIPSYCHOTICS,,2018-08-01,,2018-09-05,Demand increase for the drug.,2018-08-01,2018-09-06
95800,2241818,Shortage,AVALIDE,SANOFI-AVENTIS CANADA INC,Avalide,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,90,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-10-21,,,,Other (Please describe in comments),2019-10-09,2019-11-05
70230,2241818,Shortage,AVALIDE,SANOFI-AVENTIS CANADA INC,Avalide150/12.5,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,90,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-12-12,2019-02-28,2019-02-26,Other (Please describe in comments),2018-12-20,2019-02-27
89482,2241819,Shortage,AVALIDE,SANOFI-AVENTIS CANADA INC,Avalide,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,90,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-02,,,Demand increase for the drug.,2019-07-16,2019-11-05
75166,2241819,Shortage,AVALIDE,SANOFI-AVENTIS CANADA INC,Avalide,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,90,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-02-06,2019-02-28,2019-03-01,Other (Please describe in comments),2019-02-08,2019-03-02
83440,2241819,Shortage,AVALIDE,SANOFI-AVENTIS CANADA INC,Avalide,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,90,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-04-17,2019-05-17,2019-05-09,Demand increase for the drug.,2019-05-08,2019-05-10
2267,2247086,Shortage,AVANDAMET,GLAXOSMITHKLINE INC,Rosiglitazone maleate and metformin hydrochloride tablet,METFORMIN HYDROCHLORIDE  ROSIGLITAZONE,500MG  2MG,100's,ORAL,Actual shortage,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2016-07-07,,,Other (Please describe in comments),2017-03-14,2017-10-05
2271,2248440,Shortage,AVANDAMET,GLAXOSMITHKLINE INC,Rosiglitazone maleate and metformin hydrochloride tablet,METFORMIN HYDROCHLORIDE  ROSIGLITAZONE,1000MG  2.00MG,100's,ORAL,Actual shortage,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2016-07-20,,,Other (Please describe in comments),2017-03-14,2017-10-05
2274,2248441,Shortage,AVANDAMET,GLAXOSMITHKLINE INC,Rosiglitazone maleate and metformin hydrochloride tablet,METFORMIN HYDROCHLORIDE  ROSIGLITAZONE,1000MG  4.00MG,100's,ORAL,Actual shortage,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2016-03-28,,,Other (Please describe in comments),2017-03-14,2017-10-05
5838,2241112,Shortage,AVANDIA,GLAXOSMITHKLINE INC,Rosiglitazone maleate tablet,ROSIGLITAZONE,2MG,60's,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-06-05,,2017-06-12,2017-06-13,Disruption of the manufacture of the drug.,2017-04-06,2017-06-14
69611,2241114,Shortage,AVANDIA,GLAXOSMITHKLINE INC,rosiglitazone (as rosiglitazone maleate) tablets,ROSIGLITAZONE,8MG,60's,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-05-01,,,Disruption of the manufacture of the drug.,2018-12-14,2019-10-18
95797,2237924,Shortage,AVAPRO,SANOFI-AVENTIS CANADA INC,Avapro,IRBESARTAN,150MG,90,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-10-21,,,,Other (Please describe in comments),2019-10-09,2019-11-05
89212,2237923,Shortage,AVAPRO,SANOFI-AVENTIS CANADA INC,Avapro,IRBESARTAN,75MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-17,2019-11-15,2019-11-04,Demand increase for the drug.,2019-07-12,2019-11-05
89476,2237925,Shortage,AVAPRO,SANOFI-AVENTIS CANADA INC,Avapro,IRBESARTAN,300MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-08-15,2019-11-15,2019-10-30,Demand increase for the drug.,2019-07-16,2019-11-05
75171,2237925,Shortage,AVAPRO,SANOFI-AVENTIS CANADA INC,Avapro,IRBESARTAN,300MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-06,2019-03-15,2019-03-28,Other (Please describe in comments),2019-02-08,2019-03-29
68058,2237923,Shortage,AVAPRO,SANOFI-AVENTIS CANADA INC,Avapro RM 75mg,IRBESARTAN,75MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-12-14,,2019-02-28,2019-02-26,Other (Please describe in comments),2018-11-29,2019-02-27
49923,2237792,Shortage,AVAXIM,SANOFI PASTEUR LIMITED,"HEPATITIS A VACCINE, INACTIVATED","HEPATITIS A VACCINE, INACTIVATED",160UNIT,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2018-06-15,2018-06-15,2018-10-19,2018-10-19,Demand increase for the drug.,2018-05-20,2018-10-20
94986,2237792,Shortage,AVAXIM,SANOFI PASTEUR LIMITED,"HEPATITIS A VACCINE, INACTIVATED","HEPATITIS A VACCINE, INACTIVATED",160UNIT,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Actual shortage,SUSPENSION,J07BC,VIRAL VACCINES,2019-11-25,2019-11-07,,2020-07-01,Disruption of the manufacture of the drug.,2019-09-28,2019-11-08
18205,2237792,Shortage,AVAXIM,SANOFI PASTEUR LIMITED,Hepatitis A Vaccine Inactivated,"HEPATITIS A VACCINE, INACTIVATED",160UNIT,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2017-11-01,,2018-01-31,2018-02-01,Disruption of the manufacture of the drug.,2017-08-03,2018-02-02
80335,2237792,Shortage,AVAXIM,SANOFI PASTEUR LIMITED,Hepatitis A Vaccine Inactivated,"HEPATITIS A VACCINE, INACTIVATED",160UNIT,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2019-07-01,2019-04-24,2019-08-01,2019-07-02,Demand increase for the drug.,2019-04-03,2019-07-03
94989,2243741,Shortage,AVAXIM - PEDIATRIC       -(SYRINGE),SANOFI PASTEUR LIMITED,"HEPATITIS A VACCINE, INACTIVATED","HEPATITIS A VACCINE, INACTIVATED",80UNIT,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Anticipated shortage,SUSPENSION,J07BC,VIRAL VACCINES,2019-11-25,,,,Disruption of the manufacture of the drug.,2019-09-28,2019-09-28
57751,2243741,Shortage,AVAXIM - PEDIATRIC       -(SYRINGE),SANOFI PASTEUR LIMITED,"HEPATITIS A VACCINE, INACTIVATED","HEPATITIS A VACCINE, INACTIVATED",80UNIT,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2018-08-08,,2018-12-31,2019-01-08,Demand increase for the drug.,2018-08-09,2019-01-09
1222,2243741,Shortage,AVAXIM - PEDIATRIC       -(SYRINGE),SANOFI PASTEUR LIMITED,Hepatitis A Vaccine Inactivated,"HEPATITIS A VACCINE, INACTIVATED",80UNIT,"1 x 0.5 mL (single dose) syringe / 1 seringue de 0,5 mL (dose unique)",INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2015-11-02,2015-11-02,2018-01-31,2018-02-01,Disruption of the manufacture of the drug.,2017-03-13,2018-02-02
63973,2242965,Shortage,AVELOX,BAYER INC,Moxifloxacin,MOXIFLOXACIN,400MG,30's,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2019-02-15,,2019-08-19,2019-07-04,Disruption of the manufacture of the drug.,2018-10-12,2019-07-05
12543,2246414,Shortage,AVELOX I.V.,BAYER INC,moxifloxacin injection,MOXIFLOXACIN,400MG,250 mL Ready-to-use minibag,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,2017-06-30,,2018-03-29,2018-02-23,Disruption of the manufacture of the drug.,2017-06-12,2018-02-27
65337,15237,Shortage,AVENTYL,AA PHARMA INC,AVENTYL,NORTRIPTYLINE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2018-10-22,2018-11-05,2018-11-01,Disruption of the manufacture of the drug.,2018-10-22,2019-01-09
77934,15229,Shortage,AVENTYL,AA PHARMA INC,AVENTYL,NORTRIPTYLINE,10MG,100BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2019-03-06,2019-04-08,2019-03-28,Disruption of the manufacture of the drug.,2019-03-06,2019-03-29
46253,15237,Shortage,AVENTYL,AA PHARMA INC,Aventyl,NORTRIPTYLINE,25MG,100 Bottle,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2018-04-18,2018-05-11,2018-05-09,Disruption of the manufacture of the drug.,2018-04-18,2018-05-10
94828,2298546,Shortage,AVIANE 28,TEVA CANADA LIMITED,LEVONORGESTREL,ETHINYL ESTRADIOL  LEVONORGESTREL,20MCG  100MCG,28,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-09-26,2019-10-31,2019-10-31,Disruption of the manufacture of the drug.,2019-09-26,2019-11-01
70676,778338,Shortage,AXID,PENDOPHARM DIVISION OF PHARMASCIENCE INC,Nizatidine,NIZATIDINE,150MG,100 caps,ORAL,Resolved,CAPSULE,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-07-01,2019-01-31,2019-07-23,2019-01-31,Delay in shipping of the drug.,2018-12-28,2019-02-01
17802,778338,Shortage,AXID,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,AXID 150mg CAPS 100,NIZATIDINE,150MG,100,ORAL,Resolved,CAPSULE,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-08-09,2017-08-09,2018-10-12,2018-10-25,Disruption of the manufacture of the drug.,2017-08-01,2018-10-29
96674,778338,Shortage,AXID,PENDOPHARM DIVISION OF PHARMASCIENCE INC,Nizatidine Capsules USP,NIZATIDINE,150MG,100 caps,ORAL,Actual shortage,CAPSULE,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-10-16,2019-10-16,2019-11-22,,Demand increase for the drug.,2019-10-16,2019-10-17
54440,2331624,Shortage,AZARGA,NOVARTIS PHARMACEUTICALS CANADA INC,AZARGA OPH SUSP 5ML,TIMOLOL  BRINZOLAMIDE,0.5%  1.0%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-06-25,2018-07-25,2018-07-25,Delay in shipping of the drug.,2018-07-05,2018-07-27
74350,2368846,Shortage,AZITHROMYCIN FOR INJECTION,STERIMAX INC,AZYTHROMYCIN FOR INJECTION,AZITHROMYCIN,500MG,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-02-01,2019-04-12,2019-04-16,Disruption of the manufacture of the drug.,2019-02-01,2019-04-17
14721,2334844,Shortage,"AZITHROMYCIN FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,AZITHROMYCIN,AZITHROMYCIN,500MG,10x500mg,INTRAVENOUS,Avoided shortage,POWDER FOR SOLUTION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2018-03-06,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-24
75635,2433532,Shortage,BACKUP PLAN ONESTEP,APOTEX INC,BACK UP PLAN,LEVONORGESTREL,1.5MG,1BLS,ORAL,Resolved,TABLET,G03AD,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-02-11,2019-02-19,2019-02-19,Disruption of the manufacture of the drug.,2019-02-13,2019-02-21
81429,2287048,Shortage,BACLOFEN,SANIS HEALTH INC,BACLOFEN,BACLOFEN,20MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2019-04-22,2019-04-23,2019-08-30,2019-08-23,Disruption of the manufacture of the drug.,2019-04-11,2019-08-24
71821,2287021,Shortage,BACLOFEN,SANIS HEALTH INC,BACLOFEN TAB,BACLOFEN,10MG,100's and 500's,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2019-01-14,2019-01-14,2019-02-15,2019-01-24,Other (Please describe in comments),2019-01-10,2019-01-25
56615,37818,Shortage,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,BACTERIOSTATIC SODIUM CHLORIDE,SODIUM CHLORIDE,9MG,25 X 20mL PVL MD,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,,2018-08-27,,2018-10-26,Disruption of the manufacture of the drug.,2018-07-26,2018-10-29
47197,37818,Shortage,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,Bacteriostatic Sodium Chloride,SODIUM CHLORIDE,9MG,25x30mL PVL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Avoided shortage,SOLUTION,B05CB,IRRIGATING SOLUTIONS,2018-06-28,,,2018-05-30,Disruption of the manufacture of the drug.,2018-04-25,2018-05-31
29307,37818,Shortage,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,SODIUM CHLORIDE,SODIUM CHLORIDE,9MG,25x10mL PVL MD,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,,2018-01-31,,2018-03-06,Disruption of the manufacture of the drug.,2017-11-15,2018-03-07
77025,37818,Shortage,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,Bacteriostatic Sodium Chloride,SODIUM CHLORIDE,9MG,25 x 30mL PVL MD,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,2019-04-26,,,2019-04-29,Disruption of the manufacture of the drug.,2019-02-27,2019-04-30
45115,38202,Shortage,BACTERIOSTATIC WATER FOR INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,BACTERIOSTATIC WATER,WATER,100%,25 x 30mL PVL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2018-06-15,,2018-07-23,Disruption of the manufacture of the drug.,2018-04-06,2018-07-24
84324,38202,Shortage,BACTERIOSTATIC WATER FOR INJECTION USP,PFIZER CANADA ULC,Bacteriostatic water,WATER,100%,25 x 30mL vial,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2019-05-17,,2019-10-01,Disruption of the manufacture of the drug.,2019-05-17,2019-10-02
62373,38202,Shortage,BACTERIOSTATIC WATER FOR INJECTION USP,PFIZER CANADA INC,BACTERIOSTATIC WATER FOR INJECTION USP,WATER,100%,25 x 30mL PVL MD,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2019-02-28,,2019-04-18,Disruption of the manufacture of the drug.,2018-09-26,2019-04-22
90403,2014807,Shortage,BAL IN OIL 3ML AMPULES/10,TAYLOR PHARMACEUTICALS,"Dimercaprol Injection, USP",DIMERCAPROL,100MG,10 Ampules (3ml each),INTRAMUSCULAR,Actual shortage,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2019-07-31,2019-07-31,2019-11-15,,Shortage of an inactive ingredient or component.,2019-07-31,2019-08-01
74789,2014807,Shortage,BAL IN OIL 3ML AMPULES/10,TAYLOR PHARMACEUTICALS,"DIMERCAPROL INJECTION, USP",DIMERCAPROL,100MG,10 AMPULES (3ML EACH),INTRAMUSCULAR,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2019-01-24,,2019-02-11,2019-06-30,Disruption of the manufacture of the drug.,2019-02-05,2019-07-01
70132,2014807,Shortage,BAL IN OIL 3ML AMPULES/10,TAYLOR PHARMACEUTICALS,TAYLOR PHARMACEUTICALS,,,10 AMPULES (3ML EACH),,Actual shortage,,,,2019-01-24,2019-01-24,2019-02-11,2019-12-31,Delay in shipping of the drug.,2018-12-19,2019-01-25
16200,2282224,Shortage,BARACLUDE,BRISTOL-MYERS SQUIBB CANADA,entecavir,ENTECAVIR,0.5MG,1 BTL X 30,ORAL,Avoided shortage,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,2017-09-11,,2017-09-08,2017-09-08,Demand increase for the drug.,2017-07-18,2017-09-21
56198,2251477,Shortage,BAXEDIN 2% - 70%,OMEGA LABORATORIES LTD,Chlorhexidine Gluconate 2% w/v with Isopropyl Alcohol 70% (tinted solution),CHLORHEXIDINE GLUCONATE  ISOPROPYL ALCOHOL,2%  70%,20 x 110mL,TOPICAL,Resolved,SOLUTION,D08AC,ANTISEPTICS AND DISINFECTANTS,,2018-07-18,2018-09-15,2018-09-13,Disruption of the manufacture of the drug.,2018-07-23,2018-09-18
52931,1936441,Shortage,BAXEDIN PRE-OP,OMEGA LABORATORIES LTD,Chlorhexidine Gluconate 0.5%,CHLORHEXIDINE GLUCONATE,0.5%,20 X 500 mL vial,TOPICAL,Resolved,SOLUTION,D08AC,ANTISEPTICS AND DISINFECTANTS,,2018-06-20,2018-07-09,2018-07-06,Disruption of the manufacture of the drug.,2018-06-26,2018-07-07
76311,2443910,Shortage,BELKYRA,"KYTHERA BIOPHARMACEUTICALS, INC.",BELKYRA,DEOXYCHOLIC ACID,10MG,4 vials,SUBCUTANEOUS,Resolved,SOLUTION,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2018-10-31,2019-05-17,2019-05-21,Other (Please describe in comments),2019-02-19,2019-05-22
65967,2443910,Shortage,BELKYRA,"KYTHERA BIOPHARMACEUTICALS, INC.",Belkyra,DEOXYCHOLIC ACID,10MG,4 vials,SUBCUTANEOUS,Resolved,SOLUTION,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2018-10-31,2018-10-31,2019-02-15,2019-02-15,Other (Please describe in comments),2018-11-01,2019-02-16
23821,176141,Shortage,BELLERGAL SPACETABS,PALADIN LABS INC,PHENOBARBITAL,BELLADONNA  PHENOBARBITAL  ERGOTAMINE TARTRATE,0.2MG  40.0MG  0.6MG,100 Tabs,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),A03,ANTISPASM.AND ANTICHOL. IN COMB. WITH OTHER DRUGS,2017-10-01,2017-10-01,,,Shortage of an active ingredient.,2017-09-28,2018-12-20
47130,2273918,Shortage,BENAZEPRIL,AA PHARMA INC,BENAZEPRIL HYDROCHLORIDE,BENAZEPRIL HYDROCHLORIDE,20MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-04-02,,2018-05-09,2018-05-08,Disruption of the manufacture of the drug.,2018-04-24,2018-05-09
82764,2290332,Shortage,BENAZEPRIL,AA PHARMA INC,Benazepril,BENAZEPRIL HYDROCHLORIDE,5MG,100 BTL,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-04-29,,,Disruption of the manufacture of the drug.,2019-04-29,2019-08-22
61260,2290332,Shortage,BENAZEPRIL,AA PHARMA INC,Benazepril,BENAZEPRIL HYDROCHLORIDE,5MG,100 BTL,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-09-11,,2018-10-05,2018-11-27,Disruption of the manufacture of the drug.,2018-09-11,2019-01-09
41549,2290332,Shortage,BENAZEPRIL,AA PHARMA INC,Benazepril,BENAZEPRIL HYDROCHLORIDE,5MG,100 Bottle,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-03-02,2018-03-13,2018-03-15,Disruption of the manufacture of the drug.,2018-03-02,2018-03-16
84180,2273918,Shortage,BENAZEPRIL,AA PHARMA INC,Benazepril,BENAZEPRIL HYDROCHLORIDE,20MG,100 BTL,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-05-15,,,Disruption of the manufacture of the drug.,2019-05-15,2019-08-22
64584,2370069,Shortage,BENLYSTA,GLAXOSMITHKLINE INC,belimumab lyophilized powder for intravenous infusion,BELIMUMAB,400MG,1x20mL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L04AA,IMMUNOSUPPRESSANTS,,2018-10-12,2018-10-25,2018-10-18,Delay in shipping of the drug.,2018-10-17,2018-10-19
5282,2102978,Shortage,BENTYLOL,APTALIS PHARMA CANADA ULC,BENTYLOL 2 mg/ml Syrup,DICYCLOMINE HYDROCHLORIDE,10MG,250 mL bottle,ORAL,Resolved,SYRUP,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017-05-31,,,2018-11-19,Other (Please describe in comments),2017-04-04,2018-11-26
5465,2103087,Shortage,BENTYLOL TABLET 10MG,APTALIS PHARMA CANADA ULC,Bentylol,DICYCLOMINE HYDROCHLORIDE,10MG,bottle 100 tabs,ORAL,Resolved,TABLET,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017-12-20,,2017-07-12,2018-11-19,Other (Please describe in comments),2017-04-04,2018-11-26
34019,2103095,Shortage,BENTYLOL TABLET 20MG,APTALIS PHARMA CANADA ULC,Bentylol,DICYCLOMINE HYDROCHLORIDE,20MG,bottle,ORAL,Resolved,TABLET,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017-09-01,,,2018-11-19,Other (Please describe in comments),2017-12-20,2018-11-26
91576,2248472,Shortage,BENZACLIN TOPICAL GEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,BENZACLIN TOPICAL GEL,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,50g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-08-01,,2019-08-26,Demand increase for the drug.,2019-08-14,2019-09-10
95984,2248472,Shortage,BENZACLIN TOPICAL GEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,BENZACLIN TOPICAL GEL,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,50g pump,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-09-26,,2019-10-28,Demand increase for the drug.,2019-10-10,2019-11-05
29526,2336847,Shortage,BESIVANCE,BAUSCH & LOMB INC,BESIVANCE,BESIFLOXACIN,0.6%,N/A,OPHTHALMIC,Resolved,SUSPENSION,S01AE,ANTIINFECTIVES,,2017-10-31,,2018-07-06,Other (Please describe in comments),2017-11-17,2018-07-09
24121,716618,Shortage,BETADERM CRM 0.05%,TARO PHARMACEUTICALS INC,BETADERM CRM 0.05%,BETAMETHASONE,0.05%,454G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-10-15,2018-10-26,2018-10-29,Disruption of the manufacture of the drug.,2017-10-02,2018-10-30
78180,716618,Shortage,BETADERM CRM 0.05%,TARO PHARMACEUTICALS INC,Betaderm,BETAMETHASONE,0.05%,454 g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-03-08,2019-03-29,2019-03-28,Disruption of the manufacture of the drug.,2019-03-11,2019-03-29
91820,716618,Shortage,BETADERM CRM 0.05%,TARO PHARMACEUTICALS INC,BETADERM CRM 0.05%,BETAMETHASONE,0.05%,454 g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-08-15,2019-09-27,2019-09-06,Disruption of the manufacture of the drug.,2019-08-19,2019-09-09
16650,716626,Shortage,BETADERM CRM 0.1%,TARO PHARMACEUTICALS INC,BETADERM CRM 0.1%,BETAMETHASONE VALERATE,0.1%,454G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-02-22,2018-03-30,2018-03-28,Disruption of the manufacture of the drug.,2017-07-21,2018-03-29
96353,716626,Shortage,BETADERM CRM 0.1%,TARO PHARMACEUTICALS INC,BETADERM CRM 0.1%,BETAMETHASONE,0.1%,454 g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-10-10,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
75921,716626,Shortage,BETADERM CRM 0.1%,TARO PHARMACEUTICALS INC,Betaderm,BETAMETHASONE,0.1%,454 g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-02-15,2019-03-22,2019-03-21,Disruption of the manufacture of the drug.,2019-02-15,2019-03-29
81614,716626,Shortage,BETADERM CRM 0.1%,TARO PHARMACEUTICALS INC,BETADERM CREAM,BETAMETHASONE,0.1%,454 G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-04-05,2019-05-17,2019-05-03,Disruption of the manufacture of the drug.,2019-04-15,2019-05-04
92414,716626,Shortage,BETADERM CRM 0.1%,TARO PHARMACEUTICALS INC,BETADERM CRM 0.1%,BETAMETHASONE,0.1%,454 g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-08-16,2019-09-16,2019-09-06,Disruption of the manufacture of the drug.,2019-08-23,2019-09-09
18094,716634,Shortage,BETADERM LOTION 0.1%,TARO PHARMACEUTICALS INC,BETADERM LOTION,BETAMETHASONE,0.1%,75ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-05-23,2018-07-16,2018-08-02,Disruption of the manufacture of the drug.,2017-08-02,2018-08-03
84958,716634,Shortage,BETADERM LOTION 0.1%,TARO PHARMACEUTICALS INC,BETADERM LOTION 0.1%,BETAMETHASONE,0.1%,75 ml,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-05-21,2019-06-14,2019-06-14,Disruption of the manufacture of the drug.,2019-05-28,2019-06-17
91300,716642,Shortage,BETADERM ONT 0.05%,TARO PHARMACEUTICALS INC,BETADERM ONT 0.05%,BETAMETHASONE,0.5MG,454 g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-08-01,2019-10-04,2019-10-04,Disruption of the manufacture of the drug.,2019-08-09,2019-10-05
22255,716642,Shortage,BETADERM ONT 0.05%,TARO PHARMACEUTICALS INC,BETADERM ONT 0.05%,BETAMETHASONE,0.5MG,454G,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-03-28,2018-04-27,2018-04-26,Disruption of the manufacture of the drug.,2017-09-18,2018-04-27
36483,716650,Shortage,BETADERM ONT 0.1%,TARO PHARMACEUTICALS INC,BETADERM ONT 0.1%,BETAMETHASONE,0.1%,454G,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-03-28,2018-04-27,2018-04-26,Disruption of the manufacture of the drug.,2018-01-18,2018-04-27
5781,751286,Shortage,BETAGAN OPH SOLN 0.25%,ALLERGAN INC,"Betagan 0,25% 10 mL C Cap",LEVOBUNOLOL HYDROCHLORIDE,0.25%,10ML,OPHTHALMIC,Resolved,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2002-01-01,,2017-07-26,Other (Please describe in comments),2017-04-06,2017-08-04
81154,2466457,Shortage,BETAHISTINE,SANIS HEALTH INC,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2019-04-10,2019-11-14,2019-11-12,Disruption of the manufacture of the drug.,2019-04-10,2019-11-13
79889,2466457,Shortage,BETAHISTINE,SANIS HEALTH INC,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2019-03-29,2019-07-23,2019-07-25,Disruption of the manufacture of the drug.,2019-03-29,2019-07-26
83200,2060884,Shortage,BETNESOL RETENTION ENEMA 5MG/100ML,PALADIN LABS INC,Betamethasone,BETAMETHASONE,5MG,100mL,RECTAL,Resolved,ENEMA,A07EA,INTESTINALANTIINFLAMMATORY AGENTS,,2019-05-06,,2019-10-30,Delay in shipping of the drug.,2019-05-06,2019-10-31
67490,1908448,Shortage,BETOPTIC S,NOVARTIS PHARMACEUTICALS CANADA INC,BETOPTIC S 0.25% SUSP 10ML,BETAXOLOL,0.25%,10ML,OPHTHALMIC,Resolved,SUSPENSION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2018-12-12,2018-12-11,2018-12-20,2018-12-20,Delay in shipping of the drug.,2018-11-23,2019-01-03
47338,1908448,Shortage,BETOPTIC S,NOVARTIS PHARMACEUTICALS CANADA INC,BETOPTIC 0.25 SUSP 5ML,BETAXOLOL,0.25%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2018-05-14,2018-05-24,2018-06-05,2018-06-05,Delay in shipping of the drug.,2018-04-27,2018-06-06
59702,2417030,Shortage,BEXSERO,GLAXOSMITHKLINE INC,"Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)",Recombinant Neisseria meningitidis group B NHBA fusion protein  Recombinant Neisseria meningitidis group B NadA protein  Recombinant Neisseria meningitidis group B fHBP fusion protein  Outer membrane vesicles,50MCG  50MCG  50MCG  25MCG,10's,INTRAMUSCULAR,Resolved,SUSPENSION,J07AH,BACTERIAL VACCINES,,2018-08-29,2018-10-05,2018-09-05,Demand increase for the drug.,2018-08-31,2018-09-06
63383,2417030,Shortage,BEXSERO,GLAXOSMITHKLINE INC,"Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)",Recombinant Neisseria meningitidis group B NHBA fusion protein  Recombinant Neisseria meningitidis group B NadA protein  Recombinant Neisseria meningitidis group B fHBP fusion protein  Outer membrane vesicles,50MCG  50MCG  50MCG  25MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07AH,BACTERIAL VACCINES,,2018-10-01,2018-12-06,2018-10-29,Demand increase for the drug.,2018-10-05,2018-10-31
55706,2417030,Shortage,BEXSERO,GLAXOSMITHKLINE INC,"Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)",Recombinant Neisseria meningitidis group B NHBA fusion protein  Recombinant Neisseria meningitidis group B NadA protein  Recombinant Neisseria meningitidis group B fHBP fusion protein  Outer membrane vesicles,50MCG  50MCG  50MCG  25MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07AH,BACTERIAL VACCINES,,2018-07-10,2018-08-24,2018-08-07,Demand increase for the drug.,2018-07-13,2018-08-08
75721,2417030,Shortage,BEXSERO,GLAXOSMITHKLINE INC,"Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)",Recombinant Neisseria meningitidis group B NHBA fusion protein  Recombinant Neisseria meningitidis group B NadA protein  Recombinant Neisseria meningitidis group B fHBP fusion protein  Outer membrane vesicles,50MCG  50MCG  50MCG  25MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07AH,BACTERIAL VACCINES,,2019-02-11,2019-04-15,2019-03-21,Disruption of the manufacture of the drug.,2019-02-13,2019-03-22
75724,2417030,Shortage,BEXSERO,GLAXOSMITHKLINE INC,"Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)",Recombinant Neisseria meningitidis group B NHBA fusion protein  Recombinant Neisseria meningitidis group B NadA protein  Recombinant Neisseria meningitidis group B fHBP fusion protein  Outer membrane vesicles,50MCG  50MCG  50MCG  25MCG,10's,INTRAMUSCULAR,Resolved,SUSPENSION,J07AH,BACTERIAL VACCINES,,2019-02-08,2019-04-25,2019-03-19,Disruption of the manufacture of the drug.,2019-02-13,2019-03-21
46663,2359685,Shortage,BIACNA TOPICAL GEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,BIACNA TOPICAL GEL,TRETINOIN  CLINDAMYCIN PHOSPHATE,0.025%  1.200%,60g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2018-07-16,,,2018-07-20,Other (Please describe in comments),2018-04-20,2018-07-23
85837,2359685,Shortage,BIACNA TOPICAL GEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,BIACNA TOPICAL GEL,TRETINOIN  CLINDAMYCIN PHOSPHATE,0.025%  1.200%,60g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2019-06-24,,,2019-08-12,Other (Please describe in comments),2019-06-07,2019-08-14
35721,2126710,Shortage,BIAXIN BID,BGP PHARMA ULC,BIAXIN,CLARITHROMYCIN,500MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-01-12,,2018-01-15,Delay in shipping of the drug.,2018-01-11,2018-01-16
3978,2244756,Shortage,BIAXIN XL,BGP PHARMA ULC,Biaxin,CLARITHROMYCIN,500MG,60s,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016-12-08,,,Disruption of the manufacture of the drug.,2017-03-22,2017-10-05
35742,2230897,Shortage,BILTRICIDE,BAYER INC,Praziquatel Tablet,PRAZIQUANTEL,600MG,6's,ORAL,Resolved,TABLET,P02BA,ANTITREMATODALS,2018-01-19,,2018-05-11,2018-04-30,Disruption of the manufacture of the drug.,2018-01-11,2018-05-01
27657,2247167,Shortage,BIO-AMITRIPTYLINE,BIOMED PHARMA,Amytriptyline hydrochloride Tablets 25 mg,,,500,,Actual shortage,,,,,2011-04-20,,,Other (Please describe in comments),2017-11-01,2018-02-20
27660,2247168,Shortage,BIO-AMITRIPTYLINE,BIOMED PHARMA,Amitriptyline Hydrochloride 50mg,,,100,,Actual shortage,,,,,2011-04-20,,,Other (Please describe in comments),2017-11-01,2017-11-01
22951,2247166,Shortage,BIO-AMITRIPTYLINE,BIOMED PHARMA,Amytriptyline hydrochloride Tablets 10 mg,AMITRIPTYLINE HYDROCHLORIDE,10MG,500,,Actual shortage,,,,2011-04-20,2011-04-20,,,Other (Please describe in comments),2017-09-21,2017-10-26
58883,2392143,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE,AMLODIPINE,10.00MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-08-23,2019-01-30,2019-02-28,Delay in shipping of the drug.,2018-08-23,2019-03-01
7710,2392127,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-04-24,2017-04-24,2017-06-21,2017-07-07,Demand increase for the drug.,2017-04-24,2017-10-26
31547,2392127,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE 2.5 MG,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-11-29,2017-11-29,,2019-01-30,Demand increase for the drug.,2017-12-01,2019-01-31
89205,2392127,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-07-12,2019-09-27,2019-09-20,Demand increase for the drug.,2019-07-12,2019-09-25
68006,2392135,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE,AMLODIPINE,5.00MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-11-28,2019-01-18,2019-01-30,Delay in shipping of the drug.,2018-11-29,2019-01-31
66027,2392135,Shortage,BIO-AMLODIPINE,BIOMED PHARMA,AMLODIPINE,AMLODIPINE,5.00MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-10-30,2019-01-18,2019-01-30,Delay in shipping of the drug.,2018-11-01,2019-01-31
22886,2392488,Shortage,BIO-ANASTROZOLE,BIOMED PHARMA,ANASTROZOLE,ANASTROZOLE,1MG,100,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2016-01-01,2016-01-01,,2019-05-09,Delay in shipping of the drug.,2017-09-20,2019-05-10
27663,2392194,Shortage,BIO-ATENOLOL,BIOMED PHARMA,Atenolol Tablets 25 mg,,,100,,Actual shortage,,,,,2015-01-01,,,Other (Please describe in comments),2017-11-01,2017-11-01
27667,2392178,Shortage,BIO-ATENOLOL,BIOMED PHARMA,Atenolol Tablets 50 mg,,,100,,Actual shortage,,,,,2015-01-01,,,Other (Please describe in comments),2017-11-01,2017-11-01
27670,2392186,Shortage,BIO-ATENOLOL,BIOMED PHARMA,Atenolol Tablets 100 mg,,,100,,Actual shortage,,,,,2015-01-01,,,Other (Please describe in comments),2017-11-01,2017-11-01
79436,2426382,Shortage,BIO-CELECOXIB,BIOMED PHARMA,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-03-25,2019-07-19,2019-07-20,Delay in shipping of the drug.,2019-03-26,2019-08-21
84131,2426390,Shortage,BIO-CELECOXIB,BIOMED PHARMA,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-05-14,2019-07-19,2019-07-20,Delay in shipping of the drug.,2019-05-15,2019-08-21
66024,2426382,Shortage,BIO-CELECOXIB,BIOMED PHARMA,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-10-31,,2018-11-27,Demand increase for the drug.,2018-11-01,2018-11-28
79094,2426390,Shortage,BIO-CELECOXIB,BIOMED PHARMA,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-03-19,2019-07-19,2019-07-20,Delay in shipping of the drug.,2019-03-21,2019-08-21
43608,2444887,Shortage,BIO-CIPROFLOXACIN,BIOMED PHARMA,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-01-10,,2018-06-08,Demand increase for the drug.,2018-03-21,2018-09-19
45888,2448491,Shortage,BIO-CITALOPRAM,BIOMED PHARMA,CITALOPRAM,CITALOPRAM,20MG,3x10,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-05-08,,2018-06-28,Demand increase for the drug.,2018-04-16,2018-06-29
59460,2448475,Shortage,BIO-CITALOPRAM,BIOMED PHARMA,CITALOPRAM,CITALOPRAM,10MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2018-08-29,,,Delay in shipping of the drug.,2018-08-29,2019-09-25
22889,2448491,Shortage,BIO-CITALOPRAM,BIOMED PHARMA,CITALOPRAM,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-06-20,2017-06-20,,2018-06-28,Delay in shipping of the drug.,2017-09-20,2018-09-19
89062,2448491,Shortage,BIO-CITALOPRAM,BIOMED PHARMA,CITALOPRAM,CITALOPRAM,20MG,3x10,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-07-09,,,Demand increase for the drug.,2019-07-11,2019-07-11
79097,2448491,Shortage,BIO-CITALOPRAM,BIOMED PHARMA,CITALOPRAM,CITALOPRAM,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-03-20,,,,Delay in shipping of the drug.,2019-03-21,2019-08-21
79100,2448513,Shortage,BIO-CITALOPRAM,BIOMED PHARMA,CITALOPRAM,CITALOPRAM,40MG,3x10,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-03-20,,,Delay in shipping of the drug.,2019-03-21,2019-09-25
27675,2247173,Shortage,BIO-DIAZEPAM,BIOMED PHARMA,Diazepam Tablets 2 mg,,,100,,Actual shortage,,,,,2012-02-28,,,Other (Please describe in comments),2017-11-01,2017-11-01
27681,2247174,Shortage,BIO-DIAZEPAM,BIOMED PHARMA,Diazepam Tablets 5 mg,,,500,,Actual shortage,,,,,2012-02-28,,,Other (Please describe in comments),2017-11-01,2017-11-01
27686,2247176,Shortage,BIO-DIAZEPAM,BIOMED PHARMA,Diazepam Tablets 10 mg,,,500,,Actual shortage,,,,,2012-02-27,,,Other (Please describe in comments),2017-11-01,2017-11-01
49210,2445034,Shortage,BIO-DOMPERIDONE,BIOMED PHARMA,DOMPERIDONE,DOMPERIDONE,10MG,500,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2018-05-14,2018-06-01,2018-06-07,Requirements related to complying with good manufacturing practices.,2018-05-14,2018-06-08
72675,2445034,Shortage,BIO-DOMPERIDONE,BIOMED PHARMA,DOMPERIDONE,DOMPERIDONE,10MG,500,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2019-01-14,2019-05-31,2019-05-29,Delay in shipping of the drug.,2019-01-16,2019-05-30
51091,2412853,Shortage,BIO-DONEPEZIL,BIOMED PHARMA,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,30,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-06-01,,,Other (Please describe in comments),2018-06-01,2018-06-02
51094,2412853,Shortage,BIO-DONEPEZIL,BIOMED PHARMA,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-06-01,,2018-08-27,Delay in shipping of the drug.,2018-06-01,2018-08-28
51097,2412861,Shortage,BIO-DONEPEZIL,BIOMED PHARMA,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,30,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-06-01,,,Other (Please describe in comments),2018-06-01,2018-06-02
51100,2412861,Shortage,BIO-DONEPEZIL,BIOMED PHARMA,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-06-01,,2018-08-27,Delay in shipping of the drug.,2018-06-01,2018-08-28
66064,2425211,Shortage,BIO-EZETIMIBE,BIOMED PHARMA,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2018-10-31,,2018-11-26,Demand increase for the drug.,2018-11-02,2018-11-27
7702,2425211,Shortage,BIO-EZETIMIBE,BIOMED PHARMA,EZETIMIBE,EZETIMIBE,10MG,30,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017-04-24,2017-04-24,2017-05-02,2017-05-11,Disruption of the manufacture of the drug.,2017-04-24,2017-05-12
84140,2425211,Shortage,BIO-EZETIMIBE,BIOMED PHARMA,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-14,2019-06-30,2019-06-21,Demand increase for the drug.,2019-05-15,2019-06-22
82366,2425211,Shortage,BIO-EZETIMIBE,BIOMED PHARMA,EZETIMIBE,EZETIMIBE,10MG,3x10,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-22,2019-06-30,2019-06-21,Demand increase for the drug.,2019-04-24,2019-06-22
73754,2448432,Shortage,BIO-FLUOXETINE,BIOMED PHARMA,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-01-28,2019-05-15,2019-05-01,Delay in shipping of the drug.,2019-01-28,2019-05-02
27689,2248126,Shortage,BIO-FLURAZEPAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 15 mg,,,120,,Actual shortage,,,,,2012-05-30,,,Other (Please describe in comments),2017-11-01,2017-11-01
27692,2248127,Shortage,BIO-FLURAZEPAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 30 mg,,,120,,Actual shortage,,,,,2012-05-30,,,Other (Please describe in comments),2017-11-01,2017-11-01
27695,2247371,Shortage,BIO-FUROSEMIDE,BIOMED PHARMA,Furosemide Tablets 20 mg,FUROSEMIDE,20MG,500,ORAL,Actual shortage,TABLET,C03CA,HIGH-CEILING DIURETICS,,2016-10-02,,,Other (Please describe in comments),2017-11-01,2017-11-02
18772,2247372,Shortage,BIO-FUROSEMIDE,BIOMED PHARMA,FUROSEMIDE,FUROSEMIDE,40MG,500,ORAL,Actual shortage,TABLET,C03CA,HIGH-CEILING DIURETICS,,2015-10-01,,,Requirements related to complying with good manufacturing practices.,2017-08-11,2017-10-05
47948,2450186,Shortage,BIO-GABAPENTIN,BIOMED PHARMA,GABAPENTIN,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-05-01,,2019-05-16,Delay in shipping of the drug.,2018-05-02,2019-05-17
18775,2247170,Shortage,BIO-HYDROCHLOROTHIAZIDE,BIOMED PHARMA,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,25MG,100,ORAL,Actual shortage,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",2016-03-22,2016-03-22,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-26
26815,2247171,Shortage,BIO-HYDROCHLOROTHIAZIDE,BIOMED PHARMA,Hydrochlorothiazide,HYDROCHLOROTHIAZIDE,50MG,100,ORAL,Actual shortage,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",2015-08-01,2015-08-01,,,Other (Please describe in comments),2017-10-24,2017-10-26
79107,2446154,Shortage,BIO-IRBESARTAN,BIOMED PHARMA,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-10,,,Delay in shipping of the drug.,2019-03-21,2019-08-21
79110,2446162,Shortage,BIO-IRBESARTAN,BIOMED PHARMA,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-12,,,Delay in shipping of the drug.,2019-03-21,2019-08-21
61622,2446146,Shortage,BIO-IRBESARTAN,BIOMED PHARMA,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-09-17,,,Demand increase for the drug.,2018-09-17,2019-08-21
50476,2392496,Shortage,BIO-LETROZOLE,BIOMED PHARMA,LETROZOLE,LETROZOLE,2.5MG,3x10,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-05-28,,2018-09-24,Demand increase for the drug.,2018-05-28,2018-09-25
18781,2392496,Shortage,BIO-LETROZOLE,BIOMED PHARMA,LETROZOLE,LETROZOLE,2.5MG,100,ORAL,Actual shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2015-06-01,2015-06-01,,,Disruption of the manufacture of the drug.,2017-08-11,2019-07-17
52257,2450356,Shortage,BIO-LEVETIRACETAM,BIOMED PHARMA,LEVETIRACETAM,LEVETIRACETAM,500MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-06-12,,2018-07-31,Delay in shipping of the drug.,2018-06-12,2018-08-07
43629,2450364,Shortage,BIO-LEVETIRACETAM,BIOMED PHARMA,LEVETIRACETAM,LEVETIRACETAM,750MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2018-04-01,,,Delay in shipping of the drug.,2018-03-21,2019-08-21
43632,2450348,Shortage,BIO-LEVETIRACETAM,BIOMED PHARMA,LEVETIRACETAM,LEVETIRACETAM,250MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2018-04-01,,,Delay in shipping of the drug.,2018-03-21,2019-08-21
62893,2450356,Shortage,BIO-LEVETIRACETAM,BIOMED PHARMA,LEVETIRACETAM,LEVETIRACETAM,500MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-01,,2019-03-13,Demand increase for the drug.,2018-10-02,2019-03-14
27935,2445964,Shortage,BIO-LOSARTAN,BIOMED PHARMA,Bio-LOSARTAN 25mg-100,LOSARTAN POTASSIUM,25MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-11-01,,2018-06-15,Other (Please describe in comments),2017-11-02,2018-06-18
76076,2445972,Shortage,BIO-LOSARTAN,BIOMED PHARMA,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-18,,,Delay in shipping of the drug.,2019-02-18,2019-08-21
78418,2445980,Shortage,BIO-LOSARTAN,BIOMED PHARMA,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-12,,,Demand increase for the drug.,2019-03-12,2019-08-21
43613,2445980,Shortage,BIO-LOSARTAN,BIOMED PHARMA,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-01-10,,2018-04-24,Other (Please describe in comments),2018-03-21,2018-09-19
43616,2445972,Shortage,BIO-LOSARTAN,BIOMED PHARMA,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-11-01,,2018-06-15,Other (Please describe in comments),2018-03-21,2018-09-19
94679,2445964,Shortage,BIO-LOSARTAN,BIOMED PHARMA,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-25,,,Disruption of the manufacture of the drug.,2019-09-25,2019-09-25
7713,2442078,Shortage,BIO-MODAFINIL,BIOMED PHARMA,MODAFINIL,MODAFINIL,100MG,100,ORAL,Actual shortage,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-04-01,2017-04-01,,,Delay in shipping of the drug.,2017-04-24,2017-10-26
62890,2447266,Shortage,BIO-MOXIFLOXACIN,BIOMED PHARMA,MOXIFLOXACIN,MOXIFLOXACIN,400MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-10-01,,2018-11-28,Delay in shipping of the drug.,2018-10-02,2018-11-29
27698,2247177,Shortage,BIO-OXAZEPAM,BIOMED PHARMA,Oxazepam Tablets 10 mg,,,100,,Actual shortage,,,,,2012-02-28,,,Other (Please describe in comments),2017-11-01,2017-11-01
27701,2247178,Shortage,BIO-OXAZEPAM,BIOMED PHARMA,Oxazepam Tablets 15 mg,,,500,,Actual shortage,,,,,2012-02-28,,,Other (Please describe in comments),2017-11-01,2017-11-01
27712,2247179,Shortage,BIO-OXAZEPAM,BIOMED PHARMA,Oxazepam Tablets 30 mg,,,500,,Actual shortage,,,,,2012-02-27,,,Other (Please describe in comments),2017-11-01,2017-11-01
65813,2445867,Shortage,BIO-PANTOPRAZOLE,BIOMED PHARMA,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-10-29,,2018-11-27,Demand increase for the drug.,2018-10-30,2018-11-28
22877,2445867,Shortage,BIO-PANTOPRAZOLE,BIOMED PHARMA,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-07-01,2017-07-01,,2018-08-24,Delay in shipping of the drug.,2017-09-20,2018-08-25
96656,2444917,Shortage,BIO-PAROXETINE,BIOMED PHARMA,PAROXETINE,PAROXETINE,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-10-16,,,Delay in shipping of the drug.,2019-10-16,2019-10-17
49867,2444909,Shortage,BIO-PAROXETINE,BIOMED PHARMA,PAROXETINE,PAROXETINE,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-05-18,,2018-08-08,Delay in shipping of the drug.,2018-05-18,2018-08-09
89065,2444917,Shortage,BIO-PAROXETINE,BIOMED PHARMA,PAROXETINE,PAROXETINE,20MG,500,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-07-10,,,Delay in shipping of the drug.,2019-07-11,2019-09-25
86094,2446278,Shortage,BIO-PRAVASTATIN,BIOMED PHARMA,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-11,,,Demand increase for the drug.,2019-06-11,2019-08-21
82373,2446286,Shortage,BIO-PRAVASTATIN,BIOMED PHARMA,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-20,,,Delay in shipping of the drug.,2019-04-24,2019-08-21
39768,2447193,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,Bio-QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-02-15,,2018-09-07,Delay in shipping of the drug.,2018-02-15,2018-09-18
22874,2447193,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-09-12,2017-09-12,,2017-12-01,Delay in shipping of the drug.,2017-09-20,2018-09-19
39773,2447207,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,Bio-QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-02-01,,2018-10-25,Delay in shipping of the drug.,2018-02-15,2018-10-26
39776,2447258,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,Bio-QUETIAPINE,QUETIAPINE,300MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-02-01,2018-02-01,,2018-09-10,Delay in shipping of the drug.,2018-02-15,2018-09-18
43619,2447223,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,QUETIAPINE,QUETIAPINE,200MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-02-01,,2018-10-05,Demand increase for the drug.,2018-03-21,2018-10-06
96659,2447207,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-10-16,,,Delay in shipping of the drug.,2019-10-16,2019-10-17
89068,2447193,Shortage,BIO-QUETIAPINE,BIOMED PHARMA,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-07-08,,,Delay in shipping of the drug.,2019-07-11,2019-07-11
59139,2444976,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-07-20,,2018-09-21,Delay in shipping of the drug.,2018-08-24,2018-09-22
43782,2444976,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-03-22,,2018-09-21,Other (Please describe in comments),2018-03-23,2018-09-22
79113,2444984,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-03-21,,,Delay in shipping of the drug.,2019-03-21,2019-09-25
35865,2444992,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,Rosuvastatin,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-01-12,2018-03-31,,2018-09-21,Other (Please describe in comments),2018-01-12,2018-09-22
45358,2444968,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-04-10,,2018-09-21,Demand increase for the drug.,2018-04-10,2018-09-22
71985,2444984,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-01-11,,2019-09-20,Delay in shipping of the drug.,2019-01-11,2019-09-25
58280,2444984,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-08-16,,2018-09-21,Delay in shipping of the drug.,2018-08-16,2018-09-22
82376,2444992,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-21,,2019-09-20,Delay in shipping of the drug.,2019-04-24,2019-09-25
84195,2444968,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-14,2019-08-30,2019-09-20,Delay in shipping of the drug.,2019-05-15,2019-09-25
89071,2444976,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-07-11,,,Delay in shipping of the drug.,2019-07-11,2019-07-12
89074,2444976,Shortage,BIO-ROSUVASTATIN,BIOMED PHARMA,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-07-11,,2019-09-20,Delay in shipping of the drug.,2019-07-11,2019-09-25
51238,2445042,Shortage,BIO-SERTRALINE,BIOMED PHARMA,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-06-04,,2018-12-13,Delay in shipping of the drug.,2018-06-04,2018-12-14
51241,2445050,Shortage,BIO-SERTRALINE,BIOMED PHARMA,SERTRALINE,SERTRALINE,50MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-06-04,,2018-12-13,Delay in shipping of the drug.,2018-06-04,2018-12-14
47213,2445069,Shortage,BIO-SERTRALINE,BIOMED PHARMA,SERTRALINE,SERTRALINE,100MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-04-04,,2018-12-13,Demand increase for the drug.,2018-04-25,2018-12-14
22880,2444860,Shortage,BIO-VALACYCLOVIR,BIOMED PHARMA,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2016-12-15,2016-12-15,,,Delay in shipping of the drug.,2017-09-20,2018-02-20
92543,2131692,Shortage,BLEOMYCIN FOR INJECTION USP,PFIZER CANADA ULC,BLEOMYCIN FOR INJECTION USP,BLEOMYCIN,15UNIT,1 x 15iu vial,INTRA-ARTERIAL  INTRACAVITARY  INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,L01DC,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2019-09-30,,2019-11-18,Demand increase for the drug.,2019-08-28,2019-11-18
97094,807788,Shortage,BLEPHAMIDE,ALLERGAN INC,sulfacetamide/prednisolone,PREDNISOLONE ACETATE  SULFACETAMIDE SODIUM,0.2%  10%,10ml,OPHTHALMIC,Resolved,DROPS,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2019-11-04,,2019-11-25,2019-11-08,Disruption of the manufacture of the drug.,2019-10-24,2019-11-08
40190,307246,Shortage,BLEPHAMIDE OPH ONT,ALLERGAN INC,sulfacetamide sodium,PREDNISOLONE ACETATE  SULFACETAMIDE SODIUM,0.2%  10%,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2018-02-15,2018-02-15,2018-11-15,2019-11-08,Other (Please describe in comments),2018-02-20,2019-11-08
77338,807788,Shortage,BLEPHAMIDE OPHT SUSPENSION,ALLERGAN INC,Sulfacetamide-Prednisolone,PREDNISOLONE ACETATE  SULFACETAMIDE SODIUM,0.2%  10%,5ml,OPHTHALMIC,Resolved,DROPS,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2019-03-04,2019-03-04,2019-04-10,2019-04-12,Disruption of the manufacture of the drug.,2019-03-04,2019-04-15
77342,807788,Shortage,BLEPHAMIDE OPHT SUSPENSION,ALLERGAN INC,Sulfacetamide-Prednisolone,PREDNISOLONE ACETATE  SULFACETAMIDE SODIUM,0.2%  10%,10ml,OPHTHALMIC,Resolved,DROPS,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2019-03-04,2019-03-04,2019-04-16,2019-04-18,Disruption of the manufacture of the drug.,2019-03-04,2019-04-19
40184,807788,Shortage,BLEPHAMIDE OPHT SUSPENSION,ALLERGAN INC,Sulfacetamide sodium,PREDNISOLONE ACETATE  SULFACETAMIDE SODIUM,0.2%  10%,10mL,OPHTHALMIC,Resolved,DROPS,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2018-02-15,2018-02-15,2018-03-16,2018-04-20,Other (Please describe in comments),2018-02-20,2018-04-21
40187,807788,Shortage,BLEPHAMIDE OPHT SUSPENSION,ALLERGAN INC,Sulfacetamide sodium,PREDNISOLONE ACETATE  SULFACETAMIDE SODIUM,0.2%  10%,5mL,OPHTHALMIC,Resolved,DROPS,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2018-02-15,2018-02-15,2018-03-16,2018-04-20,Other (Please describe in comments),2018-02-20,2018-04-21
19888,2312557,Shortage,BOOSTRIX-POLIO,GLAXOSMITHKLINE INC,"Combined diphtheria, tetanus, acellular pertussis  and inactivated poliomyelitis vaccine",INACTIVATED POLIOVIRUS TYPE I  INACTIVATED POLIOVIRUS TYPE II  INACTIVATED POLIOVIRUS TYPE III  TETANUS TOXOID ADSORBED  DIPHTHERIA TOXOID ADSORBED  PERTUSSIS TOXOID ADSORBED  FILAMENTOUS HAEMAGGLUTININ ADSORBED  PERTACTIN ADSORBED,40D  8D  32D  5.0LF  2.5LF  8MCG  8MCG  2.5MCG,10's,INTRAMUSCULAR,Resolved,SUSPENSION,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",,2017-11-08,2017-12-07,2017-12-06,Delay in shipping of the drug.,2017-08-18,2017-12-07
802,2268140,Shortage,BRAVELLE,FERRING INC,BRAVELLE,Urofollitropin for injection,75 IU's per vial,5 vials,Subcutaneous,Resolved,Powder for Injection,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2015-09-09,2015-10-01,,2019-07-18,Disruption of the manufacture of the drug.,2017-03-13,2019-07-29
14644,2185377,Shortage,BRETYLIUM TOSYLATE INJECTION USP,SANDOZ CANADA INCORPORATED,BRETYLIUM,BRETYLIUM TOSYLATE,50MG,5 X 10ML VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017-07-03,2017-07-28,2017-07-28,Requirements related to complying with good manufacturing practices.,2017-07-05,2017-10-18
18340,2185377,Shortage,BRETYLIUM TOSYLATE INJECTION USP,SANDOZ CANADA INCORPORATED,BRETYLIUM,BRETYLIUM TOSYLATE,50MG,5 X 10ML VIALS,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017-08-01,,,Delay in shipping of the drug.,2017-08-07,2017-12-04
43037,2188880,Shortage,BREVIBLOC INJECTION 10MG/ML,BAXTER CORPORATION,Brevibloc Injection,ESMOLOL HYDROCHLORIDE,10MG,10mL vials,INTRAVENOUS,Resolved,SOLUTION,C07AB,BETA BLOCKING AGENTS,2018-03-09,2018-03-27,2018-05-09,2018-05-09,Disruption of the manufacture of the drug.,2018-03-15,2018-05-16
91707,2309238,Shortage,BREVIBLOC PREMIXED INJECTION,BAXTER CORPORATION,BREVIBLOC PREMIXED INJECTION,ESMOLOL HYDROCHLORIDE,10MG,250 mL Intravia Container,INTRAVENOUS,Resolved,SOLUTION,C07AB,BETA BLOCKING AGENTS,2019-08-16,2019-08-16,2019-09-16,2019-09-16,Delay in shipping of the drug.,2019-08-16,2019-09-17
17549,2309238,Shortage,BREVIBLOC PREMIXED INJECTION,BAXTER CORPORATION,Brevibloc Premixed Injection,ESMOLOL HYDROCHLORIDE,10MG,250mL Intravia Container,INTRAVENOUS,Resolved,SOLUTION,C07AB,BETA BLOCKING AGENTS,2017-07-27,2017-07-27,2017-08-08,2017-08-08,Delay in shipping of the drug.,2017-07-31,2017-08-09
42178,2187086,Shortage,BREVICON 0.5/35 TABLETS (21-DAY PACK),PFIZER CANADA INC,Brevicon,ETHINYL ESTRADIOL  NORETHINDRONE,0.035MG  0.5MG,21's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-04-02,,2018-04-23,Disruption of the manufacture of the drug.,2018-03-07,2018-04-24
41332,2187094,Shortage,BREVICON 0.5/35 TABLETS (28-DAY PACK),PFIZER CANADA INC,Brevicon,ETHINYL ESTRADIOL  NORETHINDRONE,.035MG  .5MG,28's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-03-14,,2018-05-23,Demand increase for the drug.,2018-02-28,2018-05-24
40436,2189054,Shortage,BREVICON 1/35 TABLETS (21-DAY PACK),PFIZER CANADA INC,Brevicon,ETHINYL ESTRADIOL  NORETHINDRONE,0.035MG  1MG,21's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-02-23,2018-03-21,2018-03-20,Demand increase for the drug.,2018-02-21,2018-03-21
92052,2189062,Shortage,BREVICON 1/35 TABLETS (28-DAY PACK),PFIZER CANADA ULC,Brevicon,ETHINYL ESTRADIOL  NORETHINDRONE,0.035MG  1MG,28's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-09-13,2019-09-09,2019-10-15,2019-10-15,Disruption of the manufacture of the drug.,2019-08-21,2019-10-16
78084,786616,Shortage,BRICANYL TURBUHALER,ASTRAZENECA CANADA INC,terbutaline sulfate,TERBUTALINE SULFATE,0.5MG,100 doses,INHALATION,Resolved,POWDER (METERED DOSE),R03AC,"ADRENERGICS, INHALANTS",2019-03-12,2019-03-12,2019-03-29,2019-03-28,Demand increase for the drug.,2019-03-08,2019-03-29
67037,786616,Shortage,BRICANYL TURBUHALER,ASTRAZENECA CANADA INC,terbutaline sulfate,TERBUTALINE SULFATE,0.5MG,100 doses,INHALATION,Resolved,POWDER (METERED DOSE),R03AC,"ADRENERGICS, INHALANTS",,2018-11-14,2019-02-25,2019-02-25,Delay in shipping of the drug.,2018-11-16,2019-02-26
59190,2451816,Shortage,BRIDION,MERCK CANADA INC,Sugammadex Solution for Injection,SUGAMMADEX,100MG,10x2mL,INTRAVENOUS,Avoided shortage,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2018-09-07,,2018-09-11,2018-09-04,Delay in shipping of the drug.,2018-08-27,2018-09-04
91211,2451816,Shortage,BRIDION,MERCK CANADA INC,Sugammadex Solution for Injection,SUGAMMADEX,100MG,10 x 2mL,INTRAVENOUS,Avoided shortage,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2019-08-26,,2019-08-26,2019-08-23,Delay in shipping of the drug.,2019-08-09,2019-08-23
39289,2301334,Shortage,BRIMONIDINE P,AA PHARMA INC,Brimonidine P,BRIMONIDINE TARTRATE,0.15%,10ml,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-02-09,2018-07-18,2018-07-16,Disruption of the manufacture of the drug.,2018-02-12,2018-07-17
75644,2301334,Shortage,BRIMONIDINE P,AA PHARMA INC,Brimonidine P,BRIMONIDINE TARTRATE,0.15%,10ML,OPHTHALMIC,Actual shortage,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-05-15,,,,Disruption of the manufacture of the drug.,2019-02-13,2019-05-16
75649,2301334,Shortage,BRIMONIDINE P,AA PHARMA INC,Brimonidine P,BRIMONIDINE TARTRATE,0.15%,5ML,OPHTHALMIC,Actual shortage,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-02-18,,,,Disruption of the manufacture of the drug.,2019-02-13,2019-02-19
43918,2301334,Shortage,BRIMONIDINE P,AA PHARMA INC,BRIMONIDINE P,BRIMONIDINE TARTRATE,0.15%,5ml,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-03-26,2018-07-18,2018-07-16,Disruption of the manufacture of the drug.,2018-03-26,2018-07-17
45634,2452979,Shortage,BRIVLERA,UCB CANADA INC,BRIVARACETAM,BRIVARACETAM,100MG,60 TABLETS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-04-13,2018-04-30,2018-05-04,Demand increase for the drug.,2018-04-13,2018-05-05
58785,2220520,Shortage,BROMAZEPAM-3 - TAB 3MG,PRO DOC LIMITEE,BROMAZEPAM,BROMAZEPAM,3MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-09-06,,2018-09-06,2018-09-06,Demand increase for the drug.,2018-08-22,2018-09-07
71896,2220520,Shortage,BROMAZEPAM-3 - TAB 3MG,PRO DOC LIMITEE,BROMAZEPAM - 3,BROMAZEPAM,3MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-01-10,,2019-04-10,Other (Please describe in comments),2019-01-10,2019-04-11
58788,2220539,Shortage,BROMAZEPAM-6 - TAB 6MG,PRO DOC LIMITEE,BROMAZEPAM,BROMAZEPAM,6MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-12-03,,2019-02-12,Demand increase for the drug.,2018-08-22,2019-02-13
41552,2230454,Shortage,BROMOCRIPTINE,AA PHARMA INC,BRMOCRIPTINE,BROMOCRIPTINE,5MG,100 Bottle,ORAL,Resolved,CAPSULE,N04BC,DOPAMINERGIC AGENTS,,2018-03-02,,2018-03-09,Disruption of the manufacture of the drug.,2018-03-02,2018-03-10
85650,2230454,Shortage,BROMOCRIPTINE,AA PHARMA INC,Bromocriptine,BROMOCRIPTINE,5MG,100 BTL,ORAL,Resolved,CAPSULE,N04BC,DOPAMINERGIC AGENTS,,2019-06-05,2019-08-15,2019-08-22,Disruption of the manufacture of the drug.,2019-06-05,2019-08-23
43556,2443686,Shortage,BUPIVACAINE INJECTION BP,STERIMAX INC,BUPIVACAINE INJECTION BP,BUPIVACAINE HYDROCHLORIDE,2.5MG,10 VIALS,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-03-20,2018-06-08,2018-05-25,Delay in shipping of the drug.,2018-03-20,2018-05-26
84853,2443694,Shortage,BUPIVACAINE INJECTION BP,STERIMAX INC,Bupivacaine Injection BP,BUPIVACAINE HYDROCHLORIDE,5MG,10 vials 0.5 20 ml,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-05-20,2019-05-31,2019-05-28,Other (Please describe in comments),2019-05-27,2019-05-29
51424,2443694,Shortage,BUPIVACAINE INJECTION BP,STERIMAX INC,BUPIVACAINE INJECTION BP,BUPIVACAINE HYDROCHLORIDE,5MG,10 VIALS,BLOCK/INFILTRATION  EPIDURAL,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-06-01,2018-06-27,,Delay in shipping of the drug.,2018-06-05,2018-06-05
51428,2443686,Shortage,BUPIVACAINE INJECTION BP,STERIMAX INC,BUPIVACAINE INJECTION BP,BUPIVACAINE HYDROCHLORIDE,2.5MG,10 VIALS,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-06-01,2018-06-22,2018-08-08,Delay in shipping of the drug.,2018-06-05,2018-08-09
66926,2331616,Shortage,BUPROPION SR,PRO DOC LIMITEE,BUPROPION,BUPROPION HYDROCHLORIDE,100MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2019-01-07,,,2019-01-07,Demand increase for the drug.,2018-11-14,2019-01-08
66929,2325357,Shortage,BUPROPION SR,PRO DOC LIMITEE,BUPROPION,BUPROPION HYDROCHLORIDE,150MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-11-21,,2019-01-11,Demand increase for the drug.,2018-11-14,2019-01-12
82824,2325357,Shortage,BUPROPION SR,PRO DOC LIMITEE,BUPROPION SR,BUPROPION HYDROCHLORIDE,150MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-04-30,,2019-05-28,Demand increase for the drug.,2019-04-30,2019-05-29
88866,728276,Shortage,BURINEX,KNIGHT THERAPEUTICS INC.,Burinex 5mg 3x10's,BUMETANIDE,5MG,30,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2019-07-08,2019-10-25,2019-10-25,Delay in shipping of the drug.,2019-07-08,2019-10-28
31826,363812,Shortage,BUSCOPAN,SANOFI-AVENTIS CANADA INC,Buscopan 10mg,HYOSCINE BUTYLBROMIDE,10MG,100,ORAL,Resolved,TABLET,A03BB,"BELLADONNAAND DERIVATIVES, PLAIN",2018-01-15,2018-01-15,2019-06-01,2019-03-14,Other (Please describe in comments),2017-12-05,2019-03-15
3682,363812,Shortage,BUSCOPAN,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Buscopan Tabs,HYOSCINE BUTYLBROMIDE,10MG,100,ORAL,Resolved,TABLET,A03BB,"BELLADONNAAND DERIVATIVES, PLAIN",,2017-02-03,,2017-07-18,Disruption of the manufacture of the drug.,2017-03-20,2017-07-19
81534,363812,Shortage,BUSCOPAN,SANOFI-AVENTIS CANADA INC,Buscopan,HYOSCINE BUTYLBROMIDE,10MG,100,ORAL,Resolved,TABLET,A03BB,"BELLADONNAAND DERIVATIVES, PLAIN",2019-04-15,2019-04-04,2019-09-01,2019-07-15,Other (Please describe in comments),2019-04-12,2019-07-16
68068,363839,Shortage,BUSCOPAN,SANOFI-AVENTIS CANADA INC,Busopan 20MG/1ML,HYOSCINE BUTYLBROMIDE,20MG,10 X 1ml,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Avoided shortage,SOLUTION,A03BB,"BELLADONNAAND DERIVATIVES, PLAIN",2018-12-24,,2019-01-08,2018-12-14,Delay in shipping of the drug.,2018-11-29,2018-12-18
89991,2463733,Shortage,BUSULFAN FOR INJECTION,STERIMAX INC,BUSULFAN FOR INJECTION,BUSULFAN,6MG,8 VIALS,INTRAVENOUS,Resolved,SOLUTION,L01AB,ALKYLATINGAGENTS,,2019-07-26,2019-08-30,2019-09-05,Delay in shipping of the drug.,2019-07-26,2019-09-06
15779,2242504,Shortage,BUTORPHANOL NASAL SPRAY,AA PHARMA INC,Butorphanol Nasal Spray,BUTORPHANOL TARTRATE,10MG,2.5 ml,NASAL,Resolved,SOLUTION,N02AF,OPIOIDS,,2017-07-14,2017-09-15,2017-09-14,Disruption of the manufacture of the drug.,2017-07-14,2017-09-15
18193,2361817,Shortage,BYETTA,ASTRAZENECA CANADA INC,exenatide injection,EXENATIDE,250MCG,2.4 mL prefilled pen,SUBCUTANEOUS,Resolved,SOLUTION,A10BJ,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-08-14,,2017-09-04,2017-09-06,Demand increase for the drug.,2017-08-03,2017-09-07
10355,2361817,Shortage,BYETTA,ASTRAZENECA CANADA INC,exenatide injection,EXENATIDE,250MCG,2.4 mL prefilled pen,SUBCUTANEOUS,Resolved,SOLUTION,A10BJ,,2017-06-12,,2017-06-20,2017-06-20,Delay in shipping of the drug.,2017-05-15,2017-06-21
73615,2361817,Shortage,BYETTA,ASTRAZENECA CANADA INC,exenatide injection,EXENATIDE,250MCG,"1 x 2.4 mL prefilled pen / stylo pré-rempli de 2,4 mL",SUBCUTANEOUS,Resolved,SOLUTION,A10BJ,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-02-05,,2019-03-11,2019-04-01,Demand increase for the drug.,2019-01-25,2019-04-16
84746,2399016,Shortage,BYSTOLIC,ALLERGAN INC,BYSTOLIC 10MG TAB 30 CA,Nebivolol,10.0MG,10MG TAB 30 CA,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2019-05-24,2019-05-24,,2019-06-05,Other (Please describe in comments),2019-05-25,2019-06-06
84750,2398990,Shortage,BYSTOLIC,ALLERGAN INC,BYSTOLIC 2.5MG TAB 30 CA,Nebivolol,2.5MG,BYSTOLIC 2.5MG TAB 30 CA,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
84755,2399024,Shortage,BYSTOLIC,ALLERGAN INC,BYSTOLIC 20MG TAB 30 CA,Nebivolol,20.0MG,BYSTOLIC 20MG TAB 30 CA,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
84758,2399008,Shortage,BYSTOLIC,ALLERGAN INC,BYSTOLIC 5MG TAB 30 CA,Nebivolol,5.0MG,BYSTOLIC 5MG TAB 30 CA,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
73787,2399016,Shortage,BYSTOLIC,ALLERGAN INC,BYSTOLIC 10MG TAB 30 CA,Nebivolol,10.0MG,10MG TAB 30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2019-01-29,2019-02-13,2019-02-21,Other (Please describe in comments),2019-01-29,2019-02-22
68675,2399008,Shortage,BYSTOLIC,ALLERGAN INC,BYSTOLIC 5MG TAB 30 CA,Nebivolol,5.0MG,5MG TAB 30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-12-10,2018-12-07,2019-01-14,2019-01-17,Other (Please describe in comments),2018-12-05,2019-02-08
45233,2273233,Shortage,CADUET,PFIZER CANADA INC,Caduet,AMLODIPINE  ATORVASTATIN,5MG  10MG,90s,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2018-04-11,,2018-05-07,Disruption of the manufacture of the drug.,2018-04-09,2018-05-08
72070,821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LTD,Calcium Chloride for Injection USP,CALCIUM CHLORIDE,100MG,10 x 50mL vial / fiole,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2019-01-04,2019-02-13,2019-02-15,Disruption of the manufacture of the drug.,2019-01-14,2019-02-18
55723,821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LTD,Calcium Chloride for Injection USP,CALCIUM CHLORIDE,100MG,10 x 50 mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-07-13,2018-07-31,2018-07-23,Disruption of the manufacture of the drug.,2018-07-13,2018-07-24
63427,821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LTD,Calcium Chloride for Injection USP,CALCIUM CHLORIDE,100MG,10 x 50 mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-10-05,2018-10-15,2018-10-10,Disruption of the manufacture of the drug.,2018-10-05,2018-10-16
45388,1926691,Shortage,CALCIMAR SOLUTION INJ 200UNIT/ML,SANOFI-AVENTIS CANADA INC,CALCIMAR,CALCITONIN,200UNIT,2ML VIAL,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SOLUTION,H05BA,ANTI-PARATHYROID HORMONES,2018-04-23,,2018-05-31,2018-05-14,Delay in shipping of the drug.,2018-04-10,2018-06-12
68054,1926691,Shortage,CALCIMAR SOLUTION INJ 200UNIT/ML,SANOFI-AVENTIS CANADA INC,Calcimar,CALCITONIN,200UNIT,"Vial multidose, 200 U / mL",INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SOLUTION,H05BA,ANTI-PARATHYROID HORMONES,2018-12-17,,2019-06-30,2019-05-29,Other (Please describe in comments),2018-11-29,2019-05-30
89647,2399334,Shortage,CALCITRIOL INJECTION USP,STERIMAX INC,CALCITRIOL INJECTION USP,CALCITRIOL,1MCG,25 AMPOULES,INTRAVENOUS,Actual shortage,SOLUTION,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2019-07-22,2019-11-29,,Delay in shipping of the drug.,2019-07-19,2019-10-23
48190,2399334,Shortage,CALCITRIOL INJECTION USP,STERIMAX INC,CALCITRIOL INJECTION USP,CALCITRIOL,1MCG,25 AMPOULES,INTRAVENOUS,Resolved,SOLUTION,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2018-05-03,2018-07-27,2018-07-25,Delay in shipping of the drug.,2018-05-03,2018-07-26
8288,2399342,Shortage,CALCITRIOL INJECTION USP,STERIMAX INC,CALCITRIOL INJECTION USP,CALCITRIOL,2MCG,10 AMPOULES,INTRAVENOUS,Actual shortage,SOLUTION,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2016-10-17,2016-10-17,,Other (Please describe in comments),2017-04-27,2018-08-09
28074,294748,Shortage,CALCIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,Calcium Chloride LifeShield,CALCIUM CHLORIDE,100MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017-11-17,,2017-12-29,Disruption of the manufacture of the drug.,2017-11-04,2018-01-02
26810,294748,Shortage,CALCIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,CALCIUM CHLORIDE ANSYR,CALCIUM CHLORIDE,100MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017-11-10,,2018-01-26,Disruption of the manufacture of the drug.,2017-10-24,2018-02-07
51929,294748,Shortage,CALCIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,CALCIUM CHLORIDE INJECTION USP LIFESHIELD,CALCIUM CHLORIDE,100MG,10 X 10mL PFS,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-08-08,,2018-08-29,Disruption of the manufacture of the drug.,2018-06-08,2018-08-30
86519,294748,Shortage,CALCIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,Calcium Chloride Injection USP,CALCIUM CHLORIDE,100MG,10 x 10mL ANSYR,INTRAVENOUS,Actual shortage,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-06-11,,,Disruption of the manufacture of the drug.,2019-06-12,2019-08-13
88610,2141019,Shortage,"CALCIUM GLUCONATE INJECTION, USP 10%",FRESENIUS KABI CANADA LTD,Calcium Gluconate Injection,CALCIUM GLUCONATE,94MG,100mL Vial,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-06-27,2019-07-12,2019-07-24,Disruption of the manufacture of the drug.,2019-07-05,2019-07-26
41540,2141019,Shortage,"CALCIUM GLUCONATE INJECTION, USP 10%",FRESENIUS KABI CANADA LTD,Calcium Gluconate Injection USP 10% 100 mg/mL,CALCIUM GLUCONATE  CALCIUM SACCHARATE,94MG  4.5MG,10 mL Vial,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2018-03-14,,2018-04-04,2018-04-09,Disruption of the manufacture of the drug.,2018-03-02,2018-04-10
90052,2141019,Shortage,"CALCIUM GLUCONATE INJECTION, USP 10%",FRESENIUS KABI CANADA LTD,Calcium Gluconate,CALCIUM GLUCONATE,94MG,50mL,INTRAVENOUS,Actual shortage,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-07-26,2019-10-08,,Disruption of the manufacture of the drug.,2019-07-26,2019-10-01
87656,2198630,Shortage,CALMYLIN ACE,TEVA CANADA LIMITED,CALMYLIN,PHENIRAMINE MALEATE  CODEINE PHOSPHATE  GUAIFENESIN,7.5MG  10MG  100MG,500ML,ORAL,Resolved,SYRUP,R05FA,"COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS",,2019-06-27,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-27,2019-08-06
87659,2172917,Shortage,CALMYLIN PSE WITH CODEINE,TEVA CANADA LIMITED,CALMYLIN CODEINE,PSEUDOEPHEDRINE HYDROCHLORIDE  CODEINE PHOSPHATE  GUAIFENESIN,30MG  3.3MG  100MG,100ML,ORAL,Resolved,SOLUTION,R05FA,"COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS",,2019-06-27,2019-08-30,2019-08-15,Disruption of the manufacture of the drug.,2019-06-27,2019-08-16
72306,2293269,Shortage,CAMPRAL,MYLAN PHARMACEUTICALS ULC,ACAMPROSATE SODIUM,ACAMPROSATE CALCIUM,333MG,84BL,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),N07BB,DRUGS USED IN ADDICTIVE DISORDERS,2019-02-04,2019-01-29,2019-12-15,,Delay in shipping of the drug.,2019-01-15,2019-10-01
13187,2293269,Shortage,CAMPRAL,MYLAN PHARMACEUTICALS ULC,CAMPRAL,ACAMPROSATE CALCIUM,333MG,84BL,ORAL,Resolved,TABLET (DELAYED-RELEASE),N07BB,DRUGS USED IN ADDICTIVE DISORDERS,2018-07-17,2018-07-03,2018-10-09,2018-10-09,Delay in shipping of the drug.,2017-06-16,2018-10-10
87077,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-06-21,2019-06-27,2019-07-10,2019-07-05,Disruption of the manufacture of the drug.,2019-06-19,2019-07-06
60200,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-09-07,2018-09-07,2018-11-16,2018-11-21,Demand increase for the drug.,2018-09-07,2018-11-22
73514,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN TAB,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-25,2019-01-25,2019-05-16,2019-05-15,Disruption of the manufacture of the drug.,2019-01-25,2019-05-16
73517,2388936,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN TAB,CANDESARTAN CILEXETIL,16MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-25,2019-03-08,2019-02-22,Disruption of the manufacture of the drug.,2019-01-25,2019-02-26
73520,2435845,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN TAB,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-25,2019-04-19,2019-04-23,Disruption of the manufacture of the drug.,2019-01-25,2019-04-24
76852,2377942,Shortage,CANDESARTAN,PRO DOC LIMITEE,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30-100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-26,,2019-04-17,Delay in shipping of the drug.,2019-02-26,2019-04-18
76372,2422069,Shortage,CANDESARTAN,PRO DOC LIMITEE,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-20,,2019-04-09,Delay in shipping of the drug.,2019-02-20,2019-04-10
13149,2388707,Shortage,CANDESARTAN,SIVEM PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-06-16,,2017-07-03,2017-07-30,Demand increase for the drug.,2017-06-16,2017-11-03
96874,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-10-29,2019-10-28,2020-01-03,,Disruption of the manufacture of the drug.,2019-10-21,2019-11-12
96880,2388928,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-21,2019-11-21,,Disruption of the manufacture of the drug.,2019-10-21,2019-11-12
64882,2377934,Shortage,CANDESARTAN,PRO DOC LIMITEE,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,30-100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-19,,2019-02-20,Demand increase for the drug.,2018-10-19,2019-02-21
96884,2435845,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-10-22,2019-10-28,2019-11-21,,Disruption of the manufacture of the drug.,2019-10-21,2019-11-12
6263,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN TABS,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-04-14,2017-05-19,2017-05-08,Other (Please describe in comments),2017-04-10,2017-05-10
59777,2435845,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN CILEXETIL,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-09-04,2018-09-04,2018-11-22,2018-11-21,Demand increase for the drug.,2018-09-04,2018-11-22
63623,2422069,Shortage,CANDESARTAN,PRO DOC LIMITEE,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-10,,2018-11-13,Delay in shipping of the drug.,2018-10-10,2018-11-19
62910,2377942,Shortage,CANDESARTAN,PRO DOC LIMITEE,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30-100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-02,,2018-11-12,Delay in shipping of the drug.,2018-10-02,2018-11-13
12745,2388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN TABS,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-06-15,,2017-06-30,2017-06-21,Delay in shipping of the drug.,2017-06-14,2017-06-22
80863,2388936,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-09,2019-05-16,2019-05-15,Disruption of the manufacture of the drug.,2019-04-09,2019-05-16
83176,2388707,Shortage,CANDESARTAN,SIVEM PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-23,2019-05-24,2019-06-21,2019-06-21,Delay in shipping of the drug.,2019-05-06,2019-06-22
84315,2394812,Shortage,CANDESARTAN HCT,SIVEM PHARMACEUTICALS ULC,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-06-19,2019-06-18,2019-07-19,2019-07-16,Delay in shipping of the drug.,2019-05-17,2019-07-19
66686,2394812,Shortage,CANDESARTAN HCT,SIVEM PHARMACEUTICALS ULC,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,100,ORAL,Avoided shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-12-05,,2018-12-03,2018-12-03,Requirements related to complying with good manufacturing practices.,2018-11-12,2018-12-03
91355,2394812,Shortage,CANDESARTAN HCT,SIVEM PHARMACEUTICALS ULC,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,100,ORAL,Avoided shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-09-16,,,2019-08-18,Delay in shipping of the drug.,2019-08-12,2019-08-19
84241,2392275,Shortage,CANDESARTAN-HCTZ,PRO DOC LIMITEE,CANDESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16.0MG,30-100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-05-16,,2019-07-17,Delay in shipping of the drug.,2019-05-16,2019-07-18
75262,2394804,Shortage,CANDESARTAN/HCTZ,SANIS HEALTH INC,CANDESARTAN/HCTZ TAB,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-02-18,2019-02-19,2019-03-15,2019-03-01,Other (Please describe in comments),2019-02-11,2019-03-02
12045,589500,Shortage,CANTHACUR-PS,PALADIN LABS INC,Canthacur,SALICYLIC ACID  CANTHARIDIN  PODOPHYLLIN,30%  1%  5%,7.5ml,TOPICAL,Actual shortage,LIQUID,D11,OTHER DERMATOLOGICAL PREPARATIONS,2017-06-06,2017-06-06,,,Disruption of the manufacture of the drug.,2017-06-06,2018-12-20
7008,2413604,Shortage,CARBAMAZEPINE CR,PRO DOC LIMITEE,CARBAMAZEPINE CR,CARBAMAZEPINE,400MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,,2017-04-24,2017-05-09,2017-05-09,Delay in shipping of the drug.,2017-04-13,2017-05-10
59932,2241999,Shortage,CARBOCAINE 1%,PFIZER CANADA INC,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,1%,10x30ml,EPIDURAL  INTRACAUDAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-09-04,,2018-09-18,Disruption of the manufacture of the drug.,2018-09-04,2018-09-19
57425,2241999,Shortage,CARBOCAINE 1%,PFIZER CANADA INC,CARBOCAINE 1%,MEPIVACAINE HYDROCHLORIDE,1%,10 X 30mL GVL,EPIDURAL  INTRACAUDAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-03-08,,2019-06-25,Disruption of the manufacture of the drug.,2018-08-03,2019-06-26
78702,2242000,Shortage,CARBOCAINE 1%,PFIZER CANADA ULC,Mepivacaine Hydrochloride Injection USP,MEPIVACAINE HYDROCHLORIDE,1%,5 x 50mL GVL MD,BLOCK/INFILTRATION,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-09-01,,,Disruption of the manufacture of the drug.,2019-03-14,2019-11-06
14724,2241999,Shortage,CARBOCAINE 1%,HOSPIRA HEALTHCARE CORPORATION,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,1%,10x30ml,EPIDURAL  INTRACAUDAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-09-28,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-23
14728,2242000,Shortage,CARBOCAINE 1%,HOSPIRA HEALTHCARE CORPORATION,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,1%,5x50ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-11,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-23
34273,2241999,Shortage,CARBOCAINE 1%,PFIZER CANADA INC,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,1%,10X30mL GVL,EPIDURAL  INTRACAUDAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-03-09,,2018-05-02,Disruption of the manufacture of the drug.,2017-12-22,2018-05-03
65553,2242001,Shortage,CARBOCAINE 2%,PFIZER CANADA INC,Carbocaine,MEPIVACAINE HYDROCHLORIDE,20MG,10 x 20mL GVL,INTRACAUDAL  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-11-30,,2019-07-05,Disruption of the manufacture of the drug.,2018-10-24,2019-07-06
59929,2242001,Shortage,CARBOCAINE 2%,PFIZER CANADA INC,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,20MG,10x20mL,INTRACAUDAL  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-09-04,,2018-09-19,Disruption of the manufacture of the drug.,2018-09-04,2018-09-20
14731,2242001,Shortage,CARBOCAINE 2%,HOSPIRA HEALTHCARE CORPORATION,CARBOCAINE,MEPIVACAINE HYDROCHLORIDE,20MG,10x20ml,INTRACAUDAL  EPIDURAL,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-10-31,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-23
34267,2242001,Shortage,CARBOCAINE 2%,PFIZER CANADA INC,Carbocaine,MEPIVACAINE HYDROCHLORIDE,20MG,10x20mL GVL,INTRACAUDAL  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-01-19,,2018-04-02,Disruption of the manufacture of the drug.,2017-12-22,2018-04-03
87750,2011239,Shortage,CARBOLITH,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CARBOLITH,LITHIUM CARBONATE,600MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2019-06-25,,2019-07-15,Other (Please describe in comments),2019-06-27,2019-08-01
26486,2011239,Shortage,CARBOLITH CAPSULES 600MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CARBOLITH CAPSULES 600MG,LITHIUM CARBONATE,600MG,na,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-10-20,2017-11-03,2017-10-25,Other (Please describe in comments),2017-10-20,2017-11-03
39127,2011239,Shortage,CARBOLITH CAPSULES 600MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CARBOLITH CAPSULES 600MG,LITHIUM CARBONATE,600MG,na,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2018-02-08,,2018-02-28,Other (Please describe in comments),2018-02-08,2018-03-01
31468,2011239,Shortage,CARBOLITH CAPSULES 600MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CARBOLITH CAPSULES 600MG,LITHIUM CARBONATE,600MG,na,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-12-01,2017-12-20,2018-01-19,Other (Please describe in comments),2017-12-01,2018-01-23
10874,2125439,Shortage,CARBOPLATIN INJECTION,TEVA CANADA LIMITED,CARBOPLATIN,CARBOPLATIN,10MG,45ML,INTRAVENOUS,Resolved,LIQUID,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-05-18,2017-07-27,2017-08-01,Disruption of the manufacture of the drug.,2017-05-23,2017-09-19
61362,2125439,Shortage,CARBOPLATIN INJECTION,TEVA CANADA LIMITED,CARBOPLATIN,CARBOPLATIN,10MG,45ML,INTRAVENOUS,Resolved,LIQUID,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2018-09-12,2018-10-01,2018-10-01,Disruption of the manufacture of the drug.,2018-09-12,2018-10-11
5825,2320371,Shortage,CARBOPLATIN INJECTION,ACCORD HEALTHCARE INC,CARBOPLATIN,CARBOPLATIN,10MG,"10 MG/ML, 5 ML/VIAL (50 MG/VIAL)     |     10 MG/ML, 5 ML/FLACON (50 MG/FLACON)",INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-01-31,2017-01-31,2017-05-24,2017-05-09,Disruption of the manufacture of the drug.,2017-04-06,2017-05-10
3281,2320371,Shortage,CARBOPLATIN INJECTION,ACCORD HEALTHCARE INC,CARBOPLATIN,CARBOPLATIN,10MG,45 ML VIAL OF 450 MG     |     FLACON DE 45 ML DE 450 MG,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-02-14,2017-02-14,2017-03-20,2017-03-20,Disruption of the manufacture of the drug.,2017-03-17,2017-04-06
3295,2320371,Shortage,CARBOPLATIN INJECTION,ACCORD HEALTHCARE INC,CARBOPLATIN,CARBOPLATIN,10MG,60 ML VIAL OF 600 MG     |     FLACON DE 60 ML DE 600 MG,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-03-07,2017-03-07,2017-04-05,2017-03-31,Disruption of the manufacture of the drug.,2017-03-17,2017-04-06
31955,2126680,Shortage,CARBOPLATIN INJECTION BP,PFIZER CANADA INC,CARBOPLATIN,CARBOPLATIN,10MG,15mL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2018-04-16,,,2018-04-19,Disruption of the manufacture of the drug.,2017-12-06,2018-04-20
21747,2126680,Shortage,CARBOPLATIN INJECTION BP,PFIZER CANADA INC,CARBOPLATIN,CARBOPLATIN,10MG,1x60mL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-10-26,,2017-12-15,2017-11-09,Disruption of the manufacture of the drug.,2017-09-08,2017-11-14
39199,2144344,Shortage,CARNITOR,"LEADIANT BIOSCIENCES, INC",LEVOCARNITINE,LEVOCARNITINE,200MG,5mL vial (200mg/mL),INTRAVENOUS,Resolved,SOLUTION,A16AA,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,2018-02-23,,,2018-05-08,Demand increase for the drug.,2018-02-09,2018-05-09
97654,2144328,Shortage,CARNITOR,"LEADIANT BIOSCIENCES, INC",LEVOCARNITINE,LEVOCARNITINE,330MG,90 TABLETS,ORAL,Resolved,TABLET,A16AA,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,2019-10-31,2019-10-31,,2019-11-13,Other (Please describe in comments),2019-10-31,2019-11-14
161,2144328,Shortage,CARNITOR -TAB 330MG,SIGMA-TAU PHARMACEUTICALS INC,levocarnitine,LEVOCARNITINE,330MG,90 tablets,ORAL,Resolved,TABLET,A16AA,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,,2016-04-01,2017-06-02,2017-06-02,Disruption of the manufacture of the drug.,2017-03-10,2017-06-03
28179,2248755,Shortage,CARVEDILOL,SIVEM PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,25MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017-10-13,2018-08-31,2018-09-03,Requirements related to complying with good manufacturing practices.,2017-11-06,2018-09-10
32560,2248752,Shortage,CARVEDILOL,SIVEM PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,3.125MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2018-02-19,2018-02-15,2018-11-07,2018-11-07,Other (Please describe in comments),2017-12-12,2018-11-08
36049,2248753,Shortage,CARVEDILOL,SIVEM PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,6.25MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2018-01-25,2018-01-23,2018-08-31,2018-09-03,Other (Please describe in comments),2018-01-16,2018-09-10
36052,2248754,Shortage,CARVEDILOL,SIVEM PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,12.5MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2018-02-19,2018-02-15,2018-08-31,2018-09-03,Other (Please describe in comments),2018-01-16,2018-09-10
86751,2248754,Shortage,CARVEDILOL,SIVEM PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,12.5MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2019-07-08,2019-07-10,2019-08-12,2019-08-12,Delay in shipping of the drug.,2019-06-17,2019-08-13
35377,2184478,Shortage,CASODEX,ASTRAZENECA CANADA INC,bicalutamide,BICALUTAMIDE,50MG,30 tablets,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-01-04,2018-02-16,2018-02-15,Demand increase for the drug.,2018-01-09,2018-02-16
38166,2460955,Shortage,CASPOFUNGIN FOR INJECTION,MDA INC.,Caspofungin,CASPOFUNGIN,70MG,10 ml Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J02AX,ANTIMYCOTICS FOR SYSTEMIC USE,,2018-02-02,,2018-04-12,Delay in shipping of the drug.,2018-02-02,2018-04-13
98076,2215756,Shortage,CAVERJECT STERILE POWDER,PFIZER CANADA ULC,Caverject,ALPROSTADIL,23.2MCG,5 x 20MCG VIALS,INTRACAVERNOSAL,Actual shortage,KIT  LIQUID  POWDER FOR SOLUTION,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-29,,,Disruption of the manufacture of the drug.,2019-11-06,2019-11-06
42319,2215756,Shortage,CAVERJECT STERILE POWDER - KIT 23.2MCG/VIAL,PFIZER CANADA INC,Caverject,WATER  ALPROSTADIL,99.1%  23.2MCG,5 x 20MCG,INTRACAVERNOSAL,Resolved,KIT  LIQUID  POWDER FOR SOLUTION,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-04-20,,2018-06-01,Disruption of the manufacture of the drug.,2018-03-08,2018-06-04
35122,2437112,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,1G,25 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2018-01-08,,2018-02-12,2018-02-12,Delay in shipping of the drug.,2018-01-08,2018-08-08
33371,2437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,10 vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-12-18,2018-03-26,2018-03-12,Delay in shipping of the drug.,2017-12-18,2018-06-05
21857,2437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,PACK OF 10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-09-11,2017-11-13,2017-11-08,Other (Please describe in comments),2017-09-11,2017-11-09
21860,2437112,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,1G,PACK OF 25 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-09-11,2017-11-20,2017-11-16,Other (Please describe in comments),2017-09-11,2017-11-17
8815,2437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,PACK OF 10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-05-01,,2017-06-05,Other (Please describe in comments),2017-05-03,2017-06-07
62580,2437112,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,1G,PACK OF 25,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-09-24,2018-10-19,2018-10-19,Delay in shipping of the drug.,2018-09-28,2018-10-20
94837,2108127,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN SODIUM INJ,CEFAZOLIN,1G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-09-26,2019-11-30,2019-10-09,Disruption of the manufacture of the drug.,2019-09-26,2019-10-10
10877,2108119,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN,CEFAZOLIN,0.5G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-05-17,2017-07-30,2017-09-01,Disruption of the manufacture of the drug.,2017-05-23,2017-09-19
86966,2108119,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN,CEFAZOLIN,0.5G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
17865,2108135,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN,CEFAZOLIN,10G,10G,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-08-01,2017-10-15,2017-10-20,Disruption of the manufacture of the drug.,2017-08-01,2017-10-24
93653,2108135,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN,CEFAZOLIN,10G,1,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-09-11,2019-11-30,,Disruption of the manufacture of the drug.,2019-09-12,2019-09-12
12782,2452162,Shortage,CEFAZOLIN FOR INJECTION,FRESENIUS KABI CANADA LTD,Cefazolin for Injection,CEFAZOLIN,10G,10g Vial,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2017-07-03,,,,Disruption of the manufacture of the drug.,2017-06-15,2018-12-20
88563,2437112,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,1G,25 VIALS,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-08,,,Demand increase for the drug.,2019-07-05,2019-08-16
88566,2437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,10 VIALS,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-08,,,Demand increase for the drug.,2019-07-05,2019-08-16
33327,2308959,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,1G,10 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-12-12,2018-05-04,2018-04-30,Demand increase for the drug.,2017-12-15,2018-05-03
91538,2308967,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,10G,1PSOIJ,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-29,2019-10-28,2019-10-28,Demand increase for the drug.,2019-08-14,2019-11-01
91541,2308959,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,1G,10PSOIJ,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-29,2019-11-25,,Demand increase for the drug.,2019-08-14,2019-11-01
2520,2308959,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,1G,1G,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2017-03-14,,2017-05-31,2017-05-05,Disruption of the manufacture of the drug.,2017-03-14,2017-07-05
64225,2308932,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,500MG,10PSOIJ,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-07-02,2020-03-30,,Requirements related to complying with good manufacturing practices.,2018-10-15,2019-06-12
2533,2308932,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,500MG,10 X 500MG,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2017-03-14,,2017-04-28,2017-05-05,Demand increase for the drug.,2017-03-14,2017-07-05
2536,2308932,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,500MG,10 X 500MG,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-14,2017-04-14,2017-05-05,Demand increase for the drug.,2017-03-14,2017-07-05
76590,2401029,Shortage,"CEFAZOLIN FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,"Cefazolin for Injection, USP",CEFAZOLIN,100G,100g SmartPak,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,2019-11-01,,2019-12-16,,Disruption of the manufacture of the drug.,2019-02-21,2019-11-02
88723,2237138,Shortage,"CEFAZOLIN FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,Cefazolin for Injection,CEFAZOLIN,1.0G,1g Vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-04,2019-09-06,2019-09-06,Disruption of the manufacture of the drug.,2019-07-05,2019-09-13
12777,2237140,Shortage,"CEFAZOLIN FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,Cefazolin for Injection,CEFAZOLIN,10G,10g Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-04,2019-09-06,2019-09-06,Disruption of the manufacture of the drug.,2017-06-15,2019-09-13
698,2319039,Shortage,CEFEPIME FOR INJECTION,APOTEX INC,CEFEPIME,CEFEPIME (CEFEPIME HYDROCHLORIDE),2G,20 ML,INJECTION,Actual shortage,POWDER FOR SOLUTION,J01DE,OTHER BETA-LACTAM ANTIBACTERIALS,,2012-08-23,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
92177,2128195,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,2G,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-08-22,2019-11-30,,Disruption of the manufacture of the drug.,2019-08-22,2019-09-12
3140,2128195,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,2G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-17,2017-06-09,2017-06-30,Disruption of the manufacture of the drug.,2017-03-17,2017-09-05
86614,2240773,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,10G,1,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-06-13,,,Disruption of the manufacture of the drug.,2019-06-13,2019-08-29
87662,2128187,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,1G,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-06-27,2019-11-30,,Disruption of the manufacture of the drug.,2019-06-27,2019-09-12
86969,2128195,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,2G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
17868,2240773,Shortage,CEFOXITIN FOR INJECTION,TEVA CANADA LIMITED,CEFOXITIN,CEFOXITIN,10G,10G,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-08-01,2017-11-30,2017-12-15,Demand increase for the drug.,2017-08-01,2018-01-03
8810,2437864,Shortage,CEFTAZIDIME FOR INJECTION BP,STERIMAX INC,CEFTAZIDIME FOR INJECTION BP,CEFTAZIDIME,6G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-05-01,2017-05-19,2017-05-24,Delay in shipping of the drug.,2017-05-03,2017-05-25
80085,2437848,Shortage,CEFTAZIDIME FOR INJECTION BP,STERIMAX INC,CEFTAZIDIME FOR INJECTION BP,CEFTAZIDIME,1G,10 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,2019-03-29,,2019-04-26,2019-05-13,Delay in shipping of the drug.,2019-03-29,2019-05-14
80088,2437856,Shortage,CEFTAZIDIME FOR INJECTION BP,STERIMAX INC,CEFTAZIDIME FOR INJECTION BP,CEFTAZIDIME,2G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-03-29,2019-04-26,2019-05-13,Delay in shipping of the drug.,2019-03-29,2019-05-14
35768,2212277,Shortage,CEFTIN - TAB 250MG,GLAXOSMITHKLINE INC,cefuroxime axetil tablets,CEFUROXIME,250MG,60's,ORAL,Actual shortage,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-01-11,,,Disruption of the manufacture of the drug.,2018-01-12,2019-10-18
35778,2212285,Shortage,CEFTIN - TAB 500MG,GLAXOSMITHKLINE INC,cefuroxime axetil tablets,CEFUROXIME,500MG,60's,ORAL,Actual shortage,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-01-11,,,Disruption of the manufacture of the drug.,2018-01-12,2019-10-18
15628,2409968,Shortage,CEFTRIAXONE FOR INJECTION,FRESENIUS KABI CANADA LTD,Ceftriaxone for Injection 100g SmartPak,CEFTRIAXONE,100G,100g SmartPak,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-12-11,2018-05-18,2018-05-23,Disruption of the manufacture of the drug.,2017-07-12,2018-05-24
57919,2409968,Shortage,CEFTRIAXONE FOR INJECTION,FRESENIUS KABI CANADA LTD,CefTRIAXone for Injection,CEFTRIAXONE,100G,100g SmartPak,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,2018-07-13,,,,Disruption of the manufacture of the drug.,2018-08-11,2018-11-02
6467,2292297,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,ROCEPHIN,CEFTRIAXONE,10.0G,10g VIAL,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-04-11,2017-04-28,2017-05-05,Demand increase for the drug.,2017-04-11,2017-08-02
31046,2292297,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIxone,CEFTRIAXONE,10.0G,1 VIAL,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-11-20,2017-12-15,2017-12-12,Requirements related to complying with good manufacturing practices.,2017-11-29,2017-12-15
21365,2292289,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,2.0G,10X2gV,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-09-01,2017-10-10,2017-10-09,Delay in shipping of the drug.,2017-09-07,2017-10-18
9644,2292262,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,0.25G,10 VIALS/FIOLES,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-05-09,2017-08-18,2017-08-28,Delay in shipping of the drug.,2017-05-09,2017-10-18
18143,2292289,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,2.0G,10 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,2017-08-10,,2017-08-31,2017-10-09,Delay in shipping of the drug.,2017-08-03,2017-10-18
3832,2292289,Shortage,CEFTRIAXONE FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,2.0G,10 X 2G VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-03-21,2017-03-31,2017-03-24,Requirements related to complying with good manufacturing practices.,2017-03-22,2017-03-28
86972,2287633,Shortage,CEFTRIAXONE SODIUM FOR INJECTION,TEVA CANADA LIMITED,CEFTRIAXONE SODIUM,CEFTRIAXONE,1G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
93450,2292289,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,2.0G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-07-15,2019-10-14,2019-10-01,Delay in shipping of the drug.,2019-09-10,2019-10-15
81678,2292270,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,1G,10vials,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-04-18,,2019-09-04,Requirements related to complying with good manufacturing practices.,2019-04-15,2019-09-10
96563,2292270,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,1G,10PSOIJ,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-10-07,2019-11-08,2019-11-01,Delay in shipping of the drug.,2019-10-15,2019-11-06
94637,2292297,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,10.0G,1PSOIJ,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-09-06,2019-11-18,2019-11-14,Delay in shipping of the drug.,2019-09-25,2019-11-18
77742,2292270,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE,CEFTRIAXONE,1G,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-01-16,2019-03-18,2019-03-07,Requirements related to complying with good manufacturing practices.,2019-03-05,2019-03-13
32244,2325594,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,STERIMAX INC,CEFTRIAXONE SODIUM FOR INJECTION BP,CEFTRIAXONE,250MG,10 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-12-08,2018-01-08,2017-12-22,Delay in shipping of the drug.,2017-12-08,2017-12-23
29312,2250276,Shortage,"CEFTRIAXONE SODIUM FOR INJECTION, BP",HOSPIRA HEALTHCARE CORPORATION,Ceftriaxone sodium,CEFTRIAXONE,250MG,10x250mg vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-11-13,,2017-12-20,Disruption of the manufacture of the drug.,2017-11-15,2017-12-21
29321,2250306,Shortage,"CEFTRIAXONE SODIUM FOR INJECTION, BP",HOSPIRA HEALTHCARE CORPORATION,Ceftriaxone sodium,CEFTRIAXONE,2G,10x2g vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-11-21,,2018-02-12,Disruption of the manufacture of the drug.,2017-11-15,2018-07-26
51491,2241638,Shortage,"CEFUROXIME FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,Cefuroxime,CEFUROXIME,750MG,750mg,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-06-01,2018-07-11,2018-07-04,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51497,2241639,Shortage,"CEFUROXIME FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,Cefuroxime,CEFUROXIME,1.5G,1.5g,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-06-01,2018-07-25,2018-07-25,Disruption of the manufacture of the drug.,2018-06-05,2018-07-26
51500,2241640,Shortage,"CEFUROXIME FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,Cefuroxime,CEFUROXIME,7.5G,7.5g,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-06-01,,,Disruption of the manufacture of the drug.,2018-06-05,2018-06-05
7489,2239941,Shortage,CELEBREX,PFIZER CANADA INC,CELEBREX,CELECOXIB,100MG,100's,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-04-28,,2017-05-31,2017-06-01,Disruption of the manufacture of the drug.,2017-04-20,2017-06-28
26143,2424398,Shortage,CELECOXIB,PRO DOC LIMITEE,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-10-17,,2017-10-17,Delay in shipping of the drug.,2017-10-17,2017-11-29
5679,2429675,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-04-04,,2018-07-23,Other (Please describe in comments),2017-04-05,2018-07-24
5682,2429683,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-04-04,,2018-07-23,Other (Please describe in comments),2017-04-05,2018-07-24
22070,2424398,Shortage,CELECOXIB,PRO DOC LIMITEE,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-09-13,,2017-09-21,Delay in shipping of the drug.,2017-09-13,2017-09-22
5719,2429683,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-04-04,,2018-07-23,Other (Please describe in comments),2017-04-05,2018-07-24
75387,2429683,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-02-22,2019-02-21,2019-03-19,2019-03-19,Shortage of an active ingredient.,2019-02-12,2019-03-20
47801,2436299,Shortage,CELECOXIB,SANIS HEALTH INC,CELECOXIB CAPS,CELECOXIB,100MG,500,ORAL,Actual shortage,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-05-11,2018-05-09,,,Disruption of the manufacture of the drug.,2018-05-01,2018-05-10
47804,2436302,Shortage,CELECOXIB,SANIS HEALTH INC,CELECOXIB CAPS,CELECOXIB,200MG,500,ORAL,Actual shortage,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-08-07,2018-08-07,,,Disruption of the manufacture of the drug.,2018-05-01,2018-08-08
71382,2429683,Shortage,CELECOXIB,SIVEM PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-02-19,2019-02-19,2019-05-07,2019-05-08,Shortage of an active ingredient.,2019-01-07,2019-05-13
98390,28096,Shortage,CELESTONE SOLUSPAN,MERCK CANADA INC,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE ACETATE  BETAMETHASONE,3MG  3MG,1ML VIAL,INTRA-ARTICULAR  INTRABURSAL  INTRADERMAL  INTRAMUSCULAR,Actual shortage,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-11-11,2019-11-22,,Delay in shipping of the drug.,2019-11-11,2019-11-12
7806,28096,Shortage,CELESTONE SOLUSPAN,MERCK CANADA INC,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE ACETATE  BETAMETHASONE,3MG  3MG,1mL,INTRA-ARTICULAR  INTRABURSAL  INTRADERMAL  INTRAMUSCULAR,Resolved,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017-05-01,2017-05-01,2017-05-24,2017-05-23,Delay in shipping of the drug.,2017-04-24,2017-05-24
16797,28096,Shortage,CELESTONE SOLUSPAN,MERCK CANADA INC,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE ACETATE  BETAMETHASONE,3MG  3MG,1mL,INTRA-ARTICULAR  INTRABURSAL  INTRADERMAL  INTRAMUSCULAR,Resolved,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017-09-13,2017-09-15,2017-09-29,2017-09-28,Delay in shipping of the drug.,2017-07-24,2017-09-29
94945,28096,Shortage,CELESTONE SOLUSPAN,MERCK CANADA INC,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE ACETATE  BETAMETHASONE,3MG  3MG,5ml VIAL,INTRA-ARTICULAR  INTRABURSAL  INTRADERMAL  INTRAMUSCULAR,Resolved,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2019-10-18,2019-10-17,2019-11-08,2019-11-07,Delay in shipping of the drug.,2019-09-27,2019-11-08
94948,28096,Shortage,CELESTONE SOLUSPAN,MERCK CANADA INC,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE ACETATE  BETAMETHASONE,3MG  3MG,1ML VIAL,INTRA-ARTICULAR  INTRABURSAL  INTRADERMAL  INTRAMUSCULAR,Resolved,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2019-10-14,2019-10-11,2019-11-08,2019-11-08,Delay in shipping of the drug.,2019-09-27,2019-11-09
89530,1926683,Shortage,CERUBIDINE 20MG/VIAL,ERFA CANADA 2012 INC,CERUBIDINE,DAUNORUBICIN,20MG,20ML VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,2019-07-18,2019-07-16,2019-08-20,2019-08-22,Disruption of the manufacture of the drug.,2019-07-17,2019-08-23
97019,1926683,Shortage,CERUBIDINE 20MG/VIAL,ERFA CANADA 2012 INC,CERUBIDINE,DAUNORUBICIN,20MG,VIAL,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,2019-10-25,2019-10-22,2019-12-27,,Disruption of the manufacture of the drug.,2019-10-22,2019-10-23
45668,2342227,Shortage,CERVARIX,GLAXOSMITHKLINE INC,Human Papillomavirus vaccine Types 16 and 18,RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN  RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN,20MCG  20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BM,VIRAL VACCINES,,2018-04-09,2018-11-15,2018-11-14,Other (Please describe in comments),2018-04-13,2018-11-15
59690,548375,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,1MG,n/a,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2018-08-29,,2018-11-26,Other (Please describe in comments),2018-08-31,2018-11-28
59693,2256193,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.5MG,n/a,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2018-08-27,,2018-11-26,Other (Please describe in comments),2018-08-31,2018-11-28
20078,548375,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,1MG,NA,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017-04-15,,2017-11-21,Other (Please describe in comments),2017-08-22,2017-11-22
36974,548375,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET 1mg,NABILONE,1MG,na,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018-02-15,,2018-05-15,2018-02-15,Other (Please describe in comments),2018-01-23,2018-02-16
36977,2256193,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.5MG,na,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2018-01-19,,2018-07-25,Other (Please describe in comments),2018-01-23,2018-07-27
46220,2312263,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.25MG,n/a,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2018-03-09,,2018-08-01,Other (Please describe in comments),2018-04-18,2018-08-03
46223,548375,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,1MG,n/a,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2018-03-09,,2018-07-25,Other (Please describe in comments),2018-04-18,2018-07-27
61161,2312263,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.25MG,n/a,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2018-09-04,,2018-11-26,Other (Please describe in comments),2018-09-10,2018-11-28
3308,2312263,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.25MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018-02-15,,2018-05-15,2018-02-15,Shortage of an active ingredient.,2017-03-17,2018-02-16
3317,2256193,Shortage,CESAMET,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CESAMET,NABILONE,0.5MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017-04-10,,2018-01-22,2017-11-21,Shortage of an active ingredient.,2017-03-17,2017-11-22
25863,2247766,Shortage,CETROTIDE,EMD SERONO A DIVISION OF EMD INC CANADA,cetrorelix acetate,CETRORELIX,0.25MG,1 vial / flacon,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,H01CC,HYPOTHALAMIC HORMONES,,2017-10-12,2017-12-31,2017-12-01,Demand increase for the drug.,2017-10-13,2017-12-02
82076,2298309,Shortage,CHAMPIX,PFIZER CANADA ULC,Champix,VARENICLINE  VARENICLINE,0.5MG  1.0MG,1x11+3x14 COMBO,ORAL,Resolved,KIT  TABLET,N07BA,DRUGS USED IN ADDICTIVE DISORDERS,2019-04-23,,2019-05-31,2019-05-30,Demand increase for the drug.,2019-04-18,2019-05-31
2128,2056429,Shortage,CHARAC-25,OMEGA LABORATORIES LTD,Charac-25,CHARCOAL ACTIVATED,222MG,112.5mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2016-09-28,2017-05-31,2017-05-30,Disruption of the manufacture of the drug.,2017-03-14,2017-06-19
91233,2056429,Shortage,CHARAC-25,OMEGA LABORATORIES LTD,"Charcoal, Activated USP (aqueous suspension)",CHARCOAL ACTIVATED,222MG,25 x 112.5mL,ORAL,Actual shortage,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2019-08-09,2019-12-09,,Disruption of the manufacture of the drug.,2019-08-09,2019-11-11
19841,2056429,Shortage,CHARAC-25,OMEGA LABORATORIES LTD,Charac-25,CHARCOAL ACTIVATED,222MG,112.5mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,2017-06-12,2017-06-12,2017-08-31,2017-08-31,Disruption of the manufacture of the drug.,2017-08-18,2017-09-01
72077,2056429,Shortage,CHARAC-25,OMEGA LABORATORIES LTD,"Charcoal, Activated USP (aqueous suspension)",CHARCOAL ACTIVATED,222MG,25 x 112.5mL,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2019-01-02,2019-06-30,2019-06-24,Disruption of the manufacture of the drug.,2019-01-14,2019-06-28
2116,637955,Shortage,CHARAC-50,OMEGA LABORATORIES LTD,Charac-50,CHARCOAL ACTIVATED,50G,225mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017-01-23,2017-03-31,2017-05-30,Disruption of the manufacture of the drug.,2017-03-14,2017-08-18
83797,637955,Shortage,CHARAC-50,OMEGA LABORATORIES LTD,"Charcoal, Activated USP (aqueous suspension)",CHARCOAL ACTIVATED,50G,20 x 225mL,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2019-05-09,2019-06-30,2019-06-24,Disruption of the manufacture of the drug.,2019-05-10,2019-06-28
19822,637955,Shortage,CHARAC-50,OMEGA LABORATORIES LTD,CHARAC-50,CHARCOAL ACTIVATED,50G,225mL botle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,2017-06-14,2017-06-14,2017-09-15,2017-09-09,Disruption of the manufacture of the drug.,2017-08-18,2017-09-18
67705,637955,Shortage,CHARAC-50,OMEGA LABORATORIES LTD,"Charcoal, Activated USP (aqueous suspension)",CHARCOAL ACTIVATED,50G,20 x 225mL,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2018-11-19,,2019-01-25,Disruption of the manufacture of the drug.,2018-11-27,2019-02-04
95459,637955,Shortage,CHARAC-50,OMEGA LABORATORIES LTD,"Charcoal, Activated USP (aqueous suspension)",CHARCOAL ACTIVATED,50G,20 x 225mL,ORAL,Actual shortage,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2019-09-21,2019-12-09,,Disruption of the manufacture of the drug.,2019-10-04,2019-11-11
2125,2060205,Shortage,CHARACTOL-25,OMEGA LABORATORIES LTD,Charactol-25,CHARCOAL ACTIVATED,200MG,125mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2016-10-19,2017-05-31,2017-05-30,Disruption of the manufacture of the drug.,2017-03-14,2017-06-19
2122,649236,Shortage,CHARACTOL-50,OMEGA LABORATORIES LTD,Charactol-50,CHARCOAL ACTIVATED,50G,250mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2016-07-28,2017-03-31,2017-05-30,Disruption of the manufacture of the drug.,2017-03-14,2017-06-19
98399,649236,Shortage,CHARACTOL-50,OMEGA LABORATORIES LTD,"Charcoal, Activated USP with sorbitol 20% (suspension)",CHARCOAL ACTIVATED,50G,20 x 250mL,ORAL,Actual shortage,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2019-09-13,2019-12-09,,Disruption of the manufacture of the drug.,2019-11-11,2019-11-11
19817,649236,Shortage,CHARACTOL-50,OMEGA LABORATORIES LTD,Charactol-50,CHARCOAL ACTIVATED,50G,250mL bottle,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,2017-06-14,2017-06-14,2017-09-15,2017-09-09,Disruption of the manufacture of the drug.,2017-08-18,2017-09-18
1794,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,Charcodote,CHARCOAL ACTIVATED,200MG,250 ml,ORAL,Actual shortage,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2015-11-03,,,Disruption of the manufacture of the drug.,2017-03-13,2017-12-18
4175,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250ml,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017-03-23,2017-04-12,2017-04-12,Disruption of the manufacture of the drug.,2017-03-24,2017-10-11
5460,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250ml,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017-03-23,2017-04-12,2017-04-12,Disruption of the manufacture of the drug.,2017-04-04,2017-10-11
6019,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250 mL,ORAL,Resolved,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017-04-05,2017-04-12,2017-04-12,Disruption of the manufacture of the drug.,2017-04-07,2017-10-11
7341,632333,Shortage,CHARCODOTE SUSP 200MG/ML,PHARMASCIENCE INC,CHARCODOTE,CHARCOAL ACTIVATED,200MG,250 ML,ORAL,Actual shortage,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2017-04-19,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
1805,2105470,Shortage,CHARCODOTE-AQUEOUS SUS 200MG/ML,PHARMASCIENCE INC,Charcodote,CHARCOAL ACTIVATED,200MG,250 ml,ORAL,Actual shortage,SUSPENSION,A07BA,INTESTINALADSORBENTS,,2015-11-03,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1851,618454,Shortage,CHLORAX,AA PHARMA INC,CHLORAX 5/2.5MG CAP 100 BTL,CHLORDIAZEPOXIDE HYDROCHLORIDE  CLIDINIUM BROMIDE,5/2.5MG,100 Bottle,Oral,Resolved,Capsule,A03CA,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,2017-01-18,2017-01-18,2017-09-04,2017-07-25,Shortage of an active ingredient.,2017-03-13,2017-07-26
5730,522988,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,CHLORDIAZEPOXIDE,CHLORDIAZEPOXIDE HYDROCHLORIDE,10MG,100 Bottle,ORAL,Resolved,CAPSULE,N05BA,ANXIOLYTICS,,2017-04-05,2017-09-08,2017-09-08,Shortage of an active ingredient.,2017-04-05,2017-09-09
5733,522996,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,CHLORDIAZEPOXIDE,CHLORDIAZEPOXIDE HYDROCHLORIDE,25MG,100 Bottle,ORAL,Resolved,CAPSULE,N05BA,ANXIOLYTICS,,2017-04-05,2017-10-20,2017-10-17,Shortage of an active ingredient.,2017-04-05,2017-10-18
1977,522724,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,CHLORDIAZEPOXIDE HYDROCHLORIDE,CHLORDIAZEPOXIDE HYDROCHLORIDE,5 MG,100 Bottle,Oral,Resolved,Capsule,N05BA,ANXIOLYTICS,2016-06-09,2016-06-09,2017-09-04,2017-08-11,Shortage of an active ingredient.,2017-03-13,2017-08-12
50616,312363,Shortage,CHLOROMYCETIN SUCCINATE INJECTION 1GM,ERFA CANADA 2012 INC,Chloramphenicol,CHLORAMPHENICOL,1G,box of 10,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01BA,AMPHENICOLS,,2018-05-28,2018-08-10,2018-09-06,Demand increase for the drug.,2018-05-29,2018-12-10
67482,360279,Shortage,CHLORTHALIDONE,AA PHARMA INC,Chlorthalidone,CHLORTHALIDONE,50MG,100BTL,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2018-11-23,2018-12-20,2018-11-29,Disruption of the manufacture of the drug.,2018-11-23,2019-01-09
2425,476366,Shortage,CHOLEDYL ELIXIR 100MG/5ML,ERFA CANADA 2012 INC,"Oxtriphylline Oral Solution, USP",Oxtriphylline,100 mg,bottle,Oral,Resolved,Elixir,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-01-19,2017-01-19,,2017-12-12,Disruption of the manufacture of the drug.,2017-03-14,2018-03-14
75382,476374,Shortage,CHOLEDYL EXPECTORANT ELIXIR,ERFA CANADA 2012 INC,CHOLEDYL ELIXIR EXPECTORANT,OXTRIPHYLLINE  GUAIFENESIN,100MG  50MG,250ML,ORAL,Actual shortage,ELIXIR,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2019-02-08,2019-02-11,,,Disruption of the manufacture of the drug.,2019-02-12,2019-05-16
6396,476374,Shortage,CHOLEDYL EXPECTORANT ELIXIR,ERFA CANADA 2012 INC,Oxtriphylline Guaifenesin,OXTRIPHYLLINE  GUAIFENESIN,100MG  50MG,bottle,ORAL,Resolved,ELIXIR,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-04-14,2017-05-23,2017-05-30,Other (Please describe in comments),2017-04-11,2018-03-14
96259,2455609,Shortage,CHOLESTYRAMINE-ODAN,ODAN LABORATORIES LTD,"Cholestyramine for Oral Suspension, USP",CHOLESTYRAMINE RESIN,4G,4g,ORAL,Actual shortage,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-11,2019-11-29,,Demand increase for the drug.,2019-10-11,2019-10-12
19488,,Shortage,Choletec,,MEBROFENIN powder for solution,MEBROFENIN,45mg/vial,kit of 10 vials,Intravenous,Resolved,powder for solution,V09DA,Hepatic and reticulo endothelial system,,2017-06-01,2018-04-09,2018-03-30,Disruption of the manufacture of the drug.,2017-08-15,2018-09-28
45374,,Shortage,CHOLETEC,,MEBROFENIN powder,MEBROFENIN,45 mg/vial,kits of 10 vials,Intravenous,Resolved,Powder for solution,V09DA,Hepatic and reticulo endothelial system,,2018-04-10,2019-04-01,2019-03-05,Disruption of the manufacture of the drug.,2018-04-10,2019-03-06
8489,2228556,Shortage,CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV,BRACCO IMAGING CANADA,Cholografin,MEGLUMINE IODIPAMIDE,52%,10X20ml,INTRAVENOUS,Actual shortage,LIQUID,V08AC,"X-RAY CONTRAST MEDIA, IODINATED",,2017-05-01,,,Disruption of the manufacture of the drug.,2017-05-01,2018-12-20
8306,2410346,Shortage,CICLOPIROX TOPICAL SOLUTION,STERIMAX INC,CICLOPIROX TOPICAL SOLUTION,CICLOPIROX,8%,1 BOTTLE,TOPICAL,Actual shortage,SOLUTION,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2017-04-07,,,Other (Please describe in comments),2017-04-27,2017-10-05
75343,2200864,Shortage,CILOXAN,NOVARTIS PHARMACEUTICALS CANADA INC,CILOXAN OINTMENT 3.5G,CIPROFLOXACIN,0.3%,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AE,ANTIINFECTIVES,,2019-02-11,2019-04-24,2019-04-24,Demand increase for the drug.,2019-02-11,2019-04-29
62545,1945270,Shortage,CILOXAN,NOVARTIS PHARMACEUTICALS CANADA INC,CILOXAN 0.3% SOLN 5ML,CIPROFLOXACIN,0.3%,5ML,OPHTHALMIC,Resolved,SOLUTION,S03AA,ANTIINFECTIVES,,2018-09-27,2018-10-12,2018-10-10,Other (Please describe in comments),2018-09-28,2018-10-17
85629,2200864,Shortage,CILOXAN,NOVARTIS PHARMACEUTICALS CANADA INC,CILOXAN OINTMENT 3.5G,CIPROFLOXACIN,0.3%,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AE,ANTIINFECTIVES,2019-06-25,2019-06-25,2019-07-31,2019-07-30,Delay in shipping of the drug.,2019-06-05,2019-08-02
6940,2155974,Shortage,CIPRO 750 - TAB 750MG,BAYER INC,ciprofloxacin tablet USP,CIPROFLOXACIN,750MG,50s,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2017-04-28,,2017-05-31,2017-05-31,Disruption of the manufacture of the drug.,2017-04-13,2017-06-01
30093,2251787,Shortage,CIPRO XL,BAYER INC,Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release,CIPROFLOXACIN,1000MG,50,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,2017-11-27,,2018-04-16,2018-04-09,Disruption of the manufacture of the drug.,2017-11-22,2018-04-10
51877,2251787,Shortage,CIPRO XL,BAYER INC,Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release,CIPROFLOXACIN,1000MG,50's,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,2018-07-30,,,,Disruption of the manufacture of the drug.,2018-06-07,2019-03-29
49583,2247916,Shortage,CIPRO XL,BAYER INC,Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release,CIPROFLOXACIN,500MG,50's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,,2018-05-16,2018-06-30,2018-06-06,Disruption of the manufacture of the drug.,2018-05-16,2018-06-07
62144,2247916,Shortage,CIPRO XL,BAYER INC,Ciprofloxacin Extended Release Tablet,CIPROFLOXACIN,500MG,50's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,2018-10-15,,2019-07-18,2019-05-15,Disruption of the manufacture of the drug.,2018-09-21,2019-05-16
97989,2247916,Shortage,CIPRO XL,BAYER INC,Ciprofloxacin,CIPROFLOXACIN,500MG,50's,ORAL,Anticipated shortage,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,2020-01-15,,,,Disruption of the manufacture of the drug.,2019-11-05,2019-11-05
72248,2353326,Shortage,CIPROFLOXACIN,SANIS HEALTH INC,CIPROFLOXACIN TAB,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2019-01-21,2019-01-21,2019-03-01,2019-02-27,Other (Please describe in comments),2019-01-15,2019-02-28
19335,2304546,Shortage,"CIPROFLOXACIN INTRAVENOUS INFUSION, BP",APOTEX INC,CIPROFLOX,CIPROFLOXACIN,2MG,100/200 ML,INTRAVENOUS,Actual shortage,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017-03-10,,,Disruption of the manufacture of the drug.,2017-08-14,2017-10-05
1428,2425718,Shortage,CISATRACURIUM BESYLATE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Cisatracurium Besylate,CISATRACURIUM,2MG,20 mg/10 mL x 10,INTRAVENOUS,Resolved,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2015-07-30,,2019-03-25,Requirements related to complying with good manufacturing practices.,2017-03-13,2019-03-28
34868,2408813,Shortage,CISATRACURIUM OMEGA MULTIDOSE,OMEGA LABORATORIES LTD,CISATRACURIUM,CISATRACURIUM,2MG,10 X 10mL vial,INTRAVENOUS,Resolved,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",2018-04-01,,2018-04-27,2018-04-06,Shortage of an active ingredient.,2018-01-03,2018-05-03
87665,2403188,Shortage,CISPLATIN INJECTION,TEVA CANADA LIMITED,CISPLATIN,CISPLATIN,1.0MG,50ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-06-27,2019-08-30,2019-08-28,Disruption of the manufacture of the drug.,2019-06-27,2019-08-29
98188,2403188,Shortage,CISPLATIN INJECTION,TEVA CANADA LIMITED,CISPLATIN INJECTION,CISPLATIN,1.0MG,50 & 100ml,INTRAVENOUS,Actual shortage,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-11-07,,,Demand increase for the drug.,2019-11-07,2019-11-08
3275,2355183,Shortage,"CISPLATIN INJECTION, BP",ACCORD HEALTHCARE INC,CISPLATIN,CISPLATIN,1MG,100 ML VIAL OF 100 MG     |     FLACON DE 100 ML DE 100 MG,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-03-06,2017-03-06,2017-04-12,2017-03-30,Disruption of the manufacture of the drug.,2017-03-17,2017-04-06
33689,2445719,Shortage,CITALOPRAM,SANIS HEALTH INC,CITALOPRAM TAB,CITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-12-18,2018-01-19,2018-01-17,Other (Please describe in comments),2017-12-19,2018-01-18
71374,2408996,Shortage,CLARITHROMYCIN,SANIS HEALTH INC,CLARITHROMYCIN SUSPENSION,CLARITHROMYCIN,250MG,105 ML,ORAL,Resolved,GRANULES FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2019-01-14,2019-01-14,2019-02-08,2019-02-05,Other (Please describe in comments),2019-01-07,2019-02-06
5591,2442469,Shortage,CLARITHROMYCIN,SIVEM PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-04,2017-04-11,2017-04-10,Demand increase for the drug.,2017-04-05,2017-04-11
80416,2257955,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,10MG,30 BL,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2019-04-16,,2019-05-10,2019-05-07,Delay in shipping of the drug.,2019-04-03,2019-05-08
143,2257955,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,10MG,30,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2016-01-04,2016-01-04,,2017-03-20,Requirements related to complying with good manufacturing practices.,2017-03-10,2017-03-22
88979,2257955,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,10MG,30 BL,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2019-07-09,,2019-08-30,2019-07-16,Delay in shipping of the drug.,2019-07-09,2019-07-17
148,2257963,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,40MG,30,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,,2016-01-04,,2017-03-20,Requirements related to complying with good manufacturing practices.,2017-03-10,2017-03-22
97440,2257955,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,10MG,30 BL,ORAL,Actual shortage,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2019-11-04,2019-11-04,2019-11-30,,Delay in shipping of the drug.,2019-10-29,2019-11-12
5039,2257963,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Clarus,ISOTRETINOIN,40MG,30BL,ORAL,Avoided shortage,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2017-06-29,,,2017-06-27,Disruption of the manufacture of the drug.,2017-03-31,2017-06-28
77763,2257963,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,CLARUS,ISOTRETINOIN,40MG,30 BL,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2019-04-09,2019-04-10,2019-05-10,2019-05-07,Delay in shipping of the drug.,2019-03-05,2019-05-08
89821,2257955,Shortage,CLARUS,MYLAN PHARMACEUTICALS ULC,Isotretinoin,ISOTRETINOIN,10MG,30 BL,ORAL,Resolved,CAPSULE,D10BA,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,2019-07-23,2019-07-23,2019-10-25,2019-10-01,Delay in shipping of the drug.,2019-07-23,2019-10-02
75177,1916874,Shortage,CLAVULIN 250 F ORAL SUS,GLAXOSMITHKLINE INC,amoxicillin / clavulanate potassium for oral suspension,AMOXICILLIN  CLAVULANIC ACID,250MG  62.5MG,1x100mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-02-06,2019-02-15,2019-02-12,Delay in shipping of the drug.,2019-02-08,2019-02-13
75758,2247499,Shortage,CLIMARA 25,BAYER INC,Estradiol-17ß,ESTRADIOL,2MG,4's,TRANSDERMAL,Resolved,PATCH,G03CA,ESTROGENS,2019-03-28,2019-03-06,2019-04-15,2019-04-05,Disruption of the manufacture of the drug.,2019-02-14,2019-04-06
29071,2243659,Shortage,CLINDA-T,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CLINDA-T,CLINDAMYCIN,1%,na,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-11-09,,,Disruption of the manufacture of the drug.,2017-11-13,2019-06-12
17933,2400529,Shortage,CLINDAMYCIN,SANIS HEALTH INC,CLINDAMYCIN CAPS,CLINDAMYCIN,150MG,100,ORAL,Actual shortage,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2013-05-14,,,Disruption of the manufacture of the drug.,2017-08-02,2018-03-23
17938,2400537,Shortage,CLINDAMYCIN,SANIS HEALTH INC,CLINDAMYCIN CAPS,CLINDAMYCIN,300MG,100,ORAL,Actual shortage,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2013-05-14,,,Disruption of the manufacture of the drug.,2017-08-02,2018-03-23
18146,2408511,Shortage,CLINDAMYCIN IV INFUSION,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,12MG,10 X 50ML MINIBAGS,INTRAVENOUS,Resolved,SOLUTION,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-07-21,2017-08-18,2017-08-14,Delay in shipping of the drug.,2017-08-03,2017-10-10
18149,2408538,Shortage,CLINDAMYCIN IV INFUSION,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,18MG,10 X 50ML MINIBAGS,INTRAVENOUS,Resolved,SOLUTION,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-07-21,2017-08-18,2017-08-14,Delay in shipping of the drug.,2017-08-03,2017-10-10
88507,2248525,Shortage,CLINDAMYCINE-150,PRO DOC LIMITEE,CLINDAMYCINE-150,CLINDAMYCIN,150MG,100,ORAL,Actual shortage,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2019-08-30,2019-08-26,,,Other (Please describe in comments),2019-07-04,2019-08-27
8380,2248525,Shortage,CLINDAMYCINE-150,PRO DOC LIMITEE,CLINDAMYCINE,CLINDAMYCIN,150MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-28,,2017-10-24,Delay in shipping of the drug.,2017-04-28,2017-10-25
6192,2248526,Shortage,CLINDAMYCINE-300,PRO DOC LIMITEE,CLINDAMYCINE,CLINDAMYCIN,300MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-11,,2017-10-25,Delay in shipping of the drug.,2017-04-07,2017-10-26
88510,2248526,Shortage,CLINDAMYCINE-300,PRO DOC LIMITEE,CLINDAMYCINE-300,CLINDAMYCIN,300MG,100,ORAL,Anticipated shortage,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2019-11-22,,,,Other (Please describe in comments),2019-07-04,2019-07-04
2635,2243050,Shortage,CLINDETS,GLAXOSMITHKLINE INC,Clindamycin phosphate solution in pledget,CLINDAMYCIN,1%,60's,TOPICAL,Resolved,PAD,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-02-08,,2017-05-02,Disruption of the manufacture of the drug.,2017-03-14,2017-05-03
11231,2243050,Shortage,CLINDETS,GLAXOSMITHKLINE INC,Clindamycin phosphate solution in pledget,CLINDAMYCIN,1%,60's,TOPICAL,Actual shortage,PAD,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-06-02,,,Disruption of the manufacture of the drug.,2017-05-25,2018-12-20
17444,2382822,Shortage,CLINDOXYL ADV GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE  CLINDAMYCIN,3%  1%,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-07-26,2017-10-09,2017-09-26,Disruption of the manufacture of the drug.,2017-07-28,2017-09-27
96823,2382822,Shortage,CLINDOXYL ADV GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE  CLINDAMYCIN,3%  1%,45G,TOPICAL,Actual shortage,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-10-31,,,Shortage of an active ingredient.,2019-10-18,2019-11-01
24666,2382822,Shortage,CLINDOXYL ADV GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE  CLINDAMYCIN,3%  1%,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-11-08,2017-11-24,2017-11-20,Disruption of the manufacture of the drug.,2017-10-06,2017-11-22
85790,2243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE  CLINDAMYCIN,50MG  10MG,45G,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-06-17,2019-09-16,2019-08-19,Shortage of an active ingredient.,2019-06-07,2019-08-21
82748,2243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE  CLINDAMYCIN,50MG  10MG,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-04-25,2019-05-24,2019-05-21,Disruption of the manufacture of the drug.,2019-04-29,2019-05-22
12148,2243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,Clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE  CLINDAMYCIN,50MG  10MG,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-06-12,2017-10-03,2017-09-26,Disruption of the manufacture of the drug.,2017-06-06,2017-09-27
94964,2243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,BENZOYL PEROXIDE  CLINDAMYCIN,50MG  10MG,45G,TOPICAL,Actual shortage,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-10-02,2019-12-06,,Demand increase for the drug.,2019-09-27,2019-11-07
3063,2330407,Shortage,CLOLAR,SANOFI-AVENTIS CANADA INC,CLOLAR,CLOFARABINE,1MG,20 MG/20 ML UNIDOSE VIAL,INTRAVENOUS,Resolved,SOLUTION,L01BB,ANTIMETABOLITES,,2016-12-20,2017-04-14,2017-04-19,Other (Please describe in comments),2017-03-16,2017-04-20
13141,2442035,Shortage,CLONAZEPAM,SIVEM PHARMACEUTICALS ULC,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-06-16,,2017-06-26,2017-07-23,Demand increase for the drug.,2017-06-16,2017-11-06
27985,812382,Shortage,CLOTRIMADERM CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM CREAM 1%,CLOTRIMAZOLE,1%,500G,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2018-12-10,2019-02-01,2019-01-28,Disruption of the manufacture of the drug.,2017-11-03,2019-02-04
89264,812382,Shortage,CLOTRIMADERM CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM CREAM 1%,CLOTRIMAZOLE,1%,20 g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2019-07-09,2019-08-02,2019-08-01,Disruption of the manufacture of the drug.,2019-07-15,2019-08-06
89267,812382,Shortage,CLOTRIMADERM CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM CREAM 1%,CLOTRIMAZOLE,1%,50 g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2019-07-10,2019-08-02,2019-08-01,Disruption of the manufacture of the drug.,2019-07-15,2019-08-06
93895,812382,Shortage,CLOTRIMADERM CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM CREAM 1%,CLOTRIMAZOLE,1%,30 g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2019-09-12,2019-09-20,2019-09-16,Disruption of the manufacture of the drug.,2019-09-13,2019-09-23
22258,812382,Shortage,CLOTRIMADERM CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM CREAM 1%,CLOTRIMAZOLE,1%,30 G,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017-09-15,,2017-09-22,2017-10-01,Disruption of the manufacture of the drug.,2017-09-18,2017-10-02
34379,812366,Shortage,CLOTRIMADERM VAG CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM VAG CREAM 1%,CLOTRIMAZOLE,1%,50G,VAGINAL,Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017-12-19,2018-01-30,2018-02-01,Disruption of the manufacture of the drug.,2017-12-25,2018-02-02
89273,812366,Shortage,CLOTRIMADERM VAG CREAM 1%,TARO PHARMACEUTICALS INC,CLOTRIMADERM VAG CREAM 1%,CLOTRIMAZOLE,1%,50 g,VAGINAL,Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2019-07-04,2019-10-25,2019-10-30,Disruption of the manufacture of the drug.,2019-07-15,2019-11-01
79995,812374,Shortage,CLOTRIMADERM VAG CREAM 2%,TARO PHARMACEUTICALS INC,Clotrimaderm,CLOTRIMAZOLE,2%,25 g,VAGINAL,Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2019-03-26,2019-05-10,2019-04-26,Disruption of the manufacture of the drug.,2019-03-29,2019-04-29
89270,812374,Shortage,CLOTRIMADERM VAG CREAM 2%,TARO PHARMACEUTICALS INC,CLOTRIMADERM VAG CREAM 2%,CLOTRIMAZOLE,2%,25 g,VAGINAL,Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2019-06-26,2019-10-25,2019-10-30,Disruption of the manufacture of the drug.,2019-07-15,2019-11-01
40889,812374,Shortage,CLOTRIMADERM VAG CREAM 2%,TARO PHARMACEUTICALS INC,CLOTRIMADERM VAG CREAM 2%,CLOTRIMAZOLE,2%,25ML,VAGINAL,Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2018-02-22,2018-04-10,2018-04-12,Disruption of the manufacture of the drug.,2018-02-23,2018-04-13
2671,68594,Shortage,COACTIFED,GLAXOSMITHKLINE INC,Triprolidine hydrochloride/pseudoephedrine hydrocholride/codeine phosphate syrup,PSEUDOEPHEDRINE HYDROCHLORIDE  TRIPROLIDINE HYDROCHLORIDE  CODEINE PHOSPHATE,30MG  2MG  10MG,100 mL,ORAL,Actual shortage,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2016-09-14,,,Disruption of the manufacture of the drug.,2017-03-14,2018-06-13
13399,2230302,Shortage,CODEINE CONTIN 50MG CONTROLLED RELEASE TAB,PURDUE PHARMA,codeine controlled release tablets,CODEINE,50MG,60s,ORAL,Resolved,TABLET (EXTENDED-RELEASE),R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017-06-20,2017-06-20,2017-06-30,2017-07-12,Requirements related to complying with good manufacturing practices.,2017-06-20,2017-07-13
85636,572349,Shortage,COLCHICINE TAB 0.6MG,ODAN LABORATORIES LTD,"Colchicine tablets, USP",COLCHICINE,0.6MG,"100, 500, 1000",ORAL,Resolved,TABLET,M04AC,ANTIGOUT PREPARATIONS,,2019-06-05,2019-07-31,2019-07-23,Shortage of an active ingredient.,2019-06-05,2019-07-24
8036,642975,Shortage,COLESTID GRANULES,PFIZER CANADA INC,COLESTID,COLESTIPOL HYDROCHLORIDE,5G,30's,ORAL,Resolved,GRANULES,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-21,2017-05-11,2017-05-11,Disruption of the manufacture of the drug.,2017-04-25,2017-05-12
17518,642975,Shortage,COLESTID GRANULES,PFIZER CANADA INC,Colestid,COLESTIPOL HYDROCHLORIDE,5G,30's,ORAL,Resolved,GRANULES,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2017-07-28,,2017-08-21,2017-08-21,Delay in shipping of the drug.,2017-07-31,2017-08-22
35783,1944363,Shortage,COMBANTRIN TAB 125MG,MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,PYRANTEL (PYRANTEL PAMOATE),PYRANTEL,125MG,12,ORAL,Resolved,TABLET,P02CC,ANTINEMATODAL AGENTS,2017-12-15,,2018-04-13,2018-04-02,Shortage of an active ingredient.,2018-01-12,2018-04-03
2178,2231675,Shortage,COMBIVENT UDV,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,COMBIVENT UDV,IPRATROPIUM BROMIDE  SALBUTAMOL,0.2MG  1.0MG,20 x 2.5ml,INHALATION,Resolved,SOLUTION,R03AL,"ADRENERGICS, INHALANTS",,2017-01-11,2017-04-24,2017-04-05,Disruption of the manufacture of the drug.,2017-03-14,2017-04-06
3593,223107,Shortage,CONRAY 30,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 30%,IOTHALAMATE MEGLUMINE,300MG,100 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",,2017-07-21,,2018-03-14,Shortage of an active ingredient.,2017-03-20,2018-05-03
3597,223107,Shortage,CONRAY 30,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 30 %,IOTHALAMATE MEGLUMINE,300MG,250 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2017-05-01,2017-07-21,,2018-03-14,Shortage of an active ingredient.,2017-03-20,2018-05-03
3661,477095,Shortage,CONRAY 43,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 43%,IOTHALAMATE MEGLUMINE,430MG,"50, 100 and 200 mL",INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016-01-01,,,2018-04-05,Shortage of an active ingredient.,2017-03-20,2018-05-03
3587,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,50 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016-12-01,,2017-03-31,2017-03-31,Shortage of an active ingredient.,2017-03-20,2018-01-23
3608,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine 60 %,IOTHALAMATE MEGLUMINE,600MG,200 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016-06-01,2016-06-01,,2019-02-18,Shortage of an active ingredient.,2017-03-20,2019-02-19
54742,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,50 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",,2018-07-06,2018-11-06,2018-10-22,Other (Please describe in comments),2018-07-06,2018-10-23
3575,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,20 mL Bottle,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2016-11-30,2016-11-30,,2019-02-18,Shortage of an active ingredient.,2017-03-20,2019-02-19
72956,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,50 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",,2019-01-18,2019-03-04,2019-03-04,Delay in shipping of the drug.,2019-01-18,2019-03-04
3583,131237,Shortage,CONRAY 60,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection 60 %,IOTHALAMATE MEGLUMINE,600MG,30 mL,INTRAVASCULAR,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",2017-01-31,2017-01-31,,2019-02-18,Shortage of an active ingredient.,2017-03-20,2019-03-14
84767,2417162,Shortage,CONSTELLA,ALLERGAN INC,CONSTELLA 145MCG CAP 30 CA,Linaclotide,145MCG,CONSTELLA 145MCG CAP 30 CA,ORAL,Resolved,CAPSULE,A06AX,DRUGS FOR CONSTIPATION,2019-05-24,2019-05-24,2019-06-10,2019-06-10,Other (Please describe in comments),2019-05-25,2019-06-11
84770,2417170,Shortage,CONSTELLA,ALLERGAN INC,CONSTELLA 290MCG CAP 30 CA,Linaclotide,290MCG,CONSTELLA 290MCG CAP 30 CA,ORAL,Resolved,CAPSULE,A06AX,DRUGS FOR CONSTIPATION,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
84773,2469510,Shortage,CONSTELLA,ALLERGAN INC,CONSTELLA 72MCG CAP 30,Linaclotide,72MCG,CONSTELLA 72MCG CAP 30,ORAL,Resolved,CAPSULE,A06AX,DRUGS FOR CONSTIPATION,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
67153,2417170,Shortage,CONSTELLA,ALLERGAN INC,CONSTELLA 290MCG CAP 30 CA,Linaclotide,290MCG,290MCG CAP 30,ORAL,Resolved,CAPSULE,A06AX,DRUGS FOR CONSTIPATION,,2018-11-09,2018-12-20,2018-12-19,Other (Please describe in comments),2018-11-20,2019-01-09
76263,2417170,Shortage,CONSTELLA,ALLERGAN INC,CONSTELLA 290MCG CAP 30 CA,Linaclotide,290MCG,290MCG CAP 30,ORAL,Resolved,CAPSULE,A06AX,DRUGS FOR CONSTIPATION,,2019-02-14,2019-03-01,2019-02-26,Delay in shipping of the drug.,2019-02-19,2019-02-27
28619,2425009,Shortage,CONTINGENCY ONE,MYLAN PHARMACEUTICALS ULC,CONTINGENCY ONE,LEVONORGESTREL,1.5MG,1BL,ORAL,Resolved,TABLET,G03AD,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-01-31,2018-02-02,2018-05-14,2018-05-11,Delay in shipping of the drug.,2017-11-08,2018-05-31
5960,2224577,Shortage,COPHYLAC DROPS,VALEANT CANADA LP/VALEANT CANADA S.E.C.,COPHYLAC DROPS,NORMETHADONE HYDROCHLORIDE  P-HYDROXYEPHEDRINE HYDROCHLORIDE,10MG  20MG,ORAL,ORAL,Resolved,DROPS,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017-06-30,,,2018-04-03,Other (Please describe in comments),2017-04-07,2018-04-04
97100,2112736,Shortage,CORTENEMA,APTALIS PHARMA CANADA ULC,hydrocortisone,HYDROCORTISONE,100MG,7 x 60 mL,RECTAL,Actual shortage,ENEMA,A07EA,INTESTINALANTIINFLAMMATORY AGENTS,,2019-10-24,,2019-12-03,Disruption of the manufacture of the drug.,2019-10-24,2019-10-25
69509,2112736,Shortage,CORTENEMA,APTALIS PHARMA CANADA ULC,Cortenema,HYDROCORTISONE,100MG,7*60ml bottle,RECTAL,Resolved,ENEMA,A07EA,INTESTINALANTIINFLAMMATORY AGENTS,,2018-12-10,2019-02-04,2019-02-01,Demand increase for the drug.,2018-12-13,2019-02-02
56188,579335,Shortage,CORTIFOAM,PALADIN LABS INC,CORTIFOAM,HYDROCORTISONE ACETATE,10%,15g,RECTAL,Actual shortage,"AEROSOL, FOAM",A07EA,INTESTINALANTIINFLAMMATORY AGENTS,,2018-07-23,,,Disruption of the manufacture of the drug.,2018-07-23,2019-04-01
83485,280437,Shortage,CORTISONE ACETATE TAB 25MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CORTISONE ACETATE TAB 25MG,CORTISONE ACETATE,25MG,100s,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-10,,2019-06-18,Other (Please describe in comments),2019-05-08,2019-06-21
36165,22381,Shortage,CORTROSYN INJ 0.25MG,"AMPHASTAR PHARMACEUTICALS, INC.",Cosyntropin,TETRACOSACTIDE,0.25MG,0.25 mg/vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,H01AA,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,,2018-01-02,2018-04-06,2018-04-03,Other (Please describe in comments),2018-01-17,2018-04-04
95762,263818,Shortage,COTAZYM,MERCK CANADA INC,PANCRELIPASE CAPSULES,AMYLASE  PROTEASE  LIPASE,40000UNIT  35000UNIT  10000UNIT,100CAP,ORAL,Anticipated shortage,CAPSULE (IMMEDIATE RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2019-12-06,,2019-12-20,,Delay in shipping of the drug.,2019-10-08,2019-11-11
77313,821373,Shortage,COTAZYM ECS 20,MERCK CANADA INC,PANCRELIPASE DELAYED-RELEASE CAPSULES,AMYLASE  PROTEASE  LIPASE,100000UNIT  100000UNIT  25000UNIT,100',ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",,2019-02-25,2019-03-06,2019-03-06,Delay in shipping of the drug.,2019-03-01,2019-03-07
80134,821373,Shortage,COTAZYM ECS 20,MERCK CANADA INC,PANCRELIPASE DELAYED-RELEASE CAPSULES,AMYLASE  PROTEASE  LIPASE,100000UNIT  100000UNIT  25000UNIT,100',ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2019-05-27,,2019-05-29,2019-05-24,Demand increase for the drug.,2019-04-01,2019-05-24
49586,821373,Shortage,COTAZYM ECS 20,MERCK CANADA INC,PANCRELIPASE DELAYED-RELEASE CAPSULES,AMYLASE  PROTEASE  LIPASE,100000UNIT  100000UNIT  25000UNIT,100 CAP,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2018-05-16,2018-05-16,2018-05-25,2018-05-22,Delay in shipping of the drug.,2018-05-16,2018-05-23
44487,821373,Shortage,COTAZYM ECS 20,MERCK CANADA INC,PANCRELIPASE DELAYED-RELEASE CAPSULES,AMYLASE  PROTEASE  LIPASE,100000UNIT  100000UNIT  25000UNIT,100CAP,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2018-04-02,2018-04-02,2018-04-13,2018-04-10,Delay in shipping of the drug.,2018-04-02,2018-04-11
91881,821373,Shortage,COTAZYM ECS 20,MERCK CANADA INC,PANCRELIPASE DELAYED-RELEASE CAPSULES,AMYLASE  PROTEASE  LIPASE,100000UNIT  100000UNIT  25000UNIT,100',ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2019-10-01,2019-10-01,2019-11-13,2019-11-12,Delay in shipping of the drug.,2019-08-19,2019-11-13
45060,502790,Shortage,COTAZYM ECS 8,MERCK CANADA INC,PANCRELIPASE DELAYED-RELEASE CAPSULES,AMYLASE  PROTEASE  LIPASE,42000UNIT  45000UNIT  10800UNIT,500CAP,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2018-04-05,2018-04-05,2018-04-13,2018-04-10,Delay in shipping of the drug.,2018-04-05,2018-04-11
95765,502790,Shortage,COTAZYM ECS 8,MERCK CANADA INC,PANCRELIPASE DELAYED-RELEASE CAPSULES,AMYLASE  PROTEASE  LIPASE,42000UNIT  45000UNIT  10800UNIT,500CAP,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2019-11-08,2019-11-07,2019-11-18,2019-11-18,Delay in shipping of the drug.,2019-10-08,2019-11-18
38962,1918362,Shortage,COUMADIN TAB 10MG,BRISTOL-MYERS SQUIBB CANADA,Warfarin,WARFARIN SODIUM,10MG,1 BTL x 100,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-03-30,2018-04-02,2018-05-11,2018-05-07,Delay in shipping of the drug.,2018-02-07,2018-05-08
51538,1918362,Shortage,COUMADIN TAB 10MG,BRISTOL-MYERS SQUIBB CANADA,Warfarin,WARFARIN SODIUM,10MG,1 BTL x 100,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-12-03,2018-12-03,2018-12-07,2018-12-06,Delay in shipping of the drug.,2018-06-05,2018-12-07
51516,1918311,Shortage,COUMADIN TAB 1MG,BRISTOL-MYERS SQUIBB CANADA,Warfarin,WARFARIN SODIUM,1MG,1 BTL X 100,ORAL,Avoided shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-08-23,,,2018-08-20,Delay in shipping of the drug.,2018-06-05,2018-08-21
42860,1918311,Shortage,COUMADIN TAB 1MG,BRISTOL-MYERS SQUIBB CANADA,Warfarin,WARFARIN SODIUM,1MG,1 BTL x 100,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-05-31,2018-06-04,2018-06-08,2018-06-08,Delay in shipping of the drug.,2018-03-14,2018-06-09
55694,2007959,Shortage,COUMADIN TAB 4MG,BRISTOL-MYERS SQUIBB CANADA,Warfarin,WARFARIN SODIUM,4MG,1 BTL x 100,ORAL,Avoided shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-12-03,,2018-12-05,2018-11-22,Delay in shipping of the drug.,2018-07-13,2018-11-22
51576,1918354,Shortage,COUMADIN TAB 5MG,BRISTOL-MYERS SQUIBB CANADA,Warfarin,WARFARIN SODIUM,5MG,1 BTL x 100,ORAL,Avoided shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-07-31,,2018-08-03,2018-07-23,Delay in shipping of the drug.,2018-06-05,2018-07-23
55681,2240206,Shortage,COUMADIN TAB 6 MG,BRISTOL-MYERS SQUIBB CANADA,Warfarin,WARFARIN SODIUM,6MG,1 BTL x 100,ORAL,Avoided shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-09-24,,2018-09-17,2018-09-17,Delay in shipping of the drug.,2018-07-13,2018-09-17
39664,2240206,Shortage,COUMADIN TAB 6 MG,BRISTOL-MYERS SQUIBB CANADA,warfarin,WARFARIN SODIUM,6MG,1BTL x 100,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2018-05-28,2018-05-22,2018-06-08,2018-06-08,Delay in shipping of the drug.,2018-02-13,2018-06-09
97355,2321653,Shortage,COVERSYL PLUS HD,SERVIER CANADA INC,COVERSYL PLUS HD,INDAPAMIDE  PERINDOPRIL ERBUMINE,2.5MG  8.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-10-23,2019-11-08,2019-11-06,Delay in shipping of the drug.,2019-10-28,2019-11-07
82497,2246568,Shortage,COVERSYL PLUS LD,SERVIER CANADA INC,COVERSYL PLUS LD,INDAPAMIDE  PERINDOPRIL ERBUMINE,0.625MG  2MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-04-23,2019-05-03,2019-05-02,Delay in shipping of the drug.,2019-04-26,2019-05-03
69722,2246568,Shortage,COVERSYL PLUS LD,SERVIER CANADA INC,COVERSYL PLUS LD,INDAPAMIDE  PERINDOPRIL ERBUMINE,0.625MG  2MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-12-14,2019-01-11,2019-01-17,Delay in shipping of the drug.,2018-12-17,2019-01-18
76385,2246568,Shortage,COVERSYL PLUS LD,SERVIER CANADA INC,COVERSYL PLUS LD,INDAPAMIDE  PERINDOPRIL ERBUMINE,0.625MG  2MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-02-18,2019-03-29,2019-04-05,Delay in shipping of the drug.,2019-02-20,2019-04-08
65971,2246568,Shortage,COVERSYL PLUS LD,SERVIER CANADA INC,COVERSYL PLUS LD,INDAPAMIDE  PERINDOPRIL ERBUMINE,0.625MG  2MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-10-30,2018-11-12,2018-11-16,Delay in shipping of the drug.,2018-11-01,2018-11-19
96256,2182874,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,50MG,30TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-10-11,2019-10-11,2019-11-29,,Demand increase for the drug.,2019-10-11,2019-10-12
98584,2182882,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,100MG,30TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-13,2019-11-13,2019-11-29,,Demand increase for the drug.,2019-11-13,2019-11-14
91930,2182882,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,100MG,30TAB,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-09-06,2019-08-27,2019-11-01,2019-11-01,Demand increase for the drug.,2019-08-19,2019-11-02
88869,2182874,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,50MG,30TAB,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-07-24,2019-07-11,2019-10-08,2019-10-08,Demand increase for the drug.,2019-07-08,2019-10-09
95782,2182815,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,25MG,100TAB,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-10-08,2019-10-08,2019-11-14,2019-11-14,Demand increase for the drug.,2019-10-08,2019-11-16
88873,2182882,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,100MG,30TAB,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-07-17,2019-07-09,2019-08-16,2019-08-16,Demand increase for the drug.,2019-07-08,2019-08-17
74073,2182815,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,25MG,pack of 100 tablets,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-31,2019-01-31,2019-04-30,2019-04-30,Requirements related to complying with good manufacturing practices.,2019-01-31,2019-05-01
73823,2182874,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,50MG,pack of 30 tablets,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-29,2019-01-30,2019-04-19,2019-04-15,Requirements related to complying with good manufacturing practices.,2019-01-29,2019-04-16
73826,2182882,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,100MG,pack of 30 tablets,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-02-05,2019-01-31,2019-04-04,2019-04-03,Requirements related to complying with good manufacturing practices.,2019-01-29,2019-04-04
83815,2182815,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,25MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-06-18,2019-05-29,2019-09-27,2019-09-26,Demand increase for the drug.,2019-05-10,2019-09-27
87534,2182874,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,50MG,30TAB,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-06-26,2019-06-26,2019-06-28,2019-06-28,Demand increase for the drug.,2019-06-26,2019-06-29
71154,2182874,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,50MG,pack of 30 tablets,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-07,2019-01-04,2019-04-05,2019-01-17,Requirements related to complying with good manufacturing practices.,2019-01-04,2019-01-18
71157,2182882,Shortage,COZAAR,MERCK CANADA INC,losartan potassium tablets,LOSARTAN POTASSIUM,100MG,Pack of 30 tablets,ORAL,Avoided shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-21,,2019-04-05,2019-01-17,Requirements related to complying with good manufacturing practices.,2019-01-04,2019-01-17
85565,1985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,AMYLASE PROTEASE LIPASE,AMYLASE  PROTEASE  LIPASE,25500UNIT  1600UNIT  25000UNIT,100 CA,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",,2019-06-04,2019-06-28,2019-06-25,Delay in shipping of the drug.,2019-06-04,2019-06-26
92740,1985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON MINIMICROSPHERES 25,AMYLASE  PROTEASE  LIPASE,25500UNIT  1600UNIT  25000UNIT,25,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2019-09-09,,2019-09-13,2019-09-17,Delay in shipping of the drug.,2019-08-30,2019-09-18
79003,1985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON 25,AMYLASE  PROTEASE  LIPASE,25500UNIT  1600UNIT  25000UNIT,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2019-03-20,,2019-05-24,2019-05-28,Disruption of the manufacture of the drug.,2019-03-20,2019-05-29
32433,1985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON 25,AMYLASE  PROTEASE  LIPASE,25500UNIT  1600UNIT  25000UNIT,100,ORAL,Resolved,CAPSULE,A09AA,"DIGESTIVES, INCL ENZYMES",2018-11-08,2018-11-12,2019-03-19,2019-03-15,Delay in shipping of the drug.,2017-12-11,2019-03-16
88310,1985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON MINIMICROSPHERES 25,AMYLASE  PROTEASE  LIPASE,25500UNIT  1600UNIT  25000UNIT,25,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A09AA,"DIGESTIVES, INCL ENZYMES",2019-07-11,,2019-07-16,2019-07-16,Delay in shipping of the drug.,2019-07-03,2019-07-17
88307,2445158,Shortage,CREON MINIMICROSPHERES MICRO,BGP PHARMA ULC,CREON MINIMICROSPHERES MICRO,AMYLASE  PROTEASE  LIPASE,5100UNIT  320UNIT  5000UNIT,20 G,ORAL,Actual shortage,"GRANULES FOR SUSPENSION, DELAYED RELEASE",A09AA,"DIGESTIVES, INCL ENZYMES",2019-07-02,,,,Requirements related to complying with good manufacturing practices.,2019-07-03,2019-10-29
61800,16055,Shortage,CUPRIMINE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,CUPRIMINE,D-PENICILLAMINE,250MG,n/a,ORAL,Resolved,CAPSULE,M01CC,SPECIFIC ANTIRHEUMATIC AGENTS,,2018-09-17,,2018-12-21,Other (Please describe in comments),2018-09-18,2018-12-22
2263,16055,Shortage,CUPRIMINE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,D-PENICILLAMINE capsule,D-PENICILLAMINE,250mg,100,Oral,Resolved,Capsule,M01CC,SPECIFIC ANTIRHEUMATIC AGENTS,2017-03-14,,2017-04-17,2017-08-16,Disruption of the manufacture of the drug.,2017-03-14,2017-08-17
82602,2461692,Shortage,CUVITRU,SHIRE PHARMA CANADA ULC,Immune globulin Subcutaneous 20%,IMMUNOGLOBULIN,200MG,"1g, 2g,4g and 8g",SUBCUTANEOUS,Resolved,SOLUTION,J06BA,IMMUNOGLOBULINS,2019-04-09,2019-05-09,2019-09-30,2019-08-23,Demand increase for the drug.,2019-04-29,2019-08-24
95366,2463393,Shortage,CYANOCOBALAMIN INJECTION USP,TELIGENT OU,Cyanocobalamin,VITAMIN B12,1000MCG,1 mL,INTRAMUSCULAR  SUBCUTANEOUS,Actual shortage,LIQUID,B03BA,VITAMIN B12 AND FOLIC ACID,,2019-10-01,2019-11-29,,Delay in shipping of the drug.,2019-10-03,2019-11-11
51314,2413795,Shortage,"CYANOCOBALAMIN INJECTION, USP",MYLAN PHARMACEUTICALS ULC,CYANOCOBALAMIN,VITAMIN B12,1000MCG,"10 mL, 30 mL",INTRAMUSCULAR  SUBCUTANEOUS,Actual shortage,SOLUTION,B03BA,VITAMIN B12 AND FOLIC ACID,,2018-06-04,,,Disruption of the manufacture of the drug.,2018-06-04,2018-06-05
44171,2375370,Shortage,CYANOKIT,SERB S.A.,Hydroxocobalamin Powder for Infusion,HYDROXOCOBALAMIN,5G,5 g / vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2018-03-27,2018-06-08,2018-06-07,Demand increase for the drug.,2018-03-28,2018-06-08
21228,2220644,Shortage,CYCLOBENZAPRINE-10  -  TAB 10MG,PRO DOC LIMITEE,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017-09-05,,2017-09-19,Delay in shipping of the drug.,2017-09-07,2017-09-20
18225,2192276,Shortage,CYCLOCORT,GLAXOSMITHKLINE INC,amcinonide lotion,AMCINONIDE,0.1%,60 mL,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-07-28,,,Disruption of the manufacture of the drug.,2017-08-03,2018-09-06
41957,252506,Shortage,CYCLOGYL,NOVARTIS PHARMACEUTICALS CANADA INC,CYCLOGYL 1% SOLN 15ML,CYCLOPENTOLATE HYDROCHLORIDE,1%,15ML,OPHTHALMIC,Resolved,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2018-03-06,2018-03-12,2018-03-19,Delay in shipping of the drug.,2018-03-06,2018-03-20
58113,2018144,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclomen 50mg,DANAZOL,50MG,100,ORAL,Actual shortage,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2018-09-28,,2019-12-02,,Other (Please describe in comments),2018-08-14,2019-09-17
27654,2018152,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclome,DANAZOL,100MG,100,ORAL,Resolved,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2017-12-15,,2018-05-16,2018-06-06,Other (Please describe in comments),2017-11-01,2018-06-07
45377,2018144,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,CYCLOMEN 50MG HG BL10X10,DANAZOL,50MG,10 x 10,ORAL,Resolved,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2018-04-27,,2018-06-15,2018-06-11,Other (Please describe in comments),2018-04-10,2018-06-12
45385,2018160,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,CYCLOMEN 200MG HG BL10X10,DANAZOL,200MG,10 x 10,ORAL,Resolved,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2018-04-30,,2018-06-29,2018-06-26,Other (Please describe in comments),2018-04-10,2018-06-27
76396,2018160,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclomen,DANAZOL,200MG,100,ORAL,Actual shortage,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2019-03-15,,2019-12-02,,Other (Please describe in comments),2019-02-20,2019-09-17
67003,2018160,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclomen 200mg,DANAZOL,200MG,100'S,ORAL,Resolved,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,,2018-11-15,2019-01-09,2019-01-09,Other (Please describe in comments),2018-11-16,2019-01-14
87756,2018152,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclomen,DANAZOL,100MG,100,ORAL,Actual shortage,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,,2019-03-15,2019-12-02,,Other (Please describe in comments),2019-06-27,2019-09-17
62421,2018152,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclomen,DANAZOL,100MG,100,ORAL,Resolved,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,,2018-09-25,2019-01-11,2019-01-09,Other (Please describe in comments),2018-09-26,2019-01-10
80353,2018152,Shortage,CYCLOMEN,SANOFI-AVENTIS CANADA INC,Cyclomen 100 mg,DANAZOL,100MG,100,ORAL,Resolved,CAPSULE,G03XA,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,,2019-03-15,2019-12-02,2019-06-25,Other (Please describe in comments),2019-04-03,2019-06-26
6879,2290308,Shortage,CYESTRA-35,PALADIN LABS INC,Ethinyl Estradiol Cyproterone Acetate,ETHINYL ESTRADIOL  CYPROTERONE ACETATE,0.035MG  2MG,21 Tablets,ORAL,Resolved,TABLET,G03HB,ANTIANDROGENS,2017-04-13,2017-04-13,2017-05-23,2017-05-19,Delay in shipping of the drug.,2017-04-13,2017-05-20
1992,2245898,Shortage,CYPROTERONE,AA PHARMA INC,CYPROTERONE ACETATE,CYPROTERONE ACETATE,50MG,100 Bottle,ORAL,Resolved,TABLET,G03HA,ANTIANDROGENS,2017-03-07,2017-03-07,2017-03-28,2017-03-29,Other (Please describe in comments),2017-03-13,2017-03-31
71626,2245898,Shortage,CYPROTERONE,AA PHARMA INC,CYPROTERONE,CYPROTERONE ACETATE,50MG,100 Bottle,ORAL,Resolved,TABLET,G03HA,ANTIANDROGENS,2019-01-09,2019-01-09,2019-02-06,2019-02-07,Disruption of the manufacture of the drug.,2019-01-08,2019-02-08
8941,397466,Shortage,CYSTO-CONRAY II,LIEBEL-FLARSHEIM CANADA INC,Iothalamate Meglumine Injection USP 17.2%,IOTHALAMATE MEGLUMINE,172MG,"250 mL, 500 mL",URETHRAL,Resolved,SOLUTION,V08AA,"X-RAY CONTRAST MEDIA, IODINATED",,2017-05-03,2018-10-22,2018-10-22,Shortage of an active ingredient.,2017-05-04,2018-10-23
61923,799963,Shortage,CYSTOSOL W 3% HEXITOLS,BAXTER CORPORATION,Cystosol,SORBITOL  MANNITOL,2.5G  500MG,3000 mL,IRRIGATION,Resolved,LIQUID,B05CX,IRRIGATING SOLUTIONS,2018-09-19,2018-09-19,2018-11-01,2018-10-05,Disruption of the manufacture of the drug.,2018-09-19,2018-10-06
1059,2126656,Shortage,CYTARABINE INJECTION,HOSPIRA HEALTHCARE CORPORATION,CYTARABINE,CYTARABINE,100MG,1g/mL X 10,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,2013-06-15,2013-06-15,,2017-09-20,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
73496,1919458,Shortage,CYTOMEL,PFIZER CANADA ULC,CYTOMEL,LIOTHYRONINE,5MCG,100's,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2019-01-22,,2019-03-11,Demand increase for the drug.,2019-01-24,2019-03-12
42165,1919458,Shortage,CYTOMEL,PFIZER CANADA INC,Cytomel,LIOTHYRONINE,5MCG,100's,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-05-07,,2019-01-08,Disruption of the manufacture of the drug.,2018-03-07,2019-01-09
42172,1919466,Shortage,CYTOMEL,PFIZER CANADA INC,Cytomel,LIOTHYRONINE,25MCG,100's,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-11-30,2019-07-05,2019-06-26,Disruption of the manufacture of the drug.,2018-03-07,2019-06-27
48884,225851,Shortage,DALACIN C FLAVOURED GRANULES,PFIZER CANADA INC,Dalacin C Flavoured Granules,CLINDAMYCIN,75MG,1x40g,ORAL,Resolved,POWDER FOR SOLUTION,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-05-17,,2018-06-28,Disruption of the manufacture of the drug.,2018-05-08,2018-06-29
14419,582301,Shortage,DALACIN T 1%,PFIZER CANADA INC,Dalacin T,CLINDAMYCIN,1%,30mL,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2018-01-26,,,Disruption of the manufacture of the drug.,2017-06-29,2019-03-11
14425,582301,Shortage,DALACIN T 1%,PFIZER CANADA INC,Dalacin T,CLINDAMYCIN,1%,60mL,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2018-01-26,,,Disruption of the manufacture of the drug.,2017-06-30,2019-03-11
97075,2060604,Shortage,DALACIN VAGINAL CREAM,PFIZER CANADA ULC,Dalacin Vaginal cream,CLINDAMYCIN,20MG,40G,VAGINAL,Actual shortage,CREAM,G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",2019-10-25,2019-10-29,2019-12-03,,Disruption of the manufacture of the drug.,2019-10-23,2019-11-12
52578,2060604,Shortage,DALACIN VAGINAL CREAM 20 MG,PFIZER CANADA INC,DALACIN VAGINAL CREAM,CLINDAMYCIN,20MG,40G tube,VAGINAL,Resolved,CREAM,G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2018-08-15,,2018-10-19,Disruption of the manufacture of the drug.,2018-06-18,2018-10-22
58270,2230769,Shortage,DALMACOL,LABORATOIRE RIVA INC,Dalmacol,DOXYLAMINE SUCCINATE  SODIUM CITRATE  HYDROCODONE BITARTRATE  ALCOHOL ANHYDROUS  ETAFEDRIN HYDROCHLORIDE,1.2MG  40MG  .33MG  .05ML  3.33MG,2L,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2018-08-22,2018-08-22,2018-12-01,2018-12-01,Disruption of the manufacture of the drug.,2018-08-16,2019-04-17
1733,2230769,Shortage,DALMACOL,LABORATOIRE RIVA INC,Dalmacol,DOXYLAMINE SUCCINATE  SODIUM CITRATE  HYDROCODONE BITARTRATE  ALCOHOL ANHYDROUS  ETAFEDRIN HYDROCHLORIDE,1.2MG  40MG  .33MG  .05ML  3.33MG,500ml & 2L,ORAL,Resolved,LIQUID,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017-03-13,2017-03-13,2017-05-12,2017-05-09,Shortage of an active ingredient.,2017-03-13,2017-07-04
57401,507415,Shortage,DAN-GARD,VALEO PHARMA INC,Pyrithione zinc shampoo,PYRITHIONE ZINC,2%,300 mL,TOPICAL,Actual shortage,SHAMPOO,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017-03-01,2019-05-31,,Disruption of the manufacture of the drug.,2018-08-02,2019-01-15
3045,1997602,Shortage,DANTRIUM CAPSULES,PAR PHARMACEUTICAL COMPANIES,Dantrolene Sodium Capsules,DANTROLENE SODIUM,25MG,100 capsules/bottle,ORAL,Resolved,CAPSULE,M03CA,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",,2017-01-10,,2017-04-20,Other (Please describe in comments),2017-03-16,2017-04-21
43728,1997572,Shortage,DANTRIUM INTRAVENOUS,PAR PHARMACEUTICAL COMPANIES,Dantrolene Sodium for Injection,DANTROLENE SODIUM,20MG,Box containing 6x20mg Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,M03CA,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",,2018-03-22,2018-07-15,2018-07-30,Demand increase for the drug.,2018-03-22,2018-07-31
68907,2359456,Shortage,DAXAS,ASTRAZENECA CANADA INC,roflumilast,Roflumilast,500MCG,30 tablets,ORAL,Resolved,TABLET,R03DX,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-11-27,2019-01-10,2019-01-08,Delay in shipping of the drug.,2018-12-07,2019-01-10
33830,2241600,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,PFIZER CANADA INC,DEFEROXAMINE,DEFEROXAMINE MESYLATE,500MG,10 x 500mg,INTRAMUSCULAR  INTRAPERITONEAL  INTRAVENOUS  SUBCUTANEOUS,Avoided shortage,POWDER FOR SOLUTION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,2018-05-12,,2018-05-14,2018-05-08,Disruption of the manufacture of the drug.,2017-12-19,2018-05-09
6772,2247022,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,DEFEROXAMINE,DEFEROXAMINE MESYLATE,2G,1x2g,INTRAMUSCULAR  INTRAPERITONEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2017-04-13,2017-07-07,2017-07-07,Disruption of the manufacture of the drug.,2017-04-13,2017-07-11
11690,2241600,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,Deferoxamine,DEFEROXAMINE MESYLATE,500MG,10 x 500mg,INTRAMUSCULAR  INTRAPERITONEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,2017-06-02,,2017-07-11,2017-07-11,Demand increase for the drug.,2017-06-01,2017-07-12
66583,29246,Shortage,DELATESTRYL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,n/a,INTRAMUSCULAR,Resolved,SOLUTION,G03BA,ANDROGENS,,2018-12-07,,2019-01-10,Other (Please describe in comments),2018-11-09,2019-01-11
98649,29246,Shortage,DELATESTRYL,"BAUSCH HEALTH, CANADA INC.",DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,n/a,INTRAMUSCULAR,Actual shortage,SOLUTION,G03BA,ANDROGENS,,2019-11-12,2019-12-15,,Other (Please describe in comments),2019-11-13,2019-11-13
12960,29246,Shortage,DELATESTRYL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,na,INTRAMUSCULAR,Resolved,SOLUTION,G03BA,ANDROGENS,,2017-06-15,,2017-06-23,Other (Please describe in comments),2017-06-16,2017-06-24
23236,29246,Shortage,DELATESTRYL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,5ML,INTRAMUSCULAR,Resolved,SOLUTION,G03BA,ANDROGENS,2017-12-20,,2018-01-04,2018-01-02,Other (Please describe in comments),2017-09-25,2018-01-23
61170,29246,Shortage,DELATESTRYL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,5ml,INTRAMUSCULAR,Avoided shortage,SOLUTION,G03BA,ANDROGENS,2018-11-05,,2018-11-30,2018-10-01,Other (Please describe in comments),2018-09-10,2018-10-05
76594,469327,Shortage,DEMULEN 30 (21 DAY PACK),PFIZER CANADA ULC,Demulen 21,ETHYNODIOL DIACETATE  ETHINYL ESTRADIOL,2MG  30MCG,21's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-07-03,2019-07-03,,2019-07-03,Disruption of the manufacture of the drug.,2019-02-21,2019-07-04
22959,469327,Shortage,DEMULEN 30 (21 DAY PACK),PFIZER CANADA INC,DEMULEN,ETHYNODIOL DIACETATE  ETHINYL ESTRADIOL,2MG  30MCG,21's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-01-03,,2018-04-11,Disruption of the manufacture of the drug.,2017-09-21,2018-04-12
29300,471526,Shortage,DEMULEN 30 (28 DAY PACK),PFIZER CANADA INC,DEMULEN,ETHINYL ESTRADIOL  ETHYNODIOL DIACETATE,30MCG  2MG,28's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-02-28,,2018-04-09,Disruption of the manufacture of the drug.,2017-11-15,2018-04-10
72823,471526,Shortage,DEMULEN 30 (28 DAY PACK),PFIZER CANADA ULC,DEMULEN,ETHINYL ESTRADIOL  ETHYNODIOL DIACETATE,30MCG  2MG,28's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-03-12,2019-03-12,,2019-07-03,Disruption of the manufacture of the drug.,2019-01-17,2019-07-04
82873,443832,Shortage,DEPAKENE,BGP PHARMA ULC,VALPROIC ACID,VALPROIC ACID,50MG,240 ML,ORAL,Resolved,SYRUP,N03AG,ANTIEPILEPTICS,,2019-04-30,,2019-05-14,Requirements related to complying with good manufacturing practices.,2019-04-30,2019-05-15
7165,443840,Shortage,DEPAKENE,BGP PHARMA ULC,Depakene,VALPROIC ACID,250MG,100,ORAL,Resolved,CAPSULE,N03AG,ANTIEPILEPTICS,,2017-01-25,,2017-04-24,Disruption of the manufacture of the drug.,2017-04-18,2017-06-08
47887,30767,Shortage,DEPO-MEDROL 80 MG/ML,PFIZER CANADA INC,DEPO-MEDROL,METHYLPREDNISOLONE ACETATE,80MG,5x1ML,INTRA-ARTICULAR  INTRALESIONAL  INTRAMUSCULAR  INTRASYNOVIAL,Resolved,SUSPENSION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2018-04-27,,2018-05-15,Disruption of the manufacture of the drug.,2018-05-01,2018-05-16
79397,585092,Shortage,DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML,PFIZER CANADA ULC,Depo-Provera,MEDROXYPROGESTERONE ACETATE,150MG,5x1ml,INTRAMUSCULAR,Resolved,SUSPENSION,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-03-25,2019-04-16,2019-04-16,Disruption of the manufacture of the drug.,2019-03-25,2019-04-17
88645,585092,Shortage,DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML,PFIZER CANADA ULC,DEPO-PROVERA,MEDROXYPROGESTERONE ACETATE,150MG,5x1ml,INTRAMUSCULAR,Resolved,SUSPENSION,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-09-06,2019-09-06,2019-10-11,2019-10-09,Disruption of the manufacture of the drug.,2019-07-05,2019-10-10
86056,30783,Shortage,DEPO-TESTOSTERONE INJ 100MG/ML,PFIZER CANADA ULC,DEPO-TESTOSTERONE,TESTOSTERONE CYPIONATE,100MG,1 x 10mL GVL,INTRAMUSCULAR,Resolved,SOLUTION,G03BA,ANDROGENS,,2019-06-10,,2019-10-01,Disruption of the manufacture of the drug.,2019-06-10,2019-10-02
85817,2230642,Shortage,DERMATOP EMOLLIENT CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DERMATOP EMOLLIENT CREAM,PREDNICARBATE,0.1%,60g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-05-10,,2019-07-12,Other (Please describe in comments),2019-06-07,2019-07-13
24055,2230642,Shortage,DERMATOP EMOLLIENT CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,DERMATOP EMOLLIENT CREAM,PREDNICARBATE,0.1%,N/A,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017-10-12,,,2017-10-24,Other (Please describe in comments),2017-10-02,2017-10-25
85385,2213281,Shortage,DERMOVATE SCALP APPLICATION,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",DERMOVATE SCALP APPLICATION,CLOBETASOL PROPIONATE,0.05%,60 ml,TOPICAL,Resolved,SOLUTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-05-21,2019-06-07,2019-06-14,Disruption of the manufacture of the drug.,2019-05-31,2019-06-17
68730,2216272,Shortage,DESIPRAMINE,AA PHARMA INC,DESIPRAMINE,DESIPRAMINE,75MG,100 BTL,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2018-12-15,2019-01-03,2018-12-20,Disruption of the manufacture of the drug.,2018-12-05,2019-01-10
98243,2284030,Shortage,DESMOPRESSIN,AA PHARMA INC,Desmopressin,DESMOPRESSIN ACETATE,0.1MG,100BTL,ORAL,Actual shortage,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2019-11-08,2019-12-14,,Disruption of the manufacture of the drug.,2019-11-08,2019-11-09
96776,2242465,Shortage,DESMOPRESSIN SPRAY,AA PHARMA INC,Desmopressin Spray,DESMOPRESSIN ACETATE,10MCG,2.5ML,NASAL,Actual shortage,"SPRAY, METERED DOSE",H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2019-10-17,2019-11-20,,Disruption of the manufacture of the drug.,2019-10-17,2019-10-18
96779,2242465,Shortage,DESMOPRESSIN SPRAY,AA PHARMA INC,Desmopressin Spray,DESMOPRESSIN ACETATE,10MCG,5ML,NASAL,Resolved,"SPRAY, METERED DOSE",H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2019-10-17,2019-11-07,2019-11-08,Disruption of the manufacture of the drug.,2019-10-17,2019-11-09
38160,2239064,Shortage,DETROL,PFIZER CANADA INC,Detrol 1mg,TOLTERODINE TARTRATE,1MG,60's,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-02-14,,2018-03-06,Disruption of the manufacture of the drug.,2018-02-02,2018-03-07
96055,2239064,Shortage,DETROL,PFIZER CANADA ULC,Detrol,TOLTERODINE TARTRATE,1MG,60's,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2019-11-08,,2019-11-29,,Disruption of the manufacture of the drug.,2019-10-10,2019-11-09
36015,2239065,Shortage,DETROL,PFIZER CANADA INC,Detrol 2mg,TOLTERODINE TARTRATE,2MG,60's,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-01-18,,2018-02-20,Disruption of the manufacture of the drug.,2018-01-16,2018-02-21
22963,2239064,Shortage,DETROL,PFIZER CANADA INC,DETROL,TOLTERODINE TARTRATE,1MG,60's,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-09-19,2017-11-01,2017-11-01,Other (Please describe in comments),2017-09-21,2017-11-02
69018,2244613,Shortage,DETROL LA,PFIZER CANADA ULC,DETROL LA,TOLTERODINE TARTRATE,4MG,90's,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-04-09,,2019-04-12,Disruption of the manufacture of the drug.,2018-12-10,2019-04-13
69027,2244612,Shortage,DETROL LA,PFIZER CANADA ULC,DETROL LA,TOLTERODINE TARTRATE,2MG,30's,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-04-03,,2019-04-12,Disruption of the manufacture of the drug.,2018-12-10,2019-04-13
69032,2244612,Shortage,DETROL LA,PFIZER CANADA ULC,DETROL LA,TOLTERODINE TARTRATE,2MG,90's,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-03-26,,2019-04-12,Disruption of the manufacture of the drug.,2018-12-10,2019-04-13
18152,664227,Shortage,DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML,SANDOZ CANADA INCORPORATED,DEXAMETHASONE10,DEXAMETHASONE PHOSPHATE,4MG,10 X 5ML VIALS,INTRAMUSCULAR  INTRASYNOVIAL  INTRAVENOUS,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-07-21,2017-08-18,2017-08-07,Delay in shipping of the drug.,2017-08-03,2017-10-18
94226,1977547,Shortage,"DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP",STERIMAX INC,DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP,DEXAMETHASONE PHOSPHATE,4MG,1 VIAL,INTRA-ARTICULAR  INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-09-18,2019-10-01,2019-09-30,Delay in shipping of the drug.,2019-09-18,2019-10-01
87876,2204274,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LTD,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,10MG,10 x 1mL vial / fiole,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-28,2019-08-12,2019-08-19,Disruption of the manufacture of the drug.,2019-06-28,2019-08-30
63420,2204266,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LTD,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,4MG,10 x 1 mL vial,INTRA-ARTICULAR  INTRALESIONAL  INTRAMUSCULAR  INTRAVENOUS  SOFT TISSUE INJECTION,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-05-15,,2019-06-17,Disruption of the manufacture of the drug.,2018-10-05,2019-06-28
2964,2205963,Shortage,DEXIRON,LUITPOLD PHARMACEUTICALS INC,Iron Dextran,IRON,50MG,2 ml single dose vials supplied in cartons of 10 vials,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,B03,IRON PREPARATIONS,2017-11-13,2017-11-30,2018-02-22,2018-02-28,Disruption of the manufacture of the drug.,2017-03-15,2018-03-01
98895,2467976,Shortage,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION,MDA INC.,Dexmedetomidine HCL,DEXMEDETOMIDINE,100MCG,2 mL Vial - 25's,INTRAVENOUS,Actual shortage,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,2019-11-04,2019-11-04,2019-11-30,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
23829,39551,Shortage,DEXTROSE 5% IN LACTATED RINGERS,HOSPIRA HEALTHCARE CORPORATION,Dextrose 5% in lactated ringers,SODIUM LACTATE  DEXTROSE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,3.1MG  50.0MG  0.2MG  0.3MG  6.0MG,24,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,,2017-09-28,2017-12-31,2017-12-31,Disruption of the manufacture of the drug.,2017-09-28,2018-01-01
26118,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,Dextrose 5% Inj - AVIVA,DEXTROSE,5G,250mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2018-01-04,2018-01-04,2018-11-27,2018-11-27,Disruption of the manufacture of the drug.,2017-10-17,2018-11-27
56909,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,5% Dextrose Injection,DEXTROSE,5G,100mL Mini-Bag Plus,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2018-07-30,2018-07-30,2018-10-09,2018-10-09,Disruption of the manufacture of the drug.,2018-07-30,2018-10-10
56912,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,5% Dextrose Injection,DEXTROSE,5G,50mL Mini-Bag Plus,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2018-07-30,2018-07-30,2018-10-09,2018-10-09,Disruption of the manufacture of the drug.,2018-07-30,2018-10-10
32181,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,Dextrose 5% Inj – AVIVA,DEXTROSE,5G,500mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2018-01-04,2018-01-04,2018-11-27,2018-11-27,Disruption of the manufacture of the drug.,2017-12-08,2018-11-27
19398,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,"5% Dextrose Injection, USP",DEXTROSE,5G,50mL,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2017-08-15,2017-08-15,2018-02-28,2018-02-28,Disruption of the manufacture of the drug.,2017-08-15,2018-03-01
34771,60348,Shortage,DEXTROSE 5% INJ 5GM/100ML USP,BAXTER CORPORATION,"5% Dextrose Injection, USP",DEXTROSE,5G,100mL,INTRAVENOUS,Resolved,LIQUID,B05BA,I.V. SOLUTIONS,2017-08-15,2017-08-15,2018-02-28,2018-02-28,Disruption of the manufacture of the drug.,2018-01-03,2018-03-01
76027,60348,Shortage,"DEXTROSE 5% INJECTION, USP",BAXTER CORPORATION,5% Dextrose Injection,DEXTROSE,5G,250 mL,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2019-02-15,2019-02-15,2019-03-28,2019-02-28,Delay in shipping of the drug.,2019-02-15,2019-03-01
46927,37915,Shortage,DEXTROSE INJECTION USP,ICU MEDICAL CANADA INC,5% Dextrose Injection USP,DEXTROSE,50MG,1000ML,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2018-05-01,2018-05-01,2018-09-30,2018-10-16,Disruption of the manufacture of the drug.,2018-04-23,2018-10-17
83849,37915,Shortage,DEXTROSE INJECTION USP,ICU MEDICAL CANADA INC,% 5 Dextrose Injection USP,DEXTROSE,50MG,500 ml,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2019-07-01,2019-06-28,2019-07-15,2019-10-31,Delay in shipping of the drug.,2019-05-13,2019-11-01
84663,2468514,Shortage,DEXTROSE INJECTION USP,,DEXTROSE INJECTION,DEXTROSE,500 mg/mL,25 x 50mL vials,Intravenous,Resolved,Solution,B05BA,IV Solutions,,2019-05-17,,2019-08-01,Disruption of the manufacture of the drug.,2019-05-24,2019-10-07
91585,2468514,Shortage,DEXTROSE INJECTION USP,,DEXTROSE INJECTION,DEXTROSE,500 mg/mL,10 X 50ml ANSYR,Intravenous,Actual shortage,Solution,B05BA,I.V. Solutions,,2019-08-14,,,Disruption of the manufacture of the drug.,2019-08-14,2019-08-15
64460,2468514,Shortage,DEXTROSE INJECTION USP,,DEXTROSE INJECTION USP,DEXTROSE,500mg/mL,10 x 50mL LifeShield,IV,Resolved,Solution,B05BA,IV Solutions,,2018-11-30,,2019-10-25,Disruption of the manufacture of the drug.,2018-10-16,2019-10-26
70399,37958,Shortage,DEXTROSE INJECTION USP,ICU MEDICAL CANADA INC,%10 Dextrose Injection USP (500ml),DEXTROSE,100MG,24,INTRAVENOUS,Resolved,SOLUTION,B05BA,I.V. SOLUTIONS,2018-12-21,2018-12-21,2019-01-25,2019-01-25,Delay in shipping of the drug.,2018-12-21,2019-01-26
43286,2224569,Shortage,DIABETA,SANOFI-AVENTIS CANADA INC,Diabeta 5mg 30's,GLYBURIDE,5MG,30,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-04-16,2018-04-02,2018-05-31,2018-04-30,Other (Please describe in comments),2018-03-19,2018-05-01
3322,2398982,Shortage,DIACOMIT,BIOCODEX SA,Diacomit,Stiripentol,500MG,package of 60 sachets,ORAL,Actual shortage,POWDER FOR SUSPENSION,N03AX,ANTIEPILEPTICS,2017-03-17,2017-03-17,2017-08-31,,Disruption of the manufacture of the drug.,2017-03-17,2018-12-20
80259,2242987,Shortage,DIAMICRON MR,SERVIER CANADA INC,DIAMICRON MR,GLICLAZIDE,30MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-03-27,2019-04-12,2019-04-03,Delay in shipping of the drug.,2019-04-01,2019-04-04
89601,799793,Shortage,DIANEAL PD 101 CAPD SOLUTION W 0.5% DEXTROSE,BAXTER CORPORATION,Dianeal PD101,SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE,392MG  500MG  15.2MG  23.9MG  567MG,2 L,DIALYSIS,Resolved,SOLUTION,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2019-07-23,2019-07-23,2019-08-01,2019-08-01,Disruption of the manufacture of the drug.,2019-07-18,2019-08-02
76652,799823,Shortage,DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE,BAXTER CORPORATION,Dianeal PD 101,SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE,392MG  2.5G  15.2MG  23.9MG  567MG,5L,DIALYSIS,Resolved,SOLUTION,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2019-02-25,2019-02-25,2019-02-25,2019-02-25,Disruption of the manufacture of the drug.,2019-02-22,2019-02-26
15021,865095,Shortage,DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM,BAXTER CORPORATION,"DIANEAL,PD4 1.5% 1.5L TWIN BAG",SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE,448MG  1.5G  5.08MG  18.3MG  538MG,"1.5L BAGS, 6/box",DIALYSIS,Resolved,SOLUTION,B05,HEMODIALYTICS AND HEMOFILTRATES,2017-07-21,2017-07-21,2017-07-28,2017-07-31,Disruption of the manufacture of the drug.,2017-07-10,2017-08-01
37069,865095,Shortage,DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM,BAXTER CORPORATION,Dianeal PD4 w/ 1.5% Dextrose & 1.25 mmol/L Calcium,SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE,448MG  1.5G  5.08MG  18.3MG  538MG,5L,DIALYSIS,Resolved,SOLUTION,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2018-01-24,2018-01-24,2018-02-06,2018-02-06,Shortage of an inactive ingredient or component.,2018-01-24,2018-02-07
37066,865109,Shortage,DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM,BAXTER CORPORATION,"Dianeal, PD4 w/ 2.5% Dextrose & 1.25 mmol/L Calcium",SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE,448MG  2.5G  5.08MG  18.3MG  538MG,5L,DIALYSIS,Resolved,SOLUTION,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2018-01-24,2018-01-24,2018-02-08,2018-02-08,Shortage of an inactive ingredient or component.,2018-01-24,2018-02-09
81487,865117,Shortage,DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM,BAXTER CORPORATION,Dianeal PD4,SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE,448MG  4.25G  5.08MG  18.3MG  538MG,5L,DIALYSIS,Resolved,SOLUTION,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2019-04-12,2019-04-12,2019-04-29,2019-04-29,Disruption of the manufacture of the drug.,2019-04-12,2019-04-30
18608,865117,Shortage,DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM,BAXTER CORPORATION,"DIANEAL, PD4 4.25% 2.5L TB",SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE,448MG  4.25G  5.08MG  18.3MG  538MG,"2.5L bags,  4/box",DIALYSIS,Resolved,SOLUTION,B05,HEMODIALYTICS AND HEMOFILTRATES,2017-08-22,,2017-08-22,2017-08-22,Demand increase for the drug.,2017-08-09,2017-08-23
69667,2238162,Shortage,DIASTAT,VALEANT PHARMACEUTICALS NORTH AMERICA LLC,DIASTAT,DIAZEPAM,5MG,2pk,RECTAL,Resolved,GEL,N05BA,ANXIOLYTICS,,2018-12-07,,2019-01-09,Other (Please describe in comments),2018-12-14,2019-01-10
69670,2238162,Shortage,DIASTAT,VALEANT PHARMACEUTICALS NORTH AMERICA LLC,DIASTAT,DIAZEPAM,5MG,10mg -2pk,RECTAL,Resolved,GEL,N05BA,ANXIOLYTICS,,2018-12-07,,2019-01-09,Other (Please describe in comments),2018-12-14,2019-01-10
52015,2238162,Shortage,DIASTAT,VALEANT PHARMACEUTICALS NORTH AMERICA LLC,DIASTAT,DIAZEPAM,5MG,5 mg 2pk,RECTAL,Resolved,GEL,N05BA,ANXIOLYTICS,,2018-06-01,,2018-10-18,Other (Please describe in comments),2018-06-08,2018-10-19
98671,2238162,Shortage,DIASTAT,VALEANT PHARMACEUTICALS NORTH AMERICA LLC,DIASTAT,DIAZEPAM,5MG,10mg / 2pk,RECTAL,Actual shortage,GEL,N05BA,ANXIOLYTICS,,2019-10-25,2019-11-22,,Other (Please describe in comments),2019-11-13,2019-11-13
84611,2238162,Shortage,DIASTAT,VALEANT PHARMACEUTICALS NORTH AMERICA LLC,DIASTAT,DIAZEPAM,5MG,10mg 2pk,RECTAL,Resolved,GEL,N05BA,ANXIOLYTICS,,2019-05-09,,2019-09-16,Other (Please describe in comments),2019-05-23,2019-09-18
90563,2238162,Shortage,DIASTAT,VALEANT PHARMACEUTICALS NORTH AMERICA LLC,DIASTAT,DIAZEPAM,5MG,5mg 2pk,RECTAL,Resolved,GEL,N05BA,ANXIOLYTICS,,2019-07-09,,2019-09-16,Other (Please describe in comments),2019-08-01,2019-09-18
49657,2238162,Shortage,DIASTAT,VALEANT PHARMACEUTICALS NORTH AMERICA LLC,DIASTAT,DIAZEPAM,5MG,15mg 2 pk,RECTAL,Resolved,GEL,N05BA,ANXIOLYTICS,,2018-04-24,,2019-10-07,Delay in shipping of the drug.,2018-05-17,2019-10-09
62442,2385392,Shortage,DIAZEPAM INJECTION USP,TELIGENT OU,DIAZEPAM INJECTION USP,DIAZEPAM,5MG,2 mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05BA,ANXIOLYTICS,,2018-09-03,,2019-05-03,Delay in shipping of the drug.,2018-09-27,2019-05-04
54854,2230684,Shortage,DICETEL,BGP PHARMA ULC,PINAVERIUM BROMIDE,PINAVERIUM BROMIDE,100MG,5 x 20,ORAL,Resolved,TABLET,A03AX,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2018-07-26,,2018-08-10,2018-08-08,Delay in shipping of the drug.,2018-07-09,2018-08-09
78849,2352397,Shortage,DICLOFENAC EC,SANIS HEALTH INC,DICLOFENAC SOD EC,DICLOFENAC SODIUM,50MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-07-15,,,,Disruption of the manufacture of the drug.,2019-03-16,2019-07-16
6274,2352397,Shortage,DICLOFENAC EC,SANIS HEALTH INC,DICLOFENAC EC TABS,DICLOFENAC SODIUM,50MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-04-14,,2017-05-19,2017-04-26,Other (Please describe in comments),2017-04-10,2017-04-27
91112,2351684,Shortage,DICLOFENAC K,SANIS HEALTH INC,DICLOFENAC K,DICLOFENAC POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-11-07,2019-11-11,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-07,2019-11-12
58214,2224127,Shortage,DICLOFENAC-SR,PRO DOC LIMITEE,DICLOFENAC,DICLOFENAC SODIUM,100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-08-15,2019-01-30,2019-01-30,Delay in shipping of the drug.,2018-08-15,2019-01-31
68555,2224119,Shortage,DICLOFENAC-SR,PRO DOC LIMITEE,DICLOFENAC,DICLOFENAC SODIUM,75MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-12-04,2019-01-30,2019-01-30,Delay in shipping of the drug.,2018-12-04,2019-01-31
53023,2387174,Shortage,DIFICID,MERCK CANADA INC,fidaxomicin tablets,Fidaxomicin,200MG,20's,ORAL,Resolved,TABLET,A07AA,INTESTINALANTIINFECTIVES,2018-07-27,2018-07-19,2018-09-14,2018-09-11,Delay in shipping of the drug.,2018-06-26,2018-09-12
66972,2387174,Shortage,DIFICID,MERCK CANADA INC,fidaxomicin tablets,Fidaxomicin,200MG,20',ORAL,Resolved,TABLET,A07AA,INTESTINALANTIINFECTIVES,2018-11-15,2018-11-15,2019-01-11,2019-01-09,Delay in shipping of the drug.,2018-11-15,2019-01-11
40147,2387174,Shortage,DIFICID,MERCK CANADA INC,Fidaxomicin tablets,Fidaxomicin,200MG,20 TAB,ORAL,Resolved,TABLET,A07AA,INTESTINALANTIINFECTIVES,2018-03-26,2018-03-28,2018-04-13,2018-04-10,Delay in shipping of the drug.,2018-02-19,2018-04-11
7210,2024152,Shortage,DIFLUCAN PWS 50MG/5ML,PFIZER CANADA INC,DIFLUCAN,FLUCONAZOLE,50MG,100ML VIAL,ORAL,Resolved,POWDER FOR SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017-04-18,2017-04-21,2017-04-20,Disruption of the manufacture of the drug.,2017-04-18,2017-04-25
46307,2361043,Shortage,DIGIFAB,BTG INTERNATIONAL INC,Digoxin Immune Fab (Ovine),DIGOXIN IMMUNE FAB,40MG,One vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2018-04-13,,2018-05-04,Demand increase for the drug.,2018-04-19,2018-05-05
76444,23442,Shortage,DILANTIN-30 SUSPENSION,PFIZER CANADA ULC,DILANTIN-30 SUSPENSION,PHENYTOIN,30MG,250ML,ORAL,Avoided shortage,SUSPENSION,N03AB,ANTIEPILEPTICS,2019-05-23,,,2019-05-06,Disruption of the manufacture of the drug.,2019-02-21,2019-05-07
12597,627100,Shortage,DILAUDID,PURDUE PHARMA,"Hydromorphone Hydrochloride, 2mg/mL",HYDROMORPHONE HYDROCHLORIDE,2MG,25 x 1 mL ampoules,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,LIQUID,N02AA,OPIOIDS,2017-06-12,2017-06-12,2017-12-31,,Other (Please describe in comments),2017-06-12,2018-12-20
23095,125083,Shortage,DILAUDID,PURDUE PHARMA,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017-09-22,2017-09-22,2017-10-02,2017-10-23,Demand increase for the drug.,2017-09-22,2017-10-24
12825,622133,Shortage,DILAUDID HP,PURDUE PHARMA,Hydromorphone,HYDROMORPHONE HYDROCHLORIDE,10MG,10 x 5 mL ampoules,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,LIQUID,N02AA,OPIOIDS,2017-06-15,2017-06-15,2017-12-31,,Other (Please describe in comments),2017-06-15,2018-12-20
12828,622133,Shortage,DILAUDID HP,PURDUE PHARMA,Hydromorphone,HYDROMORPHONE HYDROCHLORIDE,10MG,10 x 1 mL ampoules,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,LIQUID,N02AA,OPIOIDS,2017-06-15,2017-06-15,2017-12-31,,Other (Please describe in comments),2017-06-15,2018-12-20
12731,622133,Shortage,DILAUDID HP,PURDUE PHARMA,"Hydromorphone Hydrochloride, 10mg/mL",HYDROMORPHONE HYDROCHLORIDE,10MG,10 x 1 mL ampoules,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,LIQUID,N02AA,OPIOIDS,2017-06-13,2017-06-13,2017-12-31,,Other (Please describe in comments),2017-06-13,2018-12-20
68421,2231472,Shortage,DILTIAZEM - CD,PRO DOC LIMITEE,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-12-03,,2019-05-28,Delay in shipping of the drug.,2018-12-03,2019-05-29
77200,2231057,Shortage,DILTIAZEM - CD,PRO DOC LIMITEE,DILTIAZEM - CD,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-03-01,2019-09-27,2019-09-27,Delay in shipping of the drug.,2019-03-01,2019-09-28
69057,2231475,Shortage,DILTIAZEM - CD,PRO DOC LIMITEE,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-12-10,,2019-04-25,Delay in shipping of the drug.,2018-12-10,2019-04-26
80362,2231474,Shortage,DILTIAZEM - CD,PRO DOC LIMITEE,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-04-03,,2019-04-25,Delay in shipping of the drug.,2019-04-03,2019-04-26
17941,2400421,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016-06-22,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
17945,2400448,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016-06-13,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
17949,2400456,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016-08-25,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
17952,2400464,Shortage,DILTIAZEM CD,SANIS HEALTH INC,DILTIAZEM CD CAPS,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2016-08-02,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
72099,2446006,Shortage,DILTIAZEM CD,SIVEM PHARMACEUTICALS ULC,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-01-28,2019-01-25,2019-05-31,2019-05-31,Requirements related to complying with good manufacturing practices.,2019-01-14,2019-06-01
61380,2446014,Shortage,DILTIAZEM CD,SIVEM PHARMACEUTICALS ULC,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-09-25,2018-09-28,2019-05-31,2019-05-31,Delay in shipping of the drug.,2018-09-12,2019-06-01
65221,2445999,Shortage,DILTIAZEM CD,SIVEM PHARMACEUTICALS ULC,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-10-31,2018-11-05,2019-05-31,2019-05-31,Disruption of the manufacture of the drug.,2018-10-22,2019-06-01
41713,2446022,Shortage,DILTIAZEM CD,SIVEM PHARMACEUTICALS ULC,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-04-10,2018-04-10,2019-05-31,2019-05-31,Requirements related to complying with good manufacturing practices.,2018-03-05,2019-06-01
82695,2325314,Shortage,DILTIAZEM TZ,PRO DOC LIMITEE,DILTIAZEM TZ,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-05-23,,,Disruption of the manufacture of the drug.,2019-04-29,2019-05-28
82698,2325330,Shortage,DILTIAZEM TZ,PRO DOC LIMITEE,DILTIAZEM TZ,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-08-05,2019-08-01,,,Delay in shipping of the drug.,2019-04-29,2019-08-02
74055,2325306,Shortage,DILTIAZEM TZ,PRO DOC LIMITEE,DILTIAZEM TZ,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-01-31,,,Delay in shipping of the drug.,2019-01-31,2019-02-01
47275,2325306,Shortage,DILTIAZEM TZ,PRO DOC LIMITEE,DILTIAZEM TZ,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-07-31,2018-07-24,2018-08-31,2018-08-22,Delay in shipping of the drug.,2018-04-26,2018-08-23
47278,2325314,Shortage,DILTIAZEM TZ,PRO DOC LIMITEE,DILTIAZEM TZ,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-06-22,2018-08-31,2018-08-22,Delay in shipping of the drug.,2018-04-26,2018-08-23
47281,2325322,Shortage,DILTIAZEM TZ,PRO DOC LIMITEE,DILTIAZEM TZ,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-09-10,,,Delay in shipping of the drug.,2018-04-26,2018-09-11
42426,2325349,Shortage,DILTIAZEM TZ,PRO DOC LIMITEE,DILTIAZEM TZ,DILTIAZEM HYDROCHLORIDE,360MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-03-09,,,Delay in shipping of the drug.,2018-03-09,2018-04-26
39961,2435241,Shortage,DIMENHYDRINATE INJECTION USP WITH PRESERVATIVE,TELIGENT OU,Dimenhydrinate Injection USP,DIMENHYDRINATE,50MG,5 ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2018-02-01,2018-05-10,2018-05-10,Disruption of the manufacture of the drug.,2018-02-15,2018-05-16
96281,2244080,Shortage,DIMETANE EXPECTORANT DC,PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC,"Brompheniramine Maleate, Phenylephrine Hydrochloride, Guaifenesin and Hydrocodone Bitartrate Syrup",BROMPHENIRAMINE MALEATE  PHENYLEPHRINE HYDROCHLORIDE  HYDROCODONE BITARTRATE  GUAIFENESIN,2MG  5MG  1.8MG  100MG,1 Litre,ORAL,Actual shortage,SYRUP,R05FA,"COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS",,2019-10-09,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
11479,2160773,Shortage,DIOFLUOR STRIPS,DIOPTIC PHARMACEUTICALS INC,FLUORESCEIN SODIUM OPHTHALMIC STRIPS,FLUORESCEIN SODIUM,1MG,100 strips/box,TOPICAL,Resolved,STRIP,S01JA,DIAGNOSTICAGENTS,2017-06-19,,,2019-05-30,Requirements related to complying with good manufacturing practices.,2017-05-30,2019-06-25
2541,596612,Shortage,DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,DIPHENHYDRAMINE,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,10 X 1ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2017-03-14,2018-06-29,2018-05-18,Disruption of the manufacture of the drug.,2017-03-14,2018-05-23
36009,2018950,Shortage,DIPRIVAN 1%,ASPEN PHARMACARE CANADA INC.,Diprivan® 1% 5x20mL Vial,PROPOFOL,1%,5,INTRAVENOUS,Resolved,EMULSION,N01AX,"ANESTHETICS, GENERAL",,2018-01-01,2018-02-05,2018-02-06,Other (Please describe in comments),2018-01-16,2018-02-07
51150,629367,Shortage,DIPROLENE,MERCK CANADA INC,BETAMETHASONE DIPROPIONATE CREAM (glycol),BETAMETHASONE,0.5MG,50g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-05-31,2018-06-11,2018-06-11,Delay in shipping of the drug.,2018-06-03,2018-06-12
64471,629367,Shortage,DIPROLENE,MERCK CANADA INC,BETAMETHASONE DIPROPIONATE CREAM (glycol),BETAMETHASONE,0.5MG,50GM,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2018-11-19,2018-11-06,2018-12-21,2018-12-18,Delay in shipping of the drug.,2018-10-16,2018-12-19
50469,578436,Shortage,DIPROSALIC,MERCK CANADA INC,Betamethasone Dipropionate and Salicylic Acid Ointment,BETAMETHASONE  SALICYLIC ACID,0.5MG  30MG,50,TOPICAL,Resolved,OINTMENT,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",2018-05-28,2018-05-28,2018-06-11,2018-06-11,Delay in shipping of the drug.,2018-05-28,2018-06-12
9567,578428,Shortage,DIPROSALIC,MERCK CANADA INC,Betamethasone Dipropionate and Salicylic Acid Lotion,BETAMETHASONE  SALICYLIC ACID,0.5MG  20MG,60mL,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",2017-05-12,2017-05-11,2017-07-14,2017-07-07,Delay in shipping of the drug.,2017-05-08,2017-07-08
19673,578428,Shortage,DIPROSALIC,MERCK CANADA INC,Betamethasone Dipropionate and Salicylic Acid Lotion,BETAMETHASONE  SALICYLIC ACID,0.5MG  20MG,60mL,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",2017-08-22,2017-08-22,2017-09-08,2017-09-06,Delay in shipping of the drug.,2017-08-17,2017-09-07
40108,323071,Shortage,DIPROSONE CREAM,MERCK CANADA INC,BETAMETHASONE DIPROPIONATE CREAM,BETAMETHASONE,0.05%,50g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2018-03-26,2018-03-29,2018-04-20,2018-04-18,Delay in shipping of the drug.,2018-02-19,2018-04-19
24126,417246,Shortage,DIPROSONE LOTION,MERCK CANADA INC,Betamethasone Dipropionate Lotion,BETAMETHASONE,0.05%,75mL,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2017-10-16,2017-10-04,2017-11-10,2017-11-10,Demand increase for the drug.,2017-10-02,2017-11-11
87086,344923,Shortage,DIPROSONE OINTMENT,MERCK CANADA INC,BETAMETHASONE DIPROPIONATE OINTMENT,BETAMETHASONE,0.05%,50g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2019-08-06,2019-08-06,2019-11-07,2019-11-07,Delay in shipping of the drug.,2019-06-19,2019-11-08
47200,344923,Shortage,DIPROSONE OINTMENT,MERCK CANADA INC,BETAMETHASONE DIPROPIONATE OINTMENT,BETAMETHASONE,0.05%,50g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2018-04-25,2018-04-25,2018-06-11,2018-06-11,Delay in shipping of the drug.,2018-04-25,2018-06-12
59148,2244475,Shortage,"DIPYRIDAMOLE INJECTION, USP",FRESENIUS KABI CANADA LTD,Dipyridamole Injection,DIPYRIDAMOLE,5MG,10mL,INTRAVENOUS,Resolved,LIQUID,B01AC,ANTITHROMBOTIC AGENTS,2018-08-24,,2018-09-05,2018-09-05,Disruption of the manufacture of the drug.,2018-08-25,2018-09-06
88601,2244475,Shortage,"DIPYRIDAMOLE INJECTION, USP",FRESENIUS KABI CANADA LTD,Dipyridamole,DIPYRIDAMOLE,5MG,10mL Vial,INTRAVENOUS,Resolved,LIQUID,B01AC,ANTITHROMBOTIC AGENTS,2019-08-15,,2019-10-15,2019-10-01,Disruption of the manufacture of the drug.,2019-07-05,2019-10-02
69542,2244475,Shortage,"DIPYRIDAMOLE INJECTION, USP",FRESENIUS KABI CANADA LTD,Dipyridamole Injection,DIPYRIDAMOLE,5MG,10 mL,INTRAVENOUS,Resolved,LIQUID,B01AC,ANTITHROMBOTIC AGENTS,2018-12-11,,2019-03-18,2019-03-18,Disruption of the manufacture of the drug.,2018-12-13,2019-03-26
74828,2243961,Shortage,DITROPAN XL  -(10MG),JANSSEN INC,"oxybutynin chloride, extended-release tablets",OXYBUTYNIN CHLORIDE,10MG,1x100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2019-02-07,,2019-02-28,2019-02-20,Delay in shipping of the drug.,2019-02-05,2019-02-21
33935,2243960,Shortage,DITROPAN XL  -(5MG),JANSSEN INC,oxybutynin chloride,OXYBUTYNIN CHLORIDE,5MG,5mg bottle,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-12-21,2017-12-21,2018-01-16,2018-01-16,Disruption of the manufacture of the drug.,2017-12-20,2018-01-17
17955,2400499,Shortage,DIVALPROEX,SANIS HEALTH INC,DIVALPROEX TABS,VALPROIC ACID,125MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2016-02-19,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
17958,2400502,Shortage,DIVALPROEX,SANIS HEALTH INC,DIVALPROEX TABS,VALPROIC ACID,250MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2015-09-01,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
17961,2400510,Shortage,DIVALPROEX,SANIS HEALTH INC,DIVALPROEX TABS,VALPROIC ACID,500MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2015-09-01,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
18904,2424835,Shortage,DIVIGEL,TEVA CANADA LIMITED,DIVIGEL,ESTRADIOL,0.1%,30,TRANSDERMAL,Resolved,GEL,G03CA,ESTROGENS,,2017-08-11,2017-11-09,2017-12-29,Disruption of the manufacture of the drug.,2017-08-11,2018-01-03
25930,2210401,Shortage,DOBUTAMINE INJECTION USP,PFIZER CANADA INC,DOBUTAMINE,DOBUTAMINE,12.5MG,10x20mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-11-15,,2018-09-07,Disruption of the manufacture of the drug.,2017-10-13,2018-09-08
1680,2412225,Shortage,DOCETAXEL INJECTION,TEVA CANADA LIMITED,DOCETAXEL,DOCETAXEL,20MG,0.72ML,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1688,2412233,Shortage,DOCETAXEL INJECTION,TEVA CANADA LIMITED,DOCETAXEL,DOCETAXEL,80MG,2.88ML,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
64230,2439336,Shortage,DOCETAXEL INJECTION,SANDOZ CANADA INCORPORATED,DOCETAXEL,DOCETAXEL,10MG,16ML 1 VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-08-31,2018-12-17,2019-01-11,Demand increase for the drug.,2018-10-15,2019-01-16
2556,2439336,Shortage,DOCETAXEL INJECTION,SANDOZ CANADA INCORPORATED,DOCETAXEL,DOCETAXEL,10MG,16ML,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-03-14,2017-05-19,2017-05-15,Demand increase for the drug.,2017-03-14,2017-05-17
53315,2361957,Shortage,DOCETAXEL INJECTION USP,PFIZER CANADA INC,DOCETAXEL,DOCETAXEL,10.0MG,1 x 2mL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-07-21,,2018-08-22,Disruption of the manufacture of the drug.,2018-06-29,2018-08-23
52568,2361957,Shortage,DOCETAXEL INJECTION USP,PFIZER CANADA INC,DOCETAXEL,DOCETAXEL,10.0MG,1x8 mL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-07-05,,2018-08-22,Disruption of the manufacture of the drug.,2018-06-18,2018-08-23
52573,2361957,Shortage,DOCETAXEL INJECTION USP,PFIZER CANADA INC,DOCETAXEL,DOCETAXEL,10.0MG,1x16 mL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2018-06-25,,,2018-08-21,Disruption of the manufacture of the drug.,2018-06-18,2018-08-22
98444,2361957,Shortage,DOCETAXEL INJECTION USP,PFIZER CANADA ULC,Docetaxel Injection USP,DOCETAXEL,10.0MG,8mL vial,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2019-11-11,,,Disruption of the manufacture of the drug.,2019-11-11,2019-11-12
24907,2426838,Shortage,DOCUSATE SODIUM,SANIS HEALTH INC,DOCUSATE SODIUM CAPS,DOCUSATE SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,2017-10-10,,2017-10-27,2017-11-15,Other (Please describe in comments),2017-10-10,2017-11-16
9689,2402653,Shortage,DONEPEZIL HYDROCHLORIDE TABLETS,ACCORD HEALTHCARE INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2017-04-21,2017-04-21,2017-08-04,2017-07-21,Disruption of the manufacture of the drug.,2017-05-09,2017-07-22
25661,761850,Shortage,DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP,BAXTER CORPORATION,DOPAMINE 0.8MG/ML,DOPAMINE HYDROCHLORIDE  DEXTROSE,.8MG  50MG,250mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017-10-12,2017-10-12,2018-03-01,2018-03-05,Disruption of the manufacture of the drug.,2017-10-12,2018-03-07
25606,761826,Shortage,DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP,BAXTER CORPORATION,DOPAMINE HCL 1.6MG/ML,DOPAMINE HYDROCHLORIDE  DEXTROSE,1.6MG  50MG,250mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017-10-12,2017-10-12,2018-03-01,2018-03-05,Disruption of the manufacture of the drug.,2017-10-11,2018-03-07
25658,761834,Shortage,DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP,BAXTER CORPORATION,DOPAMINE HCL 3.2MG/ML,DEXTROSE  DOPAMINE HYDROCHLORIDE,50MG  3.2MG,250mL,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017-10-12,2017-10-12,2018-02-06,2018-02-06,Disruption of the manufacture of the drug.,2017-10-12,2018-02-07
66323,2242471,Shortage,DOSTINEX,PFIZER CANADA INC,DOSTINEX,CABERGOLINE,0.5MG,8's,ORAL,Resolved,TABLET,G02CB,OTHER GYNECOLOGICALS,,2018-11-02,,2018-11-21,Demand increase for the drug.,2018-11-06,2018-11-22
41789,2242471,Shortage,DOSTINEX,PFIZER CANADA INC,Dostinex,CABERGOLINE,0.5MG,8,ORAL,Resolved,TABLET,G02CB,OTHER GYNECOLOGICALS,,2018-02-19,,2018-03-07,Demand increase for the drug.,2018-03-05,2018-03-08
95815,2242471,Shortage,DOSTINEX,PFIZER CANADA ULC,Dostinex,CABERGOLINE,0.5MG,8's,ORAL,Actual shortage,TABLET,G02CB,OTHER GYNECOLOGICALS,,2019-10-08,2019-12-20,,Demand increase for the drug.,2019-10-09,2019-10-09
67675,2242471,Shortage,DOSTINEX,PFIZER CANADA INC,DOSTINEX,CABERGOLINE,0.5MG,8's,ORAL,Resolved,TABLET,G02CB,OTHER GYNECOLOGICALS,,2018-11-23,,2018-12-20,Demand increase for the drug.,2018-11-26,2018-12-21
73569,2242471,Shortage,DOSTINEX,PFIZER CANADA ULC,DOSTINEX,CABERGOLINE,0.5MG,8's,ORAL,Resolved,TABLET,G02CB,OTHER GYNECOLOGICALS,,2019-01-24,2019-09-20,2019-09-09,Demand increase for the drug.,2019-01-25,2019-09-10
2039,2242471,Shortage,DOSTINEX,PFIZER CANADA INC,DOSTINEX,CABERGOLINE,0.5MG,BOTTLE 8's,ORAL,Resolved,TABLET / TABLETTE,G02CB,OTHER GYNECOLOGICALS,,2017-04-13,2017-04-24,2017-04-27,Demand increase for the drug.,2017-03-14,2017-04-28
55943,2244126,Shortage,DOVOBET OINTMENT,LEO PHARMA INC,calcipotriol and betamethasone dipropionate,BETAMETHASONE  CALCIPOTRIOL,0.5MG  50MCG,120g,TOPICAL,Resolved,OINTMENT,D05AX,ANTIPSORIATICS FOR TOPICAL USE,2018-07-26,2018-07-26,2018-10-01,2018-10-01,Disruption of the manufacture of the drug.,2018-07-16,2018-10-02
40515,2410397,Shortage,DOXORUBICIN,PFIZER CANADA INC,Doxorubicin,DOXORUBICIN HYDROCHLORIDE,2MG,1 x 25mL,INTRAVENOUS  INTRAVESICAL,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2018-03-13,,2019-05-01,Disruption of the manufacture of the drug.,2018-02-21,2019-05-02
52823,2409275,Shortage,DOXORUBICIN HYDROCHLORIDE INJECTION,TEVA CANADA LIMITED,DOXORUBICIN,DOXORUBICIN HYDROCHLORIDE,2MG,100ML,INTRAVENOUS  INTRAVESICAL,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2018-06-22,2018-08-06,2018-09-05,Disruption of the manufacture of the drug.,2018-06-22,2018-10-11
95373,2409275,Shortage,DOXORUBICIN HYDROCHLORIDE INJECTION,TEVA CANADA LIMITED,DOXORUBICIN INJ,DOXORUBICIN HYDROCHLORIDE,2MG,1 x 25ml,INTRAVENOUS  INTRAVESICAL,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2019-10-02,2019-10-31,2019-10-09,Disruption of the manufacture of the drug.,2019-10-03,2019-10-10
95378,2409275,Shortage,DOXORUBICIN HYDROCHLORIDE INJECTION,TEVA CANADA LIMITED,DOXORUBICIN INJ,DOXORUBICIN HYDROCHLORIDE,2MG,1 x 100ml,INTRAVENOUS  INTRAVESICAL,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2019-10-03,2019-10-31,2019-10-09,Disruption of the manufacture of the drug.,2019-10-03,2019-10-10
95381,2409275,Shortage,DOXORUBICIN HYDROCHLORIDE INJECTION,TEVA CANADA LIMITED,DOXORUBICIN INJ,DOXORUBICIN HYDROCHLORIDE,2MG,1 x 5ml,INTRAVENOUS  INTRAVESICAL,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2019-10-03,2019-10-31,2019-10-31,Disruption of the manufacture of the drug.,2019-10-03,2019-11-01
88342,2329751,Shortage,"DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP DIAGNOSTIC",JUBILANT DRAXIMAGE INC,Sodium Iodide 131,SODIUM IODIDE 131 I,3.7MBq,5 Capsules/Vial,ORAL,Actual shortage,CAPSULE,V09FX,,2019-07-06,,,,Other (Please describe in comments),2019-07-03,2019-07-17
88345,2329743,Shortage,"DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC",JUBILANT DRAXIMAGE INC,Sodium Iodide 131,SODIUM IODIDE 131 I,7400MBq,1 Capsule/Vial,ORAL,Actual shortage,CAPSULE,V10XA,,2019-07-06,,,,Other (Please describe in comments),2019-07-03,2019-07-17
88348,2329786,Shortage,"DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC",JUBILANT DRAXIMAGE INC,Sodium Iodide 131,SODIUM IODIDE 131 I,7400MBq,1 Vial,ORAL,Resolved,SOLUTION,V09FX,,2019-07-06,,2019-07-11,2019-07-11,Shortage of an active ingredient.,2019-07-03,2019-07-12
88353,2329778,Shortage,"DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC",JUBILANT DRAXIMAGE INC,Sodium Iodide 131,SODIUM IODIDE 131 I,7400MBq,1 Vial,ORAL,Resolved,SOLUTION,V10XA,,2019-07-06,,2019-07-11,2019-07-11,Shortage of an active ingredient.,2019-07-03,2019-07-12
42282,2247208,Shortage,DUKORAL,VALNEVA SWEDEN AB,"Oral, Inactivated Cholera and ETEC Diarrhea Vaccine","VIBRIO CHOLERAE INABA 6973 E1 TOR BIOTYPE, FORMALIN INACTIVATED  VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED  VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED  VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED  RECOMBINANT CHOLERA TOXIN B SUBUNIT",25000000000UNIT  25000000000UNIT  25000000000UNIT  25000000000UNIT  1MG,Box of 1 single-dose vial of vaccine and 1 sachet (5.6 g) sodium hydrogen carbonate,ORAL,Resolved,SUSPENSION,J07AE,BACTERIAL VACCINES,2018-03-07,2018-03-08,2018-03-23,2018-03-26,Demand increase for the drug.,2018-03-08,2018-03-27
76471,2247208,Shortage,DUKORAL,VALNEVA SWEDEN AB,"Oral, Inactivated Cholera and ETEC Diarrhea Vaccine","VIBRIO CHOLERAE INABA 6973 E1 TOR BIOTYPE, FORMALIN INACTIVATED  VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED  VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED  VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED  RECOMBINANT CHOLERA TOXIN B SUBUNIT",25000000000UNIT  25000000000UNIT  25000000000UNIT  25000000000UNIT  1MG,Box of 1 single-dose vial of vaccine and 1 sachet (5.6 g) sodium hydrogen carbonate,ORAL,Resolved,SUSPENSION,J07AE,BACTERIAL VACCINES,2019-02-19,,2019-03-13,2019-03-26,Delay in shipping of the drug.,2019-02-21,2019-03-27
51219,2453630,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2018-06-27,2018-07-27,2018-08-10,2018-08-10,Delay in shipping of the drug.,2018-06-04,2018-08-11
20248,2452650,Shortage,DULOXETINE,PRO DOC LIMITEE,DULOXETINE,DULOXETINE,30MG,30-100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-11-29,,2017-12-07,Delay in shipping of the drug.,2017-08-24,2017-12-08
8299,2453649,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-05-03,,2017-05-12,2017-05-12,Demand increase for the drug.,2017-04-27,2017-05-18
47784,2452669,Shortage,DULOXETINE,PRO DOC LIMITEE,DULOXETINE,DULOXETINE,60MG,30-100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-05-01,,2018-06-06,Delay in shipping of the drug.,2018-05-01,2018-06-07
28079,2453649,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-10-26,2017-12-04,2017-12-06,Delay in shipping of the drug.,2017-11-05,2017-12-12
52181,2453649,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2018-06-18,2018-06-18,2018-07-20,2018-07-23,Delay in shipping of the drug.,2018-06-12,2018-07-24
5595,2453630,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-04-27,2017-05-31,2017-06-04,Demand increase for the drug.,2017-04-05,2017-11-03
43119,2437090,Shortage,DULOXETINE DR,TEVA CANADA LIMITED,DULOXETINE,DULOXETINE,60MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-03-01,2018-10-30,2018-10-30,Disruption of the manufacture of the drug.,2018-03-16,2018-11-08
98922,2278251,Shortage,DUOTRAV PQ,NOVARTIS PHARMACEUTICALS CANADA INC,DUOTRAV BAK-FREE SOLN 5.0ML,TIMOLOL  TRAVOPROST,0.5%  0.004%,5.0 ML,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-11-13,2019-12-31,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
38072,2278251,Shortage,DUOTRAV PQ,NOVARTIS PHARMACEUTICALS CANADA INC,DUOTRAV BAK-FREE SOLN 5.0ML,TIMOLOL  TRAVOPROST,0.5%  0.004%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2018-02-27,,2018-03-02,2018-02-27,Delay in shipping of the drug.,2018-02-01,2018-02-28
91488,2415534,Shortage,DUREZOL,NOVARTIS PHARMACEUTICALS CANADA INC,DUREZOL .05% EMUL 5ML TRD,Difluprednate,0.05%,5ML,OPHTHALMIC,Resolved,EMULSION,S01BA,ANTIINFLAMMATORY AGENTS,2019-08-13,2019-08-13,,2019-11-06,Other (Please describe in comments),2019-08-13,2019-11-07
46280,2415534,Shortage,DUREZOL,NOVARTIS PHARMACEUTICALS CANADA INC,DUREZOL .05% EMUL 5ML TRD,Difluprednate,0.05%,5ML,OPHTHALMIC,Resolved,EMULSION,S01BA,ANTIINFLAMMATORY AGENTS,2018-04-18,2018-04-18,2018-05-04,2018-04-19,Other (Please describe in comments),2018-04-18,2018-04-20
59387,2415534,Shortage,DUREZOL,NOVARTIS PHARMACEUTICALS CANADA INC,DUREZOL .05% EMUL 5ML TRD,Difluprednate,0.05%,5ML,OPHTHALMIC,Resolved,EMULSION,S01BA,ANTIINFLAMMATORY AGENTS,2018-09-10,2018-09-19,2018-10-05,2018-09-27,Delay in shipping of the drug.,2018-08-28,2018-10-04
28882,2429012,Shortage,DUTASTERIDE,SIVEM PHARMACEUTICALS ULC,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-12-04,2017-12-08,2018-01-29,2018-01-25,Disruption of the manufacture of the drug.,2017-11-10,2018-01-30
41719,2429012,Shortage,DUTASTERIDE,SIVEM PHARMACEUTICALS ULC,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-03-18,2018-03-15,2018-04-13,2018-04-12,Delay in shipping of the drug.,2018-03-05,2018-04-16
19704,2421712,Shortage,DUTASTERIDE,PRO DOC LIMITEE,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Actual shortage,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-08-17,,,Delay in shipping of the drug.,2017-08-17,2018-12-20
44705,1947931,Shortage,DUVOID TABLETS 25 MG,PALADIN LABS INC,DUVOID,BETHANECHOL CHLORIDE,25MG,100 tabs,ORAL,Resolved,TABLET,N07AB,PARASYMPATHOMIMETICS,,2018-04-02,,2018-04-19,Disruption of the manufacture of the drug.,2018-04-03,2018-04-20
10471,2432889,Shortage,DYMISTA,MEDA PHARMACEUTICALS LTD,Dymista,FLUTICASONE PROPIONATE  azelastine hydrochloride,50MCG  137MCG,25ML,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017-05-15,,2017-08-11,Disruption of the manufacture of the drug.,2017-05-16,2017-08-14
93519,2381389,Shortage,EDARBI,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBI,AZILSARTAN MEDOXOMIL,40MG,28ct,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-08-08,,,Other (Please describe in comments),2019-09-10,2019-10-09
93523,2381397,Shortage,EDARBI,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBI,AZILSARTAN MEDOXOMIL,80MG,28ct,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-08-08,,,Other (Please describe in comments),2019-09-10,2019-10-09
87192,2381389,Shortage,EDARBI,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBI,Azilsartan Medoxomil,40MG,28ct,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-13,,2019-06-25,Other (Please describe in comments),2019-06-21,2019-06-27
83468,2397765,Shortage,EDARBYCLOR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBYCLOR,CHLORTHALIDONE  Azilsartan Medoxomil,25MG  40MG,28ct,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-05-03,,,Other (Please describe in comments),2019-05-08,2019-10-09
83479,2397749,Shortage,EDARBYCLOR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBYCLOR,CHLORTHALIDONE  Azilsartan Medoxomil,12.5MG  40MG,28ct,ORAL,Avoided shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-06-30,,2019-08-31,2019-05-21,Other (Please describe in comments),2019-05-08,2019-05-23
98634,2397749,Shortage,EDARBYCLOR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBYCLOR,CHLORTHALIDONE  AZILSARTAN MEDOXOMIL,12.5MG  40MG,28ct,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-11-11,,,Other (Please describe in comments),2019-11-13,2019-11-13
58987,2397749,Shortage,EDARBYCLOR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBYCLOR,CHLORTHALIDONE  Azilsartan Medoxomil,12.5MG  40MG,NA,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-28,,2019-01-22,Other (Please describe in comments),2018-08-24,2019-01-23
58990,2397765,Shortage,EDARBYCLOR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBYCLOR,CHLORTHALIDONE  Azilsartan Medoxomil,25MG  40MG,NA,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-11-01,,,2018-11-01,Other (Please describe in comments),2018-08-24,2018-11-09
88781,2397749,Shortage,EDARBYCLOR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDARBYCLOR,CHLORTHALIDONE  Azilsartan Medoxomil,12.5MG  40MG,n/a,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-07-29,,,2019-08-02,Other (Please describe in comments),2019-07-05,2019-08-14
64977,2258528,Shortage,EDECRIN,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EDECRIN,ETHACRYNIC ACID,25MG,n/a,ORAL,Resolved,TABLET,C03CC,HIGH-CEILING DIURETICS,,2018-10-16,,2018-10-25,Other (Please describe in comments),2018-10-19,2018-10-29
27184,2237280,Shortage,EFFEXOR XR,PFIZER CANADA INC,EFFEXOR,VENLAFAXINE,75MG,90s,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-12-20,,2018-01-19,Disruption of the manufacture of the drug.,2017-10-26,2018-01-20
89900,330582,Shortage,EFUDEX CRM 5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EFUDEX CRM 5%,FLUOROURACIL,5%,40g,TOPICAL,Resolved,CREAM,L01BC,ANTIMETABOLITES,,2019-07-18,,2019-07-30,Other (Please describe in comments),2019-07-24,2019-08-01
43772,330582,Shortage,EFUDEX CRM 5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,EFUDEX CRM 5%,FLUOROURACIL,5%,n/a,TOPICAL,Resolved,CREAM,L01BC,ANTIMETABOLITES,,2018-07-24,,2018-08-06,Other (Please describe in comments),2018-03-23,2018-08-07
10091,2209764,Shortage,EGOZINC-HC,PHARMASCIENCE INC,EGOZING,HYDROCORTISONE ACETATE  ZINC SULFATE,0.5%  0.5%,15g,RECTAL  TOPICAL,Actual shortage,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017-05-01,,,Shortage of an inactive ingredient or component.,2017-05-11,2017-10-05
82729,2296314,Shortage,ELAPRASE,SHIRE HUMAN GENETIC THERAPIES INC,Idursulfase intravenous,IDURSULFASE,2MG,2mg,INTRAVENOUS,Resolved,SOLUTION,A16AB,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,2019-04-29,2019-04-29,2019-05-02,2019-05-01,Delay in shipping of the drug.,2019-04-29,2019-05-02
58933,335053,Shortage,ELAVIL,AA PHARMA INC,ELAVIL,AMITRIPTYLINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2018-08-24,2018-10-15,2018-10-02,Disruption of the manufacture of the drug.,2018-08-24,2018-10-05
3710,335088,Shortage,ELAVIL,AA PHARMA INC,ELAVIL,AMITRIPTYLINE HYDROCHLORIDE,50MG,100 Bottle,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-03-24,,2017-04-17,2017-04-11,Demand increase for the drug.,2017-03-20,2017-04-12
83482,2247238,Shortage,ELIDEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ELIDEL,PIMECROLIMUS,1%,30g,TOPICAL,Resolved,CREAM,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2019-05-23,,,2019-06-12,Delay in shipping of the drug.,2019-05-08,2019-06-13
89890,2247238,Shortage,ELIDEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ELIDEL,PIMECROLIMUS,1%,30g,TOPICAL,Resolved,CREAM,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2019-08-09,,,2019-09-03,Demand increase for the drug.,2019-07-24,2019-09-10
89893,2247238,Shortage,ELIDEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ELIDEL,PIMECROLIMUS,1%,60g,TOPICAL,Avoided shortage,CREAM,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2019-09-15,,,2019-09-09,Demand increase for the drug.,2019-07-24,2019-09-10
81052,2247238,Shortage,ELIDEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ELIDEL,PIMECROLIMUS,1%,30g,TOPICAL,Resolved,CREAM,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,,2019-04-08,,2019-04-23,Other (Please describe in comments),2019-04-10,2019-04-29
73385,2247238,Shortage,ELIDEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ELIDEL,PIMECROLIMUS,1%,60g,TOPICAL,Resolved,CREAM,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,,2019-02-01,,2019-02-11,Other (Please describe in comments),2019-01-23,2019-02-12
61463,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.1%,15gr,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2018-10-01,2018-09-20,2018-11-16,2018-11-12,Demand increase for the drug.,2018-09-13,2018-11-13
44326,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,Mometasone Furoate Cream,MOMETASONE FUROATE,0.1%,50g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-03-29,2018-04-03,2018-04-03,Delay in shipping of the drug.,2018-03-29,2018-04-04
55854,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.1%,15gr,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2018-07-16,2018-07-16,2018-09-12,2018-09-10,Demand increase for the drug.,2018-07-16,2018-09-11
46949,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.1%,50g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2018-05-28,2018-05-28,2018-07-27,2018-07-26,Delay in shipping of the drug.,2018-04-23,2018-07-27
625,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.1%,50g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017-03-02,2017-03-03,2017-03-10,2017-03-09,Other (Please describe in comments),2017-03-11,2017-03-13
58258,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.1%,50GM,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-08-16,2018-09-17,2018-09-06,Demand increase for the drug.,2018-08-16,2018-09-07
62896,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.1%,50gr,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2018-10-09,2018-10-05,2018-11-23,2018-11-19,Demand increase for the drug.,2018-10-02,2018-11-20
13234,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,Mometasone Furoate Cream,MOMETASONE FUROATE,0.1%,15g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017-06-26,2017-07-05,2017-07-14,2017-07-07,Delay in shipping of the drug.,2017-06-19,2017-07-08
40115,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,Mometasone Furoate Cream,MOMETASONE FUROATE,0.1%,15g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2018-03-19,2018-03-16,2018-04-18,2018-04-16,Delay in shipping of the drug.,2018-02-19,2018-04-17
69106,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,mometasone furoate cream,MOMETASONE FUROATE,0.1%,50gm,TOPICAL,Avoided shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2019-01-18,,2019-01-29,2019-01-17,Delay in shipping of the drug.,2018-12-11,2019-01-17
1019,851744,Shortage,ELOCOM CREAM,MERCK CANADA INC,"Mometasone Furoate Cream, BP",MOMETASONE FUROATE,0.1%,15g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017-03-14,2017-03-14,2017-03-17,2017-03-16,Demand increase for the drug.,2017-03-13,2017-03-17
45879,851736,Shortage,ELOCOM OINTMENT,MERCK CANADA INC,Mometasone Furoate Ointment,MOMETASONE FUROATE,0.1%,15g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2018-04-30,2018-04-23,2018-06-11,2018-06-11,Delay in shipping of the drug.,2018-04-16,2018-06-12
63088,851736,Shortage,ELOCOM OINTMENT,MERCK CANADA INC,Mometasone Furoate Ointment,MOMETASONE FUROATE,0.1%,15gr,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2018-10-05,2018-10-05,2018-10-26,2018-10-22,Delay in shipping of the drug.,2018-10-03,2018-10-23
39298,851736,Shortage,ELOCOM OINTMENT,MERCK CANADA INC,Mometasone Furoate Ointment,MOMETASONE FUROATE,0.1%,15g,TOPICAL,Avoided shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2018-03-09,,2018-04-20,2018-03-05,Delay in shipping of the drug.,2018-02-12,2018-03-05
39303,851736,Shortage,ELOCOM OINTMENT,MERCK CANADA INC,Mometasone Furoate Ointment,MOMETASONE FUROATE,0.1%,50g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2018-04-25,2018-04-24,2018-06-11,2018-06-11,Delay in shipping of the drug.,2018-02-12,2018-06-12
56328,2213230,Shortage,ELTROXIN,ASPEN PHARMACARE CANADA INC.,Eltroxin 300 mcg,LEVOTHYROXINE SODIUM,300MCG,500 tablets,ORAL,Actual shortage,TABLET,H03AA,THYROID PREPARATIONS,,2010-01-01,,,Other (Please describe in comments),2018-07-24,2018-07-24
56097,2213214,Shortage,ELTROXIN,ASPEN PHARMACARE CANADA INC.,Eltroxin 150 mcg,LEVOTHYROXINE SODIUM,150MCG,500 tablets,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-07-20,2018-09-21,2018-09-17,Delay in shipping of the drug.,2018-07-19,2018-09-18
17246,2213222,Shortage,ELTROXIN,ASPEN PHARMACARE CANADA INC.,levothyroxine sodium,LEVOTHYROXINE SODIUM,200MCG,500 tablets,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2017-07-26,2017-10-17,2017-10-23,Delay in shipping of the drug.,2017-07-26,2017-10-24
39006,2213214,Shortage,ELTROXIN,ASPEN PHARMACARE CANADA INC.,Eltroxin® 150mcg,LEVOTHYROXINE SODIUM,150MCG,500 Tablets,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-02-07,2018-03-23,2018-04-09,Delay in shipping of the drug.,2018-02-07,2018-04-10
81989,2298813,Shortage,EMEND TRI-PACK,MERCK CANADA INC,aprepitant capsules,APREPITANT  APREPITANT,125MG  80MG,3cap,ORAL,Avoided shortage,KIT  CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2019-08-09,,2019-08-19,2019-08-06,Delay in shipping of the drug.,2019-04-18,2019-08-06
12809,595799,Shortage,EMO CORT CREAM 2.5%,GLAXOSMITHKLINE INC,Hydrocortisone cream,HYDROCORTISONE,2.5%,45 g,TOPICAL,Actual shortage,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2017-06-16,,,Disruption of the manufacture of the drug.,2017-06-15,2018-12-20
3254,595799,Shortage,EMO CORT CREAM 2.5%,GLAXOSMITHKLINE INC,Hydrocortisone cream,HYDROCORTISONE,2.5%,225 g,TOPICAL,Actual shortage,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2017-03-27,,,Disruption of the manufacture of the drug.,2017-03-17,2018-12-20
2720,595802,Shortage,EMO CORT LOTION 2.5%,GLAXOSMITHKLINE INC,Hydrocortisone lotion,HYDROCORTISONE,2.5%,60 mL,TOPICAL,Actual shortage,LOTION,D07AA,"CORTICOSTEROIDS, PLAIN",,2016-03-07,,,Other (Please describe in comments),2017-03-14,2017-10-05
68878,2273217,Shortage,ENABLEX,MERUS LABS LUXCO S. A R.L.,darifenacin,DARIFENACIN,7.5MG,Bottles of 100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-12-07,,2019-01-02,2019-01-02,Other (Please describe in comments),2018-12-07,2019-01-03
3487,2273217,Shortage,ENABLEX,MERUS LABS LUXCO S. A R.L.,Darifenacin,DARIFENACIN,7.5MG,28,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-08-01,,,2017-10-06,Other (Please describe in comments),2017-03-20,2017-10-10
3498,2273225,Shortage,ENABLEX,MERUS LABS LUXCO S. A R.L.,Darifenacin,DARIFENACIN,15MG,28,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-10-01,,,2017-10-06,Other (Please describe in comments),2017-03-20,2017-10-10
61675,2273225,Shortage,ENABLEX,MERUS LABS LUXCO S. A R.L.,darifenacin,DARIFENACIN,15MG,Bottles of 100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-09-17,2018-12-14,2018-12-14,Other (Please describe in comments),2018-09-17,2018-12-15
42549,2400685,Shortage,ENALAPRIL,SANIS HEALTH INC,ENALAPRIL TAB,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-03-16,2018-05-25,2018-05-22,Other (Please describe in comments),2018-03-13,2018-05-23
55113,2442981,Shortage,ENALAPRIL,SIVEM PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-08-20,2018-08-17,2018-10-19,2018-10-19,Delay in shipping of the drug.,2018-07-10,2018-10-22
45924,2442973,Shortage,ENALAPRIL,SIVEM PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,8MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-05-21,2018-05-23,2018-10-19,2018-10-19,Other (Please describe in comments),2018-04-16,2018-10-22
44405,2400669,Shortage,ENALAPRIL,SANIS HEALTH INC,ENALAPRIL TAB,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-04-06,2018-04-04,2018-05-25,2018-05-22,Other (Please describe in comments),2018-04-02,2018-05-23
73668,2400650,Shortage,ENALAPRIL,SANIS HEALTH INC,ENALALPRIL TAB,ENALAPRIL SODIUM,2MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-04-05,,,,Disruption of the manufacture of the drug.,2019-01-28,2019-04-06
73671,2400669,Shortage,ENALAPRIL,SANIS HEALTH INC,ENALALPRIL TAB,ENALAPRIL SODIUM,4MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-06-07,,,,Disruption of the manufacture of the drug.,2019-01-28,2019-06-08
45255,2442957,Shortage,ENALAPRIL,SIVEM PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,2MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-05-14,2018-05-18,2018-10-19,2018-10-19,Other (Please describe in comments),2018-04-10,2018-10-22
73674,2400677,Shortage,ENALAPRIL,SANIS HEALTH INC,ENALALPRIL TAB,ENALAPRIL SODIUM,8MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-10-25,,,,Disruption of the manufacture of the drug.,2019-01-28,2019-10-26
73677,2400685,Shortage,ENALAPRIL,SANIS HEALTH INC,ENALALPRIL TAB,ENALAPRIL SODIUM,16MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-08-09,,,,Disruption of the manufacture of the drug.,2019-01-28,2019-08-10
52981,2442965,Shortage,ENALAPRIL,SIVEM PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-07-28,2018-07-27,2018-10-19,2018-10-19,Other (Please describe in comments),2018-06-26,2018-10-22
69966,2352923,Shortage,ENALAPRIL MALEATE/HCTZ,AA PHARMA INC,ENALAPRIL/HCTZ,HYDROCHLOROTHIAZIDE  ENALAPRIL MALEATE,12.5MG  5.0MG,100 BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-12-18,2019-01-16,2019-01-15,Disruption of the manufacture of the drug.,2018-12-19,2019-01-16
56002,2352931,Shortage,ENALAPRIL MALEATE/HCTZ,AA PHARMA INC,ENALAPRIL MALEATE/HCTZ,HYDROCHLOROTHIAZIDE  ENALAPRIL MALEATE,25.0MG  10.0MG,100BTL,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-07-17,2019-01-16,2019-01-15,Disruption of the manufacture of the drug.,2018-07-17,2019-01-16
17559,2388499,Shortage,ENALAPRILAT INJECTION USP,STERIMAX INC,VASOTEC IV,ENALAPRILAT,1.25MG,10 VIALS,INTRAVENOUS,Resolved,SOLUTION,C09AA,"ACE INHIBITORS, PLAIN",,2017-07-31,2017-09-11,2017-09-12,Other (Please describe in comments),2017-07-31,2017-09-13
10357,1916548,Shortage,ENDOCET,BRISTOL-MYERS SQUIBB CANADA,Oxycocet (Oxycodone and Acetaminophen),ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,Bottles of 100's and 500's,ORAL,Avoided shortage,TABLET,N02AJ,,2017-07-05,,,2017-07-04,Demand increase for the drug.,2017-05-15,2017-07-04
6511,1919431,Shortage,ENGERIX B INJ SUS 20MCG/ML,GLAXOSMITHKLINE INC,Hepatitis B vaccine (recombinant),HEPATITIS B SURFACE ANTIGEN,20MCG,1's,INTRAMUSCULAR,Actual shortage,SUSPENSION,J07BC,VIRAL VACCINES,,2017-04-06,,,Demand increase for the drug.,2017-04-11,2019-11-01
75189,2296454,Shortage,ENGERIX-B,GLAXOSMITHKLINE INC,Hepatitis B vaccine (recombinant),HEPATITIS B SURFACE ANTIGEN,10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2019-02-08,2019-09-16,2019-07-25,Demand increase for the drug.,2019-02-08,2019-07-26
49681,2296454,Shortage,ENGERIX-B          (PEDIATRIC DOSE),GLAXOSMITHKLINE INC,Hepatitis B vaccine (recombinant),HEPATITIS B SURFACE ANTIGEN,10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-05-16,,2018-11-29,Demand increase for the drug.,2018-05-17,2018-11-30
40708,2052431,Shortage,ENTOCORT ENEMA,TILLOTTS PHARMA GMBH,Entocort Enema,SODIUM CHLORIDE  BUDESONIDE,115ML  2.3MG,7 solutions,RECTAL,Resolved,KIT  TABLET  ENEMA,A07EA,INTESTINALANTIINFLAMMATORY AGENTS,2018-02-21,2018-02-21,2018-03-07,2018-03-15,Delay in shipping of the drug.,2018-02-23,2018-03-21
71462,2052431,Shortage,ENTOCORT ENEMA,TILLOTTS PHARMA GMBH,Entocort Enema,SODIUM CHLORIDE  BUDESONIDE,115ML  2.3MG,7 solutions,RECTAL,Actual shortage,KIT  TABLET  ENEMA,A07EA,INTESTINALANTIINFLAMMATORY AGENTS,2019-01-16,,2019-05-30,,Delay in shipping of the drug.,2019-01-08,2019-01-17
3112,2052431,Shortage,ENTOCORT ENEMA,TILLOTTS PHARMA GMBH,Entocort Enema,SODIUM CHLORIDE  BUDESONIDE,115ML  2.3MG,7 solutions,RECTAL,Resolved,KIT  TABLET  ENEMA,A07EA,INTESTINALANTIINFLAMMATORY AGENTS,2017-04-03,2017-04-03,2017-07-14,2017-07-10,Delay in shipping of the drug.,2017-03-17,2017-07-19
69711,2052431,Shortage,ENTOCORT ENEMA,TILLOTTS PHARMA GMBH,Entocort Enema,SODIUM CHLORIDE  BUDESONIDE,115ML  2.3MG,7 solutions,RECTAL,Resolved,KIT  TABLET  ENEMA,A07EA,INTESTINALANTIINFLAMMATORY AGENTS,,2018-11-23,2019-01-16,2019-01-16,Delay in shipping of the drug.,2018-12-17,2019-01-23
1218,38121,Shortage,EPHEDRINE SULFATE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Ephedrine,EPHEDRINE SULFATE,50MG,50mg/1mL x 50,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SOLUTION,R03CA,ADRENERGICS FOR SYSTEMIC USE,,2015-07-24,,2019-03-29,Shortage of an active ingredient.,2017-03-13,2019-03-30
35670,721891,Shortage,EPINEPHRINE INJ 1MG/ML USP,HOSPIRA HEALTHCARE CORPORATION,EPINEPHRINE,EPINEPHRINE,1MG,50x1mL AMP,INTRACARDIAC  INTRAMUSCULAR  INTRATRACHEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2018-01-10,,2018-04-13,Disruption of the manufacture of the drug.,2018-01-10,2018-05-02
76329,2435810,Shortage,EPINEPHRINE INJECTION,TELIGENT OU,EPINEPHRINE INJECTION,EPINEPHRINE,1MG,1 ML,INTRACARDIAC  INTRAMUSCULAR  INTRATRACHEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2019-03-04,,2019-06-17,2019-06-18,Disruption of the manufacture of the drug.,2019-02-19,2019-06-19
73273,2435810,Shortage,EPINEPHRINE INJECTION,TELIGENT OU,EPINEPHRINE INJECTION,EPINEPHRINE,1MG,1 ML,INTRACARDIAC  INTRAMUSCULAR  INTRATRACHEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2019-01-21,2019-01-31,2019-01-29,Demand increase for the drug.,2019-01-22,2019-01-30
34254,2435810,Shortage,EPINEPHRINE INJECTION,TELIGENT OU,EPINEPHRINE INJECTION,EPINEPHRINE,1MG,1 mL,INTRACARDIAC  INTRAMUSCULAR  INTRATRACHEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-11-15,2018-06-29,2018-06-29,Disruption of the manufacture of the drug.,2017-12-22,2018-07-09
62439,2435810,Shortage,EPINEPHRINE INJECTION,TELIGENT OU,EPINEPHRINE INJECTION,EPINEPHRINE,1MG,1 mL,INTRACARDIAC  INTRAMUSCULAR  INTRATRACHEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2018-07-30,2018-11-21,2018-11-23,Demand increase for the drug.,2018-09-27,2018-11-30
66370,721891,Shortage,EPINEPHRINE INJECTION USP,PFIZER CANADA INC,EPINEPHRINE INJECTION USP,EPINEPHRINE,1MG,50 x 1mL AMP,INTRACARDIAC  INTRAMUSCULAR  INTRATRACHEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2018-11-30,,2019-07-02,Disruption of the manufacture of the drug.,2018-11-07,2019-07-03
82807,710814,Shortage,EPINEPHRINE INJECTION USP,PFIZER CANADA ULC,Epinephrine Injection USP,EPINEPHRINE,0.1MG,10 x 10mL LifeShield Syringe,INTRACARDIAC  INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2019-04-30,,2019-05-28,Demand increase for the drug.,2019-04-30,2019-05-29
86424,710814,Shortage,EPINEPHRINE INJECTION USP,PFIZER CANADA ULC,Epinephrine Injection USP,EPINEPHRINE,0.1MG,10 x 10mL LifeShield,INTRACARDIAC  INTRAVENOUS,Actual shortage,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2019-06-11,,,Disruption of the manufacture of the drug.,2019-06-12,2019-11-13
20797,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017-09-27,,,2017-10-06,Disruption of the manufacture of the drug.,2017-09-01,2017-10-10
26964,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-10-30,,2017-11-15,Disruption of the manufacture of the drug.,2017-10-25,2017-11-16
31606,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-12-04,2018-03-23,2018-03-09,Disruption of the manufacture of the drug.,2017-12-04,2018-03-10
89478,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Actual shortage,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2019-07-16,,,Disruption of the manufacture of the drug.,2019-07-16,2019-09-25
5774,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN Auto-Injector,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-04-05,,2017-04-24,Disruption of the manufacture of the drug.,2017-04-06,2017-04-25
42395,509558,Shortage,EPIPEN,MYLAN SPECIALTY LP,EPIPEN,EPINEPHRINE,1MG,Each (0.3MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2018-04-09,2018-04-09,,2019-02-19,Disruption of the manufacture of the drug.,2018-03-09,2019-02-20
37657,578657,Shortage,EPIPEN JR,MYLAN SPECIALTY LP,EPIPEN JR,EPINEPHRINE,0.5MG,Each (0.15MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2018-04-16,2018-04-16,,2019-02-19,Disruption of the manufacture of the drug.,2018-01-30,2019-02-20
5794,578657,Shortage,EPIPEN JR,MYLAN SPECIALTY LP,EpiPen Junior Auto-Injector,EPINEPHRINE,0.5MG,Each (0.15MG/0.3ML AUTO-INJECTOR),INTRAMUSCULAR,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-04-05,2017-04-26,2017-05-01,Disruption of the manufacture of the drug.,2017-04-06,2017-05-02
68608,2324091,Shortage,EPIRUBICIN FOR INJECTION,TEVA CANADA LIMITED,EPIRUBICIN,EPIRUBICIN HYDROCHLORIDE,2MG,5ML,INTRAVENOUS,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2018-12-01,2019-07-30,2019-07-30,Demand increase for the drug.,2018-12-04,2019-08-06
92180,2324091,Shortage,EPIRUBICIN FOR INJECTION,TEVA CANADA LIMITED,EPIRUBICIN,EPIRUBICIN HYDROCHLORIDE,2MG,25ML,INTRAVENOUS,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2019-08-22,2019-10-31,2019-10-23,Disruption of the manufacture of the drug.,2019-08-22,2019-10-24
1081,2264927,Shortage,EPIRUBICIN HYDROCHLORIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,EPIRUBICIN,EPIRUBICIN HYDROCHLORIDE,2MG,10mg/5mL x 1,INTRAVENOUS,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,2014-10-14,2014-11-29,,2017-09-04,Disruption of the manufacture of the drug.,2017-03-13,2018-07-26
70773,596418,Shortage,EPIVAL,BGP PHARMA ULC,VALPROIC ACID,VALPROIC ACID,125MG,100BT,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-01-07,2019-01-07,2019-02-15,2019-01-15,Delay in shipping of the drug.,2019-01-02,2019-01-16
72937,596418,Shortage,EPIVAL,BGP PHARMA ULC,VALPROIC ACID,VALPROIC ACID,125MG,100 BT,ORAL,Avoided shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-02-14,,2019-02-28,2019-02-01,Delay in shipping of the drug.,2019-01-18,2019-02-01
1691,2405083,Shortage,EPTIFIBATIDE INJECTION,TEVA CANADA LIMITED,EPTIFIBATIDE,EPTIFIBATIDE,0.75MG,100ML,INTRAVENOUS,Actual shortage,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1694,2367858,Shortage,EPTIFIBATIDE INJECTION,TEVA CANADA LIMITED,EFTIFIBATIDE,EPTIFIBATIDE,2MG,10ML,INTRAVENOUS,Actual shortage,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
12379,2457431,Shortage,ERFA-TRANEXAMIC,,TRANEXAMIC ACID IV,TRANEXAMIC ACID,100 mg/mL,vial,Intravenous,Actual shortage,Solution,B02AA,Antifibrinolytics,,2018-04-25,2020-01-31,,Other (Please describe in comments),2017-06-09,2019-10-22
78235,2441241,Shortage,ERGONOVINE MALEATE INJECTION,TELIGENT OU,Ergonovine Maleate Injection,ERGONOVINE MALEATE,0.25MG,1ml,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,G02AB,UTEROTONICS,2019-03-11,2019-03-11,2019-04-16,2019-04-17,Disruption of the manufacture of the drug.,2019-03-11,2019-04-18
62731,2237815,Shortage,ERWINASE,JAZZ PHARMACEUTICALS FRANCE SAS,L-asparaginase,ASPARAGINASE,10000UNIT,5 vials per box,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-10-01,,,Other (Please describe in comments),2018-10-01,2018-11-19
22112,2237815,Shortage,ERWINASE,JAZZ PHARMACEUTICALS FRANCE SAS,Erwina L-asparaginase,ASPARAGINASE,10000UNIT,"3 mL vials, 5 vials per carton",INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-09-14,,,,Other (Please describe in comments),2017-09-14,2018-12-20
57204,2237815,Shortage,ERWINASE,JAZZ PHARMACEUTICALS FRANCE SAS,L-asparaginase,ASPARAGINASE,10000UNIT,3 mL vials (20 vials per carton),INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-07-30,2018-08-10,2018-08-10,Other (Please describe in comments),2018-08-01,2018-08-13
2952,2237815,Shortage,ERWINASE,JAZZ PHARMACEUTICALS FRANCE SAS,Erwinia L-asparaginase,ASPARAGINASE,10000UNIT,3 mL vials,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-03-14,,2017-06-30,2017-06-30,Other (Please describe in comments),2017-03-15,2018-03-07
47317,2237815,Shortage,ERWINASE,JAZZ PHARMACEUTICALS FRANCE SAS,Erwaina L-asparaginase,ASPARAGINASE,10000UNIT,"3 mL vials, 5 vials per carton",INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-04-23,,2018-05-25,Other (Please describe in comments),2018-04-27,2018-05-26
30979,682020,Shortage,ERYTHRO-BASE,AA PHARMA INC,ERYTHRO-BASE,ERYTHROMYCIN,250MG,100 BTL,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-11-28,2017-12-11,2017-12-12,Disruption of the manufacture of the drug.,2017-11-28,2018-04-23
4144,682020,Shortage,ERYTHRO-BASE,AA PHARMA INC,ERYTHRO-BASE,ERYTHROMYCIN,250MG,1000 BOTTLE,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2016-10-28,,,2016-10-28,Disruption of the manufacture of the drug.,2017-03-24,2017-03-28
3752,637416,Shortage,ERYTHRO-ES,AA PHARMA INC,ERYTHRO-ES,ERYTHROMYCIN,600MG,100 Bottle,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2015-06-24,,,,Disruption of the manufacture of the drug.,2017-03-21,2017-10-05
36608,545678,Shortage,ERYTHRO-S,AA PHARMA INC,ERYTHRO-S,ERYTHROMYCIN,250MG,100 Bottle,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-01-19,,,Disruption of the manufacture of the drug.,2018-01-19,2018-01-20
3795,688568,Shortage,ERYTHRO-S,AA PHARMA INC,ERYTHRO-S,ERYTHROMYCIN,500MG,100 Bottle,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2016-10-31,,2017-03-31,Disruption of the manufacture of the drug.,2017-03-21,2017-04-02
36913,2429047,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-02-15,2018-02-06,2018-11-16,2018-11-16,Demand increase for the drug.,2018-01-22,2018-12-03
48469,2429039,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-05-21,2018-05-23,2018-11-16,2018-11-16,Other (Please describe in comments),2018-05-04,2018-12-03
45927,2429047,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-05-07,2018-05-15,2018-11-16,2018-11-16,Other (Please describe in comments),2018-04-16,2018-12-03
48566,2429039,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-06-04,2018-06-10,2018-11-16,2018-11-16,Other (Please describe in comments),2018-05-04,2018-12-03
49094,2424401,Shortage,ESCITALOPRAM,PRO DOC LIMITEE,ESCITALOPRAM,ESCITALOPRAM,10MG,30-100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-05-11,,2018-06-07,Delay in shipping of the drug.,2018-05-11,2018-06-08
36040,2429047,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-12-15,,2018-02-15,Requirements related to complying with good manufacturing practices.,2018-01-16,2018-02-16
5599,2429039,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-04,2017-04-14,2017-04-10,Disruption of the manufacture of the drug.,2017-04-05,2017-04-11
5602,2429039,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-04,2017-04-14,2017-04-11,Disruption of the manufacture of the drug.,2017-04-05,2017-04-12
80359,2424428,Shortage,ESCITALOPRAM,PRO DOC LIMITEE,ESCITALOPRAM,ESCITALOPRAM,20MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-04-03,,,Delay in shipping of the drug.,2019-04-03,2019-04-04
5609,2429047,Shortage,ESCITALOPRAM,SIVEM PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-04,2017-04-12,2017-04-11,Requirements related to complying with good manufacturing practices.,2017-04-05,2017-04-12
51450,2388138,Shortage,ESME 21,MYLAN PHARMACEUTICALS ULC,Ethinylestradiol / Levonorgestrel,ETHINYL ESTRADIOL  LEVONORGESTREL,20MCG  100MCG,21 BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51453,2388146,Shortage,ESME 28,MYLAN PHARMACEUTICALS ULC,Ethinylestradiol / Levonorgestrel,ETHINYL ESTRADIOL  LEVONORGESTREL,20MCG  100MCG,28 BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
74246,2442493,Shortage,ESOMEPRAZOLE,SIVEM PHARMACEUTICALS ULC,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-02-20,2019-02-21,2019-03-08,2019-03-11,Delay in shipping of the drug.,2019-02-01,2019-03-12
4504,2394839,Shortage,ESOMEPRAZOLE,PRO DOC LIMITEE,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-28,,2017-04-26,Delay in shipping of the drug.,2017-03-28,2017-04-27
4100,2241835,Shortage,ESTALIS 140/50 MCG,NOVARTIS PHARMACEUTICALS CANADA INC,ESTALIS 140/50UG 8'S,ESTRADIOL  NORETHINDRONE ACETATE,0.62MG  2.7MG,8's,TRANSDERMAL,Resolved,PATCH,G03FA,PROGESTOGENS AND ESTROGENS IN COMBINATION,,2017-03-03,2017-06-09,2017-06-08,Delay in shipping of the drug.,2017-03-23,2017-06-09
14305,2241835,Shortage,ESTALIS 140/50 MCG,NOVARTIS PHARMACEUTICALS CANADA INC,ESTALIS 140/50UG 8'S,ESTRADIOL  NORETHINDRONE ACETATE,0.62MG  2.7MG,8's,TRANSDERMAL,Resolved,PATCH,G03FA,PROGESTOGENS AND ESTROGENS IN COMBINATION,,2017-06-28,2017-11-01,2017-10-24,Delay in shipping of the drug.,2017-06-28,2017-10-27
15049,2241837,Shortage,ESTALIS 250/50 MCG,NOVARTIS PHARMACEUTICALS CANADA INC,ESTALIS 250/50UG 8'S,ESTRADIOL  NORETHINDRONE ACETATE,0.51MG  4.8MG,8'S,TRANSDERMAL,Resolved,PATCH,G03FA,PROGESTOGENS AND ESTROGENS IN COMBINATION,2017-08-28,2017-08-23,2018-01-17,2018-01-17,Delay in shipping of the drug.,2017-07-10,2018-01-18
71996,2225190,Shortage,ESTRACE,ACERUS PHARMACEUTICALS CORPORATION,ESTRADIOL,ESTRADIOL,0.5MG,100,ORAL,Actual shortage,TABLET,G03CA,ESTROGENS,2019-07-01,2019-07-01,,,Requirements related to complying with good manufacturing practices.,2019-01-11,2019-07-02
72000,2148587,Shortage,ESTRACE,ACERUS PHARMACEUTICALS CORPORATION,ESTRADIOL,ESTRADIOL,1MG,100,ORAL,Actual shortage,TABLET,G03CA,ESTROGENS,2019-07-01,2019-07-01,,,Requirements related to complying with good manufacturing practices.,2019-01-11,2019-07-02
87227,2148595,Shortage,ESTRACE,ACERUS PHARMACEUTICALS CORPORATION,ESTRADIOL,ESTRADIOL,2MG,100,ORAL,Actual shortage,TABLET,G03CA,ESTROGENS,2019-07-01,2019-07-01,,,Requirements related to complying with good manufacturing practices.,2019-06-21,2019-07-02
94977,2469456,Shortage,ETHACRYNATE SODIUM FOR INJECTION USP,STERIMAX INC,ETHACRYNATE SODIUM FOR INJECTION USP,ETHACRYNIC ACID,50MG,1 VIAL,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,C03CC,HIGH-CEILING DIURETICS,2019-10-15,,2020-01-31,,Delay in shipping of the drug.,2019-09-27,2019-10-16
85828,247960,Shortage,ETIBI TAB 100MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ETIBI TAB 100MG,ETHAMBUTOL HYDROCHLORIDE,100MG,100,ORAL,Actual shortage,TABLET,J04AK,DRUGS FOR TREATMENT OF TUBERCULOSIS,2019-11-15,,2020-05-01,,Shortage of an active ingredient.,2019-06-07,2019-11-16
85831,247979,Shortage,ETIBI TAB 400MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ETIBI TAB 400MG,ETHAMBUTOL HYDROCHLORIDE,400MG,100,ORAL,Anticipated shortage,TABLET,J04AK,DRUGS FOR TREATMENT OF TUBERCULOSIS,2020-01-06,,2020-05-01,,Shortage of an active ingredient.,2019-06-07,2019-10-09
2001,2232317,Shortage,ETODOLAC,AA PHARMA INC,ETODOLAC,ETODOLAC,200 MG,100 Bottle,Oral,Resolved,Capsule,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2016-04-13,2017-08-09,2017-06-12,Shortage of an active ingredient.,2017-03-13,2017-09-05
2004,2232318,Shortage,ETODOLAC,AA PHARMA INC,ETODOLAC,ETODOLAC,300MG,100 Bottle,ORAL,Resolved,CAPSULE,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-02-02,2017-08-09,2017-06-12,Shortage of an active ingredient.,2017-03-13,2017-09-05
68626,2080036,Shortage,ETOPOSIDE INJECTION,TEVA CANADA LIMITED,ETOPOSIDE,ETOPOSIDE,20MG,10ML,INTRAVENOUS,Actual shortage,LIQUID,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-12-04,2020-01-31,,Demand increase for the drug.,2018-12-04,2019-10-24
68629,2080036,Shortage,ETOPOSIDE INJECTION,TEVA CANADA LIMITED,ETOPOSIDE,ETOPOSIDE,20MG,50ML,INTRAVENOUS,Actual shortage,LIQUID,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-12-04,2019-11-15,,Demand increase for the drug.,2018-12-04,2019-10-24
68632,2080036,Shortage,ETOPOSIDE INJECTION,TEVA CANADA LIMITED,ETOPOSIDE,ETOPOSIDE,20MG,5ML,INTRAVENOUS,Actual shortage,LIQUID,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-12-04,2020-01-31,,Demand increase for the drug.,2018-12-04,2019-11-07
61368,2080036,Shortage,ETOPOSIDE INJECTION,TEVA CANADA LIMITED,ETOPOSIDE,ETOPOSIDE,20MG,25ML,INTRAVENOUS,Actual shortage,LIQUID,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-09-12,2020-01-31,,Demand increase for the drug.,2018-09-12,2019-10-31
2567,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,10ML,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-03-14,2017-07-28,2017-07-28,Delay in shipping of the drug.,2017-03-14,2017-08-02
59182,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-08-20,2019-06-07,2019-01-01,Delay in shipping of the drug.,2018-08-27,2019-01-08
33330,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,25ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017-12-22,2017-12-18,2018-01-29,2018-01-26,Delay in shipping of the drug.,2017-12-16,2018-01-29
14647,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,25ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-07-03,2017-07-28,2017-07-28,Delay in shipping of the drug.,2017-07-05,2017-08-02
16287,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-07-03,,2017-07-31,Delay in shipping of the drug.,2017-07-18,2017-08-01
65762,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE INJECTION USP,ETOPOSIDE,20MG,10ML X 1VIAL,INTRAVENOUS,Actual shortage,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-12-10,2020-05-04,,Requirements related to complying with good manufacturing practices.,2018-10-30,2019-11-06
65767,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,25ML X 1VIAL,INTRAVENOUS,Actual shortage,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-12-17,2020-05-04,,Requirements related to complying with good manufacturing practices.,2018-10-30,2019-11-06
65770,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,50ML x 1VIAL,INTRAVENOUS,Actual shortage,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-12-17,2020-05-04,,Requirements related to complying with good manufacturing practices.,2018-10-30,2019-11-06
65773,2380935,Shortage,ETOPOSIDE INJECTION USP,SANDOZ CANADA INCORPORATED,ETOPOSIDE,ETOPOSIDE,20MG,5ML X 1VIAL,INTRAVENOUS,Actual shortage,SOLUTION,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2018-09-07,2020-05-04,,Requirements related to complying with good manufacturing practices.,2018-10-30,2019-03-07
86333,2253178,Shortage,EURO D 10 000,SANDOZ CANADA INCORPORATED,EURO-D,VITAMIN D3,10000UNIT,60,ORAL,Resolved,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2019-06-06,2019-06-10,2019-06-11,Delay in shipping of the drug.,2019-06-12,2019-06-12
59537,2245668,Shortage,EURO-CYPROHEPTADINE 2MG/5ML,SANDOZ CANADA INCORPORATED,CYPROHEPTADINE,CYPROHEPTADINE HYDROCHLORIDE,2MG,5ML SOLUTION,ORAL,Resolved,SYRUP,R06AX,ANTIHISTAMINES FOR SYSTEMIC USE,,2018-07-09,2018-10-19,2018-10-19,Requirements related to complying with good manufacturing practices.,2018-08-29,2018-10-20
91498,2376601,Shortage,EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES,APOTEX INC,IBUPROFEN,IBUPROFEN,400MG,50 BTL,ORAL,Actual shortage,CAPSULE,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-08-13,,,Disruption of the manufacture of the drug.,2019-08-14,2019-08-14
37072,2240806,Shortage,EXTRANEAL,BAXTER CORPORATION,Extraneal 7.5% PD2,SODIUM LACTATE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE  ICODEXTRIN,4.48G  51MG  257MG  5.35G  75G,2L Twinbag,INTRAPERITONEAL,Resolved,SOLUTION,B05D,PERITONEAL DIALYTICS,2018-01-24,2018-01-24,2018-01-24,2018-01-24,Shortage of an inactive ingredient or component.,2018-01-24,2018-01-25
37075,2240806,Shortage,EXTRANEAL,BAXTER CORPORATION,Extraneal 7.5% PD2,SODIUM LACTATE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE  ICODEXTRIN,4.48G  51MG  257MG  5.35G  75G,2.5L,INTRAPERITONEAL,Resolved,SOLUTION,B05D,PERITONEAL DIALYTICS,2018-01-24,2018-01-24,2018-02-06,2018-02-06,Shortage of an inactive ingredient or component.,2018-01-24,2018-02-07
14354,2422549,Shortage,EZETIMIBE,PRO DOC LIMITEE,EZETIMIBE,EZETIMIBE,10MG,30-100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-06-21,,2017-08-10,Delay in shipping of the drug.,2017-06-29,2017-08-17
31781,2247521,Shortage,EZETROL,MERCK CANADA INC,ezetimibe tablets,EZETIMIBE,10MG,30TAB BLIS,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-01-24,2018-01-23,2018-03-16,2018-03-15,Delay in shipping of the drug.,2017-12-05,2018-03-16
67680,2247521,Shortage,EZETROL,MERCK CANADA INC,ezetimibe tablets,EZETIMIBE,10MG,30's,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2018-11-26,2018-11-27,2018-11-27,Delay in shipping of the drug.,2018-11-27,2018-11-28
27626,2247521,Shortage,EZETROL,MERCK CANADA INC,ezetimibe tablets,EZETIMIBE,10MG,30TAB,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017-11-01,2017-11-01,2017-11-06,2017-11-06,Delay in shipping of the drug.,2017-10-31,2017-11-07
43248,2247521,Shortage,EZETROL,MERCK CANADA INC,ezetimibe tablets,EZETIMIBE,10MG,30 tab,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-04-09,2018-03-29,2018-06-01,2018-05-24,Disruption of the manufacture of the drug.,2018-03-19,2018-05-25
98409,2247745,Shortage,"FAMOTIDINE OMEGA   -(WITH PRESERVATIVE,BENZYL ALCOHOL)",OMEGA LABORATORIES LTD,Famotidine Injection,FAMOTIDINE,10MG,1 x 20mL vial / fiole,INTRAVENOUS,Actual shortage,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-23,2020-03-30,,Disruption of the manufacture of the drug.,2019-11-11,2019-11-11
52924,2247745,Shortage,"FAMOTIDINE OMEGA   -(WITH PRESERVATIVE,BENZYL ALCOHOL)",OMEGA LABORATORIES LTD,Famotidine Injection,FAMOTIDINE,10MG,1 X 20 mL vial,INTRAVENOUS,Resolved,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-06-07,2018-06-30,2018-06-29,Disruption of the manufacture of the drug.,2018-06-26,2018-06-30
98412,2247735,Shortage,FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE),OMEGA LABORATORIES LTD,Famotidine Injection,FAMOTIDINE,10MG,10 x 2mL vial / fiole,INTRAVENOUS,Actual shortage,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-23,2020-03-30,,Disruption of the manufacture of the drug.,2019-11-11,2019-11-11
95094,2351102,Shortage,FAMOTIDINE TABLETS,SANIS HEALTH INC,FAMOTIDINE,FAMOTIDINE,20MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-10-07,,,,Demand increase for the drug.,2019-10-01,2019-10-08
95100,2351110,Shortage,FAMOTIDINE TABLETS,SANIS HEALTH INC,FAMOTIDINE,FAMOTIDINE,40MG,100,ORAL,Anticipated shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-12-10,,,,Demand increase for the drug.,2019-10-01,2019-10-01
16581,2248416,Shortage,FASTURTEC,SANOFI-AVENTIS CANADA INC,Fasturtec 1.5mg vial powder plus 1.0mL solvent,RASBURICASE,1.5MG,3 vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2017-07-17,2017-09-04,2017-08-16,Other (Please describe in comments),2017-07-21,2017-08-17
64237,2384124,Shortage,FENTANYL CITRATE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FENTANYL CITRATE,FENTANYL,50MCG,2MLx10 AMP,INTRAMUSCULAR  INTRAVENOUS  EPIDURAL,Resolved,LIQUID,N01AH,"ANESTHETICS, GENERAL",,2018-07-20,2019-01-18,2019-01-14,Delay in shipping of the drug.,2018-10-15,2019-01-16
74781,2385406,Shortage,FENTANYL CITRATE INJECTION USP,TELIGENT OU,Fentanyl Citrate Injection 50 mcg/ml,FENTANYL,50MCG,2ml,INTRAMUSCULAR  INTRAVENOUS  EPIDURAL,Resolved,SOLUTION,N02AB,OPIOIDS,,2019-02-01,2019-02-28,2019-02-27,Disruption of the manufacture of the drug.,2019-02-05,2019-02-28
59185,2240434,Shortage,FENTANYL CITRATE INJECTION USP,SANDOZ CANADA INCORPORATED,FENTANYL,FENTANYL,50MCG,10 X 2ML AMPOULES,INTRAMUSCULAR  INTRAVENOUS  EPIDURAL,Resolved,LIQUID,N01AH,"ANESTHETICS, GENERAL",,2018-08-17,2018-09-03,2018-09-03,Demand increase for the drug.,2018-08-27,2018-09-10
58777,2385406,Shortage,FENTANYL CITRATE INJECTION USP,TELIGENT OU,Fentanyl Citrate,FENTANYL,50MCG,2 ML,INTRAMUSCULAR  INTRAVENOUS  EPIDURAL,Resolved,SOLUTION,N02AB,OPIOIDS,,2018-08-20,2018-10-12,2018-10-05,Disruption of the manufacture of the drug.,2018-08-22,2018-10-11
87668,2408023,Shortage,FENTORA,TEVA CANADA LIMITED,FENTANYL,FENTANYL,400MCG,28,BUCCAL  SUBLINGUAL,Resolved,TABLET (EFFERVESCENT),N02AB,OPIOIDS,,2019-06-27,2019-09-30,2019-08-28,Disruption of the manufacture of the drug.,2019-06-27,2019-08-29
42638,2408015,Shortage,FENTORA,TEVA CANADA LIMITED,FENTANYL,FENTANYL,200MCG,28,BUCCAL  SUBLINGUAL,Resolved,TABLET (EFFERVESCENT),N02AB,OPIOIDS,,2018-03-01,2018-06-08,2018-06-30,Disruption of the manufacture of the drug.,2018-03-13,2018-07-30
92143,2408058,Shortage,FENTORA,TEVA CANADA LIMITED,FENTORA,FENTANYL,800MCG,28,BUCCAL  SUBLINGUAL,Resolved,TABLET (EFFERVESCENT),N02AB,OPIOIDS,,2019-08-22,2019-11-30,2019-10-03,Disruption of the manufacture of the drug.,2019-08-22,2019-10-04
73757,2243333,Shortage,FERRLECIT,SANOFI-AVENTIS CANADA INC,Ferrlecit,IRON,12.5MG,10,INTRAVENOUS,Resolved,LIQUID,B03AC,IRON PREPARATIONS,,2019-01-25,2019-02-28,2019-02-15,Other (Please describe in comments),2019-01-28,2019-02-16
91481,2243333,Shortage,FERRLECIT,SANOFI-AVENTIS CANADA INC,Ferrlecit,IRON,12.5MG,10,INTRAVENOUS,Avoided shortage,LIQUID,B03AC,IRON PREPARATIONS,2019-09-30,,2019-11-30,2019-09-12,Other (Please describe in comments),2019-08-13,2019-09-13
80521,2243333,Shortage,FERRLECIT,SANOFI-AVENTIS CANADA INC,Sodium Ferric Gluconate,IRON,12.5MG,10,INTRAVENOUS,Resolved,LIQUID,B03AC,IRON PREPARATIONS,,2019-04-04,2019-04-12,2019-04-05,Other (Please describe in comments),2019-04-04,2019-04-06
16562,2243333,Shortage,FERRLECIT,SANOFI-AVENTIS CANADA INC,Sodium Ferric Gluconate,IRON,12.5MG,10,INTRAVENOUS,Resolved,LIQUID,B03,IRON PREPARATIONS,,2017-07-17,,2017-07-17,Other (Please describe in comments),2017-07-20,2017-07-21
84776,2440970,Shortage,FETZIMA,ALLERGAN INC,FETZIMA 20MG 30 CA,LEVOMILNACIPRAN,20MG,FETZIMA 20MG 30 CA,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
84779,2440997,Shortage,FETZIMA,ALLERGAN INC,FETZIMA 80MG CAP 30 CA,LEVOMILNACIPRAN,80MG,FETZIMA 80MG CAP 30 CA,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
79884,2270811,Shortage,FINACEA,BAYER INC,Azelaic acid,AZELAIC ACID,15%,50 g,TOPICAL,Resolved,GEL,D10AX,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-03-27,,2019-04-10,Disruption of the manufacture of the drug.,2019-03-29,2019-04-11
92080,2270811,Shortage,FINACEA,BAYER INC,Azelaic acid,AZELAIC ACID,15%,50g,TOPICAL,Avoided shortage,GEL,D10AX,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2019-09-04,,2019-09-13,2019-09-03,Disruption of the manufacture of the drug.,2019-08-22,2019-09-03
67650,2447568,Shortage,FINASTERIDE,SIVEM PHARMACEUTICALS ULC,FINASTERIDE,FINASTERIDE,1MG,30,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2018-12-03,2018-12-03,2019-03-08,2019-03-01,Requirements related to complying with good manufacturing practices.,2018-11-26,2019-03-04
11094,2445085,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TABS,FINASTERIDE,1MG,30,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017-05-23,2017-07-28,2017-09-21,Other (Please describe in comments),2017-05-24,2017-09-22
10850,2350270,Shortage,FINASTERIDE,PRO DOC LIMITEE,FINASTERIDE,FINASTERIDE,5MG,30,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-05-15,,2017-07-13,Delay in shipping of the drug.,2017-05-23,2017-07-14
75392,2447568,Shortage,FINASTERIDE,SIVEM PHARMACEUTICALS ULC,FINASTERIDE,FINASTERIDE,1MG,100,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2019-01-31,2019-06-07,2019-06-07,Requirements related to complying with good manufacturing practices.,2019-02-12,2019-06-08
30104,2445085,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TAB,FINASTERIDE,1MG,100,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2017-11-22,2017-11-06,2018-01-31,2018-01-15,Delay in shipping of the drug.,2017-11-22,2018-01-16
30107,2445077,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TABS,FINASTERIDE,5MG,30,ORAL,Avoided shortage,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-01-31,,2018-01-31,2018-01-29,Delay in shipping of the drug.,2017-11-22,2018-01-29
10955,2445077,Shortage,FINASTERIDE,SANIS HEALTH INC,FINASTERIDE TABS,FINASTERIDE,5MG,30's,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-05-23,2017-07-28,2017-08-18,Other (Please describe in comments),2017-05-23,2017-09-21
39180,1926861,Shortage,FLAGYL CREAM 10%,SANOFI-AVENTIS CANADA INC,Flagyl Vaginal Cream 10%,METRONIDAZOLE,10%,60g,VAGINAL,Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",2018-02-28,,2018-04-16,2018-04-03,Other (Please describe in comments),2018-02-09,2018-04-04
67006,1926829,Shortage,FLAGYSTATIN,SANOFI-AVENTIS CANADA INC,Flagystatin Ovules,NYSTATIN  METRONIDAZOLE,100000UNIT  500MG,10,VAGINAL,Resolved,SUPPOSITORY,G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",2018-11-27,,2018-12-21,2018-12-21,Other (Please describe in comments),2018-11-16,2018-12-22
3070,1926845,Shortage,FLAGYSTATIN CREAM,SANOFI-AVENTIS CANADA INC,FLAGYSTATIN CREAM 500MG  55G,NYSTATIN  METRONIDAZOLE,100000UNIT  500MG,55G,VAGINAL,Resolved,CREAM,G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017-01-13,2018-07-31,2017-08-16,Other (Please describe in comments),2017-03-16,2017-08-22
15722,756784,Shortage,FLAREX,NOVARTIS PHARMACEUTICALS CANADA INC,FLAREX 0.1% SUSP 5ML,FLUOROMETHOLONE ACETATE,0.1%,5 ml,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2017-06-15,2017-07-17,2017-07-17,Delay in shipping of the drug.,2017-07-13,2017-07-27
26394,2230845,Shortage,FLOLAN,GLAXOSMITHKLINE INC,Epoprostenol Powder for Injection,EPOPROSTENOL,0.5MG,vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017-10-16,2017-11-09,2017-11-08,Delay in shipping of the drug.,2017-10-19,2017-11-09
2725,2213672,Shortage,FLONASE - AEM-SUS NAS  50MCG/MD,GLAXOSMITHKLINE INC,Fluticasone propionate aqueous nasal spray,Fluticasone propionate,50 µg,120's,Intranasal,Actual shortage,Nasal spray,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2017-01-11,,,Other (Please describe in comments),2017-03-14,2017-10-05
83010,2086026,Shortage,FLORINEF,PALADIN LABS INC,Fludrocortisone,FLUDROCORTISONE 21-ACETATE,0.1MG,100 tabs,ORAL,Resolved,TABLET,H02AA,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-05-01,2019-05-31,2019-05-22,Delay in shipping of the drug.,2019-05-02,2019-05-23
87124,2086026,Shortage,FLORINEF,PALADIN LABS INC,FLUDROCORTISONE 21-ACETATE,FLUDROCORTISONE 21-ACETATE,0.1MG,100 tabs,ORAL,Resolved,TABLET,H02AA,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2019-06-20,2019-06-20,2019-10-10,2019-10-08,Delay in shipping of the drug.,2019-06-20,2019-10-09
84577,2086026,Shortage,FLORINEF,PALADIN LABS INC,Fludrocortisone,FLUDROCORTISONE 21-ACETATE,0.1MG,100 tabs,ORAL,Avoided shortage,TABLET,H02AA,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2019-06-03,,,2019-05-23,Disruption of the manufacture of the drug.,2019-05-23,2019-05-23
36634,2237245,Shortage,FLOVENT DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate powder for inhalation,FLUTICASONE PROPIONATE,100MCG,60's,INHALATION,Resolved,POWDER,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2018-01-15,2018-02-09,2018-02-06,Demand increase for the drug.,2018-01-19,2018-02-08
9053,2261472,Shortage,FLUCONAZOLE  IN SODIUM CHLORIDE INJECTION USP,BAXTER CORPORATION,"Fluconazole Injection, USP 200 mg/ 100 mL",FLUCONAZOLE,2MG,"1000mL, 2mg/mL",INTRAVENOUS,Resolved,SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2017-05-01,,2017-06-30,2017-09-14,Disruption of the manufacture of the drug.,2017-05-04,2017-09-15
58634,2283859,Shortage,FLUDARABINE PHOSPHATE FOR INJECTION,TEVA CANADA LIMITED,FLUDARABINE,FLUDARABINE PHOSPHATE,25MG,2ML,INTRAVENOUS,Resolved,SOLUTION,L01BB,ANTIMETABOLITES,,2018-08-20,2018-10-29,2018-10-30,Disruption of the manufacture of the drug.,2018-08-21,2018-11-08
74792,2283859,Shortage,FLUDARABINE PHOSPHATE FOR INJECTION,TEVA CANADA LIMITED,FLUDARABINE,FLUDARABINE PHOSPHATE,25MG,2ML,INTRAVENOUS,Resolved,SOLUTION,L01BB,ANTIMETABOLITES,,2019-02-05,2019-02-28,2019-02-28,Disruption of the manufacture of the drug.,2019-02-05,2019-03-12
90935,2283859,Shortage,FLUDARABINE PHOSPHATE FOR INJECTION,TEVA CANADA LIMITED,FLUDARABINE,FLUDARABINE PHOSPHATE,25MG,2ML,INTRAVENOUS,Actual shortage,SOLUTION,L01BB,ANTIMETABOLITES,2019-09-30,,2019-11-30,2019-11-18,Shortage of an active ingredient.,2019-08-06,2019-11-18
85468,2283859,Shortage,FLUDARABINE PHOSPHATE FOR INJECTION,TEVA CANADA LIMITED,FLUDARABINE,FLUDARABINE PHOSPHATE,25MG,2ML,INTRAVENOUS,Resolved,SOLUTION,L01BB,ANTIMETABOLITES,2019-07-12,2019-06-27,2019-08-12,2019-08-06,Disruption of the manufacture of the drug.,2019-06-03,2019-08-07
24222,2420783,Shortage,FLULAVAL TETRA,ID BIOMEDICAL CORPORATION OF QUEBEC,"Quadrivalent Influenza Vaccine (Split Virion, Inactivated)",HAEMAGGLUTININ-STRAIN B  HAEMAGGLUTININ-STRAIN B  HAEMAGGLUTININ-STRAIN A  HAEMAGGLUTININ-STRAIN A,15MCG  15MCG  15MCG  15MCG,1 vial X 10 doses,INTRAMUSCULAR,Resolved,SUSPENSION,J07BB,VIRAL VACCINES,2017-09-27,2017-09-27,2018-03-30,2018-03-30,Other (Please describe in comments),2017-10-03,2018-03-31
94139,2420783,Shortage,FLULAVAL TETRA,ID BIOMEDICAL CORPORATION OF QUEBEC,"Quadrivalent Influenza Vaccine (Split Virion, Inactivated)",HAEMAGGLUTININ-STRAIN B  HAEMAGGLUTININ-STRAIN B  HAEMAGGLUTININ-STRAIN A  HAEMAGGLUTININ-STRAIN A,15MCG  15MCG  15MCG  15MCG,1 vial X 10 doses,INTRAMUSCULAR,Actual shortage,SUSPENSION,J07BB,VIRAL VACCINES,,2019-09-12,,,Other (Please describe in comments),2019-09-17,2019-09-17
21779,2266342,Shortage,FLUMAZENIL INJECTION,FRESENIUS KABI CANADA LTD,"Flumazenil Injection, USP 0.1mg/mL MD Vial",FLUMAZENIL,0.1MG,5mL,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017-10-10,2017-10-10,2017-11-15,2017-11-17,Demand increase for the drug.,2017-09-08,2017-11-18
38754,2249561,Shortage,FLUMAZENIL INJECTION,SANDOZ CANADA INCORPORATED,FLUMAZENIL,FLUMAZENIL,0.1MG,10 X 5ML VIALS,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2018-01-29,2018-03-02,2018-02-27,Demand increase for the drug.,2018-02-06,2018-03-23
95165,2266342,Shortage,FLUMAZENIL INJECTION,FRESENIUS KABI CANADA LTD,Flumazenil,FLUMAZENIL,0.1MG,5mL,INTRAVENOUS,Actual shortage,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2019-10-01,,2019-10-31,,Demand increase for the drug.,2019-10-01,2019-10-02
82164,2426544,Shortage,FLUMIST QUADRIVALENT,ASTRAZENECA CANADA INC,"Influenza vaccine (live, attenuated)",Influenza Virus Type A  Influenza Virus Type A  Influenza virus type B  Influenza virus type B,32000000FFU  32000000FFU  32000000FFU  32000000FFU,10 single use pre-filled syringes,NASAL,Actual shortage,SPRAY,J07BB,VIRAL VACCINES,2019-10-01,2019-10-01,,,Shortage of an active ingredient.,2019-04-22,2019-10-02
54361,2246082,Shortage,FLUNARIZINE,AA PHARMA INC,Flunarizine,FLUNARIZINE,5MG,100 BTL,ORAL,Resolved,CAPSULE,N07CA,ANTIVERTIGO PREPARATIONS,,2018-07-05,2018-07-11,2018-07-11,Disruption of the manufacture of the drug.,2018-07-05,2019-01-10
11758,2237775,Shortage,"FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTALMIC SOLUTION, USP",BAUSCH & LOMB INC,"FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTALMIC SOLUTION, USP",FLUORESCEIN SODIUM  BENOXINATE HYDROCHLORIDE,0.25%  0.4%,n/a,OPHTHALMIC,Actual shortage,SOLUTION,S01JA,DIAGNOSTICAGENTS,,2018-05-01,,,Other (Please describe in comments),2017-06-02,2018-05-04
16061,505005,Shortage,FLUORESCITE,NOVARTIS PHARMACEUTICALS CANADA INC,FLUORESCITE 10% 5mg vial (1x12),FLUORESCEIN SODIUM,10%,1 x 12,INTRAVENOUS,Resolved,SOLUTION,V04,OTHER DIAGNOSTIC AGENTS,,2017-07-17,2017-08-23,2017-08-28,Delay in shipping of the drug.,2017-07-17,2017-08-31
3092,2413450,Shortage,FLUOROURACIL INJECTION,ACCORD HEALTHCARE INC,FLUOROURACIL,FLUOROURACIL,5G,1 VIAL OF 100 ML,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,2016-12-23,2016-12-23,2017-03-22,2017-03-22,Other (Please describe in comments),2017-03-16,2017-03-23
12837,2413450,Shortage,FLUOROURACIL INJECTION,ACCORD HEALTHCARE INC,FLUOROURACIL,FLUOROURACIL,5G,"50 MG/ML, 100 ML/VIAL (5 G/VIAL)     |     50 MG/ML, 100 ML/FLACON (5 G/FLACON)",INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,2017-06-23,,2017-08-14,2017-07-07,Other (Please describe in comments),2017-06-15,2017-07-13
1405,2182742,Shortage,FLUOROURACIL INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Fluorouracil (5FU),FLUOROURACIL,50MG,5 g/100 mL x 1,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017-03-02,2017-03-20,2017-03-20,Other (Please describe in comments),2017-03-13,2017-03-21
67081,2374447,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,10MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-12-24,2018-12-24,2019-01-18,2019-01-18,Other (Please describe in comments),2018-11-19,2019-01-19
44590,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Avoided shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-05-28,,2018-04-23,2018-04-23,Delay in shipping of the drug.,2018-04-02,2018-04-23
16495,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-07-05,,2017-11-04,Demand increase for the drug.,2017-07-19,2017-11-05
13172,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-06-26,2017-07-05,2018-04-03,2018-04-02,Disruption of the manufacture of the drug.,2017-06-16,2018-04-03
13175,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-06-26,2018-04-03,2018-04-02,Disruption of the manufacture of the drug.,2017-06-16,2018-04-03
69054,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2019-01-10,2019-01-09,2019-01-18,2019-01-18,Other (Please describe in comments),2018-12-10,2019-01-19
61375,2374455,Shortage,FLUOXETINE,SIVEM PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-09-21,2018-09-25,2019-01-18,2019-01-18,Other (Please describe in comments),2018-09-12,2019-01-19
28686,405345,Shortage,FLUPHENAZINE,AA PHARMA INC,FLUPHENAZINE,FLUPHENAZINE HYDROCHLORIDE,1MG,100 Bottle,ORAL,Resolved,TABLET,N05AB,ANTIPSYCHOTICS,,2017-11-06,2018-03-09,2018-03-08,Disruption of the manufacture of the drug.,2017-11-09,2018-03-09
24232,2420686,Shortage,FLUVIRAL,ID BIOMEDICAL CORPORATION OF QUEBEC,"Trivalent Influenza Vaccine (Split Virion, Inactivated)",HAEMAGGLUTININ-STRAIN B  HAEMAGGLUTININ-STRAIN A  HAEMAGGLUTININ-STRAIN A,15MCG  15MCG  15MCG,1 vial X 10 doses,INTRAMUSCULAR,Resolved,SUSPENSION,J07BB,VIRAL VACCINES,2017-09-27,2017-09-27,2018-03-30,2018-03-30,Other (Please describe in comments),2017-10-03,2018-07-13
24150,2236754,Shortage,FLUVOXAMINE-100,PRO DOC LIMITEE,FLUVOXAMINE,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-10-02,,2018-03-08,Delay in shipping of the drug.,2017-10-02,2018-03-09
73323,2236753,Shortage,FLUVOXAMINE-50,PRO DOC LIMITEE,FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-01-23,2019-01-30,2019-01-30,Delay in shipping of the drug.,2019-01-23,2019-01-31
26046,2236753,Shortage,FLUVOXAMINE-50,PRO DOC LIMITEE,FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-10-16,,2018-03-13,Delay in shipping of the drug.,2017-10-16,2018-03-14
97085,247855,Shortage,FML 0.1%,ALLERGAN INC,fluoromethalone,FLUOROMETHOLONE,0.1%,10ml,OPHTHALMIC,Resolved,DROPS,S01BA,ANTIINFLAMMATORY AGENTS,,2019-10-24,2019-11-24,2019-11-07,Disruption of the manufacture of the drug.,2019-10-24,2019-11-08
91579,247855,Shortage,FML 0.1%,ALLERGAN INC,FML 5 ml,FLUOROMETHOLONE,0.1%,5 mL,OPHTHALMIC,Resolved,DROPS,S01BA,ANTIINFLAMMATORY AGENTS,2019-08-19,2019-08-19,2019-09-20,2019-09-20,Disruption of the manufacture of the drug.,2019-08-14,2019-09-21
22207,2139480,Shortage,FOLIC ACID INJECTION,FRESENIUS KABI CANADA LTD,Folic Acid Injection 5 mg/mL MD Vial,FOLIC ACID,5MG,10mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B03BB,VITAMIN B12 AND FOLIC ACID,2017-09-29,,2017-12-12,2017-11-20,Disruption of the manufacture of the drug.,2017-09-15,2018-02-01
91678,2435667,Shortage,FOMEPIZOLE FOR INJECTION,STERIMAX INC,FOMEPIZOLE FOR INJECTION,FOMEPIZOLE,1G,2 VIALS,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2019-08-16,2019-08-23,2019-08-23,Demand increase for the drug.,2019-08-16,2019-08-24
51027,2212218,Shortage,FORTAZ - INJ 1G/VIAL,GLAXOSMITHKLINE INC,Ceftazidime for injection,CEFTAZIDIME,1G,10's,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-05-31,,,Shortage of an active ingredient.,2018-05-31,2019-10-18
51030,2212226,Shortage,FORTAZ - INJ 2G/VIAL,GLAXOSMITHKLINE INC,Ceftazidime for injection,CEFTAZIDIME,2G,10's,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-05-31,,,Shortage of an active ingredient.,2018-05-31,2019-10-18
4301,2212234,Shortage,FORTAZ - INJ 6G/VIAL,GLAXOSMITHKLINE INC,Ceftazidime for injection,CEFTAZIDIME,6G,6's,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-07-20,,,Shortage of an active ingredient.,2017-03-24,2019-10-18
52052,2314940,Shortage,FOSAVANCE,MERCK CANADA INC,alendronate sodium / cholecalciferol tablets,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4TAB,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-06-26,2018-06-14,2018-07-20,2018-07-10,Demand increase for the drug.,2018-06-11,2018-07-11
46944,2314940,Shortage,FOSAVANCE,MERCK CANADA INC,alendronate sodium / cholecalciferol tablets,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4's,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-04-23,2018-04-23,2018-05-18,2018-05-18,Demand increase for the drug.,2018-04-23,2018-05-19
58261,2314940,Shortage,FOSAVANCE,MERCK CANADA INC,alendronate sodium / cholecalciferol tablets,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4TAB,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-08-16,2018-08-16,2018-08-16,Demand increase for the drug.,2018-08-16,2018-08-17
37549,2276429,Shortage,FOSAVANCE,MERCK CANADA INC,Alendronate Sodium / Cholecalciferol Tablets,ALENDRONIC ACID  VITAMIN D3,70MG  2800UNIT,4's,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-02-13,2018-02-07,2018-04-06,2018-04-03,Demand increase for the drug.,2018-01-29,2018-04-04
37552,2314940,Shortage,FOSAVANCE,MERCK CANADA INC,Alendronate Sodium / Cholecalciferol Tablets,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4's,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-02-19,2018-02-05,2018-04-06,2018-04-04,Demand increase for the drug.,2018-01-29,2018-04-05
44992,2314940,Shortage,FOSAVANCE,MERCK CANADA INC,Alendronate Sodium / Cholecalciferol tablets,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4's,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-04-04,2018-04-04,2018-04-16,2018-04-13,Demand increase for the drug.,2018-04-04,2018-04-14
35791,2276429,Shortage,FOSAVANCE,MERCK CANADA INC,alendronate sodium / cholecalciferol tablets,ALENDRONIC ACID  VITAMIN D3,70MG  2800UNIT,4TAB BLIS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-01-19,2018-01-11,2018-02-09,2018-01-26,Delay in shipping of the drug.,2018-01-12,2018-01-27
23505,2276429,Shortage,FOSAVANCE,MERCK CANADA INC,Alendronate Sodium / Cholecalciferol tablets,ALENDRONIC ACID  VITAMIN D3,70MG  2800UNIT,4TAB BLIS,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-10-11,2017-09-27,2018-01-05,2018-01-02,Delay in shipping of the drug.,2017-09-26,2018-01-03
33516,2314940,Shortage,FOSAVANCE,MERCK CANADA INC,Alendronate Sodium / Cholecalciferol Tablets,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4's,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-01-02,2018-01-02,2018-02-09,2018-01-26,Delay in shipping of the drug.,2017-12-18,2018-01-27
31799,2303019,Shortage,FOSINOPRIL-20,PRO DOC LIMITEE,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-12-05,,2017-12-14,Delay in shipping of the drug.,2017-12-05,2017-12-15
51338,2287145,Shortage,FOSRENOL,SHIRE PHARMA CANADA ULC,Lanthanum carbonate chewable tablets,LANTHANUM,250MG,90's,ORAL,Resolved,TABLET (CHEWABLE),V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2018-06-06,,2018-07-20,2018-07-13,Disruption of the manufacture of the drug.,2018-06-04,2018-07-14
72349,2287153,Shortage,FOSRENOL,SHIRE PHARMA CANADA ULC,Lanthanum Carbonate chewable tablets,LANTHANUM,500MG,carton of 2 bottles x 45's,ORAL,Resolved,TABLET (CHEWABLE),V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2019-01-17,2019-01-18,2019-01-24,2019-01-25,Delay in shipping of the drug.,2019-01-15,2019-01-26
78611,2430789,Shortage,FRAGMIN,PFIZER CANADA ULC,FRAGMIN 3500 IU,DALTEPARIN SODIUM,3500UNIT,10 x 0.2mL SYR,INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-03-23,,2019-06-28,2019-05-07,Disruption of the manufacture of the drug.,2019-03-13,2019-05-08
56331,2450615,Shortage,FRAXIPARINE,ASPEN PHARMACARE CANADA INC.,Fraxiparine 0.2 mL (1900 IU) pre-filled syringes,NADROPARIN CALCIUM,9500UNIT,10,INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2014-01-01,,,Other (Please describe in comments),2018-07-24,2018-07-24
84512,2396491,Shortage,FREYA 21,MYLAN PHARMACEUTICALS ULC,DESOGESTREL ETHINYL ESTRADIOL,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,21 TAB,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-05-21,2019-05-21,,2019-05-28,Requirements related to complying with good manufacturing practices.,2019-05-22,2019-05-29
85557,2396491,Shortage,FREYA 21,MYLAN PHARMACEUTICALS ULC,DESOGESTREL ETHINYL ESTRADIOL,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,21 TAB,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-06-04,,2019-06-18,Requirements related to complying with good manufacturing practices.,2019-06-04,2019-06-19
68756,2396491,Shortage,FREYA 21,MYLAN PHARMACEUTICALS ULC,FREYA 21,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,21 BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-12-26,,2019-03-08,2019-03-05,Delay in shipping of the drug.,2018-12-05,2019-03-06
80441,2396610,Shortage,FREYA 28,MYLAN PHARMACEUTICALS ULC,FREYA 28,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,28 BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-04-03,,,2019-07-02,Requirements related to complying with good manufacturing practices.,2019-04-03,2019-07-03
28041,2396610,Shortage,FREYA 28,MYLAN PHARMACEUTICALS ULC,FREYA 28,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,28BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-02-01,2019-02-01,2019-03-20,2019-03-20,Delay in shipping of the drug.,2017-11-03,2019-03-21
62779,586668,Shortage,FUCIDIN CREAM 2%,LEO PHARMA INC,fusidic acid cream 2%,FUSIDIC ACID,2%,30g,TOPICAL,Resolved,CREAM,D06AX,ANTIBIOTICS FOR TOPICAL USE,2018-10-01,2018-10-01,2018-11-16,2018-11-23,Disruption of the manufacture of the drug.,2018-10-01,2018-11-24
70288,586668,Shortage,FUCIDIN CREAM 2%,LEO PHARMA INC,fusidic acid cream 2%,FUSIDIC ACID,2%,30g,TOPICAL,Resolved,CREAM,D06AX,ANTIBIOTICS FOR TOPICAL USE,2018-12-21,2018-12-21,2019-01-11,2019-01-08,Delay in shipping of the drug.,2018-12-21,2019-01-09
66890,586676,Shortage,FUCIDIN OINTMENT 2%,LEO PHARMA INC,sodium fusidate,FUSIDATE SODIUM,2%,30g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,2018-11-14,2018-11-14,2019-01-18,2019-01-18,Disruption of the manufacture of the drug.,2018-11-14,2019-01-19
16534,29149,Shortage,FUNGIZONE INTRAVENOUS INJECTION 50MG,BRISTOL-MYERS SQUIBB CANADA,Amphotericin B,AMPHOTERICIN B,50MG,(1 VL) 15 ML,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J02AA,ANTIMYCOTICS FOR SYSTEMIC USE,2018-05-22,2018-04-20,2019-05-22,2019-05-22,Other (Please describe in comments),2017-07-20,2019-05-23
66906,397792,Shortage,FUROSEMIDE 40MG,PRO DOC LIMITEE,FUROSEMIDE,FUROSEMIDE,40MG,1000,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2018-11-14,,2018-12-11,Delay in shipping of the drug.,2018-11-14,2018-12-12
2574,527033,Shortage,FUROSEMIDE INJ USP,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 4ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2017-03-14,2017-06-30,2017-04-18,Demand increase for the drug.,2017-03-14,2017-04-19
18388,527033,Shortage,FUROSEMIDE INJ USP,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 4ML VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,C03CA,HIGH-CEILING DIURETICS,2017-08-11,2017-10-02,2017-10-27,2017-10-25,Demand increase for the drug.,2017-08-07,2017-10-26
2181,2360365,Shortage,FUROSEMIDE INJECTION,OMEGA LABORATORIES LTD,Furosemide Injection,FUROSEMIDE,10MG,2mL vial,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2016-12-23,,,Disruption of the manufacture of the drug.,2017-03-14,2017-11-13
2186,2360365,Shortage,FUROSEMIDE INJECTION,OMEGA LABORATORIES LTD,Furosemide Injection,FUROSEMIDE,10MG,4mL vial,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2016-12-09,,,Disruption of the manufacture of the drug.,2017-03-14,2017-11-13
38760,2382539,Shortage,FUROSEMIDE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 4ML AMPOULES,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2018-01-22,2018-03-02,2018-03-13,Demand increase for the drug.,2018-02-06,2018-03-23
38763,2382539,Shortage,FUROSEMIDE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 2 ML AMPOULES,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2018-01-29,2018-03-02,2018-03-13,Demand increase for the drug.,2018-02-06,2018-03-23
86417,2382539,Shortage,FUROSEMIDE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,2ml X 10,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2019-06-03,2019-06-17,2019-06-14,Delay in shipping of the drug.,2019-06-12,2019-06-28
18391,2382539,Shortage,FUROSEMIDE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 2ML AMPS,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017-08-01,2017-08-31,2017-08-18,Demand increase for the drug.,2017-08-07,2017-10-18
3829,2382539,Shortage,FUROSEMIDE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 4ML AMPOULES,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017-03-21,2017-06-26,2017-04-18,Demand increase for the drug.,2017-03-22,2017-04-19
26269,2461404,Shortage,FUROSEMIDE INJECTION USP,STERIMAX INC,FUROSEMIDE INJECTION USP,FUROSEMIDE,10MG,25 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017-10-18,2018-03-05,2018-03-02,Other (Please describe in comments),2017-10-18,2018-03-03
34270,2384094,Shortage,FUROSEMIDE INJECTION USP,TELIGENT OU,FUROSEMIDE INJECTION,FUROSEMIDE,10MG,2 ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,,2017-10-31,2018-04-24,2018-04-26,Disruption of the manufacture of the drug.,2017-12-22,2018-04-27
2584,401633,Shortage,FUROSEMIDE SPECIAL,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG/ML,10 X 25ML,INJECTABLE,Resolved,LIQUID IN VIAL,C03CA,HIGH-CEILING DIURETICS,2017-03-23,,2017-05-31,2017-07-28,Demand increase for the drug.,2017-03-14,2017-10-18
31051,401633,Shortage,FUROSEMIDE SPECIAL,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 VIALS,INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,2017-12-04,,2017-12-15,2017-12-12,Delay in shipping of the drug.,2017-11-29,2017-12-15
18155,401633,Shortage,FUROSEMIDE SPECIAL,SANDOZ CANADA INCORPORATED,FUROSEMIDE,FUROSEMIDE,10MG,10 X 25ML VIALS,INTRAVENOUS,Resolved,SOLUTION,C03CA,HIGH-CEILING DIURETICS,2017-08-03,2017-08-18,2017-11-17,2017-10-24,Demand increase for the drug.,2017-08-03,2017-10-27
2189,2360446,Shortage,FUROSEMIDE SPECIAL INJECTION,OMEGA LABORATORIES LTD,Furosemide Special Injection,FUROSEMIDE,10MG,25mL vial,INTRAVENOUS,Actual shortage,LIQUID,C03CA,HIGH-CEILING DIURETICS,,2016-12-13,,,Disruption of the manufacture of the drug.,2017-03-14,2017-10-05
24913,2353261,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN CAPS,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-16,,2017-11-10,2017-10-26,Other (Please describe in comments),2017-10-10,2017-10-27
33110,2353245,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN CAP,GABAPENTIN,100MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-12-11,2017-12-29,2017-12-21,Disruption of the manufacture of the drug.,2017-12-15,2017-12-22
50535,2388200,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-06-25,2018-06-16,2018-06-29,2018-06-18,Other (Please describe in comments),2018-05-28,2018-07-31
50538,2388219,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,800MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-06-18,2018-06-14,2018-06-29,2018-06-18,Other (Please describe in comments),2018-05-28,2018-07-31
16498,2246314,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-15,2018-04-27,2018-04-27,Other (Please describe in comments),2017-07-19,2018-04-30
16501,2246314,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,100MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-15,2018-04-27,2018-04-27,Other (Please describe in comments),2017-07-19,2018-04-30
16504,2246316,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-07-17,,2017-08-09,Demand increase for the drug.,2017-07-19,2017-08-10
16507,2246316,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-07-17,2018-04-27,2018-04-27,Other (Please describe in comments),2017-07-19,2018-04-30
69781,2388200,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2019-01-28,2019-01-28,2019-05-10,2019-05-10,Other (Please describe in comments),2018-12-17,2019-05-13
30110,2353261,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN CAP,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-11-29,2017-11-22,2017-12-29,2017-12-21,Other (Please describe in comments),2017-11-22,2017-12-22
72156,2388219,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,800MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2019-02-25,2019-02-26,2019-04-05,2019-04-05,Other (Please describe in comments),2019-01-14,2019-04-30
28134,2246315,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-15,2018-04-27,2018-04-27,Other (Please describe in comments),2017-11-06,2018-04-30
28137,2246315,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-15,2018-04-27,2018-04-27,Other (Please describe in comments),2017-11-06,2018-04-30
28140,2246316,Shortage,GABAPENTIN,SIVEM PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-15,2018-04-27,2018-04-27,Other (Please describe in comments),2017-11-06,2018-04-30
65691,2392526,Shortage,GABAPENTIN TABLETS USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,600MG,100 TABS/BOTTLE  | 100 COMPRIMÉS/BOUTEILLE,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-10-29,2018-10-29,2018-10-23,2018-11-30,Disruption of the manufacture of the drug.,2018-10-29,2018-12-11
3233,2392534,Shortage,GABAPENTIN TABLETS USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,800MG,BOTTLE OF 100 TABS   |    BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2016-12-06,2016-12-06,2017-11-03,2017-11-08,Disruption of the manufacture of the drug.,2017-03-17,2017-11-13
40647,2392526,Shortage,GABAPENTIN TABLETS USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,600MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-02-02,2018-03-09,2018-03-16,Disruption of the manufacture of the drug.,2018-02-22,2018-03-22
90894,2416603,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALANTAMINE ER,GALANTAMINE,24MG,30,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-06-20,,,Other (Please describe in comments),2019-08-06,2019-08-06
83018,2416573,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALANTAMINE ER,GALANTAMINE,8MG,30,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-05-02,,,Delay in shipping of the drug.,2019-05-02,2019-05-03
25684,2416603,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALANTAMINE ER,GALANTAMINE,24MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017-10-11,,2018-01-10,Delay in shipping of the drug.,2017-10-12,2018-01-11
21233,2416573,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALANTAMINE,GALANTAMINE,8MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017-09-05,,2018-01-16,Delay in shipping of the drug.,2017-09-07,2018-01-17
14330,2416581,Shortage,GALANTAMINE ER,PRO DOC LIMITEE,GALATAMINE ER,GALANTAMINE,16MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017-08-01,,2018-01-05,Delay in shipping of the drug.,2017-06-29,2018-01-05
81842,2327759,Shortage,GALLIUM,LANTHEUS MI CANADA INC,Gallium Citrate Ga-67 Injection,GALLIUM CITRATE GA 67,74MBq,10mL vial,INTRAVENOUS,Resolved,SOLUTION,V09HX,,,2019-04-04,,2019-05-10,Disruption of the manufacture of the drug.,2019-04-16,2019-05-11
90434,2279444,Shortage,GAMMAGARD LIQUID,SHIRE PHARMA CANADA ULC,"GAMMAGARD LIQUID, Immunoglobulin Intravenous",IMMUNOGLOBULIN,10%,"2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL,  and 30g/ 300mL",INTRAVENOUS,Actual shortage,SOLUTION,J06BA,IMMUNOGLOBULINS,2019-07-31,2019-07-31,2019-09-30,,Other (Please describe in comments),2019-07-31,2019-08-23
16832,2362759,Shortage,GD-AMLODIPINE/ATORVASTATIN,GENMED A DIVISION OF PFIZER CANADA INC,GD-Amlodipine/Atorvastatin,AMLODIPINE  ATORVASTATIN,5MG  10MG,90s,ORAL,Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",2017-07-19,,2017-08-03,2017-08-03,Delay in shipping of the drug.,2017-07-24,2017-08-04
8733,2274574,Shortage,GD-AZITHROMYCIN,GENMED A DIVISION OF PFIZER CANADA INC,GD-AZITHROMYCIN,AZITHROMYCIN,200MG,600mg/15mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-21,2017-05-16,2017-05-05,Disruption of the manufacture of the drug.,2017-05-02,2017-05-06
27753,2274566,Shortage,GD-AZITHROMYCIN,GENMED A DIVISION OF PFIZER CANADA INC,AZITHROMYCIN,AZITHROMYCIN,100MG,300mg/15mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-01-17,,2018-08-14,Disruption of the manufacture of the drug.,2017-11-01,2018-08-15
7589,2291975,Shortage,GD-CELECOXIB,GENMED A DIVISION OF PFIZER CANADA INC,GD-CELECOXIB,CELECOXIB,100MG,100's,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-04-28,,2017-05-31,2017-06-01,Disruption of the manufacture of the drug.,2017-04-21,2017-06-28
33910,2285843,Shortage,GD-GABAPENTIN,GENMED A DIVISION OF PFIZER CANADA INC,GD-GABAPENTIN,GABAPENTIN,600MG,100's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-01-02,,2018-02-05,Disruption of the manufacture of the drug.,2017-12-20,2018-02-07
91964,2373068,Shortage,GD-LATANOPROST/TIMOLOL,GENMED A DIVISION OF PFIZER CANADA ULC,GD/LATANOPROST/TIMOLOL,TIMOLOL  LATANOPROST,5MG  50MCG,2.5ml,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-08-22,2019-09-20,2019-09-17,Demand increase for the drug.,2019-08-20,2019-09-18
12112,2291010,Shortage,GD-QUINAPRIL,GENMED A DIVISION OF PFIZER CANADA INC,GD-Quinapril,QUINAPRIL,40MG,90,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-07-07,,2018-09-25,Shortage of an active ingredient.,2017-06-06,2018-09-26
98089,2409097,Shortage,GD-TRANEXAMIC ACID,GENMED A DIVISION OF PFIZER CANADA ULC,LEDERLE LEUCOVORIN,TRANEXAMIC ACID,500MG,100,ORAL,Anticipated shortage,TABLET,B02AA,ANTIFIBRINOLYTICS,2019-12-06,,2020-01-10,,Disruption of the manufacture of the drug.,2019-11-06,2019-11-06
68477,2409097,Shortage,GD-TRANEXAMIC ACID,GENMED A DIVISION OF PFIZER CANADA INC,Tranexamic Acid,TRANEXAMIC ACID,500MG,100's,ORAL,Resolved,TABLET,B02AA,ANTIFIBRINOLYTICS,,2018-12-18,,2019-02-11,Disruption of the manufacture of the drug.,2018-12-03,2019-02-12
27249,2360039,Shortage,GD-VENLAFAXINE XR,GENMED A DIVISION OF PFIZER CANADA INC,VENLAFAXINE,VENLAFAXINE,75MG,90s,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-12-18,,2018-01-24,Disruption of the manufacture of the drug.,2017-10-27,2018-01-25
14909,2324210,Shortage,GEMCITABINE FOR INJECTION,ACCORD HEALTHCARE INC,GEMCITABINE,GEMCITABINE,1G,1 G POWDER IN A VIAL     |     1 G DE POUDRE DANS UN FLACON,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BC,ANTIMETABOLITES,2017-07-05,2017-07-05,2017-09-29,2017-09-20,Demand increase for the drug.,2017-07-07,2017-11-24
1697,2305534,Shortage,GEMCITABINE FOR INJECTION,TEVA CANADA LIMITED,GEMCITABINE,GEMCITABINE,1G,1000MG,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,L01BC,ANTIMETABOLITES,,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
9700,2370034,Shortage,GEMCITABINE FOR INJECTION,ACCORD HEALTHCARE INC,GEMCITABINE,GEMCITABINE,2G,2 G (POWDER) PER VIAL   |   FLACON DE 2 G (POUDRE),INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BC,ANTIMETABOLITES,2017-05-09,2017-05-09,2017-07-07,2017-07-06,Disruption of the manufacture of the drug.,2017-05-09,2017-07-13
89859,2412292,Shortage,GEMCITABINE INJECTION,SANDOZ CANADA INCORPORATED,GEMCITABIN,GEMCITABINE,40MG,5 Vials,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2019-06-24,2019-07-29,2019-08-06,Delay in shipping of the drug.,2019-07-24,2019-09-25
18317,2412292,Shortage,GEMCITABINE INJECTION,SANDOZ CANADA INCORPORATED,GEMCITABINE,GEMCITABINE,40MG,50  ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017-07-21,2017-08-18,2017-08-18,Delay in shipping of the drug.,2017-08-07,2017-10-18
11695,2402831,Shortage,GEMCITABINE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Gemcitabine,GEMCITABINE,38MG,1 x 52.6mL,INTRAVENOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017-06-01,2017-07-03,2017-07-03,Delay in shipping of the drug.,2017-06-01,2017-07-04
24836,2305003,Shortage,GEN-CLOZAPINE,MYLAN PHARMACEUTICALS ULC,CLOZAPINE,CLOZAPINE,50MG,100BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-10-18,2017-10-19,2017-10-31,2017-10-20,Delay in shipping of the drug.,2017-10-10,2017-10-21
28038,2247244,Shortage,GEN-CLOZAPINE,MYLAN PHARMACEUTICALS ULC,CLOZAPINE,CLOZAPINE,100MG,100BT,ORAL,Avoided shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017-12-19,,,2017-11-23,Delay in shipping of the drug.,2017-11-03,2017-11-23
4063,2305011,Shortage,GEN-CLOZAPINE,MYLAN PHARMACEUTICALS ULC,CLOZAPINE,CLOZAPINE,200MG,100BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-11-07,2017-11-14,2017-11-14,Delay in shipping of the drug.,2017-03-23,2017-11-15
93856,2401800,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin MQ,SOMATROPIN,1.4MG,7 pack,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,H01AC,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,2019-09-16,2019-09-18,2019-10-04,2019-10-07,Demand increase for the drug.,2019-09-13,2019-10-08
98766,2401703,Shortage,GENOTROPIN,PFIZER CANADA ULC,GENOTROPIN,SOMATROPIN,5.3MG,5 pack,SUBCUTANEOUS,Anticipated shortage,POWDER FOR SOLUTION,H01AC,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,2020-01-05,,,,Disruption of the manufacture of the drug.,2019-11-14,2019-11-14
18394,2268531,Shortage,GENTAMICIN INJECTION USP,SANDOZ CANADA INCORPORATED,GENTAMICIN,GENTAMICIN,10MG,10 X 2ML VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017-08-01,2017-11-30,2017-11-17,Requirements related to complying with good manufacturing practices.,2017-08-07,2017-11-28
18397,2242652,Shortage,GENTAMICIN INJECTION USP,SANDOZ CANADA INCORPORATED,GENTAMICIN,GENTAMICIN,40MG,20ML VIAL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017-08-01,2017-12-15,2017-12-12,Requirements related to complying with good manufacturing practices.,2017-08-07,2017-12-15
95567,2082136,Shortage,GENTAMICIN(E),BAXTER CORPORATION,GENTAMICIN(E),GENTAMICIN,1MG,100 mL (JB0863),INTRAVENOUS,Actual shortage,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,2019-10-04,2019-10-04,2019-11-18,2019-11-18,Disruption of the manufacture of the drug.,2019-10-04,2019-11-18
58562,2082152,Shortage,GENTAMICIN(E) 80MG LIQ IV 1.6MG/ML,BAXTER CORPORATION,Gentamicin 80mg in 0.9% Sodium Chloride Injection,GENTAMICIN,1.6MG,50mL,INTRAVENOUS,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,2018-08-20,2018-08-20,2018-09-04,2018-09-04,Disruption of the manufacture of the drug.,2018-08-20,2018-09-05
79881,2190893,Shortage,GLUCOBAY,BAYER INC,Acarbose,ACARBOSE,100MG,120,ORAL,Actual shortage,TABLET,A10BF,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-03-26,,,Disruption of the manufacture of the drug.,2019-03-29,2019-03-29
16068,2190885,Shortage,GLUCOBAY,BAYER INC,Acarbose,ACARBOSE,50MG,120,ORAL,Resolved,TABLET,A10BF,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-07-13,2017-07-13,2017-09-15,2017-09-14,Disruption of the manufacture of the drug.,2017-07-17,2017-09-15
16073,2190893,Shortage,GLUCOBAY,BAYER INC,Acarbose,ACARBOSE,100MG,120 Tablets,ORAL,Resolved,TABLET,A10BF,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-07-13,2017-07-13,2017-08-25,2017-08-24,Disruption of the manufacture of the drug.,2017-07-17,2017-08-25
69617,2190885,Shortage,GLUCOBAY,BAYER INC,acarbose,ACARBOSE,50MG,120,ORAL,Resolved,TABLET,A10BF,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-01-15,2019-01-15,2019-08-30,2019-07-24,Disruption of the manufacture of the drug.,2018-12-14,2019-07-25
42474,2239924,Shortage,GLUCONORM 0.5MG,NOVO NORDISK CANADA INC,REPAGLINIDE,REPAGLINIDE,0.5MG,1 x 100 tablets,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-03-12,2018-03-12,2018-05-14,2018-05-02,Demand increase for the drug.,2018-03-12,2018-05-03
98703,2239925,Shortage,GLUCONORM 1.0MG,NOVO NORDISK CANADA INC,Repaglinide,REPAGLINIDE,1.0MG,90,ORAL,Actual shortage,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-11-15,,2019-12-06,,Demand increase for the drug.,2019-11-14,2019-11-18
76402,2162849,Shortage,GLUCOPHAGE,SANOFI-AVENTIS CANADA INC,Glucophage,METFORMIN HYDROCHLORIDE,850MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-03-28,,2019-05-03,2019-04-26,Other (Please describe in comments),2019-02-20,2019-07-19
2494,2099233,Shortage,GLUCOPHAGE,SANOFI-AVENTIS CANADA INC,Glucophage 500mg,METFORMIN HYDROCHLORIDE,500MG,100 and 500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-03-03,2017-03-17,2017-03-16,Other (Please describe in comments),2017-03-14,2017-03-20
89903,2300451,Shortage,GLUMETZA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,GLUMETZA,METFORMIN HYDROCHLORIDE,1000MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-07-12,,2019-08-12,Demand increase for the drug.,2019-07-24,2019-08-14
93535,2300451,Shortage,GLUMETZA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,GLUMETZA,METFORMIN HYDROCHLORIDE,1000MG,n/a,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-09-16,,,2019-09-16,Demand increase for the drug.,2019-09-10,2019-09-18
72084,1959352,Shortage,GLYBURIDE-2.5 TAB 2.5MG,PRO DOC LIMITEE,GLYBURIDE - 2.5,GLYBURIDE,2.5MG,500,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-01-14,,2019-05-23,Other (Please describe in comments),2019-01-14,2019-05-28
75174,799955,Shortage,GLYCINE 1.5% IRRIGATION USP SOL,BAXTER CORPORATION,Glycine Irrigation,GLYCINE,1.5G,3000 mL,IRRIGATION,Resolved,LIQUID,B05CX,IRRIGATING SOLUTIONS,2019-02-27,2019-02-27,2019-03-13,2019-03-13,Disruption of the manufacture of the drug.,2019-02-08,2019-03-14
98404,2382849,Shortage,GLYCOPYRROLATE INJECTION MULTIDOSE,OMEGA LABORATORIES LTD,Glycopyrrolate Injection Multidose,GLYCOPYRROLATE,0.2MG,1 x 20mL vial / fiole,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,A03AB,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,,2019-10-24,2019-12-31,,Disruption of the manufacture of the drug.,2019-11-11,2019-11-11
94397,2270404,Shortage,GONAL-F PEN,EMD SERONO A DIVISION OF EMD INC CANADA,Follitropin alfa,FOLLITROPIN ALFA,300UNIT,1 pre-filled pen / stylo prérempli,SUBCUTANEOUS,Resolved,SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2019-10-01,,2019-10-18,2019-10-09,Delay in shipping of the drug.,2019-09-19,2019-10-10
72073,2322765,Shortage,GRANISETRON HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LTD,Granisetron Hydrochloride Injection,GRANISETRON,1MG,10 x 1mL vial / fiole,INTRAVENOUS,Resolved,LIQUID,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-12-19,2019-02-13,2019-02-08,Disruption of the manufacture of the drug.,2019-01-14,2019-03-22
74445,2322765,Shortage,GRANISETRON HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LTD,Granisetron Hydrochloride Injection,GRANISETRON,1MG,1 x 4mL vial / fiole,INTRAVENOUS,Resolved,LIQUID,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-01-24,2019-02-13,2019-02-22,Disruption of the manufacture of the drug.,2019-02-04,2019-03-22
35112,2406411,Shortage,"HALOPERIDOL INJECTION, USP",FRESENIUS KABI CANADA LTD,HALOPERIDOL,HALOPERIDOL,5MG,1mL,INTRAMUSCULAR,Resolved,SOLUTION,N05AD,ANTIPSYCHOTICS,2018-01-08,,,2018-02-28,Disruption of the manufacture of the drug.,2018-01-08,2018-03-01
81836,2406411,Shortage,"HALOPERIDOL INJECTION, USP",FRESENIUS KABI CANADA LTD,Haloperidol,HALOPERIDOL,5MG,1 mL,INTRAMUSCULAR,Resolved,SOLUTION,N05AD,ANTIPSYCHOTICS,2019-04-23,,2019-06-24,2019-07-05,Disruption of the manufacture of the drug.,2019-04-16,2019-07-06
50916,2406411,Shortage,"HALOPERIDOL INJECTION, USP",FRESENIUS KABI CANADA LTD,HALOPERIDOL,HALOPERIDOL,5MG,1mL MD Vial,INTRAMUSCULAR,Resolved,SOLUTION,N05AD,ANTIPSYCHOTICS,2018-05-28,,,2018-08-02,Disruption of the manufacture of the drug.,2018-05-30,2018-08-10
62723,2130300,Shortage,HALOPERIDOL LA,SANDOZ CANADA INCORPORATED,HALOPERIDOL,HALOPERIDOL,100MG,5ML VIAL,INTRAMUSCULAR,Resolved,LIQUID,N05AD,ANTIPSYCHOTICS,,2017-09-17,,2017-09-29,Delay in shipping of the drug.,2018-09-30,2018-10-04
56881,2130300,Shortage,HALOPERIDOL LA,SANDOZ CANADA INCORPORATED,HALOPERIDOL,HALOPERIDOL,100MG,SINGLE 5ML VIAL,INTRAMUSCULAR,Resolved,LIQUID,N05AD,ANTIPSYCHOTICS,2018-10-05,2018-10-02,2018-12-19,2018-11-30,Requirements related to complying with good manufacturing practices.,2018-07-30,2018-12-17
70161,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (prefilled syringe / seringue préremplie),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-12-18,2019-02-04,2019-01-18,Demand increase for the drug.,2018-12-20,2019-01-19
44305,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (prefilled syringe / seringue préremplie),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-03-27,2018-12-31,2018-11-06,Demand increase for the drug.,2018-03-29,2018-11-08
44310,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (vial / fiole),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-04-11,2018-05-04,2018-05-01,Demand increase for the drug.,2018-03-29,2018-05-02
18724,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (prefilled syringe),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-08-08,2018-02-28,2018-02-23,Demand increase for the drug.,2017-08-10,2018-02-26
76695,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (prefilled syringe / seringue préremplie),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2019-02-14,2019-10-01,2019-08-02,Demand increase for the drug.,2019-02-22,2019-08-03
14833,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"Hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-07-05,2017-07-10,2017-07-10,Delay in shipping of the drug.,2017-07-06,2017-07-11
69619,2187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (vial / fiole),INTRAMUSCULAR,Actual shortage,SUSPENSION,J07BC,VIRAL VACCINES,,2018-12-10,,,Disruption of the manufacture of the drug.,2018-12-14,2019-10-18
18721,2231056,Shortage,HAVRIX 720 JUNIOR,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",720UNIT,1's (prefilled syringe),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-08-08,2018-02-28,2018-02-21,Delay in shipping of the drug.,2017-08-10,2018-02-22
45127,2231056,Shortage,HAVRIX 720 JUNIOR,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",720UNIT,1's (prefilled syringe / seringue préremplie),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-04-04,2019-01-04,2018-12-20,Demand increase for the drug.,2018-04-06,2018-12-21
75192,2231056,Shortage,HAVRIX 720 JUNIOR,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",720UNIT,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2019-02-06,2019-07-22,2019-07-04,Demand increase for the drug.,2019-02-08,2019-07-05
43754,2231056,Shortage,HAVRIX 720 JUNIOR,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",720UNIT,1's (prefilled syringe),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-03-19,2018-04-05,2018-03-23,Demand increase for the drug.,2018-03-23,2018-03-24
95570,828750,Shortage,HEPARIN SOD AND 0.9% SOD CHLORIDE INJ,BAXTER CORPORATION,HEPARIN SOD AND 0.9% SOD CHLORIDE INJ,SODIUM CHLORIDE  HEPARIN,9MG  2UNIT,500 mL (JB0953),INTRAVENOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-10-04,2019-10-04,2019-11-30,,Delay in shipping of the drug.,2019-10-04,2019-10-16
28221,2209713,Shortage,HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE  HEPARIN SODIUM,5G  4000UNIT,500mL,INTRAVENOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-11-09,,,Requirements related to complying with good manufacturing practices.,2017-11-06,2019-11-10
28224,2209713,Shortage,HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE  HEPARIN SODIUM,5G  4000UNIT,500mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2018-01-02,2018-01-02,,2019-02-28,Disruption of the manufacture of the drug.,2017-11-06,2019-03-18
98073,2209721,Shortage,HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE  HEPARIN SODIUM,5G  10000UNIT,250mL,INTRAVENOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-11-09,,,,Requirements related to complying with good manufacturing practices.,2019-11-06,2019-11-10
28235,2209721,Shortage,HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE  HEPARIN SODIUM,5G  10000UNIT,250mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2017-11-03,,2017-11-15,Requirements related to complying with good manufacturing practices.,2017-11-06,2017-11-15
32666,2209721,Shortage,HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ,B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,DEXTROSE  HEPARIN SODIUM,5G  10000UNIT,250mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2017-12-12,2017-12-12,,2019-02-28,Delay in shipping of the drug.,2017-12-12,2019-03-18
98220,1990748,Shortage,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION,PFIZER CANADA ULC,Heparin Sodium in Sodium Chloride Injection,HEPARIN SODIUM,2UNIT,18 x 500ml PLBG,INTRAVENOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-11-07,,,Demand increase for the drug.,2019-11-08,2019-11-08
98070,1935941,Shortage,"HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML",B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,CITRIC ACID  DEXTROSE  SODIUM PHOSPHATE DIBASIC  HEPARIN SODIUM,93MG  5G  410MG  5000UNIT,500mL,INTRAVENOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-11-09,,,,Requirements related to complying with good manufacturing practices.,2019-11-06,2019-11-10
28238,1935941,Shortage,"HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML",B. BRAUN MEDICAL INC,Heparin Sodium in Dextrose,CITRIC ACID  DEXTROSE  SODIUM PHOSPHATE DIBASIC  HEPARIN SODIUM,93MG  5G  410MG  5000UNIT,500mL,INTRAVENOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2018-01-02,2018-01-02,,2019-02-28,Disruption of the manufacture of the drug.,2017-11-06,2019-03-18
93960,2382326,Shortage,HEPARIN SODIUM INJECTION USP,PFIZER CANADA ULC,HEPARIN SODIUM INJECTION USP,HEPARIN SODIUM,10000UNIT,25 x 1mL GVL,INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-10-11,2019-11-22,,Disruption of the manufacture of the drug.,2019-09-16,2019-10-29
88607,2392453,Shortage,"HEPARIN SODIUM INJECTION, USP",FRESENIUS KABI CANADA LTD,Heparin Sodium,HEPARIN SODIUM,10000UNIT,0.5mL Vial,INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-07-05,2019-07-31,2019-07-31,Disruption of the manufacture of the drug.,2019-07-05,2019-08-02
91024,2392453,Shortage,"HEPARIN SODIUM INJECTION, USP",FRESENIUS KABI CANADA LTD,Heparin Sodium,HEPARIN SODIUM,10000UNIT,0.5mL,INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-08-07,2019-08-23,2019-08-23,Disruption of the manufacture of the drug.,2019-08-06,2019-08-24
93918,2392453,Shortage,"HEPARIN SODIUM INJECTION, USP",FRESENIUS KABI CANADA LTD,Heparin Sodium,HEPARIN SODIUM,10000UNIT,0.5mL,INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-09-13,,2019-10-01,2019-10-01,Disruption of the manufacture of the drug.,2019-09-13,2019-10-02
18727,2239194,Shortage,HEPTOVIR,GLAXOSMITHKLINE INC,lamivudine oral solution,LAMIVUDINE,5MG,240 mL,ORAL,Resolved,SOLUTION,J05AF,DIRECT ACTING ANTIVIRALS,,2017-08-02,2017-09-22,2017-09-12,Demand increase for the drug.,2017-08-10,2017-09-13
29521,2239200,Shortage,HIBERIX,GLAXOSMITHKLINE INC,Haemophilus influenzae type b (Hib) conjugate vaccine,HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE,10MCG,1's,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07AG,BACTERIAL VACCINES,,2017-11-16,2017-12-07,2017-12-04,Demand increase for the drug.,2017-11-17,2017-12-06
38,575186,Shortage,HISTANTIL TAB 50MG,PHARMASCIENCE INC,PROMETHAZINE HYDROCHLORIDE,PROMETHAZINE HYDROCHLORIDE,50MG,100 CAPS,ORAL,Resolved,TABLET,R06AD,ANTIHISTAMINES FOR SYSTEMIC USE,2017-01-10,2017-01-10,2018-05-03,2018-05-01,Disruption of the manufacture of the drug.,2017-03-10,2018-05-02
17360,2238525,Shortage,HP-PAC,TAKEDA PHARMACEUTICALS AMERICA INC,"Lansoprazole, Clarithromycin, Amoxicillin",AMOXICILLIN  LANSOPRAZOLE  CLARITHROMYCIN,500MG  30MG  500MG,HP-PAC 7-Day,ORAL,Resolved,KIT  CAPSULE  CAPSULE (SUSTAINED-RELEASE)  TABLET,A02BD,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-21,2017-10-13,2017-10-16,Requirements related to complying with good manufacturing practices.,2017-07-26,2017-10-17
32477,2238525,Shortage,HP-PAC,TAKEDA PHARMACEUTICALS AMERICA INC,"LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN",AMOXICILLIN  LANSOPRAZOLE  CLARITHROMYCIN,500MG  30MG  500MG,Blister pack,ORAL,Resolved,KIT  CAPSULE  CAPSULE (SUSTAINED-RELEASE)  TABLET,A02BD,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-05-07,,2018-06-25,Delay in shipping of the drug.,2017-12-11,2018-06-26
90891,465283,Shortage,HYDREA CAP 500MG,BRISTOL-MYERS SQUIBB CANADA,HYDROXYUREA,HYDROXYUREA,500MG,1X100,ORAL,Actual shortage,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,2019-09-05,2019-09-05,2019-11-29,,Delay in shipping of the drug.,2019-08-06,2019-09-06
32737,465283,Shortage,HYDREA CAP 500MG,BRISTOL-MYERS SQUIBB CANADA,Hydroxyurea,HYDROXYUREA,500MG,1BTL x 100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-02-26,,2018-04-18,Demand increase for the drug.,2017-12-13,2018-04-19
37624,465283,Shortage,HYDREA CAP 500MG,BRISTOL-MYERS SQUIBB CANADA,Hydroxyurea,HYDROXYUREA,500MG,1 BTL x 100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-01-24,2018-03-16,2018-02-09,Demand increase for the drug.,2018-01-30,2018-03-16
56848,341975,Shortage,HYDROCHLOROTHIAZIDE TAB 25MG,PRO DOC LIMITEE,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,25MG,1000,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2018-07-27,,2018-07-31,Delay in shipping of the drug.,2018-07-27,2018-08-01
1700,872520,Shortage,HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,HYDROCORTISONE SODIUM SUCCINATE,HYDROCORTISONE,100MG,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1703,872539,Shortage,HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,HYDROCORTISONE SODIUM SUCCINATE,HYDROCORTISONE,250MG,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1706,878618,Shortage,HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,HYDROCORTISONE SODIUM SUCCINATE,HYDROCORTISONE,500MG,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
13885,2145928,Shortage,HYDROMORPHONE HP 10,SANDOZ CANADA INCORPORATED,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,10MG,10 X 5ML VIALS,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,N02AA,OPIOIDS,2017-06-28,,2017-07-17,2017-06-30,Demand increase for the drug.,2017-06-26,2017-07-05
2616,2244797,Shortage,HYDROMORPHONE HP FORTE INJECTION,SANDOZ CANADA INCORPORATED,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,100MG,10ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,N02AA,OPIOIDS,,2017-03-14,2017-12-22,2017-11-17,Disruption of the manufacture of the drug.,2017-03-14,2017-11-28
60106,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,PFIZER CANADA INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,10MG,10 x 5mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,N02AA,OPIOIDS,,2018-09-06,,2018-09-19,Disruption of the manufacture of the drug.,2018-09-06,2018-09-20
97022,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,HYDROmorphone Hydrochloride Injection USP HP 10,HYDROMORPHONE HYDROCHLORIDE,10MG,50mL GVL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,N02AA,OPIOIDS,,2019-10-22,2020-03-31,,Disruption of the manufacture of the drug.,2019-10-22,2019-11-13
14734,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10,HOSPIRA HEALTHCARE CORPORATION,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,10MG,10X1ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,N02AA,OPIOIDS,,2017-11-08,,2017-12-29,Other (Please describe in comments),2017-07-05,2018-01-09
14737,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10,HOSPIRA HEALTHCARE CORPORATION,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,10MG,10X5ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Avoided shortage,SOLUTION,N02AA,OPIOIDS,2018-06-24,,,2017-12-21,Other (Please describe in comments),2017-07-05,2017-12-22
8426,2382636,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10,HOSPIRA HEALTHCARE CORPORATION,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,10MG,1x50mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,N02AA,OPIOIDS,,2017-05-24,,2017-12-29,Other (Please describe in comments),2017-04-28,2018-01-09
22273,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Hydroval Cream 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",2017-09-15,2017-09-15,2017-10-31,2017-11-02,Requirements related to complying with good manufacturing practices.,2017-09-18,2017-11-03
95559,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL CREAM 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-10-01,2019-10-11,2019-10-11,Disruption of the manufacture of the drug.,2019-10-04,2019-10-12
91242,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL CREAM 0.2%,HYDROCORTISONE VALERATE,0.2%,500 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-07-18,2019-10-18,2019-10-11,Disruption of the manufacture of the drug.,2019-08-09,2019-10-12
7298,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDRO VAL 0.2%,HYDROCORTISONE VALERATE,0.2%,45 gram,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2017-04-11,2017-09-01,2017-09-01,Disruption of the manufacture of the drug.,2017-04-19,2017-09-08
7302,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDRO VAL 0.2%,HYDROCORTISONE VALERATE,0.2%,15 gram,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",2017-04-29,,2017-05-08,2017-05-08,Disruption of the manufacture of the drug.,2017-04-19,2017-06-06
93323,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL CREAM 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-09-04,2019-09-27,2019-10-11,Disruption of the manufacture of the drug.,2019-09-09,2019-10-12
24212,2242984,Shortage,HYDROVAL CREAM 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Hydroval Cream 0.2%,HYDROCORTISONE VALERATE,0.2%,500 g,TOPICAL,Resolved,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",,2018-06-15,2018-07-06,2018-08-02,Disruption of the manufacture of the drug.,2017-10-03,2018-08-03
22276,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Hydroval Ointment 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",,2018-06-15,2018-07-06,2018-08-02,Disruption of the manufacture of the drug.,2017-09-18,2018-08-03
95556,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL OINTMENT 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-09-04,2019-10-18,2019-10-11,Disruption of the manufacture of the drug.,2019-10-04,2019-10-12
34391,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Taro Pharmaceuticals Hydroval Ointment,HYDROCORTISONE VALERATE,0.2%,15 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",2017-12-27,2017-12-27,2018-02-06,2018-02-06,Disruption of the manufacture of the drug.,2017-12-27,2018-02-07
85388,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL OINTMENT 0.2%,HYDROCORTISONE VALERATE,0.2%,15 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-05-27,2019-06-14,2019-06-03,Disruption of the manufacture of the drug.,2019-05-31,2019-06-17
88753,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL OINTMENT 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-07-02,2019-07-31,2019-07-23,Disruption of the manufacture of the drug.,2019-07-05,2019-08-06
82611,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL OINTMENT 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Resolved,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-04-16,2019-05-10,2019-05-10,Disruption of the manufacture of the drug.,2019-04-29,2019-05-13
97755,2242985,Shortage,HYDROVAL OINTMENT 0.2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",HYDROVAL OINTMENT 0.2%,HYDROCORTISONE VALERATE,0.2%,60 g,TOPICAL,Actual shortage,OINTMENT,D07AA,"CORTICOSTEROIDS, PLAIN",,2019-10-22,2019-12-06,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-08
82756,646016,Shortage,HYDROXYZINE,AA PHARMA INC,Hydoxyzine,HYDROXYZINE HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,,2019-04-29,2019-05-27,2019-05-27,Disruption of the manufacture of the drug.,2019-04-29,2019-08-22
98246,646016,Shortage,HYDROXYZINE,AA PHARMA INC,Hydroxyzine,HYDROXYZINE HYDROCHLORIDE,50MG,100BTL,ORAL,Actual shortage,CAPSULE,N05BB,ANXIOLYTICS,,2019-11-08,,,Disruption of the manufacture of the drug.,2019-11-08,2019-11-09
84183,646059,Shortage,HYDROXYZINE,AA PHARMA INC,Hydoxyzine,HYDROXYZINE HYDROCHLORIDE,10MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,,2019-05-15,2019-05-27,2019-06-04,Disruption of the manufacture of the drug.,2019-05-15,2019-06-05
84186,646024,Shortage,HYDROXYZINE,AA PHARMA INC,Hydoxyzine,HYDROXYZINE HYDROCHLORIDE,25MG,100 BTL,ORAL,Resolved,CAPSULE,N05BB,ANXIOLYTICS,,2019-05-15,2019-05-27,2019-06-04,Disruption of the manufacture of the drug.,2019-05-15,2019-06-05
78719,2275864,Shortage,HYPURIN NPH INSULIN ISOPHANE PORK,WOCKHARDT UK LTD,Insulin Porcine NPH,INSULIN ISOPHANE INJECTION PORK,100UNIT,1,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SUSPENSION,A10AC,INSULINS AND ANALOGUES,2019-05-01,,,2019-05-17,Delay in shipping of the drug.,2019-03-15,2019-05-18
83818,2297841,Shortage,HYZAAR,MERCK CANADA INC,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-05-28,2019-05-28,2019-06-07,2019-06-07,Demand increase for the drug.,2019-05-10,2019-06-08
71163,2297841,Shortage,HYZAAR,MERCK CANADA INC,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,Pack of 30 tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-02-11,2019-02-05,2019-04-19,2019-04-15,Requirements related to complying with good manufacturing practices.,2019-01-04,2019-04-16
94556,2230047,Shortage,HYZAAR 50/12.5MG,MERCK CANADA INC,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30TAB,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-09-23,2019-09-23,2019-10-10,2019-10-10,Demand increase for the drug.,2019-09-23,2019-10-11
97943,2230047,Shortage,HYZAAR 50/12.5MG,MERCK CANADA INC,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30TAB,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-11-05,2019-11-05,2019-12-13,,Demand increase for the drug.,2019-11-05,2019-11-06
71160,2230047,Shortage,HYZAAR 50/12.5MG,MERCK CANADA INC,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,Pack of 30 tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-01-23,2019-01-23,2019-04-19,2019-04-15,Requirements related to complying with good manufacturing practices.,2019-01-04,2019-04-16
76149,2241007,Shortage,HYZAAR DS 100/25 MG,MERCK CANADA INC,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,pack of 30 tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-03-08,2019-03-05,2019-04-19,2019-04-15,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-04-16
97215,2241007,Shortage,HYZAAR DS 100/25 MG,MERCK CANADA INC,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30TAB,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-10-24,2019-10-24,2019-10-31,2019-10-29,Demand increase for the drug.,2019-10-24,2019-10-30
78461,2439689,Shortage,IBUPROFEN,APOTEX INC,IBUPROFEN,IBUPROFEN,200MG,100 BTL,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-03-11,2019-08-28,2019-08-27,Disruption of the manufacture of the drug.,2019-03-13,2019-08-28
12803,2014793,Shortage,IC-GREEN,AKORN INC,indocyanine green,INDOCYANINE GREEN,25MG,6 vials with 6 vials of diluent,INTRAVENOUS,Resolved,POWDER,V04,OTHER DIAGNOSTIC AGENTS,2017-06-08,2017-06-08,2017-09-04,2017-08-31,Disruption of the manufacture of the drug.,2017-06-15,2017-09-01
27651,2014793,Shortage,IC-GREEN,AKORN INC,indocyanine green,INDOCYANINE GREEN,25MG,6 vials with 6 vials of diluent,INTRAVENOUS,Resolved,POWDER,V04CX,OTHER DIAGNOSTIC AGENTS,2017-11-01,2017-11-06,2018-02-08,2018-02-05,Disruption of the manufacture of the drug.,2017-11-01,2018-02-08
40066,2014793,Shortage,IC-GREEN,AKORN INC,indocyanine green,INDOCYANINE GREEN,25MG,6 vials,INTRAVENOUS,Resolved,POWDER,V04CX,OTHER DIAGNOSTIC AGENTS,2018-02-16,2018-02-16,,2018-03-21,Other (Please describe in comments),2018-02-16,2018-03-22
49339,2014793,Shortage,IC-GREEN,AKORN INC,indocyanine green,INDOCYANINE GREEN,25MG,6 x 25mg/vial,INTRAVENOUS,Resolved,POWDER,V04CX,OTHER DIAGNOSTIC AGENTS,2018-05-18,2018-05-15,2019-02-25,2019-02-25,Disruption of the manufacture of the drug.,2018-05-15,2019-02-27
11683,2241357,Shortage,IFEX (IFOSFAMIDE) 1 G/VIAL,BAXTER CORPORATION,IFOSFAMIDE,IFOSFAMIDE,1G,1g Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01AA,ALKYLATINGAGENTS,2017-06-01,,2017-06-12,2017-06-12,Demand increase for the drug.,2017-06-01,2017-08-28
20433,2241357,Shortage,IFEX (IFOSFAMIDE) 1 G/VIAL,BAXTER CORPORATION,IFEX,IFOSFAMIDE,1G,1g Vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01AA,ALKYLATINGAGENTS,2017-08-28,2017-08-28,2017-11-06,2017-10-05,Demand increase for the drug.,2017-08-28,2017-10-06
72133,2241356,Shortage,IFEX (IFOSFAMIDE) 3 G/VIAL,BAXTER CORPORATION,Ifex,IFOSFAMIDE,3G,3g,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01AA,ALKYLATINGAGENTS,2019-01-14,2019-01-14,2019-02-04,2019-02-04,Demand increase for the drug.,2019-01-14,2019-02-05
58947,2411393,Shortage,ILEVRO,NOVARTIS PHARMACEUTICALS CANADA INC,ILEVRO 0.3% SUSP 3M,NEPAFENAC,0.3%,3ML,OPHTHALMIC,Resolved,SUSPENSION,S01BC,ANTIINFLAMMATORY AGENTS,,2018-08-16,2018-12-14,2018-12-12,Delay in shipping of the drug.,2018-08-24,2018-12-13
26411,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-10-19,2017-10-19,2018-02-08,2018-02-21,Demand increase for the drug.,2017-10-20,2018-02-22
26414,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-10-19,2017-10-19,2017-12-15,2017-12-08,Demand increase for the drug.,2017-10-20,2017-12-09
21890,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-08-18,2017-08-18,2017-10-02,2017-10-06,Demand increase for the drug.,2017-09-12,2017-10-08
21895,2126559,Shortage,IMDUR - EXTENDED RELEASE TABLETS 60 MG,ASTRAZENECA CANADA INC,isosorbide-5-mononitrate extended release tablets,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-07-28,2017-07-28,2017-10-09,2017-10-06,Demand increase for the drug.,2017-09-12,2017-10-08
2148,2357437,Shortage,IMIPENEM AND CILASTATIN FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,Imipenem and Cilastatin,CILASTATIN  IMIPENEM,500MG  500MG,500mg x 10,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DH,OTHER BETA-LACTAM ANTIBACTERIALS,,2016-04-02,,2018-08-14,Other (Please describe in comments),2017-03-14,2018-08-15
4140,326852,Shortage,IMIPRAMINE,AA PHARMA INC,IMIPRAMINE,IMIPRAMINE HYDROCHLORIDE,50MG,1000 BOTTLE,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-05-27,,2016-05-27,Disruption of the manufacture of the drug.,2017-03-24,2017-03-28
74251,2212188,Shortage,IMITREX,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2x0.5mL,SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-02-27,2019-03-14,2019-03-04,Demand increase for the drug.,2019-02-01,2019-03-05
41523,2212188,Shortage,IMITREX,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2x0.5mL (Refill pack/L’emballage de recharge),SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-03-07,2018-06-05,2018-05-30,Shortage of an active ingredient.,2018-03-02,2018-05-31
11250,2212161,Shortage,IMITREX DF - TAB 100MG,GLAXOSMITHKLINE INC,Sumatriptan succinate tablets,SUMATRIPTAN,100MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-01-11,2018-07-06,2018-06-21,Shortage of an active ingredient.,2017-05-25,2018-06-22
11245,2212153,Shortage,IMITREX DF - TAB 50MG,GLAXOSMITHKLINE INC,Sumatriptan succinate tablets,SUMATRIPTAN,50MG,6's,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-09-20,2018-06-07,2018-06-06,Shortage of an active ingredient.,2017-05-25,2018-06-08
3259,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2's,SUBCUTANEOUS,Avoided shortage,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,2017-03-27,,,2017-03-23,Disruption of the manufacture of the drug.,2017-03-17,2017-03-29
11234,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,5x0.5mL,SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-06-26,2018-06-29,2018-06-26,Shortage of an active ingredient.,2017-05-25,2018-06-27
11237,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2x0.5mL,SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-06-12,2018-03-23,2018-03-15,Shortage of an active ingredient.,2017-05-25,2018-03-16
11253,2212188,Shortage,IMITREX INJECTION 12MG/ML,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,12MG,2x0.5mL (Refill pack/L’emballage de recharge),SUBCUTANEOUS,Resolved,LIQUID,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-06-29,2018-02-28,2018-02-07,Shortage of an active ingredient.,2017-05-25,2018-02-08
65623,2230418,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,5MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-10-22,2018-11-02,2018-10-30,Disruption of the manufacture of the drug.,2018-10-26,2018-10-31
42337,2230420,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,20MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-04-10,2018-05-04,2018-04-26,Shortage of an active ingredient.,2018-03-09,2018-04-27
12156,2230420,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,20MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-08-09,2018-02-28,2018-02-22,Shortage of an active ingredient.,2017-06-06,2018-02-23
82069,2230420,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,sumatriptan nasal spray,SUMATRIPTAN,20MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-04-23,2019-05-20,2019-05-15,Delay in shipping of the drug.,2019-04-18,2019-05-17
5841,2230420,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,20MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-05-16,2017-05-26,2017-05-25,Disruption of the manufacture of the drug.,2017-04-06,2017-05-26
10741,2230418,Shortage,IMITREX NASAL SPRAY,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,5MG,2's,NASAL,Resolved,SPRAY,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-06-12,2018-02-09,2018-02-07,Shortage of an active ingredient.,2017-05-19,2018-02-08
91440,2237328,Shortage,IMOGAM RABIES PASTEURIZED,SANOFI PASTEUR LIMITED,"Rabies Immune Globulin, Pasteurized (Human)",RABIES IMMUNOGLOBULIN,150UNIT,2 mL vial (2 Doses),INTRAMUSCULAR,Actual shortage,SOLUTION,J06BB,IMMUNOGLOBULINS,2019-07-22,2019-07-22,2019-09-30,,Delay in shipping of the drug.,2019-08-12,2019-08-12
48113,2237328,Shortage,IMOGAM RABIES PASTEURIZED,SANOFI PASTEUR LIMITED,"Rabies Immune Globulin, Pasteurized (Human)",RABIES IMMUNE GLOBULIN HUMAN,150UNIT,2 mL vial (2 Doses),INTRAMUSCULAR,Resolved,SOLUTION,J06BB,IMMUNOGLOBULINS,2018-05-01,2018-05-01,2018-05-15,2018-05-16,Other (Please describe in comments),2018-05-02,2018-05-19
45394,2216167,Shortage,IMOVANE,SANOFI-AVENTIS CANADA INC,IMOVANE 5MG TB BTX100,ZOPICLONE,5.0MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-04-27,2018-04-27,2019-03-08,2019-03-07,Delay in shipping of the drug.,2018-04-10,2019-03-08
68864,1926799,Shortage,IMOVANE 7.5 - TAB 7.5MG,SANOFI-AVENTIS CANADA INC,Imovane 7.5 mg,ZOPICLONE,7.5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-12-25,,2019-02-01,2019-02-01,Other (Please describe in comments),2018-12-06,2019-02-15
31856,1959042,Shortage,IMOVAX POLIO,SANOFI PASTEUR LIMITED,Inactivated Poliomyelitis Vaccine (Vero Cell Origin),INACTIVATED POLIOMYELITIS VACCINE  INACTIVATED POLIOMYELITIS VACCINE  INACTIVATED POLIOMYELITIS VACCINE,32UNIT  8UNIT  40UNIT,1 x 0.5 mL (single dose) syringe,SUBCUTANEOUS,Resolved,SUSPENSION,J07BF,VIRAL VACCINES,2017-11-28,2017-11-28,2018-02-01,2018-02-01,Requirements related to complying with good manufacturing practices.,2017-12-06,2018-04-26
78756,1959042,Shortage,IMOVAX POLIO,SANOFI PASTEUR LIMITED,Inactivated Poliomyelitis Vaccine (Vero Cell Origin),INACTIVATED POLIOMYELITIS VACCINE  INACTIVATED POLIOMYELITIS VACCINE  INACTIVATED POLIOMYELITIS VACCINE,32UNIT  8UNIT  40UNIT,1 x 0.5 mL (single dose) syringe,SUBCUTANEOUS,Resolved,SUSPENSION,J07BF,VIRAL VACCINES,2019-03-14,2019-03-14,2019-03-25,2019-03-22,Disruption of the manufacture of the drug.,2019-03-15,2019-04-01
47673,1908286,Shortage,IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO),SANOFI PASTEUR LIMITED,Rabies Vaccine Inactivated (DCO),RABIES VACCINE INACTIVATED,2.5UNIT,1.0 mL single dose vial with 1 mL diluent,INTRAMUSCULAR,Actual shortage,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,2018-04-26,2018-04-26,2019-11-30,,Disruption of the manufacture of the drug.,2018-05-01,2019-07-22
3035,1908286,Shortage,IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO),SANOFI PASTEUR LIMITED,Rabies Vaccine Inactivated (DCO),RABIES VACCINE INACTIVATED,2.5UNIT,"1.0 mL single dose vial with 1 mL diluent / Fiole de 1,0 mL à dose unique avec 1 mL de diluant",INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,2017-11-22,2017-11-22,2017-12-15,2017-12-01,Requirements related to complying with good manufacturing practices.,2017-03-16,2017-12-02
46635,4596,Shortage,IMURAN,ASPEN PHARMACARE CANADA INC.,Imuran Tablet,AZATHIOPRINE,50MG,100 tablets,ORAL,Resolved,TABLET,L04AX,IMMUNOSUPPRESSANTS,,2018-04-20,2018-06-11,2018-06-01,Delay in shipping of the drug.,2018-04-20,2018-06-02
76337,2423596,Shortage,INCRUSE ELLIPTA,GLAXOSMITHKLINE INC,umeclidinium (as bromide) dry powder for oral inhalation,Umeclidinium,62.5MCG,1x7,INHALATION,Resolved,POWDER,R03BB,,,2019-02-14,2019-03-05,2019-03-01,Delay in shipping of the drug.,2019-02-19,2019-03-02
84515,2398869,Shortage,INDAYO,MYLAN PHARMACEUTICALS ULC,ETHINYL ESTRADIOL LEVONORGESTREL,ETHINYL ESTRADIOL  LEVONORGESTREL,0.03MG  0.15MG,91BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-05-21,,,2019-06-18,Requirements related to complying with good manufacturing practices.,2019-05-22,2019-06-19
95097,2398869,Shortage,INDAYO,MYLAN PHARMACEUTICALS ULC,ETHINYL ESTRADIOL LEVONORGESTREL,ETHINYL ESTRADIOL  LEVONORGESTREL,0.03MG  0.15MG,91BL,ORAL,Actual shortage,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-10-01,2019-11-30,,Delay in shipping of the drug.,2019-10-01,2019-10-02
94099,2398869,Shortage,INDAYO,MYLAN PHARMACEUTICALS ULC,ETHINYL ESTRADIOL LEVONORGESTREL,ETHINYL ESTRADIOL  LEVONORGESTREL,0.03MG  0.15MG,91BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-09-18,,2019-09-27,2019-09-25,Delay in shipping of the drug.,2019-09-17,2019-09-26
27093,2398869,Shortage,INDAYO,MYLAN PHARMACEUTICALS ULC,INDAYO,ETHINYL ESTRADIOL  LEVONORGESTREL,0.03MG  0.15MG,91BL,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-05-11,2018-05-14,2018-08-23,2018-08-22,Delay in shipping of the drug.,2017-10-26,2018-08-23
36373,2042231,Shortage,INDERAL-LA,PFIZER CANADA INC,INDERAL LA,PROPRANOLOL HYDROCHLORIDE,60MG,1x100 CAPS,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),C07AA,BETA BLOCKING AGENTS,,2018-01-15,,2018-02-07,Disruption of the manufacture of the drug.,2018-01-17,2018-02-08
36376,2042258,Shortage,INDERAL-LA,PFIZER CANADA INC,INDERAL LA,PROPRANOLOL HYDROCHLORIDE,80MG,1x100 CAPS,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),C07AA,BETA BLOCKING AGENTS,,2018-01-15,,2018-02-07,Disruption of the manufacture of the drug.,2018-01-17,2018-02-08
36379,2042266,Shortage,INDERAL-LA,PFIZER CANADA INC,INDERAL LA,PROPRANOLOL HYDROCHLORIDE,120MG,1x100 CAPS,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),C07AA,BETA BLOCKING AGENTS,,2018-01-15,,2018-02-07,Disruption of the manufacture of the drug.,2018-01-17,2018-02-08
36382,2042274,Shortage,INDERAL-LA,PFIZER CANADA INC,INDERAL LA,PROPRANOLOL HYDROCHLORIDE,160MG,1x100 CAPS,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),C07AA,BETA BLOCKING AGENTS,,2018-01-15,,2018-02-07,Disruption of the manufacture of the drug.,2018-01-17,2018-02-08
67581,1911473,Shortage,INHIBACE,HOFFMANN-LA ROCHE LIMITED,CLIAZAPRIL MONOHYDRATE,CILAZAPRIL,2.5MG,Blister pack of 28 tablets,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-11-26,2018-11-26,,,Other (Please describe in comments),2018-11-26,2019-02-19
92957,2229755,Shortage,INNOHEP,LEO PHARMA INC,Tinzaparin Sodium,TINZAPARIN SODIUM,10000UNIT,10 x 0.25 mL,SUBCUTANEOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-09-04,2019-09-04,2020-03-02,,Disruption of the manufacture of the drug.,2019-09-04,2019-11-12
71751,2231478,Shortage,INNOHEP,LEO PHARMA INC,Tinzaparin Sodium,TINZAPARIN SODIUM,20000UNIT,10 x 0.5mL,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-01-09,2019-01-09,2019-01-25,2019-01-24,Delay in shipping of the drug.,2019-01-09,2019-01-25
89701,2231478,Shortage,INNOHEP,LEO PHARMA INC,Tinzaparin Sodium,TINZAPARIN SODIUM,20000UNIT,10 x 0.5mL syringe,SUBCUTANEOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-07-19,,2020-01-15,,Disruption of the manufacture of the drug.,2019-07-19,2019-11-15
88437,2167840,Shortage,INNOHEP,LEO PHARMA INC,tinzaparin sodium,TINZAPARIN SODIUM,10000UNIT,10 x 2mL vials,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-07-04,2019-07-04,2019-08-30,2019-09-10,Disruption of the manufacture of the drug.,2019-07-04,2019-09-11
88440,2358174,Shortage,INNOHEP,LEO PHARMA INC,Tinzaparin sodium,TINZAPARIN SODIUM,20000UNIT,10 x 0.7mL syringe,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-07-04,2019-07-04,,2019-10-24,Disruption of the manufacture of the drug.,2019-07-04,2019-10-24
83094,2429462,Shortage,INNOHEP,LEO PHARMA INC,tinzaparin sodium,TINZAPARIN SODIUM,8000UNIT,10 x 0.4mL,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-05-02,,2019-11-08,Disruption of the manufacture of the drug.,2019-05-03,2019-11-09
71592,2229755,Shortage,INNOHEP,LEO PHARMA INC,Tinzaparin Sodium,TINZAPARIN SODIUM,10000UNIT,10 x 0.25mL,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-01-08,2019-01-08,2019-02-14,2019-02-14,Disruption of the manufacture of the drug.,2019-01-08,2019-02-15
71595,2358166,Shortage,INNOHEP,LEO PHARMA INC,Tinzaparin Sodium,TINZAPARIN SODIUM,10000UNIT,10 x 0.45mL,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-01-11,2019-01-11,2019-02-28,2019-02-26,Disruption of the manufacture of the drug.,2019-01-08,2019-02-26
84143,2358158,Shortage,INNOHEP,LEO PHARMA INC,tinzaparin sodium,TINZAPARIN SODIUM,10000UNIT,10 x 0.35 mL,SUBCUTANEOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-05-15,2020-03-02,,Disruption of the manufacture of the drug.,2019-05-15,2019-11-12
84177,2429489,Shortage,INNOHEP,LEO PHARMA INC,Tinzaparin sodium,TINZAPARIN SODIUM,16000UNIT,10 x 0.8mL,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-05-15,,2019-05-15,Disruption of the manufacture of the drug.,2019-05-15,2019-05-21
79586,2231478,Shortage,INNOHEP,LEO PHARMA INC,tinzaparin sodium,TINZAPARIN SODIUM,20000UNIT,10 x 0.5mL,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-03-27,2019-03-27,2019-05-15,2019-04-25,Disruption of the manufacture of the drug.,2019-03-27,2019-04-26
98537,2358182,Shortage,INNOHEP,LEO PHARMA INC,tinzaparin sodium,TINZAPARIN SODIUM,20000UNIT,10 x 0.9mL,SUBCUTANEOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-11-12,2019-12-02,,Disruption of the manufacture of the drug.,2019-11-12,2019-11-13
83435,2358166,Shortage,INNOHEP,LEO PHARMA INC,tinzaparin sodium,TINZAPARIN SODIUM,10000UNIT,10 x 0.45mL,SUBCUTANEOUS,Actual shortage,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-05-07,2020-03-02,,Disruption of the manufacture of the drug.,2019-05-08,2019-11-12
16559,2323052,Shortage,INSPRA,PFIZER CANADA INC,Inspra,EPLERENONE,25MG,3 x 10 TABS,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,2017-07-20,,2017-08-10,2017-08-10,Disruption of the manufacture of the drug.,2017-07-20,2017-08-11
42162,2323060,Shortage,INSPRA,PFIZER CANADA INC,Inspra,EPLERENONE,50MG,3 x 10 tabs,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,2018-03-30,,,2018-04-17,Demand increase for the drug.,2018-03-07,2018-04-18
50675,2323060,Shortage,INSPRA,PFIZER CANADA INC,INSPRA,EPLERENONE,50MG,3 x 10 TABS,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2018-07-09,,2018-07-19,Disruption of the manufacture of the drug.,2018-05-29,2018-07-20
27636,2323052,Shortage,INSPRA,PFIZER CANADA INC,INSPRA,EPLERENONE,25MG,3x10 Tabs,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017-12-15,,2018-04-16,Disruption of the manufacture of the drug.,2017-11-01,2018-04-17
5429,2294990,Shortage,INSTILLAGEL,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,INSTILLAGEL LIDO2%CHLORHEX 0.05%10X11mL,LIDOCAINE HYDROCHLORIDE  CHLORHEXIDINE GLUCONATE,2%  0.05%,10x11mL,TOPICAL,Resolved,GEL,N01BB,"ANESTHETICS, LOCAL",2017-06-14,2017-06-15,2017-07-24,2017-07-17,Disruption of the manufacture of the drug.,2017-04-04,2017-07-18
14814,2294990,Shortage,INSTILLAGEL,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,INSTILLAGEL LIDO2% CHLORHEX 0.05%,LIDOCAINE HYDROCHLORIDE  CHLORHEXIDINE GLUCONATE,2%  0.05%,10X6mL,TOPICAL,Resolved,GEL,N01BB,"ANESTHETICS, LOCAL",2017-07-17,2017-07-10,2017-07-18,2017-07-17,Disruption of the manufacture of the drug.,2017-07-06,2017-07-18
90224,2240352,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,2MG,20MG/10ML VIAL,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2019-08-12,2019-08-12,2019-09-27,2019-09-25,Delay in shipping of the drug.,2019-07-30,2019-09-26
16762,2240351,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,0.75MG,100ML VIAL,INTRAVENOUS,Avoided shortage,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017-08-21,,2017-08-31,2017-08-14,Delay in shipping of the drug.,2017-07-24,2017-08-14
2210,2240351,Shortage,INTEGRILIN,MERCK CANADA INC,eptifibatide injection Solution for Intravenous Infusion,EPTIFIBATIDE,"0,75 mg/mL",75 mg/100 mL infusion vial - Fiole de 75 mg/100 mL pour perfusion,Intravenous,Resolved,Solution,B01AC,ANTITHROMBOTIC AGENTS,2016-06-27,2016-06-27,2017-04-14,2017-04-10,Delay in shipping of the drug.,2017-03-14,2017-04-11
9382,2240352,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,2MG,20MG/10ML vial,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017-07-05,2017-08-11,2017-08-09,Delay in shipping of the drug.,2017-05-08,2017-08-10
56238,2240351,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,0.75MG,100ml,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2018-07-30,2018-07-27,2018-08-24,2018-08-16,Demand increase for the drug.,2018-07-23,2018-08-17
51168,2240352,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,2MG,20MG/10ML BOLUS VIAL,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2018-06-04,2018-06-04,2018-07-06,2018-07-03,Demand increase for the drug.,2018-06-04,2018-07-04
51171,2240351,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,0.75MG,75MG/100ML INFUSION VIAL,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2018-06-04,2018-07-13,2018-07-13,Demand increase for the drug.,2018-06-04,2018-07-14
58622,2240352,Shortage,INTEGRILIN,MERCK CANADA INC,Eptifibatide Injection,EPTIFIBATIDE,2MG,10ML,INTRAVENOUS,Avoided shortage,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2018-09-25,,2018-09-28,2018-09-24,Demand increase for the drug.,2018-08-21,2018-09-24
86790,2238674,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,6000000UNIT,1X18MIU,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L03AB,IMMUNOSTIMULANTS,,2019-06-18,2019-08-12,2019-08-09,Demand increase for the drug.,2019-06-18,2019-08-10
67593,2223406,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b  lyophilized powder,WATER  INTERFERON ALFA-2B,1ML  10000000UNIT,1 vial,INTRALESIONAL  INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID  POWDER FOR SOLUTION,L03AB,IMMUNOSTIMULANTS,2019-01-02,2019-01-03,2019-02-01,2019-01-31,Delay in shipping of the drug.,2018-11-26,2019-02-01
40971,2240693,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,15000000UNIT,18MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-02-26,2018-02-26,2018-03-05,2018-03-02,Delay in shipping of the drug.,2018-02-26,2018-03-05
34576,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,25000000UNIT,30MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-01-02,2018-01-02,2018-01-12,2018-01-09,Delay in shipping of the drug.,2018-01-02,2018-01-10
34585,2240693,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,15000000UNIT,18MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-01-05,2018-01-05,2018-02-19,2018-02-12,Delay in shipping of the drug.,2018-01-02,2018-02-13
67363,2238674,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,6000000UNIT,1 vial,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L03AB,IMMUNOSTIMULANTS,2018-11-21,2018-11-21,2018-12-05,2018-12-03,Delay in shipping of the drug.,2018-11-21,2018-12-04
41767,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,25000000UNIT,30MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-03-12,2018-03-13,2018-03-16,2018-03-15,Delay in shipping of the drug.,2018-03-05,2018-03-16
18477,2223406,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b  lyophilized powder,WATER  INTERFERON ALFA-2B,1ML  10000000UNIT,1X10MIU PWDER & DIL VIAL,INTRALESIONAL  INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID  POWDER FOR SOLUTION,L03AB,IMMUNOSTIMULANTS,,2017-08-04,2017-08-25,2017-08-22,Demand increase for the drug.,2017-08-08,2017-08-23
8757,2223406,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b  lyophilized powder,WATER  INTERFERON ALFA-2B,1ML  10000000UNIT,1X10 MIU,INTRALESIONAL  INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID  POWDER FOR SOLUTION,L03AB,IMMUNOSTIMULANTS,2017-05-03,2017-05-03,2017-07-21,2017-07-14,Demand increase for the drug.,2017-05-03,2017-07-15
53053,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,25000000UNIT,30MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-08-06,2018-08-01,2018-08-17,2018-08-13,Delay in shipping of the drug.,2018-06-27,2018-08-14
48976,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,25000000UNIT,30MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-05-10,2018-05-10,2018-05-25,2018-05-25,Requirements related to complying with good manufacturing practices.,2018-05-10,2018-05-26
48979,2240695,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,50000000UNIT,60MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-05-10,2018-05-10,2018-05-25,2018-05-25,Requirements related to complying with good manufacturing practices.,2018-05-10,2018-05-26
20821,2240695,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,50000000UNIT,60MIU PEN,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017-10-02,2017-10-02,2017-12-04,2017-12-01,Delay in shipping of the drug.,2017-09-01,2017-12-02
48985,2240693,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,15000000UNIT,18MIU,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-05-10,2018-05-10,2018-06-08,2018-06-05,Requirements related to complying with good manufacturing practices.,2018-05-10,2018-06-06
11883,2238675,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,10000000UNIT,1X10MIU HSA FREE VIAL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L03AB,IMMUNOSTIMULANTS,,2017-07-11,2017-08-04,2017-08-04,Delay in shipping of the drug.,2017-06-05,2017-08-05
2168,2240694,Shortage,INTRON A,MERCK CANADA INC,INTERFERON ALFA-2b solution for injection,INTERFERON ALFA-2B,25000000UNIT,1.2 mL - 30 x 10 6 IU/pen - 30 x 10 6 UI/stylo,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017-02-13,2017-02-13,2017-03-17,2017-03-20,Delay in shipping of the drug.,2017-03-14,2017-03-21
6265,2240693,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,15000000UNIT,18 MIU Pen,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017-05-01,2017-05-02,2017-07-31,2017-07-19,Demand increase for the drug.,2017-04-10,2017-07-20
6269,2240695,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,50000000UNIT,60 MIU pen,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017-05-01,2017-04-24,2017-06-16,2017-06-16,Delay in shipping of the drug.,2017-04-10,2017-06-17
18059,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,25000000UNIT,1X25MIU HSA FREE VIAL,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,,2017-07-11,2017-08-04,2017-08-04,Delay in shipping of the drug.,2017-08-02,2017-08-05
2194,2240695,Shortage,INTRON A,MERCK CANADA INC,INTERFERON ALFA-2b solution pour injection,INTERFERON ALFA-2B,50000000UNIT,1.2 mL - 60 x 10 6 IU/pen - 60 x 10 6 UI/stylo,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017-02-09,2017-03-09,2017-03-17,2017-03-20,Delay in shipping of the drug.,2017-03-14,2017-03-21
26524,2240694,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,25000000UNIT,30MIU PEN,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2017-10-23,2017-10-23,2017-11-24,2017-11-17,Delay in shipping of the drug.,2017-10-23,2017-11-18
15541,2238675,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,10000000UNIT,1X10MIU HSA FREE VIAL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Avoided shortage,SOLUTION,L03AB,IMMUNOSTIMULANTS,2017-08-03,,2017-08-04,2017-08-02,Delay in shipping of the drug.,2017-07-12,2017-10-10
40150,2240695,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,50000000UNIT,60MIU PEN,SUBCUTANEOUS,Resolved,LIQUID,L03AB,IMMUNOSTIMULANTS,2018-02-19,2018-02-20,2018-03-29,2018-03-29,Delay in shipping of the drug.,2018-02-19,2018-03-30
18925,2240693,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection (multi-dose pen),INTERFERON ALFA-2B,15000000UNIT,18MIU PEN,SUBCUTANEOUS,Avoided shortage,LIQUID,L03AB,IMMUNOSTIMULANTS,2017-09-07,,2017-09-18,2017-09-06,Demand increase for the drug.,2017-08-12,2017-10-11
19449,2238675,Shortage,INTRON A,MERCK CANADA INC,interferon alfa-2b solution for injection,INTERFERON ALFA-2B,10000000UNIT,1X25MIU HSA FREE VIAL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L03AB,IMMUNOSTIMULANTS,,2017-08-14,2017-09-15,2017-09-12,Demand increase for the drug.,2017-08-15,2017-09-13
91467,2409135,Shortage,INTUNIV XR,SHIRE PHARMA CANADA ULC,guanfacine hydrochloride extended-release tablets,Guanfacine,4MG,100 Tablets / Bottle,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",2019-08-13,,2019-09-30,2019-09-26,Disruption of the manufacture of the drug.,2019-08-13,2019-09-27
87506,2455439,Shortage,INVOKAMET,JANSSEN INC,canagliflozin and metformin hydrochloride tablets,METFORMIN HYDROCHLORIDE  CANAGLIFLOZIN,500MG  150MG,1x60,ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-07-02,2019-07-03,2019-07-05,2019-07-09,Disruption of the manufacture of the drug.,2019-06-26,2019-07-10
3653,2245568,Shortage,IODOVET TOPICAL SOLUTION,LABORATOIRE RIVA INC,Iodovet topical solution,POVIDONE-IODINE,10%,5L & 450ml,TOPICAL,Resolved,SOLUTION,,,2017-03-20,2017-03-20,,2017-03-24,Disruption of the manufacture of the drug.,2017-03-20,2017-03-25
41954,2076306,Shortage,IOPIDINE,NOVARTIS PHARMACEUTICALS CANADA INC,IOPIDINE 0.5% SOLN 5ML,APRACLONIDINE,0.5%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-03-06,2018-03-29,2018-04-12,Delay in shipping of the drug.,2018-03-06,2018-04-13
24465,888354,Shortage,IOPIDINE OPH SOL 1%,ALCON CANADA INC,APRACLONIDINE HCL,APRACLONIDINE,1%,(2 x 0.1mL)  x 12,OPHTHALMIC,Resolved,LIQUID,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-10-03,2018-01-24,2018-01-08,Disruption of the manufacture of the drug.,2017-10-05,2018-01-09
85654,2246084,Shortage,IPRAVENT,AA PHARMA INC,Ipravent,IPRATROPIUM BROMIDE,0.06%,15ML,NASAL,Resolved,SOLUTION,R01AX,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-06-05,2019-07-19,2019-07-18,Disruption of the manufacture of the drug.,2019-06-05,2019-08-22
2199,2246083,Shortage,IPRAVENT,AA PHARMA INC,IPRAVENT,IPRATROPIUM BROMIDE,0.03%,15 ML,NASAL,Actual shortage,SOLUTION,R01AX,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2015-04-15,,,Disruption of the manufacture of the drug.,2017-03-14,2017-10-05
91651,2365219,Shortage,IRBESARTAN,PRO DOC LIMITEE,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-08-15,2019-09-10,2019-08-23,Delay in shipping of the drug.,2019-08-15,2019-08-24
86038,2372347,Shortage,IRBESARTAN,SANIS HEALTH INC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-10,2019-11-29,,Disruption of the manufacture of the drug.,2019-06-10,2019-11-12
62786,2372347,Shortage,IRBESARTAN,SANIS HEALTH INC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-10-01,2018-10-01,2018-10-31,2018-10-30,Disruption of the manufacture of the drug.,2018-10-01,2018-10-31
62789,2372371,Shortage,IRBESARTAN,SANIS HEALTH INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-10-01,2018-10-01,2018-10-31,2018-10-30,Disruption of the manufacture of the drug.,2018-10-01,2018-10-31
82512,2372347,Shortage,IRBESARTAN,SANIS HEALTH INC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-10,2019-05-10,2019-05-31,2019-06-03,Disruption of the manufacture of the drug.,2019-04-26,2019-06-04
80246,2385287,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-04-05,2019-04-09,2019-07-05,2019-07-05,Demand increase for the drug.,2019-04-01,2019-07-06
81528,2365197,Shortage,IRBESARTAN,PRO DOC LIMITEE,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-12,,2019-04-23,Delay in shipping of the drug.,2019-04-12,2019-04-24
80249,2385309,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-04-22,2019-04-17,2019-05-29,2019-05-29,Demand increase for the drug.,2019-04-01,2019-05-31
81530,2365197,Shortage,IRBESARTAN,PRO DOC LIMITEE,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-12,,2019-04-23,Delay in shipping of the drug.,2019-04-12,2019-04-24
84603,2365200,Shortage,IRBESARTAN,PRO DOC LIMITEE,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-23,2019-06-18,2019-06-18,Delay in shipping of the drug.,2019-05-23,2019-06-19
84606,2365197,Shortage,IRBESARTAN,PRO DOC LIMITEE,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-23,2019-11-21,,Delay in shipping of the drug.,2019-05-23,2019-11-18
66689,2385287,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-12-07,2018-12-05,2018-12-18,2018-12-18,Requirements related to complying with good manufacturing practices.,2018-11-12,2018-12-21
66692,2385295,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-12-14,2018-12-14,2018-12-18,2018-12-19,Requirements related to complying with good manufacturing practices.,2018-11-12,2018-12-21
66695,2385309,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-12-07,2018-12-05,2018-12-18,2018-12-19,Requirements related to complying with good manufacturing practices.,2018-11-12,2018-12-21
83165,2385295,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-13,2019-05-08,2019-05-29,2019-05-29,Delay in shipping of the drug.,2019-05-06,2019-05-31
70366,2385287,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-12-24,2018-12-24,2019-02-20,2019-02-20,Requirements related to complying with good manufacturing practices.,2018-12-21,2019-02-22
70369,2385295,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-21,2019-01-17,2019-02-20,2019-02-20,Requirements related to complying with good manufacturing practices.,2018-12-21,2019-02-22
80252,2385317,Shortage,IRBESARTAN HCT,SIVEM PHARMACEUTICALS ULC,IRBESARTAN,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-04-15,2019-04-05,2019-05-01,2019-05-02,Demand increase for the drug.,2019-04-01,2019-05-06
66698,2385325,Shortage,IRBESARTAN HCT,SIVEM PHARMACEUTICALS ULC,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-12-07,2018-12-04,2018-12-28,2018-12-28,Requirements related to complying with good manufacturing practices.,2018-11-12,2018-12-29
82135,2385325,Shortage,IRBESARTAN HCT,SIVEM PHARMACEUTICALS ULC,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-05-06,2019-05-01,2019-06-21,2019-06-21,Demand increase for the drug.,2019-04-22,2019-06-22
2304,2365162,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-03-14,,2017-04-11,Delay in shipping of the drug.,2017-03-14,2017-04-18
78081,2365162,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-03-08,,2019-04-16,Delay in shipping of the drug.,2019-03-08,2019-04-17
75548,2365189,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-02-13,,2019-04-24,Delay in shipping of the drug.,2019-02-13,2019-04-25
14365,2365189,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-08-30,,2018-05-08,Delay in shipping of the drug.,2017-06-29,2018-05-09
77376,2365170,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-03-04,,2019-05-28,Delay in shipping of the drug.,2019-03-04,2019-05-29
15521,2365170,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-04-05,,2018-05-08,Delay in shipping of the drug.,2017-07-12,2018-05-09
9705,2365162,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-06-01,,2017-11-21,Delay in shipping of the drug.,2017-05-09,2017-11-22
72434,2365162,Shortage,IRBESARTAN-HCTZ,PRO DOC LIMITEE,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-16,,2019-03-04,Delay in shipping of the drug.,2019-01-16,2019-03-05
42112,2372908,Shortage,IRBESARTAN/HCTZ,SANIS HEALTH INC,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-03-12,2018-03-12,2018-04-30,2018-04-12,Other (Please describe in comments),2018-03-07,2018-04-13
58073,2372908,Shortage,IRBESARTAN/HCTZ,SANIS HEALTH INC,IRBESARTAN/HCTZ TAB,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-07,2018-08-31,2018-09-04,Delay in shipping of the drug.,2018-08-14,2018-09-05
73693,2372908,Shortage,IRBESARTAN/HCTZ,SANIS HEALTH INC,IRBESARTAN/HCTZ TAB,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-28,2019-04-05,2019-04-08,Disruption of the manufacture of the drug.,2019-01-28,2019-04-09
3937,2410419,Shortage,IRINOTECAN,PFIZER CANADA INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1 x 5mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017-03-22,2017-06-21,2017-06-21,Demand increase for the drug.,2017-03-22,2017-06-22
34022,2410419,Shortage,IRINOTECAN,PFIZER CANADA INC,Irinotecan,IRINOTECAN HYDROCHLORIDE,20MG,1x15mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-03-26,,2018-07-12,Demand increase for the drug.,2017-12-20,2018-07-13
2042,2410419,Shortage,IRINOTECAN,PFIZER CANADA INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1x15ML,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2016-12-21,2017-08-29,2017-08-29,Other (Please describe in comments),2017-03-14,2017-08-30
32661,2258218,Shortage,IRINOTECAN HYDROCHLORIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1 x 2mL,INTRAVENOUS,Avoided shortage,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2018-04-09,,,2018-02-26,Demand increase for the drug.,2017-12-12,2018-02-26
25312,2258218,Shortage,IRINOTECAN HYDROCHLORIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,1x5mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017-10-31,,2018-01-18,Disruption of the manufacture of the drug.,2017-10-11,2018-01-19
22186,2357585,Shortage,IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION,ACCORD HEALTHCARE INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,"2 mL vial, 10 vials per box  |  Flacon de 2 ml, Boîte de 10 flacons",INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-09-13,2017-09-13,2017-10-13,2017-10-16,Disruption of the manufacture of the drug.,2017-09-15,2017-10-20
3252,2357585,Shortage,IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION,ACCORD HEALTHCARE INC,IRINOTECAN,IRINOTECAN HYDROCHLORIDE,20MG,5 ML VIAL OF 100 MG   |   FLACON DE 5 ML DE 100 MG,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2016-12-27,2016-12-27,2017-03-22,2017-03-22,Disruption of the manufacture of the drug.,2017-03-17,2017-03-23
32906,2392429,Shortage,ISENTRESS,MERCK CANADA INC,raltegravir chewable tablets,RALTEGRAVIR,25MG,60TAB,ORAL,Resolved,TABLET (CHEWABLE),J05AX,DIRECT ACTING ANTIVIRALS,,2017-12-13,2018-02-23,2018-02-23,Demand increase for the drug.,2017-12-14,2018-02-24
5614,2446073,Shortage,ISMN,SIVEM PHARMACEUTICALS ULC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-04-25,,,2017-06-27,Demand increase for the drug.,2017-04-05,2017-11-03
5617,2446073,Shortage,ISMN,SIVEM PHARMACEUTICALS ULC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-04-25,,,2017-06-27,Demand increase for the drug.,2017-04-05,2017-11-03
63537,742554,Shortage,ISOPTIN SR,BGP PHARMA ULC,ISOPTIN SR,VERAPAMIL HYDROCHLORIDE,240MG,100S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-10-15,2018-10-15,2019-03-29,2019-03-28,Delay in shipping of the drug.,2018-10-09,2019-03-29
81791,742554,Shortage,ISOPTIN SR,BGP PHARMA ULC,VERAPAMIL HYDROCHLORIDE,VERAPAMIL HYDROCHLORIDE,240MG,100 BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-04-16,2019-06-28,2019-06-25,Disruption of the manufacture of the drug.,2019-04-16,2019-06-26
66444,1934317,Shortage,ISOPTIN SR,BGP PHARMA ULC,ISOPTIN SR,VERAPAMIL HYDROCHLORIDE,180MG,100BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-07-02,2019-07-26,2019-07-29,Delay in shipping of the drug.,2018-11-08,2019-07-30
91058,1907123,Shortage,ISOPTIN SR,BGP PHARMA ULC,VERAPAMIL HYDROCHLORIDE,VERAPAMIL HYDROCHLORIDE,120MG,100 BT,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-04-16,2019-12-20,,Delay in shipping of the drug.,2019-08-07,2019-08-07
81079,742554,Shortage,ISOPTIN SR,BGP PHARMA ULC,ISOPTIN SR,VERAPAMIL HYDROCHLORIDE,240MG,100S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-04-10,2019-06-28,2019-06-25,Demand increase for the drug.,2019-04-10,2019-06-26
68319,1907123,Shortage,ISOPTIN SR,BGP PHARMA ULC,VERAPAMIL HYDROCHLORIDE,VERAPAMIL HYDROCHLORIDE,120MG,100BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-11-30,2019-03-19,2019-03-15,Disruption of the manufacture of the drug.,2018-11-30,2019-03-16
91620,742554,Shortage,ISOPTIN SR,BGP PHARMA ULC,VERAPAMIL HYDROCHLORIDE,VERAPAMIL HYDROCHLORIDE,240MG,100 BT,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-09-03,2019-09-03,2019-11-15,,Delay in shipping of the drug.,2019-08-15,2019-10-08
88318,742554,Shortage,ISOPTIN SR,BGP PHARMA ULC,ISOPTIN SR,VERAPAMIL HYDROCHLORIDE,240MG,100 S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-07-02,2019-07-26,2019-07-29,Requirements related to complying with good manufacturing practices.,2019-07-03,2019-07-30
38076,35017,Shortage,ISOPTO ATROPINE,NOVARTIS PHARMACEUTICALS CANADA INC,ISOPTO ATROPINE 1% SOLN 5ML,ATROPINE SULFATE,1%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,2018-02-22,2018-02-22,,2018-03-13,Other (Please describe in comments),2018-02-01,2018-03-20
86636,2333279,Shortage,IXIARO,VALNEVA AUSTRIA GMBH,"Japanese encephalitis inactivated vaccine, alum adsorbed",INACT.JAPANESE ENCEPHAL VIRUS,6MCG,1 pre-filled syringe,INTRAMUSCULAR,Resolved,SUSPENSION,J07BA,VIRAL VACCINES,2019-06-17,,2019-06-25,2019-06-25,Demand increase for the drug.,2019-06-14,2019-07-08
69396,2372010,Shortage,JALYN,GLAXOSMITHKLINE INC,dutasteride/tamsulosin hydrochloride modified release capsules,TAMSULOSIN HYDROCHLORIDE  DUTASTERIDE,0.4MG  0.5MG,30's,ORAL,Resolved,CAPSULE (IMMEDIATE AND EXTENDED RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-12-07,2019-02-22,2019-02-20,Disruption of the manufacture of the drug.,2018-12-12,2019-02-22
84337,2372010,Shortage,JALYN,GLAXOSMITHKLINE INC,dutasteride/tamsulosin hydrochloride modified release capsules,TAMSULOSIN HYDROCHLORIDE  DUTASTERIDE,0.4MG  0.5MG,30's,ORAL,Resolved,CAPSULE (IMMEDIATE AND EXTENDED RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-07-02,2019-08-23,2019-08-14,Disruption of the manufacture of the drug.,2019-05-17,2019-08-16
96153,2467232,Shortage,JAMP ENTECAVIR,JAMP PHARMA CORPORATION,Entecavir,ENTECAVIR,0.5MG,30,ORAL,Actual shortage,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2019-10-07,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
64265,2406632,Shortage,JAMP OLANZAPINE ODT,JAMP PHARMA CORPORATION,Olanzapine,OLANZAPINE,10MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-10-12,,2018-11-19,Disruption of the manufacture of the drug.,2018-10-15,2018-11-27
6358,2354926,Shortage,JAMP REPAGLINIDE,JAMP PHARMA CORPORATION,REPAGLINIDE,REPAGLINIDE,0.5MG,100,ORAL,Actual shortage,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2019-01-17
6361,2354934,Shortage,JAMP REPAGLINIDE,JAMP PHARMA CORPORATION,REPAGLINIDE,REPAGLINIDE,1.0MG,100,ORAL,Actual shortage,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2019-01-17
6364,2354942,Shortage,JAMP REPAGLINIDE,JAMP PHARMA CORPORATION,REPAGLINIDE,REPAGLINIDE,2.0MG,100,ORAL,Actual shortage,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2019-01-17
42408,2385031,Shortage,JAMP-ALENDRONATE,JAMP PHARMA CORPORATION,Alendronate,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-03-08,,2018-05-18,Disruption of the manufacture of the drug.,2018-03-09,2018-05-19
71946,2400154,Shortage,JAMP-ALPRAZOLAM,JAMP PHARMA CORPORATION,Alprazolam,ALPRAZOLAM,2MG,100,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2019-01-10,2019-12-31,,Disruption of the manufacture of the drug.,2019-01-11,2019-07-08
64163,2400138,Shortage,JAMP-ALPRAZOLAM,JAMP PHARMA CORPORATION,Alprazolam,ALPRAZOLAM,0.5MG,100,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2018-10-12,2019-12-31,,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64170,2400138,Shortage,JAMP-ALPRAZOLAM,JAMP PHARMA CORPORATION,Alprazolam,ALPRAZOLAM,0.5MG,500,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2018-10-12,2019-12-31,,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64186,2400146,Shortage,JAMP-ALPRAZOLAM,JAMP PHARMA CORPORATION,Alprazolam,ALPRAZOLAM,1MG,100,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2018-10-12,2019-12-31,,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
3375,2435551,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,75MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-11-07,2017-07-31,2017-08-08,Disruption of the manufacture of the drug.,2017-03-17,2017-08-09
3396,2435543,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-11-07,2017-08-31,2017-08-31,Disruption of the manufacture of the drug.,2017-03-17,2017-09-27
3402,2435543,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-11-07,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-17,2017-09-27
3405,2435535,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride tablets,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-11-07,2017-07-31,2017-08-03,Disruption of the manufacture of the drug.,2017-03-17,2017-08-08
3409,2435535,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline Hydrochloride Tablets,AMITRIPTYLINE HYDROCHLORIDE,25MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-11-07,,2017-08-03,Disruption of the manufacture of the drug.,2017-03-17,2017-08-08
3481,2435527,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline hydrochloride,AMITRIPTYLINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2016-11-07,2016-11-07,2017-11-15,2017-11-08,Disruption of the manufacture of the drug.,2017-03-20,2017-11-09
3484,2435527,Shortage,JAMP-AMITRIPTYLINE TABLETS,JAMP PHARMA CORPORATION,Amitriptyline hydrochloride,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-11-07,2017-11-15,2017-11-08,Disruption of the manufacture of the drug.,2017-03-20,2017-11-09
3489,2357186,Shortage,JAMP-AMLODIPINE,JAMP PHARMA CORPORATION,Amlodipine besilate,AMLODIPINE,2.5MG,100,ORAL,Actual shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-01,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-20,2019-03-01
3501,2433060,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,250MG,100,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-11-14,,2018-05-01,Demand increase for the drug.,2017-03-20,2018-05-02
3508,2433060,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,250MG,1000,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-11-11,,2018-05-01,Disruption of the manufacture of the drug.,2017-03-20,2018-05-02
3511,2433079,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,500MG,100,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-11-14,,2018-05-01,Disruption of the manufacture of the drug.,2017-03-20,2018-05-02
3514,2433079,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillan trihydrate,AMOXICILLIN,500MG,500,ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-11-14,,2018-05-01,Disruption of the manufacture of the drug.,2017-03-20,2018-05-02
35385,2367556,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-01-08,,2018-02-26,Disruption of the manufacture of the drug.,2018-01-09,2018-02-27
3527,2367564,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2016-09-22,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-20,2017-09-27
3536,2367564,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2016-09-22,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-20,2017-09-27
3544,2367572,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-02-22,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-20,2017-09-27
3551,2367572,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-02-22,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-20,2017-09-27
3554,2367572,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,100MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-02-22,2017-07-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-20,2017-09-27
3558,2367564,Shortage,JAMP-ATENOLOL,JAMP PHARMA CORPORATION,Atenolol,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2016-09-22,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-20,2017-09-27
34184,2357216,Shortage,JAMP-BICALUTAMIDE,JAMP PHARMA CORPORATION,Bicalutamide,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-12-22,,2018-05-01,Disruption of the manufacture of the drug.,2017-12-22,2018-05-02
96120,2386518,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,8MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96123,2386526,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,16MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96128,2386534,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,JAMP-Candesartan,CANDESARTAN CILEXETIL,32MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
64195,2386518,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-12,,2019-07-05,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64203,2386526,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,16MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-12,,2019-07-05,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64208,2386534,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-12,,2019-07-05,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
3561,2386518,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016-09-21,2017-07-31,2017-08-03,Disruption of the manufacture of the drug.,2017-03-20,2017-08-08
3564,2386534,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-02-28,2017-07-31,2017-08-03,Disruption of the manufacture of the drug.,2017-03-20,2017-08-08
3567,2386496,Shortage,JAMP-CANDESARTAN,JAMP PHARMA CORPORATION,Candesartan,CANDESARTAN CILEXETIL,4MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016-09-15,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-20,2019-03-01
96133,2380358,Shortage,JAMP-CIPROFLOXACIN,JAMP PHARMA CORPORATION,Ciprofloxacin,CIPROFLOXACIN,250MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96138,2380366,Shortage,JAMP-CIPROFLOXACIN,JAMP PHARMA CORPORATION,Ciprofloxacin,CIPROFLOXACIN,500MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-10-07,2019-11-30,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96141,2415550,Shortage,JAMP-CLOPIDOGREL,JAMP PHARMA CORPORATION,Clopidogrel,CLOPIDOGREL,75MG,500,ORAL,Actual shortage,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2019-10-07,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
4828,2420147,Shortage,JAMP-CYANOCOBALAMIN,JAMP PHARMA CORPORATION,Cyanocobalamin Injection,VITAMIN B12,1000MCG,30,INTRAMUSCULAR  SUBCUTANEOUS,Actual shortage,SOLUTION,B03BA,VITAMIN B12 AND FOLIC ACID,,2016-09-15,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-30,2019-03-01
4831,2420147,Shortage,JAMP-CYANOCOBALAMIN,JAMP PHARMA CORPORATION,Cyanocobalamin Injection,VITAMIN B12,1000MCG,10,INTRAMUSCULAR  SUBCUTANEOUS,Actual shortage,SOLUTION,B03BA,VITAMIN B12 AND FOLIC ACID,,2016-12-13,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-30,2019-03-01
96144,2416956,Shortage,JAMP-DONEPEZIL TABLETS,JAMP PHARMA CORPORATION,Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2019-10-07,2019-12-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96147,2416956,Shortage,JAMP-DONEPEZIL TABLETS,JAMP PHARMA CORPORATION,Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,250,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2019-10-07,,,Shortage of an inactive ingredient or component.,2019-10-11,2019-10-11
96150,2416948,Shortage,JAMP-DONEPEZIL TABLETS,JAMP PHARMA CORPORATION,Donepezil,DONEPEZIL HYDROCHLORIDE,5MG,100,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2019-10-07,,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
23888,2361469,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,Gabarentin,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,,2017-11-23,Disruption of the manufacture of the drug.,2017-09-29,2017-11-24
23892,2361493,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,Gabarentin,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,,2017-11-23,Disruption of the manufacture of the drug.,2017-09-29,2017-11-24
23895,2361493,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,Gabapentin,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,,2017-11-23,Disruption of the manufacture of the drug.,2017-09-29,2017-11-24
23898,2361485,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,,2017-11-23,Disruption of the manufacture of the drug.,2017-09-29,2017-11-24
64216,2402289,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabapentin,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-12,,2018-12-19,Disruption of the manufacture of the drug.,2018-10-15,2018-12-20
64222,2402297,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabapentin,GABAPENTIN,800MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-12,,2019-01-31,Disruption of the manufacture of the drug.,2018-10-15,2019-03-01
3570,2402289,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabapentin,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2016-09-15,2017-05-08,2017-07-05,Disruption of the manufacture of the drug.,2017-03-20,2017-08-08
3573,2402297,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabarentin,GABAPENTIN,800MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2016-09-15,2017-09-30,2017-10-09,Disruption of the manufacture of the drug.,2017-03-20,2017-10-10
35389,2457873,Shortage,JAMP-HYDRALAZINE,JAMP PHARMA CORPORATION,HYDRALAZINE HYDROCHLORIDE,HYDRALAZINE HYDROCHLORIDE,25MG,100,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2018-01-08,,2018-07-04,Disruption of the manufacture of the drug.,2018-01-09,2018-07-05
70216,2457865,Shortage,JAMP-HYDRALAZINE,JAMP PHARMA CORPORATION,HYDRALAZINE HYDROCHLORIDE,HYDRALAZINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",2019-01-08,,,2019-01-31,Demand increase for the drug.,2018-12-20,2019-03-01
38513,2457881,Shortage,JAMP-HYDRALAZINE,JAMP PHARMA CORPORATION,HYDRALAZINE HYDROCHLORIDE,HYDRALAZINE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2018-02-05,2018-06-22,2018-07-04,Disruption of the manufacture of the drug.,2018-02-05,2018-07-05
96156,2457873,Shortage,JAMP-HYDRALAZINE,JAMP PHARMA CORPORATION,Hydralazine,HYDRALAZINE HYDROCHLORIDE,25MG,100,ORAL,Actual shortage,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2019-10-07,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96159,2457881,Shortage,JAMP-HYDRALAZINE,JAMP PHARMA CORPORATION,Hydralazine,HYDRALAZINE HYDROCHLORIDE,50MG,100,ORAL,Actual shortage,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2019-10-07,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
3805,2373912,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,2.5MG,100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016-09-15,2020-12-31,,Other (Please describe in comments),2017-03-21,2018-12-19
3810,2373912,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,2.5MG,30,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016-09-15,2020-12-31,,Other (Please describe in comments),2017-03-21,2018-12-19
3813,2373912,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,2.5MG,30,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016-09-15,2020-12-31,,Other (Please describe in comments),2017-03-21,2018-12-19
3580,2373904,Shortage,JAMP-INDAPAMIDE,JAMP PHARMA CORPORATION,Indapamide,INDAPAMIDE,1.25MG,100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016-09-15,,,Other (Please describe in comments),2017-03-20,2018-10-15
4427,2418215,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan Tablets,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2016-09-15,2017-06-30,2017-07-05,Disruption of the manufacture of the drug.,2017-03-27,2017-08-08
96162,2418193,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan,IRBESARTAN,75MG,28,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96165,2418215,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan,IRBESARTAN,300MG,28,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96168,2418207,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan,IRBESARTAN,150MG,28,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96171,2418193,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96174,2418207,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96177,2418215,Shortage,JAMP-IRBESARTAN,JAMP PHARMA CORPORATION,Irbesartan,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
4430,2418231,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,28,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-09-15,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-27,2017-09-27
4434,2418258,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,28,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-09-15,2017-08-31,2017-04-28,Disruption of the manufacture of the drug.,2017-03-27,2017-08-08
4437,2418223,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2016-09-15,,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-27,2017-09-27
4441,2418231,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-09-15,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-27,2017-09-27
4444,2418258,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-09-15,2017-08-31,2017-04-28,Disruption of the manufacture of the drug.,2017-03-27,2017-08-08
96180,2418223,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,28,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96183,2418231,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,28,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96186,2418258,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96189,2418258,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,28,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96192,2418231,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96195,2418258,Shortage,JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE,JAMP PHARMA CORPORATION,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-07,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
64233,2403005,Shortage,JAMP-LEVETIRACETAM,JAMP PHARMA CORPORATION,Levetiracetam,LEVETIRACETAM,250MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-12,,2019-07-01,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64240,2403021,Shortage,JAMP-LEVETIRACETAM,JAMP PHARMA CORPORATION,Levetiracetam,LEVETIRACETAM,500MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-12,,2019-07-01,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64250,2403048,Shortage,JAMP-LEVETIRACETAM,JAMP PHARMA CORPORATION,Levetiracetam,LEVETIRACETAM,750MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-12,,2019-07-01,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64256,2398834,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,25MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-12,,2019-07-02,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64259,2398834,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,25MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-12,,2019-07-02,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
95676,2398834,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-02,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95679,2398842,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-02,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95684,2398850,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-02,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95693,2398834,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,25MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-02,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95698,2398842,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,50MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-02,2019-12-01,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95701,2398850,Shortage,JAMP-LOSARTAN,JAMP PHARMA CORPORATION,Losartan,LOSARTAN POTASSIUM,100MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-01,2019-12-02,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
23901,2408244,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-01,,2018-05-18,Disruption of the manufacture of the drug.,2017-09-29,2018-05-19
23905,2408252,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-01,,2018-05-01,Disruption of the manufacture of the drug.,2017-09-29,2018-05-02
23908,2408244,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-01,,2018-05-18,Disruption of the manufacture of the drug.,2017-09-29,2018-05-19
23918,2408252,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-01,,2018-05-18,Disruption of the manufacture of the drug.,2017-09-29,2018-05-19
95704,2408252,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-01,2019-12-02,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95707,2408244,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-01,2019-12-02,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95710,2408252,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-01,2019-12-02,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
95713,2408244,Shortage,JAMP-LOSARTAN HCTZ,JAMP PHARMA CORPORATION,Losartan HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-01,2019-12-02,,Disruption of the manufacture of the drug.,2019-10-07,2019-10-07
4836,2419173,Shortage,JAMP-METHOTREXATE,JAMP PHARMA CORPORATION,Methotrexate Solution,METHOTREXATE,25MG,5x2,INTRA-ARTERIAL  INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS,Actual shortage,SOLUTION,L01BA,ANTIMETABOLITES,,2016-09-15,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-30,2019-03-01
29952,2356813,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l,METOPROLOL TARTRATE,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-11-20,,2018-05-29,Disruption of the manufacture of the drug.,2017-11-21,2018-05-30
29937,2356848,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l 100mg,METOPROLOL TARTRATE,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-11-20,,2018-01-29,Disruption of the manufacture of the drug.,2017-11-21,2018-01-30
29941,2356848,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l,METOPROLOL TARTRATE,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-11-20,,2018-01-29,Disruption of the manufacture of the drug.,2017-11-21,2018-01-30
29946,2356813,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol-l,METOPROLOL TARTRATE,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-11-20,,2018-05-29,Disruption of the manufacture of the drug.,2017-11-21,2018-05-30
96198,2433443,Shortage,JAMP-NYSTATIN ORAL SUSPENSION USP,JAMP PHARMA CORPORATION,Nystatin,NYSTATIN,100000UNIT,100,ORAL,Actual shortage,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2019-10-07,2019-12-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96202,2433443,Shortage,JAMP-NYSTATIN ORAL SUSPENSION USP,JAMP PHARMA CORPORATION,Nystatin,NYSTATIN,100000UNIT,500,ORAL,Actual shortage,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2019-10-07,2019-12-15,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96205,2461641,Shortage,JAMP-OLMESARTAN,JAMP PHARMA CORPORATION,Olmesartan,OLMESARTAN MEDOXOMIL,20MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2020-01-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96208,2461668,Shortage,JAMP-OLMESARTAN,JAMP PHARMA CORPORATION,Olmesartan,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2020-01-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96211,2461641,Shortage,JAMP-OLMESARTAN,JAMP PHARMA CORPORATION,Olmesartan,OLMESARTAN MEDOXOMIL,20MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2020-01-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96215,2461668,Shortage,JAMP-OLMESARTAN,JAMP PHARMA CORPORATION,Olmesartan,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-07,2020-01-01,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96218,2458411,Shortage,JAMP-OLOPATADINE,JAMP PHARMA CORPORATION,Olopatadine,OLOPATADINE,0.1%,5,OPHTHALMIC,Actual shortage,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2019-10-07,2019-10-31,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
34187,2313685,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,4MG,10,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-12-22,,2018-04-27,Disruption of the manufacture of the drug.,2017-12-22,2018-04-28
34192,2313693,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,8MG,10,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-12-22,,2018-04-27,Disruption of the manufacture of the drug.,2017-12-22,2018-04-28
4839,2420422,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,2MG,20ml,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016-09-21,,2018-07-04,Disruption of the manufacture of the drug.,2017-03-30,2018-07-05
4842,2420414,Shortage,JAMP-ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron,ONDANSETRON,2MG,5x2ml,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016-12-02,,2018-07-31,Disruption of the manufacture of the drug.,2017-03-30,2018-08-01
64268,2440717,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,OXCARBAZEPINE,OXCARBAZEPINE,150MG,100,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2018-10-12,,,Disruption of the manufacture of the drug.,2018-10-15,2019-04-18
64271,2440725,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,OXCARBAZEPINE,OXCARBAZEPINE,300MG,100,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2018-10-12,,,Disruption of the manufacture of the drug.,2018-10-15,2019-04-18
64276,2440733,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,OXCARBAZEPINE,OXCARBAZEPINE,600MG,100,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2018-10-12,,,Disruption of the manufacture of the drug.,2018-10-15,2019-10-11
35421,2440733,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,OXCARBAZEPINE,OXCARBAZEPINE,600MG,100,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2018-01-08,,2018-06-08,Disruption of the manufacture of the drug.,2018-01-09,2018-06-09
34198,2440717,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,Oxcarbazepine,OXCARBAZEPINE,150MG,100,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2017-12-22,,2018-05-18,Disruption of the manufacture of the drug.,2017-12-22,2018-05-19
34206,2440725,Shortage,JAMP-OXCARBAZEPINE,JAMP PHARMA CORPORATION,Oxcarbazepine,OXCARBAZEPINE,300MG,100,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2017-12-22,,2018-05-18,Disruption of the manufacture of the drug.,2017-12-22,2018-05-19
30028,2365529,Shortage,JAMP-PIOGLITAZONE,JAMP PHARMA CORPORATION,Pioglitazone 30mg,PIOGLITAZONE,30MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-11-20,,2019-06-28,Disruption of the manufacture of the drug.,2017-11-21,2019-07-08
30031,2365537,Shortage,JAMP-PIOGLITAZONE,JAMP PHARMA CORPORATION,Pioglitazone 45mg,PIOGLITAZONE,45MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-11-20,,2019-06-28,Disruption of the manufacture of the drug.,2017-11-21,2019-07-08
70089,2397307,Shortage,JAMP-PIOGLITAZONE,JAMP PHARMA CORPORATION,Pioglitazone,PIOGLITAZONE,15MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-12-19,,2019-06-28,Disruption of the manufacture of the drug.,2018-12-19,2019-07-08
4741,2330970,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium  Tablets,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016-12-20,2017-06-30,2017-07-05,Shortage of an active ingredient.,2017-03-30,2017-08-08
4761,2330954,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-01-31,2017-06-30,2017-07-05,Shortage of an active ingredient.,2017-03-30,2017-08-08
4768,2330962,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-01-26,2017-06-30,2017-07-05,Shortage of an active ingredient.,2017-03-30,2017-08-08
96223,2330962,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin,PRAVASTATIN SODIUM,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-07,2019-10-31,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96226,2330970,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-07,2019-10-31,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96229,2330970,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin,PRAVASTATIN SODIUM,40MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-07,2019-10-31,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96232,2330962,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin,PRAVASTATIN SODIUM,20MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-07,2019-10-31,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
29963,2445190,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 200mg,QUININE SULFATE,200MG,100,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017-11-20,,2018-02-19,Disruption of the manufacture of the drug.,2017-11-21,2018-02-20
29966,2445190,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 200mg,QUININE SULFATE,200MG,500,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017-11-20,,2018-08-06,Disruption of the manufacture of the drug.,2017-11-21,2018-08-07
29975,2445204,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 300mg,QUININE SULFATE,300MG,500,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017-11-20,,2018-02-19,Disruption of the manufacture of the drug.,2017-11-21,2018-02-20
29978,2445204,Shortage,JAMP-QUININE,JAMP PHARMA CORPORATION,Quinine 300mg,QUININE SULFATE,300MG,100,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2017-11-20,,2018-02-19,Disruption of the manufacture of the drug.,2017-11-21,2018-02-20
6664,2440334,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril,RAMIPRIL,15MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-04-01,,2018-08-06,Disruption of the manufacture of the drug.,2017-04-12,2018-08-07
23927,2331128,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,2.5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-08,Disruption of the manufacture of the drug.,2017-09-29,2017-11-09
23931,2331136,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-15,Disruption of the manufacture of the drug.,2017-09-29,2017-11-16
23937,2331144,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-15,Disruption of the manufacture of the drug.,2017-09-29,2017-11-16
23944,2331144,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-15,Disruption of the manufacture of the drug.,2017-09-29,2017-11-16
23950,2331136,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-15,Disruption of the manufacture of the drug.,2017-09-29,2017-11-16
23958,2331128,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-08,Disruption of the manufacture of the drug.,2017-09-29,2017-11-09
23964,2331136,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule - Blister,RAMIPRIL,5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-15,Disruption of the manufacture of the drug.,2017-09-29,2017-11-16
23970,2331144,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule - Blister,RAMIPRIL,10MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-15,Disruption of the manufacture of the drug.,2017-09-29,2017-11-16
4771,2331101,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsules,RAMIPRIL,1.25MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2016-09-08,,2018-11-19,Disruption of the manufacture of the drug.,2017-03-30,2018-11-27
23973,2331128,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril Capsule - Blister,RAMIPRIL,2.5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-01,2017-11-15,2017-11-08,Disruption of the manufacture of the drug.,2017-09-29,2017-11-09
96235,2331101,Shortage,JAMP-RAMIPRIL,JAMP PHARMA CORPORATION,Ramipril,,,30,,Actual shortage,,,,,2019-10-07,,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96238,2463717,Shortage,JAMP-RANITIDINE,JAMP PHARMA CORPORATION,Ranitidine,RANITIDINE,150MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-07,,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96241,2463717,Shortage,JAMP-RANITIDINE,JAMP PHARMA CORPORATION,Ranitidine,RANITIDINE,150MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-07,,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96244,2463725,Shortage,JAMP-RANITIDINE,JAMP PHARMA CORPORATION,Ranitidine,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-07,,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
35443,2368552,Shortage,JAMP-RISEDRONATE,JAMP PHARMA CORPORATION,RISEDRONATE SODIUM,RISEDRONATE SODIUM,35MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-01-08,,2018-10-12,Disruption of the manufacture of the drug.,2018-01-09,2018-10-15
4777,2359529,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016-09-15,2017-08-31,2017-10-02,Disruption of the manufacture of the drug.,2017-03-30,2017-10-03
4782,2359537,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,0.50MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016-09-15,2017-08-31,2017-10-02,Disruption of the manufacture of the drug.,2017-03-30,2017-10-03
4786,2359553,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,2.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016-09-15,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-30,2017-09-27
4789,2359553,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,2.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016-09-15,2018-01-01,2017-09-26,Disruption of the manufacture of the drug.,2017-03-30,2017-09-27
4791,2359588,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,4.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016-09-15,2017-08-31,2017-09-26,Disruption of the manufacture of the drug.,2017-03-30,2017-09-27
4796,2359545,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,1.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016-09-15,2018-01-01,2017-09-26,Disruption of the manufacture of the drug.,2017-03-30,2017-09-27
4800,2359588,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,4.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2016-11-15,2018-01-01,2017-09-26,Disruption of the manufacture of the drug.,2017-03-30,2017-09-27
4803,2359561,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone Tablets,RISPERIDONE,3.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2014-09-15,2018-01-01,2017-09-26,Disruption of the manufacture of the drug.,2017-03-30,2017-09-27
64279,2352354,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinirole,ROPINIROLE,2.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-10-12,,2018-11-19,Disruption of the manufacture of the drug.,2018-10-15,2018-11-27
64282,2352346,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinirole,ROPINIROLE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-10-12,,2019-06-28,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
64287,2352362,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,ROPINIROLE,ROPINIROLE,5.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-10-12,,2019-07-01,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
30025,2352362,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinirole 5mg,ROPINIROLE,5.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-11-20,,2019-07-02,Disruption of the manufacture of the drug.,2017-11-21,2019-07-08
35430,2352338,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,ROPINIROLE HYDROCHLORIDE,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-01-08,,2018-07-04,Disruption of the manufacture of the drug.,2018-01-09,2018-07-05
35435,2352354,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,ROPINIROLE HYDROCHLORIDE,ROPINIROLE,2.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-01-08,,2018-07-04,Disruption of the manufacture of the drug.,2018-01-09,2018-07-05
4806,2352362,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinole Tablets,ROPINIROLE,5.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2016-09-15,2017-05-08,2017-07-05,Disruption of the manufacture of the drug.,2017-03-30,2017-08-08
4809,2352346,Shortage,JAMP-ROPINIROLE,JAMP PHARMA CORPORATION,Ropinirole Tablets,ROPINIROLE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2016-09-15,2017-06-30,2017-07-05,Disruption of the manufacture of the drug.,2017-03-30,2017-07-12
23976,2391287,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,40.0MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-01,,2018-02-19,Disruption of the manufacture of the drug.,2017-09-29,2018-02-20
23980,2391287,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,40.0MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-01,,2018-02-19,Disruption of the manufacture of the drug.,2017-09-29,2018-02-20
34221,2391260,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,10.0MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-22,,2018-02-19,Disruption of the manufacture of the drug.,2017-12-22,2018-02-20
23983,2391279,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,20.0MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-01,,2018-02-19,Disruption of the manufacture of the drug.,2017-09-29,2018-02-20
23988,2391252,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,5MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-01,,2018-02-19,Disruption of the manufacture of the drug.,2017-09-29,2018-02-20
34235,2391260,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,10.0MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-22,,2018-02-19,Disruption of the manufacture of the drug.,2017-12-22,2018-02-20
34239,2391279,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,20.0MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-22,,2018-02-19,Disruption of the manufacture of the drug.,2017-12-22,2018-02-20
34242,2391252,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-22,,2018-02-19,Disruption of the manufacture of the drug.,2017-12-22,2018-02-20
4812,2375591,Shortage,JAMP-SIMVASTATIN,JAMP PHARMA CORPORATION,Simvastatin Tablets,SIMVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-15,,2018-10-15,Disruption of the manufacture of the drug.,2017-03-30,2018-10-16
4815,2375648,Shortage,JAMP-SIMVASTATIN,JAMP PHARMA CORPORATION,Simvastatin Tablets,SIMVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016-09-15,,2018-10-15,Disruption of the manufacture of the drug.,2017-03-30,2018-10-16
30034,2368617,Shortage,JAMP-SOTALOL,JAMP PHARMA CORPORATION,Sotalol 80mg,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-11-20,,2018-04-16,Disruption of the manufacture of the drug.,2017-11-21,2018-04-17
30037,2368617,Shortage,JAMP-SOTALOL,JAMP PHARMA CORPORATION,Sotalol,SOTALOL HYDROCHLORIDE,80MG,500,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-11-20,,2018-08-06,Disruption of the manufacture of the drug.,2017-11-21,2018-08-07
30040,2368625,Shortage,JAMP-SOTALOL,JAMP PHARMA CORPORATION,Sotalol,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-11-20,,2018-07-04,Disruption of the manufacture of the drug.,2017-11-21,2018-07-05
30011,2451824,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Tadalafil 2.5mg,TADALAFIL,2.5MG,7 x 4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-20,,2018-08-06,Disruption of the manufacture of the drug.,2017-11-21,2018-08-07
30014,2451832,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Jamp-Tadalafil,TADALAFIL,5MG,7 x 4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-20,,2018-02-19,Disruption of the manufacture of the drug.,2017-11-21,2018-02-20
30017,2451840,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Tadalafil 10mg,TADALAFIL,10MG,1 x 4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-20,,2018-02-12,Disruption of the manufacture of the drug.,2017-11-21,2018-02-13
34247,2451859,Shortage,JAMP-TADALAFIL,JAMP PHARMA CORPORATION,Tadalafil,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-12-22,,2018-02-12,Disruption of the manufacture of the drug.,2017-12-22,2018-02-13
4818,2357070,Shortage,JAMP-TERBINAFINE,JAMP PHARMA CORPORATION,Terbinafine Tablets,TERBINAFINE,250MG,30,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2016-09-15,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-30,2018-12-19
4821,2357070,Shortage,JAMP-TERBINAFINE,JAMP PHARMA CORPORATION,Terbinafine Tablets,TERBINAFINE,250MG,100,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2017-09-15,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-30,2018-12-19
4845,2420287,Shortage,JAMP-TOBRAMYCIN,JAMP PHARMA CORPORATION,Tobramycin,TOBRAMYCIN,40MG,10x2,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,LIQUID,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2016-09-21,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-30,2018-12-19
4848,2420287,Shortage,JAMP-TOBRAMYCIN,JAMP PHARMA CORPORATION,Tobramycin,TOBRAMYCIN,40MG,1x30,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,LIQUID,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2016-10-31,2020-12-31,,Disruption of the manufacture of the drug.,2017-03-30,2018-12-19
23993,2435608,Shortage,JAMP-TOPIRAMATE,JAMP PHARMA CORPORATION,Topiramate,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-25,,2017-11-27,Disruption of the manufacture of the drug.,2017-09-29,2017-11-28
23996,2441454,Shortage,JAMP-VALACYCLOVIR,JAMP PHARMA CORPORATION,Valacyclovir,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-09-15,,2018-10-12,Disruption of the manufacture of the drug.,2017-09-29,2018-10-15
30022,2449110,Shortage,JAMP-VITAMIN D,JAMP PHARMA CORPORATION,Vitamine D 50000 UI,VITAMIN D3,50000UNIT,100,ORAL,Resolved,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2017-11-20,,2018-04-16,Disruption of the manufacture of the drug.,2017-11-21,2018-04-17
35598,2421623,Shortage,JAMP-ZOLMITRIPTAN,JAMP PHARMA CORPORATION,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-01-09,,2018-01-29,Disruption of the manufacture of the drug.,2018-01-10,2018-01-30
64290,2428237,Shortage,JAMP-ZOLMITRIPTAN ODT,JAMP PHARMA CORPORATION,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2018-10-12,2019-12-31,,Disruption of the manufacture of the drug.,2018-10-15,2019-07-08
35451,2428237,Shortage,JAMP-ZOLMITRIPTAN ODT,JAMP PHARMA CORPORATION,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2018-01-08,2019-12-31,,Disruption of the manufacture of the drug.,2018-01-09,2019-07-08
4447,2387239,Shortage,JAMPZINC-HC,JAMP PHARMA CORPORATION,Zinc Sulfate Monohydrate + Hydrocortisone Acetate ointment,Zinc sulfate monohydrate  HYDROCORTISONE ACETATE,0.5%  0.5%,30g,RECTAL  TOPICAL,Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2016-11-22,2017-05-12,2017-06-09,Disruption of the manufacture of the drug.,2017-03-27,2017-06-10
71317,2333864,Shortage,JANUMET,MERCK CANADA INC,sitagliptin and metformin hydrochloride tablets,METFORMIN HYDROCHLORIDE  SITAGLIPTIN,850MG  50MG,Pack of 60 tablets /Paquet de 60 comprimés,ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-01-23,2019-01-24,2019-02-22,2019-02-11,Disruption of the manufacture of the drug.,2019-01-04,2019-02-12
74192,2416808,Shortage,JANUMET XR,MERCK CANADA INC,sitagliptin and metformin hydrochloride modified-release tablets,METFORMIN HYDROCHLORIDE  SITAGLIPTIN,1000MG  100MG,30 Tab,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-03-04,,2019-02-27,2019-02-27,Disruption of the manufacture of the drug.,2019-02-01,2019-02-27
14703,2303922,Shortage,JANUVIA,MERCK CANADA INC,sitagliptin tablets (as sitagliptin phosphate monohydrate),SITAGLIPTIN,100MG,100 tab,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-07-05,2017-07-05,2017-07-14,2017-07-14,Delay in shipping of the drug.,2017-07-05,2017-07-15
15836,2303922,Shortage,JANUVIA,MERCK CANADA INC,sitagliptin tablets (as sitagliptin phosphate monohydrate),SITAGLIPTIN,100MG,100 tab,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-07-18,2017-07-06,2017-07-20,2017-07-24,Delay in shipping of the drug.,2017-07-17,2017-10-11
29207,2441306,Shortage,JENCYCLA,SANDOZ CANADA INCORPORATED,JENCYCLA,NORETHINDRONE,0.35MG,BLISTERS 28'S,ORAL,Resolved,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017-11-13,2017-12-04,2017-12-11,Demand increase for the drug.,2017-11-14,2017-12-15
16744,2441306,Shortage,JENCYCLA,SANDOZ CANADA INCORPORATED,JENCYCLA,NORETHINDRONE,0.35MG,28,ORAL,Resolved,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017-07-07,2017-10-27,2017-10-27,Delay in shipping of the drug.,2017-07-24,2017-10-28
89966,2441306,Shortage,JENCYCLA,LUPIN PHARMA CANADA LIMITED,Jencycla,NORETHINDRONE,0.35MG,28,ORAL,Actual shortage,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-08-12,,2019-11-22,,Demand increase for the drug.,2019-07-25,2019-08-13
92890,2410818,Shortage,JETREA,THROMBOGENICS NV,Solution for intravitreal injection,OCRIPLASMIN,2.5MG,0.2mL,INTRAVITREAL,Resolved,SOLUTION,S01XA,OTHER OPHTHALMOLOGICALS,2019-09-13,2019-09-05,2019-09-30,2019-09-24,Delay in shipping of the drug.,2019-09-03,2019-09-25
19958,2410818,Shortage,JETREA,ALCON CANADA INC,solution for intravitreal injection,OCRIPLASMIN,2.5MG,0.2mL,INTRAVITREAL,Resolved,SOLUTION,S01XA,OTHER OPHTHALMOLOGICALS,2017-08-21,2017-08-21,,2017-08-31,Delay in shipping of the drug.,2017-08-21,2017-09-01
87765,2369524,Shortage,JEVTANA,SANOFI-AVENTIS CANADA INC,Jevtana,CABAZITAXEL,40MG,1,INTRAVENOUS,Avoided shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2019-07-27,,2019-08-30,2019-07-18,Other (Please describe in comments),2019-06-27,2019-07-19
32010,2242163,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,10MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,,2017-12-07,,2017-12-07,Requirements related to complying with good manufacturing practices.,2017-12-07,2017-12-08
33593,2242163,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,10MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2017-12-29,,2018-01-05,2017-12-29,Delay in shipping of the drug.,2017-12-18,2018-01-03
35938,2184443,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,50MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2018-05-25,,2018-06-01,2018-05-31,Demand increase for the drug.,2018-01-15,2018-06-01
20585,2242163,Shortage,KADIAN,BGP PHARMA ULC,Morphine ER,MORPHINE SULFATE,10MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,,2017-10-02,,2017-10-03,Delay in shipping of the drug.,2017-08-29,2017-10-04
20588,2184435,Shortage,KADIAN,BGP PHARMA ULC,Morphine ER,MORPHINE SULFATE,20MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2018-04-06,2018-04-06,2018-05-09,2018-05-09,Demand increase for the drug.,2017-08-29,2018-05-10
3704,2184435,Shortage,KADIAN,BGP PHARMA ULC,Kadian,MORPHINE SULFATE,20MG,100s,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2017-04-11,,,2017-04-11,Requirements related to complying with good manufacturing practices.,2017-03-20,2017-04-12
94104,2184451,Shortage,KADIAN,BGP PHARMA ULC,MORPHINE SULFATE,MORPHINE SULFATE,100MG,50BT,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2019-10-07,2019-09-30,2019-11-08,2019-11-12,Delay in shipping of the drug.,2019-09-17,2019-11-13
30923,2184451,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,100MG,50,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2018-04-03,2018-03-29,2018-04-06,2018-04-03,Demand increase for the drug.,2017-11-28,2018-04-04
28368,2184443,Shortage,KADIAN,BGP PHARMA ULC,KADIAN,MORPHINE SULFATE,50MG,100,ORAL,Avoided shortage,CAPSULE (SUSTAINED-RELEASE),N02AA,OPIOIDS,2017-11-22,,,2017-11-20,Delay in shipping of the drug.,2017-11-06,2017-11-20
72245,2026961,Shortage,KAYEXALATE,SANOFI-AVENTIS CANADA INC,Kayexelate,SODIUM POLYSTYRENE SULFONATE,100%,454g,ORAL  RECTAL,Resolved,POWDER,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2019-01-14,,2019-02-08,2019-02-05,Demand increase for the drug.,2019-01-15,2019-02-06
82271,2026961,Shortage,KAYEXALATE,SANOFI-AVENTIS CANADA INC,Kayexalate,SODIUM POLYSTYRENE SULFONATE,100%,1,ORAL  RECTAL,Resolved,POWDER,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2019-04-26,,2019-08-30,2019-05-22,Other (Please describe in comments),2019-04-23,2019-05-24
31054,2246795,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE,KETAMINE,10MG,1 VIAL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N01AX,"ANESTHETICS, GENERAL",,2017-11-13,2017-12-04,2017-12-11,Requirements related to complying with good manufacturing practices.,2017-11-29,2017-12-15
34394,2245662,Shortage,KETODERM CREAM 2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Taro Pharmaceuticals Ketoderm Cream,KETOCONAZOLE,2%,30,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2018-08-02,2018-08-17,2018-08-30,Disruption of the manufacture of the drug.,2017-12-27,2018-09-07
96890,2245662,Shortage,KETODERM CREAM 2%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",KETODERM CREAM 2%,KETOCONAZOLE,2%,30 g,TOPICAL,Actual shortage,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,,2019-10-18,2019-12-06,,Disruption of the manufacture of the drug.,2019-10-21,2019-11-01
3758,790427,Shortage,KETOPROFEN,AA PHARMA INC,KETOPROFEN,KETOPROFEN,50MG,100 Bottle,ORAL,Actual shortage,CAPSULE,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2016-09-13,,,,Disruption of the manufacture of the drug.,2017-03-21,2017-10-05
87054,2245821,Shortage,KETOROLAC,AA PHARMA INC,KETOROLAC,KETOROLAC TROMETHAMINE,0.5%,5ML,OPHTHALMIC,Actual shortage,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2019-06-19,2019-09-05,,Disruption of the manufacture of the drug.,2019-06-19,2019-06-26
56102,2245821,Shortage,KETOROLAC,AA PHARMA INC,Ketorolac,KETOROLAC TROMETHAMINE,0.5%,10 ml,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-01-09,2019-01-14,2019-02-07,2019-02-07,Disruption of the manufacture of the drug.,2018-07-19,2019-02-08
55999,2245821,Shortage,KETOROLAC,AA PHARMA INC,Ketorolac,KETOROLAC TROMETHAMINE,0.5%,5ml,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2018-07-17,2018-10-11,2018-10-10,Disruption of the manufacture of the drug.,2018-07-17,2019-01-08
71633,2245821,Shortage,KETOROLAC,AA PHARMA INC,KETOROLAC OPHTHALMIC SOLUTION,KETOROLAC TROMETHAMINE,0.5%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-02-08,2019-02-02,2019-03-01,2019-02-07,Disruption of the manufacture of the drug.,2019-01-08,2019-02-09
63236,2390582,Shortage,KETOROLAC TROMETHAMINE INJECTION USP,PFIZER CANADA INC,KETOROLAC,KETOROLAC TROMETHAMINE,30MG,25x1mL GVL,INTRAMUSCULAR,Resolved,SOLUTION,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-11-09,,2019-04-08,Disruption of the manufacture of the drug.,2018-10-03,2019-04-09
2621,2239944,Shortage,KETOROLAC TROMETHAMINE INJECTION USP,SANDOZ CANADA INCORPORATED,KETOROLAC Trometh,KETOROLAC TROMETHAMINE,30MG,10x1mL fiole/vial,INTRAMUSCULAR,Resolved,LIQUID,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2015-10-30,2017-04-17,2017-04-11,Requirements related to complying with good manufacturing practices.,2017-03-14,2017-04-12
84327,2390582,Shortage,KETOROLAC TROMETHAMINE INJECTION USP,PFIZER CANADA ULC,Ketorolac,KETOROLAC TROMETHAMINE,30MG,25 x 1 mL vial,INTRAMUSCULAR,Avoided shortage,SOLUTION,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-08-10,,2019-09-30,2019-07-12,Disruption of the manufacture of the drug.,2019-05-17,2019-07-12
73188,2239944,Shortage,KETOROLAC TROMETHAMINE INJECTION USP,SANDOZ CANADA INCORPORATED,KETOROLAC,KETOROLAC TROMETHAMINE,30MG,1ml,INTRAMUSCULAR,Resolved,LIQUID,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-12-10,2019-03-18,2019-03-08,Demand increase for the drug.,2019-01-22,2019-03-13
72263,2443376,Shortage,"KETOROLAC TROMETHAMINE INJECTION, USP",MDA INC.,Ketorolac,KETOROLAC TROMETHAMINE,30MG,Carton 10 Vials,INTRAMUSCULAR,Resolved,SOLUTION,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-09-03,2019-10-03,2019-11-07,2019-11-01,Demand increase for the drug.,2019-01-15,2019-11-15
71575,2244947,Shortage,"KETOROLAC TROMETHAMINE INJECTION, USP",FRESENIUS KABI CANADA LTD,Ketorolac Injection,KETOROLAC TROMETHAMINE,30MG,1mL,INTRAMUSCULAR,Resolved,LIQUID,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-01-09,,,2019-01-18,Demand increase for the drug.,2019-01-08,2019-01-19
56521,2443376,Shortage,"KETOROLAC TROMETHAMINE INJECTION, USP",MDA INC.,Ketorolac,KETOROLAC TROMETHAMINE,30MG,1 ml Vial,INTRAMUSCULAR,Resolved,SOLUTION,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-07-20,2018-07-25,2018-10-29,2018-10-31,Delay in shipping of the drug.,2018-07-25,2018-11-05
73209,2244947,Shortage,"KETOROLAC TROMETHAMINE INJECTION, USP",FRESENIUS KABI CANADA LTD,Ketorolac Injection,KETOROLAC TROMETHAMINE,30MG,1 mL,INTRAMUSCULAR,Resolved,LIQUID,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-02-14,,2019-04-05,2019-04-05,Disruption of the manufacture of the drug.,2019-01-22,2019-04-06
78723,2400871,Shortage,KETOTIFEN OPHTHALMIC SOLUTION,STERIMAX INC,KETOTIFEN OPHTHALMIC SOLUTION,KETOTIFEN,0.25MG,1 BOTTLE,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,2019-03-18,,,2019-06-27,Delay in shipping of the drug.,2019-03-15,2019-07-02
12797,2400871,Shortage,KETOTIFEN OPHTHALMIC SOLUTION,STERIMAX INC,KETOTIFEN OPHTHALMIC SOLUTION,KETOTIFEN,0.25MG,1 BOTTLE,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2017-06-13,,2017-08-14,Other (Please describe in comments),2017-06-15,2017-08-15
56228,2228602,Shortage,KINEVAC (SINCALIDE) FOR INJECTION 5MCG/VIAL,BRACCO IMAGING CANADA,Sincalide,SINCALIDE,5MCG,10 vials pr box,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,V04CC,OTHER DIAGNOSTIC AGENTS,2018-06-25,2018-06-25,2018-09-03,,Disruption of the manufacture of the drug.,2018-07-23,2018-07-23
74011,2269341,Shortage,KIVEXA,VIIV HEALTHCARE ULC,abacavir (as abacavir sulfate) and lamivudine tablets,ABACAVIR  LAMIVUDINE,600MG  300MG,30's,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-01-25,2019-03-18,2019-03-14,Demand increase for the drug.,2019-01-30,2019-03-15
83800,2457040,Shortage,LABETALOL HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LTD,Labetalol Hydrochloride Injection,LABETALOL HYDROCHLORIDE,5MG,1 X 20 mL,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,2019-05-02,,2019-05-24,2019-05-22,Demand increase for the drug.,2019-05-10,2019-05-27
56007,2457040,Shortage,LABETALOL HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LTD,Labetalol Hydrochloride Injection,LABETALOL HYDROCHLORIDE,5MG,1 x 20mL vials,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,2018-11-01,,,2018-12-10,Disruption of the manufacture of the drug.,2018-07-17,2018-12-12
67605,2231689,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,LABETALOL,LABETALOL HYDROCHLORIDE,5MG,20ML,INTRAVENOUS,Resolved,LIQUID,C07AG,BETA BLOCKING AGENTS,,2018-11-12,2018-12-03,2018-11-30,Demand increase for the drug.,2018-11-26,2018-12-05
27239,2231689,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,LABETALOL,LABETALOL HYDROCHLORIDE,5MG,10 X 25ml VIALS,INTRAVENOUS,Resolved,LIQUID,C07AG,BETA BLOCKING AGENTS,,2017-10-20,2017-11-17,2017-11-13,Requirements related to complying with good manufacturing practices.,2017-10-27,2017-11-19
70256,2231689,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,LABETALOL,LABETALOL HYDROCHLORIDE,5MG,20ML,INTRAVENOUS,Resolved,LIQUID,C07AG,BETA BLOCKING AGENTS,,2018-12-20,2019-02-04,2019-01-25,Demand increase for the drug.,2018-12-20,2019-02-04
14740,2391090,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LABETALOL HYDROCHLORIDE,LABETALOL HYDROCHLORIDE,5MG,1X20ML,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,,2017-10-05,,2017-11-13,Other (Please describe in comments),2017-07-05,2017-12-15
77737,2231689,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,LABETALOL HCl,LABETALOL HYDROCHLORIDE,5MG,20ml,INTRAVENOUS,Resolved,LIQUID,C07AG,BETA BLOCKING AGENTS,,2019-02-20,2019-05-31,2019-06-01,Demand increase for the drug.,2019-03-05,2019-06-28
60109,2391090,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,PFIZER CANADA INC,LABETALOL,LABETALOL HYDROCHLORIDE,5MG,1 x 20ML,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,,2018-11-15,,2019-05-21,Disruption of the manufacture of the drug.,2018-09-06,2019-05-22
89343,2391090,Shortage,LABETALOL HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,Labetalol,LABETALOL HYDROCHLORIDE,5MG,50x1mL Amp,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,,2019-07-15,,2019-08-27,Demand increase for the drug.,2019-07-15,2019-08-28
78454,2387468,Shortage,"LABETALOL HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"LABETALOL HYDROCHLORIDE INJECTION, USP",LABETALOL HYDROCHLORIDE,5MG,20ML 1VL,INTRAVENOUS,Actual shortage,SOLUTION,C07AG,BETA BLOCKING AGENTS,2019-09-10,,,,Demand increase for the drug.,2019-03-13,2019-09-11
10718,2387468,Shortage,"LABETALOL HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"LABETALOL HYDROCHLORIDE INJECTION, USP",LABETALOL HYDROCHLORIDE,5MG,20ML 1VL,INTRAVENOUS,Resolved,SOLUTION,C07AG,BETA BLOCKING AGENTS,2017-05-01,2018-05-05,,2019-03-08,Disruption of the manufacture of the drug.,2017-05-19,2019-03-09
24738,39470,Shortage,LACTATED RINGER'S INJECTION,HOSPIRA HEALTHCARE CORPORATION,Lactated Ringer’s Injection USP,SODIUM LACTATE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,3.1MG  0.2MG  0.3MG  6MG,1000ml,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2017-10-06,,2017-11-11,2017-10-30,Demand increase for the drug.,2017-10-06,2017-10-31
80329,61085,Shortage,LACTATED RINGERS INJ USP,BAXTER CORPORATION,Lactated Ringers Injection,SODIUM LACTATE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,310MG  20MG  30MG  600MG,1000 mL,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2019-04-02,2019-04-02,2019-05-01,2019-05-01,Shortage of an active ingredient.,2019-04-03,2019-05-02
78800,61085,Shortage,LACTATED RINGERS INJ USP,BAXTER CORPORATION,Lactated Ringers Injection,SODIUM LACTATE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,310MG  20MG  30MG  600MG,1000 mL,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2019-03-15,2019-03-15,2019-03-29,2019-03-29,Demand increase for the drug.,2019-03-15,2019-03-30
43073,2142104,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine tablets,LAMOTRIGINE,100MG,100's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-05-11,2018-06-08,2018-05-25,Shortage of an active ingredient.,2018-03-16,2018-05-26
22120,2142082,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine tablets,LAMOTRIGINE,25MG,100's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-01-11,2018-02-26,2018-02-15,Shortage of an active ingredient.,2017-09-14,2018-02-16
36734,2240115,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine tablets,LAMOTRIGINE,5MG,28's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-01-19,2018-01-26,2018-01-22,Demand increase for the drug.,2018-01-19,2018-01-23
20136,2142112,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine tablets,LAMOTRIGINE,150MG,60's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-10-26,2018-03-20,2018-03-15,Shortage of an active ingredient.,2017-08-23,2018-03-16
12467,2240115,Shortage,LAMICTAL,GLAXOSMITHKLINE INC,Lamotrigine chewable/dispersible tablets,LAMOTRIGINE,5MG,28's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-07-17,2017-09-07,2017-09-08,Shortage of an active ingredient.,2017-06-09,2017-09-13
59202,2302993,Shortage,LAMOTRIGINE-150,PRO DOC LIMITEE,LAMOTRIGINE,LAMOTRIGINE,150MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-08-27,,2018-08-30,Delay in shipping of the drug.,2018-08-27,2018-08-31
36177,2302969,Shortage,LAMOTRIGINE-25,PRO DOC LIMITEE,LAMOTRIGINE,LAMOTRIGINE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-08-03,,2018-08-28,Delay in shipping of the drug.,2018-01-17,2018-08-29
76304,2357682,Shortage,LANSOPRAZOLE,SANIS HEALTH INC,LANSOPRAZOLE CAP,LANSOPRAZOLE,15MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-03-29,2019-03-29,2020-03-31,,Disruption of the manufacture of the drug.,2019-02-19,2019-10-01
94266,2433001,Shortage,LANSOPRAZOLE,PHARMASCIENCE INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-02,2020-02-03,,Disruption of the manufacture of the drug.,2019-09-18,2019-09-18
8275,2385767,Shortage,LANSOPRAZOLE,SIVEM PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-05-03,,2017-05-15,2017-05-15,Demand increase for the drug.,2017-04-27,2017-05-18
67928,2433028,Shortage,LANSOPRAZOLE,PHARMASCIENCE INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-11-28,2019-02-20,2018-12-11,Disruption of the manufacture of the drug.,2018-11-29,2018-12-12
90467,2433028,Shortage,LANSOPRAZOLE,PHARMASCIENCE INC,LANZOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-08-01,2019-09-09,2019-12-16,,Disruption of the manufacture of the drug.,2019-07-31,2019-11-15
37275,2433001,Shortage,LANSOPRAZOLE,PHARMASCIENCE INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-01-24,,2018-09-18,Disruption of the manufacture of the drug.,2018-01-26,2018-09-19
72626,2433028,Shortage,LANSOPRAZOLE,PHARMASCIENCE INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-01-17,2019-04-15,2019-05-07,Disruption of the manufacture of the drug.,2019-01-16,2019-05-09
14792,2366282,Shortage,LANSOPRAZOLE,PRO DOC LIMITEE,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100-500,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-17,2017-10-17,2017-10-18,Delay in shipping of the drug.,2017-07-05,2017-10-19
67307,2357690,Shortage,LANSOPRAZOLE,SANIS HEALTH INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-12-12,2018-12-10,2020-03-31,,Disruption of the manufacture of the drug.,2018-11-21,2019-10-01
22773,2433028,Shortage,LANSOPRAZOLE,PHARMASCIENCE INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-15,2017-09-25,2017-10-09,Disruption of the manufacture of the drug.,2017-09-19,2017-10-11
98814,2453193,Shortage,LAX-A-DAY PHARMA,PHARMASCIENCE INC,LAX-A-DAY,POLYETHYLENE GLYCOL 3350,1G,NA,ORAL,Actual shortage,POWDER FOR SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2019-11-01,2019-12-16,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
98079,2170493,Shortage,LEDERLE LEUCOVORIN,PFIZER CANADA ULC,LEDERLE LEUCOVORIN,LEUCOVORIN,5MG,24,ORAL,Anticipated shortage,TABLET,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2019-11-18,2019-11-28,,Demand increase for the drug.,2019-11-06,2019-11-18
79973,2351668,Shortage,LEFLUNOMIDE,SANIS HEALTH INC,LEFLUNOMIDE,LEFLUNOMIDE,10MG,30,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2019-06-14,2019-06-10,2019-07-10,2019-07-05,Disruption of the manufacture of the drug.,2019-03-29,2019-07-06
82348,2415828,Shortage,LEFLUNOMIDE,PRO DOC LIMITEE,LEFLUNOMIDE,LEFLUNOMIDE,10MG,30,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2019-04-24,,2019-06-13,Delay in shipping of the drug.,2019-04-24,2019-06-14
70877,2415828,Shortage,LEFLUNOMIDE,PRO DOC LIMITEE,leflunomide,LEFLUNOMIDE,10MG,30,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2018-12-31,,2019-01-21,Delay in shipping of the drug.,2019-01-03,2019-01-22
76473,2468220,Shortage,LENVIMA,EISAI LIMITED,Lenvatinib,LENVATINIB,8MG,8mg daily-dose carton containing 6 blister cards (each 5-day blister card contains ten 4mg capsules),ORAL,Resolved,CAPSULE,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-02-19,,2019-02-28,Demand increase for the drug.,2019-02-21,2019-03-01
86601,2087316,Shortage,LEUCOVORIN CALCIUM INJECTION,TEVA CANADA LIMITED,LEUCOVORIN,LEUCOVORIN,10MG,50ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2019-07-15,2019-06-27,2019-10-30,2019-08-20,Delay in shipping of the drug.,2019-06-13,2019-08-21
93222,2183005,Shortage,LEUCOVORIN CALCIUM INJECTION USP,PFIZER CANADA ULC,LEUCOVORIN CALCIUM,LEUCOVORIN,10MG,5mL GVL,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2019-10-07,2020-09-30,,Disruption of the manufacture of the drug.,2019-09-06,2019-10-08
78918,2182998,Shortage,LEUCOVORIN CALCIUM INJECTION USP,PFIZER CANADA ULC,Leucovorin,LEUCOVORIN,10MG,50mL,INTRAVENOUS,Resolved,SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2019-04-26,2019-09-30,2019-08-19,Disruption of the manufacture of the drug.,2019-03-19,2019-08-20
14489,2183005,Shortage,LEUCOVORIN CALCIUM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Levoleucovorin Calcium,LEUCOVORIN,10MG,1x 5mL VIAL / AMPOULE,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2017-07-10,,2017-10-18,2017-10-17,Disruption of the manufacture of the drug.,2017-07-03,2017-10-18
2522,2182998,Shortage,LEUCOVORIN CALCIUM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Levoleucovorin Calcium,LEUCOVORIN,10MG,1 x 50mL,INTRAVENOUS,Resolved,LIQUID,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2017-03-14,2017-04-05,2017-07-06,2017-07-06,Disruption of the manufacture of the drug.,2017-03-14,2017-07-11
22279,4626,Shortage,LEUKERAN,ASPEN PHARMACARE CANADA INC.,Leukeran®,CHLORAMBUCIL,2MG,25 tablets,ORAL,Resolved,TABLET,L01AA,ALKYLATINGAGENTS,,2017-09-18,2017-10-27,2017-10-31,Delay in shipping of the drug.,2017-09-18,2017-11-16
67479,4626,Shortage,LEUKERAN,ASPEN PHARMACARE CANADA INC.,chlorambucil,CHLORAMBUCIL,2MG,25 tablets,ORAL,Resolved,TABLET,L01AA,ALKYLATINGAGENTS,,2018-11-23,2018-12-07,2018-12-04,Delay in shipping of the drug.,2018-11-23,2018-12-05
27719,271152,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride Tablets 50 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-01,2017-11-01
27733,306320,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride Tablets 25 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-01,2017-11-01
27744,405612,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride Tablets 75 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-01,2017-11-01
26818,293911,Shortage,LEVATE,BIOMED PHARMA,Amitriptyline Hydrochloride,,,100,,Actual shortage,,,,2014-10-23,2014-10-23,,,Other (Please describe in comments),2017-10-24,2017-10-26
25856,2353342,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-10-20,,2017-11-10,2017-11-09,Other (Please describe in comments),2017-10-13,2017-11-10
40452,2353342,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM TABS,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-03-02,2018-03-02,2018-03-30,2018-03-08,Other (Please describe in comments),2018-02-21,2018-03-09
53286,2454653,Shortage,LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-06-28,2019-01-22,2019-01-16,Disruption of the manufacture of the drug.,2018-06-29,2019-01-17
36916,2442531,Shortage,LEVETIRACETAM,SIVEM PHARMACEUTICALS ULC,LEVETIRACETAM,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-03-26,2018-03-16,2018-04-27,2018-04-27,Other (Please describe in comments),2018-01-22,2018-04-30
28226,2442566,Shortage,LEVETIRACETAM,SIVEM PHARMACEUTICALS ULC,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-11-13,2017-11-08,2018-04-27,2018-04-27,Other (Please describe in comments),2017-11-06,2018-04-30
89194,2442566,Shortage,LEVETIRACETAM,SIVEM PHARMACEUTICALS ULC,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Avoided shortage,TABLET,N03AX,ANTIEPILEPTICS,2019-08-19,,2019-09-20,2019-07-15,Delay in shipping of the drug.,2019-07-12,2019-07-15
46747,2454661,Shortage,LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,500MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-04-26,2018-05-04,2019-01-22,2019-01-16,Disruption of the manufacture of the drug.,2018-04-20,2019-01-17
27549,2353350,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM TAB,LEVETIRACETAM,500MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-11-07,,2017-11-30,2017-11-09,Other (Please describe in comments),2017-10-31,2017-11-10
46751,2454688,Shortage,LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,750MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-04-20,2019-01-22,2019-01-16,Disruption of the manufacture of the drug.,2018-04-20,2019-01-17
63410,2474468,Shortage,LEVETIRACETAM,LABORATOIRE RIVA INC,Levetiracetam,LEVETIRACETAM,250MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-10-05,2018-10-05,,2019-10-24,Disruption of the manufacture of the drug.,2018-10-05,2019-11-06
63415,2474484,Shortage,LEVETIRACETAM,LABORATOIRE RIVA INC,Levetiracetam,LEVETIRACETAM,750MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2018-10-05,2018-10-05,,,Disruption of the manufacture of the drug.,2018-10-05,2018-10-06
30910,2353369,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM TABS,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-12-04,,2017-12-29,2017-12-15,Other (Please describe in comments),2017-11-28,2017-12-16
83143,2353369,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-05-06,2019-06-14,2019-06-27,Disruption of the manufacture of the drug.,2019-05-06,2019-06-28
36055,2442558,Shortage,LEVETIRACETAM,SIVEM PHARMACEUTICALS ULC,LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-01-29,2018-01-29,2018-04-27,2018-04-27,Other (Please describe in comments),2018-01-16,2018-04-30
77536,2454653,Shortage,LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,250MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-01,2020-03-09,,Disruption of the manufacture of the drug.,2019-03-04,2019-09-12
77541,2454661,Shortage,LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,500MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-01,2020-02-17,,Disruption of the manufacture of the drug.,2019-03-04,2019-07-31
77544,2454688,Shortage,LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,750MG,120,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-01,2019-08-23,2019-06-28,Disruption of the manufacture of the drug.,2019-03-04,2019-06-29
64770,2250470,Shortage,LEVITRA,BAYER INC,Vardenafil tablets,VARDENAFIL,10MG,4's,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-11-09,,2019-01-31,2018-12-28,Disruption of the manufacture of the drug.,2018-10-18,2019-01-14
55646,2250489,Shortage,LEVITRA,BAYER INC,Vardenafil tablets,VARDENAFIL,20MG,4's,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-07-31,,2018-11-19,2018-11-06,Disruption of the manufacture of the drug.,2018-07-13,2018-11-14
49555,2250462,Shortage,LEVITRA,BAYER INC,Vardenafil tablets,VARDENAFIL,5MG,4's,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-06-30,,,,Disruption of the manufacture of the drug.,2018-05-16,2019-03-29
72120,2250470,Shortage,LEVITRA,BAYER INC,Vardenafil tablets,VARDENAFIL,10MG,4's,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2019-05-06,2019-05-02,,,Disruption of the manufacture of the drug.,2019-01-14,2019-05-27
43751,2250470,Shortage,LEVITRA,BAYER INC,Vardenafil Tablets,VARDENAFIL,10MG,4's,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-05-01,,2018-08-31,2018-08-13,Disruption of the manufacture of the drug.,2018-03-23,2018-08-14
26763,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA INC,LEVOFLOXACIN,LEVOFLOXACIN,5MG,24 X 50 mL,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017-10-31,,2018-02-02,Disruption of the manufacture of the drug.,2017-10-23,2018-02-02
26767,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA INC,LEVOFLOXACIN,LEVOFLOXACIN,5MG,24 X 150 mL,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017-10-20,,2017-12-20,Disruption of the manufacture of the drug.,2017-10-23,2017-12-21
1184,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,HOSPIRA HEALTHCARE CORPORATION,Levofloxacin,LEVOFLOXACIN,5MG,250mg / 50mL x 24  &  500mg/100mL x 24  &  750mg/150mL x24,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2015-11-09,2017-06-14,2017-06-14,Disruption of the manufacture of the drug.,2017-03-13,2017-06-15
26807,2314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA INC,LEVOFLOXACIN,LEVOFLOXACIN,5MG,24 X 100 mL,INTRAVENOUS,Resolved,SOLUTION,J01MA,QUINOLONE ANTIBACTERIALS,,2017-10-20,2017-12-07,2017-12-07,Disruption of the manufacture of the drug.,2017-10-24,2017-12-08
60222,2241981,Shortage,LEVOPHED,PFIZER CANADA INC,LEVOPHED,NOREPINEPHRINE,1MG,10 x 4mL,INTRAVENOUS,Avoided shortage,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2019-01-04,,,2018-09-19,Disruption of the manufacture of the drug.,2018-09-07,2018-09-19
1369,2241981,Shortage,LEVOPHED 1.0 MG/ML,HOSPIRA HEALTHCARE CORPORATION,Levophed,NOREPINEPHRINE,1MG,4 mg/4 mL x 10,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-03-08,2017-05-29,2017-05-29,Shortage of an active ingredient.,2017-03-13,2017-06-01
14743,2241981,Shortage,LEVOPHED 1.0 MG/ML,HOSPIRA HEALTHCARE CORPORATION,LEVOPHED,NOREPINEPHRINE,1MG,10x4ML,INTRAVENOUS,Resolved,SOLUTION,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-08-21,,2018-06-06,Other (Please describe in comments),2017-07-05,2018-06-07
52697,2163152,Shortage,LIDEMOL EMOLLIENT CREAM 0.05%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LIDEMOL EMOLLIENT CREAM 0.05%,FLUOCINONIDE,0.05%,30g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-06-07,,2018-06-21,Other (Please describe in comments),2018-06-20,2018-06-22
98655,2161974,Shortage,LIDEX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LIDEX,FLUOCINONIDE,0.05%,60g,TOPICAL,Actual shortage,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-10-31,,,Other (Please describe in comments),2019-11-13,2019-11-13
12390,2161923,Shortage,LIDEX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LIDEX,FLUOCINONIDE,0.05%,na,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-06-09,,2017-07-21,Other (Please describe in comments),2017-06-09,2017-07-22
3278,2161974,Shortage,LIDEX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LIDEX,FLUOCINONIDE,0.05%,60G,TOPICAL,Resolved,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2016-12-01,2017-04-07,2017-04-07,Disruption of the manufacture of the drug.,2017-03-17,2017-04-08
42273,2436221,Shortage,"LIDOCAINE 2% AND EPINEPHRINE 1:100,000 INJECTION",TELIGENT OU,LIDOCAINE AND EPINEPHRINE INJECTION,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.01MG,50 ML,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-03-07,2018-05-11,2018-05-03,Demand increase for the drug.,2018-03-08,2018-05-16
34258,2436221,Shortage,"LIDOCAINE 2% AND EPINEPHRINE 1:100,000 INJECTION",TELIGENT OU,LIDOCAINE AND EPINEPHRINE INJECTION,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.01MG,20 ML,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-12-08,2018-02-01,2018-02-01,Demand increase for the drug.,2017-12-22,2018-02-15
95574,828602,Shortage,LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ,BAXTER CORPORATION,LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ,DEXTROSE  LIDOCAINE HYDROCHLORIDE,50MG  4MG,500 mL (JB0973),INTRAVENOUS,Actual shortage,SOLUTION,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",2019-10-04,2019-10-04,2019-11-18,2019-11-18,Disruption of the manufacture of the drug.,2019-10-04,2019-11-18
39953,2421984,Shortage,LIDOCAINE HCL INJECTION,TELIGENT OU,Lidocaine Hydrochloride Injection,LIDOCAINE HYDROCHLORIDE,10MG,5 mL (GLASS AMPOULE),BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-02-01,2018-03-01,2018-03-09,Disruption of the manufacture of the drug.,2018-02-15,2018-03-10
73298,1901958,Shortage,LIDOCAINE HYDROCHLORIDE 1% AND EPINEPHRINE 1:100 000 INJECTION USP,HOSPIRA HEALTHCARE ULC,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,10MG  10MCG,25 x 20mL GVL MD,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2019-05-01,,,2019-03-25,Disruption of the manufacture of the drug.,2019-01-22,2019-03-26
2508,1901958,Shortage,LIDOCAINE HYDROCHLORIDE 1% AND EPINEPHRINE 1:100 000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,10MG  10MCG,25x20mL VIAL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-03-14,,2018-04-27,Disruption of the manufacture of the drug.,2017-03-14,2018-04-30
59943,1901915,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  10MCG,25x50mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-09-04,,2019-03-25,Disruption of the manufacture of the drug.,2018-09-04,2019-03-28
59946,1901915,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  10MCG,25x20mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-09-04,,2019-01-23,Disruption of the manufacture of the drug.,2018-09-04,2019-03-28
14509,1901915,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  10MCG,25x20mL VIAL/AMPOULE,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-05-16,,2018-04-03,Disruption of the manufacture of the drug.,2017-07-03,2018-04-04
59939,2439468,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:200000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.005MG,5x20mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-09-04,,2019-03-25,Disruption of the manufacture of the drug.,2018-09-04,2019-03-28
1479,2439468,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:200000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Lidocaine with Epinephrine,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.005MG,20mL x 5,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-02-02,,2017-03-13,Shortage of an inactive ingredient or component.,2017-03-13,2017-06-29
2503,2439468,Shortage,LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:200000 INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.005MG,5x20mL VIAL / AMPOULE,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-02-06,,2018-05-30,Disruption of the manufacture of the drug.,2017-03-14,2018-05-31
96746,1901915,Shortage,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP,PFIZER CANADA ULC,Lidocaine Hydrochloride and Epinephrine Injection USP,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.01MG,25 x 20mL GVLMD,BLOCK/INFILTRATION,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-07-30,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-17,2019-11-13
76551,436208,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,Lidocaine Hydrochloride Injection USP,LIDOCAINE HYDROCHLORIDE,20MG,10 x 5mL LifeShield,INTRAVENOUS,Resolved,SOLUTION,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2019-02-20,,2019-09-11,Disruption of the manufacture of the drug.,2019-02-21,2019-09-12
86522,436208,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,Lidocaine Hydrochloride Injection USP,LIDOCAINE HYDROCHLORIDE,20MG,10 x 5mL ANSYR,INTRAVENOUS,Actual shortage,SOLUTION,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2019-06-11,,,Disruption of the manufacture of the drug.,2019-06-12,2019-08-13
67632,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,10 x 2mL AMP,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-01-23,,2019-02-01,Disruption of the manufacture of the drug.,2018-11-26,2019-02-04
43083,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,5 x 5mL AMP,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-06-29,,2019-03-25,Disruption of the manufacture of the drug.,2018-03-16,2019-03-28
43086,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,25 x 20mL PVL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-04-06,,2018-04-13,Disruption of the manufacture of the drug.,2018-03-16,2018-04-14
51088,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,25 X 50mL PVL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-07-10,,2019-03-25,Disruption of the manufacture of the drug.,2018-06-01,2019-03-28
14747,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,10x2ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-04-16,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-24
14750,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,5x5ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-06-15,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-24
84418,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE ULC,Lidocaine,LIDOCAINE HYDROCHLORIDE,10MG,25 x 20mL vial,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-05-17,,2019-08-01,Disruption of the manufacture of the drug.,2019-05-18,2019-10-07
56792,884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 1%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,10MG,25 x 20 mL PVL MD,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-10-24,,2019-03-25,Disruption of the manufacture of the drug.,2018-07-27,2019-03-28
1295,1901982,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 2%,HOSPIRA HEALTHCARE CORPORATION,Lidocaine,LIDOCAINE HYDROCHLORIDE,20MG,5mL * 10,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2016-11-02,,2019-03-25,Other (Please describe in comments),2017-03-13,2019-03-28
30523,1901982,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 2%,HOSPIRA HEALTHCARE CORPORATION,Lidocaine HCL 2%,LIDOCAINE HYDROCHLORIDE,20MG,25x20mL PVL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-12-29,,2018-01-19,Disruption of the manufacture of the drug.,2017-11-23,2018-02-07
40799,1901982,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 2%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HYDROCHLORIDE,LIDOCAINE HYDROCHLORIDE,20MG,25X2mL AMP,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-04-06,,2018-10-18,Disruption of the manufacture of the drug.,2018-02-23,2018-10-19
49080,1901982,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP 2%,HOSPIRA HEALTHCARE CORPORATION,LIDOCAINE HCL,LIDOCAINE HYDROCHLORIDE,20MG,25 x 20mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-06-13,,2018-10-18,Disruption of the manufacture of the drug.,2018-05-11,2018-10-19
1029,2167603,Shortage,LIDODAN JELLY 2%(SINGLE USE SYRINGE),ODAN LABORATORIES LTD,"Lidocaine Hydrochloride Jelly, USP",LIDOCAINE HYDROCHLORIDE,2%,10 mL,TOPICAL,Actual shortage,JELLY,D04AB,"ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.",,2016-06-21,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
81157,2430827,Shortage,LINEZOLID INJECTION,FRESENIUS KABI CANADA LTD,Linezolid Injection,LINEZOLID,2MG,300mL,INTRAVENOUS,Resolved,SOLUTION,J01XX,OTHER ANTIBACTERIALS,2019-04-11,,2019-06-28,2019-07-04,Disruption of the manufacture of the drug.,2019-04-10,2019-07-05
90630,2430827,Shortage,LINEZOLID INJECTION,FRESENIUS KABI CANADA LTD,Linezolid,LINEZOLID,2MG,300mL,INTRAVENOUS,Resolved,SOLUTION,J01XX,OTHER ANTIBACTERIALS,2019-08-02,,2019-08-30,2019-09-13,Disruption of the manufacture of the drug.,2019-08-02,2019-09-14
1711,2402637,Shortage,LINEZOLID INJECTION,TEVA CANADA LIMITED,LINEZOLID,LINEZOLID,2MG,10,INTRAVENOUS,Actual shortage,SOLUTION,J01XX,OTHER ANTIBACTERIALS,,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
13392,2269074,Shortage,LIPIDIL EZ,BGP PHARMA ULC,LIPIDIL EZ,FENOFIBRATE,48MG,3x10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2019-01-17,2019-01-17,2019-09-05,2019-10-07,Delay in shipping of the drug.,2017-06-20,2019-10-08
3707,2269082,Shortage,LIPIDIL EZ,BGP PHARMA ULC,Lipidil,FENOFIBRATE,145MG,3 times 10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-24,,2017-06-14,Requirements related to complying with good manufacturing practices.,2017-03-20,2017-06-15
26008,2269074,Shortage,LIPIDIL EZ,BGP PHARMA ULC,LIPIDIL EZ,FENOFIBRATE,48MG,3x10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-26,,2017-11-06,Disruption of the manufacture of the drug.,2017-10-16,2017-11-07
80463,2241602,Shortage,LIPIDIL SUPRA,BGP PHARMA ULC,LIPIDIL SUPRA,FENOFIBRATE,160MG,3x10,ORAL,Avoided shortage,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2019-05-09,,2019-05-10,2019-04-30,Delay in shipping of the drug.,2019-04-03,2019-04-30
15035,2241602,Shortage,LIPIDIL SUPRA,BGP PHARMA ULC,LIPIDIL SUPRA,FENOFIBRATE,160MG,3x10,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-08,,2018-01-10,Requirements related to complying with good manufacturing practices.,2017-07-10,2018-01-11
57419,386685,Shortage,LIPIODOL ULTRA FLUID,GUERBET,Ethiodized Oil Injection,IODINE,380MG,10 mL,PARENTERAL (UNSPECIFIED)  INTRACAVITARY,Resolved,LIQUID,V08AD,"X-RAY CONTRAST MEDIA, IODINATED",2018-08-10,,2018-10-05,2018-10-02,Delay in shipping of the drug.,2018-08-03,2018-10-03
55552,2458640,Shortage,LIXIANA,SERVIER CANADA INC,LIXIANA,EDOXABAN,15MG,30,ORAL,Resolved,TABLET,B01AF,ANTITHROMBOTIC AGENTS,,2018-06-26,2018-07-30,2018-07-30,Delay in shipping of the drug.,2018-07-12,2018-07-31
38941,224235,Shortage,LMD 10% IN DEXTROSE 5%,PFIZER CANADA INC,LMD,DEXTROSE  DEXTRAN,50MG  100MG,12x500mL PLBG,INTRAVENOUS,Resolved,SOLUTION,B05AA,BLOOD AND RELATED PRODUCTS,,2018-03-14,,2018-07-04,Disruption of the manufacture of the drug.,2018-02-06,2018-07-05
84660,224235,Shortage,LMD 10% IN DEXTROSE 5%,PFIZER CANADA ULC,LMD 10 % in Dextrose 5%,DEXTROSE  DEXTRAN,50MG  100MG,12 x 500mL PLBG,INTRAVENOUS,Resolved,SOLUTION,B05AA,BLOOD AND RELATED PRODUCTS,,2019-05-24,2019-06-17,2019-06-10,Disruption of the manufacture of the drug.,2019-05-24,2019-06-11
95217,74462,Shortage,LOCACORTEN VIOFORM,PALADIN LABS INC,Locacorten Vioform Cream,FLUMETHASONE PIVALATE  CLIOQUINOL,0.02%  3%,30g cream,TOPICAL,Actual shortage,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-09-20,,,Delay in shipping of the drug.,2019-10-02,2019-10-02
94432,74454,Shortage,LOCACORTEN VIOFORM EARDROPS,PALADIN LABS INC,Locacorten Vioform Eardrops,FLUMETHASONE PIVALATE  CLIOQUINOL,0.02%  1%,11mL,OTIC,Actual shortage,DROPS,S02CA,CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION,2019-09-20,2019-09-20,2019-12-15,,Delay in shipping of the drug.,2019-09-20,2019-09-21
77834,2373955,Shortage,LODALIS,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LODALIS,Colesevelam hydrochloride,625MG,180's,ORAL,Resolved,TABLET,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2019-03-11,,,2019-04-01,Other (Please describe in comments),2019-03-05,2019-04-03
66589,2373955,Shortage,LODALIS,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LODALIS,Colesevelam hydrochloride,625MG,180,ORAL,Resolved,TABLET,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2018-11-30,,,2018-12-07,Other (Please describe in comments),2018-11-09,2018-12-14
11363,2373955,Shortage,LODALIS,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LODALIS,Colesevelam hydrochloride,625MG,NA,ORAL,Resolved,TABLET,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-26,2017-06-01,2017-06-01,Other (Please describe in comments),2017-05-26,2017-06-02
96089,297143,Shortage,LOESTRIN 1.5/30,ALLERGAN INC,LOESTRIN,ETHINYL ESTRADIOL  NORETHINDRONE ACETATE,30MCG  1.5MG,21,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-10-10,2019-10-10,2019-11-15,2019-11-13,Disruption of the manufacture of the drug.,2019-10-10,2019-11-14
96098,353027,Shortage,LOESTRIN 1.5/30,ALLERGAN INC,LOESTRIN,ETHINYL ESTRADIOL  NORETHINDRONE ACETATE,30MCG  1.5MG,28,ORAL,Actual shortage,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-10-10,2019-10-10,2019-12-13,,Disruption of the manufacture of the drug.,2019-10-10,2019-10-11
91339,2417456,Shortage,LOLO,ALLERGAN INC,LOLO 1MG/10MCG+10MCG TAB 1X28 CA,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORETHINDRONE ACETATE,10MCG  10MCG  1MG,28,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-08-11,2019-08-11,2019-09-06,2019-09-05,Disruption of the manufacture of the drug.,2019-08-11,2019-09-06
14416,36323,Shortage,LOMOTIL,PFIZER CANADA INC,Lomotil,ATROPINE SULFATE  DIPHENOXYLATE HYDROCHLORIDE,.025MG  2.5MG,250's,ORAL,Avoided shortage,TABLET,A07DA,ANTIPROPULSIVES,2017-08-25,,2017-08-25,2017-08-14,Disruption of the manufacture of the drug.,2017-06-29,2017-08-15
61249,2225182,Shortage,LOPERAMIDE-2,PRO DOC LIMITEE,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,500,ORAL,Resolved,TABLET,A07DA,ANTIPROPULSIVES,,2018-09-11,,2018-12-05,Delay in shipping of the drug.,2018-09-11,2018-12-06
11438,397431,Shortage,LOPRESOR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR 100MG TABS 100'S,METOPROLOL TARTRATE,100MG,1 X 100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-05-31,2017-07-20,2018-05-31,2017-07-20,Disruption of the manufacture of the drug.,2017-05-29,2018-01-09
27902,397423,Shortage,LOPRESOR 50MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR 50 MG TABS 100'S,METOPROLOL TARTRATE,50MG,100's,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017-12-20,2017-12-17,,2017-12-17,Disruption of the manufacture of the drug.,2017-11-02,2018-01-09
31273,658855,Shortage,LOPRESOR SR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 100MG 100'S,METOPROLOL TARTRATE,100MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,2018-02-06,2018-02-01,2018-06-26,2018-06-27,Disruption of the manufacture of the drug.,2017-11-30,2018-06-28
82741,658855,Shortage,LOPRESOR SR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 100MG TABS 100'S,METOPROLOL TARTRATE,100MG,100's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-04-25,2019-08-16,2019-08-08,Other (Please describe in comments),2019-04-29,2019-08-12
55437,658855,Shortage,LOPRESOR SR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 100MG 250'S,METOPROLOL TARTRATE,100MG,250'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,2018-08-20,2018-07-18,2018-10-16,2018-10-16,Delay in shipping of the drug.,2018-07-11,2018-10-24
79064,658855,Shortage,LOPRESOR SR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 100MG TABS 100'S,METOPROLOL TARTRATE,100MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-03-21,2019-04-23,2019-03-26,Other (Please describe in comments),2019-03-21,2019-03-27
79071,658855,Shortage,LOPRESOR SR 100MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 100MG TABS  250'S,METOPROLOL TARTRATE,100MG,250'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-03-21,2019-08-16,2019-08-12,Other (Please describe in comments),2019-03-21,2019-08-13
79076,534560,Shortage,LOPRESOR SR 200 MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 200MG TABS 100'S,METOPROLOL TARTRATE,200MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-03-21,2019-08-16,2019-08-08,Other (Please describe in comments),2019-03-21,2019-08-12
79079,534560,Shortage,LOPRESOR SR 200 MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 200MG TABS 250'S,METOPROLOL TARTRATE,200MG,250'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,2019-03-21,2019-03-21,2019-08-16,2019-08-08,Other (Please describe in comments),2019-03-21,2019-08-12
94696,534560,Shortage,LOPRESOR SR 200 MG,NOVARTIS PHARMACEUTICALS CANADA INC,LOPRESOR SR 200MG TABS 100'S,METOPROLOL TARTRATE,200MG,100'S,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-09-25,2020-01-10,,Other (Please describe in comments),2019-09-25,2019-11-15
96003,2221802,Shortage,LOPROX CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,LOPROX CREAM,CICLOPIROX OLAMINE,1%,60g,TOPICAL,Resolved,CREAM,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2019-10-08,,2019-10-18,Other (Please describe in comments),2019-10-10,2019-10-23
17964,2351072,Shortage,LORAZEPAM,SANIS HEALTH INC,LORAZEPAM TAB,LORAZEPAM,0.5MG,100,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2016-11-03,,,Disruption of the manufacture of the drug.,2017-08-02,2017-10-05
30518,2388669,Shortage,LORAZEPAM INJECTION USP,PFIZER CANADA INC,LORAZEPAM,LORAZEPAM,4MG,10x1mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05BA,ANXIOLYTICS,,2017-12-15,,2018-01-05,Demand increase for the drug.,2017-11-23,2018-02-07
6750,2388669,Shortage,LORAZEPAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,LORAZEPAM,LORAZEPAM,4MG,10 x 1mL Vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05BA,ANXIOLYTICS,2017-04-28,,2017-10-31,2017-10-30,Disruption of the manufacture of the drug.,2017-04-13,2017-11-06
54292,2394367,Shortage,LOSARTAN,PRO DOC LIMITEE,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-04,,,Other (Please describe in comments),2018-07-04,2018-09-21
89634,2388790,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-08-12,2019-08-08,,,Delay in shipping of the drug.,2019-07-19,2019-08-12
39743,2394383,Shortage,LOSARTAN,PRO DOC LIMITEE,LOSARTAN,LOSARTAN POTASSIUM,100MG,30-100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-02-14,,,Other (Please describe in comments),2018-02-14,2018-09-21
87882,2388804,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-07-25,,,,Delay in shipping of the drug.,2019-06-28,2019-08-05
89940,2388863,Shortage,LOSARTAN,SANIS HEALTH INC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-25,,,Disruption of the manufacture of the drug.,2019-07-25,2019-07-26
84342,2388812,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Avoided shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-27,,2019-06-07,2019-05-24,Demand increase for the drug.,2019-05-17,2019-05-24
75405,2388804,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-03-08,2019-03-06,2019-05-01,2019-05-04,Demand increase for the drug.,2019-02-12,2019-05-06
89756,2388812,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-07-29,,,,Requirements related to complying with good manufacturing practices.,2019-07-22,2019-08-05
24761,2394375,Shortage,LOSARTAN,PRO DOC LIMITEE,LOSARTAN,LOSARTAN POTASSIUM,50MG,30-100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-10-06,,,Other (Please describe in comments),2017-10-06,2018-09-21
28089,2388790,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-11-13,2017-11-06,2018-04-03,2018-04-02,Delay in shipping of the drug.,2017-11-06,2018-04-03
75993,2388812,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-03-11,2019-03-11,2019-05-03,2019-05-02,Demand increase for the drug.,2019-02-15,2019-05-06
78308,2388804,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,50MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-01,2019-05-01,,,Demand increase for the drug.,2019-03-11,2019-08-05
78311,2388812,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,100MG,30,ORAL,Avoided shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-03-26,,2019-03-27,2019-03-25,Demand increase for the drug.,2019-03-11,2019-03-25
86766,2388812,Shortage,LOSARTAN,SIVEM PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,100MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-07-01,2019-07-05,,,Demand increase for the drug.,2019-06-17,2019-08-05
67318,2388863,Shortage,LOSARTAN,SANIS HEALTH INC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-21,,2019-07-25,Shortage of an active ingredient.,2018-11-21,2019-07-26
82935,2388898,Shortage,LOSARTAN,SANIS HEALTH INC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-01,,,Disruption of the manufacture of the drug.,2019-05-01,2019-05-02
82938,2388871,Shortage,LOSARTAN,SANIS HEALTH INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-01,,,Disruption of the manufacture of the drug.,2019-05-01,2019-05-02
67324,2388871,Shortage,LOSARTAN,SANIS HEALTH INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-16,2019-01-11,,2019-02-19,Shortage of an active ingredient.,2018-11-21,2019-02-20
67327,2388898,Shortage,LOSARTAN,SANIS HEALTH INC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-16,,,2019-01-31,Shortage of an active ingredient.,2018-11-21,2019-02-26
79370,2388979,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-04-12,2019-04-11,2019-08-30,2019-08-26,Delay in shipping of the drug.,2019-03-25,2019-08-29
78886,2388979,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-04-05,2019-04-08,,,Delay in shipping of the drug.,2019-03-18,2019-08-05
74303,2388979,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-02-11,2019-02-18,2019-03-08,2019-03-08,Requirements related to complying with good manufacturing practices.,2019-02-01,2019-03-11
46976,2388979,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-05-18,2018-05-08,2018-06-08,2018-06-04,Delay in shipping of the drug.,2018-04-23,2018-06-26
84359,2388960,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-06-12,2019-06-12,,,Shortage of an active ingredient.,2019-05-17,2019-08-05
84362,2388987,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-07-01,2019-07-04,,,Shortage of an active ingredient.,2019-05-17,2019-08-05
10654,2388979,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-05-18,,2017-06-06,2017-06-04,Demand increase for the drug.,2017-05-18,2017-11-03
95656,2388960,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-10-07,,,2019-10-18,Delay in shipping of the drug.,2019-10-07,2019-10-19
91360,2388960,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-08-12,,2019-08-30,2019-08-26,Delay in shipping of the drug.,2019-08-12,2019-08-29
86777,2388987,Shortage,LOSARTAN HCT,SIVEM PHARMACEUTICALS ULC,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-11-11,2019-11-11,,,Delay in shipping of the drug.,2019-06-17,2019-11-12
25154,2394405,Shortage,LOSARTAN-HCTZ,PRO DOC LIMITEE,LOSARTAN-HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-10-10,,,Other (Please describe in comments),2017-10-10,2018-09-21
28269,2394413,Shortage,LOSARTAN-HCTZ,PRO DOC LIMITEE,LOSARTAN-HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30-100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-11-06,,,Other (Please describe in comments),2017-11-06,2018-09-21
46961,2394391,Shortage,LOSARTAN-HCTZ,PRO DOC LIMITEE,LOSARTAN-HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30-100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-04-23,,,Other (Please describe in comments),2018-04-23,2018-09-21
67312,2427648,Shortage,LOSARTAN/HCTZ,SANIS HEALTH INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-21,,,Shortage of an active ingredient.,2018-11-21,2018-11-22
67315,2427664,Shortage,LOSARTAN/HCTZ,SANIS HEALTH INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-21,,2019-02-19,Shortage of an active ingredient.,2018-11-21,2019-02-20
67321,2427656,Shortage,LOSARTAN/HCTZ,SANIS HEALTH INC,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-12-12,2018-12-10,,,Shortage of an active ingredient.,2018-11-21,2018-12-11
82941,2427664,Shortage,LOSARTAN/HCTZ,SANIS HEALTH INC,LOSARTAN/HTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-06-03,,,,Disruption of the manufacture of the drug.,2019-05-01,2019-06-04
67310,2230737,Shortage,LOSEC 10 MG,ASTRAZENECA CANADA INC,omeprazole magnesium delayed release tablets,OMEPRAZOLE,10MG,2 x 15,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-12-14,2018-12-14,,,Other (Please describe in comments),2018-11-21,2019-11-18
55690,2321114,Shortage,LOTEMAX,BAUSCH & LOMB INC,LOTEMAX,LOTEPREDNOL ETABONATE,0.5%,10ml,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,2018-08-09,,2018-08-31,2018-08-23,Other (Please describe in comments),2018-07-13,2018-08-24
67787,2321114,Shortage,LOTEMAX,BAUSCH & LOMB INC,LOTEMAX,LOTEPREDNOL ETABONATE,0.5%,10ml,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-01-09,,2019-02-05,Other (Please describe in comments),2018-11-28,2019-02-06
6449,2435853,Shortage,LOTEMAX GEL,BAUSCH & LOMB INC,LOTEMAX GEL,LOTEPREDNOL ETABONATE,0.5%,5,OPHTHALMIC,Resolved,GEL,S01BA,ANTIINFLAMMATORY AGENTS,,2018-04-11,,2018-05-30,Other (Please describe in comments),2017-04-11,2018-06-08
56807,2435853,Shortage,LOTEMAX GEL,BAUSCH & LOMB INC,LOTEMAX GEL,LOTEPREDNOL ETABONATE,0.5%,5gm,OPHTHALMIC,Resolved,GEL,S01BA,ANTIINFLAMMATORY AGENTS,,2018-09-05,,2018-09-07,Other (Please describe in comments),2018-07-27,2018-09-27
6446,2421941,Shortage,LOTEMAX OINTMENT,BAUSCH & LOMB INC,LOTEMAX OINTMENT,LOTEPREDNOL ETABONATE,0.5%,3.5,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,2017-07-01,,2017-07-08,2018-03-01,Other (Please describe in comments),2017-04-11,2018-03-13
84598,2421941,Shortage,LOTEMAX OINTMENT,BAUSCH & LOMB INC,LOTEMAX OINTMENT,LOTEPREDNOL ETABONATE,0.5%,3.5mg,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,,2019-05-17,,2019-07-09,Other (Please describe in comments),2019-05-23,2019-07-24
43730,2421941,Shortage,LOTEMAX OINTMENT,BAUSCH & LOMB INC,LOTEMAX OINTMENT,LOTEPREDNOL ETABONATE,0.5%,n/a,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,,2018-03-16,,2018-05-30,Other (Please describe in comments),2018-03-22,2018-06-01
25088,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,50,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017-10-16,2017-10-11,2017-11-17,2017-11-15,Delay in shipping of the drug.,2017-10-10,2017-11-16
11522,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,15g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017-06-06,2017-06-01,2017-09-22,2017-09-22,Delay in shipping of the drug.,2017-05-30,2017-09-23
95027,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,clotrimazole and betamethasone dipropionate cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,50gr tube,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2019-11-01,2019-11-01,2019-11-18,2019-11-01,Delay in shipping of the drug.,2019-09-30,2019-11-02
83004,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,clotrimazole and betamethasone dipropionate cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,15gr tube,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2019-07-05,2019-07-04,2019-07-19,2019-07-19,Delay in shipping of the drug.,2019-05-02,2019-07-20
30269,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,50g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017-11-23,2017-11-23,2017-12-04,2017-12-04,Delay in shipping of the drug.,2017-11-23,2017-12-05
83007,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,clotrimazole and betamethasone dipropionate cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,50gm tube,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2019-08-12,2019-08-02,2019-08-19,2019-08-14,Delay in shipping of the drug.,2019-05-02,2019-08-15
7803,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,50g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017-05-08,2017-05-11,2017-09-22,2017-09-25,Delay in shipping of the drug.,2017-04-24,2017-09-26
28284,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,Clotrimazole and Betamethasone Dipropionate Cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,15g,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2017-11-13,2017-11-09,2017-12-04,2017-12-04,Delay in shipping of the drug.,2017-11-06,2017-12-05
69109,611174,Shortage,LOTRIDERM CREAM,MERCK CANADA INC,clotrimazole and betamethasone dipropionate cream,BETAMETHASONE  CLOTRIMAZOLE,0.05%  1%,50gm,TOPICAL,Resolved,CREAM,D01AC,ANTIFUNGALS FOR TOPICAL USE,2019-01-04,2018-12-21,2019-01-18,2019-01-17,Delay in shipping of the drug.,2018-12-11,2019-01-18
87568,2353229,Shortage,LOVASTATIN,SANIS HEALTH INC,LOVASTATIN,LOVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-27,2019-07-10,2019-07-25,Disruption of the manufacture of the drug.,2019-06-27,2019-07-26
83036,2012472,Shortage,LOVENOX,SANOFI-AVENTIS CANADA INC,Lovenox,ENOXAPARIN SODIUM,30MG,10,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2019-05-03,2019-05-15,2019-05-15,Delay in shipping of the drug.,2019-05-03,2019-05-28
84930,2378434,Shortage,LOVENOX,SANOFI-AVENTIS CANADA INC,Lovenox,ENOXAPARIN SODIUM,80MG,10,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,2019-05-29,,2019-06-15,2019-06-06,Delay in shipping of the drug.,2019-05-28,2019-06-07
2476,2242692,Shortage,LOVENOX HP,SANOFI-AVENTIS CANADA INC,Lovenox HP 120mg,ENOXAPARIN SODIUM,120MG,10,SUBCUTANEOUS,Resolved,SOLUTION,B01AB,ANTITHROMBOTIC AGENTS,,2017-03-03,2017-04-14,2017-03-28,Other (Please describe in comments),2017-03-14,2017-03-29
71480,2179709,Shortage,LOZIDE,SERVIER CANADA INC,LOZIDE,INDAPAMIDE,1.25MG,30,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2019-01-07,2019-02-28,2019-03-15,Delay in shipping of the drug.,2019-01-08,2019-03-18
71483,564966,Shortage,LOZIDE,SERVIER CANADA INC,LOZIDE,INDAPAMIDE,2.5MG,30,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2019-01-07,2019-01-31,2019-01-17,Delay in shipping of the drug.,2019-01-08,2019-01-18
98230,2179709,Shortage,LOZIDE,SERVIER CANADA INC,lozide 1.25 mg,INDAPAMIDE,1.25MG,30,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2019-11-11,,2019-11-14,,Delay in shipping of the drug.,2019-11-08,2019-11-12
5736,2245860,Shortage,LUMIGAN,ALLERGAN INC,"Lumigan 0,03% 3 mL",BIMATOPROST,0.03%,3ML,OPHTHALMIC,Actual shortage,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2011-04-01,,,Other (Please describe in comments),2017-04-05,2017-10-05
2113,2242934,Shortage,LUSTRA-AF,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Lustra-AF,OCTINOXATE  HYDROQUINONE  AVOBENZONE,7.5%  4%  3%,28.4 g,TOPICAL,Resolved,CREAM,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2015-01-01,2015-01-01,,2015-06-30,Disruption of the manufacture of the drug.,2017-03-14,2019-08-19
4514,2046202,Shortage,LUTREPULSE,FERRING INC,LUTREPULSE,GONADORELIN ACETATE,3.2MG,3 VIALS 3.2 MG LUTREPULSE FOR INJECTION,INTRAVENOUS  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,H01CA,HYPOTHALAMIC HORMONES,2017-03-28,2017-03-28,,,Other (Please describe in comments),2017-03-28,2019-01-10
4516,2046202,Shortage,LUTREPULSE,FERRING INC,LUTREPULSE,GONADORELIN ACETATE,3.2MG,3 VIALS 3.2 MG LUTREPULSE FOR INJECTION,INTRAVENOUS  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,H01CA,HYPOTHALAMIC HORMONES,,2017-03-28,,2019-01-10,Other (Please describe in comments),2017-03-28,2019-01-11
32677,2269066,Shortage,LUVERIS,EMD SERONO A DIVISION OF EMD INC CANADA,Lutropin Alpha for injection,LUTROPIN ALFA,75UNIT,1 x 75 IU vial,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2017-12-13,,2017-12-22,2017-12-20,Demand increase for the drug.,2017-12-13,2017-12-21
50104,2269066,Shortage,LUVERIS,EMD SERONO A DIVISION OF EMD INC CANADA,Lutropin Alpha for injection,LUTROPIN ALFA,75UNIT,1 x 75 IU vial,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2018-05-28,,2018-06-08,Demand increase for the drug.,2018-05-23,2018-06-09
29285,1919342,Shortage,LUVOX,BGP PHARMA ULC,LUVOX,FLUVOXAMINE MALEATE,50MG,2x15,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-03-16,2018-04-13,2018-04-13,Demand increase for the drug.,2017-11-15,2018-04-16
30124,1919369,Shortage,LUVOX,BGP PHARMA ULC,LUVOX,FLUVOXAMINE MALEATE,100MG,2x15,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-11-22,2018-04-20,2018-04-27,Demand increase for the drug.,2017-11-22,2018-04-28
57606,2366924,Shortage,LUXIQ,MAYNE PHARMA INC,Betamethasone Valerate,BETAMETHASONE VALERATE,0.12%,12g and 100 g,TOPICAL,Actual shortage,"AEROSOL, FOAM",D07AC,"CORTICOSTEROIDS, PLAIN",2018-09-30,2018-08-03,2019-02-28,,Other (Please describe in comments),2018-08-07,2018-08-07
89692,716863,Shortage,LYDERM CREAM 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",LYDERM CREAM 0.05%,FLUOCINONIDE,0.05%,400 g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-07-05,2019-09-13,2019-09-06,Disruption of the manufacture of the drug.,2019-07-19,2019-09-09
50371,716863,Shortage,LYDERM CREAM 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",LYDERM CREAM,FLUOCINONIDE,0.05%,400G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-05-23,2018-06-15,2018-06-15,Disruption of the manufacture of the drug.,2018-05-25,2018-06-18
50374,716863,Shortage,LYDERM CREAM 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",LYDERM CREAM,FLUOCINONIDE,0.05%,60G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-05-23,2018-06-07,2018-06-15,Disruption of the manufacture of the drug.,2018-05-25,2018-06-18
87394,2236997,Shortage,LYDERM GEL 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",LYDERM GEL 0.05%,FLUOCINONIDE,0.05%,15 g,TOPICAL,Resolved,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-06-17,2019-08-09,2019-08-09,Disruption of the manufacture of the drug.,2019-06-24,2019-08-19
87397,2236997,Shortage,LYDERM GEL 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",LYDERM GEL 0.05%,FLUOCINONIDE,0.05%,50 g,TOPICAL,Resolved,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-06-17,2019-07-31,2019-07-12,Disruption of the manufacture of the drug.,2019-06-24,2019-07-15
81626,2236997,Shortage,LYDERM GEL 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",LYDERM GEL 0.05%,FLUOCINONIDE,0.05%,60 g,TOPICAL,Resolved,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-03-29,2019-04-26,2019-04-18,Disruption of the manufacture of the drug.,2019-04-15,2019-04-23
98295,2236997,Shortage,LYDERM GEL 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",LYDERM GEL 0.05%,FLUOCINONIDE,0.05%,60 g,TOPICAL,Actual shortage,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-11-05,2019-11-29,,Disruption of the manufacture of the drug.,2019-11-09,2019-11-08
24209,2236996,Shortage,LYDERM OINTMENT 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Lyderm Ointment,FLUOCINONIDE,0.05%,60 g,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-05-23,2018-06-15,2018-06-15,Disruption of the manufacture of the drug.,2017-10-03,2018-06-18
57276,463221,Shortage,LYSODREN,BRISTOL-MYERS SQUIBB CANADA,Mitotane,MITOTANE,500MG,1 BTL x 100,ORAL,Resolved,TABLET,L01XX,OTHER ANTINEOPLASTIC AGENTS,2018-12-28,,2018-12-28,2019-01-02,Delay in shipping of the drug.,2018-08-01,2019-01-04
76042,2019965,Shortage,M-ESLON,ETHYPHARM INC,morphine sulfate extended release capsules 100 mg,MORPHINE SULFATE,100MG,Blister pack of 20 capsules,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2019-03-01,,2019-04-20,2019-05-08,Delay in shipping of the drug.,2019-02-15,2019-05-09
68166,2019965,Shortage,M-ESLON,ETHYPHARM INC,morphine sulfate extended release capsules 100mg,MORPHINE SULFATE,100MG,bottle of 50 capsules,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2018-11-29,2018-11-29,,2018-12-17,Delay in shipping of the drug.,2018-11-29,2018-12-18
68170,2177757,Shortage,M-ESLON,ETHYPHARM INC,morphine sulfate extended release capsules 200 mg,MORPHINE SULFATE,200MG,bottle of 50 capsules,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2018-12-15,,2019-01-15,2019-01-02,Delay in shipping of the drug.,2018-11-29,2019-01-15
38835,2019957,Shortage,M-ESLON,ETHYPHARM INC,morphine sulfate extended release capsules 60mg,MORPHINE SULFATE,60MG,20 capules,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2018-02-15,,,2018-03-14,Disruption of the manufacture of the drug.,2018-02-06,2018-03-27
34025,2019965,Shortage,M-ESLON,ETHYPHARM INC,morphine sulfate,MORPHINE SULFATE,100MG,Blister pack of 20 capsules,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N02AA,OPIOIDS,2017-12-20,2017-12-20,2018-01-05,2018-01-24,Delay in shipping of the drug.,2017-12-20,2018-01-25
83513,466085,Shortage,M-M-R II,MERCK CANADA INC,"(measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection",MUMPS VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,5000UNIT  1000UNIT  1000UNIT,10X1DOSE VIAL,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,,2019-05-08,2019-06-07,2019-05-31,Demand increase for the drug.,2019-05-08,2019-06-01
4420,466085,Shortage,M-M-R II,MERCK CANADA INC,"(measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection",MEASLES VIRUS VACCINE LIVE ATTENUATED; MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN); RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN),0.5 mL dose after reconstitution  Measles: ≥1000 CCID50  Mumps: ≥5000 CCID50  Rubella: ≥1000 CCID50,10x1dose,Subcutaneous,Resolved,Powder For Solution,J07BD,VIRAL VACCINES,2017-05-10,2017-05-11,2017-05-20,2017-05-12,Requirements related to complying with good manufacturing practices.,2017-03-27,2017-05-15
85460,466085,Shortage,M-M-R II,MERCK CANADA INC,"(measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection",MUMPS VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,5000UNIT  1000UNIT  1000UNIT,10X1DOSE VIAL,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,2019-06-03,2019-06-03,2019-07-31,2019-07-08,Demand increase for the drug.,2019-06-03,2019-07-09
18919,466085,Shortage,M-M-R II,MERCK CANADA INC,"(measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection",MUMPS VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,5000UNIT  1000UNIT  1000UNIT,0.5ML 10X1DOSE VIAL,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,2017-09-27,2017-09-27,2017-10-06,2017-10-02,Delay in shipping of the drug.,2017-08-11,2017-10-03
14319,2063662,Shortage,MACROBID,ALLERGAN PHARMA CO.,Macrobid,NITROFURANTOIN,100MG,100 tabs,ORAL,Resolved,CAPSULE,J01XE,OTHER ANTIBACTERIALS,2017-07-25,,2017-08-04,2017-08-04,Other (Please describe in comments),2017-06-29,2017-10-04
50924,2139499,Shortage,MAGNESIUM SULFATE INJECTION,FRESENIUS KABI CANADA LTD,Magnesium Sulphate,MAGNESIUM SULFATE,500MG,10mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2018-05-28,,,2018-10-24,Disruption of the manufacture of the drug.,2018-05-30,2018-10-25
50929,2139499,Shortage,MAGNESIUM SULFATE INJECTION,FRESENIUS KABI CANADA LTD,Magnesium Sulphate,MAGNESIUM SULFATE,500MG,50mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2018-05-28,,,2018-10-24,Disruption of the manufacture of the drug.,2018-05-30,2018-10-25
2563,1927639,Shortage,MAJEPTIL TAB 10MG,ERFA CANADA 2012 INC,Majeptil,Majeptil,10 mg,bottle of 100,Oral,Resolved,tablets,N05AB,ANTIPSYCHOTICS,2013-06-11,2013-06-11,,2018-03-14,Shortage of an active ingredient.,2017-03-14,2018-12-11
2448,499013,Shortage,MANDELAMINE,ERFA CANADA 2012 INC,"Methenamine Mandelate,USP",Methenamine Mandelate,500 mg,bottle,Oral,Actual shortage,tablet,J01XX,OTHER ANTIBACTERIALS,2018-01-27,2018-01-27,,,Disruption of the manufacture of the drug.,2017-03-14,2019-11-07
66586,2166747,Shortage,MANERIX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MANERIX,MOCLOBEMIDE,300MG,60,ORAL,Resolved,TABLET,N06AG,ANTIDEPRESSANTS,,2019-01-25,,2019-02-11,Other (Please describe in comments),2018-11-09,2019-02-12
45133,899356,Shortage,MANERIX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MANERIX,MOCLOBEMIDE,150MG,n/a,ORAL,Resolved,TABLET,N06AG,ANTIDEPRESSANTS,2018-04-23,,,2018-04-26,Other (Please describe in comments),2018-04-06,2018-04-27
98652,899356,Shortage,MANERIX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MANERIX,MOCLOBEMIDE,150MG,60,ORAL,Actual shortage,TABLET,N06AG,ANTIDEPRESSANTS,,2019-10-24,,,Other (Please describe in comments),2019-11-13,2019-11-13
16626,38024,Shortage,MANNITOL 25%,HOSPIRA HEALTHCARE CORPORATION,Mannitol,MANNITOL,250MG,25x50mL,INTRAVENOUS,Resolved,SOLUTION,B05BC,I.V. SOLUTIONS,,2017-11-28,,2018-02-22,Disruption of the manufacture of the drug.,2017-07-21,2018-02-23
76861,38024,Shortage,MANNITOL INJECTION USP,PFIZER CANADA ULC,Mannitol Injection USP,MANNITOL,250MG,25 x 50mL GVL,INTRAVENOUS,Actual shortage,SOLUTION,B05BC,I.V. SOLUTIONS,,2019-07-02,2020-01-31,,Disruption of the manufacture of the drug.,2019-02-26,2019-11-08
43095,38016,Shortage,MANNITOL INJECTION USP,ICU MEDICAL CANADA INC,Mannitol 20% injection USP,MANNITOL,200MG,500 ML,INTRAVENOUS,Avoided shortage,SOLUTION,B05BC,I.V. SOLUTIONS,2018-03-27,,2018-04-20,2018-03-23,Disruption of the manufacture of the drug.,2018-03-16,2018-07-23
62463,38024,Shortage,MANNITOL INJECTION USP,PFIZER CANADA INC,Mannitol Injection USP,MANNITOL,250MG,25 x 50mL GVL,INTRAVENOUS,Resolved,SOLUTION,B05BC,I.V. SOLUTIONS,,2018-11-30,,2019-02-11,Disruption of the manufacture of the drug.,2018-09-27,2019-02-12
12565,2429861,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,10MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-06-01,2017-06-01,2018-09-30,2018-08-24,Delay in shipping of the drug.,2017-06-12,2018-08-25
12568,2429861,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-06-01,2017-06-01,2018-09-30,2018-08-24,Delay in shipping of the drug.,2017-06-12,2018-08-25
31323,2429888,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-11-01,2017-11-01,2018-09-05,2018-09-05,Delay in shipping of the drug.,2017-11-30,2018-09-06
959,2429918,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,75MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-03-13,,2017-07-15,2017-07-14,Delay in shipping of the drug.,2017-03-13,2017-07-15
962,2429896,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-03-13,,2017-07-15,2017-08-28,Delay in shipping of the drug.,2017-03-13,2017-08-29
967,2429896,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,50MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-03-13,,2017-07-15,2017-08-28,Delay in shipping of the drug.,2017-03-13,2017-08-29
971,2429888,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-03-13,,2017-07-15,2017-07-14,Delay in shipping of the drug.,2017-03-13,2017-07-15
978,2429888,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,25MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-03-13,,2017-07-15,2017-07-14,Delay in shipping of the drug.,2017-03-13,2017-07-15
61657,2429918,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,75MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2018-09-17,2018-09-19,2018-09-19,Delay in shipping of the drug.,2018-09-17,2018-09-20
90077,2429896,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000 Tablets,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2019-07-28,2019-07-28,2019-08-14,2019-08-13,Delay in shipping of the drug.,2019-07-29,2019-08-14
47345,2429888,Shortage,MAR-AMITRIPTYLINE,MARCAN PHARMACEUTICALS INC,MAR-Amitriptyline,AMITRIPTYLINE HYDROCHLORIDE,25MG,100 Tablet,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2018-04-27,2018-04-27,2018-09-05,2018-09-05,Delay in shipping of the drug.,2018-04-27,2018-09-06
55171,2371715,Shortage,MAR-AMLODIPINE TABLETS,MARCAN PHARMACEUTICALS INC,MAR-Amlodipine,AMLODIPINE,5MG,100 Tabs,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-07-16,2018-07-16,2018-09-27,2018-09-27,Delay in shipping of the drug.,2018-07-10,2018-09-28
54922,2371707,Shortage,MAR-AMLODIPINE TABLETS,MARCAN PHARMACEUTICALS INC,MAR-Amlodipine,AMLODIPINE,2.5MG,100 Tabs,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-07-10,2018-07-10,2019-09-12,2019-09-12,Delay in shipping of the drug.,2018-07-10,2019-10-07
87139,2379562,Shortage,MAR-ANASTROZOLE,MARCAN PHARMACEUTICALS INC,Anastrozole,ANASTROZOLE,1MG,30 Tablets,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2019-06-19,2019-06-19,2019-07-15,2019-07-16,Demand increase for the drug.,2019-06-20,2019-07-17
47757,2379562,Shortage,MAR-ANASTROZOLE,MARCAN PHARMACEUTICALS INC,Mar-Anastrozole,ANASTROZOLE,1MG,100 Tablet,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2018-05-01,2018-05-01,2018-07-27,2018-07-27,Delay in shipping of the drug.,2018-05-01,2018-07-28
954,2379562,Shortage,MAR-ANASTROZOLE,MARCAN PHARMACEUTICALS INC,MAR-Anastrozole,ANASTROZOLE,1MG,30 Tablet,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2018-01-15,2017-11-30,,2019-01-01,Delay in shipping of the drug.,2017-03-13,2019-04-23
94712,2379562,Shortage,MAR-ANASTROZOLE,MARCAN PHARMACEUTICALS INC,Anastrozole,ANASTROZOLE,1MG,100 Tablet,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2019-09-25,2019-09-25,2019-10-11,2019-10-11,Demand increase for the drug.,2019-09-25,2019-10-12
54725,2371979,Shortage,MAR-ATENOLOL,MARCAN PHARMACEUTICALS INC,MAR-Atenolol,ATENOLOL,25MG,100 Tabs,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2018-12-03,,2018-08-15,2018-08-15,Delay in shipping of the drug.,2018-07-06,2018-08-15
48092,2371987,Shortage,MAR-ATENOLOL,MARCAN PHARMACEUTICALS INC,MAR-Atenolol,ATENOLOL,50MG,30 Blister,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-05-02,2018-05-02,2018-09-25,2018-09-25,Delay in shipping of the drug.,2018-05-02,2018-09-26
98775,2454025,Shortage,MAR-ATORVASTATIN,MARCAN PHARMACEUTICALS INC,ATORVASTATIN,ATORVASTATIN,20MG,500 TABLET,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-11-14,2019-11-14,2019-12-03,,Delay in shipping of the drug.,2019-11-15,2019-11-15
31328,2452324,Shortage,MAR-AZITHROMYCIN,MARCAN PHARMACEUTICALS INC,MAR-Azithromycin,AZITHROMYCIN,250MG,100 Tablet,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017-11-30,2017-11-30,,2019-05-17,Delay in shipping of the drug.,2017-11-30,2019-05-22
35056,2452324,Shortage,MAR-AZITHROMYCIN,MARCAN PHARMACEUTICALS INC,MAR-Azithromycin,AZITHROMYCIN,250MG,6 Tablet,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2018-01-31,2018-01-31,,,Delay in shipping of the drug.,2018-01-05,2018-07-06
12571,2420058,Shortage,MAR-CELECOXIB,MARCAN PHARMACEUTICALS INC,MAR-Celecoxib,CELECOXIB,100MG,100 Capsule,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-06-01,2017-06-01,2017-10-31,2017-11-15,Delay in shipping of the drug.,2017-06-12,2017-11-23
12576,2420058,Shortage,MAR-CELECOXIB,MARCAN PHARMACEUTICALS INC,MAR-Celecoxib,CELECOXIB,100MG,500 Capsule,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-06-01,2017-06-01,2017-10-30,2017-11-15,Delay in shipping of the drug.,2017-06-12,2017-11-23
55394,2420058,Shortage,MAR-CELECOXIB,MARCAN PHARMACEUTICALS INC,MAR-Celecoxib,CELECOXIB,100MG,500 Caps,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-07-11,2018-07-11,2018-09-13,2018-09-13,Delay in shipping of the drug.,2018-07-11,2018-09-14
31334,2427133,Shortage,MAR-CETIRIZINE,MARCAN PHARMACEUTICALS INC,MAR-Cetirizine,CETIRIZINE HYDROCHLORIDE,10MG,100 Tablet,ORAL,Actual shortage,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2017-11-01,2017-11-01,,,Delay in shipping of the drug.,2017-11-30,2018-08-27
31338,2427141,Shortage,MAR-CETIRIZINE,MARCAN PHARMACEUTICALS INC,MAR-Cetirizine,CETIRIZINE HYDROCHLORIDE,20MG,500 Tablet,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2017-11-01,2017-11-01,2018-10-01,2018-06-05,Delay in shipping of the drug.,2017-11-30,2018-06-06
32927,2427141,Shortage,MAR-CETIRIZINE,MARCAN PHARMACEUTICALS INC,MAR-Cetirizine,CETIRIZINE HYDROCHLORIDE,20MG,100 Tablet,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2018-01-01,2018-01-01,2018-10-01,2018-06-05,Delay in shipping of the drug.,2017-12-14,2018-07-05
49550,2379694,Shortage,MAR-CIPROFLOXACIN,MARCAN PHARMACEUTICALS INC,Ciprofloxacin,CIPROFLOXACIN,500MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2018-05-16,2018-05-16,,,Delay in shipping of the drug.,2018-05-16,2018-07-05
48100,2379686,Shortage,MAR-CIPROFLOXACIN,MARCAN PHARMACEUTICALS INC,Mar-Ciprofloxacin,CIPROFLOXACIN,250MG,100 Tablet,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2018-05-02,2018-05-02,,,Delay in shipping of the drug.,2018-05-02,2018-07-05
42769,2371898,Shortage,MAR-CITALOPRAM,MARCAN PHARMACEUTICALS INC,Mar-Citalopram,CITALOPRAM,20MG,500 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-03-13,2018-03-13,2018-08-15,2018-04-02,Delay in shipping of the drug.,2018-03-13,2018-04-03
55381,2371901,Shortage,MAR-CITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Citalopram,CITALOPRAM,40MG,100 Tabs,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-11,2018-07-11,2018-09-27,2018-09-27,Delay in shipping of the drug.,2018-07-11,2018-09-28
39003,2371898,Shortage,MAR-CITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Citalopram,CITALOPRAM,20MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-02-07,2018-02-07,2018-05-01,2018-04-02,Delay in shipping of the drug.,2018-02-07,2018-04-03
31341,2371871,Shortage,MAR-CITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Citalopram,CITALOPRAM,10MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-10-02,2017-10-02,2018-05-15,2018-04-02,Delay in shipping of the drug.,2017-11-30,2018-04-03
52335,2371898,Shortage,MAR-CITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Citalopram,CITALOPRAM,20MG,500 Tabs,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-06-13,2018-06-13,2018-09-19,2018-09-19,Delay in shipping of the drug.,2018-06-13,2018-09-20
937,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,MAR-Clopidogrel,CLOPIDOGREL,75MG,500 Tablet,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017-03-13,,2017-07-01,2017-06-15,Delay in shipping of the drug.,2017-03-13,2017-06-16
944,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,MAR-Clopidogrel,CLOPIDOGREL,75MG,30 Tablet,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017-03-13,,2017-07-01,2017-06-15,Delay in shipping of the drug.,2017-03-13,2017-06-16
947,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,MAR-Clopidogrel,CLOPIDOGREL,75MG,100 Tablet,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2017-03-13,,2017-07-01,2017-06-15,Delay in shipping of the drug.,2017-03-13,2017-06-16
61663,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,CLOPIDOGREL,CLOPIDOGREL,75MG,100 Tablet,ORAL,Actual shortage,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2018-09-17,,,Delay in shipping of the drug.,2018-09-17,2018-09-18
61666,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,CLOPIDOGREL,CLOPIDOGREL,75MG,30 Tablets,ORAL,Actual shortage,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2018-09-17,,,Delay in shipping of the drug.,2018-09-17,2018-09-18
61669,2422255,Shortage,MAR-CLOPIDOGREL,MARCAN PHARMACEUTICALS INC,CLOPIDOGREL,CLOPIDOGREL,75MG,500 tablets,ORAL,Actual shortage,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2018-09-17,,,Delay in shipping of the drug.,2018-09-17,2018-09-18
55378,2403870,Shortage,MAR-DOMPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Domperidone,DOMPERIDONE,10MG,500 Tabs,ORAL,Actual shortage,TABLET,A03FA,PROPULSIVES,2018-07-11,2018-07-11,,,Delay in shipping of the drug.,2018-07-11,2018-07-12
55369,2402106,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,MAR-Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,100 Tabs,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018-07-11,2018-07-11,2018-08-27,2018-08-27,Delay in shipping of the drug.,2018-07-11,2018-08-28
55372,2402106,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,MAR-Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,500 Tabs,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018-07-11,2018-07-11,,2019-08-06,Delay in shipping of the drug.,2018-07-11,2019-08-26
55375,2402092,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,MAR-Donepezil,DONEPEZIL HYDROCHLORIDE,5MG,500 Caps,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018-07-11,2018-07-11,,2019-08-06,Delay in shipping of the drug.,2018-07-11,2019-08-26
931,2402092,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,MAR-Donepezil,DONEPEZIL HYDROCHLORIDE,5MG,30 Tablet,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2017-03-13,2017-03-13,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
934,2402106,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,MAR-Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,30 Tablet,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2017-03-13,2017-03-13,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
45037,2402106,Shortage,MAR-DONEPEZIL,MARCAN PHARMACEUTICALS INC,Mar-Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,100 Tablet,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018-04-05,2018-04-05,2018-08-31,2018-08-29,Delay in shipping of the drug.,2018-04-05,2018-08-30
31353,2446081,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,30MG,100 Capsule,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-09-01,2017-09-01,,2019-05-14,Delay in shipping of the drug.,2017-11-30,2019-05-22
31356,2446081,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,30MG,500 Capsule,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-09-01,2017-09-01,,,Delay in shipping of the drug.,2017-11-30,2018-11-13
31359,2446103,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,60MG,100 Capsule,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-09-01,2017-09-01,,2019-05-14,Delay in shipping of the drug.,2017-11-30,2019-05-22
31362,2446103,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Duloxetine,DULOXETINE,60MG,500 Capsule,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-09-01,2017-09-01,,2019-05-14,Delay in shipping of the drug.,2017-11-30,2019-05-22
71812,2423480,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2019-01-10,2019-01-10,2019-03-15,2019-03-14,Delay in shipping of the drug.,2019-01-10,2019-03-15
71815,2423480,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,ESCITALOPRAM,ESCITALOPRAM,10MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2019-01-10,2019-01-10,2019-03-15,2019-03-14,Delay in shipping of the drug.,2019-01-10,2019-03-15
71818,2423502,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,ESCITALOPRAM,ESCITALOPRAM,20MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2019-01-10,2019-01-10,2019-03-15,2019-03-14,Delay in shipping of the drug.,2019-01-10,2019-03-15
919,2423502,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Escitalopram,ESCITALOPRAM,20MG,500 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-03-13,,,2017-06-01,Delay in shipping of the drug.,2017-03-13,2018-07-06
925,2423502,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,MAR-Escitalopram,ESCITALOPRAM,20MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-03-13,,2017-07-01,2017-06-01,Delay in shipping of the drug.,2017-03-13,2017-06-12
92576,2423480,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,Escitalopram,ESCITALOPRAM,10MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2019-08-29,2019-08-29,2019-09-15,2019-09-09,Delay in shipping of the drug.,2019-08-29,2019-09-10
88756,2423480,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,Escitalopram,ESCITALOPRAM,10MG,500 TABLET,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2019-07-03,2019-07-03,2019-09-15,2019-09-09,Delay in shipping of the drug.,2019-07-05,2019-09-10
42193,2423502,Shortage,MAR-ESCITALOPRAM,MARCAN PHARMACEUTICALS INC,Mar-Escitalopram,ESCITALOPRAM,20MG,500 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-16,2018-07-16,,2019-09-09,Delay in shipping of the drug.,2018-03-07,2019-09-10
55363,2422662,Shortage,MAR-EZETIMIBE,MARCAN PHARMACEUTICALS INC,MAR-Ezetimibe,EZETIMIBE,10MG,500 Tabs,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-07-11,2018-07-11,,2019-01-06,Delay in shipping of the drug.,2018-07-11,2019-01-07
55366,2422662,Shortage,MAR-EZETIMIBE,MARCAN PHARMACEUTICALS INC,MAR-Ezetimibe,EZETIMIBE,10MG,100 Tabs,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-07-11,2018-07-11,2019-02-05,2019-02-05,Delay in shipping of the drug.,2018-07-11,2019-08-15
48105,2422662,Shortage,MAR-EZETIMIBE,MARCAN PHARMACEUTICALS INC,MAR-Ezetimibe,EZETIMIBE,10MG,100 Tablet,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-05-02,2018-05-02,,2018-05-22,Delay in shipping of the drug.,2018-05-02,2018-07-05
48110,2422662,Shortage,MAR-EZETIMIBE,MARCAN PHARMACEUTICALS INC,Mar-Ezetimibe,EZETIMIBE,10MG,500 Tablet,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-05-02,2018-05-02,,2018-05-22,Delay in shipping of the drug.,2018-05-02,2018-07-05
904,2392917,Shortage,MAR-FLUOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Fluoxetine,FLUOXETINE,20MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
910,2392917,Shortage,MAR-FLUOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Fluoxetine,FLUOXETINE,20MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
914,2392909,Shortage,MAR-FLUOXETINE,MARCAN PHARMACEUTICALS INC,MAR-Fluoxetine,FLUOXETINE,10MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
30475,2391473,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,100MG,100 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-10,2017-09-10,2018-05-15,2018-04-24,Delay in shipping of the drug.,2017-11-23,2018-07-06
30478,2391481,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,300MG,100 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-10,2017-09-10,2018-05-15,2018-04-24,Delay in shipping of the drug.,2017-11-23,2018-04-25
30481,2391481,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,300MG,500 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-10,2017-09-10,2018-05-15,2018-04-24,Delay in shipping of the drug.,2017-11-23,2018-04-25
30484,2391503,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,400MG,100 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-10,2017-09-10,,2018-04-24,Delay in shipping of the drug.,2017-11-23,2018-07-06
30487,2391503,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,400MG,500 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-10,2017-09-10,2018-07-27,2018-07-27,Delay in shipping of the drug.,2017-11-23,2018-07-28
899,2391473,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,MAR-Gabapentin,GABAPENTIN,100MG,500 Capsule,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-03-13,2017-04-01,2018-05-01,2018-04-24,Delay in shipping of the drug.,2017-03-13,2018-04-25
81130,2391473,Shortage,MAR-GABAPENTIN,MARCAN PHARMACEUTICALS INC,GABAPENTIN,GABAPENTIN,100MG,500 TABLET,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2019-04-10,2019-04-10,,,Other (Please describe in comments),2019-04-10,2019-04-11
880,2420821,Shortage,MAR-GALANTAMINE ER,MARCAN PHARMACEUTICALS INC,MAR-Galantamine,GALANTAMINE,8MG,30 Capsule,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
887,2420856,Shortage,MAR-GALANTAMINE ER,MARCAN PHARMACEUTICALS INC,MAR-Galantamine,GALANTAMINE,24MG,30 Capsules,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
894,2420848,Shortage,MAR-GALANTAMINE ER,MARCAN PHARMACEUTICALS INC,MAR-Galantamine,GALANTAMINE,16MG,30 Capsule,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
82881,2373424,Shortage,MAR-LETROZOLE,MARCAN PHARMACEUTICALS INC,Letrozole,LETROZOLE,2.5MG,30 Tablets,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-04-28,2019-05-01,2019-05-01,Delay in shipping of the drug.,2019-04-30,2019-05-02
859,2378639,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,850MG,100 Tablet,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-03-13,2017-03-13,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
865,2378620,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,500MG,500 Tablet,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-03-13,,2017-10-01,2017-06-01,Delay in shipping of the drug.,2017-03-13,2017-06-12
868,2378620,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,500MG,100 Tablet,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-03-13,2017-03-13,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
31377,2378620,Shortage,MAR-METFORMIN,MARCAN PHARMACEUTICALS INC,MAR-Metformin,METFORMIN HYDROCHLORIDE,500MG,500 Tablet,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-11-30,2017-11-30,,,Delay in shipping of the drug.,2017-11-30,2018-07-05
75349,2480107,Shortage,MAR-METHIMAZOLE,MARCAN PHARMACEUTICALS INC,MAR-METHIMAZOLE,THIAMAZOLE,5MG,100 Tablet,ORAL,Avoided shortage,TABLET,H03BB,ANTITHYROID PREPARATIONS,2019-04-01,,2019-05-01,2019-03-13,Delay in shipping of the drug.,2019-02-11,2019-03-13
70241,2480107,Shortage,MAR-METHIMAZOLE,MARCAN PHARMACEUTICALS INC,MAR-METHIMAZOLE,THIAMAZOLE,5MG,100 Tablet,ORAL,Resolved,TABLET,H03BB,ANTITHYROID PREPARATIONS,2018-12-18,2018-12-18,2019-01-10,2019-01-06,Delay in shipping of the drug.,2018-12-20,2019-01-08
55349,2432560,Shortage,MAR-MODAFINIL,MARCAN PHARMACEUTICALS INC,MAR-Modafinil,MODAFINIL,100MG,100 Tabs,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-07-11,2018-07-11,2018-10-18,2018-10-18,Delay in shipping of the drug.,2018-07-11,2018-10-19
841,2399873,Shortage,MAR-MONTELUKAST,MARCAN PHARMACEUTICALS INC,MAR-Montelukast,MONTELUKAST,5MG,30 Tablet,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-03-13,2017-04-01,2018-11-12,2018-11-12,Delay in shipping of the drug.,2017-03-13,2018-11-13
844,2399865,Shortage,MAR-MONTELUKAST,MARCAN PHARMACEUTICALS INC,MAR-Montelukast,MONTELUKAST,4MG,30 Tablet,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-03-13,2017-04-01,2018-11-12,2018-11-12,Delay in shipping of the drug.,2017-03-13,2018-11-13
852,2399997,Shortage,MAR-MONTELUKAST,MARCAN PHARMACEUTICALS INC,MAR-Montelukast,MONTELUKAST,10MG,30 Tablet,ORAL,Actual shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
54731,2447053,Shortage,MAR-MOXIFLOXACIN,MARCAN PHARMACEUTICALS INC,MAR-Moxifloxacin,MOXIFLOXACIN,400MG,100 Tabs,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2018-11-03,2018-08-15,2019-01-14,2019-01-14,Delay in shipping of the drug.,2018-07-06,2019-01-15
32948,2421232,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,2.5MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-01-01,2018-01-01,2018-10-12,2018-10-12,Delay in shipping of the drug.,2017-12-14,2018-10-15
32955,2421240,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,5MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-01-01,2018-01-01,2018-10-12,2018-10-12,Delay in shipping of the drug.,2017-12-14,2018-10-15
32961,2421259,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,7.5MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-01-01,2018-01-01,2018-10-12,2018-10-12,Delay in shipping of the drug.,2017-12-14,2018-10-15
32969,2421267,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,10MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-01-01,2018-01-01,2018-10-12,2018-10-12,Delay in shipping of the drug.,2017-12-14,2018-10-15
32978,2421275,Shortage,MAR-OLANZAPINE,MARCAN PHARMACEUTICALS INC,Mar-Olanzapine,OLANZAPINE,15MG,100 Tablet,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-01-01,2018-01-01,2018-10-12,2018-10-12,Delay in shipping of the drug.,2017-12-14,2018-10-15
55320,2389118,Shortage,MAR-OLANZAPINE ODT,MARCAN PHARMACEUTICALS INC,MAR-OLANZAPINE ODT,OLANZAPINE,15MG,30 BLST,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-07-11,2018-07-11,2018-07-16,2018-07-16,Delay in shipping of the drug.,2018-07-11,2018-07-17
31349,2389126,Shortage,MAR-OLANZAPINE ODT,MARCAN PHARMACEUTICALS INC,MAR-Olanzapine ODT,OLANZAPINE,20MG,30 Tablet,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017-11-15,2017-11-15,,,Delay in shipping of the drug.,2017-11-30,2018-07-16
45202,2389096,Shortage,MAR-OLANZAPINE ODT,MARCAN PHARMACEUTICALS INC,MAR-Olanzapine ODT,OLANZAPINE,10MG,30 Blister,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-04-09,2018-04-09,,,Delay in shipping of the drug.,2018-04-09,2018-07-06
76288,2371731,Shortage,MAR-ONDANSETRON,MARCAN PHARMACEUTICALS INC,ONDANSETRON,ONDANSETRON,4MG,30 Tablets,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2019-03-31,2019-03-29,2019-07-19,2019-07-10,Delay in shipping of the drug.,2019-02-19,2019-07-11
31331,2371731,Shortage,MAR-ONDANSETRON,MARCAN PHARMACEUTICALS INC,Mar-Ondansetron,ONDANSETRON,4MG,10 Tablet,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-11-30,2017-11-30,2018-05-01,2018-04-27,Delay in shipping of the drug.,2017-11-30,2018-04-28
78572,2371758,Shortage,MAR-ONDANSETRON,MARCAN PHARMACEUTICALS INC,ONDANSETRON,ONDANSETRON,8MG,30 Tablets,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-03-12,,2019-07-10,Delay in shipping of the drug.,2019-03-13,2019-07-11
12548,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,MAR-Pantoprazole,PANTOPRAZOLE,40MG,100 Tablet,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-06-01,2017-06-01,2017-10-15,2017-11-01,Delay in shipping of the drug.,2017-06-12,2017-11-23
97070,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,Pantoprazole,PANTOPRAZOLE,40MG,100 Tablet,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-10-23,2019-10-23,,,Other (Please describe in comments),2019-10-23,2019-10-24
838,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,MAR-Pantoprazole,PANTOPRAZOLE,40MG,500 Tablet,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-03-13,2017-03-13,2017-10-15,2017-11-01,Delay in shipping of the drug.,2017-03-13,2017-11-23
47975,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,MAR-Pantoprazole,PANTOPRAZOLE,40MG,100 Tablet,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-05-02,2018-05-02,2018-09-10,2018-09-10,Delay in shipping of the drug.,2018-05-02,2018-09-11
47980,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,Mar-Pantoprazole,PANTOPRAZOLE,40MG,500 Tablet,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-05-02,2018-05-02,2018-09-10,2018-09-10,Delay in shipping of the drug.,2018-05-02,2018-09-11
93585,2416565,Shortage,MAR-PANTOPRAZOLE,MARCAN PHARMACEUTICALS INC,Pantoprazole,PANTOPRAZOLE,40MG,"100,500 Tablet",ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-12,2019-09-12,2019-09-19,2019-09-18,Delay in shipping of the drug.,2019-09-11,2019-09-19
70721,2411962,Shortage,MAR-PAROXETINE,MARCAN PHARMACEUTICALS INC,PAROXETINE,PAROXETINE,30MG,100 Tablets,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-12-30,2018-12-30,2019-01-25,2019-01-25,Delay in shipping of the drug.,2019-01-02,2019-01-26
35050,2411962,Shortage,MAR-PAROXETINE,MARCAN PHARMACEUTICALS INC,MAR-Paroxetine,PAROXETINE,30MG,100 Tablet,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-01-31,2018-01-31,,2018-03-05,Delay in shipping of the drug.,2018-01-05,2018-07-06
30490,2417529,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,25MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-01,2017-10-01,,,Delay in shipping of the drug.,2017-11-23,2018-07-05
30493,2417529,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,25MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-01,2017-10-01,,,Delay in shipping of the drug.,2017-11-23,2018-07-05
30496,2417545,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,75MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-01,2017-10-01,,,Delay in shipping of the drug.,2017-11-23,2018-07-05
12579,2417537,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,50MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-06-01,2017-06-01,,,Delay in shipping of the drug.,2017-06-12,2018-07-05
30499,2417545,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,75MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-01,2017-10-01,,,Delay in shipping of the drug.,2017-11-23,2018-07-05
12582,2417537,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,50MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-06-01,2017-06-01,,,Delay in shipping of the drug.,2017-06-12,2018-07-05
30502,2417561,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,150MG,100 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-01,2017-10-01,,,Delay in shipping of the drug.,2017-11-23,2018-07-05
30505,2417561,Shortage,MAR-PREGABALIN,MARCAN PHARMACEUTICALS INC,MAR-Pregabalin,PREGABALIN,150MG,500 Capsule,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-01,2017-10-01,,,Delay in shipping of the drug.,2017-11-23,2018-07-05
79620,2399830,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,QUETIAPINE,QUETIAPINE,100MG,100 Tablet,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2019-03-30,2019-03-30,,,Other (Please describe in comments),2019-03-27,2019-03-31
79624,2399830,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,QUETIAPINE,QUETIAPINE,100MG,500 TABLET,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2019-03-30,2019-03-30,,,Other (Please describe in comments),2019-03-27,2019-03-31
79627,2399849,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,QUETIAPINE,QUETIAPINE,200MG,100 Tablet,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2019-03-30,2019-03-30,,,Other (Please describe in comments),2019-03-27,2019-03-31
79630,2399822,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,QUETIAPINE,QUETIAPINE,25MG,100 Tablet,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2019-03-30,2019-03-30,,,Other (Please describe in comments),2019-03-27,2019-03-31
79633,2399822,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,QUETIAPINE,QUETIAPINE,25MG,500 TABLET,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2019-03-30,2019-03-30,,,Other (Please describe in comments),2019-03-27,2019-03-31
79636,2399857,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,QUETIAPINE,QUETIAPINE,300MG,100 Tablet,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2019-03-30,2019-03-30,,,Other (Please describe in comments),2019-03-27,2019-03-31
811,2399857,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,300MG,500 Tablet,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
814,2399857,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,300MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,2018-03-15,2018-01-24,Delay in shipping of the drug.,2017-03-13,2018-01-25
817,2399849,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,200MG,500 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,2018-04-15,2018-01-24,Delay in shipping of the drug.,2017-03-13,2018-01-25
820,2399849,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,200MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,2018-03-01,2018-01-24,Delay in shipping of the drug.,2017-03-13,2018-01-25
823,2399830,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,100MG,500 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,2018-03-15,2018-01-10,Delay in shipping of the drug.,2017-03-13,2018-01-11
826,2399830,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,100MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,2018-03-15,2018-01-10,Delay in shipping of the drug.,2017-03-13,2018-01-11
830,2399822,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,25MG,500 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,,2018-02-07,Delay in shipping of the drug.,2017-03-13,2018-07-06
835,2399822,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,25MG,100 Tablet,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2017-03-13,2017-04-01,,2018-02-07,Delay in shipping of the drug.,2017-03-13,2018-07-06
55920,2399849,Shortage,MAR-QUETIAPINE,MARCAN PHARMACEUTICALS INC,MAR-Quetiapine,QUETIAPINE,200MG,500 Tabs,ORAL,Actual shortage,TABLET (IMMEDIATE RELEASE),N05AH,ANTIPSYCHOTICS,2018-12-31,,,,Delay in shipping of the drug.,2018-07-16,2019-01-01
796,2420503,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,15.0MG,30 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-03-13,,2017-10-01,2017-10-01,Delay in shipping of the drug.,2017-03-13,2017-10-06
799,2420503,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,15.0MG,100 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-03-13,,2017-08-01,2017-10-01,Delay in shipping of the drug.,2017-03-13,2017-10-06
12585,2420465,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,2.5MG,30 CAPSULE,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-06-01,2017-06-01,2018-05-01,2018-04-09,Delay in shipping of the drug.,2017-06-12,2018-04-10
59434,2420465,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-RAMIPRIL,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-28,,2019-07-31,Delay in shipping of the drug.,2018-08-28,2019-08-01
12588,2420465,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,2.5MG,100 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-06-01,2017-06-01,2018-05-01,2018-04-09,Delay in shipping of the drug.,2017-06-12,2018-04-10
59437,2420473,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-RAMIPRIL,RAMIPRIL,5.0MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-08-28,,2019-07-31,Delay in shipping of the drug.,2018-08-28,2019-08-01
12591,2420481,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,10.0MG,100 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-06-01,2017-06-01,2018-06-15,2018-06-05,Delay in shipping of the drug.,2017-06-12,2018-06-06
84836,2420481,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,RAMIPRIL,RAMIPRIL,10.0MG,100 Capsules,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2019-05-22,2019-05-22,2019-07-31,2019-07-31,Delay in shipping of the drug.,2019-05-27,2019-08-01
55180,2420457,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,1.25MG,30 BLST,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-09-10,2018-09-10,,,Delay in shipping of the drug.,2018-07-10,2018-09-11
12201,2420457,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,1.25MG,30 CAPSULE,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-01,2017-05-01,,2018-01-05,Delay in shipping of the drug.,2017-06-07,2018-07-06
54737,2420457,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,Ramipril,RAMIPRIL,1.25MG,30 Caps,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-08-17,2018-08-15,,,Delay in shipping of the drug.,2018-07-06,2018-08-16
35044,2420473,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,5.0MG,30 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-01-05,2018-01-05,2018-05-01,2018-04-09,Delay in shipping of the drug.,2018-01-05,2018-04-10
35047,2420481,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,10.0MG,30 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-01-05,2018-01-05,2018-06-15,2018-06-05,Delay in shipping of the drug.,2018-01-05,2018-06-06
35062,2420465,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,2.5MG,500 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-01-10,2018-01-09,2018-05-01,2018-04-09,Delay in shipping of the drug.,2018-01-05,2018-04-10
35065,2420473,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,MAR-Ramipril,RAMIPRIL,5.0MG,500 Capsule,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-01-10,2018-01-09,2018-05-01,2018-04-09,Delay in shipping of the drug.,2018-01-05,2018-07-06
79612,2420503,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,RAMIPRIL,RAMIPRIL,15.0MG,30 Tablets,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2019-04-22,,,2019-07-31,Delay in shipping of the drug.,2019-03-27,2019-08-01
79615,2420481,Shortage,MAR-RAMIPRIL,MARCAN PHARMACEUTICALS INC,RAMIPRIL,RAMIPRIL,10.0MG,30 Tablets,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-03-24,2019-08-26,2019-08-26,Delay in shipping of the drug.,2019-03-27,2019-08-29
94581,2443708,Shortage,MAR-RANITIDINE,MARCAN PHARMACEUTICALS INC,RANITIDINE,RANITIDINE,150MG,500 TABLET,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-16,2019-09-16,,,Disruption of the manufacture of the drug.,2019-09-24,2019-09-24
94584,2443716,Shortage,MAR-RANITIDINE,MARCAN PHARMACEUTICALS INC,RANITIDINE,RANITIDINE,300MG,100 Tablet,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-16,2019-09-16,,,Disruption of the manufacture of the drug.,2019-09-24,2019-09-24
793,2371812,Shortage,MAR-RISPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Risperidone,RISPERIDONE,4.0MG,100 Tablet,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-03-13,2017-04-01,2018-08-20,2018-08-20,Delay in shipping of the drug.,2017-03-13,2018-08-21
47985,2371766,Shortage,MAR-RISPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Risperidone,RISPERIDONE,0.25MG,100 Tablet,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-05-02,2018-05-02,2018-10-11,2018-10-11,Delay in shipping of the drug.,2018-05-02,2018-10-12
47991,2371782,Shortage,MAR-RISPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Risperidone,RISPERIDONE,1.0MG,100 Tablet,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-05-02,2018-05-02,2018-08-20,2018-08-20,Delay in shipping of the drug.,2018-05-02,2018-08-21
47994,2371790,Shortage,MAR-RISPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Risperidone,RISPERIDONE,2.0MG,100 Tablet,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-05-02,2018-05-02,2018-08-20,2018-08-20,Delay in shipping of the drug.,2018-05-02,2018-08-21
47997,2371804,Shortage,MAR-RISPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Risperidone,RISPERIDONE,3.0MG,100 Tablet,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-05-02,2018-05-02,2018-08-20,2018-08-20,Delay in shipping of the drug.,2018-05-02,2018-08-21
55174,2371774,Shortage,MAR-RISPERIDONE,MARCAN PHARMACEUTICALS INC,MAR-Risperidone,RISPERIDONE,0.50MG,100 Tabs,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-07-10,2018-07-10,2018-10-11,2018-10-11,Delay in shipping of the drug.,2018-07-10,2018-10-12
772,2413051,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,5MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
775,2413108,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,40MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
778,2413108,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,40MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
781,2413086,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,20MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
784,2413086,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,20MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
787,2413078,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,10MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
790,2413078,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Rosuvastatin,ROSUVASTATIN,10MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
54972,2413051,Shortage,MAR-ROSUVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-ROSUVASTATIN,ROSUVASTATIN,5MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-10,2018-07-10,,,Delay in shipping of the drug.,2018-07-10,2018-07-11
37148,2399431,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,MAR-Sertraline,SERTRALINE,100MG,250 Capsule,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-01-31,2018-01-31,,,Delay in shipping of the drug.,2018-01-24,2018-07-09
40480,2399415,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,Mar-Sertraline,SERTRALINE,25MG,100 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-02-21,2018-02-21,,2018-04-15,Delay in shipping of the drug.,2018-02-21,2018-07-06
65386,2399423,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,SERTRALINE,SERTRALINE,50MG,100 Tablet,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-10-23,2018-10-23,2018-12-17,2018-12-01,Delay in shipping of the drug.,2018-10-23,2018-12-03
62828,2399415,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,SERTRALINE,SERTRALINE,25MG,100 Capsules,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-10-15,2018-10-15,2018-12-20,2018-12-01,Demand increase for the drug.,2018-10-02,2018-12-03
67439,2399431,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,SERTRALINE,SERTRALINE,100MG,100 Capsules,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-11-22,2018-12-15,2018-12-01,Delay in shipping of the drug.,2018-11-22,2018-12-03
37112,2399423,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,MAR-Sertraline,SERTRALINE,50MG,250 Capsule,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-01-24,2018-01-24,,,Delay in shipping of the drug.,2018-01-24,2018-07-09
763,2399423,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,MAR-Sertraline,SERTRALINE,50MG,100 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-03-13,,2017-11-01,2017-07-07,Delay in shipping of the drug.,2017-03-13,2018-05-14
766,2399431,Shortage,MAR-SERTRALINE,MARCAN PHARMACEUTICALS INC,MAR-Sertraline,SERTRALINE,100MG,100 Capsule,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-03-13,,2017-08-01,2017-07-07,Delay in shipping of the drug.,2017-03-13,2017-07-08
35053,2402548,Shortage,MAR-SILDENAFIL,MARCAN PHARMACEUTICALS INC,MAR-Sildenafil,SILDENAFIL,100MG,4 Tablet,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-01-31,2018-01-31,2018-05-15,2018-04-09,Delay in shipping of the drug.,2018-01-05,2018-04-10
37151,2375052,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,20MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-03-02,2018-03-05,,,Delay in shipping of the drug.,2018-01-24,2018-07-05
37156,2375052,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,20MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-04-30,2018-05-01,,,Delay in shipping of the drug.,2018-01-24,2018-07-05
37159,2375060,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,40MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-04-30,2018-05-01,,,Delay in shipping of the drug.,2018-01-24,2018-07-05
48003,2375044,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,10MG,100 Tablet,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-05-02,2018-05-02,2018-07-27,2018-07-27,Delay in shipping of the drug.,2018-05-02,2018-07-28
48007,2375044,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,10MG,500 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-05-02,2018-05-02,,,Delay in shipping of the drug.,2018-05-02,2018-10-30
757,2375079,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,80MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
760,2375036,Shortage,MAR-SIMVASTATIN,MARCAN PHARMACEUTICALS INC,MAR-Simvastatin,SIMVASTATIN,5MG,100 Tablet,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
87142,2452278,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,Tadalafil,TADALAFIL,5MG,28 Tablets,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2019-06-20,2019-06-20,2019-08-02,2019-07-10,Delay in shipping of the drug.,2019-06-20,2019-07-11
31365,2452286,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,2.5MG,28 Tablet,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-30,2017-11-30,,,Delay in shipping of the drug.,2017-11-30,2018-07-05
31368,2452278,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,5MG,28 Tablet,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-30,2017-11-30,,2018-07-12,Delay in shipping of the drug.,2017-11-30,2018-07-13
31371,2452251,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,10MG,4 Tablet,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-30,2017-11-30,2018-07-12,2018-07-12,Delay in shipping of the drug.,2017-11-30,2018-07-13
31374,2452243,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-Tadalafil,TADALAFIL,20MG,4 Tablet,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-30,2017-11-30,,2018-07-12,Delay in shipping of the drug.,2017-11-30,2018-07-13
54941,2452278,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-TADALAFIL,TADALAFIL,5MG,28,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-07-10,2018-07-10,,2018-07-12,Delay in shipping of the drug.,2018-07-10,2018-07-13
54945,2452243,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-TADALAFIL,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-07-10,2018-07-10,,2018-07-12,Delay in shipping of the drug.,2018-07-10,2018-07-13
54951,2452251,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,MAR-TADALAFIL,TADALAFIL,10MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-07-10,2018-07-10,2018-07-12,2018-07-12,Delay in shipping of the drug.,2018-07-10,2018-07-13
81124,2452243,Shortage,MAR-TADALAFIL,MARCAN PHARMACEUTICALS INC,Tadalafil,TADALAFIL,20MG,4 Tablets,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2019-04-08,2019-04-08,2019-07-05,2019-05-24,Demand increase for the drug.,2019-04-10,2019-05-27
48013,2432099,Shortage,MAR-TOPIRAMATE,MARCAN PHARMACEUTICALS INC,MAR-Topiramate,TOPIRAMATE,25MG,100 Tablet,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2018-05-02,2018-05-02,,,Delay in shipping of the drug.,2018-05-02,2018-07-05
48018,2432102,Shortage,MAR-TOPIRAMATE,MARCAN PHARMACEUTICALS INC,MAR-Topiramate,TOPIRAMATE,100MG,200,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2018-05-02,2018-05-02,,,Delay in shipping of the drug.,2018-05-02,2018-10-30
48021,2432110,Shortage,MAR-TOPIRAMATE,MARCAN PHARMACEUTICALS INC,MAR-Topiramate,TOPIRAMATE,200MG,100 Tablet,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2018-05-02,2018-05-02,,,Delay in shipping of the drug.,2018-05-02,2018-07-05
54938,2432102,Shortage,MAR-TOPIRAMATE,MARCAN PHARMACEUTICALS INC,MAR-TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2018-07-10,,,Delay in shipping of the drug.,2018-07-10,2018-07-11
12594,2388324,Shortage,MAR-TRAMADOL/ACET,MARCAN PHARMACEUTICALS INC,MAR-TRAMADOL/ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,60 Tablet,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,2017-06-01,2017-06-01,2017-12-01,2017-11-01,Delay in shipping of the drug.,2017-06-12,2017-11-23
82413,2388324,Shortage,MAR-TRAMADOL/ACET,MARCAN PHARMACEUTICALS INC,TRAMADOL/ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,60 tablets,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,2019-07-10,2019-07-07,2020-01-30,,Other (Please describe in comments),2019-04-25,2019-11-13
48026,2441586,Shortage,MAR-VALACYCLOVIR,MARCAN PHARMACEUTICALS INC,MAR-Valacyclovir,VALACYCLOVIR,500MG,100 Tablet,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2018-05-02,2018-05-02,,,Delay in shipping of the drug.,2018-05-02,2018-07-05
754,2441586,Shortage,MAR-VALACYCLOVIR,MARCAN PHARMACEUTICALS INC,MAR-Valacyclovir,VALACYCLOVIR,500MG,100 Tablet,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-03-13,,2017-10-01,2017-06-01,Delay in shipping of the drug.,2017-03-13,2017-06-12
751,2399458,Shortage,MAR-ZOLMITRIPTAN,MARCAN PHARMACEUTICALS INC,MAR-Zolmitriptan,ZOLMITRIPTAN,2.5MG,6 Tablet,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2017-03-13,2017-04-01,,,Delay in shipping of the drug.,2017-03-13,2018-12-20
40787,2241918,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.25%,BUPIVACAINE HYDROCHLORIDE,2.5MG,10X10mL GVL,BLOCK/INFILTRATION  EPIDURAL,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-03-20,,,Disruption of the manufacture of the drug.,2018-02-23,2019-06-12
40793,2241918,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.25%,BUPIVACAINE HYDROCHLORIDE,2.5MG,10X20mL GVL,BLOCK/INFILTRATION  EPIDURAL,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-03-30,,,Disruption of the manufacture of the drug.,2018-02-23,2019-06-12
32859,2305909,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.5%,BUPIVACAINE HYDROCHLORIDE,5.0MG,1 x 50mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-03-30,,2019-05-29,Disruption of the manufacture of the drug.,2017-12-14,2019-05-30
32865,2241919,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.5%,BUPIVACAINE HYDROCHLORIDE,5.0MG,10 x 10ML,BLOCK/INFILTRATION  EPIDURAL,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-02-21,,,Disruption of the manufacture of the drug.,2017-12-14,2019-06-12
40802,2241917,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.75%,BUPIVACAINE HYDROCHLORIDE,7.5MG,10X20mL GVL,EPIDURAL  RETROBULBAR,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-04-27,,2019-06-14,Disruption of the manufacture of the drug.,2018-02-23,2019-07-03
14769,2241919,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE,BUPIVACAINE HYDROCHLORIDE,5.0MG,10x20ml,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-09-21,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-12-19
56518,2241919,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE,BUPIVACAINE HYDROCHLORIDE,5.0MG,10 x 20mL GVL,BLOCK/INFILTRATION  EPIDURAL,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-01-09,,,Disruption of the manufacture of the drug.,2018-07-25,2019-01-10
30195,2305895,Shortage,MARCAINE,PFIZER CANADA INC,MARCAINE 0.25%,BUPIVACAINE HYDROCHLORIDE,2.5MG,1x50mL GVL,BLOCK/INFILTRATION,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-01-31,,,Disruption of the manufacture of the drug.,2017-11-22,2018-02-08
14762,2305895,Shortage,MARCAINE 0.25%,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,2.5MG,1x50ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-11-03,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-23
14772,2305909,Shortage,MARCAINE 0.50%,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,5.0MG,1x50ml,BLOCK/INFILTRATION,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-05-11,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-24
14755,2241918,Shortage,MARCAINE 2.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,2.5MG,10x10ml,BLOCK/INFILTRATION  EPIDURAL,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-27,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-23
14759,2241918,Shortage,MARCAINE 2.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,2.5MG,10x20ml,BLOCK/INFILTRATION  EPIDURAL,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-12-10,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-23
14766,2241919,Shortage,MARCAINE 5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,5.0MG,10x10ml,BLOCK/INFILTRATION  EPIDURAL,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-02-05,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-23
14776,2241917,Shortage,MARCAINE 7.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE,7.5MG,10x20ml,EPIDURAL  RETROBULBAR,Avoided shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-12-04,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-24
59935,2241916,Shortage,MARCAINE E,PFIZER CANADA INC,MARCAINE,BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE BITARTRATE,5.0MG  9.1MCG,10x20mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-09-04,,2019-02-08,Disruption of the manufacture of the drug.,2018-09-04,2019-02-11
27179,2241915,Shortage,MARCAINE E,PFIZER CANADA INC,MARCAINE E 0.25%,BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE BITARTRATE,2.5MG  9.1MCG,10x20mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-11-29,,2018-10-16,Disruption of the manufacture of the drug.,2017-10-26,2018-10-17
32862,2241916,Shortage,MARCAINE E,PFIZER CANADA INC,MARCAINE E 0.5%,BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE BITARTRATE,5.0MG  9.1MCG,10 X 20ML,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-01-31,,2018-07-23,Disruption of the manufacture of the drug.,2017-12-14,2018-07-24
14779,2241915,Shortage,MARCAINE E 2.5 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE BITARTRATE,2.5MG  9.1MCG,10x20ml,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-09-06,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-24
14782,2241916,Shortage,MARCAINE E 5.0 MG/ML,HOSPIRA HEALTHCARE CORPORATION,MARCAINE,BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE BITARTRATE,5.0MG  9.1MCG,10x20ml,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-07-05,,,2017-09-30,Other (Please describe in comments),2017-07-05,2017-11-24
39044,2241914,Shortage,MARCAINE SPINAL,PFIZER CANADA INC,MARCAINE SPINAL,BUPIVACAINE HYDROCHLORIDE,7.5MG,10X2mL AMP,INTRASPINAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-02-28,,2018-03-20,Disruption of the manufacture of the drug.,2018-02-08,2018-03-21
32462,2042487,Shortage,MARVELON 21,MERCK CANADA INC,"desogestrel and ethinyl estradiol tablets,",ETHINYL ESTRADIOL  DESOGESTREL,0.03MG  0.15MG,21,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-02-15,2018-02-16,2018-03-05,2018-02-21,Delay in shipping of the drug.,2017-12-11,2018-02-22
54822,2042479,Shortage,MARVELON 28,MERCK CANADA INC,"desogestrel and ethinyl estradiol tablets,",DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,28's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-08-20,2018-08-16,2018-08-24,2018-08-20,Delay in shipping of the drug.,2018-07-09,2018-08-26
59714,2042479,Shortage,MARVELON 28,MERCK CANADA INC,"desogestrel and ethinyl estradiol tablets,",DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,28',ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-08-31,2018-08-31,2018-10-02,2018-10-02,Requirements related to complying with good manufacturing practices.,2018-08-31,2018-10-03
38467,2042479,Shortage,MARVELON 28,MERCK CANADA INC,"desogestrel and ethinyl estradiol tablets,",DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,28,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-02-06,2018-02-05,2018-02-09,2018-02-06,Delay in shipping of the drug.,2018-02-05,2018-02-07
95659,2042479,Shortage,MARVELON 28,MERCK CANADA INC,desogestrel and ethinyl estradiol tablets,DESOGESTREL  ETHINYL ESTRADIOL,0.15MG  0.03MG,28TAB,ORAL,Avoided shortage,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-11-04,,2019-11-19,2019-11-01,Delay in shipping of the drug.,2019-10-07,2019-11-01
96555,2231459,Shortage,MAVIK,BGP PHARMA ULC,Trandolapril,TRANDOLAPRIL,1MG,100 BT,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2019-10-28,2019-10-29,2019-12-10,,Delay in shipping of the drug.,2019-10-15,2019-11-12
31821,2239267,Shortage,MAVIK,BGP PHARMA ULC,MAVIK,TRANDOLAPRIL,4MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-12-13,,2017-12-14,Delay in shipping of the drug.,2017-12-05,2017-12-15
38488,2239267,Shortage,MAVIK,BGP PHARMA ULC,MAVIK,TRANDOLAPRIL,4MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-06-21,2018-06-21,2018-07-06,2018-06-27,Disruption of the manufacture of the drug.,2018-02-05,2018-06-28
209,2231457,Shortage,MAVIK,BGP PHARMA ULC,Trandolapril,Trandolapril,0.5MG,100,ORAL,Resolved,Capsule,C09AA,"ACE INHIBITORS, PLAIN",,2016-11-08,,2017-04-03,Requirements related to complying with good manufacturing practices.,2017-03-10,2017-04-04
214,2231459,Shortage,MAVIK,BGP PHARMA ULC,Trandolapril,TRANDOLAPRIL,1MG,100,ORAL,Avoided shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-11-22,,2018-11-30,2018-11-07,Delay in shipping of the drug.,2017-03-10,2018-11-08
91623,2231457,Shortage,MAVIK,BGP PHARMA ULC,TRANDOLAPRIL,TRANDOLAPRIL,0.5MG,100 BT,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2019-09-04,2019-09-17,2019-12-10,,Delay in shipping of the drug.,2019-08-15,2019-11-12
91626,2231460,Shortage,MAVIK,BGP PHARMA ULC,TRANDOLAPRIL,TRANDOLAPRIL,2MG,100 BT,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2019-09-17,2019-09-17,2019-12-10,,Delay in shipping of the drug.,2019-08-15,2019-11-12
1344,2240519,Shortage,MAXALT RPD,MERCK CANADA INC,rizatriptan benzoate wafers,RIZATRIPTAN,10MG,12,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017-03-10,2017-03-10,2017-03-15,2017-03-15,Delay in shipping of the drug.,2017-03-13,2017-03-16
64443,2240518,Shortage,MAXALT RPD,MERCK CANADA INC,rizatriptan benzoate wafers,RIZATRIPTAN,5MG,12wafers,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-11-09,2018-11-02,2019-03-01,2019-03-01,Disruption of the manufacture of the drug.,2018-10-16,2019-03-02
97281,42560,Shortage,MAXIDEX,NOVARTIS PHARMACEUTICALS CANADA INC,MAXIDEX 0.1% SUSP 5ML,DEXAMETHASONE,0.1%,5ML,OPHTHALMIC,Actual shortage,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-10-23,2019-12-31,,Other (Please describe in comments),2019-10-25,2019-10-25
17417,42579,Shortage,MAXIDEX,NOVARTIS PHARMACEUTICALS CANADA INC,MAXIDEX OINTMENT 3.5MG,DEXAMETHASONE,0.1%,3.5 MG,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,,2017-07-23,2017-09-11,2017-09-07,Demand increase for the drug.,2017-07-27,2017-09-08
35401,42579,Shortage,MAXIDEX,NOVARTIS PHARMACEUTICALS CANADA INC,MAXIDEX OINTMENT 3.5MG,DEXAMETHASONE,0.1%,3.5MG,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,2018-01-16,,2018-01-18,2018-01-18,Delay in shipping of the drug.,2018-01-09,2018-01-19
59391,42579,Shortage,MAXIDEX,NOVARTIS PHARMACEUTICALS CANADA INC,MAXIDEX OINTMENT 3.5MG,DEXAMETHASONE,0.1%,3.5MG,OPHTHALMIC,Resolved,OINTMENT,S01BA,ANTIINFLAMMATORY AGENTS,2018-09-10,2018-09-10,2019-02-04,2019-02-04,Delay in shipping of the drug.,2018-08-28,2019-02-05
52757,358177,Shortage,MAXITROL,NOVARTIS PHARMACEUTICALS CANADA INC,MAXITROL OINT 3.5G,DEXAMETHASONE  POLYMYXIN B SULFATE  NEOMYCIN,1MG  6000UNIT  3.5MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2018-06-14,2018-11-06,2018-11-06,Delay in shipping of the drug.,2018-06-22,2018-11-07
67487,42676,Shortage,MAXITROL,NOVARTIS PHARMACEUTICALS CANADA INC,MAXITROL SUS 5ML,DEXAMETHASONE  POLYMYXIN B SULFATE  NEOMYCIN,1MG  6000UNIT  3.5MG,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2018-11-16,2019-02-04,2019-02-04,Delay in shipping of the drug.,2018-11-23,2019-02-05
44012,358177,Shortage,MAXITROL,NOVARTIS PHARMACEUTICALS CANADA INC,MAXITROL OINT 3.5G,DEXAMETHASONE  POLYMYXIN B SULFATE  NEOMYCIN,1MG  6000UNIT  3.5MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2018-04-03,,2018-04-23,2018-04-23,Delay in shipping of the drug.,2018-03-26,2018-04-25
20976,358177,Shortage,MAXITROL,NOVARTIS PHARMACEUTICALS CANADA INC,MAXITROL OINT 3.5G,DEXAMETHASONE  POLYMYXIN B SULFATE  NEOMYCIN,1MG  6000UNIT  3.5MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017-08-28,2017-09-11,2017-09-13,Delay in shipping of the drug.,2017-09-05,2017-09-14
27751,504742,Shortage,MAZEPINE,BIOMED PHARMA,Carbamazepine Tablets 200 mg,,,100,,Actual shortage,,,,,2014-10-22,,,Other (Please describe in comments),2017-11-01,2017-11-01
78935,2407841,Shortage,MED-EXEMESTANE,GENERIC MEDICAL PARTNERS INC,Exemestane 25 mg.,EXEMESTANE,25MG,Blister 30 Tabs,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2019-03-18,2019-03-19,,2019-04-17,Demand increase for the drug.,2019-03-19,2019-04-18
89972,2426935,Shortage,MED-LATANOPROST,GENERIC MEDICAL PARTNERS INC,Latanoprost,LATANOPROST,50MCG,1 bottle,OPHTHALMIC,Actual shortage,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-07-15,2019-07-15,2019-11-30,,Delay in shipping of the drug.,2019-07-25,2019-10-21
25157,2253550,Shortage,MEDROXY-2.5,PRO DOC LIMITEE,MEDROXY-2.5,MEDROXYPROGESTERONE ACETATE,2.5MG,500,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017-10-10,,2017-11-07,Delay in shipping of the drug.,2017-10-10,2017-11-08
85269,2353148,Shortage,MELOXICAM,SANIS HEALTH INC,MELOXICAM,MELOXICAM,7.5MG,100,ORAL,Actual shortage,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-07-10,,,,Disruption of the manufacture of the drug.,2019-05-30,2019-07-11
85272,2353156,Shortage,MELOXICAM,SANIS HEALTH INC,MELOXICAM,MELOXICAM,15MG,100,ORAL,Anticipated shortage,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-12-10,,,,Disruption of the manufacture of the drug.,2019-05-30,2019-05-30
45930,2446049,Shortage,MEMANTINE,SIVEM PHARMACEUTICALS ULC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,30,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,2018-05-07,2018-05-14,,2018-06-29,Other (Please describe in comments),2018-04-16,2018-06-30
46983,2446049,Shortage,MEMANTINE,SIVEM PHARMACEUTICALS ULC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,2018-06-11,2018-06-18,2018-06-29,2018-06-29,Other (Please describe in comments),2018-04-23,2018-06-30
91659,2279924,Shortage,MENACTRA,SANOFI PASTEUR LIMITED,"Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine","MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A  MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C  MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y  MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135",4.0MCG  4.0MCG  4.0MCG  4.0MCG,5 x 0.5 mL vials,INTRAMUSCULAR,Actual shortage,SOLUTION,J07AH,BACTERIAL VACCINES,2019-08-12,2019-08-12,2019-11-01,,Disruption of the manufacture of the drug.,2019-08-15,2019-08-15
6731,2279924,Shortage,MENACTRA,SANOFI PASTEUR LIMITED,"Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine","MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A   MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C  MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135   MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y",4.0 μG  4.0 μG  4.0 μG  4.0 μG,5 x 0.5 mL vials,INTRAMUSCULAR,Resolved,Solution,J07AH,BACTERIAL VACCINES,2017-11-22,2017-11-22,2018-01-15,2018-01-18,Disruption of the manufacture of the drug.,2017-04-13,2018-01-22
1394,1959018,Shortage,MENOMUNE-A/C/Y/W-135,SANOFI PASTEUR LIMITED,"Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined",MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A	  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C	  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135	  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y,50 MCG / 0.5 ML  50 MCG / 0.5 ML  50 MCG / 0.5 ML  50 MCG / 0.5 ML,"1 x 0.5 mL vial plus 1 x 0.6 mL diluent / 1 flacon de 1 dose de 0,5 mL et 1 flacon de 0,6 mL de diluant",Subcutaneous,Resolved,"Kit,  Powder For Solution",J07AH,BACTERIAL VACCINES,2015-02-13,2015-02-13,,2017-03-29,Disruption of the manufacture of the drug.,2017-03-13,2017-03-30
52482,2347393,Shortage,MENVEO,GLAXOSMITHKLINE INC,"Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM-197 Conjugate Vaccine",MENINGOCOCCAL GROUP C OLIGOSACCHARIDE  CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN  MENINGOCOCCAL GROUP A OLIGOSACCHARIDE  MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE  MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE,5MCG  47MCG  10MCG  5MCG  5MCG,1's,INTRAMUSCULAR,Resolved,SOLUTION  POWDER FOR SOLUTION,J07AH,BACTERIAL VACCINES,,2018-06-14,2019-05-07,2019-04-08,Other (Please describe in comments),2018-06-15,2019-04-10
29459,2347393,Shortage,MENVEO,GLAXOSMITHKLINE INC,"Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine",MENINGOCOCCAL GROUP C OLIGOSACCHARIDE  CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN  MENINGOCOCCAL GROUP A OLIGOSACCHARIDE  MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE  MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE,5MCG  47MCG  10MCG  5MCG  5MCG,1 dose,INTRAMUSCULAR,Resolved,SOLUTION  POWDER FOR SOLUTION,J07AH,BACTERIAL VACCINES,,2017-12-06,2018-01-18,2018-01-17,Delay in shipping of the drug.,2017-11-16,2018-01-19
63919,2347393,Shortage,MENVEO,GLAXOSMITHKLINE INC,"Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM-197 Conjugate Vaccine",MENINGOCOCCAL GROUP C OLIGOSACCHARIDE  CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN  MENINGOCOCCAL GROUP A OLIGOSACCHARIDE  MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE  MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE,5MCG  47MCG  10MCG  5MCG  5MCG,5's,INTRAMUSCULAR,Actual shortage,SOLUTION  POWDER FOR SOLUTION,J07AH,BACTERIAL VACCINES,,2018-12-19,,,Disruption of the manufacture of the drug.,2018-10-12,2019-09-06
41792,2217422,Shortage,MEPRON,GLAXOSMITHKLINE INC,Atovaquone Oral Suspension,ATOVAQUONE,750MG,210 mL,ORAL,Resolved,SUSPENSION,P01AX,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.,,2018-03-05,2018-05-07,2018-03-28,Disruption of the manufacture of the drug.,2018-03-05,2018-03-29
36545,2378787,Shortage,MEROPENEM FOR INJECTION,SANDOZ CANADA INCORPORATED,MEROPENEM,MEROPENEM,500MG,10X 500MG Vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DH,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-01-16,2018-03-02,2018-02-20,Delay in shipping of the drug.,2018-01-18,2018-03-23
21863,2218488,Shortage,MERREM,ASTRAZENECA CANADA INC,Meropenem,MEROPENEM,500MG,20 mL vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DH,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-10-10,,2018-08-28,Other (Please describe in comments),2017-09-11,2018-08-29
20374,2218496,Shortage,MERREM,ASTRAZENECA CANADA INC,Meropenem,MEROPENEM,1G,30 mL vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01DH,OTHER BETA-LACTAM ANTIBACTERIALS,,2017-08-29,,2018-08-28,Other (Please describe in comments),2017-08-25,2018-08-29
88604,2244931,Shortage,MESNA FOR INJECTION,FRESENIUS KABI CANADA LTD,Mesna for Injection,MESNA,100MG,10mL Vial,INTRAVENOUS  ORAL,Resolved,SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2019-08-26,,2019-10-15,2019-09-13,Disruption of the manufacture of the drug.,2019-07-05,2019-09-14
66471,2244931,Shortage,MESNA FOR INJECTION,FRESENIUS KABI CANADA LTD,Mesna for Injection,MESNA,100MG,10 mL,INTRAVENOUS  ORAL,Resolved,SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2018-11-15,,,2019-01-23,Disruption of the manufacture of the drug.,2018-11-08,2019-01-24
87189,869961,Shortage,MESTINON TAB 60MG USP,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MESTINON TAB 60MG USP,PYRIDOSTIGMINE BROMIDE,60MG,100's,ORAL,Resolved,TABLET,N07AA,PARASYMPATHOMIMETICS,2019-07-22,,,2019-07-22,Other (Please describe in comments),2019-06-21,2019-07-24
45130,869953,Shortage,MESTINON-SR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MESTINON-SR,PYRIDOSTIGMINE BROMIDE,180MG,n/a,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N07AA,PARASYMPATHOMIMETICS,2018-04-05,,2018-04-09,2018-04-12,Other (Please describe in comments),2018-04-06,2018-04-13
28733,2247698,Shortage,METADOL,PALADIN LABS INC,Mathadone,METHADONE HYDROCHLORIDE,1MG,100tabs,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017-11-13,,2018-02-26,Disruption of the manufacture of the drug.,2017-11-09,2018-02-27
34946,2247701,Shortage,METADOL,PALADIN LABS INC,METADOL 25mg TABS 100,METHADONE HYDROCHLORIDE,25MG,100 Tabs,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2018-01-04,,2018-01-31,Disruption of the manufacture of the drug.,2018-01-04,2018-02-01
34949,2247699,Shortage,METADOL,PALADIN LABS INC,METADOL 5mg TABS 100,METHADONE HYDROCHLORIDE,5MG,100tabs,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2018-01-04,,2018-01-29,Disruption of the manufacture of the drug.,2018-01-04,2018-01-30
3471,2247698,Shortage,METADOL,PALADIN LABS INC,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,1MG,100 TABS,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017-03-01,2017-03-24,2017-03-24,Disruption of the manufacture of the drug.,2017-03-20,2017-03-27
30614,2247700,Shortage,METADOL,PALADIN LABS INC,Methadone,METHADONE HYDROCHLORIDE,10MG,100tabs,ORAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017-11-22,,2018-01-31,Disruption of the manufacture of the drug.,2017-11-24,2018-02-01
73749,2244290,Shortage,METADOL-D,PALADIN LABS INC,METADOL-D,METHADONE HYDROCHLORIDE,10MG,1L,ORAL,Resolved,SOLUTION,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2019-01-28,2019-04-30,2019-05-14,Demand increase for the drug.,2019-01-28,2019-05-15
68079,2247374,Shortage,METADOL-D,PALADIN LABS INC,Metadol-D,METHADONE HYDROCHLORIDE,1MG,250ml,ORAL,Actual shortage,SOLUTION,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2018-11-01,,,Other (Please describe in comments),2018-11-29,2018-11-29
61490,2263890,Shortage,METHACHOLINE OMEGA,OMEGA LABORATORIES LTD,Methacholine Chloride powder for inhalation solution 100mg,METHACHOLINE CHLORIDE,100MG,1 x 30 mL vial,INHALATION,Resolved,POWDER FOR SOLUTION,V04CX,OTHER DIAGNOSTIC AGENTS,,2018-09-13,2018-09-30,2018-09-21,Disruption of the manufacture of the drug.,2018-09-14,2018-10-01
61493,2263912,Shortage,METHACHOLINE OMEGA,OMEGA LABORATORIES LTD,Methacholine Chloride powder for inhalation solution 1600mg,METHACHOLINE CHLORIDE,1600MG,1 x 50 mL vial,INHALATION,Resolved,POWDER FOR SOLUTION,V04CX,OTHER DIAGNOSTIC AGENTS,,2018-09-13,2018-09-30,2018-09-21,Disruption of the manufacture of the drug.,2018-09-14,2018-10-01
69361,2263890,Shortage,METHACHOLINE OMEGA,OMEGA LABORATORIES LTD,Methacholine Chloride powder for inhalation solution 100mg,METHACHOLINE CHLORIDE,100MG,1 x 30mL vial / fiole,INHALATION,Resolved,POWDER FOR SOLUTION,V04CX,OTHER DIAGNOSTIC AGENTS,2018-12-17,,2019-01-31,2018-12-21,Disruption of the manufacture of the drug.,2018-12-12,2019-01-13
11570,2245882,Shortage,METHAZOLAMIDE,AA PHARMA INC,Methazolamide,METHAZOLAMIDE,50MG,100 BTL,ORAL,Resolved,TABLET,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-05-30,,2017-06-02,Disruption of the manufacture of the drug.,2017-05-30,2017-06-03
2010,2245882,Shortage,METHAZOLAMIDE,AA PHARMA INC,METHAZOLAMIDE,METHAZOLAMIDE,50 MG,100 Bottle,Oral,Resolved,Tablet,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-03-03,2017-07-21,2017-05-29,Shortage of an active ingredient.,2017-03-13,2017-05-30
71861,2238403,Shortage,METHOPRAZINE,AA PHARMA INC,METHOPRAZINE,METHOTRIMEPRAZINE,2MG,100 Bottle,ORAL,Resolved,TABLET,N05AA,ANTIPSYCHOTICS,,2019-01-10,2019-01-21,2019-01-25,Disruption of the manufacture of the drug.,2019-01-10,2019-02-09
56088,2327236,Shortage,METHOTREXATE INJECTION BP,ACCORD HEALTHCARE INC,METHOTREXATE,METHOTREXATE,25MG,40 ML PER VIAL  | 40 ML PAR FLACON,INTRA-ARTERIAL  INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS  INTRAVENTRICULAR,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2018-07-19,2018-07-19,2018-08-10,2018-07-31,Disruption of the manufacture of the drug.,2018-07-19,2018-08-02
56742,2327236,Shortage,METHOTREXATE INJECTION BP,ACCORD HEALTHCARE INC,METHOTREXATE,METHOTREXATE,25MG,1 VIAL OF 40 ML  | 1 FIOLE DE 40 ML,INTRA-ARTERIAL  INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS  INTRAVENTRICULAR,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2018-07-17,2018-07-17,2018-08-11,2018-07-31,Disruption of the manufacture of the drug.,2018-07-27,2018-08-02
81686,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,20ml,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,L01BA,ANTIMETABOLITES,,2019-03-25,2020-05-04,,Disruption of the manufacture of the drug.,2019-04-15,2019-11-06
2612,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,2mL fiole/vial,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017-03-14,,2017-08-28,2017-08-25,Other (Please describe in comments),2017-03-14,2017-10-18
37688,2182971,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,Methotrexate,METHOTREXATE,25MG,100 mL,INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2018-04-27,,2018-06-12,Disruption of the manufacture of the drug.,2018-01-30,2018-06-13
17472,2182777,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,Methotrexate,METHOTREXATE,25MG,1x20mL,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017-10-02,,2017-10-16,2017-10-02,Disruption of the manufacture of the drug.,2017-07-28,2017-10-13
31057,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,1 VIAL,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017-11-23,2017-12-22,2017-12-20,Delay in shipping of the drug.,2017-11-29,2018-01-08
12127,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,20ML VIAL,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017-04-28,2017-08-28,2017-07-11,Requirements related to complying with good manufacturing practices.,2017-06-06,2017-07-12
32130,2182777,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,METHOTREXATE,METHOTREXATE,25MG,5 x 2mL,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Avoided shortage,SOLUTION,L01BA,ANTIMETABOLITES,2018-03-30,,,2018-02-22,Disruption of the manufacture of the drug.,2017-12-08,2018-02-23
18320,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,20ML VIAL,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017-08-03,2017-08-31,2017-08-25,Demand increase for the drug.,2017-08-07,2017-10-18
14494,2182777,Shortage,METHOTREXATE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,METHOTREXATE,METHOTREXATE,25MG,5x2mL VIAL/AMPOULE,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017-07-31,2017-09-01,2017-10-16,2017-09-06,Disruption of the manufacture of the drug.,2017-07-03,2017-10-13
81825,2182971,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA ULC,Methotrexate,METHOTREXATE,25MG,100mL Vial,INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2019-04-19,2019-04-24,2019-05-31,2019-05-16,Disruption of the manufacture of the drug.,2019-04-16,2019-05-28
28847,2182971,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,Methotrexate,METHOTREXATE,25MG,1 x 20 mL,INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2018-01-24,,2018-04-19,Disruption of the manufacture of the drug.,2017-11-10,2018-04-20
28851,2182971,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA INC,Methotrexate,METHOTREXATE,25MG,Each - 40 mL,INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017-12-22,,2018-04-03,Disruption of the manufacture of the drug.,2017-11-10,2018-04-04
44783,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,2ML VIAL,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2018-03-23,2018-06-15,2018-06-26,Demand increase for the drug.,2018-04-03,2018-07-03
64245,2398427,Shortage,METHOTREXATE INJECTION USP,SANDOZ CANADA INCORPORATED,METHOTREXATE,METHOTREXATE,25MG,2MLx1 VIAL,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,L01BA,ANTIMETABOLITES,,2018-09-28,2020-05-04,,Disruption of the manufacture of the drug.,2018-10-15,2019-11-06
93692,2182777,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA ULC,METHOTREXATE INJECTION USP,METHOTREXATE,25MG,5 x 2mL MDV,INTRA-ARTERIAL  INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2019-09-20,,2019-10-24,Disruption of the manufacture of the drug.,2019-09-12,2019-10-28
3262,2327236,Shortage,"METHOTREXATE INJECTION, BP",ACCORD HEALTHCARE INC,METHOTREXATE,METHOTREXATE,25MG,20 ML VIAL OF 500 MG    |    FLACON DE 20 ML DE 500 MG,INTRA-ARTERIAL  INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2016-12-13,2016-12-13,2017-04-19,2017-04-07,Disruption of the manufacture of the drug.,2017-03-17,2017-04-08
3115,2099705,Shortage,METHOTREXATE SODIUM INJECTION,TEVA CANADA LIMITED,METHOTREXATE,METHOTREXATE,25MG,20ML,INTRA-ARTERIAL  INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2017-03-17,2017-04-28,2017-05-04,Disruption of the manufacture of the drug.,2017-03-17,2017-05-10
87673,2099705,Shortage,METHOTREXATE SODIUM INJECTION,TEVA CANADA LIMITED,METHOTREXATE,METHOTREXATE,25MG,20ML,INTRA-ARTERIAL  INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS  INTRACEREBROVENTRICULAR,Actual shortage,SOLUTION,L01BA,ANTIMETABOLITES,,2019-06-27,,,Disruption of the manufacture of the drug.,2019-06-27,2019-08-07
87676,2099705,Shortage,METHOTREXATE SODIUM INJECTION,TEVA CANADA LIMITED,METHOTREXATE,METHOTREXATE,25MG,2ML,INTRA-ARTERIAL  INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS  INTRACEREBROVENTRICULAR,Actual shortage,SOLUTION,L01BA,ANTIMETABOLITES,,2019-06-27,,,Disruption of the manufacture of the drug.,2019-06-27,2019-08-07
19756,2182750,Shortage,"METHOTREXATE TABLETS, USP",HOSPIRA HEALTHCARE CORPORATION,Methotrexate,METHOTREXATE,10MG,1x100,ORAL,Resolved,TABLET,L01BA,ANTIMETABOLITES,2017-08-16,,2017-09-26,2017-09-25,Delay in shipping of the drug.,2017-08-17,2017-09-26
8017,1966375,Shortage,METHOXISAL-C 1/2,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID  METHOCARBAMOL  CODEINE PHOSPHATE,325MG  400MG  32.4MG,100,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013-03-01,,,Requirements related to complying with good manufacturing practices.,2017-04-25,2017-10-05
8033,1966375,Shortage,METHOXISAL-C 1/2,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID  METHOCARBAMOL  CODEINE PHOSPHATE,325MG  400MG  32.4MG,24,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013-12-01,,,Requirements related to complying with good manufacturing practices.,2017-04-25,2017-10-05
8041,1966367,Shortage,METHOXISAL-C 1/4,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID  METHOCARBAMOL  CODEINE PHOSPHATE,325MG  400MG  16.2MG,24,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013-12-01,,,Requirements related to complying with good manufacturing practices.,2017-04-25,2017-10-05
8044,1941895,Shortage,METHOXISAL-C 1/8,TEVA CANADA LIMITED,METHOXISAL,ACETYLSALICYLIC ACID  METHOCARBAMOL  CODEINE PHOSPHATE,325MG  400MG  8MG,18,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2013-12-01,,,Requirements related to complying with good manufacturing practices.,2017-04-25,2017-10-05
44896,2431548,Shortage,METHYLENE BLUE INJECTION,TELIGENT OU,Methylene Blue Injection,METHYLENE BLUE,10MG,5 ML,INTRAVENOUS,Actual shortage,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2018-03-31,,,Other (Please describe in comments),2018-04-04,2018-04-04
39117,2230770,Shortage,METHYLENE BLUE INJECTION USP,OMEGA LABORATORIES LTD,METHYLENE BLUE,METHYLENE BLUE,10MG,10 X 5mL vial and 10X1mL vial,INTRAVENOUS,Resolved,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2018-02-02,,2018-04-13,2018-04-13,Shortage of an active ingredient.,2018-02-08,2018-05-16
60132,2230770,Shortage,METHYLENE BLUE INJECTION USP,OMEGA LABORATORIES LTD,METHYLENE BLUE INJECTION USP,METHYLENE BLUE,10MG,10x5mL vials,INTRAVENOUS,Resolved,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2018-11-01,2018-11-07,,2019-04-09,Other (Please describe in comments),2018-09-06,2019-04-10
60137,2230770,Shortage,METHYLENE BLUE INJECTION USP,OMEGA LABORATORIES LTD,METHYLENE BLUE INJECTION USP,METHYLENE BLUE,10MG,10x1mL vials,INTRAVENOUS,Resolved,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2018-12-15,2018-12-07,2019-06-30,2019-04-09,Shortage of an active ingredient.,2018-09-06,2019-06-28
75027,2326256,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-02-04,,2019-04-10,Other (Please describe in comments),2019-02-07,2019-04-11
75551,2326248,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-02-13,,2019-04-10,Other (Please describe in comments),2019-02-13,2019-04-11
75563,2326221,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-03-08,,2019-04-10,Other (Please describe in comments),2019-02-13,2019-04-11
21610,2326248,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-28,,2018-04-11,Delay in shipping of the drug.,2017-09-08,2018-04-12
12264,2326221,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-10-02,,2018-10-25,Delay in shipping of the drug.,2017-06-07,2018-10-26
21236,2326256,Shortage,METHYLPHENIDATE,PRO DOC LIMITEE,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-06-26,,2018-08-03,Delay in shipping of the drug.,2017-09-07,2018-08-04
1714,2241229,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE SODIUM SUCCINATE,METHYLPREDNISOLONE,1G,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016-02-29,,,Shortage of an inactive ingredient or component.,2017-03-13,2017-10-05
1720,2231894,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE SODIUM SUCCINATE,METHYLPREDNISOLONE,125MG,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1724,2231893,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE,METHYLPREDNISOLONE,40MG,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1729,2231895,Shortage,METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,TEVA CANADA LIMITED,METHYLPREDNISOLONE,METHYLPREDNISOLONE,500MG,5,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
70687,2230431,Shortage,METONIA,PENDOPHARM DIVISION OF PHARMASCIENCE INC,METOCLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,2018-12-17,2018-12-17,2019-01-03,2019-01-03,Delay in shipping of the drug.,2018-12-28,2019-01-04
41030,2230433,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 1mg/mL SOL 500mL,METOCLOPRAMIDE HYDROCHLORIDE,1MG,500ml,ORAL,Avoided shortage,SOLUTION,A03FA,PROPULSIVES,2018-03-30,,2018-03-30,2018-03-06,Delay in shipping of the drug.,2018-02-26,2018-03-06
13916,2230431,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 5mg TABS 100,METOCLOPRAMIDE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,2017-09-11,2017-09-11,2017-09-25,2017-09-21,Disruption of the manufacture of the drug.,2017-06-26,2017-09-22
71264,2230431,Shortage,METONIA,PENDOPHARM DIVISION OF PHARMASCIENCE INC,METOCLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,2019-02-25,,2019-03-06,2019-03-11,Demand increase for the drug.,2019-01-04,2019-03-12
3764,2230432,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 10mg TABS 100,METOCLOPRAMIDE HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,TABLET,A03FA,PROPULSIVES,2016-11-01,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-21,2017-10-05
3767,2230432,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 10mg TABS 500,METOCLOPRAMIDE HYDROCHLORIDE,10MG,500,ORAL,Actual shortage,TABLET,A03FA,PROPULSIVES,2016-11-01,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-21,2017-10-05
7155,2230433,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 1mg/mL SOL 500mL,METOCLOPRAMIDE HYDROCHLORIDE,1MG,500mL,ORAL,Resolved,SOLUTION,A03FA,PROPULSIVES,,2017-04-18,2017-05-31,2017-06-04,Demand increase for the drug.,2017-04-18,2017-06-05
28664,2230431,Shortage,METONIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,METONIA 5mg TABS 100,METOCLOPRAMIDE HYDROCHLORIDE,5MG,100,ORAL,Avoided shortage,TABLET,A03FA,PROPULSIVES,2017-12-24,,2017-12-28,2017-12-04,Delay in shipping of the drug.,2017-11-08,2017-12-04
2327,2351412,Shortage,METOPROLOL SR,PRO DOC LIMITEE,METOPROLOL SR,METOPROLOL TARTRATE,200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2017-03-14,,2018-05-30,Other (Please describe in comments),2017-03-14,2018-05-31
92699,2474271,Shortage,METOPROLOL TARTRATE INJECTION USP,MDA INC.,Metoprolol Tartrate Injection USP,METOPROLOL TARTRATE,1MG,10,INTRAVENOUS,Actual shortage,SOLUTION,C07AB,BETA BLOCKING AGENTS,2019-10-31,2019-08-29,2019-12-06,,Demand increase for the drug.,2019-08-30,2019-10-04
32573,2442124,Shortage,METOPROLOL-L,SIVEM PHARMACEUTICALS ULC,METOPROLOL-L,METOPROLOL TARTRATE,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-12-25,2017-12-23,2018-05-18,2018-05-18,Other (Please describe in comments),2017-12-12,2018-05-19
36247,2442132,Shortage,METOPROLOL-L,SIVEM PHARMACEUTICALS ULC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,1000,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-02-26,2018-01-16,2018-05-18,2018-05-18,Other (Please describe in comments),2018-01-17,2018-05-19
36252,2442132,Shortage,METOPROLOL-L,SIVEM PHARMACEUTICALS ULC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-01-29,2018-01-26,2018-05-18,2018-05-18,Other (Please describe in comments),2018-01-17,2018-05-19
89429,870420,Shortage,METRONIDAZOLE 5MG/ML INJECTION,BAXTER CORPORATION,METRONIDAZOLE,METRONIDAZOLE,5MG,100 mL,INTRAVENOUS,Resolved,LIQUID,J01XD,OTHER ANTIBACTERIALS,2019-07-16,2019-07-16,2019-08-08,2019-08-08,Demand increase for the drug.,2019-07-16,2019-08-09
70778,870420,Shortage,METRONIDAZOLE 5MG/ML INJECTION,BAXTER CORPORATION,Metronidazole,METRONIDAZOLE,5MG,100 mL,INTRAVENOUS,Resolved,LIQUID,J01XD,OTHER ANTIBACTERIALS,2019-01-02,2019-01-02,2019-02-08,2019-02-08,Disruption of the manufacture of the drug.,2019-01-02,2019-02-09
86984,870420,Shortage,METRONIDAZOLE 5MG/ML INJECTION,BAXTER CORPORATION,METRONIDAZOLE 500MG IN 100ML SWI (SINGLE PACKS) 40EA/CA,METRONIDAZOLE,5MG,100 mL,INTRAVENOUS,Resolved,LIQUID,J01XD,OTHER ANTIBACTERIALS,2019-06-18,2019-06-18,2019-07-02,2019-07-02,Demand increase for the drug.,2019-06-18,2019-07-03
85169,649074,Shortage,METRONIDAZOLE INJECTION USP,PFIZER CANADA ULC,Metronidazole Injection USP,METRONIDAZOLE,5MG,24 x 100mL PLBG,INTRAVENOUS,Resolved,SOLUTION,J01XD,OTHER ANTIBACTERIALS,,2019-05-28,,2019-06-21,Disruption of the manufacture of the drug.,2019-05-29,2019-06-22
45516,2323273,Shortage,METVIX,GALDERMA CANADA INC,methyl aminolevulinate hydrochloride,METHYL AMINOLEVULINATE,168MG,2 gram aluminum tube sealed with an aluminum membrane and a screw cap,TOPICAL,Resolved,CREAM,L01XD,OTHER ANTINEOPLASTIC AGENTS,2018-04-16,,2018-06-07,2018-06-07,Delay in shipping of the drug.,2018-04-12,2018-06-14
68995,2474026,Shortage,MEZERA,AVIR PHARMA INC,Mezera Foam,MESALAZINE,1G,1g,RECTAL,Resolved,FOAM,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,2018-12-10,2018-12-10,2019-03-01,2019-03-26,Delay in shipping of the drug.,2018-12-10,2019-03-27
68853,2474018,Shortage,MEZERA,AVIR PHARMA INC,Mezera,MESALAZINE,1G,30,RECTAL,Resolved,SUPPOSITORY,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,2018-12-06,2018-12-06,2018-12-14,2018-12-20,Disruption of the manufacture of the drug.,2018-12-06,2018-12-21
30931,2240769,Shortage,MICARDIS 40MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,MICARDIS,TELMISARTAN,40MG,28s,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-11-28,2017-11-28,2017-12-08,2018-01-19,Delay in shipping of the drug.,2017-11-28,2018-01-20
22237,2240769,Shortage,MICARDIS 40MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Micardis,TELMISARTAN,40MG,28s,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-09-22,,2018-01-22,2017-11-13,Disruption of the manufacture of the drug.,2017-09-18,2017-11-17
78332,2240769,Shortage,MICARDIS 40MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Micardis,TELMISARTAN,40MG,28's,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-08,2019-05-22,2019-05-23,Demand increase for the drug.,2019-03-12,2019-05-26
93285,2240770,Shortage,MICARDIS 80MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Micardis,TELMISARTAN,80MG,28's,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-03,2019-09-27,2019-09-20,Disruption of the manufacture of the drug.,2019-09-09,2019-09-23
38027,2240770,Shortage,MICARDIS 80MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,MICARDIS,TELMISARTAN,80MG,28s,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-02-01,2018-02-01,2018-03-12,2018-03-15,Delay in shipping of the drug.,2018-02-01,2018-03-20
78335,2240770,Shortage,MICARDIS 80MG TAB,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Micardis,TELMISARTAN,80MG,28's,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-03-22,2019-03-27,2019-04-30,2019-04-24,Demand increase for the drug.,2019-03-12,2019-04-25
71262,2318709,Shortage,MICARDIS PLUS,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,MICARDIS,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,28s,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-02,2019-01-16,2019-01-07,Demand increase for the drug.,2019-01-04,2019-01-08
38023,2244344,Shortage,MICARDIS PLUS,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,MICARDIS 80 mg,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,TABS 28S,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-02-01,2018-02-01,,2018-02-05,Delay in shipping of the drug.,2018-02-01,2018-03-02
2600,1974548,Shortage,MICRO I,SANDOZ CANADA INCORPORATED,MICRO I,Iodide (as sodium iodide),100MCG/ML 10X10MLV,100MCG/ML 10X10MLV,INJECTION,Resolved,LIQUID IN VAIL,A12,OTHER MINERAL SUPPLEMENTS,,2017-03-14,2017-07-18,2017-07-21,Disruption of the manufacture of the drug.,2017-03-14,2017-10-25
2592,2091100,Shortage,MICRO PLUS 6   (PEDIATRIC),SANDOZ CANADA INCORPORATED,MICRO+6 PED INJ,MANGANESE  CHROMIUM  SELENIUM  ZINC  COPPER  IODINE,0.1MG  4MCG  20MCG  3MG  0.4MG  60MCG,10X10MLV,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2017-03-14,2017-04-07,2017-03-21,Disruption of the manufacture of the drug.,2017-03-14,2017-03-21
73217,2242905,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam Injection,MIDAZOLAM,5MG,1mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,N05CD,HYPNOTICS AND SEDATIVES,2019-02-15,,2019-07-31,2019-07-24,Disruption of the manufacture of the drug.,2019-01-22,2019-07-26
14850,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,Midazolam,MIDAZOLAM,5MG,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,2017-07-14,,2017-10-20,2017-10-05,Demand increase for the drug.,2017-07-06,2017-10-06
26124,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,5 x 10ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017-10-31,,2018-01-12,Disruption of the manufacture of the drug.,2017-10-17,2018-02-07
66342,2240285,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,1MG,2ML X 10 VIALS,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-10-15,2018-12-17,2019-01-07,Demand increase for the drug.,2018-11-07,2019-01-16
34133,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam for Injection,MIDAZOLAM,1MG,5mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017-12-14,2018-03-29,2018-03-29,Disruption of the manufacture of the drug.,2017-12-22,2018-03-30
36712,2242905,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,MIDAZOLAM,MIDAZOLAM,5MG,1mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,N05CD,HYPNOTICS AND SEDATIVES,2018-01-19,,,2018-08-09,Disruption of the manufacture of the drug.,2018-01-19,2018-08-10
36716,2242905,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,MIDAZOLAM,MIDAZOLAM,5MG,2mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,N05CD,HYPNOTICS AND SEDATIVES,2018-01-19,,2018-03-29,2018-03-29,Disruption of the manufacture of the drug.,2018-01-19,2018-03-30
79218,2240286,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,5MG,10x1mLV,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-02-04,,,Demand increase for the drug.,2019-03-22,2019-05-07
82804,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA ULC,MIDAZOLAM,MIDAZOLAM,5MG,10 x 1mL AMP,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-05-03,,2019-06-05,Disruption of the manufacture of the drug.,2019-04-30,2019-06-06
43646,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,5 x 3mL PVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-05-25,,2018-10-17,Demand increase for the drug.,2018-03-21,2018-11-02
62346,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam Injection,MIDAZOLAM,1MG,2mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,2018-09-01,,2019-04-05,2019-04-08,Disruption of the manufacture of the drug.,2018-09-25,2019-04-09
62349,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam Injection,MIDAZOLAM,1MG,5mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,2018-10-01,,2018-11-30,2018-11-30,Disruption of the manufacture of the drug.,2018-09-25,2018-12-01
74908,2240285,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,1MG,5ml X10 Vials,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,2019-02-27,,2019-05-13,2019-03-18,Demand increase for the drug.,2019-02-06,2019-03-22
82597,2423758,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA ULC,MIDAZOLAM,MIDAZOLAM,1MG,10 x 5mL AMP,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-09-20,,2019-10-21,Demand increase for the drug.,2019-04-29,2019-10-22
47015,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam for Injection,MIDAZOLAM,1MG,10mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-04-23,2018-05-18,2018-05-23,Disruption of the manufacture of the drug.,2018-04-23,2018-05-24
47018,2242905,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam for Injection,MIDAZOLAM,5MG,10mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,N05CD,HYPNOTICS AND SEDATIVES,2018-04-27,,2018-05-18,2018-05-23,Disruption of the manufacture of the drug.,2018-04-23,2018-05-24
30645,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,10x1mL PVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-01-19,,2018-04-27,Disruption of the manufacture of the drug.,2017-11-24,2018-04-30
80849,2242905,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam Injection,MIDAZOLAM,5MG,10mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,N05CD,HYPNOTICS AND SEDATIVES,2019-04-19,,2019-07-12,2019-07-15,Disruption of the manufacture of the drug.,2019-04-09,2019-07-26
93924,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam Injection,MIDAZOLAM,1MG,2mL,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-09-13,2019-11-30,,Disruption of the manufacture of the drug.,2019-09-13,2019-09-14
30191,2423758,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,1MG,10x5mL PVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-02-20,,2018-04-27,Disruption of the manufacture of the drug.,2017-11-22,2018-04-30
84727,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam Injection,MIDAZOLAM,1MG,5mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,2019-06-08,,2019-08-22,2019-08-23,Disruption of the manufacture of the drug.,2019-05-24,2019-08-24
2045,2423766,Shortage,MIDAZOLAM INJECTION,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,10 x 1ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2016-12-06,2017-03-22,2017-03-29,Delay in shipping of the drug.,2017-03-14,2017-03-30
64253,2240286,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,5MG,50MLx1 VIAL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-09-11,2018-10-19,2018-10-19,Delay in shipping of the drug.,2018-10-15,2018-10-20
73214,2242904,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,Midazolam Injection,MIDAZOLAM,1MG,5mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,2019-01-18,,2019-04-05,2019-04-08,Disruption of the manufacture of the drug.,2019-01-22,2019-04-09
56596,2382350,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,10 x 1mL PVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-10-15,,2018-11-02,Demand increase for the drug.,2018-07-26,2018-11-03
76566,2382350,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,Midazolam Injection USP,MIDAZOLAM,5MG,10 x 1mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-02-20,,2019-03-28,Disruption of the manufacture of the drug.,2019-02-21,2019-07-03
95775,2382350,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,Midazolam Injection USP,MIDAZOLAM,5MG,10 x 2mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-10-28,,2019-11-05,Disruption of the manufacture of the drug.,2019-10-08,2019-11-06
34093,2382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA INC,Midazolam,MIDAZOLAM,1MG,10 x 2mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017-12-22,,2018-02-28,Disruption of the manufacture of the drug.,2017-12-21,2018-03-01
67635,2382350,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,5MG,10 x 2mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-01-23,,2019-03-28,Disruption of the manufacture of the drug.,2018-11-26,2019-03-29
76885,2382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,Midazolam Injection USP,MIDAZOLAM,1MG,10 x 5mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-02-25,,2019-09-23,Disruption of the manufacture of the drug.,2019-02-26,2019-10-01
79211,2382377,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,Midazolam Injection USP,MIDAZOLAM,1MG,10 x 10ml GVL MD,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-04-12,,2019-09-10,Demand increase for the drug.,2019-03-22,2019-09-11
72818,2382385,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,MIDAZOLAM,MIDAZOLAM,5MG,10 x 10mL GVL MD,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2019-03-22,,2019-09-10,Disruption of the manufacture of the drug.,2019-01-17,2019-10-01
68252,2382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,1MG,10 x 2mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-11-29,,2019-07-30,Disruption of the manufacture of the drug.,2018-11-30,2019-10-01
14497,2382377,Shortage,MIDAZOLAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MIDAZOLAM,MIDAZOLAM,1MG,VIAL/AMPOULE,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017-07-07,,2018-05-24,Disruption of the manufacture of the drug.,2017-07-03,2018-07-26
14500,2382350,Shortage,MIDAZOLAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MIDAZOLAM,MIDAZOLAM,5MG,VIAL/AMPOULE,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017-06-15,,2018-01-12,Disruption of the manufacture of the drug.,2017-07-03,2018-02-07
14503,2382385,Shortage,MIDAZOLAM INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MIDAZOLAM,MIDAZOLAM,5MG,VIAL/AMPOULE,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2017-08-02,,2018-04-23,Disruption of the manufacture of the drug.,2017-07-03,2018-04-24
30648,2382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA INC,MIDAZOLAM,MIDAZOLAM,1MG,10x5mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05CD,HYPNOTICS AND SEDATIVES,,2018-02-07,,2018-05-07,Disruption of the manufacture of the drug.,2017-11-24,2018-05-08
25869,2278685,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,5.0MG,100BTL,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2018-07-26,2018-12-17,2018-12-17,Disruption of the manufacture of the drug.,2017-10-13,2018-12-18
24363,2278677,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,2.5MG,100BTL,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-10-04,2017-10-30,2017-10-12,Disruption of the manufacture of the drug.,2017-10-04,2017-10-13
10043,2278677,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,2.5MG,100 BTL,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-05-10,2017-05-16,2017-05-16,Demand increase for the drug.,2017-05-11,2017-05-17
4521,2278685,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,5.0MG,100 Bottle,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-03-28,2017-04-17,2017-04-13,Demand increase for the drug.,2017-03-29,2017-04-14
3800,2278677,Shortage,MIDODRINE,AA PHARMA INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,2.5MG,100 Bottle,ORAL,Resolved,TABLET,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2017-03-21,2017-04-17,2017-04-13,Demand increase for the drug.,2017-03-21,2017-04-14
76363,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL  MIFEPRISTONE,200MCG  200MG,Combipack,BUCCAL  ORAL,Resolved,KIT  TABLET,G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2019-02-18,2019-02-18,,2019-04-08,Other (Please describe in comments),2019-02-20,2019-04-17
20581,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL  MIFEPRISTONE,200MCG  200MG,Combipack,BUCCAL  ORAL,Resolved,KIT  TABLET,G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2017-08-29,2017-08-29,2017-10-16,2017-10-13,Demand increase for the drug.,2017-08-29,2017-10-16
15501,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL  MIFEPRISTONE,200MCG  200MG,Combipack (1 box of 1 tablet of mifepristone 200 mg tablet + 1 box of 4 tablets of 200 µg misoprostol),BUCCAL  ORAL,Resolved,KIT  TABLET,G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2017-07-10,2017-07-10,2017-07-18,2017-10-13,Delay in shipping of the drug.,2017-07-12,2017-11-10
26866,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL  MIFEPRISTONE,200MCG  200MG,Combipack,BUCCAL  ORAL,Resolved,KIT  TABLET,G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,,2017-10-24,2017-12-31,2018-01-09,Other (Please describe in comments),2017-10-24,2018-01-11
42995,2444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone / Misoprostol,MISOPROSTOL  MIFEPRISTONE,200MCG  200MG,Combipack (1 box of 1 tablet of mifepristone + 1 box of 4 tablets of misoprostol),BUCCAL  ORAL,Resolved,KIT  TABLET,G03XB,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,2018-03-12,2018-03-12,2018-03-28,2018-04-02,Demand increase for the drug.,2018-03-15,2018-04-03
91547,2244854,Shortage,MILRINONE LACTATE INJECTION,SANDOZ CANADA INCORPORATED,MILRINONE LACTATE,MILRINONE,1.0MG,10 X 10ml,INTRAVENOUS,Resolved,SOLUTION,C01CE,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,,2019-08-05,2019-10-28,2019-10-28,Delay in shipping of the drug.,2019-08-14,2019-11-01
2996,2244622,Shortage,MILRINONE LACTATE INJECTION,FRESENIUS KABI CANADA LTD,Milrinone Lactate Injection 1 mg/mL SD Vial 20 mL,MILRINONE,1.0MG,20mL,INTRAVENOUS,Resolved,SOLUTION,C01CE,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2017-03-20,,,2017-04-07,Disruption of the manufacture of the drug.,2017-03-15,2017-04-08
19855,2042320,Shortage,MIN-OVRAL 21,PFIZER CANADA INC,Min-Ovral,ETHINYL ESTRADIOL  LEVONORGESTREL,30MCG  150MCG,21's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2017-08-16,,2017-08-30,2017-08-30,Disruption of the manufacture of the drug.,2017-08-18,2017-08-31
96092,315966,Shortage,MINESTRIN 1/20,ALLERGAN INC,MINESTRIN 1/20,ETHINYL ESTRADIOL  NORETHINDRONE ACETATE,20MCG  1MG,21,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-10-10,2019-10-10,2019-11-15,2019-11-01,Disruption of the manufacture of the drug.,2019-10-10,2019-11-04
96095,343838,Shortage,MINESTRIN 1/20,ALLERGAN INC,Minestrin 1/20,ETHINYL ESTRADIOL  NORETHINDRONE ACETATE,20MCG  1MG,28,ORAL,Actual shortage,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-10-10,2019-10-10,2019-12-13,,Disruption of the manufacture of the drug.,2019-10-10,2019-10-11
83491,2148358,Shortage,MINIMS ATROPINE SULPHATE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS ATROPINE SULPHATE 1%,ATROPINE SULFATE,1%,n/a,OPHTHALMIC,Avoided shortage,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,2019-07-05,,,2019-06-10,Shortage of an inactive ingredient or component.,2019-05-08,2019-06-12
54882,2148358,Shortage,MINIMS ATROPINE SULPHATE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS ATROPINE SULPHATE 1%,ATROPINE SULFATE,1%,n/a,OPHTHALMIC,Resolved,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2018-07-06,,2018-09-07,Other (Please describe in comments),2018-07-09,2018-09-10
44248,2148358,Shortage,MINIMS ATROPINE SULPHATE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS ATROPINE SULPHATE 1%,ATROPINE SULFATE,1%,n/a,OPHTHALMIC,Resolved,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2018-03-28,,2018-06-29,Demand increase for the drug.,2018-03-29,2018-07-04
42825,2148382,Shortage,MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%,CYCLOPENTOLATE HYDROCHLORIDE,1%,NA,OPHTHALMIC,Resolved,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2018-02-14,,2018-03-12,Other (Please describe in comments),2018-03-14,2018-03-14
50776,2148382,Shortage,MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%,CYCLOPENTOLATE HYDROCHLORIDE,1%,n/a,OPHTHALMIC,Resolved,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2018-08-14,,2018-09-05,Other (Please describe in comments),2018-05-30,2018-09-10
95876,2148382,Shortage,MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%,CYCLOPENTOLATE HYDROCHLORIDE,1%,0.5ml,OPHTHALMIC,Actual shortage,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2019-09-30,,,Shortage of an inactive ingredient or component.,2019-10-09,2019-10-09
66616,2148390,Shortage,MINIMS FLUORESCEIN SODIUM 2%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS FLUORESCEIN SODIUM 2%,FLUORESCEIN SODIUM,2%,n/a,OPHTHALMIC,Resolved,SOLUTION,S01JA,DIAGNOSTICAGENTS,2018-12-28,,,2018-12-28,Other (Please describe in comments),2018-11-09,2019-01-10
74957,2148390,Shortage,MINIMS FLUORESCEIN SODIUM 2%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS FLUORESCEIN SODIUM 2%,FLUORESCEIN SODIUM,2%,n/a,OPHTHALMIC,Resolved,SOLUTION,S01JA,DIAGNOSTICAGENTS,,2019-02-04,,2019-02-14,Other (Please describe in comments),2019-02-06,2019-03-05
53266,2148455,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,PHENYLEPHRINE HYDROCHLORIDE,10%,n/a,OPHTHALMIC,Resolved,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,2018-07-24,,,2018-10-25,Other (Please describe in comments),2018-06-29,2018-10-29
66607,2148455,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,PHENYLEPHRINE HYDROCHLORIDE,10%,n/a,OPHTHALMIC,Resolved,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2018-10-31,,2019-01-28,Other (Please describe in comments),2018-11-09,2019-01-30
42830,2148455,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,PHENYLEPHRINE HYDROCHLORIDE,10%,NA,OPHTHALMIC,Resolved,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2018-03-02,,2018-03-16,Other (Please describe in comments),2018-03-14,2018-03-17
49644,2148455,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,PHENYLEPHRINE HYDROCHLORIDE,10%,n/a,OPHTHALMIC,Resolved,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,2018-05-29,,,2018-06-27,Other (Please describe in comments),2018-05-17,2018-06-29
53263,2148447,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,PHENYLEPHRINE HYDROCHLORIDE,2.5%,n/a,OPHTHALMIC,Resolved,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,2018-09-05,,,2018-10-11,Other (Please describe in comments),2018-06-29,2018-10-12
66604,2148447,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,PHENYLEPHRINE HYDROCHLORIDE,2.5%,n/a,OPHTHALMIC,Resolved,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2018-10-31,,2019-01-17,Other (Please describe in comments),2018-11-09,2019-01-23
89910,2148447,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,PHENYLEPHRINE HYDROCHLORIDE,2.5%,n/a,OPHTHALMIC,Anticipated shortage,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,2019-11-20,,2020-02-15,,Shortage of an active ingredient.,2019-07-24,2019-11-13
50786,2148447,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PHENYLEPHRINE HYDROCHLORIDE 2.5%,PHENYLEPHRINE HYDROCHLORIDE,2.5%,n/a,OPHTHALMIC,Resolved,DROPS,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2018-06-19,,2018-06-27,Other (Please describe in comments),2018-05-30,2018-06-29
44251,2148463,Shortage,MINIMS PILOCARPINE NITRATE 2%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PILOCARPINE NITRATE 2%,PILOCARPINE NITRATE,2%,n/a,OPHTHALMIC,Resolved,DROPS,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-07-10,,2018-10-04,Other (Please describe in comments),2018-03-29,2018-10-05
83494,2148498,Shortage,MINIMS PREDNISOLONE SODIUM PHOSPHATE 0.5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PREDNISOLONE SODIUM PHOSPHATE 0.5%,PREDNISOLONE SODIUM PHOSPHATE,0.5%,n/a,OPHTHALMIC,Avoided shortage,DROPS,S01BA,ANTIINFLAMMATORY AGENTS,2019-08-05,,,2019-06-10,Shortage of an inactive ingredient or component.,2019-05-08,2019-06-12
66610,2148498,Shortage,MINIMS PREDNISOLONE SODIUM PHOSPHATE 0.5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PREDNISOLONE SODIUM PHOSPHATE 0.5%,PREDNISOLONE SODIUM PHOSPHATE,0.5%,n/a,OPHTHALMIC,Resolved,DROPS,S01BA,ANTIINFLAMMATORY AGENTS,,2019-01-09,,2019-03-05,Other (Please describe in comments),2018-11-09,2019-03-06
49647,2148498,Shortage,MINIMS PREDNISOLONE SODIUM PHOSPHATE 0.5%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS PREDNISOLONE SODIUM PHOSPHATE 0.5%,PREDNISOLONE SODIUM PHOSPHATE,0.5%,n/a,OPHTHALMIC,Resolved,DROPS,S01BA,ANTIINFLAMMATORY AGENTS,,2018-09-12,,2018-10-25,Other (Please describe in comments),2018-05-17,2018-10-29
66613,2148536,Shortage,MINIMS TROPICAMIDE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS TROPICAMIDE 1%,TROPICAMIDE,1%,n/a,OPHTHALMIC,Resolved,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2018-11-07,,2018-12-13,Other (Please describe in comments),2018-11-09,2018-12-14
50781,2148536,Shortage,MINIMS TROPICAMIDE 1%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,MINIMS TROPICAMIDE 1%,TROPICAMIDE,1%,n/a,OPHTHALMIC,Resolved,DROPS,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2018-09-12,,2018-10-04,Other (Please describe in comments),2018-05-30,2018-10-05
22094,2287226,Shortage,MINOCYCLINE,SANIS HEALTH INC,MINOCYCLINE CAPS,MINOCYCLINE,50MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017-09-30,2017-09-07,,2018-07-16,Disruption of the manufacture of the drug.,2017-09-14,2019-01-22
22098,2287234,Shortage,MINOCYCLINE,SANIS HEALTH INC,MINOCYCLINE CAPS,MINOCYCLINE,100MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017-09-30,2017-09-08,,2018-07-16,Disruption of the manufacture of the drug.,2017-09-14,2019-01-22
75569,2154366,Shortage,MINOCYCLINE-100,PRO DOC LIMITEE,MINOCYCLINE,MINOCYCLINE,100MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2019-04-01,,2019-04-10,Other (Please describe in comments),2019-02-13,2019-04-11
75566,2153394,Shortage,MINOCYCLINE-50,PRO DOC LIMITEE,MINOCYCLINE,MINOCYCLINE,50MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2019-03-06,,2019-04-10,Other (Please describe in comments),2019-02-13,2019-04-11
1601,2228319,Shortage,MINOX - LIQ TOP 20MG/ML,LABORATOIRE RIVA INC,Minoxidil Topical Solution USP,MINOXIDIL,20MG,60 ml,TOPICAL,Actual shortage,SOLUTION,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
30002,2362651,Shortage,MINT-AMLODIPINE,MINT PHARMACEUTICALS INC,Amlodipine,AMLODIPINE,5MG,250 Count bottles,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-11-21,2017-11-21,2018-01-12,2018-01-10,Shortage of an inactive ingredient or component.,2017-11-21,2018-01-11
45528,2362678,Shortage,MINT-AMLODIPINE,MINT PHARMACEUTICALS INC,Amlodipine,AMLODIPINE,10MG,250 Count bottles,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-04-09,2018-05-31,2018-05-28,Delay in shipping of the drug.,2018-04-12,2018-05-29
89913,2476916,Shortage,MINT-CANDESARTAN,MINT PHARMACEUTICALS INC,Candesartan,CANDESARTAN CILEXETIL,8MG,100 count bottles,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-19,,,Disruption of the manufacture of the drug.,2019-07-24,2019-07-24
71041,2476924,Shortage,MINT-CANDESARTAN,MINT PHARMACEUTICALS INC,Candesartan,CANDESARTAN CILEXETIL,16MG,100 count bottles,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-03,2019-12-31,,Demand increase for the drug.,2019-01-03,2019-10-09
80787,2476916,Shortage,MINT-CANDESARTAN,MINT PHARMACEUTICALS INC,Candesartan,CANDESARTAN CILEXETIL,8MG,100 count bottles,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-08,2019-06-30,2019-06-14,Disruption of the manufacture of the drug.,2019-04-08,2019-06-15
95947,2476916,Shortage,MINT-CANDESARTAN,MINT PHARMACEUTICALS INC,Candesartan,CANDESARTAN CILEXETIL,8MG,100 count bottles,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-09,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-09,2019-10-10
57055,2423561,Shortage,MINT-CIPROFLOX,MINT PHARMACEUTICALS INC,Ciprofloxacin,CIPROFLOXACIN,500MG,100 count bottles,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-07-31,2019-12-31,,Disruption of the manufacture of the drug.,2018-07-31,2019-09-03
45533,2429713,Shortage,MINT-CITALOPRAM,MINT PHARMACEUTICALS INC,Citalopram,CITALOPRAM,40MG,30 Count Blisters,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-04-09,2018-04-30,2018-05-15,Delay in shipping of the drug.,2018-04-12,2018-05-16
45117,2408910,Shortage,MINT-CLOPIDOGREL,MINT PHARMACEUTICALS INC,Mint- Clopidogrel,CLOPIDOGREL,75MG,30 Count Blisters,ORAL,Actual shortage,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2018-04-06,2018-04-06,,,Disruption of the manufacture of the drug.,2018-04-06,2018-04-07
42370,2408910,Shortage,MINT-CLOPIDOGREL,MINT PHARMACEUTICALS INC,Clopidogrel,CLOPIDOGREL,75MG,100 count bottles,ORAL,Actual shortage,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2018-03-09,,,Delay in shipping of the drug.,2018-03-09,2018-03-10
35753,2443090,Shortage,MINT-DORZOLAMIDE/TIMOLOL,MINT PHARMACEUTICALS INC,Dorzolamide/Timolo 20 /5mg /ml,TIMOLOL  DORZOLAMIDE,5MG  20MG,10 ml bottle,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-08-04,2018-09-28,2018-09-18,Delay in shipping of the drug.,2018-01-11,2018-09-19
45536,2438984,Shortage,MINT-DULOXETINE,MINT PHARMACEUTICALS INC,Duloxetine,DULOXETINE,30MG,100 count bottles,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-04-09,2018-04-30,2018-05-07,Delay in shipping of the drug.,2018-04-12,2018-05-08
45539,2438992,Shortage,MINT-DULOXETINE,MINT PHARMACEUTICALS INC,Duloxetine,DULOXETINE,60MG,100 count bottles,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-04-09,2018-05-11,2018-05-07,Delay in shipping of the drug.,2018-04-12,2018-05-08
34914,2428873,Shortage,MINT-DUTASTERIDE,MINT PHARMACEUTICALS INC,Dutasteride,DUTASTERIDE,0.5MG,30 Count Blisters,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-01-04,2018-01-04,2018-02-16,2018-02-22,Disruption of the manufacture of the drug.,2018-01-04,2018-02-23
27176,2423243,Shortage,MINT-EZETIMIBE,MINT PHARMACEUTICALS INC,Ezetimibe,EZETIMIBE,10MG,Bottles of 100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-07-24,,2017-11-10,Shortage of an inactive ingredient or component.,2017-10-26,2017-11-11
80782,2465167,Shortage,MINT-FENOFIBRATE E,MINT PHARMACEUTICALS INC,Fenofibrate,FENOFIBRATE,145MG,100 count bottles,ORAL,Actual shortage,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-08,2020-06-30,,Disruption of the manufacture of the drug.,2019-04-08,2019-07-04
57064,2380560,Shortage,MINT-FLUOXETINE,MINT PHARMACEUTICALS INC,Fluoxetine,FLUOXETINE,10MG,100 count bottles,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-07-31,2019-12-31,,Disruption of the manufacture of the drug.,2018-07-31,2019-10-09
57069,2380579,Shortage,MINT-FLUOXETINE,MINT PHARMACEUTICALS INC,Fluoxetine,FLUOXETINE,20MG,100 count bottles,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-07-31,2019-12-31,,Disruption of the manufacture of the drug.,2018-07-31,2019-10-09
77148,2468778,Shortage,MINT-HYDRALAZINE,MINT PHARMACEUTICALS INC,Hydralazine,HYDRALAZINE HYDROCHLORIDE,10MG,100 count bottles,ORAL,Resolved,TABLET,C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2019-08-30,,2019-08-30,Delay in shipping of the drug.,2019-02-28,2019-09-03
71063,2422980,Shortage,MINT-IRBESARTAN,MINT PHARMACEUTICALS INC,Irbesartan,IRBESARTAN,75MG,100 count bottles,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-03,2019-12-31,,Demand increase for the drug.,2019-01-03,2019-07-04
80800,2422999,Shortage,MINT-IRBESARTAN,MINT PHARMACEUTICALS INC,Irbesartan,IRBESARTAN,150MG,100 count bottles,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-08,2019-11-29,,Disruption of the manufacture of the drug.,2019-04-08,2019-09-03
80803,2423006,Shortage,MINT-IRBESARTAN,MINT PHARMACEUTICALS INC,Irbesartan,IRBESARTAN,300MG,100 count bottles,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-08,2019-12-31,,Disruption of the manufacture of the drug.,2019-04-08,2019-07-04
71060,2393018,Shortage,MINT-IRBESARTAN/HCTZ,MINT PHARMACEUTICALS INC,Irbesartan- Hydrochlorothiazide,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300.0MG,100 count bottles,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-03,2019-02-15,2019-01-14,Demand increase for the drug.,2019-01-03,2019-01-16
80792,2392992,Shortage,MINT-IRBESARTAN/HCTZ,MINT PHARMACEUTICALS INC,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150.0MG,100 count bottles,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-04-08,2019-12-31,,Disruption of the manufacture of the drug.,2019-04-08,2019-10-21
80797,2393026,Shortage,MINT-IRBESARTAN/HCTZ,MINT PHARMACEUTICALS INC,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25.0MG  300.0MG,100 count bottles,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-04-08,2019-12-31,,Disruption of the manufacture of the drug.,2019-04-08,2019-10-21
72666,2393018,Shortage,MINT-IRBESARTAN/HCTZ,MINT PHARMACEUTICALS INC,Irbesartan HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300.0MG,100 count bottles,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-01-03,2019-11-29,,Demand increase for the drug.,2019-01-16,2019-09-03
32263,2457954,Shortage,MINT-LEVOCARB,MINT PHARMACEUTICALS INC,Levodopa/Carbidopa,CARBIDOPA  LEVODOPA,10MG  100MG,100 count bottles,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-12-08,,,Requirements related to complying with good manufacturing practices.,2017-12-08,2017-12-09
32270,2457962,Shortage,MINT-LEVOCARB,MINT PHARMACEUTICALS INC,Levodopa/Carbidopa,CARBIDOPA  LEVODOPA,25MG  100MG,100 count bottles,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-12-08,,,Requirements related to complying with good manufacturing practices.,2017-12-08,2017-12-09
32274,2457970,Shortage,MINT-LEVOCARB,MINT PHARMACEUTICALS INC,Levodopa/Carbidopa,CARBIDOPA  LEVODOPA,25MG  250MG,100 count bottles,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-12-08,,,Requirements related to complying with good manufacturing practices.,2017-12-08,2017-12-09
71066,2405768,Shortage,MINT-LOSARTAN,MINT PHARMACEUTICALS INC,Losartan,LOSARTAN POTASSIUM,100.0MG,100 count bottles,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-03,2019-06-28,2019-06-18,Disruption of the manufacture of the drug.,2019-01-03,2019-06-19
71069,2405733,Shortage,MINT-LOSARTAN,MINT PHARMACEUTICALS INC,Losartan,LOSARTAN POTASSIUM,25.0MG,100 count bottles,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-03,2019-11-29,,Disruption of the manufacture of the drug.,2019-01-03,2019-09-03
71074,2405741,Shortage,MINT-LOSARTAN,MINT PHARMACEUTICALS INC,Losartan,LOSARTAN POTASSIUM,50.0MG,100 count bottles,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-03,2019-06-28,2019-06-18,Disruption of the manufacture of the drug.,2019-01-03,2019-06-19
80808,2389665,Shortage,MINT-LOSARTAN/HCTZ,MINT PHARMACEUTICALS INC,losartan/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100 count bottles,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-04-08,2019-11-29,,Disruption of the manufacture of the drug.,2019-04-08,2019-09-03
74450,2389657,Shortage,MINT-LOSARTAN/HCTZ,MINT PHARMACEUTICALS INC,losartan/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100 count bottles,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-02-04,2019-12-31,,Disruption of the manufacture of the drug.,2019-02-04,2019-10-21
80811,2389673,Shortage,MINT-LOSARTAN/HCTZ DS,MINT PHARMACEUTICALS INC,losartan/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25.0MG  100.0MG,100 count bottles,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-04-08,2019-12-31,,Disruption of the manufacture of the drug.,2019-04-08,2019-10-21
74455,2388766,Shortage,MINT-METFORMIN,MINT PHARMACEUTICALS INC,Metformin,METFORMIN HYDROCHLORIDE,500MG,500 count Bottles,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-02-04,,,Other (Please describe in comments),2019-02-04,2019-02-05
45542,2408635,Shortage,MINT-MONTELUKAST,MINT PHARMACEUTICALS INC,Montelukast,MONTELUKAST,5MG,30 Count Blisters,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-04-09,2018-04-30,2018-05-02,Delay in shipping of the drug.,2018-04-12,2018-05-04
35467,2436965,Shortage,MINT-OLANZAPINE ODT,MINT PHARMACEUTICALS INC,Olanzapine ODT,OLANZAPINE,5MG,30 Count Blisters,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-01-09,2018-01-09,2018-06-29,2018-07-24,Delay in shipping of the drug.,2018-01-09,2018-07-25
35470,2436973,Shortage,MINT-OLANZAPINE ODT,MINT PHARMACEUTICALS INC,Olanzapine ODT,OLANZAPINE,10MG,30 Count Blisters,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-01-09,2018-01-09,2018-06-29,2018-07-24,Delay in shipping of the drug.,2018-01-09,2018-07-25
35473,2436981,Shortage,MINT-OLANZAPINE ODT,MINT PHARMACEUTICALS INC,Olanzapine ODT,OLANZAPINE,15MG,30 Count Blisters,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-01-09,2018-01-09,2018-06-29,2018-07-24,Delay in shipping of the drug.,2018-01-09,2018-07-25
27164,2305259,Shortage,MINT-ONDANSETRON,MINT PHARMACEUTICALS INC,Ondansetron,ONDANSETRON,4MG,Bottles of 30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-07-14,,2018-03-09,Disruption of the manufacture of the drug.,2017-10-26,2018-03-10
27173,2305267,Shortage,MINT-ONDANSETRON,MINT PHARMACEUTICALS INC,Ondansetron,ONDANSETRON,8MG,Bottles of 30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-07-14,,2017-11-21,Disruption of the manufacture of the drug.,2017-10-26,2017-11-22
45121,2417448,Shortage,MINT-PANTOPRAZOLE,MINT PHARMACEUTICALS INC,Pantoprazole,PANTOPRAZOLE,40MG,100 count bottles and 500 count bottles,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-04-06,2018-04-06,2018-09-30,2018-08-21,Delay in shipping of the drug.,2018-04-06,2018-10-17
45124,2417448,Shortage,MINT-PANTOPRAZOLE,MINT PHARMACEUTICALS INC,Mint-Pantoprazole,PANTOPRAZOLE,40MG,500 count Bottles,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-04-06,2018-08-31,2018-08-21,Delay in shipping of the drug.,2018-04-06,2018-08-22
71078,2417448,Shortage,MINT-PANTOPRAZOLE,MINT PHARMACEUTICALS INC,Pantoprazole,PANTOPRAZOLE,40MG,100 count bottles,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-01-03,2019-02-08,2019-02-06,Other (Please describe in comments),2019-01-03,2019-02-07
80814,2417448,Shortage,MINT-PANTOPRAZOLE,MINT PHARMACEUTICALS INC,Pantoprazole,PANTOPRAZOLE,40MG,100 count bottles,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-04-08,2019-07-31,2019-07-10,Disruption of the manufacture of the drug.,2019-04-08,2019-07-19
95919,2417448,Shortage,MINT-PANTOPRAZOLE,MINT PHARMACEUTICALS INC,Pantoprazole,PANTOPRAZOLE,40MG,500 count bottles,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-09,2019-11-15,2019-11-14,Disruption of the manufacture of the drug.,2019-10-09,2019-11-16
35476,2421372,Shortage,MINT-PAROXETINE,MINT PHARMACEUTICALS INC,Paroxetine,PAROXETINE,10MG,100 count bottles,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-01-09,2018-01-09,2018-04-06,2018-04-05,Disruption of the manufacture of the drug.,2018-01-09,2018-04-12
35480,2421380,Shortage,MINT-PAROXETINE,MINT PHARMACEUTICALS INC,Paroxetine,PAROXETINE,20MG,100 count bottles,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-01-09,2018-01-09,2018-04-06,2018-03-02,Disruption of the manufacture of the drug.,2018-01-09,2018-03-03
95941,2476789,Shortage,MINT-PERINDOPRIL,MINT PHARMACEUTICALS INC,Perindopril,PERINDOPRIL ERBUMINE,8MG,100 count bottles,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-10-09,,2019-10-21,Disruption of the manufacture of the drug.,2019-10-09,2019-10-22
95924,2326485,Shortage,MINT-PIOGLITAZONE,MINT PHARMACEUTICALS INC,Pioglitazone,PIOGLITAZONE,30MG,100 count bottles,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-10-09,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-09,2019-10-10
88502,2326477,Shortage,MINT-PIOGLITAZONE,MINT PHARMACEUTICALS INC,Pioglitazone,PIOGLITAZONE,15MG,100 count bottles,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-07-04,2019-12-31,,Disruption of the manufacture of the drug.,2019-07-04,2019-07-05
27153,2317451,Shortage,MINT-PRAVASTATIN,MINT PHARMACEUTICALS INC,Pravastatin,,,Bottles of 100,,Resolved,,,,,2017-06-30,,2018-01-30,Shortage of an inactive ingredient or component.,2017-10-26,2018-01-31
27157,2317478,Shortage,MINT-PRAVASTATIN,MINT PHARMACEUTICALS INC,Pravastatin,,,Bottles of 100,,Resolved,,,,,2017-06-30,,2018-01-30,Shortage of an inactive ingredient or component.,2017-10-26,2018-01-31
27161,2317486,Shortage,MINT-PRAVASTATIN,MINT PHARMACEUTICALS INC,Pravastatin,,,Bottles of 100,,Resolved,,,,,2017-06-30,,2018-01-30,Shortage of an inactive ingredient or component.,2017-10-26,2018-01-31
35498,2423804,Shortage,MINT-PREGABALIN,MINT PHARMACEUTICALS INC,Pregabalin,PREGABALIN,25MG,100 count bottles,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-01-09,2018-01-09,2018-02-02,2018-02-02,Delay in shipping of the drug.,2018-01-09,2018-02-03
35501,2423812,Shortage,MINT-PREGABALIN,MINT PHARMACEUTICALS INC,Pregabalin,PREGABALIN,50MG,100 count bottles,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-01-09,2018-01-09,2018-02-28,2018-03-16,Delay in shipping of the drug.,2018-01-09,2018-03-17
46030,2438003,Shortage,MINT-QUETIAPINE,MINT PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,25MG,100 count bottles,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-16,2018-05-31,2018-05-08,Delay in shipping of the drug.,2018-04-16,2018-05-09
46033,2438011,Shortage,MINT-QUETIAPINE,MINT PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,100MG,100 count bottles,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-16,2018-05-31,2018-04-17,Delay in shipping of the drug.,2018-04-16,2018-04-18
46038,2438046,Shortage,MINT-QUETIAPINE,MINT PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,200MG,100 count bottles,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-16,2018-05-31,2018-05-08,Delay in shipping of the drug.,2018-04-16,2018-05-09
46041,2438054,Shortage,MINT-QUETIAPINE,MINT PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,300MG,100 count bottles,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-16,2018-05-31,2018-04-17,Delay in shipping of the drug.,2018-04-16,2018-04-18
92272,2397781,Shortage,MINT-ROSUVASTATIN,MINT PHARMACEUTICALS INC,Rsuvastatin,ROSUVASTATIN,5MG,100 count bottles,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-22,,,Disruption of the manufacture of the drug.,2019-08-22,2019-08-23
92275,2397811,Shortage,MINT-ROSUVASTATIN,MINT PHARMACEUTICALS INC,Rosuvastatin,ROSUVASTATIN,20MG,100 count bottles,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-22,,,Disruption of the manufacture of the drug.,2019-08-22,2019-08-23
71081,2397803,Shortage,MINT-ROSUVASTATIN,MINT PHARMACEUTICALS INC,Rosuvastatin,ROSUVASTATIN,10MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-01-03,2019-01-31,2019-01-31,Disruption of the manufacture of the drug.,2019-01-03,2019-02-01
71087,2397811,Shortage,MINT-ROSUVASTATIN,MINT PHARMACEUTICALS INC,Rosuvastatin,ROSUVASTATIN,20MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-01-03,2019-01-31,2019-01-31,Disruption of the manufacture of the drug.,2019-01-03,2019-02-01
35483,2402378,Shortage,MINT-SERTRALINE,MINT PHARMACEUTICALS INC,Sertraline,SERTRALINE,25MG,100 count bottles,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-01-09,2018-01-09,,2018-03-08,Disruption of the manufacture of the drug.,2018-01-09,2018-03-09
35486,2372932,Shortage,MINT-SIMVASTATIN,MINT PHARMACEUTICALS INC,Simvastatin,SIMVASTATIN,5MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-01-09,2018-01-09,2018-02-28,2018-02-14,Delay in shipping of the drug.,2018-01-09,2018-02-15
35489,2372975,Shortage,MINT-SIMVASTATIN,MINT PHARMACEUTICALS INC,Simvastatin,SIMVASTATIN,80MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-01-09,2018-01-09,2018-02-28,2018-02-14,Delay in shipping of the drug.,2018-01-09,2018-02-15
95927,2372932,Shortage,MINT-SIMVASTATIN,MINT PHARMACEUTICALS INC,Simvastatin,SIMVASTATIN,5MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-09,2019-11-15,2019-11-16,Disruption of the manufacture of the drug.,2019-10-09,2019-11-17
95932,2372959,Shortage,MINT-SIMVASTATIN,MINT PHARMACEUTICALS INC,Simvastatin,SIMVASTATIN,20MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-09,2019-11-15,2019-11-16,Disruption of the manufacture of the drug.,2019-10-09,2019-11-17
95935,2372967,Shortage,MINT-SIMVASTATIN,MINT PHARMACEUTICALS INC,Simvastatin,SIMVASTATIN,40MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-09,2019-11-15,2019-11-16,Disruption of the manufacture of the drug.,2019-10-09,2019-11-17
95938,2372975,Shortage,MINT-SIMVASTATIN,MINT PHARMACEUTICALS INC,Simvastatin,SIMVASTATIN,80MG,100 count bottles,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-09,2019-11-15,2019-11-16,Disruption of the manufacture of the drug.,2019-10-09,2019-11-17
35492,2443171,Shortage,MINT-SOLIFENACIN,MINT PHARMACEUTICALS INC,Solifenacin,SOLIFENACIN SUCCINATE,5MG,90 Count Bottles,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-01-09,2018-01-09,2018-02-28,2018-03-20,Disruption of the manufacture of the drug.,2018-01-09,2018-03-21
35495,2443198,Shortage,MINT-SOLIFENACIN,MINT PHARMACEUTICALS INC,Solifenacin,SOLIFENACIN SUCCINATE,10MG,90 Count Bottles,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-01-09,2018-01-09,2018-02-28,2018-03-20,Delay in shipping of the drug.,2018-01-09,2018-03-21
28570,2315653,Shortage,MINT-TOPIRAMATE,MINT PHARMACEUTICALS INC,Mint- Topiramate,TOPIRAMATE,100MG,Bottles of 100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-11-07,2017-12-15,2017-12-15,Delay in shipping of the drug.,2017-11-07,2018-01-04
95944,2389800,Shortage,MINT-TRAMADOL/ACET,MINT PHARMACEUTICALS INC,Tramadol,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100 count bottles,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,,2019-10-09,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-09,2019-10-10
6443,2133326,Shortage,MIOCHOL E,BAUSCH & LOMB INC,MIOCHOL E,ACETYLCHOLINE CHLORIDE,10MG,10,OPHTHALMIC,Resolved,POWDER FOR SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2017-05-15,,2017-05-22,2017-07-14,Other (Please describe in comments),2017-04-11,2017-07-15
57467,2133326,Shortage,MIOCHOL E,BAUSCH & LOMB INC,MIOCHOL E,ACETYLCHOLINE CHLORIDE,10MG,20mg/2ml 12 bx,OPHTHALMIC,Resolved,POWDER FOR SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-02-26,,2019-09-25,Other (Please describe in comments),2018-08-03,2019-09-26
48316,2133326,Shortage,MIOCHOL E,BAUSCH & LOMB INC,MIOCHOL E,ACETYLCHOLINE CHLORIDE,10MG,20mg/2ml/12/bx,OPHTHALMIC,Resolved,POWDER FOR SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-05-29,,2018-06-20,Other (Please describe in comments),2018-05-04,2018-06-21
96755,2133326,Shortage,MIOCHOL E,BAUSCH & LOMB INC,MIOCHOL E,ACETYLCHOLINE CHLORIDE,10MG,20MG/2ML 12/BX,OPHTHALMIC,Anticipated shortage,POWDER FOR SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-11-20,,2020-01-29,,Other (Please describe in comments),2019-10-17,2019-11-13
78602,42544,Shortage,MIOSTAT OPHTHALMIC LIQ 0.01%,ALCON CANADA INC,"CARBACHOL INTRAOCULAR SOLUTION, USP",CARBACHOL,0.01%,12 x 1.5 mL,INTRAOCULAR,Resolved,SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-04-22,2019-04-22,2019-06-26,2019-06-20,Other (Please describe in comments),2019-03-13,2019-06-21
12384,42544,Shortage,MIOSTAT OPHTHALMIC LIQ 0.01%,ALCON CANADA INC,"Carbachol Intraocular Solution, USP",CARBACHOL,0.01%,1.5mL,INTRAOCULAR,Resolved,SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2017-06-09,2017-06-09,2017-07-07,2017-06-20,Disruption of the manufacture of the drug.,2017-06-09,2017-06-21
63233,2297256,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex 0.125MG,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.125MG,30's,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-10-03,2018-10-19,2018-10-22,Demand increase for the drug.,2018-10-03,2018-10-23
18180,2241594,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,90s,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-08-08,,2017-09-11,2017-08-30,Disruption of the manufacture of the drug.,2017-08-03,2017-08-31
66317,2297256,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex 0.125MG,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.125MG,30's,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-11-06,2019-01-04,2018-12-24,Demand increase for the drug.,2018-11-06,2019-01-04
36631,2241594,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,90,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-01-19,,2018-03-31,Disruption of the manufacture of the drug.,2018-01-19,2018-04-02
59176,2237145,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex 0.25Mg,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,90's,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-10-10,2018-09-06,2018-12-17,2018-12-17,Demand increase for the drug.,2018-08-27,2019-01-04
71244,2237145,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex 0.25Mg,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,90s,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-12-18,2019-03-18,2019-03-04,Demand increase for the drug.,2019-01-04,2019-03-05
41604,2237145,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,90s,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-03-21,2018-03-15,2018-07-18,2018-07-10,Disruption of the manufacture of the drug.,2018-03-02,2018-07-11
41609,2237146,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,90s,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-03-31,2018-03-31,,2018-03-31,Disruption of the manufacture of the drug.,2018-03-02,2018-04-02
4326,2241594,Shortage,MIRAPEX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mirapex,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,90,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-03-20,2017-04-04,2017-04-05,Disruption of the manufacture of the drug.,2017-03-26,2017-04-06
54312,2410249,Shortage,MIRVALA 21,APOTEX INC,DESOGESTREL+ETHINYL ESTRADIOL,DESOGESTREL  ETHINYL ESTRADIOL,0.1500MG  0.0300MG,21 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-07-02,2018-08-13,2018-07-11,Disruption of the manufacture of the drug.,2018-07-04,2018-07-12
54315,2410257,Shortage,MIRVALA 28,APOTEX INC,DESOGESTREL+ETHINYL ESTRADIOL,DESOGESTREL  ETHINYL ESTRADIOL,0.1500MG  0.0300MG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-07-02,2018-08-13,2018-07-11,Disruption of the manufacture of the drug.,2018-07-04,2018-07-12
74028,2410257,Shortage,MIRVALA 28,APOTEX INC,MIRVALA 28,DESOGESTREL  ETHINYL ESTRADIOL,0.1500MG  0.0300MG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-01-28,2019-04-26,2019-04-22,Disruption of the manufacture of the drug.,2019-01-30,2019-04-26
65987,2230451,Shortage,MITOMYCIN FOR INJECTION,TEVA CANADA LIMITED,MITOMYCIN,MITOMYCIN,20MG,1,INTRAVENOUS  INTRAVESICAL,Anticipated shortage,POWDER FOR SOLUTION,L01DC,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,2020-05-01,,,,Demand increase for the drug.,2018-11-01,2019-07-29
49124,2230451,Shortage,MITOMYCIN FOR INJECTION,TEVA CANADA LIMITED,MITOMYCIN,MITOMYCIN,20MG,1,INTRAVENOUS  INTRAVESICAL,Resolved,POWDER FOR SOLUTION,L01DC,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2018-05-11,2018-06-30,2018-07-15,Disruption of the manufacture of the drug.,2018-05-11,2018-07-30
1148,2244614,Shortage,MITOXANTRONE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,MITOXANTRONE,MITOXANTRONE HYDROCHLORIDE,2mg,20mg/10mL x 1,Intravenous / Intraveineux,Resolved,Solution,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2015-08-21,2017-09-25,2017-09-15,Disruption of the manufacture of the drug.,2017-03-13,2017-09-25
4323,2242785,Shortage,MOBICOX,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Mobicox,MELOXICAM,7.5MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-04-03,,2017-05-19,2017-05-09,Disruption of the manufacture of the drug.,2017-03-25,2017-05-10
41557,2232148,Shortage,MOCLOBEMIDE,AA PHARMA INC,Moclobemide,MOCLOBEMIDE,100MG,100 Bottle,ORAL,Resolved,TABLET,N06AG,ANTIDEPRESSANTS,,2018-03-02,2018-04-09,2018-03-27,Disruption of the manufacture of the drug.,2018-03-02,2018-04-23
89,755575,Shortage,MODECATE CONCENTRATE,BRISTOL-MYERS SQUIBB CANADA,Fluphenazine Decanoate,FLUPHENAZINE DECANOATE,100mg,5amp x 1ml,IV,Avoided shortage,Liquid,N05AB,ANTIPSYCHOTICS,2017-05-31,,,2017-05-19,Shortage of an active ingredient.,2017-03-10,2017-07-04
39130,755575,Shortage,MODECATE CONCENTRATE,BRISTOL-MYERS SQUIBB CANADA,Fluphenazine Decanoate,FLUPHENAZINE DECANOATE,100MG,5 amp x 1ml,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,LIQUID,N05AB,ANTIPSYCHOTICS,2018-03-22,,,2018-03-22,Delay in shipping of the drug.,2018-02-08,2018-03-23
3020,803499,Shortage,MODULON,APTALIS PHARMA CANADA ULC,TRIMEBUTINE MALEATE,TRIMEBUTINE MALEATE,200MG,100,ORAL,Resolved,TABLET,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,2017-05-05,2017-05-10,2017-07-14,2017-07-14,Shortage of an inactive ingredient or component.,2017-03-16,2017-07-15
8420,511536,Shortage,MOGADON,AA PHARMA INC,Mogadon,NITRAZEPAM,10MG,100 BTL,ORAL,Resolved,TABLET,N05CD,HYPNOTICS AND SEDATIVES,2017-05-01,,,2017-05-31,Disruption of the manufacture of the drug.,2017-04-28,2017-06-01
40467,2379325,Shortage,MONTELUKAST,SANIS HEALTH INC,MONTELUKAST TAB,MONTELUKAST,5MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-02-21,2018-03-16,2018-03-13,Other (Please describe in comments),2018-02-21,2018-03-14
81977,2379325,Shortage,MONTELUKAST,SANIS HEALTH INC,MONTELUKAST,MONTELUKAST,5MG,30,ORAL,Actual shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-04-18,,,Disruption of the manufacture of the drug.,2019-04-18,2019-04-19
81981,2379317,Shortage,MONTELUKAST,SANIS HEALTH INC,MONTELUKAST,MONTELUKAST,4MG,30,ORAL,Actual shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-04-18,,,Disruption of the manufacture of the drug.,2019-04-18,2019-04-19
55110,2382466,Shortage,MONTELUKAST,SIVEM PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,5MG,100,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-07-05,2018-07-05,,2018-08-06,Delay in shipping of the drug.,2018-07-10,2018-09-11
36255,2382458,Shortage,MONTELUKAST,SIVEM PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,4MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-03-13,2018-03-12,2018-04-06,2018-04-06,Other (Please describe in comments),2018-01-17,2018-04-09
36262,2382466,Shortage,MONTELUKAST,SIVEM PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,5MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-03-19,2018-02-26,2018-04-06,2018-04-06,Other (Please describe in comments),2018-01-17,2018-04-09
36265,2382474,Shortage,MONTELUKAST,SIVEM PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,10MG,30,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-03-19,2018-03-05,2018-04-06,2018-04-06,Other (Please describe in comments),2018-01-17,2018-04-09
94955,2379821,Shortage,MONTELUKAST,PRO DOC LIMITEE,MONTELUKAST,MONTELUKAST,4MG,30,ORAL,Actual shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-09-26,2020-01-31,,Delay in shipping of the drug.,2019-09-27,2019-09-27
76272,2379317,Shortage,MONTELUKAST,SANIS HEALTH INC,MONTELUKAST TAB,MONTELUKAST,4MG,30,ORAL,Actual shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2019-04-19,,,,Disruption of the manufacture of the drug.,2019-02-19,2019-04-20
14576,2379325,Shortage,MONTELUKAST,SANIS HEALTH INC,MONTELUKAST TABS,MONTELUKAST,5MG,30's,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-07-04,2017-07-31,2017-07-21,Other (Please describe in comments),2017-07-04,2017-07-24
76275,2379325,Shortage,MONTELUKAST,SANIS HEALTH INC,MONTELUKAST TAB,MONTELUKAST,5MG,30,ORAL,Actual shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2019-04-19,,,,Disruption of the manufacture of the drug.,2019-02-19,2019-04-20
62913,2379236,Shortage,MONTELUKAST SODIUM TABLETS,ACCORD HEALTHCARE INC,MONTELUKAST,MONTELUKAST,10MG,30 TABS / BOX | BOÎTE DE 30 COMPRIMÉS,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-10-02,2018-10-02,2019-04-30,2019-04-25,Disruption of the manufacture of the drug.,2018-10-02,2019-04-26
77070,636908,Shortage,MORPHINE SULFATE INJECTION USP,ICU MEDICAL CANADA INC,MORPHINE SULFATE INJECTION USP,MORPHINE SULFATE,1MG,10,INTRAVENOUS,Actual shortage,SOLUTION,N02AA,OPIOIDS,2019-04-01,2019-04-01,2020-04-01,,Disruption of the manufacture of the drug.,2019-02-28,2019-10-31
77018,649619,Shortage,MORPHINE SULFATE INJECTION USP,ICU MEDICAL CANADA INC,MORPHINE SULFATE INJECTION USP,MORPHINE SULFATE,5MG,10,INTRAVENOUS,Actual shortage,SOLUTION,N02AA,OPIOIDS,2019-03-01,2019-03-01,2020-04-01,,Disruption of the manufacture of the drug.,2019-02-27,2019-10-31
86408,2455870,Shortage,MOSASPRAY,SANDOZ CANADA INCORPORATED,MOSASPRAY,MOMETASONE FUROATE,50MCG,140 DOS,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-05-27,2019-06-17,2019-06-14,Demand increase for the drug.,2019-06-12,2019-06-28
26211,2410303,Shortage,MOVISSE,MYLAN PHARMACEUTICALS ULC,MOVISSE,NORETHINDRONE,0.35MG,28BL,ORAL,Avoided shortage,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-02-15,,,2018-02-09,Delay in shipping of the drug.,2017-10-18,2018-02-09
84070,2410303,Shortage,MOVISSE,MYLAN PHARMACEUTICALS ULC,NORETHINDRONE,NORETHINDRONE,0.35MG,28BL,ORAL,Resolved,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2019-05-14,,,2019-08-30,Requirements related to complying with good manufacturing practices.,2019-05-14,2019-08-31
91044,2410303,Shortage,MOVISSE,MYLAN PHARMACEUTICALS ULC,NORETHINDRONE,NORETHINDRONE,0.35MG,28 BL,ORAL,Actual shortage,TABLET,G03AC,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-08-06,2019-10-31,,Delay in shipping of the drug.,2019-08-07,2019-10-08
73443,2462974,Shortage,MOXIFLOXACIN,PRO DOC LIMITEE,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-01-24,2019-07-30,2019-07-30,Delay in shipping of the drug.,2019-01-24,2019-07-31
68993,2330989,Shortage,MULTAQ,SANOFI-AVENTIS CANADA INC,MULTAQ 400MG,DRONEDARONE,400MG,4X15,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2018-12-21,,2019-01-31,2019-02-05,Other (Please describe in comments),2018-12-10,2019-02-06
86801,2238594,Shortage,MUSE,PALADIN LABS INC,ALPROSTADIL,ALPROSTADIL,500MCG,1 pouch,URETHRAL,Resolved,SUPPOSITORY,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-06-17,,2019-10-22,Delay in shipping of the drug.,2019-06-18,2019-10-23
93978,2238593,Shortage,MUSE,PALADIN LABS INC,ALPROSTADIL,ALPROSTADIL,250MCG,1 Micro-suppository,URETHRAL,Actual shortage,SUPPOSITORY,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-16,,,Delay in shipping of the drug.,2019-09-16,2019-09-17
68429,2238593,Shortage,MUSE,PALADIN LABS INC,Alprostadil,ALPROSTADIL,250MCG,1 Sachet,URETHRAL,Resolved,SUPPOSITORY,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-12-03,,2019-01-31,2019-02-26,Delay in shipping of the drug.,2018-12-03,2019-02-27
93265,2238595,Shortage,MUSE,PALADIN LABS INC,ALPROSTADIL,ALPROSTADIL,1000MCG,1 pouch,URETHRAL,Actual shortage,SUPPOSITORY,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-08-19,,,Delay in shipping of the drug.,2019-09-09,2019-09-09
74084,2238595,Shortage,MUSE,PALADIN LABS INC,Alprostadil,ALPROSTADIL,1000MCG,1 Micro-suppository,URETHRAL,Resolved,SUPPOSITORY,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-01-31,2019-05-31,2019-05-16,Delay in shipping of the drug.,2019-01-31,2019-05-17
62083,2238595,Shortage,MUSE,PALADIN LABS INC,MUSE,ALPROSTADIL,1000MCG,1,URETHRAL,Resolved,SUPPOSITORY,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-09-20,,2018-12-04,Disruption of the manufacture of the drug.,2018-09-20,2018-12-05
555,2415380,Shortage,MYA,APOTEX INC,MYA,DROSPIRENONE  ETHINYL ESTRADIOL,3.00MG  0.02MG,28 BLS,ORAL,Actual shortage,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017-03-09,,,Disruption of the manufacture of the drug.,2017-03-11,2018-12-20
98110,2479974,Shortage,MYCOPHENOLATE MOFETIL FOR INJECTION USP,STERIMAX INC,MYCOPHENOLATE MOFETIL FOR INJECTION USP,MYCOPHENOLATE MOFETIL,500MG,4 VIALS,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,L04AA,IMMUNOSUPPRESSANTS,2019-11-06,,2019-12-02,,Delay in shipping of the drug.,2019-11-06,2019-11-07
97976,2378574,Shortage,"MYCOPHENOLATE MOFETIL TABLETS, USP",ACCORD HEALTHCARE INC,Mycophenolate Mofetil,MYCOPHENOLATE MOFETIL,500MG,50,ORAL,Actual shortage,TABLET,L04AA,IMMUNOSUPPRESSANTS,2019-11-08,,2020-01-01,,Demand increase for the drug.,2019-11-05,2019-11-09
20979,465763,Shortage,MYDFRIN,NOVARTIS PHARMACEUTICALS CANADA INC,MYDFRIN 2.4% SOLN 5ML,PHENYLEPHRINE HYDROCHLORIDE,2.5%,5 ML,OPHTHALMIC,Resolved,LIQUID,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2017-08-30,,2017-09-12,Other (Please describe in comments),2017-09-05,2017-09-18
23160,2245372,Shortage,MYL-PROPAFENONE,MYLAN PHARMACEUTICALS ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100BT,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017-09-20,,2018-02-16,Delay in shipping of the drug.,2017-09-22,2018-03-02
23163,2245373,Shortage,MYL-PROPAFENONE,MYLAN PHARMACEUTICALS ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100BT,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017-09-20,,2018-02-16,Delay in shipping of the drug.,2017-09-22,2018-03-02
5931,2392577,Shortage,MYL-SILDENAFIL,MYLAN PHARMACEUTICALS ULC,SILDENAFIL,SILDENAFIL,25MG,4BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-07-16,,,2017-10-02,Delay in shipping of the drug.,2017-04-07,2017-10-03
6976,2392593,Shortage,MYL-SILDENAFIL,MYLAN PHARMACEUTICALS ULC,SILDENAFIL,SILDENAFIL,100MG,"4BL, 30BT",ORAL,Avoided shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-08-02,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
5307,2392585,Shortage,MYL-SILDENAFIL,MYLAN PHARMACEUTICALS ULC,Sildenafil,SILDENAFIL,50MG,4BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-05-01,2018-05-01,,2018-05-01,Delay in shipping of the drug.,2017-04-04,2018-08-23
85021,2450682,Shortage,MYLAN-ABACAVIR/LAMIVUDINE,MYLAN PHARMACEUTICALS ULC,ABACAVIR/LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30 BL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-06-10,,2019-06-21,2019-06-18,Delay in shipping of the drug.,2019-05-28,2019-06-19
81021,2450682,Shortage,MYLAN-ABACAVIR/LAMIVUDINE,MYLAN PHARMACEUTICALS ULC,ABACAVIR/LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30 BL,ORAL,Avoided shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-06-07,,2019-06-15,2019-05-28,Shortage of an inactive ingredient or component.,2019-04-10,2019-05-28
65420,2450682,Shortage,MYLAN-ABACAVIR/LAMIVUDINE,MYLAN PHARMACEUTICALS ULC,ABACAVIR/LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30BL,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2018-09-04,2018-09-04,2019-02-15,2019-02-15,Shortage of an inactive ingredient or component.,2018-10-23,2019-02-16
5941,2237721,Shortage,MYLAN-ACEBUTOLOL,MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL,ACEBUTOLOL,100MG,"100BT, 500BT",ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-03-23,2018-03-02,,2018-07-03,Delay in shipping of the drug.,2017-04-07,2018-07-04
35919,2237723,Shortage,MYLAN-ACEBUTOLOL,MYLAN PHARMACEUTICALS ULC,Acebutolol Tablets,ACEBUTOLOL,400MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-02-01,2018-01-15,,2018-07-03,Delay in shipping of the drug.,2018-01-15,2018-07-04
30377,2237722,Shortage,MYLAN-ACEBUTOLOL,MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL,ACEBUTOLOL,200MG,"100BT, 500BT",ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-02-09,2018-02-12,,2018-07-03,Disruption of the manufacture of the drug.,2017-11-23,2018-07-04
5922,2237886,Shortage,MYLAN-ACEBUTOLOL (TYPE S),MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL (TYPE S),ACEBUTOLOL,200MG,500BT,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017-09-21,,,2017-08-23,Delay in shipping of the drug.,2017-04-07,2017-08-24
5962,2237887,Shortage,MYLAN-ACEBUTOLOL (TYPE S),MYLAN PHARMACEUTICALS ULC,ACEBUTOLOL (TYPE S),ACEBUTOLOL,400MG,100BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-10-16,2017-10-17,,2017-11-01,Delay in shipping of the drug.,2017-04-07,2017-11-02
5987,2237885,Shortage,MYLAN-ACEBUTOLOL (TYPE S),MYLAN PHARMACEUTICALS ULC,MYLAN-ACEBUTOLOL (TYPE S),ACEBUTOLOL,100MG,500BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-01-15,2017-12-27,,2018-02-01,Delay in shipping of the drug.,2017-04-07,2018-02-02
28169,2242463,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,400MG,100BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-11-06,2018-09-21,2018-09-20,Delay in shipping of the drug.,2017-11-06,2018-09-21
29231,2242464,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,800MG,100BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-11-14,2018-09-21,2018-09-20,Delay in shipping of the drug.,2017-11-15,2018-09-21
98539,2242463,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,400MG,100 BT,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-09-10,2019-12-31,,Delay in shipping of the drug.,2019-11-12,2019-11-12
27117,2242784,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,200MG,100BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2018-04-24,2018-04-27,2018-05-25,2018-05-23,Delay in shipping of the drug.,2017-10-26,2018-05-24
5984,2286335,Shortage,MYLAN-ALENDRONATE,MYLAN PHARMACEUTICALS ULC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-07-03,2018-07-03,,2018-07-03,Delay in shipping of the drug.,2017-04-07,2018-07-05
56507,2398435,Shortage,MYLAN-ALMOTRIPTAN,MYLAN PHARMACEUTICALS ULC,ALMOTRIPTAN,ALMOTRIPTAN,6.25MG,6BL,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-10-03,2018-10-03,2019-02-15,2019-02-15,Delay in shipping of the drug.,2018-07-25,2019-02-16
27110,2398443,Shortage,MYLAN-ALMOTRIPTAN,MYLAN PHARMACEUTICALS ULC,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6BL,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-03-05,2018-03-07,2019-01-18,2019-01-21,Delay in shipping of the drug.,2017-10-26,2019-01-22
6973,2137542,Shortage,MYLAN-ALPRAZOLAM,MYLAN PHARMACEUTICALS ULC,ALPRAZOLAM,ALPRAZOLAM,0.5MG,"1000BT, 100BT",ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-07-03,2018-07-03,,2018-07-03,Delay in shipping of the drug.,2017-04-13,2018-07-05
5966,2137534,Shortage,MYLAN-ALPRAZOLAM,MYLAN PHARMACEUTICALS ULC,MYLAN-ALPRAZOLAM,ALPRAZOLAM,0.25MG,"100 BT, 1000BT",ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2017-12-01,,,2017-12-01,Delay in shipping of the drug.,2017-04-07,2017-12-02
5326,2229813,Shortage,MYLAN-ALPRAZOLAM,MYLAN PHARMACEUTICALS ULC,ALPRAZOLAM,ALPRAZOLAM,1MG,100BT,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2017-08-03,,,2017-08-23,Delay in shipping of the drug.,2017-04-04,2017-08-24
44786,2229814,Shortage,MYLAN-ALPRAZOLAM,MYLAN PHARMACEUTICALS ULC,ALPRAZOLAM,ALPRAZOLAM,2MG,100 BT,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-04-03,2018-07-05
5046,2240604,Shortage,MYLAN-AMIODARONE,MYLAN PHARMACEUTICALS ULC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Avoided shortage,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017-06-06,,,2017-05-01,Shortage of an active ingredient.,2017-03-31,2017-05-04
5335,2240604,Shortage,MYLAN-AMIODARONE,MYLAN PHARMACEUTICALS ULC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100BT,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017-07-04,,2017-09-22,Delay in shipping of the drug.,2017-04-04,2018-07-03
4090,2240604,Shortage,MYLAN-AMIODARONE,MYLAN PHARMACEUTICALS ULC,Amiodarone,AMIODARONE HYDROCHLORIDE,200MG,100BT,ORAL,Avoided shortage,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017-06-04,,,2017-05-01,Shortage of an active ingredient.,2017-03-23,2017-05-04
28029,2272121,Shortage,MYLAN-AMLODIPINE,MYLAN PHARMACEUTICALS ULC,AMLODIPINE,AMLODIPINE,10.0MG,"100BT, 500BT",ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-01-31,2018-01-31,2018-02-09,2018-02-09,Delay in shipping of the drug.,2017-11-03,2018-02-10
28616,2272113,Shortage,MYLAN-AMLODIPINE,MYLAN PHARMACEUTICALS ULC,AMLODIPINE,AMLODIPINE,5.0MG,"100BT, 500BT",ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-01-29,2018-01-22,2018-02-09,2018-02-09,Delay in shipping of the drug.,2017-11-08,2018-02-10
5972,2238172,Shortage,MYLAN-AMOXICILLIN,MYLAN PHARMACEUTICALS ULC,AMOXICILLIN,AMOXICILLIN,500MG,"100BT, 500BT",ORAL,Resolved,CAPSULE,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-02-07,,2019-09-30,Disruption of the manufacture of the drug.,2017-04-07,2019-10-03
96531,2456877,Shortage,MYLAN-ATAZANAVIR,MYLAN PHARMACEUTICALS ULC,ATAZANAVIR,ATAZANAVIR,150MG,60 BT,ORAL,Actual shortage,CAPSULE,J05AE,DIRECT ACTING ANTIVIRALS,2019-11-01,2019-11-01,,,Delay in shipping of the drug.,2019-10-15,2019-11-12
96534,2456893,Shortage,MYLAN-ATAZANAVIR,MYLAN PHARMACEUTICALS ULC,ATAZANAVIR,ATAZANAVIR,300MG,60 BT,ORAL,Actual shortage,CAPSULE,J05AE,DIRECT ACTING ANTIVIRALS,2019-11-14,2019-10-29,,,Delay in shipping of the drug.,2019-10-15,2019-11-12
76489,2456885,Shortage,MYLAN-ATAZANAVIR,MYLAN PHARMACEUTICALS ULC,ATAZANAVIR,ATAZANAVIR,200MG,60 BT,ORAL,Actual shortage,CAPSULE,J05AE,DIRECT ACTING ANTIVIRALS,2019-02-26,2019-03-05,,,Delay in shipping of the drug.,2019-02-21,2019-09-26
51255,2147432,Shortage,MYLAN-ATENOLOL,MYLAN PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,100MG,"100 BT, 500 BT",ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-04,2018-07-05
125,2146894,Shortage,MYLAN-ATENOLOL,MYLAN PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,50MG,"100BT, 500BT",ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-10,2018-07-05
10711,2303647,Shortage,MYLAN-ATENOLOL,MYLAN PHARMACEUTICALS ULC,ATENOLOL,ATENOLOL,25MG,100BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-05-25,2018-05-25,,2018-06-07,Disruption of the manufacture of the drug.,2017-05-19,2018-06-08
44802,2378949,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,25MG,100 BT,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-07-03,2018-07-03,2018-07-03,2018-07-03,Disruption of the manufacture of the drug.,2018-04-03,2018-07-05
5005,2378957,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,40MG,100BT,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-07-03,2018-05-01,,2018-07-03,Other (Please describe in comments),2017-03-31,2018-07-04
155,2378965,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,60MG,100BT,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-07-03,2018-05-01,,2018-07-03,Other (Please describe in comments),2017-03-10,2018-07-04
229,2378981,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,Atomoxetine,ATOMOXETINE,100MG,100s,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-05-01,,2018-07-03,Other (Please describe in comments),2017-03-10,2018-07-04
47862,2378973,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,80MG,100 BT,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-05-01,,2018-07-03,Other (Please describe in comments),2018-05-01,2018-07-04
44796,2378930,Shortage,MYLAN-ATOMOXETINE,MYLAN PHARMACEUTICALS ULC,ATOMOXETINE,ATOMOXETINE,18MG,100 BT,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-04-03,2018-07-05
19456,2392976,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,80MG,"90BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-20,,2018-10-26,2018-10-23,Disruption of the manufacture of the drug.,2017-08-15,2018-10-24
11785,2392968,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,40MG,"90BT, 500BT",ORAL,Avoided shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-16,,2018-10-19,2018-10-15,Disruption of the manufacture of the drug.,2017-06-02,2018-10-16
25898,2392941,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,20MG,"90BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-15,,2018-10-19,2018-10-15,Disruption of the manufacture of the drug.,2017-10-13,2018-10-16
79012,2392976,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,80MG,90 BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-03-20,2019-04-05,2019-04-03,Delay in shipping of the drug.,2019-03-20,2019-04-04
57023,2392933,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,10MG,"90 BT, 500 BT",ORAL,Avoided shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-11,,2018-10-19,2018-10-09,Demand increase for the drug.,2018-07-31,2018-10-09
10714,2392976,Shortage,MYLAN-ATORVASTATIN,MYLAN PHARMACEUTICALS ULC,ATORVASTATIN,ATORVASTATIN,80MG,90BT,ORAL,Avoided shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-08-17,,,2017-07-24,Requirements related to complying with good manufacturing practices.,2017-05-19,2017-07-25
20553,2402165,Shortage,MYLAN-ATOVAQUONE/PROGUANIL,MYLAN PHARMACEUTICALS ULC,ATOVAQUONE/PROGUANIL,PROGUANIL HYDROCHLORIDE  ATOVAQUONE,100MG  250MG,100BT,ORAL,Resolved,TABLET,P01BB,ANTIMALARIALS,2018-12-06,2018-12-10,2018-12-21,2018-12-18,Disruption of the manufacture of the drug.,2017-08-29,2018-12-19
5928,2231491,Shortage,MYLAN-AZATHIOPRINE,MYLAN PHARMACEUTICALS ULC,AZATHIOPRINE,AZATHIOPRINE,50MG,100,ORAL,Resolved,TABLET,L04AX,IMMUNOSUPPRESSANTS,2017-11-01,,,2017-11-01,Delay in shipping of the drug.,2017-04-07,2017-11-02
30365,2278359,Shortage,MYLAN-AZITHROMYCIN,MYLAN PHARMACEUTICALS ULC,AZITHROMYCIN,AZITHROMYCIN,250MG,"6BL, 30BT",ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-02-02,,2018-03-01,Disruption of the manufacture of the drug.,2017-11-23,2018-03-02
3931,2088401,Shortage,MYLAN-BACLOFEN,MYLAN PHARMACEUTICALS ULC,BACLOFEN,BACLOFEN,20MG,100BT,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017-12-13,2017-12-13,2018-03-30,2018-03-23,Delay in shipping of the drug.,2017-03-22,2018-03-24
27072,2088398,Shortage,MYLAN-BACLOFEN,MYLAN PHARMACEUTICALS ULC,BACLOFEN,BACLOFEN,10MG,"100BT, 500BT",ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2018-01-02,2017-12-29,2018-01-10,2018-01-08,Delay in shipping of the drug.,2017-10-26,2018-01-09
96537,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,MYLAN-BECLO AQ,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Actual shortage,METERED-DOSE AEROSOL  SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-10-15,2020-01-30,,Delay in shipping of the drug.,2019-10-15,2019-11-12
80428,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,BECLO AQ,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Resolved,METERED-DOSE AEROSOL  SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2019-06-05,,,2019-06-18,Delay in shipping of the drug.,2019-04-03,2019-06-19
95088,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,BECLOMETHASONE,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Resolved,METERED-DOSE AEROSOL  SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2019-10-02,,,2019-10-08,Delay in shipping of the drug.,2019-10-01,2019-10-09
88982,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,BECLOMETHASONE,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Resolved,METERED-DOSE AEROSOL  SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2019-07-17,,2019-07-30,2019-07-23,Delay in shipping of the drug.,2019-07-09,2019-07-24
87466,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,BECLOMETHASONE,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Resolved,METERED-DOSE AEROSOL  SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2019-06-26,,2019-07-30,2019-07-02,Delay in shipping of the drug.,2019-06-25,2019-07-03
78777,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,MYLAN-BECLO AQ,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Resolved,METERED-DOSE AEROSOL  SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2019-03-22,,2019-03-30,2019-03-28,Delay in shipping of the drug.,2019-03-15,2019-03-29
14271,2172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,BECLO AQ,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL,Resolved,METERED-DOSE AEROSOL  SUSPENSION,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018-11-07,2018-11-07,2019-02-28,2019-03-08,Delay in shipping of the drug.,2017-06-28,2019-03-09
6985,2384418,Shortage,MYLAN-BISOPROLOL,MYLAN PHARMACEUTICALS ULC,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
9101,2384418,Shortage,MYLAN-BISOPROLOL,MYLAN PHARMACEUTICALS ULC,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100BT,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
5313,2384426,Shortage,MYLAN-BISOPROLOL,MYLAN PHARMACEUTICALS ULC,Bisoprolol,BISOPROLOL FUMARATE,10MG,100BT,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017-07-28,,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-04,2017-07-17
23157,2383497,Shortage,MYLAN-BOSENTAN,MYLAN PHARMACEUTICALS ULC,BOSENTAN,BOSENTAN,62.5MG,56BL,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2017-09-20,,2017-09-22,Disruption of the manufacture of the drug.,2017-09-22,2018-07-03
22010,2383500,Shortage,MYLAN-BOSENTAN,MYLAN PHARMACEUTICALS ULC,BOSENTAN,BOSENTAN,125.0MG,56BL,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2017-09-11,,2017-09-22,Disruption of the manufacture of the drug.,2017-09-13,2017-09-23
23166,2230648,Shortage,MYLAN-BUDESONIDE AQ,MYLAN PHARMACEUTICALS ULC,BUDESONIDE AQ,BUDESONIDE,100MCG,165,NASAL,Actual shortage,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018-04-16,2018-04-16,,,Delay in shipping of the drug.,2017-09-22,2019-10-01
23169,2241003,Shortage,MYLAN-BUDESONIDE AQ,MYLAN PHARMACEUTICALS ULC,BUDESONIDE AQ,BUDESONIDE,64MCG,120,NASAL,Actual shortage,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018-10-30,2018-11-05,2020-02-15,,Delay in shipping of the drug.,2017-09-22,2019-11-12
3089,2408104,Shortage,MYLAN-BUPRENORPHINE/NALOXONE,MYLAN PHARMACEUTICALS ULC,BUPRENORPHINE/NALOXONE,BUPRENORPHINE  NALOXONE,8MG  2MG,100BT,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017-03-14,,2019-09-17,Delay in shipping of the drug.,2017-03-16,2019-09-18
3922,2408090,Shortage,MYLAN-BUPRENORPHINE/NALOXONE,MYLAN PHARMACEUTICALS ULC,Buprenorphine/Naloxone,BUPRENORPHINE  NALOXONE,2MG  0.5MG,100s,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017-03-20,,2017-04-11,Delay in shipping of the drug.,2017-03-22,2017-04-12
7392,2408090,Shortage,MYLAN-BUPRENORPHINE/NALOXONE,MYLAN PHARMACEUTICALS ULC,BUPRENORPHINE/NALOXONE,BUPRENORPHINE  NALOXONE,2MG  0.5MG,100BT,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,2018-07-03,2018-06-26,,2019-09-17,Disruption of the manufacture of the drug.,2017-04-20,2019-09-18
3941,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,"90BT, 500BT",ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2018-05-18,2018-05-04,2019-09-30,2019-06-18,Disruption of the manufacture of the drug.,2017-03-22,2019-06-19
3944,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,"90BT, 500BT",ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2018-05-24,2018-05-25,2019-09-30,2019-06-18,Disruption of the manufacture of the drug.,2017-03-22,2019-06-19
89459,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,"90 BT, 500 BT",ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-07-16,,2019-07-23,Delay in shipping of the drug.,2019-07-16,2019-07-24
128,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,Bupropion Once-Daily,BUPROPION HYDROCHLORIDE,150MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017-01-25,,2017-03-23,Demand increase for the drug.,2017-03-10,2017-03-24
131,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,Bupropion Once-Daily,BUPROPION HYDROCHLORIDE,300MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017-01-25,,2017-03-23,Demand increase for the drug.,2017-03-10,2017-03-24
91041,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,"90 BT, 500 BT",ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-08-06,,2019-08-14,Delay in shipping of the drug.,2019-08-07,2019-08-20
5028,2382075,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,150MG,90BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017-08-09,2017-09-30,2017-08-16,Requirements related to complying with good manufacturing practices.,2017-03-31,2017-08-17
5034,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2017-04-17,,2017-06-06,2017-06-20,Requirements related to complying with good manufacturing practices.,2017-03-31,2017-06-22
7131,2382083,Shortage,MYLAN-BUPROPION XL,MYLAN PHARMACEUTICALS ULC,BUPROPION XL,BUPROPION HYDROCHLORIDE,300MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017-04-22,,2017-05-01,Shortage of an active ingredient.,2017-04-17,2017-05-02
14695,2379147,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-04-18,2018-04-18,,2018-07-03,Delay in shipping of the drug.,2017-07-05,2018-07-05
16246,2379155,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-05-07,2018-05-08,,2018-07-03,Delay in shipping of the drug.,2017-07-18,2018-07-05
13190,2379120,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-01-22,2018-01-24,,2018-07-03,Delay in shipping of the drug.,2017-06-16,2018-07-04
5042,2379139,Shortage,MYLAN-CANDESARTAN,MYLAN PHARMACEUTICALS ULC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-05-15,2018-08-10,2018-08-10,Disruption of the manufacture of the drug.,2017-03-31,2018-08-11
9261,2347512,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,3.125MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017-12-01,,,2017-12-01,Disruption of the manufacture of the drug.,2017-05-05,2017-12-02
9271,2347520,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,6.25MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017-12-01,,,2017-12-01,Disruption of the manufacture of the drug.,2017-05-05,2017-12-02
9276,2347555,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,12.5MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017-12-01,,,2017-12-01,Disruption of the manufacture of the drug.,2017-05-05,2017-12-02
6989,2347571,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,25MG,100BT,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
9105,2347571,Shortage,MYLAN-CARVEDILOL,MYLAN PHARMACEUTICALS ULC,CARVEDILOL,CARVEDILOL,25MG,100BT,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
134,2423278,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,CELECOXIB,CELECOXIB,100MG,"100BT, 500BT",ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-07-03,2018-05-01,,2018-07-03,Other (Please describe in comments),2017-03-10,2018-07-04
137,2423278,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,Celecoxib,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2016-12-29,2016-12-29,2017-04-15,2017-03-13,Demand increase for the drug.,2017-03-10,2017-03-14
140,2399881,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,Celecoxib,CELECOXIB,200MG,100 BT,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-10,2018-07-05
5009,2423278,Shortage,MYLAN-CELECOXIB,MYLAN PHARMACEUTICALS ULC,Celecoxib,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-28,,2017-04-20,Demand increase for the drug.,2017-03-31,2017-04-21
16933,2283786,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,2.5MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-11-02,,2017-11-10,2017-11-03,Disruption of the manufacture of the drug.,2017-07-25,2017-11-04
80435,2283794,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,5.0MG,100 BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-04-03,,2019-04-05,2019-07-03,Requirements related to complying with good manufacturing practices.,2019-04-03,2019-07-04
10054,2283778,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,1MG,100,ORAL,Avoided shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-08-29,,2018-08-30,2018-08-21,Delay in shipping of the drug.,2017-05-11,2018-08-21
21588,2283794,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,5.0MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-04-27,2018-08-30,2018-08-30,Delay in shipping of the drug.,2017-09-08,2018-08-31
75928,2283778,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,1MG,100 BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-02-15,,2019-02-28,Requirements related to complying with good manufacturing practices.,2019-02-15,2019-03-01
75931,2283786,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,2.5MG,100 BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-02-15,,2019-02-28,Requirements related to complying with good manufacturing practices.,2019-02-15,2019-03-01
75934,2283794,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,5.0MG,100 BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-02-15,,2019-02-28,Requirements related to complying with good manufacturing practices.,2019-02-15,2019-03-01
7404,2283778,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,1MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-05-08,,2017-05-15,Delay in shipping of the drug.,2017-04-20,2017-05-16
6993,2227460,Shortage,MYLAN-CIMETIDINE,MYLAN PHARMACEUTICALS ULC,CIMETIDINE,CIMETIDINE,600MG,100BT,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-04-11,,2017-09-07,Disruption of the manufacture of the drug.,2017-04-13,2017-09-08
9108,2227460,Shortage,MYLAN-CIMETIDINE,MYLAN PHARMACEUTICALS ULC,CIMETIDINE,CIMETIDINE,600MG,500BT,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-05-01,,2017-09-07,Disruption of the manufacture of the drug.,2017-05-05,2017-09-08
21591,2434547,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,60MG,30BT,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,2018-12-05,2018-12-05,2019-02-08,2018-12-18,Delay in shipping of the drug.,2017-09-08,2018-12-19
70049,2434547,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,60MG,30BT,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,2019-01-01,,2019-01-18,2019-01-02,Delay in shipping of the drug.,2018-12-19,2019-01-03
81833,2434539,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,30MG,30 BT,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,2019-05-07,2019-05-07,2019-06-21,2019-06-18,Delay in shipping of the drug.,2019-04-16,2019-06-19
42738,2434555,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,90MG,30BT,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,2018-04-05,2018-04-06,2018-12-07,2018-12-05,Delay in shipping of the drug.,2018-03-13,2018-12-06
23807,2434539,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,30MG,30BT,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,2018-12-05,2018-12-05,,2019-01-15,Delay in shipping of the drug.,2017-09-28,2019-01-16
51272,2245647,Shortage,MYLAN-CIPROFLOXACIN,MYLAN PHARMACEUTICALS ULC,CIPROFLOXACIN,CIPROFLOXACIN,250MG,100 BT,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-04,2018-07-05
51278,2245648,Shortage,MYLAN-CIPROFLOXACIN,MYLAN PHARMACEUTICALS ULC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,"100 BT, 500 BT",ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-04,2018-07-05
9111,2245649,Shortage,MYLAN-CIPROFLOXACIN,MYLAN PHARMACEUTICALS ULC,CIPROFLOXACIN,CIPROFLOXACIN,750MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-05-01,,2017-12-01,Disruption of the manufacture of the drug.,2017-05-05,2017-12-02
51300,2246595,Shortage,MYLAN-CITALOPRAM,MYLAN PHARMACEUTICALS ULC,CITALOPRAM,CITALOPRAM,40MG,100 BT,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-04,2018-07-05
232,2246594,Shortage,MYLAN-CITALOPRAM,MYLAN PHARMACEUTICALS ULC,Citalopram,CITALOPRAM,20MG,"100 BT, 500 BT",ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-10,2018-07-05
6999,2248856,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
7005,2248857,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
9115,2248856,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
9118,2248857,Shortage,MYLAN-CLARITHROMYCIN,MYLAN PHARMACEUTICALS ULC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100BT,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
9036,2258331,Shortage,MYLAN-CLINDAMYCIN,MYLAN PHARMACEUTICALS ULC,CLINDAMYCIN,CLINDAMYCIN,150MG,100BT,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-05-01,,2018-07-03,Other (Please describe in comments),2017-05-04,2018-07-04
5012,2258358,Shortage,MYLAN-CLINDAMYCIN,MYLAN PHARMACEUTICALS ULC,CLINDAMYCIN,CLINDAMYCIN,300MG,100BT,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-05-01,,2018-07-03,Other (Please describe in comments),2017-03-31,2018-07-04
18684,2216213,Shortage,MYLAN-CLOBETASOL SCALP APPLICATION,MYLAN PHARMACEUTICALS ULC,CLOBETASOL SCALP APPLICATION,CLOBETASOL PROPIONATE,0.05%,1,TOPICAL,Resolved,LOTION,D07AD,"CORTICOSTEROIDS, PLAIN",2017-11-28,2017-11-28,2018-02-23,2018-02-22,Delay in shipping of the drug.,2017-08-10,2018-02-23
31518,2230950,Shortage,MYLAN-CLONAZEPAM,MYLAN PHARMACEUTICALS ULC,CLONAZEPAM,CLONAZEPAM,0.5MG,"100BT, 500BT",ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-12-01,,,2017-12-01,Disruption of the manufacture of the drug.,2017-12-01,2017-12-02
9300,2230951,Shortage,MYLAN-CLONAZEPAM,MYLAN PHARMACEUTICALS ULC,CLONAZEPAM,CLONAZEPAM,2MG,"100BT, 500BT",ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2018-04-02,,,2018-04-02,Disruption of the manufacture of the drug.,2017-05-05,2018-04-03
30326,2351536,Shortage,MYLAN-CLOPIDOGREL,MYLAN PHARMACEUTICALS ULC,MYLAN-CLOPIDOGREL,CLOPIDOGREL,75MG,"100BT, 500BT",ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2018-03-01,,,2018-03-01,Disruption of the manufacture of the drug.,2017-11-23,2018-05-02
2465,2231353,Shortage,MYLAN-CYCLOBENZAPRINE,MYLAN PHARMACEUTICALS ULC,Cyclobenzaprine,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2018-02-20,,2018-06-07,Disruption of the manufacture of the drug.,2017-03-14,2018-06-08
69423,2458934,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,DIVALPROEX,VALPROIC ACID,250MG,"100BT, 500 BT",ORAL,Avoided shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-02-11,,2019-02-15,2019-02-01,Delay in shipping of the drug.,2018-12-12,2019-02-01
70728,2459019,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,DIVALPROEX,VALPROIC ACID,500MG,100 BT,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2019-01-02,2019-02-16,2019-01-17,Delay in shipping of the drug.,2019-01-02,2019-01-18
73034,2459019,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,DIVALPROEX,VALPROIC ACID,500MG,"100 BT, 500 BT",ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-02-26,,2019-03-15,2019-03-05,Delay in shipping of the drug.,2019-01-21,2019-03-06
78971,2458934,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,MYLAN-DIVALPROEX,VALPROIC ACID,250MG,"100 BT, 500 BT",ORAL,Avoided shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-04-17,,2019-04-22,2019-03-28,Delay in shipping of the drug.,2019-03-20,2019-03-28
81031,2458926,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,DIVALPROEX,VALPROIC ACID,125MG,100 BT,ORAL,Avoided shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-05-08,,2019-05-15,2019-04-30,Delay in shipping of the drug.,2019-04-10,2019-04-30
75951,2458934,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,DIVALPROEX,VALPROIC ACID,250MG,"100 BT, 500 BT",ORAL,Avoided shortage,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-03-07,,2019-03-15,2019-02-25,Delay in shipping of the drug.,2019-02-15,2019-02-26
78774,2459019,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,MYLAN-DIVALPROEX,VALPROIC ACID,500MG,"100 BT, 500 BT",ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2019-03-21,,2019-04-15,2019-04-03,Delay in shipping of the drug.,2019-03-15,2019-04-04
65722,2459019,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,DIVALPROEX,VALPROIC ACID,500MG,100BT,ORAL,Resolved,TABLET (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,2018-11-09,2018-12-05,2018-12-21,2018-12-18,Delay in shipping of the drug.,2018-10-29,2018-12-19
10066,2359480,Shortage,MYLAN-DONEPEZIL,MYLAN PHARMACEUTICALS ULC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018-03-01,,,2018-03-01,Disruption of the manufacture of the drug.,2017-05-11,2018-03-02
9303,2359472,Shortage,MYLAN-DONEPEZIL,MYLAN PHARMACEUTICALS ULC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,100BT,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,2018-05-01,2018-05-02,,2018-05-02,Disruption of the manufacture of the drug.,2017-05-05,2018-05-18
48193,2426633,Shortage,MYLAN-DULOXETINE,MYLAN PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,30MG,"30BT, 100 BT",ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-05-01,,2018-05-01,Other (Please describe in comments),2018-05-03,2018-05-03
48201,2426641,Shortage,MYLAN-DULOXETINE,MYLAN PHARMACEUTICALS ULC,DULOXETINE,DULOXETINE,60MG,"30BT, 100BT",ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-05-01,,2018-05-01,Other (Please describe in comments),2018-05-03,2018-05-03
87463,2461412,Shortage,MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,MYLAN PHARMACEUTICALS ULC,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,EFAVIRENZ  TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,600MG  300MG  200MG,30 BT,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-06-25,2019-06-25,2019-07-30,2019-07-02,Delay in shipping of the drug.,2019-06-25,2019-07-03
47356,2461412,Shortage,MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,MYLAN PHARMACEUTICALS ULC,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,EFAVIRENZ  TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,600MG  300MG  200MG,30 BT,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-06-11,,2019-06-21,2019-06-18,Delay in shipping of the drug.,2018-04-27,2019-06-19
90113,2443902,Shortage,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,EMTRICITABINE/TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BT,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-08-08,2019-08-13,2019-09-20,2019-09-25,Delay in shipping of the drug.,2019-07-29,2019-09-26
82201,2443902,Shortage,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,EMTRICITABINE/TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BT,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-06-06,2019-06-11,2019-07-30,2019-06-25,Requirements related to complying with good manufacturing practices.,2019-04-23,2019-06-26
80423,2443902,Shortage,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,EMTRICITABINE/TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BT,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-04-10,2019-04-10,2019-05-30,2019-04-22,Delay in shipping of the drug.,2019-04-03,2019-04-23
70748,2443902,Shortage,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,EMTRICITABINE/TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30BT,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-02-02,2019-02-15,2019-03-29,2019-03-28,Delay in shipping of the drug.,2019-01-02,2019-03-29
23172,2443902,Shortage,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,EMTRICITABINE/TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30BT,ORAL,Avoided shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2018-12-19,,2019-01-11,2018-12-18,Delay in shipping of the drug.,2017-09-22,2018-12-19
88291,2443902,Shortage,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,EMTRICITABINE/TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE  EMTRICITABINE,300MG  200MG,30 BT,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,2019-07-03,,,2019-07-09,Delay in shipping of the drug.,2019-07-03,2019-07-10
54212,2300036,Shortage,MYLAN-ENALAPRIL,MYLAN PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,2MG,100 BT,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-07-03,2018-07-03,,,Disruption of the manufacture of the drug.,2018-07-04,2018-07-04
54219,2300044,Shortage,MYLAN-ENALAPRIL,MYLAN PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,4MG,"100 BT, 500 BT",ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-07-03,2018-07-03,,,Disruption of the manufacture of the drug.,2018-07-04,2018-07-04
54237,2300052,Shortage,MYLAN-ENALAPRIL,MYLAN PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,8MG,"100 BT, 500 BT",ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-07-03,2018-07-03,,,Disruption of the manufacture of the drug.,2018-07-04,2018-07-04
54242,2300060,Shortage,MYLAN-ENALAPRIL,MYLAN PHARMACEUTICALS ULC,ENALAPRIL,ENALAPRIL SODIUM,16MG,"100 BT, 500 BT",ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-07-03,2018-07-03,,,Disruption of the manufacture of the drug.,2018-07-04,2018-07-04
5954,2390337,Shortage,MYLAN-ENTACAPONE,MYLAN PHARMACEUTICALS ULC,ENTACAPONE,ENTACAPONE,200MG,100BT,ORAL,Avoided shortage,TABLET,N04BX,DOPAMINERGIC AGENTS,2017-08-19,,,2017-04-11,Delay in shipping of the drug.,2017-04-07,2017-04-13
9306,2390337,Shortage,MYLAN-ENTACAPONE,MYLAN PHARMACEUTICALS ULC,ENTACAPONE,ENTACAPONE,200MG,100BT,ORAL,Resolved,TABLET,N04BX,DOPAMINERGIC AGENTS,2017-11-01,,,2017-11-01,Disruption of the manufacture of the drug.,2017-05-05,2017-11-02
25885,2309467,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100 BT,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-11-03,2017-12-22,2017-12-20,Delay in shipping of the drug.,2017-10-13,2017-12-21
94770,2309467,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100BT,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-09-25,2019-10-18,2019-10-22,Demand increase for the drug.,2019-09-26,2019-10-23
94773,2309475,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100BT,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-09-25,2019-10-04,2019-10-01,Demand increase for the drug.,2019-09-26,2019-10-02
17756,2309475,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100BT,ORAL,Avoided shortage,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-23,,2018-07-27,2018-07-05,Delay in shipping of the drug.,2017-08-01,2018-07-05
98529,2309467,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100 BT,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-11-06,2020-03-15,,Delay in shipping of the drug.,2019-11-12,2019-11-12
98534,2309475,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,20MG,100 BT,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-11-05,2020-03-15,,Delay in shipping of the drug.,2019-11-12,2019-11-12
35667,2383039,Shortage,MYLAN-ESOMEPRAZOLE,MYLAN PHARMACEUTICALS ULC,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,100 BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-01-31,2018-01-31,2018-04-06,2018-03-26,Delay in shipping of the drug.,2018-01-10,2018-03-27
33989,2383047,Shortage,MYLAN-ESOMEPRAZOLE,MYLAN PHARMACEUTICALS ULC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100 BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-02-12,2018-01-12,2018-03-02,2018-02-28,Delay in shipping of the drug.,2017-12-20,2018-03-01
44850,2196018,Shortage,MYLAN-FAMOTIDINE,MYLAN PHARMACEUTICALS ULC,FAMOTIDINE,FAMOTIDINE,20MG,100 BT,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-04-04,2018-07-05
5341,2196026,Shortage,MYLAN-FAMOTIDINE,MYLAN PHARMACEUTICALS ULC,FAMOTIDINE,FAMOTIDINE,40MG,100BT,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-01-08,2018-01-03,2018-02-01,2018-02-01,Delay in shipping of the drug.,2017-04-04,2018-02-15
5332,2240210,Shortage,MYLAN-FENOFIBRATE MICRO,MYLAN PHARMACEUTICALS ULC,FENOFIBRATE MICRO,FENOFIBRATE,200MG,100BT,ORAL,Avoided shortage,CAPSULE,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2017-07-16,,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-04,2017-07-17
4126,2396718,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH 25 MCG,FENTANYL,25MCG,5,TRANSDERMAL,Avoided shortage,PATCH,N02AB,OPIOIDS,2017-08-29,,2017-09-15,2017-08-14,Delay in shipping of the drug.,2017-03-24,2017-08-16
10059,2396742,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH,FENTANYL,100MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017-05-08,,2017-05-31,Delay in shipping of the drug.,2017-05-11,2017-06-02
16249,2396726,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH,FENTANYL,50MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2018-11-19,,2018-12-31,Delay in shipping of the drug.,2017-07-18,2019-01-03
152,2396696,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,Fentanyl Patch,FENTANYL,12MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2018-07-27,2018-08-03,2018-08-01,Delay in shipping of the drug.,2017-03-10,2018-08-02
180,2396734,Shortage,MYLAN-FENTANYL MATRIX PATCH,MYLAN PHARMACEUTICALS ULC,FENTANYL MATRIX PATCH 75 MCG,FENTANYL,75MCG,5,TRANSDERMAL,Avoided shortage,PATCH,N02AB,OPIOIDS,2017-09-03,,2017-09-15,2017-08-14,Delay in shipping of the drug.,2017-03-10,2017-08-16
35825,2245293,Shortage,MYLAN-FLUCONAZOLE,MYLAN PHARMACEUTICALS ULC,FLUCONAZOLE,FLUCONAZOLE,100MG,50 BT,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2018-09-06,2018-09-06,2018-11-09,2018-11-07,Delay in shipping of the drug.,2018-01-12,2018-11-08
51433,2237813,Shortage,MYLAN-FLUOXETINE,MYLAN PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,10MG,100 BT,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51441,2237814,Shortage,MYLAN-FLUOXETINE,MYLAN PHARMACEUTICALS ULC,FLUOXETINE,FLUOXETINE,20MG,"100 BT, 500 BT",ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
7011,2262401,Shortage,MYLAN-FOSINOPRIL,MYLAN PHARMACEUTICALS ULC,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
9124,2262401,Shortage,MYLAN-FOSINOPRIL,MYLAN PHARMACEUTICALS ULC,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
5316,2262428,Shortage,MYLAN-FOSINOPRIL,MYLAN PHARMACEUTICALS ULC,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-05-08,2017-07-06,,2017-07-12,Delay in shipping of the drug.,2017-04-04,2017-07-17
5976,2248261,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,400MG,500BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-12-01,,,2017-12-01,Delay in shipping of the drug.,2017-04-07,2017-12-02
7014,2248260,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,500BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-04-11,,2017-08-23,Disruption of the manufacture of the drug.,2017-04-13,2017-08-24
7017,2397471,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,MYLAN-GABAPENTIN,GABAPENTIN,600MG,100BT,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-04-11,,2017-08-23,Disruption of the manufacture of the drug.,2017-04-13,2017-08-24
7020,2397498,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,800MG,100BT,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-04-11,,2017-08-23,Disruption of the manufacture of the drug.,2017-04-13,2017-08-24
5301,2248259,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,100MG,500BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-04-11,2017-07-06,,2017-08-23,Delay in shipping of the drug.,2017-04-04,2017-08-24
5322,2248260,Shortage,MYLAN-GABAPENTIN,MYLAN PHARMACEUTICALS ULC,GABAPENTIN,GABAPENTIN,300MG,100BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-08-22,,,2017-08-23,Delay in shipping of the drug.,2017-04-04,2017-08-24
62963,2339439,Shortage,MYLAN-GALANTAMINE ER,MYLAN PHARMACEUTICALS ULC,GALANTAMINE,GALANTAMINE,8MG,"30BT, 100 BT",ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2018-10-15,2018-10-15,2018-12-14,2018-11-12,Delay in shipping of the drug.,2018-10-03,2018-11-13
5913,2229519,Shortage,MYLAN-GLICLAZIDE,MYLAN PHARMACEUTICALS ULC,Gliclazide,GLICLAZIDE,80MG,"100BT, 60BL",ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-12-01,,,2017-12-01,Delay in shipping of the drug.,2017-04-07,2017-12-02
65715,2438658,Shortage,MYLAN-GLICLAZIDE MR,MYLAN PHARMACEUTICALS ULC,MYLAN-GLICLAZIDE MR,GLICLAZIDE,30MG,100BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-12-10,2018-12-10,2019-01-18,2019-01-21,Requirements related to complying with good manufacturing practices.,2018-10-29,2019-01-22
5925,2252600,Shortage,MYLAN-HYDROXYCHLOROQUINE,MYLAN PHARMACEUTICALS ULC,HYDROXYCHLOROQUINE,HYDROXYCHLOROQUINE SULFATE,200MG,100BT,ORAL,Resolved,TABLET,P01BA,ANTIMALARIALS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-04-07,2018-07-05
3372,2242920,Shortage,MYLAN-HYDROXYUREA,MYLAN PHARMACEUTICALS ULC,HYDROXYUREA,HYDROXYUREA,500MG,100BT,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-07-21,2017-07-24,2018-02-26,2018-02-27,Disruption of the manufacture of the drug.,2017-03-17,2018-02-28
72303,2242920,Shortage,MYLAN-HYDROXYUREA,MYLAN PHARMACEUTICALS ULC,HYDROXYUREA,HYDROXYUREA,500MG,100BT,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,2019-01-21,2019-01-21,2019-10-31,2019-10-28,Delay in shipping of the drug.,2019-01-15,2019-10-29
84997,2240067,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2019-05-28,2019-05-28,,2019-08-13,Delay in shipping of the drug.,2019-05-28,2019-08-14
84073,2240067,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,1.25MG,100BT,ORAL,Avoided shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2019-06-06,,2019-07-19,2019-05-28,Delay in shipping of the drug.,2019-05-14,2019-05-28
7289,2153483,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,2.5MG,100BT,ORAL,Avoided shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2018-02-01,,2018-02-09,2018-01-25,Delay in shipping of the drug.,2017-04-19,2018-01-26
75945,2153483,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,2.5MG,100 BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2019-03-04,2019-03-05,2019-06-21,2019-06-18,Delay in shipping of the drug.,2019-02-15,2019-06-19
189,2240067,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,1.25MG,100BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2018-12-18,,2019-02-08,2019-01-17,Delay in shipping of the drug.,2017-03-10,2019-01-18
191,2240067,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,Indapamide,INDAPAMIDE,1.25MG,100BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016-09-09,,2017-03-14,Requirements related to complying with good manufacturing practices.,2017-03-10,2017-03-15
194,2153483,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,Indapamide,Indapamide,2.5mg,100BT,Oral,Resolved,Tablet,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",,2016-09-22,,2017-03-29,Demand increase for the drug.,2017-03-10,2017-03-31
4073,2153483,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,Indapamide,INDAPAMIDE,2.5MG,100BT,ORAL,Resolved,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2017-04-01,,,2017-04-03,Demand increase for the drug.,2017-03-23,2017-04-04
30371,2239131,Shortage,MYLAN-IPRATROPIUM SOLUTION,MYLAN PHARMACEUTICALS ULC,IPRATROPIUM SOLUTION,IPRATROPIUM BROMIDE,0.25MG,20ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-07-02,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-11-23,2018-07-05
9217,2347296,Shortage,MYLAN-IRBESARTAN,MYLAN PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,75MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-05-05,2018-07-05
9203,2347318,Shortage,MYLAN-IRBESARTAN,MYLAN PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,150MG,90,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,2018-08-10,2018-08-10,Disruption of the manufacture of the drug.,2017-05-05,2018-08-11
9210,2347326,Shortage,MYLAN-IRBESARTAN,MYLAN PHARMACEUTICALS ULC,IRBESARTAN,IRBESARTAN,300MG,90BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-07-19,,,2017-10-02,Disruption of the manufacture of the drug.,2017-05-05,2017-10-03
11782,2265516,Shortage,MYLAN-LAMOTRIGINE,MYLAN PHARMACEUTICALS ULC,LAMOTRIGINE,LAMOTRIGINE,150MG,100BT,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-01-23,2018-01-22,2018-03-19,2018-03-19,Requirements related to complying with good manufacturing practices.,2017-06-02,2018-03-20
36703,2265494,Shortage,MYLAN-LAMOTRIGINE,MYLAN PHARMACEUTICALS ULC,LAMOTRIGINE,LAMOTRIGINE,25MG,100 BT,ORAL,Avoided shortage,TABLET,N03AX,ANTIEPILEPTICS,2018-02-19,,,2018-02-07,Delay in shipping of the drug.,2018-01-19,2018-02-08
89824,2265508,Shortage,MYLAN-LAMOTRIGINE,MYLAN PHARMACEUTICALS ULC,LAMOTRIGINE,LAMOTRIGINE,100MG,"100 BT, 500 BT",ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2019-08-14,2019-07-29,2019-09-06,2019-08-20,Delay in shipping of the drug.,2019-07-23,2019-08-23
85054,2353849,Shortage,MYLAN-LANSOPRAZOLE,MYLAN PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-06-11,,,2019-06-18,Delay in shipping of the drug.,2019-05-28,2019-06-19
14700,2353830,Shortage,MYLAN-LANSOPRAZOLE,MYLAN PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-08-10,2018-08-07,2018-08-30,2018-08-14,Delay in shipping of the drug.,2017-07-05,2018-08-15
88985,2353849,Shortage,MYLAN-LANSOPRAZOLE,MYLAN PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-07-09,2019-07-09,2019-11-22,2019-11-12,Demand increase for the drug.,2019-07-09,2019-11-13
29854,2353849,Shortage,MYLAN-LANSOPRAZOLE,MYLAN PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100BT,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-03-16,,,2018-03-02,Delay in shipping of the drug.,2017-11-20,2018-03-02
90110,2353830,Shortage,MYLAN-LANSOPRAZOLE,MYLAN PHARMACEUTICALS ULC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100 BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-07-29,2019-11-15,2019-11-12,Disruption of the manufacture of the drug.,2019-07-29,2019-11-13
9222,2274868,Shortage,MYLAN-LISINOPRIL,MYLAN PHARMACEUTICALS ULC,LISINOPRIL,LISINOPRIL,20MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-04-02,,,2018-04-02,Disruption of the manufacture of the drug.,2017-05-05,2018-04-03
7024,2274841,Shortage,MYLAN-LISINOPRIL,MYLAN PHARMACEUTICALS ULC,LISINOPRIL,LISINOPRIL,10MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
7028,2274833,Shortage,MYLAN-LISINOPRIL,MYLAN PHARMACEUTICALS ULC,LISINOPRIL,LISINOPRIL,5MG,100BT,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
51460,2368293,Shortage,MYLAN-LOSARTAN,MYLAN PHARMACEUTICALS ULC,LOSARTAN,LOSARTAN POTASSIUM,100MG,"100 BT, 30 BL",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,2018-08-10,2018-08-10,Disruption of the manufacture of the drug.,2018-06-05,2018-08-11
3335,2368277,Shortage,MYLAN-LOSARTAN,MYLAN PHARMACEUTICALS ULC,Losartan,LOSARTAN POTASSIUM,25MG,"100BT, 30 BL",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,2018-08-10,2018-08-10,Disruption of the manufacture of the drug.,2017-03-17,2018-08-11
3354,2368285,Shortage,MYLAN-LOSARTAN,MYLAN PHARMACEUTICALS ULC,Losartan,LOSARTAN POTASSIUM,50MG,"30BL, 100BT",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,2018-08-10,2018-08-10,Disruption of the manufacture of the drug.,2017-03-17,2018-08-11
7031,2378086,Shortage,MYLAN-LOSARTAN HCTZ,MYLAN PHARMACEUTICALS ULC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,"30BL, 100BT",ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-05-01,2018-05-01,,2018-05-01,Disruption of the manufacture of the drug.,2017-04-13,2018-08-23
7034,2378094,Shortage,MYLAN-LOSARTAN HCTZ,MYLAN PHARMACEUTICALS ULC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,"100BT, 30BL",ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-05-01,2018-05-01,,2018-05-01,Disruption of the manufacture of the drug.,2017-04-13,2018-08-23
7037,2378078,Shortage,MYLAN-LOSARTAN HCTZ,MYLAN PHARMACEUTICALS ULC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,"100BT, 30BL",ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-05-01,2018-05-01,,2018-05-01,Disruption of the manufacture of the drug.,2017-04-13,2018-08-23
7040,2243127,Shortage,MYLAN-LOVASTATIN,MYLAN PHARMACEUTICALS ULC,LOVASTATIN,LOVASTATIN,20MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
7043,2243129,Shortage,MYLAN-LOVASTATIN,MYLAN PHARMACEUTICALS ULC,MYLAN-LOVASTATIN,LOVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-11,,2017-07-12,Disruption of the manufacture of the drug.,2017-04-13,2017-07-17
10070,2255995,Shortage,MYLAN-MELOXICAM,MYLAN PHARMACEUTICALS ULC,MELOXICAM,MELOXICAM,15MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-06-01,2018-06-01,,2018-06-07,Disruption of the manufacture of the drug.,2017-05-11,2018-06-08
44891,2255987,Shortage,MYLAN-MELOXICAM,MYLAN PHARMACEUTICALS ULC,MELOXICAM,MELOXICAM,7.5MG,100 BT,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-06-01,2018-06-01,,2018-06-07,Disruption of the manufacture of the drug.,2018-04-04,2018-06-08
3935,2148765,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,"100BT, 360BT, 500BT",ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-22,2018-07-05
5016,2148765,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-03-16,,2017-09-21,Disruption of the manufacture of the drug.,2017-03-31,2017-09-22
5020,2229656,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,100BT,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-03-20,2017-09-30,2017-09-21,Delay in shipping of the drug.,2017-03-31,2017-09-22
5025,2229656,Shortage,MYLAN-METFORMIN,MYLAN PHARMACEUTICALS ULC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,"100BT, 500BT",ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-31,2018-07-05
5919,2230736,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,100MG,250BT,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017-08-11,2017-10-02,,2019-09-17,Disruption of the manufacture of the drug.,2017-04-07,2019-09-18
5934,2230735,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,50MG,250BT,ORAL,Avoided shortage,CAPSULE,J01AA,TETRACYCLINES,2017-07-26,,,2017-04-11,Delay in shipping of the drug.,2017-04-07,2017-04-13
7046,2230736,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,100MG,100BT,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2017-06-13,2017-10-02,,2019-09-17,Disruption of the manufacture of the drug.,2017-04-13,2019-09-18
7049,2230735,Shortage,MYLAN-MINOCYCLINE,MYLAN PHARMACEUTICALS ULC,MINOCYCLINE,MINOCYCLINE,50MG,"100BT, 250BT",ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,2018-07-03,2018-07-03,,2019-09-17,Disruption of the manufacture of the drug.,2017-04-13,2019-09-18
82204,2256096,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,15MG,100BT,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2019-04-22,2019-04-26,2019-04-30,Requirements related to complying with good manufacturing practices.,2019-04-23,2019-05-01
15646,2256126,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,45MG,100BT,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-08-12,2017-07-31,2017-10-06,2017-10-10,Delay in shipping of the drug.,2017-07-13,2017-10-11
85061,2256096,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,15MG,100 BT,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2019-07-02,2019-07-02,2019-07-19,2019-07-16,Delay in shipping of the drug.,2019-05-28,2019-07-17
197,2256096,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,15MG,100BT,ORAL,Avoided shortage,TABLET,N06AX,ANTIDEPRESSANTS,2018-09-17,,2018-09-30,2018-09-12,Delay in shipping of the drug.,2017-03-10,2018-09-13
40672,2256118,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BT,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2018-11-13,2018-11-12,2019-01-15,2019-01-17,Delay in shipping of the drug.,2018-02-23,2019-01-18
9241,2380757,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,5MG,30BL,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-02-01,,,2018-02-01,Disruption of the manufacture of the drug.,2017-05-05,2018-02-15
5946,2368226,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MYLAN-MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Avoided shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-07-13,,,2017-05-01,Delay in shipping of the drug.,2017-04-07,2017-05-05
7052,2380749,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,4MG,30BL,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-04-11,,2017-09-07,Disruption of the manufacture of the drug.,2017-04-13,2017-09-08
7055,2368226,Shortage,MYLAN-MONTELUKAST,MYLAN PHARMACEUTICALS ULC,MONTELUKAST,MONTELUKAST,10MG,"30BL, 100BT",ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-12-01,,2017-12-01,2017-12-01,Disruption of the manufacture of the drug.,2017-04-13,2017-12-08
5916,2243432,Shortage,MYLAN-NAPROXEN EC,MYLAN PHARMACEUTICALS ULC,Naproxen,NAPROXEN,375MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-07-03,2018-07-03,,2018-07-10,Disruption of the manufacture of the drug.,2017-04-07,2018-07-11
34097,2241024,Shortage,MYLAN-NAPROXEN EC,MYLAN PHARMACEUTICALS ULC,NAPROXEN EC,NAPROXEN,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-12-20,,2018-07-10,Disruption of the manufacture of the drug.,2017-12-21,2018-07-11
85554,2443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE,ESOMEPRAZOLE  NAPROXEN,20MG  500MG,60 BT,ORAL,Avoided shortage,TABLET (IMMEDIATE AND DELAYED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-06-19,,2019-06-30,2019-06-18,Delay in shipping of the drug.,2019-06-04,2019-06-18
87460,2443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE,ESOMEPRAZOLE  NAPROXEN,20MG  500MG,60 BT,ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-07-03,2019-07-03,2019-07-19,2019-07-16,Delay in shipping of the drug.,2019-06-25,2019-07-17
13528,2443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE MR,ESOMEPRAZOLE  NAPROXEN,20MG  500MG,60BT,ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-05-15,,2019-05-22,2019-05-22,Delay in shipping of the drug.,2017-06-21,2019-05-23
13532,2458608,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE MR,ESOMEPRAZOLE  NAPROXEN,20MG  375MG,60BT,ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-06-20,2018-02-02,2018-02-02,Disruption of the manufacture of the drug.,2017-06-21,2018-02-03
7414,2387727,Shortage,MYLAN-NEVIRAPINE,MYLAN PHARMACEUTICALS ULC,NEVIRAPINE,NEVIRAPINE,200MG,60,ORAL,Resolved,TABLET,J05AG,DIRECT ACTING ANTIVIRALS,,2018-05-31,2018-08-30,2018-08-27,Delay in shipping of the drug.,2017-04-20,2018-08-28
36919,2349167,Shortage,MYLAN-NIFEDIPINE EXTENDED RELEASE,MYLAN PHARMACEUTICALS ULC,MYLAN-NIFEDIPINE EXTENDED RELEASE,NIFEDIPINE,30MG,100 BT,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-12-24,2018-12-10,2020-01-05,,Delay in shipping of the drug.,2018-01-22,2019-10-29
33010,2321149,Shortage,MYLAN-NIFEDIPINE EXTENDED RELEASE,MYLAN PHARMACEUTICALS ULC,NIFEDIPINE,NIFEDIPINE,60MG,100 BT,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-10-15,2018-10-15,2020-01-05,,Delay in shipping of the drug.,2017-12-14,2019-10-29
11406,2407442,Shortage,MYLAN-NITRO PATCH 0.2,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.2,NITROGLYCERIN,20.7MG,30,TRANSDERMAL,Resolved,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-10-12,2017-10-27,2017-10-18,Disruption of the manufacture of the drug.,2017-05-26,2017-10-19
16239,2407450,Shortage,MYLAN-NITRO PATCH 0.4,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.4,NITROGLYCERIN,41.4MG,30,TRANSDERMAL,Resolved,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-08-09,2017-08-09,2017-08-11,2017-08-14,Delay in shipping of the drug.,2017-07-18,2017-08-16
4086,2407469,Shortage,MYLAN-NITRO PATCH 0.6,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.6,NITROGLYCERIN,62.2MG,30,TRANSDERMAL,Avoided shortage,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2018-01-26,,,2017-12-20,Demand increase for the drug.,2017-03-23,2017-12-20
4080,2407477,Shortage,MYLAN-NITRO PATCH 0.8,MYLAN PHARMACEUTICALS ULC,Nitro Patch,NITROGLYCERIN,82.9MG,30,TRANSDERMAL,Avoided shortage,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-04-20,,,2017-03-27,Delay in shipping of the drug.,2017-03-23,2017-03-29
7417,2407477,Shortage,MYLAN-NITRO PATCH 0.8,MYLAN PHARMACEUTICALS ULC,NITRO PATCH 0.8,NITROGLYCERIN,82.9MG,30,TRANSDERMAL,Resolved,PATCH (EXTENDED RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2017-04-29,,,2017-06-07,Delay in shipping of the drug.,2017-04-20,2017-06-16
15649,2243588,Shortage,MYLAN-NITRO SUBLINGUAL SPRAY,MYLAN PHARMACEUTICALS ULC,NITRO SUBLINGUAL SPRAY,NITROGLYCERIN,0.4MG,1BT,SUBLINGUAL,Resolved,METERED-DOSE AEROSOL,C01DA,VASODILATORS USED IN CARDIAC DISEASES,2018-04-18,2018-04-18,2018-05-22,2018-05-22,Delay in shipping of the drug.,2017-07-13,2018-05-23
51475,2337878,Shortage,MYLAN-OLANZAPINE,MYLAN PHARMACEUTICALS ULC,OLANZAPINE,OLANZAPINE,2.5MG,100 BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51478,2337886,Shortage,MYLAN-OLANZAPINE,MYLAN PHARMACEUTICALS ULC,OLANZAPINE,OLANZAPINE,5MG,100 BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51481,2337894,Shortage,MYLAN-OLANZAPINE,MYLAN PHARMACEUTICALS ULC,OLANZAPINE,OLANZAPINE,7.5MG,100 BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51484,2337908,Shortage,MYLAN-OLANZAPINE,MYLAN PHARMACEUTICALS ULC,OLANZAPINE,OLANZAPINE,10MG,100 BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51489,2337916,Shortage,MYLAN-OLANZAPINE,MYLAN PHARMACEUTICALS ULC,OLANZAPINE,OLANZAPINE,15MG,100 BT,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
9154,2382717,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,10MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
9158,2382725,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,15MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
9162,2382733,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,20MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
9165,2382709,Shortage,MYLAN-OLANZAPINE ODT,MYLAN PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,5MG,30BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
19496,2329433,Shortage,MYLAN-OMEPRAZOLE,MYLAN PHARMACEUTICALS ULC,OMEPRAZOLE,OMEPRAZOLE,20MG,"100BT, 500BT",ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-09-08,2017-09-11,,,Disruption of the manufacture of the drug.,2017-08-15,2018-12-20
235,2329425,Shortage,MYLAN-OMEPRAZOLE,MYLAN PHARMACEUTICALS ULC,OMEPRAZOLE,OMEPRAZOLE,10MG,30BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-05-01,,2018-08-16,Other (Please describe in comments),2017-03-10,2018-08-27
65407,2297868,Shortage,MYLAN-ONDANSETRON,MYLAN PHARMACEUTICALS ULC,ONDANSETRON,ONDANSETRON,4MG,"100BT, 10BL",ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2018-10-29,2018-10-29,2018-11-16,2018-11-12,Delay in shipping of the drug.,2018-10-23,2018-11-13
200,2299585,Shortage,MYLAN-PANTOPRAZOLE,MYLAN PHARMACEUTICALS ULC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,"500BT, 100BT",ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-10,2018-07-05
85560,2408570,Shortage,MYLAN-PANTOPRAZOLE T,MYLAN PHARMACEUTICALS ULC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-06-10,,2019-06-30,2019-06-18,Delay in shipping of the drug.,2019-06-04,2019-06-19
33019,2408570,Shortage,MYLAN-PANTOPRAZOLE T,MYLAN PHARMACEUTICALS ULC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-10-19,2018-10-19,2019-05-15,2019-05-28,Delay in shipping of the drug.,2017-12-14,2019-05-29
51520,2248012,Shortage,MYLAN-PAROXETINE,MYLAN PHARMACEUTICALS ULC,PAROXETINE,PAROXETINE,10MG,100 BT,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51526,2248013,Shortage,MYLAN-PAROXETINE,MYLAN PHARMACEUTICALS ULC,PAROXETINE,PAROXETINE,20MG,"100 BT, 500 BT",ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51532,2248014,Shortage,MYLAN-PAROXETINE,MYLAN PHARMACEUTICALS ULC,PAROXETINE,PAROXETINE,30MG,100 BT,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51545,2298287,Shortage,MYLAN-PIOGLITAZONE,MYLAN PHARMACEUTICALS ULC,PIOGLITAZONE,PIOGLITAZONE,30MG,90 BT,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
10722,2298279,Shortage,MYLAN-PIOGLITAZONE,MYLAN PHARMACEUTICALS ULC,PIOGLITAZONE,PIOGLITAZONE,15MG,90BT,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-05-19,2018-07-05
10725,2298295,Shortage,MYLAN-PIOGLITAZONE,MYLAN PHARMACEUTICALS ULC,PIOGLITAZONE,PIOGLITAZONE,45MG,90BT,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-07-03,2018-07-03,,2018-07-03,Delay in shipping of the drug.,2017-05-19,2018-07-05
9179,2257092,Shortage,MYLAN-PRAVASTATIN,MYLAN PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
9182,2257106,Shortage,MYLAN-PRAVASTATIN,MYLAN PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-07-15,,,2017-09-07,Disruption of the manufacture of the drug.,2017-05-05,2017-09-08
9185,2257114,Shortage,MYLAN-PRAVASTATIN,MYLAN PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
51558,2382210,Shortage,MYLAN-PREGABALIN,MYLAN PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,25MG,60 BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51564,2382229,Shortage,MYLAN-PREGABALIN,MYLAN PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,50MG,60 BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51570,2382237,Shortage,MYLAN-PREGABALIN,MYLAN PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,75MG,60 BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51578,2382245,Shortage,MYLAN-PREGABALIN,MYLAN PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,150MG,60 BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
51585,2382253,Shortage,MYLAN-PREGABALIN,MYLAN PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,300MG,60 BT,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-05,2018-07-05
42298,2457172,Shortage,MYLAN-PROPAFENONE,MYLAN PHARMACEUTICALS ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BT,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2019-03-12,,2019-03-15,2019-03-15,Delay in shipping of the drug.,2018-03-08,2019-03-16
42301,2457164,Shortage,MYLAN-PROPAFENONE,MYLAN PHARMACEUTICALS ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100 BT,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2018-05-31,,2019-01-21,Delay in shipping of the drug.,2018-03-08,2019-01-22
9016,2408392,Shortage,MYLAN-RABEPRAZOLE,MYLAN PHARMACEUTICALS ULC,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-12-01,,,2017-12-01,Disruption of the manufacture of the drug.,2017-05-04,2017-12-02
9188,2408406,Shortage,MYLAN-RABEPRAZOLE,MYLAN PHARMACEUTICALS ULC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100BT,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
27146,2390299,Shortage,MYLAN-RILUZOLE,MYLAN PHARMACEUTICALS ULC,RILUZOLE,RILUZOLE,50MG,60BT,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,2018-01-31,2018-01-31,2018-03-09,2018-03-09,Delay in shipping of the drug.,2017-10-26,2018-03-10
9368,2397773,Shortage,MYLAN-RISEDRONATE,MYLAN PHARMACEUTICALS ULC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1BL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-05-01,,2017-07-12,Disruption of the manufacture of the drug.,2017-05-05,2017-07-17
5310,2357984,Shortage,MYLAN-RISEDRONATE,MYLAN PHARMACEUTICALS ULC,Risedronate,RISEDRONATE SODIUM,35MG,4BL,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-11-01,,,2017-11-01,Delay in shipping of the drug.,2017-04-04,2017-11-02
5329,2357984,Shortage,MYLAN-RISEDRONATE,MYLAN PHARMACEUTICALS ULC,Risedronate,RISEDRONATE SODIUM,35MG,30BT,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-11-01,,,2017-11-01,Delay in shipping of the drug.,2017-04-04,2017-11-02
3368,2282291,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,Risperidone,RISPERIDONE,4.0MG,100s,ORAL,Avoided shortage,TABLET,N05AX,ANTIPSYCHOTICS,2017-05-13,,,2017-03-29,Requirements related to complying with good manufacturing practices.,2017-03-17,2017-03-29
5951,2282240,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-02-01,,,2018-02-01,Delay in shipping of the drug.,2017-04-07,2018-02-15
26702,2282259,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,0.50MG,100BT,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-02-01,,,2018-02-01,Disruption of the manufacture of the drug.,2017-10-23,2018-02-15
9045,2282283,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,3.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-07-11,,,2017-10-02,Delay in shipping of the drug.,2017-05-04,2017-10-03
5319,2282267,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,1.0MG,100BT,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-06-10,2017-07-06,,2017-09-07,Delay in shipping of the drug.,2017-04-04,2017-09-08
5338,2282275,Shortage,MYLAN-RISPERIDONE,MYLAN PHARMACEUTICALS ULC,RISPERIDONE,RISPERIDONE,2.0MG,100BT,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-06-11,2017-07-06,,2017-10-02,Delay in shipping of the drug.,2017-04-04,2017-10-04
8719,2413523,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,4MG,100BT,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-05-02,2019-12-31,,Requirements related to complying with good manufacturing practices.,2017-05-02,2019-02-21
3346,2413507,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,2MG,100BT,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-03-31,2019-12-31,,Requirements related to complying with good manufacturing practices.,2017-03-17,2019-02-21
3360,2413485,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,0.5MG,100BT,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-04-24,2019-12-31,,Requirements related to complying with good manufacturing practices.,2017-03-17,2019-02-21
8764,2413515,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,3MG,100BT,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2018-05-02,2019-12-31,,Requirements related to complying with good manufacturing practices.,2017-05-03,2019-02-21
206,2413493,Shortage,MYLAN-RISPERIDONE ODT,MYLAN PHARMACEUTICALS ULC,RISPERIDONE ODT,RISPERIDONE,1MG,100BT,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-01-23,2019-12-31,,Requirements related to complying with good manufacturing practices.,2017-03-10,2019-02-21
41780,2423421,Shortage,MYLAN-RIVASTIGMINE PATCH 10,MYLAN PHARMACEUTICALS ULC,RIVASTIGMINE,RIVASTIGMINE,18MG,30 Patches,TRANSDERMAL,Resolved,PATCH,N06DA,ANTI-DEMENTIA DRUGS,2018-04-02,2018-04-02,2018-04-10,2018-04-04,Delay in shipping of the drug.,2018-03-05,2018-04-05
83413,2423421,Shortage,MYLAN-RIVASTIGMINE PATCH 10,MYLAN PHARMACEUTICALS ULC,RIVASTIGMINE,RIVASTIGMINE,18MG,30 PATCHES,TRANSDERMAL,Resolved,PATCH,N06DA,ANTI-DEMENTIA DRUGS,2019-06-04,2019-06-04,2019-07-26,2019-07-29,Delay in shipping of the drug.,2019-05-08,2019-07-30
42873,2423413,Shortage,MYLAN-RIVASTIGMINE PATCH 5,MYLAN PHARMACEUTICALS ULC,RIVASTIGMINE,RIVASTIGMINE,9MG,30 Patches,TRANSDERMAL,Resolved,PATCH,N06DA,ANTI-DEMENTIA DRUGS,2018-04-02,2018-04-02,2018-04-10,2018-04-04,Delay in shipping of the drug.,2018-03-14,2018-04-05
83409,2423413,Shortage,MYLAN-RIVASTIGMINE PATCH 5,MYLAN PHARMACEUTICALS ULC,RIVASTIGMINE,RIVASTIGMINE,9MG,30 PATCHES,TRANSDERMAL,Resolved,PATCH,N06DA,ANTI-DEMENTIA DRUGS,2019-06-04,2019-06-04,2019-07-05,2019-07-09,Delay in shipping of the drug.,2019-05-08,2019-07-10
20575,2379201,Shortage,MYLAN-RIZATRIPTAN ODT,MYLAN PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,10MG,6BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017-09-08,2017-09-11,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-08-29,2017-09-30
20578,2379198,Shortage,MYLAN-RIZATRIPTAN ODT,MYLAN PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,5MG,6BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017-09-08,2017-09-11,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-08-29,2017-09-30
30347,2381273,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,10MG,"30BL, 100BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-04-02,,,2018-04-02,Disruption of the manufacture of the drug.,2017-11-23,2018-04-03
30353,2381303,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,"30BL, 100BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-05-01,2018-05-01,,2018-05-10,Disruption of the manufacture of the drug.,2017-11-23,2018-06-05
30392,2381281,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,20MG,"30BL, 100BT, 500BT",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-11-23,2018-07-05
212,2381265,Shortage,MYLAN-ROSUVASTATIN,MYLAN PHARMACEUTICALS ULC,Rosuvastatin,ROSUVASTATIN,5MG,"100BT, 500 BT, 30 BL",ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-10,2018-07-05
5304,2231036,Shortage,MYLAN-SELEGILINE,MYLAN PHARMACEUTICALS ULC,SELEGILINE,SELEGILINE HYDROCHLORIDE,5MG,60BT,ORAL,Avoided shortage,TABLET,N04BD,DOPAMINERGIC AGENTS,2017-07-18,,,2017-07-12,Delay in shipping of the drug.,2017-04-04,2017-07-17
5979,2242520,Shortage,MYLAN-SERTRALINE,MYLAN PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,50MG,"100BT, 500BT",ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-03-01,,,2018-03-01,Disruption of the manufacture of the drug.,2017-04-07,2018-03-02
30359,2242521,Shortage,MYLAN-SERTRALINE,MYLAN PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,100MG,100BT,ORAL,Avoided shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-07-02,2018-01-25,,2018-02-01,Disruption of the manufacture of the drug.,2017-11-23,2018-02-15
30402,2242519,Shortage,MYLAN-SERTRALINE,MYLAN PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,25MG,100BT,ORAL,Avoided shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-08-01,,,2018-02-01,Disruption of the manufacture of the drug.,2017-11-23,2018-02-15
17769,2246584,Shortage,MYLAN-SIMVASTATIN,MYLAN PHARMACEUTICALS ULC,SIMVASTATIN,SIMVASTATIN,40MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-03,2018-07-03,,2019-09-17,Disruption of the manufacture of the drug.,2017-08-01,2019-09-18
17773,2246585,Shortage,MYLAN-SIMVASTATIN,MYLAN PHARMACEUTICALS ULC,SIMVASTATIN,SIMVASTATIN,80MG,100BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-03,2018-07-03,,2019-09-17,Disruption of the manufacture of the drug.,2017-08-01,2019-09-18
38547,2246582,Shortage,MYLAN-SIMVASTATIN,MYLAN PHARMACEUTICALS ULC,SIMVASTATIN,SIMVASTATIN,5MG,100 BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-03,2018-07-03,,2019-09-17,Disruption of the manufacture of the drug.,2018-02-05,2019-09-18
51636,2246583,Shortage,MYLAN-SIMVASTATIN,MYLAN PHARMACEUTICALS ULC,SIMVASTATIN,SIMVASTATIN,10MG,100 BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-03,2018-07-03,,2019-09-17,Disruption of the manufacture of the drug.,2018-06-06,2019-09-18
51639,2246737,Shortage,MYLAN-SIMVASTATIN,MYLAN PHARMACEUTICALS ULC,SIMVASTATIN,SIMVASTATIN,20MG,100 BT,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-03,2018-07-03,,2019-09-17,Disruption of the manufacture of the drug.,2018-06-06,2019-09-18
28044,2268922,Shortage,MYLAN-SUMATRIPTAN,MYLAN PHARMACEUTICALS ULC,SUMATRIPTAN,SUMATRIPTAN,100MG,6BL,ORAL,Avoided shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-05-14,,,2018-05-02,Delay in shipping of the drug.,2017-11-03,2018-05-03
47809,2268914,Shortage,MYLAN-SUMATRIPTAN,MYLAN PHARMACEUTICALS ULC,SUMATRIPTAN,SUMATRIPTAN,50MG,6BL,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-05-08,2018-05-07,2018-07-10,2018-07-10,Delay in shipping of the drug.,2018-05-01,2018-08-01
18688,2410621,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,2.5MG,28BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-09-10,2018-09-10,2018-12-14,2018-12-18,Delay in shipping of the drug.,2017-08-10,2018-12-19
11788,2410664,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,20MG,4BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-12-18,2018-12-18,2019-08-30,2019-08-22,Delay in shipping of the drug.,2017-06-02,2019-08-23
45590,2410648,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,5MG,28 BL,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-10-29,2018-10-29,2019-08-22,2019-08-22,Delay in shipping of the drug.,2018-04-13,2019-08-23
94761,2410648,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,5MG,28BL,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-25,,,Delay in shipping of the drug.,2019-09-26,2019-10-22
94402,2410664,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,20MG,4BL,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-18,,,Delay in shipping of the drug.,2019-09-19,2019-10-22
73957,2410656,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,10MG,4BL CA,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2019-06-06,,2019-08-30,2019-06-18,Delay in shipping of the drug.,2019-01-30,2019-06-19
51615,2376717,Shortage,MYLAN-TELMISARTAN,MYLAN PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,40MG,"100 BT, 28 BL",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,2018-08-10,2018-08-10,Disruption of the manufacture of the drug.,2018-06-06,2018-08-11
51621,2376725,Shortage,MYLAN-TELMISARTAN,MYLAN PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,80MG,"100 BT, 28 BL",ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,2018-08-10,2018-08-10,Disruption of the manufacture of the drug.,2018-06-06,2018-08-11
76496,2452634,Shortage,MYLAN-TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE,300MG,30 BT,ORAL,Avoided shortage,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,2019-03-07,,2019-03-08,2019-03-05,Delay in shipping of the drug.,2019-02-21,2019-03-05
34559,2452634,Shortage,MYLAN-TENOFOVIR DISOPROXIL,MYLAN PHARMACEUTICALS ULC,TENOFOVIR DISOPROXIL,TENOFOVIR DISOPROXIL FUMARATE,300MG,30 BT,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2018-08-07,,2018-08-28,Delay in shipping of the drug.,2018-01-02,2018-08-29
25895,2404192,Shortage,MYLAN-TOLTERODINE ER,MYLAN PHARMACEUTICALS ULC,TOLTERODINE ER,TOLTERODINE TARTRATE,4MG,"30BT, 100BT",ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-16,2017-11-13,2019-12-31,,Disruption of the manufacture of the drug.,2017-10-13,2019-02-21
17787,2404184,Shortage,MYLAN-TOLTERODINE ER,MYLAN PHARMACEUTICALS ULC,TOLTERODINE ER,TOLTERODINE TARTRATE,2MG,"100BT, 30BT",ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-10-10,2017-10-10,2019-12-31,,Disruption of the manufacture of the drug.,2017-08-01,2019-02-21
81807,2351579,Shortage,MYLAN-VALACYCLOVIR,MYLAN PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,500MG,100 BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2019-04-24,,2019-05-17,2019-04-30,Delay in shipping of the drug.,2019-04-16,2019-05-01
81810,2351560,Shortage,MYLAN-VALACYCLOVIR,MYLAN PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100 BT,ORAL,Avoided shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2019-05-16,,2019-05-17,2019-04-30,Delay in shipping of the drug.,2019-04-16,2019-04-30
42157,2351579,Shortage,MYLAN-VALACYCLOVIR,MYLAN PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,500MG,100 BT,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-04-20,2018-04-27,2018-04-27,Delay in shipping of the drug.,2018-03-07,2018-04-28
9019,2383527,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,40MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-05-04,2018-07-05
9049,2383551,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,320MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,,2018-07-03,Delay in shipping of the drug.,2017-05-04,2018-07-05
26715,2383543,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,160MG,100BT,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-11-01,,,2017-11-01,Disruption of the manufacture of the drug.,2017-10-23,2017-11-02
9198,2383535,Shortage,MYLAN-VALSARTAN,MYLAN PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-05-05,2018-07-05
73041,2464209,Shortage,MYLAN-VARDENAFIL,,VARDENAFIL tablets,VARDENAFIL,5 mg,4's,Oral,Actual shortage,Tablets,G04BE,Urologicals,,2019-01-17,2019-12-15,,Disruption of the manufacture of the drug.,2019-01-21,2019-10-22
73044,2464225,Shortage,MYLAN-VARDENAFIL,,VARDENAFIL tablets,VARDENAFIL,10 mg,4's,Oral,Resolved,Tablets,G04BE,Urologicals,,2019-01-17,2019-06-30,2019-03-05,Disruption of the manufacture of the drug.,2019-01-21,2019-03-06
73047,2464233,Shortage,MYLAN-VARDENAFIL,,VARDENAFIL tablets,VARDENAFIL,20 mg,4's,Oral,Resolved,Tablets,G04BE,Urologicals,,2019-01-17,2019-06-30,2019-03-05,Disruption of the manufacture of the drug.,2019-01-21,2019-03-06
81794,2464225,Shortage,MYLAN-VARDENAFIL,MYLAN PHARMACEUTICALS ULC,VARDENAFIL,,,4 BL,,Resolved,,,,,2019-04-16,2019-07-30,2019-04-22,Delay in shipping of the drug.,2019-04-16,2019-04-23
5909,2310295,Shortage,MYLAN-VENLAFAXINE XR,MYLAN PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-07-03,2018-06-26,,2018-07-03,Disruption of the manufacture of the drug.,2017-04-07,2018-07-04
5990,2310287,Shortage,MYLAN-VENLAFAXINE XR,MYLAN PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,75MG,100BT,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-01-15,2018-01-04,,2018-02-01,Disruption of the manufacture of the drug.,2017-04-07,2018-02-15
9195,2310279,Shortage,MYLAN-VENLAFAXINE XR,MYLAN PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2017-10-22,2017-10-02,,2018-02-01,Disruption of the manufacture of the drug.,2017-05-05,2018-02-15
80452,2237921,Shortage,MYLAN-VERAPAMIL,MYLAN PHARMACEUTICALS ULC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,80MG,100 BT,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-08-29,2019-07-29,2019-10-18,2019-10-15,Delay in shipping of the drug.,2019-04-03,2019-10-16
72309,2237922,Shortage,MYLAN-VERAPAMIL,MYLAN PHARMACEUTICALS ULC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100BT,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-01-24,2019-01-21,2019-08-16,2019-06-18,Delay in shipping of the drug.,2019-01-15,2019-06-19
28047,2237922,Shortage,MYLAN-VERAPAMIL,MYLAN PHARMACEUTICALS ULC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100BT,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-05-24,2018-05-25,2018-07-20,2018-07-18,Delay in shipping of the drug.,2017-11-03,2018-07-19
88302,2237922,Shortage,MYLAN-VERAPAMIL,MYLAN PHARMACEUTICALS ULC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100 BT,ORAL,Resolved,TABLET,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-07-02,2019-10-18,2019-10-15,Demand increase for the drug.,2019-07-03,2019-10-16
30729,2450496,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,240MG,"100BT, 500BT",ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-10-15,2018-10-15,,,Delay in shipping of the drug.,2017-11-27,2019-06-18
17759,2450488,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,180MG,100BT,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-09-06,2018-09-06,,,Delay in shipping of the drug.,2017-08-01,2019-06-18
79724,2210347,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,120MG,100 BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-04-03,,2019-05-30,2019-04-10,Delay in shipping of the drug.,2019-03-28,2019-04-11
68773,2210347,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,120MG,100 BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-12-18,2018-12-18,2019-03-30,2019-03-20,Delay in shipping of the drug.,2018-12-05,2019-03-21
91047,2210347,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,120MG,100 BT,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-08-06,2019-12-15,,Demand increase for the drug.,2019-08-07,2019-09-17
81068,2210347,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,120MG,100 BT,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-05-01,2019-04-16,2019-07-26,2019-07-29,Delay in shipping of the drug.,2019-04-10,2019-07-30
51644,2369036,Shortage,MYLAN-ZOLMITRIPTAN,MYLAN PHARMACEUTICALS ULC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6 BL,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2018-06-06,2018-07-05
17818,2387158,Shortage,MYLAN-ZOLMITRIPTAN ODT,MYLAN PHARMACEUTICALS ULC,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,6BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-06-22,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-08-01,2018-07-05
2364,2238596,Shortage,MYLAN-ZOPICLONE,MYLAN PHARMACEUTICALS ULC,Zopiclone,ZOPICLONE,7.5MG,"500BT, 100BT",ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-07-03,2018-07-03,,2018-07-03,Disruption of the manufacture of the drug.,2017-03-14,2018-07-05
32195,2296616,Shortage,MYLAN-ZOPICLONE,MYLAN PHARMACEUTICALS ULC,ZOPICLONE,ZOPICLONE,5MG,100BT,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-01-04,2018-01-04,,2018-05-01,Delay in shipping of the drug.,2017-12-08,2018-06-06
47182,4618,Shortage,MYLERAN,ASPEN PHARMACARE CANADA INC.,Myleran,BUSULFAN,2MG,25 tablets,ORAL,Resolved,TABLET,L01AB,ALKYLATINGAGENTS,,2018-04-25,,2018-07-24,Demand increase for the drug.,2018-04-25,2018-07-25
14864,1927620,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,Myochrysine,GOLD SODIUM THIOMALATE,10MG,5,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2017-07-07,2017-07-07,,2017-08-03,Other (Please describe in comments),2017-07-06,2017-08-04
39185,1927620,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,Myochrysine 10mg/1ml,GOLD SODIUM THIOMALATE,10MG,5's,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2018-02-15,,2018-03-05,2018-03-02,Other (Please describe in comments),2018-02-09,2018-03-05
45370,1927620,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,MYOCHRYSINE 10MG/ML LJ AMP5,GOLD SODIUM THIOMALATE,10MG,5 AMPOULES,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2018-04-04,2018-04-04,2019-09-30,2019-06-04,Other (Please describe in comments),2018-04-10,2019-06-10
29269,1927612,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,Myochrisine 25mg/1ml,GOLD SODIUM THIOMALATE,25MG,5,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2017-11-24,2017-12-01,2019-09-30,2019-06-04,Shortage of an active ingredient.,2017-11-15,2019-06-10
29274,1927604,Shortage,MYOCHRYSINE,SANOFI-AVENTIS CANADA INC,Myochrisine 50mg/1ml,GOLD SODIUM THIOMALATE,50MG,5,INTRAMUSCULAR,Resolved,SOLUTION,M01CB,SPECIFIC ANTIRHEUMATIC AGENTS,2017-11-24,2017-12-01,2019-09-30,2019-06-04,Shortage of an active ingredient.,2017-11-15,2019-06-10
1555,2239030,Shortage,NADRYL 50MG,LABORATOIRE RIVA INC,Diphenhydramine Hydrochloride tablets USP,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,100,ORAL,Actual shortage,TABLET,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
90722,500895,Shortage,NALCROM,SANOFI-AVENTIS CANADA INC,Nalcrom,CROMOLYN SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A07EB,INTESTINALANTIINFLAMMATORY AGENTS,2019-08-12,,2019-08-30,2019-08-23,Delay in shipping of the drug.,2019-08-05,2019-08-24
80347,500895,Shortage,NALCROM,SANOFI-AVENTIS CANADA INC,Nalcrom 100 mg,CROMOLYN SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A07EB,INTESTINALANTIINFLAMMATORY AGENTS,2019-04-22,,2019-06-30,2019-06-25,Other (Please describe in comments),2019-04-03,2019-06-26
80570,2148706,Shortage,NALOXONE HCL INJECTION - 0.4MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE HCl Inj,NALOXONE HYDROCHLORIDE,0.4MG,1X10ml,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2019-04-05,2019-07-08,2019-06-19,Demand increase for the drug.,2019-04-05,2019-07-08
3820,2148706,Shortage,NALOXONE HCL INJECTION - 0.4MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE HYDROCHLORIDE,0.4MG,10ML VIAL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017-03-27,,2017-06-16,2017-04-11,Demand increase for the drug.,2017-03-22,2017-04-12
3823,2148706,Shortage,NALOXONE HCL INJECTION - 0.4MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE HYDROCHLORIDE,0.4MG,10 X 1ML AMPOULES,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Avoided shortage,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017-05-12,2017-04-11,2017-06-16,2017-05-08,Demand increase for the drug.,2017-03-22,2017-06-26
2609,2148714,Shortage,NALOXONE HCL INJECTION - 1MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE,1mg/mL,10x2mL fioles/vials,INTRA,Resolved,INJ,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2017-02-09,2017-04-28,2017-04-28,Demand increase for the drug.,2017-03-14,2017-06-26
80573,2148714,Shortage,NALOXONE HCL INJECTION - 1MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE HCl Inj,NALOXONE HYDROCHLORIDE,1MG,10X2ml,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2019-04-05,2019-06-17,2019-06-19,Shortage of an inactive ingredient or component.,2019-04-05,2019-06-28
65888,2382482,Shortage,NALOXONE HYDROCHLORIDE INJECTION USP,TELIGENT OU,NALOXONE HYDROCHLORIDE INJECTION,NALOXONE HYDROCHLORIDE,0.4MG,1 ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2018-10-30,2019-06-21,2019-06-19,Shortage of an active ingredient.,2018-10-30,2019-06-20
52317,2162423,Shortage,NAPROSYN,ATNAHS PHARMA UK LIMITED,naproxen,NAPROXEN,500MG,Bottles of 100 tablets,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-06-13,2018-09-21,2018-09-20,Demand increase for the drug.,2018-06-13,2018-09-21
56416,2350785,Shortage,NAPROXEN EC,SANIS HEALTH INC,NAPROXEN EC TAB,NAPROXEN,250MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-07-26,2018-07-26,2018-11-30,2018-12-10,Demand increase for the drug.,2018-07-25,2018-12-11
49537,2350807,Shortage,NAPROXEN EC,SANIS HEALTH INC,NAPROXEN EC TAB,NAPROXEN,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-06-15,2018-06-06,2018-08-17,2018-08-15,Disruption of the manufacture of the drug.,2018-05-16,2018-08-16
28244,887056,Shortage,NAPROXEN-NA,PRO DOC LIMITEE,NAPROXEN-NA,NAPROXEN SODIUM,275MG,100,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-11-06,,2018-07-26,Delay in shipping of the drug.,2017-11-06,2018-07-27
6195,2153386,Shortage,NAPROXEN-NA DF -TAB 550MG,PRO DOC LIMITEE,NAPROXEN-NA DF,NAPROXEN SODIUM,550MG,100,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-04-25,,2017-12-12,Delay in shipping of the drug.,2017-04-07,2017-12-13
94553,476552,Shortage,NARDIL,ERFA CANADA 2012 INC,Phenelzine sulfate,PHENELZINE,15MG,60's,ORAL,Resolved,TABLET,N06AF,ANTIDEPRESSANTS,2019-09-26,,2019-10-15,2019-10-18,Disruption of the manufacture of the drug.,2019-09-23,2019-10-22
32096,2229415,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 5mg/mL 5x20mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,5MG,5,EPIDURAL  BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-12-04,2018-04-27,2018-04-20,Demand increase for the drug.,2017-12-08,2018-04-23
41386,2229411,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 2mg/mL 5x200mL SU Polybag® Duofit®,ROPIVACAINE HYDROCHLORIDE,2MG,5x200mL,EPIDURAL  BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-05,2018-03-01,2018-07-02,2018-07-02,Delay in shipping of the drug.,2018-03-01,2018-07-04
41389,2229411,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 2mg/mL 5x100mL SU Polybag® Duofit®,ROPIVACAINE HYDROCHLORIDE,2MG,5x100mL,EPIDURAL  BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-02,,2018-07-20,2018-07-12,Delay in shipping of the drug.,2018-03-01,2018-07-25
34491,2229418,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 10mg/mL 5x10mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,10MG,5x10mL,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-01,2018-03-01,2019-04-01,2019-04-03,Demand increase for the drug.,2018-01-02,2019-04-04
22243,2229418,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 10mg/mL 5x10mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,10MG,5 PP Amps,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-09-18,2017-10-02,2017-10-12,Demand increase for the drug.,2017-09-18,2017-10-13
40951,2229418,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,Naropin® 10mg/mL 5x20mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,10MG,5x20mL,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-06-01,2018-06-01,2019-01-01,2019-01-11,Demand increase for the drug.,2018-02-26,2019-01-12
70041,2238465,Shortage,NASONEX,MERCK CANADA INC,mometasone furoate monohydrate  aqueous nasal spray,MOMETASONE FUROATE,50MCG,140dose,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2018-12-19,2019-01-05,2018-12-21,Delay in shipping of the drug.,2018-12-19,2018-12-22
67518,2409003,Shortage,NAT-CITALOPRAM,NATCO PHARMA (CANADA) INC,Citalopram,CITALOPRAM,10MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-11-23,2018-11-23,2019-01-30,2019-01-31,Demand increase for the drug.,2018-11-23,2019-02-04
55625,2439557,Shortage,NAT-DONEPEZIL,NATCO PHARMA (CANADA) INC,DONEPEZIL HYDROCHLORIDE TABLETS,DONEPEZIL HYDROCHLORIDE,5MG,Bottle of 100s,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-07-13,2020-01-13,,Disruption of the manufacture of the drug.,2018-07-13,2018-07-14
55630,2439565,Shortage,NAT-DONEPEZIL,NATCO PHARMA (CANADA) INC,DONEPEZIL HYDROCHLORIDE TABLETS,DONEPEZIL HYDROCHLORIDE,10MG,Bottle of 100s,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-07-13,2020-01-13,,Disruption of the manufacture of the drug.,2018-07-13,2018-07-14
75793,2440296,Shortage,NAT-ESCITALOPRAM,NATCO PHARMA (CANADA) INC,Escitalopram Tablets,ESCITALOPRAM,10MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-06-30,,,,Requirements related to complying with good manufacturing practices.,2019-02-15,2019-07-01
75799,2440318,Shortage,NAT-ESCITALOPRAM,NATCO PHARMA (CANADA) INC,Escitalopram Tablets,ESCITALOPRAM,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-07-01,2019-03-28,,,Requirements related to complying with good manufacturing practices.,2019-02-15,2019-04-17
81921,2440229,Shortage,NAT-LEVETIRACETAM,NATCO PHARMA (CANADA) INC,LEVETIRACETAM Tablets,LEVETIRACETAM,750MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2019-08-01,,,,Requirements related to complying with good manufacturing practices.,2019-04-17,2019-08-02
75810,2440202,Shortage,NAT-LEVETIRACETAM,NATCO PHARMA (CANADA) INC,LEVETIRACETAM Tablets,LEVETIRACETAM,250MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2019-02-15,,,Requirements related to complying with good manufacturing practices.,2019-02-15,2019-04-17
64878,2440210,Shortage,NAT-LEVETIRACETAM,NATCO PHARMA (CANADA) INC,LEVETIRACETAM Tablets,LEVETIRACETAM,500MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2018-09-26,2018-09-26,,,Requirements related to complying with good manufacturing practices.,2018-10-19,2019-04-17
82236,2439174,Shortage,NAT-QUETIAPINE,NATCO PHARMA (CANADA) INC,Quetiapine Fumarate,QUETIAPINE,150MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2019-04-23,2019-04-23,,,Requirements related to complying with good manufacturing practices.,2019-04-23,2019-06-17
65944,2439158,Shortage,NAT-QUETIAPINE,NATCO PHARMA (CANADA) INC,Quetiapine Tablets,QUETIAPINE,25MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2018-10-30,2018-10-30,,,Disruption of the manufacture of the drug.,2018-10-31,2019-04-17
81900,2439166,Shortage,NAT-QUETIAPINE,NATCO PHARMA (CANADA) INC,Quetiapine Tablets,QUETIAPINE,100MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2019-05-01,,,,Requirements related to complying with good manufacturing practices.,2019-04-17,2019-05-02
81903,2439182,Shortage,NAT-QUETIAPINE,NATCO PHARMA (CANADA) INC,Quetiapine Tablets,QUETIAPINE,200MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2019-05-01,,,,Requirements related to complying with good manufacturing practices.,2019-04-17,2019-05-02
81906,2439190,Shortage,NAT-QUETIAPINE,NATCO PHARMA (CANADA) INC,Quetiapine Tablets,QUETIAPINE,300MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2019-05-01,,,,Requirements related to complying with good manufacturing practices.,2019-04-17,2019-05-02
67512,2436604,Shortage,NAT-RIZATRIPTAN ODT,NATCO PHARMA (CANADA) INC,Rizatriptan Benzoate,RIZATRIPTAN,5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2019-01-01,,2019-02-06,2019-02-06,Demand increase for the drug.,2018-11-23,2019-02-07
67515,2436612,Shortage,NAT-RIZATRIPTAN ODT,NATCO PHARMA (CANADA) INC,Rizatriptan,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2019-01-01,,2019-02-06,2019-02-06,Demand increase for the drug.,2018-11-23,2019-02-07
90647,2450550,Shortage,NATESTO,ACERUS BIOPHARMA INC,Testosterone gel,TESTOSTERONE,4.5%,11g,NASAL,Actual shortage,GEL,G03BA,ANDROGENS,,2019-07-31,,,Disruption of the manufacture of the drug.,2019-08-02,2019-11-13
28503,24449,Shortage,NAVANE CAP 5MG,ERFA CANADA 2012 INC,TIOTIXENE,,,100 TABLETS,,Resolved,,,,2017-11-07,2017-11-07,,2017-12-12,Disruption of the manufacture of the drug.,2017-11-07,2018-03-14
67265,195057,Shortage,NEO-MEDROL ACNE LOTION,PFIZER CANADA INC,Neo-Medrol,SULFUR  METHYLPREDNISOLONE ACETATE  NEOMYCIN SULFATE  ALUMINUM CHLOROHYDRATE,50MG  2.5MG  2.5MG  100MG,25ML,TOPICAL,Resolved,LOTION,D10AA,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-01-03,2019-03-01,2019-02-27,Disruption of the manufacture of the drug.,2018-11-20,2019-02-28
69355,2387166,Shortage,NEOSTIGMINE OMEGA,OMEGA LABORATORIES LTD,Neostigmine Methylsulfate Injection USP,NEOSTIGMINE METHYLSULFATE,2.5MG,10 x 5mL vial / fiole,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,N07AA,PARASYMPATHOMIMETICS,2018-12-21,,2019-01-10,2019-01-08,Disruption of the manufacture of the drug.,2018-12-12,2019-01-13
2728,587818,Shortage,NERISONE OILY CREAM,GLAXOSMITHKLINE INC,Diflucortolone valerate oily cream,Diflucortolone valerate,0.1%,30g,Topical,Actual shortage,Oily Cream,D07AC,"CORTICOSTEROIDS, PLAIN",,2016-09-01,,,Other (Please describe in comments),2017-03-14,2017-10-05
2731,587818,Shortage,NERISONE OILY CREAM,GLAXOSMITHKLINE INC,Diflucortolone valerate oily cream,Diflucortolone valerate,0.1%,60 g,Topical,Actual shortage,Oily Cream,D07AC,"CORTICOSTEROIDS, PLAIN",,2016-09-12,,,Other (Please describe in comments),2017-03-14,2017-10-05
52245,1926772,Shortage,NEULEPTIL 10MG CAPSULES,ERFA CANADA 2012 INC,NEULTPTIL,PERICIAZINE,10MG,bottle of 100,ORAL,Resolved,CAPSULE,N05AC,ANTIPSYCHOTICS,2018-06-12,,2018-06-29,2018-06-22,Other (Please describe in comments),2018-06-12,2018-06-23
52248,1926764,Shortage,NEULEPTIL 20MG CAPSULES,ERFA CANADA 2012 INC,Neuleptil,PERICIAZINE,20MG,bottle of 100,ORAL,Resolved,CAPSULE,N05AC,ANTIPSYCHOTICS,2018-06-12,2018-06-12,,2018-10-17,Other (Please describe in comments),2018-06-12,2018-12-11
35647,1926780,Shortage,NEULEPTIL 5MG CAPSULES,ERFA CANADA 2012 INC,PERICIAZINE,,,bottle of 100,,Resolved,,,,,2018-01-09,2018-06-29,2018-06-22,Other (Please describe in comments),2018-01-10,2018-06-23
25921,2239717,Shortage,NEURONTIN 600MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,600MG,100's,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-12-29,,2018-01-31,Disruption of the manufacture of the drug.,2017-10-13,2018-02-01
33933,2084260,Shortage,NEURONTIN CAP 100MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,100MG,100's,ORAL,Avoided shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2018-02-14,,,2018-02-06,Disruption of the manufacture of the drug.,2017-12-20,2018-02-07
34010,2084279,Shortage,NEURONTIN CAP 300MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,300MG,100's,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-01-02,,2018-01-29,Disruption of the manufacture of the drug.,2017-12-20,2018-01-30
27757,2084287,Shortage,NEURONTIN CAP 400MG,PFIZER CANADA INC,NEURONTIN,GABAPENTIN,400MG,100 capsules,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-12-19,,2018-02-07,Disruption of the manufacture of the drug.,2017-11-01,2018-02-08
79161,2308983,Shortage,NEVANAC,NOVARTIS PHARMACEUTICALS CANADA INC,NEVANAC SUSP 5ML,NEPAFENAC,0.1%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01BC,ANTIINFLAMMATORY AGENTS,2019-03-25,2019-03-25,2019-04-16,2019-04-17,Shortage of an active ingredient.,2019-03-21,2019-04-18
54449,2308983,Shortage,NEVANAC,NOVARTIS PHARMACEUTICALS CANADA INC,NEVANAC SUSP 5ML,NEPAFENAC,0.1%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01BC,ANTIINFLAMMATORY AGENTS,2018-07-05,2018-07-09,2018-07-11,2018-07-20,Delay in shipping of the drug.,2018-07-05,2018-07-21
44006,2308983,Shortage,NEVANAC,NOVARTIS PHARMACEUTICALS CANADA INC,NEVANAC SUSPENSION  5ML,NEPAFENAC,0.1%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01BC,ANTIINFLAMMATORY AGENTS,2018-03-29,2018-03-29,2018-04-10,2018-04-10,Delay in shipping of the drug.,2018-03-26,2018-04-13
47334,2308983,Shortage,NEVANAC,NOVARTIS PHARMACEUTICALS CANADA INC,NEVANAC SUSP 5ML,NEPAFENAC,0.1%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01BC,ANTIINFLAMMATORY AGENTS,,2018-04-27,2018-05-14,2018-05-24,Delay in shipping of the drug.,2018-04-27,2018-05-25
4036,2262347,Shortage,NIASPAN,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,500MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",2016-09-28,,,2017-03-31,Other (Please describe in comments),2017-03-23,2017-10-05
4039,2262339,Shortage,NIASPAN,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,1000MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",2016-09-28,,,2017-06-30,Other (Please describe in comments),2017-03-23,2017-10-05
71011,2309254,Shortage,NIASPAN FCT,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,500MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",,2019-03-29,,2019-07-22,Other (Please describe in comments),2019-01-03,2019-07-24
4050,2309262,Shortage,NIASPAN FCT,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,750MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",2016-09-28,,,2017-05-31,Other (Please describe in comments),2017-03-23,2017-10-05
19676,2309289,Shortage,NIASPAN FCT,SUNOVION PHARMACEUTICALS CANADA INC,Extended-release niacin,NICOTINIC ACID,1000MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C10AD,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-05,,2019-07-22,Other (Please describe in comments),2017-08-17,2019-07-29
12393,2125226,Shortage,NIDAGEL VAGINAL GEL 0.75%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,NIDAGEL VAGINAL GEL 0.75%,METRONIDAZOLE,0.75%,NA,VAGINAL,Resolved,GEL,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017-06-09,,2017-09-28,Other (Please describe in comments),2017-06-09,2017-09-29
11727,2125226,Shortage,NIDAGEL VAGINAL GEL 0.75%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,NIDAGEL VAGINAL GEL 0.75%,METRONIDAZOLE,0.75%,NA,VAGINAL,Resolved,GEL,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",2017-06-09,,,2017-09-28,Delay in shipping of the drug.,2017-06-02,2017-09-29
57632,725110,Shortage,NIFEDIPINE,AA PHARMA INC,Nifedipine,NIFEDIPINE,5MG,100BTL,ORAL,Resolved,CAPSULE,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-08-08,2018-12-10,2018-12-10,Disruption of the manufacture of the drug.,2018-08-08,2019-01-14
85657,755907,Shortage,NIFEDIPINE,AA PHARMA INC,Nifedipine,NIFEDIPINE,10MG,100 BTL,ORAL,Resolved,CAPSULE,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-06-05,2019-11-07,2019-11-08,Disruption of the manufacture of the drug.,2019-06-05,2019-11-09
88520,725110,Shortage,NIFEDIPINE,AA PHARMA INC,Nifedipine,NIFEDIPINE,5MG,100 BTL,ORAL,Resolved,CAPSULE,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-07-04,2019-09-30,2019-10-15,Disruption of the manufacture of the drug.,2019-07-04,2019-10-17
84244,2421658,Shortage,NIFEDIPINE ER,PRO DOC LIMITEE,NIFEDIPINE ER,NIFEDIPINE,60MG,30-100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-06-10,2019-08-13,2019-08-08,Demand increase for the drug.,2019-05-16,2019-08-09
82477,2421631,Shortage,NIFEDIPINE ER,PRO DOC LIMITEE,NIFEDIPINE ER,NIFEDIPINE,30MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-05-06,,2019-06-05,Delay in shipping of the drug.,2019-04-26,2019-06-06
16633,2421658,Shortage,NIFEDIPINE ER,PRO DOC LIMITEE,NIFEDIPINE ER 60 MG,NIFEDIPINE,60MG,30-100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-07-20,,2017-10-02,Delay in shipping of the drug.,2017-07-21,2018-10-05
21244,2421631,Shortage,NIFEDIPINE ER,PRO DOC LIMITEE,NIFEDIPINE,NIFEDIPINE,30MG,30-100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-07-11,,2018-10-05,Delay in shipping of the drug.,2017-09-07,2018-10-06
45157,2325926,Shortage,NIMOTOP,BAYER INC,Nimodipine tablets,NIMODIPINE,30MG,100's,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-04-06,2018-04-23,2018-04-25,Delay in shipping of the drug.,2018-04-06,2018-04-26
65428,2325926,Shortage,NIMOTOP,BAYER INC,Nimodipine tablets,NIMODIPINE,30MG,100's,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-12-15,,2019-01-31,2019-01-24,Disruption of the manufacture of the drug.,2018-10-23,2019-02-14
49559,2325926,Shortage,NIMOTOP,BAYER INC,Nimodipine tablets,NIMODIPINE,30MG,100's,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-10-13,,2018-10-16,2018-10-15,Disruption of the manufacture of the drug.,2018-05-16,2018-10-16
75755,2325926,Shortage,NIMOTOP,BAYER INC,Nimodipine tablets,NIMODIPINE,30MG,100's,ORAL,Avoided shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-03-28,,2019-04-19,2019-03-25,Disruption of the manufacture of the drug.,2019-02-14,2019-03-26
26475,779806,Shortage,NIODAN 500 MG TIME RELEASE TABLETS,ODAN LABORATORIES LTD,Niacin Time Release Tablets,NICOTINIC ACID,500MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C04AC,PERIPHERALVASODILATORS,,2018-06-29,,2018-07-03,Disruption of the manufacture of the drug.,2017-10-20,2018-07-04
60101,2361736,Shortage,NIPRIDE,PFIZER CANADA INC,NIPRIDE,SODIUM NITROPRUSSIDE,25MG,1 x 2mL,INTRAVENOUS,Resolved,SOLUTION,C02DD,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2018-09-06,,2018-09-19,Disruption of the manufacture of the drug.,2018-09-06,2018-09-20
66019,2361736,Shortage,NIPRIDE,PFIZER CANADA INC,NIPRIDE,SODIUM NITROPRUSSIDE,25MG,1 x 2mL,INTRAVENOUS,Resolved,SOLUTION,C02DD,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2018-11-01,2018-12-18,2018-12-18,Demand increase for the drug.,2018-11-01,2018-12-20
2013,312738,Shortage,NITROFURANTOIN,AA PHARMA INC,NITROFURANTOIN,NITROFURANTOIN,100MG,100 Bottle,ORAL,Resolved,TABLET,J01XE,OTHER ANTIBACTERIALS,,2015-09-23,2017-05-15,2017-05-12,Shortage of an active ingredient.,2017-03-13,2017-05-13
2016,319511,Shortage,NITROFURANTOIN,AA PHARMA INC,NITROFURANTOIN,NITROFURANTOIN,50MG,100 Bottle,ORAL,Resolved,TABLET,J01XE,OTHER ANTIBACTERIALS,,2015-09-23,2017-05-15,2017-05-12,Shortage of an active ingredient.,2017-03-13,2017-05-13
77245,2145308,Shortage,NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML,BAXTER CORPORATION,Nitroglycerin in 5% Dextrose Injection,DEXTROSE  NITROGLYCERIN,5G  20MG,250 mL,INTRAVENOUS,Resolved,SOLUTION,C01DA,VASODILATORS USED IN CARDIAC DISEASES,2019-03-01,2019-03-01,2019-03-18,2019-03-18,Demand increase for the drug.,2019-03-01,2019-03-19
82898,2145316,Shortage,NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML,BAXTER CORPORATION,NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML,DEXTROSE  NITROGLYCERIN,5G  40MG,250 mL,INTRAVENOUS,Resolved,SOLUTION,C01DA,VASODILATORS USED IN CARDIAC DISEASES,2019-05-01,2019-05-01,2019-05-21,2019-05-21,Disruption of the manufacture of the drug.,2019-05-01,2019-05-22
19793,1926454,Shortage,"NITROL (NITROGLYCERIN OINTMENT 2%, USP)",PALADIN LABS INC,Nitrol,NITROGLYCERIN,2%,60g,TOPICAL,Actual shortage,OINTMENT,C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2018-04-16,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-20
35649,2231441,Shortage,NITROLINGUAL PUMPSPRAY,SANOFI-AVENTIS CANADA INC,Nitroglycerin,NITROGLYCERIN,0.4MG,200 dose,SUBLINGUAL,Resolved,METERED-DOSE PUMP,C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2018-01-05,2018-02-28,2018-02-15,Demand increase for the drug.,2018-01-10,2018-02-19
94235,2048485,Shortage,NOLVADEX-D TAB 20MG,ASTRAZENECA CANADA INC,tamoxifen citrate,TAMOXIFEN,20MG,1 x 30,ORAL,Actual shortage,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,2019-09-26,2019-09-26,2019-12-06,,Demand increase for the drug.,2019-09-18,2019-11-15
35329,893285,Shortage,NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP,SANDOZ CANADA INCORPORATED,NOEPINEPHRINE,NOREPINEPHRINE,1MG,10 x 4ML VIALS,INTRAVENOUS,Resolved,LIQUID,C01CA,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,2018-01-12,2018-01-12,2018-01-19,2018-01-16,Demand increase for the drug.,2018-01-09,2018-01-18
53251,2156091,Shortage,NORITATE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,NORITATE,METRONIDAZOLE,1%,45g,TOPICAL,Resolved,CREAM,D06BX,CHEMOTHERAPEUTICS FOR TOPICAL USE,2018-08-16,,,2018-08-27,Other (Please describe in comments),2018-06-29,2018-08-28
64990,2156091,Shortage,NORITATE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,NORITATE,METRONIDAZOLE,1%,45g,TOPICAL,Avoided shortage,CREAM,D06BX,CHEMOTHERAPEUTICS FOR TOPICAL USE,2018-11-09,,,2018-11-08,Other (Please describe in comments),2018-10-19,2018-11-09
83899,39500,Shortage,NORMOSOL-R,ICU MEDICAL CANADA INC,NormosolTM-R pH approx. 7.4 (Multiple Electrolytes Injection Type 1 USP),SODIUM ACETATE  MAGNESIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE  SODIUM GLUCONATE,2.22MG  0.14MG  0.37MG  5.26MG  5.02MG,1000 ml,INTRAVENOUS,Avoided shortage,SOLUTION,B05BB,I.V. SOLUTIONS,2019-07-01,,2019-07-03,2019-06-20,Delay in shipping of the drug.,2019-05-13,2019-06-20
2906,2223740,Shortage,NORPROLAC,FERRING INC,NORPROLAC,QUINAGOLIDE HYDROCHLORIDE,25mcg,3,Oral,Resolved,Tablet,G02CB,OTHER GYNECOLOGICALS,,2016-07-01,,2018-08-20,Other (Please describe in comments),2017-03-15,2018-08-21
2909,2223759,Shortage,NORPROLAC,FERRING INC,NORPROLAC,QUINAGOLIDE,0.05MG,3,ORAL,Resolved,TABLET,G02CB,OTHER GYNECOLOGICALS,,2016-07-01,,2018-08-20,Other (Please describe in comments),2017-03-15,2018-08-21
77476,878936,Shortage,NORVASC TAB 10MG,PFIZER CANADA ULC,Norvasc 10mg,AMLODIPINE,10MG,250's,ORAL,Actual shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-05-24,,,Disruption of the manufacture of the drug.,2019-03-04,2019-05-28
52370,878928,Shortage,NORVASC TAB 5MG,PFIZER CANADA INC,NORVASC,AMLODIPINE,5MG,1x100's,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-06-12,,2018-08-13,Disruption of the manufacture of the drug.,2018-06-13,2018-08-14
41428,2049481,Shortage,NOVAHISTEX DH,SANOFI-AVENTIS CANADA INC,Novahistex DH 100ml,PHENYLEPHRINE HYDROCHLORIDE  HYDROCODONE BITARTRATE,20MG  5MG,100ml,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2018-03-21,,2018-05-16,2018-05-07,Demand increase for the drug.,2018-03-01,2018-05-08
95408,452130,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,AMOXICILLIN SUSP 250MG/5ML,AMOXICILLIN,250MG,100ml,ORAL,Actual shortage,GRANULES FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-10-02,2020-02-28,,Disruption of the manufacture of the drug.,2019-10-03,2019-11-07
95411,452130,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,AMOXICILLIN SUSP 250MG/5ML,AMOXICILLIN,250MG,150ml,ORAL,Actual shortage,GRANULES FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2019-10-02,2020-02-28,,Disruption of the manufacture of the drug.,2019-10-03,2019-11-07
5165,216666,Shortage,NOVASEN,TEVA CANADA LIMITED,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,325MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017-04-03,2017-05-17,2017-05-17,Disruption of the manufacture of the drug.,2017-04-03,2017-05-23
8068,2309556,Shortage,NOVO-CYPROTERONE/ETHINYL ESTRADIOL,TEVA CANADA LIMITED,CYPROTERONE/ETHINYL ESTRADIOL,ETHINYL ESTRADIOL  CYPROTERONE ACETATE,0.035MG  2MG,21,ORAL,Resolved,TABLET,G03HB,ANTIANDROGENS,,2017-04-21,2017-05-30,2017-08-01,Disruption of the manufacture of the drug.,2017-04-25,2017-09-19
87680,389218,Shortage,NOVO-GESIC,TEVA CANADA LIMITED,GESIC,ACETAMINOPHEN,325MG,100 UD,ORAL,Actual shortage,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2019-06-15,,,Shortage of an active ingredient.,2019-06-27,2019-09-19
159,738824,Shortage,NOVO-HYDROXYZIN,TEVA CANADA LIMITED,Hydroxyzine,HYDROXYZINE HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,CAPSULE,N05BB,ANXIOLYTICS,,2014-03-26,,,Disruption of the manufacture of the drug.,2017-03-10,2017-10-05
1013,738832,Shortage,NOVO-HYDROXYZIN,TEVA CANADA LIMITED,HYDROXYZINE HYDROCHLORIDE,HYDROXYZINE HYDROCHLORIDE,25MG,100,ORAL,Actual shortage,CAPSULE,N05BB,ANXIOLYTICS,,2014-03-26,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1017,738840,Shortage,NOVO-HYDROXYZIN,TEVA CANADA LIMITED,HYDROXYZINE HYDROCHLORIDE,HYDROXYZINE HYDROCHLORIDE,50MG,100,ORAL,Actual shortage,CAPSULE,N05BB,ANXIOLYTICS,,2014-12-12,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
2278,2364883,Shortage,NOVO-MYCOPHENOLATE,TEVA CANADA LIMITED,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,250MG,100,ORAL,Resolved,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2017-03-01,2017-04-03,2017-04-15,Delay in shipping of the drug.,2017-03-14,2017-04-25
42644,629340,Shortage,NOVO-PROFEN,TEVA CANADA LIMITED,PROFEN,IBUPROFEN,400MG,50,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-03-07,2018-03-30,2018-04-30,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
18692,1927698,Shortage,NOZINAN INJ 25MG/ML,SANOFI-AVENTIS CANADA INC,Nozinan solution injectable 25 mg/ml,METHOTRIMEPRAZINE,25MG,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05AA,ANTIPSYCHOTICS,2017-09-15,,2017-11-03,2017-11-09,Other (Please describe in comments),2017-08-10,2017-11-10
68999,1927698,Shortage,NOZINAN INJ 25MG/ML,SANOFI-AVENTIS CANADA INC,NOZINAN INJ 25MG/ML,METHOTRIMEPRAZINE,25MG,10 AMPOULES,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N05AA,ANTIPSYCHOTICS,2019-01-04,2019-01-04,2019-02-28,2019-02-20,Other (Please describe in comments),2018-12-10,2019-02-21
25117,2415577,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,50MG,60 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017-12-30,2018-02-01,2018-03-05,2018-02-27,Disruption of the manufacture of the drug.,2017-10-10,2018-05-17
25122,2415585,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,100MG,60 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017-12-30,,,2017-12-30,Disruption of the manufacture of the drug.,2017-10-10,2018-05-17
25129,2415593,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,150MG,60 Tabs,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017-12-30,,2017-12-06,2017-12-06,Disruption of the manufacture of the drug.,2017-10-10,2017-12-06
25134,2415607,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,200MG,60 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2018-02-27,,,2018-02-27,Disruption of the manufacture of the drug.,2017-10-10,2018-05-17
25141,2415615,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Nucynta,Tapentadol,250MG,60 Tabs,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2018-01-15,,2018-02-19,2017-12-06,Disruption of the manufacture of the drug.,2017-10-10,2017-12-06
98383,2415607,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD,Tapentadol,TAPENTADOL,200MG,60 Tabs,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2019-11-11,2019-11-11,2019-12-05,,Delay in shipping of the drug.,2019-11-11,2019-11-12
25102,2378272,Shortage,NUCYNTA IR,ENDO VENTURES LTD,Nucynta,Tapentadol,50MG,100 Tabs,ORAL,Avoided shortage,TABLET (IMMEDIATE RELEASE),N02AX,OPIOIDS,2017-12-30,,,2017-12-06,Disruption of the manufacture of the drug.,2017-10-10,2017-12-06
25108,2378280,Shortage,NUCYNTA IR,ENDO VENTURES LTD,Nucynta,Tapentadol,75MG,100 Tabs,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),N02AX,OPIOIDS,2017-11-21,,,2017-12-19,Disruption of the manufacture of the drug.,2017-10-10,2017-12-20
25111,2378299,Shortage,NUCYNTA IR,ENDO VENTURES LTD,Nucynta,Tapentadol,100MG,100 Tabs,ORAL,Avoided shortage,TABLET (IMMEDIATE RELEASE),N02AX,OPIOIDS,2017-12-30,,,2017-12-04,Disruption of the manufacture of the drug.,2017-10-10,2017-12-04
67436,2230810,Shortage,NUTRINEAL PD4,BAXTER CORPORATION,Nutrineal PD4 Twinbag,PHENYLALANINE  HISTIDINE  TRYPTOPHAN  LEUCINE  ARGININE  SODIUM LACTATE  THREONINE  ALANINE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE  DL-METHIONINE  GLYCINE  PROLINE  TYROSINE  LYSINE  SERINE  VALINE  ISOLEUCINE,57MG  71.4MG  27MG  102MG  107.1MG  448MG  64.6MG  95.1MG  5.1MG  18.4MG  538MG  85MG  51MG  59.5MG  30MG  95.5MG  51MG  139.3MG  85MG,2.5L,DIALYSIS,Resolved,LIQUID,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2018-12-01,2018-12-01,2019-02-26,2019-02-26,Disruption of the manufacture of the drug.,2018-11-22,2019-02-27
50095,2230810,Shortage,NUTRINEAL PD4,BAXTER CORPORATION,Nutrineal PD4 Twinbag,PHENYLALANINE  HISTIDINE  TRYPTOPHAN  LEUCINE  ARGININE  SODIUM LACTATE  THREONINE  ALANINE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  SODIUM CHLORIDE  DL-METHIONINE  GLYCINE  PROLINE  TYROSINE  LYSINE  SERINE  VALINE  ISOLEUCINE,57MG  71.4MG  27MG  102MG  107.1MG  448MG  64.6MG  95.1MG  5.1MG  18.4MG  538MG  85MG  51MG  59.5MG  30MG  95.5MG  51MG  139.3MG  85MG,2L Twinbag,DIALYSIS,Resolved,LIQUID,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2018-05-24,2018-05-24,2018-06-21,2018-06-21,Disruption of the manufacture of the drug.,2018-05-23,2018-06-22
22305,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL  ETONOGESTREL,2.6MG  11.4MG,3,VAGINAL,Resolved,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2017-09-25,2017-09-26,2017-10-11,2017-10-06,Delay in shipping of the drug.,2017-09-18,2017-10-07
67629,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL  ETONOGESTREL,2.6MG  11.4MG,1 ring / anneau,VAGINAL,Resolved,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2018-12-05,2018-12-04,2018-12-21,2018-12-19,Delay in shipping of the drug.,2018-11-26,2018-12-20
4417,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL  ETONOGESTREL,2.6MG  11.4MG,1,VAGINAL,Avoided shortage,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2017-03-30,,2017-03-31,2017-03-29,Delay in shipping of the drug.,2017-03-27,2017-10-11
50768,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL  ETONOGESTREL,2.6MG  11.4MG,3Rings,VAGINAL,Resolved,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2018-06-18,2018-06-15,2018-07-20,2018-07-13,Delay in shipping of the drug.,2018-05-30,2018-07-14
71276,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL  ETONOGESTREL,2.6MG  11.4MG,1 per pack,VAGINAL,Resolved,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2019-01-04,2019-01-03,2019-01-11,2019-01-04,Delay in shipping of the drug.,2019-01-04,2019-01-05
71325,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL  ETONOGESTREL,2.6MG  11.4MG,1 per pack / 1 par paquet,VAGINAL,Avoided shortage,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,2019-01-18,,2019-02-14,2019-01-15,Delay in shipping of the drug.,2019-01-04,2019-01-15
67509,2253186,Shortage,NUVARING,MERCK CANADA INC,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL  ETONOGESTREL,2.6MG  11.4MG,1 ring/anneau,VAGINAL,Resolved,RING (SLOW-RELEASE),G02BB,CONTRACEPTIVES FOR TOPICAL USE,,2018-11-20,2018-11-26,2018-11-26,Delay in shipping of the drug.,2018-11-23,2018-11-27
68413,2363623,Shortage,NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 303),NXSTAGE MEDICAL INC,Haemodialysis Solution,SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,176.5G  23.1G  2.13G  4.63G  1.57G  116.6G,2.5 L of concentrate (produces 50 L of dialysate),DIALYSIS,Resolved,SOLUTION,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2018-12-05,2019-04-30,,2019-05-15,Other (Please describe in comments),2018-12-03,2019-06-11
68419,2363658,Shortage,NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305),NXSTAGE MEDICAL INC,Haemodialysis Solution,SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,176.5G  23.1G  2.13G  4.63G  1.57G  116.6G,2 L of concentrate (produces 40 L of dialysate),DIALYSIS,Resolved,SOLUTION,B05ZA,HEMODIALYTICS AND HEMOFILTRATES,2018-12-05,2019-03-31,,2019-05-15,Other (Please describe in comments),2018-12-03,2019-06-11
76025,2443295,Shortage,NXSTAGE PUREFLOW SOLUTION RFP-209-CAN,NXSTAGE MEDICAL INC,Hemodialysis Solution,SODIUM LACTATE  DEXTROSE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,8.408G  1.1G  0.102G  0.221G  0.15G  5.552G,5 L,DIALYSIS,Resolved,SOLUTION,B05Z,HEMODIALYTICS AND HEMOFILTRATES,,2019-02-11,,2019-03-11,Demand increase for the drug.,2019-02-15,2019-03-12
72986,716871,Shortage,NYADERM CRM 100000UNIT/GM,TARO PHARMACEUTICALS INC,NYADERM CREAM,NYSTATIN,100000UNIT,30 G,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2019-01-17,2019-02-01,2019-02-04,Disruption of the manufacture of the drug.,2019-01-18,2019-02-05
5234,716871,Shortage,NYADERM CRM 100000UNIT/GM,TARO PHARMACEUTICALS INC,NYSTATIN,NYSTATIN,100000UNIT,454 GRAM,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2018-05-23,2018-07-06,2018-06-15,Disruption of the manufacture of the drug.,2017-04-03,2018-06-18
5242,716871,Shortage,NYADERM CRM 100000UNIT/GM,TARO PHARMACEUTICALS INC,NYSTATIN,NYSTATIN,100000UNIT,30 GRAM,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2017-03-29,2017-04-28,2017-04-24,Disruption of the manufacture of the drug.,2017-04-03,2017-04-25
92822,716871,Shortage,NYADERM CRM 100000UNIT/GM,TARO PHARMACEUTICALS INC,NYADERM CRM 100000UNIT/GM,NYSTATIN,100000UNIT,30 g,TOPICAL,Actual shortage,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2019-08-30,2019-12-13,,Disruption of the manufacture of the drug.,2019-09-03,2019-11-01
186,716901,Shortage,NYADERM VAG CRM 25000UNIT/GM,TARO PHARMACEUTICALS INC,NYSTATIN,NYSTATIN,25000UNIT,120 GRAM,VAGINAL,Resolved,CREAM,G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017-11-02,2018-01-15,2018-01-15,Disruption of the manufacture of the drug.,2017-03-10,2018-01-18
1341,622893,Shortage,ODAN BALANCED SALT SOLUTION,ODAN LABORATORIES LTD,Sterile Physiological Irrigating Solution,SODIUM CITRATE  SODIUM ACETATE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,1.7MG  3.9MG  0.3MG  0.48MG  0.75MG  6.4MG,250 mL; 500 mL,IRRIGATION,Actual shortage,SOLUTION,B05CB,IRRIGATING SOLUTIONS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1032,626562,Shortage,ODAN-AKWA TEARS,ODAN LABORATORIES LTD,Lubricant Ophthalmic Ointment,PETROLATUM  LANOLIN  MINERAL OIL,55%  2%  42.5%,3.5 g,OPHTHALMIC,Actual shortage,OINTMENT,S01XA,OTHER OPHTHALMOLOGICALS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1355,622907,Shortage,ODAN-ATROPINE,ODAN LABORATORIES LTD,Atropine Sulfate & Hydroxyethyl Cellulose Ophthalmic Solution,Atropine Sulfate  Hydroxyethyl Cellulose,1%  0.35%,5 mL,Ophthalmic,Actual shortage,Solution,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
36023,2463105,Shortage,ODAN-BENZYDAMINE,ODAN LABORATORIES LTD,"Benzydamine Mouthwash, BP",BENZYDAMINE HYDROCHLORIDE,1.5MG,250 mL,BUCCAL,Resolved,MOUTHWASH/GARGLE,A01AD,STOMATOLOGICAL PREPARATIONS,,2018-01-16,2018-01-22,2018-01-22,Demand increase for the drug.,2018-01-16,2018-01-23
1293,627720,Shortage,ODAN-CHLORAMPHENICOL,ODAN LABORATORIES LTD,"Chloramphenicol Ophthalmic Ointment, USP",CHLORAMPHENICOL,10MG,3.5 g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1327,622958,Shortage,ODAN-CHLORAMPHENICOL,ODAN LABORATORIES LTD,"Chloramphenicol Ophthalmic Solution, USP",CHLORAMPHENICOL,0.5MG,15 mL,OPHTHALMIC,Actual shortage,LIQUID,S01AA,ANTIINFECTIVES,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
965,630640,Shortage,ODAN-CIDE,ODAN LABORATORIES LTD,"Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Suspension, USP",PREDNISOLONE ACETATE  SULFACETAMIDE SODIUM,5MG  100MG,5 mL; 15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1254,626627,Shortage,ODAN-CYCLOPENTOLATE,ODAN LABORATORIES LTD,"Cyclopentolate Hydrochloride Ophthalmic Solution, USP",CYCLOPENTOLATE HYDROCHLORIDE,1%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1265,626635,Shortage,ODAN-CYCLOPENTOLATE,ODAN LABORATORIES LTD,"Cyclopentolate Hydrochloride Ophthalmic Solution, USP",CYCLOPENTOLATE HYDROCHLORIDE,0.5%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1224,627763,Shortage,ODAN-DEXAMETHASONE,ODAN LABORATORIES LTD,Dexamethasone Sodium Phosphate Ophthalmic/Otic Solution,DEXAMETHASONE SODIUM PHOSPHATE,0.1%,5 mL,OPHTHALMIC  OTIC,Actual shortage,SOLUTION,S03BA,CORTICOSTEROIDS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
51973,641324,Shortage,ODAN-ERYTHROMYCIN,ODAN LABORATORIES LTD,"Erythromycin Ophthalmic Ointment, USP",ERYTHROMYCIN,5MG,3.5 g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2018-06-08,,,Demand increase for the drug.,2018-06-08,2019-01-10
24007,641324,Shortage,ODAN-ERYTHROMYCIN,ODAN LABORATORIES LTD,"Erythromycin Ophthalmic Ointment, USP",ERYTHROMYCIN,5MG,3.5 g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2017-09-29,2017-09-29,2017-12-29,2017-12-20,Shortage of an active ingredient.,2017-09-29,2017-12-21
34046,641324,Shortage,ODAN-ERYTHROMYCIN,ODAN LABORATORIES LTD,"Erythromycin Ophthalmic Ointment, USP",ERYTHROMYCIN,5MG,50 x 1g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2017-09-29,,,Disruption of the manufacture of the drug.,2017-12-20,2018-06-08
1169,629707,Shortage,ODAN-FLUORACAINE,ODAN LABORATORIES LTD,"Fluorescein Sodium & Proparacaine Hydrochloride Ophthalmic Solution, USP",PROXYMETACAINE HYDROCHLORIDE  FLUORESCEIN SODIUM,0.5%  0.25%,5 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01JA,DIAGNOSTICAGENTS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1130,622877,Shortage,ODAN-FLUORESCEIN,ODAN LABORATORIES LTD,"Fluorescein Injection, USP",FLUORESCEIN SODIUM,250MG,2 mL,INTRAVENOUS,Actual shortage,LIQUID,V04,OTHER DIAGNOSTIC AGENTS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1151,622869,Shortage,ODAN-FLUORESCEIN,ODAN LABORATORIES LTD,"Fluorescein Injection, USP",FLUORESCEIN SODIUM,100MG,5 mL,INTRAVENOUS,Actual shortage,SOLUTION,V04,OTHER DIAGNOSTIC AGENTS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1113,687812,Shortage,ODAN-FLUORETS,ODAN LABORATORIES LTD,"Fluorescein Sodium Ophthalmic Strips, USP",FLUORESCEIN SODIUM,1MG,100 strips,OPHTHALMIC,Actual shortage,STRIP,S01JA,DIAGNOSTICAGENTS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1047,832162,Shortage,ODAN-GENTAMICIN,ODAN LABORATORIES LTD,"Gentamicin Sulfate Ophthalmic Solution, USP",Gentamicin Sulfate,0.3%,5 mL,Ophthalmic,Actual shortage,Solution,S01AA,ANTIINFECTIVES,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1050,1989073,Shortage,ODAN-GENTAMICIN,ODAN LABORATORIES LTD,"Gentamicin Sulfate Ophthalmic Ointment, USP",GENTAMICIN SULFATE,5MG,3.5 g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1022,626570,Shortage,ODAN-NAPHAZOLINE,ODAN LABORATORIES LTD,"Naphazoline Hydrochloride Ophthalmic Solution, USP",NAPHAZOLINE HYDROCHLORIDE,0.1%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01GA,DECONGESTANTS AND ANTIALLERGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
995,622915,Shortage,ODAN-PHENYLEPHRINE,ODAN LABORATORIES LTD,"Phenylephrine Hydrochloride Ophthalmic Solution, USP",PHENYLEPHRINE HYDROCHLORIDE,2.5%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FB,MYDRIATICSAND CYCLOPLEGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
976,627755,Shortage,ODAN-PILOCARPINE,ODAN LABORATORIES LTD,"Pilocarpine Hydrochloride Ophthalmic Solution, USP",PILOCARPINE HYDROCHLORIDE,4%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
985,627747,Shortage,ODAN-PILOCARPINE,ODAN LABORATORIES LTD,"Pilocarpine Hydrochloride Ophthalmic Solution, USP",PILOCARPINE HYDROCHLORIDE,2%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
991,627739,Shortage,ODAN-PILOCARPINE,ODAN LABORATORIES LTD,"Pilocarpine Hydrochloride Ophthalmic Solution, USP",Pilocarpine Hydrochloride,1%,15 mL,Ophthalmic,Actual shortage,Solution,S01EB,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
923,622974,Shortage,ODAN-PROPARACAINE,ODAN LABORATORIES LTD,"Proparacaine Hydrochloride Ophthalmic Solution, USP",PROXYMETACAINE HYDROCHLORIDE,0.5%,15 mL,OPHTHALMIC  TOPICAL,Actual shortage,SOLUTION,S01HA,LOCAL ANESTHETICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
917,832170,Shortage,ODAN-ROSE,ODAN LABORATORIES LTD,Rose Bengal Ophthalmic Solution,Rose Bengal,1%,5 mL,Ophthalmic,Actual shortage,Liquid,S01JA,DIAGNOSTICAGENTS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
93479,2473968,Shortage,ODAN-SODIUM POLYSTYRENE SULFONATE,ODAN LABORATORIES LTD,Sodium Polystyrene Sulfonate Oral/Rectal Suspension,SODIUM POLYSTYRENE SULFONATE,250MG,60 mL and 500 mL,ORAL  RECTAL,Actual shortage,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,,2019-09-01,2020-01-27,,Disruption of the manufacture of the drug.,2019-09-10,2019-10-22
1044,635065,Shortage,ODAN-SPOR,ODAN LABORATORIES LTD,"Neomycin and Polymycin B Sulfates & Gramicidin Ophthalmic Solution, USP",POLYMYXIN B SULFATE  GRAMICIDIN  NEOMYCIN,10000UNIT  .025MG  1.75MG,10 mL,OPHTHALMIC,Actual shortage,LIQUID,S01AA,ANTIINFECTIVES,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1041,626600,Shortage,ODAN-SPOR-HC,ODAN LABORATORIES LTD,"Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP",Hydrocortisone  Neomycin Sulfate  Polymyxin B Sulfate,"10 mg/mL  3.5 mg/mL  10,000 unit/mL",10 mL,Otic,Actual shortage,Suspension,S02CA,CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
896,622966,Shortage,ODAN-SULFACETAMIDE,ODAN LABORATORIES LTD,"Sulfacetamide Sodium Ophthalmic Solution, USP",SULFACETAMIDE SODIUM,10%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01AB,ANTIINFECTIVES,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
876,2010240,Shortage,ODAN-TIMOLOL,ODAN LABORATORIES LTD,"Timolol Maleate Ophthalmic Solution, USP",TIMOLOL MALEATE,0.5%,5 mL; 10 mL; 15 mL,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
890,2010259,Shortage,ODAN-TIMOLOL,ODAN LABORATORIES LTD,"Timolol Maleate Ophthalmic Solution, USP",TIMOLOL MALEATE,0.25%,5 mL; 10 mL; 15 mL,OPHTHALMIC,Actual shortage,LIQUID,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1239,626597,Shortage,ODAN-TROL,ODAN LABORATORIES LTD,"Neomycin and Polymycin B Sulfates & Dexamethasone Ophthalmic Suspension, USP",DEXAMETHASONE  POLYMYXIN B SULFATE  NEOMYCIN SULFATE,1MG  10000UNIT  3.5MG,5 mL,OPHTHALMIC,Actual shortage,SUSPENSION,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
857,622885,Shortage,ODAN-TROPICAMIDE,ODAN LABORATORIES LTD,"Tropicamide Ophthalmic Solution, USP",TROPICAMIDE,1%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
870,627704,Shortage,ODAN-TROPICAMIDE,ODAN LABORATORIES LTD,"Tropicamide Ophthalmic Solution, USP",TROPICAMIDE,0.5%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01FA,MYDRIATICSAND CYCLOPLEGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1004,626643,Shortage,ODAN-VERNACON,ODAN LABORATORIES LTD,Pheniramine Maleate and Phenylephrine Hydrochloride Ophthalmic Solution,PHENYLEPHRINE HYDROCHLORIDE  PHENIRAMINE MALEATE,0.125%  0.5%,15 mL,OPHTHALMIC,Actual shortage,SOLUTION,S01GA,DECONGESTANTS AND ANTIALLERGICS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
59473,2421704,Shortage,OLANZAPINE,PRO DOC LIMITEE,OLANZAPINE,OLANZAPINE,20MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-08-29,,2019-07-03,Delay in shipping of the drug.,2018-08-29,2019-07-04
46186,2311976,Shortage,OLANZAPINE,PRO DOC LIMITEE,OLANZAPINE,OLANZAPINE,5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-16,,2018-04-20,Delay in shipping of the drug.,2018-04-17,2018-04-21
49030,2311992,Shortage,OLANZAPINE,PRO DOC LIMITEE,OLANZAPINE,OLANZAPINE,10MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-05-10,,2018-06-11,Delay in shipping of the drug.,2018-05-10,2018-06-12
41935,2311968,Shortage,OLANZAPINE,PRO DOC LIMITEE,OLANZAPINE,OLANZAPINE,2.5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-03-05,,2018-04-17,Delay in shipping of the drug.,2018-03-06,2018-04-18
36548,2416522,Shortage,OLANZAPINE FOR INJECTION,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,10MG,10MG VIAL,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,N05AH,ANTIPSYCHOTICS,,2018-01-16,2018-01-31,2018-02-02,Delay in shipping of the drug.,2018-01-18,2018-02-05
11488,2416522,Shortage,OLANZAPINE FOR INJECTION,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,10MG,1 VIAL,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,N05AH,ANTIPSYCHOTICS,2017-06-12,,2017-08-18,2017-08-18,Delay in shipping of the drug.,2017-05-30,2017-10-18
30725,2352974,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT,OLANZAPINE,5MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-02-05,2018-02-05,2018-11-30,2018-12-10,Disruption of the manufacture of the drug.,2017-11-27,2018-12-11
2320,2425114,Shortage,OLANZAPINE ODT,PRO DOC LIMITEE,OLANZAPINE ODT,OLANZAPINE,20MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-08-29,,2018-11-02,Delay in shipping of the drug.,2017-03-14,2018-11-03
12095,2352990,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT TABS,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017-06-12,2017-07-07,,2018-07-10,Delay in shipping of the drug.,2017-06-06,2018-09-28
49791,2343665,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,5MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-06-11,2018-06-04,2018-06-29,2018-07-02,Other (Please describe in comments),2018-05-18,2018-07-31
48031,2338661,Shortage,OLANZAPINE ODT,PRO DOC LIMITEE,OLANZAPINE ODT,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-09-12,,2018-11-30,Delay in shipping of the drug.,2018-05-02,2018-12-01
36307,2343673,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,10MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-01-04,,2018-07-02,Other (Please describe in comments),2018-01-17,2018-07-31
28887,2343681,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017-12-25,2017-12-04,,2018-07-02,Other (Please describe in comments),2017-11-10,2018-07-31
28890,2343703,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,OLANZAPINE ODT,OLANZAPINE,20MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-02-16,2018-02-07,,2018-07-02,Other (Please describe in comments),2017-11-10,2018-07-31
21989,2352990,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT TABS,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017-06-12,2017-07-07,,2018-07-10,Disruption of the manufacture of the drug.,2017-09-13,2018-09-28
21992,2352982,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT TABS,OLANZAPINE,10MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017-09-13,2017-09-22,2018-10-31,2018-11-15,Disruption of the manufacture of the drug.,2017-09-13,2018-11-16
79597,2352974,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT,OLANZAPINE,5MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2019-03-27,,,Disruption of the manufacture of the drug.,2019-03-27,2019-03-28
79600,2352982,Shortage,OLANZAPINE ODT,SANIS HEALTH INC,OLANZAPINE ODT,OLANZAPINE,10MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2019-03-27,,,Disruption of the manufacture of the drug.,2019-03-27,2019-03-28
69216,890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30,ORAL,Resolved,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2018-12-11,2019-01-10,2019-01-16,Disruption of the manufacture of the drug.,2018-12-11,2019-01-17
90479,2210320,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30,ORAL,Actual shortage,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2019-08-05,2019-09-09,2019-11-20,,Disruption of the manufacture of the drug.,2019-07-31,2019-11-15
87986,890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30,ORAL,Resolved,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-11,2019-12-30,2019-10-16,Demand increase for the drug.,2019-06-28,2019-10-17
18869,890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30 X 4,ORAL,Resolved,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2017-08-01,2017-08-01,2017-12-27,2018-01-24,Disruption of the manufacture of the drug.,2017-08-11,2018-01-26
21691,890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30 X 4,ORAL,Resolved,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2017-09-26,2017-09-26,,2017-12-14,Disruption of the manufacture of the drug.,2017-09-08,2017-12-15
83699,890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30,ORAL,Resolved,POWDER FOR SUSPENSION,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2019-08-05,2019-09-09,2019-10-08,2019-10-16,Demand increase for the drug.,2019-05-09,2019-10-17
15024,2352516,Shortage,OLIMEL 4.4% E,BAXTER CORPORATION,OLIMEL 4.4% E,HISTIDINE  TRYPTOPHAN  SODIUM ACETATE TRIHYDRATE  ALANINE  SOYBEAN OIL  DEXTROSE  SODIUM GLYCEROPHOSPHATE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  OLIVE OIL  METHIONINE  GLYCINE  GLUTAMIC ACID  L-TYROSINE  L-PROLINE  L-ARGININE  L-VALINE  L-ASPARTIC ACID  L-THREONINE  L-PHENYLALANINE  L-LEUCINE  L-ISOLEUCINE  LYSINE  SERINE,2.64G  0.74G  1.50G  6.41G  8G  154G  3.67G  0.81G  0.52G  2.24G  32G  2.21G  3.07G  2.21G  0.11G  2.64G  4.34G  2.83G  1.28G  2.21G  3.07G  3.07G  2.21G  3.48G  1.75G,1000mL,INTRAVENOUS,Resolved,EMULSION,B05BA,I.V. SOLUTIONS,2017-07-07,2017-07-07,2017-08-15,2017-08-15,Demand increase for the drug.,2017-07-10,2017-08-16
94721,2318679,Shortage,OLMETEC,MERCK CANADA INC,Olmesartan Medoxomil tablets,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-11,2019-10-02,2020-01-17,,Demand increase for the drug.,2019-09-25,2019-11-11
77362,2318679,Shortage,OLMETEC,MERCK CANADA INC,Olmesartan Medoxomil tablets,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-03-18,2019-03-06,2019-05-10,2019-05-08,Demand increase for the drug.,2019-03-04,2019-05-09
78421,2318660,Shortage,OLMETEC,MERCK CANADA INC,Olmesartan Medoxomil tablets,OLMESARTAN MEDOXOMIL,20MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-04-01,2019-03-25,2019-04-26,2019-04-25,Demand increase for the drug.,2019-03-12,2019-04-26
83846,2318679,Shortage,OLMETEC,MERCK CANADA INC,Olmesartan Medoxomil tablets,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-06-04,2019-05-14,2019-09-27,2019-09-24,Demand increase for the drug.,2019-05-13,2019-09-25
83356,2318660,Shortage,OLMETEC,MERCK CANADA INC,Olmesartan Medoxomil tablets,OLMESARTAN MEDOXOMIL,20MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-16,2019-05-16,2019-09-27,2019-09-24,Demand increase for the drug.,2019-05-07,2019-09-25
94716,2318660,Shortage,OLMETEC,MERCK CANADA INC,Olmesartan Medoxomil tablets,OLMESARTAN MEDOXOMIL,20MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-10-14,2019-09-30,2020-01-17,,Demand increase for the drug.,2019-09-25,2019-11-11
22577,2319616,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,30 Tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-10-09,2017-10-03,2018-01-12,2018-01-11,Other (Please describe in comments),2017-09-19,2018-01-12
22580,2319624,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  40MG,30 Tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-10-09,2017-09-25,2018-03-09,2018-03-09,Other (Please describe in comments),2017-09-19,2018-03-10
22583,2319632,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,30 Tablets,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-10-09,2017-10-02,2018-01-12,2018-01-11,Other (Please describe in comments),2017-09-19,2018-01-12
78424,2319632,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-04-15,2019-03-25,2019-10-04,2019-10-01,Demand increase for the drug.,2019-03-12,2019-10-02
80241,2319624,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  40MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-05-10,2019-04-18,2019-11-01,2019-10-31,Demand increase for the drug.,2019-04-01,2019-11-01
35713,2319616,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,30 TAB,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-01-29,2018-01-24,2018-03-09,2018-03-09,Other (Please describe in comments),2018-01-11,2018-03-10
35716,2319632,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,30 TAB,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-01-29,2018-01-24,2018-03-09,2018-03-09,Other (Please describe in comments),2018-01-11,2018-03-10
95399,2319632,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,25MG  40MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-11-15,2019-11-13,2020-01-17,,Demand increase for the drug.,2019-10-03,2019-11-14
42938,2319624,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  40MG,30 TAB,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-03-16,2018-03-15,2018-05-04,2018-05-03,Other (Please describe in comments),2018-03-14,2018-05-04
97743,2319624,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  40MG,30TAB,ORAL,Anticipated shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-12-04,,2020-01-31,,Demand increase for the drug.,2019-11-01,2019-11-01
82678,2319616,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,30 Tab,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-05-20,2019-05-07,2019-08-02,2019-08-02,Demand increase for the drug.,2019-04-29,2019-08-03
90616,2319616,Shortage,OLMETEC PLUS,MERCK CANADA INC,Olmesartan medoxomil and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  OLMESARTAN MEDOXOMIL,12.5MG  20MG,30 Tab,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-08-12,2019-08-12,2020-01-31,,Demand increase for the drug.,2019-08-02,2019-11-11
57602,2344408,Shortage,OLUX-E,MAYNE PHARMA INC,Clobestal Proprionate,CLOBETASOL PROPIONATE,0.05%,10 g and 100 g,TOPICAL,Actual shortage,"AEROSOL, FOAM",D07AD,"CORTICOSTEROIDS, PLAIN",2018-09-30,2018-08-03,2019-02-28,,Other (Please describe in comments),2018-08-07,2018-08-07
21295,2438968,Shortage,OMEP,SANDOZ CANADA INCORPORATED,OMEP,OMEPRAZOLE,20MG,2X7BL,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-01,2017-10-23,2017-10-12,Demand increase for the drug.,2017-09-07,2017-10-25
2668,2438968,Shortage,OMEP,SANDOZ CANADA INCORPORATED,OMEP,OMEPRAZOLE,20MG,2x7/Bl,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-14,2017-05-22,2017-05-15,Disruption of the manufacture of the drug.,2017-03-14,2017-05-17
39575,2438968,Shortage,OMEP,SANDOZ CANADA INCORPORATED,OMEP,OMEPRAZOLE,20MG,BLISTERS 14S,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-01-10,2018-03-23,2018-03-23,Demand increase for the drug.,2018-02-13,2018-03-24
35457,2303671,Shortage,OMNARIS,ASTRAZENECA CANADA INC,ciclesonide,CICLESONIDE,50MCG,120 sprays,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018-02-12,2018-02-13,2018-12-10,2018-12-07,Demand increase for the drug.,2018-01-09,2018-12-11
87081,2172739,Shortage,OMNIPAQUE 240,GE HEALTHCARE CANADA INC,IOHEXOL INJECTION USP,IOHEXOL,518MG,100 mL,SUBARACHNOIDAL  INTRAVASCULAR,Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",,2019-06-18,2019-06-20,2019-06-21,Delay in shipping of the drug.,2019-06-19,2019-06-22
85726,2172739,Shortage,OMNIPAQUE 240,GE HEALTHCARE CANADA INC,IOHEXOL INJECTION USP,IOHEXOL,518MG,50 mL,SUBARACHNOIDAL  INTRAVASCULAR,Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2019-06-06,2019-06-06,2019-06-11,2019-06-13,Delay in shipping of the drug.,2019-06-06,2019-06-14
93472,2172771,Shortage,OMNISCAN,GE HEALTHCARE CANADA INC,gadodiamide injection USP,GADODIAMIDE,287MG,20 mL,INTRAVENOUS,Resolved,SOLUTION,V08CA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,2019-09-10,2019-09-10,2019-09-16,2019-09-16,Delay in shipping of the drug.,2019-09-10,2019-09-17
96322,2172771,Shortage,OMNISCAN,GE HEALTHCARE CANADA INC,Gadodiamide injection USP,GADODIAMIDE,287MG,20 mL,INTRAVENOUS,Resolved,SOLUTION,V08CA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,2019-10-11,2019-10-11,2019-11-08,2019-11-05,Delay in shipping of the drug.,2019-10-11,2019-11-06
94587,2172771,Shortage,OMNISCAN,GE HEALTHCARE CANADA INC,Gadodiamide injection USP,GADODIAMIDE,287MG,5 mL,INTRAVENOUS,Resolved,SOLUTION,V08CA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,2019-09-24,2019-09-24,2019-11-01,2019-10-31,Delay in shipping of the drug.,2019-09-24,2019-11-01
63600,2153513,Shortage,ONCOTICE,MERCK CANADA INC,"Bacillus Calmette- Guérin (BCG), strain TICE powder for solution",BACILLUS CALMETTE-GUERIN,800000000UNIT,1 vial,INTRAVESICAL,Actual shortage,POWDER FOR SOLUTION,L03AX,IMMUNOSTIMULANTS,2018-10-19,2018-10-19,2020-12-31,,Other (Please describe in comments),2018-10-09,2019-08-07
11803,2421402,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON,ONDANSETRON,4MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-06-05,2017-10-20,2017-10-04,Disruption of the manufacture of the drug.,2017-06-05,2017-10-10
11806,2421410,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,8MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-06-05,2017-10-20,2017-10-04,Disruption of the manufacture of the drug.,2017-06-05,2017-10-10
82753,2291967,Shortage,ONDANSETRON,AA PHARMA INC,Ondansetron,ONDANSETRON,4MG,50ML,ORAL,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-04-29,2019-05-27,2019-05-27,Disruption of the manufacture of the drug.,2019-04-29,2019-08-22
69959,2291967,Shortage,ONDANSETRON,AA PHARMA INC,ONDANSETRON,ONDANSETRON,4MG,50ML,ORAL,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-12-18,2019-03-15,2019-03-12,Disruption of the manufacture of the drug.,2018-12-19,2019-03-21
3230,2421402,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,4MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-03-31,2017-03-31,2017-07-30,2017-10-04,Other (Please describe in comments),2017-03-17,2017-10-10
3239,2421410,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,8MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-03-31,2017-03-31,2017-07-30,2017-10-04,Other (Please describe in comments),2017-03-17,2017-10-10
7880,2291967,Shortage,ONDANSETRON,AA PHARMA INC,ONDANSETRON,ONDANSETRON,4MG,50 ML,ORAL,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-01,2018-03-19,2018-03-13,Demand increase for the drug.,2017-04-25,2018-03-14
21979,2421402,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TAB,ONDANSETRON,4MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-13,2017-10-20,2017-10-04,Disruption of the manufacture of the drug.,2017-09-13,2017-10-05
21982,2421410,Shortage,ONDANSETRON,SANIS HEALTH INC,ONDANSETRON TABS,ONDANSETRON,8MG,30,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-13,2017-10-20,2017-10-04,Disruption of the manufacture of the drug.,2017-09-13,2017-10-05
2019,2291967,Shortage,ONDANSETRON,AA PHARMA INC,ONDANSETRON,ONDANSETRON,4MG,50 ML,ORAL,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-02-28,2017-03-24,2017-03-29,Other (Please describe in comments),2017-03-13,2017-03-31
18328,2274418,Shortage,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,2MG,5 X 2ML AMPS,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-08-07,,2017-09-15,2017-08-22,Delay in shipping of the drug.,2017-08-07,2017-10-19
77732,2274418,Shortage,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,2MG,5X2ml AM,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-02-11,2019-03-25,2019-03-21,Delay in shipping of the drug.,2019-03-05,2019-04-17
1746,2265532,Shortage,ONDANSETRON INJECTION,TEVA CANADA LIMITED,ONDANSETRON,ONDANSETRON,2MG,20ML,INTRAVENOUS,Actual shortage,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1754,2265524,Shortage,ONDANSETRON INJECTION,TEVA CANADA LIMITED,ONDANSETRON,ONDANSETRON,2MG,2ML,INTRAVENOUS,Actual shortage,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
16268,2279436,Shortage,ONDANSETRON INJECTION USP     -(WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,2MG,20ML VIAL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-07-21,,2017-07-31,2017-08-04,Demand increase for the drug.,2017-07-18,2017-10-19
18325,2279436,Shortage,ONDANSETRON INJECTION USP     -(WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,2MG,20ML VIAL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-07-25,2017-08-18,2017-08-18,Delay in shipping of the drug.,2017-08-07,2017-10-19
4133,2390051,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"ONDANSETRON INJECTION, USP",ONDANSETRON,2MG,20ML 1VL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-17,2018-10-30,2018-10-19,Disruption of the manufacture of the drug.,2017-03-24,2018-10-20
13614,2390019,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"ONDANSETRON INJECTION, USP",ONDANSETRON,2MG,2ML 5VL,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-09-17,2018-10-30,2018-10-19,Disruption of the manufacture of the drug.,2017-06-22,2018-10-20
13535,2390019,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"ONDANSETRON INJECTION, USP",ONDANSETRON,2MG,"4ML 5VL, 2ML 5VL",INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-09-17,2018-10-30,2018-10-19,Disruption of the manufacture of the drug.,2017-06-21,2018-10-20
4083,2390019,Shortage,"ONDANSETRON INJECTION, USP",MYLAN PHARMACEUTICALS ULC,Ondansetron,ONDANSETRON,2MG,2ML 5VL,INTRAVENOUS,Avoided shortage,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-05-10,,,2017-05-01,Delay in shipping of the drug.,2017-03-23,2017-05-03
96485,2481723,Shortage,ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON ODT,ONDANSETRON,4MG,10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-09-30,2019-11-25,,Delay in shipping of the drug.,2019-10-15,2019-10-29
96488,2481731,Shortage,ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON ODT,ONDANSETRON,8MG,10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2019-09-30,2019-12-16,,Delay in shipping of the drug.,2019-10-15,2019-10-29
87159,2389991,Shortage,ONDISSOLVE ODF,TAKEDA CANADA INC,Ondansetron,ONDANSETRON,8MG,Carton of 10 orally disintegrating films,ORAL,Resolved,"FILM, SOLUBLE",A04AA,ANTIEMETICS AND ANTINAUSEANTS,2019-06-20,2019-06-20,2019-07-30,2019-08-06,Demand increase for the drug.,2019-06-20,2019-08-07
5605,2389983,Shortage,ONDISSOLVE ODF,TAKEDA CANADA INC,ondansetron,ONDANSETRON,4MG,Carton of 10 orally disintegrating films,ORAL,Resolved,"FILM, SOLUBLE",A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-04-17,,2017-04-28,2017-05-10,Demand increase for the drug.,2017-04-05,2017-05-11
60235,2242502,Shortage,ONE-ALPHA,LEO PHARMA INC,alfacalcidol,ALFACALCIDOL,2MCG,0.5 mL and 1 mL,INTRAVENOUS,Resolved,LIQUID,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",2018-09-10,2018-09-10,2019-04-15,2019-04-18,Disruption of the manufacture of the drug.,2018-09-07,2019-04-22
72828,2326663,Shortage,ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP,LABORATOIRES STERIGEN INC,Onguent Ophtalmique d'Érythromycine USP,ERYTHROMYCIN,5MG,3.5g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2018-12-31,2019-12-20,,Shortage of an active ingredient.,2019-01-17,2019-11-05
26749,2326663,Shortage,ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP,LABORATOIRES STERIGEN INC,Erythromycin ophthalmic ointment USP,ERYTHROMYCIN,5MG,3.5g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2018-02-08,2018-09-21,2018-09-20,Other (Please describe in comments),2017-10-23,2018-09-21
9975,2326663,Shortage,ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP,LABORATOIRES STERIGEN INC,Erythromycin Ophthalmic Ointment USP,ERYTHROMYCIN,5MG,1 g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,,2017-03-09,2020-03-31,,Disruption of the manufacture of the drug.,2017-05-10,2019-09-18
9978,2326663,Shortage,ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP,LABORATOIRES STERIGEN INC,Erythromycin Ophthalmic Ointment USP,ERYTHROMYCIN,5MG,3.5 g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2017-04-20,2017-08-31,2017-08-24,Demand increase for the drug.,2017-05-10,2017-09-06
37169,2467135,Shortage,ONIVYDE,BAXALTA CANADA CORPORATION,Irinotecan Liposome for Injection,IRINOTECAN HYDROCHLORIDE,43MG,Vials of 43g/10ML,INTRAVENOUS,Resolved,SUSPENSION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2018-01-23,2018-01-23,2018-02-09,2018-02-12,Demand increase for the drug.,2018-01-24,2018-02-15
28908,2467135,Shortage,ONIVYDE,BAXALTA CANADA CORPORATION,Irinotecan Liposome for Injection,IRINOTECAN HYDROCHLORIDE,43MG,Vials of 43g/10ML,INTRAVENOUS,Resolved,SUSPENSION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-11-07,2017-11-08,2017-12-11,2017-12-06,Demand increase for the drug.,2017-11-10,2017-12-07
97485,2035626,Shortage,OPTIRAY 320 (ULTRAJECT),LIEBEL-FLARSHEIM CANADA INC,Ioversol Injection 68%,IOVERSOL,68%,125 ml,INTRAVASCULAR,Actual shortage,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",,2019-10-30,2020-01-30,,Disruption of the manufacture of the drug.,2019-10-30,2019-10-31
97489,2035626,Shortage,OPTIRAY 320 (ULTRAJECT),LIEBEL-FLARSHEIM CANADA INC,Ioversol Injection 68%,IOVERSOL,68%,100 mL,INTRAVASCULAR,Actual shortage,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",,2019-10-30,2020-01-30,,Disruption of the manufacture of the drug.,2019-10-30,2019-10-31
89276,1964054,Shortage,ORACORT DENTAL PASTE 0.1%,TARO PHARMACEUTICALS INC,ORACORT DENTAL PASTE 0.1%,TRIAMCINOLONE ACETONIDE,0.1%,7.5 g,DENTAL,Resolved,PASTE,A01AC,STOMATOLOGICAL PREPARATIONS,,2019-07-12,2019-07-26,2019-07-23,Disruption of the manufacture of the drug.,2019-07-15,2019-08-06
2024,313815,Shortage,ORAP,AA PHARMA INC,ORAP,PIMOZIDE,2 MG,100 Bottle,Oral,Actual shortage,Tablet,N05AG,ANTIPSYCHOTICS,,2015-04-15,,,Other (Please describe in comments),2017-03-14,2017-10-05
2027,313823,Shortage,ORAP,AA PHARMA INC,ORAP,PIMOZIDE,4MG,100 Bottle,ORAL,Actual shortage,TABLET,N05AG,ANTIPSYCHOTICS,,2015-04-15,,,Other (Please describe in comments),2017-03-14,2017-10-05
72030,2236783,Shortage,ORCIPRENALINE,AA PHARMA INC,ORCIPRENALINE,ORCIPRENALINE SULFATE,2MG,250ml,ORAL,Resolved,SYRUP,R03CB,ADRENERGICS FOR SYSTEMIC USE,,2019-01-08,2019-02-11,2019-02-14,Disruption of the manufacture of the drug.,2019-01-11,2019-02-23
77931,2236783,Shortage,ORCIPRENALINE,AA PHARMA INC,ORCIPRENALINE,ORCIPRENALINE SULFATE,2MG,250ml,ORAL,Resolved,SYRUP,R03CB,ADRENERGICS FOR SYSTEMIC USE,,2019-03-06,2019-04-05,2019-04-01,Disruption of the manufacture of the drug.,2019-03-06,2019-08-22
12499,2236783,Shortage,ORCIPRENALINE,AA PHARMA INC,ORCIPRENALINE,ORCIPRENALINE SULFATE,2MG,250 ML,ORAL,Resolved,SYRUP,R03CB,ADRENERGICS FOR SYSTEMIC USE,,2018-03-26,,2018-04-04,Disruption of the manufacture of the drug.,2017-06-12,2019-01-11
17164,2245641,Shortage,ORGALUTRAN,MERCK CANADA INC,Ganirelix Acetate Injection,GANIRELIX,250MCG,0.5ML SYRINGE,SUBCUTANEOUS,Resolved,SOLUTION,H01CC,HYPOTHALAMIC HORMONES,,2017-08-09,2017-09-29,2017-09-28,Delay in shipping of the drug.,2017-07-25,2017-09-29
25320,2245641,Shortage,ORGALUTRAN,MERCK CANADA INC,Ganirelix Acetate Injection,GANIRELIX,250MCG,0.5ML,SUBCUTANEOUS,Avoided shortage,SOLUTION,H01CC,HYPOTHALAMIC HORMONES,2017-11-08,,2017-11-10,2017-11-07,Delay in shipping of the drug.,2017-10-11,2017-11-07
55938,2301911,Shortage,OSTO-D2,PALADIN LABS INC,OSTO-D2,VITAMIN D2,50000UNIT,100 capsules,ORAL,Actual shortage,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",2018-07-04,2018-07-04,,,Disruption of the manufacture of the drug.,2018-07-16,2018-07-16
91923,2387085,Shortage,OVIMA 21,APOTEX INC,OVIMA,ETHINYL ESTRADIOL  LEVONORGESTREL,30MCG  150MCG,21 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-08-12,2019-09-30,2019-09-04,Disruption of the manufacture of the drug.,2019-08-19,2019-09-05
85622,2387093,Shortage,OVIMA 28,APOTEX INC,OVIMA,ETHINYL ESTRADIOL  LEVONORGESTREL,30MCG  150MCG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-06-03,2019-09-27,2019-09-20,Disruption of the manufacture of the drug.,2019-06-05,2019-09-23
44969,2387093,Shortage,OVIMA 28,APOTEX INC,LEVONORGESTREL+ETHINYL ESTRADIOL,ETHINYL ESTRADIOL  LEVONORGESTREL,30MCG  150MCG,28 BLS,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-04-02,2018-06-15,2018-05-02,Disruption of the manufacture of the drug.,2018-04-04,2018-05-03
19750,2444763,Shortage,OXALIPLATIN,PFIZER CANADA INC,Oxaliplatin,OXALIPLATIN,5MG,1x20mL,INTRAVENOUS,Avoided shortage,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-09-30,,2017-10-31,2017-09-20,Demand increase for the drug.,2017-08-17,2017-09-29
19647,2444763,Shortage,OXALIPLATIN,PFIZER CANADA INC,Oxaliplatin,OXALIPLATIN,5MG,1x40mL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-08-18,,2017-09-30,2017-09-20,Demand increase for the drug.,2017-08-16,2017-09-29
4033,2444763,Shortage,OXALIPLATIN,HOSPIRA HEALTHCARE CORPORATION,OXALIPLATIN,OXALIPLATIN,5MG,10ML VIAL / FLACON,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,2017-04-13,,2017-06-20,2017-06-20,Disruption of the manufacture of the drug.,2017-03-23,2017-06-21
85491,2444763,Shortage,OXALIPLATIN,PFIZER CANADA ULC,Oxaliplatin,OXALIPLATIN,5MG,40mL vial,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-05-29,,2019-06-28,Demand increase for the drug.,2019-06-04,2019-07-02
2606,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,OXALIPLATIN,OXALIPLATIN,5MG,40mL fiole/vial,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-01-20,2017-04-17,2017-04-11,Delay in shipping of the drug.,2017-03-14,2017-04-12
15454,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,OXALIPLATIN,OXALIPLATIN,5MG,10ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-07-11,2017-07-31,2017-07-28,Delay in shipping of the drug.,2017-07-11,2017-08-02
10599,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,Oxaliplatin Injection,OXALIPLATIN,5MG,20mLV,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-05-17,2017-07-28,2017-07-28,Other (Please describe in comments),2017-05-17,2017-08-02
10602,2436957,Shortage,OXALIPLATIN INJECTION,SANDOZ CANADA INCORPORATED,Oxaliplatin Injection,OXALIPLATIN,5MG,40mLV,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-05-17,2017-07-28,2017-09-01,Other (Please describe in comments),2017-05-17,2017-10-25
94840,2435071,Shortage,OXALIPLATIN INJECTION,TEVA CANADA LIMITED,OXALIPLATIN INJECTION,OXALIPLATIN,5MG,40ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-09-26,2019-11-30,2019-11-13,Disruption of the manufacture of the drug.,2019-09-26,2019-11-14
86905,2435071,Shortage,OXALIPLATIN INJECTION,TEVA CANADA LIMITED,OXALIPLATIN,OXALIPLATIN,5MG,10ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
86908,2435071,Shortage,OXALIPLATIN INJECTION,TEVA CANADA LIMITED,OXALIPLATIN,OXALIPLATIN,5MG,20ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-06-18,2019-07-30,2019-07-15,Disruption of the manufacture of the drug.,2019-06-18,2019-07-16
87684,2435071,Shortage,OXALIPLATIN INJECTION,TEVA CANADA LIMITED,OXALIPLATIN,OXALIPLATIN,5MG,40ML,INTRAVENOUS,Resolved,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-06-27,2019-10-30,2019-08-20,Disruption of the manufacture of the drug.,2019-06-27,2019-08-21
93650,2435071,Shortage,OXALIPLATIN INJECTION,TEVA CANADA LIMITED,TEVA OXALIPLATIN INJECTION,OXALIPLATIN,5MG,20ml,INTRAVENOUS,Actual shortage,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2019-09-11,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-12,2019-10-31
51373,497754,Shortage,OXAZEPAM 10 TAB 10MG,PRO DOC LIMITEE,OXAZEPAM 10,OXAZEPAM,10MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-06-05,2018-07-06,2018-07-06,Delay in shipping of the drug.,2018-06-05,2018-07-09
27761,414247,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 10 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-01,2017-11-01
27764,414247,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 10 mg,,,1000,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-01,2017-11-01
27869,414255,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 15 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27872,414255,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 15 mg,,,1000,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27875,414263,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 30 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27878,414263,Shortage,OXPAM,BIOMED PHARMA,Oxazepam Tablets 30 mg,,,1000,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
33667,2350238,Shortage,OXYBUTYNIN,SANIS HEALTH INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-12-18,2019-02-05,2019-02-05,Other (Please describe in comments),2017-12-18,2019-02-06
30915,2350238,Shortage,OXYBUTYNIN,SANIS HEALTH INC,OXYBUTYNIN TABS,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-28,,2019-02-05,Other (Please describe in comments),2017-11-28,2019-02-06
3981,2220636,Shortage,OXYBUTYNINE-5  -  TAB 5MG,PRO DOC LIMITEE,OXYBUTYNINE,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-06-27,,2018-05-30,Other (Please describe in comments),2017-03-22,2018-05-31
35140,2325969,Shortage,OXYCODONE,PRO DOC LIMITEE,OXYCODONE,OXYCODONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2018-01-08,,2018-02-01,Delay in shipping of the drug.,2018-01-08,2018-02-05
42756,2361361,Shortage,OXYCODONE/ACET,SANIS HEALTH INC,OXYCODONE/ACET TAB,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,100,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,2018-03-16,2018-03-13,2018-05-11,2018-05-02,Other (Please describe in comments),2018-03-13,2018-05-03
93921,2139561,Shortage,OXYTOCIN INJECTION,FRESENIUS KABI CANADA LTD,Oxytocin Injection,OXYTOCIN,10UNIT,1mL,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2019-09-30,2019-11-08,,Demand increase for the drug.,2019-09-13,2019-10-28
95462,2139561,Shortage,OXYTOCIN INJECTION,FRESENIUS KABI CANADA LTD,Oxytocin Injection,OXYTOCIN,10UNIT,10mL,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2019-10-04,,,Demand increase for the drug.,2019-10-04,2019-10-05
21169,497398,Shortage,OXYTOCIN INJECTION 10UNIT/ML,HOSPIRA HEALTHCARE CORPORATION,Oxytocin,OXYTOCIN,10UNIT,25x5mL AMP,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2017-11-02,,2018-02-16,Disruption of the manufacture of the drug.,2017-09-06,2018-02-17
21174,497398,Shortage,OXYTOCIN INJECTION 10UNIT/ML,HOSPIRA HEALTHCARE CORPORATION,OXYTOCIN,OXYTOCIN,10UNIT,50x1mL AMP,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2017-12-07,,2018-02-16,Disruption of the manufacture of the drug.,2017-09-06,2018-02-17
88431,497398,Shortage,OXYTOCIN INJECTION USP,PFIZER CANADA ULC,OXYTOCIN,OXYTOCIN,10UNIT,25x5ml Amp,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,2019-07-09,,,2019-08-23,Delay in shipping of the drug.,2019-07-03,2019-08-26
95607,497398,Shortage,OXYTOCIN INJECTION USP,PFIZER CANADA ULC,Oxytocin Injection USP,OXYTOCIN,10UNIT,25 x 5ml AMP,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2019-11-01,2019-11-29,,Disruption of the manufacture of the drug.,2019-10-07,2019-11-02
88234,497398,Shortage,OXYTOCIN INJECTION USP,PFIZER CANADA ULC,OXYTOCIN,OXYTOCIN,10UNIT,50x1ml Amp,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,H01BB,POSTERIOR PITUITARY LOBE HORMONES,,2019-07-02,,2019-11-13,Delay in shipping of the drug.,2019-07-02,2019-11-14
62335,2254735,Shortage,OXYTROL,ALLERGAN INC,Oxytrol,OXYBUTYNIN,36MG,8 patches,TRANSDERMAL,Resolved,PATCH,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-09-10,2018-09-10,2018-10-26,2018-11-02,Other (Please describe in comments),2018-09-25,2018-11-03
76570,2363445,Shortage,OZURDEX,ALLERGAN INC,dexamethasone intravitreal implant,DEXAMETHASONE,0.7MG,0.7MG,INTRAVITREAL,Resolved,IMPLANT,S01BA,ANTIINFLAMMATORY AGENTS,2019-02-25,2019-03-04,2019-03-25,2019-03-20,Disruption of the manufacture of the drug.,2019-02-21,2019-03-21
80819,2363445,Shortage,OZURDEX,ALLERGAN INC,dexamethasone intravitreal implant,DEXAMETHASONE,0.7MG,1 implant,INTRAVITREAL,Resolved,IMPLANT,S01BA,ANTIINFLAMMATORY AGENTS,2019-04-15,,2019-04-30,2019-04-26,Disruption of the manufacture of the drug.,2019-04-08,2019-04-27
8223,2320010,Shortage,PACLITAXEL FOR INJECTION USP,STERIMAX INC,PACLITAXEL FOR INJECTION USP,PACLITAXEL,6MG,1 VIAL,INTRAVENOUS,Actual shortage,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2014-09-29,,,Other (Please describe in comments),2017-04-27,2017-10-05
62526,2391465,Shortage,PACLITAXEL INJECTION USP,ACCORD HEALTHCARE INC,PACLITAXEL,PACLITAXEL,6MG,"6 MG/ML, 5 ML/VIAL  | 6 MG/ML, 5 ML/FLACON",INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2018-09-01,2018-09-01,2018-10-27,2018-10-27,Disruption of the manufacture of the drug.,2018-09-28,2018-10-29
15457,2320150,Shortage,PACLITAXEL INJECTION USP,SANDOZ CANADA INCORPORATED,PACLITAXEL,PACLITAXEL,6MG,50ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017-07-19,,2017-07-31,2017-07-28,Demand increase for the drug.,2017-07-11,2017-08-02
15460,2320150,Shortage,PACLITAXEL INJECTION USP,SANDOZ CANADA INCORPORATED,PACLITAXEL,PACLITAXEL,6MG,5 X 5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017-07-11,,2017-08-18,2017-08-18,Requirements related to complying with good manufacturing practices.,2017-07-11,2017-10-25
18335,2320150,Shortage,PACLITAXEL INJECTION USP,SANDOZ CANADA INCORPORATED,PACLITAXEL,PACLITAXEL,6MG,16.7 ML VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CD,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-07-21,2017-08-18,2017-08-18,Delay in shipping of the drug.,2017-08-07,2017-10-25
4361,2239170,Shortage,PAL-TIZANIDINE,PALADIN LABS INC,ZANAFLEX,TIZANIDINE,4MG,150 TABS,ORAL,Actual shortage,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2012-10-03,,,Other (Please describe in comments),2017-03-27,2017-10-05
83361,2244552,Shortage,PAMIDRONATE DISODIUM FOR INJECTION,PFIZER CANADA ULC,PAMIDRONATE,PAMIDRONATE DISODIUM,9MG,10ML Vial,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-05-10,,2019-08-26,Disruption of the manufacture of the drug.,2019-05-07,2019-08-27
2163,2249669,Shortage,PAMIDRONATE DISODIUM OMEGA 3 MG/ML,OMEGA LABORATORIES LTD,Pamidrontae Disodium for Injection 30mg/10mL,PAMIDRONATE DISODIUM,3.0MG,10mL vial,INTRAVENOUS,Actual shortage,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2013-01-01,,,Disruption of the manufacture of the drug.,2017-03-14,2017-10-05
2460,1926306,Shortage,PANECTYL TAB 2.5MG,ERFA CANADA 2012 INC,Trimeprazine  Tartrate,Trimeprazine  Tartrate,2.5 mg,bottle of 100,Oral,Resolved,tablet,R06AD,ANTIHISTAMINES FOR SYSTEMIC USE,2014-11-01,2014-11-01,2017-06-16,2017-05-15,Disruption of the manufacture of the drug.,2017-03-14,2017-12-12
82527,2370808,Shortage,PANTOPRAZOLE,SANIS HEALTH INC,PANTOPROZOLE,PANTOPRAZOLE,40MG,500,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-04-26,2020-03-31,,Disruption of the manufacture of the drug.,2019-04-26,2019-10-01
93828,2437945,Shortage,PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-10-07,2019-10-15,2020-02-10,,Disruption of the manufacture of the drug.,2019-09-12,2019-11-15
77496,2437945,Shortage,PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-02-28,2019-08-20,2019-07-29,Disruption of the manufacture of the drug.,2019-03-04,2019-07-31
77499,2437945,Shortage,PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-07-30,2020-01-07,,Disruption of the manufacture of the drug.,2019-03-04,2019-07-31
3325,2431327,Shortage,PANTOPRAZOLE,LABORATOIRE RIVA INC,Pantoprazole 40mg,PANTOPRAZOLE,40MG,30,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-03-17,2017-03-17,,,Disruption of the manufacture of the drug.,2017-03-17,2018-12-20
69950,2441853,Shortage,PANTOPRAZOLE MAGNESIUM,ALTIUS HEALTHCARE INC,Pantoprazole Magnesium,PANTOPRAZOLE,40MG,100's,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-12-19,2018-12-19,2019-01-10,2019-01-09,Delay in shipping of the drug.,2018-12-19,2019-01-10
52292,2441853,Shortage,PANTOPRAZOLE MAGNESIUM,ALTIUS HEALTHCARE INC,Pantoprazole Magnesium,PANTOPRAZOLE,40MG,bottle of 100's,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-06-14,2018-06-14,2018-06-20,2018-06-19,Demand increase for the drug.,2018-06-13,2018-06-20
66896,2441853,Shortage,PANTOPRAZOLE MAGNESIUM,ALTIUS HEALTHCARE INC,Pantoprazole Magnesium,PANTOPRAZOLE,40MG,bottle of 100's,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-11-14,2018-11-14,2018-11-30,2018-11-27,Demand increase for the drug.,2018-11-14,2018-11-28
55964,2441853,Shortage,PANTOPRAZOLE MAGNESIUM,ALTIUS HEALTHCARE INC,Pantoprazole Magnesium,PANTOPRAZOLE,40MG,100's,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-07-17,2018-08-15,2018-10-31,2018-09-24,Demand increase for the drug.,2018-07-16,2018-09-25
74942,2441853,Shortage,PANTOPRAZOLE MAGNESIUM,ALTIUS HEALTHCARE INC,Pantoprazole Magnesium,PANTOPRAZOLE,40MG,bottle of 100's,ORAL,Actual shortage,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-04-04,2019-04-05,,,Disruption of the manufacture of the drug.,2019-02-06,2019-04-17
67602,2306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-11-12,2019-12-23,,Delay in shipping of the drug.,2018-11-26,2019-09-10
2603,2306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10 fioles/vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-01-23,2017-01-23,2017-03-31,2017-03-24,Delay in shipping of the drug.,2017-03-14,2017-03-28
86240,2441527,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,GENERIC MEDICAL PARTNERS INC,Pantoprazole for Injection,PANTOPRAZOLE,40MG,1 Vial,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-06-11,2019-06-11,2019-08-30,,Disruption of the manufacture of the drug.,2019-06-11,2019-06-12
11491,2306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-06-05,,2017-07-28,2017-07-17,Requirements related to complying with good manufacturing practices.,2017-05-30,2017-07-18
46589,2306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-04-17,2018-05-04,2018-04-27,Delay in shipping of the drug.,2018-04-19,2018-04-30
58053,2466147,Shortage,PANTOPRAZOLE T,SANIS HEALTH INC,PANTOPRAZOLE T TAB,PANTOPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-08-13,2018-10-31,2018-10-30,Other (Please describe in comments),2018-08-14,2018-10-31
71379,2466147,Shortage,PANTOPRAZOLE T,SANIS HEALTH INC,PANTOPRAZOLE T TAB,PANTOPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-01-08,2019-01-09,2019-05-22,2019-05-27,Other (Please describe in comments),2019-01-07,2019-05-28
59699,1919598,Shortage,PARNATE,GLAXOSMITHKLINE INC,tranylcypromine tablets,TRANYLCYPROMINE,10MG,100's,ORAL,Resolved,TABLET,N06AF,ANTIDEPRESSANTS,,2018-08-27,2018-09-21,2018-09-11,Disruption of the manufacture of the drug.,2018-08-31,2018-09-13
68510,1919598,Shortage,PARNATE,GLAXOSMITHKLINE INC,tranylcypromine tablets,TRANYLCYPROMINE,10MG,100's,ORAL,Resolved,TABLET,N06AF,ANTIDEPRESSANTS,,2018-12-03,,2018-12-10,Disruption of the manufacture of the drug.,2018-12-03,2018-12-11
3265,1919598,Shortage,PARNATE,GLAXOSMITHKLINE INC,Tranylcypromine sulfate tablet,TRANYLCYPROMINE,10MG,100's,ORAL,Avoided shortage,TABLET,N06AF,ANTIDEPRESSANTS,2017-04-17,,,2017-04-12,Demand increase for the drug.,2017-03-17,2017-04-12
73656,2282844,Shortage,PAROXETINE,SANIS HEALTH INC,PAROXETINE TAB,PAROXETINE,10MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-03-01,,,,Disruption of the manufacture of the drug.,2019-01-28,2019-03-02
73659,2282852,Shortage,PAROXETINE,SANIS HEALTH INC,PAROXETINE TAB,PAROXETINE,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-04-15,,,,Disruption of the manufacture of the drug.,2019-01-28,2019-04-16
73662,2282860,Shortage,PAROXETINE,SANIS HEALTH INC,PAROXETINE TAB,PAROXETINE,30MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-05-17,2019-05-08,,,Disruption of the manufacture of the drug.,2019-01-28,2019-05-09
71845,1927744,Shortage,PARSITAN 50MG,ERFA CANADA 2012 INC,PARSITAN,ETHOPROPAZINE,50MG,100,ORAL,Resolved,TABLET,N04AA,ANTICHOLINERGIC AGENTS,2019-01-08,2019-01-09,2019-01-23,2019-01-25,Disruption of the manufacture of the drug.,2019-01-10,2019-02-06
83364,2362171,Shortage,PATADAY,NOVARTIS PHARMACEUTICALS CANADA INC,PATADAY 0.3% SOLN 2.5ML,OLOPATADINE,0.2%,2.5ML,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,2019-05-10,2019-05-15,2019-06-26,2019-06-18,Delay in shipping of the drug.,2019-05-07,2019-06-19
51067,2233143,Shortage,PATANOL,NOVARTIS PHARMACEUTICALS CANADA INC,PATANOL 0.1% soln 5ML,OLOPATADINE,0.1%,5ML,OPHTHALMIC,Resolved,LIQUID,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2018-05-16,2018-06-08,2018-06-12,Delay in shipping of the drug.,2018-06-01,2018-06-19
15631,2248503,Shortage,PAXIL CR,GLAXOSMITHKLINE INC,paroxetine controlled release tablets,PAROXETINE,12.5MG,30's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AB,ANTIDEPRESSANTS,,2017-08-07,2017-08-17,2017-08-18,Shortage of an inactive ingredient or component.,2017-07-12,2017-08-19
13661,2248504,Shortage,PAXIL CR,GLAXOSMITHKLINE INC,paroxetine controlled release tablets,PAROXETINE,25MG,30's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AB,ANTIDEPRESSANTS,,2017-07-31,2017-08-17,2017-08-14,Disruption of the manufacture of the drug.,2017-06-22,2017-08-16
43761,1940481,Shortage,PAXIL TAB 20MG,GLAXOSMITHKLINE INC,Paroxetine Tablets,PAROXETINE,20MG,100's,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-04-05,2018-05-31,2018-05-09,Delay in shipping of the drug.,2018-03-23,2018-05-10
68895,2022826,Shortage,PDP-AMANTADINE HYDROCHLORIDE SYRUP,PENDOPHARM DIVISION OF PHARMASCIENCE INC,AMANTADINE,AMANTADINE HYDROCHLORIDE,10MG,500mL,ORAL,Resolved,SYRUP,N04BB,DOPAMINERGIC AGENTS,2018-11-29,2018-11-23,2019-01-09,2019-01-07,Demand increase for the drug.,2018-12-07,2019-01-21
7145,2022826,Shortage,PDP-AMANTADINE HYDROCHLORIDE SYRUP,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pms-AMANTADINE HCL 10mg/1mL SYRUP 500mL,AMANTADINE HYDROCHLORIDE,10MG,500mL,ORAL,Resolved,SYRUP,N04BB,DOPAMINERGIC AGENTS,,2017-04-18,2017-05-24,2017-05-24,Demand increase for the drug.,2017-04-18,2017-06-05
35082,706531,Shortage,PDP-BENZTROPINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-BENZTROPINE 1mg,BENZTROPINE MESYLATE,1MG,TABS 1000,ORAL,Resolved,TABLET,N04AC,ANTICHOLINERGIC AGENTS,2018-02-14,,2018-02-19,2018-02-14,Disruption of the manufacture of the drug.,2018-01-08,2018-02-19
17424,426857,Shortage,PDP-BENZTROPINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-BENZTROPINE 2mg TABS 1000,BENZTROPINE MESYLATE,2MG,1000,ORAL,Actual shortage,TABLET,N04AC,ANTICHOLINERGIC AGENTS,2017-09-26,2017-09-12,,,Disruption of the manufacture of the drug.,2017-07-28,2018-12-20
20812,706531,Shortage,PDP-BENZTROPINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-BENZTROPINE 1mg TABS 1000,BENZTROPINE MESYLATE,1MG,1000,ORAL,Avoided shortage,TABLET,N04AC,ANTICHOLINERGIC AGENTS,2017-10-31,,2017-10-31,2017-10-30,Disruption of the manufacture of the drug.,2017-09-01,2017-10-30
24098,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 15g,DESONIDE,0.05%,15g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017-10-02,2017-10-02,2018-01-25,2018-01-18,Demand increase for the drug.,2017-10-02,2018-01-18
5442,2229323,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% OINTMENT 60g,DESONIDE,0.05%,60g OINT,TOPICAL,Resolved,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",2017-05-12,2017-05-16,2018-01-29,2018-01-23,Disruption of the manufacture of the drug.,2017-04-04,2018-01-25
37451,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 60g,DESONIDE,0.05%,60G,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2018-01-26,2018-01-26,2018-02-12,2018-02-05,Demand increase for the drug.,2018-01-26,2018-02-06
37455,2229323,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% OINTMENT 60g,DESONIDE,0.05%,60g,TOPICAL,Resolved,OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",2018-01-26,2018-01-26,2018-02-06,2018-02-05,Demand increase for the drug.,2018-01-26,2018-02-06
41044,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR,DESONIDE,0.05%,60g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2018-02-23,2018-02-23,2018-04-18,2018-03-12,Other (Please describe in comments),2018-02-26,2018-03-14
39259,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 60g,DESONIDE,0.05%,60g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2018-02-07,2018-02-07,2018-02-26,2018-02-22,Demand increase for the drug.,2018-02-10,2018-02-23
85414,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,DESONIDE,DESONIDE,0.05%,15G,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2019-06-17,2019-06-14,2019-08-27,2019-08-05,Disruption of the manufacture of the drug.,2019-06-01,2019-08-06
97458,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PDP-DESONIDE,DESONIDE,0.05%,15G,TOPICAL,Actual shortage,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-10-28,2019-12-16,,Demand increase for the drug.,2019-10-29,2019-10-29
92597,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,DESONIDE,DESONIDE,0.05%,15G Cream,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-08-29,2019-10-23,2019-10-01,Disruption of the manufacture of the drug.,2019-08-29,2019-10-03
92600,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,DESONIDE,DESONIDE,0.05%,60G Cream,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-08-29,2019-10-04,2019-10-01,Disruption of the manufacture of the drug.,2019-08-29,2019-10-03
10466,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 60g,DESONIDE,0.05%,60g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017-06-06,2017-06-12,2018-01-19,2018-01-18,Delay in shipping of the drug.,2017-05-16,2018-01-19
7150,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-DESONIDE 0.05% CR 15g,DESONIDE,0.05%,15g CR,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2017-09-11,2017-09-11,2017-10-04,2017-09-28,Disruption of the manufacture of the drug.,2017-04-18,2017-10-05
80376,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,DESONIDE,DESONIDE,0.05%,15G,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-04-03,2019-05-20,2019-05-03,Disruption of the manufacture of the drug.,2019-04-03,2019-05-06
80379,2229315,Shortage,PDP-DESONIDE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,DESONIDE,DESONIDE,0.05%,60G,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",2019-05-06,2019-05-06,2019-07-26,2019-07-10,Disruption of the manufacture of the drug.,2019-04-03,2019-07-12
52,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,ERYTHROMYCIN OPHTALMIC OINTMENT,ERYTHROMYCIN,5MG,50x1g,OPHTHALMIC,Avoided shortage,OINTMENT,S01AA,ANTIINFECTIVES,2017-08-31,2017-08-31,2017-09-01,2017-08-04,Disruption of the manufacture of the drug.,2017-03-10,2017-10-05
41037,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ERYTHROMYCIN 5mg/g OINT OPHT 3.5g,ERYTHROMYCIN,5MG,3.5g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,2018-02-23,2018-02-23,2020-01-15,,Other (Please describe in comments),2018-02-26,2019-10-15
39254,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD,ERYTHROMYCIN,5MG,50x1g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2018-02-21,2018-02-23,2018-07-04,2018-06-28,Delay in shipping of the drug.,2018-02-10,2018-06-29
62835,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF PHARMASCIENCE INC,pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD,ERYTHROMYCIN,5MG,50x1g,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,2018-10-02,2018-10-02,2020-01-15,,Delay in shipping of the drug.,2018-10-02,2019-10-15
19373,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g U,ERYTHROMYCIN,5MG,50X1G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2017-09-20,2017-09-25,2017-10-09,2017-10-11,Disruption of the manufacture of the drug.,2017-08-15,2017-10-12
29874,1912755,Shortage,PDP-ERYTHROMYCIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD,ERYTHROMYCIN,5MG,1x50g,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2017-12-15,,2017-12-21,2017-12-15,Delay in shipping of the drug.,2017-11-20,2017-12-16
58,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,HYDROCODONE,HYDROCODONE BITARTRATE,1MG,500 ML,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017-03-06,,2017-03-24,Demand increase for the drug.,2017-03-10,2017-04-04
41018,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR,HYDROCODONE BITARTRATE,1MG,500ml,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2018-02-19,2018-02-19,2018-02-28,2018-02-26,Delay in shipping of the drug.,2018-02-26,2018-03-13
5436,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL,HYDROCODONE BITARTRATE,1MG,500mL,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017-06-12,2017-06-15,2017-06-19,Demand increase for the drug.,2017-04-04,2017-06-20
36180,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL,HYDROCODONE BITARTRATE,1MG,500mL,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2018-01-17,2018-01-17,2018-02-09,2018-02-12,Requirements related to complying with good manufacturing practices.,2018-01-17,2018-02-13
70244,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,HYDROCODONE,HYDROCODONE BITARTRATE,1MG,500mL,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2018-12-14,2018-12-12,2018-12-31,2019-01-04,Demand increase for the drug.,2018-12-20,2019-01-05
19367,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL,HYDROCODONE BITARTRATE,1MG,500mL,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017-08-14,2017-09-01,2017-09-01,Disruption of the manufacture of the drug.,2017-08-15,2017-09-02
27609,2324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL,HYDROCODONE BITARTRATE,1MG,500ML,ORAL,Resolved,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2017-10-30,2017-10-30,2017-12-28,2018-01-03,Disruption of the manufacture of the drug.,2017-10-31,2018-01-08
31685,577804,Shortage,PDP-ISONIAZID,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-ISONIAZID 300mg TABS 100,ISONIAZID,300MG,100,ORAL,Resolved,TABLET,J04AC,DRUGS FOR TREATMENT OF TUBERCULOSIS,2017-12-13,2017-12-18,2018-01-15,2018-01-16,Demand increase for the drug.,2017-12-04,2018-01-18
17427,587362,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 2.5mg/5mL 500mL,PROCYCLIDINE HYDROCHLORIDE,2.5MG,500ml,ORAL,Actual shortage,ELIXIR,N04AA,ANTICHOLINERGIC AGENTS,2017-11-16,2017-11-01,,,Disruption of the manufacture of the drug.,2017-07-28,2018-12-20
17430,587354,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 5mg TABS 100,PROCYCLIDINE HYDROCHLORIDE,5MG,100,ORAL,Actual shortage,TABLET,N04AA,ANTICHOLINERGIC AGENTS,2017-08-01,2017-07-21,,,Other (Please describe in comments),2017-07-28,2018-09-04
8754,649392,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 2.5mg TABS 100,PROCYCLIDINE HYDROCHLORIDE,2.5MG,100,ORAL,Resolved,TABLET,N04AA,ANTICHOLINERGIC AGENTS,2017-06-06,2017-06-06,,2017-06-06,Requirements related to complying with good manufacturing practices.,2017-05-03,2017-09-13
17527,649392,Shortage,PDP-PROCYCLIDINE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PROCYCLIDINE 2.5mg TABS 100,PROCYCLIDINE HYDROCHLORIDE,2.5MG,100,ORAL,Actual shortage,TABLET,N04AA,ANTICHOLINERGIC AGENTS,2017-07-31,2017-08-15,,,Disruption of the manufacture of the drug.,2017-07-31,2018-12-20
8929,618810,Shortage,PDP-PYRAZINAMIDE,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,pdp-PYRAZINAMIDE 500mg TABS 100,PYRAZINAMIDE,500MG,100,ORAL,Resolved,TABLET,J04AK,DRUGS FOR TREATMENT OF TUBERCULOSIS,2017-10-15,,2017-12-17,2017-10-15,Disruption of the manufacture of the drug.,2017-05-04,2017-10-16
4467,2243167,Shortage,PEDIACEL,SANOFI PASTEUR LIMITED,Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate),INACTIVATED POLIOMYELITIS VACCINE  INACTIVATED POLIOMYELITIS VACCINE  INACTIVATED POLIOMYELITIS VACCINE  PERTACTIN  FIMBRIAE  FILAMENTOUS HAEMAGGLUTININ  PERTUSSIS TOXOID  TETANUS PROTEIN  HAEMOPHILUS INFLUENZAE TYPE B-PRP  TETANUS TOXOID  DIPHTHERIA TOXOID,32UNIT  8UNIT  40UNIT  3MCG  5MCG  20MCG  20MCG  30MCG  10MCG  5LF  15LF,"5 x 0.5 mL vials / 5 fioles de 0,5 mL",INTRAMUSCULAR,Resolved,SUSPENSION,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2017-03-28,2017-03-28,,2018-02-01,Delay in shipping of the drug.,2017-03-28,2018-02-11
27673,2230619,Shortage,PEDIAPRED,SANOFI-AVENTIS CANADA INC,Pediapred oral liquid,PREDNISOLONE,5MG,120ml,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-11-01,2017-11-30,2017-11-28,Demand increase for the drug.,2017-11-01,2017-12-01
79642,2230619,Shortage,PEDIAPRED,SANOFI-AVENTIS CANADA INC,Pediapred oral liquid,PREDNISOLONE,5MG,120 mL,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2019-04-26,,2019-06-14,2019-05-30,Other (Please describe in comments),2019-03-27,2019-05-31
90725,2230619,Shortage,PEDIAPRED,SANOFI-AVENTIS CANADA INC,Pediapred,PREDNISOLONE,5MG,120ml,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2019-08-23,,2019-10-07,2019-10-02,Demand increase for the drug.,2019-08-05,2019-10-03
36285,2438674,Shortage,PEMETREXED DISODIUM FOR INJECTION,ACCORD HEALTHCARE INC,PEMETREXED,PEMETREXED,100MG,100 mg (powder)/vial     |     100 mg (poudre)/flacon,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BA,ANTIMETABOLITES,2018-01-10,2018-01-10,2018-02-02,2018-02-16,Disruption of the manufacture of the drug.,2018-01-17,2018-02-22
93140,2394227,Shortage,PEMETREXED DISODIUM FOR INJECTION,TEVA CANADA LIMITED,PEMETREXED DISODIUM,PEMETREXED,500MG,50ml,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BA,ANTIMETABOLITES,,2019-09-05,2019-10-31,2019-10-16,Disruption of the manufacture of the drug.,2019-09-05,2019-10-17
35034,2438682,Shortage,PEMETREXED DISODIUM FOR INJECTION,ACCORD HEALTHCARE INC,PEMETREXED,PEMETREXED,500MG,500 MG (POWDER)/VIAL  |   FLACON DE 500 MG (POUDRE),INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BA,ANTIMETABOLITES,2017-12-27,2017-12-27,2018-02-19,2018-01-02,Disruption of the manufacture of the drug.,2018-01-05,2018-01-17
15623,2220261,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,PENICILLIN G SODIUM,PENICILLIN G,1000000UNIT,1 million unit SD vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-07-12,,2018-03-06,Disruption of the manufacture of the drug.,2017-07-12,2018-03-07
1764,1930672,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,PENICILLIN G SODIUM,PENICILLIN G SODIUM,1000000UNIT,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-01-25,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1772,1930680,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,PENICILLIN G SODIUM,PENICILLIN G SODIUM,10000000UNIT,10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-01-25,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1781,883751,Shortage,"PENICILLIN G SODIUM FOR INJECTION, USP",TEVA CANADA LIMITED,PENICILLIN G SODIUM,PENICILLIN G SODIUM,5000,10,INJECTION,Actual shortage,LIQUID,J01CE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-01-25,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
43643,2183080,Shortage,PENTAMIDINE ISETIONATE FOR INJECTION BP,PFIZER CANADA INC,PENTAMIDINE ISETIONATE,PENTAMIDINE ISETIONATE,300MG,5 x 300mg GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,P01CX,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,2018-03-26,,,2018-04-19,Disruption of the manufacture of the drug.,2018-03-21,2018-04-20
38174,2240433,Shortage,PERICHLOR,PHARMASCIENCE INC,PERICHLOR ORAL RINSE 0.12% 475mL,CHLORHEXIDINE GLUCONATE,0.12%,475ML,BUCCAL,Resolved,MOUTHWASH/GARGLE,A01AB,STOMATOLOGICAL PREPARATIONS,2018-03-05,2018-05-21,2018-11-30,2018-11-30,Delay in shipping of the drug.,2018-02-02,2018-12-07
13439,2240433,Shortage,PERICHLOR,PHARMASCIENCE INC,PERICHLOR ORAL RINSE 0.12% 475mL,CHLORHEXIDINE GLUCONATE,0.12%,475 ml,BUCCAL,Resolved,LIQUID,A01AB,STOMATOLOGICAL PREPARATIONS,,2017-06-19,2017-09-01,2017-09-01,Disruption of the manufacture of the drug.,2017-06-20,2017-09-02
96667,2240433,Shortage,PERICHLOR,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PERICHLOR,CHLORHEXIDINE GLUCONATE,0.12%,475mL,BUCCAL,Actual shortage,MOUTHWASH,A01AB,STOMATOLOGICAL PREPARATIONS,,2019-10-15,2019-12-02,,Disruption of the manufacture of the drug.,2019-10-16,2019-10-16
35794,2240433,Shortage,PERICHLOR,PHARMASCIENCE INC,PERICHLOR ORAL RINSE 0.12% 475mL,CHLORHEXIDINE GLUCONATE,0.12%,475,BUCCAL,Resolved,MOUTHWASH/GARGLE,A01AB,STOMATOLOGICAL PREPARATIONS,2018-01-12,2018-01-12,2018-01-31,2018-01-30,Disruption of the manufacture of the drug.,2018-01-12,2018-01-31
20055,2247104,Shortage,PERIOSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PERIOSTAT 20mg CAPS 60,DOXYCYCLINE,20MG,60,ORAL,Resolved,CAPSULE,A01AB,STOMATOLOGICAL PREPARATIONS,2017-11-06,2017-11-03,2017-12-19,2017-12-15,Disruption of the manufacture of the drug.,2017-08-22,2017-12-18
80371,2247104,Shortage,PERIOSTAT,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PERIOSTAT,DOXYCYCLINE,20MG,60,ORAL,Resolved,CAPSULE,A01AB,STOMATOLOGICAL PREPARATIONS,,2019-04-03,2019-06-10,2019-05-27,Disruption of the manufacture of the drug.,2019-04-03,2019-05-28
28695,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Persantine,DIPYRIDAMOLE,5MG,5 X 10ML,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017-11-13,2017-11-28,2018-01-30,2018-02-02,Demand increase for the drug.,2017-11-09,2018-02-03
71259,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Persantine,DIPYRIDAMOLE,5MG,5 X 10ML,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2019-01-04,2019-01-16,2019-01-08,Demand increase for the drug.,2019-01-04,2019-01-09
2212,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,5 x 10ml,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017-02-20,2017-03-31,2017-03-20,Demand increase for the drug.,2017-03-14,2017-03-21
75195,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Persantine,DIPYRIDAMOLE,5MG,5's,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2019-02-08,2019-03-04,2019-03-04,Demand increase for the drug.,2019-02-08,2019-03-04
19911,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,Amps,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017-08-20,2017-08-20,2017-08-25,2017-09-01,Delay in shipping of the drug.,2017-08-21,2017-09-04
12502,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,5 x 10ml,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2017-06-19,,2017-07-07,2017-07-07,Demand increase for the drug.,2017-06-12,2017-07-09
22240,637734,Shortage,PERSANTINE,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,PERSANTINE,DIPYRIDAMOLE,5MG,5's,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,,2017-09-18,2017-10-23,2017-10-05,Demand increase for the drug.,2017-09-18,2017-10-05
37446,2229777,Shortage,PHARIXIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHARIXIA 0.15% ORAL RINSE 250 mL,BENZYDAMINE HYDROCHLORIDE,1.5MG,250ml,BUCCAL,Resolved,MOUTHWASH/GARGLE,A01AD,STOMATOLOGICAL PREPARATIONS,2018-01-29,2018-01-31,2018-02-13,2018-02-09,Demand increase for the drug.,2018-01-26,2018-02-10
12625,2229777,Shortage,PHARIXIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHARIXIA 0.15% ORAL RINSE 250 mL,BENZYDAMINE HYDROCHLORIDE,1.5MG,250ml,BUCCAL  ORAL,Resolved,SOLUTION  MOUTHWASH/GARGLE,A01AD,STOMATOLOGICAL PREPARATIONS,,2017-06-09,,2017-06-19,Disruption of the manufacture of the drug.,2017-06-13,2017-06-20
30810,2229777,Shortage,PHARIXIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHARIXIA 0.15% ORAL RINSE 250 mL,BENZYDAMINE HYDROCHLORIDE,1.5MG,250ml,BUCCAL,Resolved,MOUTHWASH/GARGLE,A01AD,STOMATOLOGICAL PREPARATIONS,2017-11-29,2017-12-01,2017-12-29,2017-12-15,Delay in shipping of the drug.,2017-11-27,2017-12-18
20060,2229777,Shortage,PHARIXIA,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHARIXIA,BENZYDAMINE HYDROCHLORIDE,1.5MG,250Ml,BUCCAL  ORAL,Resolved,SOLUTION  MOUTHWASH/GARGLE,A01AD,STOMATOLOGICAL PREPARATIONS,2017-09-01,2017-09-05,2017-09-20,2017-09-22,Disruption of the manufacture of the drug.,2017-08-22,2017-09-25
88028,2469022,Shortage,PHARMA-AMLODIPINE,PHARMASCIENCE INC,AMLODIPINE,AMLODIPINE,2.5MG,46,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-07-18,2019-07-30,2019-09-30,2019-11-13,Disruption of the manufacture of the drug.,2019-06-28,2019-11-14
86237,2469022,Shortage,PHARMA-AMLODIPINE,PHARMASCIENCE INC,AMLODIPINE,AMLODIPINE,2.5MG,46,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-07-18,,2019-09-07,2019-09-03,Disruption of the manufacture of the drug.,2019-06-11,2019-09-04
98781,2469049,Shortage,PHARMA-AMLODIPINE,PHARMASCIENCE INC,AMLODOPINE,AMLODIPINE,10MG,100,ORAL,Anticipated shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-11-23,,2020-02-25,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
88031,2469049,Shortage,PHARMA-AMLODIPINE,PHARMASCIENCE INC,AMLODIPINE,AMLODIPINE,10MG,50,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-08-15,2019-08-15,2019-10-03,2019-11-13,Disruption of the manufacture of the drug.,2019-06-28,2019-11-14
1985,2371499,Shortage,PHARMA-D 10000 IU,PHARMASCIENCE INC,Vitamin D,VITAMIN D3,10000UNIT,100,ORAL,Actual shortage,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2015-11-06,,,Other (Please describe in comments),2017-03-13,2017-10-05
1989,2371499,Shortage,PHARMA-D 10000 IU,PHARMASCIENCE INC,Vitamin D,VITAMIN D3,10000UNIT,500,ORAL,Actual shortage,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2016-02-03,,,Other (Please describe in comments),2017-03-13,2017-10-05
1982,2371502,Shortage,PHARMA-D 50000 IU,PHARMASCIENCE INC,Vitamin D,VITAMIN D3,50000UNIT,100,ORAL,Actual shortage,CAPSULE,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2015-02-10,,,Other (Please describe in comments),2017-03-13,2017-10-05
77549,2469243,Shortage,PHARMA-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-03-01,2020-03-18,,Shortage of an active ingredient.,2019-03-04,2019-07-31
73713,2469243,Shortage,PHARMA-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-07-30,2020-03-18,,Disruption of the manufacture of the drug.,2019-01-28,2019-07-31
77554,2469251,Shortage,PHARMA-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-03-01,2020-03-18,,Shortage of an active ingredient.,2019-03-04,2019-07-31
77559,2469251,Shortage,PHARMA-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-03-01,2020-03-18,,Shortage of an active ingredient.,2019-03-04,2019-07-31
69222,2478196,Shortage,PHARMA-LACOSAMIDE,PHARMASCIENCE INC,LACOSAMIDE,LACOSAMIDE,50MG,66,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-12-11,2019-03-01,2019-02-25,Disruption of the manufacture of the drug.,2018-12-11,2019-02-26
72651,2478218,Shortage,PHARMA-LACOSAMIDE,PHARMASCIENCE INC,LACOSAMIDE,LACOSAMIDE,100MG,67,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-01-16,2019-02-18,2019-02-25,Disruption of the manufacture of the drug.,2019-01-16,2019-02-26
40248,2247383,Shortage,PHARMA-LACTULOSE,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,500ml,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2018-02-21,2018-03-15,2018-03-19,Disruption of the manufacture of the drug.,2018-02-20,2018-03-20
69225,2247383,Shortage,PHARMA-LACTULOSE,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,500,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2018-12-11,2019-02-25,2019-02-25,Disruption of the manufacture of the drug.,2018-12-11,2019-02-26
32173,2247383,Shortage,PHARMA-LACTULOSE,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,500,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2017-12-08,2017-12-15,2017-12-12,Disruption of the manufacture of the drug.,2017-12-08,2017-12-15
77523,2247383,Shortage,PHARMA-LACTULOSE,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,1 L,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2019-03-01,2019-03-22,2019-05-07,Disruption of the manufacture of the drug.,2019-03-04,2019-05-09
88007,2469979,Shortage,PHARMA-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-27,2019-10-22,2019-11-04,Delay in shipping of the drug.,2019-06-28,2019-11-15
88010,2469979,Shortage,PHARMA-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,5MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-26,2019-10-22,2019-11-04,Delay in shipping of the drug.,2019-06-28,2019-11-15
88013,2469995,Shortage,PHARMA-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-08,2019-08-22,,Shortage of an active ingredient.,2019-06-28,2019-06-28
88016,2469995,Shortage,PHARMA-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-05,2019-08-22,2019-08-21,Shortage of an inactive ingredient or component.,2019-06-28,2019-09-12
83711,2469995,Shortage,PHARMA-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-08,2019-07-09,2019-09-03,Shortage of an active ingredient.,2019-05-09,2019-09-04
11154,1948911,Shortage,PHARMALGEN HONEY BEE VENOM,ALK ABELLO A/S,Allergenic Extract,APIS MELLIFERA VENOM PROTEIN EXTRACT,120MCG,10mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11159,1948903,Shortage,PHARMALGEN HONEY BEE VENOM,ALK ABELLO A/S,Allergenic Extract,APIS MELLIFERA VENOM PROTEIN EXTRACT,1.1MG,30mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11164,1948881,Shortage,PHARMALGEN MIXED VESPID VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,WHITE FACED HORNET VENOM PROTEIN  YELLOW JACKET VENOM PROTEIN  YELLOW HORNET VENOM PROTEIN,120MCG  120MCG  120MCG,10mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11169,1948873,Shortage,PHARMALGEN MIXED VESPID VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,WHITE FACED HORNET VENOM PROTEIN  YELLOW JACKET VENOM PROTEIN  YELLOW HORNET VENOM PROTEIN,120MCG  120MCG  120MCG,30mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11173,1948970,Shortage,PHARMALGEN WASP VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,POLISTES SPP VENOM PROTEIN EXTRACT,1.1MG,30mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11179,1948989,Shortage,PHARMALGEN WASP VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,POLISTES SPP VENOM PROTEIN EXTRACT,120MCG,10mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11191,1949004,Shortage,PHARMALGEN WHITE FACED HORNET VENOM,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT,120MCG,10mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11194,1948997,Shortage,PHARMALGEN WHITE FACED HORNET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT,1.1MG,30mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11197,1948938,Shortage,PHARMALGEN YELLOW HORNET VENOM,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT,1.1MG,30mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11204,1948946,Shortage,PHARMALGEN YELLOW HORNET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT,120MCG,10mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11209,1948954,Shortage,PHARMALGEN YELLOW JACKET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,VESPULA SPP VENOM PROTEIN EXTRACT,1.1MG,30mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
11213,1948962,Shortage,PHARMALGEN YELLOW JACKET VENOM PROTEIN,ALK ABELLO A/S,Allergenic Extract,VESPULA SPP VENOM PROTEIN EXTRACT,120MCG,10mL,INTRADERMAL  SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,V01AA,ALLERGENS,2016-11-01,2016-12-01,,,Requirements related to complying with good manufacturing practices.,2017-05-24,2017-10-05
73480,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARBITAL,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,,2019-01-22,2019-02-21,2019-02-20,Disruption of the manufacture of the drug.,2019-01-24,2019-02-21
49674,178810,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 60mg TABS 500,PHENOBARBITAL,60MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-07-23,,2018-11-05,2018-10-29,Delay in shipping of the drug.,2018-05-17,2018-11-02
35085,178810,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 60mg TABS 500,PHENOBARBITAL,60MG,TABS 500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-01-08,2018-01-08,2018-01-24,2018-02-05,Shortage of an active ingredient.,2018-01-08,2018-02-06
77584,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARBITAL,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,,2019-03-01,,2019-03-08,Requirements related to complying with good manufacturing practices.,2019-03-04,2019-03-12
35088,178829,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 100mg,PHENOBARBITAL,100MG,TABS 500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-01-08,2018-01-08,2018-04-18,2018-02-05,Shortage of an active ingredient.,2018-01-08,2018-02-06
22039,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 30mg TABS 500,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017-09-05,2017-09-05,2017-10-15,2017-10-11,Disruption of the manufacture of the drug.,2017-09-13,2017-10-12
70690,178810,Shortage,PHENOBARB,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARBITAL,PHENOBARBITAL,60MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-12-17,2018-12-17,2019-04-25,2019-04-17,Delay in shipping of the drug.,2018-12-28,2019-04-17
22341,178799,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 15mg TABS 500,PHENOBARBITAL,15MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017-09-18,2017-09-18,2017-10-15,2017-10-11,Delay in shipping of the drug.,2017-09-18,2017-10-12
44373,178829,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 100mg TABS 500,PHENOBARBITAL,100MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-05-14,,2018-05-17,2018-05-17,Delay in shipping of the drug.,2018-03-30,2018-05-18
44376,178810,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 60mg TABS 500,PHENOBARBITAL,60MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-05-22,2018-05-22,2018-05-22,2018-05-22,Delay in shipping of the drug.,2018-03-30,2018-05-23
47717,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 30mg TABS 500,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,,2018-05-14,2018-05-17,2018-05-17,Delay in shipping of the drug.,2018-05-01,2018-05-18
62844,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARB 30mg TABS 500,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-10-02,2018-10-02,2018-11-05,2018-10-29,Other (Please describe in comments),2018-10-02,2018-11-05
17293,178810,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 60mg TABS 500,PHENOBARBITAL,60MG,500,ORAL,Avoided shortage,TABLET,N03AA,ANTIEPILEPTICS,2017-08-01,2017-08-01,2017-08-07,2017-07-31,Disruption of the manufacture of the drug.,2017-07-26,2017-10-05
61601,178799,Shortage,PHENOBARB,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARBITAL,PHENOBARBITAL,15MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-09-26,2018-10-02,2018-11-05,2018-10-29,Disruption of the manufacture of the drug.,2018-09-16,2018-11-05
61604,178829,Shortage,PHENOBARB,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARBITAL,PHENOBARBITAL,100MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-10-09,2018-10-09,2018-11-05,2018-10-29,Disruption of the manufacture of the drug.,2018-09-16,2018-11-05
4011,178829,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 100mg TABS 500,PHENOBARBITAL,100MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017-10-22,,2017-10-22,2017-10-23,Disruption of the manufacture of the drug.,2017-03-23,2017-10-23
31677,178799,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 15mg TABS 500,PHENOBARBITAL,15MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2018-01-22,2018-01-22,2018-03-01,2018-03-01,Shortage of an active ingredient.,2017-12-04,2018-03-01
31680,178802,Shortage,PHENOBARB,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,PHENOBARB 30mg TABS 500,PHENOBARBITAL,30MG,500,ORAL,Resolved,TABLET,N03AA,ANTIEPILEPTICS,2017-12-22,2017-12-22,2018-03-01,2018-03-01,Delay in shipping of the drug.,2017-12-04,2018-03-01
86562,645575,Shortage,PHENOBARB ELIXIR,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARBITAL,PHENOBARBITAL,5MG,100mL,ORAL,Resolved,ELIXIR,N03AA,ANTIEPILEPTICS,2019-08-01,2019-07-22,2019-08-30,2019-08-26,Disruption of the manufacture of the drug.,2019-06-12,2019-08-29
85409,645575,Shortage,PHENOBARB ELIXIR,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARBITAL,PHENOBARBITAL,5MG,100ML,ORAL,Resolved,ELIXIR,N03AA,ANTIEPILEPTICS,,2019-05-17,,2019-06-10,Disruption of the manufacture of the drug.,2019-06-01,2019-06-12
2586,2304090,Shortage,"PHENOBARBITAL SODIUM INJECTION, USP",SANDOZ CANADA INCORPORATED,PHENOBARBITAL Na Inj 1,PHENOBARBITAL SODIUM,120MG,10x1mL Amp,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N03AA,ANTIEPILEPTICS,2017-04-07,,2017-07-17,2017-07-03,Delay in shipping of the drug.,2017-03-14,2017-07-05
96570,2304090,Shortage,"PHENOBARBITAL SODIUM INJECTION, USP",SANDOZ CANADA INCORPORATED,PHENOBARBITAL,PHENOBARBITAL SODIUM,120MG,10,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N03AA,ANTIEPILEPTICS,,2019-10-07,2019-11-01,2019-10-28,Delay in shipping of the drug.,2019-10-15,2019-11-01
15463,2304082,Shortage,"PHENOBARBITAL SODIUM INJECTION, USP",SANDOZ CANADA INCORPORATED,PHENOBARBITAL,PHENOBARBITAL SODIUM,30MG,10 X 1ML AMPOULE,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N03AA,ANTIEPILEPTICS,2017-07-21,2017-07-17,2017-10-27,2017-10-24,Demand increase for the drug.,2017-07-11,2017-10-27
83325,2243737,Shortage,PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD,SANDOZ CANADA INCORPORATED,PHENTOLAMINE,PHENTOLAMINE MESYLATE,5MG,10X1ml,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,C04AB,PERIPHERALVASODILATORS,,2019-04-29,2019-10-07,2019-09-19,Demand increase for the drug.,2019-05-07,2019-10-15
31386,2431378,Shortage,"PHENYTOIN SODIUM INJECTION, USP",STERIMAX INC,Phenytoin Sodium Injection USP,PHENYTOIN SODIUM,50MG,25 vials,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,N03AB,ANTIEPILEPTICS,,2017-11-30,2017-12-11,2017-12-13,Delay in shipping of the drug.,2017-11-30,2017-12-14
67943,2400987,Shortage,PICATO,LEO PHARMA INC,Ingenol Mebutate,Ingenol Mebutate,0.015%,3 x 0.47g,TOPICAL,Resolved,GEL,D06BX,CHEMOTHERAPEUTICS FOR TOPICAL USE,2018-11-29,2018-11-29,2018-12-10,2018-12-10,Delay in shipping of the drug.,2018-11-29,2018-12-10
8200,2402483,Shortage,"PILOCARPINE HYDROCHLORIDE TABLETS, USP",STERIMAX INC,"PILOCARPINE HYDROCHLORIDE TABLETS, USP",PILOCARPINE HYDROCHLORIDE,5MG,100 Tabs,ORAL,Actual shortage,TABLET,N07AX,PARASYMPATHOMIMETICS,,2015-04-16,,,Other (Please describe in comments),2017-04-27,2017-10-05
93066,828424,Shortage,PINDOLOL-10 TAB 10MG,PRO DOC LIMITEE,PINDOLOL-10 TAB 10MG,PINDOLOL,10MG,100,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,2019-10-31,2019-11-04,,,Other (Please describe in comments),2019-09-05,2019-11-05
93060,828416,Shortage,PINDOLOL-5 TAB 5MG,PRO DOC LIMITEE,PINDOLOL-5 TAB 5MG,PINDOLOL,5MG,100,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,2019-10-31,2019-11-04,,,Other (Please describe in comments),2019-09-05,2019-11-05
1811,2370166,Shortage,PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION,TEVA CANADA LIMITED,PIPERCILLIN/TAZOBACTAM,PIPERACILLIN  TAZOBACTAM,3G  0.375G,10,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017-01-15,,,2018-02-28,Disruption of the manufacture of the drug.,2017-03-13,2018-03-01
29438,2370174,Shortage,PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION,TEVA CANADA LIMITED,PIPERACILLIN/TAZOBACTAM,PIPERACILLIN  TAZOBACTAM,4G  0.5G,10,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-11-16,,,Disruption of the manufacture of the drug.,2017-11-16,2018-10-11
48144,2401320,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,TELIGENT OU,Piperacillin and Tazobactam for Injection,PIPERACILLIN  TAZOBACTAM,3G  0.375G,3.375 G/VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-04-24,2018-05-10,2018-05-14,Shortage of an active ingredient.,2018-05-02,2018-05-16
42266,2401339,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,TELIGENT OU,Piperacillin and Tazobactam for Injection,PIPERACILLIN  TAZOBACTAM,4G  0.5G,4.5 G/VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-03-01,2018-06-15,2018-06-08,Shortage of an active ingredient.,2018-03-08,2018-06-13
57888,2401312,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,TELIGENT OU,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN  TAZOBACTAM,2G  0.25G,2.25 G,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-10-09,2019-04-01,2019-02-19,Disruption of the manufacture of the drug.,2018-08-10,2019-02-20
30515,2377748,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN  TAZOBACTAM,12G  1.5G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-11-23,2018-01-08,2018-01-26,Delay in shipping of the drug.,2017-11-23,2018-01-27
577,2308452,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,APOTEX INC,PIPERACILLIN - TAZOBACTUM,PIPERACILLIN  TAZOBACTAM,3.0G  0.375G,30 ML,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-09-07,,,Disruption of the manufacture of the drug.,2017-03-11,2018-09-12
580,2308460,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,APOTEX INC,PIPERACILLIN - TAZOBACTUM,PIPERACILLIN  TAZOBACTAM,4.0G  0.5G,48 ML,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-09-07,,,Disruption of the manufacture of the drug.,2017-03-11,2017-10-05
583,2308444,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,APOTEX INC,PIPERACILLIN - TAZOBACTUM,PIPERACILLIN  TAZOBACTAM,2G  0.25G,30 ML,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2014-10-01,,,Disruption of the manufacture of the drug.,2017-03-11,2018-09-12
8297,2362619,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN  TAZOBACTAM,2.00G  0.25G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2016-05-25,,2018-04-13,Other (Please describe in comments),2017-04-27,2018-04-17
31390,2362627,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN  TAZOBACTAM,3.000G  0.375G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-11-30,2018-01-08,2018-01-15,Other (Please describe in comments),2017-11-30,2018-01-16
31394,2362635,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN  TAZOBACTAM,4.0G  0.5G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-05-03,2018-06-04,2018-05-30,Other (Please describe in comments),2017-11-30,2018-05-31
46287,2439131,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,STERIMAX INC,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,PIPERACILLIN  TAZOBACTAM,36G  4.5G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-04-18,2018-05-01,2018-05-03,Demand increase for the drug.,2018-04-18,2018-05-04
2570,2299658,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN-TAZO,PIPERACILLIN  TAZOBACTAM,4G  0.5G,10x4.5g fioles/vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017-03-14,,2017-04-28,2017-05-02,Shortage of an active ingredient.,2017-03-14,2017-10-25
63275,2330547,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN TAZOBACTAM,PIPERACILLIN  TAZOBACTAM,12G  1.5G,SINGLE VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-09-24,2018-10-26,2018-10-25,Delay in shipping of the drug.,2018-10-04,2018-10-25
30892,2299658,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN-TAZOBACTAM,PIPERACILLIN  TAZOBACTAM,4G  0.5G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-11-24,2018-07-20,2018-08-10,Shortage of an active ingredient.,2017-11-28,2018-08-13
30895,2330547,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN-TAZOBACTAM,PIPERACILLIN  TAZOBACTAM,12G  1.5G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",2017-11-30,2017-12-15,2018-05-11,2018-05-04,Shortage of an active ingredient.,2017-11-28,2018-05-23
4586,2299631,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,TAZOCIN,PIPERACILLIN  TAZOBACTAM,3G  0.375G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-03-27,2017-04-28,2017-05-12,Delay in shipping of the drug.,2017-03-29,2017-05-17
50678,2299631,Shortage,PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN-TAZOBACTAM,PIPERACILLIN  TAZOBACTAM,3G  0.375G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2018-05-25,2018-07-13,2018-07-13,Demand increase for the drug.,2018-05-29,2018-08-13
62418,2017709,Shortage,PLAQUENIL,SANOFI-AVENTIS CANADA INC,Plaquenil,HYDROXYCHLOROQUINE SULFATE,200MG,100,ORAL,Resolved,TABLET,P01BA,ANTIMALARIALS,,2018-09-25,2018-09-28,2018-10-03,Other (Please describe in comments),2018-09-26,2018-10-04
76031,2339358,Shortage,PLASMA-LYTE A INJECTION,BAXTER CORPORATION,Plasma-Lyte A Injection,SODIUM ACETATE  MAGNESIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE  SODIUM GLUCONATE,368MG  30MG  37MG  526MG  502MG,1000 mL,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2019-03-05,2019-03-05,2019-03-18,2019-03-18,Shortage of an active ingredient.,2019-02-15,2019-03-19
87048,2238682,Shortage,PLAVIX,SANOFI-AVENTIS CANADA INC,Plavix 75mg,CLOPIDOGREL,75MG,90,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2019-07-02,,2019-08-23,2019-08-08,Other (Please describe in comments),2019-06-19,2019-08-12
68065,2238682,Shortage,PLAVIX,SANOFI-AVENTIS CANADA INC,Plavix 75mg,CLOPIDOGREL,75MG,500,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2018-12-24,,2019-01-18,2019-01-18,Other (Please describe in comments),2018-11-29,2019-01-25
67332,851787,Shortage,PLENDIL 10 MG,ASTRAZENECA CANADA INC,felodipine extended release tablets,FELODIPINE,10MG,2 x 15 tablets,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-11-21,2018-11-21,2019-03-15,2019-03-14,Delay in shipping of the drug.,2018-11-21,2019-04-16
94601,2057778,Shortage,PLENDIL 2.5 MG,ASTRAZENECA CANADA INC,felodipine,FELODIPINE,2.5MG,30 tablets,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-10-10,2019-10-10,2019-12-13,,Other (Please describe in comments),2019-09-25,2019-10-11
8581,1946897,Shortage,PMS DEXAMETHASONE ELIXIR 0.5MG/5ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100 mL,ORAL,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-05-01,2017-06-30,2017-07-06,Disruption of the manufacture of the drug.,2017-05-02,2017-07-07
21509,1964976,Shortage,PMS DEXAMETHASONE TAB 0.5MG USP,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-09-04,2018-01-30,2018-02-08,Disruption of the manufacture of the drug.,2017-09-07,2018-02-12
8576,1964976,Shortage,PMS DEXAMETHASONE TAB 0.5MG USP,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-05-01,2017-05-16,2017-05-31,Disruption of the manufacture of the drug.,2017-05-02,2017-06-01
38899,1964968,Shortage,PMS DEXAMETHASONE TAB 0.75MG USP,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.75MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2018-02-02,2018-04-05,2018-04-17,Disruption of the manufacture of the drug.,2018-02-06,2018-04-19
8931,664553,Shortage,PMS DOCUSATE-CALCIUM CAP 240MG USP,PHARMASCIENCE INC,DOCUSATE CALCIUM,DOCUSATE CALCIUM,240MG,30,ORAL,Actual shortage,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,2017-05-22,2017-05-22,,,Disruption of the manufacture of the drug.,2017-05-04,2018-12-20
49740,1916386,Shortage,PMS HYDROMORPHONE SIROP 1MG/ML,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,1MG,90,ORAL,Resolved,SYRUP,N02AA,OPIOIDS,,2018-05-18,2018-09-10,2018-06-26,Disruption of the manufacture of the drug.,2018-05-18,2018-06-29
17060,1916394,Shortage,PMS HYDROMORPHONE SUPPOSITOIRE 3MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,3MG,10,RECTAL,Actual shortage,SUPPOSITORY,N02AA,OPIOIDS,,2017-07-01,,,Disruption of the manufacture of the drug.,2017-07-25,2017-10-05
60297,741817,Shortage,PMS HYDROXYZINE SYR 10MG/5ML,PHARMASCIENCE INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,10MG,500mL,ORAL,Actual shortage,SYRUP,N05BB,ANXIOLYTICS,2018-09-04,2018-09-04,,,Disruption of the manufacture of the drug.,2018-09-07,2018-09-07
22820,1937235,Shortage,PMS TRAZODONE HCL TAB 100MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,100MG,500,ORAL,Actual shortage,TABLET,N06AX,ANTIDEPRESSANTS,,2017-09-15,,,Other (Please describe in comments),2017-09-19,2018-12-20
67984,1937235,Shortage,PMS TRAZODONE HCL TAB 100MG,PHARMASCIENCE INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-11-28,2019-01-15,2019-01-16,Disruption of the manufacture of the drug.,2018-11-29,2019-01-17
17097,1937235,Shortage,PMS TRAZODONE HCL TAB 100MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-07-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-07-25,2018-05-05
79869,1937235,Shortage,PMS TRAZODONE HCL TAB 100MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2019-03-27,2019-06-08,2019-06-27,Disruption of the manufacture of the drug.,2019-03-29,2019-06-28
83717,1937227,Shortage,PMS TRAZODONE HCL TAB 50MG,PHARMASCIENCE INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2019-05-21,,2019-06-27,2019-07-29,Demand increase for the drug.,2019-05-09,2019-07-31
7527,1937227,Shortage,PMS TRAZODONE HCL TAB 50MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,50MG,500,ORAL,Actual shortage,TABLET,N06AX,ANTIDEPRESSANTS,,2017-04-20,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
5531,1937227,Shortage,PMS TRAZODONE HCL TAB 50MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-03-23,2018-11-25,2018-11-28,Shortage of an inactive ingredient or component.,2017-04-04,2018-11-29
5534,1937227,Shortage,PMS TRAZODONE HCL TAB 50MG,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,50MG,250,ORAL,Actual shortage,TABLET,N06AX,ANTIDEPRESSANTS,,2017-03-23,,,Shortage of an inactive ingredient or component.,2017-04-04,2017-10-05
38860,2458381,Shortage,PMS-ABACAVIR-LAMIVUDINE,PHARMASCIENCE INC,ABACAVIR-LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2018-02-02,2018-08-16,2018-08-23,Disruption of the manufacture of the drug.,2018-02-06,2018-08-24
77526,2458381,Shortage,PMS-ABACAVIR-LAMIVUDINE,PHARMASCIENCE INC,ABACAVIR/LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30,ORAL,Actual shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-03-01,2020-01-10,,Shortage of an inactive ingredient or component.,2019-03-04,2019-09-12
77531,2458381,Shortage,PMS-ABACAVIR-LAMIVUDINE,PHARMASCIENCE INC,ABACAVIR/LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30,ORAL,Actual shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-03-01,2020-03-24,,Shortage of an inactive ingredient or component.,2019-03-04,2019-11-15
25829,2458381,Shortage,PMS-ABACAVIR-LAMIVUDINE,PHARMASCIENCE INC,ABACAVIR/LAMIVUDINE,ABACAVIR  LAMIVUDINE,600MG  300MG,30,ORAL,Resolved,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2017-10-01,,2018-10-02,Disruption of the manufacture of the drug.,2017-10-12,2018-10-03
25731,816027,Shortage,PMS-ACETAMINOPHEN W CODEINE ELIXIR,PHARMASCIENCE INC,ACET CODEINE,ACETAMINOPHEN  CODEINE PHOSPHATE,160MG  8MG,90,ORAL,Resolved,ELIXIR,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2017-10-01,2017-11-15,2017-12-04,Disruption of the manufacture of the drug.,2017-10-12,2017-12-08
64805,2284006,Shortage,PMS-ALENDRONATE-FC,PHARMASCIENCE INC,ALENDRONATE FC,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-10-17,2019-01-25,2019-02-06,Disruption of the manufacture of the drug.,2018-10-19,2019-02-08
28780,2284006,Shortage,PMS-ALENDRONATE-FC,PHARMASCIENCE INC,ALENDRONATE,ALENDRONIC ACID,70MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-11-10,2018-03-02,2018-03-06,Delay in shipping of the drug.,2017-11-09,2018-03-07
25734,2284006,Shortage,PMS-ALENDRONATE-FC,PHARMASCIENCE INC,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-10-01,2018-04-02,2018-03-06,Disruption of the manufacture of the drug.,2017-10-12,2018-03-07
55726,2284006,Shortage,PMS-ALENDRONATE-FC,PHARMASCIENCE INC,ALENDRONATE,ALENDRONIC ACID,70MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-08-01,2018-08-23,2018-12-12,2018-12-11,Disruption of the manufacture of the drug.,2018-07-13,2018-12-12
30,1990403,Shortage,PMS-AMANTADINE HYDROCHLORIDE CAP 100MG,PHARMASCIENCE INC,pms-AMANTADINE HCHL CAPSULES,AMANTADINE HYDROCHLORIDE,100MG,100 CAPS,ORAL,Resolved,CAPSULES,N04BB,DOPAMINERGIC AGENTS,2016-11-18,2016-11-19,2018-02-09,2018-02-09,Disruption of the manufacture of the drug.,2017-03-10,2018-02-10
13090,2292173,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017-06-25,2017-06-25,2017-07-14,2017-07-14,Demand increase for the drug.,2017-06-16,2017-10-11
28783,2242472,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017-11-10,2018-04-27,2018-05-04,Disruption of the manufacture of the drug.,2017-11-09,2018-05-05
7322,2242472,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2017-07-10,2017-07-10,2017-07-10,2017-07-10,Disruption of the manufacture of the drug.,2017-04-20,2017-10-11
18853,2242472,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017-08-11,2017-09-04,2017-09-15,Disruption of the manufacture of the drug.,2017-08-11,2017-09-19
27323,2292173,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017-10-09,2018-04-26,2018-05-04,Disruption of the manufacture of the drug.,2017-10-27,2018-05-05
22725,2292173,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2017-09-18,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-09-19,2017-10-11
53227,2292173,Shortage,PMS-AMIODARONE,PHARMASCIENCE INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",2018-06-23,2018-07-12,2018-09-25,2018-10-02,Disruption of the manufacture of the drug.,2018-06-29,2018-10-03
38818,654523,Shortage,PMS-AMITRIPTYLINE,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2018-02-15,2018-02-19,2018-03-17,2018-03-19,Disruption of the manufacture of the drug.,2018-02-06,2018-03-20
27326,654507,Shortage,PMS-AMITRIPTYLINE,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017-10-27,2017-11-23,2017-11-14,Disruption of the manufacture of the drug.,2017-10-27,2017-11-17
83653,654523,Shortage,PMS-AMITRIPTYLINE,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2019-06-03,,2019-06-20,2019-07-29,Demand increase for the drug.,2019-05-09,2019-07-31
83657,654523,Shortage,PMS-AMITRIPTYLINE,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2019-06-03,,2019-06-20,2019-07-29,Demand increase for the drug.,2019-05-09,2019-07-31
12208,654523,Shortage,PMS-AMITRIPTYLINE TABLETS 10MG,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017-06-06,,2017-07-23,Disruption of the manufacture of the drug.,2017-06-07,2017-07-24
18856,654515,Shortage,PMS-AMITRIPTYLINE TABLETS 25MG,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,25MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-08-23,2017-08-23,2017-12-20,2017-12-15,Disruption of the manufacture of the drug.,2017-08-11,2017-12-18
21489,654515,Shortage,PMS-AMITRIPTYLINE TABLETS 25MG,PHARMASCIENCE INC,AMYTRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,25MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-10-06,2017-10-06,2017-11-28,2017-11-14,Disruption of the manufacture of the drug.,2017-09-07,2017-11-17
21492,654507,Shortage,PMS-AMITRIPTYLINE TABLETS 50MG,PHARMASCIENCE INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2017-11-13,,2017-12-05,2017-11-14,Disruption of the manufacture of the drug.,2017-09-07,2017-11-17
4987,2295148,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-23,,2019-11-13,Disruption of the manufacture of the drug.,2017-03-31,2019-11-14
6014,2295148,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-04-05,2017-09-12,2017-09-12,Disruption of the manufacture of the drug.,2017-04-07,2017-10-11
1717,2284073,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,10.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-20,,2019-03-28,Disruption of the manufacture of the drug.,2017-03-13,2019-03-29
1492,2284065,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,5.0MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-01,,2019-03-28,Disruption of the manufacture of the drug.,2017-03-13,2019-03-29
1512,2284065,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,5.0MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-03-20,2017-03-20,,2019-03-28,Disruption of the manufacture of the drug.,2017-03-13,2019-03-29
1532,2284073,Shortage,PMS-AMLODIPINE,PHARMASCIENCE INC,Amlodipine,AMLODIPINE,10.0MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-01,,2019-03-28,Disruption of the manufacture of the drug.,2017-03-13,2019-03-29
1726,2404222,Shortage,PMS-AMLODIPINE-ATORVASTATIN,PHARMASCIENCE INC,Amlodipine-Atorvastatin,AMLODIPINE  ATORVASTATIN,5MG  10MG,100,ORAL,Actual shortage,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2015-07-07,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1741,2404249,Shortage,PMS-AMLODIPINE-ATORVASTATIN,PHARMASCIENCE INC,Amlodipine- Atorvastatin,AMLODIPINE  ATORVASTATIN,10MG  10MG,100,ORAL,Actual shortage,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2015-07-07,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1758,2404257,Shortage,PMS-AMLODIPINE-ATORVASTATIN,PHARMASCIENCE INC,Amlodipine Atorvastatin,AMLODIPINE  ATORVASTATIN,10MG  20MG,100,ORAL,Actual shortage,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2015-07-07,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
17013,2230245,Shortage,PMS-AMOXICILLIN,PHARMASCIENCE INC,AMOXICILLIN,AMOXICILLIN,125MG,100 mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-07-01,2017-09-18,2017-10-10,Disruption of the manufacture of the drug.,2017-07-25,2017-10-11
39499,2440377,Shortage,PMS-AMPHETAMINES XR,PHARMASCIENCE INC,AMPHETAMINE,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,2.5MG  2.5MG  2.5MG  2.5MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-12,,,Disruption of the manufacture of the drug.,2018-02-12,2018-02-13
39507,2440393,Shortage,PMS-AMPHETAMINES XR,PHARMASCIENCE INC,AMPHETAMINE,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,5MG  5MG  5MG  5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-12,2018-02-23,2018-02-19,Disruption of the manufacture of the drug.,2018-02-12,2018-02-20
40589,2440393,Shortage,PMS-AMPHETAMINES XR,PHARMASCIENCE INC,AMPHETAMINE,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,5MG  5MG  5MG  5MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-04-01,2018-05-01,,,Disruption of the manufacture of the drug.,2018-02-22,2018-05-04
38824,2440407,Shortage,PMS-AMPHETAMINES XR,PHARMASCIENCE INC,AMPHETAMINES,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,6.25MG  6.25MG  6.25MG  6.25MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-02,,,Disruption of the manufacture of the drug.,2018-02-06,2018-02-06
6098,2440385,Shortage,PMS-AMPHETAMINES XR,PHARMASCIENCE INC,AMPHETAMINES XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,3.75MG  3.75MG  3.75MG  3.75MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-04-05,,,Disruption of the manufacture of the drug.,2017-04-07,2018-12-20
32023,2274949,Shortage,PMS-ANAGRELIDE,PHARMASCIENCE INC,ANAGRELIDE,ANAGRELIDE,0.5MG,100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-12-10,2017-12-15,2018-08-03,2018-08-23,Disruption of the manufacture of the drug.,2017-12-07,2018-08-24
88573,2274949,Shortage,PMS-ANAGRELIDE,PHARMASCIENCE INC,ANAGRELIDE,ANAGRELIDE,0.5MG,100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2019-07-29,2019-10-17,2019-11-01,Disruption of the manufacture of the drug.,2019-07-05,2019-11-15
43342,2320738,Shortage,PMS-ANASTROZOLE,PHARMASCIENCE INC,ANASTROZOLE,ANASTROZOLE,1MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-03-19,2018-06-25,2018-06-26,Disruption of the manufacture of the drug.,2018-03-19,2018-06-29
87926,2320738,Shortage,PMS-ANASTROZOLE,PHARMASCIENCE INC,ANASTROZOLE,ANASTROZOLE,1MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-06-30,2019-08-09,2019-09-09,Demand increase for the drug.,2019-06-28,2019-09-12
83729,2466635,Shortage,PMS-ARIPIPRAZOLE,PHARMASCIENCE INC,ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,30,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-07-30,2019-08-20,2019-09-09,Demand increase for the drug.,2019-05-09,2019-09-12
98784,2466643,Shortage,PMS-ARIPIPRAZOLE,PHARMASCIENCE INC,ARIPIPRAZOLE,ARIPIPRAZOLE,5MG,30,ORAL,Anticipated shortage,TABLET,N05AX,ANTIPSYCHOTICS,2019-12-09,,2020-02-17,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
67860,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-11-28,2019-01-10,2019-01-16,Disruption of the manufacture of the drug.,2018-11-28,2019-01-17
11294,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-06-29,2017-06-29,2018-05-15,2018-04-17,Shortage of an active ingredient.,2017-05-25,2018-04-19
32032,2246581,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-12-09,2017-12-15,2018-05-14,2018-05-04,Disruption of the manufacture of the drug.,2017-12-07,2018-05-05
13097,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-10-16,2017-11-08,2018-04-17,2018-05-04,Shortage of an active ingredient.,2017-06-16,2018-05-05
69206,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-12-11,2019-02-22,2019-02-06,Disruption of the manufacture of the drug.,2018-12-11,2019-02-08
28786,2246581,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-11-10,2018-04-13,2018-04-17,Disruption of the manufacture of the drug.,2017-11-09,2018-04-19
7333,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,3X10,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-04-20,2017-11-20,2017-07-18,Disruption of the manufacture of the drug.,2017-04-20,2017-07-19
8899,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-06-18,,2017-11-15,2017-06-18,Disruption of the manufacture of the drug.,2017-05-04,2017-07-19
22729,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-09-18,,2018-05-04,Disruption of the manufacture of the drug.,2017-09-19,2018-05-05
15085,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-10-16,2017-11-08,2018-06-14,2018-05-15,Shortage of an active ingredient.,2017-07-11,2018-05-18
15088,2237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-08-26,2017-07-19,2018-04-10,2018-04-17,Shortage of an active ingredient.,2017-07-11,2018-04-19
15091,2246581,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-09-14,2017-10-11,2018-05-12,2018-04-17,Shortage of an active ingredient.,2017-07-11,2018-04-19
15094,2237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,30,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-08-02,2017-08-02,2018-03-01,2017-12-04,Shortage of an active ingredient.,2017-07-11,2017-12-08
88576,2381028,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,10MG,30,ORAL,Actual shortage,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-05-28,2019-12-02,,Disruption of the manufacture of the drug.,2019-07-05,2019-07-11
77348,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,60MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-03-01,2019-04-09,2019-05-07,Shortage of an active ingredient.,2019-03-04,2019-05-09
64808,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,60MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-10-17,2018-12-04,2018-11-27,Disruption of the manufacture of the drug.,2018-10-19,2018-11-28
4156,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,Atomoxetine,ATOMOXETINE,60MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-08-17,2017-08-17,2018-01-28,2018-02-08,Disruption of the manufacture of the drug.,2017-03-24,2018-02-12
4165,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,Atomoxetine,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-23,,2017-07-23,Disruption of the manufacture of the drug.,2017-03-24,2017-07-24
8533,2381052,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,40MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-06-26,2017-06-26,2018-01-30,2018-02-08,Disruption of the manufacture of the drug.,2017-05-02,2018-02-12
8543,2381052,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMEXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-07-11,2017-07-11,2018-02-20,2018-02-19,Disruption of the manufacture of the drug.,2017-05-02,2018-02-20
38849,2381028,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,10MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-02-16,2018-02-19,2018-04-10,2018-04-16,Disruption of the manufacture of the drug.,2018-02-06,2018-04-19
8903,2381044,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,25MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-07-06,2017-07-06,2018-01-28,2018-02-08,Shortage of an inactive ingredient or component.,2017-05-04,2018-02-12
86216,2381028,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,10MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-05-28,2019-09-10,2019-09-02,Disruption of the manufacture of the drug.,2019-06-11,2019-09-03
86219,2381044,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-05-28,2019-07-05,2019-11-01,Disruption of the manufacture of the drug.,2019-06-11,2019-11-15
22732,2381036,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,18MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-09-18,,2018-05-04,Disruption of the manufacture of the drug.,2017-09-19,2018-05-05
22735,2381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-09-18,,2018-05-04,Disruption of the manufacture of the drug.,2017-09-19,2018-05-05
6101,2381044,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-04-05,2018-02-19,2018-02-19,Disruption of the manufacture of the drug.,2017-04-07,2018-02-20
38181,2399393,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-02-02,2018-02-06,2018-03-16,2018-03-22,Disruption of the manufacture of the drug.,2018-02-02,2018-03-23
77353,2399385,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-02-28,2019-06-17,2019-06-27,Disruption of the manufacture of the drug.,2019-03-04,2019-06-28
33117,2399385,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-01-01,2018-01-24,2018-02-05,2018-02-08,Disruption of the manufacture of the drug.,2017-12-15,2018-02-12
93810,2399407,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-10-01,2019-11-01,2020-03-02,,Disruption of the manufacture of the drug.,2019-09-12,2019-11-15
37238,2399393,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,atorvastatin,ATORVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-02-07,2018-02-06,2018-04-06,2018-04-16,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
22738,2399407,Shortage,PMS-ATORVASTATIN,PHARMASCIENCE INC,ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-18,2017-09-25,2017-10-10,Disruption of the manufacture of the drug.,2017-09-19,2017-10-11
88579,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-07-30,2019-08-06,2019-09-09,Disruption of the manufacture of the drug.,2019-07-05,2019-09-12
88582,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-07-04,2019-09-13,,Disruption of the manufacture of the drug.,2019-07-05,2019-08-07
94260,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2019-10-01,,2019-11-01,2019-10-28,Disruption of the manufacture of the drug.,2019-09-18,2019-11-15
4168,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-03-23,2018-01-08,2017-10-24,Disruption of the manufacture of the drug.,2017-03-24,2017-10-26
10081,2418460,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,200MG,5 mL,ORAL,Actual shortage,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-05-01,,,Other (Please describe in comments),2017-05-11,2017-10-05
17017,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-07-01,2017-11-10,2017-09-15,Disruption of the manufacture of the drug.,2017-07-25,2017-09-19
27329,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-10-09,2018-01-10,2018-01-24,Disruption of the manufacture of the drug.,2017-10-27,2018-01-26
38854,2261634,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,250MG,6,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2018-02-28,2018-03-06,2018-04-30,2018-04-17,Disruption of the manufacture of the drug.,2018-02-06,2018-04-19
8912,2418460,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,200MG,5 mL,ORAL,Actual shortage,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-05-01,,,Other (Please describe in comments),2017-05-04,2018-12-20
22741,2261642,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,600MG,30,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-09-18,,2018-10-02,Disruption of the manufacture of the drug.,2017-09-19,2018-10-03
5457,2063735,Shortage,PMS-BACLOFEN,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017-03-30,,2017-07-23,Disruption of the manufacture of the drug.,2017-04-04,2017-07-24
10086,2063735,Shortage,PMS-BACLOFEN,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017-05-01,2017-05-01,2017-07-23,2017-07-23,Disruption of the manufacture of the drug.,2017-05-11,2017-10-11
25740,2063735,Shortage,PMS-BACLOFEN,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,10MG,500,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017-10-01,2018-01-09,2018-01-24,Disruption of the manufacture of the drug.,2017-10-12,2018-01-26
27336,2063743,Shortage,PMS-BACLOFEN TAB 20MG,PHARMASCIENCE INC,BACLOFEN,BACLOFEN,20MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017-10-09,2018-02-12,2018-02-16,Disruption of the manufacture of the drug.,2017-10-27,2018-02-17
72648,2330237,Shortage,PMS-BETAHISTINE,PHARMASCIENCE INC,BETAHYSTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2019-01-16,2019-03-29,2019-05-07,Demand increase for the drug.,2019-01-16,2019-05-09
25826,2330237,Shortage,PMS-BETAHISTINE,PHARMASCIENCE INC,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017-10-01,2017-11-17,2017-11-14,Disruption of the manufacture of the drug.,2017-10-12,2017-11-17
98793,2330237,Shortage,PMS-BETAHISTINE,PHARMASCIENCE INC,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Anticipated shortage,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,2019-11-18,,2020-07-01,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
7338,2275589,Shortage,PMS-BICALUTAMIDE,PHARMASCIENCE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,100,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,2017-08-17,2017-08-17,2018-06-20,2018-06-26,Disruption of the manufacture of the drug.,2017-04-20,2018-06-29
6105,2275589,Shortage,PMS-BICALUTAMIDE,PHARMASCIENCE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-05-17,2018-05-30,2018-06-06,Disruption of the manufacture of the drug.,2017-04-07,2018-06-07
8919,582883,Shortage,PMS-BISACODYL,PHARMASCIENCE INC,BISACODYL,BISACODYL,10MG,100,RECTAL,Actual shortage,SUPPOSITORY,A06AB,DRUGS FOR CONSTIPATION,2017-07-17,2017-07-17,,,Other (Please describe in comments),2017-05-04,2018-12-20
32035,2383020,Shortage,PMS-BOSENTAN,PHARMASCIENCE INC,BOSENTAN,BOSENTAN,125MG,60,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2017-12-07,2018-02-16,2018-02-16,Disruption of the manufacture of the drug.,2017-12-07,2018-02-17
1774,2246284,Shortage,PMS-BRIMONIDINE,PHARMASCIENCE INC,Brimonidine,BRIMONIDINE TARTRATE,0.2%,5 ml & 10 ml,OPHTHALMIC,Actual shortage,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2013-07-23,,,Other (Please describe in comments),2017-03-13,2017-10-05
79878,2424851,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,BUPRENORPHINE - NALOXONE,BUPRENORPHINE  NALOXONE,2MG  0.5MG,30,SUBLINGUAL,Avoided shortage,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,2019-05-07,,2019-06-17,2019-05-01,Demand increase for the drug.,2019-03-29,2019-05-01
83732,2424878,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,BUPRENORPHINE - NALO,BUPRENORPHINE  NALOXONE,8MG  2MG,2ml,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2019-06-03,2019-07-29,2019-07-29,Demand increase for the drug.,2019-05-09,2019-07-30
2352,2424851,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,PMS - BUPRENORPHINE NALOXONE,BUPRENORPHINE  NALOXONE,2MG  0.5MG,30,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,2017-09-30,,2017-11-30,2017-11-22,Disruption of the manufacture of the drug.,2017-03-14,2017-11-23
17805,2424878,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,BUPRENORPHINE/NALOXONE,BUPRENORPHINE  NALOXONE,8MG  2MG,30,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2017-08-01,2017-11-30,2017-11-22,Disruption of the manufacture of the drug.,2017-08-01,2017-11-23
88025,2424878,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,BUPRENORPHINE-NALOXONE,BUPRENORPHINE  NALOXONE,8MG  2MG,30,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2019-06-27,2019-07-29,2019-07-29,Demand increase for the drug.,2019-06-28,2019-07-30
86234,2424851,Shortage,PMS-BUPRENORPHINE-NALOXONE,PHARMASCIENCE INC,BUPRENORPHINE - NALO,BUPRENORPHINE  NALOXONE,2MG  0.5MG,100,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2019-05-28,2019-07-10,2019-07-02,Disruption of the manufacture of the drug.,2019-06-11,2019-07-03
18860,2230942,Shortage,PMS-BUSPIRONE,PHARMASCIENCE INC,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,,2017-08-10,,2018-05-04,Disruption of the manufacture of the drug.,2017-08-11,2018-05-05
8925,2230942,Shortage,PMS-BUSPIRONE,PHARMASCIENCE INC,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,2017-06-12,,2017-07-09,2017-07-09,Disruption of the manufacture of the drug.,2017-05-04,2017-07-19
88585,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-08-12,2019-07-29,,,Disruption of the manufacture of the drug.,2019-07-05,2019-07-31
67863,2391228,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-28,2019-05-03,2019-02-07,Disruption of the manufacture of the drug.,2018-11-28,2019-02-08
63047,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,BLI 30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-02,2019-02-22,2019-02-07,Disruption of the manufacture of the drug.,2018-10-03,2019-02-08
63054,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-02,2019-01-23,2019-02-07,Disruption of the manufacture of the drug.,2018-10-03,2019-02-08
39510,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-02-16,2018-02-16,2018-04-10,2018-03-06,Disruption of the manufacture of the drug.,2018-02-12,2018-03-07
46689,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-05-12,2018-05-07,2018-07-24,2018-07-12,Disruption of the manufacture of the drug.,2018-04-20,2018-07-13
48514,2391171,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-05-18,2018-05-15,2018-08-17,2018-08-23,Disruption of the manufacture of the drug.,2018-05-04,2018-08-24
77450,2391228,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-03-11,2019-05-08,2019-05-22,2019-05-28,Disruption of the manufacture of the drug.,2019-03-04,2019-06-11
25743,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-10-01,2018-04-13,2018-04-17,Disruption of the manufacture of the drug.,2017-10-12,2018-04-19
25746,2391201,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,PMS-CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-10-01,2018-01-26,2018-02-16,Disruption of the manufacture of the drug.,2017-10-12,2018-02-17
38857,2391228,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-02-02,2018-04-30,2018-04-17,Disruption of the manufacture of the drug.,2018-02-06,2018-04-19
22744,2391201,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-09-19,2018-04-24,2018-04-17,Disruption of the manufacture of the drug.,2017-09-19,2018-04-19
59107,2391201,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-11-01,2018-10-16,2019-01-23,2019-02-07,Disruption of the manufacture of the drug.,2018-08-24,2019-02-08
79847,2391198,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-28,2019-06-03,2019-05-28,Disruption of the manufacture of the drug.,2019-03-29,2019-06-11
98796,2391201,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-01,,2020-10-01,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
98799,2391201,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-01,,2019-12-31,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
98802,2391171,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-01,,2020-01-17,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
4171,2391295,Shortage,PMS-CANDESARTAN HCTZ,PHARMASCIENCE INC,CANDESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-03-23,2017-04-05,2017-04-05,Disruption of the manufacture of the drug.,2017-03-24,2017-04-07
46692,2391295,Shortage,PMS-CANDESARTAN HCTZ,PHARMASCIENCE INC,CANDERSARTAN HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-06-11,2018-06-04,2019-02-19,2019-02-25,Disruption of the manufacture of the drug.,2018-04-20,2019-02-26
17024,2391295,Shortage,PMS-CANDESARTAN HCTZ,PHARMASCIENCE INC,CANDESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-07-01,2018-01-05,2018-01-24,Disruption of the manufacture of the drug.,2017-07-25,2018-01-26
69213,2231543,Shortage,PMS-CARBAMAZEPINE-CR,PHARMASCIENCE INC,CARBAMAZEPINE,CARBAMAZEPINE,200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,,2018-12-11,2019-02-22,2019-01-16,Disruption of the manufacture of the drug.,2018-12-11,2019-01-17
6111,2231544,Shortage,PMS-CARBAMAZEPINE-CR,PHARMASCIENCE INC,CARBAMEZAPINE,CARBAMAZEPINE,400MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,2017-07-24,2017-05-09,,2017-05-09,Disruption of the manufacture of the drug.,2017-04-07,2017-10-11
48529,2245916,Shortage,PMS-CARVEDILOL,PHARMASCIENCE INC,CARVEDILOL,CARVEDILOL,12.5MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2018-05-03,2018-06-19,2018-07-12,Disruption of the manufacture of the drug.,2018-05-04,2018-07-13
48534,2245914,Shortage,PMS-CARVEDILOL,PHARMASCIENCE INC,CARVEDILOL,CARVEDILOL,3.125MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2018-05-03,2018-06-15,2018-06-26,Disruption of the manufacture of the drug.,2018-05-04,2018-06-29
48537,2245915,Shortage,PMS-CARVEDILOL,PHARMASCIENCE INC,CARVEDILOL,CARVEDILOL,6.25MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2018-05-03,2018-06-20,2018-06-26,Disruption of the manufacture of the drug.,2018-05-04,2018-06-29
67866,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-11-28,2019-04-03,2019-03-25,Disruption of the manufacture of the drug.,2018-11-28,2019-03-29
32038,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-12-07,2018-03-15,2018-02-21,Disruption of the manufacture of the drug.,2017-12-07,2018-02-22
37244,2355450,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-01-24,2018-03-19,2018-03-06,Disruption of the manufacture of the drug.,2018-01-26,2018-03-07
25753,2355450,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-10-01,2018-03-19,2018-02-21,Disruption of the manufacture of the drug.,2017-10-12,2018-02-22
18863,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-08-18,,2017-10-02,2017-10-09,Disruption of the manufacture of the drug.,2017-08-11,2017-10-11
61874,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-09-19,2019-04-03,2019-03-25,Disruption of the manufacture of the drug.,2018-09-19,2019-03-29
22747,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-09-19,2018-03-15,2018-02-21,Disruption of the manufacture of the drug.,2017-09-19,2018-02-22
59110,2355442,Shortage,PMS-CELECOXIB,PHARMASCIENCE INC,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-08-24,2018-10-20,2018-10-02,Disruption of the manufacture of the drug.,2018-08-24,2018-10-03
22750,2315963,Shortage,PMS-CETIRIZINE,PHARMASCIENCE INC,CETIRIZINE,CETIRIZINE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,,2017-09-18,2017-11-21,2017-12-04,Disruption of the manufacture of the drug.,2017-09-19,2017-12-08
1816,2280469,Shortage,PMS-CILAZAPRIL,PHARMASCIENCE INC,Cilazapril,CILAZAPRIL,5.0MG,100 & 500,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016-01-18,,,Other (Please describe in comments),2017-03-13,2017-10-05
1822,2280450,Shortage,PMS-CILAZAPRIL,PHARMASCIENCE INC,Cilazapril,CILAZAPRIL,2.5MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016-01-25,,,Other (Please describe in comments),2017-03-13,2017-10-05
1827,2280442,Shortage,PMS-CILAZAPRIL,PHARMASCIENCE INC,Cilazapril,CILAZAPRIL,1.0MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016-02-08,,,Other (Please describe in comments),2017-03-13,2017-10-05
90458,2248437,Shortage,PMS-CIPROFLOXACIN,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,250MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2019-09-07,2019-09-09,2020-03-02,,Disruption of the manufacture of the drug.,2019-07-31,2019-11-15
46698,2248438,Shortage,PMS-CIPROFLOXACIN,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2018-05-27,,2018-10-02,2018-06-26,Disruption of the manufacture of the drug.,2018-04-20,2018-06-29
77453,2248438,Shortage,PMS-CIPROFLOXACIN,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-03-01,,2019-07-30,Disruption of the manufacture of the drug.,2019-03-04,2019-07-31
64811,2416433,Shortage,PMS-CIPROFLOXACIN XL,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,,2018-10-17,2018-11-10,2018-11-27,Disruption of the manufacture of the drug.,2018-10-19,2018-11-28
40592,2416433,Shortage,PMS-CIPROFLOXACIN XL,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,2018-03-08,2018-03-06,,2018-09-18,Disruption of the manufacture of the drug.,2018-02-22,2018-09-19
72611,2416433,Shortage,PMS-CIPROFLOXACIN XL,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J01MA,QUINOLONE ANTIBACTERIALS,,2019-01-16,2019-07-31,2019-07-29,Disruption of the manufacture of the drug.,2019-01-16,2019-07-31
29500,2270609,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-11-16,2017-11-27,2017-12-12,Disruption of the manufacture of the drug.,2017-11-17,2017-12-15
37247,2270609,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-01-24,2018-05-22,2018-05-15,Disruption of the manufacture of the drug.,2018-01-26,2018-05-18
17028,2248010,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-07-01,,2017-12-14,Disruption of the manufacture of the drug.,2017-07-25,2017-12-15
7347,2248011,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,40MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-20,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-20,2018-05-05
21496,2248010,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-09-15,2017-09-15,,2017-12-14,Disruption of the manufacture of the drug.,2017-09-07,2017-12-15
21499,2248010,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-09-23,2017-09-23,,2017-12-14,Disruption of the manufacture of the drug.,2017-09-07,2017-12-15
21503,2248011,Shortage,PMS-CITALOPRAM,PHARMASCIENCE INC,CITALOPRAM,CITALOPRAM,40MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-09-01,2018-02-26,2018-02-16,Disruption of the manufacture of the drug.,2017-09-07,2018-02-17
13694,2247574,Shortage,PMS-CLARITHROMYCIN,PHARMASCIENCE INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,250,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017-07-17,2017-07-17,2018-01-29,2018-02-08,Disruption of the manufacture of the drug.,2017-06-23,2018-02-12
17031,2247574,Shortage,PMS-CLARITHROMYCIN,PHARMASCIENCE INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-07-01,2018-01-29,2018-02-08,Disruption of the manufacture of the drug.,2017-07-25,2018-02-12
38886,2247573,Shortage,PMS-CLARITHROMYCIN,PHARMASCIENCE INC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-02-02,2018-05-10,2018-05-04,Disruption of the manufacture of the drug.,2018-02-06,2018-05-05
38893,2247573,Shortage,PMS-CLARITHROMYCIN,PHARMASCIENCE INC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,250,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-02-02,,,Disruption of the manufacture of the drug.,2018-02-06,2018-02-22
1833,2244474,Shortage,PMS-CLOBAZAM,PHARMASCIENCE INC,Clobazam,CLOBAZAM,10MG,30,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2014-04-04,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
25727,2048701,Shortage,PMS-CLONAZEPAM TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-10-01,2018-03-15,2018-03-06,Demand increase for the drug.,2017-10-12,2018-03-07
31649,2048701,Shortage,PMS-CLONAZEPAM TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-12-01,2018-03-06,2018-03-06,Disruption of the manufacture of the drug.,2017-12-04,2018-03-07
8555,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-07-29,2017-07-29,2017-10-25,2017-10-10,Disruption of the manufacture of the drug.,2017-05-02,2017-10-11
8564,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,500,ORAL,Avoided shortage,TABLET,N03AE,ANTIEPILEPTICS,2017-07-13,2017-07-13,,2017-05-31,Disruption of the manufacture of the drug.,2017-05-02,2017-10-12
28789,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-11-10,2018-02-20,2018-03-19,Disruption of the manufacture of the drug.,2017-11-09,2018-03-20
13697,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-07-25,2017-07-25,2017-10-12,2017-10-10,Disruption of the manufacture of the drug.,2017-06-23,2017-10-11
38896,2048728,Shortage,PMS-CLONAZEPAM TAB 1.0MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,1MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2018-02-02,2018-09-04,2018-06-26,Disruption of the manufacture of the drug.,2018-02-06,2018-06-29
29506,2048736,Shortage,PMS-CLONAZEPAM TAB 2MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,2MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-11-16,2017-12-18,2017-12-15,Disruption of the manufacture of the drug.,2017-11-17,2017-12-18
39519,2048736,Shortage,PMS-CLONAZEPAM TAB 2MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,2MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2018-02-21,2018-02-20,2018-05-22,2018-06-06,Disruption of the manufacture of the drug.,2018-02-12,2018-06-07
40595,2048736,Shortage,PMS-CLONAZEPAM TAB 2MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,2MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2018-03-31,2018-03-07,2018-06-15,2018-06-26,Disruption of the manufacture of the drug.,2018-02-22,2018-06-29
31652,2048736,Shortage,PMS-CLONAZEPAM TAB 2MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,2MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-12-01,2017-12-18,2017-12-15,Disruption of the manufacture of the drug.,2017-12-04,2017-12-18
8550,2179660,Shortage,PMS-CLONAZEPAM- TAB 0.25MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.25MG,100,ORAL,Avoided shortage,TABLET,N03AE,ANTIEPILEPTICS,2017-06-19,2017-06-19,2017-08-21,2017-05-23,Disruption of the manufacture of the drug.,2017-05-02,2017-10-12
87930,2179660,Shortage,PMS-CLONAZEPAM- TAB 0.25MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.25MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2019-05-28,2019-08-15,2019-08-16,Disruption of the manufacture of the drug.,2019-06-28,2019-09-12
86222,2179660,Shortage,PMS-CLONAZEPAM- TAB 0.25MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.25MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2019-05-28,2019-08-13,2019-09-02,Disruption of the manufacture of the drug.,2019-06-11,2019-09-03
22753,2179660,Shortage,PMS-CLONAZEPAM- TAB 0.25MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.25MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-09-15,2018-04-30,2018-04-17,Disruption of the manufacture of the drug.,2017-09-19,2018-04-19
21506,2207818,Shortage,PMS-CLONAZEPAM-R TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-09-04,2017-10-11,2017-10-10,Disruption of the manufacture of the drug.,2017-09-07,2017-10-11
13700,2207818,Shortage,PMS-CLONAZEPAM-R TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-07-06,2017-07-06,,2017-10-10,Disruption of the manufacture of the drug.,2017-06-23,2017-10-11
40598,2207818,Shortage,PMS-CLONAZEPAM-R TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2018-02-20,2018-08-01,2018-08-23,Disruption of the manufacture of the drug.,2018-02-22,2018-08-24
38809,2207818,Shortage,PMS-CLONAZEPAM-R TAB 0.5MG,PHARMASCIENCE INC,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2018-02-02,2018-08-01,2018-08-23,Disruption of the manufacture of the drug.,2018-02-06,2018-08-24
40601,2348004,Shortage,PMS-CLOPIDOGREL,PHARMASCIENCE INC,CLOPIDOGREL,CLOPIDOGREL,75MG,500,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2018-02-20,2018-09-10,2018-08-23,Disruption of the manufacture of the drug.,2018-02-22,2018-08-24
55732,2348004,Shortage,PMS-CLOPIDOGREL,PHARMASCIENCE INC,CLOPIDOGREL,CLOPIDOGREL,75MG,100,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2018-07-19,,,2018-10-01,Disruption of the manufacture of the drug.,2018-07-13,2018-10-18
8573,2402181,Shortage,PMS-COLCHICINE,PHARMASCIENCE INC,COLCHICINE,COLCHICINE,0.6MG,100,ORAL,Actual shortage,TABLET,M04AC,ANTIGOUT PREPARATIONS,2017-05-05,2017-05-05,2019-11-15,,Shortage of an active ingredient.,2017-05-02,2019-11-12
38812,2402181,Shortage,PMS-COLCHICINE,PHARMASCIENCE INC,COLCHICINE,COLCHICINE,0.6MG,30,ORAL,Actual shortage,TABLET,M04AC,ANTIGOUT PREPARATIONS,2018-02-02,2018-02-16,2020-01-01,,Disruption of the manufacture of the drug.,2018-02-06,2019-06-11
13100,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017-06-17,2017-06-17,2017-07-11,2017-07-11,Disruption of the manufacture of the drug.,2017-06-16,2017-10-13
28792,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017-11-13,2017-12-15,2018-04-26,2018-05-04,Disruption of the manufacture of the drug.,2017-11-09,2018-05-05
15097,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2017-09-11,2017-09-11,2018-04-26,2018-04-17,Disruption of the manufacture of the drug.,2017-07-11,2018-04-19
15100,2212048,Shortage,PMS-CYCLOBENZAPRINE - TAB 10MG,PHARMASCIENCE INC,CYCLOBENZAPRINE,CYCLOBENZAPRINE HYDROCHLORIDE,10MG,500,ORAL,Actual shortage,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",2018-06-09,2018-05-04,,,Disruption of the manufacture of the drug.,2017-07-11,2018-12-20
79875,2406764,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,20MG,5ML,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2019-03-27,2019-08-02,2019-09-09,Disruption of the manufacture of the drug.,2019-03-29,2019-09-12
83726,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,20ml,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,2019-06-03,2019-09-09,2019-11-01,2019-11-01,Demand increase for the drug.,2019-05-09,2019-11-15
38205,2406764,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,20MG,5ML,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,L01BC,ANTIMETABOLITES,,2018-02-02,,,Disruption of the manufacture of the drug.,2018-02-02,2018-06-27
4178,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,20ml,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,L01BC,ANTIMETABOLITES,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
37250,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,10ML,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Actual shortage,SOLUTION,L01BC,ANTIMETABOLITES,,2018-01-24,,,Disruption of the manufacture of the drug.,2018-01-26,2018-02-15
7353,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,20,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2017-04-19,2017-06-02,2017-06-08,Disruption of the manufacture of the drug.,2017-04-20,2017-06-09
88019,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,20ML,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2019-06-03,2019-08-02,2019-09-03,Delay in shipping of the drug.,2019-06-28,2019-09-04
88022,2406772,Shortage,PMS-CYTARABINE,PHARMASCIENCE INC,CYTARABINE,CYTARABINE,100MG,10ML,INTRATHECAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2019-07-30,2019-10-22,2019-11-01,Delay in shipping of the drug.,2019-06-28,2019-11-15
4181,2304376,Shortage,PMS-DESMOPRESSIN,PHARMASCIENCE INC,DESMOPRESSIN,DESMOPRESSIN ACETATE,0.2MG,100,ORAL,Actual shortage,TABLET,H01BA,POSTERIOR PITUITARY LOBE HORMONES,2017-08-28,2017-08-28,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
22756,2279363,Shortage,PMS-DEXAMETHASONE,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,2MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-09-18,2018-04-07,2018-04-17,Disruption of the manufacture of the drug.,2017-09-19,2018-04-19
4184,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10ml,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-09-29,2017-10-24,2017-10-24,Disruption of the manufacture of the drug.,2017-03-24,2017-11-20
5467,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10ml,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-03-23,2017-04-25,2017-04-25,Disruption of the manufacture of the drug.,2017-04-04,2017-11-20
39522,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASON PHOSPHATE,DEXAMETHASONE PHOSPHATE,10MG,90,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2018-02-12,2018-02-19,2018-10-01,2018-10-01,Disruption of the manufacture of the drug.,2018-02-12,2018-10-03
7356,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10 ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-04-19,2017-12-18,2018-01-12,Disruption of the manufacture of the drug.,2017-04-20,2018-01-13
6117,783900,Shortage,PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,10MG,10 ML,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-04-05,2017-05-29,2017-05-29,Disruption of the manufacture of the drug.,2017-04-07,2017-11-20
21517,2247492,Shortage,PMS-DIAZEPAM,PHARMASCIENCE INC,DIAZEPAM,DIAZEPAM,10MG,500,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2017-09-01,,,Other (Please describe in comments),2017-09-07,2017-10-05
21523,2247491,Shortage,PMS-DIAZEPAM,PHARMASCIENCE INC,DIAZEPAM,DIAZEPAM,5MG,500,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2017-09-01,,,Other (Please describe in comments),2017-09-07,2017-10-05
21512,891797,Shortage,PMS-DIAZEPAM SOLUTION 1MG/ML,PHARMASCIENCE INC,DIAZEPAM,DIAZEPAM,1MG,500,ORAL,Actual shortage,SOLUTION,N05BA,ANXIOLYTICS,,2017-09-01,,,Other (Please describe in comments),2017-09-07,2017-10-05
15104,2302624,Shortage,PMS-DICLOFENAC,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,50MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-10-07,2017-10-07,2018-05-04,2018-05-15,Disruption of the manufacture of the drug.,2017-07-11,2018-05-18
53232,2302616,Shortage,PMS-DICLOFENAC,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,25MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-08-11,2018-08-23,2018-10-25,2018-11-27,Disruption of the manufacture of the drug.,2018-06-29,2018-11-28
98805,2302616,Shortage,PMS-DICLOFENAC,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,25MG,100,ORAL,Anticipated shortage,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2020-03-01,,2020-05-02,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
53237,2302624,Shortage,PMS-DICLOFENAC,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,50MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-06-26,2018-09-25,2018-10-01,Disruption of the manufacture of the drug.,2018-06-29,2018-10-03
10665,2239753,Shortage,PMS-DICLOFENAC K,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC POTASSIUM,50MG,100,ORAL,Resolved,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-06-30,,2017-07-21,2017-07-18,Disruption of the manufacture of the drug.,2017-05-18,2017-07-19
83735,2413469,Shortage,PMS-DICLOFENAC-MISOPROSTOL,PHARMASCIENCE INC,DICLOFENAC-MISOPROST,MISOPROSTOL  DICLOFENAC SODIUM,200MCG  50MG,70,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-06-25,2019-07-30,2019-11-11,,Disruption of the manufacture of the drug.,2019-05-09,2019-11-15
88034,2413469,Shortage,PMS-DICLOFENAC-MISOPROSTOL,PHARMASCIENCE INC,DICLOFENAC-MISOPROSOL,MISOPROSTOL  DICLOFENAC SODIUM,200MCG  50MG,70,ORAL,Resolved,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-06-25,,2019-10-28,2019-09-03,Disruption of the manufacture of the drug.,2019-06-28,2019-09-04
98808,2413477,Shortage,PMS-DICLOFENAC-MISOPROSTOL,PHARMASCIENCE INC,DICLOFENAC - MISOPROSTOL,MISOPROSTOL  DICLOFENAC SODIUM,200MCG  75MG,250,ORAL,Anticipated shortage,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-11-18,,2020-03-01,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
32041,2231504,Shortage,PMS-DICLOFENAC-SR,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,75MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-12-17,2017-12-18,2018-04-23,2018-04-17,Disruption of the manufacture of the drug.,2017-12-07,2018-04-19
46701,2231505,Shortage,PMS-DICLOFENAC-SR,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,100MG,250,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-04-20,,,Other (Please describe in comments),2018-04-20,2018-04-21
63099,2231505,Shortage,PMS-DICLOFENAC-SR,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-10-02,2019-03-01,2019-03-25,Disruption of the manufacture of the drug.,2018-10-03,2019-03-28
61879,2231504,Shortage,PMS-DICLOFENAC-SR,PHARMASCIENCE INC,DICLONEFAC,DICLOFENAC SODIUM,75MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-09-19,2019-02-20,2019-02-25,Disruption of the manufacture of the drug.,2018-09-19,2019-02-26
15107,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017-07-19,2017-12-18,,,Disruption of the manufacture of the drug.,2017-07-11,2018-12-20
15110,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,500,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-07-03,,,Disruption of the manufacture of the drug.,2017-07-11,2019-09-12
21526,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-09-04,,2018-03-06,Other (Please describe in comments),2017-09-07,2018-03-07
21529,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,500,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-09-04,,,Other (Please describe in comments),2017-09-07,2018-12-20
4187,2355752,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,500,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
4190,2355779,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
4193,2355779,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,500,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
4196,2355760,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-23,2017-04-17,2017-03-30,Shortage of an inactive ingredient or component.,2017-03-24,2017-03-31
10677,2355752,Shortage,PMS-DILTIAZEM CD,PHARMASCIENCE INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Actual shortage,CAPSULE (CONTROLLED-DELIVERY),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2017-08-28,2017-08-28,,,Delay in shipping of the drug.,2017-05-18,2018-12-20
88590,703508,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,4MG,90,ORAL,Actual shortage,SYRUP,A06AA,DRUGS FOR CONSTIPATION,,2019-09-09,,,Disruption of the manufacture of the drug.,2019-07-05,2019-09-12
46704,703494,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-04-17,2018-10-03,2018-10-02,Disruption of the manufacture of the drug.,2018-04-20,2018-10-03
46707,703494,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,1000,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-04-17,2018-05-01,2018-05-15,Disruption of the manufacture of the drug.,2018-04-20,2018-05-18
37257,703494,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-01-24,2018-03-06,2018-03-06,Disruption of the manufacture of the drug.,2018-01-26,2018-03-07
17035,703494,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,1000,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2017-07-01,2018-02-20,2018-02-19,Delay in shipping of the drug.,2017-07-25,2018-02-20
55735,703494,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,1000,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,2018-08-09,2018-08-23,2018-10-15,2018-10-17,Disruption of the manufacture of the drug.,2018-07-13,2018-10-18
27339,848417,Shortage,PMS-DOCUSATE SODIUM,PHARMASCIENCE INC,DOCUSATE SODIUM,DOCUSATE SODIUM,50MG,90,ORAL,Actual shortage,SYRUP,A06AA,DRUGS FOR CONSTIPATION,2017-11-28,2017-12-18,,,Disruption of the manufacture of the drug.,2017-10-27,2019-09-12
8584,880140,Shortage,PMS-DOCUSATE SODIUM DROPS 10MG/ML,PHARMASCIENCE INC,DOCUSATE,DOCUSATE SODIUM,10MG,BOTTLE 500mL,ORAL,Actual shortage,DROPS,A06AA,DRUGS FOR CONSTIPATION,,2017-05-01,,,Disruption of the manufacture of the drug.,2017-05-02,2018-12-20
83660,2236466,Shortage,PMS-DOMPERIDONE,PHARMASCIENCE INC,DOMPERIDONE,DOMPERIDONE,10MG,500,ORAL,Actual shortage,TABLET,A03FA,PROPULSIVES,,2019-05-08,,,Disruption of the manufacture of the drug.,2019-05-09,2019-09-12
6120,2442426,Shortage,PMS-DORZOLAMIDE-TIMOLOL,PHARMASCIENCE INC,DORZOLAMIDE TIMOLOL,TIMOLOL  DORZOLAMIDE,5MG  20MG,10ML,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-05-01,,,Disruption of the manufacture of the drug.,2017-04-07,2018-12-20
32166,2406187,Shortage,PMS-DOXYLAMINE-PYRIDOXINE,PHARMASCIENCE INC,DOXYLAMINE-PRIDOXINE,DOXYLAMINE SUCCINATE  PYRIDOXINE HYDROCHLORIDE,10MG  10MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,2018-01-02,2018-01-24,2018-09-13,2018-09-16,Disruption of the manufacture of the drug.,2017-12-08,2018-09-17
15114,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-08-15,2017-08-15,2018-01-10,2017-12-15,Disruption of the manufacture of the drug.,2017-07-11,2017-12-18
15119,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-07-03,,2017-08-03,Disruption of the manufacture of the drug.,2017-07-11,2017-08-11
15122,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOEXTINE,DULOXETINE,60MG,100,ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-09-14,2017-09-14,2017-09-20,2017-07-07,Disruption of the manufacture of the drug.,2017-07-11,2017-10-12
21533,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-09-14,2017-09-14,2018-02-28,2018-03-23,Disruption of the manufacture of the drug.,2017-09-07,2018-03-24
11297,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-06-14,2017-06-14,2017-08-07,2017-12-15,Disruption of the manufacture of the drug.,2017-05-25,2017-12-18
64814,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-10-17,2019-06-17,2019-06-27,Disruption of the manufacture of the drug.,2018-10-19,2019-06-28
13103,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-08-12,2017-08-12,2017-10-12,2017-12-15,Disruption of the manufacture of the drug.,2017-06-16,2017-12-18
13106,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-09-06,2017-12-15,2017-09-20,2018-03-01,Disruption of the manufacture of the drug.,2017-06-16,2018-03-02
90461,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2019-08-01,,2019-08-15,2019-09-09,Disruption of the manufacture of the drug.,2019-07-31,2019-09-12
69246,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2019-01-07,2019-01-16,2019-04-05,2019-05-07,Disruption of the manufacture of the drug.,2018-12-11,2019-05-09
37260,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2018-03-18,2018-02-05,2018-11-15,2018-06-26,Disruption of the manufacture of the drug.,2018-01-26,2018-06-29
17038,2429454,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,60MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2017-11-07,2017-12-15,2018-03-29,2018-02-21,Disruption of the manufacture of the drug.,2017-07-25,2018-02-22
77456,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-28,2019-08-07,2019-09-09,Shortage of an active ingredient.,2019-03-04,2019-09-12
79786,2429446,Shortage,PMS-DULOXETINE,PHARMASCIENCE INC,DULOXETINE,DULOXETINE,30MG,30,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,2019-08-05,,2019-08-20,2019-09-09,Disruption of the manufacture of the drug.,2019-03-28,2019-09-12
13109,2393220,Shortage,PMS-DUTASTERIDE,PHARMASCIENCE INC,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-07-24,2017-07-24,2017-08-21,2017-12-15,Disruption of the manufacture of the drug.,2017-06-16,2017-12-18
17043,2393220,Shortage,PMS-DUTASTERIDE,PHARMASCIENCE INC,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Actual shortage,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-07-01,2020-01-01,,Disruption of the manufacture of the drug.,2017-07-25,2019-06-11
38866,2393220,Shortage,PMS-DUTASTERIDE,PHARMASCIENCE INC,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Actual shortage,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-02-10,2018-02-16,2020-01-01,,Disruption of the manufacture of the drug.,2018-02-06,2019-06-11
1837,2434350,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,Eletriptan,ELETRIPTAN,40MG,30,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015-08-13,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1844,2434350,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,Eletriptan,ELETRIPTAN,40MG,6,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015-06-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1853,2434342,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,Eletriptan,ELETRIPTAN,20MG,30,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2016-06-03,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
8590,2434342,Shortage,PMS-ELETRIPTAN,PHARMASCIENCE INC,ELETRIPTAN,ELETRIPTAN,20MG,6,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2017-07-13,2017-07-13,,,Disruption of the manufacture of the drug.,2017-05-02,2018-12-20
1860,2300095,Shortage,PMS-ENALAPRIL,PHARMASCIENCE INC,Enalapril,ENALAPRIL SODIUM,8MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2015-07-20,,,Other (Please describe in comments),2017-03-13,2017-10-05
1869,2300095,Shortage,PMS-ENALAPRIL,PHARMASCIENCE INC,ENALAPRIL,ENALAPRIL SODIUM,8MG,500,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2015-09-23,,,Other (Please describe in comments),2017-03-13,2017-10-05
1875,2300079,Shortage,PMS-ENALAPRIL,PHARMASCIENCE INC,Enalapril,ENALAPRIL SODIUM,2.0MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2015-09-23,,,Demand increase for the drug.,2017-03-13,2017-10-05
5472,2430576,Shortage,PMS-ENTECAVIR,PHARMASCIENCE INC,ENTECAVIR,ENTECAVIR,0.5MG,30,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,,2017-03-31,2017-10-18,2017-10-17,Disruption of the manufacture of the drug.,2017-04-04,2017-10-26
38869,2430576,Shortage,PMS-ENTECAVIR,PHARMASCIENCE INC,ENTECAVIR,ENTECAVIR,0.5MG,30,ORAL,Resolved,TABLET,J05AF,DIRECT ACTING ANTIVIRALS,2018-02-14,2018-02-16,2018-10-07,2018-06-26,Disruption of the manufacture of the drug.,2018-02-06,2018-06-29
83663,2410400,Shortage,PMS-EPIRUBICIN,PHARMASCIENCE INC,EPIRUBICIN,EPIRUBICIN HYDROCHLORIDE,2MG,5ml,INTRAVENOUS,Resolved,SOLUTION,L01DB,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,,2019-07-30,,2019-09-02,Disruption of the manufacture of the drug.,2019-05-09,2019-09-03
63102,2454394,Shortage,PMS-ERLOTINIB,PHARMASCIENCE INC,ERLOTINIB,ERLOTINIB,150MG,30,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-07-30,2019-07-31,2019-09-09,Disruption of the manufacture of the drug.,2018-10-03,2019-09-12
87941,2454386,Shortage,PMS-ERLOTINIB,PHARMASCIENCE INC,ERLOTINIB,ERLOTINIB,100MG,30,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-07-30,2019-08-02,2019-09-09,Delay in shipping of the drug.,2019-06-28,2019-09-12
6123,2454386,Shortage,PMS-ERLOTINIB,PHARMASCIENCE INC,ERLOTINIB,ERLOTINIB,100MG,30,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2017-07-14,2017-07-14,,2018-05-04,Shortage of an active ingredient.,2017-04-07,2018-05-05
6325,2303949,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6328,2303949,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6331,2303965,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6334,2303965,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
37241,2379171,Shortage,PMS-ESOMEPRAZOLE DR,PHARMASCIENCE INC,ESOMEPRAZOLE DR,ESOMEPRAZOLE,40MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-01-24,,,Disruption of the manufacture of the drug.,2018-01-26,2018-01-26
37266,2379171,Shortage,PMS-ESOMEPRAZOLE DR,PHARMASCIENCE INC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,30,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-01-24,,,Disruption of the manufacture of the drug.,2018-01-26,2018-01-26
32044,2416409,Shortage,PMS-EZETIMIBE,PHARMASCIENCE INC,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-07,2018-03-01,2018-02-21,Disruption of the manufacture of the drug.,2017-12-07,2018-02-22
83666,2416409,Shortage,PMS-EZETIMIBE,PHARMASCIENCE INC,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-08,2019-06-10,2019-07-29,Demand increase for the drug.,2019-05-09,2019-07-31
32047,2278081,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,125MG,10,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-30,,,Disruption of the manufacture of the drug.,2017-12-07,2019-09-12
4199,2278111,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,500MG,21,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-03-23,2017-04-10,2017-04-10,Disruption of the manufacture of the drug.,2017-03-24,2017-04-13
28797,2278111,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,500MG,21,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-11-10,,,Disruption of the manufacture of the drug.,2017-11-09,2017-11-11
87944,2278103,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-09-09,,,Disruption of the manufacture of the drug.,2019-06-28,2019-09-12
12211,2278103,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-06-26,2017-06-26,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-06-07,2017-10-11
22760,2278111,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-09-15,,,Disruption of the manufacture of the drug.,2017-09-19,2018-12-20
6126,2278103,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,250MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-04-12,2017-04-12,,,Disruption of the manufacture of the drug.,2017-04-07,2018-12-20
38902,2278103,Shortage,PMS-FAMCICLOVIR,PHARMASCIENCE INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-02-02,2018-07-18,2018-08-24,Disruption of the manufacture of the drug.,2018-02-06,2018-08-25
42096,2341417,Shortage,PMS-FENTANYL MTX,PHARMASCIENCE INC,FENTANYL,FENTANYL,100MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2018-03-06,2018-03-30,2018-03-23,Disruption of the manufacture of the drug.,2018-03-07,2018-03-24
25764,2341387,Shortage,PMS-FENTANYL MTX,PHARMASCIENCE INC,FENTANYL MTX,FENTANYL,25MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017-10-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-10-12,2018-05-05
25767,2341395,Shortage,PMS-FENTANYL MTX,PHARMASCIENCE INC,FENTANYL,FENTANYL,50MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017-10-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-10-12,2018-05-05
25770,2341409,Shortage,PMS-FENTANYL MTX,PHARMASCIENCE INC,FENTANYL,FENTANYL,75MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017-10-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-10-12,2018-05-05
49737,2310112,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,5MG,30,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-06-01,2018-06-04,2018-10-15,2018-10-17,Disruption of the manufacture of the drug.,2018-05-18,2018-10-18
4202,2320169,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,1MG,30,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017-03-23,,2018-05-04,Shortage of an active ingredient.,2017-03-24,2018-05-05
4205,2320169,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,1MG,100,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2017-03-23,2018-05-04,2018-05-15,Shortage of an active ingredient.,2017-03-24,2018-05-18
4208,2310112,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-03-23,2018-10-15,2018-10-17,Disruption of the manufacture of the drug.,2017-03-24,2018-10-18
7361,2310112,Shortage,PMS-FINASTERIDE,PHARMASCIENCE INC,FINASTERIDE,FINASTERIDE,5MG,30,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-04-19,2017-07-05,2017-07-23,Disruption of the manufacture of the drug.,2017-04-20,2017-07-25
1890,2282348,Shortage,PMS-FLUCONAZOLE,PHARMASCIENCE INC,Fluconazole,FLUCONAZOLE,150MG,1,ORAL,Actual shortage,CAPSULE,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2015-08-14,,,Requirements related to complying with good manufacturing practices.,2017-03-13,2019-09-12
46710,2245644,Shortage,PMS-FLUCONAZOLE,PHARMASCIENCE INC,FLUCONAZOLE,FLUCONAZOLE,100MG,50,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2018-04-20,2018-05-30,2018-05-15,Disruption of the manufacture of the drug.,2018-04-20,2018-05-18
61882,2245643,Shortage,PMS-FLUCONAZOLE,PHARMASCIENCE INC,FLUCONAZOLE,FLUCONAZOLE,50MG,50,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2018-09-19,2018-12-27,2019-01-16,Disruption of the manufacture of the drug.,2018-09-19,2019-01-17
83669,2245644,Shortage,PMS-FLUCONAZOLE,PHARMASCIENCE INC,FLUCONAZOLE,FLUCONAZOLE,100MG,50,ORAL,Resolved,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2019-08-05,,2019-09-12,2019-09-09,Disruption of the manufacture of the drug.,2019-05-09,2019-09-12
46713,2177579,Shortage,PMS-FLUOXETINE - CAP 10MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,10MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-04-25,2018-05-04,2018-06-08,2018-06-06,Disruption of the manufacture of the drug.,2018-04-20,2018-06-07
72614,2177579,Shortage,PMS-FLUOXETINE - CAP 10MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,10MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-01-16,2019-02-25,2019-02-25,Disruption of the manufacture of the drug.,2019-01-16,2019-02-26
21536,2177587,Shortage,PMS-FLUOXETINE - CAP 20MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-10-20,,2017-11-07,2017-11-14,Disruption of the manufacture of the drug.,2017-09-07,2017-11-17
32050,2177587,Shortage,PMS-FLUOXETINE - CAP 20MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-12-18,2017-12-19,2018-02-20,2018-02-19,Disruption of the manufacture of the drug.,2017-12-07,2018-02-20
37269,2177587,Shortage,PMS-FLUOXETINE - CAP 20MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-01-24,2018-02-21,2018-02-19,Disruption of the manufacture of the drug.,2018-01-26,2018-02-20
72617,2177587,Shortage,PMS-FLUOXETINE - CAP 20MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-01-16,2019-03-12,2019-03-25,Disruption of the manufacture of the drug.,2019-01-16,2019-03-28
21539,2243448,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-04,2018-04-02,2018-03-06,Disruption of the manufacture of the drug.,2017-09-07,2018-03-07
21542,2255898,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,600MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-04,,,Other (Please describe in comments),2017-09-07,2018-12-20
87947,2243446,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-06-28,2019-09-03,2019-09-02,Disruption of the manufacture of the drug.,2019-06-28,2019-09-03
17046,2243446,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-07-01,2017-10-30,2017-10-20,Disruption of the manufacture of the drug.,2017-07-25,2017-10-26
17049,2243446,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,100MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-07-01,2018-01-29,2018-02-08,Disruption of the manufacture of the drug.,2017-07-25,2018-02-12
17053,2243447,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,300MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-07-30,2017-07-30,2017-11-28,2017-11-14,Disruption of the manufacture of the drug.,2017-07-25,2017-11-17
17057,2255901,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,800MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2017-07-01,,,Disruption of the manufacture of the drug.,2017-07-25,2017-10-05
25773,2243448,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,400MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-10-01,2018-01-29,2018-02-08,Disruption of the manufacture of the drug.,2017-10-12,2018-02-12
12214,2243448,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-06-06,,2017-06-14,Disruption of the manufacture of the drug.,2017-06-07,2017-06-16
83672,2243446,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-07-30,2019-09-06,2019-09-09,Disruption of the manufacture of the drug.,2019-05-09,2019-09-12
83675,2243447,Shortage,PMS-GABAPENTIN,PHARMASCIENCE INC,GABAPENTIN,GABAPENTIN,300MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-05-08,2019-12-08,2019-11-01,Disruption of the manufacture of the drug.,2019-05-09,2019-11-15
21545,2398389,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,16MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017-09-04,2018-02-15,2018-02-08,Disruption of the manufacture of the drug.,2017-09-07,2018-02-12
21548,2398389,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,16MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017-09-04,2018-02-15,2018-02-08,Disruption of the manufacture of the drug.,2017-09-07,2018-02-12
93813,2398397,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,24MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-09-05,,,Disruption of the manufacture of the drug.,2019-09-12,2019-09-12
13703,2398370,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,8MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017-07-24,2017-09-20,2018-02-16,2018-02-16,Disruption of the manufacture of the drug.,2017-06-23,2018-02-17
87950,2398389,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE,GALANTAMINE,16MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-06-28,2020-03-05,,Disruption of the manufacture of the drug.,2019-06-28,2019-07-31
87953,2398397,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,PMS-GALANTAMINE ER,GALANTAMINE,24MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-06-28,,2019-07-29,Disruption of the manufacture of the drug.,2019-06-28,2019-07-31
77459,2398370,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,8MG,30,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-03-01,2020-01-28,,Disruption of the manufacture of the drug.,2019-03-04,2019-05-09
79789,2398370,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE,GALANTAMINE,8MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2019-03-27,2020-01-28,,Disruption of the manufacture of the drug.,2019-03-28,2019-03-28
25776,2398397,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,24MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017-10-01,2018-04-06,2018-04-17,Disruption of the manufacture of the drug.,2017-10-12,2018-04-19
7364,2398389,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE,GALANTAMINE,16MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017-07-17,,2017-09-19,2017-07-23,Disruption of the manufacture of the drug.,2017-04-20,2017-07-25
7367,2398397,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE,GALANTAMINE,24MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,2017-07-24,2017-07-24,2018-02-15,2018-02-08,Disruption of the manufacture of the drug.,2017-04-20,2018-02-12
6129,2398370,Shortage,PMS-GALANTAMINE ER,PHARMASCIENCE INC,GALANTAMINE ER,GALANTAMINE,8MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06DA,ANTI-DEMENTIA DRUGS,,2017-04-06,2018-02-16,2018-02-16,Disruption of the manufacture of the drug.,2017-04-07,2018-02-17
12217,2236734,Shortage,PMS-GLYBURIDE,PHARMASCIENCE INC,GLYBURIDE,GLYBURIDE,5MG,30,ORAL,Actual shortage,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-06-06,,,Other (Please describe in comments),2017-06-07,2018-12-20
8935,2236734,Shortage,PMS-GLYBURIDE,PHARMASCIENCE INC,GLYBURIDE,GLYBURIDE,5MG,100,ORAL,Actual shortage,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-05-03,,,Other (Please describe in comments),2017-05-04,2018-12-20
39525,2274086,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",2018-02-12,2018-02-19,2018-05-30,2018-05-15,Disruption of the manufacture of the drug.,2018-02-12,2018-05-18
87962,2274086,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2019-05-08,2019-08-01,2019-08-01,Disruption of the manufacture of the drug.,2019-06-28,2019-09-12
72620,2247386,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,25MG,1000,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2019-01-16,2019-03-06,2019-02-25,Delay in shipping of the drug.,2019-01-16,2019-02-26
25780,2247386,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,25MG,1000,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017-10-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-10-12,2018-05-05
83678,2274086,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2019-05-08,2019-07-31,2019-08-01,Disruption of the manufacture of the drug.,2019-05-09,2019-08-02
8944,2274086,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",,2017-05-01,2017-11-17,2017-11-14,Disruption of the manufacture of the drug.,2017-05-04,2017-11-17
51704,2247387,Shortage,PMS-HYDROCHLOROTHIAZIDE,PHARMASCIENCE INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,50MG,100,ORAL,Resolved,TABLET,C03AA,"LOW-CEILING DIURETICS, THIAZIDES",2018-06-17,2018-06-26,2018-12-10,2018-12-11,Disruption of the manufacture of the drug.,2018-06-06,2018-12-12
51712,885444,Shortage,PMS-HYDROMORPHONE TAB 1MG,PHARMASCIENCE INC,HYDROMORPHONE 100 TABS,HYDROMORPHONE HYDROCHLORIDE,1MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2018-06-19,2018-06-26,2018-07-24,2018-08-23,Disruption of the manufacture of the drug.,2018-06-06,2018-08-24
22168,885444,Shortage,PMS-HYDROMORPHONE TAB 1MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,1MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-09-14,2017-09-25,2017-09-25,Disruption of the manufacture of the drug.,2017-09-15,2017-10-11
51707,885444,Shortage,PMS-HYDROMORPHONE TAB 1MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,1MG,4X25,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2018-06-13,2018-06-26,2018-08-25,2018-08-23,Disruption of the manufacture of the drug.,2018-06-06,2018-08-24
22171,885436,Shortage,PMS-HYDROMORPHONE TAB 2MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-09-14,2017-10-31,2017-12-04,Disruption of the manufacture of the drug.,2017-09-15,2017-12-08
22763,885436,Shortage,PMS-HYDROMORPHONE TAB 2MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-09-18,2017-11-03,2017-12-04,Disruption of the manufacture of the drug.,2017-09-19,2017-12-08
22163,885401,Shortage,PMS-HYDROMORPHONE TAB 4MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,4MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-09-14,2017-09-29,2017-10-10,Disruption of the manufacture of the drug.,2017-09-15,2017-10-11
7370,2431122,Shortage,PMS-IMATINIB,PHARMASCIENCE INC,IMATINIB,IMATINIB,400MG,30,ORAL,Actual shortage,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2017-05-20,2017-07-30,,,Demand increase for the drug.,2017-04-20,2019-09-12
59113,2431114,Shortage,PMS-IMATINIB,PHARMASCIENCE INC,IMATINIB,IMATINIB,100MG,120,ORAL,Actual shortage,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2018-07-30,,,Disruption of the manufacture of the drug.,2018-08-24,2019-09-12
94263,2239627,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,0.30MG,90,NASAL,Actual shortage,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2019-10-30,,2019-11-26,,Disruption of the manufacture of the drug.,2019-09-18,2019-11-15
43851,2239627,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,0.30MG,90,INHALATION,Resolved,LIQUID,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2018-03-23,2018-04-30,2018-05-04,Disruption of the manufacture of the drug.,2018-03-23,2018-05-05
5476,2231245,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250MCG,10 X 2 mL,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-08-16,2017-08-16,2017-10-31,2017-12-04,Demand increase for the drug.,2017-04-04,2017-12-07
10097,2231244,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRAPROTIUM,IPRATROPIUM BROMIDE,250MCG,15g,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-06-12,,,2017-06-14,Shortage of an inactive ingredient or component.,2017-05-11,2017-06-16
46716,2231244,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250MCG,120,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-06-01,2018-06-04,2018-09-07,2018-08-23,Shortage of an active ingredient.,2018-04-20,2018-08-24
13706,2231244,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250MCG,20 X 1mL,INHALATION,Avoided shortage,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-01-01,,2018-01-01,2017-12-31,Disruption of the manufacture of the drug.,2017-06-23,2018-01-12
37272,2231136,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,250MCG,20ml,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-02-02,2018-01-30,2018-11-01,2018-06-26,Disruption of the manufacture of the drug.,2018-01-26,2018-06-29
35249,2239627,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,0.30MG,30ml,INHALATION,Resolved,LIQUID,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2018-01-08,2018-02-14,2018-02-16,Disruption of the manufacture of the drug.,2018-01-08,2018-02-17
25783,2231135,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,125MCG,120,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-10-01,2017-10-17,2017-10-24,Disruption of the manufacture of the drug.,2017-10-12,2017-10-26
12220,2231135,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,125MCG,20x2ml,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-08-24,,2017-09-25,2017-09-25,Demand increase for the drug.,2017-06-07,2017-09-26
83681,2239627,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,0.30MG,90,NASAL,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2019-05-08,,2019-07-29,Delay in shipping of the drug.,2019-05-09,2019-07-31
21551,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-09-23,2017-09-23,2017-11-28,2017-10-10,Disruption of the manufacture of the drug.,2017-09-07,2017-10-11
21554,2317087,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-09-23,2017-09-23,2018-05-10,2018-04-17,Disruption of the manufacture of the drug.,2017-09-07,2018-04-19
21558,2317087,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,300MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-09-25,2017-09-25,2018-05-10,2018-04-17,Disruption of the manufacture of the drug.,2017-09-07,2018-04-19
67925,2317060,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-28,2019-06-26,2019-05-28,Disruption of the manufacture of the drug.,2018-11-29,2019-06-11
90464,2317060,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-29,2020-02-26,,Demand increase for the drug.,2019-07-31,2019-11-15
87956,2317060,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-28,2019-08-13,2019-09-02,Disruption of the manufacture of the drug.,2019-06-28,2019-09-03
77462,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-01,2019-08-27,2019-08-18,Disruption of the manufacture of the drug.,2019-03-04,2019-09-12
77465,2317087,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-01,2020-01-28,,Disruption of the manufacture of the drug.,2019-03-04,2019-11-15
87965,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-08,2019-10-01,2019-09-03,Disruption of the manufacture of the drug.,2019-06-28,2019-09-04
87968,2317087,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,300MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-08,2019-10-01,2019-09-03,Disruption of the manufacture of the drug.,2019-06-28,2019-09-04
27343,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-10-09,2017-11-27,2017-11-14,Disruption of the manufacture of the drug.,2017-10-27,2017-11-17
27346,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-10-27,2018-03-02,2018-03-06,Disruption of the manufacture of the drug.,2017-10-27,2018-03-07
83684,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-17,2019-11-15,2019-08-16,Disruption of the manufacture of the drug.,2019-05-09,2019-09-12
83687,2317087,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,300MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-10-17,2020-01-31,,Disruption of the manufacture of the drug.,2019-05-09,2019-10-18
98811,2317079,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-11,,2020-01-24,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
21562,2328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-01,2018-03-07,2018-03-19,Disruption of the manufacture of the drug.,2017-09-07,2018-03-20
4213,2328518,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-08-28,2017-08-28,,2018-04-26,Disruption of the manufacture of the drug.,2017-03-24,2018-04-27
4216,2328526,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-03-23,2018-02-20,2017-09-15,Disruption of the manufacture of the drug.,2017-03-24,2017-09-19
13709,2328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-07-08,2017-07-08,2017-07-31,2017-07-31,Disruption of the manufacture of the drug.,2017-06-23,2017-12-18
87959,2328518,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-17,2020-04-03,,Disruption of the manufacture of the drug.,2019-06-28,2019-11-15
87971,2328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,PMS-IRBESARTAN,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-17,2019-12-04,,Disruption of the manufacture of the drug.,2019-06-28,2019-11-15
7373,2328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-04-30,,2017-05-31,2017-06-08,Disruption of the manufacture of the drug.,2017-04-20,2017-06-09
86225,2328518,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-18,2019-10-25,2019-09-03,Disruption of the manufacture of the drug.,2019-06-11,2019-09-04
10100,2301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISOSORBIDE,ISOSORBIDE-5-MONONITRATE,60MG,3X10,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-05-01,2018-05-30,2018-06-06,Shortage of an inactive ingredient or component.,2017-05-11,2018-06-07
4219,2301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISOSORBIDE,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-03-23,2018-05-30,2018-05-15,Disruption of the manufacture of the drug.,2017-03-24,2018-05-18
79850,2301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2019-04-22,2019-05-08,2019-08-20,2019-09-09,Disruption of the manufacture of the drug.,2019-03-29,2019-09-12
53245,2301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISOSORBIDE,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),C01DA,VASODILATORS USED IN CARDIAC DISEASES,2018-08-20,,,2018-08-19,Disruption of the manufacture of the drug.,2018-06-29,2018-09-19
11301,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,1L,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,2017-09-25,2017-09-25,,2018-05-04,Disruption of the manufacture of the drug.,2017-05-25,2018-05-05
11304,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,15 mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017-05-22,,2017-06-14,Disruption of the manufacture of the drug.,2017-05-25,2017-06-16
11315,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,30 mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017-05-22,,2017-06-14,Disruption of the manufacture of the drug.,2017-05-25,2017-06-16
49744,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,90,ORAL,Actual shortage,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2018-05-16,,,Disruption of the manufacture of the drug.,2018-05-18,2019-09-12
8599,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,BOTTLE,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,2017-05-03,,2017-05-15,2017-05-17,Disruption of the manufacture of the drug.,2017-05-02,2017-05-18
77468,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,30 mL,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2019-02-28,2019-07-05,2019-05-31,Disruption of the manufacture of the drug.,2019-03-04,2019-06-11
48542,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,15,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,2018-05-28,2018-05-16,2018-07-09,2018-07-12,Disruption of the manufacture of the drug.,2018-05-04,2018-07-13
48552,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,90,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,2018-05-22,2018-05-16,2018-08-21,2018-07-12,Disruption of the manufacture of the drug.,2018-05-04,2018-07-13
72623,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,15ml,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2019-01-17,2019-08-22,2019-07-29,Disruption of the manufacture of the drug.,2019-01-16,2019-07-31
25787,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,15mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017-10-01,2017-11-07,2017-11-14,Disruption of the manufacture of the drug.,2017-10-12,2017-11-17
22766,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,30mL,ORAL,Resolved,SYRUP,A06AD,DRUGS FOR CONSTIPATION,,2017-09-18,2017-10-24,2017-10-23,Disruption of the manufacture of the drug.,2017-09-19,2017-10-26
38905,703486,Shortage,PMS-LACTULOSE SYR 667MG/ML,PHARMASCIENCE INC,LACTULOSE,LACTULOSE,667MG,90,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2018-02-02,2018-04-05,2018-04-17,Disruption of the manufacture of the drug.,2018-02-06,2018-04-19
51723,2246898,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-07-15,2018-09-28,2018-08-23,Disruption of the manufacture of the drug.,2018-06-06,2018-08-24
46719,2246897,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-05-10,2018-05-15,,2018-10-02,Disruption of the manufacture of the drug.,2018-04-20,2018-10-03
77471,2246898,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-01,2019-04-29,2019-07-29,Shortage of an active ingredient.,2019-03-04,2019-07-31
79855,2246899,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,150MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-27,2019-06-03,2019-07-29,Shortage of an active ingredient.,2019-03-29,2019-07-31
22769,2246897,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-15,2017-09-25,2017-09-25,Disruption of the manufacture of the drug.,2017-09-19,2017-10-11
1904,2288273,Shortage,PMS-LEFLUNOMIDE,PHARMASCIENCE INC,Leflunomide,LEFLUNOMIDE,20MG,30,ORAL,Actual shortage,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2015-05-07,,,Other (Please describe in comments),2017-03-13,2017-10-05
1907,2288265,Shortage,PMS-LEFLUNOMIDE,PHARMASCIENCE INC,Leflunomide,LEFLUNOMIDE,10MG,30,ORAL,Actual shortage,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2016-07-06,,,Other (Please describe in comments),2017-03-13,2017-10-05
90470,2309114,Shortage,PMS-LETROZOLE,PHARMASCIENCE INC,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Actual shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-03-27,2020-02-17,,Disruption of the manufacture of the drug.,2019-07-31,2019-11-15
8605,2309114,Shortage,PMS-LETROZOLE,PHARMASCIENCE INC,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Avoided shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,2017-10-26,,2017-11-11,2017-09-04,Disruption of the manufacture of the drug.,2017-05-02,2017-09-07
25790,2309114,Shortage,PMS-LETROZOLE,PHARMASCIENCE INC,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-10-01,,2018-09-18,Disruption of the manufacture of the drug.,2017-10-12,2018-09-19
79858,2309114,Shortage,PMS-LETROZOLE,PHARMASCIENCE INC,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-03-27,2019-07-04,2019-05-31,Disruption of the manufacture of the drug.,2019-03-29,2019-06-11
6349,2421488,Shortage,PMS-LEVOCARB CR,PHARMASCIENCE INC,LEVOCARB CR,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6352,2421496,Shortage,PMS-LEVOCARB CR,PHARMASCIENCE INC,LEVOCARB CR,CARBIDOPA  LEVODOPA,50MG  200MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
8608,811874,Shortage,PMS-LIDOCAINE VISCOUS 2%,PHARMASCIENCE INC,LIDOCAINE,LIDOCAINE HYDROCHLORIDE,2%,50,DENTAL,Actual shortage,LIQUID,N01BB,"ANESTHETICS, LOCAL",2017-05-01,2017-05-01,,,Disruption of the manufacture of the drug.,2017-05-02,2018-12-20
7376,811874,Shortage,PMS-LIDOCAINE VISCOUS 2%,PHARMASCIENCE INC,LIDOCAINE,LIDOCAINE HYDROCHLORIDE,2%,100,DENTAL,Actual shortage,LIQUID,N01BB,"ANESTHETICS, LOCAL",,2017-04-19,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
1910,2292211,Shortage,PMS-LISINOPRIL,PHARMASCIENCE INC,Lisinopril,LISINOPRIL,10MG,"30, 100 & 500",ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2016-01-19,,,Other (Please describe in comments),2017-03-13,2017-10-05
4222,2216132,Shortage,PMS-LITHIUM CARBONATE - CAP 150MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,1000,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-03-23,,2017-10-01,Demand increase for the drug.,2017-03-24,2017-10-06
22776,2216132,Shortage,PMS-LITHIUM CARBONATE - CAP 150MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-11-16,2018-04-08,2018-04-17,Disruption of the manufacture of the drug.,2017-09-19,2018-04-19
64817,2216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2018-10-17,2019-02-04,2019-02-06,Disruption of the manufacture of the drug.,2018-10-19,2019-02-08
28591,2216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-11-07,2018-03-05,2018-03-06,Disruption of the manufacture of the drug.,2017-11-08,2018-03-07
7380,2216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,1000,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,2017-08-10,,,2017-10-01,Delay in shipping of the drug.,2017-04-20,2017-10-06
22779,2216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-09-15,2017-11-01,2017-10-12,Disruption of the manufacture of the drug.,2017-09-19,2017-10-13
5479,2216159,Shortage,PMS-LITHIUM CARBONATE - CAP 600MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,600MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2017-03-23,2018-03-18,2018-02-21,Demand increase for the drug.,2017-04-04,2018-02-22
42099,2216159,Shortage,PMS-LITHIUM CARBONATE - CAP 600MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,600MG,100,ORAL,Resolved,CAPSULE,N05AN,ANTIPSYCHOTICS,,2018-03-07,2018-06-15,2018-05-15,Disruption of the manufacture of the drug.,2018-03-07,2018-05-18
51726,2228351,Shortage,PMS-LOPERAMIDE - CAPLET 2MG,PHARMASCIENCE INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,500,ORAL,Resolved,TABLET,A07DA,ANTIPROPULSIVES,2018-08-27,2018-06-26,2019-01-16,2019-02-06,Disruption of the manufacture of the drug.,2018-06-06,2019-02-08
43854,2228351,Shortage,PMS-LOPERAMIDE - CAPLET 2MG,PHARMASCIENCE INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,A07DA,ANTIPROPULSIVES,2018-06-15,2018-05-01,2019-01-10,2019-01-16,Disruption of the manufacture of the drug.,2018-03-23,2019-01-17
7386,2228351,Shortage,PMS-LOPERAMIDE - CAPLET 2MG,PHARMASCIENCE INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,100,ORAL,Avoided shortage,TABLET,A07DA,ANTIPROPULSIVES,2017-07-03,2017-07-03,,2017-05-10,Disruption of the manufacture of the drug.,2017-04-20,2017-10-12
28832,2016095,Shortage,PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML,PHARMASCIENCE INC,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,0.2MG,230,ORAL,Resolved,SOLUTION,A07DA,ANTIPROPULSIVES,2017-11-16,2017-12-18,2018-01-10,2018-02-08,Disruption of the manufacture of the drug.,2017-11-10,2018-02-12
5489,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-09-23,2018-03-20,2017-12-17,Disruption of the manufacture of the drug.,2017-04-04,2017-12-18
5492,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-09-23,2017-12-18,2017-12-17,Disruption of the manufacture of the drug.,2017-04-04,2017-12-18
5495,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-04-04,2017-12-18
4234,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-03-24,2017-12-18
4237,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-03-24,2017-12-18
4240,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-03-24,2017-12-18
55738,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-08-18,2018-08-23,,2018-09-18,Disruption of the manufacture of the drug.,2018-07-13,2018-09-19
7402,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-20,2018-05-05
7411,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7420,728187,Shortage,PMS-LORAZEPAM TAB 0.5MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7426,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,2018-04-10,2017-12-04,Disruption of the manufacture of the drug.,2017-04-20,2017-12-08
5498,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-07-14,2017-07-17,Disruption of the manufacture of the drug.,2017-04-04,2017-12-18
5502,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-07-14,2017-07-14,Disruption of the manufacture of the drug.,2017-04-04,2017-12-18
4243,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-07-14,2017-07-14,Disruption of the manufacture of the drug.,2017-03-24,2017-12-18
4246,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-07-14,2017-07-14,Disruption of the manufacture of the drug.,2017-03-24,2017-12-18
77484,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-06-27,2019-07-17,2019-07-29,Disruption of the manufacture of the drug.,2019-03-04,2019-07-31
38872,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,2018-03-15,2018-03-07,2018-08-01,2018-06-26,Disruption of the manufacture of the drug.,2018-02-06,2018-06-29
7389,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,3000,ORAL,Actual shortage,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
79861,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-03-27,2019-08-16,2019-07-29,Delay in shipping of the drug.,2019-03-29,2019-07-31
7423,728195,Shortage,PMS-LORAZEPAM TAB 1MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,2018-04-10,2017-12-04,Disruption of the manufacture of the drug.,2017-04-20,2017-12-08
5482,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-04-04,2017-12-18
5486,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-04-04,2017-12-18
4228,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-03-24,2017-12-18
4231,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-23,2017-09-18,2017-09-18,Disruption of the manufacture of the drug.,2017-03-24,2017-12-18
7395,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,2018-04-07,2018-04-17,Disruption of the manufacture of the drug.,2017-04-20,2018-04-19
7399,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-04-20,2018-04-10,2018-04-17,Disruption of the manufacture of the drug.,2017-04-20,2018-04-19
59116,728209,Shortage,PMS-LORAZEPAM TAB 2MG,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,2MG,1000,ORAL,Avoided shortage,TABLET,N05BA,ANXIOLYTICS,2018-08-30,,,2018-08-29,Disruption of the manufacture of the drug.,2018-08-24,2018-09-19
7429,2309769,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-09-25,2017-09-25,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
67931,2309777,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-28,2020-03-16,,Disruption of the manufacture of the drug.,2018-11-29,2019-07-31
67934,2309750,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-28,2020-01-06,,Disruption of the manufacture of the drug.,2018-11-29,2019-07-31
39528,2309777,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-02-20,2018-02-19,2018-06-01,2018-06-06,Disruption of the manufacture of the drug.,2018-02-12,2018-06-07
77487,2309769,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-01,2020-03-30,,Disruption of the manufacture of the drug.,2019-03-04,2019-11-15
6133,2309769,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-05-17,2017-05-17,2018-04-07,2018-04-17,Disruption of the manufacture of the drug.,2017-04-07,2018-04-19
22785,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-18,2017-09-25,2017-09-25,Disruption of the manufacture of the drug.,2017-09-19,2017-10-11
38917,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-02-02,2018-04-16,2018-04-17,Disruption of the manufacture of the drug.,2018-02-06,2018-04-19
29509,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-11-16,2018-03-06,2018-02-21,Disruption of the manufacture of the drug.,2017-11-17,2018-02-22
49747,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-05-30,2018-06-04,2019-06-04,2019-06-28,Disruption of the manufacture of the drug.,2018-05-18,2019-06-29
67937,2392240,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-28,2019-06-07,2019-06-28,Disruption of the manufacture of the drug.,2018-11-29,2019-06-29
67940,2392224,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-28,2019-06-01,2019-05-28,Disruption of the manufacture of the drug.,2018-11-29,2019-06-11
90473,2392224,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-07-22,2019-11-22,,Demand increase for the drug.,2019-07-31,2019-11-15
93816,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-02,2020-01-10,,Disruption of the manufacture of the drug.,2019-09-12,2019-09-12
93819,2392240,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-02,,2020-02-03,Disruption of the manufacture of the drug.,2019-09-12,2019-09-12
90536,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-10-01,,2019-12-02,2020-10-01,Disruption of the manufacture of the drug.,2019-08-01,2019-10-02
22782,2392232,Shortage,PMS-LOSARTAN-HCTZ,PHARMASCIENCE INC,LOSARTAN HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-15,2017-10-31,2017-11-15,Disruption of the manufacture of the drug.,2017-09-19,2017-11-17
7432,2248268,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,15MG,500,ORAL,Actual shortage,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-06-04,2017-06-04,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7435,2248268,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,15MG,30,ORAL,Actual shortage,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-06-02,2017-06-02,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7438,2248267,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,7.5MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-08-28,2017-08-28,2018-04-17,2017-10-10,Disruption of the manufacture of the drug.,2017-04-20,2017-10-11
32053,2248268,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,15MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-12-31,2018-02-02,2018-02-08,2018-01-30,Disruption of the manufacture of the drug.,2017-12-07,2018-02-02
90476,2248268,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,15MG,100,ORAL,Resolved,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2019-08-28,,2019-12-03,2019-10-23,Disruption of the manufacture of the drug.,2019-07-31,2019-11-15
10103,2248267,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,7.5MG,3X10,ORAL,Actual shortage,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-07-13,2017-07-13,,,Shortage of an inactive ingredient or component.,2017-05-11,2018-12-20
13712,2248267,Shortage,PMS-MELOXICAM,PHARMASCIENCE INC,MELOXICAM,MELOXICAM,7.5MG,3X10,ORAL,Actual shortage,TABLET,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-07-20,2017-07-20,,,Disruption of the manufacture of the drug.,2017-06-23,2018-12-20
98817,2321130,Shortage,PMS-MEMANTINE,PHARMASCIENCE INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,30,ORAL,Actual shortage,TABLET,N06DX,ANTI-DEMENTIA DRUGS,2019-11-07,,2019-12-12,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
25793,2321130,Shortage,PMS-MEMANTINE,PHARMASCIENCE INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,30,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,,2017-10-01,2018-03-26,2018-03-23,Disruption of the manufacture of the drug.,2017-10-12,2018-03-24
22789,2242589,Shortage,PMS-METFORMIN,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-09-15,2017-12-07,2017-12-04,Disruption of the manufacture of the drug.,2017-09-19,2017-12-08
25796,2242589,Shortage,PMS-METFORMIN,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-01-15,2018-01-24,2018-03-07,2018-02-21,Disruption of the manufacture of the drug.,2017-10-12,2018-02-22
32056,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-01-16,,2018-03-05,2018-01-24,Disruption of the manufacture of the drug.,2017-12-07,2018-01-26
21652,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-09-01,2018-01-04,2017-12-04,Disruption of the manufacture of the drug.,2017-09-08,2017-12-08
87974,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-05-08,2019-09-25,2019-09-03,Demand increase for the drug.,2019-06-28,2019-09-04
87977,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-05-08,2019-11-08,2019-09-03,Demand increase for the drug.,2019-06-28,2019-09-04
83690,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-07-30,2019-12-30,,Demand increase for the drug.,2019-05-09,2019-11-15
83693,2223562,Shortage,PMS-METFORMIN - TAB 500MG,PHARMASCIENCE INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-08-15,2019-05-08,2019-11-08,2019-11-04,Demand increase for the drug.,2019-05-09,2019-11-15
38920,584991,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METYHLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-02,2018-03-15,2018-05-15,Disruption of the manufacture of the drug.,2018-02-06,2018-05-18
38923,584991,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-02,2018-05-26,2018-04-17,Disruption of the manufacture of the drug.,2018-02-06,2018-04-19
38926,2234749,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-02-02,2018-07-26,2018-06-26,Disruption of the manufacture of the drug.,2018-02-06,2018-06-29
64820,584991,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-10-17,2019-02-04,2019-02-06,Disruption of the manufacture of the drug.,2018-10-19,2019-02-08
63105,584991,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-10-02,2019-02-04,2019-02-06,Disruption of the manufacture of the drug.,2018-10-03,2019-02-08
46722,585009,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-05-17,2018-05-04,2018-08-03,2018-08-23,Disruption of the manufacture of the drug.,2018-04-20,2018-08-24
21655,585009,Shortage,PMS-METHYLPHENIDATE,PHARMASCIENCE INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-09-04,2017-11-13,2017-11-14,Disruption of the manufacture of the drug.,2017-09-08,2017-11-17
4249,2413736,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,27MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
4252,2413752,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,54MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
4255,2413728,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,18MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
6355,2413744,Shortage,PMS-METHYLPHENIDATE ER,PHARMASCIENCE INC,METHYLPHENIDATE ER,METHYLPHENIDATE HYDROCHLORIDE,36MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
13112,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-08-23,,2017-10-13,2017-10-13,Disruption of the manufacture of the drug.,2017-06-16,2017-12-18
32059,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-12-07,2018-01-19,2018-01-24,Disruption of the manufacture of the drug.,2017-12-07,2018-01-26
32062,2248855,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2017-12-07,2018-04-13,2018-04-17,Disruption of the manufacture of the drug.,2017-12-07,2018-04-19
43345,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL,METOPROLOL TARTRATE,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-03-14,2018-04-27,2018-05-04,Disruption of the manufacture of the drug.,2018-03-19,2018-05-05
93822,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL L,METOPROLOL TARTRATE,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2019-10-01,,2019-12-31,2019-11-01,Disruption of the manufacture of the drug.,2019-09-12,2019-11-04
13715,2248855,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-08-31,2017-08-31,,2017-10-10,Disruption of the manufacture of the drug.,2017-06-23,2017-10-11
21659,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,1000,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-09-21,2017-09-21,2018-03-19,2018-03-23,Disruption of the manufacture of the drug.,2017-09-08,2018-03-24
21662,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-11-20,2017-11-20,2018-01-23,2017-12-17,Disruption of the manufacture of the drug.,2017-09-08,2017-12-18
37278,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL,METOPROLOL TARTRATE,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-01-24,2018-04-12,2018-04-17,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
21665,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-11-27,2017-12-18,2018-01-23,2018-03-07,Disruption of the manufacture of the drug.,2017-09-08,2018-03-08
37281,2230803,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL,METOPROLOL TARTRATE,50MG,1000,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-01-24,2018-04-02,2018-04-17,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
28835,2248855,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,25MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-11-24,2017-12-18,2018-06-20,2018-06-26,Disruption of the manufacture of the drug.,2017-11-10,2018-06-29
12223,2230804,Shortage,PMS-METOPROLOL-L,PHARMASCIENCE INC,METOPROLOL-L,METOPROLOL TARTRATE,100MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-08-14,2017-08-14,2018-01-05,2018-01-24,Disruption of the manufacture of the drug.,2017-06-07,2018-01-26
8620,783137,Shortage,PMS-METRONIDAZOLE,PHARMASCIENCE INC,METRONIDAZOLE,METRONIDAZOLE,500MG,100,ORAL,Actual shortage,CAPSULE,J01XD,OTHER ANTIBACTERIALS,,2017-05-01,,,Other (Please describe in comments),2017-05-02,2019-01-16
21669,2294427,Shortage,PMS-MINOCYCLINE,PHARMASCIENCE INC,MINOCYCLINE,MINOCYCLINE,100MG,100,ORAL,Actual shortage,CAPSULE,J01AA,TETRACYCLINES,,2017-09-04,,,Other (Please describe in comments),2017-09-08,2018-12-20
7441,2273942,Shortage,PMS-MIRTAZAPINE,PHARMASCIENCE INC,MIRTAZAPINE,MIRTAZAPINE,15MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-04-20,2018-11-07,2018-11-28,Disruption of the manufacture of the drug.,2017-04-20,2018-11-29
21672,2248762,Shortage,PMS-MIRTAZAPINE,PHARMASCIENCE INC,MIRTAZAPINE,MIRTAZAPINE,30MG,30,ORAL,Actual shortage,TABLET,N06AX,ANTIDEPRESSANTS,2017-09-28,2019-07-30,,,Other (Please describe in comments),2017-09-08,2019-07-31
10680,2248762,Shortage,PMS-MIRTAZAPINE,PHARMASCIENCE INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-07-05,2017-07-05,2019-02-20,2019-02-25,Disruption of the manufacture of the drug.,2017-05-18,2019-02-26
98820,2354977,Shortage,PMS-MONTELUKAST,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,4MG,100,ORAL,Anticipated shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2019-11-18,,2019-12-18,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
87980,2354977,Shortage,PMS-MONTELUKAST,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,4MG,30,ORAL,Actual shortage,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-05-28,2020-01-28,,Disruption of the manufacture of the drug.,2019-06-28,2019-07-31
86228,2354977,Shortage,PMS-MONTELUKAST,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,4MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-05-28,2019-08-13,2019-09-03,Disruption of the manufacture of the drug.,2019-06-11,2019-09-04
32065,2373947,Shortage,PMS-MONTELUKAST FC,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,10MG,30,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-02-07,2018-01-30,2018-03-10,2018-03-10,Disruption of the manufacture of the drug.,2017-12-07,2018-03-11
43348,2373947,Shortage,PMS-MONTELUKAST FC,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,10MG,30,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-03-19,2018-04-18,2018-04-17,Disruption of the manufacture of the drug.,2018-03-19,2018-04-19
18866,2373947,Shortage,PMS-MONTELUKAST FC,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Avoided shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2017-09-10,,2017-10-20,2017-09-04,Disruption of the manufacture of the drug.,2017-08-11,2017-09-07
22792,2432218,Shortage,PMS-MOXIFLOXACIN,PHARMASCIENCE INC,MOXIFLOXACIN,MOXIFLOXACIN,0.5%,3mL,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2017-09-15,2018-05-30,2018-06-06,Disruption of the manufacture of the drug.,2017-09-19,2018-06-07
83696,2432218,Shortage,PMS-MOXIFLOXACIN,PHARMASCIENCE INC,MOXIFLOXACIN HCL,MOXIFLOXACIN,0.5%,90,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2019-05-08,2019-06-04,2019-05-28,Disruption of the manufacture of the drug.,2019-05-09,2019-06-11
5505,2380900,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017-03-23,,2019-01-24,Disruption of the manufacture of the drug.,2017-04-04,2019-01-25
5508,2380919,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,1.0MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017-03-23,,2019-01-24,Disruption of the manufacture of the drug.,2017-04-04,2019-01-25
77191,2380919,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,1.0MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2019-03-01,2019-08-26,2019-07-28,Disruption of the manufacture of the drug.,2019-03-01,2019-07-29
77195,2380900,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2019-03-01,2019-08-15,2019-07-28,Disruption of the manufacture of the drug.,2019-03-01,2019-07-29
21676,2380900,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-04,,2019-01-24,Disruption of the manufacture of the drug.,2017-09-08,2019-01-25
21679,2380919,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,1.0MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-04,,2019-01-24,Disruption of the manufacture of the drug.,2017-09-08,2019-01-25
87983,2380900,Shortage,PMS-NABILONE,PHARMASCIENCE INC,NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2019-06-28,2019-08-06,2019-07-28,Disruption of the manufacture of the drug.,2019-06-28,2019-07-29
6142,2017237,Shortage,PMS-NAPROXEN,PHARMASCIENCE INC,NAPROXEN,NAPROXEN,500MG,30,RECTAL,Actual shortage,SUPPOSITORY,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-04-12,,,Disruption of the manufacture of the drug.,2017-04-07,2018-12-20
6145,2294710,Shortage,PMS-NAPROXEN EC,PHARMASCIENCE INC,NAPROZEN,NAPROXEN,500MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-12-01,2017-12-15,,,Disruption of the manufacture of the drug.,2017-04-07,2018-12-20
28838,2405776,Shortage,PMS-NEVIRAPINE,PHARMASCIENCE INC,NEVIRAPINE,NEVIRAPINE,200MG,60,ORAL,Actual shortage,TABLET,J05AG,DIRECT ACTING ANTIVIRALS,,2017-11-10,,,Other (Please describe in comments),2017-11-10,2017-11-11
98823,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,30,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2019-11-07,,2020-05-19,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
7444,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-04-19,2017-06-01,2017-06-08,Disruption of the manufacture of the drug.,2017-04-20,2017-06-09
15125,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-07-03,2019-12-03,2019-04-19,Demand increase for the drug.,2017-07-11,2019-04-26
7447,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,30MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-04-19,2017-07-12,2017-07-12,Disruption of the manufacture of the drug.,2017-04-20,2017-07-19
7450,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-11-21,2017-11-21,,2017-12-15,Disruption of the manufacture of the drug.,2017-04-20,2017-12-18
64823,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,30MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-10-17,2020-02-17,2019-11-04,Disruption of the manufacture of the drug.,2018-10-19,2019-11-15
13115,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-06-01,2017-07-17,2017-07-17,Demand increase for the drug.,2017-06-16,2017-12-18
93825,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,30MG,30,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-09-02,2020-01-21,,Disruption of the manufacture of the drug.,2019-09-12,2019-09-12
37286,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-01-25,2018-05-20,2018-04-17,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
77490,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-03-01,2019-11-06,2019-08-27,Shortage of an inactive ingredient or component.,2019-03-04,2019-09-12
21682,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-09-01,2017-09-26,2017-09-26,Disruption of the manufacture of the drug.,2017-09-08,2017-10-11
72629,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,30MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-01-18,2019-07-09,2019-06-28,Disruption of the manufacture of the drug.,2019-01-16,2019-06-29
72632,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,60MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-10-16,2020-04-23,,Other (Please describe in comments),2019-01-16,2019-10-17
21688,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,30MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-10-05,2017-10-05,2018-05-30,2018-05-15,Disruption of the manufacture of the drug.,2017-09-08,2018-05-18
38875,2416301,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE,NIFEDIPINE,60MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-03-26,2018-03-23,,2018-09-18,Disruption of the manufacture of the drug.,2018-02-06,2018-09-19
8948,2418630,Shortage,PMS-NIFEDIPINE ER,PHARMASCIENCE INC,NIFEDIPINE ER,NIFEDIPINE,30MG,30,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-08-31,2017-08-31,,2018-10-02,Disruption of the manufacture of the drug.,2017-05-04,2018-10-03
63129,2455676,Shortage,PMS-NITROFURANTOIN,PHARMASCIENCE INC,NITROFURANTOIN,NITROFURANTOIN,100MG,100,ORAL,Resolved,CAPSULE,J01XE,OTHER ANTIBACTERIALS,,2018-10-02,2019-04-04,2019-03-18,Disruption of the manufacture of the drug.,2018-10-03,2019-03-19
22795,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,100mL,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2018-02-02,2018-10-22,2018-11-28,Disruption of the manufacture of the drug.,2017-09-19,2018-11-29
94269,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,48mL,ORAL,Actual shortage,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2019-09-09,,,Disruption of the manufacture of the drug.,2019-09-18,2019-09-18
13118,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,500 mL,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,2017-08-14,,2017-09-04,2017-09-04,Disruption of the manufacture of the drug.,2017-06-16,2017-12-18
46725,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,90,ORAL,Avoided shortage,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,2018-08-23,,,2018-08-22,Disruption of the manufacture of the drug.,2018-04-20,2018-09-19
17063,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,500 mL,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2017-07-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-07-25,2018-05-05
28841,792667,Shortage,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,PHARMASCIENCE INC,NYSTATIN,NYSTATIN,100000UNIT,90,ORAL,Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2017-11-10,2018-01-26,2018-02-12,Disruption of the manufacture of the drug.,2017-11-10,2018-02-19
94272,2303116,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,2.5MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-09-13,2019-10-20,,Disruption of the manufacture of the drug.,2019-09-18,2019-11-15
43351,2367483,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,20MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-03-19,,,Disruption of the manufacture of the drug.,2018-03-19,2018-03-20
39534,2303159,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZIPINE,OLANZAPINE,5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-02-12,2018-02-16,2018-11-06,2018-10-17,Disruption of the manufacture of the drug.,2018-02-12,2018-10-18
39537,2303167,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZIPINE,OLANZAPINE,7.5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-02-12,2018-02-16,2018-06-06,2018-05-15,Disruption of the manufacture of the drug.,2018-02-12,2018-05-18
37291,2303175,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,10MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-03-27,2018-03-23,2018-06-20,2018-06-26,Disruption of the manufacture of the drug.,2018-01-26,2018-06-29
37294,2303116,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,2.5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-03-06,2018-02-22,2018-06-20,2018-06-26,Delay in shipping of the drug.,2018-01-26,2018-06-29
79866,2303183,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,15MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-03-27,2019-06-19,2019-05-31,Disruption of the manufacture of the drug.,2019-03-29,2019-06-11
43354,2303213,Shortage,PMS-OLANZAPINE ODT,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,15MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-04-12,2018-04-17,2018-06-15,2018-06-06,Disruption of the manufacture of the drug.,2018-03-19,2018-06-07
42102,2303205,Shortage,PMS-OLANZAPINE ODT,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,10MG,30,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2018-03-01,2018-06-20,2018-06-26,Disruption of the manufacture of the drug.,2018-03-07,2018-06-29
83720,2461307,Shortage,PMS-OLMESARTAN,PHARMASCIENCE INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,20MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-28,2019-12-30,2019-11-04,Disruption of the manufacture of the drug.,2019-05-09,2019-11-15
83723,2461315,Shortage,PMS-OLMESARTAN,PHARMASCIENCE INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-01,2020-01-15,,Disruption of the manufacture of the drug.,2019-05-09,2019-07-31
63081,2461307,Shortage,PMS-OLMESARTAN,PHARMASCIENCE INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,20MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-02,2019-12-30,,Disruption of the manufacture of the drug.,2018-10-03,2019-11-15
63085,2461315,Shortage,PMS-OLMESARTAN,PHARMASCIENCE INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-02,2020-01-15,,Disruption of the manufacture of the drug.,2018-10-03,2019-07-31
46744,2461315,Shortage,PMS-OLMESARTAN,PHARMASCIENCE INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-20,2018-08-03,2018-08-23,Disruption of the manufacture of the drug.,2018-04-20,2018-08-24
29512,2320851,Shortage,PMS-OMEPRAZOLE,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-11-16,2017-12-14,,,Disruption of the manufacture of the drug.,2017-11-17,2017-12-18
63108,2320851,Shortage,PMS-OMEPRAZOLE,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-10-02,2019-01-03,2019-01-16,Disruption of the manufacture of the drug.,2018-10-03,2019-01-17
8624,2320851,Shortage,PMS-OMEPRAZOLE,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-05-01,,2017-06-21,Disruption of the manufacture of the drug.,2017-05-02,2017-06-23
77493,2320851,Shortage,PMS-OMEPRAZOLE,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-02-28,,,Disruption of the manufacture of the drug.,2019-03-04,2019-09-12
15128,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-03,2017-11-08,2017-11-08,Disruption of the manufacture of the drug.,2017-07-11,2017-12-18
13122,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-06-01,2017-10-20,2017-10-20,Disruption of the manufacture of the drug.,2017-06-16,2017-12-18
4259,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,30,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
17066,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-01,,,Disruption of the manufacture of the drug.,2017-07-25,2017-10-05
17069,2310260,Shortage,PMS-OMEPRAZOLE DR,PHARMASCIENCE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,500,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-01,,,Disruption of the manufacture of the drug.,2017-07-25,2017-10-05
32068,2258188,Shortage,PMS-ONDANSETRON,PHARMASCIENCE INC,ONDANSETRON,ONDANSETRON,4MG,100,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2017-12-20,2017-12-17,2018-07-05,2018-06-26,Disruption of the manufacture of the drug.,2017-12-07,2018-06-29
63111,2258188,Shortage,PMS-ONDANSETRON,PHARMASCIENCE INC,ONDANSETRON,ONDANSETRON,4MG,10,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-10-02,2018-11-15,2018-11-28,Disruption of the manufacture of the drug.,2018-10-03,2018-11-29
7453,2437074,Shortage,PMS-OXALIPLATIN,PHARMASCIENCE INC,OXALIPLATIN,OXALIPLATIN,5MG,10 ML,INTRAVENOUS,Actual shortage,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-04-19,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7456,2437074,Shortage,PMS-OXALIPLATIN,PHARMASCIENCE INC,OXALIPLATIN,OXALIPLATIN,5MG,20 ML,INTRAVENOUS,Actual shortage,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-04-19,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7459,2437074,Shortage,PMS-OXALIPLATIN,PHARMASCIENCE INC,OXALIPLATIN,OXALIPLATIN,5MG,40 ML,INTRAVENOUS,Actual shortage,SOLUTION,L01XA,OTHER ANTINEOPLASTIC AGENTS,,2017-04-19,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7462,2240550,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTININ,OXYBUTYNIN CHLORIDE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-04-20,2017-11-30,2017-12-04,Disruption of the manufacture of the drug.,2017-04-20,2017-12-08
49750,2240549,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,2.5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-05-16,2018-08-05,2018-08-23,Disruption of the manufacture of the drug.,2018-05-18,2018-08-24
37297,2240550,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-03-15,2018-02-02,2018-11-13,2018-08-23,Disruption of the manufacture of the drug.,2018-01-26,2018-08-24
8627,2223376,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,1MG,1 mg/mL,ORAL,Resolved,SYRUP,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-10-23,2017-12-17,,2018-06-26,Disruption of the manufacture of the drug.,2017-05-02,2018-06-29
18874,2240550,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTININ,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-08-10,2018-07-30,2018-08-23,Disruption of the manufacture of the drug.,2017-08-11,2018-08-24
21694,2240549,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTININ,OXYBUTYNIN CHLORIDE,2.5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-09,2017-12-17,2018-04-10,2018-04-17,Disruption of the manufacture of the drug.,2017-09-08,2018-04-19
59119,2223376,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,1MG,90,ORAL,Resolved,SYRUP,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-10-01,2019-02-18,2019-02-25,Disruption of the manufacture of the drug.,2018-08-24,2019-02-26
4262,2319977,Shortage,PMS-OXYCODONE,PHARMASCIENCE INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-03-23,2017-05-03,2017-05-17,Disruption of the manufacture of the drug.,2017-03-24,2017-05-18
37300,2319977,Shortage,PMS-OXYCODONE,PHARMASCIENCE INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,5MG,100,ORAL,Avoided shortage,TABLET,N02AA,OPIOIDS,2018-02-02,,2018-03-28,2018-02-01,Disruption of the manufacture of the drug.,2018-01-26,2018-02-19
15131,2309912,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-07-03,2017-07-31,2017-12-17,Requirements related to complying with good manufacturing practices.,2017-07-11,2017-12-18
7465,2309890,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OCYCODONE,OXYCODONE HYDROCHLORIDE,20MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017-12-15,,2018-02-09,2017-10-30,Delay in shipping of the drug.,2017-04-20,2017-10-27
32071,2309882,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-12-07,2018-01-05,2018-01-24,Disruption of the manufacture of the drug.,2017-12-07,2018-01-26
18877,2309912,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,,2017-08-01,2017-10-31,2017-12-04,Disruption of the manufacture of the drug.,2017-08-11,2017-12-08
8952,2309882,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,10MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N02AA,OPIOIDS,2017-10-26,,2017-11-15,2017-09-04,Disruption of the manufacture of the drug.,2017-05-04,2017-09-07
15135,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Avoided shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-08-04,,,2017-07-23,Disruption of the manufacture of the drug.,2017-07-11,2017-07-25
7468,2291665,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10 ML,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-30,2020-03-26,,Other (Please describe in comments),2017-04-20,2019-11-15
7471,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-09-12,2017-09-12,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-20,2018-05-05
13125,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-07-03,2017-07-03,2017-10-06,2017-10-06,Disruption of the manufacture of the drug.,2017-06-16,2017-12-18
90482,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Anticipated shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-11-18,,2020-03-31,,Disruption of the manufacture of the drug.,2019-07-31,2019-09-12
17072,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-08-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-07-25,2018-05-05
87989,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-10-01,,2020-02-20,,Disruption of the manufacture of the drug.,2019-06-28,2019-11-15
86231,2307871,Shortage,PMS-PANTOPRAZOLE,PHARMASCIENCE INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-06-11,,2019-12-30,2019-09-03,Disruption of the manufacture of the drug.,2019-06-11,2019-09-04
7474,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,20MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-20,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7479,2247752,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,30MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-04-20,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-20,2018-05-05
16969,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2016-02-08,2017-11-22,2017-11-22,Shortage of an active ingredient.,2017-07-25,2017-12-18
1913,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,Paroxetine,PAROXETINE,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2016-02-08,,2018-05-04,Shortage of an active ingredient.,2017-03-13,2018-05-05
1916,2247752,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,Paroxetine,PAROXETINE,30MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2016-02-25,,,Shortage of an active ingredient.,2017-03-13,2017-10-05
4265,2247750,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-03-23,,2018-05-04,Shortage of an active ingredient.,2017-03-24,2018-05-05
4268,2247750,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,10MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017-03-23,,,Shortage of an active ingredient.,2017-03-24,2018-12-20
13030,2247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-02-08,2018-01-05,2018-05-04,Shortage of an active ingredient.,2017-06-16,2018-05-05
63123,2470675,Shortage,PMS-PERINDOPRIL,PHARMASCIENCE INC,PERINDOPRIL,PERINDOPRIL ERBUMINE,2MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-10-02,2018-12-15,2018-10-17,Disruption of the manufacture of the drug.,2018-10-03,2018-10-18
63126,2470683,Shortage,PMS-PERINDOPRIL,PHARMASCIENCE INC,PERINDOPRIL,PERINDOPRIL ERBUMINE,4MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-10-02,2018-11-05,2018-11-28,Disruption of the manufacture of the drug.,2018-10-03,2018-11-29
46728,2303124,Shortage,PMS-PIOGLITAZONE,PHARMASCIENCE INC,PIOGLITAZONE,PIOGLITAZONE,15MG,100,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-04-20,,,Other (Please describe in comments),2018-04-20,2018-04-21
46731,2303132,Shortage,PMS-PIOGLITAZONE,PHARMASCIENCE INC,PIOGLITAZONE,PIOGLITAZONE,30MG,100,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-04-20,,,Other (Please describe in comments),2018-04-20,2018-04-21
32074,2290111,Shortage,PMS-PRAMIPEXOLE,PHARMASCIENCE INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-12-07,,,Disruption of the manufacture of the drug.,2017-12-07,2017-12-08
32077,2290146,Shortage,PMS-PRAMIPEXOLE,PHARMASCIENCE INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-12-07,,,Disruption of the manufacture of the drug.,2017-12-07,2017-12-08
46734,2290138,Shortage,PMS-PRAMIPEXOLE,PHARMASCIENCE INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.50MG,100,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
32080,2247656,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-07,2018-04-10,2018-04-17,Disruption of the manufacture of the drug.,2017-12-07,2018-04-19
32083,2247657,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-07,2018-05-08,2018-05-04,Other (Please describe in comments),2017-12-07,2018-05-05
10668,2247657,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-14,2017-11-07,2017-10-27,Disruption of the manufacture of the drug.,2017-05-18,2017-10-28
4271,2247656,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
4274,2247655,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-23,,2018-06-26,Disruption of the manufacture of the drug.,2017-03-24,2018-06-29
4278,2247655,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-23,,,Disruption of the manufacture of the drug.,2017-03-24,2018-12-20
61885,2247655,Shortage,PMS-PRAVASTATIN,PHARMASCIENCE INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-19,2018-10-30,2018-11-28,Disruption of the manufacture of the drug.,2018-09-19,2018-11-29
64826,2245532,Shortage,PMS-PREDNISOLONE,PHARMASCIENCE INC,PREDNISOLONE,PREDNISOLONE,5MG,90,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2018-10-17,2018-12-10,2018-12-11,Disruption of the manufacture of the drug.,2018-10-19,2018-12-12
40604,2245532,Shortage,PMS-PREDNISOLONE,PHARMASCIENCE INC,PREDNISOLONE,PREDNISOLONE,5MG,120ML,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2018-05-07,2018-05-15,2018-07-03,2018-06-26,Disruption of the manufacture of the drug.,2018-02-22,2018-06-29
77502,2245532,Shortage,PMS-PREDNISOLONE,PHARMASCIENCE INC,PREDNISOLONE,PREDNISOLONE,5MG,120 mL,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-03-01,2019-08-07,2019-09-09,Shortage of an active ingredient.,2019-03-04,2019-09-12
21697,2245532,Shortage,PMS-PREDNISOLONE,PHARMASCIENCE INC,PREDNISOLONE,PREDNISOLONE,5MG,120 mL,ORAL,Resolved,SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2017-09-01,2017-11-20,2017-12-04,Disruption of the manufacture of the drug.,2017-09-08,2017-12-08
6148,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-05-03,2017-10-26,2017-10-24,Disruption of the manufacture of the drug.,2017-04-07,2017-10-26
15138,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-07-03,2017-07-26,2017-09-15,Shortage of an active ingredient.,2017-07-11,2017-09-18
11318,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-10,2017-11-01,2017-10-27,Disruption of the manufacture of the drug.,2017-05-25,2017-10-28
7483,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-04-22,2017-07-28,2017-07-23,Disruption of the manufacture of the drug.,2017-04-20,2017-07-25
7486,2359642,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-05-18,,2017-07-31,2017-09-15,Disruption of the manufacture of the drug.,2017-04-20,2017-09-18
7491,2359626,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,75MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-17,2017-09-17,2017-10-23,2017-10-10,Disruption of the manufacture of the drug.,2017-04-20,2017-10-11
13128,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-07-01,2017-07-01,2017-07-13,2017-12-17,Disruption of the manufacture of the drug.,2017-06-16,2017-12-18
39504,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-03-22,2018-03-22,2018-04-11,2018-03-22,Disruption of the manufacture of the drug.,2018-02-12,2018-04-17
32086,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-12-07,2017-12-27,2018-01-24,Disruption of the manufacture of the drug.,2017-12-07,2018-01-26
43357,2398079,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,225MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-06-01,,,2018-06-27,Disruption of the manufacture of the drug.,2018-03-19,2018-06-29
39540,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-03-18,2018-03-22,2018-05-17,2018-04-17,Disruption of the manufacture of the drug.,2018-02-12,2018-04-19
39543,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,100,ORAL,Avoided shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2018-04-24,,2018-06-10,2018-04-17,Disruption of the manufacture of the drug.,2018-02-12,2018-04-19
10106,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,3X10,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-05-01,2017-05-19,2017-06-14,Shortage of an inactive ingredient or component.,2017-05-11,2017-06-16
39546,2359626,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-02-18,2018-02-19,2018-04-03,2018-06-26,Disruption of the manufacture of the drug.,2018-02-12,2018-06-29
42106,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Avoided shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2018-04-25,2018-04-20,,2018-04-20,Disruption of the manufacture of the drug.,2018-03-07,2018-05-04
13718,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-07-15,,2017-08-12,2017-12-18,Disruption of the manufacture of the drug.,2017-06-23,2017-12-19
10671,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-02,2017-09-02,2017-11-27,2017-10-10,Disruption of the manufacture of the drug.,2017-05-18,2017-10-11
18880,2359634,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,150MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-01,2017-11-30,2017-12-04,Disruption of the manufacture of the drug.,2017-08-11,2017-12-08
61888,2359618,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-09-19,2018-10-20,2018-11-28,Disruption of the manufacture of the drug.,2018-09-19,2018-11-29
18883,2359596,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-01,2017-11-02,2017-10-27,Disruption of the manufacture of the drug.,2017-08-11,2017-10-28
21700,2398079,Shortage,PMS-PREGABALIN,PHARMASCIENCE INC,PREGABALIN,PREGABALIN,225MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,2017-09-19,2017-09-19,Disruption of the manufacture of the drug.,2017-09-08,2017-10-11
43857,2244379,Shortage,PMS-PROPOFOL,PHARMASCIENCE INC,PROPOFOL,PROPOFOL,10MG,50ML & 100ML,INTRAVENOUS,Actual shortage,EMULSION,N01AX,"ANESTHETICS, GENERAL",2018-04-01,2018-04-05,,,Disruption of the manufacture of the drug.,2018-03-23,2018-06-27
43360,2244379,Shortage,PMS-PROPOFOL,PHARMASCIENCE INC,PROPOFOL,PROPOFOL,10MG,100ML,INTRAVENOUS,Actual shortage,EMULSION,N01AX,"ANESTHETICS, GENERAL",,2018-03-19,,,Other (Please describe in comments),2018-03-19,2018-03-20
22798,2296578,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-10-16,2017-10-27,2017-11-08,Disruption of the manufacture of the drug.,2017-09-19,2017-11-09
22802,2361892,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-09-15,2018-03-05,2018-02-21,Disruption of the manufacture of the drug.,2017-09-19,2018-02-22
67951,2296551,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,25MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-11-28,2019-01-30,2018-12-11,Disruption of the manufacture of the drug.,2018-11-29,2018-12-12
40607,2296594,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,200MG,100,ORAL,Avoided shortage,TABLET,N05AH,ANTIPSYCHOTICS,2018-04-16,,2018-04-13,2018-04-13,Disruption of the manufacture of the drug.,2018-02-22,2018-05-04
77505,2296608,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,300MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-02-28,2019-04-22,2019-05-07,Disruption of the manufacture of the drug.,2019-03-04,2019-05-09
18886,2296551,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,25MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-08-01,2017-11-21,2017-10-27,Disruption of the manufacture of the drug.,2017-08-11,2017-10-28
21703,2296551,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-09-22,2017-09-22,2017-09-28,2017-09-28,Disruption of the manufacture of the drug.,2017-09-08,2017-10-11
25801,2296608,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUETIAPINE,QUETIAPINE,300MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-10-01,2017-11-10,2017-10-27,Disruption of the manufacture of the drug.,2017-10-12,2017-10-28
21706,2296608,Shortage,PMS-QUETIAPINE,PHARMASCIENCE INC,QUTIAPINE,QUETIAPINE,300MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-09-01,2018-02-05,2018-02-08,Disruption of the manufacture of the drug.,2017-09-08,2018-02-12
1927,2340585,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,Quinapril,QUINAPRIL,40MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-07-01,2019-09-21,2019-10-29,Disruption of the manufacture of the drug.,2017-03-13,2019-10-30
17075,2340550,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-10-15,2017-12-15,2019-09-25,2019-11-04,Disruption of the manufacture of the drug.,2017-07-25,2019-11-15
25804,2340577,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-10-01,2019-09-20,2019-10-29,Disruption of the manufacture of the drug.,2017-10-12,2019-10-30
21709,2340569,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,10MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-09-04,2019-09-17,2019-11-04,Disruption of the manufacture of the drug.,2017-09-08,2019-11-15
67956,2310813,Shortage,PMS-RABEPRAZOLE EC,PHARMASCIENCE INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-11-28,2019-02-11,2019-02-06,Disruption of the manufacture of the drug.,2018-11-29,2019-02-08
93831,2310813,Shortage,PMS-RABEPRAZOLE EC,PHARMASCIENCE INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-29,,2020-01-27,,Disruption of the manufacture of the drug.,2019-09-12,2019-11-15
46738,2310813,Shortage,PMS-RABEPRAZOLE EC,PHARMASCIENCE INC,RABEPRAZOLE EC,RABEPRAZOLE SODIUM,20MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-04-17,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-20
37307,2310813,Shortage,PMS-RABEPRAZOLE EC,PHARMASCIENCE INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,500,ORAL,Actual shortage,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-03-05,2018-02-22,,,Disruption of the manufacture of the drug.,2018-01-26,2018-02-23
59122,2310805,Shortage,PMS-RABEPRAZOLE EC,PHARMASCIENCE INC,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100,ORAL,Avoided shortage,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-10-01,,,2018-09-30,Disruption of the manufacture of the drug.,2018-08-24,2018-10-03
1930,2295369,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,1.25MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1933,2247917,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,2.5MG,500,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-04-30,,,Disruption of the manufacture of the drug.,2017-03-13,2018-12-20
1936,2247918,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,5MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1939,2247917,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,2.5MG,30,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-10-01,2017-10-01,,,Disruption of the manufacture of the drug.,2017-03-13,2018-12-20
1942,2247918,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,5MG,500,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-07-30,,,Disruption of the manufacture of the drug.,2017-03-13,2019-07-31
1945,2247918,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,5MG,30,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-07-30,,,Disruption of the manufacture of the drug.,2017-03-13,2019-09-12
1948,2295369,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,1.25MG,30,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-03-01,2017-03-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
1951,2247919,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,10MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-01,2017-05-01,,,Disruption of the manufacture of the drug.,2017-03-13,2018-12-20
1954,2247919,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,10MG,500,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1957,2247919,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,10MG,30,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-11-01,2017-11-01,,,Disruption of the manufacture of the drug.,2017-03-13,2018-12-20
1960,2247917,Shortage,PMS-RAMIPRIL,PHARMASCIENCE INC,Ramipril,RAMIPRIL,2.5MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-10-01,2017-10-01,,,Disruption of the manufacture of the drug.,2017-03-13,2018-12-20
6298,2342170,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,PMS-RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-10,2018-05-05
6303,2342154,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  10.0MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-10,2018-05-05
6306,2342154,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-10,2018-05-05
6309,2342170,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  10.0MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,2019-07-10,Disruption of the manufacture of the drug.,2017-04-10,2019-07-11
6312,2342138,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  2.5MG,100,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6315,2342146,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  5.0MG,100,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6318,2342146,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  5.0MG,30,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6322,2342162,Shortage,PMS-RAMIPRIL-HCTZ,PHARMASCIENCE INC,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  5.0MG,100,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
98826,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-23,,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
98829,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,PMS-RANITIDINE 150 MG,RANITIDINE,150MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-23,,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
98832,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE 150 MG,RANITIDINE,150MG,60,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-23,,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
15141,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-03,2017-07-18,2017-07-23,Disruption of the manufacture of the drug.,2017-07-11,2017-07-25
13131,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-06-15,,2017-06-21,Disruption of the manufacture of the drug.,2017-06-16,2017-06-23
67963,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-11-28,2019-02-04,2019-02-06,Other (Please describe in comments),2018-11-29,2019-02-08
13722,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-06-30,2017-06-30,2017-07-10,2017-07-10,Disruption of the manufacture of the drug.,2017-06-23,2017-12-19
8630,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-05-01,2017-05-19,2017-06-08,Disruption of the manufacture of the drug.,2017-05-02,2017-06-09
17078,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-07-25,2018-05-05
17081,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-07-25,2018-05-05
17084,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-07-25,2018-05-05
83702,2242453,Shortage,PMS-RANITIDINE 150 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,150MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-05-09,2019-05-31,2019-07-11,2019-07-29,Demand increase for the drug.,2019-05-09,2019-07-31
98835,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE 300 MG,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-23,,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
22805,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,300MG,250,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-15,2018-09-10,2018-06-26,Disruption of the manufacture of the drug.,2017-09-19,2018-06-29
98838,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE 300 MG,RANITIDINE,300MG,250,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-23,,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
98843,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE 300 MG,RANITIDINE,300MG,30,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-10-23,,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
28844,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-11-20,2017-11-20,2018-02-05,2017-12-18,Disruption of the manufacture of the drug.,2017-11-10,2018-12-07
37318,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-01-24,2018-09-10,2018-06-26,Disruption of the manufacture of the drug.,2018-01-26,2018-06-29
38878,2242454,Shortage,PMS-RANITIDINE 300 MG,PHARMASCIENCE INC,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-03-26,2018-04-02,2018-10-06,2018-06-26,Disruption of the manufacture of the drug.,2018-02-06,2018-06-29
98850,2424177,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RESIDRONATE,RISEDRONATE SODIUM,150MG,1,ORAL,Anticipated shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2019-12-16,,2020-01-14,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
69240,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-12-11,2019-04-12,2019-05-07,Disruption of the manufacture of the drug.,2018-12-11,2019-05-09
10109,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-05-01,2017-12-18,2017-11-14,Disruption of the manufacture of the drug.,2017-05-11,2017-11-17
72635,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-01-17,2019-04-12,2019-05-07,Disruption of the manufacture of the drug.,2019-01-16,2019-05-09
17088,2424177,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-07-01,2017-11-27,2017-11-14,Disruption of the manufacture of the drug.,2017-07-25,2017-11-17
12226,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,30,ORAL,Avoided shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-07-24,,2017-08-28,2017-07-23,Shortage of an active ingredient.,2017-06-07,2017-07-25
17091,2424177,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,150MG,1,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-07-01,2017-11-22,2017-10-27,Disruption of the manufacture of the drug.,2017-07-25,2017-10-28
27351,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-10-09,2017-12-14,2017-11-14,Disruption of the manufacture of the drug.,2017-10-27,2017-11-17
59125,2302209,Shortage,PMS-RISEDRONATE,PHARMASCIENCE INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,100,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-09-13,2018-09-19,2018-10-24,2018-11-28,Disruption of the manufacture of the drug.,2018-08-24,2018-11-29
39549,2252023,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,1.0MG,500,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-04-08,2018-05-01,2018-07-03,2018-06-26,Disruption of the manufacture of the drug.,2018-02-12,2018-06-29
39552,2252058,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,3.0MG,500,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-04-18,2018-04-18,2018-08-08,2018-06-26,Disruption of the manufacture of the drug.,2018-02-12,2018-06-29
48558,2252031,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,2.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-06-11,,,2018-07-12,Disruption of the manufacture of the drug.,2018-05-04,2018-07-13
8633,2279266,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,1MG,1 mg/mL,ORAL,Resolved,SOLUTION,N05AX,ANTIPSYCHOTICS,2017-05-15,,2017-05-29,2017-06-08,Disruption of the manufacture of the drug.,2017-05-02,2017-06-09
37325,2252023,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,1.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2018-01-24,2018-04-17,2018-05-04,Disruption of the manufacture of the drug.,2018-01-26,2018-05-05
21712,2252007,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-09-01,2017-10-30,2017-11-14,Disruption of the manufacture of the drug.,2017-09-08,2017-11-17
37328,2279266,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,1MG,100,ORAL,Resolved,SOLUTION,N05AX,ANTIPSYCHOTICS,,2018-01-24,2018-05-01,2018-04-17,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
21715,2252031,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,2.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-10-22,2017-10-26,2017-11-24,2017-11-08,Disruption of the manufacture of the drug.,2017-09-08,2017-11-09
27354,2252007,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,0.25MG,500,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-10-09,2017-12-07,2017-12-12,Disruption of the manufacture of the drug.,2017-10-27,2017-12-15
6337,2291789,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,1MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6340,2291797,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,2MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6343,2370697,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,3MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
6346,2370700,Shortage,PMS-RISPERIDONE ODT,PHARMASCIENCE INC,RISPERIDONE ODT,RISPERIDONE,4MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N05AX,ANTIPSYCHOTICS,,2017-04-09,,,Disruption of the manufacture of the drug.,2017-04-10,2018-12-20
37331,2393379,Shortage,PMS-RIZATRIPTAN RDT,PHARMASCIENCE INC,RIZATRIPTAN,RIZATRIPTAN,10MG,100,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-03-03,2018-03-07,2018-10-25,2018-11-28,Shortage of an inactive ingredient or component.,2018-01-26,2018-11-29
1963,2326639,Shortage,PMS-ROPINIROLE,PHARMASCIENCE INC,Ropinirole,ROPINIROLE,5.0MG,100,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2015-11-03,,,Other (Please describe in comments),2017-03-13,2017-10-05
8961,2378523,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,3X10,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-15,2018-02-23,2018-02-19,Disruption of the manufacture of the drug.,2017-05-04,2018-02-20
15144,2378566,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-08-28,2017-08-28,2018-01-10,2018-01-24,Shortage of an inactive ingredient or component.,2017-07-11,2018-01-26
7494,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-20,2017-09-13,2017-09-13,Disruption of the manufacture of the drug.,2017-04-20,2017-10-11
7497,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-11,2018-01-18,2018-02-19,Disruption of the manufacture of the drug.,2017-04-20,2018-02-20
7500,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-05-18,2017-05-18,2018-04-29,2018-04-17,Disruption of the manufacture of the drug.,2017-04-20,2018-04-19
49753,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-05-28,2018-06-18,2018-07-09,2018-06-26,Disruption of the manufacture of the drug.,2018-05-18,2018-06-29
10112,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,4,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-25,2017-10-10,2017-10-10,Disruption of the manufacture of the drug.,2017-05-11,2017-10-11
10115,2378523,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,4,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-06-20,2018-01-29,2018-02-08,Disruption of the manufacture of the drug.,2017-05-11,2018-02-12
48563,2378566,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-05-07,2018-05-16,2018-06-19,2018-06-06,Disruption of the manufacture of the drug.,2018-05-04,2018-06-07
87992,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-27,2018-04-13,2019-07-29,Delay in shipping of the drug.,2019-06-28,2019-07-31
87995,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-27,2018-04-02,2019-07-29,Demand increase for the drug.,2019-06-28,2019-07-31
18890,2378566,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-01,2018-01-15,2018-01-24,Disruption of the manufacture of the drug.,2017-08-11,2018-01-26
18893,2378523,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-01,2017-11-28,2018-01-25,Disruption of the manufacture of the drug.,2017-08-11,2018-01-26
27359,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-09,2018-06-10,2018-05-15,Disruption of the manufacture of the drug.,2017-10-27,2018-05-18
8955,2378531,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-06-01,2017-07-24,2017-07-23,Disruption of the manufacture of the drug.,2017-05-04,2017-07-25
8958,2378558,Shortage,PMS-ROSUVASTATIN,PHARMASCIENCE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-06-16,2017-06-16,2017-10-26,2017-11-08,Disruption of the manufacture of the drug.,2017-05-04,2017-11-09
6152,2208245,Shortage,PMS-SALBUTAMOL,PHARMASCIENCE INC,SALBUTAMOL,SALBUTAMOL,0.5MG,20,INHALATION,Resolved,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2017-05-17,2017-07-12,2017-07-23,Delay in shipping of the drug.,2017-04-07,2017-07-25
39555,2208237,Shortage,PMS-SALBUTAMOL,PHARMASCIENCE INC,SALBUTAMOL,SALBUTAMOL,2MG,100,INHALATION,Resolved,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",2018-04-22,2018-04-19,2018-06-04,2018-06-06,Disruption of the manufacture of the drug.,2018-02-12,2018-06-07
22808,2244840,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,100MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-10-02,2017-10-02,2017-10-21,2017-10-10,Disruption of the manufacture of the drug.,2017-09-19,2017-10-11
98853,2244839,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,50MG,100,ORAL,Avoided shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2020-06-01,,,2019-11-17,Disruption of the manufacture of the drug.,2019-11-15,2019-11-18
98856,2244839,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,50MG,250,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2019-11-01,2019-11-04,2020-02-03,2019-11-17,Disruption of the manufacture of the drug.,2019-11-15,2019-11-18
90485,2244840,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,100MG,250,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2019-08-15,2019-09-09,2020-02-10,,Disruption of the manufacture of the drug.,2019-07-31,2019-09-12
32134,2244838,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-12-08,2018-04-01,2018-04-17,Disruption of the manufacture of the drug.,2017-12-08,2018-04-19
32139,2244839,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,50MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-12-08,2018-05-13,2018-04-17,Delay in shipping of the drug.,2017-12-08,2018-04-19
21718,2244839,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,50MG,250,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2017-10-16,2017-11-08,,2018-04-18,Disruption of the manufacture of the drug.,2017-09-08,2018-04-19
37334,2244840,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,100MG,250,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-01-24,2018-06-04,2018-05-15,Disruption of the manufacture of the drug.,2018-01-26,2018-05-18
10118,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,20MG,4,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2017-09-18,2017-11-20,2017-05-17,Disruption of the manufacture of the drug.,2017-05-11,2017-05-18
72638,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,20MG,100,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2019-01-16,2019-02-28,2019-02-25,Disruption of the manufacture of the drug.,2019-01-16,2019-02-26
87998,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,20MG,90,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2019-05-08,2019-07-19,2019-09-17,Disruption of the manufacture of the drug.,2019-06-28,2019-09-18
61891,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,20MG,100,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2018-09-19,2018-12-08,2018-11-28,Disruption of the manufacture of the drug.,2018-09-19,2018-11-29
27364,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL-R,SILDENAFIL,20MG,100,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,2017-11-01,2017-12-18,2018-03-07,2018-03-06,Disruption of the manufacture of the drug.,2017-10-27,2018-03-07
83705,2412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,20MG,90,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2019-03-28,2019-09-20,2019-09-18,Disruption of the manufacture of the drug.,2019-05-09,2019-09-19
6157,2269252,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,5MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-07-03,,,Disruption of the manufacture of the drug.,2017-04-07,2018-12-20
15147,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-07-03,,,Disruption of the manufacture of the drug.,2017-07-11,2017-10-05
13134,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,3x10,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-06-23,2017-06-23,2018-03-07,2017-12-18,Disruption of the manufacture of the drug.,2017-06-16,2017-12-19
7503,2269260,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,10MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-07-03,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
7507,2269295,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,80MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-06-10,2017-06-10,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
42109,2269260,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-03-06,,,Disruption of the manufacture of the drug.,2018-03-07,2018-04-19
10121,2269287,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,40MG,4,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-05-04,2017-05-04,,,Disruption of the manufacture of the drug.,2017-05-11,2017-10-11
25807,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-01,,,Disruption of the manufacture of the drug.,2017-10-12,2017-10-12
18896,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-01,,,Disruption of the manufacture of the drug.,2017-08-11,2017-10-05
37340,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-24,,,Disruption of the manufacture of the drug.,2018-01-26,2018-02-15
37343,2269252,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,5MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-24,,,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
37346,2269295,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,80MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-01-24,,,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
38908,2269279,Shortage,PMS-SIMVASTATIN,PHARMASCIENCE INC,SIMVASTATIN,SIMVASTATIN,20MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-02-02,,,Disruption of the manufacture of the drug.,2018-02-06,2018-02-06
88597,2046113,Shortage,PMS-SODIUM CROMOGLYCATE,PHARMASCIENCE INC,Cromolyn Sodium Inhalation Solution,CROMOLYN SODIUM,1%,50x2mL,INHALATION,Actual shortage,SOLUTION,R03BC,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2019-07-05,2019-08-22,,Disruption of the manufacture of the drug.,2019-07-05,2019-07-06
20468,2046113,Shortage,PMS-SODIUM CROMOGLYCATE,PHARMASCIENCE INC,pms-SOD CROMOGLYCATE 1% NEBUL SOL 50x2mL,CROMOLYN SODIUM,1%,50x2mL,INHALATION  ORAL,Avoided shortage,SOLUTION,R03BC,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2018-02-26,,2018-03-03,2017-12-11,Disruption of the manufacture of the drug.,2017-08-28,2017-12-12
29428,2046113,Shortage,PMS-SODIUM CROMOGLYCATE,PHARMASCIENCE INC,pms-SOD CROMOGLYCATE 1% NEBUL SOL 50x2mL,CROMOLYN SODIUM,1%,50x2mL,INHALATION  ORAL,Resolved,SOLUTION,R03BC,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2017-11-16,2017-11-16,2018-01-31,2017-12-11,Demand increase for the drug.,2017-11-16,2017-12-12
7510,2417731,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-07-27,2017-07-27,,2018-05-04,Disruption of the manufacture of the drug.,2017-04-20,2018-05-05
7514,2417731,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-04-20,,,Disruption of the manufacture of the drug.,2017-04-20,2018-12-20
63114,2417723,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-10-02,2019-12-18,,Disruption of the manufacture of the drug.,2018-10-03,2019-07-31
10124,2417731,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-07-21,2017-07-21,,2018-05-04,Shortage of an inactive ingredient or component.,2017-05-11,2018-05-05
61894,2417723,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-09-19,2019-12-18,,Disruption of the manufacture of the drug.,2018-09-19,2019-07-31
61897,2417723,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-09-19,2019-07-25,,Disruption of the manufacture of the drug.,2018-09-19,2018-09-20
21721,2417723,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-09-01,2018-04-27,2018-05-04,Disruption of the manufacture of the drug.,2017-09-08,2018-05-05
43366,2238327,Shortage,PMS-SOTALOL - 160 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2018-04-19,2018-04-19,2018-05-30,2018-05-15,Disruption of the manufacture of the drug.,2018-03-19,2018-05-18
32142,2238327,Shortage,PMS-SOTALOL - 160 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2018-01-14,2018-01-24,2018-02-19,2018-02-19,Disruption of the manufacture of the drug.,2017-12-08,2018-02-20
8636,2238327,Shortage,PMS-SOTALOL - 160 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,CAPL 100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017-07-04,2017-07-04,2017-12-14,2017-11-14,Disruption of the manufacture of the drug.,2017-05-02,2017-11-17
6164,2238326,Shortage,PMS-SOTALOL - 80 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-04-05,2018-02-13,2017-11-08,Delay in shipping of the drug.,2017-04-07,2017-11-10
8639,2238326,Shortage,PMS-SOTALOL - 80 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,CAPL 500,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-06-12,,2017-11-21,Disruption of the manufacture of the drug.,2017-05-02,2017-11-22
37349,2238326,Shortage,PMS-SOTALOL - 80 MG,PHARMASCIENCE INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2018-01-24,2018-03-29,2018-04-17,Disruption of the manufacture of the drug.,2018-01-26,2018-04-19
7517,598461,Shortage,PMS-SULFASALAZINE 500MG/TAB USP,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017-04-20,2018-10-15,2018-10-17,Disruption of the manufacture of the drug.,2017-04-20,2018-10-18
5511,598461,Shortage,PMS-SULFASALAZINE 500MG/TAB USP,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2019-05-08,,2019-07-10,Shortage of an inactive ingredient or component.,2017-04-04,2019-07-11
64835,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2018-10-17,2019-02-10,2019-02-06,Disruption of the manufacture of the drug.,2018-10-19,2019-02-08
7520,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017-04-19,2017-04-19,2017-04-19,Disruption of the manufacture of the drug.,2017-04-20,2017-04-20
7523,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017-06-14,2017-08-21,2017-09-04,Disruption of the manufacture of the drug.,2017-04-20,2017-09-07
5514,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017-03-23,2017-08-21,2017-09-11,Shortage of an inactive ingredient or component.,2017-04-04,2017-10-05
1966,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,Sulfasalazine,SULFASALAZINE,500MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2016-08-16,2019-02-10,2019-02-06,Shortage of an active ingredient.,2017-03-13,2019-02-08
77509,598488,Shortage,PMS-SULFASALAZINE-E.C. TAB 500MG,PHARMASCIENCE INC,SULFASALAZINE,SULFASALAZINE,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,2019-09-03,2019-09-09,2019-10-08,2019-11-04,Demand increase for the drug.,2019-03-04,2019-11-15
53259,2256428,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,25MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-08-31,2018-08-23,2019-02-15,2019-02-07,Disruption of the manufacture of the drug.,2018-06-29,2019-02-08
22811,2256428,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,25MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-09-15,2018-01-09,2018-01-24,Disruption of the manufacture of the drug.,2017-09-19,2018-01-26
22814,2256436,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,50MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-09-15,,2018-06-26,Disruption of the manufacture of the drug.,2017-09-19,2018-06-29
69219,2256436,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-12-11,2019-01-10,2019-01-16,Disruption of the manufacture of the drug.,2018-12-11,2019-01-17
90488,2256444,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,100MG,250,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2019-09-11,,2019-09-28,,Disruption of the manufacture of the drug.,2019-07-31,2019-09-12
90491,2256444,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,100MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2019-08-05,,2019-09-10,2019-09-11,Disruption of the manufacture of the drug.,2019-07-31,2019-09-12
63117,2256444,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,100MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-10-02,2018-11-15,2018-11-28,Disruption of the manufacture of the drug.,2018-10-03,2018-11-29
63120,2256444,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,100MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-10-02,2018-11-10,2018-11-28,Disruption of the manufacture of the drug.,2018-10-03,2018-11-29
32145,2256444,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,100MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-01-22,2018-01-18,2018-05-20,2018-05-04,Disruption of the manufacture of the drug.,2017-12-08,2018-05-05
40610,2256436,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-05-01,2018-05-04,2018-08-10,2018-08-23,Disruption of the manufacture of the drug.,2018-02-22,2018-08-24
55741,2256428,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,25MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2018-08-31,2018-08-23,2018-09-30,2018-10-02,Disruption of the manufacture of the drug.,2018-07-13,2018-10-03
18901,2256436,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-08-01,2017-09-29,2017-09-29,Disruption of the manufacture of the drug.,2017-08-11,2017-10-11
25816,2256428,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,25MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-10-01,2017-11-06,2017-12-04,Disruption of the manufacture of the drug.,2017-10-12,2017-12-08
37352,2256444,Shortage,PMS-SUMATRIPTAN,PHARMASCIENCE INC,SUMATRIPTAN,SUMATRIPTAN,100MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-01-24,2018-05-20,2018-05-15,Disruption of the manufacture of the drug.,2018-01-26,2018-05-18
22817,2409445,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-09-15,2017-10-25,2017-10-23,Disruption of the manufacture of the drug.,2017-09-19,2017-10-26
64838,2409445,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,20MG,4,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-10-17,2020-01-03,,Disruption of the manufacture of the drug.,2018-10-19,2019-11-15
67969,2409429,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,5MG,100,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-11-28,2020-01-06,,Disruption of the manufacture of the drug.,2018-11-29,2019-06-28
67972,2409445,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,20MG,30,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-11-28,2020-01-06,,Disruption of the manufacture of the drug.,2018-11-29,2019-06-28
32148,2409445,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,20MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-12-08,2018-04-10,2018-04-17,Other (Please describe in comments),2017-12-08,2018-04-19
72645,2409429,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,5MG,30,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-01-16,2020-01-03,,Disruption of the manufacture of the drug.,2019-01-16,2019-11-15
12231,2409437,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,10MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-07-10,2017-07-10,2018-04-10,2018-04-17,Disruption of the manufacture of the drug.,2017-06-07,2018-04-19
61900,2409437,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,10MG,4,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-09-19,,,Disruption of the manufacture of the drug.,2018-09-19,2019-01-16
38863,2409410,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,2.5MG,30,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-02-02,,,Disruption of the manufacture of the drug.,2018-02-06,2019-01-16
59128,2409445,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,20MG,4,ORAL,Avoided shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-09-25,,2019-02-10,2018-09-24,Disruption of the manufacture of the drug.,2018-08-24,2018-09-19
53269,2243518,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,1MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-07-16,2018-07-12,2018-09-05,2018-10-02,Disruption of the manufacture of the drug.,2018-06-29,2018-10-03
51734,2243521,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,10MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-06-15,2018-06-26,2018-10-05,2018-10-03,Disruption of the manufacture of the drug.,2018-06-06,2018-10-04
53272,2243520,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,5MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-08-01,2018-10-05,2018-10-02,Disruption of the manufacture of the drug.,2018-06-29,2018-10-03
32151,2243521,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,10MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-12-08,2018-04-30,2018-04-17,Disruption of the manufacture of the drug.,2017-12-08,2018-04-19
32154,2243518,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,1MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-12-08,2018-04-30,2018-04-17,Disruption of the manufacture of the drug.,2017-12-08,2018-04-19
32157,2243519,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,2MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-12-08,2018-03-21,2018-04-30,Disruption of the manufacture of the drug.,2017-12-08,2018-05-01
32160,2243520,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,5MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-12-08,2018-04-30,2018-04-17,Disruption of the manufacture of the drug.,2017-12-08,2018-04-19
55744,2243519,Shortage,PMS-TERAZOSIN,PHARMASCIENCE INC,TERAZOSIN,TERAZOSIN,2MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-07-30,2018-08-23,2018-11-07,2018-11-28,Disruption of the manufacture of the drug.,2018-07-13,2018-11-29
67975,2294273,Shortage,PMS-TERBINAFINE,PHARMASCIENCE INC,TERBINAFINE,TERBINAFINE,250MG,100,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2018-11-28,2019-03-26,2019-03-25,Disruption of the manufacture of the drug.,2018-11-29,2019-03-28
67978,2294273,Shortage,PMS-TERBINAFINE,PHARMASCIENCE INC,TERBINAFINE,TERBINAFINE,250MG,30,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2018-11-28,2019-04-08,2019-05-07,Disruption of the manufacture of the drug.,2018-11-29,2019-05-09
64843,2322498,Shortage,PMS-TESTOSTERONE,PHARMASCIENCE INC,TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,100,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2018-10-17,2019-01-08,2019-01-16,Disruption of the manufacture of the drug.,2018-10-19,2019-01-17
93834,2322498,Shortage,PMS-TESTOSTERONE,PHARMASCIENCE INC,TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,30,ORAL,Actual shortage,CAPSULE,G03BA,ANDROGENS,2019-09-23,2019-10-28,2020-02-21,,Disruption of the manufacture of the drug.,2019-09-12,2019-11-15
93837,2322498,Shortage,PMS-TESTOSTERONE,PHARMASCIENCE INC,TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,100,ORAL,Actual shortage,CAPSULE,G03BA,ANDROGENS,2019-09-16,2019-10-28,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-12,2019-11-15
32163,2322498,Shortage,PMS-TESTOSTERONE,PHARMASCIENCE INC,TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,30,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,2018-01-02,2018-01-24,2018-04-25,2018-04-17,Disruption of the manufacture of the drug.,2017-12-08,2018-04-19
77513,2322498,Shortage,PMS-TESTOSTERONE,PHARMASCIENCE INC,TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,30,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2019-02-01,2019-06-27,2019-06-27,Disruption of the manufacture of the drug.,2019-03-04,2019-06-28
93840,2402424,Shortage,PMS-TETRABENAZINE,PHARMASCIENCE INC,TETRABENAZINE,TETRABENAZINE,25MG,100,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,2019-10-01,,2019-10-17,2019-10-31,Disruption of the manufacture of the drug.,2019-09-12,2019-11-01
17094,2402424,Shortage,PMS-TETRABENAZINE,PHARMASCIENCE INC,TETRABENAZINE,TETRABENAZINE,25MG,100,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2017-07-01,2018-04-04,2018-04-17,Disruption of the manufacture of the drug.,2017-07-25,2018-04-19
6174,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-04-05,2017-05-18,2017-06-08,Shortage of an active ingredient.,2017-04-07,2017-06-09
6181,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,500,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-04-05,2017-04-27,2017-04-27,Shortage of an active ingredient.,2017-04-07,2017-12-19
67981,2263017,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-11-28,2019-02-13,2019-02-06,Disruption of the manufacture of the drug.,2018-11-29,2019-02-08
5517,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-03-23,2017-05-01,2017-12-18,Shortage of an active ingredient.,2017-04-04,2017-12-19
5520,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,500,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-03-23,2017-04-27,2017-04-27,Shortage of an active ingredient.,2017-04-04,2017-12-19
46741,2312085,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,50MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-05-25,2018-06-04,2018-09-28,2018-10-02,Disruption of the manufacture of the drug.,2018-04-20,2018-10-03
8642,2263009,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-06-19,2017-11-21,2017-11-14,Shortage of an active ingredient.,2017-05-02,2017-11-17
12234,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,500,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-06-06,,2018-05-04,Shortage of an active ingredient.,2017-06-07,2018-05-05
77517,2263017,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-03-01,2019-04-08,2019-05-07,Disruption of the manufacture of the drug.,2019-03-04,2019-05-09
21724,2262991,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-04,2017-11-01,2017-10-27,Disruption of the manufacture of the drug.,2017-09-08,2017-10-28
21727,2312085,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,50MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-04,2018-01-30,2018-02-08,Disruption of the manufacture of the drug.,2017-09-08,2018-02-12
27368,2263017,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-10-09,2018-02-22,2018-02-19,Disruption of the manufacture of the drug.,2017-10-27,2018-02-20
1969,2406446,Shortage,PMS-TOPOTECAN,PHARMASCIENCE INC,Topotecan,TOPOTECAN,4MG,1,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2015-07-20,,,Other (Please describe in comments),2017-03-13,2019-01-16
6186,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,60,ORAL,Resolved,TABLET,N02AJ,,,2017-03-23,2017-11-02,2017-10-30,Delay in shipping of the drug.,2017-04-07,2017-10-31
6189,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017-03-23,2018-04-04,2017-10-30,Delay in shipping of the drug.,2017-04-07,2017-10-31
5523,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,60,ORAL,Resolved,TABLET,N02AJ,,,2017-03-23,2017-05-01,2017-12-18,Delay in shipping of the drug.,2017-04-04,2017-12-19
5528,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017-03-23,2017-05-01,2017-05-01,Delay in shipping of the drug.,2017-04-04,2017-12-19
4284,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,60,ORAL,Resolved,TABLET,N02AJ,,,2017-03-23,2017-05-01,2017-05-01,Delay in shipping of the drug.,2017-03-24,2017-12-19
4288,2401657,Shortage,PMS-TRAMADOL-ACET,PHARMASCIENCE INC,TRAMADOL-ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017-03-23,2017-05-01,2017-05-01,Delay in shipping of the drug.,2017-03-24,2017-12-19
79872,2237339,Shortage,PMS-TRAZODONE,PHARMASCIENCE INC,TRAZADONE,TRAZODONE HYDROCHLORIDE,75MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2019-03-27,2019-05-16,2019-05-31,Disruption of the manufacture of the drug.,2019-03-29,2019-06-11
10683,2237339,Shortage,PMS-TRAZODONE,PHARMASCIENCE INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,75MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-07-04,2017-07-04,2018-04-20,2018-04-17,Disruption of the manufacture of the drug.,2017-05-18,2018-04-19
59648,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,,2018-08-31,2018-10-29,2019-02-06,Disruption of the manufacture of the drug.,2018-08-31,2019-02-08
59653,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,500,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,,2018-08-31,2018-09-14,2019-02-06,Disruption of the manufacture of the drug.,2018-08-31,2019-02-08
59656,2273500,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,500MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,,2018-08-31,2018-09-25,2019-02-06,Disruption of the manufacture of the drug.,2018-08-31,2019-02-08
13138,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017-07-10,2017-07-10,2017-07-28,2017-07-28,Disruption of the manufacture of the drug.,2017-06-16,2017-12-19
17100,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,,2017-07-01,,2018-05-04,Disruption of the manufacture of the drug.,2017-07-25,2018-05-05
17103,2273500,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,500MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,,2017-07-01,2017-10-18,2017-10-23,Disruption of the manufacture of the drug.,2017-07-25,2017-10-26
21731,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,500,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017-10-19,2017-11-08,2017-12-22,2017-11-14,Disruption of the manufacture of the drug.,2017-09-08,2017-11-17
37355,2273497,Shortage,PMS-URSODIOL C,PHARMASCIENCE INC,URSODIOL,URSODIOL,250MG,500,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2018-02-02,2018-02-05,2018-03-20,2018-03-19,Disruption of the manufacture of the drug.,2018-01-26,2018-03-20
8967,2381230,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-05-18,,2017-06-16,2017-07-06,Disruption of the manufacture of the drug.,2017-05-04,2017-07-07
22824,2381230,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-09-15,,2017-12-12,Disruption of the manufacture of the drug.,2017-09-19,2017-12-14
7532,2298457,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-05-23,2017-05-23,,2017-10-02,Disruption of the manufacture of the drug.,2017-04-20,2017-10-11
40614,2298457,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Avoided shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2018-03-28,2018-03-26,,2018-03-26,Disruption of the manufacture of the drug.,2018-02-22,2018-05-04
10686,2381230,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-05-17,,,2017-06-14,Disruption of the manufacture of the drug.,2017-05-18,2017-06-16
77520,2298457,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-03-01,2019-11-25,2019-11-04,Disruption of the manufacture of the drug.,2019-03-04,2019-11-15
21734,2230768,Shortage,PMS-VALPROIC ACID,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,250MG,100,ORAL,Resolved,CAPSULE,N03AG,ANTIEPILEPTICS,,2017-11-08,2018-04-04,2018-04-17,Disruption of the manufacture of the drug.,2017-09-08,2018-04-19
6023,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,500MG,100,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017-04-05,2018-08-30,2018-08-23,Disruption of the manufacture of the drug.,2017-04-07,2018-08-24
6027,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,500MG,500,ORAL,Actual shortage,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017-04-05,,,Disruption of the manufacture of the drug.,2017-04-07,2018-12-20
1974,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,Valproic Acid,VALPROIC ACID,500MG,500,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2016-02-24,2017-03-30,2017-03-30,Requirements related to complying with good manufacturing practices.,2017-03-13,2017-12-19
1979,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,Valproic Acid,VALPROIC ACID,500MG,100,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2016-03-23,2017-03-30,2017-03-30,Requirements related to complying with good manufacturing practices.,2017-03-13,2017-03-31
4291,2229628,Shortage,PMS-VALPROIC ACID E.C.,PHARMASCIENCE INC,VALPROIC ACID,VALPROIC ACID,500MG,500,ORAL,Resolved,CAPSULE (ENTERIC-COATED),N03AG,ANTIEPILEPTICS,,2017-03-23,2017-07-08,2017-07-08,Disruption of the manufacture of the drug.,2017-03-24,2017-12-19
1924,2241821,Shortage,PMS-VANCOMYCIN 1 G,PHARMASCIENCE INC,Vancomycin,VANCOMYCIN,1.0G,1g,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2012-03-23,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1921,2241820,Shortage,PMS-VANCOMYCIN 500 MG,PHARMASCIENCE INC,Vancomycin,VANCOMYCIN,500MG,10,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2012-03-23,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
94073,2278545,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,37.5MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-07-29,2019-12-17,,Disruption of the manufacture of the drug.,2019-09-17,2019-09-17
6849,2278561,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,150MG,100,ORAL,Anticipated shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-12-13,2019-12-13,,Disruption of the manufacture of the drug.,2017-04-13,2019-11-15
6852,2278545,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-04-10,,,Disruption of the manufacture of the drug.,2017-04-13,2018-12-20
6855,2278545,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,PMS-VENLAFAXINE,VENLAFAXINE,37.5MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-04-10,,2019-07-29,Disruption of the manufacture of the drug.,2017-04-13,2019-07-31
6859,2278553,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,75MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-07-30,2019-12-13,,Disruption of the manufacture of the drug.,2017-04-13,2019-11-15
6862,2278561,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,150MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-04-10,,,Disruption of the manufacture of the drug.,2017-04-13,2018-12-20
6868,2278553,Shortage,PMS-VENLAFAXINE XR,PHARMASCIENCE INC,VENLAFAXINE,VENLAFAXINE,75MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-07-30,2019-12-13,,Disruption of the manufacture of the drug.,2017-04-13,2019-11-15
61906,2237791,Shortage,PMS-VERAPAMIL SR,PHARMASCIENCE INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,240MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-09-19,,,Disruption of the manufacture of the drug.,2018-09-19,2018-09-20
25819,2237791,Shortage,PMS-VERAPAMIL SR,PHARMASCIENCE INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,240MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-10-01,2017-11-02,2017-11-14,Disruption of the manufacture of the drug.,2017-10-12,2017-11-17
22828,2324229,Shortage,PMS-ZOLMITRIPTAN,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-09-15,2017-11-01,2017-11-08,Disruption of the manufacture of the drug.,2017-09-19,2017-11-09
69236,2324229,Shortage,PMS-ZOLMITRIPTAN,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-01-01,,,Disruption of the manufacture of the drug.,2018-12-11,2019-09-12
55747,2324229,Shortage,PMS-ZOLMITRIPTAN,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,30,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-07-30,,,Disruption of the manufacture of the drug.,2018-07-13,2019-09-12
25823,2324229,Shortage,PMS-ZOLMITRIPTAN,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-10-01,2017-11-06,2017-12-04,Disruption of the manufacture of the drug.,2017-10-12,2017-12-08
10674,2324768,Shortage,PMS-ZOLMITRIPTAN ODT,PHARMASCIENCE INC,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017-07-11,2017-07-11,2018-12-21,2018-12-11,Disruption of the manufacture of the drug.,2017-05-18,2018-12-12
39558,2436175,Shortage,PMS-ZOLPIDEM ODT,PHARMASCIENCE INC,ZOLPIDEM,ZOLPIDEM TARTRATE,5MG,30,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2018-02-12,2018-05-20,2018-05-15,Disruption of the manufacture of the drug.,2018-02-12,2018-05-18
21739,2243426,Shortage,PMS-ZOPICLONE,PHARMASCIENCE INC,ZOPICLONE,ZOPICLONE,5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017-09-04,,2017-12-07,Disruption of the manufacture of the drug.,2017-09-08,2017-12-14
93984,431648,Shortage,PNEUMOVAX 23,MERCK CANADA INC,"(pneumococcal vaccine, polyvalent)",PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F,25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG,10X1DOSE VIAL,INTRAMUSCULAR  SUBCUTANEOUS,Actual shortage,SOLUTION,J07AL,BACTERIAL VACCINES,2019-01-17,2019-01-17,2019-12-31,,Demand increase for the drug.,2019-09-16,2019-09-16
49957,431648,Shortage,PNEUMOVAX 23,MERCK CANADA INC,"(pneumococcal vaccine, polyvalent)",PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F,25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG,1 dose vial,INTRAMUSCULAR  SUBCUTANEOUS,Avoided shortage,SOLUTION,J07AL,BACTERIAL VACCINES,2018-07-23,,2018-08-03,2018-07-11,Other (Please describe in comments),2018-05-22,2018-07-11
72798,431648,Shortage,PNEUMOVAX 23,MERCK CANADA INC,"(pneumococcal vaccine, polyvalent)",PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F,25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG  25MCG,1dose vial,INTRAMUSCULAR  SUBCUTANEOUS,Actual shortage,SOLUTION,J07AL,BACTERIAL VACCINES,2019-01-17,2019-01-17,2019-12-31,,Demand increase for the drug.,2019-01-17,2019-09-16
95259,598208,Shortage,PODOFILM LIQ 250MG/ML,PALADIN LABS INC,Podophyllum,PODOPHYLLIN,250MG,25mL,TOPICAL,Actual shortage,LIQUID,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2019-09-27,,,Delay in shipping of the drug.,2019-10-02,2019-10-02
41315,598208,Shortage,PODOFILM LIQ 250MG/ML,PALADIN LABS INC,PODOPHYLLIN,PODOPHYLLIN,250MG,25mL,TOPICAL,Resolved,LIQUID,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2018-04-01,2018-04-01,2018-07-31,2018-07-31,Shortage of an inactive ingredient or component.,2018-02-28,2018-10-11
92831,2181908,Shortage,POLYDERM OINTMENT USP,TARO PHARMACEUTICALS INC,POLYDERM OINTMENT USP,BACITRACIN ZINC  POLYMYXIN B SULFATE,500UNIT  10000UNIT,15 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-08-01,2019-10-04,2019-10-04,Disruption of the manufacture of the drug.,2019-09-03,2019-10-11
92834,2181908,Shortage,POLYDERM OINTMENT USP,TARO PHARMACEUTICALS INC,POLYDERM OINTMENT USP,BACITRACIN ZINC  POLYMYXIN B SULFATE,500UNIT  10000UNIT,30 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-08-21,2019-09-27,2019-09-20,Disruption of the manufacture of the drug.,2019-09-03,2019-09-23
91312,2181908,Shortage,POLYDERM OINTMENT USP,TARO PHARMACEUTICALS INC,POLYDERM OINTMENT USP,BACITRACIN ZINC  POLYMYXIN B SULFATE,500UNIT  10000UNIT,15 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-08-01,2019-08-16,2019-08-15,Disruption of the manufacture of the drug.,2019-08-09,2019-08-19
79286,2181908,Shortage,POLYDERM OINTMENT USP,TARO PHARMACEUTICALS INC,Polyderm,BACITRACIN ZINC  POLYMYXIN B SULFATE,500UNIT  10000UNIT,15g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-03-19,2019-04-26,2019-04-18,Disruption of the manufacture of the drug.,2019-03-22,2019-04-23
83911,2181908,Shortage,POLYDERM OINTMENT USP,TARO PHARMACEUTICALS INC,POLYDERM OINTMENT USP,BACITRACIN ZINC  POLYMYXIN B SULFATE,500UNIT  10000UNIT,15 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-05-06,2019-06-21,2019-06-14,Disruption of the manufacture of the drug.,2019-05-13,2019-06-17
8303,2375893,Shortage,POLYMYXIN B FOR INJECTION USP,STERIMAX INC,POLYMYXIN B FOR INJECTION USP,POLYMYXIN B,50MG,1 VIAL,INTRAMUSCULAR  INTRATHECAL  INTRAVENOUS  OPHTHALMIC,Actual shortage,POWDER FOR SOLUTION,J01XB,OTHER ANTIBACTERIALS,,2017-01-17,,,Other (Please describe in comments),2017-04-27,2017-10-05
29189,1942921,Shortage,POLYTOPIC,SANDOZ CANADA INCORPORATED,POLYTOPIC,BACITRACIN  POLYMYXIN B,500UNIT  10000UNIT,15G,TOPICAL,Actual shortage,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2017-09-04,,,Requirements related to complying with good manufacturing practices.,2017-11-14,2017-12-15
59534,422908,Shortage,POLYTOPIC CREAM,SANDOZ CANADA INCORPORATED,POLYTOPIC,POLYMYXIN B  GRAMICIDIN,10000UNIT  0.25MG,15G TUBE,TOPICAL,Resolved,CREAM,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2018-08-24,2018-09-28,2018-09-04,Disruption of the manufacture of the drug.,2018-08-29,2018-09-10
20789,155225,Shortage,PONSTAN,AA PHARMA INC,Ponstan,MEFENAMIC ACID,250MG,100 BTL,ORAL,Actual shortage,CAPSULE,M01AG,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-09-01,,,Disruption of the manufacture of the drug.,2017-09-01,2018-12-20
94870,2295946,Shortage,PORTIA 21,TEVA CANADA LIMITED,ETHINYL ESTRADIOL LEVONORGESTREL,ETHINYL ESTRADIOL  LEVONORGESTREL,0.03MG  0.15MG,21,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-09-26,2019-01-31,2019-10-09,Disruption of the manufacture of the drug.,2019-09-26,2019-10-10
94874,2295954,Shortage,PORTIA 28,TEVA CANADA LIMITED,ETHINYL ESTRADIOL LEVONORGESTREL,ETHINYL ESTRADIOL  LEVONORGESTREL,0.03MG  0.15MG,28,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-09-26,2020-01-31,2019-10-09,Disruption of the manufacture of the drug.,2019-09-26,2019-10-10
59968,2432676,Shortage,POSANOL,MERCK CANADA INC,posaconazole Solution for Injection,POSACONAZOLE,18MG,1 vial per pack (18mg/ml 300mg),INTRAVENOUS,Resolved,SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2018-09-05,2018-09-04,2018-10-19,2018-10-19,Demand increase for the drug.,2018-09-05,2018-10-20
849,2293404,Shortage,POSANOL,MERCK CANADA INC,Posaconazole Oral Suspension,POSACONAZOLE,40MG/ML,105ML,ORAL,Resolved,ORAL SUSPENSION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2016-12-08,2016-12-08,2017-03-24,2017-03-22,Demand increase for the drug.,2017-03-13,2017-03-23
68737,2293404,Shortage,POSANOL,MERCK CANADA INC,posaconazole Oral Suspension,POSACONAZOLE,40MG,1 vial per pack,ORAL,Avoided shortage,SUSPENSION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2019-02-04,,2019-02-15,2019-01-29,Demand increase for the drug.,2018-12-05,2019-01-29
47010,2432676,Shortage,POSANOL,MERCK CANADA INC,posaconazole Solution for Injection,POSACONAZOLE,18MG,1 vial per pack,INTRAVENOUS,Resolved,SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2018-04-23,2018-06-29,2018-06-22,Demand increase for the drug.,2018-04-23,2018-06-23
9057,786306,Shortage,POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR,BAXTER CORPORATION,40 mmol Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP,DEXTROSE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,5G  300MG  900MG,1000mL,INTRAVENOUS,Resolved,SOLUTION,B05BB,I.V. SOLUTIONS,2017-05-01,2017-05-01,2017-09-25,2017-09-25,Delay in shipping of the drug.,2017-05-04,2017-09-26
21765,2362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LTD,Potassium Acetate,POTASSIUM ACETATE,39.2%,10 x 50mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2017-10-13,2017-10-05,2017-12-01,2017-11-20,Disruption of the manufacture of the drug.,2017-09-08,2017-11-21
61482,2362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LTD,Potassium Acetate Injection,POTASSIUM ACETATE,39.2%,10 x 50 mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-09-12,,2018-11-30,Disruption of the manufacture of the drug.,2018-09-14,2018-12-01
83803,2362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LTD,Potassium Acetate Injection,POTASSIUM ACETATE,39.2%,10 x 50mL vial / fiole,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2019-05-10,2019-09-30,2019-10-02,Demand increase for the drug.,2019-05-10,2019-10-04
98415,2362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LTD,Potassium Acetate Injection,POTASSIUM ACETATE,39.2%,10 x 50mL vial / fiole,INTRAVENOUS,Actual shortage,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2019-10-09,2019-12-15,,Disruption of the manufacture of the drug.,2019-11-11,2019-11-11
87215,2299100,Shortage,POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE,ICU MEDICAL CANADA INC,Potassium Chloride 20 MEQ in 0.9% Sodium Chloride,POTASSIUM CHLORIDE  SODIUM CHLORIDE,0.15G  0.9G,1000 ml,INTRAVENOUS,Actual shortage,SOLUTION,B05BB,I.V. SOLUTIONS,2019-07-15,2019-07-15,2020-01-01,,Delay in shipping of the drug.,2019-06-21,2019-10-31
96052,2480034,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LTD,Potassium Chloride for Injection Concentrate,POTASSIUM CHLORIDE,200mEq,1 x 100mL vial / fiole,INTRAVENOUS,Actual shortage,SOLUTION,,,,2019-10-10,,,Disruption of the manufacture of the drug.,2019-10-10,2019-10-11
78955,37869,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP,PFIZER CANADA ULC,Potassium Chloride for Injection Concentrate USP,POTASSIUM CHLORIDE,149MG,25 x 10mL PVL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-04-30,,2019-10-29,Disruption of the manufacture of the drug.,2019-03-20,2019-10-30
43635,37869,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP,PFIZER CANADA INC,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,149MG,25 X 20mL PVL,INTRAVENOUS,Avoided shortage,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2018-08-06,,,2018-06-06,Disruption of the manufacture of the drug.,2018-03-21,2018-06-07
71580,37869,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP,PFIZER CANADA ULC,Potassium Chloride for Injection Concentrate USP,POTASSIUM CHLORIDE,149MG,25 x 20mL PVL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-03-04,2019-09-30,2019-08-20,Disruption of the manufacture of the drug.,2019-01-08,2019-08-21
94470,2241677,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,POTASSIUM CHLORIDE INJECTION,POTASSIUM CHLORIDE,14.9MG,100 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-09-20,2019-09-20,2019-10-31,2019-10-31,Disruption of the manufacture of the drug.,2019-09-20,2019-11-01
69676,2241676,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,POTASSIUM CHLORIDE 10MMOL IN 100ML SWI  30EA/CA,POTASSIUM CHLORIDE,7.46MG,100 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-12-14,2018-12-14,2018-12-19,2018-12-19,Other (Please describe in comments),2018-12-14,2018-12-20
89426,2241676,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,POTASSIUM CHLORIDE INJECTION,POTASSIUM CHLORIDE,7.46MG,100 mL (JB0826),INTRAVENOUS,Actual shortage,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-07-16,2019-07-16,2019-12-16,,Delay in shipping of the drug.,2019-07-16,2019-10-30
73584,2241677,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,Potassium Chloride Injection,POTASSIUM CHLORIDE,14.9MG,100 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-01-25,2019-01-25,2019-02-04,2019-02-04,Disruption of the manufacture of the drug.,2019-01-25,2019-02-05
62874,2241679,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,Potassium Chloride 20mmol in 50mL,POTASSIUM CHLORIDE,29.8MG,50mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-10-02,2018-10-02,2018-10-15,2018-10-15,Delay in shipping of the drug.,2018-10-02,2018-10-18
58038,2241676,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,Potassium Chloride 10mmol in 100mL,POTASSIUM CHLORIDE,7.46MG,100mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-08-13,2018-08-13,2018-08-28,2018-08-28,Disruption of the manufacture of the drug.,2018-08-13,2018-08-29
35770,2241676,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,10mmol Potassium Chloride in 100mL Sterile Water Injection,POTASSIUM CHLORIDE,7.46MG,100 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-01-12,2018-01-12,2018-02-05,2018-02-05,Demand increase for the drug.,2018-01-12,2018-02-06
77248,2241677,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,Potassium Chloride Injection,POTASSIUM CHLORIDE,14.9MG,100 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-03-01,2019-03-01,2019-03-06,2019-03-06,Delay in shipping of the drug.,2019-03-01,2019-03-07
98262,2241679,Shortage,POTASSIUM CHLORIDE INJECTION,BAXTER CORPORATION,POTASSIUM CHLORIDE INJECTION,POTASSIUM CHLORIDE,29.8MG,50 mL (JB0822),INTRAVENOUS,Actual shortage,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-11-08,2019-11-08,2019-11-29,,Disruption of the manufacture of the drug.,2019-11-08,2019-11-09
10000,2139545,Shortage,"POTASSIUM PHOSPHATES INJECTION, USP",FRESENIUS KABI CANADA LTD,Potassium Phosphate,POTASSIUM PHOSPHATE DIBASIC  POTASSIUM PHOSPHATE MONOBASIC,236MG  224MG,50mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017-05-12,,2017-06-09,2017-05-26,Delay in shipping of the drug.,2017-05-10,2017-05-27
88835,2312433,Shortage,PRADAXA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Pradaxa 75 mg,DABIGATRAN ETEXILATE,75MG,30s,ORAL,Resolved,CAPSULE,B01AE,ANTITHROMBOTIC AGENTS,,2019-07-03,2019-07-22,2019-07-29,Demand increase for the drug.,2019-07-08,2019-08-19
95404,2358808,Shortage,PRADAXA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Pradaxa,DABIGATRAN ETEXILATE,150MG,60's,ORAL,Actual shortage,CAPSULE,B01AE,ANTITHROMBOTIC AGENTS,,2019-10-03,2019-11-22,,Demand increase for the drug.,2019-10-03,2019-10-04
73630,2453835,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,Praluent,ALIROCUMAB,150MG,2,SUBCUTANEOUS,Resolved,SOLUTION,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2019-02-18,,2019-02-28,2019-02-26,Other (Please describe in comments),2019-01-25,2019-02-27
80305,2453819,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,Praluent Pen 75mg/mL,ALIROCUMAB,75MG,2 pre-filled pens,SUBCUTANEOUS,Resolved,SOLUTION,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2019-04-15,,2019-05-06,2019-04-17,Other (Please describe in comments),2019-04-02,2019-04-18
80308,2453835,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,PRALUENT PEN 150MG/ML,ALIROCUMAB,150MG,2 pre-filled pens,SUBCUTANEOUS,Resolved,SOLUTION,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2019-05-06,,2019-05-13,2019-05-09,Other (Please describe in comments),2019-04-02,2019-05-10
64484,2453819,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,"PRALUENT Pre-filled pens, 75 mg/mL",ALIROCUMAB,75MG,2,SUBCUTANEOUS,Avoided shortage,SOLUTION,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2018-11-20,,2018-12-14,2018-10-17,Other (Please describe in comments),2018-10-17,2018-10-18
58642,2325810,Shortage,PRAMIPEXOLE,PRO DOC LIMITEE,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.50MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-08-21,,2018-12-20,Delay in shipping of the drug.,2018-08-21,2018-12-21
36403,2309149,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-04-23,2018-04-13,2018-12-04,2018-12-03,Other (Please describe in comments),2018-01-18,2018-12-04
28229,2309122,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-10-30,2018-11-30,2018-12-03,Other (Please describe in comments),2017-11-06,2018-12-04
25160,2325810,Shortage,PRAMIPEXOLE,PRO DOC LIMITEE,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.50MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-08-21,,2018-12-20,Delay in shipping of the drug.,2017-10-10,2018-12-21
28232,2309130,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-11-10,2017-11-06,2019-01-11,2019-01-11,Other (Please describe in comments),2017-11-06,2019-01-14
11376,2367610,Shortage,PRAMIPEXOLE,SANIS HEALTH INC,PRAMIPEXOLE TABS,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-05-26,2017-05-26,2017-06-16,2017-06-07,Other (Please describe in comments),2017-05-26,2017-06-08
60063,2367629,Shortage,PRAMIPEXOLE,SANIS HEALTH INC,PRAMIPEXOLE TAB,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-11-16,2018-11-21,,2019-03-26,Disruption of the manufacture of the drug.,2018-09-06,2019-03-27
45487,2325829,Shortage,PRAMIPEXOLE,PRO DOC LIMITEE,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-09-06,,2019-01-17,Delay in shipping of the drug.,2018-04-11,2019-01-18
56257,2367602,Shortage,PRAMIPEXOLE,SANIS HEALTH INC,PRAMIPEXOLE TAB,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-08-13,2018-08-07,2019-03-26,2019-03-26,Disruption of the manufacture of the drug.,2018-07-24,2019-03-27
29904,2325802,Shortage,PRAMIPEXOLE,PRO DOC LIMITEE,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-08-03,,2018-12-24,Delay in shipping of the drug.,2017-11-21,2018-12-25
58070,2367610,Shortage,PRAMIPEXOLE,SANIS HEALTH INC,PRAMIPEXOLE TAB,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2018-09-18,2018-09-20,,2019-03-26,Disruption of the manufacture of the drug.,2018-08-14,2019-03-27
80860,2309130,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-04-04,2019-05-07,2019-05-06,Delay in shipping of the drug.,2019-04-09,2019-05-07
28893,2309157,Shortage,PRAMIPEXOLE,SIVEM PHARMACEUTICALS ULC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-11-27,2017-12-02,2018-12-04,2018-12-03,Other (Please describe in comments),2017-11-10,2018-12-04
50668,2325837,Shortage,PRAMIPEXOLE,PRO DOC LIMITEE,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-10-05,,2018-12-24,Delay in shipping of the drug.,2018-05-29,2018-12-25
79361,2389703,Shortage,PRAVASTATIN,SIVEM PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-04-26,2019-04-26,2019-07-12,2019-07-12,Disruption of the manufacture of the drug.,2019-03-25,2019-07-13
96871,2356562,Shortage,PRAVASTATIN,SANIS HEALTH INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-11-01,2019-11-01,2020-02-14,,Disruption of the manufacture of the drug.,2019-10-21,2019-11-04
28092,2389746,Shortage,PRAVASTATIN,SIVEM PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-20,2018-03-02,2018-03-09,Other (Please describe in comments),2017-11-06,2018-03-26
87246,2389703,Shortage,PRAVASTATIN,SIVEM PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-07-08,2019-07-04,2019-08-23,2019-08-23,Delay in shipping of the drug.,2019-06-21,2019-08-29
80875,2389746,Shortage,PRAVASTATIN,SIVEM PHARMACEUTICALS ULC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-04-12,2019-04-10,2019-07-12,2019-07-05,Disruption of the manufacture of the drug.,2019-04-09,2019-07-06
65540,2454343,Shortage,PRAXBIND,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Praxbind,IDARUCIZUMAB,50MG,2 x 50ml,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2018-10-24,2018-11-16,2018-11-06,Disruption of the manufacture of the drug.,2018-10-24,2018-11-07
67844,2283700,Shortage,PRAXIS ASA EC 81 MG DAILY LOW DOSE,PHARMASCIENCE INC,ASA,ACETYLSALICYLIC ACID,81MG,1000,ORAL,Resolved,TABLET (DELAYED-RELEASE),B01AC,ANTITHROMBOTIC AGENTS,,2018-11-28,2019-03-30,2019-03-25,Disruption of the manufacture of the drug.,2018-11-28,2019-03-29
60183,2437147,Shortage,PRECEDEX,PFIZER CANADA INC,PRECEDEX,DEXMEDETOMIDINE,4MCG,20x50ml,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,,2018-09-06,,2019-04-02,Disruption of the manufacture of the drug.,2018-09-07,2019-04-03
93225,2437147,Shortage,PRECEDEX,PFIZER CANADA ULC,PRECEDEX,DEXMEDETOMIDINE,4MCG,20 x 50mL GVL,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,,2019-09-20,,2019-11-01,Disruption of the manufacture of the drug.,2019-09-06,2019-11-02
76599,2339366,Shortage,PRECEDEX,PFIZER CANADA ULC,Precedex,DEXMEDETOMIDINE,100MCG,1x2mL,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,,2019-02-18,,2019-03-28,Disruption of the manufacture of the drug.,2019-02-21,2019-03-29
60232,2339366,Shortage,PRECEDEX,PFIZER CANADA INC,PRECEDEX,DEXMEDETOMIDINE,100MCG,25x2ml,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,,2018-09-07,,2018-10-30,Demand increase for the drug.,2018-09-07,2018-10-31
60013,2437147,Shortage,PRECEDEX,PFIZER CANADA INC,PRECEDEX,DEXMEDETOMIDINE,4MCG,10x100ml,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,,2018-09-06,,2019-03-05,Disruption of the manufacture of the drug.,2018-09-05,2019-03-06
45703,2437147,Shortage,PRECEDEX,PFIZER CANADA INC,PRECEDEX,DEXMEDETOMIDINE,4MCG,10x100ML,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,,2018-06-29,,2018-07-10,Disruption of the manufacture of the drug.,2018-04-13,2018-07-11
44185,2437147,Shortage,PRECEDEX,HOSPIRA HEALTHCARE CORPORATION,Precedex,DEXMEDETOMIDINE,4MCG,20x50ML,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,,2018-05-04,,2018-06-05,Disruption of the manufacture of the drug.,2018-03-28,2018-06-06
57826,2437147,Shortage,PRECEDEX,PFIZER CANADA INC,PRECEDEX,DEXMEDETOMIDINE,4MCG,20x50ml,INTRAVENOUS,Resolved,SOLUTION,N05CM,HYPNOTICS AND SEDATIVES,2018-08-14,,,2018-08-16,Disruption of the manufacture of the drug.,2018-08-09,2018-08-17
88845,301175,Shortage,PRED FORTE,ALLERGAN INC,Pred Forte 1% 5 mL,PREDNISOLONE ACETATE,1%,5 mL,OPHTHALMIC,Resolved,DROPS,S01BA,ANTIINFLAMMATORY AGENTS,2019-07-08,2019-07-08,2019-08-05,2019-08-07,Demand increase for the drug.,2019-07-08,2019-08-08
69793,156876,Shortage,PREDNISONE TAB 5MG,PRO DOC LIMITEE,PREDNISONE,PREDNISONE,5MG,1000,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2018-12-17,,2018-12-21,Other (Please describe in comments),2018-12-18,2018-12-22
48427,2403730,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-05-07,2018-05-15,2018-05-25,2018-05-18,Delay in shipping of the drug.,2018-05-04,2018-05-19
36414,2403706,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-12-22,,2018-06-29,Other (Please describe in comments),2018-01-18,2018-06-30
36417,2403714,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,75MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-12-22,,2018-06-29,Other (Please describe in comments),2018-01-18,2018-06-30
36420,2403722,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,150MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-12-22,,2018-06-29,Other (Please describe in comments),2018-01-18,2018-06-30
28267,2403692,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-10-11,2017-12-22,2017-12-22,Other (Please describe in comments),2017-11-06,2018-01-18
28273,2403692,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,25MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-11-20,2017-12-04,,2018-06-29,Other (Please describe in comments),2017-11-06,2018-06-30
28276,2403706,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-10-15,2017-12-22,2017-12-22,Other (Please describe in comments),2017-11-06,2018-01-18
32628,2403722,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-12-11,2017-12-22,2017-12-22,Other (Please describe in comments),2017-12-12,2018-01-18
28279,2403706,Shortage,PREGABALIN,SIVEM PHARMACEUTICALS ULC,PREGABALIN,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-12-18,,,2017-12-22,Other (Please describe in comments),2017-11-06,2017-12-23
23674,2405547,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN CAP,PREGABALIN,50MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-10-02,,2017-10-23,2017-10-23,Other (Please describe in comments),2017-09-27,2017-10-31
20442,2396548,Shortage,PREGABALIN,PRO DOC LIMITEE,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-08-28,,2017-08-31,Delay in shipping of the drug.,2017-08-28,2017-09-29
43056,2182904,Shortage,PREGNYL,MERCK CANADA INC,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN  WATER,10000UNIT  10ML,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR,Resolved,KIT  LIQUID  POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2018-03-16,2018-03-16,2018-03-30,2018-03-27,Demand increase for the drug.,2018-03-16,2018-03-28
54875,2182904,Shortage,PREGNYL,MERCK CANADA INC,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN  WATER,10000UNIT  10ML,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR,Resolved,KIT  LIQUID  POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2018-07-17,2018-07-17,2018-11-30,2018-11-30,Disruption of the manufacture of the drug.,2018-07-09,2018-12-01
75371,2182904,Shortage,PREGNYL,MERCK CANADA INC,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN  WATER,10000UNIT  10ML,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR,Resolved,KIT  LIQUID  POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2019-02-12,2019-02-25,2019-02-22,Requirements related to complying with good manufacturing practices.,2019-02-12,2019-02-23
97198,2182904,Shortage,PREGNYL,MERCK CANADA INC,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN  WATER,10000UNIT  10ML,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR,Resolved,KIT  LIQUID  POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2019-10-24,2019-10-24,2019-11-07,2019-10-29,Delay in shipping of the drug.,2019-10-24,2019-10-30
18097,2182904,Shortage,PREGNYL,MERCK CANADA INC,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN  WATER,10000UNIT  10ML,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR,Resolved,KIT  LIQUID  POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2017-08-02,2017-08-18,2017-08-11,Delay in shipping of the drug.,2017-08-02,2017-08-12
76749,2182904,Shortage,PREGNYL,MERCK CANADA INC,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN  WATER,10000UNIT  10ML,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR,Resolved,KIT  LIQUID  POWDER FOR SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2019-02-24,2019-02-24,2019-07-03,2019-07-03,Delay in shipping of the drug.,2019-02-24,2019-07-04
67892,2043440,Shortage,PREMARIN VAGINAL CREAM,PFIZER CANADA INC,PREMARIN VAGINAL CREAM,CONJUGATED ESTROGENS,0.625MG,30G TUBE,VAGINAL,Resolved,CREAM,G03CA,ESTROGENS,,2018-11-28,,2018-12-17,Demand increase for the drug.,2018-11-28,2018-12-19
14413,2043440,Shortage,PREMARIN VAGINAL CREAM,PFIZER CANADA INC,Premarin,CONJUGATED ESTROGENS,0.625MG,Tube 14g,TOPICAL  VAGINAL,Resolved,CREAM,G03CA,ESTROGENS,2017-06-29,,2017-07-24,2017-07-24,Disruption of the manufacture of the drug.,2017-06-29,2017-07-25
42340,2043440,Shortage,PREMARIN VAGINAL CREAM,PFIZER CANADA INC,Premarin vaginal cream,CONJUGATED ESTROGENS,0.625MG,14G,VAGINAL,Resolved,CREAM,G03CA,ESTROGENS,2018-05-15,,,2018-05-16,Other (Please describe in comments),2018-03-09,2018-05-17
22631,2043440,Shortage,PREMARIN VAGINAL CREAM,PFIZER CANADA INC,PREMARIN,CONJUGATED ESTROGENS,0.625MG,14G TUBE,VAGINAL,Resolved,CREAM,G03CA,ESTROGENS,2017-10-09,,2017-11-21,2017-11-21,Disruption of the manufacture of the drug.,2017-09-19,2017-11-22
74052,2249464,Shortage,PREVACID FASTAB,TAKEDA PHARMACEUTICALS AMERICA INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,3 x 10,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-02-01,,2019-03-28,Delay in shipping of the drug.,2019-01-31,2019-03-29
74058,2249472,Shortage,PREVACID FASTAB,TAKEDA PHARMACEUTICALS AMERICA INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,"3x10, 10x10",ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-02-22,,,2019-03-08,Delay in shipping of the drug.,2019-01-31,2019-03-09
80466,2249464,Shortage,PREVACID FASTAB,TAKEDA PHARMACEUTICALS AMERICA INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,3 x 10,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-04-22,,2019-04-30,Delay in shipping of the drug.,2019-04-03,2019-05-01
80469,2249472,Shortage,PREVACID FASTAB,TAKEDA PHARMACEUTICALS AMERICA INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,"3 x 10, 10 x 10",ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-04-03,,,2019-04-05,Delay in shipping of the drug.,2019-04-03,2019-05-08
79032,2249472,Shortage,PREVACID FASTAB,TAKEDA PHARMACEUTICALS AMERICA INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,"3 x 10, 10 x 10",ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-03-20,,,2019-03-28,Delay in shipping of the drug.,2019-03-20,2019-03-29
64707,2249464,Shortage,PREVACID FASTAB,TAKEDA PHARMACEUTICALS AMERICA INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,3 x 10,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-11-12,2018-11-12,2019-01-11,2019-01-15,Delay in shipping of the drug.,2018-10-18,2019-01-16
82925,2249464,Shortage,PREVACID FASTAB,TAKEDA PHARMACEUTICALS AMERICA INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,3 x 10,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-05-13,,,2019-05-14,Delay in shipping of the drug.,2019-05-01,2019-05-15
2734,804541,Shortage,PREVEX B CREAM 0.1%,GLAXOSMITHKLINE INC,Betamethasone valerate cream,BETAMETHASONE VALERATE,0.1%,30 g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2016-07-27,,,Disruption of the manufacture of the drug.,2017-03-14,2017-11-24
88123,2046245,Shortage,PREVORA STAGE 1,CHX TECHNOLOGIES INC,Chlorhexidine solution,CHLORHEXIDINE ACETATE,10%,6 vials,DENTAL,Actual shortage,SOLUTION  KIT,A01AB,STOMATOLOGICAL PREPARATIONS,,2019-06-28,2019-12-31,,Disruption of the manufacture of the drug.,2019-07-02,2019-07-02
47946,2469375,Shortage,PREVYMIS,MERCK CANADA INC,LETERMOVIR TABLETS,LETERMOVIR,240MG,4X7TAB,ORAL,Resolved,TABLET,J05AX,DIRECT ACTING ANTIVIRALS,2018-05-02,2018-05-02,2018-06-08,2018-05-24,Demand increase for the drug.,2018-05-02,2018-05-25
92759,2469367,Shortage,PREVYMIS,MERCK CANADA INC,Letermovir for injection,LETERMOVIR,20MG,1 x Vial,INTRAVENOUS,Anticipated shortage,SOLUTION,J05AX,DIRECT ACTING ANTIVIRALS,2020-03-01,,2020-08-27,,Disruption of the manufacture of the drug.,2019-08-30,2019-09-19
92768,2469405,Shortage,PREVYMIS,MERCK CANADA INC,Letermovir for injection,LETERMOVIR,20MG,1 x Vial,INTRAVENOUS,Anticipated shortage,SOLUTION,J05AX,DIRECT ACTING ANTIVIRALS,2020-03-01,,2020-08-27,,Disruption of the manufacture of the drug.,2019-08-30,2019-08-30
62424,2017776,Shortage,PRIMAQUINE,SANOFI-AVENTIS CANADA INC,Primaquine,PRIMAQUINE PHOSPHATE,26.3MG,100,ORAL,Resolved,TABLET,P01BA,ANTIMALARIALS,,2018-09-25,2019-09-30,2019-08-08,Shortage of an active ingredient.,2018-09-26,2019-08-12
48697,839396,Shortage,PRINIVIL,MERCK CANADA INC,lisinopril tablets,LISINOPRIL,10MG,28TAB,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-06-18,2018-06-13,2018-07-06,2018-06-29,Disruption of the manufacture of the drug.,2018-05-07,2018-06-30
9580,839396,Shortage,PRINIVIL,MERCK CANADA INC,lisinopril tablets,LISINOPRIL,10MG,28,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-05-18,2017-05-23,2017-06-01,2017-05-26,Delay in shipping of the drug.,2017-05-08,2017-10-11
16777,839396,Shortage,PRINIVIL,MERCK CANADA INC,lisinopril tablets,LISINOPRIL,10MG,28,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-07-31,2017-08-03,2017-08-18,2017-08-15,Delay in shipping of the drug.,2017-07-24,2017-08-16
56235,839418,Shortage,PRINIVIL,MERCK CANADA INC,lisinopril tablets,LISINOPRIL,20MG,28TAB,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-08-10,2018-08-10,2018-08-24,2018-08-20,Delay in shipping of the drug.,2018-07-23,2018-08-21
82762,2239208,Shortage,PRIORIX,GLAXOSMITHKLINE INC,"Combined measles, mumps and rubella vaccine, live, attenuated",MUMPS VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED  WATER,10000UNIT  1000UNIT  1000UNIT  0.5ML,10's,SUBCUTANEOUS  INTRAMUSCULAR,Resolved,KIT  POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,,2019-04-24,2019-07-12,2019-07-12,Other (Please describe in comments),2019-04-29,2019-07-13
69657,2297884,Shortage,PRIORIX-TETRA,GLAXOSMITHKLINE INC,"Combined measles, mumps, rubella and varicella vaccine, live, attenuated",MUMPS VIRUS VACCINE LIVE ATTENUATED  VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,25118.9UNIT  1995.2623UNIT  1000UNIT  1000UNIT,10's,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,,2018-12-13,2019-02-04,2019-01-17,Demand increase for the drug.,2018-12-14,2019-01-18
82768,2297884,Shortage,PRIORIX-TETRA,GLAXOSMITHKLINE INC,"Combined measles, mumps, rubella and varicella vaccine, live, attenuated",MUMPS VIRUS VACCINE LIVE ATTENUATED  VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,25118.9UNIT  1995.2623UNIT  1000UNIT  1000UNIT,10's,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,,2019-04-24,2019-07-12,2019-07-12,Other (Please describe in comments),2019-04-29,2019-07-13
55679,2297884,Shortage,PRIORIX-TETRA,GLAXOSMITHKLINE INC,"Combined measles, mumps, rubella and varicella vaccine, live, attenuated",MUMPS VIRUS VACCINE LIVE ATTENUATED  VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,25118.9UNIT  1995.2623UNIT  1000UNIT  1000UNIT,10's,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,,2018-07-10,2018-09-07,2018-08-21,Delay in shipping of the drug.,2018-07-13,2018-08-22
82441,2444445,Shortage,PRIVA-AMLODIPINE,PHARMAPAR INC,Priva-AMLODIPINE,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2019-04-22,2019-06-17,2019-06-18,Delay in shipping of the drug.,2019-04-25,2019-06-19
63886,2444453,Shortage,PRIVA-AMLODIPINE,PHARMAPAR INC,AMLODIPINE 5 MG,AMLODIPINE,5MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-10-11,2019-05-01,2019-05-03,Other (Please describe in comments),2018-10-12,2019-05-06
32398,2427192,Shortage,PRIVA-CETIRIZINE,PHARMAPAR INC,CETIRIZINE,CETIRIZINE HYDROCHLORIDE,20MG,100,ORAL,Resolved,TABLET,R06AE,ANTIHISTAMINES FOR SYSTEMIC USE,2017-12-08,2017-12-08,2019-02-08,2019-02-07,Requirements related to complying with good manufacturing practices.,2017-12-11,2019-02-08
86570,2440245,Shortage,PRIVA-CITALOPRAM,PHARMAPAR INC,CITALOPRAM 20MG,CITALOPRAM,20MG,30,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,2019-06-30,2019-06-25,,,Requirements related to complying with good manufacturing practices.,2019-06-13,2019-09-03
39017,2440253,Shortage,PRIVA-CITALOPRAM,PHARMAPAR INC,CITALOPRAM 40 MG,CITALOPRAM,40MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-02-07,2018-02-07,2019-01-29,2019-01-29,Requirements related to complying with good manufacturing practices.,2018-02-07,2019-02-06
73587,2440237,Shortage,PRIVA-CITALOPRAM,PHARMAPAR INC,CITALOPRAM,CITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-01-24,,2019-01-29,Requirements related to complying with good manufacturing practices.,2019-01-25,2019-01-30
73591,2440245,Shortage,PRIVA-CITALOPRAM,PHARMAPAR INC,CITALOPRAM 20MG,CITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-01-24,,2019-01-29,Requirements related to complying with good manufacturing practices.,2019-01-25,2019-01-30
73594,2440245,Shortage,PRIVA-CITALOPRAM,PHARMAPAR INC,CITALOPRAM 20MG,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-01-24,2019-01-29,2019-01-29,Requirements related to complying with good manufacturing practices.,2019-01-25,2019-01-30
73599,2440253,Shortage,PRIVA-CITALOPRAM,PHARMAPAR INC,PRIVA CITALOPRAM 40 MG,CITALOPRAM,40MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-01-24,2019-01-29,2019-01-29,Requirements related to complying with good manufacturing practices.,2019-01-25,2019-02-06
65667,2440245,Shortage,PRIVA-CITALOPRAM,PHARMAPAR INC,CITALOPRAM,CITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-10-28,2019-01-31,2019-01-22,Other (Please describe in comments),2018-10-29,2019-01-23
59375,2433702,Shortage,PRIVA-FLUCONAZOLE,PHARMAPAR INC,PRIVA-FLUCONAZOLE 150mg-1x1,FLUCONAZOLE,150MG,1x1,ORAL,Actual shortage,CAPSULE,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017-11-17,,,Disruption of the manufacture of the drug.,2018-08-28,2018-08-28
92901,2448408,Shortage,PRIVA-FLUOXETINE,PHARMAPAR INC,FLUOXINE 20MG,FLUOXETINE,20MG,100,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-08-21,2019-11-21,,Delay in shipping of the drug.,2019-09-03,2019-10-29
57134,2450097,Shortage,PRIVA-GABAPENTIN,PHARMAPAR INC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-31,2018-07-31,2019-02-01,2019-02-05,Delay in shipping of the drug.,2018-07-31,2019-02-06
57139,2450100,Shortage,PRIVA-GABAPENTIN,PHARMAPAR INC,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-31,2018-07-31,2018-11-23,2018-11-28,Delay in shipping of the drug.,2018-07-31,2018-11-29
57142,2450119,Shortage,PRIVA-GABAPENTIN,PHARMAPAR INC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-07-31,2018-07-31,2018-11-23,2018-11-28,Delay in shipping of the drug.,2018-07-31,2018-11-29
62805,2450127,Shortage,PRIVA-GABAPENTIN,PHARMAPAR INC,GABAPENTIN 600MG,GABAPENTIN,600MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,,2018-10-01,,,Other (Please describe in comments),2018-10-01,2018-10-02
27943,2446499,Shortage,PRIVA-IRBESARTAN,PHARMAPAR INC,Priva-IRBESARTAN 75mg,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-11-01,2018-04-15,2018-04-09,Shortage of an active ingredient.,2017-11-02,2018-04-10
81448,2446510,Shortage,PRIVA-IRBESARTAN,PHARMAPAR INC,IRBESARTAN 300 MG,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-09,,,Disruption of the manufacture of the drug.,2019-04-11,2019-04-11
83539,2446502,Shortage,PRIVA-IRBESARTAN,PHARMAPAR INC,IRBESARTAN 150 MG,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-08,,,Disruption of the manufacture of the drug.,2019-05-08,2019-05-09
73602,2446499,Shortage,PRIVA-IRBESARTAN,PHARMAPAR INC,IRBESARTAN 75 MG,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-24,,,Requirements related to complying with good manufacturing practices.,2019-01-25,2019-02-11
73605,2446502,Shortage,PRIVA-IRBESARTAN,PHARMAPAR INC,IRBESARTAN 150 MG,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-24,,2019-01-29,Requirements related to complying with good manufacturing practices.,2019-01-25,2019-01-30
73612,2446510,Shortage,PRIVA-IRBESARTAN,PHARMAPAR INC,PRIVA IRBESARTAN 300 MG,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-24,,2019-01-29,Requirements related to complying with good manufacturing practices.,2019-01-25,2019-01-30
62802,2450380,Shortage,PRIVA-LEVETIRACETAM,PHARMAPAR INC,LEVETIRACETAM 500MG,LEVETIRACETAM,500MG,120,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2018-11-01,2018-11-28,,,Other (Please describe in comments),2018-10-01,2018-11-29
27948,2446693,Shortage,PRIVA-LOSARTAN,PHARMAPAR INC,Priva-LOSARTAN 25mg,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-11-01,,,Other (Please describe in comments),2017-11-02,2017-11-02
35023,2446707,Shortage,PRIVA-LOSARTAN,PHARMAPAR INC,LOSARTAN 50MG,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-01-03,,,Other (Please describe in comments),2018-01-05,2018-01-05
35026,2446715,Shortage,PRIVA-LOSARTAN,PHARMAPAR INC,LOSARTAN 100 MG,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-01-03,,,Other (Please describe in comments),2018-01-05,2018-01-05
62799,2447371,Shortage,PRIVA-MOXIFLOXACIN,PHARMAPAR INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-10-01,,,Other (Please describe in comments),2018-10-01,2018-10-02
56085,2425378,Shortage,PRIVA-PANTOPRAZOLE,PHARMAPAR INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-08-17,2018-08-21,2018-08-21,2018-08-21,Shortage of an active ingredient.,2018-07-19,2018-08-22
22844,2425378,Shortage,PRIVA-PANTOPRAZOLE,PHARMAPAR INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-07-01,2017-07-01,2017-10-25,2017-10-24,Delay in shipping of the drug.,2017-09-20,2017-10-26
22848,2425378,Shortage,PRIVA-PANTOPRAZOLE,PHARMAPAR INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-07-01,2017-07-01,2017-10-06,2017-10-24,Delay in shipping of the drug.,2017-09-20,2017-10-26
98590,2444321,Shortage,PRIVA-PAROXETINE,PHARMAPAR INC,PAROXETINE,PAROXETINE,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-11-13,2019-12-20,,Delay in shipping of the drug.,2019-11-13,2019-11-14
98594,2444321,Shortage,PRIVA-PAROXETINE,PHARMAPAR INC,PAROXETINE,PAROXETINE,20MG,500,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-11-13,2020-01-30,,Delay in shipping of the drug.,2019-11-13,2019-11-14
98597,2445379,Shortage,PRIVA-PRAVASTATIN,PHARMAPAR INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-11-01,2020-01-30,,Delay in shipping of the drug.,2019-11-13,2019-11-13
98600,2445395,Shortage,PRIVA-PRAVASTATIN,PHARMAPAR INC,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-11-01,2020-01-30,,Delay in shipping of the drug.,2019-11-13,2019-11-13
98604,2445409,Shortage,PRIVA-PRAVASTATIN,PHARMAPAR INC,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-11-01,2020-01-30,,Delay in shipping of the drug.,2019-11-13,2019-11-13
40175,2445409,Shortage,PRIVA-PRAVASTATIN,PHARMAPAR INC,PRAVASTATIN 40 MG,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-02-16,2018-02-16,,2018-09-13,Delay in shipping of the drug.,2018-02-19,2018-09-14
40178,2445395,Shortage,PRIVA-PRAVASTATIN,PHARMAPAR INC,PRAVASTATIN 20 MG,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-03-01,2018-02-28,,2018-09-13,Delay in shipping of the drug.,2018-02-19,2018-09-14
40181,2445379,Shortage,PRIVA-PRAVASTATIN,PHARMAPAR INC,PRAVASTATIN  10 MG,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-03-01,2018-02-28,,2018-09-13,Delay in shipping of the drug.,2018-02-19,2018-09-14
59394,2447126,Shortage,PRIVA-QUETIAPINE,PHARMAPAR INC,PRIVA-QUETIAPINE,QUETIAPINE,200MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-01-15,,,Other (Please describe in comments),2018-08-28,2018-08-28
59398,2447134,Shortage,PRIVA-QUETIAPINE,PHARMAPAR INC,PRIVA-QUETIAPINE,QUETIAPINE,300MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-01-19,,,Other (Please describe in comments),2018-08-28,2018-08-28
22864,2447088,Shortage,PRIVA-QUETIAPINE,PHARMAPAR INC,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-09-15,2017-09-15,2017-12-01,2017-12-01,Delay in shipping of the drug.,2017-09-20,2017-12-04
22867,2447096,Shortage,PRIVA-QUETIAPINE,PHARMAPAR INC,QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017-08-24,2017-08-24,,,Delay in shipping of the drug.,2017-09-20,2017-10-26
78960,2445433,Shortage,PRIVA-ROSUVASTATIN,PHARMAPAR INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-03-19,2019-03-19,,,Other (Please describe in comments),2019-03-20,2019-03-20
70129,2445417,Shortage,PRIVA-ROSUVASTATIN,PHARMAPAR INC,PRIVA-ROSUVASTATIN 5MG-100,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-12-14,2019-07-22,2019-07-25,Delay in shipping of the drug.,2018-12-19,2019-07-26
64618,2445387,Shortage,PRIVA-SERTRALINE,PHARMAPAR INC,SERTRALINE 100MG,SERTRALINE,100MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-10-16,2018-10-16,2019-01-11,2019-01-10,Disruption of the manufacture of the drug.,2018-10-17,2019-01-11
57813,2445352,Shortage,PRIVA-SERTRALINE,PHARMAPAR INC,SERTRALINE 25MG,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2018-08-17,2018-08-13,2019-01-11,2019-01-10,Disruption of the manufacture of the drug.,2018-08-09,2019-01-11
27940,2448807,Shortage,PRIVA-SILDENAFIL,PHARMAPAR INC,Priva-SILDENAFIL 100mg,SILDENAFIL,100MG,1X4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-10-27,2018-02-07,2018-01-24,Delay in shipping of the drug.,2017-11-02,2018-01-25
38038,2452480,Shortage,PRIVA-TADALAFIL,PHARMAPAR INC,TADALAFIL 5 MG,TADALAFIL,5MG,7X4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-02-01,2018-02-01,,2018-04-02,Other (Please describe in comments),2018-02-01,2018-04-03
38043,2452499,Shortage,PRIVA-TADALAFIL,PHARMAPAR INC,TADALAFIL 10 MG,TADALAFIL,10MG,1X4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-02-01,2018-02-01,2018-07-27,2018-07-12,Other (Please describe in comments),2018-02-01,2018-07-13
41291,2391554,Shortage,PRIVA-TRAMADOL/ACET,PHARMAPAR INC,TRAMADOL/ACET 37.5/325MG,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,6X10,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,2018-02-28,2018-02-28,2018-10-05,2018-09-05,Requirements related to complying with good manufacturing practices.,2018-02-28,2018-09-06
22852,2441861,Shortage,PRIVA-VALACYCLOVIR,PHARMAPAR INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2016-12-15,2016-12-15,2018-02-15,2018-01-17,Shortage of an active ingredient.,2017-09-20,2018-02-19
57816,2441861,Shortage,PRIVA-VALACYCLOVIR,PHARMAPAR INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2018-08-31,2018-08-30,,,Delay in shipping of the drug.,2018-08-09,2018-09-04
7676,2441861,Shortage,PRIVA-VALACYCLOVIR,PHARMAPAR INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2016-12-15,2016-12-15,2018-01-18,2018-01-17,Delay in shipping of the drug.,2017-04-24,2018-01-18
42843,2425882,Shortage,PRIVA-ZOPICLONE,PHARMAPAR INC,ZOPICLONE 7.5 MG  TABLETS,ZOPICLONE,7.5MG,100,ORAL,Actual shortage,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2018-03-13,,,Other (Please describe in comments),2018-03-14,2018-03-14
61738,2309661,Shortage,PRO-AMIODARONE - 200,PRO DOC LIMITEE,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2018-09-18,,2018-09-25,Delay in shipping of the drug.,2018-09-18,2018-09-26
5295,2310600,Shortage,PRO-AZITHROMYCINE,PRO DOC LIMITEE,AZITHROMYCINE,AZITHROMYCIN,250MG,6,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-03,,2017-07-13,Delay in shipping of the drug.,2017-04-04,2017-07-14
21223,2311038,Shortage,PRO-BICALUTAMIDE - 50,PRO DOC LIMITEE,BICALUTAMIDE,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-09-05,,2018-05-31,Delay in shipping of the drug.,2017-09-07,2018-06-04
22067,2311607,Shortage,PRO-CLONAZEPAM,PRO DOC LIMITEE,CLONAZEPAM,CLONAZEPAM,1MG,500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2017-09-13,,2017-12-07,Delay in shipping of the drug.,2017-09-13,2017-12-08
75560,2311267,Shortage,PRO-DEXAMETHASONE - 4,PRO DOC LIMITEE,DEXAMETHASONE,DEXAMETHASONE,4MG,100,ORAL,Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-03-08,,2019-04-10,Other (Please describe in comments),2019-02-13,2019-04-11
32848,2311437,Shortage,PRO-ENALAPRIL - 20,PRO DOC LIMITEE,ENALAPRIL,ENALAPRIL MALEATE,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-12-14,,2018-01-10,Delay in shipping of the drug.,2017-12-14,2018-01-11
81262,2310228,Shortage,PRO-FENO-SUPER - 100,PRO DOC LIMITEE,FENOFIBRATE,FENOFIBRATE,100MG,100,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-04,,2019-06-25,Other (Please describe in comments),2019-04-11,2019-06-26
66903,2310473,Shortage,PRO-GABAPENTIN,PRO DOC LIMITEE,PRO-GABAPENTIN,GABAPENTIN,600MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-11-14,,2019-01-16,Delay in shipping of the drug.,2018-11-14,2019-01-17
66219,2310481,Shortage,PRO-GABAPENTIN,PRO DOC LIMITEE,GABAPENTIN,GABAPENTIN,800MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-11-05,,2019-01-16,Delay in shipping of the drug.,2018-11-05,2019-01-17
81265,2311011,Shortage,PRO-HYDROXYQUINE - 200,PRO DOC LIMITEE,PRO-HYDROXYQUINE - 200,HYDROXYCHLOROQUINE SULFATE,200MG,100,ORAL,Resolved,TABLET,P01BA,ANTIMALARIALS,2019-06-04,2019-05-22,,2019-06-25,Other (Please describe in comments),2019-04-11,2019-06-26
32241,2311399,Shortage,PRO-LEVETIRACETAM - 750,PRO DOC LIMITEE,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-12-08,2018-01-03,2017-12-22,Delay in shipping of the drug.,2017-12-08,2017-12-23
2324,655643,Shortage,PRO-LORAZEPAM TAB 0.5MG,PRO DOC LIMITEE,LORAZEPAM,LORAZEPAM,0.5MG,500,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-12-04,,2019-02-07,Delay in shipping of the drug.,2017-03-14,2019-02-08
67702,655651,Shortage,PRO-LORAZEPAM TAB 1.0MG,PRO DOC LIMITEE,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-11-27,,2018-11-29,Requirements related to complying with good manufacturing practices.,2018-11-27,2018-11-30
55388,2312689,Shortage,PRO-LOVASTATIN,PRO DOC LIMITEE,LOVASTATIN,LOVASTATIN,40MG,30-100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-07-11,,2018-07-26,Delay in shipping of the drug.,2018-07-11,2018-07-27
54646,2312670,Shortage,PRO-LOVASTATIN,PRO DOC LIMITEE,LOVASTATIN,LOVASTATIN,20MG,30-100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-07-05,,2018-07-26,Delay in shipping of the drug.,2018-07-06,2018-07-27
14341,2312778,Shortage,PRO-MIRTAZAPINE,PRO DOC LIMITEE,MIRTAZAPINE,MIRTAZAPINE,15MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2017-07-12,,2018-11-20,Delay in shipping of the drug.,2017-06-29,2018-11-21
40857,2312786,Shortage,PRO-MIRTAZAPINE,PRO DOC LIMITEE,MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-02-22,,2019-04-03,Delay in shipping of the drug.,2018-02-23,2019-04-04
47125,2310945,Shortage,PRO-NAPROXEN EC - 375,PRO DOC LIMITEE,NAPROXEN EC,NAPROXEN,375MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-04-24,2018-08-17,2018-08-14,Delay in shipping of the drug.,2018-04-24,2018-08-15
37653,2310953,Shortage,PRO-NAPROXEN EC - 500,PRO DOC LIMITEE,NAPROXEN EC - 500,NAPROXEN,500MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-06-27,,2019-10-30,Delay in shipping of the drug.,2018-01-30,2019-10-31
62321,2311216,Shortage,PRO-QUININE - 200,PRO DOC LIMITEE,QUININE,QUININE SULFATE,200MG,100,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2018-09-25,,2018-10-11,Delay in shipping of the drug.,2018-09-25,2018-10-12
58956,2315181,Shortage,PRO-RABEPRAZOLE,PRO DOC LIMITEE,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-08-24,,2018-09-27,Delay in shipping of the drug.,2018-08-24,2018-09-28
84827,2315181,Shortage,PRO-RABEPRAZOLE,PRO DOC LIMITEE,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-05-27,2019-08-01,2019-08-01,Delay in shipping of the drug.,2019-05-27,2019-08-02
93043,2315181,Shortage,PRO-RABEPRAZOLE,PRO DOC LIMITEE,PRO-RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100,ORAL,Anticipated shortage,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-12-31,,,,Other (Please describe in comments),2019-09-05,2019-09-05
93046,2315203,Shortage,PRO-RABEPRAZOLE,PRO DOC LIMITEE,PRO-RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100,ORAL,Actual shortage,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-30,2019-10-02,,,Other (Please describe in comments),2019-09-05,2019-10-03
78927,2310023,Shortage,PRO-RAMIPRIL - 1.25,PRO DOC LIMITEE,PRO-RAMIPRIL - 1.25,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-03-19,,2019-05-15,Delay in shipping of the drug.,2019-03-19,2019-05-28
20226,2312727,Shortage,PRO-RISPERIDONE,PRO DOC LIMITEE,PRO-RISPERIDONE,RISPERIDONE,1.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-08-24,,2017-09-21,Delay in shipping of the drug.,2017-08-24,2017-09-22
9735,2312735,Shortage,PRO-RISPERIDONE,PRO DOC LIMITEE,RISPERIDONE,RISPERIDONE,2.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2017-07-20,,,2017-07-21,Delay in shipping of the drug.,2017-05-09,2017-07-31
21239,2312700,Shortage,PRO-RISPERIDONE,PRO DOC LIMITEE,RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2017-09-05,,2017-11-08,Delay in shipping of the drug.,2017-09-07,2017-11-09
91654,2316528,Shortage,PRO-SOTALOL,PRO DOC LIMITEE,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,2019-09-26,2019-09-20,,,Other (Please describe in comments),2019-08-15,2019-09-21
25689,2316528,Shortage,PRO-SOTALOL,PRO DOC LIMITEE,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-10-11,,2017-11-24,Delay in shipping of the drug.,2017-10-12,2017-11-25
19395,2316536,Shortage,PRO-SOTALOL,PRO DOC LIMITEE,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-08-14,2017-12-21,2017-12-19,Delay in shipping of the drug.,2017-08-15,2017-12-20
26146,2313650,Shortage,PRO-TOPIRAMATE,PRO DOC LIMITEE,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-10-17,,2017-11-07,Delay in shipping of the drug.,2017-10-17,2017-11-08
30115,2313677,Shortage,PRO-TOPIRAMATE,PRO DOC LIMITEE,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-11-22,,2018-02-07,Delay in shipping of the drug.,2017-11-22,2018-02-08
22984,2313669,Shortage,PRO-TOPIRAMATE,PRO DOC LIMITEE,TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-09-21,,2017-10-10,Delay in shipping of the drug.,2017-09-21,2017-10-12
9709,2315173,Shortage,PRO-VALACYCLOVIR,PRO DOC LIMITEE,PRO-VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-07-05,,2017-10-05,Delay in shipping of the drug.,2017-05-09,2017-10-06
47314,2312697,Shortage,PRO-VERAPAMIL SR,PRO DOC LIMITEE,PRO-VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,240MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-04-27,,2018-07-26,Delay in shipping of the drug.,2018-04-27,2018-07-27
2559,2184486,Shortage,PROCAINAMIDE HYDROCHLORIDE INJ. USP,SANDOZ CANADA INCORPORATED,PROCAINAMIDE,PROCAINAMIDE,100mg/mL,10x10mLV,Intra,Resolved,INJ,C01BA,"ANTIARRHYTHMICS, CLASS I AND III",2017-03-14,,2017-08-18,2017-08-18,Demand increase for the drug.,2017-03-14,2017-10-25
3773,638692,Shortage,PROCAN SR,ERFA CANADA 2012 INC,Procainamide,PROCAINAMIDE HYDROCHLORIDE,250MG,bottle of 100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C01BA,"ANTIARRHYTHMICS, CLASS I AND III",2013-09-17,2013-09-17,,,Other (Please describe in comments),2017-03-21,2018-03-14
7313,886432,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE,10MG,100 Bottle,ORAL,Resolved,TABLET,N05AB,ANTIPSYCHOTICS,2017-04-21,,2017-06-02,2017-05-11,Demand increase for the drug.,2017-04-20,2017-09-05
2030,886432,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE (PROCHLORPERAZINE MALEATE),10 MG,100 Bottle,Oral,Resolved,Tablet,N05AB,ANTIPSYCHOTICS,,2016-05-04,2017-03-17,2017-03-17,Shortage of an active ingredient.,2017-03-14,2017-03-25
2033,886440,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE,5MG,100 Bottle,ORAL,Resolved,TABLET,N05AB,ANTIPSYCHOTICS,,2016-05-17,2017-03-17,2017-03-17,Shortage of an active ingredient.,2017-03-14,2017-03-25
96265,2240851,Shortage,PROCTODAN-HC SUPPOSITORIES,ODAN LABORATORIES LTD,"Pramoxine hydrochloride, Hydrocortisone Acetate and Zinc Sulfate Hemorroidal Suppositories",PRAMOXINE HYDROCHLORIDE  HYDROCORTISONE ACETATE  ZINC SULFATE,20MG  10MG  10MG,12,RECTAL,Actual shortage,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2019-10-11,2019-11-29,,Disruption of the manufacture of the drug.,2019-10-11,2019-11-14
46814,2240851,Shortage,PROCTODAN-HC SUPPOSITORIES,ODAN LABORATORIES LTD,Hemorroidal Suppositories,PRAMOXINE HYDROCHLORIDE  HYDROCORTISONE ACETATE  ZINC SULFATE,20MG  10MG  10MG,12,RECTAL,Resolved,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2018-04-20,2018-05-11,2018-05-11,Disruption of the manufacture of the drug.,2018-04-20,2018-05-15
18028,363014,Shortage,PROCTOFOAM HC,DUCHESNAY INC,Proctofoam HC,PRAMOXINE HYDROCHLORIDE  HYDROCORTISONE ACETATE,1%  1%,22.4g,RECTAL,Actual shortage,AEROSOL,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017-08-17,2019-11-30,,Disruption of the manufacture of the drug.,2017-08-02,2019-10-31
5285,2223260,Shortage,PROCTOSEDYL SUPPOSITORIES,APTALIS PHARMA CANADA ULC,PrPROCTOSEDYL® 0.5% Suppositories,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,12 and 24 suppositories,RECTAL,Resolved,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2013-03-01,,2017-04-05,Other (Please describe in comments),2017-04-04,2019-03-05
77345,2241795,Shortage,PROCYTOX TAB 25MG,BAXTER CORPORATION,Procytox,CYCLOPHOSPHAMIDE,25MG,25 mg,ORAL,Resolved,TABLET,L01AA,ALKYLATINGAGENTS,2019-03-04,2019-03-04,2019-03-15,2019-03-15,Demand increase for the drug.,2019-03-04,2019-03-16
5778,2241795,Shortage,PROCYTOX TAB 25MG,BAXTER CORPORATION,Cyclophosphamide,CYCLOPHOSPHAMIDE,25MG,25mg tablets,ORAL,Resolved,TABLET,L01AA,ALKYLATINGAGENTS,2017-04-06,2017-04-06,2017-08-28,2017-08-28,Demand increase for the drug.,2017-04-06,2017-08-29
70237,503347,Shortage,PROGLYCEM,MERCK CANADA INC,diazoxide capsules,DIAZOXIDE,100MG,100CAP,ORAL,Resolved,CAPSULE,V03AH,ALL OTHER THERAPEUTIC PRODUCTS,2019-02-15,2019-02-15,2019-03-01,2019-02-28,Delay in shipping of the drug.,2018-12-20,2019-03-01
47479,503347,Shortage,PROGLYCEM,MERCK CANADA INC,diazoxide capsules,DIAZOXIDE,100MG,100 cap,ORAL,Avoided shortage,CAPSULE,V03AH,ALL OTHER THERAPEUTIC PRODUCTS,2018-05-18,,2018-06-01,2018-05-17,Delay in shipping of the drug.,2018-04-30,2018-05-17
31940,503347,Shortage,PROGLYCEM,MERCK CANADA INC,Diazoxide capsules,DIAZOXIDE,100MG,100 caps,ORAL,Resolved,CAPSULE,V03AH,ALL OTHER THERAPEUTIC PRODUCTS,2018-01-02,2017-12-21,2018-01-26,2018-01-24,Delay in shipping of the drug.,2017-12-06,2018-01-25
43053,2439123,Shortage,PROLENSA,BAUSCH & LOMB INC,PROLENSA,Bromfenac,0.07%,3ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2018-05-10,,2018-06-15,Other (Please describe in comments),2018-03-16,2018-06-20
13158,2439123,Shortage,PROLENSA,BAUSCH & LOMB INC,PROLENSA,Bromfenac,0.07%,N/A,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2017-06-14,2017-07-01,2017-03-01,Other (Please describe in comments),2017-06-16,2018-03-13
63355,2439123,Shortage,PROLENSA,BAUSCH & LOMB INC,PROLENSA,Bromfenac,0.07%,3ml,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2018-10-03,,2018-11-05,Other (Please describe in comments),2018-10-05,2018-11-09
56803,2439123,Shortage,PROLENSA,BAUSCH & LOMB INC,PROLENSA,Bromfenac,0.07%,3ml,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,,2018-07-26,2018-08-14,2018-08-21,Other (Please describe in comments),2018-07-27,2018-08-22
11754,2439123,Shortage,PROLENSA,BAUSCH & LOMB INC,Prolensa,Bromfenac,0.07%,n/a,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2017-04-26,,2017-06-16,2017-06-09,Other (Please describe in comments),2017-06-02,2017-06-16
56072,2130181,Shortage,PROLEUKIN,NOVARTIS PHARMACEUTICALS CANADA INC,PROLEUKIN 1.3MG VIALS 1X1,ALDESLEUKIN,22000000UNIT,1.3MG 1X1,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L03AC,IMMUNOSTIMULANTS,2018-12-20,,2018-12-21,2018-12-20,Delay in shipping of the drug.,2018-07-18,2019-01-03
75155,2130181,Shortage,PROLEUKIN,NOVARTIS PHARMACEUTICALS CANADA INC,PROLEUKIN 1.3MG VIALS,ALDESLEUKIN,22000000UNIT,1.3MG,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L03AC,IMMUNOSTIMULANTS,2019-03-26,,2019-03-29,2019-03-26,Delay in shipping of the drug.,2019-02-08,2019-03-27
9713,2229736,Shortage,PRONAL TABLETS,PRO DOC LIMITEE,PRONAL,ACETYLSALICYLIC ACID  BUTALBITAL  CAFFEINE,330MG  50MG  40MG,100,ORAL,Resolved,TABLET,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017-05-24,,2018-05-30,Other (Please describe in comments),2017-05-09,2018-05-31
32539,2343061,Shortage,PROPAFENONE,SANIS HEALTH INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017-12-12,2017-12-15,2018-03-16,2018-03-07,Delay in shipping of the drug.,2017-12-12,2018-03-08
26243,2343053,Shortage,PROPAFENONE,SANIS HEALTH INC,PROPARENONE,PROPAFENONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2017-10-27,2017-11-03,2018-03-16,2018-03-07,Disruption of the manufacture of the drug.,2017-10-18,2018-03-08
52919,2343061,Shortage,PROPAFENONE,SANIS HEALTH INC,PROPAFENONE TAB,PROPAFENONE HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2018-07-31,2018-07-06,2019-02-08,2019-02-05,Other (Please describe in comments),2018-06-26,2019-02-06
45511,2343053,Shortage,PROPAFENONE,SANIS HEALTH INC,PROPAFENONE TAB,PROPAFENONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2018-05-07,2018-05-07,2019-02-15,2019-02-19,Other (Please describe in comments),2018-04-12,2019-02-20
80717,2238213,Shortage,PROPECIA,MERCK CANADA INC,Finasteride tablets,FINASTERIDE,1MG,28,ORAL,Avoided shortage,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2019-04-10,,2019-04-17,2019-04-09,Delay in shipping of the drug.,2019-04-08,2019-04-09
28294,2238213,Shortage,PROPECIA,MERCK CANADA INC,Finasteride tablets,FINASTERIDE,1MG,28 Tabs,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2018-01-05,2018-01-05,2018-02-16,2018-02-16,Delay in shipping of the drug.,2017-11-06,2018-02-17
40118,2238213,Shortage,PROPECIA,MERCK CANADA INC,Finasteride Tablets,FINASTERIDE,1MG,28's,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,2018-03-01,2018-02-28,2018-03-27,2018-03-26,Delay in shipping of the drug.,2018-02-19,2018-03-27
90084,2468336,Shortage,PROPOFOL,BAXTER CORPORATION,Propofol,PROPOFOL,10MG,20 mL,INTRAVENOUS,Resolved,EMULSION,N01AX,"ANESTHETICS, GENERAL",2019-07-29,2019-07-29,2019-08-26,2019-08-26,Demand increase for the drug.,2019-07-29,2019-08-27
84202,2468336,Shortage,PROPOFOL,BAXTER CORPORATION,"Propofol Injectable Emulsion, BP, 1% W/V, 10mg/mL",PROPOFOL,10MG,100mL,INTRAVENOUS,Resolved,EMULSION,N01AX,"ANESTHETICS, GENERAL",2019-05-15,2019-05-15,2019-06-06,2019-06-06,Demand increase for the drug.,2019-05-15,2019-06-07
82386,2225883,Shortage,PROPRANOLOL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,1MG,10 X 1ML VIALS,INTRAVENOUS,Resolved,SOLUTION,C07AA,BETA BLOCKING AGENTS,2019-07-12,,2019-07-26,2019-08-05,Demand increase for the drug.,2019-04-24,2019-09-25
90641,2399229,Shortage,PROQUAD,MERCK CANADA INC,"measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection",MUMPS VIRUS VACCINE LIVE ATTENUATED  VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,4.30Log10 TCID50  3.99Log10 PFU  3.00Log10 TCID50  3.00Log10 TCID50,10X1DOSE VIAL,SUBCUTANEOUS,Avoided shortage,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,2019-11-01,,2019-11-29,2019-09-19,Delay in shipping of the drug.,2019-08-02,2019-09-19
29055,2399229,Shortage,PROQUAD,MERCK CANADA INC,"measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection",MUMPS VIRUS VACCINE LIVE ATTENUATED  VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED  RUBELLA VIRUS VACCINE LIVE ATTENUATED  MEASLES VIRUS VACCINE LIVE ATTENUATED,4.30Log10 TCID50  3.99Log10 PFU  3.00Log10 TCID50  3.00Log10 TCID50,0.5ML 10 X 1 DOSE VIAL,SUBCUTANEOUS,Avoided shortage,POWDER FOR SOLUTION,J07BD,VIRAL VACCINES,2017-12-01,,2017-12-08,2017-11-30,Delay in shipping of the drug.,2017-11-13,2017-11-30
87101,400688,Shortage,PROSTIN E2 TABLETS,PFIZER CANADA ULC,Prostin,DINOPROSTONE,0.5MG,10's Tablets,ORAL,Actual shortage,TABLET,G02AD,UTEROTONICS,,2019-04-30,,,Disruption of the manufacture of the drug.,2019-06-19,2019-06-19
16290,2231674,Shortage,PROTAMINE SULFATE INJECTION USP,SANDOZ CANADA INCORPORATED,PROTAMINE,PROTAMINE SULFATE,10MG,25ML VIAL,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017-07-19,,2017-07-31,2017-07-28,Delay in shipping of the drug.,2017-07-18,2017-08-02
90060,2139537,Shortage,"PROTAMINE SULFATE INJECTION, USP",FRESENIUS KABI CANADA LTD,Protamine Sulfate,PROTAMINE SULFATE,10MG,25mL,INTRAVENOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2019-07-26,2019-08-16,2019-08-16,Disruption of the manufacture of the drug.,2019-07-26,2019-08-17
68640,2244148,Shortage,PROTOPIC,LEO PHARMA INC,Tacrolimus ointment,TACROLIMUS,0.1%,30g and 60g,TOPICAL,Resolved,OINTMENT,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2018-12-04,2018-12-04,2018-12-19,2018-12-20,Delay in shipping of the drug.,2018-12-05,2019-01-07
66412,2244149,Shortage,PROTOPIC,LEO PHARMA INC,Tacrolimus ointment,TACROLIMUS,0.03%,30g,TOPICAL,Resolved,OINTMENT,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2018-11-07,2018-11-07,2019-07-31,2019-08-02,Disruption of the manufacture of the drug.,2018-11-07,2019-08-06
88434,2244148,Shortage,PROTOPIC,LEO PHARMA INC,Tacrolimus Ointment,TACROLIMUS,0.1%,60g,TOPICAL,Resolved,OINTMENT,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2019-07-03,2019-07-03,2019-09-16,2019-09-17,Disruption of the manufacture of the drug.,2019-07-04,2019-09-18
71578,2244148,Shortage,PROTOPIC,LEO PHARMA INC,Tacrolimus Ointment,TACROLIMUS,0.1%,30g and 60g,TOPICAL,Resolved,OINTMENT,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2019-01-14,,2019-04-12,2019-04-17,Disruption of the manufacture of the drug.,2019-01-08,2019-04-22
62177,2244148,Shortage,PROTOPIC,LEO PHARMA INC,Tacrolimus ointment,TACROLIMUS,0.1%,60g,TOPICAL,Resolved,OINTMENT,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,2018-09-21,2018-09-21,,2018-10-15,Disruption of the manufacture of the drug.,2018-09-21,2018-11-06
75572,287709,Shortage,PROTYLOL,PRO DOC LIMITEE,PROTYLOL,DICYCLOMINE HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,CAPSULE,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,,2019-03-21,,,Other (Please describe in comments),2019-02-13,2019-03-22
64581,287709,Shortage,PROTYLOL,PRO DOC LIMITEE,PROTYLOL,DICYCLOMINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,CAPSULE,A03AA,DRUGS FOR FUNCTIONAL BOWEL DISORDERS,,2018-10-17,,2018-10-23,Delay in shipping of the drug.,2018-10-17,2018-10-24
23849,729973,Shortage,PROVERA 10MG TABLETS,PFIZER CANADA INC,Provera,MEDROXYPROGESTERONE ACETATE,10MG,100’s,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,2017-10-10,,2017-10-31,2017-10-27,Disruption of the manufacture of the drug.,2017-09-28,2017-10-30
57413,708917,Shortage,PROVERA 2.5MG TABLETS,PFIZER CANADA INC,Provera,MEDROXYPROGESTERONE ACETATE,2.5MG,100's,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2018-09-11,,2018-10-09,Disruption of the manufacture of the drug.,2018-08-03,2018-10-10
68473,708917,Shortage,PROVERA 2.5MG TABLETS,PFIZER CANADA INC,PROVERA,MEDROXYPROGESTERONE ACETATE,2.5MG,100's,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2019-01-08,,2019-01-10,Disruption of the manufacture of the drug.,2018-12-03,2019-01-11
1652,466409,Shortage,PULMOPHYLLINE ELX,LABORATOIRE RIVA INC,Theophylline oral solution USP,THEOPHYLLINE,80MG,1,ORAL,Actual shortage,ELIXIR,R03DA,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1616,513741,Shortage,PULMORPHAN,LABORATOIRE RIVA INC,"Dextromethorpan hydrobromide, guaifenesin, pheniramine maleate and phenylephrine hydrochloride syrup",DEXTROMETHORPHAN HYDROBROMIDE  PHENYLEPHRINE HYDROCHLORIDE  PHENIRAMINE MALEATE  GUAIFENESIN,10MG  3.75MG  7.5MG  50MG,250 ml,ORAL,Actual shortage,SYRUP,R05FA,"COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1623,590282,Shortage,PULMORPHAN PEDIATRIQUE,LABORATOIRE RIVA INC,"Dextromethorpan hydrobromide, pheniramine maleate and phenylephrine hydrochloride syrup",DEXTROMETHORPHAN HYDROBROMIDE  PHENYLEPHRINE HYDROCHLORIDE  PHENIRAMINE MALEATE,5MG  2MG  5MG,175 ml,ORAL,Actual shortage,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
17167,2243948,Shortage,PUREGON,MERCK CANADA INC,follitropin beta Solution for injection-cartriges,FOLLITROPIN BETA,833UNIT,900IU/1.08ML 1CARTRIDGE,SUBCUTANEOUS,Resolved,SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2017-07-26,2017-09-29,2017-09-26,Delay in shipping of the drug.,2017-07-25,2017-09-27
1586,2242441,Shortage,PUREGON,MERCK CANADA INC,follitropin beta solution for injection (rec FSH),FOLLITROPIN BETA,100UNIT,5,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,2016-10-26,2016-10-26,2017-03-17,2017-03-15,Delay in shipping of the drug.,2017-03-13,2017-03-16
16077,2243948,Shortage,PUREGON,MERCK CANADA INC,follitropin beta Solution for injection-cartriges,FOLLITROPIN BETA,833UNIT,600IU/0.72ML,SUBCUTANEOUS,Resolved,SOLUTION,G03GA,GONADOTROPHINS AND OTHER OVULATION STIMULANTS,,2017-07-21,,2017-09-11,Other (Please describe in comments),2017-07-17,2017-09-12
2392,476714,Shortage,PYRIDIUM 100MG,ERFA CANADA 2012 INC,"Phenazopyridine Hydrochloride,USP",PHENAZOPYRIDINE HYDROCHLORIDE,100MG,bottle,ORAL,Actual shortage,TABLET,G04BX,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-02-09,2017-02-09,,,Shortage of an active ingredient.,2017-03-14,2017-12-12
2378,476722,Shortage,PYRIDIUM 200MG,ERFA CANADA 2012 INC,"Phenazopyridine Hydrochloride,USP",PHENAZOPYRIDINE HYDROCHLORIDE,200MG,bottle,ORAL,Actual shortage,TABLET,G04BX,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-02-09,2017-02-09,,,Shortage of an active ingredient.,2017-03-14,2017-12-12
95091,2245215,Shortage,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,PYRIDOXINE HYDROCHLORIDE,PYRIDOXINE HYDROCHLORIDE,100MG,30 ML VIAL,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,A11HA,OTHER PLAIN VITAMIN PREPARATIONS,,2019-10-01,2020-01-30,,Other (Please describe in comments),2019-10-01,2019-10-08
73912,2245215,Shortage,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,PYRIDOXINE,PYRIDOXINE HYDROCHLORIDE,100MG,30 ML VIAL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,A11HA,OTHER PLAIN VITAMIN PREPARATIONS,2019-07-31,2019-08-08,2019-08-15,2019-08-09,Disruption of the manufacture of the drug.,2019-01-30,2019-08-10
238,2245215,Shortage,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,Pyridoxine,PYRIDOXINE HYDROCHLORIDE,100MG,1VL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,A11HA,OTHER PLAIN VITAMIN PREPARATIONS,2018-07-03,2018-07-03,,2018-08-03,Disruption of the manufacture of the drug.,2017-03-10,2018-08-07
1317,2230946,Shortage,QUADRACEL,SANOFI PASTEUR LIMITED,Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine,DIPHTHERIA TOXOID  FILAMENTOUS HAEMAGGLUTININ  FIMBRIAE  INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY  INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1  INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT  PERTACTIN  PERTUSSIS TOXOID	  TETANUS TOXOID,15 LF / 0.5 ML  20 MCG / 0.5 ML  5 MCG / 0.5 ML  8 UNIT / 0.5 ML  3 MCG / 0.5 ML  20 MCG / 0.5 ML  5 LF / 0.5 ML,"5 x 0.5 mL vials / 5 fioles de 0,5 mL",Intramuscular,Actual shortage,Suspension,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2015-05-31,,,,Demand increase for the drug.,2017-03-13,2017-10-05
85266,38172,Shortage,QUELICIN,PFIZER CANADA ULC,Quelicin,SUCCINYLCHOLINE CHLORIDE,20MG,10mL vial,INTRAVENOUS,Resolved,SOLUTION,M03AB,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2019-05-28,,2019-08-07,Demand increase for the drug.,2019-05-30,2019-08-21
92058,38172,Shortage,QUELICIN,PFIZER CANADA ULC,Quelicin,SUCCINYLCHOLINE CHLORIDE,20MG,10mL vial,INTRAVENOUS,Resolved,SOLUTION,M03AB,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2019-05-28,,2019-10-31,Demand increase for the drug.,2019-08-21,2019-11-01
93973,2317893,Shortage,QUETIAPINE,SIVEM PHARMACEUTICALS ULC,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2019-09-23,,2019-10-14,2019-10-11,Delay in shipping of the drug.,2019-09-16,2019-10-12
98342,2317893,Shortage,QUETIAPINE,SIVEM PHARMACEUTICALS ULC,QUETIAPINE,QUETIAPINE,25MG,500,ORAL,Avoided shortage,TABLET,N05AH,ANTIPSYCHOTICS,2019-11-25,,2019-12-02,2019-11-18,Delay in shipping of the drug.,2019-11-11,2019-11-18
72239,2353172,Shortage,QUETIAPINE,SANIS HEALTH INC,QUETIAPINE TAB,QUETIAPINE,100MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-01-15,2019-02-22,2019-02-19,Other (Please describe in comments),2019-01-15,2019-02-20
84672,2317893,Shortage,QUETIAPINE,SIVEM PHARMACEUTICALS ULC,QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2019-07-01,2019-06-28,2019-07-12,2019-07-09,Delay in shipping of the drug.,2019-05-24,2019-07-12
83939,2317893,Shortage,QUETIAPINE,SIVEM PHARMACEUTICALS ULC,QUETIAPINE,QUETIAPINE,25MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2019-06-12,2019-06-13,2019-07-12,2019-07-12,Delay in shipping of the drug.,2019-05-13,2019-07-13
80880,2317907,Shortage,QUETIAPINE,SIVEM PHARMACEUTICALS ULC,QUETIAPINE,QUETIAPINE,100MG,500,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2019-04-23,2019-04-23,2019-05-17,2019-05-18,Delay in shipping of the drug.,2019-04-09,2019-05-21
8290,2417383,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,300MG,60,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017-05-17,,2017-06-15,2017-05-01,Demand increase for the drug.,2017-04-27,2017-05-18
32631,2417359,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,50MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-11-20,,2018-03-16,Other (Please describe in comments),2017-12-12,2018-03-26
32634,2417367,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,150MG,60,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2018-04-19,,,2018-03-16,Other (Please describe in comments),2017-12-12,2018-03-26
28287,2417383,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,300MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-10-23,,2018-03-16,Other (Please describe in comments),2017-11-06,2018-03-26
32639,2417375,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,200MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2018-01-01,2017-12-29,,2018-03-16,Other (Please describe in comments),2017-12-12,2018-03-26
32643,2417391,Shortage,QUETIAPINE XR,SIVEM PHARMACEUTICALS ULC,QUETIAPINE XR,QUETIAPINE,400MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2018-02-12,2018-02-14,,2018-03-16,Other (Please describe in comments),2017-12-12,2018-03-26
19405,2417782,Shortage,QUETIAPINE XR,PRO DOC LIMITEE,QUETIAPINE XR,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-08-10,,2017-08-18,Delay in shipping of the drug.,2017-08-15,2017-08-19
14344,2415925,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,10MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-07-27,,2018-07-26,Other (Please describe in comments),2017-06-29,2018-07-27
14379,2415917,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-31,,2018-07-26,Other (Please describe in comments),2017-06-29,2018-07-27
14382,2415933,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-21,,2018-07-26,Other (Please describe in comments),2017-06-29,2018-07-27
20068,2415941,Shortage,QUINAPRIL,PRO DOC LIMITEE,QUINAPRIL,QUINAPRIL,40MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-11-29,,2018-07-26,Delay in shipping of the drug.,2017-08-22,2018-07-27
88242,695459,Shortage,QUININE - ODAN,ODAN LABORATORIES LTD,"Quinine Sulfate Tablets, USP",QUININE SULFATE,300MG,100,ORAL,Resolved,CAPSULE,P01BC,ANTIMALARIALS,,2019-07-02,2019-09-20,2019-10-03,Disruption of the manufacture of the drug.,2019-07-02,2019-10-22
34043,695432,Shortage,QUININE - ODAN,ODAN LABORATORIES LTD,"Quinine Sulfate Tablets, USP",QUININE SULFATE,300MG,100,ORAL,Avoided shortage,TABLET,P01BC,ANTIMALARIALS,2018-08-01,,,2018-04-25,Disruption of the manufacture of the drug.,2017-12-20,2018-04-25
41472,2242029,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,50MCG,NA,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2018-03-01,,2018-04-19,Other (Please describe in comments),2018-03-01,2018-04-20
83465,2242029,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,50MCG,n/a,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2019-05-03,,2019-06-26,Delay in shipping of the drug.,2019-05-08,2019-06-27
83488,2242030,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,100MCG,n/a,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2019-06-24,,2019-09-09,Other (Please describe in comments),2019-05-08,2019-09-10
97065,2242029,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,50MCG,200,INHALATION,Actual shortage,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",2019-10-24,,2020-01-24,,Other (Please describe in comments),2019-10-23,2019-11-13
11354,2242029,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,50MCG,NA,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-05-26,,2017-06-22,Other (Please describe in comments),2017-05-26,2017-06-23
11357,2242030,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,100MCG,NA,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-05-25,,2017-06-22,Other (Please describe in comments),2017-05-26,2017-06-23
46244,2242030,Shortage,QVAR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,QVAR,BECLOMETHASONE DIPROPIONATE,100MCG,n/a,INHALATION,Resolved,METERED-DOSE AEROSOL,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2018-03-08,2018-04-30,2018-04-30,Other (Please describe in comments),2018-04-18,2018-05-30
90652,2267667,Shortage,RABAVERT,GLAXOSMITHKLINE INC,Rabies Vaccine,RABIES VACCINE INACTIVATED,2.5UNIT,1's,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,,2019-07-31,,2019-09-03,Demand increase for the drug.,2019-08-02,2019-09-04
96846,2267667,Shortage,RABAVERT,GLAXOSMITHKLINE INC,Rabies Vaccine,RABIES VACCINE INACTIVATED,2.5UNIT,1's,INTRAMUSCULAR,Actual shortage,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,,2019-10-17,2019-12-13,,Demand increase for the drug.,2019-10-18,2019-10-18
55698,2267667,Shortage,RABAVERT,GLAXOSMITHKLINE INC,Rabies Vaccine,RABIES VACCINE INACTIVATED,2.5UNIT,1's,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,,2018-07-10,,2019-02-06,Demand increase for the drug.,2018-07-13,2019-02-08
3285,2267667,Shortage,RABAVERT,GLAXOSMITHKLINE INC,Rabies vaccine,RABIES VACCINE INACTIVATED,2.5UNIT,1's,INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,J07BG,VIRAL VACCINES,,2017-03-27,2017-08-31,2017-08-30,Demand increase for the drug.,2017-03-17,2017-08-31
63342,2299194,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,100MG,90's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2018-10-22,,2018-11-05,Other (Please describe in comments),2018-10-05,2018-11-09
22150,2299194,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,100MG,na,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2017-09-15,,2017-09-22,Other (Please describe in comments),2017-09-15,2017-09-25
22155,2299208,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,200MG,na,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2017-09-15,,2017-09-22,Other (Please describe in comments),2017-09-15,2017-09-25
22158,2299216,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,300MG,na,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2017-09-15,,2017-09-22,Other (Please describe in comments),2017-09-15,2017-09-25
73388,2299194,Shortage,RALIVIA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RALIVIA,TRAMADOL HYDROCHLORIDE,100MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2019-03-18,,2019-10-28,Disruption of the manufacture of the drug.,2019-01-23,2019-11-05
42913,2415852,Shortage,RALOXIFENE,PRO DOC LIMITEE,RALOXIFENE,RALOXIFENE HYDROCHLORIDE,60MG,30-100,ORAL,Resolved,TABLET,G03XC,OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM,,2018-03-14,,2018-05-30,Other (Please describe in comments),2018-03-14,2018-05-31
5632,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-20,2017-05-20,2018-07-23,2018-07-06,Other (Please describe in comments),2017-04-05,2018-07-10
5635,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-04-16,2017-04-16,2018-04-27,2018-04-27,Requirements related to complying with good manufacturing practices.,2017-04-05,2018-04-30
5638,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-04-24,2017-04-24,2018-04-27,2018-04-27,Other (Please describe in comments),2017-04-05,2018-04-30
5641,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-15,2017-05-15,2018-07-23,2018-07-06,Requirements related to complying with good manufacturing practices.,2017-04-05,2018-07-10
5644,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-04-25,2017-04-25,2018-04-27,2018-04-27,Other (Please describe in comments),2017-04-05,2018-04-30
5649,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-04-28,2017-04-28,2018-04-27,2018-04-27,Requirements related to complying with good manufacturing practices.,2017-04-05,2018-04-30
22588,2255316,Shortage,RAMIPRIL,LABORATOIRE RIVA INC,Ramipril 2.5mg,RAMIPRIL,2.5MG,30UD + 100 + 500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-09-19,2017-09-19,2018-05-31,2018-06-20,Disruption of the manufacture of the drug.,2017-09-19,2018-07-10
22591,2255324,Shortage,RAMIPRIL,LABORATOIRE RIVA INC,Ramipril 5mg,RAMIPRIL,5MG,30 UD + 100 + 500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-09-19,2017-09-19,2018-05-31,2018-06-20,Disruption of the manufacture of the drug.,2017-09-19,2018-07-10
62794,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-10-11,2018-10-11,2018-12-07,2018-12-07,Delay in shipping of the drug.,2018-10-01,2018-12-08
64081,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-11-12,2018-11-09,2018-11-30,2018-11-29,Disruption of the manufacture of the drug.,2018-10-15,2018-12-03
65647,2287935,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-11-15,2018-11-15,2018-12-19,2018-12-18,Disruption of the manufacture of the drug.,2018-10-26,2018-12-21
50550,2308363,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-06-25,2018-07-27,2019-01-04,2018-12-30,Delay in shipping of the drug.,2018-05-28,2019-01-03
8432,2299372,Shortage,RAMIPRIL,LABORATOIRE RIVA INC,Ramipril,RAMIPRIL,1.25MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-04-28,2017-04-28,2018-05-31,2018-06-20,Disruption of the manufacture of the drug.,2017-04-28,2018-07-10
5620,2308363,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-17,2017-05-17,2018-04-27,2018-04-27,Requirements related to complying with good manufacturing practices.,2017-04-05,2018-04-30
5623,2287927,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,2.5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-21,2017-05-21,2018-07-02,2018-07-06,Requirements related to complying with good manufacturing practices.,2017-04-05,2018-07-10
5626,2287927,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,2.5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-04-23,2017-04-23,2018-04-27,2018-04-27,Requirements related to complying with good manufacturing practices.,2017-04-05,2018-04-30
67069,2287943,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-11-15,2018-11-30,2018-12-03,Disruption of the manufacture of the drug.,2018-11-19,2018-12-04
5629,2287927,Shortage,RAMIPRIL,SIVEM PHARMACEUTICALS ULC,RAMIPRIL,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-03,2017-05-03,2018-04-27,2018-04-27,Other (Please describe in comments),2017-04-05,2018-04-30
9729,2415887,Shortage,RAMIPRIL-HCTZ,PRO DOC LIMITEE,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  5.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-06-13,,2018-12-21,Other (Please describe in comments),2017-05-09,2018-12-22
9732,2415895,Shortage,RAMIPRIL-HCTZ,PRO DOC LIMITEE,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2017-08-08,,2017-08-24,Delay in shipping of the drug.,2017-05-09,2017-10-05
75575,2415895,Shortage,RAMIPRIL-HCTZ,PRO DOC LIMITEE,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2019-02-22,2019-02-21,,2019-04-10,Other (Please describe in comments),2019-02-13,2019-04-11
34875,2415909,Shortage,RAMIPRIL-HCTZ,PRO DOC LIMITEE,RAMIPRIL-HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-01-03,,2018-01-16,Delay in shipping of the drug.,2018-01-04,2018-01-17
73343,2415909,Shortage,RAMIPRIL-HCTZ,PRO DOC LIMITEE,RAMIPRIL HCTZ 10-25,HYDROCHLOROTHIAZIDE  RAMIPRIL,25.0MG  10.0MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-01-23,,2019-04-10,Other (Please describe in comments),2019-01-23,2019-04-11
25709,2321858,Shortage,RAN-AMLODIPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-AMLODIPINE,AMLODIPINE,5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2018-07-24,,2018-07-24,2018-08-17,Disruption of the manufacture of the drug.,2017-10-12,2018-08-23
33274,2321866,Shortage,RAN-AMLODIPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-AMLODIPINE,AMLODIPINE,10MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-12-15,2017-12-15,2018-01-25,2018-08-17,Disruption of the manufacture of the drug.,2017-12-15,2018-08-23
12320,2373963,Shortage,RAN-ATENOLOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ATENOLOL,ATENOLOL,25MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-01-01,2017-01-01,2018-02-23,2018-02-21,Disruption of the manufacture of the drug.,2017-06-08,2019-02-01
12326,2267985,Shortage,RAN-ATENOLOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ATENOLOL,ATENOLOL,50MG,100,ORAL,Avoided shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017-01-01,2017-08-06,2018-05-31,2017-07-14,Disruption of the manufacture of the drug.,2017-06-08,2019-02-04
21964,2267993,Shortage,RAN-ATENOLOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ATENOLOL,ATENOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-02-10,2018-02-10,2018-11-09,2018-09-25,Disruption of the manufacture of the drug.,2017-09-12,2019-02-04
41753,2313758,Shortage,RAN-ATORVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-03-05,2018-03-05,2018-03-13,2018-06-01,Disruption of the manufacture of the drug.,2018-03-05,2018-07-24
72724,2380706,Shortage,RAN-CANDESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,Candesartan,CANDESARTAN CILEXETIL,16MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-17,2019-01-17,2019-11-29,,Disruption of the manufacture of the drug.,2019-01-17,2019-11-01
72727,2380692,Shortage,RAN-CANDESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,Candesartan,CANDESARTAN CILEXETIL,8MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-17,2019-01-17,2019-11-29,,Disruption of the manufacture of the drug.,2019-01-17,2019-11-01
85078,2380714,Shortage,RAN-CANDESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CANDESARTAN,CANDESARTAN CILEXETIL,32MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-05-21,2019-11-29,,Disruption of the manufacture of the drug.,2019-05-28,2019-11-01
78745,2380684,Shortage,RAN-CANDESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,Ran-Candesartan,CANDESARTAN CILEXETIL,4MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-03-14,2019-11-29,,Disruption of the manufacture of the drug.,2019-03-15,2019-11-01
74574,2293579,Shortage,RAN-CEFPROZIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CEFPROZIL,CEFPROZIL,250MG,75 mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-01-07,2019-04-18,2019-04-12,Disruption of the manufacture of the drug.,2019-02-04,2019-04-15
38637,2293579,Shortage,RAN-CEFPROZIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CEFPROZIL,CEFPROZIL,250MG,100,ORAL,Resolved,POWDER FOR SUSPENSION,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,2018-02-05,2018-02-05,2019-03-01,2018-12-28,Disruption of the manufacture of the drug.,2018-02-05,2019-02-04
38670,2412373,Shortage,RAN-CELECOXIB,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-02-05,2018-02-05,2018-11-28,2018-11-21,Disruption of the manufacture of the drug.,2018-02-05,2019-02-04
61837,2412381,Shortage,RAN-CELECOXIB,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-09-14,2018-09-14,2018-12-07,2018-11-20,Disruption of the manufacture of the drug.,2018-09-18,2019-02-04
82648,2412381,Shortage,RAN-CELECOXIB,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-04-24,2019-07-05,2019-07-05,Disruption of the manufacture of the drug.,2019-04-29,2019-07-06
21955,2303736,Shortage,RAN-CIPROFLOX,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CIPROFLOX,CIPROFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,2017-09-12,2017-09-12,2017-09-29,2018-08-17,Disruption of the manufacture of the drug.,2017-09-12,2018-08-23
33280,2285622,Shortage,RAN-CITALO,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CITALO,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-02-10,2018-09-05,2018-11-16,2018-11-16,Delay in shipping of the drug.,2017-12-15,2018-11-21
52425,2285630,Shortage,RAN-CITALO,RANBAXY PHARMACEUTICALS CANADA INC.,CITALOPRAM,CITALOPRAM,40MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-11-23,2018-11-28,,2018-12-03,Disruption of the manufacture of the drug.,2018-06-14,2019-02-04
1666,2361434,Shortage,RAN-CLARITHROMYCIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-CLARITHROMYCIN,CLARITHROMYCIN,500MG,100,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017-03-01,,2017-03-16,2017-03-17,Shortage of an active ingredient.,2017-03-13,2017-04-12
82651,2361426,Shortage,RAN-CLARITHROMYCIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CLARITHROMYCIN,CLARITHROMYCIN,250MG,500,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-04-26,2019-05-10,2019-05-10,Disruption of the manufacture of the drug.,2019-04-29,2019-05-13
97772,2361434,Shortage,RAN-CLARITHROMYCIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CLARITHROMYCIN,CLARITHROMYCIN,500MG,500,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-10-25,,2019-11-15,Disruption of the manufacture of the drug.,2019-11-01,2019-11-16
1432,2379813,Shortage,RAN-CLOPIDOGREL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-CLOPIDOGREL,CLOPIDOGREL,75MG,500,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2017-02-01,2017-04-21,2018-08-17,Disruption of the manufacture of the drug.,2017-03-13,2018-08-23
9843,2425017,Shortage,RAN-CYPROTERONE/ETHINYL ESTRADIOL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-CYPROTERONE/ETHINYL ESTRADIOL,ETHINYL ESTRADIOL  CYPROTERONE ACETATE,0.035MG  2.0MG,100,ORAL,Resolved,TABLET,G03HB,ANTIANDROGENS,2017-03-01,2017-03-01,2017-05-28,2017-05-10,Disruption of the manufacture of the drug.,2017-05-10,2019-02-01
74579,2268078,Shortage,RAN-DOMPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-DOMPERIDONE,DOMPERIDONE,10MG,500,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,,2019-01-10,2019-09-20,2019-09-20,Disruption of the manufacture of the drug.,2019-02-04,2019-09-23
25749,2268078,Shortage,RAN-DOMPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-DOMPERIDONE,DOMPERIDONE,10MG,100,ORAL,Resolved,TABLET,A03FA,PROPULSIVES,2017-10-12,2018-10-29,,2018-12-14,Disruption of the manufacture of the drug.,2017-10-12,2018-12-15
1387,2381508,Shortage,RAN-DONEPEZIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,500,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017-02-01,2017-05-10,2017-04-24,Disruption of the manufacture of the drug.,2017-03-13,2019-02-01
1399,2381508,Shortage,RAN-DONEPEZIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2017-02-01,2017-05-10,2017-04-10,Disruption of the manufacture of the drug.,2017-03-13,2019-02-01
67393,2352249,Shortage,RAN-ENALAPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-10-29,2018-10-29,2018-12-07,2018-12-11,Disruption of the manufacture of the drug.,2018-11-21,2018-12-12
72782,2352249,Shortage,RAN-ENALAPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-01-17,2019-01-17,2019-07-07,2019-07-05,Disruption of the manufacture of the drug.,2019-01-17,2019-07-06
74582,2352265,Shortage,RAN-ENALAPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-11-26,2019-04-16,2019-04-18,Disruption of the manufacture of the drug.,2019-02-04,2019-04-24
89734,2352249,Shortage,RAN-ENALAPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-07-16,2019-10-25,2019-10-30,Disruption of the manufacture of the drug.,2019-07-19,2019-11-01
67725,2352257,Shortage,RAN-ENALAPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ENALAPRIL,ENALAPRIL SODIUM,8MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-11-27,2018-11-27,2019-02-15,2019-02-15,Disruption of the manufacture of the drug.,2018-11-27,2019-02-16
93874,2352257,Shortage,RAN-ENALAPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ENALAPRIL,ENALAPRIL SODIUM,8MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-09-10,2019-10-31,2019-11-01,Disruption of the manufacture of the drug.,2019-09-13,2019-11-02
87382,2385481,Shortage,RAN-ESCITALOPRAM,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2019-06-19,2019-12-31,,Disruption of the manufacture of the drug.,2019-06-24,2019-08-19
30231,2423979,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-11-22,2017-11-22,2018-03-09,2018-08-17,Disruption of the manufacture of the drug.,2017-11-22,2018-08-23
9259,2423987,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-11-28,2018-11-28,2019-12-20,,Disruption of the manufacture of the drug.,2017-05-05,2019-10-04
85326,2423979,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-05-28,2019-12-20,,Disruption of the manufacture of the drug.,2019-05-31,2019-10-04
85331,2423979,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-05-28,2019-08-23,2019-08-09,Disruption of the manufacture of the drug.,2019-05-31,2019-08-10
85334,2423987,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-05-28,2019-08-23,2019-08-09,Disruption of the manufacture of the drug.,2019-05-31,2019-08-10
85337,2423987,Shortage,RAN-ESOMEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,500,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-05-28,2019-08-23,2019-08-09,Disruption of the manufacture of the drug.,2019-05-31,2019-08-10
25654,2419548,Shortage,RAN-EZETIMIBE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-EZETIMIBE,EZETIMIBE,10MG,500,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2017-10-12,,2017-12-08,2017-12-07,Disruption of the manufacture of the drug.,2017-10-12,2019-02-01
92848,2419548,Shortage,RAN-EZETIMIBE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-29,2019-09-27,2019-09-30,Disruption of the manufacture of the drug.,2019-09-03,2019-10-04
41759,2330156,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FENTANYL MATRIX PATCH,FENTANYL,100MCG,100,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,2018-03-05,2018-03-05,,2018-08-17,Disruption of the manufacture of the drug.,2018-03-05,2018-08-23
41762,2330113,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FENTANYL MATRIX PATCH,FENTANYL,25MCG,100,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,2018-03-05,2018-03-05,,2018-08-17,Disruption of the manufacture of the drug.,2018-03-05,2018-08-23
10567,2330105,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FENTANYL MATRIX PATCH,FENTANYL,12MCG,100,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,2017-05-10,2017-05-10,,2018-08-17,Disruption of the manufacture of the drug.,2017-05-17,2018-08-23
3967,2330121,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,Fentanyl Matrix Patch,FENTANYL,50MCG,each,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,2017-03-01,2017-09-06,,2018-08-17,Other (Please describe in comments),2017-03-22,2018-08-23
45453,2330148,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FENTANYL MATRIX PATCH,FENTANYL,75MCG,100,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,2018-04-11,2018-04-11,,2018-08-17,Disruption of the manufacture of the drug.,2018-04-11,2018-08-23
75256,2330105,Shortage,RAN-FENTANYL MATRIX PATCH,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FENTANYL MATRIX PATCH,FENTANYL,12MCG,5,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2019-02-01,2019-04-12,2019-04-05,Disruption of the manufacture of the drug.,2019-02-11,2019-04-06
16425,2371820,Shortage,RAN-FINASTERIDE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-07-19,2017-07-19,,2017-12-01,Disruption of the manufacture of the drug.,2017-07-19,2019-02-04
1546,2319063,Shortage,RAN-GABAPENTIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-02-01,2017-02-01,2018-09-24,2018-09-12,Disruption of the manufacture of the drug.,2017-03-13,2019-02-01
1549,2319071,Shortage,RAN-GABAPENTIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-GABAPENTIN,GABAPENTIN,400MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-10-29,2018-10-29,2019-01-15,2018-12-03,Disruption of the manufacture of the drug.,2017-03-13,2019-02-04
19636,2319055,Shortage,RAN-GABAPENTIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-GABAPENTIN,GABAPENTIN,100MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2018-10-29,2018-10-29,2019-01-15,2018-12-03,Disruption of the manufacture of the drug.,2017-08-16,2019-02-04
75259,2439328,Shortage,RAN-GLICLAZIDE MR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-GLICLAZIDE MR,GLICLAZIDE,60MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-02-05,2019-04-18,2019-04-12,Disruption of the manufacture of the drug.,2019-02-11,2019-04-15
31236,2406810,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-11-30,2017-11-30,2017-12-08,2017-12-01,Disruption of the manufacture of the drug.,2017-11-30,2019-02-01
74585,2406810,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-07,2019-11-29,,Disruption of the manufacture of the drug.,2019-02-04,2019-11-01
75896,2406837,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-05,2019-11-29,,Disruption of the manufacture of the drug.,2019-02-15,2019-11-01
80632,2406829,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-02,2019-11-29,,Disruption of the manufacture of the drug.,2019-04-05,2019-11-01
31228,2406829,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-11-30,2017-11-30,2018-03-15,2017-12-04,Disruption of the manufacture of the drug.,2017-11-30,2019-02-01
31231,2406837,Shortage,RAN-IRBESARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-11-30,2017-11-30,,2019-01-11,Disruption of the manufacture of the drug.,2017-11-30,2019-01-17
9987,2402610,Shortage,RAN-LANSOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-03-01,2017-03-01,2018-05-15,2018-08-22,Disruption of the manufacture of the drug.,2017-05-10,2019-02-01
25712,2402629,Shortage,RAN-LANSOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-10-12,2017-11-22,2017-10-27,Disruption of the manufacture of the drug.,2017-10-12,2019-02-01
91258,2402629,Shortage,RAN-LANSOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-07-30,2019-11-15,,Disruption of the manufacture of the drug.,2019-08-09,2019-10-04
30237,2294230,Shortage,RAN-LISINOPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LISINOPRIL,LISINOPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-11-22,2017-11-22,2018-01-26,2018-01-10,Disruption of the manufacture of the drug.,2017-11-22,2019-02-01
83075,2294257,Shortage,RAN-LISINOPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-LISINOPRIL,LISINOPRIL,20MG,500,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-04-30,2019-06-28,2019-06-21,Disruption of the manufacture of the drug.,2019-05-03,2019-06-24
80016,2294230,Shortage,RAN-LISINOPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,Lisinopril,LISINOPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-03-25,2019-05-17,2019-04-12,Disruption of the manufacture of the drug.,2019-03-29,2019-04-15
80019,2294230,Shortage,RAN-LISINOPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,Lisinopril,LISINOPRIL,5MG,500,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-03-25,2019-05-17,2019-04-12,Disruption of the manufacture of the drug.,2019-03-29,2019-04-15
98306,2269031,Shortage,RAN-METFORMIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-METFORMIN,METFORMIN HYDROCHLORIDE,500MG,500,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-11-06,2019-11-15,,Disruption of the manufacture of the drug.,2019-11-09,2019-11-08
87385,2269031,Shortage,RAN-METFORMIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-06-20,2019-08-31,2019-08-09,Disruption of the manufacture of the drug.,2019-06-24,2019-08-19
97781,2269058,Shortage,RAN-METFORMIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-METFORMIN,METFORMIN HYDROCHLORIDE,850MG,100,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-10-25,2019-11-15,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
41756,2389517,Shortage,RAN-MONTELUKAST,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-03-05,2018-03-05,,2018-08-17,Disruption of the manufacture of the drug.,2018-03-05,2018-08-23
11133,2402807,Shortage,RAN-MONTELUKAST,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-MONTELUKAST,MONTELUKAST,5MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2016-10-01,2016-10-01,,2017-11-24,Disruption of the manufacture of the drug.,2017-05-24,2019-02-01
11167,2402793,Shortage,RAN-MONTELUKAST,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-MONTELUKAST,MONTELUKAST,4MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2016-10-01,2016-10-01,,2017-11-24,Disruption of the manufacture of the drug.,2017-05-24,2019-02-01
97784,2389517,Shortage,RAN-MONTELUKAST,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-10-25,2019-11-15,2019-11-08,Disruption of the manufacture of the drug.,2019-11-01,2019-11-08
12331,2358093,Shortage,RAN-NABILONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-NABILONE,NABILONE,1MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017-03-10,2017-03-10,,2017-12-31,Disruption of the manufacture of the drug.,2017-06-08,2019-02-01
12334,2358077,Shortage,RAN-NABILONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-NABILONE,NABILONE,0.25MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017-05-10,2017-05-10,2017-06-10,2017-12-31,Disruption of the manufacture of the drug.,2017-06-08,2019-02-01
12342,2358085,Shortage,RAN-NABILONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-NABILONE,NABILONE,0.5MG,100,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2017-05-03,2017-05-03,,2017-12-31,Disruption of the manufacture of the drug.,2017-06-08,2019-02-01
30228,2414090,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,5MG,100,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017-11-22,,,2018-08-20,Disruption of the manufacture of the drug.,2017-11-22,2018-08-21
85342,2414120,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,20MG,28,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2019-05-28,2019-08-30,2019-08-09,Disruption of the manufacture of the drug.,2019-05-31,2019-08-19
85347,2414090,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,5MG,28,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2019-05-28,2019-08-30,2019-08-07,Disruption of the manufacture of the drug.,2019-05-31,2019-09-09
27316,2414104,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,10MG,100,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2017-10-27,2017-10-27,2018-10-08,2018-11-20,Disruption of the manufacture of the drug.,2017-10-27,2019-02-04
36060,2414112,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,15MG,100,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-01-16,2018-01-16,2018-03-09,2018-03-07,Disruption of the manufacture of the drug.,2018-01-16,2019-02-01
36063,2414120,Shortage,RAN-OLANZAPINE ODT,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-OLANZAPINE ODT,OLANZAPINE,20MG,100,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-01-16,2018-01-16,2018-03-09,2018-03-07,Disruption of the manufacture of the drug.,2018-01-16,2019-02-01
12294,2305046,Shortage,RAN-PANTOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-02-01,2017-06-16,2018-09-24,2017-06-23,Disruption of the manufacture of the drug.,2017-06-08,2019-02-04
12307,2305038,Shortage,RAN-PANTOPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PANTOPRAZOLE,PANTOPRAZOLE,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-04-28,2017-04-28,,2018-10-19,Disruption of the manufacture of the drug.,2017-06-08,2019-02-04
16334,2284456,Shortage,RAN-PRAVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-07-18,2017-07-18,2018-11-02,2017-07-18,Disruption of the manufacture of the drug.,2017-07-18,2019-02-04
9960,2284448,Shortage,RAN-PRAVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2016-10-01,2016-10-01,,2018-08-17,Disruption of the manufacture of the drug.,2017-05-10,2018-08-23
1524,2284421,Shortage,RAN-PRAVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016-10-01,,2018-08-17,Disruption of the manufacture of the drug.,2017-03-13,2018-08-23
80635,2284448,Shortage,RAN-PRAVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PRAVASTATIN,PRAVASTATIN SODIUM,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-02,2019-08-30,2019-08-22,Disruption of the manufacture of the drug.,2019-04-05,2019-08-23
97793,2392836,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-10-25,2019-11-15,2019-11-08,Disruption of the manufacture of the drug.,2019-11-01,2019-11-08
16431,2392801,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-07-19,2017-07-19,2017-12-01,2018-08-14,Disruption of the manufacture of the drug.,2017-07-19,2018-08-15
90764,2392860,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-07-25,2019-09-06,2019-09-06,Disruption of the manufacture of the drug.,2019-08-06,2019-09-09
21937,2392828,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-12,2017-11-06,2018-04-16,2018-08-14,Disruption of the manufacture of the drug.,2017-09-12,2018-08-15
93877,2392852,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,225MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-09-11,2019-09-30,2019-09-27,Disruption of the manufacture of the drug.,2019-09-13,2019-10-04
21950,2392860,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-12,2017-09-12,2018-05-15,2018-08-14,Disruption of the manufacture of the drug.,2017-09-12,2018-08-15
21952,2392860,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-09-12,2017-09-12,2018-06-29,2018-08-14,Disruption of the manufacture of the drug.,2017-09-12,2018-08-15
33271,2392836,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,2017-12-15,2017-12-15,2018-05-22,2018-08-14,Disruption of the manufacture of the drug.,2017-12-15,2018-08-15
97787,2392844,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,150MG,500,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-10-25,2019-11-15,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
97790,2392852,Shortage,RAN-PREGABALIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-PREGABALIN,PREGABALIN,225MG,100,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2019-10-25,2019-11-29,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
97816,2397099,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-10-31,2019-12-27,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
97819,2397102,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-10-31,2019-12-27,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
61829,2397129,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,300MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-09-14,2018-09-14,2019-05-31,2019-05-28,Disruption of the manufacture of the drug.,2018-09-18,2019-05-29
61831,2397129,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,300MG,100,ORAL,Avoided shortage,TABLET,N05AH,ANTIPSYCHOTICS,2018-09-14,,,2018-09-13,Disruption of the manufacture of the drug.,2018-09-18,2019-02-15
61834,2397110,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,200MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-09-14,2018-09-14,2019-08-31,2019-07-22,Disruption of the manufacture of the drug.,2018-09-18,2019-08-06
17139,2397102,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,100MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-11-28,2018-11-28,2019-05-31,2019-05-28,Disruption of the manufacture of the drug.,2017-07-25,2019-05-29
33277,2397099,Shortage,RAN-QUETIAPINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-QUETIAPINE,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2018-11-23,2018-11-23,2019-04-26,2019-04-12,Disruption of the manufacture of the drug.,2017-12-15,2019-04-15
12297,2298082,Shortage,RAN-RABEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-04-28,2017-04-28,,2018-08-17,Disruption of the manufacture of the drug.,2017-06-08,2018-08-23
12339,2298074,Shortage,RAN-RABEPRAZOLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-02-01,2018-02-01,2018-09-03,2018-08-31,Disruption of the manufacture of the drug.,2017-06-08,2019-02-04
75265,2310546,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-02-01,2019-06-14,2019-06-14,Disruption of the manufacture of the drug.,2019-02-11,2019-06-17
12303,2310546,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,10MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-05-02,2017-05-02,,2018-08-17,Disruption of the manufacture of the drug.,2017-06-08,2018-08-23
9252,2310511,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,2.5MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-04-28,2017-04-28,,2018-08-17,Disruption of the manufacture of the drug.,2017-05-05,2018-08-23
12346,2310503,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,1.25MG,100,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-02-01,2017-09-18,,2018-08-17,Disruption of the manufacture of the drug.,2017-06-08,2018-08-23
82318,2310546,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-04-15,2019-04-26,2019-04-26,Disruption of the manufacture of the drug.,2019-04-24,2019-04-29
16328,2310538,Shortage,RAN-RAMIPRIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL,RAMIPRIL,5MG,100,ORAL,Avoided shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2017-07-18,2017-07-18,2018-10-08,2017-07-17,Disruption of the manufacture of the drug.,2017-07-18,2019-02-04
97796,2449439,Shortage,RAN-RAMIPRIL HCTZ,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,12.5MG  2.5MG,100,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-10-25,2019-12-13,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
85899,2449463,Shortage,RAN-RAMIPRIL HCTZ,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RAMIPRIL HCTZ,HYDROCHLOROTHIAZIDE  RAMIPRIL,25MG  5MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-06-04,2019-06-21,2019-06-14,Disruption of the manufacture of the drug.,2019-06-07,2019-06-17
12300,2336480,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,150MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-04-28,2017-04-28,,2018-08-17,Disruption of the manufacture of the drug.,2017-06-08,2018-08-23
12310,2336502,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2017-02-02,2017-02-02,,2018-08-17,Disruption of the manufacture of the drug.,2017-06-08,2018-08-23
94548,2336502,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-13,,,Disruption of the manufacture of the drug.,2019-09-23,2019-09-23
87388,2336480,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,150MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-21,,,Disruption of the manufacture of the drug.,2019-06-24,2019-09-23
85902,2336480,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,150MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-06,,,Disruption of the manufacture of the drug.,2019-06-07,2019-09-23
88746,2336502,Shortage,RAN-RANITIDINE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RANITIDINE,RANITIDINE,300MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-25,,,Disruption of the manufacture of the drug.,2019-07-05,2019-09-23
98309,2328313,Shortage,RAN-RISPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RISPERIDONE,RISPERIDONE,0.5MG,100,ORAL,Actual shortage,TABLET,N05AX,ANTIPSYCHOTICS,,2019-10-28,2019-11-22,,Disruption of the manufacture of the drug.,2019-11-09,2019-11-08
85081,2328348,Shortage,RAN-RISPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RISPERIDONE,RISPERIDONE,2.0MG,60,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-05-16,2019-07-05,2019-07-05,Disruption of the manufacture of the drug.,2019-05-28,2019-07-06
87391,2328313,Shortage,RAN-RISPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RISPERIDONE,RISPERIDONE,0.5MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-21,2019-07-05,2019-07-05,Disruption of the manufacture of the drug.,2019-06-24,2019-07-06
90767,2328364,Shortage,RAN-RISPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RISPERIDONE,RISPERIDONE,3.0MG,250,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-07-26,2019-08-30,2019-08-09,Disruption of the manufacture of the drug.,2019-08-06,2019-08-19
69549,2328305,Shortage,RAN-RISPERIDONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,2018-12-07,2018-12-14,2019-06-28,2019-07-04,Disruption of the manufacture of the drug.,2018-12-13,2019-07-05
75268,2314053,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-01-16,2019-07-12,2019-07-05,Disruption of the manufacture of the drug.,2019-02-11,2019-07-06
75271,2314061,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,2.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-01-16,2019-04-18,2019-04-12,Disruption of the manufacture of the drug.,2019-02-11,2019-04-15
75274,2314088,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,5.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-01-25,2019-04-18,2019-04-11,Disruption of the manufacture of the drug.,2019-02-11,2019-04-15
85084,2314061,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,2.0MG,100,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-05-15,2019-12-31,,Disruption of the manufacture of the drug.,2019-05-28,2019-09-13
75900,2314037,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,0.25MG,100,ORAL,Actual shortage,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-02-08,2019-12-31,,Disruption of the manufacture of the drug.,2019-02-15,2019-09-13
27310,2314053,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,1.0MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-10-27,2017-10-27,,2018-08-17,Disruption of the manufacture of the drug.,2017-10-27,2018-08-23
16331,2314037,Shortage,RAN-ROPINIROLE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROPINIROLE,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-07-18,2017-07-18,,2018-08-17,Disruption of the manufacture of the drug.,2017-07-18,2018-08-23
9992,2382644,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-03-13,,2018-11-23,Disruption of the manufacture of the drug.,2017-05-10,2018-11-28
75277,2382644,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,5MG,90,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-11,2019-05-24,2019-05-28,Disruption of the manufacture of the drug.,2019-02-11,2019-05-29
75280,2382644,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,5MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-05,2019-05-24,2019-05-27,Disruption of the manufacture of the drug.,2019-02-11,2019-05-28
75283,2382679,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,40MG,90,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-07-31,2019-07-12,2019-07-12,Disruption of the manufacture of the drug.,2019-02-11,2019-07-15
9236,2382660,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-04-28,2017-04-28,2017-11-22,2017-10-31,Disruption of the manufacture of the drug.,2017-05-05,2019-02-01
75286,2382679,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-07-31,2019-11-22,,Disruption of the manufacture of the drug.,2019-02-11,2019-11-01
10530,2382652,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-03-13,2017-03-13,2018-11-30,2017-10-31,Disruption of the manufacture of the drug.,2017-05-16,2019-02-04
21961,2382679,Shortage,RAN-ROSUVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Avoided shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-11-28,2018-11-28,2018-12-31,2017-10-31,Disruption of the manufacture of the drug.,2017-09-12,2019-02-04
30234,2329166,Shortage,RAN-SIMVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SIMVASTATIN,SIMVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-11-22,2017-11-22,,2018-01-31,Disruption of the manufacture of the drug.,2017-11-22,2019-02-01
58716,2329174,Shortage,RAN-SIMVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SIMVASTATIN,SIMVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-08-21,2018-08-21,2018-10-08,2018-09-20,Disruption of the manufacture of the drug.,2018-08-21,2019-02-04
77429,2329158,Shortage,RAN-SIMVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SIMVASTATIN,SIMVASTATIN,10MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-02-19,2019-09-30,2019-09-27,Disruption of the manufacture of the drug.,2019-03-04,2019-10-04
82654,2329158,Shortage,RAN-SIMVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SIMVASTATIN,SIMVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-26,2019-07-31,2019-07-26,Disruption of the manufacture of the drug.,2019-04-29,2019-08-06
80638,2329166,Shortage,RAN-SIMVASTATIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SIMVASTATIN,SIMVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-02,2019-07-31,2019-07-19,Disruption of the manufacture of the drug.,2019-04-05,2019-07-20
43668,2437988,Shortage,RAN-SOLIFENACIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-03-22,2018-03-22,,2018-12-01,Disruption of the manufacture of the drug.,2018-03-22,2019-02-01
21958,2437996,Shortage,RAN-SOLIFENACIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-09-12,2017-09-12,,2018-02-13,Disruption of the manufacture of the drug.,2017-09-12,2019-02-04
95482,2437988,Shortage,RAN-SOLIFENACIN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-04,2019-10-11,2019-10-11,Disruption of the manufacture of the drug.,2019-10-04,2019-10-12
31239,2452073,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,5MG,100,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-30,2017-11-30,,2018-07-09,Disruption of the manufacture of the drug.,2017-11-30,2019-02-01
97799,2452081,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,2.5MG,28,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-25,2019-11-15,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
31242,2452081,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,2.5MG,100,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-11-30,2017-11-30,,2018-08-13,Disruption of the manufacture of the drug.,2017-11-30,2019-02-01
97802,2452103,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,10MG,4,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-25,2019-12-13,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-08
97805,2452111,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,20MG,4,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-25,2019-12-13,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-08
30240,2452103,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,10MG,100,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-02-01,2018-02-01,,2018-08-08,Disruption of the manufacture of the drug.,2017-11-22,2019-02-01
56467,2452111,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,20MG,100,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-06-30,2018-06-30,2018-08-06,2018-08-08,Disruption of the manufacture of the drug.,2018-07-25,2019-02-01
92851,2452073,Shortage,RAN-TADALAFIL,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TADALAFIL,TADALAFIL,5MG,28,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-08-28,2019-11-30,,Disruption of the manufacture of the drug.,2019-09-03,2019-10-04
9877,2388197,Shortage,RAN-TRAMADOL/ACET,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-TRAMADOL/ACET,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,,2017-03-01,2017-03-01,2017-06-21,2017-06-21,Disruption of the manufacture of the drug.,2017-05-10,2019-02-01
80641,2363100,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,80MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-04-05,2019-11-29,,Disruption of the manufacture of the drug.,2019-04-05,2019-11-01
75289,2363119,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,160MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-02-05,2019-11-29,,Disruption of the manufacture of the drug.,2019-02-11,2019-11-01
9297,2363119,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,160MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-04-28,2017-04-28,,2017-06-02,Disruption of the manufacture of the drug.,2017-05-05,2019-02-04
74590,2363062,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-14,2019-11-29,,Disruption of the manufacture of the drug.,2019-02-04,2019-11-01
74596,2363100,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,80MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-03,2019-11-29,,Disruption of the manufacture of the drug.,2019-02-04,2019-11-01
9317,2363100,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VALSARTAN,VALSARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2017-04-28,2017-04-28,,2017-04-28,Disruption of the manufacture of the drug.,2017-05-05,2019-02-04
1473,2363119,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-VALSARTAN,VALSARTAN,160MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-11-28,2018-11-28,2019-11-29,,Disruption of the manufacture of the drug.,2017-03-13,2019-11-01
1500,2363062,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-VALSARTAN,VALSARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-02-01,2017-03-31,2017-03-31,Disruption of the manufacture of the drug.,2017-03-13,2019-02-04
1507,2363100,Shortage,RAN-VALSARTAN,RANBAXY PHARMACEUTICALS CANADA INC.,RAN™-VALSARTAN,VALSARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-01-01,,2018-12-11,Disruption of the manufacture of the drug.,2017-03-13,2018-12-12
9220,2380099,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-05-25,,,2018-09-21,Disruption of the manufacture of the drug.,2017-05-05,2018-11-28
75292,2380072,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,37.5MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-05-23,,2019-06-28,2019-07-05,Disruption of the manufacture of the drug.,2019-02-11,2019-07-06
75295,2380099,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-02-26,2019-08-23,2019-08-08,Disruption of the manufacture of the drug.,2019-02-11,2019-08-09
75298,2380080,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-08-24,2019-08-30,2019-08-30,Disruption of the manufacture of the drug.,2019-02-11,2019-09-03
75301,2380080,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,75MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-09-14,2019-08-30,2019-08-30,Disruption of the manufacture of the drug.,2019-02-11,2019-09-03
96317,2380080,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,75MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-10-11,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-12
96325,2380099,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,150MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-10-11,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-12
74601,2380099,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Avoided shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-09-14,2019-06-28,2018-06-14,Disruption of the manufacture of the drug.,2019-02-04,2019-06-17
93294,2380072,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-09-04,2019-12-20,,Disruption of the manufacture of the drug.,2019-09-09,2019-10-04
11125,2380080,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2017-03-27,2017-03-27,,2018-08-17,Disruption of the manufacture of the drug.,2017-05-24,2018-08-23
96893,2380080,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,75MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-10-18,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-21,2019-10-21
96896,2380099,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-10-18,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-21,2019-10-21
11207,2380072,Shortage,RAN-VENLAFAXINE XR,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-11-28,2018-11-28,2019-06-28,2019-07-05,Disruption of the manufacture of the drug.,2017-05-24,2019-07-06
19633,2267926,Shortage,RAN-ZOPICLONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ZOPICLONE,ZOPICLONE,7.5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017-08-16,2017-08-16,2018-01-25,2018-01-30,Disruption of the manufacture of the drug.,2017-08-16,2019-02-04
36066,2267918,Shortage,RAN-ZOPICLONE,RANBAXY PHARMACEUTICALS CANADA INC.,RAN-ZOPICLONE,ZOPICLONE,5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-02-01,2018-02-10,2018-08-09,2018-07-26,Disruption of the manufacture of the drug.,2018-01-16,2019-02-01
49421,2385953,Shortage,RANITIDINE,SIVEM PHARMACEUTICALS ULC,RANITIDINE,RANITIDINE,150MG,60,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-06-11,2018-05-24,,2018-07-02,Other (Please describe in comments),2018-05-15,2018-07-31
93981,2353024,Shortage,RANITIDINE,SANIS HEALTH INC,RANITIDINE,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-16,,,Requirements related to complying with good manufacturing practices.,2019-09-16,2019-09-17
93986,2353016,Shortage,RANITIDINE,SANIS HEALTH INC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-16,,,Requirements related to complying with good manufacturing practices.,2019-09-16,2019-09-17
94078,2385953,Shortage,RANITIDINE,SIVEM PHARMACEUTICALS ULC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-17,2019-09-17,,,Disruption of the manufacture of the drug.,2019-09-17,2019-09-18
94081,2385961,Shortage,RANITIDINE,SIVEM PHARMACEUTICALS ULC,RANITIDINE,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-17,2019-09-17,,,Disruption of the manufacture of the drug.,2019-09-17,2019-09-18
39312,2385953,Shortage,RANITIDINE,SIVEM PHARMACEUTICALS ULC,RANITIDINE,RANITIDINE,150MG,500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-03-30,2018-03-29,,2018-07-02,Other (Please describe in comments),2018-02-12,2018-07-31
41106,2385961,Shortage,RANITIDINE,SIVEM PHARMACEUTICALS ULC,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-04-23,2018-04-26,,2018-07-02,Other (Please describe in comments),2018-02-26,2018-07-31
47846,2385953,Shortage,RANITIDINE,SIVEM PHARMACEUTICALS ULC,RANITIDINE,RANITIDINE,150MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-04-24,,2018-07-02,Other (Please describe in comments),2018-05-01,2018-07-31
47849,2385961,Shortage,RANITIDINE,SIVEM PHARMACEUTICALS ULC,RANITIDINE,RANITIDINE,300MG,30,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-05-14,2018-04-27,,2018-07-02,Other (Please describe in comments),2018-05-01,2018-07-31
14189,740748,Shortage,RANITIDINE - 150,PRO DOC LIMITEE,RANITIDINE,RANITIDINE,150MG,60-500,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-08-01,,2017-08-03,Delay in shipping of the drug.,2017-06-28,2017-10-30
94391,740748,Shortage,RANITIDINE - 150,PRO DOC LIMITEE,RANITIDINE - 150,RANITIDINE,150MG,60 - 500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-19,,,Other (Please describe in comments),2019-09-19,2019-09-20
94394,740756,Shortage,RANITIDINE - 300,PRO DOC LIMITEE,RANITIDINE - 300,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-19,,,Other (Please describe in comments),2019-09-19,2019-09-20
17351,740756,Shortage,RANITIDINE - 300,PRO DOC LIMITEE,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-07-24,,2017-08-03,Delay in shipping of the drug.,2017-07-26,2017-08-04
93455,2256711,Shortage,RANITIDINE INJECTION USP,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,25MG,2ml X 10,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-08-19,,,Disruption of the manufacture of the drug.,2019-09-10,2019-10-15
93458,2256711,Shortage,RANITIDINE INJECTION USP,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,25MG,50ml,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-08-19,,,Disruption of the manufacture of the drug.,2019-09-10,2019-10-15
27242,2256711,Shortage,RANITIDINE INJECTION USP,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,25MG,50ML VIAL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-25,2017-11-17,2017-11-13,Delay in shipping of the drug.,2017-10-27,2017-11-27
93953,2361671,Shortage,RAPAFLO,ALLERGAN INC,RAPAFLO 8MG,SILODOSIN,8MG,90,ORAL,Resolved,CAPSULE,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2019-09-23,2019-10-11,2019-10-28,2019-10-25,Disruption of the manufacture of the drug.,2019-09-16,2019-10-26
56121,2361663,Shortage,RAPAFLO,ALLERGAN INC,Rapaflo,SILODOSIN,4MG,30 cap bottle,ORAL,Resolved,CAPSULE,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-07-06,2018-08-10,2018-09-03,Other (Please describe in comments),2018-07-20,2018-09-25
10880,2247097,Shortage,RATIO-AMCINONIDE,TEVA CANADA LIMITED,AMCINONIDE,AMCINONIDE,0.1%,60ML,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-05-17,,,Disruption of the manufacture of the drug.,2017-05-23,2017-10-05
17796,2247096,Shortage,RATIO-AMCINONIDE,TEVA CANADA LIMITED,AMCINONIDE,AMCINONIDE,0.1%,60G,TOPICAL,Actual shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-07-30,,,Disruption of the manufacture of the drug.,2017-08-01,2018-12-21
17799,2247098,Shortage,RATIO-AMCINONIDE,TEVA CANADA LIMITED,AMCINONIDE,AMCINONIDE,0.1%,60G,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-07-30,,,Disruption of the manufacture of the drug.,2017-08-01,2018-12-21
1797,2171791,Shortage,RATIO-ATENOLOL,TEVA CANADA LIMITED,ATENOLOL,ATENOLOL,50MG,30,ORAL,Actual shortage,TABLET,C07AB,BETA BLOCKING AGENTS,,2015-02-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1790,2171805,Shortage,RATIO-ATENOLOL,TEVA CANADA LIMITED,ATENOLOL,ATENOLOL,100MG,30,ORAL,Actual shortage,TABLET,C07AB,BETA BLOCKING AGENTS,,2015-02-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1803,2350327,Shortage,RATIO-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,40MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2016-06-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
2343,2350335,Shortage,RATIO-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-01,,,Delay in shipping of the drug.,2017-03-14,2018-12-21
10883,2350335,Shortage,RATIO-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,80MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-17,,,Requirements related to complying with good manufacturing practices.,2017-05-23,2017-10-05
2359,2252325,Shortage,RATIO-CARVEDILOL,TEVA CANADA LIMITED,CARVEDILOL,CARVEDILOL,12.5MG,100,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,2017-03-15,,2017-06-10,2017-05-17,Delay in shipping of the drug.,2017-03-14,2017-05-23
2370,1910299,Shortage,RATIO-CLOBETASOL,TEVA CANADA LIMITED,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,60ML,TOPICAL,Resolved,LOTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2017-03-15,2017-10-30,2017-11-01,Disruption of the manufacture of the drug.,2017-03-14,2017-11-06
22942,1910272,Shortage,RATIO-CLOBETASOL,TEVA CANADA LIMITED,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,50G,TOPICAL,Resolved,CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",,2017-09-20,2017-11-01,2017-11-01,Disruption of the manufacture of the drug.,2017-09-21,2017-11-06
167,1910299,Shortage,RATIO-CLOBETASOL,TEVA CANADA LIMITED,Clobetasol,CLOBETASOL PROPIONATE,0.05%,20ML,TOPICAL,Resolved,LOTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2017-02-03,2017-11-07,2017-11-06,Disruption of the manufacture of the drug.,2017-03-10,2017-11-07
2374,653217,Shortage,RATIO-ECTOSONE,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.1%,30ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-03-01,2018-01-10,2018-02-15,Disruption of the manufacture of the drug.,2017-03-14,2018-02-21
2380,653217,Shortage,RATIO-ECTOSONE,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.1%,75ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-03-01,2018-02-28,2018-03-07,Disruption of the manufacture of the drug.,2017-03-14,2018-03-08
22945,653209,Shortage,RATIO-ECTOSONE MILD LOTION 0.05%,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.05%,60ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-09-20,2018-02-09,2018-02-28,Disruption of the manufacture of the drug.,2017-09-21,2018-03-07
42622,535435,Shortage,RATIO-ECTOSONE REGULAR CREAM 0.1%,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.1%,450G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-03-01,,2018-09-30,Disruption of the manufacture of the drug.,2018-03-13,2018-10-11
19304,750050,Shortage,RATIO-ECTOSONE REGULAR LOTION 0.1%,TEVA CANADA LIMITED,ECTOSONE,BETAMETHASONE,0.1%,60ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-08-11,2017-12-19,2017-12-29,Disruption of the manufacture of the drug.,2017-08-14,2018-01-03
3137,2243789,Shortage,RATIO-IPRA SAL UDV,TEVA CANADA LIMITED,IPRATROPIUM/SALBUTAMOL,IPRATROPIUM BROMIDE  SALBUTAMOL,0.5MG  2.5MG,20X2.5ML,INHALATION,Resolved,SOLUTION,R03AL,"ADRENERGICS, INHALANTS",,2017-03-17,2017-06-28,2017-07-27,Disruption of the manufacture of the drug.,2017-03-17,2017-07-28
88167,2243789,Shortage,RATIO-IPRA SAL UDV,TEVA CANADA LIMITED,IPRATROPIUM  SALBUTAMOL,IPRATROPIUM BROMIDE  SALBUTAMOL,0.5MG  2.5MG,20x2.5ML,INHALATION,Resolved,SOLUTION,R03AL,"ADRENERGICS, INHALANTS",,2019-07-02,2019-07-30,2019-07-15,Disruption of the manufacture of the drug.,2019-07-02,2019-07-16
10892,2097168,Shortage,RATIO-IPRATROPIUM UDV,TEVA CANADA LIMITED,IPRATROPIUM BROMIDE,IPRATROPIUM BROMIDE,250MCG,20X1ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-05-17,2017-07-19,2017-09-01,Demand increase for the drug.,2017-05-23,2017-09-19
19308,2316404,Shortage,RATIO-IRBESARTAN,TEVA CANADA LIMITED,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-08-11,2017-09-08,2017-09-15,Disruption of the manufacture of the drug.,2017-08-14,2017-09-19
9785,2330520,Shortage,RATIO-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-05-04,2017-07-28,2017-09-15,Disruption of the manufacture of the drug.,2017-05-10,2017-09-19
42582,2330520,Shortage,RATIO-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN/HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-03-10,2018-03-23,2018-05-20,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
17839,2330539,Shortage,RATIO-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-07-30,2017-09-08,2017-09-15,Disruption of the manufacture of the drug.,2017-08-01,2017-09-19
2400,854409,Shortage,RATIO-LACTULOSE,TEVA CANADA LIMITED,LACTULOSE,LACTULOSE,667MG/ML,500ML,ORAL LIQUID,Resolved,BOTTLE,A06AD,DRUGS FOR CONSTIPATION,,2017-07-15,2017-11-13,2017-12-10,Demand increase for the drug.,2017-03-14,2017-12-15
3118,653241,Shortage,RATIO-LENOLTEC NO 2,TEVA CANADA LIMITED,LENOLTEC,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  15MG  15MG,500,ORAL,Resolved,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,2017-04-15,,2017-06-30,2017-07-30,Requirements related to complying with good manufacturing practices.,2017-03-17,2017-09-05
2986,653276,Shortage,RATIO-LENOLTEC NO 3,TEVA CANADA LIMITED,LENOLTEC,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  30MG  15MG,500,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-06-01,2017-11-30,2017-11-30,Requirements related to complying with good manufacturing practices.,2017-03-15,2017-12-15
3121,621463,Shortage,RATIO-LENOLTEC NO 4,TEVA CANADA LIMITED,LENOLTEC,ACETAMINOPHEN  CODEINE PHOSPHATE,300MG  60MG,100,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017-05-01,,2017-05-30,2017-07-20,Disruption of the manufacture of the drug.,2017-03-17,2017-09-05
5168,2242931,Shortage,RATIO-METFORMIN,TEVA CANADA LIMITED,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,500,ORAL,Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-04-03,2017-09-15,2017-10-06,Disruption of the manufacture of the drug.,2017-04-03,2017-10-10
93162,2242931,Shortage,RATIO-METFORMIN,TEVA CANADA LIMITED,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,500,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-09-05,,,Disruption of the manufacture of the drug.,2019-09-05,2019-09-06
29441,2248130,Shortage,RATIO-MOMETASONE,TEVA CANADA LIMITED,MOMETASONE,MOMETASONE FUROATE,0.1%,50G,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-11-16,2018-01-12,2018-01-03,Disruption of the manufacture of the drug.,2017-11-16,2018-01-04
92678,2194236,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,15g,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,2019-08-28,,,2019-10-25,Disruption of the manufacture of the drug.,2019-08-29,2019-10-26
92681,2194236,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,30g,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2019-08-28,2019-10-25,2019-10-25,Disruption of the manufacture of the drug.,2019-08-29,2019-10-26
3145,2194228,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,30G,TOPICAL,Resolved,OINTMENT,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2017-03-17,2017-06-30,2017-07-10,Disruption of the manufacture of the drug.,2017-03-17,2017-09-05
3148,2194236,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,15G,TOPICAL,Resolved,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2017-03-17,2017-05-10,2017-04-17,Disruption of the manufacture of the drug.,2017-03-17,2017-04-25
2410,2194201,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,1L,ORAL,Resolved,DROPS,A07AA,INTESTINALANTIINFECTIVES,,2017-12-15,2018-01-30,2018-03-07,Delay in shipping of the drug.,2017-03-14,2018-03-08
1739,2194236,Shortage,RATIO-NYSTATIN,TEVA CANADA LIMITED,NYSTATIN,NYSTATIN,100000UNIT,450GM,TOPICAL,Actual shortage,CREAM,D01AA,ANTIFUNGALS FOR TOPICAL USE,,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
2975,608165,Shortage,RATIO-OXYCOCET,TEVA CANADA LIMITED,OXYCOCET,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017-06-01,2018-04-30,2018-04-30,Requirements related to complying with good manufacturing practices.,2017-03-15,2018-05-11
2978,608165,Shortage,RATIO-OXYCOCET,TEVA CANADA LIMITED,500,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,500,ORAL,Resolved,TABLET,N02AJ,,,2017-06-01,2018-04-30,2018-04-30,Requirements related to complying with good manufacturing practices.,2017-03-15,2018-05-11
2983,608165,Shortage,RATIO-OXYCOCET,TEVA CANADA LIMITED,OXYCOCET,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,100 U/D,ORAL,Resolved,TABLET,N02AJ,,,2017-06-01,2018-02-28,2018-02-21,Requirements related to complying with good manufacturing practices.,2017-03-15,2018-02-22
2419,2239365,Shortage,RATIO-SALBUTAMOL,TEVA CANADA LIMITED,SALBUTAMOL,SALBUTAMOL,0.5MG,20 x 2.5ML,INHALATION,Actual shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2016-11-01,,,Requirements related to complying with good manufacturing practices.,2017-03-14,2017-10-10
17814,2319500,Shortage,RATIO-SILDENAFIL R,TEVA CANADA LIMITED,SILDENAFIL R,SILDENAFIL,20MG,100,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2017-07-30,2017-08-25,2017-09-15,Disruption of the manufacture of the drug.,2017-08-01,2017-09-19
3151,608238,Shortage,RATIO-TECNAL,TEVA CANADA LIMITED,TECNAL,ACETYLSALICYLIC ACID  BUTALBITAL  CAFFEINE,330MG  50MG  40MG,100,ORAL,Resolved,CAPSULE,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2017-12-15,2018-02-28,2018-02-21,Disruption of the manufacture of the drug.,2017-03-17,2018-02-22
17822,2245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,TOPISALIC,BETAMETHASONE  SALICYLIC ACID,0.5MG  20MG,30 ML,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",,2017-07-01,2017-10-05,2017-10-06,Requirements related to complying with good manufacturing practices.,2017-08-01,2017-10-10
17827,2245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,TOPISALIC,BETAMETHASONE  SALICYLIC ACID,0.5MG  20MG,60ML,TOPICAL,Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",,2017-07-30,2017-10-10,2017-10-06,Requirements related to complying with good manufacturing practices.,2017-08-01,2017-10-10
98744,2245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,TOPISALIC LOTION,BETAMETHASONE  SALICYLIC ACID,0.5MG  20MG,30ml,TOPICAL,Actual shortage,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",,2019-11-13,2020-03-31,,Disruption of the manufacture of the drug.,2019-11-14,2019-11-14
8055,809187,Shortage,RATIO-TOPISONE,TEVA CANADA LIMITED,TOPISONE,BETAMETHASONE,0.05%,30ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-04-21,2017-12-19,2017-12-29,Disruption of the manufacture of the drug.,2017-04-25,2018-01-03
17832,809187,Shortage,RATIO-TOPISONE,TEVA CANADA LIMITED,TOPISONE,BETAMETHASONE,0.05%,75ML,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-07-30,2017-09-30,2017-10-16,Requirements related to complying with good manufacturing practices.,2017-08-01,2017-10-17
52350,2245977,Shortage,RECOMBIVAX HB     -(ADULT DIALYSIS-PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,40MCG,1DOSE VIAL,INTRAMUSCULAR,Actual shortage,SOLUTION,J07BC,VIRAL VACCINES,2018-06-18,2018-06-18,2021-03-01,,Disruption of the manufacture of the drug.,2018-06-13,2019-09-09
18922,2245977,Shortage,RECOMBIVAX HB     -(ADULT DIALYSIS-PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,40MCG,40MCG/1ML 1DOSE VIAL,INTRAMUSCULAR,Resolved,SOLUTION,J07BC,VIRAL VACCINES,2017-10-06,2017-10-03,2017-10-30,2017-10-06,Delay in shipping of the drug.,2017-08-12,2017-10-07
43284,2243676,Shortage,RECOMBIVAX HB     -(PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,10MCG,5MCG/0.5ML 1DOSE VIAL,INTRAMUSCULAR,Actual shortage,SOLUTION,J07BC,VIRAL VACCINES,2018-03-21,2018-03-19,2020-08-17,,Disruption of the manufacture of the drug.,2018-03-19,2019-07-04
873,2243676,Shortage,RECOMBIVAX HB     -(PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,10MCG,10MCG/1ML 10X1DOSE VIAL,INTRAMUSCULAR,Actual shortage,SOLUTION,J07BC,VIRAL VACCINES,2017-08-01,2017-08-04,2021-03-01,,Disruption of the manufacture of the drug.,2017-03-13,2019-07-04
15524,2243676,Shortage,RECOMBIVAX HB     -(PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,10MCG,5MCG/0.5ML 1DOSE VIAL (Ped),INTRAMUSCULAR,Resolved,SOLUTION,J07BC,VIRAL VACCINES,2017-08-02,2017-08-02,2017-09-18,2017-08-24,Delay in shipping of the drug.,2017-07-12,2017-10-12
23503,2243676,Shortage,RECOMBIVAX HB     -(PRESERVATIVE FREE),MERCK CANADA INC,(hepatitis B vaccine [recombinant]),HEPATITIS B SURFACE ANTIGEN,10MCG,10MCG/1ML  1DOSE VIAL,INTRAMUSCULAR,Actual shortage,SOLUTION,J07BC,VIRAL VACCINES,2017-09-21,2017-09-21,2021-03-01,,Disruption of the manufacture of the drug.,2017-09-26,2019-07-04
1584,662461,Shortage,RECTOGEL HC,LABORATOIRE RIVA INC,"Hydrocortisone acetate, zinc sulfate and  benzocaine ointment",HYDROCORTISONE ACETATE  ZINC SULFATE  BENZOCAINE,1.0%  0.5%  10%,15g & 30 g,RECTAL,Actual shortage,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
949,2224615,Shortage,RELEFACT TRH INJECTION 200MCG/ML,ODAN LABORATORIES LTD,Protirelin Injection i.v.,Protirelin,0.2 mg/mL,1 mL,I.V. injection,Actual shortage,Liquid,V04CJ,OTHER DIAGNOSTIC AGENTS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
12396,2308215,Shortage,RELISTOR,SALIX PHARMACEUTICALS INC,Relistor,METHYLNALTREXONE BROMIDE,20MG,One vial in a carton (each vial contains 12 mg/0.6 mL),SUBCUTANEOUS,Actual shortage,SOLUTION,A06AH,DRUGS FOR CONSTIPATION,2016-08-01,,2019-12-15,,Disruption of the manufacture of the drug.,2017-06-09,2019-01-31
90386,2256304,Shortage,RELPAX,PFIZER CANADA ULC,Relpax,ELETRIPTAN,40MG,6's,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-07-31,2019-12-16,,Disruption of the manufacture of the drug.,2019-07-31,2019-08-01
71281,2243910,Shortage,REMERON,MERCK CANADA INC,(mirtazapine) Tablets,MIRTAZAPINE,30MG,pack of 30 tablets,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2019-01-04,2019-01-04,2019-01-11,2019-01-11,Delay in shipping of the drug.,2019-01-04,2019-01-12
23459,2243910,Shortage,REMERON,MERCK CANADA INC,(mirtazapine) Tablets,MIRTAZAPINE,30MG,30TAB,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-10-16,2017-10-16,2017-10-23,2017-10-17,Delay in shipping of the drug.,2017-09-25,2017-10-18
26382,2248542,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,15MG,30TAB,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017-11-01,2017-11-02,2017-11-10,2017-11-08,Delay in shipping of the drug.,2017-10-19,2017-11-09
31785,2248542,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,15MG,30TAB BLIS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017-12-04,2017-12-04,2018-02-28,2017-12-06,Disruption of the manufacture of the drug.,2017-12-05,2017-12-07
31788,2248544,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,45MG,30TAB BLIS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017-12-04,2017-12-04,2018-02-28,2017-12-06,Disruption of the manufacture of the drug.,2017-12-05,2017-12-12
74066,2248542,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,15MG,pack of 30 tablets,ORAL,Avoided shortage,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2019-06-03,,2019-06-14,2019-05-31,Delay in shipping of the drug.,2019-01-31,2019-05-31
23462,2248543,Shortage,REMERON RD,MERCK CANADA INC,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,30MG,30TAB,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06AX,ANTIDEPRESSANTS,2017-10-20,2017-10-19,2018-01-12,2018-01-12,Disruption of the manufacture of the drug.,2017-09-25,2018-01-13
71284,2354586,Shortage,RENVELA,SANOFI-AVENTIS CANADA INC,Renvela,Sevelamer Carbonate,800MG,180,ORAL,Resolved,TABLET,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,,2019-01-03,2019-01-11,2019-01-09,Delay in shipping of the drug.,2019-01-04,2019-01-10
45073,2216973,Shortage,REOPRO,JANSSEN INC,Abciximab,ABCIXIMAB,2MG,1x5,INTRAVENOUS,Resolved,SOLUTION,B01AC,ANTITHROMBOTIC AGENTS,2018-05-04,,2019-12-31,2018-06-14,Disruption of the manufacture of the drug.,2018-04-05,2018-06-15
66646,2415976,Shortage,REPAGLINIDE,PRO DOC LIMITEE,REPAGLINIDE,REPAGLINIDE,1MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-11-12,,2019-01-30,Delay in shipping of the drug.,2018-11-12,2019-01-31
55397,2415968,Shortage,REPAGLINIDE,PRO DOC LIMITEE,REPAGLINIDE,REPAGLINIDE,0.5MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-11-15,,2019-01-11,Delay in shipping of the drug.,2018-07-11,2019-01-12
66478,2415984,Shortage,REPAGLINIDE,PRO DOC LIMITEE,REPAGLINIDE,REPAGLINIDE,2MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-11-08,,2019-02-13,Delay in shipping of the drug.,2018-11-08,2019-02-19
35070,2415968,Shortage,REPAGLINIDE,PRO DOC LIMITEE,REPAGLINIDE,REPAGLINIDE,0.5MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-11-15,,2019-01-11,Delay in shipping of the drug.,2018-01-06,2019-01-12
28242,1963953,Shortage,RESECTISOL (5% MANNITOL IRRIGATION),B. BRAUN MEDICAL INC,Mannitol,MANNITOL,5%,2000mL,IRRIGATION,Actual shortage,LIQUID,B05CX,IRRIGATING SOLUTIONS,,2017-11-03,,,Requirements related to complying with good manufacturing practices.,2017-11-06,2019-11-06
84937,2017741,Shortage,RESONIUM CALCIUM,SANOFI-AVENTIS CANADA INC,Resonium Calcium,CALCIUM POLYSTYRENE SULFONATE,999MG,1,ORAL  RECTAL,Resolved,POWDER FOR SOLUTION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2019-06-07,,2019-09-30,2019-08-13,Delay in shipping of the drug.,2019-05-28,2019-10-15
74356,2476835,Shortage,RESTASIS MULTIDOSE,ALLERGAN INC,CYCLOSPORINE,CYCLOSPORINE,0.05%,5.5mL,OPHTHALMIC,Actual shortage,EMULSION,S01XA,OTHER OPHTHALMOLOGICALS,2019-01-31,2019-01-31,,,Disruption of the manufacture of the drug.,2019-02-01,2019-02-01
36518,604453,Shortage,RESTORIL,AA PHARMA INC,RESTORIL,TEMAZEPAM,15MG,100BTL,ORAL,Resolved,CAPSULE,N05CD,HYPNOTICS AND SEDATIVES,,2018-01-18,2018-01-29,2018-01-31,Disruption of the manufacture of the drug.,2018-01-18,2018-04-23
19739,443794,Shortage,RETIN-A,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RETIN-A,TRETINOIN,0.05%,na,TOPICAL,Resolved,CREAM,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-08-15,,2018-03-29,Other (Please describe in comments),2017-08-17,2018-03-30
45139,443816,Shortage,RETIN-A,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RETIN-A,TRETINOIN,0.025%,n/a,TOPICAL,Resolved,GEL,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2018-05-28,,2018-06-11,Other (Please describe in comments),2018-04-06,2018-06-20
73391,443794,Shortage,RETIN-A,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RETIN-A,TRETINOIN,0.05%,30g,TOPICAL,Avoided shortage,CREAM,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2019-04-15,,,2019-03-04,Other (Please describe in comments),2019-01-23,2019-03-05
79311,443816,Shortage,RETIN-A,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RETIN-A,TRETINOIN,0.025%,30g,TOPICAL,Resolved,GEL,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-05-06,,2019-08-19,Other (Please describe in comments),2019-03-22,2019-09-10
80393,2264633,Shortage,RETIN-A MICRO,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RETIN-A MICRO,TRETINOIN,0.04%,50g,TOPICAL,Resolved,GEL,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-04-01,,2019-04-08,Other (Please describe in comments),2019-04-03,2019-04-10
46669,2264633,Shortage,RETIN-A MICRO,VALEANT CANADA LP/VALEANT CANADA S.E.C.,RETIN-A MICRO,TRETINOIN,0.04%,50g,TOPICAL,Avoided shortage,GEL,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2018-05-15,,,2018-05-10,Other (Please describe in comments),2018-04-20,2018-05-11
63649,2341611,Shortage,REVATIO,PFIZER CANADA INC,REVATIO,SILDENAFIL,0.8MG,1x 12.5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,C02KX,OTHER ANTIHYPERTENSIVES,,2018-10-09,,2018-12-17,Demand increase for the drug.,2018-10-10,2018-12-18
2036,2279401,Shortage,REVATIO,PFIZER CANADA INC,REVATIO,SILDENAFIL,20MG,6x15,ORAL,Resolved,TABLET,C02,OTHER ANTIHYPERTENSIVES,,2017-01-19,2017-03-15,2017-03-17,Disruption of the manufacture of the drug.,2017-03-14,2017-03-18
52366,2231923,Shortage,RHINOCORT AQUA,MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,BUDESONIDE,BUDESONIDE,64MCG,120 sprays,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2018-03-26,2018-09-02,2018-09-06,Demand increase for the drug.,2018-06-13,2018-09-13
51036,2035324,Shortage,RHINOCORT TURBUHALER 100 MCG/DOSE,ASTRAZENECA CANADA INC,budesonide,BUDESONIDE,100MCG,200 doses,INHALATION  NASAL,Resolved,POWDER,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2018-06-11,2018-05-28,2018-07-12,2018-07-12,Demand increase for the drug.,2018-05-31,2018-07-13
29079,2238998,Shortage,RHO-NITRO PUMPSPRAY,SANDOZ CANADA INCORPORATED,RHO NITRO,NITROGLYCERIN,0.4MG,200 DOSES,SUBLINGUAL,Resolved,METERED-DOSE PUMP,C01DA,VASODILATORS USED IN CARDIAC DISEASES,,2017-10-02,2018-01-31,2018-01-30,Demand increase for the drug.,2017-11-14,2018-02-05
35644,2091887,Shortage,RIFADIN,SANOFI-AVENTIS CANADA INC,Rifadin 150mg,RIFAMPIN,150MG,100's,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2018-01-05,2018-01-30,2018-01-31,Other (Please describe in comments),2018-01-10,2018-02-02
79293,2091887,Shortage,RIFADIN,SANOFI-AVENTIS CANADA INC,Rifadin 150mg,RIFAMPIN,150MG,100,ORAL,Actual shortage,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,2019-06-28,2019-07-03,2020-04-01,,Other (Please describe in comments),2019-03-22,2019-07-12
79314,2092808,Shortage,RIFADIN,SANOFI-AVENTIS CANADA INC,Rifadin 300mg,RIFAMPIN,300MG,100,ORAL,Actual shortage,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,2019-07-15,,2020-04-01,,Other (Please describe in comments),2019-03-22,2019-07-16
98763,2242763,Shortage,RILUTEK,SANOFI-AVENTIS CANADA INC,Rilutek,RILUZOLE,50MG,60,ORAL,Anticipated shortage,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,2019-12-16,,2020-04-24,,Shortage of an inactive ingredient or component.,2019-11-14,2019-11-14
95465,493392,Shortage,RIMSO-50,MYLAN PHARMACEUTICALS ULC,Dimethyl Sulfoxide Solution,DIMETHYL SULFOXIDE,500MG,1 VL,INTRAVESICAL,Actual shortage,SOLUTION,G04BX,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-04,2019-12-15,,Other (Please describe in comments),2019-10-04,2019-11-13
57599,493392,Shortage,RIMSO-50,MYLAN PHARMACEUTICALS ULC,Dimethyl Sulfoxide Solution,DIMETHYL SULFOXIDE,500MG,1 VL,INTRAVESICAL,Resolved,SOLUTION,G04BX,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-08-02,,2018-10-31,Disruption of the manufacture of the drug.,2018-08-07,2018-11-01
5675,2411407,Shortage,RISEDRONATE-35,SIVEM PHARMACEUTICALS ULC,RISEDRONATE-35,RISEDRONATE SODIUM,35MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-04-04,,2017-05-15,Disruption of the manufacture of the drug.,2017-04-05,2017-05-16
83152,2411407,Shortage,RISEDRONATE-35,SIVEM PHARMACEUTICALS ULC,RISEDRONATE,RISEDRONATE SODIUM,35MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2019-05-16,2019-05-16,2019-05-29,2019-05-30,Delay in shipping of the drug.,2019-05-06,2019-05-31
83950,2411407,Shortage,RISEDRONATE-35,SIVEM PHARMACEUTICALS ULC,RISEDRONATE,RISEDRONATE SODIUM,35MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2019-05-17,2019-05-17,2019-11-08,2019-11-06,Requirements related to complying with good manufacturing practices.,2019-05-13,2019-11-07
26182,2356902,Shortage,RISPERIDONE,SANIS HEALTH INC,RISPERIDONE TAB,RISPERIDONE,1MG,100,ORAL,Avoided shortage,TABLET,N05AX,ANTIPSYCHOTICS,2017-10-27,,2017-11-10,2017-10-24,Other (Please describe in comments),2017-10-18,2017-10-24
12261,5614,Shortage,RITALIN 20MG,NOVARTIS PHARMACEUTICALS CANADA INC,RITALIN 20MG TABS 100'S,METHYLPHENIDATE HYDROCHLORIDE,20MG,100'S,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-07-10,2017-07-10,2017-08-28,2017-08-22,Delay in shipping of the drug.,2017-06-07,2017-08-31
11280,632775,Shortage,RITALIN-SR TAB 20MG,NOVARTIS PHARMACEUTICALS CANADA INC,RITALIN 20MG SR TABS 100'S,METHYLPHENIDATE HYDROCHLORIDE,20MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-05-11,2017-06-26,2017-06-01,Other (Please describe in comments),2017-05-25,2017-06-02
3417,2331500,Shortage,RIVA-AMLODIPINE,LABORATOIRE RIVA INC,Amlodipine,AMLODIPINE,10MG,100 & 500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-04-14,,,2017-05-23,Demand increase for the drug.,2017-03-17,2017-05-24
3421,2331489,Shortage,RIVA-AMLODIPINE,LABORATOIRE RIVA INC,Amlodipine,AMLODIPINE,2.5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-04-14,,,2017-05-23,Demand increase for the drug.,2017-03-17,2017-05-24
3424,2331497,Shortage,RIVA-AMLODIPINE,LABORATOIRE RIVA INC,Amlodipine,AMLODIPINE,5MG,100 & 500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,2017-04-14,,,2017-05-23,Demand increase for the drug.,2017-03-17,2017-05-24
33381,2277379,Shortage,RIVA-ATENOLOL,LABORATOIRE RIVA INC,Atenolol 25mg,ATENOLOL,25MG,100 & 500 pack,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-12-18,2017-12-18,2018-05-25,2018-05-25,Disruption of the manufacture of the drug.,2017-12-18,2018-07-10
14126,2242094,Shortage,RIVA-ATENOLOL 50 MG,LABORATOIRE RIVA INC,Riva-Atenolol 50mg,ATENOLOL,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-07-07,2017-07-14,2018-03-23,2018-03-22,Delay in shipping of the drug.,2017-06-27,2018-03-30
29043,2425386,Shortage,RIVA-CELECOX,LABORATOIRE RIVA INC,Celcox 100mg,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2017-11-13,2017-11-13,2017-12-22,2017-12-05,Disruption of the manufacture of the drug.,2017-11-13,2018-01-18
28996,2242077,Shortage,RIVA-CLONAZEPAM,LABORATOIRE RIVA INC,Clonazepam 0.5mg,CLONAZEPAM,0.5MG,100 & 500,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-11-17,2017-11-17,2018-04-20,2018-04-20,Disruption of the manufacture of the drug.,2017-11-13,2018-05-02
98092,2441659,Shortage,RIVA-DORZOLAMIDE/TIMOLOL,LABORATOIRE RIVA INC,Riva-dorzolamide / Timolol,TIMOLOL  DORZOLAMIDE,5MG  20MG,10ml,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2019-11-11,,2020-01-15,,Demand increase for the drug.,2019-11-06,2019-11-12
12400,2428830,Shortage,RIVA-ESCITALOPRAM,LABORATOIRE RIVA INC,Riva-Escitalopram,ESCITALOPRAM,10MG,30 & 100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-06-09,2017-06-09,2019-01-18,2019-01-18,Disruption of the manufacture of the drug.,2017-06-09,2019-01-19
12403,2428857,Shortage,RIVA-ESCITALOPRAM,LABORATOIRE RIVA INC,Riva-Escitalopram,ESCITALOPRAM,20MG,30 & 100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-06-09,2017-06-09,2019-01-18,2019-01-18,Disruption of the manufacture of the drug.,2017-06-09,2019-01-19
31757,2303345,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,fluvoxamine 50mg,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-12-04,2017-12-04,2018-02-28,2018-02-23,Demand increase for the drug.,2017-12-05,2018-02-24
75659,2303345,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Riva-Fluvox 50mg 100comp.,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2019-02-13,2019-02-13,2019-05-31,2019-05-28,Delay in shipping of the drug.,2019-02-13,2019-11-06
75667,2303361,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Riva-Fluvox 100mg 100comp.,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2019-02-13,2019-02-13,2019-05-31,2019-05-28,Delay in shipping of the drug.,2019-02-13,2019-11-06
31661,2303361,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Fluvoxamine 100mg,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-12-04,2017-12-04,2018-02-28,2018-02-26,Demand increase for the drug.,2017-12-04,2018-03-30
26076,2303345,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Fluvoxamine 50mg,FLUVOXAMINE MALEATE,50MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-10-16,2017-10-16,2017-10-27,2017-10-26,Demand increase for the drug.,2017-10-16,2017-11-01
26079,2303361,Shortage,RIVA-FLUVOX,LABORATOIRE RIVA INC,Fluvoxamine 100mg,FLUVOXAMINE MALEATE,100MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2017-10-16,2017-10-16,2017-10-27,2017-10-27,Demand increase for the drug.,2017-10-16,2017-11-01
1575,2259796,Shortage,RIVA-GABAPENTIN,LABORATOIRE RIVA INC,Gabapentin tablets,GABAPENTIN,600MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1580,2259818,Shortage,RIVA-GABAPENTIN,LABORATOIRE RIVA INC,Gabapentin tablets,GABAPENTIN,800MG,100 & 500,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1593,2247245,Shortage,RIVA-INDAPAMIDE 1.25,LABORATOIRE RIVA INC,Indapamide Tablets USP,INDAPAMIDE,1.25MG,30 & 100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2016-06-02,2016-06-02,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1596,2242125,Shortage,RIVA-INDAPAMIDE 2.5 MG,LABORATOIRE RIVA INC,Indapamide Tablets USP,INDAPAMIDE,2.5MG,30 & 100,ORAL,Actual shortage,TABLET,C03BA,"LOW-CEILING DIURETICS, EXCL THIAZIDES",2016-06-02,2016-06-02,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
95042,2422816,Shortage,RIVA-LANSOPRAZOLE,LABORATOIRE RIVA INC,Riva-Lansoprazole,LANSOPRAZOLE,30MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-30,2019-09-30,,,Disruption of the manufacture of the drug.,2019-09-30,2019-10-01
49001,2341085,Shortage,RIVA-LATANOPROST,LABORATOIRE RIVA INC,Riva-Latanoprost opht. 50mcg/mL 2.5mL,LATANOPROST,50MCG,2.5ml,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2018-05-31,2018-05-31,2018-11-02,2018-11-05,Demand increase for the drug.,2018-05-10,2019-02-13
88854,2482274,Shortage,RIVA-LEVETIRACETAM,LABORATOIRE RIVA INC,Riva-Levetiracetam 250mg,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2019-07-08,2019-07-08,,2019-10-24,Disruption of the manufacture of the drug.,2019-07-08,2019-11-06
88861,2482282,Shortage,RIVA-LEVETIRACETAM,LABORATOIRE RIVA INC,Riva-Levetiracetam 500mg,LEVETIRACETAM,500MG,100,ORAL,Actual shortage,TABLET,N03AX,ANTIEPILEPTICS,2019-07-08,2019-07-08,,,Disruption of the manufacture of the drug.,2019-07-08,2019-07-09
88864,2482290,Shortage,RIVA-LEVETIRACETAM,LABORATOIRE RIVA INC,Riva-Levetiracetam 750mg,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2019-07-08,2019-07-08,,2019-10-24,Disruption of the manufacture of the drug.,2019-07-08,2019-11-06
3672,2315327,Shortage,RIVA-METOPROLOL L,LABORATOIRE RIVA INC,Metoprolol,METOPROLOL TARTRATE,100MG,1000,ORAL,Actual shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2017-03-20,2017-03-20,,,Disruption of the manufacture of the drug.,2017-03-20,2018-12-21
55204,2471353,Shortage,RIVA-OLMESARTAN,LABORATOIRE RIVA INC,Riva-Olmesartan 20mg,OLMESARTAN MEDOXOMIL,20MG,30 / 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-10,2018-07-10,,2019-04-17,Shortage of an active ingredient.,2018-07-10,2019-04-18
55210,2471361,Shortage,RIVA-OLMESARTAN,LABORATOIRE RIVA INC,Riva-Olmesartan 40mg,OLMESARTAN MEDOXOMIL,40MG,30 / 100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-10,2018-07-10,,2019-04-17,Shortage of an active ingredient.,2018-07-10,2019-04-18
26906,2299364,Shortage,RIVA-OXYBUTYNIN,LABORATOIRE RIVA INC,Oxybutynin 5mg,OXYBUTYNIN CHLORIDE,5MG,100 & 500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-10-31,2017-11-08,2018-04-20,2018-04-20,Disruption of the manufacture of the drug.,2017-10-24,2018-05-02
1629,2270234,Shortage,RIVA-PRAVASTATIN,LABORATOIRE RIVA INC,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,10MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1640,2270242,Shortage,RIVA-PRAVASTATIN,LABORATOIRE RIVA INC,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,20MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1645,2270250,Shortage,RIVA-PRAVASTATIN,LABORATOIRE RIVA INC,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,40MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
93927,2247814,Shortage,RIVA-RANITIDINE 150,LABORATOIRE RIVA INC,Riva-Ranitidine 150,RANITIDINE,150MG,60,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-13,2019-09-13,,,Other (Please describe in comments),2019-09-13,2019-09-14
93930,2247815,Shortage,RIVA-RANITIDINE 300,LABORATOIRE RIVA INC,Riva-Ranitidine 300,RANITIDINE,300MG,30 & 100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-09-13,2019-09-13,,,Other (Please describe in comments),2019-09-13,2019-09-14
8435,2423464,Shortage,RIVA-RIZATRIPTAN ODT,LABORATOIRE RIVA INC,Riva-Rizatriptan ODT,RIZATRIPTAN,10MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017-04-28,2017-04-28,,,Disruption of the manufacture of the drug.,2017-04-28,2018-12-21
65917,2247298,Shortage,RIVA-SIMVASTATIN,LABORATOIRE RIVA INC,Riva-Simvastatin 10mg,SIMVASTATIN,10MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-31,2018-10-31,,,Disruption of the manufacture of the drug.,2018-10-31,2018-11-01
65920,2247299,Shortage,RIVA-SIMVASTATIN,LABORATOIRE RIVA INC,Riva-Simvastatin 20mg,SIMVASTATIN,20MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-31,2018-10-31,,,Disruption of the manufacture of the drug.,2018-10-31,2018-11-01
65923,2247300,Shortage,RIVA-SIMVASTATIN,LABORATOIRE RIVA INC,Riva-Simvastatin 40mg,SIMVASTATIN,40MG,30 & 100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-31,2018-10-31,,,Disruption of the manufacture of the drug.,2018-10-31,2018-11-01
65926,2247297,Shortage,RIVA-SIMVASTATIN,LABORATOIRE RIVA INC,Riva-Simvastatin 5mg,SIMVASTATIN,5MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-31,2018-10-31,,,Disruption of the manufacture of the drug.,2018-10-31,2018-11-01
65929,2247301,Shortage,RIVA-SIMVASTATIN,LABORATOIRE RIVA INC,Riva-Simvastatin 80mg,SIMVASTATIN,80MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-31,2018-10-31,,,Disruption of the manufacture of the drug.,2018-10-31,2018-11-01
26924,2272172,Shortage,RIVA-SOTALOL,LABORATOIRE RIVA INC,Sotalol 160mg,SOTALOL HYDROCHLORIDE,160MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017-09-04,2017-09-04,2018-06-01,2018-05-07,Disruption of the manufacture of the drug.,2017-10-24,2018-05-08
27643,2272164,Shortage,RIVA-SOTALOL,LABORATOIRE RIVA INC,Sotalol 80mg,SOTALOL HYDROCHLORIDE,80MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,2017-11-15,2017-11-08,2018-04-13,2018-04-18,Disruption of the manufacture of the drug.,2017-11-01,2018-05-02
62663,2454726,Shortage,RIVA-TADALAFIL,LABORATOIRE RIVA INC,Riva- Tadalafil,TADALAFIL,5MG,30,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-09-28,2018-09-28,,,Disruption of the manufacture of the drug.,2018-09-28,2018-09-29
62666,2454742,Shortage,RIVA-TADALAFIL,LABORATOIRE RIVA INC,Riva-Tadalafil,TADALAFIL,20MG,4,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-09-28,2018-09-28,,,Disruption of the manufacture of the drug.,2018-09-28,2018-09-29
62771,2307774,Shortage,RIVA-VENLAFAXINE XR,LABORATOIRE RIVA INC,Riva- Venlafaxine,VENLAFAXINE,37.5MG,100 & 500 tabs,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-10-01,2018-09-24,2018-10-26,2018-10-10,Disruption of the manufacture of the drug.,2018-10-01,2018-10-11
1662,2248082,Shortage,RIVA-VERAPAMIL SR,LABORATOIRE RIVA INC,Verapamil Hydrochloride,VERAPAMIL HYDROCHLORIDE,240MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2016-10-20,2016-10-20,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1672,2401304,Shortage,RIVA-ZOLMITRIPTAN,LABORATOIRE RIVA INC,Zolmitriptan film-coated tablets,ZOLMITRIPTAN,2.5MG,6 & 30,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,2016-10-14,2016-10-14,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1392,2228300,Shortage,RIVANASE AQ.NASAL SPRAY 50MCG/METERED DOSE,LABORATOIRE RIVA INC,Beclometasone dipropionate aqueous suspension,BECLOMETHASONE DIPROPIONATE,50MCG,200,NASAL,Actual shortage,METERED-DOSE AEROSOL,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1588,2240112,Shortage,RIVASOL-HC SUPPOSITORIES,LABORATOIRE RIVA INC,Hydrocortisone acetate and zinc sulfate monohydrate suppositories,HYDROCORTISONE ACETATE  ZINC SULFATE,10MG  10MG,12,RECTAL,Actual shortage,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1410,1940112,Shortage,RIVASONE SCALP LOT 0.1%,LABORATOIRE RIVA INC,Betamethasone lotion,BETAMETHASONE,0.1%,30ml & 75 ml,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
2307,2417014,Shortage,RIVASTIGMINE,PRO DOC LIMITEE,RIVASTIGMINE,RIVASTIGMINE,4.5MG,100,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2017-03-14,,2017-03-16,Delay in shipping of the drug.,2017-03-14,2017-03-24
34871,382825,Shortage,RIVOTRIL 0.5TAB,HOFFMANN-LA ROCHE LIMITED,CLONAZEPAM,CLONAZEPAM,0.5MG,Bottles of 100 tablets,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,,2018-01-03,2018-05-11,2018-04-20,Demand increase for the drug.,2018-01-03,2018-04-21
28573,382825,Shortage,RIVOTRIL 0.5TAB,HOFFMANN-LA ROCHE LIMITED,CLONAZEPAM,CLONAZEPAM,0.5MG,Bottles of 100 tablets,ORAL,Resolved,TABLET,N03AE,ANTIEPILEPTICS,2017-11-17,2017-11-09,2017-12-13,2017-12-12,Demand increase for the drug.,2017-11-07,2017-12-13
5659,2446138,Shortage,RIZATRIPTAN ODT,SIVEM PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017-04-04,2017-04-11,2017-04-11,Demand increase for the drug.,2017-04-05,2017-04-12
90221,2442906,Shortage,RIZATRIPTAN ODT,SANIS HEALTH INC,RIZATRIPTAN,RIZATRIPTAN,5MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2019-08-30,2019-09-04,2019-11-28,,Disruption of the manufacture of the drug.,2019-07-30,2019-10-21
32648,2446138,Shortage,RIZATRIPTAN ODT,SIVEM PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-01-22,2018-01-22,2018-02-23,2018-02-23,Other (Please describe in comments),2017-12-12,2018-02-26
75988,2446111,Shortage,RIZATRIPTAN ODT,SIVEM PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2019-03-01,2019-02-27,2019-03-08,2019-02-27,Delay in shipping of the drug.,2019-02-15,2019-03-12
28900,2446111,Shortage,RIZATRIPTAN ODT,SIVEM PHARMACEUTICALS ULC,RIZATRIPTAN ODT,RIZATRIPTAN,5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2017-12-04,2017-12-06,2018-02-23,2018-02-23,Other (Please describe in comments),2017-11-10,2018-02-26
48666,2415801,Shortage,RIZATRIPTAN RDT,PRO DOC LIMITEE,RIZATRIPTAN RDT,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2018-05-07,2018-11-08,2018-10-18,Delay in shipping of the drug.,2018-05-07,2018-10-19
17458,2415798,Shortage,RIZATRIPTAN RDT,PRO DOC LIMITEE,RIZATRIPTAN RDT,RIZATRIPTAN,5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017-07-27,,2017-10-11,Delay in shipping of the drug.,2017-07-28,2017-10-12
96287,1934740,Shortage,ROBITUSSIN AC,PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC,"Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup",CODEINE PHOSPHATE  GUAIFENESIN  PHENIRAMINE MALEATE,10MG  100MG  7.5MG,1 Litre,ORAL,Actual shortage,SYRUP,R05FA,"COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS",,2019-10-09,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
95768,2469774,Shortage,ROCURONIUM BROMIDE INJECTION,MDA INC.,Rocuronium Bromide Injection,ROCURONIUM BROMIDE,10MG,10,INTRAVENOUS,Resolved,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",2019-10-08,2019-10-08,2019-10-15,2019-10-15,Delay in shipping of the drug.,2019-10-08,2019-10-16
30511,2318121,Shortage,ROCURONIUM BROMIDE INJECTION,HOSPIRA HEALTHCARE CORPORATION,ROCURONIUM BROMIDE,ROCURONIUM BROMIDE,10MG,10x5mL,INTRAVENOUS,Resolved,LIQUID,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2017-12-07,,2018-02-09,Disruption of the manufacture of the drug.,2017-11-23,2018-02-10
12130,2318415,Shortage,ROCURONIUM BROMIDE INJECTION,SANDOZ CANADA INCORPORATED,ROCURONIUM,ROCURONIUM BROMIDE,10MG,10 X 5ML VIALS,INTRAVENOUS,Resolved,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",2017-06-09,,2017-06-30,2017-07-21,Delay in shipping of the drug.,2017-06-06,2017-10-10
77963,2318121,Shortage,ROCURONIUM BROMIDE INJECTION,PFIZER CANADA ULC,Rocuronium,ROCURONIUM BROMIDE,10MG,10 x 5mL Vial,INTRAVENOUS,Resolved,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2019-04-23,,2019-07-30,Disruption of the manufacture of the drug.,2019-03-06,2019-10-01
93236,393444,Shortage,ROFACT,"BAUSCH HEALTH, CANADA INC.",ROFACT,RIFAMPIN,150MG,n/a,ORAL,Anticipated shortage,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,2019-12-16,,,,Shortage of an active ingredient.,2019-09-06,2019-11-13
93246,343617,Shortage,ROFACT,"BAUSCH HEALTH, CANADA INC.",ROFACT,RIFAMPIN,300MG,n/a,ORAL,Anticipated shortage,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,2020-01-15,,,,Shortage of an active ingredient.,2019-09-06,2019-09-09
11360,393444,Shortage,ROFACT 150MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ROFACT 150MG,RIFAMPIN,150MG,NA,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2017-05-25,2017-06-15,2017-06-15,Other (Please describe in comments),2017-05-26,2017-06-16
3290,393444,Shortage,ROFACT 150MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ROFACT,RIFAMPIN,150MG,100,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2017-03-15,2017-04-18,2017-06-15,Disruption of the manufacture of the drug.,2017-03-17,2017-06-16
1621,343617,Shortage,ROFACT 300MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,Rifampin Capsule,RIFAMPIN,300MG,100,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2017-02-16,2017-04-11,2017-04-11,Disruption of the manufacture of the drug.,2017-03-13,2017-04-12
49062,343617,Shortage,ROFACT 300MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ROFACT 300MG,RIFAMPIN,300MG,100's,ORAL,Avoided shortage,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,2018-08-31,,,2018-07-09,Other (Please describe in comments),2018-05-11,2018-07-09
65751,343617,Shortage,ROFACT 300MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ROFACT 300MG,RIFAMPIN,300MG,100's,ORAL,Resolved,CAPSULE,J04AB,DRUGS FOR TREATMENT OF TUBERCULOSIS,,2019-05-02,,2019-07-29,Demand increase for the drug.,2018-10-29,2019-08-01
1520,2122073,Shortage,ROLENE CREAM 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate cream,BETAMETHASONE DIPROPIONATE,0.05%,50g & 450g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1530,2122065,Shortage,ROLENE LOTION 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate lotion,BETAMETHASONE DIPROPIONATE,0.05%,30ml & 75ml,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1537,2122081,Shortage,ROLENE OINTMENT 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate ointment,BETAMETHASONE DIPROPIONATE,0.05%,50g & 450g,TOPICAL,Actual shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
87069,2353040,Shortage,ROPINIROLE,SANIS HEALTH INC,ROPINIROLE,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-06-19,2019-09-18,2019-09-06,Disruption of the manufacture of the drug.,2019-06-19,2019-09-07
72242,2353040,Shortage,ROPINIROLE,SANIS HEALTH INC,ROPINIROLE,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2019-01-15,2019-03-01,2019-02-27,Other (Please describe in comments),2019-01-15,2019-02-28
23677,2353040,Shortage,ROPINIROLE,SANIS HEALTH INC,ROPINIROLE TAB,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-10-02,,2017-10-16,2017-10-13,Other (Please describe in comments),2017-09-27,2017-10-16
29895,2353040,Shortage,ROPINIROLE,SANIS HEALTH INC,ROPINIROLE TABS,ROPINIROLE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,2017-11-21,,2017-12-15,2017-12-15,Other (Please describe in comments),2017-11-21,2017-12-16
76554,2347822,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,Ropivacaine Hydrochloride Injection USP,ROPIVACAINE HYDROCHLORIDE,5MG,10 x 30mL GVL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-02-20,,2019-09-11,Disruption of the manufacture of the drug.,2019-02-21,2019-09-12
76559,2347830,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,Ropivacaine Hydrochloride Injection USP,ROPIVACAINE HYDROCHLORIDE,10MG,10 x 10mL GVL,EPIDURAL,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-02-20,2019-12-20,,Disruption of the manufacture of the drug.,2019-02-21,2019-08-28
71961,2347830,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,Ropivacaine Hydrochloride Injection USP,ROPIVACAINE HYDROCHLORIDE,10MG,10 x 20mL GVL,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-02-21,,2019-09-11,Disruption of the manufacture of the drug.,2019-01-11,2019-09-12
46145,2347830,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA INC,ROPIVACAINE,ROPIVACAINE HYDROCHLORIDE,10MG,10 x 20mL GVL,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-04-17,,2018-07-06,Disruption of the manufacture of the drug.,2018-04-17,2018-07-10
49024,2347822,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA INC,ROPIVACAINE HCL,ROPIVACAINE HYDROCHLORIDE,5MG,10 x 30mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-05-14,,2018-08-29,Disruption of the manufacture of the drug.,2018-05-10,2018-08-30
8417,2347830,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,ROPIVACAINE,ROPIVACAINE HYDROCHLORIDE,10MG,10x10mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-05-09,,2018-10-01,Disruption of the manufacture of the drug.,2017-04-28,2018-10-02
16621,2347822,Shortage,ROPIVACAINE HYDROCHLORIDE INJECTION USP,HOSPIRA HEALTHCARE CORPORATION,Ropivacaine,ROPIVACAINE HYDROCHLORIDE,5MG,10x30mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-07-13,,2018-03-07,Disruption of the manufacture of the drug.,2017-07-21,2018-03-08
90057,2439379,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,Ropivacaine,ROPIVACAINE HYDROCHLORIDE,2MG,200mL Freeflex bag,EPIDURAL  INFILTRATION,Actual shortage,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-07-26,2019-10-31,,Disruption of the manufacture of the drug.,2019-07-26,2019-10-01
51677,2439379,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",ROPIVACAINE HYDROCHLORIDE,2mg/mL,100 mL bag,"Epidural,  Infiltration",Resolved,Solution,N01BB,Anesthetics. Local,,2018-06-01,,2018-10-01,Disruption of the manufacture of the drug.,2018-06-06,2018-10-02
51680,2439379,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",ROPIVACAINE HYDROCHLORIDE,2 mg/mL,200 mL bag,"Epidural,  Infiltration",Resolved,Solution,N01BB,Anesthectics. local,,2018-06-01,,2018-10-01,Disruption of the manufacture of the drug.,2018-06-06,2018-10-02
51683,2439387,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",ROPIVACAINE HYDROCHLORIDE,5 mg/mL,10 mL Ampoule,"Block/Infiltration,  Epidural",Resolved,Solution,N01BB,"Anesthecics, local",,2018-06-01,2019-06-30,2019-09-12,Disruption of the manufacture of the drug.,2018-06-06,2019-09-13
51686,2439409,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",ROPIVACAINE HYDROCHLORIDE,10 mg/mL,10 mL Ampoule,Epidural,Resolved,Solution,N01BB,"Anesthecis, local",,2018-06-01,,2019-02-27,Disruption of the manufacture of the drug.,2018-06-06,2019-03-01
51691,2439409,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",ROPIVACAINE HYDROCHLORIDE,10 mg/mL,20 mL Ampoule,Epidural,Resolved,Solution,N01BB,"Anesthetics, local",,2018-06-01,,2019-02-27,Disruption of the manufacture of the drug.,2018-06-06,2019-03-01
1540,2122049,Shortage,ROSONE CREAM 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate cream,BETAMETHASONE DIPROPIONATE,0.05%,50 g & 450 g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
1542,2122030,Shortage,ROSONE LOTION 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate lotion,BETAMETHASONE DIPROPIONATE,0.05%,30 ml & 75 ml,TOPICAL,Actual shortage,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",2014-04-11,2014-04-11,,,Delay in shipping of the drug.,2017-03-13,2017-10-05
1544,2122057,Shortage,ROSONE OINTMENT 0.05%,LABORATOIRE RIVA INC,Betamethasone diproprionate ointment,BETAMETHASONE DIPROPIONATE,0.05%,50g & 450 g,TOPICAL,Actual shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",2014-04-11,2014-04-11,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
85435,2411652,Shortage,ROSUVASTATIN,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-06-11,2019-06-11,2019-06-21,2019-06-20,Delay in shipping of the drug.,2019-06-03,2019-06-21
78354,2411636,Shortage,ROSUVASTATIN-10,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-04-04,2019-04-08,2019-05-24,2019-05-24,Other (Please describe in comments),2019-03-12,2019-05-25
5663,2411636,Shortage,ROSUVASTATIN-10,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN-10,ROSUVASTATIN,10MG,90,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-04-27,2017-05-10,2017-05-10,Demand increase for the drug.,2017-04-05,2017-05-18
8282,2411636,Shortage,ROSUVASTATIN-10,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-04-27,,2017-05-10,2017-05-10,Demand increase for the drug.,2017-04-27,2017-05-18
80274,2411636,Shortage,ROSUVASTATIN-10,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-05-01,2019-04-26,2019-05-24,2019-05-24,Other (Please describe in comments),2019-04-01,2019-05-25
79385,2411644,Shortage,ROSUVASTATIN-20,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-04-05,2019-04-04,2019-05-24,2019-05-24,Other (Please describe in comments),2019-03-25,2019-05-25
5666,2411644,Shortage,ROSUVASTATIN-20,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN-20,ROSUVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-04-27,,2017-06-15,2017-05-05,Demand increase for the drug.,2017-04-05,2017-11-03
49723,2411644,Shortage,ROSUVASTATIN-20,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,20MG,90,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-06-25,2018-07-05,2018-08-03,2018-08-10,Delay in shipping of the drug.,2018-05-18,2018-08-11
75411,2411644,Shortage,ROSUVASTATIN-20,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-03-11,2019-03-12,2019-05-24,2019-05-24,Other (Please describe in comments),2019-02-12,2019-05-25
79388,2411652,Shortage,ROSUVASTATIN-40,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-05-01,2019-04-22,2019-05-24,2019-05-24,Other (Please describe in comments),2019-03-25,2019-05-25
8285,2411652,Shortage,ROSUVASTATIN-40,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2017-04-30,,2017-05-10,2017-05-10,Demand increase for the drug.,2017-04-27,2017-05-18
76010,2411652,Shortage,ROSUVASTATIN-40,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-03-19,2019-03-19,2019-05-24,2019-05-24,Other (Please describe in comments),2019-02-15,2019-05-25
52974,2411652,Shortage,ROSUVASTATIN-40,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-07-02,2018-07-02,2018-08-06,2018-08-10,Delay in shipping of the drug.,2018-06-26,2018-08-11
80271,2411628,Shortage,ROSUVASTATIN-5,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,5MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-04-22,2019-04-16,2019-05-24,2019-05-24,Other (Please describe in comments),2019-04-01,2019-05-25
75408,2411628,Shortage,ROSUVASTATIN-5,SIVEM PHARMACEUTICALS ULC,ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-03-13,2019-03-13,2019-05-24,2019-05-24,Other (Please describe in comments),2019-02-12,2019-05-25
44836,2284413,Shortage,ROTATEQ,MERCK CANADA INC,"rotavirus vaccine, live, oral, pentavalent oral solution",HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1  HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G2  HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G3  HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G4  HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE P1,2210000UNIT  2840000UNIT  2220000UNIT  2040000UNIT  2290000UNIT,1DOSE TUBE,ORAL,Resolved,SOLUTION,J07BH,VIRAL VACCINES,2018-04-03,2018-04-03,2018-04-20,2018-04-17,Delay in shipping of the drug.,2018-04-04,2018-04-18
3208,2284413,Shortage,ROTATEQ,MERCK CANADA INC,"rotavirus vaccine, live, oral, pentavalent oral solution",HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1 /G2/G3/G4/P1(8),2ML,1DOSE TUBE,oral,Resolved,Solution,J07BH,VIRAL VACCINES,,2017-08-01,2017-09-18,2017-09-15,Delay in shipping of the drug.,2017-03-17,2017-09-16
19341,1927825,Shortage,ROVAMYCINE 250 CAPSULE 750000 UNIT,ODAN LABORATORIES LTD,Spiramycin capsules,SPIRAMYCIN,750000UNIT,50,ORAL,Resolved,CAPSULE,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2018-02-01,2018-01-31,2018-05-18,2018-05-18,Disruption of the manufacture of the drug.,2017-08-14,2018-05-22
85641,1927817,Shortage,ROVAMYCINE 500 CAPSULE 1500000 UNIT,ODAN LABORATORIES LTD,Spiramycin Capsules,SPIRAMYCIN,1500000UNIT,50,ORAL,Resolved,CAPSULE,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-06-05,2019-08-12,2019-08-06,Delay in shipping of the drug.,2019-06-05,2019-08-07
19338,1927817,Shortage,ROVAMYCINE 500 CAPSULE 1500000 UNIT,ODAN LABORATORIES LTD,Spiramycin capsules,SPIRAMYCIN,1500000UNIT,50,ORAL,Resolved,CAPSULE,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2017-08-14,2017-08-14,,2018-05-22,Disruption of the manufacture of the drug.,2017-08-14,2018-05-23
70170,2374285,Shortage,RUBY-FILL,JUBILANT DRAXIMAGE INC,Rubidium Rb 82 Generator,Rubidium chloride Rb 82,3.7GBQ,1 Generator,INTRAVENOUS,Resolved,SOLUTION,,,,2018-12-11,2019-02-14,2019-02-14,Other (Please describe in comments),2018-12-20,2019-07-03
36174,603708,Shortage,RYTHMOL,BGP PHARMA ULC,RYTHMOL,PROPAFENONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2018-04-09,2018-03-14,2019-03-22,2019-03-20,Demand increase for the drug.,2018-01-17,2019-03-21
37204,603716,Shortage,RYTHMOL,BGP PHARMA ULC,RYTHMOL,PROPAFENONE HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",2018-03-28,2018-03-29,2019-01-31,2019-01-21,Demand increase for the drug.,2018-01-25,2019-01-22
220,603716,Shortage,RYTHMOL,BGP PHARMA ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2016-12-14,,2017-06-20,Requirements related to complying with good manufacturing practices.,2017-03-10,2017-06-23
223,603708,Shortage,RYTHMOL,BGP PHARMA ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2017-02-03,,2017-06-20,Requirements related to complying with good manufacturing practices.,2017-03-10,2017-06-23
80576,2453258,Shortage,S.O.S. NALOXONE HYDROCHLORIDE INJECTION,SANDOZ CANADA INCORPORATED,NALOXONE HCl Inj SOS,NALOXONE HYDROCHLORIDE,0.4MG,10X1ml,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2019-05-10,2019-05-03,2019-07-01,2019-07-01,Requirements related to complying with good manufacturing practices.,2019-04-05,2019-07-03
3826,2453258,Shortage,S.O.S. NALOXONE HYDROCHLORIDE INJECTION,SANDOZ CANADA INCORPORATED,NALOXONE,NALOXONE HYDROCHLORIDE,0.4MG,10 X 1ML AMPOULES,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2017-04-07,,2017-06-16,2017-05-01,Demand increase for the drug.,2017-03-22,2017-06-26
67584,2350122,Shortage,SAIZEN,EMD SERONO A DIVISION OF EMD INC CANADA,Somatropin,SOMATROPIN,5.83MG,"I pre-filled cartridge / 1 cartouche préremplie, 6 mg (5.83 mg/mL)",SUBCUTANEOUS,Resolved,SOLUTION,H01AC,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,2018-11-26,2018-11-26,2018-12-21,2018-12-14,Disruption of the manufacture of the drug.,2018-11-26,2018-12-15
66383,2350149,Shortage,SAIZEN,EMD SERONO A DIVISION OF EMD INC CANADA,Somatropin,SOMATROPIN,8MG,"1 pre-filled cartridge / 1 cartouche préremplie, 20 mg (8.00 mg/mL)",SUBCUTANEOUS,Resolved,SOLUTION,H01AC,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,,2018-11-07,2018-12-07,2018-11-29,Disruption of the manufacture of the drug.,2018-11-07,2018-11-30
35530,2350130,Shortage,SAIZEN,EMD SERONO A DIVISION OF EMD INC CANADA,Somatropin,SOMATROPIN,8MG,"1 pre-filled cartridge / 1 cartouche préremplie, 12 mg (8.00 mg/mL)",SUBCUTANEOUS,Resolved,SOLUTION,H01AC,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,2018-01-12,,2018-01-26,2018-01-25,Other (Please describe in comments),2018-01-10,2018-01-26
67578,2350130,Shortage,SAIZEN,EMD SERONO A DIVISION OF EMD INC CANADA,Somatropin,SOMATROPIN,8MG,"I pre-filled cartridge / 1 cartouche préremplie, 12 mg (8.00 mg/mL)",SUBCUTANEOUS,Resolved,SOLUTION,H01AC,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,2018-11-26,2018-11-26,2019-01-02,2019-01-02,Disruption of the manufacture of the drug.,2018-11-26,2019-01-03
20768,2064480,Shortage,SALAZOPYRIN TAB 500MG,PFIZER CANADA INC,Salazopyrin,SULFASALAZINE,500MG,100,ORAL,Resolved,TABLET,A07EC,INTESTINALANTIINFLAMMATORY AGENTS,2017-09-05,,2017-10-16,2017-10-13,Demand increase for the drug.,2017-09-01,2017-10-14
19806,511552,Shortage,SANDOMIGRAN DS,PALADIN LABS INC,Sandomigran,PIZOTIFEN,1MG,100 tablets,ORAL,Resolved,TABLET,N02CX,ANTIMIGRAINE PREPARATIONS,2019-04-24,,,2019-04-24,Disruption of the manufacture of the drug.,2017-08-18,2019-04-25
29082,2288109,Shortage,SANDOZ ALENDRONATE,SANDOZ CANADA INCORPORATED,ALENDRONATE,ALENDRONIC ACID,70MG,BLISTERS 4'S,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-09-28,2017-11-27,2017-11-24,Delay in shipping of the drug.,2017-11-14,2017-11-27
29085,2429160,Shortage,SANDOZ ALENDRONATE/CHOLECALCIFEROL,SANDOZ CANADA INCORPORATED,ALENDRONATE VITAMIN D,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,BLISTERS 4'S,ORAL,Resolved,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-11-01,2018-06-08,2018-06-04,Demand increase for the drug.,2017-11-14,2018-07-03
14659,2405334,Shortage,SANDOZ ALMOTRIPTAN,SANDOZ CANADA INCORPORATED,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,BLISTERS OF 6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-07-03,2017-09-20,2017-09-25,Delay in shipping of the drug.,2017-07-05,2017-10-25
74593,2405334,Shortage,SANDOZ ALMOTRIPTAN,SANDOZ CANADA INCORPORATED,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,1X6/Bl,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-02-04,2019-03-08,2019-03-05,Delay in shipping of the drug.,2019-02-04,2019-03-13
55564,2243836,Shortage,SANDOZ AMIODARONE,SANDOZ CANADA INCORPORATED,ESTRADIOL,AMIODARONE HYDROCHLORIDE,200MG,100S,ORAL,Resolved,TABLET,C01BD,"ANTIARRHYTHMICS, CLASS I AND III",,2018-07-06,2018-07-27,2018-07-30,Requirements related to complying with good manufacturing practices.,2018-07-12,2018-08-13
2857,2284391,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,10MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-14,2017-04-07,2017-04-07,Demand increase for the drug.,2017-03-15,2017-04-11
2860,2284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-14,2017-05-01,2017-05-14,Demand increase for the drug.,2017-03-15,2017-05-15
2674,2284391,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,10MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-14,2017-04-07,2017-05-22,Demand increase for the drug.,2017-03-14,2017-06-26
2677,2284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-03-14,2017-04-14,2017-04-11,Demand increase for the drug.,2017-03-14,2017-04-12
88393,2457326,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,20MG,100s,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-07-03,,2019-09-06,Delay in shipping of the drug.,2019-07-03,2019-09-10
74599,2457318,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,3.75MG  3.75MG  3.75MG  3.75MG,100/Btl,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-01-28,2019-06-17,2019-06-19,Demand increase for the drug.,2019-02-04,2019-06-28
74605,2457334,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,6.25MG  6.25MG  6.25MG  6.25MG,100/Btl,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-01-28,2019-03-25,2019-02-08,Demand increase for the drug.,2019-02-04,2019-02-12
91506,2457288,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-08-05,,2019-09-09,Delay in shipping of the drug.,2019-08-14,2019-09-10
59546,2457326,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,5MG  5MG  5MG  5MG,100S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-09-17,2018-12-14,2018-11-02,Demand increase for the drug.,2018-08-29,2018-11-04
59549,2457342,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,7.5MG  7.5MG  7.5MG  7.5MG,100S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-09-17,2018-12-17,2018-12-31,Demand increase for the drug.,2018-08-29,2019-01-16
9451,2457318,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,SANDOZ AMPHETAMINE XR,DEXTROAMPHETAMINE SACCHARATE  DEXTROAMPHETAMINE SULFATE  AMPHETAMINE ASPARTATE MONOHYDRATE  AMPHETAMINE SULFATE,3.75MG  3.75MG  3.75MG  3.75MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-05-05,2017-07-17,2017-07-31,Delay in shipping of the drug.,2017-05-08,2017-09-07
16716,2260107,Shortage,SANDOZ ANAGRELIDE,SANDOZ CANADA INCORPORATED,ANAGRELIDE,ANAGRELIDE,0.5MG,100,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2017-07-21,2017-08-21,2017-08-11,Delay in shipping of the drug.,2017-07-24,2017-09-06
48791,2260107,Shortage,SANDOZ ANAGRELIDE,SANDOZ CANADA INCORPORATED,ANAGRELIDE,ANAGRELIDE,0.5MG,100S,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-05-04,2018-09-03,2018-09-03,Demand increase for the drug.,2018-05-07,2018-09-10
9454,2338467,Shortage,SANDOZ ANASTROZOLE,SANDOZ CANADA INCORPORATED,SANDOZ ANASTAZOLE,ANASTROZOLE,1MG,3X10BP,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-05-05,,2017-05-12,Delay in shipping of the drug.,2017-05-08,2017-05-15
38706,2386437,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,25MG,30'S,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-01-01,2018-03-30,2018-03-16,Demand increase for the drug.,2018-02-06,2018-04-13
16719,2386437,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,25MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-07-28,2017-11-27,2017-10-27,Demand increase for the drug.,2017-07-24,2017-11-27
16722,2386445,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-07-28,2018-02-05,2018-01-26,Demand increase for the drug.,2017-07-24,2018-02-05
16728,2386453,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-07-28,2018-05-04,2018-04-26,Demand increase for the drug.,2017-07-24,2018-05-03
16731,2386461,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,80MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-07-28,2018-02-05,2018-01-26,Demand increase for the drug.,2017-07-24,2018-02-05
79506,2386410,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,10MG,30 cap,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-03-18,2019-10-07,2019-09-23,Delay in shipping of the drug.,2019-03-26,2019-10-15
5558,2386445,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-31,2017-04-24,2017-04-11,Demand increase for the drug.,2017-04-05,2017-04-12
5562,2386453,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-03-31,2017-04-24,2017-04-13,Demand increase for the drug.,2017-04-05,2017-04-18
21261,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-01,2017-09-22,2017-09-22,Demand increase for the drug.,2017-09-07,2017-10-25
29088,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,80MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-13,2017-11-27,2017-11-24,Demand increase for the drug.,2017-11-14,2017-11-27
93358,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,80MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-19,2019-09-13,2019-09-09,Delay in shipping of the drug.,2019-09-10,2019-09-25
62920,2324946,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,10MG,3 X 10 BLISTERS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-27,2018-10-19,2018-10-19,Demand increase for the drug.,2018-10-03,2018-10-20
62923,2324954,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,20MG,3 X 10 BLISTERS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-27,2018-10-19,2018-10-19,Demand increase for the drug.,2018-10-03,2018-10-20
62926,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,80MG,3 X 10 BLISTERS,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-27,2019-01-14,2019-01-14,Demand increase for the drug.,2018-10-03,2019-01-16
9457,2324954,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,SANDOZ ATORVASTATIN,ATORVASTATIN,20MG,3X10,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-05,2017-05-22,2017-05-16,Delay in shipping of the drug.,2017-05-08,2017-06-26
9461,2324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,SANDOZ ATORVASTATIN,ATORVASTATIN,80MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-05,2017-09-22,2017-09-22,Delay in shipping of the drug.,2017-05-08,2017-10-25
93361,2332396,Shortage,SANDOZ AZITHROMYCIN,SANDOZ CANADA INCORPORATED,AZITHROMYCIN,AZITHROMYCIN,200MG,37.5ml,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-08-26,2019-09-16,2019-09-16,Demand increase for the drug.,2019-09-10,2019-09-25
83757,2247439,Shortage,SANDOZ BISOPROLOL,SANDOZ CANADA INCORPORATED,BISOPROLOL,BISOPROLOL FUMARATE,5MG,Bottle of 100s,ORAL,Actual shortage,TABLET,C07AB,BETA BLOCKING AGENTS,,2019-07-04,2020-02-03,,Disruption of the manufacture of the drug.,2019-05-10,2019-10-29
83760,2247440,Shortage,SANDOZ BISOPROLOL,SANDOZ CANADA INCORPORATED,BISOPROLOL,BISOPROLOL FUMARATE,10MG,Bottle of 100s,ORAL,Anticipated shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2019-12-30,,2020-02-03,,Disruption of the manufacture of the drug.,2019-05-10,2019-10-29
38711,2386275,Shortage,SANDOZ BOSENTAN,SANDOZ CANADA INCORPORATED,BOSENTAN,BOSENTAN,62.5MG,4X15'S,ORAL,Resolved,TABLET,C02KX,OTHER ANTIHYPERTENSIVES,,2018-01-19,2018-03-02,2018-03-23,Delay in shipping of the drug.,2018-02-06,2018-04-13
41626,2305429,Shortage,SANDOZ BRIMONIDINE,SANDOZ CANADA INCORPORATED,BRIMONIDINE,BRIMONIDINE TARTRATE,0.2%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2018-03-05,2018-03-16,2018-05-18,2018-05-04,Requirements related to complying with good manufacturing practices.,2018-03-02,2018-05-23
64200,2305429,Shortage,SANDOZ BRIMONIDINE,SANDOZ CANADA INCORPORATED,BRIMONIDINE Oph,BRIMONIDINE TARTRATE,0.2%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01EA,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-07-27,2018-10-26,2018-10-26,Delay in shipping of the drug.,2018-10-15,2018-10-29
29091,2275082,Shortage,SANDOZ BUPROPION SR,SANDOZ CANADA INCORPORATED,BUPROPION,BUPROPION HYDROCHLORIDE,150MG,60'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2017-10-23,2017-11-20,2017-11-17,Delay in shipping of the drug.,2017-11-14,2017-11-27
21267,2417340,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-09-01,2017-09-11,2017-09-08,Delay in shipping of the drug.,2017-09-07,2017-09-09
21270,2326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-09-01,2017-09-18,2017-09-11,Delay in shipping of the drug.,2017-09-07,2017-10-25
21274,2326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-09-01,2017-09-11,2017-09-11,Delay in shipping of the drug.,2017-09-07,2017-09-12
70461,2326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANSESARTAN,CANDESARTAN CILEXETIL,4MG,3X10/Bl,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-09-20,2019-12-06,,Requirements related to complying with good manufacturing practices.,2018-12-24,2019-11-18
70464,2326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,3X10/Bl,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-09-20,2019-12-06,,Requirements related to complying with good manufacturing practices.,2018-12-24,2019-11-18
79513,2326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30 TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-26,2019-11-18
73116,2326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-09-20,2019-12-06,,Disruption of the manufacture of the drug.,2019-01-22,2019-11-18
79516,2326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,500 TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-26,2019-11-18
79519,2417340,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100 TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-26,2019-11-18
79524,2326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100 TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-26,2019-11-18
29094,2326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,BLISTERS 3 X 10'S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-10-20,2017-11-20,2017-11-16,Demand increase for the drug.,2017-11-14,2017-11-27
79529,2326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100 TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-26,2019-11-18
79532,2326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,500 TAB,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-26,2019-11-18
5565,2326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-04-03,2017-04-24,2017-05-05,Delay in shipping of the drug.,2017-04-05,2017-05-08
55561,2420740,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100S,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-07-06,2018-08-24,2018-08-17,Delay in shipping of the drug.,2018-07-12,2018-08-23
29198,2420732,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,100'S,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-11-09,2018-01-11,2018-01-11,Delay in shipping of the drug.,2017-11-14,2018-01-18
29201,2420740,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN HCT,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100'S,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-11-09,2018-03-02,2018-03-23,Requirements related to complying with good manufacturing practices.,2017-11-14,2018-03-24
76110,2420732,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-02-04,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-11-18
73123,2327902,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-01,2019-12-06,,Disruption of the manufacture of the drug.,2019-01-22,2019-11-18
73126,2327902,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-01,2019-12-06,,Disruption of the manufacture of the drug.,2019-01-22,2019-11-18
75449,2420740,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,25MG  32MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-01,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-12,2019-11-18
2863,2421917,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,CAPECITABINE,CAPECITABINE,150MG,60,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017-03-14,2017-11-01,2017-10-30,Disruption of the manufacture of the drug.,2017-03-15,2017-11-06
88879,2421925,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,CAPECITABINE,CAPECITABINE,500MG,120s,ORAL,Actual shortage,TABLET,L01BC,ANTIMETABOLITES,,2019-06-28,2019-11-25,,Delay in shipping of the drug.,2019-07-08,2019-10-29
2866,2421925,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,CAPECITABINE,CAPECITABINE,500MG,120,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017-03-14,2017-04-14,2017-04-13,Demand increase for the drug.,2017-03-15,2017-04-18
2680,2421925,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,Sandoz CAPECITABINE,CAPECITABINE,500MG,12x10Bl,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017-03-14,2017-04-14,2017-04-13,Disruption of the manufacture of the drug.,2017-03-14,2017-04-18
79543,2421925,Shortage,SANDOZ CAPECITABINE,SANDOZ CANADA INCORPORATED,CAPECITABINE,CAPECITABINE,500MG,12 x 10BL,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2019-03-18,2019-04-01,2019-03-28,Delay in shipping of the drug.,2019-03-26,2019-04-17
73846,2302187,Shortage,SANDOZ CEFPROZIL,SANDOZ CANADA INCORPORATED,CEFPROZIL,CEFPROZIL,500MG,100,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,2019-04-30,2019-03-18,,2019-07-08,Requirements related to complying with good manufacturing practices.,2019-01-30,2019-07-16
73849,2302179,Shortage,SANDOZ CEFPROZIL,SANDOZ CANADA INCORPORATED,CEFPROZIL,CEFPROZIL,250MG,100,ORAL,Actual shortage,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,2019-04-30,,,,Requirements related to complying with good manufacturing practices.,2019-01-30,2019-05-01
44765,2302187,Shortage,SANDOZ CEFPROZIL,SANDOZ CANADA INCORPORATED,CEFPROZIL,CEFPROZIL,500MG,100 TABLETS,ORAL,Resolved,TABLET,J01DC,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-03-23,2018-06-01,2018-06-01,Requirements related to complying with good manufacturing practices.,2018-04-03,2018-07-03
44808,2248757,Shortage,SANDOZ CIPROFLOXACIN,SANDOZ CANADA INCORPORATED,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100 TABLETS,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-03-23,2018-05-11,2018-05-08,Demand increase for the drug.,2018-04-03,2018-05-23
83226,2248170,Shortage,SANDOZ CITALOPRAM,SANDOZ CANADA INCORPORATED,CITALOPRAM,CITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-04-15,2019-05-13,2019-05-17,Delay in shipping of the drug.,2019-05-07,2019-06-28
14876,2248170,Shortage,SANDOZ CITALOPRAM,SANDOZ CANADA INCORPORATED,CITALOPRAM,CITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-07-03,2017-08-14,2017-08-21,Demand increase for the drug.,2017-07-06,2017-09-06
48794,2248170,Shortage,SANDOZ CITALOPRAM,SANDOZ CANADA INCORPORATED,CITALOPRAM,CITALOPRAM,20MG,100S,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-05-04,2018-06-01,2018-06-01,Demand increase for the drug.,2018-05-07,2018-07-03
63290,2359316,Shortage,SANDOZ CLOPIDOGREL,SANDOZ CANADA INCORPORATED,CLOPIDOGREL,CLOPIDOGREL,75MG,500 tab,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2018-09-13,2019-03-04,2019-03-08,Delay in shipping of the drug.,2018-10-04,2019-03-13
70467,2359316,Shortage,SANDOZ CLOPIDOGREL,SANDOZ CANADA INCORPORATED,CLOPIDOGREL,CLOPIDOGREL,75MG,100 Tab,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2018-12-10,2019-03-04,2019-03-08,Delay in shipping of the drug.,2018-12-24,2019-03-13
72994,287873,Shortage,SANDOZ COLCHICINE,SANDOZ CANADA INCORPORATED,COLCHICINE,COLCHICINE,0.6MG,100,ORAL,Resolved,TABLET,M04AC,ANTIGOUT PREPARATIONS,,2018-12-10,2019-03-21,2019-03-22,Delay in shipping of the drug.,2019-01-18,2019-04-17
74753,2247073,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,25MG,30,ORAL,Resolved,CAPSULE,L04AD,IMMUNOSUPPRESSANTS,,2019-01-07,2019-06-03,2019-05-28,Demand increase for the drug.,2019-02-04,2019-05-29
21277,2247074,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,50MG,3X10,ORAL,Resolved,CAPSULE,L04AD,IMMUNOSUPPRESSANTS,,2017-09-01,2017-09-17,2017-09-30,Delay in shipping of the drug.,2017-09-07,2017-10-18
39984,2242821,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,100MG,100S,ORAL,Resolved,CAPSULE,L04AD,IMMUNOSUPPRESSANTS,,2018-02-09,2018-03-02,2018-03-02,Delay in shipping of the drug.,2018-02-15,2018-04-13
26256,2247074,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,50MG,30,ORAL,Resolved,CAPSULE,L04AD,IMMUNOSUPPRESSANTS,2017-11-15,2017-12-11,2018-01-31,2018-02-01,Delay in shipping of the drug.,2017-10-18,2018-02-05
96420,2247074,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,50MG,30,ORAL,Resolved,CAPSULE,L04AD,IMMUNOSUPPRESSANTS,,2019-09-23,2019-11-08,2019-10-28,Delay in shipping of the drug.,2019-10-15,2019-11-06
74629,2261774,Shortage,SANDOZ DICLOFENAC RAPIDE,SANDOZ CANADA INCORPORATED,DICLOFENAC,DICLOFENAC POTASSIUM,50MG,100,ORAL,Resolved,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-01-03,2019-03-25,2019-03-25,Delay in shipping of the drug.,2019-02-04,2019-05-07
39987,2243341,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,300MG,100S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-02-09,2019-10-07,2019-10-07,Delay in shipping of the drug.,2018-02-15,2019-10-15
2881,2243340,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-14,2017-03-31,2017-03-17,Demand increase for the drug.,2017-03-15,2017-03-21
59502,2243338,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,100S,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-06-08,2019-12-13,,Disruption of the manufacture of the drug.,2018-08-29,2019-10-15
59505,2243339,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,180MG,100S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-06-08,2019-10-07,2019-10-07,Disruption of the manufacture of the drug.,2018-08-29,2019-10-15
2699,2243340,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,240MG,100/BTL,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-03-14,2017-03-31,2017-03-17,Disruption of the manufacture of the drug.,2017-03-14,2017-03-21
44770,2243340,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM HYDROCHLORIDE,DILTIAZEM HYDROCHLORIDE,240MG,100 TABLETS,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-03-23,2018-05-18,2018-04-27,Delay in shipping of the drug.,2018-04-03,2018-05-23
63463,2243340,Shortage,SANDOZ DILTIAZEM CD,SANDOZ CANADA INCORPORATED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,240MG,100 cap,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-06-01,2019-10-07,2019-10-07,Requirements related to complying with good manufacturing practices.,2018-10-09,2019-10-15
14879,2245922,Shortage,SANDOZ DILTIAZEM T,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,360MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-07-03,,,Demand increase for the drug.,2017-07-06,2018-12-21
38703,2245918,Shortage,SANDOZ DILTIAZEM T,SANDOZ CANADA INCORPORATED,DILTIAZEM T,DILTIAZEM HYDROCHLORIDE,120MG,100'S,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-01-04,,,Disruption of the manufacture of the drug.,2018-02-06,2018-07-03
59528,2245920,Shortage,SANDOZ DILTIAZEM T,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,240MG,100S,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-08-01,,,Disruption of the manufacture of the drug.,2018-08-29,2018-08-29
59531,2245921,Shortage,SANDOZ DILTIAZEM T,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,300MG,100S,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-08-01,,,Disruption of the manufacture of the drug.,2018-08-29,2018-08-29
29100,2245919,Shortage,SANDOZ DILTIAZEM T,SANDOZ CANADA INCORPORATED,DILTIAZEM T,DILTIAZEM HYDROCHLORIDE,180MG,100'S,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-10-02,,,Delay in shipping of the drug.,2017-11-14,2018-08-13
83304,392553,Shortage,SANDOZ DIMENHYDRINATE,SANDOZ CANADA INCORPORATED,DIMENHYDRINATE,DIMENHYDRINATE,50MG,10,RECTAL,Resolved,SUPPOSITORY,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2019-05-03,2019-05-13,2019-05-24,Delay in shipping of the drug.,2019-05-07,2019-06-28
21281,2367688,Shortage,SANDOZ DONEPEZIL ODT,SANDOZ CANADA INCORPORATED,DONEPEZIL ODT,DONEPEZIL HYDROCHLORIDE,5MG,3X10BL,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N06DA,ANTI-DEMENTIA DRUGS,,2017-09-01,2018-05-11,2018-05-18,Delay in shipping of the drug.,2017-09-07,2018-05-23
76174,2367696,Shortage,SANDOZ DONEPEZIL ODT,SANDOZ CANADA INCORPORATED,DONEPEZIL ODT,DONEPEZIL HYDROCHLORIDE,10MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N06DA,ANTI-DEMENTIA DRUGS,,2019-02-12,,,Demand increase for the drug.,2019-02-18,2019-02-18
76177,2367688,Shortage,SANDOZ DONEPEZIL ODT,SANDOZ CANADA INCORPORATED,DONEPEZIL ODT,DONEPEZIL HYDROCHLORIDE,5MG,30,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N06DA,ANTI-DEMENTIA DRUGS,,2019-02-11,,,Demand increase for the drug.,2019-02-18,2019-02-18
66347,2316307,Shortage,SANDOZ DORZOLAMIDE,SANDOZ CANADA INCORPORATED,DORZOLAMIDE,DORZOLAMIDE,20MG,5ML,OPHTHALMIC,Resolved,SOLUTION,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-11-22,2019-01-21,2019-01-18,Delay in shipping of the drug.,2018-11-07,2019-01-21
74740,2316307,Shortage,SANDOZ DORZOLAMIDE,SANDOZ CANADA INCORPORATED,DORZOLAMIDE,DORZOLAMIDE,20MG,5ml,OPHTHALMIC,Resolved,SOLUTION,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-01-21,2019-03-11,2019-03-25,Delay in shipping of the drug.,2019-02-04,2019-05-07
72487,2344351,Shortage,SANDOZ DORZOLAMIDE/TIMOLOL,SANDOZ CANADA INCORPORATED,DORZOLAMIDE/TIMOLOL,TIMOLOL  DORZOLAMIDE,5MG  20MG,10ML,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-12-14,2020-01-27,,Delay in shipping of the drug.,2019-01-16,2019-10-15
21357,2344351,Shortage,SANDOZ DORZOLAMIDE/TIMOLOL,SANDOZ CANADA INCORPORATED,DORZOLAMIDE/TIMOLOL,TIMOLOL  DORZOLAMIDE,5MG  20MG,10mLbtl,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-09-01,2017-09-19,2017-09-12,Delay in shipping of the drug.,2017-09-07,2017-10-25
39990,2439948,Shortage,SANDOZ DULOXETINE,SANDOZ CANADA INCORPORATED,DULOXETINE,DULOXETINE,30MG,100S,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-02-09,2018-06-01,2018-06-08,Demand increase for the drug.,2018-02-15,2018-07-03
39993,2439956,Shortage,SANDOZ DULOXETINE,SANDOZ CANADA INCORPORATED,DULOXETINE,DULOXETINE,60MG,100S,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-02-09,2018-05-04,2018-05-01,Demand increase for the drug.,2018-02-15,2018-05-07
29105,2439948,Shortage,SANDOZ DULOXETINE,SANDOZ CANADA INCORPORATED,DULOXETINE,DULOXETINE,30MG,100'S,ORAL,Resolved,CAPSULE (DELAYED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-10-25,2017-11-15,2017-11-15,Demand increase for the drug.,2017-11-14,2017-11-27
80177,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Actual shortage,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-03-05,2020-05-25,,Delay in shipping of the drug.,2019-04-01,2019-09-25
10295,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,SANDOZ DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-05-12,,2017-06-26,2017-08-18,Demand increase for the drug.,2017-05-15,2017-10-25
2884,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-03-14,2017-07-24,2017-08-03,Delay in shipping of the drug.,2017-03-15,2017-09-06
2702,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,3x10/Bl,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-03-14,2017-07-24,2017-07-26,Demand increase for the drug.,2017-03-14,2017-09-07
76189,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Actual shortage,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2019-02-28,2019-03-05,2020-05-25,,Delay in shipping of the drug.,2019-02-18,2019-09-25
29108,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,100'S,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-10-16,2018-03-02,2018-03-08,Demand increase for the drug.,2017-11-14,2018-04-13
29111,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,30'S,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-09-11,2018-03-09,2018-03-08,Demand increase for the drug.,2017-11-14,2018-04-13
5573,2424444,Shortage,SANDOZ DUTASTERIDE CAPSULE,SANDOZ CANADA INCORPORATED,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-03-31,2017-07-24,2017-07-26,Demand increase for the drug.,2017-04-05,2017-09-06
16736,2299976,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-07-21,2017-08-28,2017-08-21,Demand increase for the drug.,2017-07-24,2017-09-06
62935,2299933,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,2.0MG,100S,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-07-31,2018-11-30,2018-11-30,Requirements related to complying with good manufacturing practices.,2018-10-03,2018-12-05
63466,2299968,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,8.0MG,100 tab,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-09-20,2018-12-17,2018-12-31,Requirements related to complying with good manufacturing practices.,2018-10-09,2019-01-16
63469,2299976,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,16MG,100 tab,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-09-20,2018-12-21,2018-12-24,Requirements related to complying with good manufacturing practices.,2018-10-09,2019-01-16
63477,2299941,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,4.0MG,100 tab,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-09-20,2018-12-21,2018-12-31,Requirements related to complying with good manufacturing practices.,2018-10-09,2019-01-16
89376,2380005,Shortage,SANDOZ ENTACAPONE,SANDOZ CANADA INCORPORATED,ENTACAPONE,ENTACAPONE,200MG,100,ORAL,Resolved,TABLET,N04BX,DOPAMINERGIC AGENTS,,2019-06-25,2019-08-19,2019-09-30,Delay in shipping of the drug.,2019-07-16,2019-10-01
99063,2380005,Shortage,SANDOZ ENTACAPONE,SANDOZ CANADA INCORPORATED,ENTACAPONE,ENTACAPONE,200MG,100,ORAL,Actual shortage,TABLET,N04BX,DOPAMINERGIC AGENTS,,2019-11-15,2020-01-17,,Delay in shipping of the drug.,2019-11-18,2019-11-18
3863,2364077,Shortage,SANDOZ ESCITALOPRAM,SANDOZ CANADA INCORPORATED,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-03-17,2017-04-07,2017-04-13,Demand increase for the drug.,2017-03-22,2017-04-18
3866,2364077,Shortage,SANDOZ ESCITALOPRAM,SANDOZ CANADA INCORPORATED,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-03-17,2017-04-07,2017-04-13,Demand increase for the drug.,2017-03-22,2017-04-18
77648,2364085,Shortage,SANDOZ ESCITALOPRAM,SANDOZ CANADA INCORPORATED,EXCITALOPRAM,ESCITALOPRAM,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2019-02-22,2019-03-08,2019-03-08,Delay in shipping of the drug.,2019-03-05,2019-03-13
86330,2460920,Shortage,SANDOZ ESOMEPRAZOLE,SANDOZ CANADA INCORPORATED,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-07,2019-06-17,2019-06-19,Delay in shipping of the drug.,2019-06-12,2019-06-28
99066,2460939,Shortage,SANDOZ ESOMEPRAZOLE,SANDOZ CANADA INCORPORATED,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-11-11,2019-12-23,,Demand increase for the drug.,2019-11-18,2019-11-18
94642,2246967,Shortage,SANDOZ ESTRADIOL DERM 50,SANDOZ CANADA INCORPORATED,ESTRADIOL,ESTRADIOL,4MG,8,TRANSDERMAL,Actual shortage,PATCH,G03CA,ESTROGENS,,2019-09-09,2019-11-25,,Delay in shipping of the drug.,2019-09-25,2019-11-18
98030,2246968,Shortage,SANDOZ ESTRADIOL DERM 75,SANDOZ CANADA INCORPORATED,ESTRADIOL,ESTRADIOL,6MG,8TTS,TRANSDERMAL,Actual shortage,PATCH,G03CA,ESTROGENS,,2019-10-28,2019-11-22,,Delay in shipping of the drug.,2019-11-06,2019-11-06
3869,2416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-17,2017-04-07,2017-04-04,Demand increase for the drug.,2017-03-22,2017-04-04
5576,2416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,30,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-31,2017-05-29,2017-05-23,Requirements related to complying with good manufacturing practices.,2017-04-05,2017-10-25
62938,2416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,100S,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2018-09-24,2018-10-19,2018-10-19,Delay in shipping of the drug.,2018-10-03,2018-10-20
90830,2278634,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,FAMCICLOVIR,FAMCICLOVIR,125MG,10,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-31,2019-12-02,,Disruption of the manufacture of the drug.,2019-08-06,2019-10-29
90840,2278642,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,FAMCICLOVIR,FAMCICLOVIR,250MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-31,2019-12-02,,Disruption of the manufacture of the drug.,2019-08-06,2019-10-29
90843,2278642,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,FAMCICLOVIR,FAMCICLOVIR,250MG,30,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-31,2019-12-02,,Disruption of the manufacture of the drug.,2019-08-06,2019-10-29
90846,2278650,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,FAMCICLOVIR,FAMCICLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-31,2019-12-02,,Disruption of the manufacture of the drug.,2019-08-06,2019-10-29
90849,2278650,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,FAMCICLOVIR,FAMCICLOVIR,500MG,21,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-07-31,2019-12-02,,Disruption of the manufacture of the drug.,2019-08-06,2019-10-29
9467,2278634,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,SANDOZ FAMCICLOVIR,FAMCICLOVIR,125MG,1X10,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-05-05,,2017-05-15,Delay in shipping of the drug.,2017-05-08,2017-05-16
9470,2278650,Shortage,SANDOZ FAMCICLOVIR,SANDOZ CANADA INCORPORATED,SANDOZ FAMCICLOVIR,FAMCICLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-05-05,2017-05-15,2017-06-02,Delay in shipping of the drug.,2017-05-08,2017-06-06
89379,2390698,Shortage,SANDOZ FENOFIBRATE E,SANDOZ CANADA INCORPORATED,FENOFIBRATE E,FENOFIBRATE,48.0MG,30,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-11,2019-10-07,2019-10-03,Delay in shipping of the drug.,2019-07-16,2019-10-15
67590,2288052,Shortage,SANDOZ FENOFIBRATE S,SANDOZ CANADA INCORPORATED,FENOFIBRATE,FENOFIBRATE,160MG,90,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2018-12-07,,2019-01-28,2018-12-11,Demand increase for the drug.,2018-11-26,2018-12-13
38716,2288044,Shortage,SANDOZ FENOFIBRATE S,SANDOZ CANADA INCORPORATED,FENOFIBRATE,FENOFIBRATE,100MG,90'S,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-22,2018-05-04,2018-04-19,Demand increase for the drug.,2018-02-06,2018-05-07
38719,2288052,Shortage,SANDOZ FENOFIBRATE S,SANDOZ CANADA INCORPORATED,FENOFIBRATE,FENOFIBRATE,160MG,90'S,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-12-22,2018-05-04,2018-04-19,Demand increase for the drug.,2018-02-06,2018-05-07
16739,2288052,Shortage,SANDOZ FENOFIBRATE S,SANDOZ CANADA INCORPORATED,FENOFIBRATE,FENOFIBRATE,160MG,90,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2017-07-21,2017-09-18,2017-08-28,Delay in shipping of the drug.,2017-07-24,2017-09-06
74634,2288044,Shortage,SANDOZ FENOFIBRATE S,SANDOZ CANADA INCORPORATED,FENOFIBRATE,FENOFIBRATE,100MG,90,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2018-12-03,2019-09-30,2019-09-20,Demand increase for the drug.,2019-02-04,2019-10-15
85176,2288052,Shortage,SANDOZ FENOFIBRATE S,SANDOZ CANADA INCORPORATED,FENOFIBRATE S,FENOFIBRATE,160MG,90,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2019-05-15,2019-08-12,2019-08-05,Demand increase for the drug.,2019-05-29,2019-09-25
89384,2322579,Shortage,SANDOZ FINASTERIDE,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Actual shortage,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-06-11,2020-05-08,,Delay in shipping of the drug.,2019-07-16,2019-10-15
89387,2322579,Shortage,SANDOZ FINASTERIDE,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,5MG,500,ORAL,Actual shortage,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-05-28,2020-05-08,,Requirements related to complying with good manufacturing practices.,2019-07-16,2019-10-15
76129,2322579,Shortage,SANDOZ FINASTERIDE,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,5MG,500,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-02-11,2019-02-25,2019-02-20,Demand increase for the drug.,2019-02-18,2019-03-05
13929,2322579,Shortage,SANDOZ FINASTERIDE,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-06-23,2017-07-14,2017-08-11,Delay in shipping of the drug.,2017-06-26,2017-09-07
99069,2322579,Shortage,SANDOZ FINASTERIDE,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,5MG,30,ORAL,Actual shortage,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-11-04,2019-12-20,,Delay in shipping of the drug.,2019-11-18,2019-11-18
74637,2339471,Shortage,SANDOZ FINASTERIDE A,SANDOZ CANADA INCORPORATED,FINASTERIDE A,FINASTERIDE,1MG,100,ORAL,Resolved,TABLET,D11AX,OTHER DERMATOLOGICAL PREPARATIONS,,2019-02-01,2019-02-25,2019-02-20,Requirements related to complying with good manufacturing practices.,2019-02-04,2019-03-05
83229,2285673,Shortage,SANDOZ FOLIC ACID,SANDOZ CANADA INCORPORATED,FOLIC ACID,FOLIC ACID,5MG,100 TAB,ORAL,Resolved,TABLET,B03BB,VITAMIN B12 AND FOLIC ACID,,2019-04-15,2019-05-17,2019-05-17,Demand increase for the drug.,2019-05-07,2019-05-29
9473,2269589,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,SANDOZ GLIMEPIRIDE,GLIMEPIRIDE,1MG,3X10,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-05-05,2017-07-17,2017-07-06,Delay in shipping of the drug.,2017-05-08,2017-09-06
83232,2269589,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,1MG,30,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-04-08,2019-08-12,2019-09-06,Requirements related to complying with good manufacturing practices.,2019-05-07,2019-09-10
80182,2269597,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,2MG,3X10,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-02-25,2019-08-12,2019-09-06,Demand increase for the drug.,2019-04-01,2019-09-10
80185,2269619,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,4MG,3X10,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-02-25,2019-08-12,2019-09-06,Demand increase for the drug.,2019-04-01,2019-09-10
38722,2269589,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,1MG,30'S,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-01-26,2018-03-02,2018-03-23,Demand increase for the drug.,2018-02-06,2018-03-24
38725,2269597,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,2MG,30'S,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-01-26,2018-03-02,2018-03-23,Demand increase for the drug.,2018-02-06,2018-03-24
38728,2269619,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,4MG,30'S,ORAL,Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-01-26,2018-07-30,2018-07-30,Demand increase for the drug.,2018-02-06,2018-08-13
80205,2328488,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-04-01,2019-11-18
80210,2328496,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-04-01,2019-11-18
74642,2328488,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,150MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-01,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-04,2019-11-18
78500,2328496,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,300MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-01,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-13,2019-11-18
29114,2328461,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,75MG,100'S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-11-03,2017-11-20,2017-11-22,Delay in shipping of the drug.,2017-11-14,2017-11-27
75492,2328461,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-01,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-12,2019-11-18
21284,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,500,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-09-01,2017-09-26,2017-09-15,Delay in shipping of the drug.,2017-09-07,2017-10-25
80194,2337436,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,500,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-04-01,2019-11-18
80197,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-04-01,2019-11-18
2887,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,500,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-03-14,2017-04-28,2017-05-05,Delay in shipping of the drug.,2017-03-15,2017-05-08
80200,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,500,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-04-01,2019-11-18
77655,2337436,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-01,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-03-05,2019-11-18
2705,2337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,500/Btl,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-03-14,2017-04-30,2017-05-05,Delay in shipping of the drug.,2017-03-14,2017-05-08
73141,2337428,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-29,2019-12-06,,Demand increase for the drug.,2019-01-22,2019-11-18
73144,2337428,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,500,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-29,2019-12-06,,Demand increase for the drug.,2019-01-22,2019-11-18
73852,2474670,Shortage,SANDOZ LACOSAMIDE,SANDOZ CANADA INCORPORATED,LACOSAMIDE,LACOSAMIDE,50MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-01-30,2019-04-26,2019-04-29,Demand increase for the drug.,2019-01-30,2019-05-01
73855,2474700,Shortage,SANDOZ LACOSAMIDE,SANDOZ CANADA INCORPORATED,LACOSAMIDE,LACOSAMIDE,200MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-01-25,2019-04-26,2019-04-29,Demand increase for the drug.,2019-01-30,2019-05-01
73858,2474689,Shortage,SANDOZ LACOSAMIDE,SANDOZ CANADA INCORPORATED,LACOSAMIDE,LACOSAMIDE,100MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-01-25,2019-04-26,2019-04-29,Demand increase for the drug.,2019-01-30,2019-05-01
77662,2385651,Shortage,SANDOZ LANSOPRAZOLE,SANDOZ CANADA INCORPORATED,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-02-28,2019-12-30,,Demand increase for the drug.,2019-03-05,2019-10-15
46761,2385643,Shortage,SANDOZ LANSOPRAZOLE,SANDOZ CANADA INCORPORATED,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100S,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-04-23,2018-04-26,2018-07-20,2018-07-23,Requirements related to complying with good manufacturing practices.,2018-04-20,2018-08-13
44775,2367335,Shortage,SANDOZ LATANOPROST,SANDOZ CANADA INCORPORATED,LATANOPROST,LATANOPROST,50MCG,LIQUID DROP,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-03-23,2018-06-08,2018-06-07,Delay in shipping of the drug.,2018-04-03,2018-07-03
76180,2394685,Shortage,SANDOZ LATANOPROST/TIMOLOL,SANDOZ CANADA INCORPORATED,Latano/Timo,TIMOLOL  LATANOPROST,5MG  50MCG,2.5ml,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-02-04,,,Demand increase for the drug.,2019-02-18,2019-02-18
80755,2461986,Shortage,SANDOZ LEVETIRACETAM,SANDOZ CANADA INCORPORATED,LEVETIRACETAM,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-04-08,2019-08-26,2019-08-26,Requirements related to complying with good manufacturing practices.,2019-04-08,2019-09-25
29117,2461994,Shortage,SANDOZ LEVETIRACETAM,SANDOZ CANADA INCORPORATED,LEVETIRACETAM,LEVETIRACETAM,500MG,100'S,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-10-16,2018-03-05,2018-03-27,Delay in shipping of the drug.,2017-11-14,2018-04-13
85199,2462001,Shortage,SANDOZ LEVETIRACETAM,SANDOZ CANADA INCORPORATED,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-05-08,2019-08-26,2019-08-26,Delay in shipping of the drug.,2019-05-29,2019-09-25
96465,2461994,Shortage,SANDOZ LEVETIRACETAM,SANDOZ CANADA INCORPORATED,LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-09-23,2019-11-15,2019-10-30,Delay in shipping of the drug.,2019-10-15,2019-11-06
39996,2298635,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,250MG,50S,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-02-09,2018-07-13,2018-07-06,Demand increase for the drug.,2018-02-15,2018-07-13
39999,2298643,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100S,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-02-09,2018-07-20,2018-07-27,Demand increase for the drug.,2018-02-15,2018-08-13
40002,2298651,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,750MG,50S,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-02-09,2018-07-20,2018-07-27,Demand increase for the drug.,2018-02-15,2018-08-13
74651,2298643,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2019-01-07,2019-04-15,2019-04-22,Demand increase for the drug.,2019-02-04,2019-05-07
63480,2298635,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,250MG,50 tab,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-09-04,2019-04-15,2019-04-22,Demand increase for the drug.,2018-10-09,2019-05-07
63483,2298643,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 tab,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-09-04,2019-01-07,2019-01-15,Demand increase for the drug.,2018-10-09,2019-01-16
2890,2289199,Shortage,SANDOZ LISINOPRIL,SANDOZ CANADA INCORPORATED,LISINOPRIL,LISINOPRIL,5MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-14,,2017-04-28,Delay in shipping of the drug.,2017-03-15,2017-04-29
2708,2289199,Shortage,SANDOZ LISINOPRIL,SANDOZ CANADA INCORPORATED,LISINOPRIL,LISINOPRIL,5MG,2x15/Bl,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-03-14,2017-04-30,2017-05-05,Delay in shipping of the drug.,2017-03-14,2017-05-08
94614,2302381,Shortage,SANDOZ LISINOPRIL HCT,SANDOZ CANADA INCORPORATED,LISINO+HCT,HYDROCHLOROTHIAZIDE  LISINOPRIL,25MG  20MG,100 tab,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-09-09,2020-02-24,,Requirements related to complying with good manufacturing practices.,2019-09-25,2019-09-25
93394,2302365,Shortage,SANDOZ LISINOPRIL HCT,SANDOZ CANADA INCORPORATED,LISINO+HCT,HYDROCHLOROTHIAZIDE  LISINOPRIL,12.5MG  10MG,100,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-08-05,2020-02-24,,Requirements related to complying with good manufacturing practices.,2019-09-10,2019-09-25
96468,2302365,Shortage,SANDOZ LISINOPRIL HCT,SANDOZ CANADA INCORPORATED,LISINO+HCT,HYDROCHLOROTHIAZIDE  LISINOPRIL,12.5MG  10MG,30,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-09-19,2020-02-24,,Requirements related to complying with good manufacturing practices.,2019-10-15,2019-10-15
98005,2302373,Shortage,SANDOZ LISINOPRIL HCT,SANDOZ CANADA INCORPORATED,LISINO+HCT,HYDROCHLOROTHIAZIDE  LISINOPRIL,12.5MG  20MG,100 tablets,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-10-28,2020-02-24,,Requirements related to complying with good manufacturing practices.,2019-11-06,2019-11-06
96471,2302381,Shortage,SANDOZ LISINOPRIL HCT,SANDOZ CANADA INCORPORATED,LISINO+HCT,HYDROCHLOROTHIAZIDE  LISINOPRIL,25MG  20MG,30,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-09-17,2020-02-24,,Requirements related to complying with good manufacturing practices.,2019-10-15,2019-10-15
21287,2313340,Shortage,SANDOZ LOSARTAN,SANDOZ CANADA INCORPORATED,LOSARTAN,LOSARTAN POTASSIUM,50MG,3X10BL,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-09-01,2017-10-09,2017-10-06,Delay in shipping of the drug.,2017-09-07,2017-10-25
73164,2313340,Shortage,SANDOZ LOSARTAN,SANDOZ CANADA INCORPORATED,LOSARTAN,LOSARTAN POTASSIUM,50MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73167,2313340,Shortage,SANDOZ LOSARTAN,SANDOZ CANADA INCORPORATED,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73170,2313332,Shortage,SANDOZ LOSARTAN,SANDOZ CANADA INCORPORATED,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73173,2313359,Shortage,SANDOZ LOSARTAN,SANDOZ CANADA INCORPORATED,LOSARTAN,LOSARTAN POTASSIUM,100MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73176,2313359,Shortage,SANDOZ LOSARTAN,SANDOZ CANADA INCORPORATED,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
44734,2362449,Shortage,SANDOZ LOSARTAN HCT,SANDOZ CANADA INCORPORATED,LOSARTAN Hydrochlorothiazide,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100 TABLETS,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-03-23,2018-05-31,2018-06-14,Demand increase for the drug.,2018-04-03,2018-07-03
73152,2362449,Shortage,SANDOZ LOSARTAN HCT,SANDOZ CANADA INCORPORATED,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-08,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73155,2362449,Shortage,SANDOZ LOSARTAN HCT,SANDOZ CANADA INCORPORATED,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73158,2313375,Shortage,SANDOZ LOSARTAN HCT,SANDOZ CANADA INCORPORATED,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73161,2313375,Shortage,SANDOZ LOSARTAN HCT,SANDOZ CANADA INCORPORATED,LOSARTAN HCT,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  50MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73179,2313383,Shortage,SANDOZ LOSARTAN HCT DS,SANDOZ CANADA INCORPORATED,LOSARTAN HCT DS,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
73182,2313383,Shortage,SANDOZ LOSARTAN HCT DS,SANDOZ CANADA INCORPORATED,LOSARTAN HCT DS,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-29,,,Disruption of the manufacture of the drug.,2019-01-22,2019-01-21
91519,2375532,Shortage,SANDOZ MEMANTINE FCT,SANDOZ CANADA INCORPORATED,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06DX,ANTI-DEMENTIA DRUGS,,2019-08-05,2019-09-09,2019-09-23,Delay in shipping of the drug.,2019-08-14,2019-09-25
96474,2375532,Shortage,SANDOZ MEMANTINE FCT,SANDOZ CANADA INCORPORATED,MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,TABLET,N06DX,ANTI-DEMENTIA DRUGS,,2019-09-24,2019-11-25,,Delay in shipping of the drug.,2019-10-15,2019-10-29
74660,2303418,Shortage,SANDOZ METOPROLOL SR,SANDOZ CANADA INCORPORATED,METOPROLOL SR,METOPROLOL TARTRATE,200MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-01-28,2020-02-03,,Demand increase for the drug.,2019-02-04,2019-11-18
74929,2303396,Shortage,SANDOZ METOPROLOL SR,SANDOZ CANADA INCORPORATED,METOPROLOL SR,METOPROLOL TARTRATE,100MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C07AB,BETA BLOCKING AGENTS,,2019-02-04,2020-02-03,,Demand increase for the drug.,2019-02-06,2019-11-18
38731,2250594,Shortage,SANDOZ MIRTAZAPINE,SANDOZ CANADA INCORPORATED,MIRTAZAPINE,MIRTAZAPINE,15MG,50'S,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-01-19,2018-05-25,2018-04-27,Delay in shipping of the drug.,2018-02-06,2018-05-07
38734,2250608,Shortage,SANDOZ MIRTAZAPINE,SANDOZ CANADA INCORPORATED,MIRTAZAPINE,MIRTAZAPINE,30MG,100'S,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-01-12,2018-05-18,2018-05-04,Delay in shipping of the drug.,2018-02-06,2018-05-07
62941,2250608,Shortage,SANDOZ MIRTAZAPINE,SANDOZ CANADA INCORPORATED,MIRTAZAPINE,MIRTAZAPINE,30MG,100S,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-08-24,2018-11-23,2018-11-26,Demand increase for the drug.,2018-10-03,2018-11-27
77711,2449811,Shortage,SANDOZ MOMETASONE,SANDOZ CANADA INCORPORATED,MOMETASONE,MOMETASONE FUROATE,50MCG,140 DOSES,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-02-11,2019-03-18,2019-04-09,Requirements related to complying with good manufacturing practices.,2019-03-05,2019-04-17
74745,2449811,Shortage,SANDOZ MOMETASONE,SANDOZ CANADA INCORPORATED,MOMETASONE,MOMETASONE FUROATE,50MCG,140,NASAL,Resolved,"SPRAY, METERED DOSE",R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-01-21,2019-02-12,2019-02-11,Demand increase for the drug.,2019-02-04,2019-02-18
46800,2330393,Shortage,SANDOZ MONTELUKAST,SANDOZ CANADA INCORPORATED,MONTELUKAST CHEW,MONTELUKAST,5MG,100S,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-04-13,2018-06-15,2018-06-08,Delay in shipping of the drug.,2018-04-20,2018-07-03
16747,2328593,Shortage,SANDOZ MONTELUKAST TABLET,SANDOZ CANADA INCORPORATED,MONTELUKAST,MONTELUKAST,10MG,100,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2017-07-21,2017-08-07,2017-07-26,Requirements related to complying with good manufacturing practices.,2017-07-24,2017-09-06
44744,2328593,Shortage,SANDOZ MONTELUKAST TABLET,SANDOZ CANADA INCORPORATED,MONTELUKAST,MONTELUKAST,10MG,100 TABLETS,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-03-23,2018-05-18,2018-05-11,Requirements related to complying with good manufacturing practices.,2018-04-03,2018-05-23
29186,2411520,Shortage,SANDOZ MOXIFLOXACIN,SANDOZ CANADA INCORPORATED,MOXIFLOXACIN,MOXIFLOXACIN,0.5%,500'S,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2017-09-25,2017-11-20,2017-11-23,Demand increase for the drug.,2017-11-14,2017-11-27
81743,2411520,Shortage,SANDOZ MOXIFLOXACIN,SANDOZ CANADA INCORPORATED,MOXIFLOXACIN,MOXIFLOXACIN,0.5%,3ml,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2019-03-11,2019-05-13,2019-06-19,Delay in shipping of the drug.,2019-04-15,2019-06-28
10329,2411520,Shortage,SANDOZ MOXIFLOXACIN,SANDOZ CANADA INCORPORATED,SANDOZ MOXIFLOXACIN,MOXIFLOXACIN,0.5%,3ML BTL/BOUT,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,,2017-05-12,2017-05-22,2017-05-22,Delay in shipping of the drug.,2017-05-15,2017-06-26
45797,2411520,Shortage,SANDOZ MOXIFLOXACIN,SANDOZ CANADA INCORPORATED,MOXIFLOXACIN,MOXIFLOXACIN,0.5%,3ML,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,2018-04-10,2018-04-13,2018-05-04,2018-04-19,Delay in shipping of the drug.,2018-04-13,2018-05-07
59543,2320630,Shortage,SANDOZ MYCOPHENOLATE MOFETIL,SANDOZ CANADA INCORPORATED,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,250MG,100,ORAL,Resolved,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2018-07-27,2018-09-14,2018-08-31,Demand increase for the drug.,2018-08-29,2018-09-28
93403,2313855,Shortage,SANDOZ MYCOPHENOLATE MOFETIL,SANDOZ CANADA INCORPORATED,MYCOPHENOLAT MOFE,MYCOPHENOLATE MOFETIL,500MG,50,ORAL,Actual shortage,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2019-08-19,2019-12-30,,Demand increase for the drug.,2019-09-10,2019-11-18
93406,2320630,Shortage,SANDOZ MYCOPHENOLATE MOFETIL,SANDOZ CANADA INCORPORATED,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,250MG,50,ORAL,Actual shortage,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2019-08-19,2019-12-30,,Demand increase for the drug.,2019-09-10,2019-10-29
99100,2310376,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,7.5MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2019-11-04,2019-12-20,,Requirements related to complying with good manufacturing practices.,2019-11-18,2019-11-18
73147,2310392,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,15.0MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2019-01-15,2019-01-28,2019-01-24,Delay in shipping of the drug.,2019-01-22,2019-01-30
45803,2310368,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,5.0MG,100S,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-16,2018-05-11,2018-05-15,Demand increase for the drug.,2018-04-13,2018-05-23
45806,2310392,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,15.0MG,100S,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-16,2018-06-08,2018-06-08,Demand increase for the drug.,2018-04-13,2018-07-03
13932,2327783,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,10MG,3X10 BLISTERS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-06-23,2017-10-30,2017-10-30,Demand increase for the drug.,2017-06-26,2017-11-06
13935,2327791,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,15MG,3X10 BLISTERS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-06-23,2017-10-30,2017-10-30,Demand increase for the drug.,2017-06-26,2017-11-06
13938,2327805,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,20MG,3X10 BLISTERS,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-06-23,2017-10-30,2017-10-30,Demand increase for the drug.,2017-06-26,2017-11-27
39569,2327783,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,10MG,BLISTERS 30S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-12-05,2018-07-20,2018-07-23,Demand increase for the drug.,2018-02-13,2018-08-13
39572,2327791,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,15MG,BLISTERS 30S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,,2017-12-05,2018-07-27,2018-07-23,Demand increase for the drug.,2018-02-13,2018-08-13
45809,2327775,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,5MG,BLISTERS 30S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-04-16,,2018-07-06,2018-04-16,Delay in shipping of the drug.,2018-04-13,2018-04-19
45812,2327805,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,20MG,BLISTERS 30S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05AH,ANTIPSYCHOTICS,2018-04-16,,2018-06-15,2018-04-16,Demand increase for the drug.,2018-04-13,2018-04-19
29204,2443414,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMERSARTAN,OLMESARTAN MEDOXOMIL,20MG,BLISTERS 3 X 10'S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-11-06,2018-05-11,2018-05-18,Demand increase for the drug.,2017-11-14,2018-05-23
80934,2443414,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,20MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-16,,Requirements related to complying with good manufacturing practices.,2019-04-10,2019-09-25
80937,2443414,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,20MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2020-01-20,,Requirements related to complying with good manufacturing practices.,2019-04-10,2019-10-15
21291,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-09-01,2017-11-20,2017-10-30,Demand increase for the drug.,2017-09-07,2017-11-13
80944,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-30,,Requirements related to complying with good manufacturing practices.,2019-04-10,2019-10-15
38739,2443414,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,20MG,100'S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-01-05,2018-04-20,2018-04-06,Demand increase for the drug.,2018-02-06,2018-04-19
16750,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-07-14,2017-08-14,2017-09-04,Demand increase for the drug.,2017-07-24,2017-09-06
39578,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,100S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-12-13,2018-05-31,2018-04-20,Demand increase for the drug.,2018-02-13,2018-05-03
39581,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,30S,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-12-13,2018-05-31,2018-06-07,Demand increase for the drug.,2018-02-13,2018-07-03
74665,2443422,Shortage,SANDOZ OLMESARTAN,SANDOZ CANADA INCORPORATED,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-29,2019-12-16,,Requirements related to complying with good manufacturing practices.,2019-02-04,2019-09-25
89412,2358913,Shortage,SANDOZ OLOPATADINE,SANDOZ CANADA INCORPORATED,OLOPATADINE,OLOPATADINE,0.1%,5ml,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2019-06-24,2019-08-26,2019-09-06,Requirements related to complying with good manufacturing practices.,2019-07-16,2019-09-10
21353,2420171,Shortage,SANDOZ OLOPATADINE 0.2%,SANDOZ CANADA INCORPORATED,OLOPATADINE 0.2%,OLOPATADINE,0.2%,2.5mLbtl,OPHTHALMIC,Resolved,SOLUTION,S01GX,DECONGESTANTS AND ANTIALLERGICS,,2017-09-01,2017-09-18,2017-10-03,Demand increase for the drug.,2017-09-07,2017-10-25
2893,2296446,Shortage,SANDOZ OMEPRAZOLE,SANDOZ CANADA INCORPORATED,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-14,2017-04-28,2017-04-28,Demand increase for the drug.,2017-03-15,2017-05-08
59540,2296438,Shortage,SANDOZ OMEPRAZOLE,SANDOZ CANADA INCORPORATED,OMEPRAZOLE,OMEPRAZOLE,10MG,30S,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-07-27,2018-10-12,2018-10-05,Delay in shipping of the drug.,2018-08-29,2018-10-16
2711,2296446,Shortage,SANDOZ OMEPRAZOLE,SANDOZ CANADA INCORPORATED,OMEPRAZOLE,OMEPRAZOLE,20MG,100/Btl,ORAL,Resolved,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-14,2017-04-30,2017-04-30,Delay in shipping of the drug.,2017-03-14,2017-05-08
21298,2274310,Shortage,SANDOZ ONDANSETRON,SANDOZ CANADA INCORPORATED,Sandoz ONDANSETRON,ONDANSETRON,4MG,100,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-01,,2017-09-25,Demand increase for the drug.,2017-09-07,2017-09-26
21301,2274329,Shortage,SANDOZ ONDANSETRON,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,8MG,100,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-01,2017-10-30,2017-10-13,Demand increase for the drug.,2017-09-07,2017-11-06
44753,2274310,Shortage,SANDOZ ONDANSETRON,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,4MG,100 TABLETS,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-03-23,2018-07-20,2018-07-20,Delay in shipping of the drug.,2018-04-03,2018-08-13
44757,2274329,Shortage,SANDOZ ONDANSETRON,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,8MG,100 TABLETS,ORAL,Resolved,TABLET,A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2018-03-23,2018-07-20,2018-08-20,Demand increase for the drug.,2018-04-03,2018-08-21
68659,2444674,Shortage,SANDOZ ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON ODT,ONDANSETRON,4MG,10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,2019-02-25,2019-03-08,2019-06-03,,Demand increase for the drug.,2018-12-05,2019-04-17
68662,2444682,Shortage,SANDOZ ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON ODT,ONDANSETRON,8MG,10,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,2019-01-30,2019-01-17,2019-06-20,,Demand increase for the drug.,2018-12-05,2019-04-15
10326,2444674,Shortage,SANDOZ ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,SANDOZ ONDANSETRON ODT,ONDANSETRON,4MG,1X10,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-05-05,2017-07-10,2017-07-10,Delay in shipping of the drug.,2017-05-15,2017-09-07
29122,2444682,Shortage,SANDOZ ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,8MG,BLISTERS 10'S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),A04AA,ANTIEMETICS AND ANTINAUSEANTS,,2017-10-03,2017-11-20,2017-11-15,Demand increase for the drug.,2017-11-14,2017-11-27
50545,1901869,Shortage,SANDOZ OPIUM & BELLADONNA,SANDOZ CANADA INCORPORATED,OPIUM BELLADONNA,BELLADONNA  OPIUM,15MG  65MG,12/BOX,RECTAL,Actual shortage,SUPPOSITORY,N02AA,OPIOIDS,2018-05-31,2018-05-31,,,Shortage of an active ingredient.,2018-05-28,2018-06-01
64104,2243559,Shortage,SANDOZ ORPHENADRINE,SANDOZ CANADA INCORPORATED,ORPHENADRINE,ORPHENADRINE CITRATE,100MG,100 tab,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M03BC,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2018-10-05,2018-11-02,2018-11-02,Delay in shipping of the drug.,2018-10-15,2018-11-04
9505,2307898,Shortage,SANDOZ OXYCODONE/ACETAMINOPHEN,SANDOZ CANADA INCORPORATED,sandoz OXYCODONE+ACET,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,100,ORAL,Resolved,TABLET,N02AJ,,,2017-04-28,2017-09-18,2017-10-20,Demand increase for the drug.,2017-05-08,2017-10-25
9508,2307898,Shortage,SANDOZ OXYCODONE/ACETAMINOPHEN,SANDOZ CANADA INCORPORATED,SANDOZ OXYCODONE+ACET,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,500,ORAL,Resolved,TABLET,N02AJ,,,2017-04-28,2017-10-16,2017-10-20,Demand increase for the drug.,2017-05-08,2017-10-25
39585,2307898,Shortage,SANDOZ OXYCODONE/ACETAMINOPHEN,SANDOZ CANADA INCORPORATED,OXYCODONE ACETAMINOPHENE,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,500S,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2018-01-30,2018-03-09,2018-03-22,Demand increase for the drug.,2018-02-13,2018-03-23
39588,2307898,Shortage,SANDOZ OXYCODONE/ACETAMINOPHEN,SANDOZ CANADA INCORPORATED,OXYCODONE ACETAMINOPHENE,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,100S,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2018-01-30,2018-03-09,2018-03-22,Demand increase for the drug.,2018-02-13,2018-03-23
99103,2301075,Shortage,SANDOZ PANTOPRAZOLE,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,20MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-11-04,2019-12-20,,Delay in shipping of the drug.,2019-11-18,2019-11-18
83259,2301083,Shortage,SANDOZ PANTOPRAZOLE,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-04-15,2019-12-02,,Delay in shipping of the drug.,2019-05-07,2019-10-29
83262,2301083,Shortage,SANDOZ PANTOPRAZOLE,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-04-15,2019-12-02,,Delay in shipping of the drug.,2019-05-07,2019-10-29
74672,2301083,Shortage,SANDOZ PANTOPRAZOLE,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-12-10,2019-02-25,2019-02-28,Delay in shipping of the drug.,2019-02-04,2019-03-05
44760,2301075,Shortage,SANDOZ PANTOPRAZOLE,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,20MG,100 TABLETS,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-03-23,2018-03-27,2018-06-01,2018-05-30,Requirements related to complying with good manufacturing practices.,2018-04-03,2018-05-31
90873,2301083,Shortage,SANDOZ PANTOPRAZOLE,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,30,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-07-29,2019-12-02,,Delay in shipping of the drug.,2019-08-06,2019-10-29
64112,2470225,Shortage,SANDOZ PERINDOPRIL ERBUMINE,SANDOZ CANADA INCORPORATED,Perindopril Erbu,PERINDOPRIL ERBUMINE,2MG,30 tab,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2018-09-10,2018-10-26,2018-10-26,Demand increase for the drug.,2018-10-15,2018-10-29
74677,2470233,Shortage,SANDOZ PERINDOPRIL ERBUMINE,SANDOZ CANADA INCORPORATED,Perindopril Erbu,PERINDOPRIL ERBUMINE,4MG,500,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-01-25,2019-03-04,2019-02-28,Demand increase for the drug.,2019-02-04,2019-03-05
75503,2470233,Shortage,SANDOZ PERINDOPRIL ERBUMINE,SANDOZ CANADA INCORPORATED,Perindopril Erbu,PERINDOPRIL ERBUMINE,4MG,1X30/plq,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-02-04,2019-03-04,2019-02-28,Demand increase for the drug.,2019-02-12,2019-03-05
88882,2470438,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE,SANDOZ CANADA INCORPORATED,PERINDOPRIL ERBUMINE INDAPAMIDE,PERINDOPRIL ERBUMINE  INDAPAMIDE,4MG  1.25MG,30'S,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-06-28,2019-08-02,2019-09-06,Delay in shipping of the drug.,2019-07-08,2019-09-10
81730,2470438,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE,SANDOZ CANADA INCORPORATED,Perindopril Erbu/Inda,PERINDOPRIL ERBUMINE  INDAPAMIDE,4MG  1.25MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-03-25,2019-05-20,2019-05-24,Demand increase for the drug.,2019-04-15,2019-06-28
76144,2470438,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE,SANDOZ CANADA INCORPORATED,Perindopril Erbu/Inda,PERINDOPRIL ERBUMINE  INDAPAMIDE,4MG  1.25MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-02-14,2019-02-25,2019-02-28,Demand increase for the drug.,2019-02-18,2019-03-05
74696,2470438,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE,SANDOZ CANADA INCORPORATED,PerindoprilErbu/Inda,PERINDOPRIL ERBUMINE  INDAPAMIDE,4MG  1.25MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-01-21,2019-02-11,2019-02-08,Demand increase for the drug.,2019-02-04,2019-02-12
74687,2470446,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD,SANDOZ CANADA INCORPORATED,Perindopril Erbu/Inda,PERINDOPRIL ERBUMINE  INDAPAMIDE,8MG  2.5MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2018-12-18,2019-05-06,2019-05-03,Demand increase for the drug.,2019-02-04,2019-05-07
99106,2470411,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD,SANDOZ CANADA INCORPORATED,PERINDOPRIL/INDA,PERINDOPRIL ERBUMINE  INDAPAMIDE,2MG  0.625MG,30,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-11-04,2019-11-22,,Delay in shipping of the drug.,2019-11-18,2019-11-18
90876,2470411,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD,SANDOZ CANADA INCORPORATED,PERINDO/INDAPA LD,PERINDOPRIL ERBUMINE  INDAPAMIDE,2MG  0.625MG,30,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-08-05,2019-09-02,2019-09-06,Delay in shipping of the drug.,2019-08-06,2019-09-10
72473,2297922,Shortage,SANDOZ PIOGLITAZONE,SANDOZ CANADA INCORPORATED,PIOGLITAZONE,PIOGLITAZONE,45MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-02-25,,2019-03-04,2019-02-28,Demand increase for the drug.,2019-01-16,2019-03-05
83265,2297906,Shortage,SANDOZ PIOGLITAZONE,SANDOZ CANADA INCORPORATED,PIOGLITAZONE,PIOGLITAZONE,15MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-04-29,2019-07-22,2019-07-02,Demand increase for the drug.,2019-05-07,2019-07-24
75506,2297914,Shortage,SANDOZ PIOGLITAZONE,SANDOZ CANADA INCORPORATED,PIOGLITAZONE,PIOGLITAZONE,30MG,90,ORAL,Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-02-04,2019-04-01,2019-03-25,Demand increase for the drug.,2019-02-12,2019-04-10
91544,2239234,Shortage,SANDOZ POLYTRIMETHOPRIM,SANDOZ CANADA INCORPORATED,POLYTRIMETHOPRIM,TRIMETHOPRIM  POLYMYXIN B SULFATE,1MG  10000UNIT,10ML LDP,OPHTHALMIC,Resolved,SOLUTION,S01AA,ANTIINFECTIVES,,2019-08-05,2019-08-19,2019-09-06,Delay in shipping of the drug.,2019-08-14,2019-09-10
63488,2315262,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 tab,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-09-26,2019-01-07,2019-01-14,Delay in shipping of the drug.,2018-10-09,2019-01-16
63491,2315270,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 tab,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-09-26,2018-12-17,2018-12-17,Delay in shipping of the drug.,2018-10-09,2018-12-18
21305,2315262,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-09-01,2018-06-22,2018-06-13,Demand increase for the drug.,2017-09-07,2018-07-03
21308,2315270,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2017-09-01,2018-06-01,2018-06-13,Demand increase for the drug.,2017-09-07,2018-07-03
59508,2315297,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100S,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-06-18,2019-01-07,2019-01-14,Disruption of the manufacture of the drug.,2018-08-29,2019-01-16
59511,2315289,Shortage,SANDOZ PRAMIPEXOLE,SANDOZ CANADA INCORPORATED,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.0MG,100S,ORAL,Resolved,TABLET,N04BC,DOPAMINERGIC AGENTS,,2018-06-22,2019-01-07,2019-01-14,Disruption of the manufacture of the drug.,2018-08-29,2019-01-16
89402,2468719,Shortage,SANDOZ PRAVASTATIN TABLETS,SANDOZ CANADA INCORPORATED,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-24,2019-07-29,2019-07-29,Delay in shipping of the drug.,2019-07-16,2019-09-25
89405,2468727,Shortage,SANDOZ PRAVASTATIN TABLETS,SANDOZ CANADA INCORPORATED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-24,2019-07-29,2019-07-29,Delay in shipping of the drug.,2019-07-16,2019-09-25
81748,1916203,Shortage,SANDOZ PREDNISOLONE,SANDOZ CANADA INCORPORATED,PREDNISOLONE,PREDNISOLONE ACETATE,1%,5ml,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-04-08,2019-07-12,2019-07-05,Demand increase for the drug.,2019-04-15,2019-07-24
73861,1916203,Shortage,SANDOZ PREDNISOLONE,SANDOZ CANADA INCORPORATED,PREDNISOLONE,PREDNISOLONE ACETATE,1%,10ml,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,2019-02-18,2019-02-18,2019-07-12,2019-07-05,Demand increase for the drug.,2019-01-30,2019-07-24
74750,1916203,Shortage,SANDOZ PREDNISOLONE,SANDOZ CANADA INCORPORATED,PREDNISOLONE,PREDNISOLONE ACETATE,1%,5ml,OPHTHALMIC,Avoided shortage,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-02-18,2019-04-01,2019-02-08,Demand increase for the drug.,2019-02-04,2019-03-05
3872,2390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-21,2017-04-14,2017-04-13,Demand increase for the drug.,2017-03-22,2017-04-18
3875,2390868,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-21,2017-06-23,2017-05-05,Demand increase for the drug.,2017-03-22,2017-05-08
21312,2390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,2018-02-05,2018-02-01,Demand increase for the drug.,2017-09-07,2018-02-05
21315,2390817,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,2018-03-02,2018-02-22,Demand increase for the drug.,2017-09-07,2018-04-13
21319,2390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-09-01,2018-02-05,2018-02-01,Demand increase for the drug.,2017-09-07,2018-02-05
2896,2390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-14,2017-04-07,2017-04-13,Demand increase for the drug.,2017-03-15,2017-04-18
2899,2390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-14,2017-03-31,2017-04-13,Demand increase for the drug.,2017-03-15,2017-04-18
2714,2390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100Btl,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-14,2017-03-31,2017-04-13,Demand increase for the drug.,2017-03-14,2017-04-18
2717,2390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,Sandoz PREGABALIN,PREGABALIN,75MG,100Btl,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-14,2017-03-31,2017-04-13,Demand increase for the drug.,2017-03-14,2017-04-18
29129,2390868,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,300MG,100'S,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-10-30,2018-05-18,2018-05-18,Delay in shipping of the drug.,2017-11-14,2018-05-23
29132,2390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,75MG,100'S,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-10-30,2018-02-05,2018-02-05,Demand increase for the drug.,2017-11-14,2018-02-06
62720,789720,Shortage,SANDOZ PROCHLORPERAZINE,SANDOZ CANADA INCORPORATED,PROCHLOPERAZINE,PROCHLORPERAZINE,10MG,10,RECTAL,Resolved,SUPPOSITORY,N05AB,ANTIPSYCHOTICS,,2018-07-27,2018-10-19,2018-10-19,Delay in shipping of the drug.,2018-09-30,2018-10-25
3888,2242527,Shortage,SANDOZ PROCTOMYXIN HC,SANDOZ CANADA INCORPORATED,PROCTOMYXIN,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,15G,RECTAL,Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017-03-21,2017-04-07,2017-04-07,Requirements related to complying with good manufacturing practices.,2017-03-22,2017-05-08
3891,2242527,Shortage,SANDOZ PROCTOMYXIN HC,SANDOZ CANADA INCORPORATED,PROCTOMYXIN,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,30G,RECTAL,Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017-03-21,2017-04-07,2017-04-07,Requirements related to complying with good manufacturing practices.,2017-03-22,2017-05-08
89417,2242527,Shortage,SANDOZ PROCTOMYXIN HC,SANDOZ CANADA INCORPORATED,PROCTOMYXIN,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,15G,RECTAL,Actual shortage,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2019-07-03,2020-01-31,,Demand increase for the drug.,2019-07-16,2019-11-06
78523,2242527,Shortage,SANDOZ PROCTOMYXIN HC,SANDOZ CANADA INCORPORATED,PROCTOMYXIN HC,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,15g,RECTAL,Resolved,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2019-02-11,2019-04-01,2019-04-01,Delay in shipping of the drug.,2019-03-13,2019-04-10
3885,2242528,Shortage,SANDOZ PROCTOMYXIN HC SUPPOSITORIES,SANDOZ CANADA INCORPORATED,PROCTOMYXIN,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,12,RECTAL,Resolved,SUPPOSITORY,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2017-03-21,2017-04-07,2017-03-23,Disruption of the manufacture of the drug.,2017-03-22,2017-03-28
63494,2313995,Shortage,SANDOZ QUETIAPINE,SANDOZ CANADA INCORPORATED,QUETIAPINE,QUETIAPINE,25MG,100 tab,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2018-10-09,2019-01-07,2019-01-07,Demand increase for the drug.,2018-10-09,2019-01-16
2624,2313995,Shortage,SANDOZ QUETIAPINE,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE,QUETIAPINE,25MG,25mg 500/Btl,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-03-14,2017-04-07,2017-04-12,Demand increase for the drug.,2017-03-14,2017-04-18
2629,2313995,Shortage,SANDOZ QUETIAPINE,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE,QUETIAPINE,25MG,25mg 500/Btl,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-03-14,2017-04-30,2017-05-15,Demand increase for the drug.,2017-03-14,2017-05-17
29155,2314002,Shortage,SANDOZ QUETIAPINE,SANDOZ CANADA INCORPORATED,QUETIAPINE,QUETIAPINE,100MG,500'S,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2017-10-02,2018-06-08,2018-06-15,Delay in shipping of the drug.,2017-11-14,2018-07-03
2626,2407698,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE XRT,QUETIAPINE,150MG,150mg 100/Btl,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-03-14,2017-08-28,2017-05-16,Demand increase for the drug.,2017-03-14,2017-05-17
2632,2407701,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,Sandoz QUETIAPINE XRT,QUETIAPINE,200MG,200mg 100/Btl,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-03-14,2017-05-01,2017-05-01,Demand increase for the drug.,2017-03-14,2017-05-15
21322,2407701,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-09-01,2017-12-18,2017-10-24,Demand increase for the drug.,2017-09-07,2017-11-14
21328,2407728,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,300MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-09-01,2017-10-23,2017-10-06,Demand increase for the drug.,2017-09-07,2017-10-25
2641,2407728,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,300MG,300mg 100/Btl,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-03-14,2017-04-30,2017-05-01,Demand increase for the drug.,2017-03-14,2017-05-15
21331,2407671,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-09-01,2017-09-18,2017-10-06,Demand increase for the drug.,2017-09-07,2017-10-25
2645,2407736,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,400MG,400mg 100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-03-14,2017-05-31,2017-05-01,Demand increase for the drug.,2017-03-14,2017-05-15
2648,2407671,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE XRT,QUETIAPINE,50MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-03-14,2017-09-18,2017-10-06,Demand increase for the drug.,2017-03-14,2017-10-25
29160,2407728,Shortage,SANDOZ QUETIAPINE XRT,SANDOZ CANADA INCORPORATED,QUETIAPINE,QUETIAPINE,300MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-10-23,2018-01-15,2017-12-22,Demand increase for the drug.,2017-11-14,2018-01-18
83270,2314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-04-22,,2019-05-03,Delay in shipping of the drug.,2019-05-07,2019-05-07
76147,2314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-02-06,2019-02-25,2019-02-28,Delay in shipping of the drug.,2019-02-18,2019-03-05
75511,2314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,3X10 / Plq,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-02-04,2019-05-06,2019-04-29,Delay in shipping of the drug.,2019-02-12,2019-05-07
21334,2243230,Shortage,SANDOZ RANITIDINE,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,300MG,100,ORAL,Resolved,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-01,2017-11-06,2017-10-06,Demand increase for the drug.,2017-09-07,2017-11-06
93419,2243229,Shortage,SANDOZ RANITIDINE,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,150MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-02,,,Requirements related to complying with good manufacturing practices.,2019-09-10,2019-10-15
93422,2243229,Shortage,SANDOZ RANITIDINE,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,150MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-02,,,Requirements related to complying with good manufacturing practices.,2019-09-10,2019-10-15
93425,2243230,Shortage,SANDOZ RANITIDINE,SANDOZ CANADA INCORPORATED,RANITIDINE,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-02,,,Requirements related to complying with good manufacturing practices.,2019-09-10,2019-10-15
63497,2357461,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,1MG,100 tab,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-08-30,2019-02-04,2019-01-31,Requirements related to complying with good manufacturing practices.,2018-10-09,2019-02-04
66331,2357453,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,0.5MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-10-31,2019-01-14,2019-01-14,Requirements related to complying with good manufacturing practices.,2018-11-07,2019-01-16
10310,2357453,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,SANDOZ REPAGLINIDE,REPAGLINIDE,0.5MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-05-12,2017-06-19,2017-06-21,Delay in shipping of the drug.,2017-05-15,2017-06-26
2651,2357488,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,2MG,100,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2017-03-14,2017-04-21,2017-04-28,Demand increase for the drug.,2017-03-14,2017-05-08
38766,2357453,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,0.5MG,100'S,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-01-26,2018-03-09,2018-03-27,Requirements related to complying with good manufacturing practices.,2018-02-06,2018-04-13
64121,2357488,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,2MG,100 tab,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-09-27,2019-02-08,2019-02-11,Requirements related to complying with good manufacturing practices.,2018-10-15,2019-02-18
48797,2357453,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,0.5MG,100S,ORAL,Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2018-05-04,2018-06-01,2018-07-13,Requirements related to complying with good manufacturing practices.,2018-05-07,2018-07-14
96497,2357461,Shortage,SANDOZ REPAGLINIDE,SANDOZ CANADA INCORPORATED,REPAGLINIDE,REPAGLINIDE,1MG,100,ORAL,Actual shortage,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-09-16,2019-12-09,,Demand increase for the drug.,2019-10-15,2019-11-06
64126,2327295,Shortage,SANDOZ RISEDRONATE,SANDOZ CANADA INCORPORATED,RISEDRONATE,RISEDRONATE SODIUM,35MG,1x4Bl,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-09-04,2018-12-07,2018-12-05,Demand increase for the drug.,2018-10-15,2018-12-06
3878,2324563,Shortage,SANDOZ RIVASTIGMINE,SANDOZ CANADA INCORPORATED,RIVASTIGMINE,RIVASTIGMINE,1.5MG,56,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2017-03-21,2017-05-22,2017-05-16,Disruption of the manufacture of the drug.,2017-03-22,2017-05-17
74710,2324571,Shortage,SANDOZ RIVASTIGMINE,SANDOZ CANADA INCORPORATED,RIVASTIGMINE,RIVASTIGMINE,3MG,4X14/bl,ORAL,Resolved,CAPSULE,N06DA,ANTI-DEMENTIA DRUGS,,2019-01-23,2019-03-18,2019-03-22,Requirements related to complying with good manufacturing practices.,2019-02-04,2019-04-10
77695,2351889,Shortage,SANDOZ RIZATRIPTAN ODT,SANDOZ CANADA INCORPORATED,rizatriptan odt,RIZATRIPTAN,10MG,1X6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2019-02-25,2019-05-13,2019-06-07,Delay in shipping of the drug.,2019-03-05,2019-06-28
40007,2338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,BLISTERS 30S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-02-09,2018-03-02,2018-03-09,Demand increase for the drug.,2018-02-15,2018-03-23
83273,2338742,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-29,,2019-05-03,Delay in shipping of the drug.,2019-05-07,2019-05-07
21337,2338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,2x15BL,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-01,2017-09-18,2017-09-15,Demand increase for the drug.,2017-09-07,2017-10-25
48800,2338750,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,40MG,BLISTERS 30S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-05-04,2018-07-20,2018-07-20,Demand increase for the drug.,2018-05-07,2018-08-13
29168,2338734,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,10MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-10-30,2018-03-30,2018-03-23,Demand increase for the drug.,2017-11-14,2018-04-13
29171,2338742,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,20MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-11-09,2018-03-09,2018-03-16,Demand increase for the drug.,2017-11-14,2018-03-23
96500,2338750,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-16,2020-01-13,,Shortage of an active ingredient.,2019-10-15,2019-11-18
29174,2338750,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,40MG,100'S,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-11-01,2018-07-13,2018-07-06,Delay in shipping of the drug.,2017-11-14,2018-07-12
29177,2338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,BLISTERS 2 X 15,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-11-01,2017-11-20,2017-11-14,Demand increase for the drug.,2017-11-14,2017-11-27
77700,2247390,Shortage,SANDOZ SENNA S,SANDOZ CANADA INCORPORATED,SENNA S,SENNOSIDES  DOCUSATE SODIUM,8.6MG  50MG,500,ORAL,Resolved,TABLET,A06AB,DRUGS FOR CONSTIPATION,,2019-02-04,,2019-09-02,Delay in shipping of the drug.,2019-03-05,2019-09-10
88075,2245159,Shortage,SANDOZ SERTRALINE,SANDOZ CANADA INCORPORATED,SERTRALINE,SERTRALINE,25MG,100s,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,2019-07-30,,,,Disruption of the manufacture of the drug.,2019-06-28,2019-07-31
21340,2245159,Shortage,SANDOZ SERTRALINE,SANDOZ CANADA INCORPORATED,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-09-01,2017-10-09,2017-10-19,Delay in shipping of the drug.,2017-09-07,2017-10-25
59516,2245161,Shortage,SANDOZ SERTRALINE,SANDOZ CANADA INCORPORATED,SERTRALINE,SERTRALINE,100MG,100S,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-05-04,2018-10-19,2018-10-19,Demand increase for the drug.,2018-08-29,2018-10-20
39591,2245159,Shortage,SANDOZ SERTRALINE,SANDOZ CANADA INCORPORATED,SERTRALINE,SERTRALINE,25MG,100S,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-02-01,2018-06-01,2018-06-01,Demand increase for the drug.,2018-02-13,2018-07-03
39594,2245160,Shortage,SANDOZ SERTRALINE,SANDOZ CANADA INCORPORATED,SERTRALINE,SERTRALINE,50MG,100S,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-01-15,2018-07-20,2018-07-27,Demand increase for the drug.,2018-02-13,2018-08-13
72482,2399032,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-01-07,2019-03-04,2019-02-28,Demand increase for the drug.,2019-01-16,2019-03-05
3882,2399040,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-03-21,2017-05-15,2017-05-05,Delay in shipping of the drug.,2017-03-22,2017-05-08
76157,2399040,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-02-11,2019-04-19,2019-04-22,Delay in shipping of the drug.,2019-02-18,2019-05-07
97423,2399040,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-10,2019-12-23,,Delay in shipping of the drug.,2019-10-29,2019-10-29
90879,2399032,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-07-29,2019-12-23,,Delay in shipping of the drug.,2019-08-06,2019-10-29
2654,2263033,Shortage,SANDOZ SUMATRIPTAN,SANDOZ CANADA INCORPORATED,SUMATRIPTAN,SUMATRIPTAN,100MG,1x6bl,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-03-14,2017-06-12,2017-05-12,Demand increase for the drug.,2017-03-14,2017-05-15
21350,2319217,Shortage,SANDOZ TAMSULOSIN,SANDOZ CANADA INCORPORATED,TAMSULOSIN SR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100,ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-09-01,2017-11-20,2017-11-14,Delay in shipping of the drug.,2017-09-07,2017-11-27
21343,2340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-09-01,2017-11-06,2017-10-27,Demand increase for the drug.,2017-09-07,2017-10-28
21347,2340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,Sandoz TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-09-01,2017-11-06,2017-10-27,Demand increase for the drug.,2017-09-07,2017-10-28
10317,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,SANDOZ TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-05-05,2017-05-22,2017-05-22,Delay in shipping of the drug.,2017-05-15,2017-06-13
2657,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,10x3,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-03-14,2017-04-24,2017-05-05,Demand increase for the drug.,2017-03-14,2017-05-08
13941,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,500,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-06-16,2017-07-26,2017-07-26,Delay in shipping of the drug.,2017-06-26,2017-09-07
64138,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,100 tab,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-09-13,2018-10-19,2018-10-26,Demand increase for the drug.,2018-10-15,2018-10-29
64153,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,500 tab,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-10-05,2018-12-31,2018-11-26,Demand increase for the drug.,2018-10-15,2018-11-27
76224,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-11-18
76227,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-11-18
76233,2375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-11-18
76236,2375966,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,80MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2020-01-20,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-10-15
76239,2375966,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,80MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-11-18
76242,2375966,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,80MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-05,2020-02-03,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-11-18
13944,2393557,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-06-23,2017-07-17,2017-06-27,Demand increase for the drug.,2017-06-26,2017-09-07
64132,2393565,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HCT,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,100 tab,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-03,2019-12-06,,Demand increase for the drug.,2018-10-15,2019-11-18
64158,2393565,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,Telmisartan HCT,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,30 tab,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-09-13,2019-12-06,,Delay in shipping of the drug.,2018-10-15,2019-11-18
69545,2393557,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HCT,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,3X10 Bl,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-19,2019-12-06,,Delay in shipping of the drug.,2018-12-13,2019-11-18
76221,2393557,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HCT,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-05,2019-12-06,,Requirements related to complying with good manufacturing practices.,2019-02-18,2019-11-18
93442,2166720,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,TIMOLOL,TIMOLOL,0.5%,10ml,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-08-19,2019-12-06,,Delay in shipping of the drug.,2019-09-10,2019-11-18
93445,2166720,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,TIMOLOL,TIMOLOL,0.5%,5ml,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-08-19,2019-12-06,,Delay in shipping of the drug.,2019-09-10,2019-11-18
10333,2166720,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,SANDOZ TIMOLOL,TIMOLOL,0.5%,10ML BTL/BOUT,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-05-05,2017-05-29,2017-06-05,Delay in shipping of the drug.,2017-05-15,2017-06-26
64213,2166720,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,TIMOLOL,TIMOLOL,0.5%,10ml,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-09-10,2018-11-02,2018-11-02,Demand increase for the drug.,2018-10-15,2018-11-04
64219,2166720,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,TIMOLOL,TIMOLOL,0.5%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-09-10,2018-11-02,2018-11-02,Requirements related to complying with good manufacturing practices.,2018-10-15,2018-11-04
93435,2166712,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,TIMOLOL,TIMOLOL,0.25%,10ml,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-08-19,2019-12-06,,Delay in shipping of the drug.,2019-09-10,2019-11-18
10336,2241755,Shortage,SANDOZ TOBRAMYCIN 0.3%,SANDOZ CANADA INCORPORATED,SANDOZ TOBRAMYCIN,TOBRAMYCIN,0.3%,5ML BTL/BOUT,OPHTHALMIC,Resolved,SOLUTION,S01AA,ANTIINFECTIVES,,2017-05-12,2017-05-22,2017-08-25,Delay in shipping of the drug.,2017-05-15,2017-09-07
44813,2413140,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE TARTRATE,TOLTERODINE TARTRATE,2MG,100 TABLETS,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-03-23,2018-05-04,2018-04-20,Delay in shipping of the drug.,2018-04-03,2018-05-07
2660,2413140,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,Sandoz TOLTERODINE LA,TOLTERODINE TARTRATE,2MG,30/Btl,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-03-14,2017-03-31,2017-04-13,Disruption of the manufacture of the drug.,2017-03-14,2017-04-18
2663,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE LA,TOLTERODINE TARTRATE,4MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-03-14,2017-03-31,2017-04-07,Disruption of the manufacture of the drug.,2017-03-14,2017-04-11
2666,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE LA,TOLTERODINE TARTRATE,4MG,30,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-03-14,2017-03-31,2017-04-07,Disruption of the manufacture of the drug.,2017-03-14,2017-04-11
76162,2413140,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE LA,TOLTERODINE TARTRATE,2MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-02-11,2019-03-18,2019-03-18,Demand increase for the drug.,2019-02-18,2019-04-17
64176,2413140,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE LA,TOLTERODINE TARTRATE,2MG,100 cap,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-09-26,2018-10-26,2018-11-02,Delay in shipping of the drug.,2018-10-15,2018-11-04
93428,2413140,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE LA,TOLTERODINE TARTRATE,2MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-08-19,2019-10-28,2019-10-28,Delay in shipping of the drug.,2019-09-10,2019-11-06
29180,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE,TOLTERODINE TARTRATE,4MG,100'S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-10-23,2017-11-20,2017-11-22,Delay in shipping of the drug.,2017-11-14,2017-11-27
29183,2413159,Shortage,SANDOZ TOLTERODINE LA,SANDOZ CANADA INCORPORATED,TOLTERODINE,TOLTERODINE TARTRATE,4MG,30'S,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-01,2017-11-20,2017-11-22,Demand increase for the drug.,2017-11-14,2017-11-27
29192,2431815,Shortage,SANDOZ TOPIRAMATE TABLETS,SANDOZ CANADA INCORPORATED,TOPIRAMATE,TOPIRAMATE,100MG,100'S,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-11-06,2018-11-09,2018-11-12,Delay in shipping of the drug.,2017-11-14,2018-11-13
16757,2431823,Shortage,SANDOZ TOPIRAMATE TABLETS,SANDOZ CANADA INCORPORATED,TOPIRAMATE,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-07-21,2018-11-09,2018-11-12,Delay in shipping of the drug.,2017-07-24,2018-11-13
59525,2431807,Shortage,SANDOZ TOPIRAMATE TABLETS,SANDOZ CANADA INCORPORATED,TOPIRAMATE,TOPIRAMATE,25MG,100S,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-08-07,2018-11-09,2018-11-12,Disruption of the manufacture of the drug.,2018-08-29,2018-11-13
98012,2325756,Shortage,SANDOZ TRANDOLAPRIL,SANDOZ CANADA INCORPORATED,TRANDOLAPRIL,TRANDOLAPRIL,2MG,100 HGC,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-10-28,2019-11-15,2019-11-18,Delay in shipping of the drug.,2019-11-06,2019-11-18
9491,2347091,Shortage,SANDOZ VALACYCLOVIR,SANDOZ CANADA INCORPORATED,SANDOZ VALACYCLOVIR,VALACYCLOVIR,500MG,90,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-05-05,2018-05-04,2018-05-04,Other (Please describe in comments),2017-05-08,2018-05-07
55045,2356767,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,160MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55050,2356775,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,320MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-09,2018-07-11,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-12
55057,2356740,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55060,2356759,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,80MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55063,2356759,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,80MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55003,2356740,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55029,2356775,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,SANDOZ VALSARTAN,VALSARTAN,320MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55032,2356767,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,160MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55035,2356767,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,160MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55038,2356759,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,80MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
80979,2356724,Shortage,SANDOZ VALSARTAN HCT,SANDOZ CANADA INCORPORATED,VALSARTAN HCT,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  320MG,2X15bl,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-05,2019-04-22,2019-04-22,Requirements related to complying with good manufacturing practices.,2019-04-10,2019-05-07
63514,2310317,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100 cap,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-09-26,2018-11-09,2018-12-17,Demand increase for the drug.,2018-10-09,2018-12-18
96540,2310325,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,75.0MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-09-30,2019-12-20,,Demand increase for the drug.,2019-10-15,2019-10-15
96547,2310325,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,75.0MG,250,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-09-30,2019-12-20,,Demand increase for the drug.,2019-10-15,2019-10-15
83298,2310333,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,150.0MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-05-03,2019-12-20,,Demand increase for the drug.,2019-05-07,2019-10-15
83301,2310333,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,150.0MG,250,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-05-03,2019-12-20,,Demand increase for the drug.,2019-05-07,2019-10-15
86402,2310317,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-06-03,2019-12-20,,Demand increase for the drug.,2019-06-12,2019-10-15
76169,2310325,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,75.0MG,250,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-04,2019-03-04,2019-03-08,Demand increase for the drug.,2019-02-18,2019-03-13
64189,2310333,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,150.0MG,100 CAP,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-09-27,2019-04-15,2019-03-22,Demand increase for the drug.,2018-10-15,2019-04-17
64192,2310333,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,150.0MG,250 CAP,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-09-27,2019-04-15,2019-03-22,Demand increase for the drug.,2018-10-15,2019-04-17
74734,2310317,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-12-17,2019-03-04,2019-03-08,Demand increase for the drug.,2019-02-04,2019-03-13
74737,2310325,Shortage,SANDOZ VENLAFAXINE XR,SANDOZ CANADA INCORPORATED,VENLAFAXINE XR,VENLAFAXINE,75.0MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-01,2019-02-11,2019-02-12,Requirements related to complying with good manufacturing practices.,2019-02-04,2019-02-13
86405,2399253,Shortage,SANDOZ VORICONAZOLE,SANDOZ CANADA INCORPORATED,VORICONAZOLE,VORICONAZOLE,200MG,30,ORAL,Actual shortage,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2019-06-03,2019-12-06,,Demand increase for the drug.,2019-06-12,2019-11-18
63518,2362988,Shortage,SANDOZ ZOLMITRIPTAN,SANDOZ CANADA INCORPORATED,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,1X3BL tab,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-09-24,2018-12-21,2019-01-14,Delay in shipping of the drug.,2018-10-09,2019-01-16
76192,2362988,Shortage,SANDOZ ZOLMITRIPTAN,SANDOZ CANADA INCORPORATED,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,30,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-02-15,2019-04-29,2019-04-26,Delay in shipping of the drug.,2019-02-18,2019-05-01
46803,2362996,Shortage,SANDOZ ZOLMITRIPTAN ODT,SANDOZ CANADA INCORPORATED,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,2S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-04-23,2018-04-26,2018-12-31,2019-01-07,Demand increase for the drug.,2018-04-20,2019-01-16
45800,2362996,Shortage,SANDOZ ZOLMITRIPTAN ODT,SANDOZ CANADA INCORPORATED,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,BLISTERS 6'S,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-04-16,2018-04-20,2018-10-19,2018-10-16,Delay in shipping of the drug.,2018-04-13,2018-10-17
9497,2257572,Shortage,SANDOZ ZOPICLONE,SANDOZ CANADA INCORPORATED,SANDOZ ZOPICLONE,ZOPICLONE,5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017-05-05,,2017-05-12,Delay in shipping of the drug.,2017-05-08,2017-05-15
64440,2257572,Shortage,SANDOZ ZOPICLONE,SANDOZ CANADA INCORPORATED,ZOPICLONE,ZOPICLONE,5MG,100 tab,ORAL,Actual shortage,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2018-07-20,,,Requirements related to complying with good manufacturing practices.,2018-10-16,2018-10-16
83221,2261839,Shortage,SANDOZ-CARBAMAZEPINE CR,SANDOZ CANADA INCORPORATED,CARBAMAZEPINE,CARBAMAZEPINE,200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,,2019-04-22,2019-05-10,2019-05-08,Demand increase for the drug.,2019-05-07,2019-05-09
5569,2261847,Shortage,SANDOZ-CARBAMAZEPINE CR,SANDOZ CANADA INCORPORATED,CARBAMAZEPINE,CARBAMAZEPINE,400MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,,2017-03-31,2017-06-19,2017-06-02,Requirements related to complying with good manufacturing practices.,2017-04-05,2017-06-06
99058,2261847,Shortage,SANDOZ-CARBAMAZEPINE CR,SANDOZ CANADA INCORPORATED,CARBAMAZEPINE CR,CARBAMAZEPINE,400MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,,2019-11-04,2019-11-29,,Delay in shipping of the drug.,2019-11-18,2019-11-18
97389,2261960,Shortage,SANDOZ-DICLOFENAC,SANDOZ CANADA INCORPORATED,DICLOFENAC,DICLOFENAC SODIUM,50MG,120 FCT,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-10-21,2019-12-20,,Requirements related to complying with good manufacturing practices.,2019-10-29,2019-11-18
58856,2261960,Shortage,SANDOZ-DICLOFENAC,SANDOZ CANADA INCORPORATED,DICLOFENAC,DICLOFENAC SODIUM,50MG,100s,ORAL,Resolved,TABLET (DELAYED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-08-10,2019-03-19,2019-03-18,Delay in shipping of the drug.,2018-08-23,2019-05-07
63294,2261944,Shortage,SANDOZ-DICLOFENAC SR,SANDOZ CANADA INCORPORATED,DICLOFENAC,DICLOFENAC SODIUM,100MG,100 tab,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-09-24,2019-01-28,2019-01-25,Delay in shipping of the drug.,2018-10-04,2019-01-30
76121,2261944,Shortage,SANDOZ-DICLOFENAC SR,SANDOZ CANADA INCORPORATED,DICLOFENAC SR,DICLOFENAC SODIUM,100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-02-04,2019-09-02,2019-09-09,Demand increase for the drug.,2019-02-18,2019-09-25
76124,2261901,Shortage,SANDOZ-DICLOFENAC SR,SANDOZ CANADA INCORPORATED,DICLOFENAC SR,DICLOFENAC SODIUM,75MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2019-02-04,2019-09-02,2019-09-09,Demand increase for the drug.,2019-02-18,2019-09-25
44737,2261901,Shortage,SANDOZ-DICLOFENAC SR,SANDOZ CANADA INCORPORATED,DICLOFENAC,DICLOFENAC SODIUM,75MG,100 TABLETS,ORAL,Resolved,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-03-23,2018-03-26,2019-01-28,2019-01-25,Delay in shipping of the drug.,2018-04-03,2019-01-30
38171,2020793,Shortage,SCLERODINE 6 INJECTION,OMEGA LABORATORIES LTD,Sclerodine,IODINE  SODIUM IODIDE,60MG  90MG,5 X 10mL,INTRAVENOUS,Actual shortage,LIQUID,C05BB,ANTIVARICOSE THERAPY,2018-02-01,2018-02-01,,,Shortage of an inactive ingredient or component.,2018-02-02,2018-02-02
66030,2242810,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION,OMEGA LABORATORIES LTD,Scopolamine Hydrobromide Injection,SCOPOLAMINE HYDROBROMIDE,0.4MG,10 x 1 mL vial,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID,N05CM,HYPNOTICS AND SEDATIVES,2019-01-02,,2019-03-31,2019-03-22,Disruption of the manufacture of the drug.,2018-11-01,2019-03-23
66033,2242811,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION,OMEGA LABORATORIES LTD,Scopolamine Hydrobromide Injection,SCOPOLAMINE HYDROBROMIDE,0.6MG,10 x 1 mL vial,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID,N05CM,HYPNOTICS AND SEDATIVES,2019-01-02,,2019-03-31,2019-03-22,Disruption of the manufacture of the drug.,2018-11-01,2019-03-23
1099,541869,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML,HOSPIRA HEALTHCARE CORPORATION,SCOPOLAMINE,SCOPOLAMINE HYDROBROMIDE,0.4mg,0.4mg/mL x 10,INTRAVENOUS  INTRAMUSCULAR  SUBCUTANEOUS,Resolved,Solution,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2015-07-28,2017-08-11,2017-08-08,Disruption of the manufacture of the drug.,2017-03-13,2017-08-09
30651,541869,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML,HOSPIRA HEALTHCARE CORPORATION,Scopolamine,SCOPOLAMINE HYDROBROMIDE,.4MG,10x1mL AMP,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017-12-29,,2018-10-23,Other (Please describe in comments),2017-11-24,2018-10-24
23832,541877,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.6MG/ML,HOSPIRA HEALTHCARE CORPORATION,Scopolamine,SCOPOLAMINE HYDROBROMIDE,.6MG,10x1mL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2017-09-29,,2018-10-23,Other (Please describe in comments),2017-09-28,2018-11-05
1123,541877,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION 0.6MG/ML,HOSPIRA HEALTHCARE CORPORATION,SCOPOLAMINE,SCOPOLAMINE HYDROBROMIDE,.6MG,0.6mg/mL x 10,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2015-07-28,2017-08-31,2017-08-31,Disruption of the manufacture of the drug.,2017-03-13,2017-09-01
14873,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-07-03,2018-02-26,2018-03-02,Delay in shipping of the drug.,2017-07-06,2018-03-03
66351,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-12-07,2018-11-12,2019-08-22,2019-08-12,Demand increase for the drug.,2018-11-07,2019-09-25
2869,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-04-21,2017-05-05,Disruption of the manufacture of the drug.,2017-03-15,2017-05-08
63286,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,100 cap,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-09-28,2019-05-13,2019-06-07,Demand increase for the drug.,2018-10-04,2019-06-28
2872,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-04-21,2017-05-05,Disruption of the manufacture of the drug.,2017-03-15,2017-05-08
2875,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-08-18,2017-05-05,Disruption of the manufacture of the drug.,2017-03-15,2017-05-08
2878,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-04-21,2017-05-05,Disruption of the manufacture of the drug.,2017-03-15,2017-05-08
2683,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,Sandoz CELECOXIB,CELECOXIB,100MG,100/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-04-30,2017-05-05,Demand increase for the drug.,2017-03-14,2017-05-08
74620,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,100,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-11-12,2019-08-22,2019-08-12,Demand increase for the drug.,2019-02-04,2019-09-25
2685,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-04-30,2017-05-05,Demand increase for the drug.,2017-03-14,2017-05-08
2693,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,100/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-08-31,2017-05-05,Demand increase for the drug.,2017-03-14,2017-05-08
2696,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,500/Btl,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-03-14,2017-04-30,2017-05-05,Demand increase for the drug.,2017-03-14,2017-05-08
73113,2442647,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,200MG,500,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-10-29,2019-05-13,2019-06-07,Delay in shipping of the drug.,2019-01-22,2019-06-28
29097,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,100'S,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-09-19,2018-02-23,2018-02-26,Requirements related to complying with good manufacturing practices.,2017-11-14,2018-03-02
62929,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,100S,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-09-27,,2018-11-12,2018-11-12,Delay in shipping of the drug.,2018-10-03,2018-11-13
62932,2442639,Shortage,SDZ CELECOXIB,SANDOZ CANADA INCORPORATED,CELECOXIB,CELECOXIB,100MG,500S,ORAL,Resolved,CAPSULE,M01AH,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-07-09,2018-10-12,2018-10-02,Delay in shipping of the drug.,2018-10-03,2018-10-16
94940,2296659,Shortage,SEASONALE,TEVA WOMENS HEALTH INC. SUBSIDIARY OF TEVA PHARMACEUTICALS USA INC,Ethinyl estradiol Levonorgestrel tablets,ETHINYL ESTRADIOL  LEVONORGESTREL,0.03MG  0.15MG,3x91,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-05-01,,2019-09-25,Disruption of the manufacture of the drug.,2019-09-27,2019-09-27
94905,2346176,Shortage,SEASONIQUE,TEVA WOMENS HEALTH INC. SUBSIDIARY OF TEVA PHARMACEUTICALS USA INC,Ethinyl Estradiol tablets,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  LEVONORGESTREL,0.01MG  0.03MG  0.15MG,91,ORAL,Actual shortage,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-05-01,2019-10-11,,Disruption of the manufacture of the drug.,2019-09-26,2019-09-27
46276,1926551,Shortage,SECTRAL,SANOFI-AVENTIS CANADA INC,SECTRAL 200MG,ACEBUTOLOL,200MG,100'S,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-04-18,2018-07-27,2018-07-26,Demand increase for the drug.,2018-04-18,2018-07-27
48844,1926543,Shortage,SECTRAL,SANOFI-AVENTIS CANADA INC,Sectral,ACEBUTOLOL,100MG,100'S,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2018-05-01,2018-05-01,2018-08-10,2018-07-30,Demand increase for the drug.,2018-05-08,2018-07-31
1193,695033,Shortage,SELAX SYR 20MG/5ML USP,ODAN LABORATORIES LTD,"Docusate Sodium Syrup, USP",DOCUSATE SODIUM,20MG,250 mL,ORAL,Actual shortage,SYRUP,A06AA,DRUGS FOR CONSTIPATION,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-05
40985,1976141,Shortage,SENSORCAINE,ASPEN PHARMACARE CANADA INC.,Sensorcaine® 0.25% Plain 50x10mL SU Polyamp® Duofit®,BUPIVACAINE HYDROCHLORIDE,2.5MG,50x10mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-12,,2018-06-11,2018-06-15,Demand increase for the drug.,2018-02-26,2018-06-25
40988,1976168,Shortage,SENSORCAINE,ASPEN PHARMACARE CANADA INC.,Sensorcaine® 0.5% Plain 50x10mL SU Polyamp® Duofit®,BUPIVACAINE HYDROCHLORIDE,5MG,50x10mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-01,,2018-06-11,2018-06-19,Demand increase for the drug.,2018-02-26,2018-06-25
72477,1976184,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,"bupivacaine HCI  0.25% w/epi1:200M, 10x20mL SU Vial",BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE,2.5MG  5MCG,10 vials,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2019-02-04,,2019-03-08,2019-03-06,Delay in shipping of the drug.,2019-01-16,2019-03-07
81198,1976184,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,"Sensorcaine® 0.25% w/epi1:200M, 10x20mL SU Vial",BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE,2.5MG  5MCG,10,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2019-04-19,,2019-06-04,2019-06-06,Delay in shipping of the drug.,2019-04-11,2019-06-27
44217,1976206,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,"Sensorcaine® 0.5% w/epi. 1:200M, 10x20mL SU Vial",BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE,5MG  5MCG,10 vials,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-04-06,,2018-05-28,2018-05-28,Delay in shipping of the drug.,2018-03-29,2018-06-25
26084,1976184,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,"Sensorcaine® 0.25% w/epi1:200M, 10x20mL SU Vial",BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE,2.5MG  5MCG,10,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-10-20,,2018-02-23,2018-02-21,Other (Please describe in comments),2017-10-16,2018-02-22
31985,1976206,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,"Sensorcaine® 0.5% w/epi. 1:200M, 10x20mL SU Vial",BUPIVACAINE HYDROCHLORIDE  EPINEPHRINE,5MG  5MCG,10 x 20mL,BLOCK/INFILTRATION  EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-12-04,2018-03-05,2018-03-13,Delay in shipping of the drug.,2017-12-07,2018-03-14
67784,2428490,Shortage,SEPTA DONEPEZIL,SEPTA PHARMACEUTICALS INC,Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,30s Pack,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-11-28,,,Other (Please describe in comments),2018-11-28,2018-11-29
12813,2431629,Shortage,SEPTA-CITALOPRAM,SEPTA PHARMACEUTICALS INC,Citalopram,CITALOPRAM,10MG,100s,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2017-06-15,,,Other (Please describe in comments),2017-06-15,2018-12-21
63580,2355272,Shortage,SEPTA-CITALOPRAM,SEPTA PHARMACEUTICALS INC,Citalopram Hydrobromide,CITALOPRAM,20MG,100s,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-10-10,2019-01-31,2019-01-17,Other (Please describe in comments),2018-10-09,2019-01-22
63584,2355272,Shortage,SEPTA-CITALOPRAM,SEPTA PHARMACEUTICALS INC,Citalopram Hydrobromide,CITALOPRAM,20MG,500s,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,2018-10-10,,2019-01-31,2019-01-17,Other (Please describe in comments),2018-10-09,2019-01-22
65937,2355272,Shortage,SEPTA-CITALOPRAM,SEPTA PHARMACEUTICALS INC,Citalopram Hydrobromide,CITALOPRAM,20MG,100s & 500s,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-11-05,2018-12-14,2019-01-17,Delay in shipping of the drug.,2018-10-31,2019-01-22
26238,2424975,Shortage,SEPTA-LOSARTAN,SEPTA PHARMACEUTICALS INC,Losartan 50 mg,LOSARTAN POTASSIUM,50MG,100s,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-10-05,2017-11-05,2017-11-23,Other (Please describe in comments),2017-10-18,2017-11-24
72089,2424967,Shortage,SEPTA-LOSARTAN,SEPTA PHARMACEUTICALS INC,LOSARTAN POTASSIUM,LOSARTAN POTASSIUM,25MG,100 tabs,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-14,2019-01-15,2019-12-31,,Other (Please describe in comments),2019-01-14,2019-08-01
62907,2424975,Shortage,SEPTA-LOSARTAN,SEPTA PHARMACEUTICALS INC,Losartan Potassium,LOSARTAN POTASSIUM,50MG,100 tabs,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-10-03,2018-10-03,2019-12-31,,Other (Please describe in comments),2018-10-02,2019-08-01
70874,2424983,Shortage,SEPTA-LOSARTAN,SEPTA PHARMACEUTICALS INC,Losartan,LOSARTAN POTASSIUM,100MG,100s,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-01-03,2019-12-31,,Other (Please describe in comments),2019-01-03,2019-08-01
30627,2379767,Shortage,SEPTA-METFORMIN,SEPTA PHARMACEUTICALS INC,Metformin,METFORMIN HYDROCHLORIDE,500MG,500s,ORAL,Actual shortage,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-11-24,2017-11-24,,,Other (Please describe in comments),2017-11-24,2017-11-25
14082,2428474,Shortage,SEPTA-ZOLMITRIPTAN-ODT,SEPTA PHARMACEUTICALS INC,Zolmitriptan Orally Disintegrating tablets,ZOLMITRIPTAN,2.5MG,6s,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017-06-27,,,Disruption of the manufacture of the drug.,2017-06-27,2019-08-01
13422,2386909,Shortage,SEPTA-ZOPICLONE,SEPTA PHARMACEUTICALS INC,Zopiclone,ZOPICLONE,5MG,100s,ORAL,Actual shortage,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2017-06-20,2017-06-20,,,Other (Please describe in comments),2017-06-20,2018-12-21
13442,2386917,Shortage,SEPTA-ZOPICLONE,SEPTA PHARMACEUTICALS INC,Zopiclone,ZOPICLONE,7.5MG,100s and 500s,ORAL,Actual shortage,TABLET,N05CF,HYPNOTICS AND SEDATIVES,,2017-06-20,,,Other (Please describe in comments),2017-06-20,2018-12-21
46638,550086,Shortage,SEPTRA INJECTION,ASPEN PHARMACARE CANADA INC.,sulfamethoxazole 80mg/ml - trimethoprim 16mg/ml (5ml/amp),SULFAMETHOXAZOLE  TRIMETHOPRIM,80MG  16MG,10 amps,INTRAVENOUS,Resolved,SOLUTION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2018-04-24,2018-09-07,2018-09-07,Delay in shipping of the drug.,2018-04-20,2018-09-08
29395,550086,Shortage,SEPTRA INJECTION,ASPEN PHARMACARE CANADA INC.,Septra® Injection,SULFAMETHOXAZOLE  TRIMETHOPRIM,80MG  16MG,10 amps,INTRAVENOUS,Resolved,SOLUTION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017-11-20,2018-01-19,2018-01-17,Delay in shipping of the drug.,2017-11-16,2018-01-18
20740,2214261,Shortage,SEREVENT DISKHALER DISK (50MCG/DOSE),GLAXOSMITHKLINE INC,salmeterol xinafoate dry powder for inhalation,SALMETEROL,50MCG,15's,INHALATION  ORAL,Actual shortage,POWDER,R03AC,"ADRENERGICS, INHALANTS",,2017-08-30,,,Other (Please describe in comments),2017-08-31,2018-12-21
74306,2231129,Shortage,SEREVENT DISKUS (50MCG/DOSE),GLAXOSMITHKLINE INC,salmeterol xinafoate dry powder for inhalation,SALMETEROL,50MCG,1x60,INHALATION,Resolved,POWDER,R03AC,"ADRENERGICS, INHALANTS",,2019-02-06,2019-02-15,2019-02-14,Delay in shipping of the drug.,2019-02-01,2019-02-15
16549,2231129,Shortage,SEREVENT DISKUS (50MCG/DOSE),GLAXOSMITHKLINE INC,salmeterol xinafoate dry powder for inhalation,SALMETEROL,50MCG,1x60 doses,INHALATION,Avoided shortage,POWDER,R03AC,"ADRENERGICS, INHALANTS",2017-08-03,,2017-08-04,2017-07-31,Delay in shipping of the drug.,2017-07-20,2017-08-02
2471,2300206,Shortage,SEROQUEL XR,ASTRAZENECA CANADA INC,quetiapine fumarate extended-release tablets,QUETIAPINE,300MG,60 tablets,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017-04-24,2017-04-24,2017-04-26,2017-04-26,Demand increase for the drug.,2017-03-14,2017-04-27
6371,2300192,Shortage,SEROQUEL XR,ASTRAZENECA CANADA INC,quetiapine fumarate extended-release tablets,QUETIAPINE,200MG,60 tablets,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017-04-14,,,2017-05-15,Demand increase for the drug.,2017-04-10,2017-05-16
74341,2386089,Shortage,SERTRALINE,SIVEM PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,50MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2019-03-08,2019-03-07,2019-04-19,2019-04-19,Other (Please describe in comments),2019-02-01,2019-04-30
41089,2386070,Shortage,SERTRALINE,SIVEM PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-02-15,2018-03-30,2018-03-27,Delay in shipping of the drug.,2018-02-26,2018-04-02
75420,2386070,Shortage,SERTRALINE,SIVEM PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,25MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2019-03-11,2019-03-12,2019-04-19,2019-04-19,Other (Please describe in comments),2019-02-12,2019-04-30
76016,2386097,Shortage,SERTRALINE,SIVEM PHARMACEUTICALS ULC,SERTRALINE,SERTRALINE,100MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2019-03-13,2019-03-13,2019-04-19,2019-04-19,Other (Please describe in comments),2019-02-15,2019-04-30
49948,2241304,Shortage,SERTRALINE-100,PRO DOC LIMITEE,SERTRALINE-100,SERTRALINE,100.0MG,250,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-05-22,,2018-06-06,Delay in shipping of the drug.,2018-05-22,2018-06-07
91502,2241304,Shortage,SERTRALINE-100,PRO DOC LIMITEE,SERTRALINE,SERTRALINE,100.0MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2019-08-14,2019-09-18,2019-08-30,Delay in shipping of the drug.,2019-08-14,2019-08-31
59142,2468425,Shortage,SHINGRIX,GLAXOSMITHKLINE INC,Herpes Zoster vaccine,VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN,50MCG,1's,INTRAMUSCULAR,Actual shortage,SUSPENSION,J07BK,,,2018-08-24,,,Other (Please describe in comments),2018-08-24,2019-10-18
59145,2468425,Shortage,SHINGRIX,GLAXOSMITHKLINE INC,Herpes Zoster vaccine,VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN,50MCG,10's,INTRAMUSCULAR,Actual shortage,SUSPENSION,J07BK,,,2018-08-24,,,Other (Please describe in comments),2018-08-24,2019-10-18
45716,2468425,Shortage,SHINGRIX,GLAXOSMITHKLINE INC,Herpes Zoster vaccine,VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN,50MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BK,,,2018-04-30,2018-06-15,2018-06-06,Demand increase for the drug.,2018-04-13,2018-06-08
62560,2413310,Shortage,SIGNIFOR,NOVARTIS PHARMACEUTICALS CANADA INC,SIGNIFOR 0.9MG 1 ml (X60) AMP,PASIREOTIDE,0.9MG,0.9MG 1 ML (X60),SUBCUTANEOUS,Resolved,SOLUTION,H01CB,HYPOTHALAMIC HORMONES,,2018-09-25,2018-11-07,2018-11-07,Demand increase for the drug.,2018-09-28,2018-11-08
92048,2413299,Shortage,SIGNIFOR,NOVARTIS PHARMACEUTICALS CANADA INC,SIGNIFOR 0.3MG/1ML (X60) AMPS,PASIREOTIDE,0.3MG,60,SUBCUTANEOUS,Resolved,SOLUTION,H01CB,HYPOTHALAMIC HORMONES,2019-08-21,2019-08-21,2019-10-11,2019-10-04,Delay in shipping of the drug.,2019-08-21,2019-10-05
80302,2437279,Shortage,SIGNIFOR LAR,NOVARTIS PHARMACEUTICALS CANADA INC,SIGNIFOR LAR 60MG,PASIREOTIDE,60MG,60 MG,INTRAMUSCULAR,Avoided shortage,"KIT  POWDER FOR SUSPENSION, SUSTAINED-RELEASE",H01CB,HYPOTHALAMIC HORMONES,2019-04-18,,2019-05-27,2019-04-12,Delay in shipping of the drug.,2019-04-02,2019-04-12
8964,2317583,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,100MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2017-09-15,2017-09-15,2017-10-10,2017-10-10,Disruption of the manufacture of the drug.,2017-05-04,2017-10-11
53253,2317583,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,100MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-08-07,2018-08-23,2018-12-17,2018-12-11,Disruption of the manufacture of the drug.,2018-06-29,2018-12-12
51731,2317575,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,50MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-07-16,2018-06-26,2018-10-29,2018-11-28,Disruption of the manufacture of the drug.,2018-06-06,2018-11-29
25163,2424312,Shortage,SILDENAFIL,PRO DOC LIMITEE,SILDENAFIL,SILDENAFIL,50MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-10-10,,2018-01-30,Delay in shipping of the drug.,2017-10-10,2018-01-31
84557,2424312,Shortage,SILDENAFIL,PRO DOC LIMITEE,SILDENAFIL,SILDENAFIL,50MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-05-22,2019-06-20,2019-06-18,Delay in shipping of the drug.,2019-05-22,2019-06-19
56945,2424320,Shortage,SILDENAFIL,PRO DOC LIMITEE,SILDENAFIL,SILDENAFIL,100MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-07-30,,2019-01-17,Delay in shipping of the drug.,2018-07-30,2019-01-18
59784,2406152,Shortage,SILDENAFIL,SANIS HEALTH INC,SILDENAFIL CITRATE,SILDENAFIL,50MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-09-04,2018-09-04,2018-09-21,2018-09-20,Delay in shipping of the drug.,2018-09-04,2018-09-21
72641,2317575,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,50MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-01-16,2019-06-21,2019-07-29,Other (Please describe in comments),2019-01-16,2019-07-31
88001,2317583,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,100MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-05-28,2019-08-08,2019-09-03,Disruption of the manufacture of the drug.,2019-06-28,2019-09-04
88004,2317583,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,100MG,4,ORAL,Avoided shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-06-28,2019-10-02,2018-12-11,Disruption of the manufacture of the drug.,2019-06-28,2019-07-31
37337,2317575,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,50MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-02-01,2018-12-10,2018-12-11,Disruption of the manufacture of the drug.,2018-01-26,2018-12-12
38881,2317583,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,100MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-02-12,2018-02-12,2018-06-20,2018-06-06,Disruption of the manufacture of the drug.,2018-02-06,2018-06-07
83708,2317583,Shortage,SILDENAFIL,PHARMASCIENCE INC,SILDENAFIL,SILDENAFIL,100MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2019-05-08,2019-05-28,2019-10-11,2019-11-04,Disruption of the manufacture of the drug.,2019-05-09,2019-11-15
54790,2284723,Shortage,SIMVASTATIN,SANIS HEALTH INC,SIMVASTATIN TAB,SIMVASTATIN,5MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-08-31,2018-09-04,,,Disruption of the manufacture of the drug.,2018-07-09,2018-09-05
54794,2284766,Shortage,SIMVASTATIN,SANIS HEALTH INC,SIMVASTATIN TAB,SIMVASTATIN,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-31,2018-11-21,,,Disruption of the manufacture of the drug.,2018-07-09,2018-11-22
54798,2284774,Shortage,SIMVASTATIN,SANIS HEALTH INC,SIMVASTATIN TAB,SIMVASTATIN,80MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-10-31,2018-11-21,,,Disruption of the manufacture of the drug.,2018-07-09,2018-11-22
54802,2284731,Shortage,SIMVASTATIN,SANIS HEALTH INC,SIMVASTATIN TAB,SIMVASTATIN,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2019-01-01,,,,Disruption of the manufacture of the drug.,2018-07-09,2019-01-02
54783,2284758,Shortage,SIMVASTATIN,SANIS HEALTH INC,SIMVASTATIN TAB,SIMVASTATIN,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-08-31,2018-09-04,,,Disruption of the manufacture of the drug.,2018-07-09,2018-09-05
29727,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,levodopa and carbidopa tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,2018-01-11,2018-01-12,2018-02-09,2018-02-09,Delay in shipping of the drug.,2017-11-20,2018-02-10
57126,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,levodopa and carbidopa tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100TAB,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,2018-11-16,2018-11-08,2020-07-17,,Disruption of the manufacture of the drug.,2018-07-31,2019-04-03
1397,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,"levodopa and carbidopa tablets, USP",CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,2017-03-13,2017-03-13,2017-03-23,2017-03-20,Delay in shipping of the drug.,2017-03-13,2017-03-21
11904,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,levodopa and carbidopa tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,2017-06-23,2017-06-22,2017-08-25,2017-07-31,Other (Please describe in comments),2017-06-05,2017-08-04
18907,513997,Shortage,SINEMET 100/25,MERCK CANADA INC,Levodopa and Carbidopa Tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Avoided shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,2017-09-07,,2017-09-08,2017-09-05,Other (Please describe in comments),2017-08-11,2017-10-11
57129,328219,Shortage,SINEMET 250/25,MERCK CANADA INC,levodopa and carbidopa tablets,CARBIDOPA  LEVODOPA,25MG  250MG,100TAB,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,2018-10-15,2018-10-15,2019-02-08,2019-02-05,Disruption of the manufacture of the drug.,2018-07-31,2019-02-06
80490,328219,Shortage,SINEMET 250/25,MERCK CANADA INC,levodopa and carbidopa tablets,CARBIDOPA  LEVODOPA,25MG  250MG,100TAB,ORAL,Anticipated shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,2019-11-22,,2020-07-17,,Disruption of the manufacture of the drug.,2019-04-03,2019-07-03
49684,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100TAB,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2018-06-29,2018-06-28,2019-01-22,2019-01-22,Disruption of the manufacture of the drug.,2018-05-17,2019-01-23
6943,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017-05-03,2017-05-04,2017-05-10,2017-05-05,Demand increase for the drug.,2017-04-13,2017-05-06
29730,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2018-03-05,,2018-03-06,2018-03-02,Delay in shipping of the drug.,2017-11-20,2018-08-13
11901,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017-06-16,,2017-06-21,2017-06-13,Delay in shipping of the drug.,2017-06-05,2017-10-11
16782,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017-08-07,2017-08-04,2017-08-28,2017-08-28,Other (Please describe in comments),2017-07-24,2017-08-29
20658,2028786,Shortage,SINEMET CR 100/25,MERCK CANADA INC,levodopa and carbidopa controlled release tablets,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2017-09-21,2017-09-21,2017-10-06,2017-09-21,Other (Please describe in comments),2017-08-30,2017-09-22
57132,870935,Shortage,SINEMET CR 200/50,MERCK CANADA INC,levodopa and carbidopa controlledrelease tablets,CARBIDOPA  LEVODOPA,50MG  200MG,100TAB,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,2019-02-15,2019-02-11,2019-04-01,2019-04-01,Disruption of the manufacture of the drug.,2018-07-31,2019-04-03
16790,870935,Shortage,SINEMET CR 200/50,MERCK CANADA INC,levodopa and carbidopa controlledrelease tablets,CARBIDOPA  LEVODOPA,50MG  200MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N04BA,DOPAMINERGIC AGENTS,,2017-08-02,2017-08-28,2017-08-28,Other (Please describe in comments),2017-07-24,2017-08-29
35908,24333,Shortage,SINEQUAN,AA PHARMA INC,SINEQUAN,DOXEPIN,25MG,100 Bottle,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2018-01-15,2018-01-30,2018-01-31,Disruption of the manufacture of the drug.,2018-01-15,2018-02-01
31988,24325,Shortage,SINEQUAN,AA PHARMA INC,SINEQUAN,DOXEPIN,10MG,100BTL,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2017-12-07,2017-12-21,2017-12-21,Disruption of the manufacture of the drug.,2017-12-07,2017-12-22
39689,2238217,Shortage,SINGULAIR,MERCK CANADA INC,montelukast tablets,MONTELUKAST,10MG,30TAB BLIS,ORAL,Avoided shortage,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-03-12,2018-03-07,2018-03-16,2018-03-09,Delay in shipping of the drug.,2018-02-13,2018-03-09
58199,2238217,Shortage,SINGULAIR,MERCK CANADA INC,montelukast tablets,MONTELUKAST,10MG,30TAB BLIS,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-08-15,2018-08-27,2018-08-21,Delay in shipping of the drug.,2018-08-15,2018-08-22
52354,2238217,Shortage,SINGULAIR,MERCK CANADA INC,montelukast tablets,MONTELUKAST,10MG,30TAB BLIS,ORAL,Resolved,TABLET,R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2018-06-13,2018-06-25,2018-06-18,Delay in shipping of the drug.,2018-06-13,2018-06-19
54750,2238216,Shortage,SINGULAIR,MERCK CANADA INC,montelukast tablets,MONTELUKAST,5MG,30TAB BLIS,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,2018-07-27,2018-07-19,2018-08-10,2018-07-31,Delay in shipping of the drug.,2018-07-07,2018-08-01
8495,2228599,Shortage,SINOGRAFIN - LIQ IU,BRACCO IMAGING CANADA,SINOGRAFIN,DIATRIZOATE MEGLUMINE  MEGLUMINE IODIPAMIDE,52.7%  26.9%,10 X 10ml,INTRAUTERINE,Actual shortage,LIQUID,V08,"X-RAY CONTRAST MEDIA, IODINATED",,2017-05-01,,,Disruption of the manufacture of the drug.,2017-05-01,2018-12-21
19809,10383,Shortage,SINTROM,PALADIN LABS INC,Sintrom,ACENOCOUMAROL,1MG,100 Tablets,ORAL,Actual shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2019-05-31,,,,Disruption of the manufacture of the drug.,2017-08-18,2019-06-01
19812,10391,Shortage,SINTROM,PALADIN LABS INC,Sintrom,ACENOCOUMAROL,4MG,100 Tablets,ORAL,Anticipated shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,2020-06-30,,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-21
91086,10383,Shortage,SINTROM,PALADIN LABS INC,SINTROM 1MG 100 TABS,ACENOCOUMAROL,1MG,100 Tabs,ORAL,Actual shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2019-08-07,,,Other (Please describe in comments),2019-08-07,2019-08-08
27881,554308,Shortage,SLO-POT,BIOMED PHARMA,Slow-Release Potassium Chloride Tablets 600 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27884,554308,Shortage,SLO-POT,BIOMED PHARMA,Slow-Release Potassium Chloride Tablets 600 mg,,,1000,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27887,554308,Shortage,SLO-POT,BIOMED PHARMA,Slow-Release Potassium Chloride Tablets 600 mg,,,500,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
59659,2181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LTD,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50 mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-08-31,2018-09-15,2018-09-14,Disruption of the manufacture of the drug.,2018-08-31,2018-09-15
68887,2181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LTD,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50 mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-12-05,2019-01-31,2018-12-21,Disruption of the manufacture of the drug.,2018-12-07,2019-01-13
61485,2181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LTD,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50 mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-09-12,,2018-11-30,Disruption of the manufacture of the drug.,2018-09-14,2018-12-01
52934,2181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LTD,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50 mL vial,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-05-30,2018-07-31,2018-07-23,Disruption of the manufacture of the drug.,2018-06-26,2018-07-25
12477,261998,Shortage,SODIUM BICARBONATE INJ 8.4%,HOSPIRA HEALTHCARE CORPORATION,Sodium bicarbonate,SODIUM BICARBONATE,84MG,25 x 50mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017-06-08,2017-10-16,2017-10-04,Disruption of the manufacture of the drug.,2017-06-09,2017-10-05
59926,261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA INC,SODIUM BICARBONATE,SODIUM BICARBONATE,84MG,25x50mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-09-04,,2018-11-21,Disruption of the manufacture of the drug.,2018-09-04,2018-11-22
61499,2467585,Shortage,SODIUM BICARBONATE INJECTION USP,OMEGA LABORATORIES LTD,Sodium Bicarbonate Injecion USP,SODIUM BICARBONATE,4.2G,10 x 50 mL vial,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-09-07,,2018-11-30,Disruption of the manufacture of the drug.,2018-09-14,2018-12-01
43092,38083,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA INC,SODIUM BICARBONATE LIFESHIELD,SODIUM BICARBONATE,75MG,10 x 50mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2018-05-04,,,2018-05-16,Disruption of the manufacture of the drug.,2018-03-16,2018-05-17
98418,2467585,Shortage,SODIUM BICARBONATE INJECTION USP,OMEGA LABORATORIES LTD,Sodium Bicarbonate Injecion USP,SODIUM BICARBONATE,4.2G,10 x 50 mL vial / fiole,INTRAVENOUS,Actual shortage,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-10-18,2020-03-31,,Disruption of the manufacture of the drug.,2019-11-11,2019-11-11
63388,261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA INC,Sodium Bicarbonate Injection USP,SODIUM BICARBONATE,84MG,10 x 50mL LifeShield Syringes,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-11-27,,2019-04-17,Disruption of the manufacture of the drug.,2018-10-05,2019-04-18
26272,261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA INC,Sodium Bicarbonate,SODIUM BICARBONATE,84MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017-10-23,,2017-10-31,2017-11-02,Disruption of the manufacture of the drug.,2017-10-18,2017-11-06
34276,261971,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA INC,SODIUM BICARBONATE INJECTION LIFESHIELD 4.2%,SODIUM BICARBONATE,42MG,10x10mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-01-19,,2018-02-02,Demand increase for the drug.,2017-12-22,2018-02-07
86511,261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,Sodium Bicarbonate Injection USP,SODIUM BICARBONATE,84MG,10 x 50mL LifeShield,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-06-11,,2019-11-06,Disruption of the manufacture of the drug.,2019-06-12,2019-11-07
86525,261971,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,Sodium Bicarbonate Injection USP,SODIUM BICARBONATE,42MG,10 x 10mL LifeShield,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-09-30,,2019-11-07,Disruption of the manufacture of the drug.,2019-06-12,2019-11-08
26121,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Inj - AVIVA,SODIUM CHLORIDE,900MG,250mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-01-04,2018-01-04,2018-11-27,2018-11-27,Disruption of the manufacture of the drug.,2017-10-17,2018-11-27
56915,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Injection,SODIUM CHLORIDE,900MG,100mL Mini-Bag Plus,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-07-30,2018-07-30,2018-10-09,2018-10-09,Disruption of the manufacture of the drug.,2018-07-30,2018-10-10
56918,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Injection,SODIUM CHLORIDE,900MG,50mL Mini-Bag Plus,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-07-30,2018-07-30,2018-10-09,2018-10-09,Disruption of the manufacture of the drug.,2018-07-30,2018-10-10
68703,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Injection,SODIUM CHLORIDE,900MG,500mL AVIVA bag,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-12-17,2018-12-17,2019-02-25,2019-02-25,Disruption of the manufacture of the drug.,2018-12-05,2019-02-26
32177,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Inj – AVIVA,SODIUM CHLORIDE,900MG,500mL AVIVA,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2018-01-04,2018-01-04,2018-11-27,2018-11-27,Disruption of the manufacture of the drug.,2017-12-08,2018-11-27
19378,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,"0.9% Sodium Chloride Injection, USP",SODIUM CHLORIDE,900MG,"50mL, 100mL",INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2017-08-15,2017-08-15,2018-02-28,2018-02-28,Disruption of the manufacture of the drug.,2017-08-15,2018-03-01
80332,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Injection,SODIUM CHLORIDE,900MG,250 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-04-02,2019-04-02,2019-05-01,2019-05-01,Demand increase for the drug.,2019-04-03,2019-05-02
76013,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Injection,SODIUM CHLORIDE,900MG,100 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-02-15,2019-02-15,2019-04-10,2019-04-10,Shortage of an active ingredient.,2019-02-15,2019-04-11
76018,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Injection,SODIUM CHLORIDE,900MG,500 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-02-15,2019-02-15,2019-02-28,2019-02-28,Delay in shipping of the drug.,2019-02-15,2019-03-01
76022,60208,Shortage,SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP,BAXTER CORPORATION,0.9% Sodium Chloride Injection,SODIUM CHLORIDE,900MG,250 mL,INTRAVENOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,2019-02-15,2019-02-15,2019-03-28,2019-02-28,Delay in shipping of the drug.,2019-02-15,2019-03-01
15059,783633,Shortage,SODIUM CHLORIDE 1.6% SOLUTION USP,BAXTER CORPORATION,1.6% Sodium Chloride Solution,SODIUM CHLORIDE,1.6G,"Product Code 4B7871, 2000 mL",IRRIGATION,Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,2017-07-10,2017-07-10,2017-12-18,2017-12-18,Disruption of the manufacture of the drug.,2017-07-10,2017-12-19
15056,783625,Shortage,SODIUM CHLORIDE 12% USP,BAXTER CORPORATION,12% Sodium Chloride Solution,SODIUM CHLORIDE,12G,"Product Code 4B7874Q, 150 mL",IRRIGATION,Resolved,LIQUID,B05CB,IRRIGATING SOLUTIONS,2017-07-10,2017-07-10,2017-12-18,2017-12-18,Disruption of the manufacture of the drug.,2017-07-10,2017-12-19
54756,402249,Shortage,SODIUM CHLORIDE BACTERIOSTATIC INJ,OMEGA LABORATORIES LTD,Sodium Chloride Bacteriostatic for Injection USP,SODIUM CHLORIDE,9MG,10 x 30 mL vial,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID,B05XA,I.V. SOLUTION ADDITIVES,,2018-07-09,2018-07-31,2018-07-20,Disruption of the manufacture of the drug.,2018-07-09,2018-07-25
2131,402230,Shortage,SODIUM CHLORIDE INJ 23.4%,OMEGA LABORATORIES LTD,Sodium Chloride Injection USP 23.4%,SODIUM CHLORIDE,234MG,30mL vial,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2016-09-19,2017-04-15,2017-03-29,Disruption of the manufacture of the drug.,2017-03-14,2017-06-19
92781,402230,Shortage,SODIUM CHLORIDE INJ 23.4%,OMEGA LABORATORIES LTD,Sodium Chloride for Injection USP,SODIUM CHLORIDE,234MG,10 x 30mL vial / fiole,INTRAVENOUS,Actual shortage,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-10-30,,,Disruption of the manufacture of the drug.,2019-08-30,2019-11-11
39754,37842,Shortage,SODIUM CHLORIDE INJECTION USP,ICU MEDICAL CANADA INC,0.9% Sodium Chloride Injection USP,SODIUM CHLORIDE,9MG,50ml & 250ml,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-02-14,2018-02-20,2018-02-20,Demand increase for the drug.,2018-02-14,2018-02-27
2160,2150204,Shortage,SODIUM CHLORIDE INJECTION USP,OMEGA LABORATORIES LTD,Sodium Chloride for Injection USP,SODIUM CHLORIDE,9MG,10mL vial,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017-04-15,2017-02-09,,2018-05-23,Disruption of the manufacture of the drug.,2017-03-14,2018-06-11
30073,37796,Shortage,SODIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,SODIUM CHLORIDE,SODIUM CHLORIDE,9MG,25x10mL,INTRAMUSCULAR  INTRAPERITONEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2017-11-24,,2018-11-17,Disruption of the manufacture of the drug.,2017-11-21,2018-11-19
58255,37842,Shortage,SODIUM CHLORIDE INJECTION USP,ICU MEDICAL CANADA INC,0.9% Sodium Chloride Injection USP 50 mL,SODIUM CHLORIDE,9MG,50ML,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2018-09-01,,2018-09-30,2018-10-22,Other (Please describe in comments),2018-08-16,2018-11-29
43932,37796,Shortage,SODIUM CHLORIDE INJECTION USP,PFIZER CANADA INC,SODIUM CHLORIDE,SODIUM CHLORIDE,9MG,25 x 20mL PVL,INTRAMUSCULAR  INTRAPERITONEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-07-06,,2018-07-25,Disruption of the manufacture of the drug.,2018-03-26,2018-07-26
39965,2304341,Shortage,SODIUM CHLORIDE INJECTION USP 0.9%,TELIGENT OU,Sodium Chloride Injection  USP,SODIUM CHLORIDE,9MG,10 ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2018-02-14,2018-03-01,2018-03-07,Demand increase for the drug.,2018-02-15,2018-03-08
44923,2304341,Shortage,SODIUM CHLORIDE INJECTION USP 0.9%,TELIGENT OU,Sodium Chloride Injection,SODIUM CHLORIDE,9MG,10 ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2018-04-01,2018-04-27,2018-04-26,Other (Please describe in comments),2018-04-04,2018-04-27
14445,2139510,Shortage,"SODIUM CHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,Sodium Chloride Injection,SODIUM CHLORIDE,234MG,200mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017-07-03,,2017-11-01,2017-10-27,Disruption of the manufacture of the drug.,2017-06-30,2017-10-28
14448,2139510,Shortage,"SODIUM CHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,Sodium Chloride Injection,SODIUM CHLORIDE,234MG,30mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,2017-07-28,,2017-08-31,2017-08-25,Disruption of the manufacture of the drug.,2017-06-30,2017-08-28
91029,2139510,Shortage,"SODIUM CHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,Sodium Chloride Injection,SODIUM CHLORIDE,234MG,100mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-07-10,2019-09-30,2019-10-01,Disruption of the manufacture of the drug.,2019-08-06,2019-10-02
41175,37834,Shortage,SODIUM CHLORIDE IRRIGATION USP,ICU MEDICAL CANADA INC,0.9% Sodium Chloride Irrigation USP,SODIUM CHLORIDE,9MG,250ML,INTRAPERITONEAL  IRRIGATION  TOPICAL,Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,2018-02-27,2018-02-27,2018-06-30,2018-06-19,Disruption of the manufacture of the drug.,2018-02-27,2018-07-23
10089,786160,Shortage,SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP,BAXTER CORPORATION,SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP,SODIUM CHLORIDE,900MG,1000mL,IRRIGATION,Resolved,LIQUID,B05CB,IRRIGATING SOLUTIONS,2017-05-11,2017-05-11,2017-09-06,2017-09-06,Disruption of the manufacture of the drug.,2017-05-11,2017-09-07
93257,896187,Shortage,SODIUM PHOSPHATES INJECTION USP,SANDOZ CANADA INCORPORATED,SODIUM PHOSPHATES,SODIUM PHOSPHATE DIBASIC  SODIUM PHOSPHATE MONOBASIC,268MG  276MG,10 X 10ML,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2019-06-03,2019-12-02,2019-10-31,Disruption of the manufacture of the drug.,2019-09-09,2019-11-01
79024,2137186,Shortage,SODIUM THIOSULFATE INJECTION USP,PFIZER CANADA ULC,Sodium,SODIUM THIOSULFATE,25%,10mL Glass vial,INTRAVENOUS,Actual shortage,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,,2019-09-09,2020-01-06,,Disruption of the manufacture of the drug.,2019-03-20,2019-09-10
94406,2428393,Shortage,SODIUM THIOSULFATE INJECTION USP,HOPE PHARMACEUTICALS LTD,Sodium Thiosulfate Injection USP,SODIUM THIOSULFATE,250MG,1 x 50 mL Vials,INTRAVENOUS,Actual shortage,SOLUTION,V03AB,ALL OTHER THERAPEUTIC PRODUCTS,2019-09-25,2019-09-27,,,Delay in shipping of the drug.,2019-09-19,2019-09-28
83714,2029529,Shortage,SOFLAX,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,200MG,500,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2019-05-08,2019-10-07,2019-09-09,Disruption of the manufacture of the drug.,2019-05-09,2019-09-12
38914,2029529,Shortage,SOFLAX,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,200MG,500,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-02-02,2019-03-05,2019-03-25,Disruption of the manufacture of the drug.,2018-02-06,2019-03-28
64829,1994344,Shortage,SOFLAX CAPSULES 100MG,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,100MG,100,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-10-17,2018-11-22,2018-11-28,Disruption of the manufacture of the drug.,2018-10-19,2018-11-29
64832,1994344,Shortage,SOFLAX CAPSULES 100MG,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,100MG,1000,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-10-17,2018-11-20,2018-11-28,Disruption of the manufacture of the drug.,2018-10-19,2018-11-29
25813,1994344,Shortage,SOFLAX CAPSULES 100MG,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,100MG,100,ORAL,Actual shortage,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2017-10-01,,,Disruption of the manufacture of the drug.,2017-10-12,2017-10-26
25810,2006758,Shortage,SOFLAX SYRUP 4MG/ML,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,4MG,500mL,ORAL,Resolved,SYRUP,A06AA,DRUGS FOR CONSTIPATION,,2017-10-01,2017-11-27,2017-12-18,Disruption of the manufacture of the drug.,2017-10-12,2017-12-19
38911,2006758,Shortage,SOFLAX SYRUP 4MG/ML,PHARMASCIENCE INC,SOFLAX,DOCUSATE SODIUM,4MG,500ML,ORAL,Resolved,SYRUP,A06AA,DRUGS FOR CONSTIPATION,,2018-02-02,2018-07-25,2018-07-12,Disruption of the manufacture of the drug.,2018-02-06,2018-07-13
2489,1988840,Shortage,SOFRA-TULLE DRESSING 1%,ERFA CANADA 2012 INC,Framycetin Sulfate,Framycetin Sulfate,1%,box of 50,to apply,Actual shortage,10/10cm,D09AA,MEDICATED DRESSINGS,2013-10-23,2013-10-23,,,Requirements related to complying with good manufacturing practices.,2017-03-14,2018-03-14
2332,1987682,Shortage,SOFRA-TULLE STRIP 1%,ERFA CANADA 2012 INC,"Framycetin Sulfate,BP 1%",FRAMYCETIN SULFATE,1%,box of 10,TOPICAL,Actual shortage,DRESSING,D09AA,MEDICATED DRESSINGS,2017-02-09,2017-02-09,,,Requirements related to complying with good manufacturing practices.,2017-03-14,2018-03-14
3060,2224623,Shortage,SOFRACORT STERILE EAR/EYE DROPS,SANOFI-AVENTIS CANADA INC,Sofracort Sterile Ear/Eye Drops,DEXAMETHASONE  GRAMICIDIN  FRAMYCETIN SULFATE,0.5MG  0.05MG  5MG,8 mL,OPHTHALMIC  OTIC,Resolved,DROPS,S03CA,CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION,2017-05-15,2017-05-15,2018-12-14,2018-12-18,Other (Please describe in comments),2017-03-16,2019-01-10
2954,2224887,Shortage,SOFRAMYCIN EYE DROPS 0.5%,ERFA CANADA 2012 INC,Soframycin Eye Drops,FRAMYCETIN SULFATE,5MG,bottle,OPHTHALMIC,Actual shortage,DROPS,S01AA,ANTIINFECTIVES,2013-06-11,2013-06-11,,,Disruption of the manufacture of the drug.,2017-03-15,2018-03-14
2949,2224879,Shortage,SOFRAMYCIN SKIN OINTMENT,ERFA CANADA 2012 INC,Framycetin Sulfate,GRAMICIDIN  FRAMYCETIN SULFATE,50MCG  15MG,tube,TOPICAL,Actual shortage,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,2013-06-11,2013-06-11,,,Disruption of the manufacture of the drug.,2017-03-15,2018-03-14
2579,2224895,Shortage,SOFRAMYCIN STERILE EYE OINTMENT 0.5%,ERFA CANADA 2012 INC,Framycetin Sulfate,FRAMYCETIN SULFATE,5MG,tube,OPHTHALMIC,Actual shortage,OINTMENT,S01AA,ANTIINFECTIVES,2013-06-11,2013-06-11,,,Disruption of the manufacture of the drug.,2017-03-14,2018-03-14
86061,2458241,Shortage,SOLIFENACIN,SANIS HEALTH INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-06-10,2019-10-18,2019-10-09,Disruption of the manufacture of the drug.,2019-06-10,2019-10-10
86064,2458268,Shortage,SOLIFENACIN,SANIS HEALTH INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-06-10,2019-10-08,2019-10-09,Disruption of the manufacture of the drug.,2019-06-10,2019-10-10
86502,30635,Shortage,SOLU-CORTEF 1 GM ACT-O-VIAL,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,1G,5 X 8mL AOV,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-11,,2019-08-05,Disruption of the manufacture of the drug.,2019-06-12,2019-08-06
49715,30600,Shortage,SOLU-CORTEF 100 MG ACT-O-VIAL,PFIZER CANADA INC,SOLU-CORTEF AOV,HYDROCORTISONE,100MG,10 x 2mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2018-05-18,,2018-05-24,Disruption of the manufacture of the drug.,2018-05-18,2018-05-25
86491,30600,Shortage,SOLU-CORTEF 100 MG ACT-O-VIAL,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,100MG,10 X 2mL AOV,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-11,,2019-08-05,Disruption of the manufacture of the drug.,2019-06-12,2019-08-06
20792,30619,Shortage,SOLU-CORTEF 250 MG ACT-O-VIAL,PFIZER CANADA INC,Solu-Cortef,HYDROCORTISONE,250MG,10x2mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2017-09-30,,2017-10-11,2017-10-18,Demand increase for the drug.,2017-09-01,2017-10-19
86496,30619,Shortage,SOLU-CORTEF 250 MG ACT-O-VIAL,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,250MG,10 X 2mL aov,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-11,,2019-08-05,Disruption of the manufacture of the drug.,2019-06-12,2019-08-06
86033,2367971,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,1G,1 x 8mL AOV,INTRAMUSCULAR  INTRAVENOUS,Resolved,KIT  POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-07,,2019-08-05,Disruption of the manufacture of the drug.,2019-06-10,2019-08-06
93117,2367947,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,40MG,10 x 1mL AOV,INTRAMUSCULAR  INTRAVENOUS,Resolved,KIT  POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-09-06,,2019-09-16,Demand increase for the drug.,2019-09-05,2019-09-17
86484,2367947,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,40MG,10 X 1 mL AOV,INTRAMUSCULAR  INTRAVENOUS,Resolved,KIT  POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-11,,2019-08-07,Disruption of the manufacture of the drug.,2019-06-12,2019-08-08
86499,36137,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,1G,1 X 30mL GVL,INTRAMUSCULAR  INTRAVENOUS,Resolved,POWDER FOR SOLUTION  KIT,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2019-06-11,,2019-09-05,Disruption of the manufacture of the drug.,2019-06-12,2019-09-06
40427,2367955,Shortage,SOLU-MEDROL,PFIZER CANADA INC,SOLU-MEDROL,METHYLPREDNISOLONE,125MG,10X2mL AOV,INTRAMUSCULAR  INTRAVENOUS,Resolved,KIT  POWDER FOR SOLUTION,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2018-02-21,,2018-02-28,Demand increase for the drug.,2018-02-21,2018-03-01
6661,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT ORAL SUSPENSION,SODIUM POLYSTYRENE SULFONATE,250MG,60mL,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017-06-06,2017-06-06,2017-06-06,2017-06-06,Disruption of the manufacture of the drug.,2017-04-12,2017-10-05
70683,755338,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF PHARMASCIENCE INC,SODIUM POLYSTYRENE SULFONATE,SODIUM POLYSTYRENE SULFONATE,94.3MG,454G,ORAL  RECTAL,Avoided shortage,POWDER,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2019-04-15,,2019-04-23,2019-03-31,Delay in shipping of the drug.,2018-12-28,2019-04-12
68901,755338,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF PHARMASCIENCE INC,SODIUM POLYSTYRENE SULFONATE,SODIUM POLYSTYRENE SULFONATE,94.3MG,454G,ORAL  RECTAL,Resolved,POWDER,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2018-11-19,2018-11-15,2018-12-27,2018-12-14,Disruption of the manufacture of the drug.,2018-12-07,2018-12-20
5416,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL U.D.SUSP,SODIUM POLYSTYRENE SULFONATE,250MG,60mL,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017-06-06,2017-06-06,2017-10-16,2017-10-11,Disruption of the manufacture of the drug.,2017-04-04,2017-10-12
5422,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL SUSP,SODIUM POLYSTYRENE SULFONATE,250MG,500mL,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017-06-13,2017-06-16,2017-10-16,2017-10-11,Disruption of the manufacture of the drug.,2017-04-04,2017-10-12
26779,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL SUSP 500mL,SODIUM POLYSTYRENE SULFONATE,250MG,500ML,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017-12-01,2017-12-01,2018-02-07,2018-02-02,Disruption of the manufacture of the drug.,2017-10-24,2018-02-05
29863,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL U.D.SUSP 60mL,SODIUM POLYSTYRENE SULFONATE,250MG,60ml,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2017-12-18,2017-12-01,2018-03-12,2018-03-06,Disruption of the manufacture of the drug.,2017-11-20,2018-03-13
40154,769541,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SOLYSTAT 250mg/mL U.D.SUSP,SODIUM POLYSTYRENE SULFONATE,250MG,500mL,ORAL,Resolved,SUSPENSION,V03AE,ALL OTHER THERAPEUTIC PRODUCTS,2018-03-07,,2018-03-12,2018-03-07,Delay in shipping of the drug.,2018-02-19,2018-03-13
27890,414220,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 15 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27893,414220,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 15 mg,,,1000,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27896,414239,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 30 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27899,414239,Shortage,SOM-PAM,BIOMED PHARMA,Flurazepam Hydrochloride Capsules 30 mg,,,1000,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
12119,2448858,Shortage,SOMAVERT,PFIZER CANADA INC,Somavert,PEGVISOMANT,30MG,1 x 1mL pre filled syringe,SUBCUTANEOUS,Resolved,KIT  POWDER FOR SOLUTION,H01AX,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,,2017-06-05,2017-06-12,2017-06-12,Delay in shipping of the drug.,2017-06-06,2017-06-13
3761,2237578,Shortage,SPASMHALT-8,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SPASMHALT-8 325mgACET/8mgCOD CAPL BL3X9,ACETAMINOPHEN  METHOCARBAMOL  CODEINE PHOSPHATE,325MG  400MG  8MG,BL3X9,ORAL,Actual shortage,TABLET,M03BA,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017-03-16,,,Disruption of the manufacture of the drug.,2017-03-21,2018-12-21
38087,2237578,Shortage,SPASMHALT-8,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,SPASMHALT-8 325mg ACET/8mg COD CAPL 50,ACETAMINOPHEN  METHOCARBAMOL  CODEINE PHOSPHATE,325MG  400MG  8MG,50,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2018-02-01,,,Disruption of the manufacture of the drug.,2018-02-01,2018-02-02
16413,2360810,Shortage,SPRYCEL,BRISTOL-MYERS SQUIBB CANADA,dasatinib,DASATINIB,80MG,1 BTL X 30,ORAL,Avoided shortage,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2017-08-04,,2017-08-04,2017-08-03,Demand increase for the drug.,2017-07-19,2017-08-02
69624,2360829,Shortage,SPRYCEL,BRISTOL-MYERS SQUIBB CANADA,Dasatanib 140mg,DASATINIB,140MG,1 BTL x 30,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,2019-01-21,2019-01-21,2019-01-21,2019-01-21,Demand increase for the drug.,2018-12-14,2019-01-22
97274,2305941,Shortage,STALEVO,NOVARTIS PHARMACEUTICALS CANADA INC,STALEVO FCT 100MG 100'S,ENTACAPONE  CARBIDOPA  LEVODOPA,200MG  25MG  100MG,100'S,ORAL,Actual shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,,2019-10-24,2019-12-09,,Other (Please describe in comments),2019-10-25,2019-11-08
97278,2305968,Shortage,STALEVO,NOVARTIS PHARMACEUTICALS CANADA INC,STALEVO FCT 150MG 100'S,ENTACAPONE  CARBIDOPA  LEVODOPA,200MG  37.5MG  150MG,100'S,ORAL,Anticipated shortage,TABLET,N04BA,DOPAMINERGIC AGENTS,2019-11-26,,2019-12-09,,Other (Please describe in comments),2019-10-25,2019-11-08
89833,2217465,Shortage,STANDARDIZED CAT PELT AP,JUBILANT HOLLISTERSTIER LLC,Standardized Cat Pelt AP,STANDARDIZED CAT PELT ACETONE PRECIPITATED,10000UNIT,"5 mL, 10 mL, 30 mL, 50 mL",INTRADERMAL  SUBCUTANEOUS,Actual shortage,SOLUTION,V01AA,ALLERGENS,,2019-04-22,2019-11-11,,Shortage of an active ingredient.,2019-07-23,2019-07-25
61477,1938991,Shortage,STANHEXIDINE 2% WITH ISOPROPYL ALCOHOL 4%,OMEGA LABORATORIES LTD,Chlorhexidine Gluconate 2% w/v with Isopropyl Alcohol 4%,CHLORHEXIDINE GLUCONATE  ISOPROPYL ALCOHOL,2%  4%,20 x 450 mL,TOPICAL,Resolved,SOLUTION,D08AC,ANTISEPTICS AND DISINFECTANTS,,2018-05-31,2018-11-05,2018-11-07,Disruption of the manufacture of the drug.,2018-09-14,2018-12-12
61496,1938983,Shortage,STANHEXIDINE 4% WITH ISOPROPYL ALCOHOL 4%,OMEGA LABORATORIES LTD,Chlorhexidine Gluconate 4% w/v aqueous with Isopropyl Alcohol 4%,CHLORHEXIDINE GLUCONATE  ISOPROPYL ALCOHOL,4%  4%,1 x 4 L,TOPICAL,Resolved,SOLUTION,D08AC,ANTISEPTICS AND DISINFECTANTS,,2018-09-12,2018-09-30,2018-09-28,Disruption of the manufacture of the drug.,2018-09-14,2018-09-29
66136,705799,Shortage,STATEX DPS 50MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,50MG,50ml,ORAL,Actual shortage,DROPS,N02AA,OPIOIDS,,2017-11-01,,,Disruption of the manufacture of the drug.,2018-11-02,2018-11-02
19844,705799,Shortage,STATEX DPS 50MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,50MG,50ml,ORAL,Actual shortage,DROPS,N02AA,OPIOIDS,2019-01-31,,,,Disruption of the manufacture of the drug.,2017-08-18,2019-02-01
13664,621935,Shortage,STATEX DROPS 20MG/ML,PALADIN LABS INC,Morphine Sulfate 20mg/ml,MORPHINE SULFATE,20MG,25ml bottle,ORAL,Actual shortage,DROPS,N02AA,OPIOIDS,2017-06-26,2017-08-06,,,Disruption of the manufacture of the drug.,2017-06-22,2018-12-21
19877,596965,Shortage,STATEX SUPPOSITORIES 20MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,20MG,Box of 10,RECTAL,Anticipated shortage,SUPPOSITORY,N02AA,OPIOIDS,2021-11-30,,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-21
19880,639389,Shortage,STATEX SUPPOSITORIES 30MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,30MG,Box of 10,RECTAL,Anticipated shortage,SUPPOSITORY,N02AA,OPIOIDS,2021-08-31,,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-21
19848,632228,Shortage,STATEX SUPPOSITORIES 5MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,5MG,Box of 10,RECTAL,Anticipated shortage,SUPPOSITORY,N02AA,OPIOIDS,2021-10-30,,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-21
7723,591467,Shortage,STATEX SYRUP 1MG/ML,PALADIN LABS INC,MORPHINE SULFATE 1mg/ml 500ml,MORPHINE SULFATE,1MG,500ml,ORAL,Resolved,SYRUP,N02AA,OPIOIDS,,2017-04-17,,2017-07-11,Demand increase for the drug.,2017-04-24,2017-07-12
19826,591467,Shortage,STATEX SYRUP 1MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,1MG,250ml,ORAL,Actual shortage,SYRUP,N02AA,OPIOIDS,,2017-09-06,,,Disruption of the manufacture of the drug.,2017-08-18,2018-04-03
19829,591467,Shortage,STATEX SYRUP 1MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,1MG,500ml,ORAL,Actual shortage,SYRUP,N02AA,OPIOIDS,,2018-04-02,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-21
5251,591467,Shortage,STATEX SYRUP 1MG/ML,PALADIN LABS INC,Morphine Sulfate 1mg/ml 250ml,MORPHINE SULFATE,1MG,250ml,ORAL,Resolved,SYRUP,N02AA,OPIOIDS,2017-04-04,,2017-04-26,2017-06-30,Demand increase for the drug.,2017-04-03,2017-08-18
19834,591475,Shortage,STATEX SYRUP 5MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,5MG,250ml,ORAL,Resolved,SYRUP,N02AA,OPIOIDS,,2018-01-09,,2018-01-09,Disruption of the manufacture of the drug.,2017-08-18,2018-01-29
19838,591475,Shortage,STATEX SYRUP 5MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,5MG,500ml,ORAL,Actual shortage,SYRUP,N02AA,OPIOIDS,2017-12-04,2017-12-08,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-21
34943,591475,Shortage,STATEX SYRUP 5MG/ML,PALADIN LABS INC,Statex,MORPHINE SULFATE,5MG,250ml,ORAL,Actual shortage,SYRUP,N02AA,OPIOIDS,,2018-01-09,,,Disruption of the manufacture of the drug.,2018-01-04,2018-01-29
5409,594644,Shortage,STATEX TAB 10MG,PALADIN LABS INC,MORPHINE SULFATE 10mg Tablets,MORPHINE SULFATE,10MG,100 tabs/bottle,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017-04-04,2017-04-04,,2017-05-22,Demand increase for the drug.,2017-04-04,2017-05-23
2462,594644,Shortage,STATEX TAB 10MG,PALADIN LABS INC,Morphine Sulfate 10mg tablets,MORPHINE SULFATE,10MG,4x25 Control Pack,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017-03-13,2017-03-13,2017-05-27,2017-08-23,Demand increase for the drug.,2017-03-14,2017-10-02
4018,594644,Shortage,STATEX TAB 10MG,PALADIN LABS INC,Morphine Sulfate 10mg Tablets,MORPHINE SULFATE,10MG,100 tab bottles,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017-02-01,2017-02-01,2017-03-27,2017-03-31,Disruption of the manufacture of the drug.,2017-03-23,2017-04-03
28736,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,Morphine,MORPHINE SULFATE,5MG,Control Pack (4x25 tabs),ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-11-13,,2018-01-30,Disruption of the manufacture of the drug.,2017-11-09,2018-01-31
56906,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,5MG,100tabs,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2018-07-30,,2018-10-02,Disruption of the manufacture of the drug.,2018-07-30,2018-10-03
3461,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,MORPHINE SULFATE,MORPHINE SULFATE,5MG,100 TABS,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-03-01,2017-03-24,2017-03-31,Disruption of the manufacture of the drug.,2017-03-20,2017-04-03
7067,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,Morphine Sulfate 5mg tabs,MORPHINE SULFATE,5MG,100 tab bottles,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017-04-17,,2017-05-22,2017-05-22,Demand increase for the drug.,2017-04-14,2017-08-17
12794,594652,Shortage,STATEX TAB 5MG,PALADIN LABS INC,Morphine Sulfate 5mg,MORPHINE SULFATE,5MG,100 tabs/bottle,ORAL,Resolved,TABLET,N02AA,OPIOIDS,2017-06-14,2017-06-14,2017-06-23,2017-06-23,Demand increase for the drug.,2017-06-15,2017-08-17
31270,594636,Shortage,STATEX TABLET 25MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,25MG,100tabs,ORAL,Resolved,TABLET,N02AA,OPIOIDS,,2017-11-30,,2017-12-22,Disruption of the manufacture of the drug.,2017-11-30,2017-12-29
19852,632201,Shortage,STATEX-SUPPOSITORIES 10MG,PALADIN LABS INC,Statex,MORPHINE SULFATE,10MG,Box of 10,RECTAL,Anticipated shortage,SUPPOSITORY,N02AA,OPIOIDS,2021-08-31,,,,Disruption of the manufacture of the drug.,2017-08-18,2018-12-21
62147,2372436,Shortage,STAXYN,BAYER INC,Vardenafil Tablets,VARDENAFIL,10MG,4's,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2018-11-15,2018-11-13,,,Disruption of the manufacture of the drug.,2018-09-21,2019-03-29
44911,2299186,Shortage,STERILE WATER FOR INJECTION USP,TELIGENT OU,Sterile Water for Injection,WATER,100%,10 ML,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2018-04-01,,2018-04-24,Other (Please describe in comments),2018-04-04,2018-04-26
43935,2142546,Shortage,STERILE WATER FOR INJECTION USP,PFIZER CANADA INC,STERILE WATER,WATER,100%,25 x 20mL PVL,INTRAMUSCULAR  INTRAPERITONEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2018-03-23,,2018-06-22,Disruption of the manufacture of the drug.,2018-03-26,2018-06-23
35796,2142546,Shortage,STERILE WATER FOR INJECTION USP,PFIZER CANADA INC,STERILE WATER,WATER,100%,25X10mL PVL,INTRAMUSCULAR  INTRAPERITONEAL  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2018-03-21,,2018-09-24,Disruption of the manufacture of the drug.,2018-01-12,2018-09-25
80141,799998,Shortage,STERILE WATER FOR IRRIGATION,BAXTER CORPORATION,Sterile Water for Irrigation,WATER,100%,500 mL,IRRIGATION,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2019-04-01,2019-04-01,2019-08-06,2019-08-06,Shortage of an active ingredient.,2019-04-01,2019-08-07
80145,799998,Shortage,STERILE WATER FOR IRRIGATION,BAXTER CORPORATION,Sterile Water for Irrigation,WATER,100%,1000 mL,IRRIGATION,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2019-04-01,2019-04-01,2019-08-06,2019-08-06,Shortage of an active ingredient.,2019-04-01,2019-08-07
71954,498785,Shortage,STERILE WATER FOR IRRIGATION USP,ICU MEDICAL CANADA INC,STERILE WATER FOR IRRIGATION USP,WATER,100%,3000 ml,INTRAPERITONEAL  IRRIGATION,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2019-03-01,2019-03-01,2019-03-30,2019-03-30,Delay in shipping of the drug.,2019-01-11,2019-05-31
41247,38229,Shortage,STERILE WATER FOR IRRIGATION USP,ICU MEDICAL CANADA INC,Sterile Water for Irrigation USP,WATER,100%,250ML,INTRAPERITONEAL  IRRIGATION  TOPICAL,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2018-02-27,2018-02-27,2018-06-30,2018-06-25,Disruption of the manufacture of the drug.,2018-02-27,2018-07-23
85285,38229,Shortage,STERILE WATER FOR IRRIGATION USP,ICU MEDICAL CANADA INC,Sterile Water for Irrigation USP,WATER,100%,250 ml,INTRAPERITONEAL  IRRIGATION  TOPICAL,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2019-06-14,,2019-07-12,2019-10-31,Delay in shipping of the drug.,2019-05-31,2019-11-01
28246,1963961,Shortage,STERILE WATER FOR IRRIGATION USP,B. BRAUN MEDICAL INC,Sterile Water,WATER,100%,"500mL, 1000mL, 2000mL, 4000mL",IRRIGATION,Actual shortage,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2017-11-03,,,Requirements related to complying with good manufacturing practices.,2017-11-06,2019-11-06
43155,498785,Shortage,STERILE WATER FOR IRRIGATION USP,ICU MEDICAL CANADA INC,Sterile Water for Irrigation USP,WATER,100%,1000ML,INTRAPERITONEAL  IRRIGATION,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2018-04-01,,2018-04-30,2018-04-17,Disruption of the manufacture of the drug.,2018-03-16,2018-04-23
44135,402257,Shortage,STERILE WATER INJ,OMEGA LABORATORIES LTD,Steril Water,WATER,100%,10 X 10mL vial,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,,2018-01-29,,2018-05-04,Demand increase for the drug.,2018-03-27,2018-06-11
14401,2247228,Shortage,STIEPROX SHAMPOO,GLAXOSMITHKLINE INC,ciclopirox olamine shampoo,CICLOPIROX OLAMINE,1.5%,150 mL,TOPICAL,Resolved,SHAMPOO,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2017-06-28,,2017-06-30,Delay in shipping of the drug.,2017-06-29,2017-07-04
78695,2247228,Shortage,STIEPROX SHAMPOO,GLAXOSMITHKLINE INC,ciclopirox olamine shampoo,CICLOPIROX OLAMINE,1.5%,150mL,TOPICAL,Resolved,SHAMPOO,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2019-04-12,2019-11-15,2019-10-09,Disruption of the manufacture of the drug.,2019-03-14,2019-10-10
98223,518182,Shortage,STIEVA-A CREAM,GLAXOSMITHKLINE INC,Tretinoin cream,TRETINOIN,0.05%,25G,TOPICAL,Actual shortage,CREAM,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-11-11,2019-12-19,,Demand increase for the drug.,2019-11-08,2019-11-13
96014,2391678,Shortage,SUBLINOX,"BAUSCH HEALTH, CANADA INC.",SUBLINOX,ZOLPIDEM TARTRATE,5MG,n/a,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2019-10-03,,2019-10-14,Delay in shipping of the drug.,2019-10-10,2019-10-17
41543,2391678,Shortage,SUBLINOX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,SUBLINOX,ZOLPIDEM TARTRATE,5MG,na,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2018-03-28,,2018-06-29,Other (Please describe in comments),2018-03-02,2018-06-30
41546,2370433,Shortage,SUBLINOX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,SUBLINOX,ZOLPIDEM TARTRATE,10MG,na,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,,2018-03-21,,2018-06-18,Other (Please describe in comments),2018-03-02,2018-06-20
86505,2391678,Shortage,SUBLINOX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,SUBLINOX,ZOLPIDEM TARTRATE,5MG,30,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,2019-06-14,,,2019-07-02,Other (Please describe in comments),2019-06-12,2019-07-05
24049,2370433,Shortage,SUBLINOX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,SUBLINOX,ZOLPIDEM TARTRATE,10MG,N/A,SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),N05CF,HYPNOTICS AND SEDATIVES,2017-10-21,,2017-11-03,2017-11-10,Other (Please describe in comments),2017-10-02,2017-11-13
65865,2295709,Shortage,SUBOXONE,INDIVIOR UK LIMITED,Suboxone 8mg tabs 28packs,BUPRENORPHINE  NALOXONE,8MG  2MG,28 tablets/unit,SUBLINGUAL,Resolved,TABLET,N07BC,DRUGS USED IN ADDICTIVE DISORDERS,,2018-11-06,,2018-11-12,Other (Please describe in comments),2018-10-30,2018-11-13
39956,2422336,Shortage,SUCCINYLCHOLINE CHLORIDE INJECTION,TELIGENT OU,Succinylcholine Chloride Injection,SUCCINYLCHOLINE CHLORIDE,20MG,10 ML,INTRAVENOUS,Resolved,SOLUTION,M03AB,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2018-02-01,2018-07-01,2018-07-16,Disruption of the manufacture of the drug.,2018-02-15,2018-07-17
85107,2422336,Shortage,SUCCINYLCHOLINE CHLORIDE INJECTION,TELIGENT OU,Succinylcholine Chloride,SUCCINYLCHOLINE CHLORIDE,20MG,20ML,INTRAVENOUS,Actual shortage,SOLUTION,M03AB,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",2019-05-28,2019-05-28,2020-05-29,,Disruption of the manufacture of the drug.,2019-05-28,2019-10-03
62448,2422336,Shortage,SUCCINYLCHOLINE CHLORIDE INJECTION,TELIGENT OU,Succinylcholine Chloride Injection,SUCCINYLCHOLINE CHLORIDE,20MG,10 mL,INTRAVENOUS,Actual shortage,SOLUTION,M03AB,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",,2018-09-03,2019-12-31,,Disruption of the manufacture of the drug.,2018-09-27,2019-07-29
13600,441767,Shortage,SULFINPYRAZONE,AA PHARMA INC,Sulfinpyrazone,SULFINPYRAZONE,200MG,100 Bottle,ORAL,Resolved,TABLET,M04AB,ANTIGOUT PREPARATIONS,,2017-06-22,2017-07-17,2017-07-06,Disruption of the manufacture of the drug.,2017-06-22,2017-09-05
41938,2324652,Shortage,SUMATRIPTAN,PRO DOC LIMITEE,SUMATRIPTAN,SUMATRIPTAN,50MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-03-06,,2018-05-09,Delay in shipping of the drug.,2018-03-06,2018-05-10
82665,2382660,Shortage,SUNPHARMA ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-04-22,2019-05-10,2019-05-10,Disruption of the manufacture of the drug.,2019-04-29,2019-05-13
15472,2452294,Shortage,SUNVEPRA,BRISTOL-MYERS SQUIBB CANADA,Asunaprevir,ASUNAPREVIR,100MG,1 BTL x 56,ORAL,Resolved,CAPSULE,J05AE,DIRECT ACTING ANTIVIRALS,2017-07-24,2017-07-21,2017-11-30,2017-10-16,Other (Please describe in comments),2017-07-11,2017-10-17
30258,2227428,Shortage,SUPRANE,BAXTER CORPORATION,"Desflurane, USP",DESFLURANE,100%,"240mL bottle,   6 units/Case",INHALATION,Resolved,LIQUID,N01AB,"ANESTHETICS, GENERAL",2017-11-22,2017-11-22,2017-12-15,2017-12-15,Delay in shipping of the drug.,2017-11-23,2017-12-16
38418,868965,Shortage,SUPRAX,ODAN LABORATORIES LTD,Cefixime for oral suspension,CEFIXIME,100MG,50 mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,2018-02-07,2018-02-07,2018-02-21,2018-02-22,Delay in shipping of the drug.,2018-02-05,2018-02-23
50483,868981,Shortage,SUPRAX,ODAN LABORATORIES LTD,Cefixime tablets,CEFIXIME,400MG,7 tablets or 10 tablets,ORAL,Resolved,TABLET,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-05-28,2018-08-31,2018-08-31,Delay in shipping of the drug.,2018-05-28,2018-09-01
45974,868965,Shortage,SUPRAX,ODAN LABORATORIES LTD,Cefixime for oral suspension,CEFIXIME,100MG,50 mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01DD,OTHER BETA-LACTAM ANTIBACTERIALS,,2018-04-16,2018-05-25,2018-05-24,Delay in shipping of the drug.,2018-04-16,2018-05-25
83015,2225158,Shortage,SUPREFACT,SANOFI-AVENTIS CANADA INC,Suprefact,BUSERELIN,1MG,2,NASAL,Resolved,SOLUTION,L02AE,HORMONES AND RELATED AGENTS,2019-05-10,,2019-06-28,2019-06-03,Other (Please describe in comments),2019-05-02,2019-06-04
10149,2225166,Shortage,SUPREFACT,SANOFI-AVENTIS CANADA INC,Suprefact Inj. M.D. 1mg/ml - vials,BUSERELIN,1MG,2 X 5.5ml,SUBCUTANEOUS,Resolved,SOLUTION,L02AE,HORMONES AND RELATED AGENTS,,2017-05-15,2017-06-09,2017-06-05,Other (Please describe in comments),2017-05-12,2017-07-06
93565,2016109,Shortage,SURVANTA,ABBVIE CORPORATION,SURVANTA 8mL vial,BERACTANT,25MG,8mL vial (010401320),INTRATRACHEAL,Resolved,SUSPENSION,R07AA,OTHER RESPIRATORY SYSTEM PRODUCTS,2019-09-10,2019-09-10,2019-09-18,2019-09-18,Demand increase for the drug.,2019-09-11,2019-09-19
56829,2016109,Shortage,SURVANTA,ABBVIE CORPORATION,"SURVANTA VIAL, 4mL",BERACTANT,25MG,4mL vial,INTRATRACHEAL,Resolved,SUSPENSION,R07AA,OTHER RESPIRATORY SYSTEM PRODUCTS,,2018-07-24,2018-09-04,2018-08-29,Demand increase for the drug.,2018-07-27,2018-08-30
72327,253952,Shortage,SYNACTHEN DEPOT,MALLINCKRODT SPECIALTY PHARMACEUTICALS IRELAND LTD.,Tetracosactide Zinc Injection,TETRACOSACTIDE,1MG,1 mL ampoule,INTRAMUSCULAR,Actual shortage,SUSPENSION,H01AA,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,2019-02-28,,,,Disruption of the manufacture of the drug.,2019-01-15,2019-04-12
3283,2162512,Shortage,SYNALAR OINTMENT 0.025%,VALEANT CANADA LP/VALEANT CANADA S.E.C.,SYNALAR,FLUOCINOLONE ACETONIDE,0.025%,60G,TOPICAL,Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-01-04,2017-05-15,2017-06-05,Disruption of the manufacture of the drug.,2017-03-17,2017-06-06
36018,2188783,Shortage,SYNAREL,PFIZER CANADA INC,SYNAREL,NAFARELIN,2MG,1x8mL,NASAL,Resolved,METERED-DOSE AEROSOL,H01CA,HYPOTHALAMIC HORMONES,,2018-01-02,,2018-01-22,Disruption of the manufacture of the drug.,2018-01-16,2018-01-24
55709,2320541,Shortage,SYNFLORIX,GLAXOSMITHKLINE INC,"Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed",PNEUMOCOCCAL POLYSACC. SEROT. 18C CONJUG. TO TETANUS TOXOID CARRIER PROT.  PNEUMOCOCCAL POLYSACCHARID SEROT. 19F CONJUG. TO DIPHTHERIA TOXOID CARRIER PROT.  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D CARRIER PROTEIN  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D CARRIER PROTEIN  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D CARRIER PROTEIN  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D CARRIER PROTEIN  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D CARRIER PROTEIN  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D CARRIER PROTEIN  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D CARRIER PROTEIN  PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D CARRIER PROTEIN,3MCG  3MCG  3MCG  1MCG  3MCG  1MCG  1MCG  1MCG  1MCG  1MCG  1MCG,10's,INTRAMUSCULAR,Resolved,SUSPENSION,J07AL,BACTERIAL VACCINES,,2018-07-10,2018-08-17,2018-08-01,Delay in shipping of the drug.,2018-07-13,2018-08-02
91766,2456575,Shortage,SYNJARDY,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,SYNAJRDY,METFORMIN HYDROCHLORIDE  EMPAGLIFLOZIN,500MG  5MG,60s,ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-08-08,2019-09-16,2019-08-23,Delay in shipping of the drug.,2019-08-19,2019-08-24
29739,2172100,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,100MCG,90,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017-11-24,,,2017-11-23,Disruption of the manufacture of the drug.,2017-11-20,2017-11-23
29743,2172119,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,125MCG,90,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017-11-24,,,2017-11-23,Disruption of the manufacture of the drug.,2017-11-20,2017-11-23
33596,2172119,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,125MCG,90,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017-12-21,,,2017-12-19,Disruption of the manufacture of the drug.,2017-12-18,2017-12-19
29798,2172127,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,150MCG,1000,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2017-12-04,,,2017-11-23,Disruption of the manufacture of the drug.,2017-11-20,2017-11-23
19316,2172151,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,300MCG,90,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-11-05,,2018-11-09,Requirements related to complying with good manufacturing practices.,2017-08-14,2018-11-10
66447,2171228,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,112MCG,90BT,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2018-11-13,,2018-11-23,2018-11-12,Delay in shipping of the drug.,2018-11-08,2018-11-13
75981,2172127,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,150MCG,1000 BT,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-09-27,2019-03-08,2019-02-21,Delay in shipping of the drug.,2019-02-15,2019-02-22
72941,2172127,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,150MCG,1000BT,ORAL,Avoided shortage,TABLET,H03AA,THYROID PREPARATIONS,2019-01-31,,2019-02-01,2019-01-21,Delay in shipping of the drug.,2019-01-18,2019-01-21
73970,2172127,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,150MCG,1000BT,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,2018-09-27,,2019-02-08,2019-02-01,Delay in shipping of the drug.,2019-01-30,2019-02-02
77810,2172127,Shortage,SYNTHROID,BGP PHARMA ULC,SYNTHROID,LEVOTHYROXINE SODIUM,150MCG,"90 BT, 1000 BT",ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,2019-03-04,2019-03-04,2019-03-07,2019-03-08,Requirements related to complying with good manufacturing practices.,2019-03-05,2019-03-09
14596,2455366,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,10MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-07-03,,2017-11-02,Delay in shipping of the drug.,2017-07-04,2017-11-03
95241,2455366,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,10MG,4,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-10-02,2019-12-06,,Delay in shipping of the drug.,2019-10-02,2019-10-03
29195,2455358,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,5MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-14,,2017-12-06,Delay in shipping of the drug.,2017-11-14,2017-12-07
17354,2455374,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-11-02,,2018-12-11,Delay in shipping of the drug.,2017-07-26,2018-12-12
98778,2455374,Shortage,TADALAFIL,PRO DOC LIMITEE,TADALAFIL,TADALAFIL,20MG,4,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-11-14,2019-12-24,,Delay in shipping of the drug.,2019-11-15,2019-11-15
58104,2137984,Shortage,TALWIN,SANOFI-AVENTIS CANADA INC,Talwin 50mg,PENTAZOCINE,50MG,100,ORAL,Resolved,TABLET,N02AD,OPIOIDS,2018-10-08,2018-10-08,2019-04-15,2019-04-02,Other (Please describe in comments),2018-08-14,2019-04-03
14785,2241976,Shortage,TALWIN 30 MG/ML,HOSPIRA HEALTHCARE CORPORATION,TALWIN,PENTAZOCINE,30MG,25x1ml,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Avoided shortage,SOLUTION,N02AD,OPIOIDS,2018-11-23,,,2018-09-04,Other (Please describe in comments),2017-07-05,2018-09-04
39146,2381842,Shortage,TAMIFLU,HOFFMANN-LA ROCHE LIMITED,OSELTAMIVIR,OSELTAMIVIR,6MG,Powder for Oral Suspension,ORAL,Avoided shortage,POWDER FOR SUSPENSION,J05AH,DIRECT ACTING ANTIVIRALS,2018-03-01,,2018-03-01,2018-02-28,Demand increase for the drug.,2018-02-08,2018-02-28
44601,2429667,Shortage,TAMSULOSIN CR,SIVEM PHARMACEUTICALS ULC,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-04-16,2018-04-16,2018-05-18,2018-05-18,Delay in shipping of the drug.,2018-04-02,2018-06-26
25166,2413612,Shortage,TAMSULOSIN CR,PRO DOC LIMITEE,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,30-500,ORAL,Resolved,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-10-10,,2017-10-27,Delay in shipping of the drug.,2017-10-10,2017-10-30
28095,2429667,Shortage,TAMSULOSIN CR,SIVEM PHARMACEUTICALS ULC,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-01-04,,2018-01-12,2017-12-29,Delay in shipping of the drug.,2017-11-06,2018-01-18
17697,2240946,Shortage,TARKA,BGP PHARMA ULC,TARKA,VERAPAMIL HYDROCHLORIDE  TRANDOLAPRIL,240MG  2MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C09BB,"ACE INHIBITORS, COMBINATIONS",,2018-01-30,,,Disruption of the manufacture of the drug.,2017-08-01,2018-12-21
58217,2238097,Shortage,TARKA,BGP PHARMA ULC,Trandolapril/Verapamil Hydrochloride Sustained-Release Tablets,VERAPAMIL HYDROCHLORIDE  TRANDOLAPRIL,240MG  4MG,BT 100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),C09BB,"ACE INHIBITORS, COMBINATIONS",2019-01-31,,,,Disruption of the manufacture of the drug.,2018-08-15,2019-02-01
95522,2466082,Shortage,TARO-ACITRETIN,TARO PHARMACEUTICALS INC,TARO-ACITRETIN,ACITRETIN,25MG,30 blister,ORAL,Actual shortage,CAPSULE,D05BB,ANTIPSORIATICS FOR SYSTEMIC USE,,2019-09-27,2020-01-17,,Disruption of the manufacture of the drug.,2019-10-04,2019-11-08
92816,2466074,Shortage,TARO-ACITRETIN,TARO PHARMACEUTICALS INC,TARO-ACITRETIN,ACITRETIN,10MG,30 blister,ORAL,Actual shortage,CAPSULE,D05BB,ANTIPSORIATICS FOR SYSTEMIC USE,,2019-08-28,2020-01-17,,Disruption of the manufacture of the drug.,2019-09-03,2019-11-08
36486,2246714,Shortage,TARO-AMCINONIDE,TARO PHARMACEUTICALS INC,TARO AMCINONIDE,AMCINONIDE,0.1%,30 G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-01-15,2018-10-19,2018-10-17,Disruption of the manufacture of the drug.,2018-01-18,2018-10-18
31634,2246714,Shortage,TARO-AMCINONIDE,TARO PHARMACEUTICALS INC,TARO AMCINONIDE,AMCINONIDE,0.1%,60G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2017-12-03,2018-10-19,2018-10-17,Disruption of the manufacture of the drug.,2017-12-04,2018-10-18
38332,2246714,Shortage,TARO-AMCINONIDE,TARO PHARMACEUTICALS INC,TARO AMCINONIDE,AMCINONIDE,0.1%,15G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-02-01,2018-10-19,2018-10-17,Disruption of the manufacture of the drug.,2018-02-02,2018-10-18
19790,2365650,Shortage,TARO-ANASTROZOLE,TARO PHARMACEUTICALS INC,TARO ANASTROZOLE,ANASTROZOLE,1MG,3x10BL,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-05-23,2019-02-27,2019-02-27,Disruption of the manufacture of the drug.,2017-08-18,2019-03-04
87416,2464519,Shortage,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,TARO PHARMACEUTICALS INC,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,50 g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-06-13,2019-07-19,2019-07-19,Disruption of the manufacture of the drug.,2019-06-24,2019-07-20
91297,2464519,Shortage,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,TARO PHARMACEUTICALS INC,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,50 g,TOPICAL,Actual shortage,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-08-02,2019-11-22,,Disruption of the manufacture of the drug.,2019-08-09,2019-11-01
64419,2464519,Shortage,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,TARO PHARMACEUTICALS INC,TARO-BENZOYL PEROXIDE / CLINDAMYCIN,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,50G,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2018-10-15,2018-11-16,2018-11-21,Disruption of the manufacture of the drug.,2018-10-16,2019-02-04
81611,2464519,Shortage,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,TARO PHARMACEUTICALS INC,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,50g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-04-04,2019-04-26,2019-04-26,Disruption of the manufacture of the drug.,2019-04-15,2019-04-29
74729,2464519,Shortage,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,TARO PHARMACEUTICALS INC,TARO-BENZOYL PEROXIDE / CLINDAMYCIN,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,50g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-01-18,2019-03-01,2019-02-22,Disruption of the manufacture of the drug.,2019-02-04,2019-02-23
97830,2457504,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,500MG,120 bottle,ORAL,Actual shortage,TABLET,L01BC,ANTIMETABOLITES,,2019-10-24,2019-12-20,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
96356,2457490,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,150MG,60 blister,ORAL,Actual shortage,TABLET,L01BC,ANTIMETABOLITES,,2019-10-10,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
96359,2457504,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,500MG,120 blister,ORAL,Actual shortage,TABLET,L01BC,ANTIMETABOLITES,,2019-10-10,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-11,2019-10-11
85370,2457504,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,500MG,120,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2019-05-28,2019-09-20,2019-09-20,Disruption of the manufacture of the drug.,2019-05-31,2019-09-23
64413,2457490,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,150MG,10x6 BL,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2018-10-15,2018-12-14,2018-11-21,Disruption of the manufacture of the drug.,2018-10-16,2019-02-04
64416,2457490,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,150MG,60s,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2018-10-15,2018-12-14,2018-11-21,Disruption of the manufacture of the drug.,2018-10-16,2019-02-04
86700,2457490,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,150MG,60 blister,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2019-06-11,2019-07-26,2019-07-24,Disruption of the manufacture of the drug.,2019-06-17,2019-08-06
86703,2457504,Shortage,TARO-CAPECITABINE,TARO PHARMACEUTICALS INC,TARO-CAPECITABINE,CAPECITABINE,500MG,120 blister,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2019-06-11,2019-09-20,2019-09-20,Disruption of the manufacture of the drug.,2019-06-17,2019-09-23
97844,2367394,Shortage,TARO-CARBAMAZEPINE,TARO PHARMACEUTICALS INC,TARO-CARBAMAZEPINE,CARBAMAZEPINE,100MG,450 ml,ORAL,Actual shortage,SUSPENSION,N03AF,ANTIEPILEPTICS,,2019-11-01,2019-11-22,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-02
39237,2407515,Shortage,TARO-CARBAMAZEPINE,TARO PHARMACEUTICALS INC,TARO CARBAMAZEPINE,CARBAMAZEPINE,200MG,100'S,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2018-10-15,,,Disruption of the manufacture of the drug.,2018-02-09,2019-08-19
31631,2407515,Shortage,TARO-CARBAMAZEPINE,TARO PHARMACEUTICALS INC,TARO CARBAMAZEPINE,CARBAMAZEPINE,200MG,500's,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2018-10-29,,,Disruption of the manufacture of the drug.,2017-12-04,2019-08-19
92819,2367394,Shortage,TARO-CARBAMAZEPINE,TARO PHARMACEUTICALS INC,TARO-CARBAMAZEPINE,CARBAMAZEPINE,100MG,450 ml,ORAL,Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,,2019-08-30,2019-10-18,2019-10-18,Disruption of the manufacture of the drug.,2019-09-03,2019-10-21
22252,2367394,Shortage,TARO-CARBAMAZEPINE,TARO PHARMACEUTICALS INC,TARO CARBAMAZEPINE,CARBAMAZEPINE,100MG,450 ML,ORAL,Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,,2018-10-29,2018-12-14,2018-11-13,Disruption of the manufacture of the drug.,2017-09-18,2019-02-04
7213,2244403,Shortage,TARO-CARBAMAZEPINE CHEWABLE TABLETS 100MG,TARO PHARMACEUTICALS INC,CARBAMAZEPINE,CARBAMAZEPINE,100MG,100 tablets,ORAL,Resolved,TABLET (CHEWABLE),N03AF,ANTIEPILEPTICS,,2017-07-13,2017-08-31,2017-08-23,Disruption of the manufacture of the drug.,2017-04-18,2017-09-06
84968,2244403,Shortage,TARO-CARBAMAZEPINE CHEWABLE TABLETS 100MG,TARO PHARMACEUTICALS INC,TARO-CARBAMAZEPINE CHEWABLE TABLETS 100MG,CARBAMAZEPINE,100MG,100,ORAL,Resolved,TABLET (CHEWABLE),N03AF,ANTIEPILEPTICS,,2019-05-17,2019-09-06,2019-08-23,Disruption of the manufacture of the drug.,2019-05-28,2019-08-24
5246,2244404,Shortage,TARO-CARBAMAZEPINE CHEWABLE TABLETS 200MG,TARO PHARMACEUTICALS INC,CARBAMAZEPINE,CARBAMAZEPINE,200MG,100'S,ORAL,Resolved,TABLET (CHEWABLE),N03AF,ANTIEPILEPTICS,,2018-02-01,2018-03-05,2018-02-08,Disruption of the manufacture of the drug.,2017-04-03,2018-02-09
83902,2244404,Shortage,TARO-CARBAMAZEPINE CHEWABLE TABLETS 200MG,TARO PHARMACEUTICALS INC,TARO-CARBAMAZEPINE CHEWABLE TABLETS,CARBAMAZEPINE,200MG,100,ORAL,Resolved,TABLET (CHEWABLE),N03AF,ANTIEPILEPTICS,,2019-05-07,2019-09-30,2019-10-04,Disruption of the manufacture of the drug.,2019-05-13,2019-10-05
52557,2353288,Shortage,TARO-CICLOPIROX,TARO PHARMACEUTICALS INC,TARO-CICLOPIROX,CICLOPIROX,8%,6G,TOPICAL,Resolved,SOLUTION,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2018-06-15,2019-01-25,2019-01-24,Disruption of the manufacture of the drug.,2018-06-18,2019-02-04
81617,2353288,Shortage,TARO-CICLOPIROX,TARO PHARMACEUTICALS INC,TARO-CICLOPIROX,CICLOPIROX,8%,6 g,TOPICAL,Resolved,SOLUTION,D01AE,ANTIFUNGALS FOR TOPICAL USE,,2019-04-11,2019-08-16,2019-08-09,Disruption of the manufacture of the drug.,2019-04-15,2019-08-10
47403,2390450,Shortage,TARO-CLARITHROMYCIN,TARO PHARMACEUTICALS INC,TARO CLARITHROMYCIN,CLARITHROMYCIN,250MG,105 ML,ORAL,Resolved,GRANULES FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-08-02,2018-09-07,2018-09-12,Disruption of the manufacture of the drug.,2018-04-27,2018-09-13
50339,2390442,Shortage,TARO-CLARITHROMYCIN,TARO PHARMACEUTICALS INC,TARO CLARITHROMYCIN,CLARITHROMYCIN,125MG,105 ML,ORAL,Resolved,GRANULES FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-05-23,2018-08-10,2018-08-30,Disruption of the manufacture of the drug.,2018-05-25,2018-09-07
97833,2266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN,CLINDAMYCIN,1%,60 ml,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-10-22,2019-11-22,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
15693,2266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN,CLINDAMYCIN,1%,30 ML,TOPICAL,Resolved,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-09-15,2019-04-12,2019-04-08,Disruption of the manufacture of the drug.,2017-07-13,2019-04-09
15697,2266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN,CLINDAMYCIN,1%,60 ML,TOPICAL,Resolved,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2017-09-05,2019-04-12,2019-04-10,Disruption of the manufacture of the drug.,2017-07-13,2019-04-15
96886,2266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN,CLINDAMYCIN,1%,30 ml,TOPICAL,Actual shortage,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-10-18,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-21,2019-10-21
84979,2266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN,CLINDAMYCIN,1%,60 ml,TOPICAL,Resolved,SOLUTION,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-05-15,2019-06-07,2019-05-30,Disruption of the manufacture of the drug.,2019-05-28,2019-05-31
72989,2440180,Shortage,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,TARO PHARMACEUTICALS INC,TARO CLINDAMYCIN /BENZOYL PEROXIDE GEL,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,45G,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-01-17,2019-02-01,2019-01-28,Disruption of the manufacture of the drug.,2019-01-18,2019-02-04
7217,2440180,Shortage,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,TARO PHARMACEUTICALS INC,CLINDAMYCIN/BENZOYL PEROXIDE GEL,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,45 gram,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2017-04-25,,2017-08-31,2017-08-25,Disruption of the manufacture of the drug.,2017-04-18,2017-09-06
78185,2440180,Shortage,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-03-04,2019-03-29,2019-03-27,Disruption of the manufacture of the drug.,2019-03-11,2019-03-29
82303,2440180,Shortage,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-04-17,2019-09-13,2019-09-03,Disruption of the manufacture of the drug.,2019-04-24,2019-09-04
76679,2440180,Shortage,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,TARO PHARMACEUTICALS INC,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,BENZOYL PEROXIDE  CLINDAMYCIN,5%  1%,45g,TOPICAL,Resolved,GEL,D10AF,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2019-02-15,2019-03-01,2019-03-01,Disruption of the manufacture of the drug.,2019-02-22,2019-03-04
47406,2245523,Shortage,"TARO-CLOBETASOL CREAM USP, 0.05%",TARO PHARMACEUTICALS INC,TARO CLOBETASOL CREAM USP,CLOBETASOL PROPIONATE,0.05%,454G,TOPICAL,Resolved,CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",,2018-04-26,2018-05-18,2018-05-23,Disruption of the manufacture of the drug.,2018-04-27,2018-05-25
85373,2245523,Shortage,"TARO-CLOBETASOL CREAM USP, 0.05%",TARO PHARMACEUTICALS INC,"TARO-CLOBETASOL CREAM USP, 0.05%",CLOBETASOL PROPIONATE,0.05%,454 g,TOPICAL,Resolved,CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-05-29,2019-07-12,2019-07-12,Disruption of the manufacture of the drug.,2019-05-31,2019-07-15
83905,2245523,Shortage,"TARO-CLOBETASOL CREAM USP, 0.05%",TARO PHARMACEUTICALS INC,"TARO-CLOBETASOL CREAM USP, 0.05%",CLOBETASOL PROPIONATE,0.05%,50 g,TOPICAL,Resolved,CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-05-10,2019-05-31,2019-05-22,Disruption of the manufacture of the drug.,2019-05-13,2019-05-28
79992,2245524,Shortage,"TARO-CLOBETASOL OINTMENT USP, 0.05%",TARO PHARMACEUTICALS INC,Taro-Clobetasol,CLOBETASOL PROPIONATE,0.05%,15g,TOPICAL,Resolved,OINTMENT,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-03-25,2019-04-26,2019-04-08,Disruption of the manufacture of the drug.,2019-03-29,2019-04-09
91303,2245524,Shortage,"TARO-CLOBETASOL OINTMENT USP, 0.05%",TARO PHARMACEUTICALS INC,"TARO-CLOBETASOL OINTMENT USP, 0.05%",CLOBETASOL PROPIONATE,0.05%,15 g,TOPICAL,Resolved,OINTMENT,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-08-08,2019-09-13,2019-09-06,Disruption of the manufacture of the drug.,2019-08-09,2019-09-09
91306,2245524,Shortage,"TARO-CLOBETASOL OINTMENT USP, 0.05%",TARO PHARMACEUTICALS INC,"TARO-CLOBETASOL OINTMENT USP, 0.05%",CLOBETASOL PROPIONATE,0.05%,454 g,TOPICAL,Resolved,OINTMENT,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-07-22,2019-10-04,2019-10-04,Disruption of the manufacture of the drug.,2019-08-09,2019-10-05
83908,2245524,Shortage,"TARO-CLOBETASOL OINTMENT USP, 0.05%",TARO PHARMACEUTICALS INC,"TARO-CLOBETASOL OINTMENT USP, 0.05%",CLOBETASOL PROPIONATE,0.05%,50 g,TOPICAL,Resolved,OINTMENT,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-05-07,2019-05-31,2019-05-30,Disruption of the manufacture of the drug.,2019-05-13,2019-05-31
93892,2245522,Shortage,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",TARO PHARMACEUTICALS INC,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",CLOBETASOL PROPIONATE,0.05%,60 ml,TOPICAL,Resolved,SOLUTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-09-12,2019-09-20,2019-09-24,Disruption of the manufacture of the drug.,2019-09-13,2019-10-04
84986,2245522,Shortage,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",TARO PHARMACEUTICALS INC,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",CLOBETASOL PROPIONATE,0.05%,60 ml,TOPICAL,Resolved,SOLUTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2019-05-21,2019-06-14,2019-06-14,Disruption of the manufacture of the drug.,2019-05-28,2019-06-17
57516,2463520,Shortage,TARO-DEFERASIROX,TARO PHARMACEUTICALS INC,TARO DEFERASIROX,DEFERASIROX,125MG,30's,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2018-08-02,2018-11-09,2018-10-26,Disruption of the manufacture of the drug.,2018-08-03,2019-02-04
57519,2463539,Shortage,TARO-DEFERASIROX,TARO PHARMACEUTICALS INC,TARO DEFERASIROX,DEFERASIROX,250MG,30's,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2018-08-02,2018-09-07,2018-08-30,Disruption of the manufacture of the drug.,2018-08-03,2018-09-07
57522,2463547,Shortage,TARO-DEFERASIROX,TARO PHARMACEUTICALS INC,TARO DEFERASIROX,DEFERASIROX,500MG,30's,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2018-08-02,2018-08-17,2018-08-30,Disruption of the manufacture of the drug.,2018-08-03,2018-09-07
84991,2420988,Shortage,TARO-DICLOFENAC,TARO PHARMACEUTICALS INC,TARO-DICLOFENAC,DICLOFENAC SODIUM,1.5%,60 ml,TOPICAL,Resolved,SOLUTION,M02AA,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,,2019-05-15,2019-06-28,2019-06-14,Disruption of the manufacture of the drug.,2019-05-28,2019-06-17
96362,2471051,Shortage,TARO-DIPYRIDAMOLE/ ASA,TARO PHARMACEUTICALS INC,TARO-DIPYRIDAMOLE/ ASA,ACETYLSALICYLIC ACID  DIPYRIDAMOLE,25MG  200MG,60,ORAL,Resolved,CAPSULE (IMMEDIATE AND EXTENDED RELEASE),B01AC,ANTITHROMBOTIC AGENTS,,2019-10-10,2019-11-08,2019-11-08,Disruption of the manufacture of the drug.,2019-10-11,2019-11-08
79998,2471051,Shortage,TARO-DIPYRIDAMOLE/ ASA,TARO PHARMACEUTICALS INC,Taro-Dipyridamole / ASA,ACETYLSALICYLIC ACID  DIPYRIDAMOLE,25MG  200MG,60's,ORAL,Resolved,CAPSULE (IMMEDIATE AND EXTENDED RELEASE),B01AC,ANTITHROMBOTIC AGENTS,,2019-03-22,2019-04-12,2019-04-18,Disruption of the manufacture of the drug.,2019-03-29,2019-04-23
85376,2471051,Shortage,TARO-DIPYRIDAMOLE/ ASA,TARO PHARMACEUTICALS INC,TARO-DIPYRIDAMOLE/ ASA,ACETYLSALICYLIC ACID  DIPYRIDAMOLE,25MG  200MG,60,ORAL,Resolved,CAPSULE (IMMEDIATE AND EXTENDED RELEASE),B01AC,ANTITHROMBOTIC AGENTS,,2019-05-23,2019-06-21,2019-06-14,Disruption of the manufacture of the drug.,2019-05-31,2019-06-17
91811,716731,Shortage,TARO-DOCUSATE,TARO PHARMACEUTICALS INC,TARO-DOCUSATE,DOCUSATE SODIUM,100MG,1000,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2019-08-15,2019-09-13,2019-09-13,Disruption of the manufacture of the drug.,2019-08-19,2019-09-14
50342,716731,Shortage,TARO-DOCUSATE,TARO PHARMACEUTICALS INC,TARO DOCUSATE,DOCUSATE SODIUM,100MG,1000'S,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-05-23,2018-06-07,2018-06-15,Disruption of the manufacture of the drug.,2018-05-25,2018-06-18
44284,716731,Shortage,TARO-DOCUSATE,TARO PHARMACEUTICALS INC,TARO DOCUSATE,DOCUSATE SODIUM,100MG,100'S,ORAL,Resolved,CAPSULE,A06AA,DRUGS FOR CONSTIPATION,,2018-10-29,2018-11-09,2018-11-01,Disruption of the manufacture of the drug.,2018-03-29,2019-02-04
84994,2482983,Shortage,TARO-IMIQUIMOD PUMP,TARO PHARMACEUTICALS INC,TARO-IMIQUIMOD PUMP,IMIQUIMOD,5%,7.5 mg,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2019-05-21,2019-09-20,2019-09-20,Disruption of the manufacture of the drug.,2019-05-28,2019-09-23
36731,2367157,Shortage,TARO-MOMETASONE CREAM,TARO PHARMACEUTICALS INC,TARO MOMETASONE CREAM,MOMETASONE FUROATE,0.1%,50G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-05-24,2018-10-19,2018-10-17,Disruption of the manufacture of the drug.,2018-01-19,2018-10-18
41693,2367157,Shortage,TARO-MOMETASONE CREAM,TARO PHARMACEUTICALS INC,TARO MOMETASONE CREAM,MOMETASONE FUROATE,0.1%,15G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-12-10,2019-01-18,2018-12-19,Disruption of the manufacture of the drug.,2018-03-05,2019-02-04
85000,2266385,Shortage,TARO-MOMETASONE LOTION,TARO PHARMACEUTICALS INC,TARO-MOMETASONE LOTION,MOMETASONE FUROATE,0.1%,30 ml,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-05-21,2019-06-14,2019-06-07,Disruption of the manufacture of the drug.,2019-05-28,2019-06-08
85004,2266385,Shortage,TARO-MOMETASONE LOTION,TARO PHARMACEUTICALS INC,TARO-MOMETASONE LOTION,MOMETASONE FUROATE,0.1%,75 ml,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-05-21,2019-06-07,2019-06-14,Disruption of the manufacture of the drug.,2019-05-28,2019-06-17
80001,2266385,Shortage,TARO-MOMETASONE LOTION,TARO PHARMACEUTICALS INC,Taro-Mometasone Lotion,MOMETASONE FUROATE,0.1%,75 ml,TOPICAL,Resolved,LOTION,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-03-29,2019-04-26,2019-04-18,Disruption of the manufacture of the drug.,2019-03-29,2019-04-23
91814,2279983,Shortage,TARO-MUPIROCIN,TARO PHARMACEUTICALS INC,TARO-MUPIROCIN,MUPIROCIN,2%,15 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-08-16,2019-08-30,2019-08-23,Disruption of the manufacture of the drug.,2019-08-19,2019-08-24
91309,2279983,Shortage,TARO-MUPIROCIN,TARO PHARMACEUTICALS INC,TARO-MUPIROCIN,MUPIROCIN,2%,30 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-08-02,2019-08-23,2019-08-16,Disruption of the manufacture of the drug.,2019-08-09,2019-08-19
86706,2279983,Shortage,TARO-MUPIROCIN,TARO PHARMACEUTICALS INC,TARO-MUPIROCIN,MUPIROCIN,2%,15 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-06-11,2019-07-12,2019-07-05,Disruption of the manufacture of the drug.,2019-06-17,2019-07-06
82626,2279983,Shortage,TARO-MUPIROCIN,TARO PHARMACEUTICALS INC,TARO-MUPIROCIN,MUPIROCIN,2%,30 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-04-25,2019-07-19,2019-07-19,Disruption of the manufacture of the drug.,2019-04-29,2019-07-20
80623,2279983,Shortage,TARO-MUPIROCIN,TARO PHARMACEUTICALS INC,TARO-MUPIROCIN,MUPIROCIN,2%,15 g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-03-29,2019-05-17,2019-05-28,Disruption of the manufacture of the drug.,2019-04-05,2019-05-29
92825,2429209,Shortage,TARO-PEMETREXED,TARO PHARMACEUTICALS INC,TARO-PEMETREXED,PEMETREXED,500MG,20 ml,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,L01BA,ANTIMETABOLITES,,2019-08-28,2019-11-29,,Disruption of the manufacture of the drug.,2019-09-03,2019-11-01
92828,2429195,Shortage,TARO-PEMETREXED,TARO PHARMACEUTICALS INC,TARO-PEMETREXED,PEMETREXED,100MG,4 ml,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,L01BA,ANTIMETABOLITES,,2019-08-28,2019-12-20,,Disruption of the manufacture of the drug.,2019-09-03,2019-10-04
92417,2250896,Shortage,TARO-PHENYTOIN,TARO PHARMACEUTICALS INC,TARO-PHENYTOIN,PHENYTOIN,125MG,237 ml,ORAL,Resolved,SUSPENSION,N03AB,ANTIEPILEPTICS,,2019-08-23,2019-10-11,2019-10-11,Disruption of the manufacture of the drug.,2019-08-23,2019-10-12
97853,2250896,Shortage,TARO-PHENYTOIN,TARO PHARMACEUTICALS INC,TARO-PHENYTOIN,PHENYTOIN,125MG,237 ml,ORAL,Actual shortage,SUSPENSION,N03AB,ANTIEPILEPTICS,,2019-10-30,2019-11-22,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
57525,2250896,Shortage,TARO-PHENYTOIN,TARO PHARMACEUTICALS INC,TARO PHENYTOIN,PHENYTOIN,125MG,237 mL,ORAL,Resolved,SUSPENSION,N03AB,ANTIEPILEPTICS,,2018-08-02,2018-09-21,2018-10-15,Disruption of the manufacture of the drug.,2018-08-03,2018-10-16
98312,2382660,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,TARO-ROSUVASTATIN,ROSUVASTATIN,20MG,90,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-11-07,2019-11-22,,Disruption of the manufacture of the drug.,2019-11-09,2019-11-08
96901,2382652,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,10MG,90,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-18,2019-11-22,,Disruption of the manufacture of the drug.,2019-10-21,2019-10-21
96908,2382652,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-18,2019-11-22,,Disruption of the manufacture of the drug.,2019-10-21,2019-10-21
97750,2382660,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,TARO-ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-24,2019-11-22,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-01
60213,1925350,Shortage,TARO-SONE,TARO PHARMACEUTICALS INC,TARO SONE,BETAMETHASONE,0.05%,50G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-08-30,2018-09-30,2018-10-15,Disruption of the manufacture of the drug.,2018-09-07,2018-10-16
6953,2361698,Shortage,TARO-SUMATRIPTAN,TARO PHARMACEUTICALS INC,SUMATRIPTAN,SUMATRIPTAN,6MG,2x0.5mL,SUBCUTANEOUS,Resolved,SOLUTION,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-05-23,2018-06-07,2018-06-15,Disruption of the manufacture of the drug.,2017-04-13,2018-06-18
6914,2443538,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,140MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-04-25,,2017-10-09,2017-10-01,Disruption of the manufacture of the drug.,2017-04-13,2017-10-02
6928,2443481,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-04-25,,2017-10-09,2017-10-01,Disruption of the manufacture of the drug.,2017-04-13,2017-10-02
6935,2443473,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,5MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2018-01-18,2018-07-07,2018-08-02,Disruption of the manufacture of the drug.,2017-04-13,2018-08-03
6938,2443473,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,5MG,20 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-05-10,,2017-11-30,2017-11-29,Disruption of the manufacture of the drug.,2017-04-13,2017-12-04
95525,2443473,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TARO-TEMOZOLOMIDE,TEMOZOLOMIDE,5MG,5 blister,ORAL,Actual shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,,2019-09-27,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-04,2019-10-11
95528,2443473,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TARO-TEMOZOLOMIDE,TEMOZOLOMIDE,5MG,20 blister,ORAL,Actual shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,,2019-09-27,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-04,2019-10-11
95531,2443511,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TARO-TEMOZOLOMIDE,TEMOZOLOMIDE,100MG,20 blister,ORAL,Actual shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,,2019-09-27,2019-12-20,,Disruption of the manufacture of the drug.,2019-10-04,2019-10-11
92837,2443481,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TARO-TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,5 blister,ORAL,Actual shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,,2019-08-28,2019-12-20,,Disruption of the manufacture of the drug.,2019-09-03,2019-10-11
90790,2443538,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TARO-TEMOZOLOMIDE,TEMOZOLOMIDE,140MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2019-07-26,2019-08-30,2019-08-30,Disruption of the manufacture of the drug.,2019-08-06,2019-09-03
92841,2443481,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TARO-TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,20 blister,ORAL,Actual shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,,2019-08-28,2019-12-20,,Disruption of the manufacture of the drug.,2019-09-03,2019-10-11
182,2443554,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,250MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2018-01-18,2018-07-07,2018-08-02,Disruption of the manufacture of the drug.,2017-03-10,2018-08-03
18102,2443481,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,20 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2017-08-02,2017-10-09,2017-10-01,Disruption of the manufacture of the drug.,2017-08-02,2017-10-02
18105,2443511,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,100MG,5 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2018-03-02,2018-04-30,2018-04-26,Disruption of the manufacture of the drug.,2017-08-02,2018-04-27
18108,2443511,Shortage,TARO-TEMOZOLOMIDE,TARO PHARMACEUTICALS INC,TEMOZOLOMIDE,TEMOZOLOMIDE,100MG,20 blister,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2017-08-02,2017-10-09,2017-10-01,Disruption of the manufacture of the drug.,2017-08-02,2017-10-02
14481,2247651,Shortage,TARO-TERCONAZOLE CREAM,TARO PHARMACEUTICALS INC,TARO-TERCONAZOLE CREAM,TERCONAZOLE,0.4%,45G,VAGINAL,Resolved,CREAM,G01AG,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2017-06-30,2017-08-30,2017-08-24,Disruption of the manufacture of the drug.,2017-07-01,2017-09-06
92420,2421186,Shortage,TARO-TESTOSTERONE,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,60 blister,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2019-08-23,2019-09-27,2019-09-23,Disruption of the manufacture of the drug.,2019-08-23,2019-09-24
92423,2421186,Shortage,TARO-TESTOSTERONE,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,120 blister,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2019-08-23,2019-08-30,2019-08-30,Disruption of the manufacture of the drug.,2019-08-23,2019-09-03
95534,2421186,Shortage,TARO-TESTOSTERONE,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,120 blister,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2019-09-24,2019-10-31,2019-10-11,Disruption of the manufacture of the drug.,2019-10-04,2019-10-12
78188,2421186,Shortage,TARO-TESTOSTERONE,TARO PHARMACEUTICALS INC,Testosterone,TESTOSTERONE UNDECANOATE,40MG,60,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2019-03-06,2019-04-12,2019-04-05,Disruption of the manufacture of the drug.,2019-03-11,2019-04-06
85379,2421186,Shortage,TARO-TESTOSTERONE,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,120,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2019-05-28,2019-07-19,2019-07-12,Disruption of the manufacture of the drug.,2019-05-31,2019-07-15
90793,2421186,Shortage,TARO-TESTOSTERONE,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,60 blister,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2019-07-22,2019-08-30,2019-08-08,Disruption of the manufacture of the drug.,2019-08-06,2019-08-09
50359,2421186,Shortage,TARO-TESTOSTERONE,TARO PHARMACEUTICALS INC,TARO TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,6x10BL,ORAL,Resolved,CAPSULE,G03BA,ANDROGENS,,2018-08-02,2018-09-14,2018-09-12,Disruption of the manufacture of the drug.,2018-05-25,2018-09-13
95537,2463806,Shortage,TARO-TESTOSTERONE GEL,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE GEL,TESTOSTERONE,1%,30,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,,2019-09-24,2019-11-08,2019-11-08,Disruption of the manufacture of the drug.,2019-10-04,2019-11-08
36739,2463806,Shortage,TARO-TESTOSTERONE GEL,TARO PHARMACEUTICALS INC,TARO TESTOSTERONE GEL,TESTOSTERONE,1%,5Gx30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2018-09-24,2019-03-29,2019-03-19,Disruption of the manufacture of the drug.,2018-01-19,2019-03-29
40894,2463792,Shortage,TARO-TESTOSTERONE GEL,TARO PHARMACEUTICALS INC,TARO TESTOSTERONE GEL,TESTOSTERONE,1%,2.5Gx30,TOPICAL,Resolved,GEL,G03BA,ANDROGENS,,2018-09-24,2019-03-29,2019-03-19,Disruption of the manufacture of the drug.,2018-02-23,2019-03-29
83914,2463806,Shortage,TARO-TESTOSTERONE GEL,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE GEL,TESTOSTERONE,1%,5 g,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,,2019-05-06,2019-07-19,2019-07-16,Disruption of the manufacture of the drug.,2019-05-13,2019-07-19
81620,2463806,Shortage,TARO-TESTOSTERONE GEL,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE GEL,TESTOSTERONE,1%,5 g,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,,2019-04-11,2019-05-03,2019-05-02,Delay in shipping of the drug.,2019-04-15,2019-05-03
98290,2463792,Shortage,TARO-TESTOSTERONE GEL,TARO PHARMACEUTICALS INC,TARO-TESTOSTERONE GEL,TESTOSTERONE,1%,2.5g x30,TRANSDERMAL,Actual shortage,GEL,G03BA,ANDROGENS,,2019-11-06,2019-11-22,,Disruption of the manufacture of the drug.,2019-11-09,2019-11-08
72980,2450437,Shortage,TARO-TRAMADOL ER,TARO PHARMACEUTICALS INC,TARO-TRAMADOL ER,TRAMADOL HYDROCHLORIDE,200MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2019-01-17,2019-01-31,2019-01-28,Disruption of the manufacture of the drug.,2019-01-18,2019-02-04
95546,2450429,Shortage,TARO-TRAMADOL ER,TARO PHARMACEUTICALS INC,TARO-TRAMADOL ER,TRAMADOL HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2019-10-04,2019-10-25,2019-10-11,Disruption of the manufacture of the drug.,2019-10-04,2019-10-12
76682,2450445,Shortage,TARO-TRAMADOL ER,TARO PHARMACEUTICALS INC,TARO-TRAMADOL ER,TRAMADOL HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2019-02-22,2019-08-30,2019-08-30,Disruption of the manufacture of the drug.,2019-02-22,2019-09-03
64422,2450445,Shortage,TARO-TRAMADOL ER,TARO PHARMACEUTICALS INC,TARO-TRAMADOL ER,TRAMADOL HYDROCHLORIDE,300MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2018-10-15,2019-01-31,2019-01-28,Disruption of the manufacture of the drug.,2018-10-16,2019-02-04
89279,2450429,Shortage,TARO-TRAMADOL ER,TARO PHARMACEUTICALS INC,TARO-TRAMADOL ER,TRAMADOL HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,,2019-07-04,2019-08-30,2019-09-03,Disruption of the manufacture of the drug.,2019-07-15,2019-09-04
95543,2242685,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO-WARFARIN,WARFARIN SODIUM,5MG,100 blister,ORAL,Actual shortage,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2019-09-27,2019-11-15,,Disruption of the manufacture of the drug.,2019-10-04,2019-11-01
95549,2242682,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO-WARFARIN,WARFARIN SODIUM,2.5MG,1000,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2019-10-04,2019-10-31,2019-11-01,Disruption of the manufacture of the drug.,2019-10-04,2019-11-02
88698,2242680,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO-WARFARIN,WARFARIN SODIUM,1MG,250,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2019-06-27,2019-07-19,2019-07-09,Disruption of the manufacture of the drug.,2019-07-05,2019-07-15
85382,2242680,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO-WARFARIN,WARFARIN SODIUM,1MG,250,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2019-05-29,2019-06-28,2019-06-21,Disruption of the manufacture of the drug.,2019-05-31,2019-06-24
36491,2242680,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO WARFARIN,WARFARIN SODIUM,1MG,100'S,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2018-03-28,2018-04-30,2018-04-26,Disruption of the manufacture of the drug.,2018-01-18,2018-04-27
38335,2242680,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO WARFARIN,WARFARIN SODIUM,1MG,250'S,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2018-02-01,2018-03-01,2018-02-08,Disruption of the manufacture of the drug.,2018-02-02,2018-02-09
38338,2242681,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO WARFARIN,WARFARIN SODIUM,2MG,100'S,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2018-02-01,2018-02-21,2018-02-08,Disruption of the manufacture of the drug.,2018-02-02,2018-02-09
38341,2242681,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO WARFARIN,WARFARIN SODIUM,2MG,250'S,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2018-02-01,2018-02-21,2018-02-08,Disruption of the manufacture of the drug.,2018-02-02,2018-02-09
41696,2242684,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO WARFARIN,WARFARIN SODIUM,4MG,100'S,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2018-03-02,2018-04-30,2018-04-26,Disruption of the manufacture of the drug.,2018-03-05,2018-04-27
44281,2242681,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,TARO WARFARIN,WARFARIN SODIUM,2MG,100'S,ORAL,Resolved,TABLET,B01AA,ANTITHROMBOTIC AGENTS,,2018-03-28,2018-05-07,2018-05-23,Disruption of the manufacture of the drug.,2018-03-29,2018-05-25
177,2415100,Shortage,TARO-ZOLEDRONIC ACID,TARO PHARMACEUTICALS INC,ZOLEDRONIC ACID,ZOLEDRONIC ACID,5MG,100 mL,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2016-11-01,2018-07-31,2018-08-02,Disruption of the manufacture of the drug.,2017-03-10,2018-08-03
170,2415186,Shortage,TARO-ZOLEDRONIC ACID CONCENTRATE,TARO PHARMACEUTICALS INC,Zoledronic Acid for injection,ZOLEDRONIC ACID,4MG,5ml,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2016-01-01,2016-01-01,2018-02-26,2018-02-08,Disruption of the manufacture of the drug.,2017-03-10,2018-02-09
82629,2415186,Shortage,TARO-ZOLEDRONIC ACID CONCENTRATE,TARO PHARMACEUTICALS INC,TARO-ZOLEDRONIC ACID CONCENTRATE,ZOLEDRONIC ACID,4MG,5ml,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-04-26,2019-06-28,2019-06-07,Disruption of the manufacture of the drug.,2019-04-29,2019-06-08
66116,2243894,Shortage,TAZORAC,ALLERGAN INC,Tazorac,TAZAROTENE,0.05%,30g,TOPICAL,Resolved,CREAM,D05AX,ANTIPSORIATICS FOR TOPICAL USE,2018-09-25,2018-09-25,2018-11-30,2018-11-30,Other (Please describe in comments),2018-11-02,2018-12-01
66125,2230785,Shortage,TAZORAC,ALLERGAN INC,tazorac,TAZAROTENE,0.1%,30g,TOPICAL,Resolved,GEL,D05AX,ANTIPSORIATICS FOR TOPICAL USE,2018-09-25,2018-09-25,2018-11-30,2018-11-30,Other (Please describe in comments),2018-11-02,2018-12-01
65978,2230784,Shortage,TAZORAC,ALLERGAN INC,Tazorac,TAZAROTENE,0.05%,30 gram,TOPICAL,Resolved,GEL,D05AX,ANTIPSORIATICS FOR TOPICAL USE,2018-10-31,2018-10-31,2019-05-17,2019-05-17,Other (Please describe in comments),2018-11-01,2019-05-18
93944,2243894,Shortage,TAZORAC,ALLERGAN INC,"TAZORAC 0,05% 30 GRAM",TAZAROTENE,0.05%,30 gram,TOPICAL,Resolved,CREAM,D05AX,ANTIPSORIATICS FOR TOPICAL USE,2019-09-16,2019-09-16,2019-10-21,2019-11-08,Disruption of the manufacture of the drug.,2019-09-16,2019-11-08
93947,2243895,Shortage,TAZORAC,ALLERGAN INC,TAZORAC CREAM 0.1% 30 G,TAZAROTENE,0.1%,30 gram,TOPICAL,Actual shortage,CREAM,D05AX,ANTIPSORIATICS FOR TOPICAL USE,2019-09-16,2019-09-16,2020-01-20,,Disruption of the manufacture of the drug.,2019-09-16,2019-11-08
66088,2328550,Shortage,Technelite,,Technetium Tc 99m Generator,Technetium Tc 99m,740 GBq/Generator,single units,"Instillation, Intravenous, oral",Actual shortage,Solution,V09FX,Diagnostic Radiopharmaceuticals,,2018-11-02,,,Other (Please describe in comments),2018-11-02,2019-04-29
14093,,Shortage,Technetium Tc 99m TSC,,Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection,sodium thiosulfate anhydrous,not applicable,5-kit package,Intravenous and oral use,Resolved,Reaction vial - lyophilized form; Components - Solution A and Solution B,V09DB,HEPATIC AND RETICULO ENDOTHELIAL SYSTEM,,2017-06-23,2017-07-17,2017-07-05,Other (Please describe in comments),2017-06-27,2017-07-06
57003,2267233,Shortage,TECTA,TAKEDA CANADA INC,Pantoprazole Magnesium,PANTOPRAZOLE,40MG,Blisters - 30 ct.,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2018-07-31,2018-07-31,2018-09-17,2018-09-20,Disruption of the manufacture of the drug.,2018-07-31,2018-09-21
76478,2267233,Shortage,TECTA,TAKEDA CANADA INC,pantoprazole magnesium,PANTOPRAZOLE,40MG,Blisters - 30 count,ORAL,Resolved,TABLET (ENTERIC-COATED),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),2019-02-22,2019-02-22,2019-05-27,2019-06-10,Disruption of the manufacture of the drug.,2019-02-21,2019-06-11
30982,2194333,Shortage,TEGRETOL - SUS 100MG/5ML,NOVARTIS PHARMACEUTICALS CANADA INC,TEGRETOL SUSPENSION,CARBAMAZEPINE,100MG,450ML,ORAL,Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,2017-11-30,,2017-12-15,2017-12-19,Demand increase for the drug.,2017-11-28,2018-01-08
64629,2194333,Shortage,TEGRETOL - SUS 100MG/5ML,NOVARTIS PHARMACEUTICALS CANADA INC,TEGRETOL SUSP 100MG/5ML 450ML,CARBAMAZEPINE,100MG,450 ML,ORAL,Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,2018-10-19,2018-10-19,2019-12-11,2018-12-17,Demand increase for the drug.,2018-10-17,2018-12-18
79017,10405,Shortage,TEGRETOL 200MG,NOVARTIS PHARMACEUTICALS CANADA INC,TEGRETOL 200MG TABS 100'S,CARBAMAZEPINE,200MG,100'S,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,2019-04-03,2019-04-03,2019-07-22,2019-07-22,Delay in shipping of the drug.,2019-03-20,2019-07-23
98249,10405,Shortage,TEGRETOL 200MG,NOVARTIS PHARMACEUTICALS CANADA INC,TEGRETOL 200MG TABS 100'S,CARBAMAZEPINE,200MG,100'S,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2019-11-06,2019-11-21,,Demand increase for the drug.,2019-11-08,2019-11-08
27924,773611,Shortage,TEGRETOL CR TAB 200MG,NOVARTIS PHARMACEUTICALS CANADA INC,TEGRETOL CR 200MG TABS 100'S,CARBAMAZEPINE,200MG,100's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N03AF,ANTIEPILEPTICS,2017-11-28,,2017-12-07,2017-12-07,Delay in shipping of the drug.,2017-11-02,2017-12-13
67078,2390345,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-13,2019-05-29,2019-05-31,Requirements related to complying with good manufacturing practices.,2018-11-19,2019-06-01
79373,2390345,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,40MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-04-12,2019-04-12,2019-06-28,2019-06-27,Requirements related to complying with good manufacturing practices.,2019-03-25,2019-06-28
6169,2432900,Shortage,TELMISARTAN,PHARMASCIENCE INC,TELMISARTAN,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-04-05,,2017-12-18,Delay in shipping of the drug.,2017-04-07,2017-12-19
86050,2388944,Shortage,TELMISARTAN,SANIS HEALTH INC,TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-10,2019-07-12,2019-07-19,Disruption of the manufacture of the drug.,2019-06-10,2019-07-20
69049,2390353,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-21,2019-01-25,2019-05-29,2019-05-29,Requirements related to complying with good manufacturing practices.,2018-12-10,2019-05-31
4281,2432900,Shortage,TELMISARTAN,PHARMASCIENCE INC,TELMISARTAN,TELMISARTAN,80MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-03-23,2017-07-11,2017-07-11,Delay in shipping of the drug.,2017-03-24,2017-12-19
72124,2390353,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,80MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-31,2019-01-30,2019-07-05,2019-07-04,Requirements related to complying with good manufacturing practices.,2019-01-14,2019-07-05
97229,2390345,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-21,2019-11-13,,,Delay in shipping of the drug.,2019-10-25,2019-11-15
80866,2388944,Shortage,TELMISARTAN,SANIS HEALTH INC,TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-04-09,2019-04-15,2019-05-27,2019-05-15,Disruption of the manufacture of the drug.,2019-04-09,2019-05-16
91363,2390345,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-09-02,,,,Delay in shipping of the drug.,2019-08-12,2019-09-03
79382,2390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-04-12,2019-04-10,2019-04-19,2019-04-18,Demand increase for the drug.,2019-03-25,2019-04-22
5669,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-05-10,,2017-06-15,2017-08-06,Requirements related to complying with good manufacturing practices.,2017-04-05,2017-11-03
5672,2390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2017-04-27,,2017-05-10,2017-05-10,Requirements related to complying with good manufacturing practices.,2017-04-05,2017-05-18
86078,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-06-06,2019-06-28,2019-06-28,Delay in shipping of the drug.,2019-06-10,2019-06-29
36444,2390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-01-04,2018-02-23,2018-02-23,Other (Please describe in comments),2018-01-18,2018-02-26
97633,2390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,100,ORAL,Anticipated shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-11-25,,,,Delay in shipping of the drug.,2019-10-31,2019-10-31
13155,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-06-16,2017-07-17,2017-08-06,Demand increase for the drug.,2017-06-16,2017-11-03
76655,2390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,30,ORAL,Avoided shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-04-08,,2019-04-19,2019-03-11,Delay in shipping of the drug.,2019-02-22,2019-03-11
66701,2390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-11-30,2018-11-23,2019-02-15,2019-02-15,Requirements related to complying with good manufacturing practices.,2018-11-12,2019-02-16
90037,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80.0MG,30,ORAL,Avoided shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-09-30,,,2019-08-18,Delay in shipping of the drug.,2019-07-26,2019-08-19
66486,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-11-13,2018-11-12,2018-12-14,2018-12-07,Other (Please describe in comments),2018-11-09,2018-12-08
90040,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80.0MG,100,ORAL,Avoided shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-08-12,,,2019-08-05,Delay in shipping of the drug.,2019-07-26,2019-08-05
71397,2390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-01-21,2019-01-22,2019-02-15,2019-02-15,Requirements related to complying with good manufacturing practices.,2019-01-07,2019-02-16
70983,2407485,Shortage,TELMISARTAN TABLETS,ACCORD HEALTHCARE INC,TELMISARTAN,TELMISARTAN,40MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-03,2019-01-03,,2019-10-14,Disruption of the manufacture of the drug.,2019-01-03,2019-10-15
70992,2407493,Shortage,TELMISARTAN TABLETS,ACCORD HEALTHCARE INC,TELMISARTAN,TELMISARTAN,80MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-01-03,2019-01-03,,,Disruption of the manufacture of the drug.,2019-01-03,2019-01-04
70480,2395533,Shortage,TELMISARTAN-HCTZ,PRO DOC LIMITEE,TELMISARTAN-HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,30-100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-12-24,,2019-01-11,Delay in shipping of the drug.,2018-12-24,2019-01-12
86053,2395355,Shortage,TELMISARTAN/HCTZ,SANIS HEALTH INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-06-10,2019-06-21,2019-06-27,Disruption of the manufacture of the drug.,2019-06-10,2019-06-28
83138,2395363,Shortage,TELMISARTAN/HCTZ,SANIS HEALTH INC,TELMISARTAN/HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-05-06,2019-05-31,2019-06-07,Disruption of the manufacture of the drug.,2019-05-06,2019-06-08
16392,2241093,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,5MG,5 cap sachet,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-08-21,2017-08-17,2017-08-29,2017-08-22,Demand increase for the drug.,2017-07-19,2017-08-23
12317,2312794,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,140MG,5 sachets (1capsule/sachet),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-06-08,2017-06-08,2017-06-16,2017-06-09,Delay in shipping of the drug.,2017-06-08,2017-06-10
12322,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,20 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-06-08,2017-06-08,2017-06-16,2017-06-19,Delay in shipping of the drug.,2017-06-08,2017-07-11
18236,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,20 CAP,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-08-03,2017-08-03,2017-08-25,2017-08-21,Demand increase for the drug.,2017-08-03,2017-08-22
13376,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-06-20,2017-06-20,2017-08-25,2017-08-22,Demand increase for the drug.,2017-06-20,2017-08-23
3677,2312794,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,140MG,5 sachets (1 capsule/sachet ),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-03-20,2017-03-20,2017-03-31,2017-03-30,Delay in shipping of the drug.,2017-03-20,2017-03-31
6257,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,20 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-04-17,2017-04-17,2017-06-02,2017-05-23,Delay in shipping of the drug.,2017-04-10,2017-05-24
6260,2241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,20 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-04-17,2017-04-17,2017-05-05,2017-04-26,Delay in shipping of the drug.,2017-04-10,2017-04-27
99194,2241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,5CAP,ORAL,Anticipated shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,2019-11-18,2019-11-18,2019-11-19,,Demand increase for the drug.,2019-11-18,2019-11-18
20352,2241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,5 CAP,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-09-25,2017-09-12,2017-10-13,2017-10-11,Demand increase for the drug.,2017-08-25,2017-10-12
10626,2241096,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,250MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-05-18,2017-05-22,2017-06-16,2017-06-06,Demand increase for the drug.,2017-05-18,2017-06-07
11431,2241093,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,5MG,5 cap sachet,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-05-29,2017-05-29,2017-06-16,2017-06-15,Demand increase for the drug.,2017-05-29,2017-06-16
5298,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-04-04,2017-04-04,2017-04-13,2017-04-10,Delay in shipping of the drug.,2017-04-04,2017-04-11
2227,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsule,TEMOZOLOMIDE,100MG,20 sachets (1 capsule/sachet),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-03-03,2017-03-03,2017-04-07,2017-03-24,Delay in shipping of the drug.,2017-03-14,2017-03-25
2246,2312794,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,140MG,5 sachets (1 capsule/sachet ),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-02-22,2017-02-22,2017-03-17,2017-03-30,Delay in shipping of the drug.,2017-03-14,2017-03-31
2252,2241096,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,250MG,5 sachets (1 capsule/sachet),ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-02-16,2017-02-16,2017-03-17,2017-03-24,Delay in shipping of the drug.,2017-03-14,2017-03-29
17373,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,5 cap,ORAL,Avoided shortage,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-09-28,,2017-09-29,2017-09-27,Demand increase for the drug.,2017-07-27,2017-10-11
92894,2241095,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,100MG,5CAP,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2019-09-23,2019-09-17,2019-11-06,2019-11-05,Delay in shipping of the drug.,2019-09-03,2019-11-06
18402,2241096,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,250MG,5 cap,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,2017-08-02,2017-08-02,2017-09-29,2017-09-26,Demand increase for the drug.,2017-08-07,2017-09-27
15614,2241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,5CAP SACHET,ORAL,Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2017-07-04,2017-08-07,2017-07-27,Demand increase for the drug.,2017-07-12,2017-07-28
86671,2462680,Shortage,TEPADINA,ADIENNE SA,Thiotepa for Injection,THIOTEPA,15MG,1 vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01AC,,,2019-07-12,,2019-07-30,Delay in shipping of the drug.,2019-06-17,2019-07-31
42542,2350475,Shortage,TERAZOSIN,SANIS HEALTH INC,TERAZOSIN,TERAZOSIN,1MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-03-19,2018-03-19,2018-04-13,2018-04-11,Other (Please describe in comments),2018-03-13,2018-04-12
53076,2350505,Shortage,TERAZOSIN,SANIS HEALTH INC,TERAZOSIN TABS,TERAZOSIN,10MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2018-07-05,2018-07-04,2018-10-05,2018-10-12,Other (Please describe in comments),2018-06-28,2018-10-13
23666,2350505,Shortage,TERAZOSIN,SANIS HEALTH INC,TERAZOSIN TAB,TERAZOSIN,10MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,2017-10-02,,2017-10-31,2017-10-06,Other (Please describe in comments),2017-09-27,2017-10-07
49215,2237477,Shortage,TERAZOSIN-2,PRO DOC LIMITEE,TERAZOSIN-2,TERAZOSIN,2MG,100,ORAL,Resolved,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-05-14,,2018-08-07,Delay in shipping of the drug.,2018-05-14,2018-08-08
52993,2385279,Shortage,TERBINAFINE,SIVEM PHARMACEUTICALS ULC,TERBINAFINE,TERBINAFINE,250MG,100,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,2018-07-09,2018-07-16,2018-09-17,2018-09-14,Delay in shipping of the drug.,2018-06-26,2018-09-20
90687,2385279,Shortage,TERBINAFINE,SIVEM PHARMACEUTICALS ULC,TERBINAFINE,TERBINAFINE,250MG,30,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,2019-10-28,2019-11-14,,,Delay in shipping of the drug.,2019-08-05,2019-11-15
90690,2385279,Shortage,TERBINAFINE,SIVEM PHARMACEUTICALS ULC,TERBINAFINE,TERBINAFINE,250MG,100,ORAL,Anticipated shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,2019-11-18,,,,Delay in shipping of the drug.,2019-08-05,2019-09-23
90836,2353121,Shortage,TERBINAFINE,SANIS HEALTH INC,TERBINAFINE,TERBINAFINE,250MG,100,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,2019-08-12,2019-08-16,2019-09-30,2019-10-01,Disruption of the manufacture of the drug.,2019-08-06,2019-10-02
52990,2385279,Shortage,TERBINAFINE,SIVEM PHARMACEUTICALS ULC,TERBINAFINE,TERBINAFINE,250MG,30,ORAL,Resolved,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,2018-07-02,2018-07-04,2018-09-17,2018-09-14,Delay in shipping of the drug.,2018-06-26,2018-09-20
71951,2280248,Shortage,TESTIM 1%,PALADIN LABS INC,Testosterone,TESTOSTERONE,1%,30x5g,TRANSDERMAL,Resolved,GEL,G03BA,ANDROGENS,,2019-01-25,2019-11-29,2019-07-22,Delay in shipping of the drug.,2019-01-11,2019-07-23
35110,2410338,Shortage,TETRABENAZINE TABLETS,STERIMAX INC,TETRABENAZINE TABLETS,TETRABENAZINE,25MG,Bottle - 112 tabs,ORAL,Resolved,TABLET,N07XX,OTHER NERVOUS SYSTEM DRUGS,,2018-05-03,2018-06-15,2018-06-22,Other (Please describe in comments),2018-01-08,2018-06-23
84151,580929,Shortage,TETRACYCLINE,AA PHARMA INC,Tetracycline,TETRACYCLINE HYDROCHLORIDE,250MG,1000 BTL,ORAL,Actual shortage,CAPSULE,J01AA,TETRACYCLINES,,2019-05-15,,,Disruption of the manufacture of the drug.,2019-05-15,2019-06-05
94825,2171929,Shortage,TEVA-5 ASA,TEVA CANADA LIMITED,ASA,MESALAZINE,400MG,500,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2019-09-26,2019-10-31,2019-10-03,Disruption of the manufacture of the drug.,2019-09-26,2019-10-04
17844,2171929,Shortage,TEVA-5 ASA,TEVA CANADA LIMITED,5 ASA,MESALAZINE,400MG,100,ORAL,Resolved,TABLET (ENTERIC-COATED),A07EC,INTESTINALANTIINFLAMMATORY AGENTS,,2017-07-30,2018-04-13,2018-04-30,Disruption of the manufacture of the drug.,2017-08-01,2018-05-11
50023,2204517,Shortage,TEVA-ACEBUTOLOL,TEVA CANADA LIMITED,ACEBUTOLOL,ACEBUTOLOL,100MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-05-30,,2019-05-30,Demand increase for the drug.,2018-05-22,2019-08-20
50026,2204525,Shortage,TEVA-ACEBUTOLOL,TEVA CANADA LIMITED,ACEBUTOLOL,ACEBUTOLOL,200MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-05-30,,2019-05-30,Demand increase for the drug.,2018-05-22,2019-08-20
50029,2204533,Shortage,TEVA-ACEBUTOLOL,TEVA CANADA LIMITED,ACEBUTOLOL,ACEBUTOLOL,400MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-05-30,,2019-05-30,Demand increase for the drug.,2018-05-22,2019-08-20
29444,2285967,Shortage,TEVA-ACYCLOVIR,TEVA CANADA LIMITED,ACYCLOVIR,ACYCLOVIR,400MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-11-16,2018-11-12,2018-11-08,Demand increase for the drug.,2017-11-16,2018-11-09
92137,2285967,Shortage,TEVA-ACYCLOVIR,TEVA CANADA LIMITED,ACYCLOVIR,ACYCLOVIR,400MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-08-22,2019-09-30,2019-10-03,Disruption of the manufacture of the drug.,2019-08-22,2019-10-04
92174,2261715,Shortage,TEVA-ALENDRONATE,TEVA CANADA LIMITED,ALENDRONATE,ALENDRONIC ACID,70MG,50,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-08-22,2019-11-30,2019-10-31,Disruption of the manufacture of the drug.,2019-08-22,2019-11-01
43116,2261715,Shortage,TEVA-ALENDRONATE,TEVA CANADA LIMITED,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-03-01,2018-08-10,2018-09-15,Demand increase for the drug.,2018-03-16,2018-10-11
10886,2261715,Shortage,TEVA-ALENDRONATE,TEVA CANADA LIMITED,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-05-17,2017-06-30,2017-09-01,Disruption of the manufacture of the drug.,2017-05-23,2017-09-19
23143,2403633,Shortage,TEVA-ALENDRONATE/CHOLECALCIFEROL,TEVA CANADA LIMITED,ALENDRONATE VIT D,ALENDRONIC ACID  VITAMIN D3,70MG  2800UNIT,4,ORAL,Actual shortage,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-10-30,,,Shortage of an active ingredient.,2017-09-22,2018-12-21
23146,2403641,Shortage,TEVA-ALENDRONATE/CHOLECALCIFEROL,TEVA CANADA LIMITED,ALENDRONATE VIT  D,ALENDRONIC ACID  VITAMIN D3,70MG  5600UNIT,4,ORAL,Actual shortage,TABLET,M05BB,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-11-20,,,Shortage of an active ingredient.,2017-09-22,2018-12-21
19922,2434849,Shortage,TEVA-ALMOTRIPTAN,TEVA CANADA LIMITED,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-08-17,2019-08-30,2019-08-28,Requirements related to complying with good manufacturing practices.,2017-08-21,2019-08-29
5171,2326043,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017-12-15,2018-02-15,2018-03-07,Disruption of the manufacture of the drug.,2017-04-03,2018-03-08
2427,2326043,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017-12-15,2018-02-12,2018-03-07,Delay in shipping of the drug.,2017-03-14,2018-03-08
42619,2326051,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,25MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2018-03-01,2018-03-29,2018-04-20,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
2434,2326078,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017-03-01,2017-05-20,2017-05-17,Disruption of the manufacture of the drug.,2017-03-14,2017-05-23
2437,2326078,Shortage,TEVA-AMITRIPTYLINE,TEVA CANADA LIMITED,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,50MG,1000,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2017-03-01,2017-05-20,2017-05-17,Disruption of the manufacture of the drug.,2017-03-14,2017-05-23
9788,2250497,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,5MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-05-04,2018-01-30,2018-02-28,Shortage of an active ingredient.,2017-05-10,2018-03-13
9791,2250497,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,5MG,500,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-05-04,2018-01-30,2018-02-28,Shortage of an active ingredient.,2017-05-10,2018-03-13
17847,2250497,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,5MG,250,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-07-30,2018-01-30,2018-02-28,Shortage of an active ingredient.,2017-08-01,2018-03-13
17850,2250500,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,10MG,250,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-07-30,2018-01-30,2018-02-28,Shortage of an active ingredient.,2017-08-01,2018-03-13
19925,2250500,Shortage,TEVA-AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE,AMLODIPINE,10MG,100,ORAL,Resolved,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2017-08-17,2018-01-30,2018-02-28,Shortage of an active ingredient.,2017-08-21,2018-03-13
86825,2464195,Shortage,TEVA-ARIPIPRAZOLE,TEVA CANADA LIMITED,ARIPIPRAZOLE,ARIPIPRAZOLE,30MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
87687,2464195,Shortage,TEVA-ARIPIPRAZOLE,TEVA CANADA LIMITED,ARIPIPRAZOLE,ARIPIPRAZOLE,30MG,30,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-27,2019-10-31,2019-10-09,Disruption of the manufacture of the drug.,2019-06-27,2019-10-10
86945,2464144,Shortage,TEVA-ARIPIPRAZOLE,TEVA CANADA LIMITED,ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,30,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
86948,2464144,Shortage,TEVA-ARIPIPRAZOLE,TEVA CANADA LIMITED,ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
86951,2464179,Shortage,TEVA-ARIPIPRAZOLE,TEVA CANADA LIMITED,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
86954,2464179,Shortage,TEVA-ARIPIPRAZOLE,TEVA CANADA LIMITED,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,30,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
86957,2464187,Shortage,TEVA-ARIPIPRAZOLE,TEVA CANADA LIMITED,ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,30,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
19928,2443813,Shortage,TEVA-ATAZANAVIR,TEVA CANADA LIMITED,ATAZANAVIR,ATAZANAVIR,200MG,60,ORAL,Resolved,CAPSULE,J05AE,DIRECT ACTING ANTIVIRALS,,2017-08-17,2017-09-15,2017-09-15,Disruption of the manufacture of the drug.,2017-08-21,2017-09-19
952,2302926,Shortage,TEVA-ATENOLOL/CHLORTHALIDONE,TEVA CANADA LIMITED,Atenolol Chlorthalidone,CHLORTHALIDONE  ATENOLOL,25MG  100MG,100,ORAL,Actual shortage,TABLET,C07CB,BETA BLOCKING AGENTS AND OTHER DIURETICS,2016-11-01,2016-10-17,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
92166,2362511,Shortage,TEVA-ATOMOXETINE,TEVA CANADA LIMITED,ATOMOXETINE,ATOMOXETINE,80MG,100,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-08-22,2019-11-30,2019-11-06,Disruption of the manufacture of the drug.,2019-08-22,2019-11-07
29447,2314592,Shortage,TEVA-ATOMOXETINE,TEVA CANADA LIMITED,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-11-16,2018-01-17,2018-02-15,Disruption of the manufacture of the drug.,2017-11-16,2018-02-21
17853,2314584,Shortage,TEVA-ATOMOXETINE,TEVA CANADA LIMITED,ATOMOXETINE,ATOMOXETINE,40MG,30,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2017-07-30,2018-01-17,2018-02-15,Disruption of the manufacture of the drug.,2017-08-01,2018-02-21
94372,2310929,Shortage,TEVA-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,80MG,90,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-18,2019-10-31,2019-10-03,Disruption of the manufacture of the drug.,2019-09-19,2019-10-04
92140,2310910,Shortage,TEVA-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN,ATORVASTATIN,40MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-31,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-11-01
96720,2380927,Shortage,TEVA-ATOVAQUONE PROGUANIL,TEVA CANADA LIMITED,ATOVAQUONE/PROGUANIL,PROGUANIL HYDROCHLORIDE  ATOVAQUONE,100MG  250MG,12,ORAL,Actual shortage,TABLET,P01BB,ANTIMALARIALS,,2019-10-16,2019-11-30,,Disruption of the manufacture of the drug.,2019-10-17,2019-10-17
17856,2267845,Shortage,TEVA-AZITHROMYCIN,TEVA CANADA LIMITED,AZITHROMYCIN,AZITHROMYCIN,250MG,6,ORAL,Actual shortage,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-07-30,,,Disruption of the manufacture of the drug.,2017-08-01,2018-12-21
17859,2280205,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017-08-01,2017-11-17,2017-10-10,Disruption of the manufacture of the drug.,2017-08-01,2017-10-11
19931,2280205,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL,Resolved,TABLET,N07CA,ANTIVERTIGO PREPARATIONS,,2017-08-17,2017-11-15,2017-10-10,Disruption of the manufacture of the drug.,2017-08-21,2017-10-11
29450,2270226,Shortage,TEVA-BICALUTAMIDE,TEVA CANADA LIMITED,BICALUTAMIDE,BICALUTAMIDE,50MG,100,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-11-16,2018-01-15,2018-03-05,Disruption of the manufacture of the drug.,2017-11-16,2018-03-13
5174,2270226,Shortage,TEVA-BICALUTAMIDE,TEVA CANADA LIMITED,BICALUTAMIDE,BICALUTAMIDE,50MG,30,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-04-03,2017-05-08,2017-05-04,Disruption of the manufacture of the drug.,2017-04-03,2017-05-10
86960,2270226,Shortage,TEVA-BICALUTAMIDE,TEVA CANADA LIMITED,BICALUTAMIDE,BICALUTAMIDE,50MG,100,ORAL,Resolved,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
86818,2267489,Shortage,TEVA-BISOPROLOL,TEVA CANADA LIMITED,BISOPROLOL,BISOPROLOL FUMARATE,10MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
42585,2267489,Shortage,TEVA-BISOPROLOL,TEVA CANADA LIMITED,BISOPROLOL,BISOPROLOL FUMARATE,10MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2018-03-10,2018-04-20,2018-04-20,Disruption of the manufacture of the drug.,2018-03-13,2018-07-30
202,2267470,Shortage,TEVA-BISOPROLOL,TEVA CANADA LIMITED,BISOPROLOL FUMARATE,BISOPROLOL FUMARATE,5MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,2017-01-15,,2017-03-10,2017-03-10,Disruption of the manufacture of the drug.,2017-03-10,2017-04-25
93131,2465957,Shortage,TEVA-BUDESONIDE,TEVA CANADA LIMITED,BUDESONIDE,BUDESONIDE,0.5MG,20,INHALATION,Actual shortage,SUSPENSION,R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2019-09-05,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-05,2019-11-07
86846,2231492,Shortage,TEVA-BUSPIRONE,TEVA CANADA LIMITED,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,,2019-06-18,2019-07-15,2019-07-10,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
92192,2366320,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-08-22,2019-11-30,2019-10-31,Disruption of the manufacture of the drug.,2019-08-22,2019-11-01
87690,2366320,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-06-27,2019-11-30,2019-10-31,Demand increase for the drug.,2019-06-27,2019-11-01
86963,2395541,Shortage,TEVA-CANDESARTAN/HCTZ,TEVA CANADA LIMITED,CANDESARTAN/HCTZ,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  16MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-06-18,2019-11-30,,Disruption of the manufacture of the drug.,2019-06-18,2019-09-26
974,2395568,Shortage,TEVA-CANDESARTAN/HCTZ,TEVA CANADA LIMITED,Hydrochlorothiazide Candesartan Cilexetil,HYDROCHLOROTHIAZIDE  CANDESARTAN CILEXETIL,12.5MG  32MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2016-11-22,2017-03-31,2017-09-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
8062,2400030,Shortage,TEVA-CAPECITABINE,TEVA CANADA LIMITED,CAPECITABINE,CAPECITABINE,500MG,120,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2017-04-21,2017-05-31,2017-05-17,Disruption of the manufacture of the drug.,2017-04-25,2017-05-23
17862,2400022,Shortage,TEVA-CAPECITABINE,TEVA CANADA LIMITED,CAPECITABINE,CAPECITABINE,150MG,PP60,ORAL,Resolved,TABLET,L01BC,ANTIMETABOLITES,,2018-01-03,2018-04-30,2018-04-30,Demand increase for the drug.,2017-08-01,2018-05-11
97611,1942972,Shortage,TEVA-CAPTOPRIL,TEVA CANADA LIMITED,CAPTOPRIL 25MG TABLETS,CAPTOPRIL,25MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-10-31,2020-03-31,,Disruption of the manufacture of the drug.,2019-10-31,2019-11-07
94378,1942999,Shortage,TEVA-CAPTOPRIL,TEVA CANADA LIMITED,CAPTOPRIL,CAPTOPRIL,100MG,100,ORAL,Actual shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2019-09-18,2020-03-31,,Disruption of the manufacture of the drug.,2019-09-19,2019-09-26
86859,782718,Shortage,TEVA-CARBAMAZEPINE,TEVA CANADA LIMITED,CARBAMAZEPINE,CARBAMAZEPINE,200MG,100,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2019-06-18,2020-01-31,,Demand increase for the drug.,2019-06-18,2019-11-14
86879,782718,Shortage,TEVA-CARBAMAZEPINE,TEVA CANADA LIMITED,CARBAMAZEPINE,CARBAMAZEPINE,200MG,500,ORAL,Actual shortage,TABLET,N03AF,ANTIEPILEPTICS,,2019-06-18,2020-01-31,,Demand increase for the drug.,2019-06-18,2019-11-14
983,782718,Shortage,TEVA-CARBAMAZEPINE,TEVA CANADA LIMITED,Carbamazepine,CARBAMAZEPINE,200MG,100,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2016-11-01,2019-05-30,2019-05-15,Disruption of the manufacture of the drug.,2017-03-13,2019-05-28
82410,782718,Shortage,TEVA-CARBAMAZEPINE,TEVA CANADA LIMITED,CARBAMAZEPINE,CARBAMAZEPINE,200MG,500,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2019-04-25,2019-05-15,2019-05-15,Demand increase for the drug.,2019-04-25,2019-05-28
96076,583413,Shortage,TEVA-CEPHALEXIN,TEVA CANADA LIMITED,CEPHALEXIN  TABLETS,CEPHALEXIN,250MG,1000,ORAL,Actual shortage,TABLET,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-10-09,2019-11-30,,Disruption of the manufacture of the drug.,2019-10-10,2019-10-10
87693,583421,Shortage,TEVA-CEPHALEXIN,TEVA CANADA LIMITED,CEPHALEXIN,CEPHALEXIN,500MG,500,ORAL,Resolved,TABLET,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-06-27,2019-08-30,2019-07-15,Disruption of the manufacture of the drug.,2019-06-27,2019-07-16
95384,342092,Shortage,TEVA-CEPHALEXIN 250,TEVA CANADA LIMITED,CEPHALEXIN SUSP,CEPHALEXIN,250MG,150ml,ORAL,Actual shortage,POWDER FOR SUSPENSION,J01DB,OTHER BETA-LACTAM ANTIBACTERIALS,,2019-10-02,2019-11-30,,Disruption of the manufacture of the drug.,2019-10-03,2019-11-07
8065,232823,Shortage,TEVA-CHLORPROMAZINE,TEVA CANADA LIMITED,CHLORPROMAZINE,CHLORPROMAZINE,25.0MG,100,ORAL,Resolved,TABLET,N05AA,ANTIPSYCHOTICS,,2017-04-21,2017-06-20,2017-07-30,Disruption of the manufacture of the drug.,2017-04-25,2017-09-19
86975,2313731,Shortage,TEVA-CILAZAPRIL/HCTZ,TEVA CANADA LIMITED,CILAZAPRIL/HCTZ,HYDROCHLOROTHIAZIDE  CILAZAPRIL,12.5MG  5MG,100,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2019-06-15,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
17871,2441624,Shortage,TEVA-CINACALCET,TEVA CANADA LIMITED,CINACALCET,CINACALCET,30MG,30,ORAL,Resolved,TABLET,H05BX,ANTI-PARATHYROID HORMONES,,2017-08-01,2017-09-30,2017-09-30,Disruption of the manufacture of the drug.,2017-08-01,2017-10-10
43129,2293218,Shortage,TEVA-CITALOPRAM,TEVA CANADA LIMITED,CITALOPRAM,CITALOPRAM,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-03-15,2018-04-30,2018-04-30,Disruption of the manufacture of the drug.,2018-03-16,2018-05-30
17874,2293226,Shortage,TEVA-CITALOPRAM,TEVA CANADA LIMITED,CITALOPRAM,CITALOPRAM,40MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-08-01,2017-09-29,2017-09-15,Disruption of the manufacture of the drug.,2017-08-01,2017-09-19
19934,2293218,Shortage,TEVA-CITALOPRAM,TEVA CANADA LIMITED,CITALOPRAM,CITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2017-08-17,2017-11-15,2017-10-06,Disruption of the manufacture of the drug.,2017-08-21,2017-10-10
5177,2241709,Shortage,TEVA-CLINDAMYCIN,TEVA CANADA LIMITED,CLINDAMYCIN,CLINDAMYCIN,150MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-04-03,2017-05-05,2017-05-04,Demand increase for the drug.,2017-04-03,2017-05-10
5180,2241710,Shortage,TEVA-CLINDAMYCIN,TEVA CANADA LIMITED,CLINDAMYCIN,CLINDAMYCIN,300MG,100,ORAL,Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-08-10,2017-10-15,2017-10-20,Demand increase for the drug.,2017-04-03,2017-10-24
19683,2239024,Shortage,TEVA-CLONAZEPAM,TEVA CANADA LIMITED,CLONAZEPAM,CLONAZEPAM,0.5MG,100,ORAL,Actual shortage,TABLET,N03AE,ANTIEPILEPTICS,,2017-08-11,,,Shortage of an active ingredient.,2017-08-17,2017-10-11
19688,2239024,Shortage,TEVA-CLONAZEPAM,TEVA CANADA LIMITED,CLONAZEPAM,CLONAZEPAM,0.5MG,500,ORAL,Actual shortage,TABLET,N03AE,ANTIEPILEPTICS,,2017-08-11,,,Shortage of an active ingredient.,2017-08-17,2017-10-11
86599,2293161,Shortage,TEVA-CLOPIDOGREL,TEVA CANADA LIMITED,CLOPIDOGREL,CLOPIDOGREL,75MG,500,ORAL,Resolved,TABLET,B01AC,ANTITHROMBOTIC AGENTS,,2019-06-13,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-13,2019-07-15
19937,337757,Shortage,TEVA-CLOXACILLIN,TEVA CANADA LIMITED,CLOXACILLIN,CLOXACILLIN SODIUM,125MG,100ML,ORAL,Resolved,GRANULES FOR SOLUTION,J01CF,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2017-08-17,2017-09-05,2017-09-15,Disruption of the manufacture of the drug.,2017-08-21,2017-09-19
87696,2309556,Shortage,TEVA-CYPROTERONE / ETHINYL ESTRADIOL,TEVA CANADA LIMITED,CYPROTERONE / ETHINYL ESTRADIO,ETHINYL ESTRADIOL  CYPROTERONE ACETATE,0.035MG  2MG,21,ORAL,Resolved,TABLET,G03HB,ANTIANDROGENS,,2019-06-27,2019-08-30,2019-08-23,Disruption of the manufacture of the drug.,2019-06-27,2019-08-24
96730,2407973,Shortage,TEVA-DEFERASIROX,TEVA CANADA LIMITED,DEFERASIROX,DEFERASIROX,500MG,30,ORAL,Resolved,TABLET FOR SUSPENSION,V03AC,ALL OTHER THERAPEUTIC PRODUCTS,,2019-10-16,2019-10-25,2019-10-25,Other (Please describe in comments),2019-10-17,2019-10-26
65490,2158582,Shortage,TEVA-DICLOFENAC SR,TEVA CANADA LIMITED,DICLOFENAC SR,DICLOFENAC SODIUM,75MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2017-01-01,,,Disruption of the manufacture of the drug.,2018-10-23,2018-10-23
42610,862924,Shortage,TEVA-DILTIAZEM,TEVA CANADA LIMITED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,30MG,100,ORAL,Actual shortage,TABLET,C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2018-03-01,,,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
81415,2242539,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-04-11,2019-05-30,2019-05-30,Delay in shipping of the drug.,2019-04-11,2019-06-03
5183,2242538,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,120MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-04-03,2017-06-19,2017-05-04,Demand increase for the drug.,2017-04-03,2017-05-10
5186,2242539,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2017-04-03,2017-05-15,2017-05-04,Demand increase for the drug.,2017-04-03,2017-05-10
87699,2242539,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-06-27,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-27,2019-08-06
87702,2242540,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-06-27,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-27,2019-08-06
93647,2242539,Shortage,TEVA-DILTIAZEM CD,TEVA CANADA LIMITED,DILTIAZEM CD,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-09-11,2019-11-30,2019-11-07,Disruption of the manufacture of the drug.,2019-09-12,2019-11-08
42629,2340615,Shortage,TEVA-DONEPEZIL,TEVA CANADA LIMITED,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,30,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-03-07,2018-05-20,2018-05-20,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
17878,2340615,Shortage,TEVA-DONEPEZIL,TEVA CANADA LIMITED,DONEPOZIL,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-01-03,2018-04-30,2018-04-30,Delay in shipping of the drug.,2017-08-01,2018-05-11
42632,2242729,Shortage,TEVA-DOXAZOSIN,TEVA CANADA LIMITED,DOXAZOSIN,DOXAZOSIN,2MG,100,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2018-03-13,2018-04-30,2018-04-20,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
42635,2242730,Shortage,TEVA-DOXAZOSIN,TEVA CANADA LIMITED,DOXAZOSIN,DOXAZOSIN,4MG,100,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2018-03-13,2018-04-30,2018-04-22,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
98182,2158574,Shortage,TEVA-DOXYCYCLINE,TEVA CANADA LIMITED,DOXYCYCLINE TABS,DOXYCYCLINE,100MG,100,ORAL,Actual shortage,TABLET,J01AA,TETRACYCLINES,,2019-11-06,2019-12-31,,Disruption of the manufacture of the drug.,2019-11-07,2019-11-07
87705,2158574,Shortage,TEVA-DOXYCYCLINE,TEVA CANADA LIMITED,DOXYCYCLINE,DOXYCYCLINE,100MG,100,ORAL,Resolved,TABLET,J01AA,TETRACYCLINES,,2019-06-27,2019-08-30,2019-08-15,Disruption of the manufacture of the drug.,2019-06-27,2019-08-16
17881,725250,Shortage,TEVA-DOXYCYCLINE,TEVA CANADA LIMITED,DOXYCYCLINE,DOXYCYCLINE,100MG,100,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017-08-01,2017-09-05,2017-09-13,Disruption of the manufacture of the drug.,2017-08-01,2017-09-19
17884,725250,Shortage,TEVA-DOXYCYCLINE,TEVA CANADA LIMITED,DOXYCYCLINE,DOXYCYCLINE,100MG,200,ORAL,Resolved,CAPSULE,J01AA,TETRACYCLINES,,2017-08-01,2017-09-01,2017-09-13,Disruption of the manufacture of the drug.,2017-08-01,2017-09-19
5189,2408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-07-30,2018-12-28,2018-12-28,Disruption of the manufacture of the drug.,2017-04-03,2019-01-03
5192,2408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-07-30,2018-12-28,2018-12-28,Disruption of the manufacture of the drug.,2017-04-03,2019-01-03
95370,2408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL,Resolved,CAPSULE,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2019-10-03,2019-10-31,2019-10-09,Disruption of the manufacture of the drug.,2019-10-03,2019-10-10
42553,2382105,Shortage,TEVA-ELETRIPTAN,TEVA CANADA LIMITED,ELETRIPTAN,ELETRIPTAN,40MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-03-01,2018-03-19,2018-04-15,Disruption of the manufacture of the drug.,2018-03-13,2018-05-11
17887,2382105,Shortage,TEVA-ELETRIPTAN,TEVA CANADA LIMITED,ELETRIPTAN,ELETRIPTAN,40MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-08-01,2017-10-01,2017-10-06,Disruption of the manufacture of the drug.,2017-08-01,2017-10-10
42562,2318202,Shortage,TEVA-ESCITALOPRAM,TEVA CANADA LIMITED,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2018-03-07,2018-04-20,2018-04-20,Disruption of the manufacture of the drug.,2018-03-13,2018-12-07
9796,2354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,EZETIMIBE,EZETIMIBE,10MG,100,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-04,2017-06-05,2017-08-15,Disruption of the manufacture of the drug.,2017-05-10,2017-09-19
17890,2354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,EZETIMIBE,EZETIMIBE,10MG,PP30,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-01,2017-10-30,2017-11-01,Disruption of the manufacture of the drug.,2017-08-01,2017-11-06
19941,2354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,EZETIMIBE,EZETIMIBE,10MG,500,ORAL,Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-17,2017-09-20,2017-09-15,Disruption of the manufacture of the drug.,2017-08-21,2017-09-19
94877,2022133,Shortage,TEVA-FAMOTIDINE,TEVA CANADA LIMITED,FAMOTIDINE,FAMOTIDINE,20MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-26,2019-12-31,,Other (Please describe in comments),2019-09-26,2019-11-14
94880,2022141,Shortage,TEVA-FAMOTIDINE,TEVA CANADA LIMITED,TEVA-FAMOTIDINE,FAMOTIDINE,40MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-09-26,2019-12-31,,Other (Please describe in comments),2019-09-26,2019-11-14
88158,2282976,Shortage,TEVA-FENTANYL,TEVA CANADA LIMITED,FENTANYL,FENTANYL,75MCG,5PK,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2019-07-02,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-07-02,2019-08-06
22948,2282968,Shortage,TEVA-FENTANYL,TEVA CANADA LIMITED,FENTANYL,FENTANYL,50MCG,5PK,TRANSDERMAL,Resolved,PATCH,N02AB,OPIOIDS,,2017-09-21,2017-11-01,2017-11-06,Disruption of the manufacture of the drug.,2017-09-21,2017-11-07
19944,2348500,Shortage,TEVA-FINASTERIDE,TEVA CANADA LIMITED,FINASTERIDE,FINASTERIDE,5MG,100,ORAL,Resolved,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2017-08-17,2017-09-30,2017-10-06,Demand increase for the drug.,2017-08-21,2017-10-10
17893,2236979,Shortage,TEVA-FLUCONAZOLE,TEVA CANADA LIMITED,FLUCONAZOLE,FLUCONAZOLE,100MG,50,ORAL,Actual shortage,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2017-08-01,,,Disruption of the manufacture of the drug.,2017-08-01,2018-12-21
19947,2216590,Shortage,TEVA-FLUOXETINE,TEVA CANADA LIMITED,FLUOXETINE,FLUOXETINE,20MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-08-17,2017-10-30,2017-11-01,Shortage of an active ingredient.,2017-08-21,2017-11-06
19950,2216590,Shortage,TEVA-FLUOXETINE,TEVA CANADA LIMITED,FLUOXETINE,FLUOXETINE,20MG,500,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2017-08-17,2017-10-30,2017-11-01,Shortage of an active ingredient.,2017-08-21,2017-11-06
88161,2453738,Shortage,TEVA-FLUTICASONE,TEVA CANADA LIMITED,FLUTICASONE,FLUTICASONE PROPIONATE,50MCG,120,NASAL,Resolved,METERED-DOSE PUMP,R01AD,DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE,,2019-07-02,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-07-02,2019-08-06
71550,2299224,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,FLUVASTATIN,FLUVASTATIN,20MG,100,ORAL,Actual shortage,CAPSULE,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-12-01,2019-11-30,,Disruption of the manufacture of the drug.,2019-01-08,2019-08-20
71553,2299232,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,FLUVASTATIN,FLUVASTATIN,40MG,100,ORAL,Actual shortage,CAPSULE,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-01-08,2019-12-31,,Disruption of the manufacture of the drug.,2019-01-08,2019-11-14
989,2299224,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,FLUVASTATIN,FLUVASTATIN,20MG,100,ORAL,Resolved,CAPSULE,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2016-11-01,2016-03-30,2017-03-31,2017-03-31,Disruption of the manufacture of the drug.,2017-03-13,2017-04-03
2301,2299232,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,FLUVASTATIN,FLUVASTATIN,40MG,100,ORAL,Resolved,CAPSULE,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-03-01,2017-04-17,2017-03-31,Disruption of the manufacture of the drug.,2017-03-14,2017-04-03
19955,2247802,Shortage,TEVA-FOSINOPRIL,TEVA CANADA LIMITED,FOSINOPRIL,FOSINOPRIL SODIUM,10MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-20,2017-09-14,2017-09-15,Disruption of the manufacture of the drug.,2017-08-21,2017-09-19
19960,2247803,Shortage,TEVA-FOSINOPRIL,TEVA CANADA LIMITED,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,30,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-18,2017-09-14,2017-09-15,Shortage of an inactive ingredient or component.,2017-08-21,2017-09-19
5197,337730,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,FUROSEMIDE,FUROSEMIDE,20MG,100,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2017-04-03,2017-05-15,2017-05-17,Disruption of the manufacture of the drug.,2017-04-03,2017-05-23
43141,765953,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,FUROSEMIDE,FUROSEMIDE,80MG,100,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2018-03-16,2018-04-05,2018-04-15,Disruption of the manufacture of the drug.,2018-03-16,2018-05-30
42651,337749,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,FUROSEMIDE,FUROSEMIDE,40MG,1000,ORAL,Resolved,TABLET,C03CA,HIGH-CEILING DIURETICS,,2018-03-13,2018-03-30,2018-04-15,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
3124,2244514,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN,GABAPENTIN,300MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-03-17,2017-05-31,2017-04-17,Disruption of the manufacture of the drug.,2017-03-17,2017-04-25
42588,2244513,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN,GABAPENTIN,100MG,500,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-03-13,2018-04-15,2018-04-20,Disruption of the manufacture of the drug.,2018-03-13,2018-07-30
10889,2244514,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-05-17,2017-06-12,2017-09-01,Disruption of the manufacture of the drug.,2017-05-23,2017-09-19
43152,2244514,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN,GABAPENTIN,300MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-03-15,2018-06-20,2018-07-15,Disruption of the manufacture of the drug.,2018-03-16,2018-07-30
42613,2142074,Shortage,TEVA-GEMFIBROZIL,TEVA CANADA LIMITED,GEMFIBROZIL,GEMFIBROZIL,600MG,100,ORAL,Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",,2018-03-07,2018-04-30,2018-05-01,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
88164,2238103,Shortage,TEVA-GLICLAZIDE,TEVA CANADA LIMITED,GLICLAZIDE,GLICLAZIDE,80MG,100,ORAL,Actual shortage,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2019-07-02,2020-02-28,,Shortage of an active ingredient.,2019-07-02,2019-10-31
1841,363677,Shortage,TEVA-HALOPERIDOL,TEVA CANADA LIMITED,HALOPERIDOL,HALOPERIDOL,1MG,100,ORAL,Resolved,TABLET,N05AD,ANTIPSYCHOTICS,,2017-02-01,2017-04-13,2017-04-17,Delay in shipping of the drug.,2017-03-13,2017-04-25
3127,363685,Shortage,TEVA-HALOPERIDOL,TEVA CANADA LIMITED,HALOPERIDOL,HALOPERIDOL,0.5MG,100,ORAL,Resolved,TABLET,N05AD,ANTIPSYCHOTICS,,2017-03-17,2017-07-16,2017-03-30,Disruption of the manufacture of the drug.,2017-03-17,2017-04-03
43132,363685,Shortage,TEVA-HALOPERIDOL,TEVA CANADA LIMITED,HALOPERIDOL,HALOPERIDOL,0.5MG,100,ORAL,Resolved,TABLET,N05AD,ANTIPSYCHOTICS,,2018-03-01,2018-07-30,2018-08-15,Disruption of the manufacture of the drug.,2018-03-16,2018-10-11
43135,363669,Shortage,TEVA-HALOPERIDOL,TEVA CANADA LIMITED,HALOPERIDOL,HALOPERIDOL,2MG,100,ORAL,Resolved,TABLET,N05AD,ANTIPSYCHOTICS,,2018-03-01,2018-06-06,2018-07-20,Disruption of the manufacture of the drug.,2018-03-16,2018-07-30
997,2319403,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,1MG,100,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2014-11-05,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
1001,2319411,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,2MG,100,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2014-11-05,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
1006,2319438,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,4MG,100,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2014-11-05,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
1009,2319446,Shortage,TEVA-HYDROMORPHONE,TEVA CANADA LIMITED,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,8MG,100,ORAL,Actual shortage,TABLET,N02AA,OPIOIDS,,2014-11-05,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
92148,2399806,Shortage,TEVA-IMATINIB,TEVA CANADA LIMITED,IMATINIB MESYLATE,IMATINIB,100MG,120,ORAL,Resolved,TABLET,L01XE,OTHER ANTINEOPLASTIC AGENTS,,2019-08-21,2019-11-30,2019-11-13,Disruption of the manufacture of the drug.,2019-08-22,2019-11-14
8071,2216221,Shortage,TEVA-IPRATROPIUM STERINEBS,TEVA CANADA LIMITED,IPRATROPIUM,IPRATROPIUM BROMIDE,0.025%,10X2ML,INHALATION,Resolved,SOLUTION,R03BB,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2017-04-21,2017-09-30,2017-10-06,Demand increase for the drug.,2017-04-25,2017-10-10
68616,2316390,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-12-04,2019-05-31,2019-05-31,Disruption of the manufacture of the drug.,2018-12-04,2019-06-03
92171,2316390,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,IRBESARTAN,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-08-22,2019-11-30,,Disruption of the manufacture of the drug.,2019-08-22,2019-09-26
88171,2316412,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,IRBESARTAN,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-02,2019-11-30,,Disruption of the manufacture of the drug.,2019-07-02,2019-09-26
94369,2316404,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,IRBESARTAN,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-09-18,2019-11-30,,Disruption of the manufacture of the drug.,2019-09-19,2019-10-24
68619,2330512,Shortage,TEVA-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-12-04,2019-03-18,2019-03-30,Disruption of the manufacture of the drug.,2018-12-04,2019-04-11
68622,2330520,Shortage,TEVA-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  300MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-12-04,2019-03-30,2019-03-30,Disruption of the manufacture of the drug.,2018-12-04,2019-04-11
88174,2330512,Shortage,TEVA-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN HCTZ,HYDROCHLOROTHIAZIDE  IRBESARTAN,12.5MG  150MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-07-02,2019-11-30,2019-10-31,Disruption of the manufacture of the drug.,2019-07-02,2019-11-01
97153,2330539,Shortage,TEVA-IRBESARTAN HCTZ,TEVA CANADA LIMITED,IRBESARTAN/HCTZ TABS,HYDROCHLOROTHIAZIDE  IRBESARTAN,25MG  300MG,100,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-10-23,2019-11-30,,Disruption of the manufacture of the drug.,2019-10-24,2019-10-24
5201,2231061,Shortage,TEVA-KETOCONAZOLE,TEVA CANADA LIMITED,KETOCONAZOLE,KETOCONAZOLE,200MG,100,ORAL,Resolved,TABLET,J02AB,ANTIMYCOTICS FOR SYSTEMIC USE,,2017-04-03,2017-05-25,2017-06-30,Disruption of the manufacture of the drug.,2017-04-03,2017-09-06
94831,2472910,Shortage,TEVA-LACOSAMIDE,TEVA CANADA LIMITED,LACOSAMIDE,LACOSAMIDE,100MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-09-26,2019-11-30,2019-11-13,Disruption of the manufacture of the drug.,2019-09-26,2019-11-14
95387,2472929,Shortage,TEVA-LACOSAMIDE,TEVA CANADA LIMITED,LACOSAMIDE TABS,LACOSAMIDE,150MG,60,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2019-10-02,2019-11-30,2019-10-09,Disruption of the manufacture of the drug.,2019-10-03,2019-10-10
19964,2331551,Shortage,TEVA-LACTULOSE,TEVA CANADA LIMITED,LACTULOSE,LACTULOSE,667MG,20,ORAL,Resolved,SOLUTION,A06AD,DRUGS FOR CONSTIPATION,,2017-08-20,2017-09-30,2017-10-06,Disruption of the manufacture of the drug.,2017-08-21,2017-10-10
5204,2248233,Shortage,TEVA-LAMOTRIGINE,TEVA CANADA LIMITED,LAMOTRIGINE,LAMOTRIGINE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2017-04-03,2017-05-03,2017-05-04,Disruption of the manufacture of the drug.,2017-04-03,2017-05-10
88177,2280515,Shortage,TEVA-LANSOPRAZOLE,TEVA CANADA LIMITED,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-30,,,Disruption of the manufacture of the drug.,2019-07-02,2019-07-02
88180,2280523,Shortage,TEVA-LANSOPRAZOLE,TEVA CANADA LIMITED,TEVA-LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-30,,,Disruption of the manufacture of the drug.,2019-07-02,2019-07-02
88183,2280523,Shortage,TEVA-LANSOPRAZOLE,TEVA CANADA LIMITED,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-30,,,Disruption of the manufacture of the drug.,2019-07-02,2019-07-02
86930,2254786,Shortage,TEVA-LATANOPROST,TEVA CANADA LIMITED,LATANOPROST,LATANOPROST,0.05MG,1,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
93159,2254786,Shortage,TEVA-LATANOPROST,TEVA CANADA LIMITED,LATANOPROST,LATANOPROST,0.05MG,1,OPHTHALMIC,Actual shortage,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-09-05,,,Disruption of the manufacture of the drug.,2019-09-05,2019-09-06
88186,2261278,Shortage,TEVA-LEFLUNOMIDE,TEVA CANADA LIMITED,LEFLUNOMIDE,LEFLUNOMIDE,20MG,30,ORAL,Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2019-07-02,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-07-02,2019-08-06
97594,653233,Shortage,TEVA-LENOLTEC NO. 1,TEVA CANADA LIMITED,LENOLTEC NO.1 CAPLETS,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  8MG  15MG,100's & 200's,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,,2019-10-31,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-31,2019-11-07
19968,2343657,Shortage,TEVA-LETROZOLE,TEVA CANADA LIMITED,LETROZOLE,LETROZOLE,2.5MG,30,ORAL,Resolved,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-08-18,2017-09-15,2017-09-15,Disruption of the manufacture of the drug.,2017-08-21,2017-09-19
19973,2244496,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA  LEVODOPA,25MG  250MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-12-29,2018-06-05,2018-02-21,Disruption of the manufacture of the drug.,2017-08-21,2018-02-22
5207,2244495,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-08-27,2017-11-06,2017-11-06,Demand increase for the drug.,2017-04-03,2017-11-07
94864,2244495,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVODOPA/CARBIDOPA,CARBIDOPA  LEVODOPA,25MG  100MG,100,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2019-09-26,2020-01-31,2019-10-09,Disruption of the manufacture of the drug.,2019-09-26,2019-10-10
17896,2244496,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA  LEVODOPA,25MG  250MG,500,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2018-01-03,2018-06-05,2018-02-21,Disruption of the manufacture of the drug.,2017-08-01,2018-02-22
2297,2244495,Shortage,TEVA-LEVOCARBIDOPA,TEVA CANADA LIMITED,LEVOCARBIDOPA,CARBIDOPA  LEVODOPA,25MG  100MG,500,ORAL,Resolved,TABLET,N04BA,DOPAMINERGIC AGENTS,,2017-06-30,2017-11-06,2017-11-06,Delay in shipping of the drug.,2017-03-14,2017-11-07
2310,2285096,Shortage,TEVA-LISINOPRIL (TYPE P),TEVA CANADA LIMITED,LISINOPRIL P,LISINOPRIL,20MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-04-03,2017-06-06,2017-07-03,Disruption of the manufacture of the drug.,2017-03-14,2017-07-27
2312,2285061,Shortage,TEVA-LISINOPRIL (TYPE P),TEVA CANADA LIMITED,LISINOPRIL P,LISINOPRIL,5MG,100,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-04-01,,2017-04-27,2017-05-04,Delay in shipping of the drug.,2017-03-14,2017-05-10
97622,2301768,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,LISINOPRIL/HCTZ,HYDROCHLOROTHIAZIDE  LISINOPRIL,12.5MG  10MG,100,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2019-11-01,,,,Demand increase for the drug.,2019-10-31,2019-11-07
97625,2301776,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,LISINOPRIL/HCTZ Z,HYDROCHLOROTHIAZIDE  LISINOPRIL,12.5MG  20MG,30's & 100's,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2019-11-01,,,,Demand increase for the drug.,2019-10-31,2019-11-07
97628,2301784,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,LISINOPRIL/HCTZ Z,HYDROCHLOROTHIAZIDE  LISINOPRIL,25MG  20MG,30's & 100's,ORAL,Actual shortage,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2019-11-01,,,,Demand increase for the drug.,2019-10-31,2019-11-02
42591,2132591,Shortage,TEVA-LOPERAMIDE,TEVA CANADA LIMITED,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,100,ORAL,Resolved,TABLET,A07DA,ANTIPROPULSIVES,,2018-03-01,2018-04-30,2018-05-10,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
42594,2132591,Shortage,TEVA-LOPERAMIDE,TEVA CANADA LIMITED,LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,500,ORAL,Resolved,TABLET,A07DA,ANTIPROPULSIVES,,2018-03-01,2018-04-30,2018-05-10,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
1026,711101,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,TEVA-LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2016-10-18,,2019-04-01,Disruption of the manufacture of the drug.,2017-03-13,2019-04-11
1035,637742,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,LORAZEPAM,LORAZEPAM,1MG,100,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2016-10-18,,2019-04-01,Disruption of the manufacture of the drug.,2017-03-13,2019-04-11
59704,711101,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-08-30,2018-10-19,2018-10-19,Disruption of the manufacture of the drug.,2018-08-31,2018-10-20
43122,637742,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,LORAZEPAM,LORAZEPAM,1MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-03-15,2018-10-30,2018-07-29,Disruption of the manufacture of the drug.,2018-03-16,2018-07-30
2292,711101,Shortage,TEVA-LORAZEPAM,TEVA CANADA LIMITED,LORAZEPAM,LORAZEPAM,0.5MG,1000,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2017-03-14,2017-06-15,2017-06-30,Demand increase for the drug.,2017-03-14,2017-07-27
88189,2357976,Shortage,TEVA-LOSARTAN,TEVA CANADA LIMITED,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-02,2019-11-30,,Demand increase for the drug.,2019-07-02,2019-08-09
88192,2357976,Shortage,TEVA-LOSARTAN,TEVA CANADA LIMITED,LOSARTAN,LOSARTAN POTASSIUM,100MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-02,2019-11-30,2019-10-31,Demand increase for the drug.,2019-07-02,2019-11-01
88195,2380838,Shortage,TEVA-LOSARTAN,TEVA CANADA LIMITED,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-02,2019-11-30,,Demand increase for the drug.,2019-07-02,2019-08-09
88198,2380838,Shortage,TEVA-LOSARTAN,TEVA CANADA LIMITED,LOSARTAN,LOSARTAN POTASSIUM,25MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-02,2019-11-30,,Demand increase for the drug.,2019-07-02,2019-08-09
88201,2357968,Shortage,TEVA-LOSARTAN,TEVA CANADA LIMITED,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-02,2019-11-30,2019-10-31,Demand increase for the drug.,2019-07-02,2019-11-01
88204,2357968,Shortage,TEVA-LOSARTAN,TEVA CANADA LIMITED,TEVA-LOSARTAN,LOSARTAN POTASSIUM,50MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2019-07-02,2019-11-30,2019-10-31,Demand increase for the drug.,2019-07-02,2019-11-01
88207,2377144,Shortage,TEVA-LOSARTAN/HCTZ,TEVA CANADA LIMITED,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,12.5MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-07-02,2020-01-31,,Demand increase for the drug.,2019-07-02,2019-11-14
88210,2377152,Shortage,TEVA-LOSARTAN/HCTZ,TEVA CANADA LIMITED,LOSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  LOSARTAN POTASSIUM,25MG  100MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-07-02,2020-01-31,,Demand increase for the drug.,2019-07-02,2019-11-14
3130,2221306,Shortage,TEVA-MEDROXYPROGESTERONE,TEVA CANADA LIMITED,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017-03-17,2017-06-04,2017-06-04,Disruption of the manufacture of the drug.,2017-03-17,2017-10-10
86606,2221292,Shortage,TEVA-MEDROXYPROGESTERONE,TEVA CANADA LIMITED,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,5MG,100,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2019-06-13,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-13,2019-07-15
5213,2221284,Shortage,TEVA-MEDROXYPROGESTERONE,TEVA CANADA LIMITED,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2017-12-15,2018-01-29,2018-02-15,Disruption of the manufacture of the drug.,2017-04-03,2018-02-21
86884,2221284,Shortage,TEVA-MEDROXYPROGESTERONE,TEVA CANADA LIMITED,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100,ORAL,Resolved,TABLET,G03DA,PROGESTOGENS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
30668,2315068,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-01-30,2018-01-30,,,Delay in shipping of the drug.,2017-11-24,2018-10-11
30685,2315076,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-01-30,2018-01-30,,,Delay in shipping of the drug.,2017-11-24,2018-10-11
30688,2315084,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,MTHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-01-30,2018-01-30,,,Delay in shipping of the drug.,2017-11-24,2018-10-11
30691,2315092,Shortage,TEVA-METHYLPHENIDATE ER-C,TEVA CANADA LIMITED,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-01-30,2018-01-30,,,Delay in shipping of the drug.,2017-11-24,2018-10-11
86896,842648,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL,METOPROLOL TARTRATE,50MG,100,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
86899,842648,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL,METOPROLOL TARTRATE,50MG,500,ORAL,Resolved,TABLET,C07AB,BETA BLOCKING AGENTS,,2019-06-18,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-15
98747,648035,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL 50MG FC TABLETS,METOPROLOL TARTRATE,50MG,100's,ORAL,Anticipated shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2020-03-01,,2020-07-01,,Shortage of an inactive ingredient or component.,2019-11-14,2019-11-14
98750,648035,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL 50MG FC TABLETS,METOPROLOL TARTRATE,50MG,500,ORAL,Anticipated shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2020-03-01,,2020-07-01,,Shortage of an inactive ingredient or component.,2019-11-14,2019-11-14
98753,648043,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL 100MG FC TABLETS,METOPROLOL TARTRATE,100MG,100,ORAL,Anticipated shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2020-03-01,,2020-07-01,,Shortage of an inactive ingredient or component.,2019-11-14,2019-11-14
98756,648043,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL 100MG FC TABLETS,METOPROLOL TARTRATE,100MG,500,ORAL,Anticipated shortage,TABLET,C07AB,BETA BLOCKING AGENTS,2020-03-01,,2020-07-01,,Shortage of an inactive ingredient or component.,2019-11-14,2019-11-14
19978,2230360,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,MEXILETINE,MEXILETINE HYDROCHLORIDE,200MG,100,ORAL,Resolved,CAPSULE,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2017-08-21,2018-01-15,2018-02-15,Demand increase for the drug.,2017-08-21,2018-02-21
29453,2230359,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,MEXILETINE,MEXILETINE HYDROCHLORIDE,100MG,100,ORAL,Resolved,CAPSULE,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2017-11-16,2018-01-15,2018-02-15,Disruption of the manufacture of the drug.,2017-11-16,2018-02-21
86902,2420260,Shortage,TEVA-MODAFINIL,TEVA CANADA LIMITED,MODAFINIL,MODAFINIL,100MG,30,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-06-18,,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-07-31
93137,2420260,Shortage,TEVA-MODAFINIL,TEVA CANADA LIMITED,MODAFINIL,MODAFINIL,100MG,30,ORAL,Resolved,TABLET,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2019-09-05,2019-10-31,2019-10-03,Disruption of the manufacture of the drug.,2019-09-05,2019-10-04
93134,2355515,Shortage,TEVA-MONTELUKAST,TEVA CANADA LIMITED,MONTELUKAST,MONTELUKAST,5MG,30,ORAL,Resolved,TABLET (CHEWABLE),R03DC,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,,2019-09-05,2019-09-30,2019-09-26,Disruption of the manufacture of the drug.,2019-09-05,2019-09-27
5216,2375702,Shortage,TEVA-MOXIFLOXACIN,TEVA CANADA LIMITED,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30,ORAL,Resolved,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2017-04-03,2017-06-05,2017-06-05,Disruption of the manufacture of the drug.,2017-04-03,2017-10-10
96727,2348675,Shortage,TEVA-MYCOPHENOLATE,TEVA CANADA LIMITED,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50,ORAL,Actual shortage,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2019-10-16,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-17,2019-10-17
92675,2384884,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,0.5MG,50,ORAL,Actual shortage,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2019-08-28,2019-09-12,,Disruption of the manufacture of the drug.,2019-08-29,2019-09-12
2218,2384892,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,1.0MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018-02-15,2018-02-15,2018-07-15,2018-08-30,Demand increase for the drug.,2017-03-14,2018-09-13
2256,2384884,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,0.5MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018-02-15,2018-02-15,2018-07-15,2018-08-30,Demand increase for the drug.,2017-03-14,2018-09-13
17899,2392925,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,0.25MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,2018-02-18,2018-02-18,2018-06-30,2018-06-30,Demand increase for the drug.,2017-08-01,2018-07-03
91645,2384892,Shortage,TEVA-NABILONE,TEVA CANADA LIMITED,NABILONE,NABILONE,1.0MG,50,ORAL,Resolved,CAPSULE,A04AD,ANTIEMETICS AND ANTINAUSEANTS,,2019-08-15,2019-09-30,2019-10-03,Disruption of the manufacture of the drug.,2019-08-15,2019-10-04
1038,2314290,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,NARATRIPTAN,NARATRIPTAN,1MG,8,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015-10-15,2018-02-28,2018-03-13,Disruption of the manufacture of the drug.,2017-03-13,2018-03-14
1137,2314304,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,NARATRIPTAM HCL,NARATRIPTAN,2.5MG,8,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2015-10-15,2018-02-28,2018-03-13,Disruption of the manufacture of the drug.,2017-03-13,2018-03-14
1143,2237682,Shortage,TEVA-NORFLOXACIN,TEVA CANADA LIMITED,NORFLOXACIN,NORFLOXACIN,400MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2015-12-22,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
42607,2295407,Shortage,TEVA-OMEPRAZOLE,TEVA CANADA LIMITED,OMEPRAZOLE,OMEPRAZOLE,10MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-03-07,2018-04-20,2018-04-30,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
24103,2230394,Shortage,TEVA-OXYBUTYNIN,TEVA CANADA LIMITED,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-01,2019-02-01,2019-01-31,Demand increase for the drug.,2017-10-02,2019-02-01
24106,2230394,Shortage,TEVA-OXYBUTYNIN,TEVA CANADA LIMITED,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,500,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-11-01,2019-02-01,2019-01-31,Demand increase for the drug.,2017-10-02,2019-02-01
88213,608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,OXYCOCET,ACETAMINOPHEN  OXYCODONE HYDROCHLORIDE,325MG  5MG,UD 100,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,,2019-07-02,2019-08-30,2019-08-09,Disruption of the manufacture of the drug.,2019-07-02,2019-08-10
88216,2285487,Shortage,TEVA-PANTOPRAZOLE,TEVA CANADA LIMITED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-30,,,Disruption of the manufacture of the drug.,2019-07-02,2019-07-02
88219,2285487,Shortage,TEVA-PANTOPRAZOLE,TEVA CANADA LIMITED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-06-30,,,Disruption of the manufacture of the drug.,2019-07-02,2019-07-02
59708,2440628,Shortage,TEVA-PANTOPRAZOLE MAGNESIUM,TEVA CANADA LIMITED,PANTOPRAZOLE MAGNESIUM,PANTOPRAZOLE,40MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-07-15,2019-03-30,2019-03-30,Demand increase for the drug.,2018-08-31,2019-04-11
59711,2440628,Shortage,TEVA-PANTOPRAZOLE MAGNESIUM,TEVA CANADA LIMITED,PANTOPRAZOLE MAGNESIUM,PANTOPRAZOLE,40MG,30,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-07-15,2019-03-30,2019-03-30,Demand increase for the drug.,2018-08-31,2019-04-11
1153,2248556,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,10MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1161,2248556,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1167,2248556,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,10MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1175,2248557,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,20MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1179,2248557,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,20MG,500,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1191,2248557,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,20MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1454,2248558,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,30MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1199,2248558,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,30MG,100,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1204,2248558,Shortage,TEVA-PAROXETINE,TEVA CANADA LIMITED,PAROXETINE,PAROXETINE,30MG,30,ORAL,Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2015-10-05,2017-06-30,2017-08-01,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
92212,869007,Shortage,TEVA-PINDOLOL,TEVA CANADA LIMITED,PINDOLOL,PINDOLOL,5MG,100,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2019-08-22,2020-03-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-11-07
42570,695718,Shortage,TEVA-PIROXICAM,TEVA CANADA LIMITED,PIROXICAM,PIROXICAM,10MG,100,ORAL,Resolved,CAPSULE,M01AC,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-03-07,2018-03-21,2018-04-15,Disruption of the manufacture of the drug.,2018-03-13,2018-05-11
92209,2247008,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,TEVA-PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-22,2019-12-31,2019-11-07,Disruption of the manufacture of the drug.,2019-08-22,2019-11-08
92215,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-22,2020-01-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-08-23
42565,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2018-03-07,2018-04-15,2018-04-30,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
9799,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-01,2018-01-26,2018-02-05,Disruption of the manufacture of the drug.,2017-05-10,2018-02-21
86611,2247009,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-13,2019-12-31,,Disruption of the manufacture of the drug.,2019-06-13,2019-10-31
86617,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-13,2019-07-30,2019-07-15,Disruption of the manufacture of the drug.,2019-06-13,2019-07-16
5219,2247009,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-09-06,2017-12-22,2018-02-01,Disruption of the manufacture of the drug.,2017-04-03,2018-02-21
94843,2247008,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-26,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-26,2019-10-03
94858,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-26,2020-02-28,,Disruption of the manufacture of the drug.,2019-09-26,2019-10-24
10896,2247009,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,20MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-15,2018-01-26,2018-02-05,Disruption of the manufacture of the drug.,2017-05-23,2018-02-21
10899,2247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,40MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-05-17,2018-01-26,2018-02-05,Disruption of the manufacture of the drug.,2017-05-23,2018-02-21
94867,2247009,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,TEVA-PRAVASTATIN,PRAVASTATIN SODIUM,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-09-26,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-26,2019-10-03
1784,2247008,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-11-06,2018-01-30,2017-12-15,Delay in shipping of the drug.,2017-03-13,2017-12-16
1787,2247008,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-11-06,2017-12-30,2018-02-28,Delay in shipping of the drug.,2017-03-13,2018-03-13
65494,1934228,Shortage,TEVA-PRAZOSIN,TEVA CANADA LIMITED,PRAZOSIN,PRAZOSIN,5MG,100,ORAL,Resolved,TABLET,C02CA,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",,2018-10-01,2019-04-30,2019-04-26,Disruption of the manufacture of the drug.,2018-10-23,2019-04-27
86933,700401,Shortage,TEVA-PREDNISOLONE,TEVA CANADA LIMITED,PREDNISOLONE,PREDNISOLONE ACETATE,1%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-06-18,2019-07-30,2019-07-30,Disruption of the manufacture of the drug.,2019-06-18,2019-08-06
86936,700401,Shortage,TEVA-PREDNISOLONE,TEVA CANADA LIMITED,PREDNISOLONE,PREDNISOLONE ACETATE,1%,10ML,OPHTHALMIC,Actual shortage,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-06-18,2019-11-30,,Disruption of the manufacture of the drug.,2019-06-18,2019-09-19
96724,700401,Shortage,TEVA-PREDNISOLONE,TEVA CANADA LIMITED,PREDNISOLONE,PREDNISOLONE ACETATE,1%,5ML,OPHTHALMIC,Actual shortage,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-10-16,2019-11-30,,Disruption of the manufacture of the drug.,2019-10-17,2019-10-17
29456,2361159,Shortage,TEVA-PREGABALIN,TEVA CANADA LIMITED,PREGABALIN,PREGABALIN,25MG,60,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2017-11-16,2018-01-19,2018-02-15,Disruption of the manufacture of the drug.,2017-11-16,2018-02-21
42573,2361183,Shortage,TEVA-PREGABALIN,TEVA CANADA LIMITED,PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-03-13,2018-03-21,2018-04-15,Disruption of the manufacture of the drug.,2018-03-13,2018-05-11
42616,2361183,Shortage,TEVA-PREGABALIN,TEVA CANADA LIMITED,PREGABALIN,PREGABALIN,75MG,60,ORAL,Resolved,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-03-13,2018-04-30,2018-05-10,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
88222,2226383,Shortage,TEVA-PROCTOSONE,TEVA CANADA LIMITED,PROCTOSONE,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,15G,RECTAL,Actual shortage,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2019-07-02,2019-11-30,,Disruption of the manufacture of the drug.,2019-07-02,2019-10-03
88225,2226383,Shortage,TEVA-PROCTOSONE,TEVA CANADA LIMITED,PROCTOSONE,DIBUCAINE HYDROCHLORIDE  HYDROCORTISONE  FRAMYCETIN SULFATE  ESCULIN,5MG  5MG  10MG  10MG,30G,RECTAL,Actual shortage,OINTMENT,C05AA,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,,2019-07-02,2019-11-30,,Disruption of the manufacture of the drug.,2019-07-02,2019-10-03
42597,629359,Shortage,TEVA-PROFEN,TEVA CANADA LIMITED,PROFEN,IBUPROFEN,600MG,500,ORAL,Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-03-07,2018-03-23,2018-04-20,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
17983,2439913,Shortage,TEVA-PROGESTERONE,TEVA CANADA LIMITED,PROGESTERONE,PROGESTERONE,100MG,PP 30,ORAL,Resolved,CAPSULE,G03DA,PROGESTOGENS,,2017-08-01,2017-09-30,2017-10-06,Disruption of the manufacture of the drug.,2017-08-02,2017-10-10
17976,740675,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,20MG,100,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-08-30,,,Disruption of the manufacture of the drug.,2017-08-02,2018-12-21
17979,740675,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,20MG,500,ORAL,Actual shortage,TABLET,C07AA,BETA BLOCKING AGENTS,,2017-08-30,,,Disruption of the manufacture of the drug.,2017-08-02,2018-12-21
43126,496499,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,40MG,100,ORAL,Resolved,TABLET,C07AA,BETA BLOCKING AGENTS,,2018-03-15,2018-04-03,2018-04-20,Demand increase for the drug.,2018-03-16,2018-05-30
5223,2395479,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,300MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-11-01,2018-01-26,2018-02-15,Disruption of the manufacture of the drug.,2017-04-03,2018-02-21
43168,2395444,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,50MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2018-03-16,2018-04-07,2018-04-20,Disruption of the manufacture of the drug.,2018-03-16,2018-05-30
94375,2395487,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE,QUETIAPINE,400MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2019-09-18,2019-10-31,2019-10-03,Disruption of the manufacture of the drug.,2019-09-19,2019-10-04
1748,2395452,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,150MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,2017-04-15,,2017-05-26,2017-05-26,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
93656,2395479,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,300MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2019-09-11,2019-10-31,2019-10-03,Disruption of the manufacture of the drug.,2019-09-12,2019-10-04
1760,2395487,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,400MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-08-30,2017-09-29,2017-10-10,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
1769,2395460,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,200MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-12-15,2018-01-26,2018-02-15,Disruption of the manufacture of the drug.,2017-03-13,2018-02-21
1778,2395444,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,QUETIAPINE XR,QUETIAPINE,50MG,60,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N05AH,ANTIPSYCHOTICS,,2017-08-30,2017-10-06,2017-10-06,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
95393,21016,Shortage,TEVA-QUININE,TEVA CANADA LIMITED,QUININE CAPS,QUININE SULFATE,300MG,500,ORAL,Actual shortage,CAPSULE,P01BC,ANTIMALARIALS,,2019-10-03,,,Other (Please describe in comments),2019-10-03,2019-10-04
3133,2296640,Shortage,TEVA-RABEPRAZOLE EC,TEVA CANADA LIMITED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-03-17,2017-11-30,2017-10-10,Disruption of the manufacture of the drug.,2017-03-17,2017-10-11
19981,2247946,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-20,2017-11-30,2018-01-03,Demand increase for the drug.,2017-08-21,2018-01-04
19984,2247946,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-21,2018-04-30,2018-04-30,Demand increase for the drug.,2017-08-21,2018-05-11
17987,2247945,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,2.5MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-01,2017-11-30,2017-12-20,Disruption of the manufacture of the drug.,2017-08-02,2018-01-03
9802,2247945,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,2.5MG,30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-05-04,2017-11-30,2017-12-29,Disruption of the manufacture of the drug.,2017-05-10,2018-01-03
17994,2247947,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,10MG,500,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-01,2017-11-30,2017-12-29,Disruption of the manufacture of the drug.,2017-08-02,2018-01-03
17997,2247947,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL,RAMIPRIL,10MG,PP 30,ORAL,Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-01,2017-11-30,2018-01-03,Disruption of the manufacture of the drug.,2017-08-02,2018-01-04
97156,2247946,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,RAMIPRIL CAPSULES,RAMIPRIL,5MG,30,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2019-10-23,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-24,2019-10-24
1510,828564,Shortage,TEVA-RANITIDINE,TEVA CANADA LIMITED,RANITIDINE,RANITIDINE,150MG,60,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-07-16,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
1522,828556,Shortage,TEVA-RANITIDINE,TEVA CANADA LIMITED,RANITIDINE,RANITIDINE,300MG,100,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-04-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1534,828556,Shortage,TEVA-RANITIDINE,TEVA CANADA LIMITED,RANITIDINE,RANITIDINE,300MG,500,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-04-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
42626,2418444,Shortage,TEVA-RASAGILINE,TEVA CANADA LIMITED,RASAGILINE,RASAGILINE,1MG,30,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2018-03-13,2018-05-30,2018-05-30,Disruption of the manufacture of the drug.,2018-03-13,2018-05-31
10902,2418444,Shortage,TEVA-RASAGILINE,TEVA CANADA LIMITED,RASAGILINE,RASAGILINE,1MG,30,ORAL,Resolved,TABLET,N04BD,DOPAMINERGIC AGENTS,,2017-05-17,2017-06-30,2017-07-30,Disruption of the manufacture of the drug.,2017-05-23,2017-09-19
1607,2413809,Shortage,TEVA-RISEDRONATE,TEVA CANADA LIMITED,RISEDRONATE,RISEDRONATE SODIUM,150MG,3,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2017-02-01,2017-04-07,2017-05-01,Delay in shipping of the drug.,2017-03-13,2017-10-10
86911,2298376,Shortage,TEVA-RISEDRONATE,TEVA CANADA LIMITED,RISEDRONATE,RISEDRONATE SODIUM,5MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2019-06-18,2019-07-30,2019-07-15,Disruption of the manufacture of the drug.,2019-06-18,2019-07-16
43138,2298392,Shortage,TEVA-RISEDRONATE,TEVA CANADA LIMITED,RISEDRONATE,RISEDRONATE SODIUM,35MG,30,ORAL,Resolved,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-03-15,2018-06-15,2018-07-29,Disruption of the manufacture of the drug.,2018-03-16,2018-07-30
1566,2264188,Shortage,TEVA-RISPERIDONE,TEVA CANADA LIMITED,RISPERIDONE,RISPERIDONE,0.5MG,100,ORAL,Actual shortage,TABLET,N05AX,ANTIPSYCHOTICS,,2016-11-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-11
42601,2264196,Shortage,TEVA-RISPERIDONE,TEVA CANADA LIMITED,RISPERIDONE,RISPERIDONE,1.0MG,100,ORAL,Resolved,TABLET,N05AX,ANTIPSYCHOTICS,,2018-03-10,2018-04-15,2018-04-20,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
9805,2396688,Shortage,TEVA-RIZATRIPTAN ODT,TEVA CANADA LIMITED,RIZATRIPTAN,RIZATRIPTAN,10MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017-05-04,2017-06-29,2017-08-01,Disruption of the manufacture of the drug.,2017-05-10,2017-09-19
92151,2396661,Shortage,TEVA-RIZATRIPTAN ODT,TEVA CANADA LIMITED,RIZATRIPTAN,RIZATRIPTAN,5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2019-08-22,2019-09-30,2019-09-18,Disruption of the manufacture of the drug.,2019-08-22,2019-09-19
92154,2396688,Shortage,TEVA-RIZATRIPTAN ODT,TEVA CANADA LIMITED,RIZATRIPTAN,RIZATRIPTAN,10MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2019-08-22,2019-09-12,,Disruption of the manufacture of the drug.,2019-08-22,2019-09-12
86914,2354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-18,2019-09-30,,Disruption of the manufacture of the drug.,2019-06-18,2019-08-15
86917,2354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-18,2019-09-12,,Disruption of the manufacture of the drug.,2019-06-18,2019-09-12
86920,2354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN,ROSUVASTATIN,20MG,30,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-06-18,2019-09-12,,Disruption of the manufacture of the drug.,2019-06-18,2019-09-12
96717,2354616,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-16,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-17,2019-11-14
92157,2354632,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN,ROSUVASTATIN,40MG,30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-08-22,2019-09-30,2019-09-18,Disruption of the manufacture of the drug.,2019-08-22,2019-09-19
42658,2240481,Shortage,TEVA-SERTRALINE,TEVA CANADA LIMITED,SERTRALINE,SERTRALINE,100MG,100,ORAL,Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-03-13,2018-04-15,2018-04-25,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
10907,2308738,Shortage,TEVA-SILDENAFIL,TEVA CANADA LIMITED,SILDENAFIL,SILDENAFIL,25MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-05-17,2017-06-17,2017-07-15,Disruption of the manufacture of the drug.,2017-05-23,2017-09-19
18004,2250160,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,SIMVASTATIN,SIMVASTATIN,20MG,PP 30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-01,,2017-08-25,Disruption of the manufacture of the drug.,2017-08-02,2017-08-26
18014,2250187,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,SIMVASTATIN,SIMVASTATIN,80MG,PP 30,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2017-08-01,2017-08-25,2017-09-15,Disruption of the manufacture of the drug.,2017-08-02,2017-09-19
95390,2250187,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,SIMVASTATIN TABS,SIMVASTATIN,80MG,100,ORAL,Actual shortage,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2019-10-02,2020-03-31,,Disruption of the manufacture of the drug.,2019-10-03,2019-10-03
18017,2397919,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2017-08-02,2017-10-20,2017-09-18,Disruption of the manufacture of the drug.,2017-08-02,2017-09-19
94861,2397919,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,TEVA-SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL,Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-26,2019-12-31,2019-10-09,Disruption of the manufacture of the drug.,2019-09-26,2019-10-10
93149,2397900,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-05,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-05,2019-09-19
1560,613223,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,TEVA-SPIRONOLACTONE 100MG TABLETS 100,SPIRONOLACTONE,100MG,100,ORAL,Actual shortage,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017-03-01,,,Shortage of an inactive ingredient or component.,2017-03-13,2017-10-10
1568,613215,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,TEVA-SPIRONOLACTONE 25MG TABLETS 500,SPIRONOLACTONE,25MG,500,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2017-07-01,2017-09-30,2017-10-10,Shortage of an inactive ingredient or component.,2017-03-13,2017-10-11
18025,613223,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,SPIRONOLACTONE,SPIRONOLACTONE,100MG,100,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2018-01-03,2018-01-19,2018-02-15,Disruption of the manufacture of the drug.,2017-08-02,2018-02-21
42604,613215,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,SPIRONOLACTONE,SPIRONOLACTONE,25MG,100 UD,ORAL,Resolved,TABLET,C03DA,POTASSIUM-SPARING AGENTS,,2018-03-07,2018-04-15,2018-04-30,Disruption of the manufacture of the drug.,2018-03-13,2018-05-30
18021,613231,Shortage,TEVA-SPIRONOLACTONE/HCTZ,TEVA CANADA LIMITED,SPIRONOLACTONE/HCTZ,HYDROCHLOROTHIAZIDE  SPIRONOLACTONE,25MG  25MG,100,ORAL,Resolved,TABLET,C03EA,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB,,2017-08-01,2017-10-30,2017-11-06,Disruption of the manufacture of the drug.,2017-08-02,2017-11-07
92663,2045702,Shortage,TEVA-SUCRALFATE,TEVA CANADA LIMITED,SUCRALFATE,SUCRALFATE,1G,500,ORAL,Actual shortage,TABLET,A02BX,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2019-08-28,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-29,2019-09-26
18030,2286815,Shortage,TEVA-SUMATRIPTAN DF,TEVA CANADA LIMITED,SUMATRIPTAN,SUMATRIPTAN,25MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-08-02,2017-08-22,2017-09-15,Disruption of the manufacture of the drug.,2017-08-02,2017-09-19
92160,2440156,Shortage,TEVA-TADALAFIL,TEVA CANADA LIMITED,TADALAFIL,TADALAFIL,5MG,30,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-08-22,2019-09-30,2019-09-25,Disruption of the manufacture of the drug.,2019-08-22,2019-09-26
98738,2440172,Shortage,TEVA-TADALAFIL,TEVA CANADA LIMITED,TADALAFIL 20MG TABLETS,TADALAFIL,20MG,4's,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-11-13,2019-12-31,,Disruption of the manufacture of the drug.,2019-11-14,2019-11-14
93143,2440164,Shortage,TEVA-TADALAFIL,TEVA CANADA LIMITED,TADALAFIL,TADALAFIL,10MG,4,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-05,2019-09-30,2019-09-26,Disruption of the manufacture of the drug.,2019-09-05,2019-09-27
63757,851973,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,20MG,30,ORAL,Resolved,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-09-01,2019-04-30,2019-04-26,Disruption of the manufacture of the drug.,2018-10-11,2019-04-27
92183,851965,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,10MG,100,ORAL,Actual shortage,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-08-22,2020-01-31,,Demand increase for the drug.,2019-08-22,2019-11-18
92186,851973,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,20MG,100,ORAL,Actual shortage,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-08-22,2020-01-31,,Demand increase for the drug.,2019-08-22,2019-11-18
92189,851965,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,10MG,60,ORAL,Actual shortage,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-08-22,2020-01-31,,Demand increase for the drug.,2019-08-22,2019-11-18
5226,851973,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,20MG,100,ORAL,Resolved,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2017-04-03,2017-05-08,2017-05-04,Disruption of the manufacture of the drug.,2017-04-03,2017-05-10
43171,851973,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,20MG,100,ORAL,Resolved,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-03-15,2018-04-09,2018-04-20,Disruption of the manufacture of the drug.,2018-03-16,2018-05-30
43174,851973,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,20MG,30,ORAL,Resolved,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-03-15,2018-04-09,2018-04-25,Disruption of the manufacture of the drug.,2018-03-16,2018-05-30
94381,851973,Shortage,TEVA-TAMOXIFEN,TEVA CANADA LIMITED,TAMOXIFEN,TAMOXIFEN,20MG,30UD,ORAL,Actual shortage,TABLET,L02BA,HORMONE ANTAGONISTS AND RELATED AGENTS,,2019-09-18,2020-01-31,,Demand increase for the drug.,2019-09-19,2019-11-18
86620,608211,Shortage,TEVA-TECNAL,TEVA CANADA LIMITED,TECNAL,ACETYLSALICYLIC ACID  BUTALBITAL  CAFFEINE,330MG  50MG  40MG,100,ORAL,Resolved,TABLET,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2019-06-13,2019-06-30,2019-06-30,Disruption of the manufacture of the drug.,2019-06-13,2019-07-15
92657,608238,Shortage,TEVA-TECNAL,TEVA CANADA LIMITED,TECNAL,ACETYLSALICYLIC ACID  BUTALBITAL  CAFFEINE,330MG  50MG  40MG,100,ORAL,Actual shortage,CAPSULE,N02BA,OTHER ANALGESICS AND ANTIPYRETICS,,2019-08-28,,,Disruption of the manufacture of the drug.,2019-08-29,2019-09-12
97608,608181,Shortage,TEVA-TECNAL C 1/2,TEVA CANADA LIMITED,TECNAL C-1/2 CAPSULES,ACETYLSALICYLIC ACID  BUTALBITAL  CODEINE PHOSPHATE  CAFFEINE,330MG  50MG  30MG  40MG,100,ORAL,Actual shortage,CAPSULE,N02AA,OPIOIDS,,2019-10-31,2020-01-31,,Disruption of the manufacture of the drug.,2019-10-31,2019-11-01
98741,608203,Shortage,TEVA-TECNAL C 1/4,TEVA CANADA LIMITED,TECNAL C-1/4 CAPSULES,ACETYLSALICYLIC ACID  BUTALBITAL  CODEINE PHOSPHATE  CAFFEINE,330MG  50MG  15MG  40MG,100,ORAL,Actual shortage,CAPSULE,N02AA,OPIOIDS,,2019-11-13,2020-01-31,,Disruption of the manufacture of the drug.,2019-11-14,2019-11-14
67219,2320177,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN,TELMISARTAN,40MG,100,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-20,2019-03-30,2019-03-30,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-04-11
67222,2320177,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN,TELMISARTAN,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-20,2020-01-31,,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-10-31
67225,2320185,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN,TELMISARTAN,80MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-20,2020-01-31,,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-10-31
67228,2320185,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN,TELMISARTAN,80MG,500,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-20,2020-01-31,,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-10-31
67231,2320185,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN,TELMISARTAN,80MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-11-20,2020-01-31,,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-10-31
92195,2330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-08-22,2020-01-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-10-31
5229,2330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-04-03,2017-06-16,2017-07-30,Disruption of the manufacture of the drug.,2017-04-03,2017-09-19
67234,2330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-20,2019-04-30,2019-04-26,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-04-27
67237,2330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-20,2019-06-30,2019-06-30,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-07-15
67240,2330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,12.5MG  80MG,500,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-20,2019-04-30,2019-04-26,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-04-27
67243,2379252,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-20,2019-02-20,2019-02-28,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-03-12
67246,2379252,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE  TELMISARTAN,25.0MG  80.0MG,100,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-11-20,2019-02-20,2019-02-28,Requirements related to complying with good manufacturing practices.,2018-11-20,2019-03-12
1619,2230808,Shortage,TEVA-TERAZOSIN,TEVA CANADA LIMITED,TERAZOSIN,TERAZOSIN,10MG,100,ORAL,Actual shortage,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2014-03-07,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
1635,2230805,Shortage,TEVA-TERAZOSIN,TEVA CANADA LIMITED,TERAZOSIN,TERAZOSIN HCL,1MG,100,ORAL,Actual shortage,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2014-03-07,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
1643,2230807,Shortage,TEVA-TERAZOSIN,TEVA CANADA LIMITED,TERAZOSIN,TERAZOSIN,5MG,100,ORAL,Actual shortage,TABLET,G04CA,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2014-03-07,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
1655,2240346,Shortage,TEVA-TERBINAFINE,TEVA CANADA LIMITED,TERBINAFINE,TERBINAFINE,250MG,28,ORAL,Actual shortage,TABLET,D01BA,ANTIFUNGALS FOR SYSTEMIC USE,,2016-10-18,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
10911,2389622,Shortage,TEVA-TOBRAMYCIN,TEVA CANADA LIMITED,TOBRAMYCIN,TOBRAMYCIN,60MG,5,INHALATION,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017-12-29,2018-07-06,2018-07-12,Disruption of the manufacture of the drug.,2017-05-23,2018-07-30
92218,2299593,Shortage,TEVA-TOLTERODINE,TEVA CANADA LIMITED,TOLTERODINE,TOLTERODINE TARTRATE,1MG,60,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-08-22,,,Disruption of the manufacture of the drug.,2019-08-22,2019-09-12
93152,2299593,Shortage,TEVA-TOLTERODINE,TEVA CANADA LIMITED,TOLTERODINE,TOLTERODINE TARTRATE,1MG,60,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-09-05,,,Disruption of the manufacture of the drug.,2019-09-05,2019-09-12
97150,2347180,Shortage,TEVA-TRAMADOL/ACETAMINOPHEN,TEVA CANADA LIMITED,TRAMADOL/ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,,2019-10-24,2019-11-30,,Disruption of the manufacture of the drug.,2019-10-24,2019-10-25
1659,2412063,Shortage,TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION,TEVA CANADA LIMITED,TRAVAPROST,TRAVOPROST,0.004%,2.5ML,OPHTHALMIC,Actual shortage,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1664,2412063,Shortage,TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION,TEVA CANADA LIMITED,TRAVAPROST,TRAVOPROST,0.004%,5ML,OPHTHALMIC,Actual shortage,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2016-02-29,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
97599,2144263,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TRAZODONE 50MG FC TABLETS,TRAZODONE HYDROCHLORIDE,50MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2019-10-31,2019-11-30,2019-11-07,Disruption of the manufacture of the drug.,2019-10-31,2019-11-08
42576,2144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-03-13,2018-06-15,2018-06-30,Demand increase for the drug.,2018-03-13,2018-07-30
42579,2144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,500,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-03-13,2018-06-15,2018-06-30,Disruption of the manufacture of the drug.,2018-03-13,2018-07-30
1582,510637,Shortage,TEVA-TRIMEL,TEVA CANADA LIMITED,SULFAMETHOXAZOLE/TRIMETHOPRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,400MG  80MG,100,ORAL,Actual shortage,TABLET,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2016-11-23,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-10
1591,726540,Shortage,TEVA-TRIMEL,TEVA CANADA LIMITED,SULFAMETHOXAZOLE TRIMETHOPRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,40MG  8MG,100ML,ORAL,Actual shortage,SUSPENSION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017-02-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
1609,726540,Shortage,TEVA-TRIMEL,TEVA CANADA LIMITED,SULFAMETHOXAZOLE TRIMETHOPRIM,SULFAMETHOXAZOLE  TRIMETHOPRIM,40MG  8MG,400ML,ORAL,Actual shortage,SUSPENSION,J01EE,SULFONAMIDES AND TRIMETHOPRIM,,2017-03-01,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
97605,2357534,Shortage,TEVA-VALACYCLOVIR,TEVA CANADA LIMITED,VALACYCLOVIR 500MG TABLETS,VALACYCLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2019-10-31,2019-12-31,,Disruption of the manufacture of the drug.,2019-10-31,2019-11-01
18033,2413825,Shortage,TEVA-VALGANCICLOVIR,TEVA CANADA LIMITED,VALGANCICLOVIR,VALGANCICLOVIR,450MG,60,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-08-01,2018-02-16,2018-02-28,Demand increase for the drug.,2017-08-02,2018-03-13
1552,2357003,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,TEVA-VALSARTAN/HCTZ 160/12.5MG TAB PP 30,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  160MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-05-20,2017-09-20,2017-09-30,Delay in shipping of the drug.,2017-03-13,2017-10-10
65369,2357038,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  320MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-15,,,Disruption of the manufacture of the drug.,2018-10-23,2019-07-15
65372,2357011,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,25MG  160MG,50,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-15,,,Disruption of the manufacture of the drug.,2018-10-23,2019-07-15
65375,2357011,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,25MG  160MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-10-15,,,Disruption of the manufacture of the drug.,2018-10-23,2019-07-15
94834,2356996,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  80MG,30,ORAL,Actual shortage,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-09-26,,,Disruption of the manufacture of the drug.,2019-09-26,2019-11-14
8074,2357038,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,12.5MG  320MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-04-21,2018-01-30,2018-02-15,Disruption of the manufacture of the drug.,2017-04-25,2018-02-21
1226,2357046,Shortage,TEVA-VALSARTAN/HCTZ,TEVA CANADA LIMITED,TEVA-VALSARTAN/HCTZ,HYDROCHLOROTHIAZIDE  VALSARTAN,25MG  320MG,30,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2017-02-01,2018-04-30,2018-04-30,Delay in shipping of the drug.,2017-03-13,2018-05-11
92206,2426234,Shortage,TEVA-VARENICLINE,TEVA CANADA LIMITED,VARENICLINE,VARENICLINE,1MG,28,ORAL,Resolved,TABLET,N07BA,DRUGS USED IN ADDICTIVE DISORDERS,,2019-08-22,2019-10-31,2019-10-03,Disruption of the manufacture of the drug.,2019-08-22,2019-10-04
97159,2426781,Shortage,TEVA-VARENICLINE,TEVA CANADA LIMITED,VARENICLINE TABS,VARENICLINE  VARENICLINE,0.5MG  1MG,25,ORAL,Actual shortage,TABLET,N07BA,DRUGS USED IN ADDICTIVE DISORDERS,,2019-10-23,2020-02-28,,Disruption of the manufacture of the drug.,2019-10-24,2019-10-24
92672,2275058,Shortage,TEVA-VENLAFAXINE XR,TEVA CANADA LIMITED,VENLAFAXINE,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-08-28,2019-12-31,2019-11-07,Disruption of the manufacture of the drug.,2019-08-29,2019-11-08
92201,2275031,Shortage,TEVA-VENLAFAXINE XR,TEVA CANADA LIMITED,VENLAFAXINE,VENLAFAXINE,75MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-08-22,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-10-24
93146,2275031,Shortage,TEVA-VENLAFAXINE XR,TEVA CANADA LIMITED,VENLAFAXINE,VENLAFAXINE,75MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-09-05,2019-12-31,,Disruption of the manufacture of the drug.,2019-09-05,2019-10-24
92666,2275023,Shortage,TEVA-VENLAFAXINE XR,TEVA CANADA LIMITED,VENLAFAXINE,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-08-28,2019-10-31,2019-10-23,Disruption of the manufacture of the drug.,2019-08-29,2019-10-24
92669,2275058,Shortage,TEVA-VENLAFAXINE XR,TEVA CANADA LIMITED,VENLAFAXINE,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-08-28,2019-10-31,2019-10-23,Disruption of the manufacture of the drug.,2019-08-29,2019-10-24
92163,2396874,Shortage,TEVA-VORICONAZOLE,TEVA CANADA LIMITED,VORICONAZOLE,VORICONAZOLE,200MG,30,ORAL,Actual shortage,TABLET,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2019-08-22,2019-12-31,,Disruption of the manufacture of the drug.,2019-08-22,2019-10-24
1674,2342545,Shortage,TEVA-ZOLMITRIPTAN OD,TEVA CANADA LIMITED,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2016-11-22,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
29736,2240432,Shortage,TEVETEN,BGP PHARMA ULC,TEVETEN,EPROSARTAN,400MG,2x14,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2017-12-04,,2018-01-05,Delay in shipping of the drug.,2017-11-20,2018-01-06
97447,2243942,Shortage,TEVETEN,BGP PHARMA ULC,Eprosartan mesylate,EPROSARTAN,600MG,28 CA,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-11-15,,2019-11-22,,Delay in shipping of the drug.,2019-10-29,2019-11-16
83432,2240432,Shortage,TEVETEN,BGP PHARMA ULC,EPROSARTAN,EPROSARTAN,400MG,2 x 14,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2019-05-29,2019-06-04,2019-10-18,2019-10-22,Delay in shipping of the drug.,2019-05-08,2019-10-23
66450,2253631,Shortage,TEVETEN PLUS,BGP PHARMA ULC,TEVETEN PLUS,HYDROCHLOROTHIAZIDE  EPROSARTAN,12.5MG  600MG,2x14CA,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-11-15,2018-11-20,2019-01-11,2019-01-15,Delay in shipping of the drug.,2018-11-08,2019-01-16
72948,2253631,Shortage,TEVETEN PLUS,BGP PHARMA ULC,TEVETEN PLUS,HYDROCHLOROTHIAZIDE  EPROSARTAN,12.5MG  600MG,2 x 14CA,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-02-11,,2019-04-15,2019-04-03,Delay in shipping of the drug.,2019-01-18,2019-04-04
81781,2327945,Shortage,THALLIUM,LANTHEUS MI CANADA INC,Tl-201 Injection,THALLIUM CHLORIDE,2MCI,10mL glass vial,INTRAVENOUS,Resolved,SOLUTION,V09GX,,,2019-03-15,,2019-05-10,Disruption of the manufacture of the drug.,2019-04-16,2019-05-11
14396,,Shortage,Thallous Chloride TI 201 Injection,,Thallous Chloride TI 201 Injection,Thallous Chloride (TI 201),1 mCi/mL,glass vial,Intravenous,Resolved,Solution,V09GX,Cardiovascular system,,2017-06-27,2017-06-30,2017-06-30,Requirements related to complying with good manufacturing practices.,2017-06-29,2017-07-04
87850,2193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LTD,Thiamine Hydrochloride Injection USP,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,A11DA,"VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12",,2019-06-28,2019-08-05,2019-08-02,Disruption of the manufacture of the drug.,2019-06-28,2019-08-09
92784,2193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LTD,Thiamiject®,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,A11DA,"VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12",,2019-08-30,2019-09-30,2019-09-27,Disruption of the manufacture of the drug.,2019-08-30,2019-10-04
52928,2193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LTD,Thiamine Hydrochloride Injection USP,THIAMINE HYDROCHLORIDE,100MG,5 X 10 mL vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,A11DA,"VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12",,2018-06-06,2018-09-15,2018-09-14,Disruption of the manufacture of the drug.,2018-06-26,2018-09-18
63430,2193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LTD,Thiamine Hydrochloride Injection USP,THIAMINE HYDROCHLORIDE,100MG,5 x 10 mL vial,INTRAMUSCULAR  INTRAVENOUS,Resolved,LIQUID,A11DA,"VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12",,2018-10-05,2018-11-15,2018-11-09,Disruption of the manufacture of the drug.,2018-10-05,2018-11-10
73721,2246805,Shortage,THYMOGLOBULIN,SANOFI-AVENTIS CANADA INC,Thymoglobulin,ANTI-THYMOCYTE GLOBULIN,25MG,1 X 10ml,INTRAVENOUS,Avoided shortage,POWDER FOR SOLUTION,L04AA,IMMUNOSUPPRESSANTS,2019-04-01,,2019-04-15,2019-03-20,Other (Please describe in comments),2019-01-28,2019-03-22
5691,23965,Shortage,THYROID TAB 125MG,ERFA CANADA 2012 INC,Natural Desiccated Thyroid,THYROID,125MG,100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-05-28,2018-06-15,2018-06-12,Other (Please describe in comments),2017-04-05,2018-06-13
64695,23965,Shortage,THYROID TAB 125MG,ERFA CANADA 2012 INC,Thyroid tab 125mg,THYROID,125MG,100,ORAL,Actual shortage,TABLET,H03AA,THYROID PREPARATIONS,2018-09-04,2018-09-06,2019-12-21,,Demand increase for the drug.,2018-10-18,2019-11-07
78375,23949,Shortage,THYROID TAB 30MG,ERFA CANADA 2012 INC,THYROID,THYROID,30MG,100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,2019-03-12,2019-03-09,2019-06-05,2019-06-07,Disruption of the manufacture of the drug.,2019-03-12,2019-06-12
88624,23949,Shortage,THYROID TAB 30MG,ERFA CANADA 2012 INC,THYROID 30MG,THYROID,30MG,100'S,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,2019-07-05,2019-07-09,2019-10-16,2019-10-18,Disruption of the manufacture of the drug.,2019-07-05,2019-10-22
6389,23949,Shortage,THYROID TAB 30MG,ERFA CANADA 2012 INC,Natural Desiccated Thyroid,THYROID,30MG,bottle of 100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-05-28,2018-06-29,2018-07-18,Demand increase for the drug.,2017-04-11,2018-07-25
82982,23957,Shortage,THYROID TAB 60MG,ERFA CANADA 2012 INC,THYROID 60MG,THYROID,60MG,100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,2019-03-30,2019-04-03,2019-08-23,2019-08-27,Disruption of the manufacture of the drug.,2019-05-02,2019-08-28
95610,23957,Shortage,THYROID TAB 60MG,ERFA CANADA 2012 INC,THYROID 60MG,THYROID,60MG,100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,2019-09-28,2019-09-26,2019-10-16,2019-10-15,Disruption of the manufacture of the drug.,2019-10-07,2019-10-22
69038,23957,Shortage,THYROID TAB 60MG,ERFA CANADA 2012 INC,THYROID 60MG,THYROID,60MG,100 TAB,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,2018-11-28,2018-11-23,2019-02-26,2019-02-25,Demand increase for the drug.,2018-12-10,2019-03-05
6882,23957,Shortage,THYROID TAB 60MG,ERFA CANADA 2012 INC,Natural Desiccated Thyroid,THYROID,60MG,100,ORAL,Resolved,TABLET,H03AA,THYROID PREPARATIONS,,2018-05-28,2018-10-29,2018-11-14,Demand increase for the drug.,2017-04-13,2018-11-15
95562,598933,Shortage,TIAMOL CREAM 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",TIAMOL CREAM 0.05%,FLUOCINONIDE,0.05%,100 g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-10-03,2019-10-25,2019-10-10,Disruption of the manufacture of the drug.,2019-10-04,2019-10-11
50362,598933,Shortage,TIAMOL CREAM 0.05%,"TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",TIAMOL CREAM,FLUOCINONIDE,0.05%,100G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-05-23,2018-06-08,2018-06-15,Disruption of the manufacture of the drug.,2018-05-25,2018-06-18
93532,2256754,Shortage,TIAZAC XC,VALEANT CANADA LP/VALEANT CANADA S.E.C.,TIAZAC XC,DILTIAZEM HYDROCHLORIDE,240MG,n/a,ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2019-09-12,,,2019-09-11,Demand increase for the drug.,2019-09-10,2019-09-13
64999,2256738,Shortage,TIAZAC XC,VALEANT CANADA LP/VALEANT CANADA S.E.C.,TIAZAC XC,DILTIAZEM HYDROCHLORIDE,120MG,90,ORAL,Resolved,TABLET (EXTENDED-RELEASE),C08DB,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,2018-10-31,,,2018-11-07,Other (Please describe in comments),2018-10-19,2018-11-09
71589,2237701,Shortage,TICLOPIDINE,AA PHARMA INC,TICLOPIDINE,TICLOPIDINE HYDROCHLORIDE,250MG,100 Bottle,ORAL,Actual shortage,TABLET,B01AC,ANTITHROMBOTIC AGENTS,2019-02-28,,,,Disruption of the manufacture of the drug.,2019-01-08,2019-03-01
36356,2409356,Shortage,TIGECYCLINE,APOTEX INC,TIGECYCLINE,TIGECYCLINE,50MG,5 ML,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01AA,TETRACYCLINES,,2018-01-15,2018-09-28,2018-08-21,Disruption of the manufacture of the drug.,2018-01-17,2018-08-22
94633,2242275,Shortage,TIMOLOL MALEATE-EX,SANDOZ CANADA INCORPORATED,TIMOLO,TIMOLOL,0.25%,5ml,OPHTHALMIC,Actual shortage,SOLUTION (EXTENDED RELEASE),S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2019-09-02,2020-01-27,,Delay in shipping of the drug.,2019-09-25,2019-10-15
82759,2259893,Shortage,TIZANIDINE,AA PHARMA INC,Tizanidine,TIZANIDINE,4MG,100MG,ORAL,Resolved,TABLET,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2019-04-29,2019-05-10,2019-05-15,Disruption of the manufacture of the drug.,2019-04-29,2019-05-27
17414,778915,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX OINT 3.5G,DEXAMETHASONE  TOBRAMYCIN,0.1%  0.3%,1,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017-07-20,2017-09-12,2017-09-12,Demand increase for the drug.,2017-07-27,2017-09-13
13861,778915,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX OINT 3.5G,DEXAMETHASONE  TOBRAMYCIN,0.1%  0.3%,1,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017-06-01,2017-07-04,2017-07-10,Delay in shipping of the drug.,2017-06-23,2017-07-11
22359,778915,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX OINTMENT 3.5G,DEXAMETHASONE  TOBRAMYCIN,0.1%  0.3%,3.5g,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017-09-14,2017-10-25,2017-10-26,Demand increase for the drug.,2017-09-18,2017-11-02
70039,778915,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX OINT 3.5G,DEXAMETHASONE  TOBRAMYCIN,0.1%  0.3%,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,2018-12-14,,2019-02-04,2019-02-01,Delay in shipping of the drug.,2018-12-19,2019-02-02
20969,778907,Shortage,TOBRADEX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBRADEX SUSP 5ML,DEXAMETHASONE  TOBRAMYCIN,0.1%  0.3%,5ML,OPHTHALMIC,Resolved,SUSPENSION,S01CA,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB,,2017-08-25,2017-09-11,2017-09-13,Demand increase for the drug.,2017-09-05,2017-09-14
39011,2285150,Shortage,TOBRAMYCIN FOR INJECTION U.S.P.,STERIMAX INC,TOBRAMYCIN FOR INJECTION U.S.P.,TOBRAMYCIN,1.2G,6 VIALS,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2018-02-05,,,Delay in shipping of the drug.,2018-02-07,2019-03-29
38757,2443368,Shortage,TOBRAMYCIN INHALATION SOLUTION,SANDOZ CANADA INCORPORATED,TOBRAMYCIN,TOBRAMYCIN,300MG,56 AMPOULES,INHALATION,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2018-02-05,2018-06-29,2018-06-18,Demand increase for the drug.,2018-02-06,2018-07-03
2553,2443368,Shortage,TOBRAMYCIN INHALATION SOLUTION,SANDOZ CANADA INCORPORATED,TOBRAMYCIN,TOBRAMYCIN,300MG,5mL x 56 Amp,INHALATION,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017-02-06,2017-04-14,2017-05-15,Requirements related to complying with good manufacturing practices.,2017-03-14,2017-05-17
66481,2230640,Shortage,TOBRAMYCIN INJECTION,FRESENIUS KABI CANADA LTD,Tobramycin for Injection,TOBRAMYCIN,40MG,2 mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,2018-11-26,,,2019-01-08,Disruption of the manufacture of the drug.,2018-11-08,2019-01-09
80604,2230640,Shortage,TOBRAMYCIN INJECTION,FRESENIUS KABI CANADA LTD,Tobramycin for Injection,TOBRAMYCIN,40MG,30 mL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,2019-04-08,,2019-05-06,2019-05-10,Disruption of the manufacture of the drug.,2019-04-05,2019-05-11
6979,2382814,Shortage,"TOBRAMYCIN INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"TOBRAMYCIN INJECTION, USP",TOBRAMYCIN,40MG,2ML 10VL,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017-05-01,,,Delay in shipping of the drug.,2017-04-13,2018-12-21
6982,2382814,Shortage,"TOBRAMYCIN INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"TOBRAMYCIN INJECTION, USP",TOBRAMYCIN,40MG,30ML 1VL,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2017-05-01,,,Delay in shipping of the drug.,2017-04-13,2018-12-21
226,2382814,Shortage,"TOBRAMYCIN INJECTION, USP",MYLAN PHARMACEUTICALS ULC,Tobramycin,TOBRAMYCIN,40MG,10VL,INTRAMUSCULAR  INTRAVENOUS,Resolved,SOLUTION,J01GB,AMINOGLYCOSIDE ANTIBACTERIALS,,2016-12-13,2017-07-15,2017-03-13,Delay in shipping of the drug.,2017-03-10,2017-03-14
75340,614254,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX OINT 3.5G,TOBRAMYCIN,3MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2019-02-11,2019-03-08,2019-03-08,Demand increase for the drug.,2019-02-11,2019-03-09
80771,614254,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX OINT 3.5G,TOBRAMYCIN,3MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2019-04-08,2019-04-25,2019-04-25,Delay in shipping of the drug.,2019-04-08,2019-04-26
69257,513962,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX 0.3% SOLN 5 ML,TOBRAMYCIN,0.3%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01AA,ANTIINFECTIVES,,2018-12-11,2019-02-04,2019-02-04,Demand increase for the drug.,2018-12-11,2019-02-05
87200,614254,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX OINT 3.5G,TOBRAMYCIN,3MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2019-06-27,2019-06-20,2019-09-10,2019-09-05,Delay in shipping of the drug.,2019-06-21,2019-09-06
78252,614254,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX OINT 3.5G,TOBRAMYCIN,3MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,2019-03-13,2019-03-18,2019-04-03,2019-04-05,Delay in shipping of the drug.,2019-03-11,2019-04-06
71609,614254,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX OINT 3.5G,TOBRAMYCIN,3MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2019-01-03,2019-01-25,2019-01-25,Demand increase for the drug.,2019-01-08,2019-01-28
35259,614254,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX OINTMENT 3.5G,TOBRAMYCIN,3MG,3.5G,OPHTHALMIC,Resolved,OINTMENT,S01AA,ANTIINFECTIVES,,2018-01-04,2018-01-30,2018-01-29,Delay in shipping of the drug.,2018-01-08,2018-01-30
20963,513962,Shortage,TOBREX,NOVARTIS PHARMACEUTICALS CANADA INC,TOBREX 0.3% SOLN 5ML,TOBRAMYCIN,0.3%,5 ml,OPHTHALMIC,Resolved,SOLUTION,S01AA,ANTIINFECTIVES,,2017-07-20,2017-09-12,2017-09-13,Demand increase for the drug.,2017-09-05,2017-09-14
72897,2337630,Shortage,TOCTINO,GLAXOSMITHKLINE INC,alitretinoin soft capsule,ALITRETINOIN,10MG,30's,ORAL,Resolved,CAPSULE,D11AH,OTHER DERMATOLOGICAL PREPARATIONS,,2019-01-17,2019-02-05,2019-02-04,Disruption of the manufacture of the drug.,2019-01-18,2019-02-05
2,2242320,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.05mg/mL ORAL SOL 115mL,DIGOXIN,0.05MG,115 mL,ORAL,Resolved,SOLUTION,C01AA,CARDIAC GLYCOSIDES,2017-02-23,2017-02-23,2017-03-23,2017-03-23,Disruption of the manufacture of the drug.,2017-03-10,2017-10-05
35091,2335700,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.0625mg,DIGOXIN,0.0625MG,TABS 250,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,2018-02-05,2018-01-26,2018-03-13,2018-02-16,Delay in shipping of the drug.,2018-01-08,2018-02-19
6423,2335700,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.0625mg TABS 250,DIGOXIN,0.0625MG,250,ORAL,Avoided shortage,TABLET,C01AA,CARDIAC GLYCOSIDES,2017-12-03,,2018-01-05,2017-09-01,Disruption of the manufacture of the drug.,2017-04-11,2017-09-01
34333,2242320,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.05mg/mL ORAL SOL 115mL,DIGOXIN,0.05MG,115ml,ORAL,Avoided shortage,SOLUTION,C01AA,CARDIAC GLYCOSIDES,2018-02-19,,2018-02-19,2018-02-12,Disruption of the manufacture of the drug.,2017-12-22,2018-02-13
5439,2335719,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.125mg TABS 250,DIGOXIN,0.125MG,250 Tabs,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,2017-09-27,2017-09-29,2018-01-04,2017-12-20,Delay in shipping of the drug.,2017-04-04,2017-12-21
41597,2335700,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.0625mg TABS 250,DIGOXIN,0.0625MG,250,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,2018-03-02,2018-03-02,2018-06-12,2018-06-08,Delay in shipping of the drug.,2018-03-02,2018-06-12
26035,2335700,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.0625mg TABS 250,DIGOXIN,0.0625MG,250,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,2017-11-24,2017-11-24,2017-12-29,2017-12-20,Delay in shipping of the drug.,2017-10-16,2017-12-21
35799,2335719,Shortage,TOLOXIN,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,TOLOXIN 0.125mg TABS 250,DIGOXIN,0.125MG,250,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,2018-02-02,,2018-02-02,2018-02-02,Delay in shipping of the drug.,2018-01-12,2018-02-05
90588,2335719,Shortage,TOLOXIN,PENDOPHARM DIVISION OF PHARMASCIENCE INC,TOLOXIN,DIGOXIN,0.125MG,115ML,ORAL,Resolved,TABLET,C01AA,CARDIAC GLYCOSIDES,,2019-08-01,2019-10-07,2019-10-01,Disruption of the manufacture of the drug.,2019-08-01,2019-10-03
60044,2229566,Shortage,TOMUDEX,PFIZER CANADA INC,TOMUDEX,RALTITREXED,2MG,1 x 2mg GVL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BA,ANTIMETABOLITES,,2018-09-18,,2018-10-12,Disruption of the manufacture of the drug.,2018-09-06,2018-10-13
2496,2229566,Shortage,TOMUDEX,HOSPIRA HEALTHCARE CORPORATION,Raltitrexed powder,TOMUDEX,2MG,VIAL / AMPOULE,INTRAVENOUS / INTRAVEINEUSE,Resolved,SOLUTION,L01BA,ANTIMETABOLITES,2017-04-14,,2017-05-25,2017-05-25,Disruption of the manufacture of the drug.,2017-03-14,2017-06-01
91890,2229566,Shortage,TOMUDEX,PFIZER CANADA ULC,Tomudex,RALTITREXED,2MG,2mg vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,L01BA,ANTIMETABOLITES,,2019-08-16,2019-09-30,2019-09-30,Disruption of the manufacture of the drug.,2019-08-19,2019-10-01
4347,816132,Shortage,TOPACTIN CREAM 0.05% U.S.P.,PALADIN LABS INC,FLUOCINONIDE,FLUOCINONIDE,0.05%,450g,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2014-01-01,,,Other (Please describe in comments),2017-03-27,2017-10-13
4350,2240269,Shortage,TOPACTIN EMOLLIENT CREAM 0.05%,PALADIN LABS INC,FLUOCINONIDE,FLUOCINONIDE,0.5MG,60G/225G,TOPICAL,Actual shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2014-01-01,,,Other (Please describe in comments),2017-03-27,2017-10-13
53240,2221896,Shortage,TOPICORT,VALEANT CANADA LP/VALEANT CANADA S.E.C.,TOPICORT,DESOXIMETASONE,0.25%,60g,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2018-06-22,,2018-07-06,Other (Please describe in comments),2018-06-29,2018-07-09
96017,2221926,Shortage,TOPICORT GEL,"BAUSCH HEALTH, CANADA INC.",TOPICORT GEL,DESOXIMETASONE,0.05%,60g,TOPICAL,Actual shortage,GEL,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-10-02,2019-11-29,,Other (Please describe in comments),2019-10-10,2019-11-13
98639,2221934,Shortage,TOPICORT OINTMENT,"BAUSCH HEALTH, CANADA INC.",TOPICORT OINTMENT,DESOXIMETASONE,0.25%,60g,TOPICAL,Actual shortage,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2019-10-24,2019-11-29,,Other (Please describe in comments),2019-11-13,2019-11-13
4344,749834,Shortage,TOPIDERM HC 2%,PALADIN LABS INC,HYDROCORTISONE ACETAT,HYDROCORTISONE ACETATE,2%,30gr AND 225gr,TOPICAL,Actual shortage,CREAM,D07AA,"CORTICOSTEROIDS, PLAIN",2016-07-31,2016-07-31,,,Other (Please describe in comments),2017-03-27,2017-11-24
13152,2389460,Shortage,TOPIRAMATE,SIVEM PHARMACEUTICALS ULC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-06-16,,2017-07-10,2017-10-01,Demand increase for the drug.,2017-06-16,2017-11-03
32651,2389487,Shortage,TOPIRAMATE,SIVEM PHARMACEUTICALS ULC,TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2018-01-01,2017-12-28,2018-05-18,2018-05-18,Other (Please describe in comments),2017-12-12,2018-05-19
58056,2356872,Shortage,TOPIRAMATE,SANIS HEALTH INC,TOPIRAMATE TAB,TOPIRAMATE,200MG,100,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2018-08-13,2018-08-27,2018-08-27,Other (Please describe in comments),2018-08-14,2018-08-28
21797,2395746,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,100MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-08-25,2017-08-25,2017-11-03,2017-11-01,Disruption of the manufacture of the drug.,2017-09-08,2017-11-13
21800,2395754,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,200MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-08-15,2017-08-15,2017-11-10,2017-11-01,Disruption of the manufacture of the drug.,2017-09-08,2017-11-13
21803,2395738,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,25MG,100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2017-08-24,2017-08-24,2017-11-03,2017-11-01,Disruption of the manufacture of the drug.,2017-09-08,2017-11-13
3269,2395738,Shortage,TOPIRAMATE TABLETS,ACCORD HEALTHCARE INC,TOPIRANATE,TOPIRAMATE,25MG,BOTTLE OF 100 TABS   |    BOUTEILLE DE 100 COMPRIMÉS,ORAL,Resolved,TABLET,N03AX,ANTIEPILEPTICS,2016-12-28,2016-12-28,2017-07-21,2017-07-24,Disruption of the manufacture of the drug.,2017-03-17,2017-07-26
14854,2379422,Shortage,TOPOTECAN HYDROCHLORIDE FOR INJECTION,PFIZER CANADA INC,Topotecan,TOPOTECAN,1MG,5 x 4mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-07-12,,2017-08-30,2017-08-29,Demand increase for the drug.,2017-07-06,2017-08-30
28645,2379422,Shortage,TOPOTECAN HYDROCHLORIDE FOR INJECTION,PFIZER CANADA INC,TOPOTECAN,TOPOTECAN,1MG,5x4mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-11-07,,2017-11-22,2017-11-20,Disruption of the manufacture of the drug.,2017-11-08,2017-11-21
54773,2379422,Shortage,TOPOTECAN HYDROCHLORIDE FOR INJECTION,PFIZER CANADA INC,TOPOTECAN,TOPOTECAN,1MG,5 x 4mL,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2018-08-07,,2018-09-04,Demand increase for the drug.,2018-07-09,2018-09-05
2550,2390981,Shortage,TOPOTECAN INJECTION,SANDOZ CANADA INCORPORATED,Topotecan HCl,TOPOTECAN,1MG,5x4mL fiole/vial,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,,2016-12-13,2017-07-28,2017-07-28,Demand increase for the drug.,2017-03-14,2017-08-07
56105,2162660,Shortage,TORADOL,AA PHARMA INC,Toradol,KETOROLAC TROMETHAMINE,10MG,100 BTL,ORAL,Resolved,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2018-07-19,2018-08-07,2018-07-30,Disruption of the manufacture of the drug.,2018-07-19,2019-01-14
21742,590215,Shortage,TPN ELECTROLYTES,PFIZER CANADA INC,TPN ELECTROLYTES,SODIUM ACETATE  MAGNESIUM CHLORIDE  CALCIUM CHLORIDE  POTASSIUM CHLORIDE  SODIUM CHLORIDE,121MG  25.4MG  16.55MG  74.55MG  16.05MG,25x20mL,INTRAVENOUS,Resolved,SOLUTION,B05XA,I.V. SOLUTION ADDITIVES,,2018-01-26,,2018-07-16,Disruption of the manufacture of the drug.,2017-09-08,2018-07-17
16543,2370921,Shortage,TRAJENTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Trajenta,LINAGLIPTIN,5MG,30's,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-07-21,,2017-07-31,2017-07-31,Disruption of the manufacture of the drug.,2017-07-20,2017-08-01
28642,2370921,Shortage,TRAJENTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Trajenta,LINAGLIPTIN,5MG,90's,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2017-11-10,2017-11-14,2017-11-21,2017-12-21,Disruption of the manufacture of the drug.,2017-11-08,2017-12-22
35364,2426153,Shortage,TRAMADOL,AA PHARMA INC,TRAMADOL,TRAMADOL HYDROCHLORIDE,50MG,100 BTL,ORAL,Resolved,TABLET,N02AX,OPIOIDS,,2018-01-09,2018-02-01,2018-01-31,Disruption of the manufacture of the drug.,2018-01-09,2018-02-01
77928,2426153,Shortage,TRAMADOL,AA PHARMA INC,TRAMADOL,TRAMADOL HYDROCHLORIDE,50MG,100BTL,ORAL,Resolved,TABLET,N02AX,OPIOIDS,,2019-03-06,2019-03-19,2019-03-20,Disruption of the manufacture of the drug.,2019-03-06,2019-03-21
55105,2429969,Shortage,TRAMADOL / ACETAMINOPHEN,SIVEM PHARMACEUTICALS ULC,TRAMADOL HCL/ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE  ACETAMINOPHEN,37.5MG  325MG,100,ORAL,Resolved,TABLET,N02AJ,OPIOIDS,2018-08-01,2018-07-30,2018-09-17,2018-09-10,Delay in shipping of the drug.,2018-07-10,2018-09-20
62096,2106280,Shortage,TRANDATE,PALADIN LABS INC,Trandate,LABETALOL HYDROCHLORIDE,200MG,100tabs,ORAL,Resolved,TABLET,C07AG,BETA BLOCKING AGENTS,,2018-09-20,2018-10-14,2018-10-12,Disruption of the manufacture of the drug.,2018-09-20,2018-10-15
31060,2246365,Shortage,TRANEXAMIC ACID INJECTION BP,SANDOZ CANADA INCORPORATED,TRANEXAMIC ACID,TRANEXAMIC ACID,100MG,10 X 10ML VIALS,INTRAVENOUS,Resolved,SOLUTION,B02AA,ANTIFIBRINOLYTICS,,2017-11-24,2017-12-29,2017-12-22,Delay in shipping of the drug.,2017-11-29,2018-01-08
85765,2401231,Shortage,TRANEXAMIC ACID TABLETS,STERIMAX INC,TRANEXAMIC ACID TABLETS,TRANEXAMIC ACID,500MG,100 TABS,ORAL,Resolved,TABLET,B02AA,ANTIFIBRINOLYTICS,,2019-06-06,2019-06-21,2019-06-20,Delay in shipping of the drug.,2019-06-06,2019-06-21
75140,2401231,Shortage,TRANEXAMIC ACID TABLETS,STERIMAX INC,TRANEXAMIC ACID TABLETS,TRANEXAMIC ACID,500MG,100 TABS,ORAL,Resolved,TABLET,B02AA,ANTIFIBRINOLYTICS,,2019-02-11,2019-02-22,2019-02-22,Delay in shipping of the drug.,2019-02-08,2019-02-23
3779,2186845,Shortage,TRASYLOL,NORDIC GROUP B.V.,APROTININ (BOVINE),APROTININ,10000UNIT,"50 ML VIAL (500,000 KIU); 200 ML VIAL (2,000,000 KIU)",INTRAVENOUS,Actual shortage,SOLUTION,B02AB,ANTIFIBRINOLYTICS,,2014-10-30,,,Other (Please describe in comments),2017-03-21,2017-10-13
42773,2318008,Shortage,TRAVATAN Z,NOVARTIS PHARMACEUTICALS CANADA INC,TRAVATAN Z SOLUTION 5ML,TRAVOPROST,0.004%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-03-19,2018-04-24,2018-04-23,Demand increase for the drug.,2018-03-13,2018-04-25
35254,2318008,Shortage,TRAVATAN Z,NOVARTIS PHARMACEUTICALS CANADA INC,TRAVATAN Z SOLUTION 5 ML,TRAVOPROST,0.004%,5ML,OPHTHALMIC,Resolved,SOLUTION,S01EE,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2018-01-04,2018-02-19,2018-02-01,Delay in shipping of the drug.,2018-01-08,2018-02-08
6201,2164361,Shortage,TRAZODONE - 100 - TAB 100MG,PRO DOC LIMITEE,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-07-24,,2018-09-27,Delay in shipping of the drug.,2017-04-07,2018-09-28
6204,2164388,Shortage,TRAZODONE-150 D - TAB 150MG,PRO DOC LIMITEE,TRAZODONE,TRAZODONE HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-11-12,,2019-01-11,Delay in shipping of the drug.,2017-04-07,2019-01-12
6198,2164353,Shortage,TRAZODONE-50 - TAB 50MG,PRO DOC LIMITEE,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,250,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2018-04-17,,2018-08-28,Delay in shipping of the drug.,2017-04-07,2018-08-29
83058,716960,Shortage,TRIADERM CRM 0.1%,TARO PHARMACEUTICALS INC,TRIADERM CRM 0.1%,TRIAMCINOLONE ACETONIDE,0.1%,500 g,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2019-04-29,2019-05-31,2019-06-07,Disruption of the manufacture of the drug.,2019-05-03,2019-06-08
12719,716960,Shortage,TRIADERM CRM 0.1%,TARO PHARMACEUTICALS INC,TRIADERM CRM 0.1%,TRIAMCINOLONE ACETONIDE,0.1%,500G,TOPICAL,Resolved,CREAM,D07AB,"CORTICOSTEROIDS, PLAIN",,2018-10-15,2018-10-26,2018-10-29,Disruption of the manufacture of the drug.,2017-06-13,2018-10-30
65932,852163,Shortage,TRIATEC-8,LABORATOIRE RIVA INC,Triatec-8,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,325MG  8MG  15MG,30 & 100 & 200,ORAL,Actual shortage,TABLET,N02AJ,OPIOIDS,2018-10-31,2018-10-31,,,Disruption of the manufacture of the drug.,2018-10-31,2018-11-01
43911,808571,Shortage,TRIAZOLAM,AA PHARMA INC,Triazolam,TRIAZOLAM,0.25MG,7x10 BListers,ORAL,Resolved,TABLET,N05CD,HYPNOTICS AND SEDATIVES,,2018-03-26,2018-07-06,2018-06-01,Disruption of the manufacture of the drug.,2018-03-26,2018-06-02
85664,808571,Shortage,TRIAZOLAM,AA PHARMA INC,Triazolam,TRIAZOLAM,0.25MG,7x10 Blisters,ORAL,Resolved,TABLET,N05CD,HYPNOTICS AND SEDATIVES,,2019-06-05,,2019-10-17,Disruption of the manufacture of the drug.,2019-06-05,2019-10-18
8423,808571,Shortage,TRIAZOLAM,AA PHARMA INC,Triazolam,TRIAZOLAM,0.25MG,7 x 10 blister,ORAL,Resolved,TABLET,N05CD,HYPNOTICS AND SEDATIVES,,2017-05-19,2017-08-15,2017-07-25,Disruption of the manufacture of the drug.,2017-04-28,2017-07-26
98575,2401975,Shortage,TRICIRA LO,APOTEX INC,TRICIRA LO,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORGESTIMATE  NORGESTIMATE  NORGESTIMATE,0.025MG  0.025MG  0.025MG  0.180MG  0.215MG  0.250MG,28 BLS,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-11-11,2019-12-16,2019-11-15,Disruption of the manufacture of the drug.,2019-11-13,2019-11-18
80931,2401967,Shortage,TRICIRA LO,APOTEX INC,TRICIRA LO,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORGESTIMATE  NORGESTIMATE  NORGESTIMATE,0.025MG  0.025MG  0.025MG  0.180MG  0.215MG  0.250MG,21 BLS,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-04-09,,2019-08-23,Disruption of the manufacture of the drug.,2019-04-10,2019-08-26
36429,2401967,Shortage,TRICIRA LO,APOTEX INC,NORGESTIMATE/ETHINYL  ESTRADIOL,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORGESTIMATE  NORGESTIMATE  NORGESTIMATE,0.025MG  0.025MG  0.025MG  0.180MG  0.215MG  0.250MG,21 BLS,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-01-15,2018-03-09,2018-02-19,Disruption of the manufacture of the drug.,2018-01-18,2018-02-23
77902,2401975,Shortage,TRICIRA LO,APOTEX INC,TRICIRA LO,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORGESTIMATE  NORGESTIMATE  NORGESTIMATE,0.025MG  0.025MG  0.025MG  0.180MG  0.215MG  0.250MG,28 BLS,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-03-04,2019-05-31,2019-05-17,Disruption of the manufacture of the drug.,2019-03-06,2019-05-21
70526,2401975,Shortage,TRICIRA LO,APOTEX INC,NORGESTIMATE/ETHINYL  ESTRADIOL,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORGESTIMATE  NORGESTIMATE  NORGESTIMATE,0.025MG  0.025MG  0.025MG  0.180MG  0.215MG  0.250MG,28BLS,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2018-12-24,2019-01-25,2019-01-21,Disruption of the manufacture of the drug.,2018-12-27,2019-01-23
78558,2401975,Shortage,TRICIRA LO,APOTEX INC,TRICIRA LO,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORGESTIMATE  NORGESTIMATE  NORGESTIMATE,0.025MG  0.025MG  0.025MG  0.180MG  0.215MG  0.250MG,28 BLS,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-03-11,2019-05-31,2019-05-17,Disruption of the manufacture of the drug.,2019-03-13,2019-05-21
91109,2401975,Shortage,TRICIRA LO,APOTEX INC,TRICIRA,ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  ETHINYL ESTRADIOL  NORGESTIMATE  NORGESTIMATE  NORGESTIMATE,0.025MG  0.025MG  0.025MG  0.180MG  0.215MG  0.250MG,28 BLS,ORAL,Resolved,TABLET,G03AB,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2019-08-06,,2019-08-23,Disruption of the manufacture of the drug.,2019-08-07,2019-08-26
6723,2296381,Shortage,TRIDURAL,PALADIN LABS INC,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,100MG,100 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017-04-13,2017-04-13,2017-05-10,2017-05-09,Delay in shipping of the drug.,2017-04-13,2017-05-10
8351,2296411,Shortage,TRIDURAL,PALADIN LABS INC,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,300MG,100 Tabs,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N02AX,OPIOIDS,2017-05-01,2017-05-02,2017-05-12,2017-05-10,Delay in shipping of the drug.,2017-04-28,2017-05-11
73545,2368676,Shortage,TRIESENCE,NOVARTIS PHARMACEUTICALS CANADA INC,TRIESENCE 1ML SUSP x 12,TRIAMCINOLONE ACETONIDE,40MG,1 ML,INTRAVITREAL,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,,2019-01-25,2019-03-15,2019-03-12,Delay in shipping of the drug.,2019-01-25,2019-03-13
83368,2368676,Shortage,TRIESENCE,NOVARTIS PHARMACEUTICALS CANADA INC,TRIESENCE 1ML SUSP X12,TRIAMCINOLONE ACETONIDE,40MG,12,INTRAVITREAL,Actual shortage,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,2019-06-03,2019-05-27,2020-03-31,,Delay in shipping of the drug.,2019-05-07,2019-09-25
65471,2368676,Shortage,TRIESENCE,NOVARTIS PHARMACEUTICALS CANADA INC,TRIESENCE 1ML SUSP,TRIAMCINOLONE ACETONIDE,40MG,1ML,INTRAVITREAL,Resolved,SUSPENSION,S01BA,ANTIINFLAMMATORY AGENTS,2018-11-02,,2018-11-21,2018-11-06,Delay in shipping of the drug.,2018-10-23,2018-11-07
75655,345539,Shortage,TRIFLUOPERAZINE,AA PHARMA INC,Trifluoperazine,TRIFLUOPERAZINE,1MG,100BTL,ORAL,Actual shortage,TABLET,N05AB,ANTIPSYCHOTICS,,2019-03-15,2020-01-20,,Disruption of the manufacture of the drug.,2019-02-13,2019-09-13
89782,545058,Shortage,TRIHEXYPHENIDYL,AA PHARMA INC,TRIHEXYPHENIDYL,TRIHEXYPHENIDYL HYDROCHLORIDE,2MG,100 Bottle,ORAL,Actual shortage,TABLET,N04AA,ANTICHOLINERGIC AGENTS,,2019-05-21,2019-10-01,,Other (Please describe in comments),2019-07-22,2019-07-22
76783,2242068,Shortage,TRILEPTAL 300 MG,NOVARTIS PHARMACEUTICALS CANADA INC,TRILEPTAL 300MG 5X10,OXCARBAZEPINE,300MG,5 X 10,ORAL,Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2019-02-25,2019-03-05,2019-03-06,Delay in shipping of the drug.,2019-02-25,2019-03-07
4147,740802,Shortage,TRIMIPRAMINE,AA PHARMA INC,TRIMIPRAMINE,TRIMIPRAMINE,25MG,500 BOTTLE,ORAL,Resolved,TABLET,N06AA,ANTIDEPRESSANTS,,2016-08-19,,2017-03-28,Disruption of the manufacture of the drug.,2017-03-24,2017-03-28
72983,2246693,Shortage,TRIPLE ANTIBIOTIC OINTMENT,TARO PHARMACEUTICALS INC,TRIPLE ANTIBIOTIC OINTMENT,BACITRACIN ZINC  POLYMYXIN B  GRAMICIDIN,500UNIT  10000UNIT  0.25MG,30 G,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-01-17,2019-06-28,2019-06-28,Disruption of the manufacture of the drug.,2019-01-18,2019-07-05
88689,2246693,Shortage,TRIPLE ANTIBIOTIC OINTMENT,TARO PHARMACEUTICALS INC,TRIPLE ANTIBIOTIC OINTMENT,BACITRACIN ZINC  POLYMYXIN B  GRAMICIDIN,500UNIT  10000UNIT  0.25MG,15g,TOPICAL,Resolved,OINTMENT,D06AX,ANTIBIOTICS FOR TOPICAL USE,,2019-06-27,2019-09-06,2019-09-06,Disruption of the manufacture of the drug.,2019-07-05,2019-09-09
15753,2407833,Shortage,TRISENOX,LUNDBECK CANADA INC,Arsenic Trioxide for Injection,ARSENIC TRIOXIDE,1MG,10 mg/10mL ampoule,INTRAVENOUS,Resolved,SOLUTION,L01XX,OTHER ANTINEOPLASTIC AGENTS,2017-09-08,2017-09-08,2018-07-20,2018-07-24,Disruption of the manufacture of the drug.,2017-07-14,2018-07-30
90619,2244757,Shortage,TRIZIVIR,VIIV HEALTHCARE ULC,"abacavir (as abacavir sulfate), lamivudine and zidovudine tablets",ZIDOVUDINE  ABACAVIR  LAMIVUDINE,300MG  300MG  150MG,60's,ORAL,Actual shortage,TABLET,J05AR,DIRECT ACTING ANTIVIRALS,,2019-08-23,,,Demand increase for the drug.,2019-08-02,2019-09-18
49698,511234,Shortage,TROMBOJECT 1% INJ 10MG/ML,OMEGA LABORATORIES LTD,Tromboject,SODIUM TETRADECYL SULFATE,10MG,10 X 2ml vial,INTRAVENOUS,Resolved,SOLUTION,C05BB,ANTIVARICOSE THERAPY,,2018-04-17,2018-05-31,2018-06-11,Other (Please describe in comments),2018-05-18,2018-06-12
53727,511234,Shortage,TROMBOJECT 1% INJ 10MG/ML,OMEGA LABORATORIES LTD,Sodium Tetradecyl  Sulfate Injection,SODIUM TETRADECYL SULFATE,10MG,10 x 2mL vial,INTRAVENOUS,Resolved,SOLUTION,C05BB,ANTIVARICOSE THERAPY,2018-07-12,,,2019-02-04,Disruption of the manufacture of the drug.,2018-07-03,2019-02-05
49703,511226,Shortage,TROMBOJECT 3% INJ 30MG/ML,OMEGA LABORATORIES LTD,Tromboject,SODIUM TETRADECYL SULFATE,30MG,10 x 2mL vial / fiole,INTRAVENOUS,Resolved,SOLUTION,C05BB,ANTIVARICOSE THERAPY,,2018-04-17,2018-05-31,2018-06-11,Other (Please describe in comments),2018-05-18,2018-06-12
49706,511226,Shortage,TROMBOJECT 3% INJ 30MG/ML,OMEGA LABORATORIES LTD,Tromboject,SODIUM TETRADECYL SULFATE,30MG,5 x 5mL vial / fiole,INTRAVENOUS,Resolved,SOLUTION,C05BB,ANTIVARICOSE THERAPY,,2018-04-17,2018-05-31,2018-06-11,Other (Please describe in comments),2018-05-18,2018-06-12
53735,511226,Shortage,TROMBOJECT 3% INJ 30MG/ML,OMEGA LABORATORIES LTD,Sodium Tetradecyl Sulfate Injection,SODIUM TETRADECYL SULFATE,30MG,10 x 2mL vial,INTRAVENOUS,Resolved,SOLUTION,C05BB,ANTIVARICOSE THERAPY,2018-07-20,,,2019-02-04,Disruption of the manufacture of the drug.,2018-07-03,2019-02-05
53748,511226,Shortage,TROMBOJECT 3% INJ 30MG/ML,OMEGA LABORATORIES LTD,Sodium Tetradecyl Sulfate Injection,SODIUM TETRADECYL SULFATE,30MG,5 x 5mL vial,INTRAVENOUS,Resolved,SOLUTION,C05BB,ANTIVARICOSE THERAPY,2018-10-31,,,2019-02-04,Disruption of the manufacture of the drug.,2018-07-03,2019-02-05
4030,2269090,Shortage,TRUSOPT,PURDUE PHARMA,Trusopt,DORZOLAMIDE,2%,60 x 0.2mL pipettes,OPHTHALMIC,Resolved,SOLUTION,S01EC,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,2017-02-23,2017-02-23,2017-04-07,2017-04-06,Demand increase for the drug.,2017-03-23,2017-04-07
53248,718149,Shortage,TRYPTAN CAP 500MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,TRYPTAN CAP 500MG,TRYPTOPHAN,500MG,100,ORAL,Resolved,CAPSULE,N06AX,ANTIDEPRESSANTS,2018-08-08,,2018-08-20,2018-08-23,Other (Please describe in comments),2018-06-29,2018-08-24
26489,654531,Shortage,TRYPTAN TAB 1000MG,VALEANT CANADA LP/VALEANT CANADA S.E.C.,TRYPTAN TAB 1000MG,TRYPTOPHAN,1G,na,ORAL,Resolved,TABLET,N06AX,ANTIDEPRESSANTS,2017-10-20,,2017-11-17,2017-11-23,Other (Please describe in comments),2017-10-20,2017-11-24
54279,317268,Shortage,TUBERSOL,SANOFI PASTEUR LIMITED,Tuberculin Purified Protein Derivative (Mantoux),PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN,5TUB,5 mL multidose vial (5 TU per test),INTRADERMAL,Resolved,SOLUTION,V04CF,OTHER DIAGNOSTIC AGENTS,2018-06-29,2018-06-29,,2018-07-11,Other (Please describe in comments),2018-07-04,2018-07-12
14058,317268,Shortage,TUBERSOL,SANOFI PASTEUR LIMITED,Tuberculin Purified Protein Derivative (Mantoux),PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN,5TUB,5 mL multidose vial (5 TU per test) / Flacon multidose de 5 mL (5 UT par épreuve),INTRADERMAL,Resolved,SOLUTION,V04CF,OTHER DIAGNOSTIC AGENTS,,2017-06-22,2017-07-12,2017-07-12,Other (Please describe in comments),2017-06-27,2017-07-13
3086,1916963,Shortage,TUSSIONEX,SANOFI-AVENTIS CANADA INC,TUSSIONEX 5-10MG TABLETS,HYDROCODONE  PHENYLTOLOXAMINE,5MG  10MG,100'S,ORAL,Resolved,TABLET (EXTENDED-RELEASE),R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2017-01-06,,2017-08-03,Other (Please describe in comments),2017-03-16,2017-08-22
42990,1916971,Shortage,TUSSIONEX,SANOFI-AVENTIS CANADA INC,Tussionex Suspension,HYDROCODONE  PHENYLTOLOXAMINE,5MG  10MG,500ml,ORAL,Resolved,SUSPENSION,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,2018-05-01,2018-05-01,2018-08-15,2018-07-25,Shortage of an active ingredient.,2018-03-15,2018-07-26
1213,720208,Shortage,TUSSODAN DM SYRUP,ODAN LABORATORIES LTD,Cough Syrup,DEXTROMETHORPHAN HYDROBROMIDE  PSEUDOEPHEDRINE HYDROCHLORIDE,15MG  30MG,250 mL,ORAL,Actual shortage,SYRUP,R05DA,COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS,,2016-04-15,,,Disruption of the manufacture of the drug.,2017-03-13,2017-10-13
62029,2230578,Shortage,TWINRIX,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",720UNIT  20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-09-14,2019-07-22,2019-03-14,Demand increase for the drug.,2018-09-19,2019-03-15
83033,2230578,Shortage,TWINRIX,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",720UNIT  20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2019-05-01,2019-11-14,2019-10-21,Disruption of the manufacture of the drug.,2019-05-03,2019-10-22
11383,2230578,Shortage,TWINRIX,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",720UNIT  20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-05-24,2017-07-11,2017-07-10,Demand increase for the drug.,2017-05-26,2017-07-19
16553,2230578,Shortage,TWINRIX,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",720UNIT  20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-07-18,2017-12-07,2017-12-04,Delay in shipping of the drug.,2017-07-20,2017-12-06
35785,2230578,Shortage,TWINRIX,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",720UNIT  20MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-01-10,2018-01-19,2018-01-17,Demand increase for the drug.,2018-01-12,2018-01-19
19518,2237548,Shortage,TWINRIX JUNIOR,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",360UNIT  10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-08-10,2017-11-16,2017-10-10,Delay in shipping of the drug.,2017-08-16,2017-10-11
28016,2237548,Shortage,TWINRIX JUNIOR,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",360UNIT  10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-11-08,2017-12-07,2017-12-04,Demand increase for the drug.,2017-11-03,2017-12-06
48544,2237548,Shortage,TWINRIX JUNIOR,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",360UNIT  10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2018-05-03,2019-02-18,2019-02-06,Demand increase for the drug.,2018-05-04,2019-02-08
80599,2237548,Shortage,TWINRIX JUNIOR,GLAXOSMITHKLINE INC,Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine,"HEPATITIS A VACCINE, INACTIVATED  HEPATITIS B SURFACE ANTIGEN",360UNIT  10MCG,1's,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2019-04-02,2019-05-16,2019-05-10,Demand increase for the drug.,2019-04-05,2019-05-11
49695,2371022,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 40 + 5 MG,AMLODIPINE  TELMISARTAN,5MG  40MG,4 x 7,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-05-17,2018-06-22,2018-05-29,Disruption of the manufacture of the drug.,2018-05-18,2018-05-30
87104,2371049,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 80 + 5 mg,AMLODIPINE  TELMISARTAN,5MG  80MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2019-06-18,2019-07-08,2019-08-09,Disruption of the manufacture of the drug.,2019-06-19,2019-08-19
71256,2371030,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 40 + 10 MG,AMLODIPINE  TELMISARTAN,10MG  40MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-01-11,,2019-01-21,2019-01-24,Disruption of the manufacture of the drug.,2019-01-04,2019-01-25
68953,2371057,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 80 + 10 MG,AMLODIPINE  TELMISARTAN,10MG  80MG,28's,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-02-19,,2019-02-28,2019-03-08,Disruption of the manufacture of the drug.,2018-12-10,2019-03-12
68958,2371049,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 80 + 5 mg,AMLODIPINE  TELMISARTAN,5MG  80MG,28's,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2019-01-11,2019-01-11,2019-01-24,2019-01-28,Disruption of the manufacture of the drug.,2018-12-10,2019-01-28
38030,2371057,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 80 + 10 MG,AMLODIPINE  TELMISARTAN,10MG  80MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-02-09,2018-02-01,2018-04-16,2018-04-05,Disruption of the manufacture of the drug.,2018-02-01,2018-04-06
38033,2371030,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 40 + 10 MG,AMLODIPINE  TELMISARTAN,10MG  40MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-02-01,2018-02-01,2018-03-16,2018-02-26,Disruption of the manufacture of the drug.,2018-02-01,2018-03-02
51627,2371057,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 80 + 10 MG,AMLODIPINE  TELMISARTAN,10MG  80MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-06-06,2018-07-02,2018-06-21,Disruption of the manufacture of the drug.,2018-06-06,2018-06-22
67521,2371022,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 40 + 5 MG,AMLODIPINE  TELMISARTAN,5MG  40MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-11-23,2018-11-23,2018-12-17,2018-12-04,Disruption of the manufacture of the drug.,2018-11-23,2019-01-04
43458,2371022,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 40 + 5 MG,AMLODIPINE  TELMISARTAN,5MG  40MG,4 x 7,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-03-23,,2018-04-18,2018-04-19,Disruption of the manufacture of the drug.,2018-03-20,2018-04-20
57588,2371022,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 40 + 5 MG,AMLODIPINE  TELMISARTAN,5MG  40MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2018-08-07,2018-08-22,2018-08-27,Disruption of the manufacture of the drug.,2018-08-07,2018-08-28
57591,2371022,Shortage,TWYNSTA,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,TWYNSTA 40 + 5 MG,AMLODIPINE  TELMISARTAN,5MG  40MG,28s,ORAL,Resolved,TABLET,C09DB,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2018-09-24,2018-09-19,2018-10-29,2018-10-31,Disruption of the manufacture of the drug.,2018-08-07,2018-11-01
2737,2242727,Shortage,TYPHERIX,GLAXOSMITHKLINE INC,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,1's,INTRAMUSCULAR,Actual shortage,LIQUID,J07AP,BACTERIAL VACCINES,,2016-05-05,,,Disruption of the manufacture of the drug.,2017-03-14,2017-12-22
19508,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,10 mL multidose vial (20 Doses),INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017-08-15,2017-08-15,2018-01-31,2018-02-09,Disruption of the manufacture of the drug.,2017-08-15,2018-02-10
19511,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,1 x 0.5 mL (single dose) syringe,INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017-08-15,2017-08-15,2018-01-15,2018-02-01,Disruption of the manufacture of the drug.,2017-08-15,2018-02-09
3770,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,"1 x 0.5 mL (single dose) syringe / 1 seringue de 0,5 mL (dose unique)",INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017-03-21,,2017-04-15,2017-03-29,Delay in shipping of the drug.,2017-03-21,2017-03-30
3775,2130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,Salmonella typhi Vi Capsular Polysaccharide Vaccine,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,10 mL multidose vial (20 Doses) / Fiole multidose de 10 mL,INTRAMUSCULAR,Resolved,SOLUTION,J07AP,BACTERIAL VACCINES,2017-03-21,,2017-04-15,2017-03-29,Disruption of the manufacture of the drug.,2017-03-21,2017-03-30
91609,2441608,Shortage,ULTRA-TECHNEKOW V4,,SODIUM PERTECHNETATE TC-99M,SODIUM PERTECHNETATE TC-99M,19 CI / GEN,5 and 10 mL Eluant (saline) vial Box of 30,Intravenous,Actual shortage,Solution,V09FX,Thyroid,,2019-08-14,2019-12-15,,Disruption of the manufacture of the drug.,2019-08-15,2019-10-17
91615,2441608,Shortage,ULTRA-TECHNEKOW V4,,SODIUM PERTECHNETATE TC-99M,SODIUM PERTECHNETATE TC-99M,19 CI / GEN,20 mL Eluant (saline) vial Box of 30,Intravenous,Resolved,Solution,V09FX,Thyroid,,2019-08-14,2019-09-16,2019-09-12,Disruption of the manufacture of the drug.,2019-08-15,2019-09-13
5957,1962701,Shortage,ULTRAVATE CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ULTRAVATE CREAM,HALOBETASOL PROPIONATE,0.05%,50G,TOPICAL,Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2017-08-30,,,2017-09-15,Other (Please describe in comments),2017-04-07,2017-09-16
86508,1962701,Shortage,ULTRAVATE CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ULTRAVATE CREAM,HALOBETASOL PROPIONATE,0.05%,50g,TOPICAL,Anticipated shortage,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",2020-01-06,,2020-05-15,,Disruption of the manufacture of the drug.,2019-06-12,2019-10-09
36160,2373300,Shortage,UNISOM SLEEP GELS,PALADIN LABS INC,Unisom,DIPHENHYDRAMINE HYDROCHLORIDE,25MG,20capsules,ORAL,Resolved,CAPSULE,R06AA,ANTIHISTAMINES FOR SYSTEMIC USE,,2018-01-04,,2018-07-23,Other (Please describe in comments),2018-01-17,2019-09-27
4355,728179,Shortage,URISPAS TAB 200MG,PALADIN LABS INC,FLAVOXATE HYDROCHLORIDE,FLAVOXATE HYDROCHLORIDE,200MG,100 TABS,ORAL,Actual shortage,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2008-03-19,,,Other (Please describe in comments),2017-03-27,2017-10-13
46930,39373,Shortage,UROLOGIC G FOR IRRIGATION,ICU MEDICAL CANADA INC,Urological G Solution for Irrigation,CITRIC ACID  SODIUM CARBONATE  MAGNESIUM OXIDE,32.4MG  4.3MG  3.8MG,1000ML,IRRIGATION,Resolved,SOLUTION,B05CB,IRRIGATING SOLUTIONS,2018-04-02,2018-04-09,2018-05-28,2018-05-28,Shortage of an active ingredient.,2018-04-23,2018-05-29
51103,2371839,Shortage,UROMITEXAN,BAXTER CORPORATION,Uromitexan,MESNA,100MG,10mL,INTRAVENOUS,Resolved,SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2018-06-01,2018-06-01,2018-06-21,2018-06-21,Demand increase for the drug.,2018-06-01,2018-06-22
97201,2241411,Shortage,UROMITEXAN,BAXTER CORPORATION,MESNA,MESNA,100MG,4mL Ampoule,INTRAVENOUS  ORAL,Actual shortage,SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,2019-10-24,2019-10-24,2019-11-29,,Demand increase for the drug.,2019-10-24,2019-10-25
27905,263893,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 25 mg,,,100,,Actual shortage,,,,,2014-10-24,2025-02-01,,Other (Please describe in comments),2017-11-02,2018-02-15
27908,263907,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 50 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27911,263907,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 50 mg,,,1000,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27914,263907,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 50 mg,,,500,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
27917,405620,Shortage,UROZIDE,BIOMED PHARMA,Hydrochlorothiazide Tablets 100 mg,,,100,,Actual shortage,,,,,2014-10-23,,,Other (Please describe in comments),2017-11-02,2017-11-02
95285,2245894,Shortage,URSO DS,APTALIS PHARMA CANADA ULC,ursodiol,URSODIOL,500MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2019-10-03,2019-10-03,2019-10-18,2019-10-22,Disruption of the manufacture of the drug.,2019-10-03,2019-10-23
30985,2426900,Shortage,URSODIOL TABLETS USP,GLENMARK PHARMACEUTICALS CANADA INC.,Ursodiol,URSODIOL,250MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017-11-29,2017-11-29,2017-12-15,2018-01-01,Demand increase for the drug.,2017-11-28,2018-01-02
30989,2426919,Shortage,URSODIOL TABLETS USP,GLENMARK PHARMACEUTICALS CANADA INC.,Ursodiol,URSODIOL,500MG,100,ORAL,Resolved,TABLET,A05AA,BILE THERAPY,2017-11-29,2017-11-29,2017-12-15,2018-01-01,Demand increase for the drug.,2017-11-28,2018-01-02
22147,2413639,Shortage,VAL-BACLOFEN INTRATHECAL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VAL-BACLOFEN INTRATHECAL,BACLOFEN,0.5MG,na,INTRATHECAL,Resolved,SOLUTION,M03BX,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",,2017-09-15,,2017-09-19,Other (Please describe in comments),2017-09-15,2017-09-20
12947,2405830,Shortage,VAL-VANCOMYCIN,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VAL-VANCOMYCIN,VANCOMYCIN,10G,na,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-06-15,2017-06-27,2017-08-16,Other (Please describe in comments),2017-06-16,2017-08-17
13162,2442000,Shortage,VALACYCLOVIR,SIVEM PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-06-05,2018-05-18,2018-05-18,Disruption of the manufacture of the drug.,2017-06-16,2018-05-19
13165,2442019,Shortage,VALACYCLOVIR,SIVEM PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2017-07-03,,2017-12-11,Disruption of the manufacture of the drug.,2017-06-16,2017-12-12
95652,2442000,Shortage,VALACYCLOVIR,SIVEM PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL,Actual shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2019-11-18,2019-11-13,,,Requirements related to complying with good manufacturing practices.,2019-10-07,2019-11-14
39080,2454645,Shortage,VALACYCLOVIR,SANIS HEALTH INC,VALACYCLOVIR CAPS,VALACYCLOVIR,500MG,100,ORAL,Resolved,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,,2018-02-08,2018-03-01,2018-02-21,Other (Please describe in comments),2018-02-08,2018-02-22
3272,177016,Shortage,VALISONE-G CREAM,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VALISONE-G CREAM,BETAMETHASONE  GENTAMICIN,0.1%  0.1%,30g,TOPICAL,Resolved,CREAM,D07CC,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2017-03-16,,2017-04-23,Other (Please describe in comments),2017-03-17,2017-04-24
55083,2366940,Shortage,VALSARTAN,SANIS HEALTH INC,VALSARTAN TAB,VALSARTAN,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55088,2366959,Shortage,VALSARTAN,SANIS HEALTH INC,VALSARTAN TAB,VALSARTAN,80MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55093,2366967,Shortage,VALSARTAN,SANIS HEALTH INC,VALSARTAN TAB,VALSARTAN,160MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55098,2366975,Shortage,VALSARTAN,SANIS HEALTH INC,VALSARTAN TAB,VALSARTAN,320MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-10
55139,2384523,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,40MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-10,2018-07-10,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-11
55149,2384531,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,80MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-10,2018-07-10,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-11
54894,2367726,Shortage,VALSARTAN,PRO DOC LIMITEE,VALSARTAN,VALSARTAN,40MG,30-100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Other (Please describe in comments),2018-07-10,2018-07-09
55152,2384531,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,80MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-10,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-11
54897,2367734,Shortage,VALSARTAN,PRO DOC LIMITEE,VALSARTAN,VALSARTAN,80MG,30-100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Other (Please describe in comments),2018-07-10,2018-07-09
55155,2384558,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,160MG,30,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-10,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-11
54900,2367742,Shortage,VALSARTAN,PRO DOC LIMITEE,VALSARTAN,VALSARTAN,160MG,30-100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Other (Please describe in comments),2018-07-10,2018-07-09
55158,2384558,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,160MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-10,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-11
54903,2367750,Shortage,VALSARTAN,PRO DOC LIMITEE,VALSARTAN,VALSARTAN,320MG,30-100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-09,,,Other (Please describe in comments),2018-07-10,2018-07-09
50553,2384523,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,40MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",2018-07-02,2018-07-10,,,Requirements related to complying with good manufacturing practices.,2018-05-28,2018-07-11
55161,2384566,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,320MG,30,ORAL,Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-10,,2018-12-28,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-12-29
55164,2384566,Shortage,VALSARTAN,SIVEM PHARMACEUTICALS ULC,VALSARTAN,VALSARTAN,320MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-07-10,,,Requirements related to complying with good manufacturing practices.,2018-07-10,2018-07-11
10019,2219492,Shortage,VALTREX,GLAXOSMITHKLINE INC,valacyclovir caplets,VALACYCLOVIR,500MG,30's,ORAL,Avoided shortage,TABLET,J05AB,DIRECT ACTING ANTIVIRALS,2017-06-26,,2017-07-18,2017-05-31,Disruption of the manufacture of the drug.,2017-05-11,2017-05-31
35868,2428733,Shortage,VAN-ALENDRONATE,VANC PHARMACEUTICALS INC,Alendronate,ALENDRONIC ACID,70MG,4,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-01-12,2018-01-12,,,Disruption of the manufacture of the drug.,2018-01-13,2018-01-15
45979,2428717,Shortage,VAN-ALENDRONATE,VANC PHARMACEUTICALS INC,Alendronate,,,28,,Actual shortage,,,,,2018-04-16,,,Other (Please describe in comments),2018-04-16,2018-08-17
45987,2428725,Shortage,VAN-ALENDRONATE,VANC PHARMACEUTICALS INC,Alendronate,ALENDRONIC ACID,10MG,28,ORAL,Actual shortage,TABLET,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
56524,2426994,Shortage,VAN-AMLODIPINE,VANC PHARMACEUTICALS INC,Amlodipine,AMLODIPINE,10MG,100,ORAL,Actual shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-07-31,,,Disruption of the manufacture of the drug.,2018-07-25,2018-08-01
50902,2426986,Shortage,VAN-AMLODIPINE,VANC PHARMACEUTICALS INC,Amlodipine,AMLODIPINE,5MG,100,ORAL,Actual shortage,TABLET,C08CA,SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.,,2018-05-31,,,Disruption of the manufacture of the drug.,2018-05-30,2018-06-01
46009,2427818,Shortage,VAN-ANASTROZOLE,VANC PHARMACEUTICALS INC,Anastrazole,ANASTROZOLE,1MG,100,ORAL,Actual shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46012,2428709,Shortage,VAN-BICALUTAMIDE,VANC PHARMACEUTICALS INC,Bicalutamide,BICALUTAMIDE,50MG,100,ORAL,Actual shortage,TABLET,L02BB,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46017,2426978,Shortage,VAN-CIPROFLOXACIN,VANC PHARMACEUTICALS INC,Ciprofloxacin,CIPROFLOXACIN,250MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46021,2427001,Shortage,VAN-CIPROFLOXACIN,VANC PHARMACEUTICALS INC,Ciprofloxacin,CIPROFLOXACIN,500MG,100,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46049,2427028,Shortage,VAN-CIPROFLOXACIN,VANC PHARMACEUTICALS INC,Ciprofloxacin,CIPROFLOXACIN,750MG,50,ORAL,Actual shortage,TABLET,J01MA,QUINOLONE ANTIBACTERIALS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46054,2438739,Shortage,VAN-CITALOPRAM,VANC PHARMACEUTICALS INC,Citalopram,CITALOPRAM,10MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46063,2438747,Shortage,VAN-CITALOPRAM,VANC PHARMACEUTICALS INC,Citalopram,CITALOPRAM,20MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46066,2438755,Shortage,VAN-CITALOPRAM,VANC PHARMACEUTICALS INC,Citalopram,CITALOPRAM,40MG,100,ORAL,Actual shortage,TABLET,N06AB,ANTIDEPRESSANTS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
47540,2426951,Shortage,VAN-DONEPEZIL,VANC PHARMACEUTICALS INC,Donepezil,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-04-30,,,Disruption of the manufacture of the drug.,2018-05-01,2018-04-30
46069,2426943,Shortage,VAN-DONEPEZIL,VANC PHARMACEUTICALS INC,Donepezil,DONEPEZIL HYDROCHLORIDE,5MG,100,ORAL,Actual shortage,TABLET,N06DA,ANTI-DEMENTIA DRUGS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
38620,2451271,Shortage,VAN-DORZOLAMIDE-TIMOLOL,VANC PHARMACEUTICALS INC,Dorzolamide-Timolol,TIMOLOL  DORZOLAMIDE,5MG  20MG,10,OPHTHALMIC,Actual shortage,SOLUTION,S01ED,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,,2017-10-31,,,Disruption of the manufacture of the drug.,2018-02-05,2018-02-05
46072,2428741,Shortage,VAN-FINASTERIDE,VANC PHARMACEUTICALS INC,Finasteride,FINASTERIDE,5MG,100,ORAL,Actual shortage,TABLET,G04CB,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
53113,2432412,Shortage,VAN-FLUOXETINE,VANC PHARMACEUTICALS INC,Fluoxetine,,,100,,Actual shortage,,,,2018-06-30,2018-06-30,,,Disruption of the manufacture of the drug.,2018-06-28,2018-07-01
50907,2432420,Shortage,VAN-FLUOXETINE,VANC PHARMACEUTICALS INC,Fluoxetine,FLUOXETINE,20MG,100,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-05-31,,,Disruption of the manufacture of the drug.,2018-05-30,2018-06-01
37469,2431424,Shortage,VAN-GABAPENTIN,VANC PHARMACEUTICALS INC,Gabapentin,GABAPENTIN,400MG,100,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2018-01-26,2018-01-26,,,Disruption of the manufacture of the drug.,2018-01-27,2018-01-26
37472,2431408,Shortage,VAN-GABAPENTIN,VANC PHARMACEUTICALS INC,Gabapentin,GABAPENTIN,100MG,100,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,2018-01-26,2018-01-26,,,Disruption of the manufacture of the drug.,2018-01-27,2018-01-26
46075,2431416,Shortage,VAN-GABAPENTIN,VANC PHARMACEUTICALS INC,Gabapentin,GABAPENTIN,300MG,100,ORAL,Actual shortage,CAPSULE,N03AX,ANTIEPILEPTICS,,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46604,2427095,Shortage,VAN-IRBESARTAN,VANC PHARMACEUTICALS INC,Irbesartan,IRBESARTAN,150MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-19
46607,2427087,Shortage,VAN-IRBESARTAN,VANC PHARMACEUTICALS INC,Irbesartan,IRBESARTAN,75MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-19,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-19
46610,2427109,Shortage,VAN-IRBESARTAN,VANC PHARMACEUTICALS INC,Irbesartan,IRBESARTAN,300MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-19,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-19
46613,2428156,Shortage,VAN-LETROZOLE,VANC PHARMACEUTICALS INC,Letrozole,LETROZOLE,2.5MG,100,ORAL,Actual shortage,TABLET,L02BG,HORMONE ANTAGONISTS AND RELATED AGENTS,,2018-04-19,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-19
46616,2426595,Shortage,VAN-LOSARTAN,VANC PHARMACEUTICALS INC,Losartan,LOSARTAN POTASSIUM,25MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-19,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-19
46619,2426609,Shortage,VAN-LOSARTAN,VANC PHARMACEUTICALS INC,Losartan,LOSARTAN POTASSIUM,50MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-19,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-19
46622,2426617,Shortage,VAN-LOSARTAN,VANC PHARMACEUTICALS INC,Losartan,LOSARTAN POTASSIUM,100MG,100,ORAL,Actual shortage,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2018-04-19,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-19
53116,2432625,Shortage,VAN-MYCOPHENOLATE,VANC PHARMACEUTICALS INC,Mycophenolate,MYCOPHENOLATE MOFETIL,500MG,50,ORAL,Actual shortage,TABLET,L04AA,IMMUNOSUPPRESSANTS,2018-06-30,2018-06-30,,,Disruption of the manufacture of the drug.,2018-06-28,2018-07-01
56527,2433680,Shortage,VAN-MYCOPHENOLATE,VANC PHARMACEUTICALS INC,Mycophenolate,MYCOPHENOLATE MOFETIL,250MG,100,ORAL,Actual shortage,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2018-07-31,,,Disruption of the manufacture of the drug.,2018-07-25,2018-08-01
46817,2428008,Shortage,VAN-OLANZAPINE,VANC PHARMACEUTICALS INC,Olanzapine,OLANZAPINE,2.5MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46820,2428016,Shortage,VAN-OLANZAPINE,VANC PHARMACEUTICALS INC,Olanzapine,OLANZAPINE,5.0MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46823,2428024,Shortage,VAN-OLANZAPINE,VANC PHARMACEUTICALS INC,Olanzapine,OLANZAPINE,7.5MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46826,2428032,Shortage,VAN-OLANZAPINE,VANC PHARMACEUTICALS INC,Olanzapine,OLANZAPINE,10MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46829,2428040,Shortage,VAN-OLANZAPINE,VANC PHARMACEUTICALS INC,Olanzapine,OLANZAPINE,15MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46832,2432404,Shortage,VAN-OMEPRAZOLE,VANC PHARMACEUTICALS INC,Omeprazole,OMEPRAZOLE,20MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
38616,2428164,Shortage,VAN-PANTOPRAZOLE,VANC PHARMACEUTICALS INC,Pantoprazole,PANTOPRAZOLE,40MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),A02BC,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-09-30,,,Disruption of the manufacture of the drug.,2018-02-05,2018-02-05
35871,2434156,Shortage,VAN-PIOGLITAZONE,VANC PHARMACEUTICALS INC,Pioglitazone,PIOGLITAZONE,45MG,90,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-01-12,2018-01-12,,,Disruption of the manufacture of the drug.,2018-01-13,2018-01-15
45815,2434121,Shortage,VAN-PIOGLITAZONE,VANC PHARMACEUTICALS INC,Pioglitazone,PIOGLITAZONE,15MG,90,ORAL,Actual shortage,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2018-04-09,2018-04-09,,,Delay in shipping of the drug.,2018-04-13,2018-08-17
47543,2434024,Shortage,VAN-QUETIAPINE,VANC PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,25MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-30,,,Disruption of the manufacture of the drug.,2018-05-01,2018-04-30
46835,2434032,Shortage,VAN-QUETIAPINE,VANC PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,100MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46838,2434040,Shortage,VAN-QUETIAPINE,VANC PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,200MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46841,2434059,Shortage,VAN-QUETIAPINE,VANC PHARMACEUTICALS INC,Quetiapine,QUETIAPINE,300MG,100,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46081,2438909,Shortage,VAN-RAMIPRIL,VANC PHARMACEUTICALS INC,Rampril,RAMIPRIL,15MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
35874,2438879,Shortage,VAN-RAMIPRIL,VANC PHARMACEUTICALS INC,Ramipril,RAMIPRIL,2.5MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-01-12,2018-01-12,,,Disruption of the manufacture of the drug.,2018-01-13,2018-01-15
35877,2438887,Shortage,VAN-RAMIPRIL,VANC PHARMACEUTICALS INC,Ramipril,RAMIPRIL,5MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-01-12,2018-01-12,,,Disruption of the manufacture of the drug.,2018-01-13,2018-01-15
35880,2438895,Shortage,VAN-RAMIPRIL,VANC PHARMACEUTICALS INC,Ramipril,RAMIPRIL,10MG,100,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",2018-01-12,2018-01-12,,,Disruption of the manufacture of the drug.,2018-01-13,2018-01-15
46078,2438860,Shortage,VAN-RAMIPRIL,VANC PHARMACEUTICALS INC,Ramipril,RAMIPRIL,1.25MG,30,ORAL,Actual shortage,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2018-04-16,,,Disruption of the manufacture of the drug.,2018-04-16,2018-04-17
46844,2428512,Shortage,VAN-RIZATRIPTAN,VANC PHARMACEUTICALS INC,Rizatriptan,RIZATRIPTAN,5MG,12,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46847,2428520,Shortage,VAN-RIZATRIPTAN,VANC PHARMACEUTICALS INC,Rizatriptan,RIZATRIPTAN,10MG,6,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
35883,2448505,Shortage,VAN-RIZATRIPTAN ODT,VANC PHARMACEUTICALS INC,Rizatriptan ODT,RIZATRIPTAN,10MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-01-12,2018-01-12,,,Disruption of the manufacture of the drug.,2018-01-13,2018-01-15
46850,2427761,Shortage,VAN-SERTRALINE,VANC PHARMACEUTICALS INC,Sertraline,SERTRALINE,25MG,100,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46853,2427788,Shortage,VAN-SERTRALINE,VANC PHARMACEUTICALS INC,Sertraline,SERTRALINE,50MG,100,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
46856,2427796,Shortage,VAN-SERTRALINE,VANC PHARMACEUTICALS INC,Sertraline,SERTRALINE,100MG,100,ORAL,Actual shortage,CAPSULE,N06AB,ANTIDEPRESSANTS,,2018-04-20,,,Disruption of the manufacture of the drug.,2018-04-20,2018-04-21
35886,2438763,Shortage,VAN-ZOLMITRIPTAN ODT,VANC PHARMACEUTICALS INC,Zolmitriptan ODT,ZOLMITRIPTAN,2.5MG,6,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-01-12,2018-01-12,,,Disruption of the manufacture of the drug.,2018-01-13,2018-01-15
39680,2342863,Shortage,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,STERIMAX INC,VANCOMYCIN HYDROCHLORIDE FOR INJECTION,VANCOMYCIN,1G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2018-02-13,2018-03-09,2018-04-11,Delay in shipping of the drug.,2018-02-13,2018-06-05
80082,2342863,Shortage,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,STERIMAX INC,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,VANCOMYCIN,1G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2019-03-29,,2019-04-26,2019-05-01,Delay in shipping of the drug.,2019-03-29,2019-05-21
70380,2342855,Shortage,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,STERIMAX INC,VANCOMYCIN HYDROCHLORIDE FOR INJECTION,VANCOMYCIN,500MG,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2018-12-21,2019-04-26,2019-05-02,Demand increase for the drug.,2018-12-21,2019-05-21
7168,2394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,Vancocyn,VANCOMYCIN,1G,10 x 1G vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-04-17,2017-04-28,2017-05-15,Requirements related to complying with good manufacturing practices.,2017-04-18,2017-05-17
64773,2230191,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",PFIZER CANADA INC,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,500MG,10 x 10mL GVL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2018-11-02,,2019-04-09,Disruption of the manufacture of the drug.,2018-10-18,2019-04-10
24841,2407930,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",VANCOMYCIN,5G,1VL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-10-04,,2018-06-07,Disruption of the manufacture of the drug.,2017-10-10,2018-06-08
50193,2394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,1G,10 VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2018-05-25,2018-05-28,2018-06-29,2018-06-29,Delay in shipping of the drug.,2018-05-24,2018-07-03
67608,2394642,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,5G,1 VIAL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2018-11-12,2019-01-21,2019-01-25,Demand increase for the drug.,2018-11-26,2019-01-30
42315,2378345,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",PFIZER CANADA INC,VANCOMYCIN,VANCOMYCIN,10G,1x10g GVL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2018-05-25,,2019-07-29,Disruption of the manufacture of the drug.,2018-03-08,2019-07-30
29772,2407922,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",VANCOMYCIN,1G,10VL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-11-17,,2018-06-07,Delay in shipping of the drug.,2017-11-20,2018-06-08
29777,2407914,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",MYLAN PHARMACEUTICALS ULC,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",VANCOMYCIN,500MG,10VL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-11-17,,2018-06-07,Delay in shipping of the drug.,2017-11-20,2018-06-08
31063,2394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,1G,10 X 1G VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-11-28,2017-12-22,2018-01-03,Requirements related to complying with good manufacturing practices.,2017-11-29,2018-01-08
31066,2394626,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,500MG,10 X 500MG VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-11-28,2017-12-22,2018-01-03,Requirements related to complying with good manufacturing practices.,2017-11-29,2018-01-08
56413,2230192,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",PFIZER CANADA INC,VANCOMYCIN,VANCOMYCIN,1000MG,10 x 20mL PVL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2018-10-12,,2019-06-26,Disruption of the manufacture of the drug.,2018-07-25,2019-06-27
15466,2394626,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,500MG,10VIALS,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2017-07-19,,2017-08-18,2017-08-18,Demand increase for the drug.,2017-07-11,2017-10-25
74902,2394642,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,5G,1 LYVI,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2019-03-11,2019-02-11,2019-09-30,2019-10-01,Demand increase for the drug.,2019-02-06,2019-10-15
10648,2378345,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,Vancomycin HCL,VANCOMYCIN,10G,1 x 10g,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2017-06-01,,,2017-10-20,Other (Please describe in comments),2017-05-18,2017-10-21
73886,2394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN HCl,VANCOMYCIN,1G,10 vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2018-12-17,2019-09-30,2019-10-01,Demand increase for the drug.,2019-01-30,2019-10-15
73890,2394626,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN HCl,VANCOMYCIN,500MG,10 vials,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2019-01-04,2019-09-30,2019-10-01,Demand increase for the drug.,2019-01-30,2019-10-15
14506,2230192,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,VANCOMYCIN,VANCOMYCIN,1000MG,10x1g  VIAL/AMPOULES,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-06-14,2017-09-22,2017-09-22,Disruption of the manufacture of the drug.,2017-07-03,2017-09-25
14789,2378337,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",HOSPIRA HEALTHCARE CORPORATION,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,5G,1x5g,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,,2017-09-06,,,Other (Please describe in comments),2017-07-05,2018-12-22
2539,2394650,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,10G,10g 1 fiole/vial,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,J01XA,OTHER ANTIBACTERIALS,2017-03-14,2017-03-17,,,Shortage of an active ingredient.,2017-03-14,2018-12-22
4358,2278383,Shortage,VANTAS,PALADIN LABS INC,HISTRELIN ACETATE,HISTRELIN ACETATE,50MG,1 vial,SUBCUTANEOUS,Actual shortage,IMPLANT  KIT,L02AE,HORMONES AND RELATED AGENTS,,2006-07-15,,,Other (Please describe in comments),2017-03-27,2017-10-13
6249,2229702,Shortage,VAQTA,MERCK CANADA INC,"hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,vial (fiole),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,,2017-06-19,2017-08-31,2017-08-02,Demand increase for the drug.,2017-04-10,2017-08-03
56191,2229702,Shortage,VAQTA,MERCK CANADA INC,"hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,50U/1ML 1DOSE VIAL,INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2018-07-30,2018-07-27,2019-12-31,2019-10-18,Demand increase for the drug.,2018-07-23,2019-10-21
37061,2229702,Shortage,VAQTA,MERCK CANADA INC,"hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,25U/0.5ML 1DOSE VIAL (PEDIATRIC),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2018-02-22,2018-02-23,2019-12-31,2019-10-17,Demand increase for the drug.,2018-01-24,2019-10-18
32720,2229702,Shortage,VAQTA,MERCK CANADA INC,"hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,50U/1ML 1DOSE VIAL (ADULT),INTRAMUSCULAR,Resolved,SUSPENSION,J07BC,VIRAL VACCINES,2018-02-02,2018-01-11,2018-03-26,2018-03-26,Delay in shipping of the drug.,2017-12-13,2018-03-27
82771,2241047,Shortage,VARILRIX,GLAXOSMITHKLINE INC,"Varicella virus vaccine, live, attenuated (Oka-strain)",WATER  VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED,0.5ML  2000UNIT,10's,SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,J07BK,VIRAL VACCINES,,2019-04-24,2019-07-12,2019-07-12,Other (Please describe in comments),2019-04-29,2019-07-13
71510,2444267,Shortage,VARITHENA,PROVENSIS LTD,Polidocanol 1% Injectable Foam,POLIDOCANOL,1.3MG,18ml,INTRAVENOUS,Actual shortage,FOAM,C05BB,,2019-02-01,2019-02-01,,,Other (Please describe in comments),2019-01-08,2019-02-02
30754,657298,Shortage,VASERETIC,MERCK CANADA INC,Enalapril and Hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  ENALAPRIL SODIUM,25MG  8MG,28,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017-12-08,2017-12-06,2017-12-20,2017-12-20,Delay in shipping of the drug.,2017-11-27,2017-12-21
75352,657298,Shortage,VASERETIC,MERCK CANADA INC,enalapril and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  ENALAPRIL SODIUM,25MG  8MG,pack of 28 tablets,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2019-02-25,2019-02-21,2019-03-20,2019-03-14,Demand increase for the drug.,2019-02-11,2019-03-15
10855,657298,Shortage,VASERETIC,MERCK CANADA INC,Enalapril and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE  ENALAPRIL SODIUM,25MG  8MG,28,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2017-06-05,2017-05-26,2017-06-09,2017-06-06,Delay in shipping of the drug.,2017-05-23,2017-06-07
79221,657298,Shortage,VASERETIC,MERCK CANADA INC,enalapril and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE  ENALAPRIL SODIUM,25MG  8MG,28,ORAL,Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",2019-04-25,2019-04-24,2019-04-29,2019-04-25,Delay in shipping of the drug.,2019-03-22,2019-04-26
3988,2139502,Shortage,VASOPRESSIN INJECTION,FRESENIUS KABI CANADA LTD,"Vasopressin Injection, USP 20 units/mL MD Vial 1 mL",VASOPRESSIN,20UNIT,1mL,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SOLUTION,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2017-02-16,2017-04-20,2017-04-20,Demand increase for the drug.,2017-03-22,2017-04-21
15469,2247938,Shortage,VASOPRESSIN INJECTION USP,SANDOZ CANADA INCORPORATED,VASOPRESSIN,VASOPRESSIN,20UNIT,5ML VIAL,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SOLUTION,H01BA,POSTERIOR PITUITARY LOBE HORMONES,2017-07-11,,2017-07-31,2017-07-28,Delay in shipping of the drug.,2017-07-11,2017-08-02
2530,2247938,Shortage,VASOPRESSIN INJECTION USP,SANDOZ CANADA INCORPORATED,VASOPRESSIN INJECTION USP,VASOPRESSIN,20UNIT,5mL fioles/vials,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,SOLUTION,H01BA,POSTERIOR PITUITARY LOBE HORMONES,,2016-11-07,2017-07-28,2017-07-03,Requirements related to complying with good manufacturing practices.,2017-03-14,2017-07-05
10860,670928,Shortage,VASOTEC,MERCK CANADA INC,Enalapril tablets,ENALAPRIL SODIUM,16MG,28,ORAL,Avoided shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2017-05-31,,2017-05-30,2017-05-30,Delay in shipping of the drug.,2017-05-23,2017-10-11
37557,708879,Shortage,VASOTEC,MERCK CANADA INC,Enalapril Tablets,ENALAPRIL SODIUM,4MG,28's,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2018-03-08,2018-03-08,2018-03-13,2018-03-09,Delay in shipping of the drug.,2018-01-29,2018-03-10
19917,708879,Shortage,VASOTEC,MERCK CANADA INC,Enalapril Tablets,ENALAPRIL SODIUM,4MG,28,ORAL,Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2017-08-17,2017-09-01,2017-08-31,Delay in shipping of the drug.,2017-08-21,2017-09-01
79328,670901,Shortage,VASOTEC,MERCK CANADA INC,enalapril tablets,ENALAPRIL SODIUM,8MG,28,ORAL,Avoided shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-08-26,,2019-12-17,2019-04-25,Shortage of an active ingredient.,2019-03-22,2019-04-25
79331,670928,Shortage,VASOTEC,MERCK CANADA INC,enalapril tablets,ENALAPRIL SODIUM,16MG,28,ORAL,Avoided shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-09-03,,2019-12-17,2019-04-25,Shortage of an active ingredient.,2019-03-22,2019-04-25
79334,708879,Shortage,VASOTEC,MERCK CANADA INC,enalapril tablets,ENALAPRIL SODIUM,4MG,28,ORAL,Avoided shortage,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2019-11-29,,2019-12-17,2019-04-25,Shortage of an active ingredient.,2019-03-22,2019-04-25
84255,2458039,Shortage,VENCLEXTA,ABBVIE CORPORATION,Venclexta,VENETOCLAX,10MG,2 unit dose blister,ORAL,Resolved,TABLET,L01XX,OTHER ANTINEOPLASTIC AGENTS,2019-05-14,,2019-08-01,2019-07-03,Demand increase for the drug.,2019-05-16,2019-07-04
84402,2458047,Shortage,VENCLEXTA,ABBVIE CORPORATION,Venclexta 50mg unit dose,VENETOCLAX,50MG,1 tablet blister,ORAL,Resolved,TABLET,L01XX,OTHER ANTINEOPLASTIC AGENTS,2019-05-14,2019-05-14,2019-08-08,2019-07-30,Demand increase for the drug.,2019-05-17,2019-07-31
84405,2458055,Shortage,VENCLEXTA,ABBVIE CORPORATION,Venclexta 100mg unit dose,VENETOCLAX,100MG,1 tablet blister,ORAL,Resolved,TABLET,L01XX,OTHER ANTINEOPLASTIC AGENTS,2019-05-14,2019-05-14,2019-08-01,2019-07-29,Demand increase for the drug.,2019-05-17,2019-07-31
84408,2458063,Shortage,VENCLEXTA,ABBVIE CORPORATION,Venclexta Start pack,VENETOCLAX  VENETOCLAX  VENETOCLAX,10MG  100MG  50MG,4x7day wallet,ORAL,Resolved,KIT  TABLET,L01XX,OTHER ANTINEOPLASTIC AGENTS,2019-05-14,2019-05-14,2019-09-18,2019-09-18,Demand increase for the drug.,2019-05-17,2019-09-19
82182,2339242,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-04-19,2019-06-19,2019-06-18,Delay in shipping of the drug.,2019-04-23,2019-06-19
44039,2385945,Shortage,VENLAFAXINE XR,SIVEM PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-05-07,2018-05-10,,2018-07-02,Other (Please describe in comments),2018-03-26,2018-07-31
98056,2339242,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE,VENLAFAXINE,37.5MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-11-01,2019-11-30,,Delay in shipping of the drug.,2019-11-06,2019-11-06
87571,2354748,Shortage,VENLAFAXINE XR,SANIS HEALTH INC,VENLAFAXINE,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-06-27,2019-07-10,2019-07-05,Disruption of the manufacture of the drug.,2019-06-27,2019-07-06
6676,2339250,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,75MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-04-12,,2017-06-05,Delay in shipping of the drug.,2017-04-12,2017-06-06
49428,2385937,Shortage,VENLAFAXINE XR,SIVEM PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,75MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-06-04,2018-06-05,2018-06-29,2018-07-02,Other (Please describe in comments),2018-05-15,2018-07-31
79895,2339269,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-03-29,,2019-04-02,Delay in shipping of the drug.,2019-03-29,2019-04-03
72253,2354713,Shortage,VENLAFAXINE XR,SANIS HEALTH INC,VENLAFAXINE CAPSULE,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2019-01-19,2019-01-17,2019-02-15,2019-02-12,Other (Please describe in comments),2019-01-15,2019-02-13
6996,2339242,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100-500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-05-09,,2017-07-06,Delay in shipping of the drug.,2017-04-13,2017-07-07
7002,2339269,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,150MG,100-500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2017-05-31,,2017-05-31,Delay in shipping of the drug.,2017-04-13,2018-01-04
36457,2385929,Shortage,VENLAFAXINE XR,SIVEM PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-01-04,,2018-07-02,Requirements related to complying with good manufacturing practices.,2018-01-18,2018-07-31
45938,2385945,Shortage,VENLAFAXINE XR,SIVEM PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2018-05-07,2018-05-11,,2018-07-02,Other (Please describe in comments),2018-04-16,2018-07-31
93859,2354713,Shortage,VENLAFAXINE XR,SANIS HEALTH INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2019-09-23,2019-09-27,2019-11-15,2019-11-13,Disruption of the manufacture of the drug.,2019-09-13,2019-11-14
72114,2385945,Shortage,VENLAFAXINE XR,SIVEM PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2019-03-04,2019-02-26,2019-06-07,2019-06-07,Demand increase for the drug.,2019-01-14,2019-06-08
64701,2339269,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-10-18,,2018-11-28,Delay in shipping of the drug.,2018-10-18,2018-11-29
64704,2339269,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-10-18,,2018-11-28,Delay in shipping of the drug.,2018-10-18,2018-11-29
85698,2339250,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,75MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-06-06,2019-10-10,2019-10-09,Delay in shipping of the drug.,2019-06-06,2019-10-10
78280,2385945,Shortage,VENLAFAXINE XR,SIVEM PHARMACEUTICALS ULC,VENLAFAXINE XR,VENLAFAXINE,150MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,2019-04-26,2019-04-26,2019-06-07,2019-06-07,Demand increase for the drug.,2019-03-11,2019-06-08
74960,2339269,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE XR,VENLAFAXINE,150MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-06,,2019-03-21,Demand increase for the drug.,2019-02-06,2019-03-22
58066,2339242,Shortage,VENLAFAXINE XR,PRO DOC LIMITEE,VENLAFAXINE,VENLAFAXINE,37.5MG,100,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-08-14,2018-10-24,2018-10-18,Delay in shipping of the drug.,2018-08-14,2018-10-19
67303,2354748,Shortage,VENLAFAXINE XR,SANIS HEALTH INC,VENLAFAXINE XR,VENLAFAXINE,150MG,"100, 500",ORAL,Resolved,CAPSULE (EXTENDED RELEASE),N06AX,ANTIDEPRESSANTS,,2018-11-21,2019-02-15,2019-02-12,Disruption of the manufacture of the drug.,2018-11-21,2019-02-13
74002,2243115,Shortage,VENTOLIN DISKUS,GLAXOSMITHKLINE INC,salbutamol sulfate dry powder for inhalation,SALBUTAMOL,200MCG,1x60,INHALATION,Resolved,POWDER,R03AC,"ADRENERGICS, INHALANTS",,2019-01-25,2019-02-15,2019-02-06,Delay in shipping of the drug.,2019-01-30,2019-02-08
16556,2243115,Shortage,VENTOLIN DISKUS,GLAXOSMITHKLINE INC,salbutamol sulfate dry powder for inhalation,SALBUTAMOL,200MCG,1x60 doses,INHALATION,Resolved,POWDER,R03AC,"ADRENERGICS, INHALANTS",,2017-08-08,2017-08-25,2017-08-16,Delay in shipping of the drug.,2017-07-20,2017-08-16
24661,2213451,Shortage,VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML),GLAXOSMITHKLINE INC,salbutamol sulfate for injection,SALBUTAMOL,1MG,5 x 5mL,INTRAVENOUS,Resolved,SOLUTION,R03CC,ADRENERGICS FOR SYSTEMIC USE,,2017-10-03,2017-11-17,2017-11-14,Demand increase for the drug.,2017-10-06,2017-11-16
2740,2213419,Shortage,VENTOLIN NEBULES P.F. - 2.5MG/2.5ML,GLAXOSMITHKLINE INC,Salbutamol sulfate solution,SALBUTAMOL,2.5MG,20's,INHALATION,Resolved,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2016-12-08,,2017-03-21,Demand increase for the drug.,2017-03-14,2017-03-22
26397,2213486,Shortage,VENTOLIN RESPIRATOR SOLUTION,GLAXOSMITHKLINE INC,salbutamol sulfate solution,SALBUTAMOL,5MG,10ML,INHALATION,Avoided shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",2017-11-30,,2017-11-30,2017-11-28,Demand increase for the drug.,2017-10-19,2017-11-29
71271,2213486,Shortage,VENTOLIN RESPIRATOR SOLUTION,GLAXOSMITHKLINE INC,salbutamol sulfate solution,SALBUTAMOL,5MG,10ML,INHALATION,Resolved,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2019-01-02,2019-01-18,2019-01-17,Demand increase for the drug.,2019-01-04,2019-01-18
98963,2213486,Shortage,VENTOLIN RESPIRATOR SOLUTION,GLAXOSMITHKLINE INC,salbutamol sulfate solution,SALBUTAMOL,5MG,10s,INHALATION,Anticipated shortage,SOLUTION,R03AC,"ADRENERGICS, INHALANTS",2019-12-06,,2020-01-31,,Disruption of the manufacture of the drug.,2019-11-15,2019-11-15
70228,616192,Shortage,VEPESID,BRISTOL-MYERS SQUIBB CANADA,Etoposide,ETOPOSIDE,50MG,1 BTL x 20,ORAL,Resolved,CAPSULE,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2019-07-01,,2019-07-01,2019-07-01,Delay in shipping of the drug.,2018-12-20,2019-07-05
49573,616192,Shortage,VEPESID,BRISTOL-MYERS SQUIBB CANADA,Etoposide,ETOPOSIDE,50MG,1 BTL x 20,ORAL,Avoided shortage,CAPSULE,L01CB,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2018-12-18,2018-12-20,2018-12-28,2018-12-19,Delay in shipping of the drug.,2018-05-16,2018-12-20
71598,839299,Shortage,VERAPAMIL HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,2.5MG,5 x 2 mL,INTRAVENOUS,Actual shortage,SOLUTION,C08DA,SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF,,2019-02-06,,,Disruption of the manufacture of the drug.,2019-01-08,2019-08-28
71304,2411849,Shortage,VEREGEN,PALADIN LABS INC,Sinecatechins,Sinecatechins,10%,15g,TOPICAL,Resolved,OINTMENT,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2019-01-04,2019-01-30,2019-02-15,Delay in shipping of the drug.,2019-01-04,2019-02-16
72891,2279991,Shortage,VFEND,PFIZER CANADA ULC,VFEND,VORICONAZOLE,3G,BTL 70ml,ORAL,Resolved,POWDER FOR SUSPENSION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2019-01-25,,2019-05-13,Disruption of the manufacture of the drug.,2019-01-18,2019-07-03
10074,2256487,Shortage,VFEND FOR INJECTION,PFIZER CANADA INC,VFEND,VORICONAZOLE,200MG,each,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,2017-05-31,,2017-08-18,2017-08-18,Disruption of the manufacture of the drug.,2017-05-11,2017-08-19
89533,2256487,Shortage,VFEND FOR INJECTION,PFIZER CANADA ULC,VFEND FOR INJECTION,VORICONAZOLE,200MG,Each,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2019-07-17,,2019-09-30,Disruption of the manufacture of the drug.,2019-07-17,2019-10-01
79152,2451557,Shortage,VIACORAM,SERVIER CANADA INC,viacoram,AMLODIPINE  PERINDOPRIL ARGININE,10MG  14MG,30,ORAL,Resolved,TABLET,C09BB,"ACE INHIBITORS, COMBINATIONS",,2019-03-18,2019-03-31,2019-04-11,Delay in shipping of the drug.,2019-03-21,2019-04-12
83030,2451557,Shortage,VIACORAM,SERVIER CANADA INC,Viacoram,AMLODIPINE  PERINDOPRIL ARGININE,10MG  14MG,30,ORAL,Resolved,TABLET,C09BB,"ACE INHIBITORS, COMBINATIONS",,2019-04-30,2019-05-10,2019-05-07,Delay in shipping of the drug.,2019-05-03,2019-05-08
84334,2451549,Shortage,VIACORAM,SERVIER CANADA INC,Viacoram,AMLODIPINE  PERINDOPRIL ARGININE,5MG  7MG,30,ORAL,Resolved,TABLET,C09BB,"ACE INHIBITORS, COMBINATIONS",,2019-05-13,2019-05-31,2019-06-20,Delay in shipping of the drug.,2019-05-17,2019-06-21
97836,717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC CRM,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,15 g,TOPICAL,Actual shortage,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-10-22,2019-12-20,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-08
97839,717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC CRM,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,30 g,TOPICAL,Actual shortage,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-10-22,2019-12-20,,Disruption of the manufacture of the drug.,2019-11-01,2019-11-08
88692,717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC CRM,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,15g,TOPICAL,Resolved,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-07-04,2019-08-09,2019-07-31,Disruption of the manufacture of the drug.,2019-07-05,2019-08-06
88695,717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC CRM,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,30 g,TOPICAL,Resolved,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-06-27,2019-08-09,2019-08-01,Disruption of the manufacture of the drug.,2019-07-05,2019-08-06
91817,717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC CRM,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,30 g,TOPICAL,Resolved,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-08-14,2019-09-30,2019-09-13,Disruption of the manufacture of the drug.,2019-08-19,2019-09-14
93898,717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC CRM,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,15 g,TOPICAL,Resolved,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-09-12,2019-09-27,2019-09-20,Disruption of the manufacture of the drug.,2019-09-13,2019-09-23
93901,717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC CRM,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,454 g,TOPICAL,Resolved,CREAM,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-09-09,2019-09-27,2019-09-20,Disruption of the manufacture of the drug.,2019-09-13,2019-09-23
95540,717029,Shortage,VIADERM KC ONT,TARO PHARMACEUTICALS INC,VIADERM KC ONT,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,30 g,TOPICAL,Actual shortage,OINTMENT,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-09-19,2019-11-27,,Disruption of the manufacture of the drug.,2019-10-04,2019-11-08
89689,717029,Shortage,VIADERM KC ONT,TARO PHARMACEUTICALS INC,VIADERM KC ONT,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,15 g,TOPICAL,Resolved,OINTMENT,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",2019-07-15,,2019-08-09,2019-08-09,Disruption of the manufacture of the drug.,2019-07-19,2019-08-19
7883,717029,Shortage,VIADERM KC ONT,TARO PHARMACEUTICALS INC,VIADERM K.C OINTMENT,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,15 GRAM,TOPICAL,Resolved,OINTMENT,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2017-04-24,2017-04-28,2017-04-28,Disruption of the manufacture of the drug.,2017-04-25,2017-04-29
7886,717029,Shortage,VIADERM KC ONT,TARO PHARMACEUTICALS INC,VIADERM K.C. OINT,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,30 GRAM,TOPICAL,Resolved,OINTMENT,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2017-04-24,2017-04-28,2017-04-28,Disruption of the manufacture of the drug.,2017-04-25,2017-04-29
81623,717029,Shortage,VIADERM KC ONT,TARO PHARMACEUTICALS INC,VIADERM KC ONT,TRIAMCINOLONE ACETONIDE  NYSTATIN  GRAMICIDIN  NEOMYCIN,1MG  100000UNIT  0.25MG  2.5MG,30 g,TOPICAL,Resolved,OINTMENT,D07CB,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-04-09,2019-05-10,2019-05-03,Disruption of the manufacture of the drug.,2019-04-15,2019-05-04
45110,2239767,Shortage,VIAGRA,PFIZER CANADA INC,VIAGRA,SILDENAFIL,50MG,4's,ORAL,Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2018-04-05,,2018-04-23,Disruption of the manufacture of the drug.,2018-04-06,2018-04-24
11840,2244598,Shortage,VIDEX EC,BRISTOL-MYERS SQUIBB CANADA,Didanosine,DIDANOSINE,250MG,1 BTL X 30,ORAL,Avoided shortage,CAPSULE (ENTERIC-COATED),J05AF,DIRECT ACTING ANTIVIRALS,2017-07-10,,,2017-07-04,Demand increase for the drug.,2017-06-05,2017-07-04
72680,2252260,Shortage,VIGAMOX,NOVARTIS PHARMACEUTICALS CANADA INC,VIGAMOX 0.5% SOLN 3ML,MOXIFLOXACIN,0.5%,3ML,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,2019-01-16,2019-01-16,2019-03-25,2019-03-22,Delay in shipping of the drug.,2019-01-16,2019-03-26
84782,2443732,Shortage,VIIBRYD,ALLERGAN INC,VIIBRYD 20MG TAB 30 CA,VILAZODONE HYDROCHLORIDE,20MG,VIIBRYD 20MG TAB 30 CA,ORAL,Resolved,TABLET,N06AX,,2019-05-24,2019-05-24,2019-06-05,2019-06-06,Other (Please describe in comments),2019-05-25,2019-06-07
77159,2443724,Shortage,VIIBRYD,ALLERGAN INC,VIIBRYD 10MG TAB 30 CA,VILAZODONE HYDROCHLORIDE,10MG,10MG TAB 30 CA,ORAL,Resolved,TABLET,N06AX,,2019-03-18,2019-03-29,2019-05-13,2019-05-13,Demand increase for the drug.,2019-02-28,2019-05-14
72342,2443732,Shortage,VIIBRYD,FOREST LABORATORIES CANADA INC,VIIBRYD 20MG TAB  30 CA,VILAZODONE HYDROCHLORIDE,20MG,20MG TAB  30 CA,ORAL,Resolved,TABLET,N06AX,,2019-01-25,2019-01-25,2019-05-06,2019-05-08,Demand increase for the drug.,2019-01-15,2019-05-09
72344,2443724,Shortage,VIIBRYD,FOREST LABORATORIES CANADA INC,VIIBRYD 10MG TAB 30 CA,VILAZODONE HYDROCHLORIDE,10MG,10MG TAB 30 CA,ORAL,Resolved,TABLET,N06AX,,2019-01-25,2019-01-25,2019-02-28,2019-02-27,Demand increase for the drug.,2019-01-15,2019-02-28
82479,2357666,Shortage,VIMPAT,UCB CANADA INC,VIMPAT IV 10mg/mL,LACOSAMIDE,10MG,5 x 20mL vials/carton,INTRAVENOUS,Resolved,SOLUTION,N03AX,ANTIEPILEPTICS,2019-05-15,2019-05-20,2019-06-17,2019-06-21,Demand increase for the drug.,2019-04-26,2019-06-26
92198,2401460,Shortage,VINBLASTINE SULPHATE INJECTION,TEVA CANADA LIMITED,VINBLASTINE,VINBLASTINE SULFATE,1MG,10ML,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2019-08-22,2019-10-31,2019-10-09,Disruption of the manufacture of the drug.,2019-08-22,2019-10-10
98185,2401460,Shortage,VINBLASTINE SULPHATE INJECTION,TEVA CANADA LIMITED,VINBLASTINE SULFATE INJECTION,VINBLASTINE SULFATE,1MG,10ml,INTRAVENOUS,Actual shortage,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2019-11-06,2020-01-31,,Disruption of the manufacture of the drug.,2019-11-07,2019-11-14
98179,2143305,Shortage,VINCRISTINE SULFATE INJECTION,TEVA CANADA LIMITED,VINCRISTINE INJECTION 1MG/ML,VINCRISTINE SULFATE,1MG,5ML,INTRAVENOUS,Actual shortage,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2019-11-06,2020-01-31,,Disruption of the manufacture of the drug.,2019-11-07,2019-11-07
33098,2265990,Shortage,VINORELBINE INJECTION,FRESENIUS KABI CANADA LTD,"Vinorelbine Injection, USP 10 mg/mL",VINORELBINE,10MG,5mL SD Vial,INTRAVENOUS,Actual shortage,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017-12-14,,,,Disruption of the manufacture of the drug.,2017-12-15,2018-02-12
33103,2265990,Shortage,VINORELBINE INJECTION,FRESENIUS KABI CANADA LTD,"Vinorelbine Injection, USP 10 mg/mL",VINORELBINE,10MG,1mL SD Vial,INTRAVENOUS,Actual shortage,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017-12-14,,,,Disruption of the manufacture of the drug.,2017-12-15,2018-02-12
11676,2265990,Shortage,VINORELBINE INJECTION,FRESENIUS KABI CANADA LTD,VINORELBINE INJECTION,VINORELBINE,10MG,5mL,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017-06-19,,2017-07-14,2017-07-10,Delay in shipping of the drug.,2017-06-01,2017-07-11
73634,2431130,Shortage,"VINORELBINE INJECTION, USP",GENERIC MEDICAL PARTNERS INC,10 mg/ml Vinorelbine (as vinorelbine tartrate),VINORELBINE,10MG,5 ML IN CLEAR GLASS VIAL,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2019-02-25,,2019-03-14,2019-03-14,Delay in shipping of the drug.,2019-01-25,2019-03-15
35007,2431130,Shortage,"VINORELBINE INJECTION, USP",GENERIC MEDICAL PARTNERS INC,10 mg/ml Vinorelbine (as vinorelbine tartrate),VINORELBINE,10MG,5ml in clear glass vial,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-12-06,,2018-08-01,Disruption of the manufacture of the drug.,2018-01-05,2018-08-09
89588,2431130,Shortage,"VINORELBINE INJECTION, USP",GENERIC MEDICAL PARTNERS INC,Vinorelbine for Injection,VINORELBINE,10MG,5 ml Vial. Each pack contains one vial.,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2019-07-01,2019-07-01,2019-10-01,2019-10-10,Demand increase for the drug.,2019-07-18,2019-10-11
14599,2257777,Shortage,VINORELBINE TARTRATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,VINORELBINE,VINORELBINE,10MG,1x5 ml,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2017-07-07,,2017-10-18,2017-10-17,Disruption of the manufacture of the drug.,2017-07-04,2017-10-18
17779,2271214,Shortage,VINORELBINE TARTRATE FOR INJECTION,TEVA CANADA LIMITED,VINORELBINE,VINORELBINE,10MG,5ML,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-07-30,2018-04-30,2018-05-01,Shortage of an active ingredient.,2017-08-01,2018-05-08
17556,2257777,Shortage,VINORELBINE TARTRATE FOR INJECTION,HOSPIRA HEALTHCARE CORPORATION,Vinorelbine,VINORELBINE,10MG,1x1mL,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,,2017-10-18,,2018-08-14,Other (Please describe in comments),2017-07-31,2018-08-15
31951,2257777,Shortage,VINORELBINE TARTRATE FOR INJECTION,PFIZER CANADA INC,VINORELBINE,VINORELBINE,10MG,1x5mL,INTRAVENOUS,Resolved,SOLUTION,L01CA,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,2018-06-15,,,2018-08-14,Other (Please describe in comments),2017-12-06,2018-08-15
95220,74500,Shortage,VIOFORM HYDROCORTISONE,PALADIN LABS INC,Vioform Hydrocortisone Cream,HYDROCORTISONE  CLIOQUINOL,1%  3%,30g cream,TOPICAL,Actual shortage,CREAM,D07CA,"CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",,2019-10-02,,,Delay in shipping of the drug.,2019-10-02,2019-10-03
73777,2230019,Shortage,VIOKACE,APTALIS PHARMA CANADA ULC,Viokace,AMYLASE  PROTEASE  LIPASE,56400UNIT  57100UNIT  10440UNIT,100's count bottle,ORAL,Avoided shortage,TABLET,A09AA,"DIGESTIVES, INCL ENZYMES",2019-02-15,,2019-04-19,2019-01-29,Other (Please describe in comments),2019-01-29,2019-01-29
73800,2241933,Shortage,VIOKACE,APTALIS PHARMA CANADA ULC,VIOKACE 20880,AMYLASE  PROTEASE  LIPASE,113400UNIT  112500UNIT  20880UNIT,100's count bottle,ORAL,Resolved,TABLET,A09AA,"DIGESTIVES, INCL ENZYMES",2019-03-08,2019-03-05,2019-06-21,2019-05-31,Other (Please describe in comments),2019-01-29,2019-06-01
62330,2241933,Shortage,VIOKACE,APTALIS PHARMA CANADA ULC,Viokace,AMYLASE  PROTEASE  LIPASE,113400UNIT  112500UNIT  20880UNIT,100 count bottle,ORAL,Avoided shortage,TABLET,A09AA,"DIGESTIVES, INCL ENZYMES",,2018-08-27,2018-10-12,2016-10-05,Other (Please describe in comments),2018-09-25,2018-10-09
87801,2230019,Shortage,VIOKACE,APTALIS PHARMA CANADA ULC,Viokace 10440,AMYLASE  PROTEASE  LIPASE,56400UNIT  57100UNIT  10440UNIT,100's bottle,ORAL,Resolved,TABLET,A09AA,"DIGESTIVES, INCL ENZYMES",2019-07-12,2019-07-12,2019-08-16,2019-08-12,Demand increase for the drug.,2019-06-28,2019-08-13
59608,2248761,Shortage,VIRACEPT,PFIZER CANADA INC,Viracept -625MG,NELFINAVIR,625MG,1x120 BTL,ORAL,Resolved,TABLET,J05AE,DIRECT ACTING ANTIVIRALS,,2018-08-27,2019-07-19,2019-07-16,Disruption of the manufacture of the drug.,2018-08-30,2019-07-17
56141,2238617,Shortage,VIRACEPT -250MG,PFIZER CANADA INC,Viracept,NELFINAVIR,250MG,1 x 300's,ORAL,Resolved,TABLET,J05AE,DIRECT ACTING ANTIVIRALS,,2018-07-17,,2018-09-07,Demand increase for the drug.,2018-07-20,2018-09-10
65178,2238617,Shortage,VIRACEPT -250MG,PFIZER CANADA INC,Viracept,NELFINAVIR,250MG,1x300 BTL,ORAL,Resolved,TABLET,J05AE,DIRECT ACTING ANTIVIRALS,2019-05-31,2019-05-31,2019-07-05,2019-07-05,Disruption of the manufacture of the drug.,2018-10-22,2019-07-06
71268,2367289,Shortage,VIRAMUNE XR,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Viramune,NEVIRAPINE,400MG,30's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),J05AG,DIRECT ACTING ANTIVIRALS,,2019-01-02,,2019-08-21,Other (Please describe in comments),2019-01-04,2019-08-22
5969,687456,Shortage,VIROPTIC,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VIROPTIC,TRIFLURIDINE,1%,OPHTHALMIC,OPHTHALMIC,Actual shortage,SOLUTION,S01AD,ANTIINFECTIVES,2017-06-14,,,,Shortage of an active ingredient.,2017-04-07,2019-06-27
12940,687456,Shortage,VIROPTIC,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VIROPTIC,TRIFLURIDINE,1%,na,OPHTHALMIC,Resolved,SOLUTION,S01AD,ANTIINFECTIVES,,2017-06-14,,2017-10-24,Other (Please describe in comments),2017-06-16,2017-10-25
66580,1926462,Shortage,VITAMIN A ACID 0.01% GEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VITAMIN A ACID 0.01% GEL,TRETINOIN,0.01%,25g,TOPICAL,Resolved,GEL,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,,2018-10-29,,2019-03-05,Other (Please describe in comments),2018-11-09,2019-03-06
85834,1926470,Shortage,VITAMIN A ACID 0.025% GEL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VITAMIN A ACID 0.025% GEL,TRETINOIN,0.025%,25g,TOPICAL,Resolved,GEL,D10AD,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,2019-06-08,,,2019-06-10,Other (Please describe in comments),2019-06-07,2019-06-12
33333,521515,Shortage,VITAMIN B12,SANDOZ CANADA INCORPORATED,CYANOCOBALAMIN,VITAMIN B12,1MG,30ML VIAL,INTRAMUSCULAR  SUBCUTANEOUS,Resolved,LIQUID,B03BA,VITAMIN B12 AND FOLIC ACID,,2017-11-29,2018-01-31,2018-02-02,Delay in shipping of the drug.,2017-12-16,2018-02-05
27102,2245214,Shortage,VITAMIN C,MYLAN PHARMACEUTICALS ULC,VITAMIN C,VITAMIN C,500MG,50ML 1 VIAL,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,SOLUTION,A11GA,"ASCORBIC ACID (VIT C), INCL COMBINATIONS",2018-05-16,2018-05-04,2018-07-27,2018-07-20,Delay in shipping of the drug.,2017-10-26,2018-07-21
54014,804312,Shortage,VITAMIN K1 INJ 10MG/ML USP,SANDOZ CANADA INCORPORATED,VITAMIN K1 10MG/ML,VITAMIN K1,10MG,10 x 10mL vials,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,EMULSION,B02BA,VITAMIN K AND OTHER HEMOSTATICS,,2018-07-09,2018-12-07,2018-11-26,Delay in shipping of the drug.,2018-07-03,2018-11-27
54011,781878,Shortage,VITAMIN K1 INJ 1MG/0.5ML USP,SANDOZ CANADA INCORPORATED,VITAMIN K1 2MG/ML,VITAMIN K1,2MG,10 x 0.5mL amps,INTRAMUSCULAR  INTRAVENOUS  SUBCUTANEOUS,Resolved,EMULSION,B02BA,VITAMIN K AND OTHER HEMOSTATICS,,2018-07-09,2018-12-07,2018-11-26,Delay in shipping of the drug.,2018-07-03,2018-11-27
1300,2248361,Shortage,VIVAXIM,SANOFI PASTEUR LIMITED,Combined purified Vi polysaccharide typhoid and inactivated hepatitis A vaccine,"SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE  HEPATITIS A VACCINE, INACTIVATED",25MCG  160UNIT,"1 x 1.0 mL (single dose) dual chamber syringe / 1 seringue (dose unique) à double compartiment de 1,0 mL",INTRAMUSCULAR,Resolved,SOLUTION  SUSPENSION,J07CA,"BACTERIAL AND VIRAL VACCINES, COMBINED",2016-11-16,2016-11-16,2019-01-31,2019-09-05,Disruption of the manufacture of the drug.,2017-03-13,2019-09-06
29497,885975,Shortage,VIVOTIF,PAXVAX BERNA GMBH,Typhoid vaccine live oral attenuated Ty21a vaccine,TYPHOID VACCINE,10B,Single foil blister with 4 enteric-coated capsules,ORAL,Resolved,CAPSULE (ENTERIC-COATED),J07AP,BACTERIAL VACCINES,,2017-11-17,2017-12-22,2017-12-11,Demand increase for the drug.,2017-11-17,2017-12-12
39083,885975,Shortage,VIVOTIF,PAXVAX BERNA GMBH,Typhoid vaccine live oral attenuated Ty21a vaccine,TYPHOID VACCINE,10B,Single foil blister with 4 enteric-coated capsules,ORAL,Resolved,CAPSULE (ENTERIC-COATED),J07AP,BACTERIAL VACCINES,2018-02-15,,2018-02-22,2018-02-16,Demand increase for the drug.,2018-02-08,2018-02-17
31276,1940414,Shortage,VOLTAREN OPHTHA,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN,DICLOFENAC SODIUM,0.1%,2 X 5ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2017-12-04,2017-12-11,2018-01-30,2018-01-17,Disruption of the manufacture of the drug.,2017-11-30,2018-01-18
71606,1940414,Shortage,VOLTAREN OPHTHA,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN OPH 0.1.% SOLN 2x5ML,DICLOFENAC SODIUM,0.1%,2 x 5 ml,OPHTHALMIC,Avoided shortage,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2019-04-30,,2019-05-01,2019-04-29,Delay in shipping of the drug.,2019-01-08,2019-04-29
44015,1940414,Shortage,VOLTAREN OPHTHA,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN OPH 0.1.% SOLN 2x5ML,DICLOFENAC SODIUM,0.1%,2 X 5 ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2018-04-27,2018-05-04,2018-12-10,2018-12-10,Delay in shipping of the drug.,2018-03-26,2018-12-11
44018,1940414,Shortage,VOLTAREN OPHTHA,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN oph 0.1% SOLN 5ML,DICLOFENAC SODIUM,0.1%,5 ML,OPHTHALMIC,Resolved,SOLUTION,S01BC,ANTIINFLAMMATORY AGENTS,2018-04-30,2018-05-04,2018-06-25,2018-06-21,Delay in shipping of the drug.,2018-03-26,2018-06-22
39940,881635,Shortage,VOLTAREN RAPIDE TABLETS 50MG,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN RAPIDE TABLETS 50MG,DICLOFENAC POTASSIUM,50MG,100'S,ORAL,Resolved,TABLET,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2018-03-07,2018-03-21,2018-05-25,2018-05-10,Delay in shipping of the drug.,2018-02-15,2018-05-11
38004,2278057,Shortage,VOLUVEN,FRESENIUS KABI CANADA LTD,Voluven,HYDROXYETHYL STARCH 130/0.4,6%,250 mL Bag,INTRAVENOUS,Resolved,SOLUTION,B05AA,BLOOD AND RELATED PRODUCTS,2018-02-01,,2018-03-01,2018-03-05,Demand increase for the drug.,2018-02-01,2018-03-06
80984,2381966,Shortage,VORICONAZOLE FOR INJECTION,SANDOZ CANADA INCORPORATED,VORICONAZOLE,VORICONAZOLE,200MG,1 vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J02AC,ANTIMYCOTICS FOR SYSTEMIC USE,,2019-04-01,2019-07-19,2019-07-16,Demand increase for the drug.,2019-04-10,2019-07-24
52708,2365561,Shortage,VYLOMA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,VYLOMA,IMIQUIMOD,3.75%,7.5g pump,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2019-01-31,,2019-07-12,Other (Please describe in comments),2018-06-20,2019-07-13
96759,2365561,Shortage,VYLOMA,"BAUSCH HEALTH, CANADA INC.",VYLOMA,IMIQUIMOD,3.75%,7.5g,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2019-10-10,,2019-11-06,Shortage of an active ingredient.,2019-10-17,2019-11-08
51253,2458071,Shortage,VYVANSE,SHIRE PHARMA CANADA ULC,Lisdexamfetamine Dimesylate capsules,LISDEXAMFETAMINE DIMESYLATE,70MG,100's,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2018-06-06,,2018-06-13,2018-06-12,Demand increase for the drug.,2018-06-04,2018-06-13
5797,2439603,Shortage,VYVANSE,SHIRE PHARMA CANADA ULC,Lisdexamfetamine,LISDEXAMFETAMINE DIMESYLATE,10MG,Bottles of 100 capsules,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,2017-04-04,2017-04-04,2017-04-11,2017-04-12,Demand increase for the drug.,2017-04-06,2017-04-13
54721,2439603,Shortage,VYVANSE,SHIRE PHARMA CANADA ULC,Lisdexamfetamine Dimesylate capsules,LISDEXAMFETAMINE DIMESYLATE,10MG,100's,ORAL,Resolved,CAPSULE,N06BA,PSYCHOSTIMULANTS AND NOOTROPICS,,2018-07-06,2018-07-16,2018-07-13,Demand increase for the drug.,2018-07-06,2018-07-14
30976,2453703,Shortage,WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE,JAMP PHARMA CORPORATION,Acetaminophen/Codeine/Caffeine,ACETAMINOPHEN  CODEINE PHOSPHATE  CAFFEINE,300MG  8MG  15MG,100,ORAL,Actual shortage,TABLET,N02BE,OTHER ANALGESICS AND ANTIPYRETICS,,2017-11-27,2020-12-31,,Disruption of the manufacture of the drug.,2017-11-28,2019-03-01
31152,38245,Shortage,WATER FOR INJECTION STERILE USP,HOSPIRA HEALTHCARE CORPORATION,Sterile Water for Injection,WATER,100%,1000ML,INTRAVENOUS,Resolved,LIQUID,V07AB,ALL OTHER NON-THERAPEUTIC PRODUCTS,2017-12-20,,2018-01-08,2018-01-31,Disruption of the manufacture of the drug.,2017-11-29,2018-02-27
85235,2237825,Shortage,WELLBUTRIN SR,VALEANT CANADA LP/VALEANT CANADA S.E.C.,WELLBUTRIN SR,BUPROPION HYDROCHLORIDE,150MG,60,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-01,,,Shortage of an active ingredient.,2019-05-29,2019-06-07
68108,2275090,Shortage,WELLBUTRIN XL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,WELLBUTRIN XL,BUPROPION HYDROCHLORIDE,150MG,n/a,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2018-12-15,,,2018-12-20,Demand increase for the drug.,2018-11-29,2018-12-21
68111,2275104,Shortage,WELLBUTRIN XL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,WELLBUTRIN XL,BUPROPION HYDROCHLORIDE,300MG,n/a,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,2018-12-15,,,2018-12-20,Demand increase for the drug.,2018-11-29,2018-12-21
71880,2275090,Shortage,WELLBUTRIN XL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,WELLBUTRIN XL,BUPROPION HYDROCHLORIDE,150MG,90's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-03,,2019-04-02,Demand increase for the drug.,2019-01-10,2019-04-03
71883,2275104,Shortage,WELLBUTRIN XL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,WELLBUTRIN XL,BUPROPION HYDROCHLORIDE,300MG,90's,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-02-03,,2019-04-02,Demand increase for the drug.,2019-01-10,2019-04-03
61164,2275104,Shortage,WELLBUTRIN XL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,WELLBUTRIN XL,BUPROPION HYDROCHLORIDE,300MG,90s,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-12-13,,2018-12-20,Demand increase for the drug.,2018-09-10,2018-12-21
61167,2275090,Shortage,WELLBUTRIN XL,VALEANT CANADA LP/VALEANT CANADA S.E.C.,WELLBUTRIN XL,BUPROPION HYDROCHLORIDE,150MG,90s,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2018-11-28,,2018-12-20,Demand increase for the drug.,2018-09-10,2018-12-21
87576,723770,Shortage,XANAX TAB 1MG,PFIZER CANADA ULC,XANAX,ALPRAZOLAM,1MG,100's,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-07-24,2019-08-07,2019-08-07,Disruption of the manufacture of the drug.,2019-06-27,2019-08-08
57537,723770,Shortage,XANAX TAB 1MG,PFIZER CANADA INC,XANAX,ALPRAZOLAM,1MG,100's,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-07-19,,2018-09-04,Disruption of the manufacture of the drug.,2018-08-04,2018-09-05
73766,813958,Shortage,XANAX TS,PFIZER CANADA ULC,XANAX,ALPRAZOLAM,2MG,100's,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2019-02-01,,2019-02-08,Disruption of the manufacture of the drug.,2019-01-29,2019-02-09
65869,813958,Shortage,XANAX TS,PFIZER CANADA INC,XANAX,ALPRAZOLAM,2MG,100's,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-10-31,,2018-12-04,Disruption of the manufacture of the drug.,2018-10-30,2018-12-05
42916,813958,Shortage,XANAX TS,PFIZER CANADA INC,Xanax,ALPRAZOLAM,2MG,100's,ORAL,Resolved,TABLET,N05BA,ANXIOLYTICS,,2018-04-20,,2018-07-31,Disruption of the manufacture of the drug.,2018-03-14,2018-08-01
45574,2404044,Shortage,XERESE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,XERESE,ACYCLOVIR  HYDROCORTISONE,5%  1%,5g,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2018-05-02,,2018-06-04,Other (Please describe in comments),2018-04-12,2018-06-07
23233,2404044,Shortage,XERESE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,XERESE,ACYCLOVIR  HYDROCORTISONE,5%  1%,n/a,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017-10-31,,2018-02-28,2018-02-12,Other (Please describe in comments),2017-09-25,2018-02-13
3303,2404044,Shortage,XERESE,VALEANT CANADA LP/VALEANT CANADA S.E.C.,XERESE,ACYCLOVIR  HYDROCORTISONE,5%  1%,5G,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017-04-24,,2017-05-22,2017-05-24,Disruption of the manufacture of the drug.,2017-03-17,2017-05-25
66796,2388316,Shortage,XIAFLEX,ENDO VENTURES LTD,Collagenase Clostridium Histolyticum,Collagenase Clostridium Histolyticum,0.9MG,0.9mg,INTRALESIONAL,Resolved,POWDER FOR SOLUTION,M09AB,OTHER DRUGS FOR DISORD. OF THE MUSCULO-SKELET.SYST,2018-11-12,2018-11-12,2018-12-12,2018-12-05,Delay in shipping of the drug.,2018-11-13,2018-12-06
72331,2449943,Shortage,XIGDUO,ASTRAZENECA CANADA INC,dapagliflozin and metformin hydrochloride tablets,METFORMIN HYDROCHLORIDE  Dapagliflozin,1000MG  5MG,6 x 10 (blister),ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",2019-01-28,,2019-02-04,2019-04-12,Demand increase for the drug.,2019-01-15,2019-04-16
5445,2230837,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 5mg TABS 100,LOXAPINE,5MG,100 Tabs,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017-06-26,2017-06-26,,,Disruption of the manufacture of the drug.,2017-04-04,2018-12-22
5448,2230840,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 50mg TABS 100,LOXAPINE,50MG,100 Tabs,ORAL,Actual shortage,TABLET,N05AH,ANTIPSYCHOTICS,,2017-04-05,,,Disruption of the manufacture of the drug.,2017-04-04,2018-12-22
12630,2242868,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 2.5mg TABS 100,LOXAPINE,2.5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-08-16,2017-08-16,2017-08-16,2017-08-16,Delay in shipping of the drug.,2017-06-13,2017-10-05
17288,2230839,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 25mg TABS 100,LOXAPINE,25MG,100,ORAL,Avoided shortage,TABLET,N05AH,ANTIPSYCHOTICS,2017-09-02,2017-09-02,2017-09-07,2017-09-01,Disruption of the manufacture of the drug.,2017-07-26,2017-10-05
19370,2242868,Shortage,XYLAC,PENDOPHARM DIVISION OF DE PHARMASCIENCE INC,XYLAC 2.5mg TABS 100,LOXAPINE,2.5MG,100,ORAL,Resolved,TABLET,N05AH,ANTIPSYCHOTICS,2017-08-30,2017-08-30,2017-09-01,2017-09-01,Disruption of the manufacture of the drug.,2017-08-15,2017-10-05
32105,2372983,Shortage,XYLOCAINE 0.5%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 0.5% Plain 10x20mL SU Vial,LIDOCAINE HYDROCHLORIDE,5MG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-12-15,,,2017-12-18,Other (Please describe in comments),2017-12-08,2017-12-19
40980,1732,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% 50x2mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,10MG,50x2mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-01,,2018-03-16,2018-03-19,Other (Please describe in comments),2018-02-26,2018-09-04
32099,1732,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% Plain 50x5mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,10MG,50x5mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-12-19,2018-02-23,2018-02-26,Delay in shipping of the drug.,2017-12-08,2018-09-04
27313,1732,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% Plain 50x10mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,10MG,50x10mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-10-30,2018-03-16,2018-03-29,Other (Please describe in comments),2017-10-27,2018-09-04
44220,1791,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:100000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% w/epi.1:100M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,10MG  0.01MG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-04-15,,2018-06-11,2018-04-16,Delay in shipping of the drug.,2018-03-29,2018-04-26
26087,1791,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:100000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% w/epi.1:100M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,10MG  0.01MG,10,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2017-10-27,,2018-02-19,2018-02-26,Other (Please describe in comments),2017-10-16,2018-02-27
29702,1805,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% w/epi.1:200M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,10MG  5MCG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-11-15,2018-06-01,2018-06-01,Delay in shipping of the drug.,2017-11-20,2018-09-04
72785,2302438,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% Plain 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE,20MG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2019-01-18,2019-02-25,2019-02-21,Delay in shipping of the drug.,2019-01-17,2019-02-22
47236,36641,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% Plain 50x5mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,20MG,50 PE Amps,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-03-16,2018-07-02,2018-07-11,Delay in shipping of the drug.,2018-04-26,2018-07-12
41635,36641,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% Plain 50x2mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,20MG,50x2mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-03-02,2018-03-02,2018-03-16,2018-04-05,Other (Please describe in comments),2018-03-02,2018-04-26
36012,36641,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% Plain 50x2mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,20MG,50x2mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-12-22,2018-02-19,2018-02-15,Other (Please describe in comments),2018-01-16,2018-03-09
31972,36641,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% Plain 50x10mL SU Polyamp® Duofit®,LIDOCAINE HYDROCHLORIDE,20MG,50x10mL,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-12-06,2018-07-02,2018-07-09,Delay in shipping of the drug.,2017-12-07,2018-07-11
44214,284106,Shortage,XYLOCAINE 2% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% w/epi. 1:200M 10x20mL SU Vial,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  5MCG,10 vials,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-04-06,,2018-06-11,2018-06-22,Delay in shipping of the drug.,2018-03-29,2018-06-25
40923,284106,Shortage,XYLOCAINE 2% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,Xylocaine 2% w/epinephrine 1:200M 10x20mL SU Vials,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  5MCG,10,EPIDURAL,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2018-02-26,2018-02-26,2018-03-31,2018-03-06,Other (Please describe in comments),2018-02-26,2018-03-07
29705,2373130,Shortage,XYLOCAINE 2% WITH EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 2% w/epi.1:200M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.005MG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2017-11-15,2018-08-31,2018-08-31,Delay in shipping of the drug.,2017-11-20,2018-09-04
62231,2373130,Shortage,XYLOCAINE 2% WITH EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% w/epi.1:200M 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE  EPINEPHRINE,20MG  0.005MG,10 vials,BLOCK/INFILTRATION,Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2018-09-24,2018-10-01,2018-10-03,Other (Please describe in comments),2018-09-24,2018-10-09
32102,2003767,Shortage,XYLOCAINE ENDOTRACHEAL,ASPEN PHARMACARE CANADA INC.,"Xylocaine® Endo Spray 10mg, 1x50mL Bottle",LIDOCAINE,100MG,1 bottle,ORAL,Resolved,SOLUTION,R02AD,THROAT PREPARATIONS,,2017-10-23,,2018-01-05,Other (Please describe in comments),2017-12-08,2018-01-11
1053,1686,Shortage,XYLOCAINE VISCOUS 2%,ASTRAZENECA CANADA INC,lidocaine hydrochloride solution,LIDOCAINE HYDROCHLORIDE,20MG,1x100mL,ORAL  TOPICAL,Resolved,LIQUID,N01BB,"ANESTHETICS, LOCAL",2016-07-07,2016-07-07,,2018-09-24,Shortage of an inactive ingredient or component.,2017-03-13,2018-09-25
62228,1937,Shortage,XYLOCARD,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 100mg 10x5mL SU Glass Ampoule,LIDOCAINE HYDROCHLORIDE,100MG,10 amps,INTRAVENOUS,Resolved,SOLUTION,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2018-09-24,2018-10-15,2018-10-11,Delay in shipping of the drug.,2018-09-24,2018-10-12
71834,1937,Shortage,XYLOCARD,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 100mg 10x5mL SU Glass Ampoule,LIDOCAINE HYDROCHLORIDE,100MG,10,INTRAVENOUS,Resolved,SOLUTION,C01BB,"ANTIARRHYTHMICS, CLASS I AND III",,2019-01-08,2019-01-16,2019-01-15,Delay in shipping of the drug.,2019-01-10,2019-01-16
49534,2387433,Shortage,YAZ PLUS,BAYER INC,drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets,DROSPIRENONE  Levomefolate Calcium  ETHINYL ESTRADIOL,3.00MG  0.451MG  0.02MG,28's,ORAL,Resolved,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,2018-05-25,,2018-09-25,2018-09-12,Disruption of the manufacture of the drug.,2018-05-16,2018-09-13
1247,428833,Shortage,YF-VAX (YELLOW FEVER VACCINE),SANOFI PASTEUR LIMITED,Yellow Fever Vaccine,Yellow fever virus strain 17D-204,109648PFU,"5 x 0.5 mL dose vials with diluent / 5 fioles de 1 dose de 0,5 mL avec diluant",INTRAMUSCULAR,Actual shortage,POWDER FOR SOLUTION,J07BL,VIRAL VACCINES,,2019-08-22,2019-09-09,,Disruption of the manufacture of the drug.,2017-03-13,2019-09-05
85644,1985604,Shortage,YOHIMBINE-ODAN 6MG,ODAN LABORATORIES LTD,Yohimbine Hydrochloride Tablets,YOHIMBINE HYDROCHLORIDE,6MG,100,ORAL,Actual shortage,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2019-06-05,2020-02-28,,Shortage of an active ingredient.,2019-06-05,2019-10-22
558,2410788,Shortage,ZAMINE 21,APOTEX INC,ZAMINE,DROSPIRENONE  ETHINYL ESTRADIOL,3.0MG  0.030MG,21 BLS,ORAL,Actual shortage,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017-03-09,,,Disruption of the manufacture of the drug.,2017-03-11,2018-12-22
561,2410796,Shortage,ZAMINE 28,APOTEX INC,ZAMINE,DROSPIRENONE  ETHINYL ESTRADIOL,3.0MG  0.030MG,28 BLS,ORAL,Actual shortage,TABLET,G03AA,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,,2017-03-09,,,Disruption of the manufacture of the drug.,2017-03-11,2018-12-22
4364,622141,Shortage,ZANOSAR STERILE POWDER,PALADIN LABS INC,STREPTOZOCIN,STREPTOZOCIN,1G,1 vial,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,L01AD,ALKYLATINGAGENTS,,2014-01-01,,,Other (Please describe in comments),2017-03-27,2017-10-13
2745,2212331,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine tablets,RANITIDINE,150MG,100's,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-10-04,,,Shortage of an active ingredient.,2017-03-14,2017-10-13
2748,2212331,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine tablets,RANITIDINE,150MG,500's,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-11-08,,,Shortage of an active ingredient.,2017-03-15,2017-10-13
2751,2212366,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine injection,RANITIDINE,25MG,2mL x 10's,INTRAMUSCULAR  INTRAVENOUS,Actual shortage,SOLUTION,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2016-04-25,,,Shortage of an active ingredient.,2017-03-15,2017-10-13
2761,2212358,Shortage,ZANTAC,GLAXOSMITHKLINE INC,Ranitidine tablets,RANITIDINE,300MG,60's,ORAL,Actual shortage,TABLET,A02BA,DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD),,2017-04-19,,,Disruption of the manufacture of the drug.,2017-03-15,2018-12-22
94573,2298597,Shortage,ZELDOX,PFIZER CANADA ULC,Zeldox 20mg,ZIPRASIDONE,20.0MG,60's,ORAL,Actual shortage,CAPSULE,N05AE,ANTIPSYCHOTICS,,2019-09-23,2019-11-15,,Disruption of the manufacture of the drug.,2019-09-24,2019-10-31
3193,2108208,Shortage,ZEMURON,MERCK CANADA INC,ZEMURON Solution for Injection,ROCURONIUM BROMIDE,10MG,10 x 5 mL vials,INTRAVENOUS,Avoided shortage,SOLUTION,M03AC,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",2017-07-31,,,2017-07-14,Other (Please describe in comments),2017-03-17,2017-07-17
95790,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE  MOMETASONE FUROATE,5MCG  200MCG,120 dose,INHALATION,Actual shortage,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",2019-11-01,2019-11-01,2019-12-06,,Delay in shipping of the drug.,2019-10-09,2019-11-02
88399,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE  MOMETASONE FUROATE,5MCG  200MCG,60dose,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",2019-07-29,2019-07-18,2019-08-30,2019-08-09,Delay in shipping of the drug.,2019-07-03,2019-08-10
11366,2361752,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE  MOMETASONE FUROATE,5MCG  100MCG,60 & 120 dose,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",,2017-05-23,2017-06-05,2017-06-06,Other (Please describe in comments),2017-05-26,2017-06-07
11369,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE  MOMETASONE FUROATE,5MCG  200MCG,60 & 120 dose,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",,2017-05-23,2017-06-05,2017-06-06,Other (Please describe in comments),2017-05-26,2017-06-07
26770,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE  MOMETASONE FUROATE,5MCG  200MCG,60DOSE,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",2017-12-18,2017-12-18,2018-02-09,2018-01-30,Disruption of the manufacture of the drug.,2017-10-23,2018-01-31
5540,2361760,Shortage,ZENHALE,MERCK CANADA INC,mometasone furoate & formoterol fumarate dihydrate inhalation aerosol,FORMOTEROL FUMARATE DIHYDRATE  MOMETASONE FUROATE,5MCG  200MCG,120dose,INHALATION,Resolved,"AEROSOL, METERED DOSE",R03AK,"ADRENERGICS, INHALANTS",2017-04-10,2017-04-10,2017-04-12,2017-04-10,Delay in shipping of the drug.,2017-04-04,2017-10-10
55662,2216094,Shortage,ZERIT - CAP 20MG,BRISTOL-MYERS SQUIBB CANADA,STAVUDINE,STAVUDINE,20MG,1 BTL x 60,ORAL,Resolved,CAPSULE,J05AF,DIRECT ACTING ANTIVIRALS,2019-03-25,,2019-03-25,2019-03-28,Demand increase for the drug.,2018-07-13,2019-03-29
93576,2239162,Shortage,ZINCOFAX,PALADIN LABS INC,Zincofax Fragrance Free,WHITE PETROLATUM  ZINC OXIDE,69%  15%,50g,TOPICAL,Resolved,OINTMENT,D02AB,EMOLLIENTS AND PROTECTIVES,,2019-09-11,2019-10-24,2019-10-24,Delay in shipping of the drug.,2019-09-11,2019-10-25
98265,2239160,Shortage,ZINCOFAX EXTRA STRENGTH,PALADIN LABS INC,Zinc Oxide,WHITE PETROLATUM  ZINC OXIDE,47%  40%,100g,TOPICAL,Actual shortage,OINTMENT,D02AB,EMOLLIENTS AND PROTECTIVES,,2019-11-08,2019-12-04,,Delay in shipping of the drug.,2019-11-08,2019-11-09
2050,2153440,Shortage,ZINECARD,PFIZER CANADA INC,ZINECARD,DEXRAZOXANE,500MG,1 EACH / CHAQUE,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2016-12-15,2020-07-01,,Disruption of the manufacture of the drug.,2017-03-14,2018-03-07
38163,2153432,Shortage,ZINECARD,PFIZER CANADA INC,Zinecard 250mg,DEXRAZOXANE,250MG,25ml,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2018-04-25,,2018-06-05,Disruption of the manufacture of the drug.,2018-02-02,2018-06-06
75468,2153432,Shortage,ZINECARD,PFIZER CANADA ULC,Zinecard,DEXRAZOXANE,250MG,1x25mL vial,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,V03AF,ALL OTHER THERAPEUTIC PRODUCTS,,2019-02-12,,2019-09-09,Disruption of the manufacture of the drug.,2019-02-12,2019-09-10
47342,2212021,Shortage,ZITHROMAX,PFIZER CANADA INC,Zithromax,AZITHROMYCIN,250MG,3x6 TABS,ORAL,Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-04-25,,2018-07-23,Disruption of the manufacture of the drug.,2018-04-27,2018-07-24
1360,2223716,Shortage,ZITHROMAX - PWS ORL 100MG/5ML,PFIZER CANADA INC,ZITHROMAX,AZITHROMYCIN,100MG,BOTTLE/BOUTEILLE,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2017-01-20,2017-04-21,2017-04-20,Disruption of the manufacture of the drug.,2017-03-13,2017-04-21
33938,2223716,Shortage,ZITHROMAX - PWS ORL 100MG/5ML,PFIZER CANADA INC,Zithromax,AZITHROMYCIN,100MG,300mg/15mL,ORAL,Resolved,POWDER FOR SUSPENSION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2018-04-20,,2018-11-01,Disruption of the manufacture of the drug.,2017-12-20,2018-11-02
72813,2239952,Shortage,ZITHROMAX FOR INTRAVENOUS INJECTION,PFIZER CANADA ULC,ZITHROMAX,AZITHROMYCIN,500MG,10 x 5 mL,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2019-01-16,,2019-07-09,Demand increase for the drug.,2019-01-17,2019-07-10
58531,884359,Shortage,ZOCOR,MERCK CANADA INC,simvastatin tablets,SIMVASTATIN,40MG,28's,ORAL,Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2018-09-14,2018-09-12,2018-10-26,2018-10-26,Delay in shipping of the drug.,2018-08-20,2018-10-27
75937,2229639,Shortage,ZOFRAN,NOVARTIS PHARMACEUTICALS CANADA INC,ZOFRAN 4MG/5ML ORAL SOLN 50ML,ONDANSETRON,4MG,50ML,ORAL,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2019-02-25,2019-02-26,2019-04-08,2019-04-08,Demand increase for the drug.,2019-02-15,2019-04-09
40627,2213745,Shortage,ZOFRAN,NOVARTIS PHARMACEUTICALS CANADA INC,ZOFRAN INJ 8MG AMP 4ML 5'S,ONDANSETRON,2MG,5'S,INTRAVENOUS,Resolved,SOLUTION,A04AA,ANTIEMETICS AND ANTINAUSEANTS,2018-03-13,2018-03-15,2018-03-26,2018-04-04,Demand increase for the drug.,2018-02-22,2018-04-09
46754,2401606,Shortage,ZOLEDRONIC ACID - Z,SANDOZ CANADA INCORPORATED,ZOLEDRONIC ACID,ZOLEDRONIC ACID,4MG,5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-04-20,2018-10-12,2018-09-14,Delay in shipping of the drug.,2018-04-20,2018-09-30
36551,2401606,Shortage,ZOLEDRONIC ACID - Z,SANDOZ CANADA INCORPORATED,ZOLEDRONIC ACID,ZOLEDRONIC ACID,4MG,4MG/5ML VIAL,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,,2018-01-16,2018-01-30,2018-02-01,Requirements related to complying with good manufacturing practices.,2018-01-18,2018-02-05
2513,2401606,Shortage,ZOLEDRONIC ACID - Z,SANDOZ CANADA INCORPORATED,ZOLEDRONIC ACID,ZOLEDRONIC ACID,4MG,5mL fioles/vials,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2017-03-14,2017-03-17,2017-03-31,2017-05-15,Requirements related to complying with good manufacturing practices.,2017-03-14,2017-05-17
58307,2422425,Shortage,ZOLEDRONIC ACID FOR INJECTION CONCENTRATE,DR REDDYS LABORATORIES LTD,Zoledronic Acid for Injection,ZOLEDRONIC ACID,4MG,1 Vial per Carton,INTRAVENOUS,Resolved,SOLUTION,M05BA,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,2018-08-16,2018-08-16,2018-09-15,2018-09-15,Other (Please describe in comments),2018-08-17,2018-09-28
53020,2327619,Shortage,ZOLINZA,MERCK CANADA INC,vorinostat capsules,VORINOSTAT,100MG,120's,ORAL,Resolved,CAPSULE,L01XX,OTHER ANTINEOPLASTIC AGENTS,2018-07-03,2018-07-03,2018-08-03,2018-07-16,Delay in shipping of the drug.,2018-06-26,2018-07-17
84481,2379929,Shortage,ZOLMITRIPTAN,PRO DOC LIMITEE,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Actual shortage,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2019-05-21,,,Delay in shipping of the drug.,2019-05-21,2019-05-22
9738,2379929,Shortage,ZOLMITRIPTAN,PRO DOC LIMITEE,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET,N02CC,ANTIMIGRAINE PREPARATIONS,,2017-07-14,,2017-12-06,Delay in shipping of the drug.,2017-05-09,2017-12-07
62783,2442671,Shortage,ZOLMITRIPTAN ODT,SANIS HEALTH INC,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-10-01,2018-10-01,2018-10-26,2018-10-30,Disruption of the manufacture of the drug.,2018-10-01,2018-10-31
15518,2379988,Shortage,ZOLMITRIPTAN ODT,PRO DOC LIMITEE,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,6,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2017-07-12,,2019-01-09,Delay in shipping of the drug.,2017-07-12,2019-01-10
65698,2243045,Shortage,ZOMIG RAPIMELT,ASTRAZENECA CANADA INC,zolmitriptan,ZOLMITRIPTAN,2.5MG,6 tablets,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,2018-11-12,2018-11-12,2018-12-10,2018-12-09,Demand increase for the drug.,2018-10-29,2018-12-10
59864,2243045,Shortage,ZOMIG RAPIMELT,ASTRAZENECA CANADA INC,zolmitriptan,ZOLMITRIPTAN,2.5MG,6 tablets,ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),N02CC,ANTIMIGRAINE PREPARATIONS,,2018-09-03,2018-09-28,2018-09-27,Demand increase for the drug.,2018-09-04,2018-09-28
52998,2385848,Shortage,ZOPICLONE,SIVEM PHARMACEUTICALS ULC,ZOPICLONE,ZOPICLONE,7.5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-07-16,2018-07-20,,2018-08-31,Delay in shipping of the drug.,2018-06-26,2018-09-01
49431,2385848,Shortage,ZOPICLONE,SIVEM PHARMACEUTICALS ULC,ZOPICLONE,ZOPICLONE,7.5MG,500,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-06-25,2018-06-23,2018-08-24,2018-08-31,Other (Please describe in comments),2018-05-15,2018-09-01
49822,2385821,Shortage,ZOPICLONE,SIVEM PHARMACEUTICALS ULC,ZOPICLONE,ZOPICLONE,5MG,100,ORAL,Resolved,TABLET,N05CF,HYPNOTICS AND SEDATIVES,2018-07-02,2018-07-05,,2018-08-31,Other (Please describe in comments),2018-05-18,2018-09-11
5237,2375516,Shortage,ZOSTAVAX II,MERCK CANADA INC,"(zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection",VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED,19400PFU,1 Dose Vial,SUBCUTANEOUS,Avoided shortage,POWDER FOR SUSPENSION,J07BK,VIRAL VACCINES,2017-05-25,,2017-06-16,2017-05-17,Demand increase for the drug.,2017-04-03,2017-05-17
52797,886157,Shortage,ZOVIRAX,GLAXOSMITHKLINE INC,Acyclovir Oral Suspension,ACYCLOVIR,200MG,475 mL,ORAL,Resolved,SUSPENSION,J05AB,DIRECT ACTING ANTIVIRALS,,2018-08-07,2018-10-19,2018-10-10,Disruption of the manufacture of the drug.,2018-06-22,2018-10-12
45136,2039524,Shortage,ZOVIRAX,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZOVIRAX,ACYCLOVIR,5%,5g,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2018-05-22,,2018-08-01,Other (Please describe in comments),2018-04-06,2018-08-03
75180,886157,Shortage,ZOVIRAX,GLAXOSMITHKLINE INC,Acyclovir Oral Suspension,ACYCLOVIR,200MG,475 mL,ORAL,Resolved,SUSPENSION,J05AB,DIRECT ACTING ANTIVIRALS,,2019-03-05,2019-05-15,2019-04-08,Shortage of an active ingredient.,2019-02-08,2019-04-10
3200,2354772,Shortage,ZUACTA,SANOFI-AVENTIS CANADA INC,ZUACTA,ZUCAPSAICIN,0.075%,30G & 60G TUBES,TOPICAL,Actual shortage,CREAM,M02AB,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,,2016-03-29,,,Other (Please describe in comments),2017-03-17,2017-10-13
73394,2238441,Shortage,ZYBAN,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZYBAN,BUPROPION HYDROCHLORIDE,150MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),N06AX,ANTIDEPRESSANTS,,2019-01-17,,2019-02-18,Other (Please describe in comments),2019-01-23,2019-03-05
89896,2340445,Shortage,ZYCLARA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZYCLARA,IMIQUIMOD,3.75%,7.5g,TOPICAL,Avoided shortage,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2019-09-16,,,2019-09-15,Demand increase for the drug.,2019-07-24,2019-09-18
8343,2340445,Shortage,ZYCLARA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZYCLARA,IMIQUIMOD,3.75%,TOPICAL,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,2017-05-03,,2017-05-10,2017-05-10,Delay in shipping of the drug.,2017-04-28,2017-05-12
21685,2340445,Shortage,ZYCLARA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZYCLARA,IMIQUIMOD,3.75%,na,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2017-09-08,2017-09-22,2017-09-22,Other (Please describe in comments),2017-09-08,2017-09-25
52702,2340445,Shortage,ZYCLARA,VALEANT CANADA LP/VALEANT CANADA S.E.C.,ZYCLARA,IMIQUIMOD,3.75%,7.5g pump,TOPICAL,Resolved,CREAM,D06BB,CHEMOTHERAPEUTICS FOR TOPICAL USE,,2019-04-01,,2019-07-12,Other (Please describe in comments),2018-06-20,2019-07-13
18241,2257270,Shortage,ZYMAR,ALLERGAN INC,ZYMAR 1mL,GATIFLOXACIN,0.3%,1 mL,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,2017-08-03,2017-08-03,2017-09-18,2017-10-06,Disruption of the manufacture of the drug.,2017-08-03,2017-10-13
33440,2257270,Shortage,ZYMAR,ALLERGAN INC,ZYMAR 1mL,GATIFLOXACIN,0.3%,5mL,OPHTHALMIC,Resolved,SOLUTION,S01AE,ANTIINFECTIVES,2019-09-16,2019-09-16,2019-09-20,2019-09-18,Disruption of the manufacture of the drug.,2017-12-18,2019-09-19
54338,2243686,Shortage,ZYVOXAM,PFIZER CANADA INC,Zyvoxam,LINEZOLID,3G,1x240ml Btl,ORAL,Resolved,POWDER FOR SUSPENSION,J01XX,OTHER ANTIBACTERIALS,,2018-08-21,,2018-10-23,Disruption of the manufacture of the drug.,2018-07-04,2018-10-24
14132,2243684,Shortage,ZYVOXAM 600 MG,PFIZER CANADA INC,Zyvoxam,LINEZOLID,600MG,20,ORAL,Avoided shortage,TABLET,J01XX,OTHER ANTIBACTERIALS,2017-07-28,,2017-07-24,2017-07-24,Disruption of the manufacture of the drug.,2017-06-27,2017-07-24